,assay_id,doi,year,volume,issue,assay_description,compound_smiles,compound_name,value,unit,relation,log_value,classification_label,scaffold_smiles
0,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3ccc(OCCNC(=O)CCc4ccc(F)c(F)c4)cc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-7-yloxy)ethyl)-3-(3,4-difluorophenyl)propanamide",0.327,uM,=,-0.4854522473397139,0,O=C(CCc1ccccc1)NCCOc1ccc2cc(-c3ccc(CNCc4ccccc4)cc3)c(=O)oc2c1
1,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1c2c(nc3nc(-c4ccccc4)cc(C(F)(F)F)c13)-c1ccccc1C2,"2-Phenyl-4-(trifluoromethyl)-6H-indeno[1,2-b][1,8]-naphthyridin-5-amine",17.56,uM,=,1.2445245115700838,1,c1ccc(-c2ccc3cc4c(nc3n2)-c2ccccc2C4)cc1
2,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-],"{4-[Bis-(4-dimethylamino-phenyl)-methylene]-cyclohexa-2,5-dienylidene}-dimethyl-ammonium chloride",5.847,uM,=,0.7669330938372839,1,[N+]=C1C=CC(=C(c2ccccc2)c2ccccc2)C=C1
3,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CC(C)NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"(S)-5-Isopropylcarbamoyloxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",35.0,uM,=,1.5440680443502757,1,c1ccc2c(c1)NC1NCCC21
4,513727,10.1016/j.bmc.2008.07.009,,,,Inhibition of AchE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.5,uM,=,-0.3010299956639812,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,O=C(O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethoxy)thiazole-5-carboxylic acid",0.58,uM,=,-0.2365720064370627,0,O=C(Nc1cc(-c2nc(OCCNc3c4c(nc5ccccc35)CCCC4)cs2)ccn1)C1CC1
6,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccccc4C(F)(F)F)CC3)sc2-c2ccc(C)cc2)cc1,"1-(2-Trifluoromethylbenzyl)-N-[4,5-bis(p-tolyl)thiazol-2-yl]-piperidine-4-carboxamide",7.57,uM,=,0.8790958795000727,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
7,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)N2CCN(c3ccc(F)cc3)CC2)ccc1O,(E)-1-(4-(4-fluorophenyl)piperazin-1-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one,11.04,uM,=,1.04296907339318,1,O=C(/C=C/c1ccccc1)N1CCN(c2ccccc2)CC1
8,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,COC(=O)C(CC1=NO[C@@H]2CCC[C@@H]2[C@H]1c1ccccc1)C(=O)OC,"dimethyl 2-(((4S,4aS)-4-phenyl-4,4a,5,6,7,7a-hexahydrocyclopenta[e][1,2]oxazin-3-yl)methyl)malonate",75.35,uM,=,1.8770832566506503,1,C1=NO[C@@H]2CCC[C@@H]2[C@H]1c1ccccc1
9,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Oc1ccccc1CNC1CCN(Cc2ccccc2)C1,2-(((1-Benzylpyrrolidin-3-yl)amino)methyl)phenol,2.258,uM,=,0.353723937588949,1,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
10,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,O/N=C/c1cc(Cl)cc(CNc2ccc(-n3cccn3)cc2)c1O,(E)-3-((4-(1H-pyrazol-1-yl)phenylamino)methyl)-5-chloro-2-hydroxybenzaldehyde oxime,3035.0,uM,=,3.482158695411276,1,c1ccc(CNc2ccc(-n3cccn3)cc2)cc1
11,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,CC(C)=CCC/C(C)=C/Cc1c(O)cc2c(c1O)C(=O)C[C@@H](c1ccc(O)cc1)O2,bonannione A,91.5,uM,=,1.9614210940664485,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
12,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,O=C(CCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NCCc1cc2ccccc2[nH]1,"N-(2-(1H-indol-2-yl)ethyl)-6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexanamide",0.00073,uM,=,-3.136677139879544,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1cc2ccccc2[nH]1
13,1641224,,,,,AChE/BuChE Inhibition Assay: The cholinesterase assays were performed using colorimetric method reported by Ellman. The appearance of product was monitored at 412 nm for 5 min using a spectrophotometer. The reaction rates were compared and the percent inhibition due to the presence of test compounds was calculated. Inhibition curve was obtained for each compound. The linear regression parameters were determined and the IC50 values extrapolated.,O=[N+]([O-])c1ccc2nc(NCCc3cc[n+](Cc4ccc(F)cc4)cc3)sc2c1,"US9255091, 4e",0.096,uM,=,-1.0177287669604316,0,c1ccc(C[n+]2ccc(CCNc3nc4ccccc4s3)cc2)cc1
14,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,COc1ccc(-c2cc3cc(OCCCN(C)Cc4cccc(OC(=O)NCCCCCc5ccccc5)c4)ccc3oc2=O)cc1,3-(((3-((3-(4-Methoxyphenyl)-2-oxo-2H-chromen-6-yl)oxy)propyl)(methyl)amino)methyl)phenyl(5-Phenylpentyl)carbamate,0.179,uM,=,-0.7471469690201069,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3oc(=O)c(-c4ccccc4)cc3c2)c1
15,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,COc1ccc(CSS(=O)(=O)c2ccc(C)cc2)cc1,S-4-methoxybenzyl 4-methylbenzenthiosulfonate,0.4881999999999999,uM,=,-0.3114022249188302,0,O=S(=O)(SCc1ccccc1)c1ccccc1
16,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,O=C(NCCCCCc1ccccc1)Oc1cccc(-n2cc(COc3ccc4ccc(=O)oc4c3)nn2)c1,"3-(4-(((2-Oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)phenyl(5-Phenylpentyl)carbamate",1.175,uM,=,0.0700378666077551,1,O=C(NCCCCCc1ccccc1)Oc1cccc(-n2cc(COc3ccc4ccc(=O)oc4c3)nn2)c1
17,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(C)Cc1ccc(C(=O)CC(Sc2ccccc2N)c2cccc([N+](=O)[O-])c2)cc1,3-(2-Amino-phenylsulfanyl)-1-(4-isobutyl-phenyl)-3-(3-nitro-phenyl)-propan-1-one,1.3,uM,=,0.1139433523068367,1,O=C(CC(Sc1ccccc1)c1ccccc1)c1ccccc1
18,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1ccc(CN2CCN(C(=O)/C=C/c3ccc(O)c(OC)c3)CC2)cc1,(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-(4-methoxybenzyl)piperazin-1-yl)prop-2-en-1-one,16.39,uM,=,1.2145789535704992,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
19,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccccc2F)C(=O)[C@@]2(C1)[C@H](c1ccccc1F)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(2-fluorophenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(2-fluorophenylmethylidene)-1''-N-acrolylpiperidin-4''-one,6.88,uM,=,0.8375884382355113,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
20,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,CC(=O)c1c(-c2ccc(OCCCCCCCN(C)Cc3ccccc3)cc2)oc2ccccc12,1-(2-{4-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)ethanone,17.4,uM,=,1.2405492482825995,1,c1ccc(CNCCCCCCCOc2ccc(-c3cc4ccccc4o3)cc2)cc1
21,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)-c1ccccc1C2,"11H-Indeno[1,2-b]quinolin-10-ylamine",0.35,uM,=,-0.4559319556497244,0,c1ccc2c(c1)Cc1cc3ccccc3nc1-2
22,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,COc1ccc2c(c1)c(CC(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc3c(C)n(C(=O)c4ccc(Cl)cc4)c4ccc(OC)cc34)=CC1=O)c(C)n2C(=O)c1ccc(Cl)cc1,"N,N'-(3,3'-(3,3'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)bis(propane-3,1-diyl))bis(azanediyl)bis(propane-3,1-diyl))bis(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetamide)",10.3,uM,=,1.0128372247051722,1,O=C(Cc1cn(C(=O)c2ccccc2)c2ccccc12)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2cn(C(=O)c3ccccc3)c3ccccc23)=CC1=O
23,1702964,10.1016/j.ejmech.2017.04.054,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"N-(6-(ethyl(2-methoxybenzyl)amino)hexyl)-2-(4-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",1.25,uM,=,0.0969100130080564,1,O=C(COc1ccc(-c2cc(=O)c3ccccc3o2)cc1)NCCCCCCNCc1ccccc1
24,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccc(Cl)cc32)cc1OC,"2-Chloro-10H-phenoselenazin-10-yl-(3,4-dimethoxyphenyl)-methanone",6.2,uM,=,0.7923916894982539,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
25,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",8.4,uM,=,0.9242792860618816,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
26,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OC(C)c1ccccc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(methylbenzyl)berberine bromide,0.79,uM,=,-0.1023729087095585,0,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
27,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccc(F)cc2)c2ccccc12,1-Benzyl-3-[1-(4-fluoro-benzoyl)-1H-indol-3-ylmethylene]-piperidin-4-one,60.0,uM,=,1.7781512503836436,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12
28,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc(Br)cc2)ccc1O,(E)-N-(2-((4-bromophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,10.24,uM,=,1.010299956639812,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
29,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,CN1CCc2c(c3ccccc3n2CCC(=O)N2c3ccccc3Sc3ccccc32)C1,"3-(2-Methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indole-5-yl)-1-(10H-phenothiazine-10-yl)propane-1-one",7.8,uM,=,0.8920946026904804,1,O=C(CCn1c2c(c3ccccc31)CNCC2)N1c2ccccc2Sc2ccccc21
30,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@H](C1)C2.Cl.Cl.Cl,"(-)-(7S,11S)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-({7-[(1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}amino)-7,11-methanocycloocta[b]quinoline Dihydrochloride",0.00133,uM,=,-2.876148359032914,0,C1=C[C@@H]2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@H](C1)C2
31,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cn[nH]c2-c2c(Br)sc(Br)c21,"N-(5,7-Dibromo-1,4-dihydrothieno[3',4':4,5]cyclopenta[1,2-c]pyrazol-4-yl)-2-(4-benzylpiperazine)acetamide",1.13,uM,=,0.0530784434834196,1,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cscc2-c2[nH]ncc21
32,1278097,10.1016/j.bmcl.2013.10.034,,,,Inhibition of human AChE using acetylthiocholine chloride as substrate preincubated for 15 mins by Ellman's method,O=c1c2ccccc2[se]n1CCCCCCNc1c2c(nc3ccccc13)CCCC2,"2-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)benzo[d][1,2]selenazol-3(2H)-one",0.01952,uM,=,-1.709520186669327,0,O=c1c2ccccc2[se]n1CCCCCCNc1c2c(nc3ccccc13)CCCC2
33,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](C[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,1-bis(4-tert.butylpyridinium)-meth-1,1-diyl dibromide",20.0,uM,=,1.3010299956639813,1,c1cc[n+](C[n+]2ccccc2)cc1
34,1783503,10.1016/j.ejmech.2018.01.007,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(Cc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-2-(1H-indol-3-yl)-acetamide,3.55,uM,=,0.5502283530550941,1,O=C(Cc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
35,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,"N-(4-((3,4-dimethoxybenzyl)amino)quinazolin-2-yl)acetamide",8.5,uM,=,0.9294189257142929,1,c1ccc(CNc2ncnc3ccccc23)cc1
36,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc3[nH]ccc3c2)ccc1O,(E)-N-(2-((1H-indol-5-yl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,5.74,uM,=,0.7589118923979735,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccc2[nH]ccc2c1
37,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),CN(C)CCNC(=O)COc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1.Cl,N-(2-(dimethylamino)ethyl)-2-((5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)acetamide hydrochloride,2.75,uM,=,0.4393326938302626,1,O=c1c(-c2ccccc2)coc2ccccc12
38,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccccc3Cl)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-1-(2-chlorobenzyl)-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium bromide",0.0295,uM,=,-1.530177984021837,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
39,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,"N4-(3,4-dimethoxybenzyl)-N2-methylquinazoline-2,4-diamine",7.3,uM,=,0.8633228601204559,1,c1ccc(CNc2ncnc3ccccc23)cc1
40,1852480,10.1016/j.ejmech.2019.05.020,,,,Irreversible inhibition of AChE (unknown origin),C#CCN(C)Cc1ccc(O)c2ncccc12,5-((methyl(prop-2-ynyl)amino)methyl)quinolin-8-ol,1.8,uM,=,0.255272505103306,1,c1ccc2ncccc2c1
41,1655449,10.1016/j.ejmech.2016.10.060,,,,Inhibition of human AchE-induced amyloid beta (1 to 40) aggregation after 48 hrs by thioflavin T fluorescence spectroscopic method,O=C(CCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(8-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.253,uM,=,-0.5968794788241821,0,O=C(CCCC1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2
42,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,COC(=O)CC1=NO[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2[C@H]1c1ccccc1,"((S)-(R)-6-Phenyl-3-oxa-4-aza-tricyclo[6.2.1.0*2,7*]undec-4-en-5-yl)-acetic acid (R)-methyl ester",6.3,uM,=,0.7993405494535817,1,C1=NO[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2[C@H]1c1ccccc1
43,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O,"5,7-Dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-chroman-4-one",2476.1,uM,=,3.393768180158745,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
44,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCCCC[n+]1ccn(COC)c1/C=N/O.[Cl-],1-Hex-5-ynyl-2-(hydroxyimino-methyl)-3-methoxymethyl-3H-imidazol-1-ium chloride,185.0,uM,=,2.2671717284030137,1,c1c[nH+]c[nH]1
45,1827463,10.1016/j.ejmech.2018.10.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by Ellman's method,Cc1c(C)c2ccc(OCC3CCN(Cc4cccc(OCCCO[N+](=O)[O-])c4)CC3)cc2oc1=O,"3-{3-[(4-{[(3,4-Dimethyl-2-oxo-2H-chromen-7-yl)oxy]methyl}piperidin-1-yl)methyl]phenoxy}propyl nitrate",0.48,uM,=,-0.3187587626244128,0,O=c1ccc2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2o1
46,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1F,"2-(5-(2-Fluorobenzylamino)pentyl)isoindoline-1,3-dione",0.168,uM,=,-0.7746907182741372,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
47,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,O=C(NCCCCCCNCc1ccc2ccccc2c1)c1cc(Cl)nc(Cl)c1,"2,6-Dichloro-N-(6-((naphthalen-2-ylmethyl)amino)hexyl)isonicotinamide",99.7,uM,=,1.998695158311656,1,O=C(NCCCCCCNCc1ccc2ccccc2c1)c1ccncc1
48,969870,10.1016/j.bmcl.2013.05.092,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,"3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione",6.6,uM,=,0.8195439355418687,1,O=c1[nH]c(=O)c2[nH]cnc2[nH]1
49,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNc1ccc(NCCCCCCN(CC)Cc2ccccc2OC)cc1)Cc1ccccc1OC,"N,N'-bis{6-[ethyl(2-methoxybenzyl)amino]hexyl}benzene-1,4-diamine",0.0425,uM,=,-1.3716110699496884,0,c1ccc(CNCCCCCCNc2ccc(NCCCCCCNCc3ccccc3)cc2)cc1
50,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(-c4ccccc4)cc3)C2)c(OC)c1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1128.0,uM,=,3.0523090996473234,1,c1ccc(C2=NNC(c3ccc(-c4ccccc4)cc3)C2)cc1
51,1673532,10.1021/acs.jmedchem.7b01760,,,,Inhibition of human erythrocyte AChE using ATC iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.0185,uM,=,-1.7328282715969865,0,c1ccc2nc3c(cc2c1)CCCC3
52,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CN(CCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NCCCCCCc2ccccc2)c1,3-((Methyl(3-((2-oxo-2H-chromen-7-yl)oxy)propyl)amino)-methyl)phenyl(6-Phenylhexyl)carbamate,0.109,uM,=,-0.9625735020593764,0,O=C(NCCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3ccc(=O)oc3c2)c1
53,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-Amino-3-(1H-indol-3-yl)-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)propanamide",0.0963,uM,=,-1.0163737128754655,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
54,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCNC1N2C,"Methyl-carbamic acid 3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.021,uM,=,-1.6777807052660807,0,c1ccc2c(c1)NC1NCCC21
55,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1nc2ccc(C(=O)CCC3CCN(Cc4ccccc4)CC3)cc2s1,3-(1-benzylpiperidin-4-yl)-1-(2-methylbenzo[d]thiazol-6-yl)propan-1-one,0.0068,uM,=,-2.167491087293764,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2ncsc2c1
56,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12,3-(4-(4-Benzylpiperidin-1-yl)butoxy)-6H-benzo[c]chromen-6-one,14.2,uM,=,1.1522883443830565,1,O=c1oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12
57,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNC(=O)Oc1ccc2c(c1)C1CCN(CCC)C1C2,"1-propyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl heptylcarbamate",0.629,uM,=,-0.201349354554731,0,c1ccc2c(c1)CC1NCCC21
58,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,CCn1c(C)nc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21.Cl,3-(1-Benzyl-piperidin-4-yl)-1-(1-ethyl-2-methyl-1H-benzoimidazol-5-yl)-propan-1-one hydrochloride,0.0043,uM,=,-2.3665315444204134,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]cnc2c1
59,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,Clc1ccc2c(NCCCCCCCOc3ccc(-c4cc5ccccc5o4)cc3)c3c(nc2c1)CCCC3,"[7-(4-Benzofuran-2-yl-phenoxy)heptyl]-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amine",0.31,uM,=,-0.5086383061657274,0,c1ccc2oc(-c3ccc(OCCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3)cc2c1
60,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc(/C=C/c2cc(=O)oc3c2ccc2oc(-c4ccccc4)cc23)cc(OC)c1,"4-(3,5-dimethoxystyryl)-8-phenyl-2H-furo[2,3-h]chromen-2-one",1.8,uM,=,0.255272505103306,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
61,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4cccc(Cl)c4)[nH]3)ccc21,"(S)-3-{5-[5-(3-Chlorophenyl)-4H-1,2,4-triazol-3-yl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",412.56,uM,=,2.6154871183986583,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
62,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1,N-benzyl-2-(piperazin-1-yl)pyrimidin-4-amine,15.5,uM,=,1.1903316981702914,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
63,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=c1c(-c2ccc(OCCCCN3CCC(Cc4ccccc4)CC3)cc2)coc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)cc(O)c12,7-(4-(4-benzylpiperidin-1-yl)butoxy)-3-(4-(4-(4-benzylpiperidin-1-yl)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one,7.3,uM,=,0.8633228601204559,1,O=c1c(-c2ccc(OCCCCN3CCC(Cc4ccccc4)CC3)cc2)coc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc12
64,1635360,10.1016/j.ejmech.2016.09.078,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,O=C1c2ccccc2S(=O)(=O)N1CCCCCNCc1ccccc1,"2-(5-Benzylamino-pentyl)-1,1-dioxo-1,2-dihydro-1lambda'6-benzo[d]isothiazol-3-one",0.033,uM,=,-1.4814860601221125,0,O=C1c2ccccc2S(=O)(=O)N1CCCCCNCc1ccccc1
65,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCCCCCC[n+]1cccc2ccccc21,"1,9-di(1-quinoliniumyl)nonane; dibromide",0.08,uM,=,-1.0969100130080565,0,c1ccc2c(c1)ccc[n+]2CCCCCCCCC[n+]1cccc2ccccc21
66,1507558,10.1016/j.bmcl.2015.05.002,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CN(Cc1ccccc1)Cc1ccc(/C=C2\CCc3cc(OCCCCCN4CCN(Cc5ccc(F)cc5)CC4)ccc3C2=O)cc1,"(E)-2-(4-((benzylmethylamino)methyl)benzylidene)-6-((5-(4-(4-fluorobenzyl)piperazin-1-yl)pentyl)oxy)-3,4-dihydronaphthalen-1(2H)-one",7.83,uM,=,0.8937617620579434,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)CCc2cc(OCCCCCN3CCN(Cc4ccccc4)CC3)ccc21
67,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C[C@H](CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC3=O)C(=O)O,ganoderic acid E,18.35,uM,=,1.2636360685881085,1,O=C1CCC2C3=C(C(=O)C[C@H]2C1)C1C(=O)CCC1CC3=O
68,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(O)c(C(=O)/C=C/c2ccc(F)cc2)cc1I,3-(4-fluorophenyl)-1-(2-hydroxy-5-iodo-4-methoxyphenyl)prop-2-en-1-one,0.00938,uM,=,-2.027797161620936,0,O=C(/C=C/c1ccccc1)c1ccccc1
69,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{7-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.00699,uM,=,-2.1555228242543185,0,O=C(CC1CCc2cc(OCc3ccccc3)ccc2O1)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
70,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCOc2cccc(Cc3ccccc3)c2)c1.Cl,Methyl-carbamic acid 3-({[3-(3-benzyl-phenoxy)-propyl]-methyl-amino}-methyl)-phenyl ester hydrochloride,0.0247,uM,=,-1.6073030467403342,0,c1ccc(CNCCCOc2cccc(Cc3ccccc3)c2)cc1
71,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCNC(=O)Oc1ccc2c(c1)C1CCN(CC)C1C2,"1-ethyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl propylcarbamate",2.192,uM,=,0.3408405498123316,1,c1ccc2c(c1)CC1NCCC21
72,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1ccc2c(c1)CC(Cc1cc[n+](Cc3ccccc3C)cc1C(C)=O)C2=O.[Br-],(+/-)-2-[[3-Acetyl-1-(o-tolylmethyl)pyridin-1-ium-4-yl]methyl]-5-methoxy-indan-1-one Bromide,0.03,uM,=,-1.5228787452803376,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
73,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CN(C)Cc1ccc(CSCCCCCCCSCc2ccc(CN(C)C)o2)o1,{5-[7-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-heptylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.61,uM,=,-0.2146701649892329,0,c1coc(CSCCCCCCCSCc2ccco2)c1
74,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCNCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-N'-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]octane-1,8-diamine",0.0001199999999999,uM,=,-3.9208187539523753,0,c1ccc2c(c1)CCC(CCNCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2
75,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCC(O)(Cc4ccccc4)CC3)cc1)NCC2,"4-benzyl-1-(6-(4-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)phenoxy)hexyl)piperidin-4-ol",39.63,uM,=,1.5980240723341896,1,c1ccc(CC2CCN(CCCCCCOc3ccc(CC4NCCc5ccccc54)cc3)CC2)cc1
76,28629,10.1021/jm981101z,,,,Inhibitory concentration against acetylcholinesterase (AChE) from human erythrocytes,Cl.c1ccc(-c2ccc(NCCCCCN3CCc4ccccc4C3)nn2)cc1,"[5-(3,4-Dihydro-1H-isoquinolin-2-yl)-pentyl]-(6-phenyl-pyridazin-3-yl)-amine hydrochloride",47.0,uM,=,1.6720978579357175,1,c1ccc(-c2ccc(NCCCCCN3CCc4ccccc4C3)nn2)cc1
77,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=c1ccc2cc(/N=C/c3ccc(Br)cc3)ccc2o1,6-[(4-Bromobenzylidene)amino]-2H-chromen-2-one,0.0569,uM,=,-1.2448877336049289,0,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1
78,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(C=C2Cc3ccc(OC)cc3C2=O)cc1,2-[[4-(diethylaminomethyl)phenyl]methylene]-6-methoxy-indan-1-one,1.1,uM,=,0.041392685158225,1,O=C1C(=Cc2ccccc2)Cc2ccccc21
79,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CC1c2ccccc2CCN1CCCCOc1ccc(-c2coc3cc(OCCCCN4CCc5ccccc5C4C)cc(O)c3c2=O)cc1,"5-hydroxy-7-(4-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)butoxy)-3-(4-(4-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)butoxy)phenyl)-4H-chromen-4-one",5.3,uM,=,0.724275869600789,1,O=c1c(-c2ccc(OCCCCN3CCc4ccccc4C3)cc2)coc2cc(OCCCCN3CCc4ccccc4C3)ccc12
80,513727,10.1016/j.bmc.2008.07.009,,,,Inhibition of AchE,Oc1cccc(C2=Nc3ccccc3SC(c3cccc(O)c3)C2)c1,"2-(3''-Hydroxyphenyl)-4-(3'-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepine",71.1,uM,=,1.8518696007297664,1,c1ccc(C2=Nc3ccccc3SC(c3ccccc3)C2)cc1
81,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,Galanthamine hydrogenbromide,2.6,uM,=,0.414973347970818,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
82,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(O)c4ncccc34)CC1)C2,"2-((1-((8-hydroxyquinolin-5-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",20.9,uM,=,1.320146286111054,1,O=C1c2ccccc2CC1CC1CCN(Cc2cccc3ncccc23)CC1
83,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN(C)Cc3cccc([N+](=O)[O-])c3)cc2)cc1OC,"(3,4-Dimethoxyphenyl)-(4-{[methyl-(3-nitrobenzyl)amino]methyl}phenyl)methanone",4.27,uM,=,0.6304278750250238,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
84,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)C12,"Phenyl-carbamic acid (S)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.35,uM,=,-0.4559319556497244,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
85,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,N#CC1=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C([N+](=O)[O-])C12c1ccccc1-c1nc3ccccc3nc12,"2'-amino-1'-benzyl-6'-(benzylamino)-5'-nitro-1'H-spiro[indeno[1,2-b]quinoxaline-11,4'-pyridine]-3'-carbonitrile",5.3,uM,=,0.724275869600789,1,C1=CC2(C=C(NCc3ccccc3)N1Cc1ccccc1)c1ccccc1-c1nc3ccccc3nc12
86,2215315,10.1016/j.bmc.2022.116742,,,,Inhibition of AChE (unknown origin) by spectrophotometric based Ellman's method,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H]1O)c1cc(O)c(O)c(O)c1,"1,2,3,6-tetra-O-galloyl-beta-D-glucose",11.86,uM,=,1.0740846890282438,1,O=C(OC[C@@H]1C[C@H](OC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)O1)c1ccccc1
87,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(7-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)-3-(5-phenyl-3,4-dihydro-2H-pyrano[3,2-c]quinolin-9-yl)propanamide",0.0114,uM,=,-1.9430951486635275,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
88,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2ccc(F)c(F)c2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1,"5-(2-(Cyclopropanecarboxamido)isonicotinamido)-N-((1-(3,4-difluorobenzyl)piperidin-4-yl)methyl)nicotinamide",3.067,uM,=,0.4867137759824854,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
89,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccc2c(=O)cc(-c3ccc(CN(C)Cc4ccccc4)cc3)oc2c1,2-{4-[(benzylmethylamino)methyl]phenyl}-7-methoxychromen-4-one,80.5,uM,=,1.9057958803678683,1,O=c1cc(-c2ccc(CNCc3ccccc3)cc2)oc2ccccc12
90,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC,Gallamine,2110.0,uM,=,3.3242824552976926,1,c1ccccc1
91,410400,10.1021/jm060945c,,,,Inhibition of human erythrocyte AChE,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2N,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2,4(9),5,7,10,14-hexaene-3,17-diamine",0.225,uM,=,-0.6478174818886375,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
92,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1cccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-{7-[(3-methoxybenzyl)methylamino]heptyloxy}xanthen-9-one,40.0,uM,=,1.6020599913279625,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
93,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,O=C(/C=C/c1ccc(F)cc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-fluorophenyl)acrylamide,3.3,uM,=,0.5185139398778875,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
94,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2cc(=O)c3ccc(OCCN4CCN(CCO)CC4)cc3o2)cc1,7-(2-(4-(2-hydroxyethyl)piperazin-1-yl)ethoxy)-2-(4-methoxyphenyl)-4H-chromen-4-one,0.00756,uM,=,-2.1214782044987937,0,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCNCC3)ccc12
95,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1cc(OCC[N+](CC)(CC)CC)c(C(=O)NCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc1OCC[N+](CC)(CC)CC.Cl.[Br-].[Br-].[Br-],"N,N,N-triethyl-2-(5-(((6-(2-(1,2,3,4-tetrahydroacridin-9-yl)-hydrazino)-6-oxohexyl)amino)carbonyl)-2,3-bis((2-triethylammonio)ethoxy)phenoxy)ethanammonium tribromide hydrochloride",1480.0,uM,=,3.170261715394957,1,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
96,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)-c1ccccc1CC2,"5,6-Dihydro-benzo[c]acridin-7-ylamine",37.0,uM,=,1.568201724066995,1,c1ccc2c(c1)CCc1cc3ccccc3nc1-2
97,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,CN1CCN(c2cccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)c2)CC1,"3-(3-(4-Methylpiperazin-1-yl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carbonitrile",4.77,uM,=,0.6785183790401139,1,c1cc(-c2cnc3[nH]c4cnccc4c3c2)cc(N2CCNCC2)c1
98,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CN(C)C(=O)Oc1cccc2c1cc(C(=O)Nc1ccccc1)c[n+]2C.[I-],"[1-Methyl-3-(phenylcarbamoyl)quinolin-1-ium-5-yl]-N,N-dimethylcarbamate iodide",0.03,uM,=,-1.5228787452803376,0,O=C(Nc1ccccc1)c1c[nH+]c2ccccc2c1
99,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(Cl)cc2)C[C@@H](c2ccc(C)cc2)N(c2ccc(Cl)cc2)[C@@H]1c1ccc(C)cc1,"(2R,6S)-methyl 1-(4-chlorophenyl)-4-(4-chlorophenylamino)-2,6-dip-tolyl-1,2,5,6-tetrahydropyridine-3-carboxylate",2150.0,uM,=,3.3324384599156054,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
100,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1ccc(O)c(OC)c1)c1ccc(=O)[nH]c1C2,"(1R,9R)-13-Eth-(E)-ylidene-1-{[1-(4-hydroxy-3-methoxy-phenyl)-methylidene]-amino}-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.016,uM,=,-1.7958800173440752,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
101,466877,10.1021/jm070154q,,,,Inhibition of human recombinant AChE-induced amyloid beta aggregation by thioflavin T fluorescence method,CC[C@@]1(c2cccc(O)c2)CCCCN(CCCCCCCCCN2CCCC[C@@](CC)(c3cccc(O)c3)C2)C1,"N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP",16.6,uM,=,1.2201080880400552,1,c1ccc(C2CCCCN(CCCCCCCCCN3CCCCC(c4ccccc4)C3)C2)cc1
102,1702964,10.1016/j.ejmech.2017.04.054,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"N-(6-(ethyl(2-methoxybenzyl)amino)hexyl)-2-(4-(5-hydroxy-6,7-dimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",1.37,uM,=,0.1367205671564068,1,O=C(COc1ccc(-c2cc(=O)c3ccccc3o2)cc1)NCCCCCCNCc1ccccc1
103,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OC,"4-methoxy-N-methyl-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0974,uM,=,-1.0114410431213845,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nccs2)ccn1
104,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCNc1ccc(-c2ccccc2)nn1)Cc1ccccc1,"N1-benzyl-N1-methyl-N2-(6-phenylpyridazin-3-yl)ethane-1,2-diamine",170.0,uM,=,2.230448921378274,1,c1ccc(CNCCNc2ccc(-c3ccccc3)nn2)cc1
105,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,COc1ccc(CN(C)[C@@H](C)[C@H]2[C@H](O)C[C@@]3(C)[C@@H]4CC[C@H]5[C@]6(C)CSC(C(C)C)=N[C@H]6CC[C@@]56C[C@@]46C(=O)C[C@]23C)cc1,"20S-[(4-methoxybenzyl)(methyl)amino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.009,uM,=,-2.0457574905606752,0,O=C1CC2C(CC[C@@H]2CNCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
106,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN2CCN(CCOc3ccc4c5c(c(=O)oc4c3)CCCC5)CC2)c1,"3-(2-(4-(3-methoxybenzyl)piperazin-1-yl)ethoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",7.3,uM,=,0.8633228601204559,1,O=c1oc2cc(OCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2
107,462117,10.1021/jm7009364,,,,Inhibition of human AchE,C#CCN(C)C(C)Cc1cccc(OC(=O)N(C)CCCCCC)c1,Hexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,3.06,uM,=,0.48572142648158,1,c1ccccc1
108,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2cccc3ccccc23)C(=O)[C@@]2(C1)[C@H](c1cccc3ccccc13)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(1-naphthyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(1-naphthylmethylidene)-1''-N-acrolylpiperidin-4''-one,7.59,uM,=,0.8802417758954804,1,O=C1/C(=C/c2cccc3ccccc23)CNC[C@@]12[C@H](c1cccc3ccccc13)CN[C@]21C(=O)Nc2ccccc21
109,1539619,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 8,CO[P@]1(=O)CC[C@@H]2COC(=O)C2=C(C)O1,"rac-cis-(6R,8aS)-6-Methoxy-4-methyl-6-oxo-6,7,8,8a-tetrahydro-1H-2,5-dioxa-6lambda*5*-phospha-azulen-3-one",3.0,uM,=,0.4771212547196624,1,O=C1OC[C@H]2CC[PH](=O)OC=C12
110,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Oc1cc(O)cc(Oc2c(O)cc(O)c3c2Oc2c(cc(O)c(-c4c(O)cc5c(c4O)Oc4c(Oc6cc(O)cc(O)c6)c(O)cc(O)c4O5)c2O)O3)c1,"9,9'-Bis-(3,5-dihydroxy-phenoxy)-[2,2']bi[dibenzo[1,4]dioxinyl]-1,3,6,8,1',3',6',8'-octaol",4.59,uM,=,0.6618126855372612,1,c1ccc(Oc2cccc3c2Oc2cc(-c4ccc5c(c4)Oc4c(Oc6ccccc6)cccc4O5)ccc2O3)cc1
111,2263808,10.1016/j.bmc.2020.115895,,,,Inhibition of AChE (unknown origin),O=C1/C(=C/c2ccc(OCCN3CCCC3)cc2)Oc2ccccc21,2-(4-(2-(pyrrolidin-1-yl)ethoxy)benzylidene)benzofuran-3(2H)-one,0.545,uM,=,-0.2636034977233575,0,O=C1/C(=C/c2ccc(OCCN3CCCC3)cc2)Oc2ccccc21
112,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,"N2-cyclopropyl-N4-(3,4-dimethoxybenzyl)quinazoline-2,4-diamine",7.2,uM,=,0.8573324964312685,1,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1
113,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1.O=C(O)C(O)C(O)C(=O)O,"(4-Isopropyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester; compound with 2,3-dihydroxy-succinic acid",0.76,uM,=,-0.1191864077192086,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
114,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3,"N1-(pyridin-4-yl)-N7-(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine",0.0128,uM,=,-1.892790030352132,0,c1ccc2c(NCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3
115,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,C=C(C)[C@H](O)Cc1cc2ccc(=O)oc2cc1O,7-hydroxy-6-(2-(R)-hydroxy-3-methylbut-3-enyl)coumarin,130.00000000000003,uM,=,2.113943352306837,1,O=c1ccc2ccccc2o1
116,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C(=O)CNc2ccc3oc(=O)ccc3c2)cc1,6-[(2-(4-Methoxyphenyl)-2-oxo-ethyl]amino)-2H-chromen-2-one,0.055,uM,=,-1.259637310505756,0,O=C(CNc1ccc2oc(=O)ccc2c1)c1ccccc1
117,1908427,10.1016/j.bmcl.2019.126754,,,,Inhibition of AChE (unknown origin) by Ellman's method,Fc1ccc2[nH]c3c(c2c1)C[PH](Cc1cccc2ccccc12)(c1ccccc1)CC3,"8-Fluoro-2-naphthalen-1-ylmethyl-2-phenyl-2,3,4,5-tetrahydro-1H-2lambda5-phosphinino[4,3-b]indole",2.111,uM,=,0.3244882333076564,1,c1ccc([PH]2(Cc3cccc4ccccc34)CCc3[nH]c4ccccc4c3C2)cc1
118,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccc([N+](=O)[O-])cc2C(=O)N1CCC1CCN(Cc2ccc(Cl)cc2)CC1,"2-{2-[1-(4-Chloro-benzyl)-piperidin-4-yl]-ethyl}-5-nitro-isoindole-1,3-dione",0.24,uM,=,-0.619788758288394,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
119,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,4-[1-ethyl-2-(4-hydroxyphenyl)-(E)-1-butenyl]phenol,25.55,uM,=,1.4073909044707316,1,C(=Cc1ccccc1)c1ccccc1
120,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCC(=O)N[C@H]1CCCC[C@H]1NC(=O)CCCCCN(CC)Cc1ccccc1OC)Cc1ccccc1OC,cis-6-[Ethyl-(2-methoxybenzyl)amino]hexanoic acid (2-{6-[ethyl-(2-methoxybenzyl)amino]hexanoylamino}cyclohexyl)amide,4.16,uM,=,0.6190933306267428,1,O=C(CCCCCNCc1ccccc1)N[C@H]1CCCC[C@H]1NC(=O)CCCCCNCc1ccccc1
121,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)cc3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-(4-aminophenylsulfonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.06802,uM,=,-1.1673633724032968,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
122,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,Cc1ccc2c(c1)C1(C(=O)N2)C(C#N)=C(N)N2CC(C)(C)CNC2=C1[N+](=O)[O-],"6'-amino-3',3',5-trimethyl-9'-nitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",1.39,uM,=,0.143014800254095,1,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
123,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)N2CCN(c3cccc([N+](=O)[O-])c3)CC2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-(3-nitrophenyl)piperazin-1-yl)prop-2-en-1-one,23.43,uM,=,1.3697722885969628,1,O=C(/C=C/c1ccccc1)N1CCN(c2ccccc2)CC1
124,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1OC,"5-hydroxy-7,8-dimethoxy-2-phenyl-4H-chromen-4-one",2.46,uM,=,0.3909351071033791,1,O=c1cc(-c2ccccc2)oc2ccccc12
125,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(/C=C/C(=O)c2cc(I)c(OC)cc2O)cc1,1-(2-hydroxy-5-iodo-4-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one,0.01096,uM,=,-1.9601894458516496,0,O=C(/C=C/c1ccccc1)c1ccccc1
126,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)C1CCC2C1,"9-Amino-1,4-methano-1,2,3,4-tetrahydroacridine",0.24,uM,=,-0.619788758288394,0,c1ccc2nc3c(cc2c1)C1CCC3C1
127,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)C12,"Phenyl-carbamic acid (S)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.024,uM,=,-1.619788758288394,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
128,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),O=C1C2Cc3c([nH]c4ccccc34)[C@@H](c3ccc4c(c3)OCO4)N2C(=O)CN1CCC1CCN(Cc2ccccc2)CC1,"(2R,3R)-2-(1,3-benzodioxol-5-yl)-6-[2-(1-benzyl-4-piperidyl)ethyl]-3,6,17-triazatetracyclo[8.7.0.0^3,8.0^11,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione",0.036,uM,=,-1.4436974992327127,0,O=C1C2Cc3c([nH]c4ccccc34)[C@@H](c3ccc4c(c3)OCO4)N2C(=O)CN1CCC1CCN(Cc2ccccc2)CC1
129,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,COc1ccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)cc1OC,"(2-{4-[7-(benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-(3,4-dimethoxyphenyl)-methanone",177.0,uM,=,2.247973266361807,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
130,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1c(F)ccc[n+]1C.F[B-](F)(F)F,3-fluoro-2-methoxy-1-methylpyridinium tetrafluoroborate,70.0,uM,=,1.845098040014257,1,c1cc[nH+]cc1
131,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,Clc1ccc2c(NCc3ccccc3)c3c(nc2c1)CCCC3,"Benzyl-(6-chloro-1,2,3,4-tetrahydro-acridin-9-yl)-amine",0.17,uM,=,-0.7695510786217261,0,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
132,1586651,10.1016/j.bmcl.2016.05.046,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay,O=C(CCCCCCCCc1ccc(O)cc1)c1c(O)cc(O)cc1O,"1-(2,4,6-trihydroxyphenyl)-9-(4-hydroxyphenyl)-nonanone",6.44,uM,=,0.8088858673598122,1,O=C(CCCCCCCCc1ccccc1)c1ccccc1
133,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,"1-(4-((3,4-Dimethoxybenzyl)amino)quinazolin-2-yl)urea",8.6,uM,=,0.9344984512435676,1,c1ccc(CNc2ncnc3ccccc23)cc1
134,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(NC(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1,1-benzoyl-N-(4-methoxyphenyl)piperidine-4-carboxamide,0.0097799999999999,uM,=,-2.0096611452123985,0,O=C(Nc1ccccc1)C1CCN(C(=O)c2ccccc2)CC1
135,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CC2CCNCC2)CC1.Cl,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(4-piperidylmethyl)-4-piperidyl]propan-1-one dihydrochloride,0.118,uM,=,-0.9281179926938746,0,O=C(CCC1CCN(CC2CCNCC2)CC1)c1ccccc1
136,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Cc1cccc(C(=O)N2Cc3ccc(N4C(=O)c5ccccc5C4=O)cc3CC2=O)c1,"2-(2-(3-methylbenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-6-yl)isoindoline-1,3-dione",0.02548,uM,=,-1.5938005763366871,0,O=C1Cc2cc(N3C(=O)c4ccccc4C3=O)ccc2CN1C(=O)c1ccccc1
137,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,C[C@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,"(2S,2'S)-N,N'-(3,3'-(3,3'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)bis(propane-3,1-diyl))bis(azanediyl)bis(propane-3,1-diyl))bis(2-(2-fluorobiphenyl-4-yl)propanamide)",2.89,uM,=,0.4608978427565479,1,O=C(Cc1ccc(-c2ccccc2)cc1)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccc(-c3ccccc3)cc2)=CC1=O
138,2263808,10.1016/j.bmc.2020.115895,,,,Inhibition of AChE (unknown origin),COc1ccc2c(c1)O/C(=C\c1ccc(OCCN3CCCCC3)c(Cl)c1)C2=O,(Z)-2-(3-chloro-4-(2-(piperidin-1-yl)ethoxy)benzylidene)-6-methoxybenzofuran-3(2H)-one,0.16,uM,=,-0.7958800173440752,0,O=C1/C(=C/c2ccc(OCCN3CCCCC3)cc2)Oc2ccccc21
139,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,CN(Cc1ccccc1)Cc1ccc(C(=O)NCCc2c[nH]c3cc(F)ccc23)cc1,4-{[Benzyl(methyl)amino]methyl}-N-[2-(6-fluoro-1H-indol-3-yl)ethyl]benzamide,2.5,uM,=,0.3979400086720376,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
140,1702964,10.1016/j.ejmech.2017.04.054,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"N-(4-(ethyl(2-methoxybenzyl)amino)butyl)-2-(4-(5-hydroxy-6,7-dimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",0.039,uM,=,-1.408935392973501,0,O=C(COc1ccc(-c2cc(=O)c3ccccc3o2)cc1)NCCCCNCc1ccccc1
141,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1cccc([N+](=O)[O-])c1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(3-nitrobenzyl)berberine bromide,1.45,uM,=,0.1613680022349748,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
142,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1cccc(-c2cn3c(Cl)cccc3[n+]2C)c1.[Cl-],"5-chloro-2-(3-(dimethylcarbamoyloxy)phenyl)-1-methylimidazo[1,2-a]pyridin-1-ium",12.6,uM,=,1.100370545117563,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
143,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,"2-(6-((3-Chlorobenzyl)(methyl)amino)hexyl)isoindoline-1,3-dione hydrochloride",1.189,uM,=,0.0751818546186916,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
144,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCOC(=O)CC[C@@H](NC(=O)OCc1ccccc1)C(=O)NCCC1CCN(Cc2ccccc2)CC1,N-carboxybenzyl-D-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-ethyl,3.0,uM,=,0.4771212547196624,1,O=C(CNC(=O)OCc1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
145,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,Cc1cc2nc3c(nc2cc1C)C1(C(C#N)=C(N)N2CCNC2=C1[N+](=O)[O-])c1ccccc1-3,"5-amino-7',8'-dimethyl-8-nitro-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,11'-indeno[1,2-b]quinoxaline]-6-carbonitrile",6.6,uM,=,0.8195439355418687,1,C1=CC2(C=C3NCCN13)c1ccccc1-c1nc3ccccc3nc12
146,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-octyl-7-methoxytacrine hydrochloride,0.36,uM,=,-0.4436974992327127,0,c1ccc2nc3c(cc2c1)CCCC3
147,1761987,10.1016/j.ejmech.2018.01.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by DTNB addition for 5 mins and subsequent addition of substrate measured after 3 mins by Ellman's method,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OCc1nc(C)c(C)nc1C,"(E)-3-(3,5-dimethoxy-4-((3,5,6-trimethylpyrazin-2-yl)methoxy)phenyl)-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)acrylamide",0.1084,uM,=,-0.964970717797632,0,O=C(/C=C/c1ccc(OCc2cnccn2)cc1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
148,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCCCN1CCCCC1,(E)-3-(4-((8-(piperidin-1-yl)octyl)oxy)3-methoxyphenyl)-N-phenylacrylamide,4.12,uM,=,0.6148972160331346,1,O=C(/C=C/c1ccc(OCCCCCCCCN2CCCCC2)cc1)Nc1ccccc1
149,1337582,10.1021/np400978x,,,,Inhibition of human AChE by spectrophotometry,CC[C@@H]1[C@H]2OC(=O)[C@@](C)(O)[C@H]2[C@]23CC[C@@H]([C@@H]4C[C@H](C)C(=O)O4)N2CCCC[C@H]13,Sessilistemonamine A,68.8,uM,=,1.8375884382355112,1,O=C1CC[C@@H]([C@@H]2CC[C@]34[C@H](CCCCN23)C[C@H]2OC(=O)C[C@H]24)O1
150,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)-c1ccccc1NCCC2,"5,6,7,8-tetrahydrobenzo[2,3]azocino[4,5-b]quinolin-9-amine",391.1,uM,=,2.5922878159521305,1,c1ccc2c(c1)NCCCc1cc3ccccc3nc1-2
151,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc(C(C)C)cc2)cc1,S-4-isopropylbenzyl 4-methylbenzenthiosulfonate,0.0119,uM,=,-1.9244530386074687,0,O=S(=O)(SCc1ccccc1)c1ccccc1
152,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1cnc2nc3c(c(NCCCCCCNc4c5c(nc6ncccc46)CCCC5)c2c1)CCCC3,"N,N'-Bis-(6,7,8,9-tetrahydro-benzo[b][1,8]naphthyridin-5-yl)-hexane-1,6-diamine",0.0048,uM,=,-2.318758762624413,0,c1cnc2nc3c(c(NCCCCCCNc4c5c(nc6ncccc46)CCCC5)c2c1)CCCC3
153,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,CC(=O)c1c[n+](Cc2ccccc2C)ccc1CC1Cc2cc3c(cc2C1=O)OCO3.[Br-],"(+/-)-6-[[3-Acetyl-1-(o-tolylmethyl)pyridin-1-ium-4-yl]methyl]-5,6-dihydrocyclopenta[f][1,3]benzodioxol-7-one Bromide",0.06,uM,=,-1.2218487496163564,0,O=C1c2cc3c(cc2CC1Cc1cc[n+](Cc2ccccc2)cc1)OCO3
154,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,CC[N+](C)(C)c1cccc(O)c1.[Cl-],Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium chloride,5.0,uM,=,0.6989700043360189,1,c1ccccc1
155,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,COc1ccc2[nH]c3c(c2c1)CN(Cc1ccccc1)CC3,"2-benzyl-8-methoxy-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole",52.7,uM,=,1.7218106152125467,1,c1ccc(CN2CCc3[nH]c4ccccc4c3C2)cc1
156,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),O=c1c(OC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,kaempferol 3-O-D-galactoside,0.012,uM,=,-1.9208187539523751,0,O=c1c(OC2CCCCO2)c(-c2ccccc2)oc2ccccc12
157,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2cnc(NCN3CCCCC3)nc2)cc1,5-phenyl-N-(piperidin-1-ylmethyl)pyrimidin-2-amine,100.0,uM,=,2.0,1,c1ccc(-c2cnc(NCN3CCCCC3)nc2)cc1
158,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(Cc1cc(F)cc(/C=N/O)c1O)CC2,"3-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-5-fluoro-2-hydroxybenzaldehyde oxime",692.5,uM,=,2.840419777736486,1,c1ccc(CN2CCc3ccccc3C2)cc1
159,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(NCCCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,"(S)-2-amino-3-(1H-indol-3-yl)-N-(8-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)propanamide dihydrochloride",1.3,uM,=,0.1139433523068367,1,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
160,749399,10.1016/j.bmcl.2009.04.089,,,,Inhibition of human recombinant AChE preincubated for 30 mins before DTNB substrate addition by spectrophotometric assay based Ellman's method,C[C@@H](Cc1ccccc1)NC(=O)Oc1cccc([C@H](C)N(C)C)c1.Cl,3-((S)-1-(dimethylamino)ethyl)phenyl(S)-1-phenylpropan-2-ylcarbamate hydrochloride,0.508,uM,=,-0.2941362877160807,0,O=C(NCCc1ccccc1)Oc1ccccc1
161,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CN(CCCCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NCCCCCc2ccccc2)c1,3-((Methyl-(5-((2-oxo-2H-chromen-7-yl)oxy)pentyl)amino)-methyl)phenyl(5-Phenylpentyl)carbamate,0.0881,uM,=,-1.055024091587952,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCCCOc2ccc3ccc(=O)oc3c2)c1
162,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CN1c2ccc(OC(=O)NCC3CCCCC3)cc2[C@]2(C)CCN(CCc3ccccc3)[C@H]12,"3alpha,8-dimethyl-1-phenethyl-1,2,3,3alpha,8,8alpha-hexahydropyrrolo[2,3-b]indol-5-ylcyclohexylmethylcarbamate",0.0018,uM,=,-2.744727494896694,0,O=C(NCC1CCCCC1)Oc1ccc2c(c1)C1CCN(CCc3ccccc3)[C@@H]1N2
163,1274974,10.1016/j.ejmech.2013.09.050,,,,Inhibition of acetylcholinesterase (unknown origin),CCOC(=O)C1=C(C)Oc2nc3c(c(N)c2C1c1ccc(C)cc1)CCCC3,"ethyl 5-amino-2-methyl-4-p-tolyl-6,7,8,9-tetrahydro-4H-pyrano[2,3-b]quinoline-3-carboxylate",0.182,uM,=,-0.7399286120149252,0,C1=CC(c2ccccc2)c2cc3c(nc2O1)CCCC3
164,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(F)cc13)CCCCC2,"2-fluoro-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",0.624,uM,=,-0.204815410317576,0,c1ccc2nc3c(cc2c1)CCCCC3
165,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCC4)c3c(nc2c1)CCC3,"N,N'-Bis-(2,3-dihydro-1H-cyclopenta[b]quinolin-9-yl)-heptane-1,7-diamine",0.075,uM,=,-1.1249387366083,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCC4)c3c(nc2c1)CCC3
166,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1cc[nH]c1,"1,3-Dimethyl-2-(1H-pyrrol-3-yl)-1,2,3,4-tetrahydroquinazolin-6-ol",115.9,uM,=,2.064083435963596,1,c1ccc2c(c1)CNC(c1cc[nH]c1)N2
167,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCCC(C)n1cc(C(=O)CF)cn1,2-fluoro-1-(1-(pentan-2-yl)-1H-pyrazol-4-yl)ethan-1-one,17.6,uM,=,1.24551266781415,1,c1cn[nH]c1
168,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCCCSC(=S)N3CCCCC3)ccc12,4-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)butyl piperidine-1-carbodithioate,0.027,uM,=,-1.5686362358410126,0,O=c1ccc2ccc(OCCCCSC(=S)N3CCCCC3)cc2o1
169,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1cccc(OC)c1C(C)NS(N)(=O)=O,"N-(1-(2,6-Dimethoxyphenyl)ethyl)sulfamide",2.685e-05,uM,=,-4.571055709964425,0,c1ccccc1
170,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(C[N+](C)(C)Cc4ccccc4)cc3)c(=O)oc2cc1OC.[I-],"benzyl-[4-(6,7-dimethoxy-2-oxo-2H-chromen-3-yl)benzyl]dimethylammoniumiodide",0.0105,uM,=,-1.978810700930062,0,O=c1oc2ccccc2cc1-c1ccc(C[NH2+]Cc2ccccc2)cc1
171,877957,10.1021/jm3015519,,,,Inhibition of human AChE,COc1cc2c(cc1OC)C(c1ccccc1)N(CCCCCCc1cc(C)nc(/C=N/O)c1O)CC2,"4-(6-(6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)hexyl)-3-hydroxy-6-methylpicolinaldehyde oxime",300.0,uM,=,2.4771212547196626,1,c1ccc(C2c3ccccc3CCN2CCCCCCc2ccncc2)cc1
172,305005,10.1021/jm049113+,,,,Inhibitory concentration against Acetylcholinesterase; (range = 2-20 uM),O=C1CN(CCN2CCCC2)C(=O)CN1CCCn1ccnc1,"1-(3-Imidazol-1-yl-propyl)-4-(2-pyrrolidin-1-yl-ethyl)-piperazine-2,5-dione",20.0,uM,=,1.3010299956639813,1,O=C1CN(CCN2CCCC2)C(=O)CN1CCCn1ccnc1
173,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(CNCCCCCCNc3c4c(nc5ccccc35)CCC4)oc12,"N1-(2,3-Dihydro-1H-cyclopenta[b]quinolin-9-yl)-N6-((7-methoxybenzofuran-2-yl)methyl)hexane-1,6-diamine",0.0631,uM,=,-1.1999706407558657,0,c1ccc2oc(CNCCCCCCNc3c4c(nc5ccccc35)CCC4)cc2c1
174,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1ccc([N+]2=Cc3c(cccc3OC)CC2)cc1.[Br-],"8-methoxy-2-(4-methoxyphenyl)-3,4-dihydroisoquinolinium bromide",1.04,uM,=,0.0170333392987803,1,C1=[N+](c2ccccc2)CCc2ccccc21
175,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCCC2)cc(OC)c1OC,"rac-2-(3,4,5-Trimethoxyphenyl)-2-(pyrrolidin-1-yl)acetonitrile",321.0,uM,=,2.5065050324048723,1,c1ccc(CN2CCCC2)cc1
176,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C[C@H](CCC=C(CO)CO)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@]12C,Ganoderiol F,21.84,uM,=,1.3392526340326996,1,O=C1CCC2C3=CCC4CCCC4C3=CC[C@H]2C1
177,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,O=C1C(=O)N(C(=O)c2ccccc2)c2ccc(CNc3ccc(Br)cc3)cc21,"1-benzoyl-5-((4-bromophenylamino)methyl)indoline-2,3-dione",0.3981,uM,=,-0.400007822415902,0,O=C1C(=O)N(C(=O)c2ccccc2)c2ccc(CNc3ccccc3)cc21
178,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1cccc(-c2cn3ccccc3[n+]2C)c1.[Cl-],"2-(3-(dimethylcarbamoyloxy)phenyl)-1-methylimidazo[1,2-a]pyridin-1-ium",7.1,uM,=,0.8512583487190752,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
179,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC(O)CCC3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[5-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-hydroxy-5-oxo-pentyl]-1-methyl-piperidinium bromide",0.38,uM,=,-0.4202164033831898,0,O=C(CCCCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
180,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1.[Cl-].[Cl-],4-[(E)-(hydroxyimino)methyl]-1-[({4-[(E)-(hydroxyimino)methyl]pyridinium-1-yl}methoxy)methyl]pyridinium dichloride (toxogonin),870.0,uM,=,2.9395192526186187,1,c1cc[n+](COC[n+]2ccccc2)cc1
181,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(CCN1CCN(c2ccccc2)CC1)Nc1n[nH]c2ncccc12,"3-(4-Phenylpiperazin-1-yl)-N-(1H-pyrazolo[3,4-b]pyridin-3-yl)propanamide",0.23,uM,=,-0.6382721639824072,0,O=C(CCN1CCN(c2ccccc2)CC1)Nc1n[nH]c2ncccc12
182,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,C=CC[N+](C)(C)c1ccc(OCC(=O)c2ccc(OC)c(OC)c2)cc1.[Br-],"Allyl-{4-[2-(3,4-dimethoxy-phenyl)-2-oxo-ethoxy]-phenyl}-dimethyl-ammonium bromide",10.0,uM,=,1.0,1,O=C(COc1ccccc1)c1ccccc1
183,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(CN(C)Cc4cccc(C)c4)cc3)c(=O)oc2cc1OC,"6,7-dimethoxy-3-(4-{[(3-methylbenzyl)methylamino]methyl}phenyl)chromen-2-one",0.122,uM,=,-0.9136401693252518,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
184,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,CN(CCC(=O)NCCNc1c2c(nc3ccccc13)CCCC2)C1CCCCC1,"N1-[2-(1,2,3,4-Tetrahydroacridin-9-ylamino)ethyl]-3-[cyclohexyl(methyl)amino]propanamide",0.58,uM,=,-0.2365720064370627,0,O=C(CCNC1CCCCC1)NCCNc1c2c(nc3ccccc13)CCCC2
185,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CNC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](C)c1.[I-],"[1-Methyl-3-(methylcarbamoyl)quinolin-1-ium-5-yl]-N,N-dimethylcarbamate iodide",0.077,uM,=,-1.1135092748275182,0,c1ccc2[nH+]cccc2c1
186,745140,10.1021/jm101299d,,,,Inhibition of human recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCC3)cc2)ccc1C[n+]1ccc(N2CCCCC2)cc1,4-hexahydro-1-pyridinyl-1-[4-(4-hexahydro-1-pyridinyl-1-pyridiniumylmethyl)benzyl]pyridinium; dibromide,0.075,uM,=,-1.1249387366083,0,c1cc(C[n+]2ccc(N3CCCCC3)cc2)ccc1C[n+]1ccc(N2CCCCC2)cc1
187,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,Nc1c2c(nc3c1C(c1c(Cl)cccc1Cl)c1ccc4ccccc4c1O3)CCCC2,"rac-7-(2,6-Dichlorophenyl)-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",4.01,uM,=,0.6031443726201823,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
188,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2ccccc2F)CC1)c1n[nH]c2ccc(-c3cccnc3)cc12,N-((1-(2-fluorobenzyl)piperidin-4-yl)methyl)-5-(pyridin-3-yl)-1H-indazole-3-carboxamide,2.176,uM,=,0.3376588910261423,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1n[nH]c2ccc(-c3cccnc3)cc12
189,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1ccc(/C=C2\CN(Cc3ccc4ccccc4c3)C/C(=C\c3ccc(C)cc3)C2=O)cc1,"(3E,5E)-3,5-bis(4-methylbenzylidene)-1-(naphthalen-2-ylmethyl)piperidin-4-one",1.59,uM,=,0.2013971243204514,1,O=C1/C(=C/c2ccccc2)CN(Cc2ccc3ccccc3c2)C/C1=C\c1ccccc1
190,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),COc1ccccc1C1C([N+](=O)[O-])C(Cc2c[nH]cn2)NC12c1ccccc1-c1nc3ccccc3nc12,"5'-(1H-imidazol-4-ylmethyl)-3'-(2-methoxyphenyl)-4'-nitro-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",5.22,uM,=,0.7176705030022621,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
191,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CCN(C)C(=O)Oc1cccc(C(C)N(C)C)c1,SID174006853,35.2,uM,=,1.546542663478131,1,c1ccccc1
192,28472,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.85-6.01,CN(C(=O)Oc1ccc2c(c1)C(N)CC2)C1CCCCC1.Cl,Cyclohexyl-methyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,3.96,uM,=,0.5976951859255123,1,O=C(NC1CCCCC1)Oc1ccc2c(c1)CCC2
193,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",90.0,uM,=,1.954242509439325,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
194,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(CC/C=C2\Cc3ccccc3C2=O)CC1,2-[3-(1-Methyl-piperidin-4-yl)-propylidene]-indan-1-one,0.00082,uM,=,-3.086186147616284,0,O=C1/C(=C/CCC2CCNCC2)Cc2ccccc21
195,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(=O)(=O)c1ccc(C(C)(C)C)cc1,"1-(4-tert-butyl benzene)-sulfonyl-cis-2,6-dimethyl piperidine",0.458,uM,=,-0.3391345219961308,0,O=S(=O)(c1ccccc1)N1CCCCC1
196,2185504,10.1016/j.bmc.2021.116143,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's colorimetric method,COc1ccc2cc3[n+](cc2c1OC)CCc1cc(O)c(O)cc1-3.[Br-],"2,3-Dihydroxy-9,10-dimethoxy-5,6-dihydro-isoquino[3,2-a]isoquinolinylium bromide",7.8,uM,=,0.8920946026904804,1,c1ccc2c(c1)CC[n+]1cc3ccccc3cc1-2
197,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(Cc4cccc(Cl)c4)CC3)cc1)C2.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-(3-chlorobenzyl)-4-methylpiperazinium-1-yl)benzylidinel-1H-inden-1-one bromide",0.32,uM,=,-0.494850021680094,0,O=C1/C(=C/c2ccc(N3CC[NH+](Cc4ccccc4)CC3)cc2)Cc2ccccc21
198,28611,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 6.9-40.6,C#CCNC1CCc2ccc(OC(=O)N(CC)C3CCCCC3)cc21.Cl,Cyclohexyl-ethyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,17.9,uM,=,1.252853030979893,1,O=C(NC1CCCCC1)Oc1ccc2c(c1)CCC2
199,793322,10.1021/jm200853t,,,,Inhibition of cerebral human recombinant AchE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 10 mins measured after 15 mins of substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.122,uM,=,-0.9136401693252518,0,c1ccc2nc3c(cc2c1)CCCC3
200,2261403,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 45 to 90 mins by Ellman's method,CN(CCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NC2CCCCC2)c1,[3-[[methyl-[3-(2-oxochromen-7-yl)oxypropyl]amino]methyl]phenyl]N-cyclohexylcarbamate,0.104,uM,=,-0.9829666607012196,0,O=C(NC1CCCCC1)Oc1cccc(CNCCCOc2ccc3ccc(=O)oc3c2)c1
201,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CCCC2)o1,2-(1-{2-[(5-Pyrrolidin-1-ylmethyl-furan-2-ylmethyl)-amino]-ethyl}-imidazolidin-2-ylidene)-malononitrile,0.08,uM,=,-1.0969100130080565,0,C=C1NCCN1CCNCc1ccc(CN2CCCC2)o1
202,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CCN(C)Cc1ccc(CNCCN2CCNC2=C(C#N)C#N)o1,2-{1-[2-({5-[(Ethyl-methyl-amino)-methyl]-furan-2-ylmethyl}-amino)-ethyl]-imidazolidin-2-ylidene}-malononitrile,0.43,uM,=,-0.3665315444204134,0,C=C1NCCN1CCNCc1ccco1
203,2164642,10.1021/acs.jmedchem.1c01748,,,,Inhibition of recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells using acetylthiocholine iodide as substrate measured for 6 mins by Ellman's method,OC[C@H]1O[C@@H](OCCCc2ccc(O)c(/C=N/O)n2)[C@H](O)[C@@H](O)[C@@H]1O,"(E)-3-hydroxy-6-(3-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)propyl)picolinaldehyde oxime",140.0,uM,=,2.146128035678238,1,c1ccc(CCCO[C@H]2CCCCO2)nc1
204,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3ccc(OCCNC(=O)/C=C/c4cc(F)cc(F)c4)cc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-7-yloxy)ethyl)-3-(3,5-difluorophenyl)acrylamide",4.57,uM,=,0.6599162000698503,1,O=C(/C=C/c1ccccc1)NCCOc1ccc2cc(-c3ccc(CNCc4ccccc4)cc3)c(=O)oc2c1
205,305005,10.1021/jm049113+,,,,Inhibitory concentration against Acetylcholinesterase; (range = 2-20 uM),O=C1CN(CCN2CCOCC2)C(=O)CN1CCC(c1ccccc1)c1ccccc1,"1-(3,3-Diphenyl-propyl)-4-(2-morpholin-4-yl-ethyl)-piperazine-2,5-dione",20.0,uM,=,1.3010299956639813,1,O=C1CN(CCN2CCOCC2)C(=O)CN1CCC(c1ccccc1)c1ccccc1
206,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc([N+](=O)[O-])cc1)N1CCN(c2ccccn2)CC1,N'-(4-Nitrobenzylidene)-4-(pyridin-2-yl)piperazine-1-carbohydrazide,1.16,uM,=,0.0644579892269184,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
207,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,"5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one",0.012,uM,=,-1.9208187539523751,0,O=c1cc(-c2ccccc2)oc2ccccc12
208,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CC(OC[n+]1ccn(C)c1/C=N/O)C1CCCCC1.[Cl-],1-(1-Cyclohexyl-ethoxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,26.0,uM,=,1.414973347970818,1,c1c[n+](COCC2CCCCC2)c[nH]1
209,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCC(CCC)OC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-(1-propyl-but-3-ynyloxymethyl)-3H-imidazol-1-ium chloride,5.21,uM,=,0.7168377232995244,1,c1c[nH+]c[nH]1
210,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,COc1cc(C2c3ccc4ccccc4c3Oc3nc4c(c(N)c32)CCCC4)cc(OC)c1OC,"rac-7-(3,4,5-Trimethoxyphenyl)-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",3.51,uM,=,0.5453071164658241,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
211,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-amino-3-(1H-indol-3-yl)-N-(5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl)propanamide dihydrochloride",0.32,uM,=,-0.494850021680094,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
212,28470,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.5-5.8,CCCNC1CCc2ccc(OC(=O)N(C)CC)cc21.Cl,Ethyl-methyl-carbamic acid 3-propylamino-indan-5-yl ester hydrochloride,3.6,uM,=,0.5563025007672873,1,c1ccc2c(c1)CCC2
213,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccc([N+](=O)[O-])cc2C(=O)N1C1CCN(Cc2ccccc2)CC1,"2-(1-Benzyl-piperidin-4-yl)-5-nitro-isoindole-1,3-dione",27.0,uM,=,1.4313637641589874,1,O=C1c2ccccc2C(=O)N1C1CCN(Cc2ccccc2)CC1
214,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),CCOC(=O)[n+]1ccc2c([nH]c3cc(OC)ccc32)c1C,"ethyl 7-methoxy-1-methyl-9H-pyrido[3,4-b]indol-2-ium-2-carboxylate",0.25,uM,=,-0.6020599913279624,0,c1ccc2c(c1)[nH]c1c[nH+]ccc12
215,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3c1C(c1ccc(F)cc1)NC(=S)N3)CCCC2,"5-amino-4-(4-fluorophenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",31.0,uM,=,1.4913616938342726,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
216,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)C/C(=C\c2cc(O)c(O)c(O)c2)C3=O)c1,"3-((methyl(7-(1-oxo-2-(3,4,5-trihydroxybenzylidene)-2,3-dihydro-1H-inden-5-yloxy)heptyl)amino)methyl)phenyl methylcarbamate",0.0018,uM,=,-2.744727494896694,0,O=C1/C(=C/c2ccccc2)Cc2cc(OCCCCCCCNCc3ccccc3)ccc21
217,2272278,10.1016/j.bmc.2021.116270,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins by DTNB reagent based Ellman's method,C/C=C1/CN2CCc3c([nH]c4ccccc34)[C@@H]2CC1/C(=C\C(=O)OC)OC,Geissoschizine methyl ether,3.7,uM,=,0.568201724066995,1,C=C1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1
218,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cn[nH]c2-c2sccc21,"2-(4-Benzylpiperazin-1-yl)-N-(1,4-dihydrothieno[3',2':4,5]cyclopenta[1,2-c]pyrazol-4-yl)acetamide",9.18,uM,=,0.9628426812012424,1,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cn[nH]c2-c2sccc21
219,1439748,10.1021/np500412f,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as inhibition of acetylcholine hydrolysis after 30 mins by Ellmann's method,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.00054,uM,=,-3.2676062401770314,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
220,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1ccc2c(c1)CC(NS(=O)(=O)N(C)C)CC2,"3-(7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylsulfamide",0.01582,uM,=,-1.8007935208383423,0,c1ccc2c(c1)CCCC2
221,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1F,"2-(7-(2-Fluorobenzylamino)heptyl)isoindoline-1,3-dione",0.329,uM,=,-0.4828041020500256,0,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
222,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3ccc(OC)c(OC)c3)cn2)cc1,"N-(3-(3,4-dimethoxyphenoxy)propyl)-2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-methylpyrimidine-5-carboxamide",29.8,uM,=,1.4742162640762553,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
223,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccc(F)cc2)C(=O)/C(=C/c2ccc(F)cc2)C1,"1-Acryloyl-3,5-bis-(4-fluoro-benzylidene)-piperidin-4-one",15.12,uM,=,1.1795517911651878,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
224,2224411,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 5 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.032,uM,=,-1.494850021680094,0,c1ccc2nc3c(cc2c1)CCCC3
225,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,O/N=C/c1cc[n+](C[n+]2ccc(/C=N/O)cc2)cc1.[Br-].[Br-],"1,1-bis(4-hydroxyiminomethylpyridinium)-methane dibromide",2010.0,uM,=,3.303196057420489,1,c1cc[n+](C[n+]2ccccc2)cc1
226,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,CC(=O)O[C@@H]1C[C@@]2(C)[C@@H]3C[C@H]4OC[C@@]5(C)[C@@H](NC(=O)c6ccccc6)C=C[C@@](O)(CC3=CC[C@]2(C)[C@H]1[C@H](C)N(C)C)[C@@H]45,buxafuranamide,14.0,uM,=,1.146128035678238,1,O=C(N[C@H]1C=CC2CC3=CCC4CCCC4[C@@H]3C[C@H]3OCC1[C@@H]23)c1ccccc1
227,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCN1CCc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-pentyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.047,uM,=,-1.3279021420642825,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
228,2198746,10.1039/d2md00087c,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 sec for 3 mins by DTNB-based UV analysis,CCCCCCCNC(=O)Oc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCC(C)C)cc1,4-((5-(Diethylcarbamoyl)-1-isopentyl-1H-benzo[d]imidazol-2-yl)methyl)phenyl heptylcarbamate,0.175,uM,=,-0.7569619513137056,0,c1ccc(Cc2nc3ccccc3[nH]2)cc1
229,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(6-(6-methoxy-1-methylpyridinium-2-yl)hexyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",0.19,uM,=,-0.721246399047171,0,c1ccc(CCCCCC[NH+]2CCc3ccccc3C2)[nH+]c1
230,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1c(/C=N/Nc2ccc(C(F)(F)F)cc2)coc2c1ccc1oc(-c3cccc(F)c3)cc12,"8-(3-fluorophenyl)-3-((2-(4-(trifluoromethyl)phenyl)hydrazineylidene)methyl)-4H-furo[2,3-h]chromen-4-one",10.4,uM,=,1.0170333392987805,1,O=c1c(/C=N/Nc2ccccc2)coc2c1ccc1oc(-c3ccccc3)cc12
231,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(4-(4-((1-(phenylsulfonyl)-1H-indol-4-yl)methyl)piperazin-1-yl)butyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",7.61,uM,=,0.8813846567705729,1,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
232,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,Clc1ccc(CN2CCN(c3nccc(NCc4ccccc4)n3)CC2)cc1,N-Benzyl-2-[4-(4-chlorobenzyl)piperazin-1-yl]pyrimidin-4-amine,20.2,uM,=,1.305351369446624,1,c1ccc(CNc2ccnc(N3CCN(Cc4ccccc4)CC3)n2)cc1
233,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc(C#N)cc2)cc1,S-4-cyanobenzyl 4-methylbenzenthiosulfonate,0.1956999999999999,uM,=,-0.7084091743419989,0,O=S(=O)(SCc1ccccc1)c1ccccc1
234,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,CCN1CCc2cc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)ccc2C1,"3-(2-Ethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.16,uM,=,-0.7958800173440752,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc4c(c3)CCNC4)cc12
235,2019674,10.1039/d0md00009d,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",17.1,uM,=,1.2329961103921538,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
236,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1ccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)cc1,3-{7-[(4-methoxybenzyl)methylamino]heptyloxy}xanthen-9-one,360.0,uM,=,2.556302500767288,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
237,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COC(=O)c1c(CCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)cccc1OC,"methyl 2-(8-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)-6-methoxybenzoate",0.00254,uM,=,-2.595166283380062,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
238,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,CN(Cc1ccccc1)Cc1ccc(-c2cc3cc([N+](=O)[O-])ccc3oc2=O)cc1,3-{4-[(benzylmethylamino)methyl]phenyl}-6-nitrochromen-2-one,0.148,uM,=,-0.8297382846050426,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
239,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2ccccc2Cl)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1Cl,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-2-chlorophenylmethylidene]tetrahydro-4''(1H)-pyridinone",11.92,uM,=,1.0762762554042176,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
240,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CNC(NCCNCc1ccc(CN2CCCC2)o1)=C(C#N)C#N,2-(Methylamino-{2-[(5-pyrrolidin-1-ylmethyl-furan-2-ylmethyl)-amino]-ethylamino}-methylene)-malononitrile,0.28,uM,=,-0.5528419686577808,0,c1coc(CN2CCCC2)c1
241,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,C[C@H]1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)OCC[N+](C)(C)Cc4ccccc4)[C@@H]2CC[C@]1(Cl)C3.[Br-],,9.0,uM,=,0.9542425094393248,1,O=C(OCC[NH2+]Cc1ccccc1)C1CCCC2[C@@H]1CC[C@]13CCC(CC[C@@H]21)C3
242,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc(/C=N/O)c(O)c(CN2CCc3cc(OC)c(OC)cc3C2c2ccccc2)c1,"3-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxy-5-methoxybenzaldehyde oxime",911.3,uM,=,2.9596613702734955,1,c1ccc(CN2CCc3ccccc3C2c2ccccc2)cc1
243,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCCCCN(C)Cc3ccccc3)cc2oc1=O,"7-(4-(N-Benzyl-N-methylamino)butyloxy)-3,4-dimethyl-2H-chromen-2-one",0.79,uM,=,-0.1023729087095585,0,O=c1ccc2ccc(OCCCCNCc3ccccc3)cc2o1
244,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCCOc1ccc2c(C)cc(=O)oc2c1.O=S(=O)([O-])C(F)(F)F,2-methoxy-1-(4-(4-methyl-2-oxo-2H-chromen-7-yloxy)butyl)-5-(trifluoromethyl)pyridinium trifluoromethanesulfonate,0.76,uM,=,-0.1191864077192086,0,O=c1ccc2ccc(OCCCC[n+]3ccccc3)cc2o1
245,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,O=C(Nc1ccncc1Br)OCCCCCNCc1ccccc1,5-(benzylamino)pentyl-(3-bromopyridin-4-yl)carbamate,4.04,uM,=,0.6063813651106049,1,O=C(Nc1ccncc1)OCCCCCNCc1ccccc1
246,28321,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.49-0.58,CCCCCCN(C)C(=O)Oc1ccc2c(c1)C(N)CC2.Cl,Hexyl-methyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,0.53,uM,=,-0.2757241303992109,0,c1ccc2c(c1)CCC2
247,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,NS(=O)(=O)c1ccc(NC(=S)NCCN2CCCCC2)cc1,1-(2-(Piperidin-1-yl)ethyl)-3-(4-sulfamoylphenyl)thiourea,90.0,uM,=,1.954242509439325,1,S=C(NCCN1CCCCC1)Nc1ccccc1
248,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC3(O)CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[2-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-2-oxo-ethyl]-4-hydroxy-1-methyl-piperidinium bromide",0.09,uM,=,-1.0457574905606752,0,O=C(CC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
249,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCCCCNC(=O)Oc1ccc2c(c1)C1(C)CCN(CC)C2C1,"Heptyl-carbamic acid 9-ethyl-1-methyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.159,uM,=,-0.7986028756795485,0,c1ccc2c(c1)C1CCNC2C1
250,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Fc1ccc(N(Cc2ccc3c(c2)OCO3)C(=S)Nc2cccc(C(F)(F)F)c2)cc1,"1-Benzo[1,3]dioxol-5-ylmethyl-1-(4-fluoro-phenyl)-3-(3-trifluoromethyl-phenyl)-thiourea",8.0,uM,=,0.9030899869919436,1,S=C(Nc1ccccc1)N(Cc1ccc2c(c1)OCO2)c1ccccc1
251,1539617,10.1016/j.bmc.2015.10.044,,,,Inhibition of AChE (unknown origin),CO[P@]1(=O)OC[C@H]2COC(=O)C2=C(C)O1,cyclophostin,0.045,uM,=,-1.3467874862246565,0,O=C1OC[C@@H]2CO[PH](=O)OC=C12
252,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,COP1(=O)CCCC(CO)=C(C)O1,"(2-Methoxy-7-methyl-2-oxo-2,3,4,5-tetrahydro-2lambda*5*-[1,2]oxaphosphepin-6-yl)-methanol",600.0,uM,=,2.778151250383644,1,O=[PH]1CCCC=CO1
253,1978343,10.1016/j.bmcl.2019.126888,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1CCN1CCN(Cc2ccccc2)CC1,"3-(2-(4-benzylpiperazin-1-yl)ethyl)-1-((5-(4-nitrophenyl)furan-2-yl)methyleneamino)imidazolidine-2,4-dione",0.201,uM,=,-0.6968039425795112,0,O=C1CN(/N=C/c2ccc(-c3ccccc3)o2)C(=O)N1CCN1CCN(Cc2ccccc2)CC1
254,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)C/C(=C\c2cc(OC)c(OC)c(OC)c2)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(7-{1-oxo-2-[1-(3,4,5-trimethoxy-phenyl)-meth-(E)-ylidene]-indan-5-yloxy}-heptyl)-amino]-methyl}-phenyl ester",0.0018,uM,=,-2.744727494896694,0,O=C1/C(=C/c2ccccc2)Cc2cc(OCCCCCCCNCc3ccccc3)ccc21
255,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,CN(CCCCCCCOc1ccc(-c2oc3ccccc3c2C(=O)c2ccccc2)cc1)Cc1ccccc1,(2-{4-[7-(benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)phenylmethanone,40.7,uM,=,1.60959440922522,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
256,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cn1c2ccccc2c2cc[n+](-c3ccc(Cl)cc3)cc21,"2-(4-chlorophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.3,uM,=,-0.5228787452803376,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
257,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.021,uM,=,-1.6777807052660807,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
258,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccc([N+](=O)[O-])cc2C(=O)N1CC1CCN(Cc2ccccc2)CC1,"2-(1-Benzyl-piperidin-4-ylmethyl)-5-nitro-isoindole-1,3-dione",3.0,uM,=,0.4771212547196624,1,O=C1c2ccccc2C(=O)N1CC1CCN(Cc2ccccc2)CC1
259,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(I)cc3F)cc12.[Br-],2-(2-Fluoro-4-iodopheny1)-8-methoxyisoquinolin-2-ium bromide,1.23,uM,=,0.0899051114393979,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
260,717112,10.1021/np100416v,,,,Inhibition of human erythrocytes acetylcholinesterase after 15 mins,Cc1ccc([C@@H](C)CC(=O)CC(C)C)cc1,(+)-(S)-dihydro-ar-turmerone,81.5,uM,=,1.9111576087399769,1,c1ccccc1
261,28608,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 6.0-41.2,C#CCNCCc1cccc(OC(=O)N(C)CCC)c1,Methyl-propyl-carbamic acid 3-(2-prop-2-ynylamino-ethyl)-phenyl ester,15.4,uM,=,1.187520720836463,1,c1ccccc1
262,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(=O)(=O)c1ccc([N+](=O)[O-])cc1,"1-(4-nitro benzene)-sulfonyl-cis-2,6-dimethylpiperidine",1.15,uM,=,0.0606978403536116,1,O=S(=O)(c1ccccc1)N1CCCCC1
263,2261374,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2cccc(-c3cc(=O)c4ccccc4o3)c2)c1,[3-[[methyl-[7-[3-(4-oxochromen-2-yl)phenoxy]heptyl]amino]methyl]phenyl]N-methylcarbamate,0.00052,uM,=,-3.283996656365201,0,O=c1cc(-c2cccc(OCCCCCCCNCc3ccccc3)c2)oc2ccccc12
264,1620689,10.1021/acs.jmedchem.6b00967,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,O=C(COc1ccc(Cl)cc1Cl)Nc1ccc(CN2CCCCC2)cc1,SID24793496,0.03,uM,=,-1.5228787452803376,0,O=C(COc1ccccc1)Nc1ccc(CN2CCCCC2)cc1
265,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,4-(4-Benzhydryloxy-piperidin-1-yl)-1-(4-tert-butyl-phenyl)-butan-1-one,7.4799,uM,=,0.873895791749689,1,O=C(CCCN1CCC(OC(c2ccccc2)c2ccccc2)CC1)c1ccccc1
266,1842234,10.1016/j.bmc.2019.01.025,,,,Inhibition of human acetylcholinesterase,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",3.8,uM,=,0.5797835966168101,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
267,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,COc1ccc(C(=O)COc2ccc([N+](C)(C)C)cc2)cc1OC.[Br-],"{4-[2-(3,4-Dimethoxy-phenyl)-2-oxo-ethoxy]-phenyl}-trimethyl-ammonium bromide",10.0,uM,=,1.0,1,O=C(COc1ccccc1)c1ccccc1
268,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC1(C)Oc2cc3oc(=O)ccc3cc2C[C@@H]1O,decursinol,28.0,uM,=,1.4471580313422192,1,O=c1ccc2cc3c(cc2o1)OCCC3
269,2015826,10.1016/j.bmcl.2020.127370,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by UV-vis spectrophotometry based Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",7.56,uM,=,0.8785217955012066,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
270,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCN1CCc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-butyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.029,uM,=,-1.537602002101044,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
271,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1ccoc1,"2-(Furan-3-yl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-ol",341.7,uM,=,2.5336449787987627,1,c1ccc2c(c1)CNC(c1ccoc1)N2
272,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,COc1ccc(CN2CCC(CCNC(=O)/C=C/c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)CC2)cc1,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(4-methoxybenzyl)piperidin-4-yl)ethyl)acrylamide",2.12,uM,=,0.3263358609287514,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
273,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,C[n+]1cc2c3c(ccc2c2ccc4cc5c(cc4c21)OCO5)OCO3,"13-methyl[1,3]dioxolo[4',5':4,5]benzo[c][1,3]dioxolo[5,4-i]phenanthridin-13-ium",1.22,uM,=,0.0863598306747482,1,c1cc2c(c[nH+]c3c4cc5c(cc4ccc23)OCO5)c2c1OCO2
274,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C=C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophen-2-ylmethylene)-1-methyl-piperidinium bromide",2.67,uM,=,0.4265112613645752,1,C(=C1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
275,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,CCN(CCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1OC,"2-[4-[[(2-Methoxyphenyl)methyl]ethylamino]butyl]-1H-isoindole-1,3(2H)-dione",0.28,uM,=,-0.5528419686577808,0,O=C1c2ccccc2C(=O)N1CCCCNCc1ccccc1
276,1553281,10.1016/j.bmc.2016.02.023,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by spectrophotometric-based Ellman's method,O=c1cc(Cl)c2ccc(OCCNC3CCN(Cc4ccccc4)CC3)cc2o1,7-(2-((1-Benzylpiperidin-4-yl)amino)ethoxy)-4-chloro-2H-chromen-2-one,2.04,uM,=,0.3096301674258988,1,O=c1ccc2ccc(OCCNC3CCN(Cc4ccccc4)CC3)cc2o1
277,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,Cc1ccc2c(c1)C(=O)C(=O)N2C(=O)N(C)C,"N,N,5-trimethyl-2,3-dioxoindoline-1-carboxamide",0.1445,uM,=,-0.8401321529074334,0,O=C1Nc2ccccc2C1=O
278,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CC[N+](C)(C)C2N3C)cc1.[Br-],"(3aS)-5-(4-isopropylphenylcarbamoyloxy)-1,1,3a,8-tetramethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium bromide",0.145,uM,=,-0.8386319977650252,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+]C1N2
279,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=C(F)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(F)C1=O)Cc1ccccc1OC,"2,5-bis{6-[ethyl(2-methoxybenzyl)amino]hexylamino}-3,6-difluoro-[1,4]-benzoquinone",0.00517,uM,=,-2.2865094569060576,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
280,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3cccc(C)n3)cc1C(N)=O)C2.[Br-],"4-[(5,6-Dimethoxy-1-oxo-indan-2-yl)methyl]-1-[(6-methyl-2-pyridyl)methyl]pyridin-1-ium-3-carboxamide bromide",1.861,uM,=,0.269746373130767,1,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccn2)cc1
281,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(CCCOc2ccc3c(=O)c4ccccc4oc3c2)C(C)C)c1,Methyl-carbamic acid 3-({isopropyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0007,uM,=,-3.154901959985743,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
282,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCc3cc[n+](Cc4ccsc4)cc3)sc2cc1OC,"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-thiophen-3-ylmethyl-pyridinium",0.006,uM,=,-2.2218487496163566,0,O=C(CCc1cc[n+](Cc2ccsc2)cc1)c1cc2ccccc2s1
283,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4ccccc4o3)cc2c1,"N1,N1-Bis(benzofuran-2-ylmethyl)-N7-(2,3-dihydro-1Hcyclopenta[b]quinolin-9-yl)heptane-1,7-diamine",0.222,uM,=,-0.6536470255493614,0,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4ccccc4o3)cc2c1
284,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,"2-(6-(Benzyl(methyl)amino)hexyl)isoindoline-1,3-dione hydrochloride",1.831,uM,=,0.2626883443016964,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
285,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,Cc1ccc(/C=C2\CN(C(=O)C[C@H]3C[C@H]4CCCN4[C@]34C(=O)Nc3ccccc34)C/C(=C\c3ccc(C)cc3)C2=O)cc1,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-4-methylpheylmethylidene]tetrahydro-4''(1H)-pyridinones",20.07,uM,=,1.3025473724874856,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
286,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.NC(Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"2-amino-N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.0074,uM,=,-2.130768280269024,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
287,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(CC1C=CN(Cc3ccccc3C)C=C1C(C)=O)C2,"2-[[3-Acetyl-1-(o-tolylmethyl)-4H-pyridin-4-yl]methyl]-5,6-dimethoxy-indan-1-one",0.428,uM,=,-0.368556230986828,0,O=C1c2ccccc2CC1CC1C=CN(Cc2ccccc2)C=C1
288,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,COc1ccc(NC(=S)NCCN(C)C)cc1Cl,1-(3-Chloro-4-methoxyphenyl)-3-(2-(dimethylamino)ethyl)thiourea,46.0,uM,=,1.662757831681574,1,c1ccccc1
289,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(3-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-methoxythiazole-5-carboxamide",0.0036,uM,=,-2.4436974992327127,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1
290,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cc1ccc(-[n+]2ccc3c4ccccc4n(C)c3c2)cc1,"9-methyl-2-(p-tolyl)pyrido[3,4-b]indol-2-ium",0.29,uM,=,-0.5376020021010439,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
291,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)c3c(nc2c1)CCCCC3,"N,N'-Bis-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)-heptane-1,7-diamine",0.0027,uM,=,-2.5686362358410126,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)c3c(nc2c1)CCCCC3
292,1653858,10.1016/j.ejmech.2016.11.050,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by spectrophotometry based Ellman method,Nc1c2c(nc3c1C(c1cccc(F)c1)c1ccc4cccnc4c1O3)CCCC2,"7-(3-Fluorophenyl)-9,10,11,12-tetrahydro-7H-pyrano[2,3-b:5,6-h']diquinolin-8-amine",2.2,uM,=,0.3424226808222063,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2cccnc32)CCCC4)cc1
293,1768646,10.1016/j.bmc.2018.01.029,,,,Inhibition of AChE (unknown origin),COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,"Tetrahydro-furan-2-carboxylic acid {3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]-propyl}-amide",0.018,uM,=,-1.744727494896694,0,O=C(NCCCNc1ncc2ccccc2n1)C1CCCO1
294,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(c1ccccc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-phenyl-benzamide (C4H4O4),0.035,uM,=,-1.4559319556497243,0,O=C(c1ccccc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
295,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(CN(CCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4cccc(OC)c4o3)oc12,"N1,N1-Bis((7-methoxybenzofuran-2-yl)methyl)-N6-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)hexane-1,6-diamine",1.036,uM,=,0.0153597554092142,1,c1ccc2oc(CN(CCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4ccccc4o3)cc2c1
296,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(C)CCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-((methyl(4-(9-oxo-9H-xanthen-3-yloxy)butyl)amino)methyl)phenyl hexylcarbamate,0.1,uM,=,-1.0,0,O=c1c2ccccc2oc2cc(OCCCCNCc3ccccc3)ccc12
297,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(-n4ccnc4)cc3)C2)cc1OC,"1-(5-(4-(1H-Imidazol-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",205.6,uM,=,2.313023110323238,1,c1ccc(C2=NNC(c3ccc(-n4ccnc4)cc3)C2)cc1
298,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCCOC[n+]1ccn(C)c1/C=N/O.[Cl-],3-But-3-ynyloxymethyl-2-(hydroxyimino-methyl)-1-methyl-3H-imidazol-1-ium chloride,14.5,uM,=,1.1613680022349748,1,c1c[nH+]c[nH]1
299,2266747,10.1021/acs.jmedchem.0c01664,,,,Inhibition of AChe (unknown origin),CN1c2ccc(OC(=O)Nc3cccnc3)cc2[C@]2(C)CCO[C@H]12,"(3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl pyridin-3-ylcarbamate",1.7,uM,=,0.2304489213782739,1,O=C(Nc1cccnc1)Oc1ccc2c(c1)C1CCO[C@@H]1N2
300,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](Cc2ccc(C[n+]3ccccc3)cc2)cc1,"1,1'-bis(pyridinium)-1,4-phenyldimethylene dibromide",1540.0,uM,=,3.187520720836463,1,c1cc[n+](Cc2ccc(C[n+]3ccccc3)cc2)cc1
301,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCc3cccc(CN(C)CCCC(F)F)c3)cc2oc1=O,"7-((3-(((4,4-difluorobutyl)(methyl)amino)methyl)benzyl)oxy)-3,4-dimethyl-2H-chromen-2-one",1.7,uM,=,0.2304489213782739,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
302,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1C2,"(3aS,8aR)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl heptylcarbamate",0.114,uM,=,-0.9430951486635274,0,c1ccc2c(c1)C[C@H]1NCCC21
303,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1cccc(CN2C/C(=C\c3ccccc3)C(=O)/C(=C/c3ccccc3)C2)c1,"(3E,5E)-3,5-dibenzylidene-1-(3-methylbenzyl)piperidin-4-one",3.18,uM,=,0.5024271199844327,1,O=C1/C(=C/c2ccccc2)CN(Cc2ccccc2)C/C1=C\c1ccccc1
304,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCN1CCC2CC1c1ccc(OC(=O)NC)cc12,"Methyl-carbamic acid 9-ethyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.171,uM,=,-0.7670038896078462,0,c1ccc2c(c1)C1CCNC2C1
305,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3ccccc13)C1CCC2C1,"9-Amino-1,4-methano-1,2,3,4-tetrahydroacridine",0.0315,uM,=,-1.5016894462103996,0,c1ccc2nc3c(cc2c1)C1CCC3C1
306,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-ethyl-7-methoxytacrine hydrochloride,66.0,uM,=,1.8195439355418688,1,c1ccc2nc3c(cc2c1)CCCC3
307,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3ccc(=O)oc3c2)c1,Heptyl-carbamic acid 3-({methyl-[3-(2-oxo-2H-chromen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0373999999999999,uM,=,-1.42712839779952,0,O=c1ccc2ccc(OCCCNCc3ccccc3)cc2o1
308,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1cccc(Cl)c1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(3-chlorbenzyl)berberine bromide,1.9,uM,=,0.2787536009528289,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
309,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1cccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)c1,(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(3-methoxyphenyl)acrylamide,4.67,uM,=,0.6693168805661122,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
310,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(Cc1ccc(O)cc1)C1CCC(C)C(c2ccc(O)cc2)C1,4-{5-[2-(4-hydroxyphenyl)-1-methylethyl]-2-methylcyclohexyl}phenol,0.62,uM,=,-0.2076083105017461,0,c1ccc(CCC2CCCC(c3ccccc3)C2)cc1
311,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(7-(6-methoxy-1-methylpyridinium-2-yl)heptyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",0.049,uM,=,-1.3098039199714864,0,c1ccc(CCCCCCC[NH+]2CCc3ccccc3C2)[nH+]c1
312,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(Cl)c3)CC1)C2,"2-((1-(3-chlorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.114,uM,=,-0.9430951486635274,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
313,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(C4CCN(C)CC4)CC3)nc12,N-(4-Methylbenzo[d]thiazol-2-yl)-3-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)propanamide,10.52,uM,=,1.0220157398177203,1,O=C(CCN1CCN(C2CCNCC2)CC1)Nc1nc2ccccc2s1
314,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cn2cc(C(N)=O)ccc2[n+]1C.[I-],"6-carbamoyl-1,2-dimethylimidazo[1,2-a]pyridin-1-ium",27.0,uM,=,1.4313637641589874,1,c1ccn2cc[nH+]c2c1
315,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(F)cc1)CCCC3,"ethyl 5-amino-4-(4-fluorophenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.19,uM,=,-0.721246399047171,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
316,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C2\CNC/C(=C\c3ccc(C(OCC)OCC)cc3)C2=O)cc1,"3,5-Bis[4-(diethoxymethyl)benzylidene]piperidin-4-one",0.92,uM,=,-0.0362121726544447,0,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
317,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"3-chloro-5,6,7,8-tetrahydroacridin-9-amine hydrochloride",0.00832,uM,=,-2.079876673709276,0,c1ccc2nc3c(cc2c1)CCCC3
318,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,CC(=O)Nc1cc(C(=O)Nc2cncc(OCC3CCN(Cc4ccc(F)cc4)CC3)c2)ccn1,2-acetamido-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide,0.009,uM,=,-2.0457574905606752,0,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccncc1
319,1807943,10.1016/j.ejmech.2019.07.051,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry analysis,O=C(CCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NC12CC3CC(F)(CC(C1)c1ccccc13)C2,"4-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-N-(9-fluoro-7H-5,6,8,9,10,11-hexahydro-5,9:7,11-dimethanobenzo[9]annulen-7-yl)butanamide",0.0014,uM,=,-2.853871964321762,0,O=C(CCCNc1c2c(nc3ccccc13)CCCC2)NC12CC3CC(C1)c1ccccc1C(C3)C2
320,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c3ccccc32)cc1,"1-[(4-methoxyphenyl)methyl]-4-oxo-N-{7-[(1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-1,4-dihydroquinoline-3-carboxamide",0.194,uM,=,-0.712198270069774,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
321,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,CN(C)c1ccc(/C=C2/S/C(=N/c3ccc4oc(=O)ccc4c3)NC2=O)cc1,5-[4-(Dimethylamino)benzylidene]-2-[(2-oxo-2H-chromen-6-yl)imino]thiazolidin-4-one,0.084,uM,=,-1.0757207139381184,0,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1
322,28314,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.16-0.18,C#CC(C)NCCc1cccc(OC(=O)N(C)C)c1,Dimethyl-carbamic acid 3-[2-(1-methyl-prop-2-ynylamino)-ethyl]-phenyl ester,0.17,uM,=,-0.7695510786217261,0,c1ccccc1
323,2261363,10.1016/j.ejmech.2022.114606,,,,Inhibition of human AChE,COC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+]([11CH3])c1,methyl 5-(dimethylcarbamoyloxy)-1-(11C)methyl-quinolin-1-ium-3-carboxylate,0.02,uM,=,-1.6989700043360187,0,c1ccc2[nH+]cccc2c1
324,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,C/N=C1/CCc2c1n(C)c1ccc(OC(=O)NC)c(Br)c21,"Methyl-carbamic acid 8-bromo-4-methyl-3-[(Z)-methylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.18,uM,=,-0.744727494896694,0,N=C1CCc2c1[nH]c1ccccc21
325,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,Cc1ccc(CN2CCC(CCNC(=O)/C=C/c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)CC2)cc1,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(4-methylbenzyl)piperidin-4-yl)ethyl)acrylamide",2.01,uM,=,0.3031960574204888,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
326,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(N4CCCCC4)c2c1)CCCC3,"7-Methyl-9-(piperidin-1-yl)-1,2,3,4-tetrahydroacridine",0.118,uM,=,-0.9281179926938746,0,c1ccc2c(N3CCCCC3)c3c(nc2c1)CCCC3
327,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0062,uM,=,-2.207608310501746,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
328,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,COc1ccc(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,"3-(3,4-Dimethoxyphenyl)-8,8-dimethylpyrano[2,3-f]chromen-4(8H)-one",131.17,uM,=,2.117834518543748,1,O=c1c(-c2ccccc2)coc2c3c(ccc12)OCC=C3
329,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,COc1ccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1,(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(4-methoxyphenyl)acrylamide,4.56,uM,=,0.658964842664435,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
330,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CC2CCCCC2C)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-[(2-methylcyclohexyl)methyl]-4-piperidyl]propan-1-one,0.321,uM,=,-0.4934949675951279,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccccc1
331,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCCCNc3c4c(nc5cc(Cl)cc(Cl)c35)CCCC4)c2c1,"7-(6,8-dichloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
332,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COC(=O)c1c[n+](Cc2ccccc2C)ccc1CC1Cc2cc(OC)c(OC)cc2C1=O.[Br-],"(+/-)-Methyl-4-[(5,6-Dimethoxy-1-oxo-indan-2-yl)methyl]-1-(o-tolylmethyl)pyridin-1-ium-3-carboxylate Bromide",0.0058,uM,=,-2.2365720064370627,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
333,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CC/N=C1/CCc2c1n(C)c1ccc(OC(=O)NC)c(Br)c21,"Methyl-carbamic acid 8-bromo-3-[(Z)-ethylimino]-4-methyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.14,uM,=,-0.8538719643217619,0,N=C1CCc2c1[nH]c1ccccc21
334,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2cc(-c3ccccc3)c(NCCN3CCOCC3)nn2)cc1,"(4,6-Diphenyl-pyridazin-3-yl)-(2-morpholin-4-yl-ethyl)-amine (2HCl)",260.0,uM,=,2.414973347970818,1,c1ccc(-c2cc(-c3ccccc3)c(NCCN3CCOCC3)nn2)cc1
335,1757796,10.1016/j.ejmech.2017.06.048,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method,c1ccc2c(NCCCCCSSCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"Bis[5-(1',2',3',4'-tetrahydroacridin-9'-ylamino)pentyl]disulfide",0.00162,uM,=,-2.790484985457369,0,c1ccc2c(NCCCCCSSCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
336,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,CN(Cc1ccccc1)Cc1ccc(NC(=O)/C=C/c2cccc(O)c2)cc1,(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(3-hydroxyphenyl)acrylamide,3.49,uM,=,0.5428254269591799,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
337,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)CC2,"2-{4-[(Benzylmethylamino)methyl]benzylidene}-6,7-dimethoxy-3,4-dihydro-2H-naphthalen-1-one",0.18,uM,=,-0.744727494896694,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)CCc2ccccc21
338,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,COc1cc2c(cc1OC)C(NC(=O)CN1CCN(Cc3ccccc3)CC1)c1cnn(-c3ccccc3)c1-2,"2-(4-Benzylpiperazin-1-yl)-N-(6,7-dimethoxy-1-phenyl-1,4-dihydroindeno[1,2-c]pyrazol-4-yl)acetamide",2.99,uM,=,0.4756711883244297,1,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2ccccc2-c2c1cnn2-c1ccccc1
339,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1,"N-(7-((1,2,3,4-Tetrahydroacridin-9-yl)amino)heptyl)benzofuran-2-carboxamide",0.0769,uM,=,-1.114073660198569,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1
340,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(5-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)pentyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.12,uM,=,-0.9208187539523752,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
341,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,"N4-Benzyl-N2-isopropylquinazoline-2,4-diamine",6.4,uM,=,0.8061799739838872,1,c1ccc(CNc2ncnc3ccccc23)cc1
342,1807943,10.1016/j.ejmech.2019.07.051,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry analysis,O=C(CCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NC12CC3CC(F)(CC(C1)c1ccccc13)C2,"5-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-N-(9-fluoro-7H-5,6,8,9,10,11-hexahydro-5,9:7,11-dimethanobenzo[9]annulen-7-yl)pentanamide",0.0013,uM,=,-2.886056647693163,0,O=C(CCCCNc1c2c(nc3ccccc13)CCCC2)NC12CC3CC(C1)c1ccccc1C(C3)C2
343,1853673,10.1016/j.ejmech.2019.06.041,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition measured for 15 mins by Ellman's method,Cn1ncc2cc(C(=O)Nc3ccc(Cl)c(Cl)c3)ccc21,"N-(3,4-Dichlorophenyl)-1-methyl-1H-indazole-5-carboxamide",78.3,uM,=,1.893761762057944,1,O=C(Nc1ccccc1)c1ccc2[nH]ncc2c1
344,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CN(Cc1ccccc1)Cc1ccc(/C=C2\Cc3ccc(OCCCCN4CCOCC4)cc3C2=O)cc1,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(4-morpholin-4-yl-butoxy)indan-1-one,0.89,uM,=,-0.0506099933550872,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccc(OCCCCN3CCOCC3)cc21
345,2198746,10.1039/d2md00087c,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 sec for 3 mins by DTNB-based UV analysis,CCN(CC)C(=O)c1ccc2c(c1)nc(Cc1ccc(OC(=O)NCCCCCCN3CCc4ccccc4C3)cc1)n2CCC(C)C,"4-((5-(Diethylcarbamoyl)-1-isopentyl-1H-benzo[d]imidazol-2-yl)methyl)phenyl (6-(3,4-dihydroisoquinolin-2(1H)-yl)hexyl)carbamate",9.522,uM,=,0.9787281771384918,1,O=C(NCCCCCCN1CCc2ccccc2C1)Oc1ccc(Cc2nc3ccccc3[nH]2)cc1
346,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccc(C(C)NS(=O)(=O)NC(=O)OCc2ccccc2)cc1,Benzyl N-(1-(4-methoxyphenyl)ethyl)sulfamoylcarbamate,2.685e-05,uM,=,-4.571055709964425,0,O=C(NS(=O)(=O)NCc1ccccc1)OCc1ccccc1
347,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)NCCc2c[nH]c3ccc(Cl)cc23)ccc1O,(E)-N-(2-((2-(5-chloro-1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)actylamide,0.84,uM,=,-0.0757207139381183,0,O=C(/C=C/c1ccccc1)NCC(=O)NCCc1c[nH]c2ccccc12
348,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2ccccc2)C3=O)c1,"Methyl-carbamic acid 3-({[7-(2-benzylidene-3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-methyl-amino}-methyl)-phenyl ester",1.95,uM,=,0.290034611362518,1,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
349,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCNC(=O)CSCc2ccc(CN(C)C)o2)o1,2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-N-[2-(5-dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-acetamide,2.5,uM,=,0.3979400086720376,1,O=C(CSCc1ccco1)NCCSCc1ccco1
350,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCn1c(C)nc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21,3-(1-benzylpiperidin-4-yl)-1-(1-ethyl-2-methyl-1H-benzo[d]imidazol-5-yl)propan-1-one,0.0043,uM,=,-2.3665315444204134,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]cnc2c1
351,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c2)nc1OCC1CC1,"2-(2-(2-((2-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)-4-(cyclopropylmethoxy)-N-methylthiazole-5-carboxamide",0.0405,uM,=,-1.3925449767853315,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
352,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-6-methoxy-benzo[d]isoxazole,0.0088,uM,=,-2.055517327849832,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
353,2213907,10.1016/j.ejmech.2021.113949,,,,Inhibition of human AChE,c1ccc2c(c1)CCN1Cc3cc(OCCCN4CCCCC4)ccc3N=C21,"10-(3-(piperidin-1-yl)propoxy)-6,8-dihydro-5H-isoquinolino[1,2-b]quinazoline",0.216,uM,=,-0.6655462488490691,0,c1ccc2c(c1)CCN1Cc3cc(OCCCN4CCCCC4)ccc3N=C21
354,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,COc1ccc2[nH]c3cc[n+](C)cc3c2c1.[I-],"8-methoxy-2-methyl-5H-pyrido[4,3-b]indol-2-ium iodide",14.7,uM,=,1.167317334748176,1,c1ccc2c(c1)[nH]c1cc[nH+]cc12
355,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN3CCc4ccccc4C3)cc2)cc1OC,"[4-(3,4-Dihydro-1H-isoquinolin-2-ylmethyl)phenyl]-(3,4-dimethoxyphenyl)methanone",54.0,uM,=,1.7323937598229686,1,O=C(c1ccccc1)c1ccc(CN2CCc3ccccc3C2)cc1
356,1443169,10.1016/j.ejmech.2014.09.081,,,,Inhibition of human erythrocyte AChE preincubated for 15 mins by Ellman's method,CCN(C)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,"(E)-2-(4-(ethyl(methyl)amino)benzylidene)-5-methoxy-6-(2-(piperidin-1-yl)ethoxy)-2,3-dihydro-1H-inden-1-one",0.426,uM,=,-0.3705904008972811,0,O=C1/C(=C/c2ccccc2)Cc2ccc(OCCN3CCCCC3)cc21
357,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OC(=O)N(C)C,(E)-4-(3-(4-benzylpiperidin-1-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl dimethylcarbamate,16.6,uM,=,1.2201080880400552,1,O=C(/C=C/c1ccccc1)N1CCC(Cc2ccccc2)CC1
358,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,Cc1cccc(C2N(C)Cc3cc(O)ccc3N2C)c1,"1,3-Dimethyl-2-m-tolyl-1,2,3,4-tetrahydroquinazolin-6-ol",437.0,uM,=,2.640481436970422,1,c1ccc(C2NCc3ccccc3N2)cc1
359,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)/C(=N\NC(=O)CNC(=O)C(C)c1ccc(CC(C)C)cc1)C(CC1CCN(Cc3ccccc3)CC1)C2,"N-[2-[(2Z)-2-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]hydrazino]-2-oxo-ethyl]-2-(4-isobutylphenyl)propanamide",1.19,uM,=,0.0755469613925307,1,O=C(Cc1ccccc1)NCC(=O)N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
360,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-N-methyl-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0012,uM,=,-2.920818753952376,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
361,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cccc2c(CCC3CCN(Cc4ccccc4)CC3)noc12,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-7-methoxy-benzo[d]isoxazole,0.0070999999999999,uM,=,-2.148741651280925,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
362,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccccc1CN1CCC(CCC(=O)c2ccc3c(c2)NCCCC3)CC1,"3-[1-(2-Methoxy-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",2.652,uM,=,0.4235735197327355,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
363,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,CC(=O)O[C@@H]1C[C@@]2(C)[C@@H]3CC[C@H]4[C@](C)(CO)[C@@H](NC(=O)c5ccccc5)C=C[C@]4(O)CC3=CC[C@]2(C)[C@H]1[C@H](C)N(C)C,buxalongifolamidine,30.2,uM,=,1.4800069429571507,1,O=C(N[C@H]1C=CC2CC3=CCC4CCCC4[C@@H]3CC[C@H]2C1)c1ccccc1
364,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/C(C)=C/c1ccccc1)c1ccc(=O)[nH]c1C2,"13-Ethylidene-11-methyl-1-[2-methyl-3-phenyl-prop-2-enylideneamino]-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.025,uM,=,-1.6020599913279625,0,C=C1[C@H]2C=CC[C@]1(/N=C/C=C/c1ccccc1)c1ccc(=O)[nH]c1C2
365,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,COc1ccc(C(=O)COc2cccc([N+](C)(C)C)c2)cc1OC.[Br-],"{3-[2-(3,4-Dimethoxy-phenyl)-2-oxo-ethoxy]-phenyl}-trimethyl-ammonium bromide",10.0,uM,=,1.0,1,O=C(COc1ccccc1)c1ccccc1
366,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc2nc3c(c(N)c2c1)CCC3.Cl,"7-methoxy-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",8.22,uM,=,0.9148718175400504,1,c1ccc2nc3c(cc2c1)CCC3
367,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc2c(cc1OC)C(=O)C(CCCCCc1cccc(OC)[n+]1C)C2.O=S(=O)([O-])C(F)(F)F,"2-(5-(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)pentyl)-6-methoxy-1-methylpyridinium trifluoromethanesulfonate",0.13,uM,=,-0.8860566476931633,0,O=C1c2ccccc2CC1CCCCCc1cccc[nH+]1
368,462117,10.1021/jm7009364,,,,Inhibition of human AchE,c1ccc2c(NCCc3ccc(OCCCN4CCCCC4)cc3)c3c(nc2c1)CCCC3,"{2-[4-(3-Piperidin-1-yl-propoxy)-phenyl]-ethyl}-(1,2,3,4-tetrahydro-acridin-9-yl)-amine oxalic acid",0.0026,uM,=,-2.5850266520291822,0,c1ccc2c(NCCc3ccc(OCCCN4CCCCC4)cc3)c3c(nc2c1)CCCC3
369,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,CCOCCN1CCN(CCC(=O)Nc2nc3c(C)cccc3s2)CC1,3-(4-(2-Ethoxyethyl)piperazin-1-yl)-N-(4-methylbenzo[d]-thiazol-2-yl)propanamide,20.08,uM,=,1.3027637084729815,1,O=C(CCN1CCNCC1)Nc1nc2ccccc2s1
370,2050396,10.1016/j.bmc.2020.115826,,,,Inhibition of human AchE expressed in HEK293 cells using acetylthiocholine as substrate by Ellman's method,CS[C@@H](Cn1nnc2cc(C#Cc3ccc(CN4CCOCC4)cc3)ccc21)N(O)C=O,N-hydroxy-N-[(1S)-1-methylsulfanyl-2-[5-[2-[4-(morpholinomethyl)phenyl]ethynyl]benzotriazol-1-yl]ethyl]formamide,3.5,uM,=,0.5440680443502757,1,C(#Cc1ccc2[nH]nnc2c1)c1ccc(CN2CCOCC2)cc1
371,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccccc1CN(C)Cc1ccc(-c2cc3cc(OC)c(OC)cc3oc2=O)cc1,"6,7-dimethoxy-3-(4-{[(2-methoxybenzyl)methylamino]methyl}phenyl)chromen-2-one",0.0621,uM,=,-1.2069083998234198,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
372,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCC(F)CC4)cc3)cc12,"3-(4-((4-Fluoropiperidin-1-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.89,uM,=,-0.0506099933550872,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
373,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,Clc1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1,"3-(4-Chlorophenyl)-6-(furan-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1
374,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3cccc(Cl)c13)C1CCC2C1,"5-chloro-10-azatetracyclo[10.2.1.02,11.04,9]pentadeca-2,4,6,8,10-pentaen-3-amine",0.0422,uM,=,-1.374687549038326,0,c1ccc2nc3c(cc2c1)C1CCC3C1
375,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),C[n+]1ccc2c3ccccc3n(CCCCCCCCCn3c4ccccc4c4cc[n+](C)cc43)c2c1,"9,9'-(nonane-1,9-diyl)bis(2-methyl-9H-pyrido[3,4-b]indol-2-ium)",0.0006,uM,=,-3.2218487496163566,0,c1ccc2c(c1)c1cc[nH+]cc1n2CCCCCCCCCn1c2ccccc2c2cc[nH+]cc21
376,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(Cl)n3)CC1)C2,"2-((1-((6-chloropyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.883,uM,=,-0.0540392964224314,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
377,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(CN1CCN(c2ccccc2)CC1)Nc1n[nH]c2ncccc12,"2-(4-Phenylpiperazin-l-yl)-N-(1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide",1.946,uM,=,0.2891428359323331,1,O=C(CN1CCN(c2ccccc2)CC1)Nc1n[nH]c2ncccc12
378,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CC2CCC2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclobutylmethyl)-4-piperidyl]propan-1-one,0.577,uM,=,-0.2388241868442686,0,O=C(CCC1CCN(CC2CCC2)CC1)c1ccccc1
379,2273297,10.1039/D1MD00217A,,,,Inhibition of AChE (unknown origin),CC1=C(CO[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)C(C)(C)CCC1,Nuciferoside,3.2,uM,=,0.505149978319906,1,C1=C(CO[C@H]2CCC[C@@H](CO[C@H]3CCCCO3)O2)CCCC1
380,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,"1-[2-(4-Chloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole (Econazole)",13.677,uM,=,1.1359908469216249,1,c1ccc(COC(Cn2ccnc2)c2ccccc2)cc1
381,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2cccc(F)c2)CC1)c1ccc2c(c1)NCCCC2,"3-[1-(3-Fluoro-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.145,uM,=,-0.8386319977650252,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
382,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2cc(=O)c3ccc(OCCN4CCC(C)CC4)cc3o2)cc1,2-(4-methoxyphenyl)-7-(2-(4-methylpiperidin-1-yl)ethoxy)-4H-chromen-4-one,0.00633,uM,=,-2.198596289982645,0,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCCCC3)ccc12
383,28593,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 3.69-33.1,C#CCN(C)C(C)Cc1cccc(OC(=O)N(C)C2CCCCC2)c1,Cyclohexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,8.67,uM,=,0.9380190974762104,1,O=C(NC1CCCCC1)Oc1ccccc1
384,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cccc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1,N-(3-((1-benzylpiperidin-4-yl)methoxy)phenyl)-2-(cyclopropanecarboxamido)isonicotinamide,1.394,uM,=,0.1442627737619906,1,O=C(Nc1cccc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1
385,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,1-(4-(Phenethylamino)quinazolin-2-yl)urea,7.9,uM,=,0.8976270912904415,1,c1ccc(CCNc2ncnc3ccccc23)cc1
386,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(C(F)(F)F)cc3)CC1)C2,"5,6-dimethoxy-2-((1-(4-(trifluoromethyl)benzyl)piperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",5.43,uM,=,0.7347998295888469,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
387,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3cccc([N+](=O)[O-])c3)C(=O)[C@@]3(C2)[C@H](c2cccc([N+](=O)[O-])c2)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(3-nitrophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(3-nitrophenyl)pyrrolidine,2.47,uM,=,0.3926969532596658,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
388,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl 2-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)acetate",0.21634,uM,=,-0.6648631746283751,0,O=C(CN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
389,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CCNC(=O)Oc1ccc2c(c1)C1(C)CCOC1O2,"Ethyl-carbamic acid 3a-methyl-2,3,3a,8a-tetrahydro-benzo[b]furo[3,2-d]furan-5-yl ester",0.36,uM,=,-0.4436974992327127,0,c1ccc2c(c1)OC1OCCC21
390,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cc2c(cc1OC)C(O)C(CC1CCN(c3ccccc3)CC1)C2,"5,6-dimethoxy-2-((1-phenylpiperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-ol",0.3,uM,=,-0.5228787452803376,0,c1ccc(N2CCC(CC3Cc4ccccc4C3)CC2)cc1
391,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,O=C(CC[C@H](NC(=O)c1c[nH]c2ccccc12)C(=O)O)NCCC1CCN(Cc2ccccc2)CC1,N-[Indole-3-carbonyl]-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-OH,6.4,uM,=,0.8061799739838872,1,O=C(CCCNC(=O)c1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
392,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0376,uM,=,-1.424812155072339,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
393,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2oc1=O,"(+)-3,4-Dimethyl-7-[(N-benzylpiperidin-3-yl)methoxy]-2H-chromen-2-one",0.84,uM,=,-0.0757207139381183,0,O=c1ccc2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2o1
394,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CC(C)n1cc(C(=O)C(F)(F)F)cn1,"2,2,2-trifluoro-1-(1-isopropyl-1H-pyrazol-4-yl)ethanone",0.121,uM,=,-0.91721462968355,0,c1cn[nH]c1
395,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Cc1ccc2[nH]c(-c3ccc(OCCN4CCCC4)cc3)nc2c1,5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-1H-benzo[d]imidazole,0.4,uM,=,-0.3979400086720376,0,c1ccc2[nH]c(-c3ccc(OCCN4CCCC4)cc3)nc2c1
396,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc12,"7-Methoxy-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)-benzofuran-2-carboxamide",0.0243999999999999,uM,=,-1.6126101736612706,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1
397,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccccc1C)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(2-methylbenzyl)berberine bromide,10.4,uM,=,1.0170333392987805,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
398,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1)CCCC3,"ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.122,uM,=,-0.9136401693252518,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
399,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CNC(NCCNCc1ccc(CN2CCCCC2)o1)=C(C#N)C#N.Cl,"2-(Methylamino-{2-[(5-piperidin-1-ylmethyl-furan-2-ylmethyl)-amino]-ethylamino}-methylene)-malononitrile, Di-hydrochloride",0.83,uM,=,-0.0809219076239261,0,c1coc(CN2CCCCC2)c1
400,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(NC(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1OC,SID7974988,0.00411,uM,=,-2.3861581781239307,0,O=C(Nc1ccccc1)C1CCN(C(=O)c2ccccc2)CC1
401,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(C[C@@H]2Cc3ccccc3C2=O)CC1,2-(1-Methyl-piperidin-4-ylmethyl)-indan-1-one,0.0053,uM,=,-2.275724130399211,0,O=C1c2ccccc2C[C@H]1CC1CCNCC1
402,1581164,10.1021/acs.jnatprod.5b00877,,,,Inhibition AChE (unknown origin) using ATCI as substrate assessed as hydrolysis of ATCI after 10 mins measured every 1 min for 10 times,COc1cc2occ(-c3ccc(O)cc3O)c(=O)c2c(O)c1CC=C(C)C,7-O-methylluteone,9.9,uM,=,0.99563519459755,1,O=c1c(-c2ccccc2)coc2ccccc12
403,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,FC(F)(F)c1cc(-c2ccccc2)nnc1NCCN1CCOCC1,N-(2-morpholinoethyl)-6-phenyl-4-(trifluoromethyl)pyridazin-3-amine,740.0,uM,=,2.869231719730976,1,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1
404,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(CN2CCC(Nc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)s3)CC2)cc1,"4-Methylbenzyl-N-[4,5-bis(4-chlorophenyl)thiazol-2-yl]-piperidin-4-ylamine",3.19,uM,=,0.5037906830571811,1,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
405,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"5-Hydroxy-4'-(3-((ethyl)(2-Methoxybenzyl)amino)butoxy)-6,7-dimethoxyflavone",0.25,uM,=,-0.6020599913279624,0,O=c1cc(-c2ccc(OCCCCNCc3ccccc3)cc2)oc2ccccc12
406,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccccc1I)CC2.[Br-],"2-(2-iodophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.79,uM,=,0.2528530309798932,1,C1=[N+](c2ccccc2)CCc2ccccc21
407,2261346,10.1016/j.ejmech.2022.114606,,,,Inhibition of AChE (unknown origin),CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN[C@@H]2N3)cc1,Bisnorcymserine,0.11,uM,=,-0.958607314841775,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
408,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCCCCNC(=O)C4(C)CCc5c(C)c(O)c(C)c(C)c5O4)c2c1)CCCC3,"6-hydroxy-N-(5-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)pentyl)-2,5,7,8-tetramethylchroman-2-carboxamide",13.29,uM,=,1.123524980942732,1,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
409,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3[N+](=O)[O-])CC1)C2,"5,6-Dimethoxy-2-[1-(2-nitro-benzyl)-piperidin-4-ylmethyl]-indan-1-one",3.11,uM,=,0.4927603890268375,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
410,29406,10.1021/jm990174v,,,,Enzyme inhibitory activity towards Acetylcholinesterase,NC(=O)O,Carbamic acid,67.0,uM,=,1.8260748027008264,1,
411,2022983,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",6.4,uM,=,0.8061799739838872,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
412,2289119,10.1016/j.ejmech.2022.114841,,,,Inhibition of AChE in human SH-SY5Ycells assessed as reduction AChE activity using acetylthiocholine as substrate incubated for 24 hrs by DTNB based Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",198.0,uM,=,2.296665190261531,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
413,2052542,10.1016/j.ejmech.2019.111958,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)CC)cc3o2)cc1,2-(4-((Ethyl(methyl)carbamoyl)oxy)phenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl ethyl(methyl)carbamate,6.8,uM,=,0.8325089127062363,1,O=c1cc(-c2ccccc2)oc2ccccc12
414,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCN(CC)CCNC(=O)c1ccc(N)cc1,4-Amino-N-(2-diethylamino-ethyl)-benzamide,1.0,uM,=,0.0,0,c1ccccc1
415,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2c1ccccc1,3-(1-benzylpiperidin-4-yl)-1-(1-phenylindolin-5-yl)propan-1-one,0.068,uM,=,-1.1674910872937636,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2c1ccccc1
416,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N+](C)(C)C1N2C.COS(=O)(=O)[O-],"(S)-1,1,3a,8-Tetramethyl-5-methylcarbamoyloxy-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium; sulfate",0.034,uM,=,-1.4685210829577449,0,c1ccc2c(c1)NC1[NH2+]CCC21
417,513727,10.1016/j.bmc.2008.07.009,,,,Inhibition of AchE,Oc1cccc(C2=Nc3ccccc3SC(c3ccccc3)C2)c1,"2-(Phenyl)-4-(3'-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepine",40.0,uM,=,1.6020599913279625,1,c1ccc(C2=Nc3ccccc3SC(c3ccccc3)C2)cc1
418,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,"2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one",353.86,uM,=,2.5488314731741526,1,O=c1cc(-c2ccccc2)oc2ccccc12
419,28622,10.1021/jm010949b,,,,In vitro inhibitory concentration against acetylcholinesterase of human erythrocytes,CC1=CC2Cc3nc4ccccc4c(N)c3C(C1)C2.Cl,"(+/-) 15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine hydrochloride",0.0516,uM,=,-1.2873502983727887,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
420,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2ccccc2Br)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(2-Bromophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",27.1,uM,=,1.4329692908744058,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
421,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc2c(CNc3ccnc(N4CCSCC4)n3)cccc2c1,N-(naphthalen-1-ylmethyl)-2-thiomorpholinopyrimidin-4-amine,12.8,uM,=,1.1072099696478683,1,c1ccc2c(CNc3ccnc(N4CCSCC4)n3)cccc2c1
422,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,C[n+]1c(/C=C/c2cc3ccccc3[nH]2)cc(N2CCOCC2)c2ccccc21.[I-],(E)-2-(2-(1H-indol-2-yl)vinyl)-1-methyl-4-(morpholin-4-yl)quinolinium iodide,4.4,uM,=,0.6434526764861874,1,C(=C/c1cc(N2CCOCC2)c2ccccc2[nH+]1)\c1cc2ccccc2[nH]1
423,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1cccc2nc3c(c(N)c12)CCCC3.Cl,"8-methyl-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.125,uM,=,-0.9030899869919436,0,c1ccc2nc3c(cc2c1)CCCC3
424,510556,10.1021/np800305b,,,,Inhibition of acetylcholinesterase,C/C=C(\C)C(=O)N[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)NC)CC[C@H]4[C@@H]3CC[C@H]2[C@H]1OC(C)=O,sarcovagine C,8.1,uM,=,0.9084850188786496,1,C1CC[C@@H]2CC[C@H]3[C@@H]4CCCC4CC[C@@H]3C2C1
425,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCCCC3)ccc12,2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)ethyl piperidine-1-carbodithioate,0.47,uM,=,-0.3279021420642826,0,O=c1ccc2ccc(OCCSC(=S)N3CCCCC3)cc2o1
426,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(hexylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-7-yl)acetamide",0.0253,uM,=,-1.596879478824182,0,O=c1c2ccccc2nc2n1CCC2
427,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccccc3Cl)cc12.[Br-],2-(2-chlorophenyl)-8-methoxyisoquinolinium bromide,5.33,uM,=,0.7267272090265723,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
428,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,COc1cc2c(c(OC)c1OC)C(=O)O[C@]21[C@H](O)[C@@H](O)C=C2CCN(C)[C@H]21,10-O-methylhostasine,113.0,uM,=,2.05307844348342,1,O=C1O[C@]2(CCC=C3CCN[C@H]32)c2ccccc21
429,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2oc3cc(OC)c(I)cc3c(=O)c2O)cc1,3-hydroxy-6-iodo-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one,0.00719,uM,=,-2.143271109617117,0,O=c1cc(-c2ccccc2)oc2ccccc12
430,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,COc1ccc2c(c1)c1cnccc1n2CCC(=O)N1c2ccccc2Sc2ccccc21,"3-(8-methoxy-5H-pyrido[4,3-b]indol-5-yl)-1-(10H-phenothiazin-10-yl)propan-1-one",0.54,uM,=,-0.2676062401770315,0,O=C(CCn1c2ccccc2c2cnccc21)N1c2ccccc2Sc2ccccc21
431,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,Fc1ccc(Cc2nnc3sc(-c4ccoc4)nn23)cc1,"3-(4-Fluorobenzyl)-6-(furan-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(Cc2nnc3sc(-c4ccoc4)nn23)cc1
432,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCN1CCN(CCCCCCN(CC)Cc2ccccc2OC)C(=O)C1=O)Cc1ccccc1OC,"1,4-Bis-{6-[ethyl-(2-methoxybenzyl)amino]hexyl}piperazine-2,3-dione",0.0689,uM,=,-1.161780778092374,0,O=C1C(=O)N(CCCCCCNCc2ccccc2)CCN1CCCCCCNCc1ccccc1
433,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(Br)cc23)cc1,N-Hydroxy-4-(2-bromoacridin-9-ylamino)benzamide,0.88,uM,=,-0.0555173278498313,0,c1ccc(Nc2c3ccccc3nc3ccccc23)cc1
434,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COC(=O)c1c(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cccc1OC,"methyl 2-methoxy-6-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)benzoate",0.0208,uM,=,-1.6819366650372385,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
435,972045,10.1016/j.bmcl.2013.04.081,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylcholine iodide as substrate preincubated for 15 mins prior to substrate addition by spectrophotometric analysis,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0029,uM,=,-2.537602002101044,0,c1ccc2c(c1)N[C@H]1NCCC21
436,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccccc1F)CC2.[Br-],"2-(2-fluorophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",2.94,uM,=,0.4683473304121572,1,C1=[N+](c2ccccc2)CCc2ccccc21
437,28478,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 29.3-103,C#CCC1CCCc2ccc(OC(=O)N(C)CC)cc21,"Ethyl-methyl-carbamic acid 8-prop-2-ynyl-5,6,7,8-tetrahydro-naphthalen-2-yl ester",52.4,uM,=,1.7193312869837267,1,c1ccc2c(c1)CCCC2
438,462129,10.1021/jm7009364,,,,Inhibition of human AchE induced amyloid beta42 aggregation,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis(6-((2-methoxybenzyl)(ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",5.93,uM,=,0.7730546933642626,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
439,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1ccc(C(=O)NC(=S)NCCOCCN(C)Cc2ccccc2)cc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(4-methyl-benzoyl)-thiourea,0.077,uM,=,-1.1135092748275182,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccccc1
440,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccc(O)cc21,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-6-hydroxy-2,3-dihydro-1H-inden-1-one",1.5,uM,=,0.1760912590556812,1,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
441,28460,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 13.6-128,C#CCN[C@H]1CCc2ccc(OC(=O)N(C)CC)cc21.Cl,Ethyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,34.9,uM,=,1.54282542695918,1,c1ccc2c(c1)CCC2
442,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCCCCCCC[n+]1cccc2ccccc21,"1,1'-(Decane-1,10-diyl)bis(9-amino-1,2,3,4-tetra-hydroacridinium) dibromide",0.001,uM,=,-3.0,0,c1ccc2c(c1)ccc[n+]2CCCCCCCCCC[n+]1cccc2ccccc21
443,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,9.94,uM,=,0.9973863843973132,1,c1ccccc1
444,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N+](C)(C)C1N2C.[Br-],"(3aS)-1,1,3a,8-tetramethyl-5-(o-tolylcarbamoyloxy)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium bromide",0.0146,uM,=,-1.8356471442155629,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+]C1N2
445,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CC(C)NP(=O)(NC(C)C)OP(=O)(NC(C)C)NC(C)C,iso-OMPA,340.0,uM,=,2.531478917042256,1,
446,2261397,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human AChE,C#CCNC1CCc2c(OC(=O)N(C)CC)cccc21,[1-(prop-2-ynylamino)indan-4-yl]N-ethyl-N-methyl-carbamate,150.0,uM,=,2.1760912590556813,1,c1ccc2c(c1)CCC2
447,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCC3CC[N+](C)(CCOc4ccccc4)CC3)sc2cc1OC.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-1-(2-phenoxy-ethyl)-piperidinium bromide",0.39,uM,=,-0.4089353929735008,0,O=C(CCC1CC[NH+](CCOc2ccccc2)CC1)c1cc2ccccc2s1
448,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc(CCCCCCCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(heptane-1,7-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",0.12,uM,=,-0.9208187539523752,0,c1ccc(CCCCCCCc2cccc[nH+]2)[nH+]c1
449,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1,"2-(5-(4-Fluorobenzylamino)pentyl)isoindoline-1,3-dione",0.268,uM,=,-0.5718652059712112,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
450,1335188,10.1016/j.ejmech.2014.03.042,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(O)c(F)c2)cc1,(4-((benzyl(methyl)amino)methyl)phenyl)(3-fluoro-4-hydroxyphenyl)methanone,3.66,uM,=,0.5634810853944107,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
451,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2oc(C(=O)NCC3CCN(Cc4ccccc4)CC3)cc(=O)c2cc1OC,"N-((1-benzylpiperidin-4-yl)methyl)-6,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide",1.46,uM,=,0.1643528557844371,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
452,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCCCCNC(=O)Oc1ccc2c(c1)C1CCN(CC)C2C1,"Heptyl-carbamic acid 9-ethyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.169,uM,=,-0.7721132953863264,0,c1ccc2c(c1)C1CCNC2C1
453,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N@@+](C)([O-])[C@@H]1N2C.Cl,"1-Hydroxy-1,3a,8-trimethyl-5-methylcarbamoyloxy-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium: hydrochloride",0.1,uM,=,-1.0,0,c1ccc2c(c1)N[C@H]1[NH2+]CCC21
454,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(CNCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)oc12,"N1-((7-Methoxybenzofuran-2-yl)methyl)-N7-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)heptane-1,7-diamine",0.00256,uM,=,-2.5917600346881504,0,c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)cc2c1
455,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(Cl)cc3)cc12.[Br-],2-(4-chlorophenyl)-8-methoxyisoquinolinium bromide,0.17,uM,=,-0.7695510786217261,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
456,1928808,10.1021/acs.jmedchem.6b00356,,,,Inhibition of human AChE using ACTI as substrate incubated for 40 mins measured at 1 min intervals for 10 mins by Ellman's assay,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,6.33,uM,=,0.8014037100173551,1,c1ccccc1
457,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(C)cc1)CCCC3,"ethyl 5-amino-2-methyl-4-(4-methylphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.169,uM,=,-0.7721132953863264,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
458,683819,10.1016/j.ejmech.2010.08.025,,,,Inhibition of human AChE by Ellman method,O=P(NN1CCOCC1)(NN1CCOCC1)Oc1ccccc1,"N,N'-Bis(4-aminomorpholine)phosphoramidic acid phenyl ester",9550.0,uM,=,3.9800033715837455,1,O=P(NN1CCOCC1)(NN1CCOCC1)Oc1ccccc1
459,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(Br)cc13)CCC2,"7-bromo-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",5.69,uM,=,0.7551122663950712,1,c1ccc2nc3c(cc2c1)CCC3
460,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,C[C@@H]([C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4C(=CC3=CC[C@]12C)CC[C@H](N(C)C)C4(C)C)N(C)C,buxaminol A,29.8,uM,=,1.4742162640762553,1,C1=C2CCCC[C@@H]2CC[C@@H]2C1=CCC1CCCC12
461,2261366,10.1016/j.ejmech.2022.114606,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by Ellman's method,CCN(C)C(=O)Oc1cccc(CN2CCC(CCC(=O)c3cc(Cl)c(N)cc3OC)CC2)c1,[3-[[4-[3-(4-amino-5-chloro-2-methoxy-phenyl)-3-oxo-propyl]-1-piperidyl]methyl]phenyl]N-ethyl-N-methyl-carbamate,4.15,uM,=,0.6180480967120927,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
462,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)ccoc3c2)c1,3-((methyl(3-(4-oxo-4H-chromen-7-yloxy)propyl)amino)methyl)phenyl butylcarbamate,0.25,uM,=,-0.6020599913279624,0,O=c1ccoc2cc(OCCCNCc3ccccc3)ccc12
463,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C/C(=C\CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)C3=CC[C@]12C)C(=O)O,Ganoderic acid Y,21.11,uM,=,1.3244882333076564,1,C1=C2C(=CCC3CCCC23)C2CCCC[C@@H]2C1
464,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cncc(C(=O)NC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1,N-(1-benzylpiperidin-4-yl)-5-(2-(cyclopropanecarboxamido)isonicotinamido)nicotinamide,0.622,uM,=,-0.2062096153091813,0,O=C(Nc1cncc(C(=O)NC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1
465,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,O=C(CCN1CCCCC1)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1,"3-(piperidino)-1-{4-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-piperazino}-1-propanone",0.0517,uM,=,-1.2865094569060576,0,O=C(CCN1CCCCC1)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1
466,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CCN(CC)Cc1ccc(CNCCN2CCNC2=C(C#N)C#N)o1.Cl,"2-(1-{2-[(5-Diethylaminomethyl-furan-2-ylmethyl)-amino]-ethyl}-imidazolidin-2-ylidene)-malononitrile, Di-hydrochloride",0.6,uM,=,-0.2218487496163563,0,C=C1NCCN1CCNCc1ccco1
467,751130,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human plasma AChE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.8,uM,=,-0.0969100130080563,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
468,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccc(F)cc12,"5-amino-5'-fluoro-8-nitro-2'-oxo-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,3'-indoline]-6-carbonitrile",3.29,uM,=,0.5171958979499743,1,O=C1Nc2ccccc2C12C=CN1CCNC1=C2
469,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccccc3C)cc1C(F)(F)F)C2=O,"4-((6-Methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)-1-(2-methylbenzyl)-3-(trifluoromethyl)pyridinium",0.2424,uM,=,-0.6154673845057514,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
470,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,"N4-(3,4-dimethoxybenzyl)-N2-ethylquinazoline-2,4-diamine",6.3,uM,=,0.7993405494535817,1,c1ccc(CNc2ncnc3ccccc23)cc1
471,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCOC1N2C,"Methyl-carbamic acid (S)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.027,uM,=,-1.5686362358410126,0,c1ccc2c(c1)NC1OCCC21
472,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(Cl)c3)CC2)nc1-c1ccccc1,Ethyl 2-(4-((4-acetamido-3-chlorophenyl)sulfonyl)piperazin-1-yl)-4-methyl-6-phenylpyrimidine-5-carboxylate,0.14351,uM,=,-0.8431178355606235,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
473,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCOCCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"3-(2-(1H-indol-3-yl)ethoxy)-N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)propanamide",0.0007,uM,=,-3.154901959985743,0,O=C(CCOCCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
474,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CN(C(=O)NCc1ccccc1)C(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"5-(2-Benzyl-acetamino-methylcarbomylo)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",6.3,uM,=,0.7993405494535817,1,O=C(NCc1ccccc1)NC(=O)Oc1ccc2c(c1)C1CCNC1N2
475,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)O[C@@H]1N2C,"o-Tolyl-carbamic acid 2,4a,9-trimethyl-2,3,4,4a,9,9a-hexahydro-1-oxa-2,9-diaza-fluoren-6-yl ester",0.175,uM,=,-0.7569619513137056,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNO[C@@H]1N2
476,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1nc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc2[nH]1,3-(1-benzylpiperidin-4-yl)-1-(2-methyl-1H-benzo[d]imidazol-5-yl)propan-1-one,0.012,uM,=,-1.9208187539523751,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]cnc2c1
477,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)Nc1ccc(Cl)cc1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(4-chloro-phenyl)-thiourea,1.8,uM,=,0.255272505103306,1,S=C(NCCOCCNCc1ccccc1)Nc1ccccc1
478,88385,10.1021/jm00377a010,,,,Concentration of the HOX that inhibits 50% of AChE (Acetylcholinesterase) activity,COC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-1-methoxymethyl-3-methyl-3H-imidazol-1-ium chloride,290.0,uM,=,2.462397997898956,1,c1c[nH+]c[nH]1
479,1461400,10.1016/j.bmcl.2014.12.071,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate by Ellman method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.484,uM,=,-0.3151546383555875,0,c1ccc2nc3c(cc2c1)CCCC3
480,2266926,10.1016/j.ejmech.2020.113102,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1OC)C(=O)[C@]1(C2)[C@H](c2ccc(C)cc2)[C@H](Cc2c[nH]c3ccccc23)NC12C(=O)Nc1ccccc12,"(2R,4'S,5'S)-5'-((1H-indol-3-yl)methyl)-5,6-dimethoxy-4'-(p-tolyl)dispiro[indene-2,3'-pyrrolidine-2',3''-indoline]-1,2''(3H)-dione",14.24,uM,=,1.1535099893008376,1,O=C1Nc2ccccc2C12N[C@@H](Cc1c[nH]c3ccccc13)[C@@H](c1ccccc1)[C@]21Cc2ccccc2C1=O
481,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CC2CCCCC2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one,0.016,uM,=,-1.7958800173440752,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccccc1
482,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1cc(=O)oc2cc(OCc3ccc(CN(C)Cc4ccccc4)cc3)ccc12.Cl,7-(4-(N-Benzyl-N-methylaminomethyl)benzyloxy)-4-methyl-2H-chromen-2-one hydrochloride,0.91,uM,=,-0.0409586076789063,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
483,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCCCCSC(=O)OCC[N+](C)(C)C.[Cl-],Trimethyl-(2-pentylsulfanylcarbonyloxy-ethyl)-ammonium chloride,0.7999999999999999,uM,=,-0.0969100130080564,0,
484,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1cc([C@H]2Oc3cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c3C(=O)[C@@H]2O)ccc1O,3'-O-Methyldiplacol,48.5,uM,=,1.6857417386022635,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
485,510556,10.1021/np800305b,,,,Inhibition of acetylcholinesterase,C[C@@H]([C@H]1CC=C2[C@@H]3CCC4=C[C@@H](N(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C)N(C)C,"(20S)-20-(N-dimethylamino)-3beta-(N-dimethylamino)-pregn-4,14-diene",24.2,uM,=,1.383815365980431,1,C1=C2CC[C@H]3C4=CCCC4CC[C@@H]3C2CCC1
486,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[6-(benzylmethylamino)hexyloxy]xanthen-9-one,2.89,uM,=,0.4608978427565479,1,O=c1c2ccccc2oc2cc(OCCCCCCNCc3ccccc3)ccc12
487,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1cncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)c1,"3-(4-(Piperidin-1-ylmethyl)phenyl)-6-(pyridin-3-yl)-9H-pyrrolo-[2,3-b:5,4-c']dipyridine",0.493,uM,=,-0.30715308072277,0,c1cncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)c1
488,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc(COc2c(OC)ccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1.[Br-],9-O-(4-methoxybenzyl)berberine bromide,5.3,uM,=,0.724275869600789,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
489,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCC(CC)n1cc(C(=O)C(F)(F)F)cn1,"2,2,2-trifluoro-1-(1-(pentan-3-yl)-1H-pyrazol-4-yl)ethanone",0.00227,uM,=,-2.643974142806877,0,c1cn[nH]c1
490,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,COc1ccc(-c2cc3c(c(=O)o2)C(=O)C2[C@@]4(C)CC[C@H](O)[C@@](C)(CO)C4C[C@H](O)[C@@]2(C)O3)cc1,"3,6-Dihydroxy-4-hydroxymethyl-9-(4-methoxy-phenyl)-4,6a,12b-trimethyl-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-7,10-dioxa-benzo[a]anthracene-11,12-dione",70.0,uM,=,1.845098040014257,1,O=C1c2c(cc(-c3ccccc3)oc2=O)OC2CCC3CCCCC3C12
491,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccc(F)cc2)CC1)c1ccc2c(c1)CCN2,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(4-fluoro-benzyl)-piperidin-4-yl]-propan-1-one",0.089,uM,=,-1.0506099933550872,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
492,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,2-bis(4-tert.butylpyridinium)-eth-1,2-diyl dibromide",17.0,uM,=,1.230448921378274,1,c1cc[n+](CC[n+]2ccccc2)cc1
493,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-pentyl-7-methoxytacrine hydrochloride,6.7,uM,=,0.8260748027008264,1,c1ccc2nc3c(cc2c1)CCCC3
494,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1cccc(C)c1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(3-methylbenzyl)berberine bromide,7.3,uM,=,0.8633228601204559,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
495,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C/C(=O)/C=C/c2ccc(C(OCC)OCC)cc2)cc1,"1,5-Bis-(4-diethoxymethyl-phenyl)-penta-1,4-dien-3-one",55.34,uM,=,1.743039154804933,1,O=C(/C=C/c1ccccc1)/C=C/c1ccccc1
496,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,COc1cc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc(OC)c1OC,"4a,12a-Dihydroxy-4,4,6a,12b-tetramethyl-9-(3,4,5-trimethoxy-phenyl)-4a,6,6a,12,12a,12b-hexahydro-4H,5H-7,10-dioxa-benzo[a]anthracene-1,11-dione",0.008,uM,=,-2.096910013008056,0,O=C1C=CCC2CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC3C12
497,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2cccc(Cl)c2)CC1)c1ccc2c(c1)CCN2,"3-[1-(3-Chloro-benzyl)-piperidin-4-yl]-1-(2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.059,uM,=,-1.2291479883578558,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
498,1675794,10.1016/j.ejmech.2017.03.062,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured at 1 min interval for 5 mins by Ellman's method,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)nc1,"N-(pyridin-2-ylmethyl)-1,2,3,4-tetrahydroacridin-9-amine",6.7,uM,=,0.8260748027008264,1,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)nc1
499,2264449,10.1039/d1md00394a,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=c1c(O)c(-c2ccccc2)oc2cc(Br)c(I)cc12,7-bromo-3-hydroxy-6-iodo-2-phenyl-4H-chromen-4-one,10.0,uM,=,1.0,1,O=c1cc(-c2ccccc2)oc2ccccc12
500,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,COc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1,"N-[5'-(4''-Methoxyphenethyloxy)pentyl]-1,2,3,4-tetrahydroacridin-9-amine",0.216,uM,=,-0.6655462488490691,0,c1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
501,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12,3-(1-Benzoyl-1H-indol-3-ylmethylene)-1-benzyl-piperidin-4-one,70.0,uM,=,1.845098040014257,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12
502,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N/O)Nc1ccc[n+](Cc2ccc(C[n+]3cccc(NC(=O)/C=N/O)c3)cc2)c1.[Br-].[Br-],"1,1'-(1,4-phenylenebis(methylene))bis(3-(2-(hydroxyimino)acetamido)pyridinium)dibromide",2100.0,uM,=,3.322219294733919,1,c1cc[n+](Cc2ccc(C[n+]3ccccc3)cc2)cc1
503,2059377,10.1016/j.bmc.2021.116074,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc2c(cc1OC)/C(=C\c1ccc(N3CCCCC3)c(O)c1)OC2=O,"(E)-3-(3-hydroxy-4-(piperidin-1-yl)benzylidene)-5,6-dimethoxyisobenzofuran-1(3H)-one",0.012,uM,=,-1.9208187539523751,0,O=C1O/C(=C/c2ccc(N3CCCCC3)cc2)c2ccccc21
504,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(-c2cc(-c3ccc(N(C)C)cc3)nc(NS(=O)(=O)c3ccc(NC(C)=O)cc3)n2)cc1,N-{4-[4-(4-Dimethylamino-phenyl)-6-(4-methoxy-phenyl)-pyrimidin-2-ylsulfamoyl]-phenyl}-acetamide,8.5,uM,=,0.9294189257142929,1,O=S(=O)(Nc1nc(-c2ccccc2)cc(-c2ccccc2)n1)c1ccccc1
505,1442760,10.1016/j.bmcl.2014.10.055,,,,Inhibition of human acetylcholinesterase by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CCCCCc1ccc(O)c(/C=N/O)n1)CC2,"6-(5-(6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)pentyl)-3-hydroxypicolinaldehyde oxime",890.0,uM,=,2.949390006644913,1,c1ccc(C2c3ccccc3CCN2CCCCCc2ccccn2)cc1
506,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Cc1ccc2c(c1)c1c[n+](C)ccc1n2CCC(=O)N1c2ccccc2Sc2ccccc21.[I-],"2,8-dimethyl-5-(3-oxo-3-(10H-phenothiazin-10-yl)propyl)-5H-pyrido[4,3-b]indol-2-ium iodide",1.1,uM,=,0.041392685158225,1,O=C(CCn1c2ccccc2c2c[nH+]ccc21)N1c2ccccc2Sc2ccccc21
507,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cccc2n1cc(-c1cccc(OC(=O)N(C)C)c1)[n+]2C.[Cl-],"2-(3-(dimethylcarbamoyloxy)phenyl)-5-methoxy-1-methylimidazo[1,2-a]pyridin-1-ium",20.5,uM,=,1.3117538610557542,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
508,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl.Cl.Cl,"(+/-)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-((9-[(1,2,3,4-tetrahydroacridin-9-yl)amino]nonyl)amino)-7,11-methanocycloocta[b]quinoline dihydrochloride",0.0035299999999999,uM,=,-2.4522252946121776,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
509,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1c[nH]c2ccccc12,"1H-Indole-3-carboxylic acid [5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-amide",0.18,uM,=,-0.744727494896694,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1c[nH]c2ccccc12
510,513727,10.1016/j.bmc.2008.07.009,,,,Inhibition of AchE,Oc1cccc(C2=Nc3ccccc3SC(c3ccccc3F)C2)c1,"2-(2''-Fluorophenyl)-4-(3'-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepine",70.6,uM,=,1.848804701051804,1,c1ccc(C2=Nc3ccccc3SC(c3ccccc3)C2)cc1
511,2260019,10.1016/j.ejmech.2020.112872,,,,Inhibition of human AchE by spectrophotometric analysis,O=c1c(NCCCCCCCc2c3c(nc4ccccc24)CCCC3)c(NCCCCCCCc2c3c(nc4ccccc24)CCCC3)c1=O,"3,4-bis[7-(1,2,3,4-tetrahydroacridin-9-yl)heptylamino]cyclobut-3-ene-1,2-dione",0.013,uM,=,-1.8860566476931635,0,O=c1c(NCCCCCCCc2c3c(nc4ccccc24)CCCC3)c(NCCCCCCCc2c3c(nc4ccccc24)CCCC3)c1=O
512,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cc2c(cc1OC)CC(CC1CCN(c3ccccc3)CC1)=C2,"4-((5,6-dimethoxy-1H-inden-2-yl)methyl)-1-phenylpiperidine",4.4,uM,=,0.6434526764861874,1,C1=C(CC2CCN(c3ccccc3)CC2)Cc2ccccc21
513,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,CN(CCC(=O)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1)c1ccccc1,"3-(methylanilino)-1-{4-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-piperazino}-1-propanone",0.0703,uM,=,-1.1530446749801762,0,O=C(CCNc1ccccc1)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1
514,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(CC)Cc1ccccc1OC)Cc1ccccc1OC,6-[Ethyl-(2-methoxy-benzyl)-amino]-hexanoic acid [8-({6-[ethyl-(2-methoxy-benzyl)-amino]-hexanoyl}-methyl-amino)-octyl]-methyl-amide,0.0161,uM,=,-1.7931741239681502,0,O=C(CCCCCNCc1ccccc1)NCCCCCCCCNC(=O)CCCCCNCc1ccccc1
515,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2cccc([N+](=O)[O-])c2)CC1)c1ccc2c(c1)NCCCC2,"3-[1-(3-Nitro-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.39,uM,=,-0.4089353929735008,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
516,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(Cc1ccc(O)c(/C=N/O)c1)CC2,"5-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",625.6,uM,=,2.796296740051792,1,c1ccc(CN2CCc3ccccc3C2c2ccccc2)cc1
517,489450,10.1021/jm800577j,,,,Inhibition of human recombinant AChE by Ellman's method,Clc1ccc2c(NCCCNCCCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3,"N-[5-(9H-Carbazol-4-yloxy)pentyl]-N'-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)propane-1,3-diamine",0.00154,uM,=,-2.812479279163537,0,c1ccc2c(NCCCNCCCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3
518,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCNC1N2,"Methyl-carbamic acid (R)-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",1.49,uM,=,0.173186268412274,1,c1ccc2c(c1)NC1NCCC21
519,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CCC(O)CC2)o1,2-[1-(2-{[5-(4-Hydroxy-piperidin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile,0.39,uM,=,-0.4089353929735008,0,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
520,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1cnc2nc3c(c(NCCCCCCCCNc4c5c(nc6ncccc46)CCCC5)c2c1)CCCC3,"N,N'-Bis-(6,7,8,9-tetrahydro-benzo[b][1,8]naphthyridin-5-yl)-octane-1,8-diamine",0.0019,uM,=,-2.721246399047171,0,c1cnc2nc3c(c(NCCCCCCCCNc4c5c(nc6ncccc46)CCCC5)c2c1)CCCC3
521,2019674,10.1039/d0md00009d,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by Ellman's method,Cc1cc(S(=O)(=O)N2CCOCC2)c(C(C)C)cc1O,5-isopropyl-2-methyl-4-morpholinosulfonylphenol,5.64,uM,=,0.7512791039833423,1,O=S(=O)(c1ccccc1)N1CCOCC1
522,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,COc1cccc(-c2nnc(-c3ccc4c(c3)CO[C@@]4(CCCN(C)C)c3ccc(F)cc3)[nH]2)c1,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(3-methoxyphenyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",123.77,uM,=,2.0926153909415546,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
523,1539619,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 8,COP1(=O)OCCC(C(=O)OC(C)(C)C)=C(C)O1,"tert-Butyl 2-methoxy-4-methyl-6,7-dihydro-1,3,2-dioxaphosphepine-5-carboxylate 2-oxide",5.9,uM,=,0.7708520116421442,1,O=[PH]1OC=CCCO1
524,717112,10.1021/np100416v,,,,Inhibition of human erythrocytes acetylcholinesterase after 15 mins,CC(C)=CC(=O)C[C@H](C)c1ccc(C)cc1,(+)-(S)-ar-turmerone,191.1,uM,=,2.281260687055013,1,c1ccccc1
525,1757796,10.1016/j.ejmech.2017.06.048,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method,c1ccc2c(NCCCCC[Se][Se]CCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"Bis[5-(1',2',3',4'-tetrahydroacridin-9'-ylamino)pentyl]diselenide",0.00264,uM,=,-2.578396073130169,0,c1ccc2c(NCCCCC[Se][Se]CCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
526,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(F)cc(/C=N/O)c3O)CC1)CC2,"3-((4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-5-fluoro-2-hydroxybenzaldehyde oxime",658.1,uM,=,2.818291890799996,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1
527,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,Fc1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1,"N2-(1-Benzylpiperidin-4-yl)-N4-(4-fluorobenzyl)pyrimidine-2,4-diamine",7.7,uM,=,0.8864907251724818,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
528,28312,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.12-0.32,CN(C)CCc1cccc(OC(=O)N(C)C)c1,Dimethyl-carbamic acid 3-(2-dimethylamino-ethyl)-phenyl ester,0.16,uM,=,-0.7958800173440752,0,c1ccccc1
529,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,COc1ccccc1C1NC(=S)Nc2nc3c(c(N)c21)CCCC3,"5-amino-4-(2-methoxyphenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",31.2,uM,=,1.4941545940184429,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
530,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1c(F)c[n+](C)cc1F.O=S(=O)([O-])C(F)(F)F,"N-Methyl-3,5-difluoro-4-methoxypyridinium Trifluoromethanesulfonate",98.0,uM,=,1.9912260756924949,1,c1cc[nH+]cc1
531,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1cc(C#N)c(NCCCC2CCN(Cc3ccccc3)CC2)nc1N,"2-Amino-6-((3-(1-benzylpiperidin-4-yl)propyl)amino)pyridine-3,5-dicarbonitrile",0.0094,uM,=,-2.026872146400301,0,c1ccc(CN2CCC(CCCNc3ccccn3)CC2)cc1
532,2224364,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins by Ellman's method,COC1CC(=O)c2c(O)ccc(O)c2C1,"5,8-dihydroxy-3-methoxy-3,4-dihydronaphthalen-1(2H)-one",950.1447520740476,uM,=,2.9777897739605304,1,O=C1CCCc2ccccc21
533,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21.Cl,SID26748043,1020.0,uM,=,3.008600171761917,1,c1ccc2c(c1)Nc1ccccc1S2
534,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCCN3CCc4ccccc4C3)nn2)cc1,"N-(2-(3,4-dihydroisoquinolin-2(1H)-yl)ethyl)-6-phenylpyridazin-3-amine",83.0,uM,=,1.919078092376074,1,c1ccc(-c2ccc(NCCN3CCc4ccccc4C3)nn2)cc1
535,1335188,10.1016/j.ejmech.2014.03.042,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.25,uM,=,-0.6020599913279624,0,c1ccc2nc3c(cc2c1)CCCC3
536,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Clc1ccc2c(NCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(6-chloro-1,2,3,4-tetrahydro-acridin-9-yl)-hexane-1,6-diamine",0.0006,uM,=,-3.2218487496163566,0,c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
537,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Cc1cccc(C2NC(=S)Nc3nc4c(c(N)c32)CCCC4)c1,"5-amino-4-m-tolyl-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",10.1,uM,=,1.0043213737826426,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
538,28158,10.1021/jm00161a008,,,,Compound was tested for the concentration required for reversible inhibition of human acetylcholinesterase. ,CCCCCCCCc1noc(/C(=N/O)SCCN(CC)CC)n1,"N-Hydroxy-3-octyl-[1,2,4]oxadiazole-5-carboximidothioic acid 2-diethylamino-ethyl ester",1.0,uM,=,0.0,0,c1ncon1
539,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCC(C)n1cc(C(=O)CF)cn1,1-(1-(sec-butyl)-1H-pyrazol-4-yl)-2-fluoroethan-1-one,18.0,uM,=,1.255272505103306,1,c1cn[nH]c1
540,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{4-[(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino]butyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",9.5,uM,=,0.9777236052888478,1,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
541,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,CCc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,4-(benzofuran-2-yl)-1-(4-ethylbenzyl)piperidine,64.23,uM,=,1.8077379220141008,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
542,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CC[N+](C)(C)c1cccc(O)c1.[Br-],Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium bromide,0.78,uM,=,-0.1079053973095195,0,c1ccccc1
543,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C[C@H](CCC(=O)O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O,lucidenic acid A,24.04,uM,=,1.380934463330702,1,O=C1CCC2C3=C(CC[C@H]2C1)C1C(=O)CCC1CC3=O
544,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](COC[n+]2ccc(C(C)(C)C)cc2)cc1.[Cl-].[Cl-],"1,3-bis(4-tert.butylpyridinium)-2-oxaprop-1,3-diyl dichloride",12.0,uM,=,1.0791812460476249,1,c1cc[n+](COC[n+]2ccccc2)cc1
545,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2cccs2)=CC1=O)Cc1cccs1,"2,5-bis{6-[ethyl(thiophen-2-ylmethyl)amino]hexylamino}-[1,4]-benzoquinone",0.0603999999999999,uM,=,-1.2189630613788682,0,O=C1C=C(NCCCCCCNCc2cccs2)C(=O)C=C1NCCCCCCNCc1cccs1
546,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,CCN(CCC(=O)NCCNc1c2c(nc3ccccc13)CCCC2)C1CCCCC1,"N1-[2-(1,2,3,4-Tetrahydroacridin-9-ylamino)ethyl]-3-[cyclohexyl(ethyl)amino]propanamide",0.233,uM,=,-0.632644078973981,0,O=C(CCNC1CCCCC1)NCCNc1c2c(nc3ccccc13)CCCC2
547,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1c[nH]c2ccccc12,"1H-indole-3-carboxylic acid [6-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-amide",0.033,uM,=,-1.4814860601221125,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1c[nH]c2ccccc12
548,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CN(C)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1.[I-],(E)-2-(4-(dimethylamino)styryl)-1-methylquinolinium iodide,0.5,uM,=,-0.3010299956639812,0,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
549,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cccc2c1C(=O)/C(=C/C1CCN(Cc3ccccc3)CC1)C2,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-7-methoxy-2,3-dihydro-1H-inden-1-one",1.509,uM,=,0.1786892397755898,1,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
550,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc(/C=N/O)c(O)c(CN2CCc3cc(OC)c(OC)cc3C2)c1,"3-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxy-5-methoxybenzaldehyde oxime",1382.0,uM,=,3.14050804303818,1,c1ccc(CN2CCc3ccccc3C2)cc1
551,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1O2,"(-)-(3aS)-3a-methyl-2,3,3a,8a-Tetrahydrofuro[2,3-b]benzofuran-5-yl N-(o-Tolyl)carbamate",0.02,uM,=,-1.6989700043360187,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@@H]1O2
552,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1ccc2c(c1)CCC(NS(=O)(=O)N(C)C)C2,"3-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylsulfamide",0.01697,uM,=,-1.770318157682324,0,c1ccc2c(c1)CCCC2
553,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2c(F)cccc2F)CC1,"2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1-(2,6-difluorobenzyl)piperidin-4-yl)ethoxy)thiazole-5-carboxamide",19.5,uM,=,1.290034611362518,1,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
554,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2Cc3ccsc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1,"2-(4-(4-benzylpiperazin-1-yl)butyl)-2,4,4a,5-tetrahydro-3H-thieno[3',2'-4,5]cyclopenta[1,2-c]pyridazin-3-one",0.538,uM,=,-0.2692177243336108,0,O=C1CC2Cc3ccsc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1
555,1553281,10.1016/j.bmc.2016.02.023,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by spectrophotometric-based Ellman's method,Cc1c(C)c2ccc(OCCNC3CCN(Cc4ccccc4)CC3)cc2oc1=O,"7-(2-((1-Benzylpiperidin-4-yl)amino)ethoxy)-3,4-dimethyl-2H-chromen-2-one",1.69,uM,=,0.2278867046136735,1,O=c1ccc2ccc(OCCNC3CCN(Cc4ccccc4)CC3)cc2o1
556,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-amino-3-(1H-indol-3-yl)-N-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)propanamide dihydrochloride",0.73,uM,=,-0.1366771398795441,0,O=C(CCc1c[nH]c2ccccc12)NCCNc1c2c(nc3ccccc13)CCCC2
557,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CC(c1ccc2c(c1)oc(=O)c1ccccc12)N(C)C.Cl,(+/-)-3-(1-(Dimethylamino)ethyl)-6H-benzo[c]chromen-6-one hydrochloride,10.9,uM,=,1.0374264979406236,1,O=c1oc2ccccc2c2ccccc12
558,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3cc(OCCNC(=O)/C=C/c4cc(F)cc(F)c4)ccc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-6-yloxy)ethyl)-3-(3,5-difluorophenyl)acrylamide",7.16,uM,=,0.8549130223078556,1,O=C(/C=C/c1ccccc1)NCCOc1ccc2oc(=O)c(-c3ccc(CNCc4ccccc4)cc3)cc2c1
559,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=C1CC(c2ccc(OCCCCN3CCC(Cc4ccccc4)CC3)cc2)Oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)cc(O)c21,7-(4-(4-benzylpiperidin-1-yl)butoxy)-2-(4-(4-(4-benzylpiperidin-1-yl)butoxy)phenyl)-5-hydroxychroman-4-one,7.6,uM,=,0.8808135922807914,1,O=C1CC(c2ccc(OCCCCN3CCC(Cc4ccccc4)CC3)cc2)Oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc21
560,430853,10.1021/jm0503289,,,,Inhibition of human brain AchE,O=C(CCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-4-(1H-indol-3-yl)-butyramide",0.00013,uM,=,-3.886056647693164,0,O=C(CCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
561,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C1Cc2ccc(NC(=O)c3cccc(Cl)c3)cc2CN1,"3-Chloro-N-(3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",0.914,uM,=,-0.0390538042661686,0,O=C1Cc2ccc(NC(=O)c3ccccc3)cc2CN1
562,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(-c2ccc3c(c2)OCO3)nnc1NCCN1CCCCC1,"6-(benzo[d][1,3]dioxol-5-yl)-4-methyl-N-(2-(piperidin-1-yl)ethyl)pyridazin-3-amine",1.0,uM,=,0.0,0,c1cc2c(cc1-c1ccc(NCCN3CCCCC3)nn1)OCO2
563,1507873,10.1016/j.bmc.2015.05.027,,,,Inhibition of human acetylcholinesterase incubated for 60 mins using ATChI substrate by DTNB dye based UV-visible spectrophotometry,Cc1ccc(-c2csc(NC(=O)C[n+]3ccc(/C=N/O)cc3)n2)cc1.[Cl-],4-((Hydroxyimino)methyl)-1-(2-oxo-2-(4-p-tolylthiazol-2-ylamino)ethyl)pyridinium chloride,970.0,uM,=,2.9867717342662448,1,O=C(C[n+]1ccccc1)Nc1nc(-c2ccccc2)cs1
564,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-],1-Hexadecyl-pyridinium bromide,2.753,uM,=,0.4398062113933302,1,c1cc[nH+]cc1
565,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,Cn1ncc2c1-c1c(Br)sc(Br)c1C2NC(=O)CN1CCN(Cc2ccccc2)CC1,"N-(5,7-Dibromo-1-methyl-1,4-dihydrothieno[3',4':4,5]cyclopenta[1,2-c]pyrazol-4-yl)-2-(4-benzyl-piperazine)acetamide",0.33,uM,=,-0.4814860601221125,0,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cscc2-c2[nH]ncc21
566,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccc([N+](=O)[O-])cc4)cc3)ccc12.[Br-],4-(((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)-1-(4-nitrobenzyl)pyridin-1-ium bromide,1.077,uM,=,0.0322157032979815,1,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
567,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc(OC)c1O,"(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylamide",0.321,uM,=,-0.4934949675951279,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
568,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCCc1cc(OC)c2oc(-c3ccc4c(c3)OCO4)cc2c1,"egonol-9(Z),12(Z)linoleate",1.7,uM,=,0.2304489213782739,1,c1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1
569,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Fc1ccc(CNC2CCN(Cc3ccccc3)C2)c(F)c1,"1-Benzyl-N-(2,4-difluorobenzyl)pyrrolidin-3-amine",0.069,uM,=,-1.1611509092627446,0,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
570,2213879,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(Nc3ccc(C(=O)/C=C/c4nc(C)c(C)nc4C)cc3)ncnc2c(OC)c1OC,"1-(4-(6,7,8-trimethoxyquinazolin-4-ylamino)phenyl)-3-(3,5,6-trimethylpyrazin-2-yl)prop-2-en-1-one",0.1,uM,=,-1.0,0,O=C(/C=C/c1cnccn1)c1ccc(Nc2ncnc3ccccc23)cc1
571,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cccc(CN2CCC(/C=C3\Cc4cccc(OC)c4C3=O)CC2)c1,"(E)-7-methoxy-2-((1-(3-methoxybenzyl)piperidin-4-yl)methylene)-2,3-dihydro-1H-inden-1-one",12.155,uM,=,1.0847549631793545,1,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
572,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CC2CCN(CCOc3ccc4c5c(c(=O)oc4c3)CCCC5)CC2)c1,"3-(2-(4-(3-methoxybenzyl)piperidin-1-yl)ethoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",37.2,uM,=,1.5705429398818975,1,O=c1oc2cc(OCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2
573,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.7,uM,=,-0.1549019599857432,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
574,430856,10.1021/jm0503289,,,,Inhibition of human AChE-induced beta amyloid peptide(1-40) aggregation by thioflavin T-based fluorometric assay,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-3-(1H-indol-3-yl)-propionamide",2.0,uM,=,0.3010299956639812,1,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
575,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)CC/C(=C\c2cc(OC)c(OC)c(OC)c2)C3=O)c1,"Methyl-carbamic acid 3-[(methyl-{7-[5-oxo-6-(3,4,5-trimethoxy-benzylidene)-5,6,7,8-tetrahydro-naphthalen-2-yloxy]-heptyl}-amino)-methyl]-phenyl ester",4.94,uM,=,0.693726948923647,1,O=C1/C(=C/c2ccccc2)CCc2cc(OCCCCCCCNCc3ccccc3)ccc21
576,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCN1CC(=O)N(CCCCCCN(CC)Cc2ccccc2OC)CC1=O)Cc1ccccc1OC,"1,4-Bis-{6-[ethyl-(2-methoxybenzyl)amino]hexyl}piperazine-2,5-dione",0.0159,uM,=,-1.7986028756795485,0,O=C1CN(CCCCCCNCc2ccccc2)C(=O)CN1CCCCCCNCc1ccccc1
577,1785044,10.1021/acs.jnatprod.7b00627,,,,Inhibition of AChE (unknown origin),C[C@@H]1C[C@H]2CC(=O)[C@H]3CCC[N+]4([O-])CCC[C@]2(O)[C@]34C1,12-epi-lycodoline N-oxide,0.59,uM,=,-0.2291479883578558,0,O=C1C[C@@H]2CCC[C@]34C2CCC[NH+]3CCC[C@H]14
578,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(2-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.21,uM,=,-0.6777807052660807,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
579,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCCCCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,10-bis(4-tert.butylpyridinium)-dec-1,10-diyl dibromide",0.012,uM,=,-1.9208187539523751,0,c1cc[n+](CCCCCCCCCC[n+]2ccccc2)cc1
580,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCC(=O)N[C@H]1CC[C@H](NC(=O)CCCCCN(CC)Cc2ccccc2OC)CC1)Cc1ccccc1OC,trans-6-[Ethyl-(2-methoxybenzyl)amino]hexanoic acid (4-{6-[ethyl-(2-methoxybenzyl)amino]hexanoylamino}cyclohexyl) amide,8.55,uM,=,0.9319661147281728,1,O=C(CCCCCNCc1ccccc1)N[C@H]1CC[C@H](NC(=O)CCCCCNCc2ccccc2)CC1
581,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3cc(OCCNC(=O)/C=C/c4ccc(Cl)c(Cl)c4)ccc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-6-yloxy)ethyl)-3-(3,4-dichlorophenyl)acrylamide",267.0,uM,=,2.4265112613645754,1,O=C(/C=C/c1ccccc1)NCCOc1ccc2oc(=O)c(-c3ccc(CNCc4ccccc4)cc3)cc2c1
582,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CC(C)Cn1cc(C(=O)C(F)(F)F)cn1,"2, 2, 2-trifluoro-1-(1-isobutyl-1H-pyrazol-4-yl)ethan-1-one",0.678,uM,=,-0.1687703061329366,0,c1cn[nH]c1
583,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,C#CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)-2-(prop-2-yn-1-ylamino)acetamide",0.0464,uM,=,-1.3334820194451191,0,O=c1c2ccccc2nc2n1CCC2
584,1675783,10.1016/j.ejmech.2017.03.062,,,,Inhibition of human plasma AChE using acetyl-(beta-methyl)thiocholine as substrate pretreated for 30 mins followed by substrate addition after 25 mins by spectrophotometric method,CC1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3C(C)[C@@H]12,Phenserine,0.022,uM,=,-1.6575773191777938,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCC[C@@H]1C2
585,1922071,10.1016/j.bmc.2018.12.030,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,CCOc1ccc2[nH]c(SCc3cn(CC4CCN(Cc5ccccc5)CC4)nn3)nc2c1,"2-(((1-((1-Benzylpiperidin-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-5-ethoxy-1H-benzo[d]imidazole",6.9,uM,=,0.8388490907372553,1,c1ccc(CN2CCC(Cn3cc(CSc4nc5ccccc5[nH]4)nn3)CC2)cc1
586,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",2.9,uM,=,0.4623979978989561,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
587,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(-c2cn3c(NC(C)=O)cccc3[n+]2C)c1.[I-],"5-acetamido-1-methyl-2-(3-(methylcarbamoyloxy)phenyl)imidazo[1,2-a]pyridin-1-ium",4.5,uM,=,0.6532125137753437,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
588,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccc(F)cc3)CC2)cc(C(C)(C)C)c1O,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(4-fluorobenzyl)piperidin-4-yl)ethyl)acrylamide",0.98,uM,=,-0.0087739243075051,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
589,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(CN(C)Cc4cccc([N+](=O)[O-])c4)cc3)c(=O)oc2cc1OC,"6,7-dimethoxy-3-(4-{[(3-nitrobenzyl)methylamino]methyl}phenyl)-chromen-2-one",0.368,uM,=,-0.4341521813264823,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
590,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,COc1ccccc1/C=C1\CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C[C@@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1=O,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(2-methoxyphenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(2-methoxyphenylmethylidene)hexahydro-1H-pyrrolizine,11.41,uM,=,1.0572856444182146,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
591,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CCN(CC)Cc1ccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)cc1,(2-{4-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-[4-(diethylaminomethyl)-phenyl]methanone,100.0,uM,=,2.0,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
592,1632485,10.1016/j.ejmech.2016.08.016,,,,Inhibition of human recombinant AChE preincubated for 5 mins followed by acetylthiocholine iodide substrate addition measured after 5 mins by Ellman's method,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21,"N-(6-(4-(1-(phenylsulfonyl)-1H-indol-4-yl)piperazin-1-yl)hexyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0129,uM,=,-1.889410289700751,0,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21
593,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,O=C(CNCc1ccccc1F)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-((2-fluorobenzyl)amino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-7-yl)acetamide",0.528,uM,=,-0.2773660774661877,0,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
594,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)Nc1ccc2c(c1)CN(C(=O)c1ccccc1OC)C(=O)C2,"2-Methoxy-N-(2-(2-methoxybenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",2.158e-05,uM,=,-4.665948559653108,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
595,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccn2)=CC1=O)Cc1ccccn1,"2,5-bis{6-[ethyl(pyridin-2-ylmethyl)amino]hexylamino}-[1,4]-benzoquinone",0.125,uM,=,-0.9030899869919436,0,O=C1C=C(NCCCCCCNCc2ccccn2)C(=O)C=C1NCCCCCCNCc1ccccn1
596,1842289,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 60 mins followed by substrate addition by Ellman's method,C#CCNC1CCc2cc(Cl)c(OC(=O)N(C)CCC)cc21,"6-chloro-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl methyl(propyl)carbamate",43.9,uM,=,1.6424645202421213,1,c1ccc2c(c1)CCC2
597,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(NCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,"(S)-2-amino-3-(1H-indol-3-yl)-N-(3-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)propanamide dihydrochloride",1.3,uM,=,0.1139433523068367,1,O=C(CCc1c[nH]c2ccccc12)NCCCNc1c2c(nc3ccccc13)CCCC2
598,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2oc(C(=O)OCC3CCN(Cc4ccccc4)CC3)cc(=O)c2c1,(1-Benzylpiperidin-4-yl)methyl 6-methoxy-4-oxo-4H-chromene-2-carboxylate,7.49,uM,=,0.8744818176994665,1,O=C(OCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
599,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,Fc1cccc(Cc2nnc3sc(-c4ccoc4)nn23)c1,"3-(3-Fluorobenzyl)-6-(furan-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(Cc2nnc3sc(-c4ccoc4)nn23)cc1
600,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,CCC[n+]1ccc(CCC(=O)c2cc3cc(OC)c(OC)cc3s2)cc1.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-propyl-pyridinium bromide",2.57,uM,=,0.4099331233312945,1,O=C(CCc1cc[nH+]cc1)c1cc2ccccc2s1
601,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCCCCCCCCC[n+]1cccc2ccccc21,"1,12-di(1-quinoliniumyl)dodecane; dibromide",0.02,uM,=,-1.6989700043360187,0,c1ccc2c(c1)ccc[n+]2CCCCCCCCCCCC[n+]1cccc2ccccc21
602,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2[nH]1,N-((5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine,15.4,uM,=,1.187520720836463,1,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
603,1734273,10.1021/acsmedchemlett.8b00030,,,,Inhibition of AChE (unknown origin),c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2,"(S)-N-(2-((R)-piperidin-3-yl)ethyl)-N-(((R)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine",10.7,uM,=,1.0293837776852095,1,c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2
604,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(/C=C2\Cc3ccc(OC)cc3C2=O)cc1,(2E)-2-[[4-(diethylaminomethyl)phenyl]methylene]-6-methoxy-indan-1-one,0.964,uM,=,-0.0159229660971691,0,O=C1/C(=C/c2ccccc2)Cc2ccccc21
605,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{8-[(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",74.3,uM,=,1.8709888137605752,1,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
606,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzamide HCl,0.56,uM,=,-0.2518119729937995,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1ccccc1
607,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)C/C(=C\c2cc(OC)c(OC)c(OC)c2)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(7-{1-oxo-2-[1-(3,4,5-trimethoxy-phenyl)-meth-(E)-ylidene]-indan-5-yloxy}-heptyl)-amino]-methyl}-phenyl ester",1.8,uM,=,0.255272505103306,1,O=C1/C(=C/c2ccccc2)Cc2cc(OCCCCCCCNCc3ccccc3)ccc21
608,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC3=CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[2-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-2-oxo-ethyl]-1-methyl-1,2,3,6-tetrahydro-pyridinium bromide",0.75,uM,=,-0.1249387366082999,0,O=C(CC1=CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
609,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC3CCN(Cc4ccc(C(F)(F)F)cc4)CC3)sc2-c2ccc(OC)cc2)cc1,"4-Trifluoromethoxybenzyl-N-[4,5-bis(4-methoxyphenyl)-thiazol-2-yl]piperidin-4-ylamine",0.75,uM,=,-0.1249387366082999,0,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
610,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2[se]n(-c3ccc(CCN4CCCCC4)cc3)c(=O)c2cc1OC,"5,6-Dimethoxy-2-(4-(2-(piperidin-1-yl)ethyl)phenyl)benzo[d][1,2]selenazol-3(2H)-one",10.52,uM,=,1.0220157398177203,1,O=c1c2ccccc2[se]n1-c1ccc(CCN2CCCCC2)cc1
611,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),c1ccc2c(c1)[nH]c1c[n+](CCCCCCCCCCCC[n+]3ccc4c(c3)[nH]c3ccccc34)ccc12,"2-[12-(9H-pyrido[3,4-b]indol-2-ium-2-yl)dodecyl]-9H-pyrido[3,4-b]indol-2-ium",86.0,uM,=,1.934498451243568,1,c1ccc2c(c1)[nH]c1c[n+](CCCCCCCCCCCC[n+]3ccc4c(c3)[nH]c3ccccc34)ccc12
612,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.143,uM,=,-0.8446639625349383,0,c1ccc2nc3c(cc2c1)CCCC3
613,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-3-(1H-indol-3-yl)-propionamide",0.004,uM,=,-2.397940008672037,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
614,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCCNc1c2c(nc3cc(Cl)cc(Cl)c13)CCCC2)NCCc1c[nH]c2ccccc12,"7-(6,8-dichloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
615,2261397,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human AChE,C#CCNC1CCc2c(OC(=O)N(C)C)cccc21,"[1-(prop-2-ynylamino)indan-4-yl]N,N-dimethylcarbamate",86.0,uM,=,1.934498451243568,1,c1ccc2c(c1)CCC2
616,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(Cc2ccccc2[N+](=O)[O-])CC1,4-Methyl-1-(2-nitro-benzyl)-piperidine,0.16,uM,=,-0.7958800173440752,0,c1ccc(CN2CCCCC2)cc1
617,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCCCCCSC(=O)OCC[N+](C)(C)C.[Cl-],(2-Hexylsulfanylcarbonyloxy-ethyl)-trimethyl-ammonium chloride,80.0,uM,=,1.9030899869919435,1,
618,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc(Cl)cc2)ccc1O,(E)-N-(2-((4-chlorophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,3.43,uM,=,0.5352941200427705,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
619,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCN(C)CCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl,"[3-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)propyl](methyl){3-[(1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}amine hydrochloride",0.0004199999999999,uM,=,-3.3767507096021,0,C1=CC2Cc3nc4ccccc4c(NCCCNCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
620,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)OCO2,"1-(benzo[d][1,3]dioxol-5-yl)-3-(1-benzylpiperidin-4-yl)propan-1-one",0.03,uM,=,-1.5228787452803376,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)OCO2
621,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(Cl)c(Cl)c1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(34-dichlorbenzyl)berberine bromide,1.22,uM,=,0.0863598306747482,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
622,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccnc1)CCCC3,"Ethyl Ester 5-Amino-1,4,6,7,8,9-hexahydro-2-methyl-4-(3'-pyridyl)benzo[b][1,8]naphthyridine-3-carboxylic Acid",0.158,uM,=,-0.8013429130455774,0,C1=CC(c2cccnc2)c2cc3c(nc2N1)CCCC3
623,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=O)Nc1ccc([N+](=O)[O-])cc1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(4-nitro-phenyl)-urea,2.3,uM,=,0.3617278360175928,1,O=C(NCCOCCNCc1ccccc1)Nc1ccccc1
624,2266926,10.1016/j.ejmech.2020.113102,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1OC)C(=O)[C@]1(C2)[C@H](c2cccc([N+](=O)[O-])c2)[C@H](Cc2c[nH]c3ccccc23)NC12C(=O)Nc1ccccc12,"(2R,4'S,5'S)-5'-((1H-indol-3-yl)methyl)-5,6-dimethoxy-4'-(3-nitrophenyl)dispiro[indene-2,3'-pyrrolidine-2',3''-indoline]-1,2''(3H)-dione",1.89,uM,=,0.2764618041732441,1,O=C1Nc2ccccc2C12N[C@@H](Cc1c[nH]c3ccccc13)[C@@H](c1ccccc1)[C@]21Cc2ccccc2C1=O
625,1671084,10.1016/j.bmc.2017.03.058,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 30 secs by Ellman's method,CCO[P@@](=O)(SCC)c1ccccc1,"(R)-O,S-diethylphenylphosphonothioate",150.0,uM,=,2.1760912590556813,1,c1ccccc1
626,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,Cc1ccc2c(c1)C1(C(=O)N2)C(C#N)=C(N)N2CCCNC2=C1[N+](=O)[O-],"6'-amino-5-methyl-9'-nitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",0.94,uM,=,-0.0268721464003013,0,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
627,1655449,10.1016/j.ejmech.2016.10.060,,,,Inhibition of human AchE-induced amyloid beta (1 to 40) aggregation after 48 hrs by thioflavin T fluorescence spectroscopic method,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],"3-(3,8-diamino-6-phenyl-5-phenanthridiniumyl)propyl(diethyl)methylammonium",45.0,uM,=,1.6532125137753435,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
628,27788,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in monkey red blood cell,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.075,uM,=,-1.1249387366083,0,c1ccc2nc3c(cc2c1)CCCC3
629,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CC1(OC[n+]2ccn(C)c2/C=N/O)CCCC1.[Cl-],1-(1-Ethynyl-cyclopentyloxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,24.2,uM,=,1.383815365980431,1,c1c[n+](COC2CCCC2)c[nH]1
630,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1,"(2R,6S)-methyl 1,2,6-triphenyl-4-(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",6520.0,uM,=,3.81424759573192,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
631,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,34.7,uM,=,1.5403294747908738,1,c1ccccc1
632,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,CC(CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,ganoderic acid B,22.63,uM,=,1.3546845539547283,1,O=C1CC2CCC(=O)C2C2=C1C1CCCC[C@@H]1CC2
633,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1C=CN(Cc3ccccc3)C=C1C(C)=O)CC2,"2-((3-Acetyl-1-benzyl-1,4-dihydropyridin-4-yl)methyl)-6,7-dimethoxy-3,4-dihydronaphthalen-1(2H)-one",0.286,uM,=,-0.543633966870957,0,O=C1c2ccccc2CCC1CC1C=CN(Cc2ccccc2)C=C1
634,28454,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 11.3-56.8,C#CCNC1CCc2c(Cl)cc(OC(=O)N(C)CC)cc21.Cl,Ethyl-methyl-carbamic acid 7-chloro-3-prop-2-ynylamino-indan-5-yl ester hydrochloride,25.5,uM,=,1.4065401804339552,1,c1ccc2c(c1)CCC2
635,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,N#Cc1ccc(C[n+]2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2)cc1.[Br-],4-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-(4-cyanobenzyl)pyridin-1-ium bromide,22.9,uM,=,1.359835482339888,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
636,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3c(Br)cc(Br)cc13)CCCCC2,"2,4-dibromo-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",15.1,uM,=,1.1789769472931697,1,c1ccc2nc3c(cc2c1)CCCCC3
637,2022983,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin),CCCCCCCCCCCCCCCCc1ccc(C(=O)[O-])c[n+]1C,Platisidine A,2800.0,uM,=,3.4471580313422194,1,c1cc[nH+]cc1
638,613428,10.1016/j.bmc.2010.01.063,,,,Inhibition of AChE by modified Ellman's spectrophotometric method,CO[P@]1(=O)OC[C@H]2COC(=O)C2=C(C)O1,cyclophostin,0.0008,uM,=,-3.096910013008056,0,O=C1OC[C@@H]2CO[PH](=O)OC=C12
639,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2Cl)=CC1=O)Cc1ccccc1Cl,"2,5-bis{6-[(2-chlorobenzyl)ethylamino]hexylamino}-[1,4]-benzoquinone",0.593,uM,=,-0.2269453066357374,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
640,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2cccc(Cl)c2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1,N-((1-(3-chlorobenzyl)piperidin-4-yl)methyl)-5-(2-(cyclopropanecarboxamido)isonicotinamido)nicotinamide,1.091,uM,=,0.0378247505883418,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
641,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1,6-(Benzylideneamino)-2H-chromen-2-one,0.1144,uM,=,-0.9415739755429946,0,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1
642,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(c4ccncc4)CC3)nc12,N-(4-Methylbenzo[d]thiazol-2-yl)-3-(4-(pyridin-4-yl)-piperazin-1-yl)propanamide,18.21,uM,=,1.26030994579492,1,O=C(CCN1CCN(c2ccncc2)CC1)Nc1nc2ccccc2s1
643,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCC2,"3-(1-Benzyl-piperidin-4-yl)-1-(2,3-dihydro-1H-indol-6-yl)-propan-1-one",0.113,uM,=,-0.9469215565165804,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCC2
644,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,Oc1cccc(CCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)c1,"3-(8-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)phenol",0.00419,uM,=,-2.377785977033705,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
645,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3cc(OC)c(OC)cc3oc2=O)cc1,"3-{4-[(benzylethylamino)methyl]phenyl}-6,7-dimethoxychromen-2-one",0.018,uM,=,-1.744727494896694,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
646,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),COc1ccc(/C=C2\COc3cc(OCCCN4CCCCC4)ccc3C2=O)cc1,3-(4-methoxybenzylidene)-7-(3-(piperidin-1-yl)propoxy)chroman-4-one,3.94,uM,=,0.5954962218255742,1,O=C1/C(=C/c2ccccc2)COc2cc(OCCCN3CCCCC3)ccc21
647,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CCn1c2ccccc2c2cc(/C=C/c3ccc4ccccc4[n+]3C)ccc21.[I-],(E)-2-(2-(9-Ethyl-9H-carbazol-2-yl)vinyl)-1-methyl-quinolin-1-ium Iodide,0.3,uM,=,-0.5228787452803376,0,C(=C/c1ccc2ccccc2[nH+]1)\c1ccc2[nH]c3ccccc3c2c1
648,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,"Methyl 2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethoxy)thiazole-5-carboxylate",0.13,uM,=,-0.8860566476931633,0,O=C(Nc1cc(-c2nc(OCCNc3c4c(nc5ccccc35)CCCC4)cs2)ccn1)C1CC1
649,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(c2)O/C(=C\c2cccc4ccccc24)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(3-{2-[1-naphthalen-1-yl-meth-(Z)-ylidene]-3-oxo-2,3-dihydro-benzofuran-6-yloxy}-propyl)-amino]-methyl}-phenyl ester",0.00686,uM,=,-2.1636758842932484,0,O=C1/C(=C/c2cccc3ccccc23)Oc2cc(OCCCNCc3ccccc3)ccc21
650,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2cccc3ccccc23)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-1'-Methyl-4'-(naphthalen-1-yl)dispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",2.12,uM,=,0.3263358609287514,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1cccc3ccccc13)[C@@]21CSc2ccccc2C1=O
651,1565223,10.1016/j.ejmech.2016.02.049,,,,Inhibition of human AChE assessed as hydrolytic activity using acetylthiocholine iodide as substrate measured for 15 mins by Ellmans assay,CC(COC(=O)c1ccc(Oc2nc(Oc3ccc(C(=O)OCC(C)N(C)C)cc3)nc(Oc3ccc(C(=O)OCC(C)N(C)C)cc3)n2)cc1)N(C)C,"tris(2-(dimethylamino)propyl) 4,4',4''-(1,3,5-triazine-2,4,6-triyl)tris(oxy)tribenzoate",80.8,uM,=,1.9074113607745864,1,c1ccc(Oc2nc(Oc3ccccc3)nc(Oc3ccccc3)n2)cc1
652,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,Cc1ccccc1/C=C1\CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C[C@@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1=O,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(2-methylphenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(2-methylphenylmethylidene)hexahydro-1H-pyrrolizine,27.45,uM,=,1.4385423487861106,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
653,28624,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in human red blood cell,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.078,uM,=,-1.1079053973095196,0,c1ccc2nc3c(cc2c1)CCCC3
654,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](Cc2cccc(C[n+]3ccccc3)c2)cc1,"1,1'-bis(pyridinium)-1,3-phenyldimethylene dibromide",2360.0,uM,=,3.3729120029701067,1,c1cc[n+](Cc2cccc(C[n+]3ccccc3)c2)cc1
655,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,O=C(/C=C/c1ccccc1O)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(2-hydroxyphenyl)acrylamide,2.68,uM,=,0.4281347940287888,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
656,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(8-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.08,uM,=,-1.0969100130080565,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
657,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,Cc1ccc(/C=C2\CN(C(=O)[C@@H]3CCN(C)[C@]34C(=O)Nc3ccccc34)C[C@]3(C2=O)[C@H](c2ccc(C)cc2)CN(C)[C@]32C(=O)Nc3ccccc32)cc1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(4-methylphenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(4-methylphenyl)pyrrolidine,7.67,uM,=,0.884795363948981,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
658,1626872,10.1016/j.bmc.2016.10.016,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins followed by substrate addition measured after 20 mins by UV-Vis spectrophotometric analysis,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.09,uM,=,-1.0457574905606752,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
659,1461400,10.1016/j.bmcl.2014.12.071,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate by Ellman method,C=CC[C@@H]1[C@H](O)[C@@H](OCc2ccccc2)[C@H](O)CN1CCCCCCCC,"(2R,3S,4S,5R)-2-allyl-4-(benzyloxy)-1-octylpiperidine-3,5-diol",22.0,uM,=,1.3424226808222062,1,c1ccc(COC2CCNCC2)cc1
660,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCCOc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(4-diethylaminobutoxy)indan-1-one,0.89,uM,=,-0.0506099933550872,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
661,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0018,uM,=,-2.744727494896694,0,c1ccc2nc3c(cc2c1)CCCC3
662,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(C(=O)c2c(C3CCN(Cc4ccccc4)CC3)oc3ccccc23)cc1,(2-(1-benzylpiperidin-4-yl)benzofuran-3-yl)(4-methoxyphenyl)methanone,48.3,uM,=,1.683947130751512,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
663,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-2-amino-N-(7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.019,uM,=,-1.7212463990471711,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
664,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCCCCOc1ccc(/C=C/C(=O)Nc2ccccc2)cc1OC,(E)-3-(4-((6-(diethylamino)hexyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,1.83,uM,=,0.2624510897304295,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
665,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,CN(Cc1ccccc1)Cc1ccc(COc2ccc3c(CO)cc(=O)oc3c2)cc1,7-(4-((benzyl(methyl)amino)methyl)benzyloxy)-4-(hydroxymethyl)-2H-chromen-2-one,0.12,uM,=,-0.9208187539523752,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
666,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,5.6,uM,=,0.7481880270062004,1,c1ccccc1
667,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC(C)(O)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1,marmesin,67.0,uM,=,1.8260748027008264,1,O=c1ccc2cc3c(cc2o1)OCC3
668,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,CS(=O)(=O)[O-].CS(=O)(=O)[O-].O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1,Obidoxime mesylate,2169.0,uM,=,3.336259552014193,1,c1cc[n+](COC[n+]2ccccc2)cc1
669,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2cccc([N+](=O)[O-])c2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1cccc([N+](=O)[O-])c1,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(3-nitrobenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",4.28,uM,=,0.631443769013172,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
670,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,COc1ccc(C2C3=C(CC(C)(C)CC3=O)Nc3nc4c(c(N)c32)CCCC4)cc1,"11-Amino-12-(4-methoxy-phenyl)-3,3-dimethyl-3,4,5,7,8,9,10,12-octahydro-2H-dibenzo[b,g][1,8]naphthyridin-1-one",0.37,uM,=,-0.431798275933005,0,O=C1CCCC2=C1C(c1ccccc1)c1cc3c(nc1N2)CCCC3
671,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4cccc([N+](=O)[O-])c4)cc3)ccc12.[Br-],4-(((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)-1-(3-nitrobenzyl)pyridin-1-ium bromide,0.23,uM,=,-0.6382721639824072,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
672,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CN(CCCOc1ccc2cc(-c3ccc(Cl)cc3)c(=O)oc2c1)Cc1cccc(OC(=O)NCCCCCc2ccccc2)c1,3-(((3-((3-(4-Chlorophenyl)-2-oxo-2H-chromen-7-yl)oxy)propyl)(methyl)amino)methyl)phenyl(5-Phenylpentyl)carbamate,0.9,uM,=,-0.0457574905606751,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3cc(-c4ccccc4)c(=O)oc3c2)c1
673,1589694,10.1016/j.bmc.2016.07.005,,,,Inhibition of hemoglobin free erythrocyte ghost human AChE using acetylcholine iodide as substrate measured for 1 hr by spectrophotometry based Ellman method,C[n+]1ccccc1/C=N/O.[Cl-],2-Pyridine aldoxime methohalide,1210.0,uM,=,3.0827853703164503,1,c1cc[nH+]cc1
674,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc(C)c3)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(3-methylbenzyl)pyridin-1-ium bromide",0.004,uM,=,-2.397940008672037,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
675,2288317,10.1016/j.ejmech.2022.114806,,,,Inhibition of human AChE using ATC and BTC iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by DTNB reagent based assay,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.148,uM,=,-0.8297382846050426,0,c1ccc2nc3c(cc2c1)CCCC3
676,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccc2ccccc2c1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(naphthalene-2-carbonyl)-thiourea,0.1,uM,=,-1.0,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccc2ccccc2c1
677,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.2,uM,=,-0.6989700043360187,0,c1ccccc1
678,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,Clc1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1,"N2-(1-Benzylpiperidin-4-yl)-N4-(4-chlorobenzyl)pyrimidine-2,4-diamine",8.8,uM,=,0.9444826721501688,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
679,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,CN(CCCN1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1)C1CCCCC1,"N-(2-{4-[3-(cyclohexyl(methyl)amino)propyl]piperazino}ethyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.0407,uM,=,-1.39040559077478,0,c1ccc2c(NCCN3CCN(CCCNC4CCCCC4)CC3)c3c(nc2c1)CCCC3
680,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCCNC1=CC(=O)C(NCCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis{7-[ethyl(2-methoxybenzyl)amino]heptylamino}-[1,4]-benzoquinone",0.00779,uM,=,-2.108462542327436,0,O=C1C=C(NCCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCCNCc1ccccc1
681,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(CCc1ccccc1)N1c2ccccc2[Se]c2ccccc21,1-(10H-Phenoselenazin-10-yl)-3-phenylpropan-1-one,6.7,uM,=,0.8260748027008264,1,O=C(CCc1ccccc1)N1c2ccccc2[Se]c2ccccc21
682,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CN1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,2-(4-methylpiperazin-1-yl)-N-(naphthalen-1-ylmethyl)pyrimidin-4-amine,17.5,uM,=,1.2430380486862944,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
683,430853,10.1021/jm0503289,,,,Inhibition of human brain AchE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-3-(1H-indol-3-yl)-propionamide",2e-05,uM,=,-4.698970004336019,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
684,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1ccc(/C=C2\CN(Cc3cccc(C)c3)C/C(=C\c3ccc(C)cc3)C2=O)cc1,"(3E,5E)-1-(3-methylbenzyl)-3,5-bis(4-methylbenzylidene)piperidin-4-one",3.22,uM,=,0.5078558716958309,1,O=C1/C(=C/c2ccccc2)CN(Cc2ccccc2)C/C1=C\c1ccccc1
685,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1cccc2c1CCC(NS(=O)(=O)N(C)C)C2,"3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylsulfamide",0.01206,uM,=,-1.9186526921958675,0,c1ccc2c(c1)CCCC2
686,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2ccc(F)cc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1,5-(2-(Cyclopropanecarboxamido)isonicotinamido)-N-((1-(4-fluorobenzyl)piperidin-4-yl)methyl)nicotinamide,3.029,uM,=,0.4812992733328557,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
687,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=C(C)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(C)C1=O)Cc1ccccc1OC,"2,5-bis{6-[ethyl(2-methoxybenzyl)amino]hexylamino}-3,6-dimethyl-[1,4]-benzoquinone",0.0095,uM,=,-2.0222763947111524,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
688,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,O=C(c1c(F)ccc(F)c1F)n1nc(OCCN2CCCCC2)c2ccccc21,"(2,3,6-trifluorophenyl)(3-(2-piperidinoethoxy)indazol-1-yl)ketone",9.4,uM,=,0.9731278535996988,1,O=C(c1ccccc1)n1nc(OCCN2CCCCC2)c2ccccc21
689,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(NCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,"(S)-2-amino-3-(1H-indol-3-yl)-N-(4-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)butyl)propanamide dihydrochloride",12.0,uM,=,1.0791812460476249,1,O=C(CCc1c[nH]c2ccccc12)NCCCCNc1c2c(nc3ccccc13)CCCC2
690,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccccc3C)cc1C(N)=O)C2=O.[Br-],"3-Carbamoyl-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)-1-(2-methylbenzyl)pyridinium bromide",0.8937999999999999,uM,=,-0.0487596496756597,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
691,28628,10.1021/jm970210v,,,,Inhibition of human acetylcholinesterase from erythrocytes (RBC),CN1CC[C@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3NC12,"Phenyl-carbamic acid (R)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",5.6545,uM,=,0.7523942084053632,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
692,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CN(CCCOc1ccc2c3c(c(=O)oc2c1)CCCC3)Cc1ccccc1,"3-(3-(Benzyl(methyl)amino)propoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",2.1,uM,=,0.3222192947339193,1,O=c1oc2cc(OCCCNCc3ccccc3)ccc2c2c1CCCC2
693,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc2c(CNc3ccnc(N4CCOCC4)n3)cccc2c1,2-morpholino-N-(naphthalen-1-ylmethyl)pyrimidin-4-amine,14.7,uM,=,1.167317334748176,1,c1ccc2c(CNc3ccnc(N4CCOCC4)n3)cccc2c1
694,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1,"N1-(quinolin-4-yl)-N7-(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine",0.0101,uM,=,-1.9956786262173567,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1
695,2260120,10.1016/j.ejmech.2020.112960,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate by BioTek Synergy HT microplate reader method,C/C=C1\CN2CCc3c([nH]c4ccccc34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,Geissoschizine methyl ether N-oxide,63.90049564387006,uM,=,1.8055042267744088,1,C=C1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1
696,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCOC1O2,"(3aS)-3a-methyl-2,3,3a,8a-tetrahydrofuro[2,3-b]benzofuran-5-yl ethylcarbamate",0.006,uM,=,-2.2218487496163566,0,c1ccc2c(c1)OC1OCCC21
697,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(F)ccc4c(N)c3C(C1)C2,"(+)-15-ethyl-7-fluoro-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.106,uM,=,-0.9746941347352298,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
698,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(C(=O)CNCCC2CCN(Cc3ccccc3)CC2)cc(C(C)(C)C)c1O,"2-((2-(1-benzylpiperidin-4-yl)ethyl)amino)-1-(3,5-di-tertbutyl-4-hydroxyphenyl)ethan-1-one",1.38,uM,=,0.1398790864012364,1,O=C(CNCCC1CCN(Cc2ccccc2)CC1)c1ccccc1
699,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CCCCCCSc1nc(-c2ccc(C)cc2)nn1C(=O)N(C)C,"5-Hexylsulfanyl-3-p-tolyl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.2,uM,=,-0.6989700043360187,0,c1ccc(-c2nc[nH]n2)cc1
700,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.1,uM,=,-1.0,0,c1ccccc1
701,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=c1c2ccccc2ccn1CCC1CCN(Cc2ccccc2)CC1,2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-2H-isoquinolin-1-one,1.1,uM,=,0.041392685158225,1,O=c1c2ccccc2ccn1CCC1CCN(Cc2ccccc2)CC1
702,1849549,10.1016/j.bmc.2019.07.001,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1cc(NCc2ccc(Oc3c(N)cccc3Cl)cc2)cc(OC)c1,"N-(4-(2-amino-6-chlorophenoxy)benzyl)-3,5-dimethoxyaniline",2.88,uM,=,0.4593924877592308,1,c1ccc(NCc2ccc(Oc3ccccc3)cc2)cc1
703,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3Sc3ccccc32)cc1OC,"(3,4-Dimethoxyphenyl)-10H-phenothiazin-10-ylmethanone",5.8,uM,=,0.7634279935629373,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
704,1776929,10.1016/j.bmcl.2018.07.019,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate by UV-visible spectrophotometric Ellman's method,COc1ccc2c(c1)C/C(=C/C1CCN(Cc3ccccc3)CC1)C2=O,"2-((1-benzylpiperidin-4-yl)methylene)-5-methoxy-2,3-dihydro-1H-inden-1-one",0.0441,uM,=,-1.3555614105321614,0,O=C1/C(=C\C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
705,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.383,uM,=,-0.4168012260313772,0,c1ccc2nc3c(cc2c1)CCCC3
706,1842245,10.1016/j.bmc.2019.01.025,,,,Inhibition of human acetylcholinesterase using acetylthiocholine as substrate pretreated followed by substrate addition and measured after 15 mins by Ellman's method,COc1cc(/C=C/C(=O)NCCNc2c3c(nc4ccccc24)CCCC3)ccc1OCc1ccccc1,"3-(4-(benzyloxy)-3-methoxyphenyl)-N-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)acrylamide",0.0551,uM,=,-1.2588484011482148,0,O=C(/C=C/c1ccc(OCc2ccccc2)cc1)NCCNc1c2c(nc3ccccc13)CCCC2
707,28445,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.52-2.21,C#CC(C)NC1CCc2ccc(SC(=O)N(C)C)cc21,Dimethyl-thiocarbamic acid S-[3-(1-methyl-prop-2-ynylamino)-indan-5-yl] ester,1.8,uM,=,0.255272505103306,1,c1ccc2c(c1)CCC2
708,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[10-(benzylmethylamino)decyloxy]xanthen-9-one,388.0,uM,=,2.588831725594208,1,O=c1c2ccccc2oc2cc(OCCCCCCCCCCNCc3ccccc3)ccc12
709,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccccc2F)C(=O)/C(=C/c2ccccc2F)C1,"(3E,5E)-1-Acryloyl-3,5-bis(2-fluorophenylmethylidene)piperidin-4-one",11.81,uM,=,1.0722498976135149,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
710,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),CCC(=O)CNC(=O)Nc1nc2ccc(-c3oc4c(OC)c(O)c(O)c(OC)c4c(=O)c3O)cc2s1,"1-(2-oxobutyl)-3-(6-(3,6,7-trihydroxy-5,8-dimethoxy-4-oxo-4H-chromen-2-yl)benzo[d]thiazol-2-yl)urea",0.1,uM,=,-1.0,0,O=c1cc(-c2ccc3ncsc3c2)oc2ccccc12
711,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(CN2CCC(CCC(=O)c3ccc4c(c3)NCCCC4)CC2)cc1,"3-[1-(4-Methoxy-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",55.2,uM,=,1.741939077729199,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
712,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-9-{{7-[3-(3,4-dihydro-5-phenyl-2H-pyrano[3,2-c]quinolin-9-yl)propanamido]heptyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.0144,uM,=,-1.8416375079047504,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
713,744973,10.1016/j.bmcl.2010.12.093,,,,Inhibition of human serum AChE,O=C1C=C(NCCCCCCNCc2nc3ccccc3s2)C(=O)C=C1NCCCCCCNCc1nc2ccccc2s1,"2,5-bis(6-(benzo[d]thiazol-2-ylmethylamino)hexylamino)cyclohexa-2,5-diene-1,4-dione",22.0,uM,=,1.3424226808222062,1,O=C1C=C(NCCCCCCNCc2nc3ccccc3s2)C(=O)C=C1NCCCCCCNCc1nc2ccccc2s1
714,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCC[n+]2ccc3ccccc3c2)cc1,1-(7-(pyridinium-1-yl)heptyl)isoquinoliniumdibromide,0.8,uM,=,-0.0969100130080563,0,c1cc[n+](CCCCCCC[n+]2ccc3ccccc3c2)cc1
715,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3c(Br)cc(Br)cc13)CCC2,"5,7-dibromo-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",15.1,uM,=,1.1789769472931697,1,c1ccc2nc3c(cc2c1)CCC3
716,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,CCCCOC(=O)CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1C[C@@H]3O,n-Butyl lucidenate N,11.58,uM,=,1.0637085593914173,1,O=C1CC2CCCC2C2=C1C1CCCC[C@@H]1CC2
717,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3ccc([N+](=O)[O-])cc3)cn2)cc1,2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-methyl-N-(3-(4-nitrophenoxy)propyl)pyrimidine-5-carboxamide,4.56,uM,=,0.658964842664435,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
718,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(C)[C@H]1N2C,"methyl-carbamic acid (3aR,8aS)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",9.89,uM,=,0.9951962915971796,1,c1ccc2c(c1)N[C@@H]1NCCC21
719,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CCNc2nc(NC(C)C)nc3ccccc23)cc1OC,"N4-(3,4-dimethoxyphenethyl)-N2-isopropylquinazoline-2,4-diamine",7.6,uM,=,0.8808135922807914,1,c1ccc(CCNc2ncnc3ccccc23)cc1
720,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC(O)C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-1-hydroxy-3-oxo-propyl]-1-methyl-piperidinium bromide",0.665,uM,=,-0.1771783546968953,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
721,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccccc2Cl)C(=O)/C(=C/c2ccccc2Cl)C1,"(3E,5E)-1-acryloyl-3,5-bis(2-chlorobenzylidene)piperidin-4-one",16.32,uM,=,1.2127201544178423,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
722,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,CC12CC3CC(C)(C1)CC(N)(C3)C2,"3,5-Dimethyl-adamantan-1-ylamine",0.0049,uM,=,-2.309803919971486,0,C1C2CC3CC1CC(C2)C3
723,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,Cc1ccc([C@@H]2[C@H]3CSCN3C3(C(=O)c4ccccc4C3=O)[C@]23CSc2ccccc2C3=O)cc1,"(6'R,7'S,7a'S)-7'-(p-Tolyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",7.11,uM,=,0.8518696007297664,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
724,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1cc(C2CC(=O)c3c(cc(O)c(C/C=C(\C)CCC=C(C)C)c3O)O2)cc(OC)c1O,"6-Geranyl-4',5,7-trihydroxy-3',5'-dimethoxyflavanone",316.3,uM,=,2.500099191915723,1,O=C1CC(c2ccccc2)Oc2ccccc21
725,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,FC(F)(F)Oc1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,1-Benzyl-N-(4-(trifluoromethoxy)benzyl)pyrrolidin-3-amine,0.0579999999999999,uM,=,-1.2365720064370629,0,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
726,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NC1CCN(Cc2ccc(F)cc2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1,"N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)carbamoyl)pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide",0.2269999999999999,uM,=,-0.6439741428068774,0,O=C(NC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1
727,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,"N4-(Benzyl)-N2-cyclopropylquinazoline-2,4-diamine",6.6,uM,=,0.8195439355418687,1,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1
728,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CC1CCCN(Cc2ccc(CNCCN3CCNC3=C(C#N)C#N)o2)C1,2-[1-(2-{[5-(3-Methyl-piperidin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile,0.37,uM,=,-0.431798275933005,0,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
729,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,COc1ccccc1-c1nnc(-c2ccc3c(c2)CO[C@@]3(CCCN(C)C)c2ccc(F)cc2)[nH]1,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(2-methoxyphenyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",161.34,uM,=,2.207742052606945,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
730,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CN(CCCOc1ccc2c(c1)oc(=O)c1ccccc12)Cc1cccc(OC(=O)NCCCCCc2ccccc2)c1,3-((Methyl(3-((6-oxo-6H-benzo[c]chromen-3-yl)oxy)propyl)-amino)methyl)phenyl(5-Phenylpentyl)carbamate,0.39,uM,=,-0.4089353929735008,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3c(c2)oc(=O)c2ccccc23)c1
731,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCc3ncnc4ccccc34)CC2)cc1,4-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-quinazoline,0.34,uM,=,-0.4685210829577448,0,c1ccc(CN2CCC(CCc3ncnc4ccccc34)CC2)cc1
732,1827463,10.1016/j.ejmech.2018.10.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by Ellman's method,Cc1c(C)c2ccc(OCC3CCN(CCCO[N+](=O)[O-])CC3)cc2oc1=O,"3-(4-{[(3,4-Dimethyl-2-oxo-2H-chromen-7-yl)oxy]methyl}piperidin-1-yl)propyl nitrate",0.86,uM,=,-0.0655015487564322,0,O=c1ccc2ccc(OCC3CCNCC3)cc2o1
733,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(4-(6-methoxy-1-methylpyridinium-2-yl)butyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",5.2,uM,=,0.7160033436347992,1,c1ccc(CCCC[NH+]2CCc3ccccc3C2)[nH+]c1
734,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)ccc1F.[I-],(E)-2-(4-Fluoro-3-methoxystyryl)-1-methylquinolin-1-ium iodide,2.8,uM,=,0.4471580313422192,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
735,2076989,10.1039/d1md00105a,,,,Inhibition of human AChE,O=c1ccoc2ccc(OCCCN3CCCCC3)cc12,6-(3-(piperidin-1-yl)propoxy)-4H-chromen-4-one,15.9,uM,=,1.2013971243204515,1,O=c1ccoc2ccc(OCCCN3CCCCC3)cc12
736,1439748,10.1021/np500412f,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as inhibition of acetylcholine hydrolysis after 30 mins by Ellmann's method,C/C=C1\[C@H]2C=C(C)C[C@]1(NC1OCC3=C4CC(C)(C)[C@H](O)[C@H]4[C@@H](C)CCC31O)c1ccc(=O)[nH]c1C2,Huptremule D,0.06,uM,=,-1.2218487496163564,0,C=C1[C@H]2C=CC[C@]1(NC1OCC3=C4CCC[C@H]4CCCC31)c1ccc(=O)[nH]c1C2
737,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NCCCCCCCN2CCOCC2)c1,(7-Morpholin-4-yl-heptyl)-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0261999999999999,uM,=,-1.5816987086802543,0,O=C(NCCCCCCCN1CCOCC1)Oc1cccc(CNCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1
738,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)/C=C/c3cc[n+](Cc4ccccc4F)cc3)c2c1.[Br-],1-(2-fluorobenzyl)-4-(3-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-3-oxoprop-1-en-1-yl)pyridin-1-ium bromide,0.26,uM,=,-0.585026652029182,0,O=C(/C=C/c1cc[n+](Cc2ccccc2)cc1)NCCc1c[nH]c2ccccc12
739,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,COc1cc2oc(-c3ccc(OCCCCN(C)Cc4ccccc4)cc3)cc(=O)c2c(OC)c1OC,"4'-(4-(Benzyl(methyl)amino)butoxy)-5,6,7-trimethoxyflavone",0.95,uM,=,-0.0222763947111522,0,O=c1cc(-c2ccc(OCCCCNCc3ccccc3)cc2)oc2ccccc12
740,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,COc1cc2c(cc1OC)-c1cccc3c1N(CC3)C2,"9,10-dimethoxy-5,7-dihydro-4H-pyrrolo[3,2,1-de]phenanthridine",3.87,uM,=,0.5877109650189114,1,c1ccc2c(c1)CN1CCc3cccc-2c31
741,430853,10.1021/jm0503289,,,,Inhibition of human brain AchE,O=C(Cc1c[nH]c2ccc(Br)cc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"2-(5-bromo-1H-indol-3-yl)-N-[7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-acetamide",0.00023,uM,=,-3.638272163982407,0,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
742,1983599,10.1016/j.bmcl.2019.126880,,,,Inhibition of human AChE using acetylthiocholine chloride as substrate peincubated for 15 mins followed by substrate addition measured at 1 min interval by Ellman's method,C#CCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-chloro-N-(prop-2-ynyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0094,uM,=,-2.026872146400301,0,c1ccc2nc3c(cc2c1)CCCC3
743,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCCC2)cc1OC,"rac-2-(3,4-Dimethoxyphenyl)-2-(pyrrolidin-1-yl)acetonitrile",42.0,uM,=,1.6232492903979006,1,c1ccc(CN2CCCC2)cc1
744,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccc(C(C)NS(N)(=O)=O)cc1,N-(1-(4-Methoxyphenyl)ethyl)sulfamide,2.685e-05,uM,=,-4.571055709964425,0,c1ccccc1
745,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,O=C(/C=C/c1ccc(Cl)cc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-chlorophenyl)acrylamide,0.362,uM,=,-0.4412914294668343,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
746,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,COC(=O)c1cc2c(N)c3c(nc2nc1C)CCCCCC3,"Methyl 5-Amino-2-methyl-6,7,8,9,10,11-hexahydrocycloocta-[b][1,8]naphthyridine-3-carboxylate",1.8,uM,=,0.255272505103306,1,c1cnc2nc3c(cc2c1)CCCCCC3
747,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CC[n+]1cc(C(=O)NC)cc2c(OC(=O)N(C)C)cccc21.[I-],"[1-Ethyl-3-(methylcarbamoyl)quinolin-1-ium-5-yl]-N,N-dimethylcarbamate iodide",0.314,uM,=,-0.5030703519267851,0,c1ccc2[nH+]cccc2c1
748,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCCC[n+]1cccc2ccccc21,"1,1'-(hexane-1,6-diyl)diquinolinium bromide",25.0,uM,=,1.3979400086720375,1,c1ccc2c(c1)ccc[n+]2CCCCCC[n+]1cccc2ccccc21
749,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.19,uM,=,-0.721246399047171,0,c1ccc2c(c1)N[C@H]1NCCC21
750,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CN(C)c1ccc(/C=C2/CNC/C(=C\c3ccc(N(C)C)cc3[N+](=O)[O-])C2=O)c([N+](=O)[O-])c1,"3,5-Bis[4-(dimethylamino)2-nitro-benzylidene]piperidin-4-one",0.88,uM,=,-0.0555173278498313,0,O=C1/C(=C\c2ccccc2)CNC/C1=C\c1ccccc1
751,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O,"5-Amino-2-[2-(1-benzyl-piperidin-4-yl)-ethyl]-isoindole-1,3-dione",0.0088,uM,=,-2.055517327849832,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
752,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2cccc([N+](=O)[O-])c2)C(=O)[C@@]2(C1)[C@H](c1cccc([N+](=O)[O-])c1)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(3-nitrophenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(3-nitrophenylmethylidene)-1''-N-acrolylpiperidin-4''-one,5.34,uM,=,0.7275412570285564,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
753,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[9-(benzylmethylamino)nonyloxy]xanthen-9-one,152.0,uM,=,2.1818435879447726,1,O=c1c2ccccc2oc2cc(OCCCCCCCCCNCc3ccccc3)ccc12
754,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CN(C)c1ccc(/C=C2/COC/C(=C\c3ccc(N(C)C)cc3[N+](=O)[O-])C2=O)c([N+](=O)[O-])c1,"3,5-Bis[4-(dimethylamino)2-nitro-benzylidene]tetrahydropyran-4-one",1.54,uM,=,0.1875207208364631,1,O=C1/C(=C\c2ccccc2)COC/C1=C\c1ccccc1
755,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1CCc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc2N1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5,8-dihydro-6H-isoxazolo[4,5-g]quinolin-7-one",0.00057,uM,=,-3.2441251443275085,0,O=C1CCc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc2N1
756,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2oc(C(=O)NC3CCN(Cc4ccccc4)CC3)cc(=O)c2cc1OC,"N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide",0.66,uM,=,-0.1804560644581313,0,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
757,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2cc(=O)c3ccc(OCCN4CCCC4)cc3o2)cc1,2-(4-methoxyphenyl)-7-(2-(pyrrolidin-1-yl)ethoxy)-4H-chromen-4-one,0.1047999999999999,uM,=,-0.9796387173522922,0,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCCC3)ccc12
758,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C(CNc1ccc2oc(=O)ccc2c1)N1CCOCC1,6-[(2-Morpholino-2-oxoethyl)amino]-2H-chromen-2-one,0.037,uM,=,-1.431798275933005,0,O=C(CNc1ccc2oc(=O)ccc2c1)N1CCOCC1
759,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CN(C)C(=O)Oc1cccc2c1cc(C(=O)N(C)C)c[n+]2C.[I-],"[3-(Dimethylcarbamoyl)-1-methyl-quinolin-1-ium-5-yl]-N,N-dimethylcarbamate iodide",0.154,uM,=,-0.8124792791635369,0,c1ccc2[nH+]cccc2c1
760,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,CN(CCC(=O)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1)C1CCCCC1,"3-[cyclohexyl(methyl)amino]-1-{4-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]piperazino}-1-propanone",0.0149,uM,=,-1.826813731587726,0,O=C(CCNC1CCCCC1)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1
761,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),CCC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCN4CCC(CC5Cc6cc(OC)c(OC)cc6C5)CC4)c3C(C1)C2.Cl.Cl,"(+/-)36b-3-chloro-N-(3-(4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)propyl)-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinolin-12-amine Dihydrochloride",0.00385,uM,=,-2.4145392704914994,0,C1=CC2Cc3nc4ccccc4c(NCCCN4CCC(CC5Cc6ccccc6C5)CC4)c3C(C1)C2
762,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(F)cc3)CC1)C2,"2-((1-(4-fluorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.041,uM,=,-1.3872161432802643,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
763,2299836,10.1039/d2md00415a,,,,Inhibition of human AchE,CC1(C)O[C@@H]2[C@@H](O)[C@H]3NC(=O)O[C@H]3C[C@@H]2O1,"(3aS,4aS,7aR,8S,8aR)-8-hydroxy-2,2-dimethylhexahydro-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]oxazol-6(3aH)-one",58.7,uM,=,1.7686381012476144,1,O=C1N[C@@H]2C[C@H]3OCO[C@H]3C[C@@H]2O1
764,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccc(F)cc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(4-fluorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(4-fluorophenylmethylidene)hexahydro-1H-pyrrolizine,23.67,uM,=,1.3741982579290828,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
765,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,COc1ccc(-c2ccc(OCC(=O)NCCCN3CCCCC3)cc2)cc1,"2-((4'-Methoxy-[1,1'-biphenyl]-4-yl)oxy)-N-(3-(piperidin-1-yl)propyl)acetamide",14.0,uM,=,1.146128035678238,1,O=C(COc1ccc(-c2ccccc2)cc1)NCCCN1CCCCC1
766,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc(C#N)c[n+]1C.F[B-](F)(F)F,5-cyano-2-methoxy-1-methylpyridinium tetrafluoroborate,64.0,uM,=,1.806179973983887,1,c1cc[nH+]cc1
767,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,C#CCN(C)Cc1ccc(OC(=O)N(C)C)c2ncccc12,5-((methyl(prop-2-ynyl)amino)methyl)quinolin-8-yl dimethylcarbamate,0.52,uM,=,-0.2839966563652008,0,c1ccc2ncccc2c1
768,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccccc3)cc12.[Br-],8-Methoxy-2-phenylisoquinolin-2-ium bromide,1.42,uM,=,0.1522883443830564,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
769,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(C)OC,"(E)-4-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl methoxy(methyl)carbamate",12.3,uM,=,1.089905111439398,1,O=C(/C=C/c1ccccc1)N1CCc2ccccc2C1
770,2215293,10.1016/j.bmc.2022.116742,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2oc(C(=O)Nc3cccc(CN(C)Cc4ccccc4)c3)cc(=O)c2cc1OC,"N-(3-((benzyl(methyl)amino)methyl)phenyl)-6,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide",4.5,uM,=,0.6532125137753437,1,O=C(Nc1cccc(CNCc2ccccc2)c1)c1cc(=O)c2ccccc2o1
771,775052,10.1016/j.ejmech.2011.09.001,,,,Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,O=C(CCCC[C@H]1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-N-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-5-(1,2-dithiolan-3-yl)pentanamide",0.000471,uM,=,-3.326979092871104,0,O=C(CCCC[C@H]1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2
772,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CC1CCN(Cc3cccc(/C=N/O)c3O)CC1)CC2,"3-((4-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",740.4,uM,=,2.8694664100808667,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3c3ccccc3)CC2)cc1
773,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1cccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3ccc([N+](=O)[O-])cc3)cn2)c1,2-(2-(3-methoxyphenyl)-2-oxoethyl)-N-methyl-N-(3-(4-nitrophenoxy)propyl)pyrimidine-5-carboxamide,4.0,uM,=,0.6020599913279624,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
774,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,Cc1ccc(-c2nc(SCC(F)(F)F)n(C(=O)N(C)C)n2)cc1,"3-p-Tolyl-5-(2,2,2-trifluoro-ethylsulfanyl)-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.2,uM,=,-0.6989700043360187,0,c1ccc(-c2nc[nH]n2)cc1
775,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1c(/C=N/Nc2ccc(C(F)(F)F)cc2)coc2cc3oc(-c4cccc(Cl)c4)cc3cc12,"2-(3-chlorophenyl)-6-((2-(4-(trifluoromethyl)phenyl)hydrazineylidene)methyl)-5H-furo[3,2-g]chromen-5-one",18.3,uM,=,1.2624510897304295,1,O=c1c(/C=N/Nc2ccccc2)coc2cc3oc(-c4ccccc4)cc3cc12
776,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,Cc1ccccc1-c1nnc(-c2ccc3c(c2)CO[C@@]3(CCCN(C)C)c2ccc(F)cc2)[nH]1,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(o-tolyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",9.52,uM,=,0.9786369483844743,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
777,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1ccc2c(N)c3c(nc2c1)CCCCC3.Cl,"3-methyl-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",0.104,uM,=,-0.9829666607012196,0,c1ccc2nc3c(cc2c1)CCCCC3
778,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1ccc(C2=CSC3=NC4=C(CNC/C4=C/c4ccc(Cl)cc4)C(c4ccc(Cl)cc4)N23)cc1,"(E)-9-(4-chlorobenzylidene)-5-(4-chlorophenyl)-3-(p-tolyl)-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",1.09,uM,=,0.0374264979406236,1,C1=C(c2ccccc2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
779,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,COc1cccc2nc3c(c(N)c12)CCCC3,"8-Methoxy-1,2,3,4-tetrahydro-acridin-9-ylamine",0.615,uM,=,-0.2111248842245832,0,c1ccc2nc3c(cc2c1)CCCC3
780,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1ccc(/C=C2/CNCC3=C2N=C2SC=C(c4ccc(C)cc4)N2C3c2ccc(C)cc2)cc1,"(E)-9-(4-methylbenzylidene)-3,5-di-p-tolyl-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",1.8,uM,=,0.255272505103306,1,C1=C(c2ccccc2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
781,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,Brc1ccc(CN2CCN(c3nccc(NCc4ccccc4)n3)CC2)cc1,N-Benzyl-2-[4-(4-bromobenzyl)piperazin-1-yl]pyrimidin-4-amine,25.5,uM,=,1.4065401804339552,1,c1ccc(CNc2ccnc(N3CCN(Cc4ccccc4)CC3)n2)cc1
782,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccccc2CN1CCC1CCN(Cc2ccccc2)CC1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-2,3-dihydro-isoindol-1-one",0.098,uM,=,-1.0087739243075051,0,O=C1c2ccccc2CN1CCC1CCN(Cc2ccccc2)CC1
783,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=C1CC(c2ccc(OCCCCN3CCN(Cc4ccccc4)CC3)cc2)Oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)cc(O)c21,7-(4-(4-benzylpiperazin-1-yl)butoxy)-2-(4-(4-(4-benzylpiperazin-1-yl)butoxy)phenyl)-5-hydroxychroman-4-one,18.7,uM,=,1.271841606536499,1,O=C1CC(c2ccc(OCCCCN3CCN(Cc4ccccc4)CC3)cc2)Oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc21
784,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,CN(C)CCOc1ccc(-c2nc3ccccc3[nH]2)cc1,"2-[4-(1H-Benzo[d]imidazol-2-yl)phenoxy]-N,N-dimethylethanamine",10.68,uM,=,1.0285712526925377,1,c1ccc(-c2nc3ccccc3[nH]2)cc1
785,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2oc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2c1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-6-methoxy-4-oxo-4H-chromene-2-carboxamide,0.17,uM,=,-0.7695510786217261,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
786,489450,10.1021/jm800577j,,,,Inhibition of human recombinant AChE by Ellman's method,Clc1ccc2c(NCCCNCCCCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3,"N-[6-(9H-Carbazol-4-yloxy)hexyl]-N'-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)propane-1,3-diamine",0.00257,uM,=,-2.5900668766687054,0,c1ccc2c(NCCCNCCCCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3
787,28936,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase activity from octopus brain,CCCCCCSC(=O)OCC[N+](C)(C)C.[Cl-],(2-Hexylsulfanylcarbonyloxy-ethyl)-trimethyl-ammonium chloride,100.0,uM,=,2.0,1,
788,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,Cc1ccc2c(c1)C(=O)C(=O)N2Cc1ccccc1[N+](=O)[O-],"5-methyl-1-(2-nitrobenzyl)indoline-2,3-dione",0.1995,uM,=,-0.700057099977233,0,O=C1C(=O)N(Cc2ccccc2)c2ccccc21
789,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C([N+](=O)[O-])C12C(=O)c1ccc(Br)c3c(Br)ccc2c13,"2'-amino-1'-benzyl-6'-(benzylamino)-5,6-dibromo-5'-nitro-2-oxo-1'H,2H-spiro[acenaphthylene-1,4'-pyridine]-3'-carbonitrile",6.24,uM,=,0.795184589682424,1,O=C1c2cccc3cccc(c23)C12C=CN(Cc1ccccc1)C(NCc1ccccc1)=C2
790,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,COc1ccccc1CNCCCCCCNC1=CC(=O)c2ccccc2C1=O,"2-(6-(2-Methoxybenzylamino)hexylamino)naphthalene-1,4-dione",1.85,uM,=,0.2671717284030138,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)c2ccccc21
791,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,"N2-cyclopropyl-N4-(phenethyl)quinazoline-2,4-diamine",8.6,uM,=,0.9344984512435676,1,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1
792,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(C)cc3)cc12.[Br-],8-Methoxy-2-(p-toly)isoquinolin-2-ium bromide,1.08,uM,=,0.0334237554869497,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
793,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCCCNC(=O)Oc1ccc2c(c1)C1CCN(CC)C2C1,"Hexyl-carbamic acid 9-ethyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.125,uM,=,-0.9030899869919436,0,c1ccc2c(c1)C1CCNC2C1
794,579488,10.1016/j.bmcl.2009.05.087,,,,Inhibition of human recombinant AChE preincubated 20 mins before substrate addition by Ellman method,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@H](C)c2ccccc2OC)=CC1=O)[C@H](C)c1ccccc1OC,"2,5-bis(6-(ethyl((R)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",0.0005,uM,=,-3.3010299956639813,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
795,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc([N+](=O)[O-])c3)CC1)C2,"5,6-Dimethoxy-2-[1-(3-nitro-benzyl)-piperidin-4-ylmethyl]-indan-1-one",0.652,uM,=,-0.1857524042680797,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
796,1884186,10.1016/j.ejmech.2019.02.076,,,,Inhibition of human AChE,Cc1ccc2[nH]c3c(c2c1)CN(CCCCCCN1CCc2[nH]c4ccc(C)cc4c2C1)CC3,"1,6-bis(8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)hexane",0.195,uM,=,-0.7099653886374819,0,c1ccc2c3c([nH]c2c1)CCN(CCCCCCN1CCc2[nH]c4ccccc4c2C1)C3
797,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(Nc4[nH]nc5ncccc45)c2c1)CCCC3,"7-methyl-N-(2H-pyrazolo[3,4-b]pyridin-3-yl)-1,2,3,4-tetrahydroacridin-9-amine",0.8109999999999999,uM,=,-0.090979145788844,0,c1ccc2c(Nc3[nH]nc4ncccc34)c3c(nc2c1)CCCC3
798,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,O=C(/C=C/c1ccc(O)cc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide,2.51,uM,=,0.3996737214810381,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
799,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1,1-(4-Amino-5-chloro-2-methoxy-phenyl)-3-(1-butyl-piperidin-4-yl)-propan-1-one,0.403,uM,=,-0.3946949538588905,0,O=C(CCC1CCNCC1)c1ccccc1
800,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCOCCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"3-(2-(1H-indol-3-yl)ethoxy)-N-(7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)propanamide",0.003,uM,=,-2.5228787452803374,0,O=C(CCOCCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
801,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12,3-(4-(4-Benzylpiperazin-1-yl)butoxy)-6H-benzo[c]chromen-6-one,8.2,uM,=,0.9138138523837168,1,O=c1oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12
802,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc2onc(CCC3CCN(Cc4ccccc4)CC3)c2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5-methoxy-benzo[d]isoxazole,0.0072,uM,=,-2.1426675035687315,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
803,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1ccc(C2CC(c3cc(F)ccc3F)=NN2c2ccc(S(N)(=O)=O)cc2)cc1OC,"4-(3-(2,5-difluorophenyl)-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
804,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CN(C)Cc1ccc(CSCCCCCCCCCCSCc2ccc(CN(C)C)o2)o1,{5-[10-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-decylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,1.3,uM,=,0.1139433523068367,1,c1coc(CSCCCCCCCCCCSCc2ccco2)c1
805,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CCN(C)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((ethyl(methyl)amino)methyl)phenol dihydrochloride,965.1,uM,=,2.9845723156216324,1,c1ccccc1
806,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,CC(=O)c1c[n+](Cc2ccccc2C)ccc1CC1Cc2cc(Cl)ccc2C1=O.[Br-],(+/-)-2-[[3-Acetyl-1-(o-tolylmethyl)pyridin-1-ium-4-yl]methyl]-5-chloro-indan-1-one Bromide,0.262,uM,=,-0.5816987086802545,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
807,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C2\CCC/C(=C\c3ccc(C(OCC)OCC)cc3)C2=O)cc1,"2,6-Bis[4-(diethoxymethyl)benzylidene]cyclohexanone",12.43,uM,=,1.0944711286416449,1,O=C1/C(=C/c2ccccc2)CCC/C1=C\c1ccccc1
808,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccccc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-benzyl-berberine bromide,5.0,uM,=,0.6989700043360189,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
809,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN2CCN(CCCOc3ccc4c(c3)oc(=O)c3ccccc34)CC2)c1,3-(3-(4-(3-Methoxybenzyl)piperazin-1-yl)propoxy)-6H-benzo[c]chromen-6-one,18.0,uM,=,1.255272505103306,1,O=c1oc2cc(OCCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12
810,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCCNC(=O)C4(C)CCc5c(C)c(O)c(C)c(C)c5O4)c2c1)CCCC3,"6-hydroxy-N-(3-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-2,5,7,8-tetramethylchroman-2-carboxamide",1.54,uM,=,0.1875207208364631,1,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
811,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCCCCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-N-methyl-2-(2-(2-((6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0219,uM,=,-1.6595558851598815,0,O=C(CNCCCCCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
812,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N\O)Nc1ccc[n+](CCCCCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],"1,1'-(heptane-1,7-diyl)bis(3-((Z)-2-(hydroxyimino)acetamido)pyridinium)dibromide",930.0,uM,=,2.9684829485539352,1,c1cc[n+](CCCCCCC[n+]2ccccc2)cc1
813,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,Cc1cc(=O)oc2cc(OCCCN(C)Cc3cccc(OC(=O)NCCCCCc4ccccc4)c3)ccc12,3-((Methyl(3-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)propyl)-amino)methyl)phenyl(5-Phenylpentyl)carbamate,0.0805,uM,=,-1.0942041196321317,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3ccc(=O)oc3c2)c1
814,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(Br)cc2)C[C@@H](c2ccc(Cl)cc2)N(c2ccc(Br)cc2)[C@@H]1c1ccc(Cl)cc1,"(2R,6S)-methyl 1-(4-bromophenyl)-4-(4-bromophenylamino)-2,6-bis(4-chlorophenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate",880.0,uM,=,2.9444826721501687,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
815,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,O=C(c1ccccc1Cl)n1nc(OCCCN2CCCCC2)c2ccccc21,(2-chlorophenyl)(3-(3-(piperidino)propoxy)indazol-1-yl)ketone,9.7,uM,=,0.9867717342662448,1,O=C(c1ccccc1)n1nc(OCCCN2CCCCC2)c2ccccc21
816,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21,(10H-phenothiazin-10-yl)(phenyl)methanone,8.0,uM,=,0.9030899869919436,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
817,462117,10.1021/jm7009364,,,,Inhibition of human AchE,CN[C@@H](CCOc1ccc([N+](=O)[O-])cc1)c1ccc(OC(=O)N(C)C)cc1,Dimethyl-carbamic acid 4-[(S)-1-methylamino-3-(4-nitro-phenoxy)-propyl]-phenyl ester,0.101,uM,=,-0.9956786262173574,0,c1ccc(CCCOc2ccccc2)cc1
818,1653858,10.1016/j.ejmech.2016.11.050,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by spectrophotometry based Ellman method,COc1ccc(C2c3ccc4cccnc4c3Oc3nc4c(c(N)c32)CCCC4)cc1,"7-(4-Methoxyphenyl)-9,10,11,12-tetrahydro-7H-pyrano[2,3-b:5,6-h']diquinolin-8-amine",1.51,uM,=,0.1789769472931694,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2cccnc32)CCCC4)cc1
819,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)chroman-2-carboxamide",0.36,uM,=,-0.4436974992327127,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
820,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC1=C(C)c2nc3ccccc3c(N)c2C1,"2,3-Dimethyl-1H-cyclopenta[b]quinolin-9-ylamine",3.5,uM,=,0.5440680443502757,1,C1=Cc2nc3ccccc3cc2C1
821,1439748,10.1021/np500412f,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as inhibition of acetylcholine hydrolysis after 30 mins by Ellmann's method,C/C=C1/[C@@H]2Cc3[nH]c(=O)ccc3[C@@]1(N)C[C@]1(C)O[C@H]21,"8alpha,15alpha-epoxyhuperzine A",12.11,uM,=,1.0831441431430522,1,C=C1C2CC3O[C@@H]3[C@H]1Cc1[nH]c(=O)ccc12
822,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCN1CCCCC1,(E)-3-(3-methoxy-4-(3-(piperidin-1-yl)propoxy)phenyl)-N-phenylacrylamide,14.48,uM,=,1.160768561861128,1,O=C(/C=C/c1ccc(OCCCN2CCCCC2)cc1)Nc1ccccc1
823,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,"N4-(Benzyl)-N2-propylquinazoline-2,4-diamine",7.8,uM,=,0.8920946026904804,1,c1ccc(CNc2ncnc3ccccc23)cc1
824,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccccc2)C[C@@H](c2cccc([N+](=O)[O-])c2)N(c2ccccc2)[C@@H]1c1cccc([N+](=O)[O-])c1,"(2R,6S)-methyl 2,6-bis(3-nitrophenyl)-1-phenyl-4-(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",510.0,uM,=,2.7075701760979363,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
825,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1ccccc1C[n+]1ccc(COc2ccc3c(C)cc(=O)oc3c2)cc1.[Br-],4-(((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)-1-(2-methylbenzyl)pyridin-1-ium bromide,0.0354,uM,=,-1.450996737974212,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
826,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1,"N-(6-((7,8,9,10-Tetrahydro-6H-cyclohepta[b]quinolin-11-yl)-amino)hexyl)benzofuran-2-carboxamide",0.308,uM,=,-0.5114492834995558,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1
827,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3cccc(C)c3)cc12.[Br-],8-Methoxy-2-(m-toly)isoquinolin-2-ium bromide,2.21,uM,=,0.3443922736851107,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
828,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N/O)Nc1ccc[n+](Cc2cccc(C[n+]3cccc(NC(=O)/C=N/O)c3)c2)c1.[Br-].[Br-],"1,1'-(1,3-phenylenebis(methylene))bis(3-(2-(hydroxyimino)acetamido)pyridinium)dibromide",1670.0,uM,=,3.222716471147584,1,c1cc[n+](Cc2cccc(C[n+]3ccccc3)c2)cc1
829,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CC(CC(C)(C)C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],"2-(Hydroxyimino-methyl)-3-methyl-1-(1,3,3-trimethyl-butoxymethyl)-3H-imidazol-1-ium chloride",32.5,uM,=,1.5118833609788744,1,c1c[nH+]c[nH]1
830,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(F)c3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-((4-amino-3-fluorophenyl)suffonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.0660699999999999,uM,=,-1.1799956931916822,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
831,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.Cl.O=C(NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"6-Chloro-9-{{7-[5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-carboxamido]heptyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.0183,uM,=,-1.7375489102695705,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
832,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(N4CCOCC4)c2c1)CCCC3,"4-(7-Methyl-1,2,3,4-tetrahydroacridin-9-yl)morpholine",1.775,uM,=,0.2491983573911128,1,c1ccc2c(N3CCOCC3)c3c(nc2c1)CCCC3
833,1842289,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 60 mins followed by substrate addition by Ellman's method,C#CCNC1CCCc2ccc(OC(=O)N(C)CC)cc21,"8-(prop-2-ynylamino)-5,6,7,8-tetrahydronaphthalen-2-yl ethyl(methyl)carbamate",52.4,uM,=,1.7193312869837267,1,c1ccc2c(c1)CCCC2
834,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3ccc(OCCNC(=O)/C=C/c4ccc(Cl)c(Cl)c4)cc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-7-yloxy)ethyl)-3-(3,4-dichlorophenyl)acrylamide",4.23,uM,=,0.6263403673750424,1,O=C(/C=C/c1ccccc1)NCCOc1ccc2cc(-c3ccc(CNCc4ccccc4)cc3)c(=O)oc2c1
835,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCC(=O)N[C@H]1CCCC[C@@H]1NC(=O)CCCCCN(CC)Cc1ccccc1OC)Cc1ccccc1OC,(+/-)-trans-6-[Ethyl-(2-methoxybenzyl)amino]hexanoic acid (2-{6-[ethyl-(2-methoxybenzyl)amino]hexanoylamino}cyclohexyl)amide,5.47,uM,=,0.7379873263334308,1,O=C(CCCCCNCc1ccccc1)N[C@H]1CCCC[C@@H]1NC(=O)CCCCCNCc1ccccc1
836,1871369,10.1016/j.bmcl.2018.12.011,,,,Inhibition of AchE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 20 secs for 20 times by Ellman's assay,COC(=O)/C(=C\C(=O)c1cc(O)ccc1O)CC/C=C(\C)CCC=C(C)C,Cochlearin I,8.2,uM,=,0.9138138523837168,1,c1ccccc1
837,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CCCCCCCNC(=O)Oc1cccc(CN(CCCOc2ccc3c(=O)c4ccccc4oc3c2)C(C)C)c1,Heptyl-carbamic acid 3-({isopropyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.17,uM,=,-0.7695510786217261,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
838,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,O=[N+]([O-])c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,1-Benzyl-N-(4-nitrobenzyl)pyrrolidin-3-amine,0.741,uM,=,-0.1301817920206718,0,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
839,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCCCCCSCc2ccc(CN(C)C)o2)o1,{5-[6-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-hexylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.74,uM,=,-0.1307682802690238,0,c1coc(CSCCCCCCSCc2ccco2)c1
840,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(C)[C@H]1N2C,"(+)-(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo-[2,3-b]indol-5-yl N-(2'-Methylphenyl)carbamate",5.51,uM,=,0.741151598851785,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@H]1N2
841,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,COC(=O)CNC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](C)c1.[I-],Methyl 2-[[5-(dimethylcarbamoyloxy)-1-methyl-quinolin-1-ium-3-carbonyl]amino]acetate iodide,0.093,uM,=,-1.031517051446065,0,c1ccc2[nH+]cccc2c1
842,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),CCC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCN4CCC(CC5Cc6cc(OC)c(OC)cc6C5)CC4)c3C(C1)C2.Cl.Cl,"(+/-)36b-3-chloro-N-(3-(4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)propyl)-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinolin-12-amine Dihydrochloride",0.00632,uM,=,-2.199282921717615,0,C1=CC2Cc3nc4ccccc4c(NCCCN4CCC(CC5Cc6ccccc6C5)CC4)c3C(C1)C2
843,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccc(F)cc2)N(c2ccccc2)[C@@H]1c1ccc(F)cc1,"(2R,6S)-ethyl 2,6-bis(4-fluorophenyl)-1-phenyl-4-(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",390.0,uM,=,2.591064607026499,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
844,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccc(Cl)cc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(4-chlorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(4-chlorophenylmethylidene)hexahydro-1H-pyrrolizine,7.92,uM,=,0.8987251815894935,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
845,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3cccc(F)c3)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-1-(3-fluorobenzyl)-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium bromide",0.0555,uM,=,-1.2557070168773237,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
846,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4cccnc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[3-(10-oxo-10H-9-oxa-1-aza-anthracen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0011,uM,=,-2.958607314841775,0,O=c1c2ccc(OCCCNCc3ccccc3)cc2oc2ncccc12
847,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NCC3CCN(Cc4ccc(F)cc4)CC3)sc2-c2ccc(C)cc2)cc1,"N-[(1-(4-Fluorobenzyl)piperidin-4-yl)methyl]-4,5-bis(p-tolyl)-thiazol-2-ylamine",0.37,uM,=,-0.431798275933005,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
848,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,10.54,uM,=,1.0228406108765278,1,c1ccccc1
849,1439748,10.1021/np500412f,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as inhibition of acetylcholine hydrolysis after 30 mins by Ellmann's method,C/C=C1\[C@H]2C=C(C)C[C@]1(NC1OCC3=C4CC(C)(C)C[C@H]4[C@@H](C)[C@H](O)CC31O)c1ccc(=O)[nH]c1C2,Huptremule C,0.11,uM,=,-0.958607314841775,0,C=C1[C@H]2C=CC[C@]1(NC1OCC3=C4CCC[C@H]4CCCC31)c1ccc(=O)[nH]c1C2
850,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(CN(C)CCCCCOc2ccc3c(c2)Oc2ncccc2C3)c1,"3-((Methyl-(5-((5-oxo-5H-chromeno[2,3-b]pyridin-8-yl)oxy)-pentyl)amino)methyl)phenyl Heptylcarbamate",0.00692,uM,=,-2.159893905543242,0,c1ccc(CNCCCCCOc2ccc3c(c2)Oc2ncccc2C3)cc1
851,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,Cl.Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine hydrochloride",0.16,uM,=,-0.7958800173440752,0,c1ccc2nc3c(cc2c1)CCCC3
852,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4[C@]5(C)CSC(C(C)C)=N[C@H]5CC[C@@]45C[C@@]35C(=O)C[C@]12C,"16alpha-Hydroxy-4beta,14alpha-dimethyl-20S-(methylamino)-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.076,uM,=,-1.1191864077192086,0,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
853,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCC[n+]2cccc3ccccc32)cc1,1-(9-(pyridinium-1-yl)nonyl)quinoliniumdibromide,0.12,uM,=,-0.9208187539523752,0,c1cc[n+](CCCCCCCCC[n+]2cccc3ccccc32)cc1
854,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(C(C)C)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-isopropylbenzyl)berberine bromide,4.2,uM,=,0.6232492903979004,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
855,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2ccc(Cl)c(Cl)c2)C3=O)c1,"Methyl-carbamic acid 3-[({7-[2-(3,4-dichloro-benzylidene)-3-oxo-2,3-dihydro-benzofuran-6-yloxy]-heptyl}-methyl-amino)-methyl]-phenyl ester",8.0,uM,=,0.9030899869919436,1,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
856,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)C(=O)OC(C)(C)C)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"tert-butyl{16alpha-hydroxy-4beta,14alpha-dimethyl-11-oxo-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-20S-yl}methylcarbamate",0.159,uM,=,-0.7986028756795485,0,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
857,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,Oc1ccc(/C=N/c2c3c(nc4ccccc24)CCCC3)cc1O,"(E)-N-[3',4'-(Dihydroxy)benzylidene]-1,2,3,4-tetrahydroacridin-9-amine",0.609,uM,=,-0.2153827073671246,0,C(=N/c1c2c(nc3ccccc13)CCCC2)\c1ccccc1
858,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,CC#CCCOC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-pent-3-ynyloxymethyl-3H-imidazol-1-ium chloride,76.8,uM,=,1.885361220031512,1,c1c[nH+]c[nH]1
859,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1cccc(C#N)c1)CC2.[Br-],"2-(3-cyanophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",5.13,uM,=,0.7101173651118162,1,C1=[N+](c2ccccc2)CCc2ccccc21
860,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCCCCSCc2ccc(CN(C)C)o2)o1,{5-[5-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-pentylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.9,uM,=,-0.0457574905606751,0,c1coc(CSCCCCCSCc2ccco2)c1
861,1842255,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc2oc(-c3ccc(NCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,"2-(4-(4-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)butylamino)phenyl)-5,6,7-trimethoxy-4H-chromen-4-one",0.00515,uM,=,-2.288192770958809,0,O=c1cc(-c2ccc(NCCCCNc3c4c(nc5ccccc35)CCCC4)cc2)oc2ccccc12
862,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,COc1ccc(CC(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1OC,"N-(4-((benzyl(methyl)amino)methyl)phenyl)-2-(3,4-dimethoxyphenyl)acetamide",1.85,uM,=,0.2671717284030138,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
863,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCNC(=O)C4(C)CCc5c(C)c(O)c(C)c(C)c5O4)c2c1)CCCC3,"6-hydroxy-N-(2-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)-2,5,7,8-tetramethylchroman-2-carboxamide",4.36,uM,=,0.6394864892685861,1,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
864,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(/C=C/CN(C)Cc3ccccc3)cc2)cc1OC,"{4-[3-(Benzylmethylamino)propenyl]phenyl}-(3,4-dimethoxyphenyl)methanone",2.1,uM,=,0.3222192947339193,1,O=C(c1ccccc1)c1ccc(/C=C/CNCc2ccccc2)cc1
865,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CC(NC(=O)Oc1cccc2c1OCC1CCN(C)C21)c1ccccc1,"(1-Phenyl-ethyl)-carbamic acid 1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalen-6-yl ester",1.87,uM,=,0.2718416065364989,1,O=C(NCc1ccccc1)Oc1cccc2c1OCC1CCNC21
866,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccccc1[N+](=O)[O-])C(=O)C(F)(F)F,"Ethyl(2Z)-4,4,4-trifluoro-2-[2-(2-nitrophenyl)hydrazinylidene]-3-oxobutanoate",0.759,uM,=,-0.1197582241045196,0,c1ccccc1
867,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C([N+](=O)[O-])C12C(=O)Nc1ccc([N+](=O)[O-])cc12,"2'-amino-1'-benzyl-6'-(benzylamino)-5,5'-dinitro-2-oxo-1'H-spiro[indoline-3,4'-pyridine]-3'-carbonitrile",3.37,uM,=,0.5276299008713387,1,O=C1Nc2ccccc2C12C=CN(Cc1ccccc1)C(NCc1ccccc1)=C2
868,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC(C)=CCc1cc2ccc(=O)oc2cc1O,7-demethylsuberosine,2400.0,uM,=,3.380211241711606,1,O=c1ccc2ccccc2o1
869,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4ccc(Cl)cc4c(N)c3C(C1)C2,"6-chloro-15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.425,uM,=,-0.3716110699496884,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
870,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,COc1ccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1OC,"(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(3,4-dimethoxyphenyl)acrylamide",2.96,uM,=,0.4712917110589386,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
871,1852470,10.1016/j.ejmech.2019.05.020,,,,Inhibition of AChE (unknown origin),Cc1ccc2[nH]c3c(c2c1)CN(CCCCCN1CCc2[nH]c4ccc(C)cc4c2C1)CC3,"1,5-bis(8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)pentane",0.195,uM,=,-0.7099653886374819,0,c1ccc2c3c([nH]c2c1)CCN(CCCCCN1CCc2[nH]c4ccccc4c2C1)C3
872,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.223,uM,=,-0.6516951369518393,0,c1ccc2nc3c(cc2c1)CCCC3
873,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCNC(=O)Oc1ccc2c(c1)C1CCN(CC)C2C1,"Butyl-carbamic acid 9-ethyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.206,uM,=,-0.6861327796308466,0,c1ccc2c(c1)C1CCNC2C1
874,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,S=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-8-(1,2,3,4-tetrahydroacridin-9-ylamino)octanethioamide",5e-09,uM,=,-8.301029995663981,0,S=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
875,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,COc1cc2c(cc1OC)C(NC(=O)CN1CCN(Cc3ccccc3F)CC1)c1cnn(C)c1-2,"2-[4-(2-Fluorobenzyl)piperazin-1-yl]-N-(6,7-dimethoxy-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-4-yl)acetamide",2.44,uM,=,0.3873898263387294,1,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2ccccc2-c2[nH]ncc21
876,2215312,10.1016/j.bmc.2022.116742,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by Ellman's method,CO[C@@H]1C=C[C@@]23c4cc5c(cc4CN(C[C@@H]2OC(=O)c2ccc([N+](=O)[O-])cc2)C3C1)OCO5,11-O-(4-nitrobenzoyl)haemanthamine,14.7,uM,=,1.167317334748176,1,O=C(O[C@H]1CN2Cc3cc4c(cc3[C@]13C=CCCC23)OCO4)c1ccccc1
877,938311,10.1016/j.bmcl.2012.11.064,,,,Inhibition of human recombinant AChE measured for 1 min by Ellman's method,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,N'-(4-Methoxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide,88.5,uM,=,1.9469432706978247,1,O=C(CN1CCN(Cc2ccccc2)CC1)N/N=C/c1ccccc1
878,489450,10.1021/jm800577j,,,,Inhibition of human recombinant AChE by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.424,uM,=,-0.3726341434072674,0,c1ccc2nc3c(cc2c1)CCCC3
879,1565223,10.1016/j.ejmech.2016.02.049,,,,Inhibition of human AChE assessed as hydrolytic activity using acetylthiocholine iodide as substrate measured for 15 mins by Ellmans assay,C[N+](C)(C)CCOC(=O)c1ccc(Oc2nc(Oc3ccc(C(=O)OCC[N+](C)(C)C)cc3)nc(Oc3ccc(C(=O)OCC[N+](C)(C)C)cc3)n2)cc1,"2-[4-[[4,6-bis[4-[2-(trimethylammonio)ethoxycarbonyl]phenoxy]-1,3,5-triazin-2-yl]oxy]benzoyl]oxyethyl-trimethyl-ammonium",0.3,uM,=,-0.5228787452803376,0,c1ccc(Oc2nc(Oc3ccccc3)nc(Oc3ccccc3)n2)cc1
880,1465704,10.1016/j.bmcl.2015.02.015,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate after 15 mins by Ellman spectrophotometric method,COc1cc2oc(-c3cccc(OCC(=O)NCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3)cc(=O)c2c(OC)c1OC,"N-(5-((6-chloro-1,2,3,4-tetrahydroanthracen-9-yl)amino)pentyl)-2-(3-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",0.0173,uM,=,-1.7619538968712043,0,O=C(COc1cccc(-c2cc(=O)c3ccccc3o2)c1)NCCCCCNc1c2c(nc3ccccc13)CCCC2
881,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,O=C(Cc1cc(=O)oc2cc(O)ccc12)NNC(=S)Nc1c2c(nc3ccccc13)CCCC2,"2-(2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetyl)-N-(1,2,3,4-tetrahydroacridin-9-yl)hydrazinecarbothioamide",8.17,uM,=,0.9122220565324156,1,O=C(Cc1cc(=O)oc2ccccc12)NNC(=S)Nc1c2c(nc3ccccc13)CCCC2
882,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2ccccc2)CC1)c1n[nH]c2ccc(-c3cccnc3)cc12,N-((1-benzylpiperidin-4-yl)methyl)-5-(pyridin-3-yl)-1H-indazole-3-carboxamide,1.093,uM,=,0.0386201619497027,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1n[nH]c2ccc(-c3cccnc3)cc12
883,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,O=C(Nc1cc(Cl)nc(Cl)c1)OCCCCCCNCc1ccccc1,"6-(benzylamino)hexyl-(2,6-dichloropyridin-4-yl)carbamate",0.759,uM,=,-0.1197582241045196,0,O=C(Nc1ccncc1)OCCCCCCNCc1ccccc1
884,2264476,10.1039/d1md00394a,,,,Inhibition of AchE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured upto 4 mins by Ellman's spectrophotometric method,CCOP(=O)(OCC)C(NCCc1ccc(OC)cc1)c1coc2ccccc2c1=O,Diaportheone A2,0.1,uM,=,-1.0,0,O=c1c(CNCCc2ccccc2)coc2ccccc12
885,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,6-bis(4-tert.butylpyridinium)-hex-1,6-diyl dibromide",0.032,uM,=,-1.494850021680094,0,c1cc[n+](CCCCCC[n+]2ccccc2)cc1
886,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.004,uM,=,-2.397940008672037,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
887,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(CCCNC(=O)COc2ccc(I)cc2)CC1,N-(3-(4-ethylpiperazin-1-yl)propyl)-2-(4-iodophenoxy)acetamide,87.0,uM,=,1.9395192526186185,1,O=C(COc1ccccc1)NCCCN1CCNCC1
888,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1cc(C[n+]2cccc3ccccc32)cc(C[n+]2cccc3ccccc32)c1,"1,1'-(phenylene-1,3-dimethylenyl)-bis(quinolinium)dibromide",40.0,uM,=,1.6020599913279625,1,c1cc(C[n+]2cccc3ccccc32)cc(C[n+]2cccc3ccccc32)c1
889,1455127,10.1016/j.bmc.2014.07.053,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins before substrate addition by Ellman method,COc1cc(CCC(=O)/C=C/c2ccc(CNc3c4c(nc5cc(Cl)ccc35)CC3CC(C)=CC4C3)cc2)ccc1O,"1-{4-{[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]methyl}phenyl}-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one",0.0183,uM,=,-1.7375489102695705,0,O=C(/C=C/c1ccc(CNc2c3c(nc4ccccc24)CC2CC=CC3C2)cc1)CCc1ccccc1
890,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccc(F)cc4C(F)(F)F)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(4-Fluoro-2-trifluoromethylbenzyl)-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]piperidine-4-carboxamide",1.23,uM,=,0.0899051114393979,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
891,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,Nc1c2c(nc3c1C(c1ccc(Cl)c(Cl)c1)c1ccc4ccccc4c1O3)CCCC2,"rac-7-(3,4-Dichlorophenyl)-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",5.07,uM,=,0.705007959333336,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
892,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN(C)S(=O)(=O)NC1CCc2c(O)cccc2C1,"3-(5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylsulfamide",0.03085,uM,=,-1.5107448316307397,0,c1ccc2c(c1)CCCC2
893,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3cccc(Cl)c3)cc12.[Br-],2-(3-chlorophenyl)-8-methoxyisoquinolinium bromide,9.45,uM,=,0.9754318085092628,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
894,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CN(CCCCCCCOc1cccc(-c2oc3ccccc3c2C(=O)c2ccccc2)c1)Cc1ccccc1,(2-{3-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)phenylmethanone,0.24,uM,=,-0.619788758288394,0,O=C(c1ccccc1)c1c(-c2cccc(OCCCCCCCNCc3ccccc3)c2)oc2ccccc12
895,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,C/C(=N\O)c1ccc(Cl)c(NC(=O)c2c(-c3ccccc3Cl)noc2C)c1,N-(2-chloro-5-(1-(hydroxyimino)ethyl)phenyl)-3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamide,6.7,uM,=,0.8260748027008264,1,O=C(Nc1ccccc1)c1conc1-c1ccccc1
896,751129,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes AChE,CN(C)CC(C)(C)c1cccc(OC(=O)NCCCCN2CCOCC2)c1,"[4-(4-morpholinyl)butyl]carbamic acid-3-(1,1-dimethyl-2-dimethylaminoethyl)phenylester",100.0,uM,=,2.0,1,O=C(NCCCCN1CCOCC1)Oc1ccccc1
897,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C/c2nnc(-c3ccc(F)cc3)o2)ccc1O,"4-(2-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)vinyl)-2-methoxyphenol",0.0002839999999999,uM,=,-3.5466816599529625,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
898,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1,"(2-(5-(Benzylamino)pentyl)isoindoline-1,3-dione",0.202,uM,=,-0.6946486305533762,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
899,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1ccc(/C=C2/CNCC3=C2N=C2SC=C(c4ccc5ccccc5c4)N2C3c2ccc(C)cc2)cc1,"(E)-9-(4-methylbenzylidene)-3-(naphthalen-2-yl)-5-(p-tolyl)-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",0.98,uM,=,-0.0087739243075051,0,C1=C(c2ccc3ccccc3c2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
900,28481,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 3.6-18.5,C#CCN(C)C1CCc2cccc(OC(=O)N(C)C)c21.Cl,Dimethyl-carbamic acid 3-(methyl-prop-2-ynyl-amino)-indan-4-yl ester hydrochloride,7.0,uM,=,0.8450980400142568,1,c1ccc2c(c1)CCC2
901,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.017,uM,=,-1.769551078621726,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
902,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)NCc3ccc(OC)c(OC)c3)cn2)cc1,"N-(3,4-dimethoxybenzyl)-2-(2-(4-methoxyphenyl)-2-oxoethyl)pyrimidine-5-carboxamide",10.0,uM,=,1.0,1,O=C(Cc1ncc(C(=O)NCc2ccccc2)cn1)c1ccccc1
903,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3cccc(F)c3)CC2)cc(C(C)(C)C)c1O,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(3-fluorobenzyl)piperidin-4-yl)ethyl)acrylamide",1.33,uM,=,0.1238516409670858,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
904,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccccc2OC)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-(2-((2-methoxyphenyl)amino)-2-oxoethyl)acrylamide,5.75,uM,=,0.7596678446896306,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
905,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-2-amino-N-(4-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)butyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.062,uM,=,-1.207608310501746,0,O=C(CCc1c[nH]c2ccccc12)NCCCCNc1c2c(nc3ccccc13)CCCC2
906,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1ccc2cc(OC)ccc2c1,N-[6-Methoxy-2-naphthoyl]-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-ethyl,0.89,uM,=,-0.0506099933550872,0,O=C(CCCNC(=O)c1ccc2ccccc2c1)NCCC1CCN(Cc2ccccc2)CC1
907,2185034,10.1016/j.ejmech.2021.113278,,,,Inhibition of human AchE preincubated for 15 mins followed by substrate addition and measured for 5 mins using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,C[N+](C)(C)CCNC(=O)/C=C/c1ccc(O)c(O)c1,"2-(3-(3,4-dihydroxyphenyl)acrylamido)-N,N,N-trimethylethan-1-aminium",7.3,uM,=,0.8633228601204559,1,c1ccccc1
908,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1cc(/C=C/C(=O)Nc2cccc(CN(C)Cc3ccccc3)c2)ccc1O,(E)-N-(3-((Benzyl(methyl)amino)methyl)phenyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,5.99,uM,=,0.7774268223893114,1,O=C(/C=C/c1ccccc1)Nc1cccc(CNCc2ccccc2)c1
909,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCCCC[n+]1cccc2ccccc21,"1,1'-hept-1,7-diyl-bis(quinolinium)dibromide",0.09,uM,=,-1.0457574905606752,0,c1ccc2c(c1)ccc[n+]2CCCCCCC[n+]1cccc2ccccc21
910,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{9-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]nonyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.0020499999999999,uM,=,-2.688246138944246,0,O=C(CC1CCc2ccccc2O1)NCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
911,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3c1CCC3)CCCC2,"2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-ylamine",0.658,uM,=,-0.1817741063860445,0,c1c2c(nc3c1CCC3)CCCC2
912,798011,10.1016/j.bmc.2011.12.042,,,,Inhibition of AChE,COc1cc2c(C)c(OC)c(=O)oc2cc1OCCCCOc1cc(O)cc(N(C)C)c1,"7-(4-(3-(dimethylamino)-5-hydroxyphenoxy)butoxy)-3,6-dimethoxy-4-methyl-2H-chromen-2-one",0.275,uM,=,-0.5606673061697374,0,O=c1ccc2ccc(OCCCCOc3ccccc3)cc2o1
913,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1ccc(C2CC(c3cc(F)cc(F)c3)=NN2c2ccc(S(N)(=O)=O)cc2)c(OC)c1,"4-(3-(3,5-difluorophenyl)-5-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
914,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccccc1CN1CCC(C(=O)Nc2nc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3)s2)CC1,"1-(2-Methylbenzyl)-N-[4,5-bis(4-chlorophenylthiazol-2-yl]-piperidine-4-carboxamide",1.1,uM,=,0.041392685158225,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
915,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,CCOCC[n+]1ccc(CCC(=O)c2cc3cc(OC)c(OC)cc3s2)cc1,"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(2-ethoxy-ethyl)-pyridinium",0.007,uM,=,-2.154901959985743,0,O=C(CCc1cc[nH+]cc1)c1cc2ccccc2s1
916,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CN(CCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one,6.25,uM,=,0.7958800173440752,1,O=c1c2ccccc2oc2cc(OCCCCCNCc3ccccc3)ccc12
917,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C(CNc1ccc2oc(=O)ccc2c1)c1ccccc1,6-[(2-Oxo-2-phenylethyl)amino]-2H-chromen-2-one,0.148,uM,=,-0.8297382846050426,0,O=C(CNc1ccc2oc(=O)ccc2c1)c1ccccc1
918,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CN(CCOc1ccc2c(c1)oc(=O)c1ccccc12)Cc1ccccc1,3-(2-(Benzyl(methyl)amino)ethoxy)-6H-benzo[c]chromen-6-one,6.7,uM,=,0.8260748027008264,1,O=c1oc2cc(OCCNCc3ccccc3)ccc2c2ccccc12
919,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,CC(=O)Nc1ccc2nc3c(c(N4CCCCC4)c2c1)CCCC3,"N-(9-(piperidin-1-yl)-5,6,7,8-tetrahydroacridin-2-yl)acetamide",0.301,uM,=,-0.5214335044061567,0,c1ccc2c(N3CCCCC3)c3c(nc2c1)CCCC3
920,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),O=c1[nH]c(CCCO)nc2ccccc12,Pagamine,155.1,uM,=,2.190611797813605,1,O=c1[nH]cnc2ccccc12
921,1331163,10.1039/C1MD00221J,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured after 10 mins by Ellman's method,O=C(Nc1cc2ccccc2oc1=O)c1ccc(Cl)cc1,4-chloro-N-(2-oxo-2H-chromen-3-yl)benzamide,18.71,uM,=,1.27207378750001,1,O=C(Nc1cc2ccccc2oc1=O)c1ccccc1
922,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccccc1NC(=O)C1CCN(C(=O)c2ccccc2)CC1,1-benzoyl-N-(2-methoxyphenyl)piperidine-4-carboxamide,0.00846,uM,=,-2.0726296369609765,0,O=C(Nc1ccccc1)C1CCN(C(=O)c2ccccc2)CC1
923,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3,"N1-(pyridin-4-yl)-N9-(1,2,3,4-tetrahydroacridin-9-yl)nonane-1,9-diamine",0.083,uM,=,-1.080921907623926,0,c1ccc2c(NCCCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3
924,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2cccs2)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-1'-Methyl-4'-(thiophen-2-yl)dispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",21.16,uM,=,1.3255156633631482,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1cccs1)[C@@]21CSc2ccccc2C1=O
925,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccn2)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1-(pyridin-2-ylmethyl)piperidin-4-yl)ethoxy)thiazole-5-carboxamide,6.6,uM,=,0.8195439355418687,1,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccn4)CC3)cs2)ccn1)C1CC1
926,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCc1ccccc1SC(=O)OCC[N+](C)(C)C.[Cl-],[2-(2-Ethyl-phenylsulfanylcarbonyloxy)-ethyl]-trimethyl-ammonium chloride,50.0,uM,=,1.6989700043360187,1,c1ccccc1
927,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CCN(C)C(=O)OCC1CCCN(Cc2ccccc2)C1,(1-benzylpiperidin-3-yl)methyl ethyl(methyl)carbamate,96.6,uM,=,1.9849771264154927,1,c1ccc(CN2CCCCC2)cc1
928,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CC(OC[n+]1ccn(C)c1/C=N/O)C(C)(C)C.[Cl-],"2-(Hydroxyimino-methyl)-3-methyl-1-(1,2,2-trimethyl-propoxymethyl)-3H-imidazol-1-ium chloride",11.5,uM,=,1.0606978403536118,1,c1c[nH+]c[nH]1
929,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cn1c2ccccc2c2cc[n+](-c3ccc(I)cc3)cc21,"2-(4-iodophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.24,uM,=,-0.619788758288394,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
930,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3cc(Cl)c(Cl)cc13)CCCC2,"6,7-Dichloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.47,uM,=,-0.3279021420642826,0,c1ccc2nc3c(cc2c1)CCCC3
931,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,CCN(CC)Cc1ccc(C(=O)c2ccc(OC)c(OC)c2)cc1,"(4-((diethylamino)methyl)phenyl)(3,4-dimethoxyphenyl)methanone",36.8,uM,=,1.5658478186735176,1,O=C(c1ccccc1)c1ccccc1
932,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1cccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)c1,2-Chloro-10H-phenothiazin-10-yl-(3-methoxyphenyl)-methanone,4.6,uM,=,0.6627578316815741,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
933,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,COc1c2occc2cc2ccc(=O)oc12,"9-Methoxy-furo[3,2-g]chromen-7-one",54.00000000000001,uM,=,1.7323937598229686,1,O=c1ccc2cc3ccoc3cc2o1
934,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccc(C(=O)OCC)cc1)C(=O)C(F)(F)F,"Ethyl 4-[(2Z)-2-(1-ethoxy-4,4,4-trifluoro-1,3-dioxobutan-2-ylidene)hydrazinyl]benzoate",3.79,uM,=,0.5786392099680724,1,c1ccccc1
935,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,SID11111527,2.4,uM,=,0.380211241711606,1,c1ccccc1
936,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,Cl.O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]c(-c3ccccc3)nc2c1,3-(1-Benzyl-piperidin-4-yl)-1-(2-phenyl-1H-benzoimidazol-5-yl)-propan-1-one hydrochloride,0.033,uM,=,-1.4814860601221125,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]c(-c3ccccc3)nc2c1
937,28936,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase activity from octopus brain,CCCCCCCSC(=O)OCC[N+](C)(C)C.[Cl-],(2-Heptylsulfanylcarbonyloxy-ethyl)-trimethyl-ammonium chloride,500.0,uM,=,2.6989700043360187,1,
938,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1cc(-c2cnc3[nH]c4cnc(-c5cnoc5)cc4c3c2)ccc1CN1CCCCC1,"4-(3-(4-(Piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridin-6-yl)isoxazole",0.659,uM,=,-0.1811145854059901,0,c1cc(-c2cnc3[nH]c4cnc(-c5cnoc5)cc4c3c2)ccc1CN1CCCCC1
939,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3c1C(c1cccc([N+](=O)[O-])c1)NC(=S)N3)CCCC2,"5-amino-4-(3-nitrophenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",29.8,uM,=,1.4742162640762553,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
940,1768646,10.1016/j.bmc.2018.01.029,,,,Inhibition of AChE (unknown origin),CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1,SID11112403,0.181,uM,=,-0.7423214251308154,0,O=C(CCN1CCCCC1)c1ccccc1
941,1718675,10.1021/acs.jnatprod.7b00301,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1O)[C@@H]1[C@H](O)[C@@H](O)C=C3CCN(C2)[C@H]31,Pseudolycorine,187.63,uM,=,2.2733022785676567,1,C1=C2CCN3Cc4ccccc4[C@H](CC1)[C@@H]23
942,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.467,uM,=,-0.3306831194338878,0,c1ccc2nc3c(cc2c1)CCCC3
943,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,CO[P@@]1(=O)CC[C@H]2COC(=O)C2=C(C)O1,"(3R,8aR)-3-Methoxy-5-methyl-3-oxo-8,8a-dihydro-1H-3lambda*5*-furo[3,4-e][1,3,2]dioxaphosphepin-6-one",3.0,uM,=,0.4771212547196624,1,O=C1OC[C@@H]2CC[PH](=O)OC=C12
944,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2ccccc2)C3=O)c1,"Methyl-carbamic acid 3-({[7-(2-benzylidene-3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-methyl-amino}-methyl)-phenyl ester",0.00195,uM,=,-2.709965388637482,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
945,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",2.17,uM,=,0.3364597338485295,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
946,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cncc(C(=O)NC2CCN(Cc3cccc(Cl)c3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1,N-(1-(3-chlorobenzyl)piperidin-4-yl)-5-(2-(cyclopropanecarboxamido)isonicotinamido)nicotinamide,2.501,uM,=,0.3981136917305025,1,O=C(Nc1cncc(C(=O)NC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1
947,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,CSc1ccc(/C=N/c2ccc3oc(=O)ccc3c2)cc1,6-[(4-(Methylthio)benzylidene)amino]-2H-chromen-2-one,0.1721,uM,=,-0.7642191296724398,0,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1
948,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.79,uM,=,-0.1023729087095585,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
949,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,CCN(CC)C(=S)SCCOc1ccc2c(C)cc(=O)oc2c1,2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)ethyldiethylcarbamodithioate,1.94,uM,=,0.287801729930226,1,O=c1ccc2ccccc2o1
950,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccccc1CN(C)Cc1ccc(C(=O)c2ccc(OC)c(OC)c2)cc1,"(3,4-Dimethoxyphenyl)-(4-{[(2-methoxybenzyl)methylamino]methyl}phenyl)-methanone",3.71,uM,=,0.5693739096150459,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
951,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Oc1ccccc1-c1nnc(N2CCN(c3ccccn3)CC2)o1,"2-(5-(4-(Pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazol-2-yl)phenol",1.23,uM,=,0.0899051114393979,1,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
952,2050396,10.1016/j.bmc.2020.115826,,,,Inhibition of human AchE expressed in HEK293 cells using acetylthiocholine as substrate by Ellman's method,CS[C@@H](Cn1nnc2cc(C#Cc3ccc(N4CC5(COC5)C4)cc3)ccc21)N(O)C=O,"S)-N-(2-(5-((4-(2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenyl)ethyny1)-1H-benzo[d][1,2,3]triazol-1-y1)-1-(methylthio)ethyl)-N-hydroxyformamide",32.0,uM,=,1.505149978319906,1,C(#Cc1ccc2[nH]nnc2c1)c1ccc(N2CC3(COC3)C2)cc1
953,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,CCCCCCCC1OCc2c[n+](C)c(C)c(OC(=O)N(C)C)c2CO1.[Br-],"1,5-Dihydro-3-heptyl-7,8-dimethyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",2.1,uM,=,0.3222192947339193,1,c1cc2c(c[nH+]1)COCOC2
954,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COC(=O)c1c[n+](Cc2ccccc2)ccc1CC1Cc2cc(OC)c(OC)cc2C1=O.[Br-],"(+/-)-Methyl-1-Benzyl-4-[(5,6-dimethoxy-1-oxo-indan-2-yl)-methyl]pyridin-1-ium-3-carboxylate Bromide",0.0256,uM,=,-1.5917600346881504,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
955,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.042,uM,=,-1.3767507096020994,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
956,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,COc1cccc(CN(C)[C@@H](C)[C@H]2[C@H](O)C[C@@]3(C)[C@@H]4CC[C@H]5[C@]6(C)CSC(C(C)C)=N[C@H]6CC[C@@]56C[C@@]46C(=O)C[C@]23C)c1,"20S-[(3-methoxybenzyl)(methyl)amino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'aH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.003,uM,=,-2.5228787452803374,0,O=C1CC2C(CC[C@@H]2CNCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
957,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.43,uM,=,-0.3665315444204134,0,c1ccc2nc3c(cc2c1)CCCC3
958,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc(C(=O)CCc2cc[n+](Cc3cccc(Cl)c3)cc2C#N)cc1OC.[Br-],"1-(3-chlorobenzyl)-3-cyano-4-(3-(3,4-dimethoxyphenyl)-3-oxopropyl)pyridinium bromide",0.0222,uM,=,-1.6536470255493614,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccccc1
959,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1-(1,2,3,4-tetrahydroacridin-9-yl)decane-1,10-diamine",0.147,uM,=,-0.8326826652518239,0,c1ccc2nc3c(cc2c1)CCCC3
960,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3,"N1-(pyridin-4-yl)-N8-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine",0.0136,uM,=,-1.8664610916297824,0,c1ccc2c(NCCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3
961,28160,10.1016/S0960-894X(97)10025-7,,,,Compound was tested in vitro for inhibitory activity against Acetylcholinesterase,Nc1c2c(nc3ccccc13)-c1ccccc1CO2,5H-6-Oxa-12-aza-benzo[a]anthracen-7-ylamine,245.0,uM,=,2.3891660843645326,1,c1ccc2c(c1)COc1cc3ccccc3nc1-2
962,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CCN(C)C(=O)OCC1CCN(Cc2ccccc2)CC1,(1-benzylpiperidin-4-yl)methyl ethyl(methyl)carbamate,72.0,uM,=,1.8573324964312683,1,c1ccc(CN2CCCCC2)cc1
963,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,O=C(N1CCCCC1)n1nc(-c2ccc(Cl)cc2)nc1SCC1CC1,"[3-(4-Chloro-phenyl)-5-cyclopropylmethylsulfanyl-[1,2,4]triazol-1-yl]-piperidin-1-yl-methanone",0.1,uM,=,-1.0,0,O=C(N1CCCCC1)n1nc(-c2ccccc2)nc1SCC1CC1
964,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C(Nc1ccc2c(c1)CN(C(=O)c1cccc(Cl)c1)C(=O)C2)c1ccccc1,"N-(2-(3-chlorobenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",2.836e-05,uM,=,-4.547293773488971,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
965,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-],"3-(dimethylcarbamoyloxy)-N,N,N-trimethylbenzenaminium methyl sulfate",0.0188,uM,=,-1.7258421507363202,0,c1ccccc1
966,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl.Cl,Huprine-Tacrine Heterodimer,0.0004,uM,=,-3.397940008672037,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
967,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccccc2Br)CC1)N1CCN(CCCc2c[nH]c3ccc(F)cc23)CC1,2-(4-(2-bromobenzoyl)piperazin-1-yl)-1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)ethanone,33.3,uM,=,1.5224442335063195,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
968,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCN(C)CCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3[C@H](C1)C2.Cl.Cl.Cl,Huprine-Tacrine Heterodimer,0.00029,uM,=,-3.537602002101044,0,C1=C[C@@H]2Cc3nc4ccccc4c(NCCCNCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@H](C1)C2
969,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CCc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-ethyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.011,uM,=,-1.958607314841775,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
970,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,CC1(C)CNC2=C([N+](=O)[O-])C3(C(C#N)=C(N)N2C1)c1ccccc1-c1nc2ccc([N+](=O)[O-])cc2nc13,"6'-amino-3',3'-dimethyl-8,9'-dinitro-1',2',3',4'-tetrahydrospiro[indeno[1,2-b]quinoxaline-11,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",3.6,uM,=,0.5563025007672873,1,C1=CC2(C=C3NCCCN13)c1ccccc1-c1nc3ccccc3nc12
971,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1cccc(C)c1)C(=O)C(F)(F)F,"Ethyl(2Z)-4,4,4-trifluoro-2-[2-(3-methylphenyl)hydrazinylidene]-3-oxobutanoate",30.4,uM,=,1.4828735836087537,1,c1ccccc1
972,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccc(C)cc2)C(=O)/C(=C/c2ccc(C)cc2)C1,"1-Acryloyl-3,5-bis-[1-p-tolyl-methylidene]-piperidin-4-one",18.06,uM,=,1.256717745977487,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
973,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2ccc(Cl)cc2Cl)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(2,4-Dichlorophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",24.12,uM,=,1.3823773034681135,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
974,1718675,10.1021/acs.jnatprod.7b00301,,,,Inhibition of AChE (unknown origin),COc1cc2c3c(c1)c1cc(=O)c(OC)cc-1cn3CC2,Zephycarinatine I,35.61,uM,=,1.5515719736742537,1,O=c1ccc2cn3c4c(cccc4c-2c1)CC3
975,2215312,10.1016/j.bmc.2022.116742,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by Ellman's method,CCN1CCN(c2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,2-(4-(4-ethylpiperazin-1-yl)phenyl)-1H-benzo[d]imidazole,5.18,uM,=,0.714329759745233,1,c1ccc2[nH]c(-c3ccc(N4CCNCC4)cc3)nc2c1
976,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(/C=C/c1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[6-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-3-(1H-indol-3-yl)-acrylamide",0.018,uM,=,-1.744727494896694,0,O=C(/C=C/c1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
977,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CC(C)c1ccc([C@@H]2[C@H]3CSCN3C3(C(=O)c4ccccc4C3=O)[C@]23CSc2ccccc2C3=O)cc1,"(6'R,7'S,7a'S)-7'-(4-Isopropylphenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",28.34,uM,=,1.4523998459114416,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
978,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]cc(CCNC(=O)Cn3cc(CCCCN(C)CCCC4c5cc(OC)c(OC)cc5CCN4C)nn3)c2c1,"2-(4-(4-((3-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)propyl)(methyl)amino)butyl)-1H-1,2,3-triazol-1-yl)-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)acetamide",2.2,uM,=,0.3424226808222063,1,O=C(Cn1cc(CCCCNCCCC2NCCc3ccccc32)nn1)NCCc1c[nH]c2ccccc12
979,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Cn1ccc2nc3ccccc3c-2c1.I,"2-Methyl-2H-pyrido[4,3-b]indole hydrogeniodide",8.7,uM,=,0.9395192526186184,1,c1ccc2c3c[nH]ccc-3nc2c1
980,1589694,10.1016/j.bmc.2016.07.005,,,,Inhibition of hemoglobin free erythrocyte ghost human AChE using acetylcholine iodide as substrate measured for 1 hr by spectrophotometry based Ellman method,NC(=O)c1cc[n+](CCCCC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],1-(3-(4-carbamoylpyridinium-1-yl)pentyl)-3-(2-(hydroxyimino)acetamido)pyridinium dibromide,770.0,uM,=,2.886490725172482,1,c1cc[n+](CCCCC[n+]2ccccc2)cc1
981,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2Cl)CC1,4-(2-(1-(2-Chlorobenzyl)piperidin-4-yl)ethoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)thiazole-5-carboxamide,3.7,uM,=,0.568201724066995,1,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
982,2076989,10.1039/d1md00105a,,,,Inhibition of human AChE,O=c1ccoc2ccc(OCCCCN3CCCC3)cc12,6-(4-(pyrrolidin-1-yl)butoxy)-4H-chromen-4-one,3.74,uM,=,0.5728716022004802,1,O=c1ccoc2ccc(OCCCCN3CCCC3)cc12
983,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cn1c2ccccc2c2cc[n+](-c3ccc(Cl)cc3)cc21,"2-(4-chlorophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.56,uM,=,-0.2518119729937995,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
984,1827463,10.1016/j.ejmech.2018.10.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by Ellman's method,Cc1c(C)c2ccc(OCC3CCN(Cc4cccc(CO)c4)CC3)cc2oc1=O,"7-({1-[3-(Hydroxymethyl)benzyl]piperidin-4-yl}methoxy)-3,4-dimethyl-2H-chromen-2-one",1.4,uM,=,0.1461280356782379,1,O=c1ccc2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2o1
985,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(CC4CCCCC4)CC3)nc12,3-(4-(Cyclohexylmethyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,0.34,uM,=,-0.4685210829577448,0,O=C(CCN1CCN(CC2CCCCC2)CC1)Nc1nc2ccccc2s1
986,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC(OC)C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-1-methoxy-3-oxo-propyl]-1-methyl-piperidinium bromide",0.12,uM,=,-0.9208187539523752,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
987,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccc2cc(-c3ccc(CN(C)Cc4ccccc4)cc3)c(=O)oc2c1,3-{4-[(benzylmethylamino)methyl]phenyl}-7-methoxychromen-2-one,0.892,uM,=,-0.0496351456238769,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
988,29408,10.1021/jm00081a022,,,,In vitro inhibitory activity against acetylcholinesterase,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.00043,uM,=,-3.3665315444204134,0,c1ccc2c(c1)N[C@H]1NCCC21
989,2221647,10.1016/j.bmcl.2022.128602,,,,Inhibition of AChE (unknown origin),CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1,Bambuterol,30.0,uM,=,1.4771212547196624,1,c1ccccc1
990,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCC(CC)n1cc(C(=O)CF)cn1,2-fluoro-1-(1-(pentan-3-yl)-1H-pyrazol-4-yl)ethan-1-one,5.19,uM,=,0.7151673578484579,1,c1cn[nH]c1
991,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(Cc1cc(Cl)cc(/C=N/O)c1O)CC2,"5-chloro-3-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",1567.0,uM,=,3.1950689964685903,1,c1ccc(CN2CCc3ccccc3C2)cc1
992,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)Nc2ccccc2)c1,Phenyl-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0028,uM,=,-2.552841968657781,0,O=C(Nc1ccccc1)Oc1cccc(CNCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1
993,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(/N=C/c2cn(-c3ccc(OC)cc3)cc2/C=N/c2ccc(OC)cc2)cc1,N-(4-methoxyphenyl)-1-(4-methoxyphenyl)-4-(4-methoxyphenyliminomethyl)-1H-3-pyrrolylmethanimine,14.0,uM,=,1.146128035678238,1,C(=N/c1ccccc1)\c1cn(-c2ccccc2)cc1/C=N/c1ccccc1
994,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(c1ccc(F)cc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-4-fluoro-N-phenyl-benzamide,0.018,uM,=,-1.744727494896694,0,O=C(c1ccccc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
995,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1cc(C#N)c(NCCC2CCN(Cc3ccccc3)CC2)nc1Cl,"2-((2-(1-Benzylpiperidin-4-yl)ethyl)amino)-6-chloropyridine-3,5-dicarbonitrile",0.31,uM,=,-0.5086383061657274,0,c1ccc(CN2CCC(CCNc3ccccn3)CC2)cc1
996,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COCC2CCCCC2)c1/C=N/O.[Cl-],1-Cyclohexylmethoxymethyl-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,42.0,uM,=,1.6232492903979006,1,c1c[n+](COCC2CCCCC2)c[nH]1
997,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccc(Cl)cc13)CCCC2,"7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.55,uM,=,-0.2596373105057561,0,c1ccc2nc3c(cc2c1)CCCC3
998,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(octylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.0106,uM,=,-1.9746941347352296,0,O=c1c2ccccc2nc2n1CCC2
999,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2Cc3ccsc3C2=NN1CCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(5-(4-((1-(phenylsulfonyl)-1H-indol-4-yl)methyppiperazin-1-yl)pentyl)-2,4,4a,5-tetrahydro-3H-thieno[3',2':4,5]cyclopenta[1,2-c]pyridazin-3-one",6.89,uM,=,0.8382192219076258,1,O=C1CC2Cc3ccsc3C2=NN1CCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
1000,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3C[C@@H]12,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl phenylcarbamate",0.176,uM,=,-0.7544873321858502,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1C2
1001,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1O2,"(-)-(3aS)-3a-methyl-2,3,3a,8a-tetrahydrofuro[2,3-b]benzofuran-5-yl N-Ethylcarbamate",0.1,uM,=,-1.0,0,c1ccc2c(c1)O[C@H]1OCCC21
1002,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,CCN(CCCCCCNC1=CC(=O)C(OC)=CC1=O)Cc1ccccc1OC,"2-(6-(ethyl(2-methoxybenzyl)amino)hexylamino)-5-methoxycyclohexa-2,5-diene-1,4-dione",0.0653,uM,=,-1.1850868187249262,0,O=C1C=CC(=O)C(NCCCCCCNCc2ccccc2)=C1
1003,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(C)cc2)C[C@@H](c2ccc(C)cc2)N(c2ccc(C)cc2)[C@@H]1c1ccc(C)cc1,"(2R,6S)-methyl 1,2,6-trip-tolyl-4-(p-tolylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",6780.0,uM,=,3.831229693867064,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
1004,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12C(=O)c1cccc3cccc2c13,"6'-amino-9'-nitro-2-oxo-1',2',3',4'-tetrahydro-2H-spiro[acenaphthylene-1,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",6.59,uM,=,0.8188854145940099,1,O=C1c2cccc3cccc(c23)C12C=CN1CCCNC1=C2
1005,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(OC)c1.[I-],(E)-2-(4-(Diethylamino)-2-methoxystyryl)-1-methyl quinolinium iodide,0.7,uM,=,-0.1549019599857432,0,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
1006,1455386,10.1016/j.bmc.2014.05.032,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",2.67,uM,=,0.4265112613645752,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1007,510556,10.1021/np800305b,,,,Inhibition of acetylcholinesterase,C[C@@H]([C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](N(C)C)CC[C@]4(C)[C@H]3CC[C@]12C)N(C)C,N-methypachysamine A,22.1,uM,=,1.3443922736851108,1,C1CC[C@@H]2CC[C@H]3[C@@H]4CCCC4CC[C@@H]3C2C1
1008,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,"2-(7-((3-Chlorobenzyl)(methyl)amino)heptyl)isoindoline-1,3-dione hydrochloride",1.303,uM,=,0.1149444157125846,1,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
1009,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(CC1CCN(Cc2ccccc2F)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12,2-(1-(2-Fluorobenzyl)piperidin-4-yl)-N-(6-(pyridin-3-yl)-1Hindazol-3-yl)acetamide,0.691,uM,=,-0.1605219526258016,0,O=C(CC1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12
1010,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccc2cc(-c3cccc(CN(C)Cc4ccccc4)c3)c(=O)oc2c1,3-{3-[(benzylmethylamino)methyl]phenyl}-7-methoxychromen-2-one,2.29,uM,=,0.359835482339888,1,O=c1oc2ccccc2cc1-c1cccc(CNCc2ccccc2)c1
1011,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.6,uM,=,0.2041199826559248,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1012,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(CCCNC(=O)COc2ccc(-c3ccccc3)cc2)CC1,"2-([1,1'-Biphenyl]-4-yloxy)-N-(3-(4-ethylpiperazin-1-yl)propyl)acetamide",113.0,uM,=,2.05307844348342,1,O=C(COc1ccc(-c2ccccc2)cc1)NCCCN1CCNCC1
1013,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC1Cc2c(nc3ccccc3c2N)C1(C)O,"9-Amino-2,3-dimethyl-2,3-dihydro-1H-cyclopenta[b]quinolin-3-ol",134.0,uM,=,2.127104798364808,1,c1ccc2nc3c(cc2c1)CCC3
1014,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,4-(benzofuran-2-yl)-1-benzylpiperidine,5.07,uM,=,0.705007959333336,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
1015,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccc(Cl)c(Cl)c1)Cc1ccccc1,"1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(3,4-dichloro-benzoyl)-thiourea",0.055,uM,=,-1.259637310505756,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccccc1
1016,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1c(Cl)nc(NCCC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-((2-(1-Benzylpiperidin-4-yl)ethyl)amino)-6-chloro-4-phenylpyridine-3,5-dicarbonitrile",4.4,uM,=,0.6434526764861874,1,c1ccc(CN2CCC(CCNc3cc(-c4ccccc4)ccn3)CC2)cc1
1017,683819,10.1016/j.ejmech.2010.08.025,,,,Inhibition of human AChE by Ellman method,O=C(NP(=O)(NN1CCCCC1)NN1CCCCC1)c1ccccc1,"N-Benzoyl-N',N''-bis(4-aminopiperidine)phosphoric triamide",1950.0,uM,=,3.290034611362518,1,O=C(NP(=O)(NN1CCCCC1)NN1CCCCC1)c1ccccc1
1018,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,2-[4-(4-Chloro-benzoyl)-phenoxy]-2-methyl-propionic acid isopropyl ester,15.551,uM,=,1.191758321370448,1,O=C(c1ccccc1)c1ccccc1
1019,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(Br)cc3F)cc12.[Br-],2-(4-Bromo-2-fluorophenyI)-8-methoxyisoquinolin-2-ium bromide,0.9,uM,=,-0.0457574905606751,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
1020,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(C(=O)N(CCC2CCN(Cc3ccccc3)CC2)c2ccccc2)cc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-4-methoxy-N-phenyl-benzamide,0.59,uM,=,-0.2291479883578558,0,O=C(c1ccccc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
1021,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCOc2ccccc2)c1.Cl,Methyl-carbamic acid 3-{[methyl-(3-phenoxy-propyl)-amino]-methyl}-phenyl ester hydrochloride,0.0795999999999999,uM,=,-1.0990869322623311,0,c1ccc(CNCCCOc2ccccc2)cc1
1022,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,CN1CC[C@@]23C=C[C@H](O)C[C@@H]2Oc2c(O)ccc(c23)C1,Sanguinine,0.1,uM,=,-1.0,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1023,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),COc1cc2occ(-c3ccc(OC4CCN(Cc5ccccc5)CC4)cc3)c(=O)c2cc1OC,"3-(4-(1-benzylpiperidin-4-yloxy)phenyl)-6,7-dimethoxy-4H-chromen-4-one",0.093,uM,=,-1.031517051446065,0,O=c1c(-c2ccc(OC3CCN(Cc4ccccc4)CC3)cc2)coc2ccccc12
1024,597529,10.1021/jm901296p,,,,Inhibition of human recombinant AChE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",2.1,uM,=,0.3222192947339193,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1025,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cccc(CN2CCC(/C=C3\Cc4cc(OC)ccc4C3=O)CC2)c1,"(E)-5-methoxy-2-((1-(3-methoxybenzyl)piperidin-4-yl)methylene)-2,3-dihydro-1H-inden-1-one",0.853,uM,=,-0.0690509688324769,0,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
1026,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,Cc1ccccc1CN(C)CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1,3-{7-[methyl-(2-Methylbenzyl)amino]-heptyloxy}xanthen-9-one,565.0,uM,=,2.7520484478194387,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
1027,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Cc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-(4-(Pyridin-2-yl)piperazin-1-yl)-5-(p-tolyl)-1,3,4-oxadiazole",1.02,uM,=,0.0086001717619175,1,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
1028,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,3-(1-benzylpiperidin-4-yl)-1-phenylpropan-1-one,0.305,uM,=,-0.5157001606532141,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
1029,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c([nH]c3ccccc32)c(-c2ccc(F)cc2)n1,"1-(4-Fluorophenyl)-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)-9H-pyrido[3,4-b]indole-3-carboxamide",0.306,uM,=,-0.51427857351842,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c([nH]c3ccccc32)c(-c2ccccc2)n1
1030,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.04321,uM,=,-1.36441573368877,0,c1ccc2nc3c(cc2c1)CCCC3
1031,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,O=C(NCCCCCc1ccccc1)Oc1ccc(-n2cc(COc3ccc4ccc(=O)oc4c3)nn2)cc1,"4-(4-(((2-Oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)phenyl(5-Phenylpentyl)carbamate",47.9,uM,=,1.6803355134145632,1,O=C(NCCCCCc1ccccc1)Oc1ccc(-n2cc(COc3ccc4ccc(=O)oc4c3)nn2)cc1
1032,938311,10.1016/j.bmcl.2012.11.064,,,,Inhibition of human recombinant AChE measured for 1 min by Ellman's method,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1OC,"N'-(3,4-Dimethoxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide",81.1,uM,=,1.909020854211156,1,O=C(CN1CCN(Cc2ccccc2)CC1)N/N=C/c1ccccc1
1033,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1ccc(OC)c(C2CC(c3ccc(-c4ccccc4)cc3)=NN2C(C)=O)c1,"1-(3-([1,1'-Biphenyl]-4-yl)-5-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1421.0,uM,=,3.15259407792747,1,c1ccc(-c2ccc(C3=NNC(c4ccccc4)C3)cc2)cc1
1034,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(c1)Cc1c-2nc2ccccc2c1NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N-(11H-Indeno[1,2-b]quinolin-10-yl)-N'-(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine",0.0139,uM,=,-1.8569851997459048,0,c1ccc2c(c1)Cc1c-2nc2ccccc2c1NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
1035,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,N-Hydroxy-4-(acridin-9-ylamino)benzamide,0.72,uM,=,-0.1426675035687315,0,c1ccc(Nc2c3ccccc3nc3ccccc23)cc1
1036,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2F)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(2-fluorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(2-fluorobenzylidene)hexahydro-1H-pyrrolizine,24.58,uM,=,1.3905818785504354,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
1037,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COC(=O)c1ccc(C[n+]2ccc(CCC(=O)c3cc4cc(OC)c(OC)cc4s3)cc2)cc1,"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(4-methoxycarbonyl-benzyl)-pyridinium",1.0,uM,=,0.0,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1cc2ccccc2s1
1038,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN(C)CCN(C)C)cc2)cc1OC,"(3,4-Dimethoxyphenyl)-(4-{[(2-dimethylaminoethyl)-methylamino]methyl}phenyl)-methanone",2.37,uM,=,0.3747483460101038,1,O=C(c1ccccc1)c1ccccc1
1039,1837074,10.1016/j.ejmech.2019.07.040,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 5 mins,Cc1c(OCc2ccccc2)cccc1N1CCN(CCCCCCNc2c3c(nc4c2CCCC4)CCCC3)CC1,"N-[6-[4-(3-benzyloxy-2-methyl-phenyl)piperazin-1-yl]hexyl]-1,2,3,4,5,6,7,8-octahydroacridin-9-amine",0.014,uM,=,-1.853871964321762,0,c1ccc(COc2cccc(N3CCN(CCCCCCNc4c5c(nc6c4CCCC6)CCCC5)CC3)c2)cc1
1040,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cccc2n1cc(-c1ccc(OC(=O)N(C)C)cc1)[n+]2C.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-5-methoxy-1-methylimidazo[1,2-a]pyridin-1-ium",8.1,uM,=,0.9084850188786496,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
1041,1673532,10.1021/acs.jmedchem.7b01760,,,,Inhibition of human erythrocyte AChE using ATC iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's method,CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCCCCCN2CCCCC2)cc1,"2-(4-Ethoxybenzyl)-N,N-diethyl-1-(6-(piperidin-1-yl)hexyl)-1H-benzo[d]imidazole-5-carboxamide",20.0,uM,=,1.3010299956639813,1,c1ccc(Cc2nc3ccccc3n2CCCCCCN2CCCCC2)cc1
1042,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1ccc(C2CC(c3cc(F)ccc3F)=NN2c2ccc(S(N)(=O)=O)cc2)c(OC)c1,"4-(3-(2,5-difluorophenyl)-5-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
1043,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCOc1ccc(/C=C/C(=O)Nc2ccccc2)cc1OC,(E)-3-(4-(3-(diethylamino)propoxy)-3-methoxyphenyl)-N-phenylacrylamide,23.72,uM,=,1.375114684692225,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
1044,1471666,10.1016/j.ejmech.2015.02.048,,,,Inhibition of AChE (unknown origin),Nc1oc2ccccc2c(=O)c1/C=C1\COc2ccccc2C1=O,2-amino-3-((4-oxochroman-3-ylidene)methyl)-4H-chromen-4-one,0.27,uM,=,-0.5686362358410126,0,O=C1/C(=C/c2coc3ccccc3c2=O)COc2ccccc21
1045,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1,"(2-(8-(Benzylamino)octyl)isoindoline-1,3-dione",0.496,uM,=,-0.3045183235098025,0,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1
1046,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CC(C)c1ccc(NC(=O)OCC2CCN(Cc3ccccc3)CC2)cc1,(1-benzylpiperidin-4-yl)methyl (4-isopropylphenyl)carbamate,2.248,uM,=,0.3517963068970235,1,O=C(Nc1ccccc1)OCC1CCN(Cc2ccccc2)CC1
1047,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(Cl)c3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-amino-3-chlorophenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.07791,uM,=,-1.1084067956510348,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
1048,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)OCC[N+](C)(C)C)(CC1=O)C2.[I-],,150.0,uM,=,2.1760912590556813,1,O=C1C[C@]23CC[C@@H]4CCCCC4[C@@H]2CCC1C3
1049,1539619,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 8,COC(=O)C1=C(C)OP(=O)(OC)OCC1,"Methyl 2-methoxy-4-methyl-6,7-dihydro-1,3,2-dioxaphosphepine-5-carboxylate 2-oxide",1.03,uM,=,0.0128372247051722,1,O=[PH]1OC=CCCO1
1050,775052,10.1016/j.ejmech.2011.09.001,,,,Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,CC(c1cccc(OCCCNC(=O)CCCCC2CCSS2)c1)N(C)C,"N-(3-(3-(1-(dimethylamino)ethyl)phenoxy)propyl)-5-(1,2-dithiolan-3-yl)pentanamide",25.200000000000003,uM,=,1.4014005407815442,1,O=C(CCCCC1CCSS1)NCCCOc1ccccc1
1051,1442760,10.1016/j.bmcl.2014.10.055,,,,Inhibition of human acetylcholinesterase by Ellman's method,O/N=C/c1cc[n+](CCC[n+]2ccc(/C=N/O)cc2)cc1,Bispyridinium oxime (TMB),2570.0,uM,=,3.4099331233312946,1,c1cc[n+](CCC[n+]2ccccc2)cc1
1052,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2Cc3ccsc3C2=NN1CCCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(7-(4-((1-(phenylsulfonyl)-1H-indol-4-yl)methyl)piperazin-1-yl)heptyl)-2,4,4a,5-tetrahydro-3H-thieno[3',2':4,5]cyclopenta[1,2-c]pyridazin-3-one",7.18,uM,=,0.8561244442423004,1,O=C1CC2Cc3ccsc3C2=NN1CCCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
1053,28459,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 12.7-36.8,CCN(C)C(=O)Oc1cccc(CCNC)c1,Ethyl-methyl-carbamic acid 3-(2-methylamino-ethyl)-phenyl ester,20.7,uM,=,1.3159703454569178,1,c1ccccc1
1054,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc(C(=O)CCc2cc[n+](Cc3ccccc3C(F)(F)F)cc2C#N)cc1OC.[Br-],"3-Cyano-4-(3-(3,4-dimethoxyphenyl)-3-oxopropyl)-1-(2-(trifluoromethyl)benzyl)pyridinium bromide",0.275,uM,=,-0.5606673061697374,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccccc1
1055,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,Cc1ccc(/C=C2\CN(C(=O)[C@H]3C[C@H]4CCCN4[C@]34C(=O)Nc3cc(Cl)ccc34)C/C(=C\c3ccc(C)cc3)C2=O)cc1,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(4-methylbenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",7.6,uM,=,0.8808135922807914,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
1056,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Clc1ccc(/C=N\C2CCN(Cc3ccccc3)C2)cc1,N-(1-Benzylpyrrolidin-3-yl)-1-(4-chlorophenyl)methanimine,1.241,uM,=,0.0937717814987297,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
1057,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,N-(4-(Benzylamino)quinazolin-2-yl)acetamide,7.5,uM,=,0.8750612633917001,1,c1ccc(CNc2ncnc3ccccc23)cc1
1058,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),Cc1ccc(C(=O)/C=C/c2ccc(N3CCCCC3)cc2)s1,(2E)-1-(5-Methylthiophen-2-yl)-3-(4-piperidin-1-ylphenyl)prop-2-en-1-one,0.13,uM,=,-0.8860566476931633,0,O=C(/C=C/c1ccc(N2CCCCC2)cc1)c1cccs1
1059,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(Cl)cc3Cl)cc12.[Br-],"2-(2,4-Dichlorophenyl)-8-methoxyisoquinolin-2-ium bromide",3.42,uM,=,0.534026106056135,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
1060,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCCCC2)CC1,"2-([1,1'-Biphenyl]-4-yloxy)-1-([1,4'-bipiperidin]-1'-yl)ethanone",4.6,uM,=,0.6627578316815741,1,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCCCC2)CC1
1061,1834120,10.1021/acs.jnatprod.8b00592,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by Ellman's method,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2,SID11112431,0.7,uM,=,-0.1549019599857432,0,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
1062,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,COc1ccc(NC(S)=NCCN2CCC(C)CC2)cc1Cl,SID24794001,12.0,uM,=,1.0791812460476249,1,C(=NCCN1CCCCC1)Nc1ccccc1
1063,2059377,10.1016/j.bmc.2021.116074,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(CC)c1cc(/C=C2/OC(=O)c3cc(OC)c(OC)cc32)ccc1O,"(E)-3-(3-(diethylamino)-4-hydroxybenzylidene)-5,6-dimethoxyisobenzofuran-1(3H)-one",0.00128,uM,=,-2.892790030352132,0,O=C1O/C(=C/c2ccccc2)c2ccccc21
1064,1632485,10.1016/j.ejmech.2016.08.016,,,,Inhibition of human recombinant AChE preincubated for 5 mins followed by acetylthiocholine iodide substrate addition measured after 5 mins by Ellman's method,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21,"N-(2-(4-(1-(phenylsulfonyl)-1H-indol-4-yl)piperazin-1-yl)ethyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0436,uM,=,-1.360513510731414,0,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21
1065,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),COc1ccc([C@@H]2c3[nH]c4ccccc4c3C[C@@H]3C(=O)N(CCC4CCN(Cc5ccccc5)CC4)CC(=O)N23)cc1,"(2R,8R)-6-[2-(1-benzyl-4-piperidyl)ethyl]-2-(4-methoxyphenyl)-3,6,17-triazatetracyclo[8.7.0.0^3,8.0^11,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione",0.031,uM,=,-1.5086383061657274,0,O=C1[C@H]2Cc3c([nH]c4ccccc34)[C@@H](c3ccccc3)N2C(=O)CN1CCC1CCN(Cc2ccccc2)CC1
1066,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl.Cl.Cl.Cl,"(+/-)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-((10-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]decyl)amino)-7,11-methanocycloocta[b]quinoline dihydrochloride",0.0090899999999999,uM,=,-2.0414361167780326,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
1067,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)cc(-c4ccccc4)oc3c2)c1,Butyl-carbamic acid 3-({methyl-[3-(4-oxo-2-phenyl-4H-chromen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.031,uM,=,-1.5086383061657274,0,O=c1cc(-c2ccccc2)oc2cc(OCCCNCc3ccccc3)ccc12
1068,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,C[n+]1c(/C=C/c2cc3ccccc3[nH]2)ccc2ccccc21.[I-],(E)-2-(2-(1H-Indol-2-yl)vinyl)-1-methylquinolin-1-ium iodide,0.7,uM,=,-0.1549019599857432,0,C(=C/c1ccc2ccccc2[nH+]1)\c1cc2ccccc2[nH]1
1069,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2cccc(C(F)(F)F)c2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-oxo-2-((3-(trifluoromethyl)phenyl)amino)ethyl)acrylamide,9.31,uM,=,0.9689496809813428,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
1070,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,Cl.Cl.Nc1ccc(O)c(CN2CCCC2)c1,4-amino-2-(pyrrolidin-1-ylmethyl)phenol dihydrochloride,6.3,uM,=,0.7993405494535817,1,c1ccc(CN2CCCC2)cc1
1071,2054941,10.1016/j.ejmech.2020.112743,,,,Inhibition of recombinant human AChE using ATCI as substrate incubated for 5 mins followed by substrate addition and measured after 5 mins by spectrophotometric based Ellman's method,O=c1c2ccccc2oc2ccc(OCCCCCN3CCCCCC3)cc12,2-(5-(Azepan-1-yl)pentyloxy)-9H-xanthen-9-one,0.392,uM,=,-0.4067139329795427,0,O=c1c2ccccc2oc2ccc(OCCCCCN3CCCCCC3)cc12
1072,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CC(C)C1=N[C@H]2CC=C3CC4C(=O)C[C@]5(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]5(C)[C@@H]4CC[C@H]3[C@]2(C)CO1,"8H-indeno[5',4':4,5]cyclohepta[1,2-f][3,1]benzoxazin-8-one, 10-[(1S)-1-(dimethylamino)ethyl]-1,4a,5,7,7a,9,9a,10,11,12,12a,12b,13,14,14a,14b-hexadecahydro-11-hydroxy-9a,12a,14b-trimethyl-3-(1-methylethyl)-, (4aS,7aR,9aR,10S,11R,12aS,12bR,14aR,14bS)",0.299,uM,=,-0.5243288116755703,0,O=C1CC2CCCC2[C@@H]2CC[C@@H]3C(=CC[C@@H]4N=COCC43)CC12
1073,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.047,uM,=,-1.3279021420642825,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
1074,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl.Cl,Huprine-Tacrine Heterodimer,0.00033,uM,=,-3.4814860601221125,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
1075,1497677,10.1021/acs.jnatprod.5b00057,,,,Inhibition of human erythrocytes acetylcholinesterase after 30 mins using S-acetylthiocholine iodide substrate by spectrophotometry based Ellman method,C/C(=C\C[C@]12C[C@H]3C[C@@H]4C(C)(C)CC[C@@]4(C1=O)C(=O)[C@](C(=O)c1ccccc1)(C2=O)C3(C)C)CC/C=C/C(C)C,"(1R,5R,7R,9R,11S)-9-benzoyl-11-[(2E,6E)-3,8-dimethylnona-2,6-dien-1-yl]-4,4,8,8-tetramethyltetracyclo[7.3.1.1^{7,11}.0^{1,5}]tetradecane-10,12,13-trione",9.8,uM,=,0.9912260756924948,1,O=C(c1ccccc1)[C@]12C[C@H]3CC(C1=O)C(=O)[C@]1(CCC[C@H]1C3)C2=O
1076,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,COC(=O)C(CC1=C(c2ccc(OC)cc2)CC(C)(C)ON1C(C)=O)C(=O)OC,"Dimethyl{[2-acetyl-4-(4-methoxyphenyl)-6,6-dimethyl-5,6-dihydro-2H-1,2-oxazin-3-yl]methyl}malonate",14.35,uM,=,1.1568519010700111,1,C1=C(c2ccccc2)CCON1
1077,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1cc(-c2cccs2)nc2nc(-c3ccccc3)cc(C(F)(F)F)c12,"7-Phenyl-2-(thiophen-2-yl)-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",10.36,uM,=,1.0153597554092142,1,c1ccc(-c2ccc3ccc(-c4cccs4)nc3n2)cc1
1078,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3cccc(CN(C)Cc4ccccc4)c3)c(=O)oc2cc1OC,"3-{3-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxychromen-2-one",0.202,uM,=,-0.6946486305533762,0,O=c1oc2ccccc2cc1-c1cccc(CNCc2ccccc2)c1
1079,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)C=C1,"20S-(dimethylamino)-16a-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{6'-isopropyl-2'alpha,3'-dihydropyridino[2',3':3,4]}-5alpha,9beta-pregnan-11-one",0.025,uM,=,-1.6020599913279625,0,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4C=CC=N[C@H]4CC[C@@]34C[C@@]124
1080,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccco2)=CC1=O)Cc1ccco1,"2,5-bis{6-[ethyl(furan-2-ylmethyl)amino]hexylamino}-[1,4]-benzoquinone",0.144,uM,=,-0.8416375079047503,0,O=C1C=C(NCCCCCCNCc2ccco2)C(=O)C=C1NCCCCCCNCc1ccco1
1081,2263808,10.1016/j.bmc.2020.115895,,,,Inhibition of AChE (unknown origin),CCOc1ccc2c(c1)O/C(=C\c1ccc(OCCN3CCCCC3)cc1)C2=O,6-ethoxy-2-(4-(2-(piperidin-1-yl)ethoxy)benzylidene)benzofuran-3(2H)-one,0.045,uM,=,-1.3467874862246565,0,O=C1/C(=C/c2ccc(OCCN3CCCCC3)cc2)Oc2ccccc21
1082,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC1CCN(c2nccc(NCc3ccccc3)n2)CC1,N-benzyl-2-(4-methylpiperidin-1-yl)pyrimidin-4-amine,18.4,uM,=,1.2648178230095364,1,c1ccc(CNc2ccnc(N3CCCCC3)n2)cc1
1083,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-2-amino-N-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.07,uM,=,-1.154901959985743,0,O=C(CCc1c[nH]c2ccccc12)NCCCNc1c2c(nc3ccccc13)CCCC2
1084,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccccc4C(F)(F)F)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(2-Trifluoromethylbenzyl)-N-[4,5-bis(4-methoxyphenyl)-thiazol-2-yl]piperidine-4-carboxamide",0.68,uM,=,-0.1674910872937636,0,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
1085,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc(C(F)(F)F)cc2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-oxo-2-((4-(trifluoromethyl)phenyl)amino)ethyl)acrylamide,8.23,uM,=,0.91539983521227,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
1086,775052,10.1016/j.ejmech.2011.09.001,,,,Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,O=C(CCCC[C@@H]1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(R)-N-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-5-(1,2-dithiolan-3-yl)pentanamide",0.0002299999999999,uM,=,-3.638272163982408,0,O=C(CCCC[C@@H]1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2
1087,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)CC(CC1CCN(CCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)CC1)C2.Cl.Cl.Cl,"6-Chloro-9-[(3-{4-[(5,6-dimethoxyindan-2-yl)methyl]piperidin-1-yl}propyl)amino]-1,2,3,4-tetrahydroacridine dihydrochloride",0.00106,uM,=,-2.9746941347352296,0,c1ccc2c(c1)CC(CC1CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC1)C2
1088,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"5-Hydroxy-4'-(3-((ethyl)(2-Methoxybenzyl)amino)hexyloxy)-6,7-dimethoxyflavone",2.0,uM,=,0.3010299956639812,1,O=c1cc(-c2ccc(OCCCCCCNCc3ccccc3)cc2)oc2ccccc12
1089,1507873,10.1016/j.bmc.2015.05.027,,,,Inhibition of human acetylcholinesterase incubated for 60 mins using ATChI substrate by DTNB dye based UV-visible spectrophotometry,O=C(C[n+]1ccc(/C=N/O)cc1)Nc1nccs1.[Cl-],4-((Hydroxyimino)methyl)-1-(2-oxo-2-(thiazol-2-ylamino)ethyl)pyridinium chloride,2360.0,uM,=,3.3729120029701067,1,O=C(C[n+]1ccccc1)Nc1nccs1
1090,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN(C)C(=O)N[C@H]1CCc2c(O)cccc2C1,"(S)-3-(5-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylurea",0.13203,uM,=,-0.8793273767173925,0,c1ccc2c(c1)CCCC2
1091,775052,10.1016/j.ejmech.2011.09.001,,,,Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,CCN(CCCCCCNC(=O)CCCCC1CCSS1)Cc1ccccc1OC,"rac-5-(1,2-dithiolan-3-yl)-N-(6-(ethyl(2-methoxybenzyl)amino)hexyl)pentanamide",0.256,uM,=,-0.5917600346881504,0,O=C(CCCCC1CCSS1)NCCCCCCNCc1ccccc1
1092,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3ccc(OCCNC(=O)Cc4cc(F)cc(F)c4)cc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-7-yloxy)ethyl)-2-(3,5-difluorophenyl)acetamide",0.181,uM,=,-0.7423214251308154,0,O=C(Cc1ccccc1)NCCOc1ccc2cc(-c3ccc(CNCc4ccccc4)cc3)c(=O)oc2c1
1093,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1ccc(OC)cc1)c1ccc(=O)[nH]c1C2,"(1R,9R)-13-Eth-(E)-ylidene-1-{[1-(4-methoxy-phenyl)-methylidene]-amino}-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.031,uM,=,-1.5086383061657274,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
1094,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,COc1cc2c(cc1OC)[C@]1(OC2=O)[C@H](O)[C@@H](O)C=C2CCN(C)[C@H]21,8-demethoxy-10-O-methylhostasine,2.32,uM,=,0.3654879848908996,1,O=C1O[C@]2(CCC=C3CCN[C@H]32)c2ccccc21
1095,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)NO)cc3)c2n1,"N-Hydroxy-4-(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-ylamino)benzamide",9.25,uM,=,0.9661417327390326,1,c1ccc(Nc2c3ccccc3nc3cccnc23)cc1
1096,791001,10.1016/j.bmcl.2011.09.030,,,,Inhibition of human erythrocyte AChE incubated for 12 mins before addition of acetylthiocholine iodide substrate by spectrophotometric analysis,C#CCOP(C)(=O)OC(C(=O)OC)C(F)(F)F,"rac-3,3,3-Trifluoro-2-(methyl-prop-2-ynyloxy-phosphinoyloxy)-propionic acid methyl ester",43.60000000000001,uM,=,1.639486489268586,1,
1097,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccccc1CN1CCC(CCC(=O)c2ccc3c(c2)CCN3)CC1,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(2-methoxy-benzyl)-piperidin-4-yl]-propan-1-one",0.812,uM,=,-0.0904439707588246,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
1098,579492,10.1016/j.bmcl.2009.05.087,,,,Inhibition of human AChE-induced amyloid beta (1-40) aggregation by thioflavin T fluorescence-based assay,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@@H](C)c2ccccc2OC)=CC1=O)[C@@H](C)c1ccccc1OC,"2,5-bis(6-(ethyl((S)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",7.91,uM,=,0.8981764834976765,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
1099,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,"2-(8-(Benzyl(methyl)amino)octyl)isoindoline-1,3-dione hydrochloride",0.86,uM,=,-0.0655015487564322,0,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1
1100,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,O=C1C(NCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)=CC(=O)c2c(O)cccc21,"2-(2-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)ethylamino)-5-hydroxynaphthalene-1,4-dione",0.0007199999999999,uM,=,-3.1426675035687315,0,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
1101,751131,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes BChE,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,0.037,uM,=,-1.431798275933005,0,c1ccccc1
1102,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1O)C(=O)C(Cc1cc[n+](Cc3cccc(Cl)c3)cc1C(C)=O)C2,2-[[3-Acetyl-1-[(3-chlorophenyl)methyl]pyridin-1-ium-4-yl]methyl]-6-hydroxy-5-methoxy-indan-1-one,0.0027,uM,=,-2.5686362358410126,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
1103,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CN2CCN(c3ccncc3)CC2)c1,(E)-2-hydroxy-5-methyl-3-((4-(pyridin-4-yl)piperazin-1-yl)methyl)benzaldehyde oxime,484.0,uM,=,2.6848453616444123,1,c1ccc(CN2CCN(c3ccncc3)CC2)cc1
1104,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1ccc(C2=CSC3=NC4=C(CNC/C4=C/c4ccc(Br)cc4)C(c4ccc(Br)cc4)N23)cc1,"(E)-9-(4-bromobenzylidene)-5-(4-bromophenyl)-3-(p-tolyl)-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",1.01,uM,=,0.0043213737826425,1,C1=C(c2ccccc2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
1105,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc(C#N)cc[n+]1C.F[B-](F)(F)F,4-cyano-2-methoxy-1-methylpyridinium tetrafluoroborate,61.0,uM,=,1.7853298350107671,1,c1cc[nH+]cc1
1106,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,C=CCNCc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2[nH]1,N-((5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-en-1-amine,4.6,uM,=,0.6627578316815741,1,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
1107,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one hydrochloride",0.12,uM,=,-0.9208187539523752,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1108,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.0765,uM,=,-1.1163385648463824,0,c1ccc2nc3c(cc2c1)CCCC3
1109,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3F)CC2)c1)c1ccnc(NC(=O)C2CC2)c1,2-(cyclopropanecarboxamido)-N-(5-((1-(2-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide,0.0047,uM,=,-2.3279021420642825,0,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1
1110,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),COc1cc(O)c(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1C/C=C(\C)CCC=C(C)C,"2-(5-(3,7-dimethylocta-2,6-dienyl)-2-hydroxy-4-methoxyphenyl)-5,7-dihydroxy-4H-chromen-4-one",10.95,uM,=,1.0394141191761372,1,O=c1cc(-c2ccccc2)oc2ccccc12
1111,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2F)cc1.[Br-],4-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-(2-fluorobenzyl)pyridin-1-ium bromide,3.2,uM,=,0.505149978319906,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
1112,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCOC(=O)c1ccc2nc(-c3cccnc3)c3c(c2c1)N(Cc1ccccc1)C(=O)CC3,"Ethyl 1-benzyl-1,2,3,4-tetrahydro-2-oxo-5-(3-pyridyl)benzo[h][1,6]naphthyridine-9-carboxylate",13.0,uM,=,1.1139433523068367,1,O=C1CCc2c(-c3cccnc3)nc3ccccc3c2N1Cc1ccccc1
1113,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](Cc2cccc(C[n+]3ccc(C(C)(C)C)cc3)c2)cc1.[Br-].[Br-],"1,1'-bis(4-tert.butylpyridinium)-1,3-phenyldimethylenyl dibromide",0.7,uM,=,-0.1549019599857432,0,c1cc[n+](Cc2cccc(C[n+]3ccccc3)c2)cc1
1114,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCCCN2,"3-(1-Benzyl-piperidin-4-yl)-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-yl)-propan-1-one",0.125,uM,=,-0.9030899869919436,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCCCN2
1115,2059377,10.1016/j.bmc.2021.116074,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc2c(cc1OC)/C(=C\c1ccc(O)c(N3CCCCC3)c1)OC2=O,"(E)-3-(4-hydroxy-3-(piperidin-1-yl)benzylidene)-5,6-dimethoxyisobenzofuran-1(3H)-one",0.000338,uM,=,-3.4710832997223453,0,O=C1O/C(=C/c2cccc(N3CCCCC3)c2)c2ccccc21
1116,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2occ(-c3cccc(CN(C)Cc4ccccc4)c3)c(=O)c2cc1OC,"3-{3-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxychromen-4-one",2.02,uM,=,0.3053513694466238,1,O=c1c(-c2cccc(CNCc3ccccc3)c2)coc2ccccc12
1117,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=C1CC(c2ccc(OCCCCN3CCc4ccccc4C3)cc2)Oc2cc(OCCCCN3CCc4ccccc4C3)cc(O)c21,"7-(4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy)-2-(4-(4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy)phenyl)-5-hydroxychroman-4-one",13.2,uM,=,1.1205739312058498,1,O=C1CC(c2ccc(OCCCCN3CCc4ccccc4C3)cc2)Oc2cc(OCCCCN3CCc4ccccc4C3)ccc21
1118,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12,"7-(1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
1119,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,Cc1ccc(C(=O)N2CCN(CC(=O)N3CCN(CCCc4c[nH]c5ccccc45)CC3)CC2)cc1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-methylbenzoyl)piperazin-1-yl)ethanone,29.4,uM,=,1.4683473304121573,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
1120,1795962,10.1016/j.ejmech.2018.09.031,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CN(CCCCCN1C(=O)c2ccccc2S1(=O)=O)Cc1ccccc1,"2-[5-(Benzyl-methyl-amino)-pentyl]-1,1-dioxo-1,2-dihydro-1lambda(6)-benzo[d]isothiazol-3-one",0.033,uM,=,-1.4814860601221125,0,O=C1c2ccccc2S(=O)(=O)N1CCCCCNCc1ccccc1
1121,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazole,0.055,uM,=,-1.259637310505756,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
1122,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3c(Cl)cc(Cl)cc13)CCCCC2,"2,4-dichloro-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",9.04,uM,=,0.9561684304753632,1,c1ccc2nc3c(cc2c1)CCCCC3
1123,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=[N+]([O-])c1ccc2nc3c(c(N4CCCCC4)c2c1)CCCC3,"7-Nitro-9-(piperidin-1-yl)-1,2,3,4-tetrahydroacridine",1.885,uM,=,0.2753113545418116,1,c1ccc2c(N3CCCCC3)c3c(nc2c1)CCCC3
1124,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCCCC2)cc1O,rac-2-(3-Hydroxy-4-methoxyphenyl)-2-(piperidin-1-yl)acetonitrile,478.0,uM,=,2.6794278966121188,1,c1ccc(CN2CCCCC2)cc1
1125,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(c2)O/C(=C\c2ccc4ccccc4c2)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(3-{2-[1-naphthalen-2-yl-meth-(Z)-ylidene]-3-oxo-2,3-dihydro-benzofuran-6-yloxy}-propyl)-amino]-methyl}-phenyl ester",0.00341,uM,=,-2.4672456210075024,0,O=C1/C(=C/c2ccc3ccccc3c2)Oc2cc(OCCCNCc3ccccc3)ccc21
1126,2198746,10.1039/d2md00087c,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 sec for 3 mins by DTNB-based UV analysis,CCCCCCCNC(=O)Oc1ccc(Cc2nc3cc(C(=O)N4CCCCC4)ccc3n2CCC(C)C)cc1,4-((1-Isopentyl-5-(piperidine-1-carbonyl)-1H-benzo[d]imidazol-2-yl)methyl)phenyl heptylcarbamate,0.058,uM,=,-1.2365720064370629,0,O=C(c1ccc2[nH]c(Cc3ccccc3)nc2c1)N1CCCCC1
1127,28328,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.27-1.80,CCCNC(=O)Oc1ccc2c(c1)C(N)CC2.Cl,Propyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,1.48,uM,=,0.1702617153949573,1,c1ccc2c(c1)CCC2
1128,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1ccccc1,"1,3-Dimethyl-2-phenyl-1,2,3,4-tetrahydroquinazolin-6-ol",327.0,uM,=,2.514547752660286,1,c1ccc(C2NCc3ccccc3N2)cc1
1129,1668099,10.1016/j.bmcl.2017.04.006,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition by Ellman's method,COc1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1OC,"N-(3,4-dimethoxybenzyl)-1,2,3,4-tetrahydroacridin-9-amine",2.2,uM,=,0.3424226808222063,1,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
1130,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccc([N+](=O)[O-])cc2)c2ccccc12,1-Benzyl-3-[1-(4-nitro-benzoyl)-1H-indol-3-ylmethylene]-piperidin-4-one,50.0,uM,=,1.6989700043360187,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12
1131,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](CCc3ccccc3)cc1C(N)=O)C2.[Br-],"3-Carbamoyl-4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)-1-phenethylpyridinium bromide",0.896,uM,=,-0.0476919903378747,0,O=C1c2ccccc2CC1Cc1cc[n+](CCc2ccccc2)cc1
1132,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3ncccc13)CCCC2,"6,7,8,9-Tetrahydro-benzo[b][1,8]naphthyridin-5-ylamine",0.429,uM,=,-0.3675427078152757,0,c1cnc2nc3c(cc2c1)CCCC3
1133,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1ccc([C@@H]2CC(=O)c3c(cc(O)c(C/C=C(\C)CCC=C(C)C)c3O)O2)cc1O,4'-O-methyldiplacone,92.4,uM,=,1.9656719712201067,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
1134,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,"2-(3,4-Dihydroxy-phenyl)-3,7-dihydroxy-chromen-4-one",0.012,uM,=,-1.9208187539523751,0,O=c1cc(-c2ccccc2)oc2ccccc12
1135,1718675,10.1021/acs.jnatprod.7b00301,,,,Inhibition of AChE (unknown origin),CO[C@@H]1C=C[C@@]23c4cc5c(cc4C[N@@+]([O-])(CCO)[C@@H]2C(=O)N(C)[C@H]3C1)OCO5,Zephycarinatines F,126.16,uM,=,2.1009216803208464,1,O=C1N[C@H]2CCC=C[C@]23c2cc4c(cc2C[NH2+][C@H]13)OCO4
1136,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,NC(=O)c1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazole-6-carboxylic acid amide,0.0088,uM,=,-2.055517327849832,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
1137,1908427,10.1016/j.bmcl.2019.126754,,,,Inhibition of AChE (unknown origin) by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.079,uM,=,-1.1023729087095586,0,c1ccc2nc3c(cc2c1)CCCC3
1138,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CC[C@H](C)C1=N[C@H]2CC=C3C[C@H]4C(=O)C[C@]5(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]5(C)[C@@H]4CC[C@H]3[C@]2(C)CO1,"(4aS,7aR,9aR,10S,11R,12aS,12bR,14bS)-10-[1-(dimethylamino)ethyl]-11-hydroxy-9a,12a,14b-trimethyl-3-[(1S)-1-methylpropyl]-1,4a,5,7,7a,9,9a,10,11,12,12a,12b,13,14,14a,14b-hexadecahydro-8H-indeno[5'',4'':4',5']cyclohepta[1',2':3,4]benzo[1,2-d][1,3]oxazin-8-one",0.265,uM,=,-0.5767541260631921,0,O=C1CC2CCCC2[C@@H]2CC[C@@H]3C(=CC[C@@H]4N=COCC43)C[C@@H]12
1139,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12c1ccccc1-c1nc3ccccc3nc12,"6'-amino-9'-nitro-1',2',3',4'-tetrahydrospiro[indeno[1,2-b]quinoxaline-11,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",4.2,uM,=,0.6232492903979004,1,C1=CC2(C=C3NCCCN13)c1ccccc1-c1nc3ccccc3nc12
1140,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(C)n3)CC1)C2,"5,6-Dimethoxy-2-((1-((3-methylpyridin-2-yl)methyl)piperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",0.073,uM,=,-1.136677139879544,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
1141,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CC[C@H](C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CN1,"(4aS,6aR,7aR,9aR,10S,11R,12aS,12bS,14aR,14bR)-10-[1-(dimethylamino)ethyl]-11-hydroxy-9a,12a,14b-trimethyl-3-[(1S)-1-methylpropyl]-1,2,4a,5,6,9,9a,10,11,12,12a,12b,13,14,14a,14b-hexadecahydro-8H-cyclopenta[5,6]cyclopropa[1,8a]naphtho[2,1-f]quinazolin-8-one",4.368,uM,=,0.6402826296966808,1,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4CNC=N[C@H]4CC[C@@]34C[C@@]124
1142,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.01776,uM,=,-1.7505570385574178,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1143,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccc(Cl)cc1)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(4-Chlorophenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",21.28,uM,=,1.3279716236230106,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
1144,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(Nc1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O)c1ccccc1,"N-{2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl}-benzamide",0.0012,uM,=,-2.920818753952376,0,O=C(Nc1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O)c1ccccc1
1145,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),OC1CCN2Cc3ccccc3N=C12,SID582292,13.68,uM,=,1.1360860973840974,1,c1ccc2c(c1)CN1CCCC1=N2
1146,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,COc1ccccc1NC(=S)NCCN1CCCCC1.Cl,1-(2-Methoxyphenyl)-3-(2-(piperidin-1-yl)ethyl)thiourea hydrochloride,32.0,uM,=,1.505149978319906,1,S=C(NCCN1CCCCC1)Nc1ccccc1
1147,28290,10.1016/S0960-894X(01)81088-X,,,,Concentration required to inhibit acetylcholinesterase isolated from human erythrocytes,CCCCCCNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(CC)[C@H]1C2,"Hexyl-carbamic acid (3aR,8aS)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-indeno[2,1-b]pyrrol-5-yl ester",0.233,uM,=,-0.632644078973981,0,c1ccc2c(c1)C[C@@H]1NCCC21
1148,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1c(O)c(-c2ccc(F)cc2)oc2cc(F)c(I)cc12,7-fluoro-2-(4-fluorophenyl)-3-hydroxy-6-iodo-4H-chromen-4-one,0.00323,uM,=,-2.490797477668897,0,O=c1cc(-c2ccccc2)oc2ccccc12
1149,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1cc(C)cc(C)c1)CCc1cc2c(cc1-3)OCO2.[Br-],"9-O-(3,5-dimethylbenzyl)berberine bromide",2.5,uM,=,0.3979400086720376,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
1150,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(C(F)(F)F)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-trifluormethylbenzyl)berberine bromide,1.3,uM,=,0.1139433523068367,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
1151,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2c(O)cc(O)cc2o1,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-5,7-dihydroxy-4-oxo-4H-chromene-2-carboxamide",0.58,uM,=,-0.2365720064370627,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
1152,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCc3cc[n+](C)cc3)sc2cc1OC.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-pyridinium bromide",0.9,uM,=,-0.0457574905606751,0,O=C(CCc1cc[nH+]cc1)c1cc2ccccc2s1
1153,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2cccc(F)c2)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1-(3-fluorobenzyl)piperidin-4-yl)ethoxy)thiazole-5-carboxamide,4.7,uM,=,0.6720978579357175,1,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
1154,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,c1ccc2c(c1)Nc1ccccc1S2,10H-Phenothiazine,7.3,uM,=,0.8633228601204559,1,c1ccc2c(c1)Nc1ccccc1S2
1155,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CC1=N[C@H]2CC=C3C[C@H]4C(=O)C[C@]5(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]5(C)[C@@H]4CC[C@H]3[C@]2(C)CO1,"(4aS,7aR,9aR,10S,11R,12aS,12bR,14bS)-10-[1-(dimethylamino)ethyl]-11-hydroxy-3,9a,12a,14b-tetramethyl-1,4a,5,7,7a,9,9a,10,11,12,12a,12b,13,14,14a,14b-hexadecahydro-8H-indeno-[5'',4'':4',5']cyclohepta[1',2':3,4]benzo[1,2-d][1,3]oxazin-8-one",5.242,uM,=,0.7194970166105816,1,O=C1CC2CCCC2[C@@H]2CC[C@@H]3C(=CC[C@@H]4N=COCC43)C[C@@H]12
1156,28455,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 11.5-133,C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21.Cl,Ethyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,31.8,uM,=,1.5024271199844328,1,c1ccc2c(c1)CCC2
1157,1875190,10.1016/j.ejmech.2019.111785,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins prior to substrate addition measured after 5 mins by Ellman's method,Cc1ccc2oc(-c3ccc(OCCCCCCN4CCCCC4)cc3)cc(=O)c2c1,6-Methyl-2-(4-(6-(piperidin-1-yl)hexyloxy)phenyl)-4H-chromen-4-one,0.36,uM,=,-0.4436974992327127,0,O=c1cc(-c2ccc(OCCCCCCN3CCCCC3)cc2)oc2ccccc12
1158,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(CN2CCC(Nc3nc(-c4ccc(C)cc4)c(-c4ccc(C)cc4)s3)CC2)cc1,"4-Methylbenzyl-N-[4,5-bis(p-tolyl)thiazol-2yl]piperidin-4-ylamine",1.09,uM,=,0.0374264979406236,1,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
1159,2223705,10.1039/D1MD00046B,,,,Inhibition of AChE in human serum by Ellman's method,OCCCCCCCCc1ccc(CN2CCCCCC2)c(O)c1,2-[(azepan-1-yl)methyl]-5-(8-hydroxyoctyl)phenol,785.0,uM,=,2.8948696567452528,1,c1ccc(CN2CCCCCC2)cc1
1160,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCCCC[n+]2cccc3ccccc32)cc1,1-(11-(pyridinium-1-yl)undecyl)quinoliniumdibromide,0.017,uM,=,-1.769551078621726,0,c1cc[n+](CCCCCCCCCCC[n+]2cccc3ccccc32)cc1
1161,462117,10.1021/jm7009364,,,,Inhibition of human AchE,CCN(CCCCCC(=O)Nc1ccc(-c2ccc(NC(=O)CCCCCN(CC)Cc3ccccc3OC)cc2)cc1)Cc1ccccc1OC,6-[ethyl-(2-methoxy-benzyl)-amino]-hexanoic acid (4'-{6-[ethyl-(2-methoxy-benzyl)-amino]-hexanoylamino}-biphenyl-4-yl)-amide,0.0363,uM,=,-1.4400933749638876,0,O=C(CCCCCNCc1ccccc1)Nc1ccc(-c2ccc(NC(=O)CCCCCNCc3ccccc3)cc2)cc1
1162,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2cccc([N+](=O)[O-])c2)CC1)c1ccc2c(c1)CCN2,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(3-nitro-benzyl)-piperidin-4-yl]-propan-1-one",0.064,uM,=,-1.193820026016113,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
1163,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2ccccc2)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-1'-Methyl-4'-phenyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",11.12,uM,=,1.0461047872460387,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
1164,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc2c(cc1OC)C(=O)C(CCCCCCCc1cccc(OC)[n+]1C)C2.O=S(=O)([O-])C(F)(F)F,"2-(7-(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)heptyl)-6-methoxy-1-methylpyridinium trifluoromethanesulfonate",0.19,uM,=,-0.721246399047171,0,O=C1c2ccccc2CC1CCCCCCCc1cccc[nH+]1
1165,1761987,10.1016/j.ejmech.2018.01.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by DTNB addition for 5 mins and subsequent addition of substrate measured after 3 mins by Ellman's method,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1O,"(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)acrylamide",0.0652,uM,=,-1.1857524042680798,0,O=C(/C=C/c1ccccc1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
1166,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc3ncccc3c2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-oxo-2-(quinolin-6-ylamino)ethyl)acrylamide,4.89,uM,=,0.6893088591236203,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccc2ncccc2c1
1167,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1cnc2nc3c(c(NCCCCCCCNc4c5c(nc6ncccc46)CCCC5)c2c1)CCCC3,"N,N'-Bis-(6,7,8,9-tetrahydro-benzo[b][1,8]naphthyridin-5-yl)-heptane-1,7-diamine",0.0013,uM,=,-2.886056647693163,0,c1cnc2nc3c(c(NCCCCCCCNc4c5c(nc6ncccc46)CCCC5)c2c1)CCCC3
1168,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,C(=C\C[n+]1ccccc1)\C[n+]1ccccc1.[Cl-].[Cl-],"(Z)-1,4-bis(pyridinium)-but-2-ene dichloride",1990.0,uM,=,3.298853076409707,1,C(=C\C[n+]1ccccc1)\C[n+]1ccccc1
1169,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,NC(=O)c1cc[n+](CCC[n+]2ccc(/C=N/O)cc2)cc1.[Br-].[Br-],4-(aminocarbonyl)-1-(3-{4-[(E)-(hydroxyimino)methyl]pyridinium-1-yl}propyl)pyridinium dibromide,711.0,uM,=,2.851869600729766,1,c1cc[n+](CCC[n+]2ccccc2)cc1
1170,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1cc(C#N)c(NC2CCN(Cc3ccccc3)CC2)nc1N,"2-Amino-6-((1-benzylpiperidin-4-yl)amino)pyridine-3,5-dicarbonitrile",3.1,uM,=,0.4913616938342727,1,c1ccc(CN2CCC(Nc3ccccn3)CC2)cc1
1171,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,O/N=C/c1cc(Cl)cc(CN2CCN(c3ccncc3)CC2)c1O,(E)-5-chloro-2-hydroxy-3-((4-(pyridin-4-yl)piperazin-1-yl)methyl)benzaldehyde oxime,262.0,uM,=,2.4183012913197457,1,c1ccc(CN2CCN(c3ccncc3)CC2)cc1
1172,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,"N2-cyclopropyl-N4-(3,4-dimethoxyphenethyl)quinazoline-2,4-diamine",7.2,uM,=,0.8573324964312685,1,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1
1173,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,O/N=C/c1nc(CCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,"2-[1-(hydroxyimino)methyl]-6-{4-[(1,2,3,4-tetrahydroacridin-9-yl)amino]butyl}pyridin-3-ol",1.4,uM,=,0.1461280356782379,1,c1ccc(CCCCNc2c3c(nc4ccccc24)CCCC3)nc1
1174,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CCCN(C)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((methyl(propyl)amino)methyl)phenol dihydrochloride,1151.0,uM,=,3.061075323629792,1,c1ccccc1
1175,28156,10.1021/jm00161a008,,,,Reactivation of human acetylcholinesterase,CCN(CC)CCS/C(=N\O)c1nc(C)no1,"N-Hydroxy-3-methyl-[1,2,4]oxadiazole-5-carboximidothioic acid 2-diethylamino-ethyl ester",90.0,uM,=,1.954242509439325,1,c1ncon1
1176,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCCCOC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-pent-4-ynyloxymethyl-3H-imidazol-1-ium chloride,27.9,uM,=,1.4456042032735976,1,c1c[nH+]c[nH]1
1177,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccccc1C(C)NS(=O)(=O)NC(=O)OCc1ccccc1,Benzyl N-(1-(2-methoxyphenyl)ethyl)sulfamoylcarbamate,2.685e-05,uM,=,-4.571055709964425,0,O=C(NS(=O)(=O)NCc1ccccc1)OCc1ccccc1
1178,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3,"N1-(pyridin-4-yl)-N10-(1,2,3,4-tetrahydroacridin-9-yl)decane-1,10-diamine",0.176,uM,=,-0.7544873321858502,0,c1ccc2c(NCCCCCCCCCCNc3ccncc3)c3c(nc2c1)CCCC3
1179,1461400,10.1016/j.bmcl.2014.12.071,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate by Ellman method,c1ccc(COC[C@H]2NC[C@H](OCc3ccccc3)[C@@H](OCc3ccccc3)[C@@H]2OCc2ccccc2)cc1,"(2R,3R,4R,5S)-3,4,5-tris(benzyloxy)-2-(benzyloxymethyl)piperidine",60.0,uM,=,1.7781512503836436,1,c1ccc(COC[C@H]2NC[C@H](OCc3ccccc3)[C@@H](OCc3ccccc3)[C@@H]2OCc2ccccc2)cc1
1180,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,C=CCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(but-3-en-1-ylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.0133,uM,=,-1.8761483590329144,0,O=c1c2ccccc2nc2n1CCC2
1181,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCCCSCc2ccc(CN(C)C)o2)o1,{5-[4-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-butylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.21,uM,=,-0.6777807052660807,0,c1coc(CSCCCCSCc2ccco2)c1
1182,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CNc2ncccc2OCc2ccccc2)c1,(E)-3-((3-(benzyloxy)pyridin-2-ylamino)methyl)-2-hydroxy-5-methylbenzaldehyde oxime,96.7,uM,=,1.9854264740830017,1,c1ccc(CNc2ncccc2OCc2ccccc2)cc1
1183,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,COC1CCCN(Cc2ccc(CNCCN3CCNC3=C(C#N)C#N)o2)C1.Cl,"2-[1-(2-{[5-(3-Methoxy-piperidin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile, Di-hydrochloride",3.3,uM,=,0.5185139398778875,1,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
1184,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1cc(C#N)c(NCCCCC2CCN(Cc3ccccc3)CC2)nc1N,"2-Amino-6-((4-(1-benzylpiperidin-4-yl)butyl)amino)pyridine-3,5-dicarbonitrile",0.07,uM,=,-1.154901959985743,0,c1ccc(CN2CCC(CCCCNc3ccccn3)CC2)cc1
1185,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,Cc1nc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc2[nH]1.Cl,3-(1-Benzyl-piperidin-4-yl)-1-(2-methyl-1H-benzoimidazol-5-yl)-propan-1-one hydrochloride,0.012,uM,=,-1.9208187539523751,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]cnc2c1
1186,2059377,10.1016/j.bmc.2021.116074,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(CC)c1cc(/C=C2\OC(=O)c3cc(OC)c(OC)cc32)ccc1O,"(Z)-3-(3-(diethylamino)-4-hydroxybenzylidene)-5,6-dimethoxyisobenzofuran-1(3H)-one",0.00155,uM,=,-2.8096683018297086,0,O=C1O/C(=C\c2ccccc2)c2ccccc21
1187,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,CCN(CCCCCCNC1=CC(=O)c2ccccc2C1=O)Cc1ccccc1OC,"2-(6-(ethyl(2-methoxybenzyl)amino)hexylamino)naphthalene-1,4-dione",0.00973,uM,=,-2.011887159731648,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)c2ccccc21
1188,28298,10.1021/jm00015a002,,,,In vitro inhibition of Acetylcholinesterase from human erythrocytes,O=C(O)/C=C\C(=O)O.O=C1Cc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc2N1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5,7-dihydro-isoxazolo[4,5-f]indol-6-one; compound with (Z)-but-2-enedioic acid",0.00033,uM,=,-3.4814860601221125,0,O=C1Cc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc2N1
1189,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OC(C)C,"4-Isopropoxy-N-methyl-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.2374,uM,=,-0.6245192853814276,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nccs2)ccn1
1190,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN(C)C(=O)N[C@H]1CCc2ccc(O)cc2C1,"(S)-3-(7-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylurea",0.1033,uM,=,-0.9858996784803794,0,c1ccc2c(c1)CCCC2
1191,29408,10.1021/jm00081a022,,,,In vitro inhibitory activity against acetylcholinesterase,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.052,uM,=,-1.2839966563652008,0,c1ccc2nc3c(cc2c1)CCCC3
1192,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccc(OC)cc2)C[C@@H](c2ccc(C)cc2)N(c2ccc(OC)cc2)[C@@H]1c1ccc(C)cc1,"(2R,6S)-ethyl 1-(4-methoxyphenyl)-4-(4-methoxyphenylamino)-2,6-dip-tolyl-1,2,5,6-tetrahydropyridine-3-carboxylate",4980.0,uM,=,3.6972293427597176,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
1193,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc(CCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)c1,"6-chloro-N-(8-(3-methoxyphenyl)octyl)-1,2,3,4-tetrahydroacridin-9-amine",0.00571,uM,=,-2.243363891754152,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
1194,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,N/C(=N\O)c1cc[n+](CCC[n+]2ccc(/C=N/O)cc2)cc1.[Br-].[Br-],"4-(1-Amino-1-hydroxyiminomethyl)-4'-hydroxyiminomethyl-1,1'-(prop-1,3-diyl)-bispyridinium dibromide",291.0,uM,=,2.463892988985908,1,c1cc[n+](CCC[n+]2ccccc2)cc1
1195,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=C(c2ccccc2)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(c2ccccc2)C1=O)Cc1ccccc1OC,"2,5-bis{6-[ethyl(2-methoxybenzyl)amino]hexylamino}-3,6-diphenyl-[1,4]-benzoquinone",0.123,uM,=,-0.910094888560602,0,O=C1C(NCCCCCCNCc2ccccc2)=C(c2ccccc2)C(=O)C(NCCCCCCNCc2ccccc2)=C1c1ccccc1
1196,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCNC1=CC(=O)C(NCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis{5-[ethyl(2-methoxybenzyl)amino]pentylamino}-[1,4]-benzoquinone",0.0023599999999999,uM,=,-2.6270879970298937,0,O=C1C=C(NCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCNCc1ccccc1
1197,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCN(Cc4cccc(F)c4)CC3)cc2oc1=O,"(+/-)-7-((1-(3-fluorobenzyl)piperidin-4-yl)methoxy)-3,4-dimethyl-2H-chromen-2-one",0.46,uM,=,-0.3372421683184259,0,O=c1ccc2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2o1
1198,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cccc(CN2CCC(/C=C3\Cc4ccc(OC)cc4C3=O)CC2)c1,"(E)-6-methoxy-2-((1-(3-methoxybenzyl)piperidin-4-yl)methylene)-2,3-dihydro-1H-inden-1-one",34.5,uM,=,1.5378190950732742,1,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
1199,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC(C)=CC(=O)O[C@H]1Cc2cc3ccc(=O)oc3cc2OC1(C)C,Decursin,390.0,uM,=,2.591064607026499,1,O=c1ccc2cc3c(cc2o1)OCCC3
1200,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(Cc3ccccc3)C(=O)C2C12C(=O)c1ccccc1C2=O,"5'-Benzyl-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",41.16,uM,=,1.6144753660903952,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1Cc1ccccc1
1201,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.093,uM,=,-1.0315170514460648,0,c1ccc2nc3c(cc2c1)CCCC3
1202,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(1,2,3,4-tetrahydro-acridin-9-yl)-heptane-1,7-diamine (bis(7)-Tacrine)",0.004,uM,=,-2.397940008672037,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
1203,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1cc(=O)oc2cc(OCc3ccc(CN(C)Cc4cccc(Cl)c4)cc3)ccc12.Cl,7-(4-(N-(3-Chlorobenzyl)-N-methylaminomethyl)benzyloxy)-4-methyl-2H-chromen-2-one hydrochloride,1.0,uM,=,0.0,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
1204,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one,7.78,uM,=,0.890979596989689,1,O=c1c2ccccc2oc2cc(OCCCCCNCc3ccccc3)ccc12
1205,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1.Cl,"9-(2-(4-((1-Phenyl-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",0.9,uM,=,-0.0457574905606751,0,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
1206,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazol-6-ylamine,0.02,uM,=,-1.6989700043360187,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
1207,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CCNC(=O)Oc1cccc2c1CCC1CCN(C)C21,"Ethyl-carbamic acid 1-methyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indol-6-yl ester",0.393,uM,=,-0.4056074496245733,0,c1ccc2c(c1)CCC1CCNC21
1208,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cccc(Cl)c4c(N)c3C(C1)C2,"5-chloro-15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.0116999999999999,uM,=,-1.9318141382538383,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
1209,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,CC(C)N(CCOc1ccc(-c2nc3ccccc3[nH]2)cc1)C(C)C,N-{2-[4-(1H-Benzo[d]imidazol-2-yl)phenoxy]ethyl}-N-isopropylpropan-2-amine,23.42,uM,=,1.3695868907363444,1,c1ccc(-c2nc3ccccc3[nH]2)cc1
1210,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCC2,"3-(1-Benzyl-piperidin-4-yl)-1-(1,2,3,4-tetrahydro-quinolin-7-yl)-propan-1-one",0.164,uM,=,-0.7851561519523022,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCC2
1211,2022983,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin),CCCCCCCCCCCCCCCCc1c(C(=O)[O-])ccc[n+]1C,Platisidine C,2100.0,uM,=,3.322219294733919,1,c1cc[nH+]cc1
1212,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,C=CC[N+](C)(C)c1ccc(CCC(=O)CCc2ccc([N+](C)(C)CC=C)cc2)cc1.[Br-].[Br-],"1,5-bis(4-isopropylphenyl)pentan-3-one",0.018,uM,=,-1.744727494896694,0,O=C(CCc1ccccc1)CCc1ccccc1
1213,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3)cc1Br)C2.[Br-],"2-[(1-Benzyl-3-bromo-pyridin-1-ium-4-yl)methyl]-5,6-dimethoxy-indan-1-one bromide",0.0003599999999999,uM,=,-3.4436974992327127,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
1214,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1cccs1)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(Thiophen-2-yl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",19.12,uM,=,1.2814878879400813,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1cccs1)[C@@]21CSc2ccccc2C1=O
1215,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5-methoxy-isoindole-1,3-dione",0.008,uM,=,-2.096910013008056,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
1216,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),O=c1c2ccccc2nc2n1CCC2,"2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one",35.16,uM,=,1.5460488664017342,1,O=c1c2ccccc2nc2n1CCC2
1217,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,Cl.Cl.c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N1,N7-bis(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine dihydrochloride",0.00081,uM,=,-3.09151498112135,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
1218,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Fc1ccc(/C=N\C2CCN(Cc3ccccc3)C2)c(F)c1,"N-(1-Benzylpyrrolidin-3-yl)-1-(2,4-difluorophenyl)methanimine",0.965,uM,=,-0.0154726866562074,0,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
1219,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(CC1CCN(Cc3cccc(/C=N/O)c3O)CC1)CC2,"3-((4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",802.4,uM,=,2.9043909200123617,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1
1220,1718675,10.1021/acs.jnatprod.7b00301,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.27,uM,=,0.1038037209559568,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1221,2261397,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human AChE,C#CCN(C)C1CCc2c(OC(=O)N(C)CC)cccc21,[1-[methyl(prop-2-ynyl)amino]indan-4-yl]N-ethyl-N-methyl-carbamate,4.0,uM,=,0.6020599913279624,1,c1ccc2c(c1)CCC2
1222,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCCCCCCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-tetradecyl-7-methoxytacrine hydrochloride,46.0,uM,=,1.662757831681574,1,c1ccc2nc3c(cc2c1)CCCC3
1223,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccccc2)cc1,N-(4-((benzyl(methyl)amino)methyl)phenyl)-2-phenylacetamide,5.8,uM,=,0.7634279935629373,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
1224,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-heptyl-7-methoxytacrine hydrochloride,0.27,uM,=,-0.5686362358410126,0,c1ccc2nc3c(cc2c1)CCCC3
1225,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,CN(CCCO)Cc1ccc(COc2ccc3c(CO)cc(=O)oc3c2)cc1,4-(hydroxymethyl)-7-((4-(((3-hydroxypropyl)(methyl)amino)methyl)benzyl)oxy)-2H-chromen-2-one,2.2,uM,=,0.3424226808222063,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
1226,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(Cc1ccccc1)N1c2ccccc2Sc2ccc(Cl)cc21,1-(2-chloro-10H-phenothiazin-10-yl)-2-phenylethanone,7.5,uM,=,0.8750612633917001,1,O=C(Cc1ccccc1)N1c2ccccc2Sc2ccccc21
1227,305005,10.1021/jm049113+,,,,Inhibitory concentration against Acetylcholinesterase; (range = 2-20 uM),CC(C)N(CCN1CC(=O)N(CCc2ccc(Cl)cc2Cl)CC1=O)C(C)C,"1-[2-(2,4-Dichloro-phenyl)-ethyl]-4-(2-diisopropylamino-ethyl)-piperazine-2,5-dione",20.0,uM,=,1.3010299956639813,1,O=C1CN(CCc2ccccc2)C(=O)CN1
1228,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(Cl)c3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-((4-amino-3-chlorophenyl)sulfonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.05136,uM,=,-1.289374984939203,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
1229,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(-c3ccccc3)cc2)CC1c1cccc([N+](=O)[O-])c1,"1-(3-([1,1'-Biphenyl]-4-yl)-5-(3-nitrophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1028.0,uM,=,3.011993114659257,1,c1ccc(-c2ccc(C3=NNC(c4ccccc4)C3)cc2)cc1
1230,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1ccc(-c2cn3c(Cl)cccc3[n+]2C)cc1.[Cl-],"5-chloro-2-(4-(dimethylcarbamoyloxy)phenyl)-1-methylimidazo[1,2-a]pyridin-1-ium",12.6,uM,=,1.100370545117563,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
1231,28298,10.1021/jm00015a002,,,,In vitro inhibition of Acetylcholinesterase from human erythrocytes,CC(=O)Nc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1.O=C(O)/C=C/C(=O)O,N-{3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazol-6-yl}-acetamide; compound with (E)-but-2-enedioic acid,0.0028,uM,=,-2.552841968657781,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
1232,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(-c3ccccc3)cc2)nn1C(=O)N(C)C,"3-Biphenyl-4-yl-5-methylsulfanyl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.56,uM,=,-0.2518119729937995,0,c1ccc(-c2ccc(-c3nc[nH]n3)cc2)cc1
1233,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CN(C)Cc1ccc(CNCCN2CCNC2=C(C#N)C#N)o1,2-(1-{2-[(5-Dimethylaminomethyl-furan-2-ylmethyl)-amino]-ethyl}-imidazolidin-2-ylidene)-malononitrile,0.39,uM,=,-0.4089353929735008,0,C=C1NCCN1CCNCc1ccco1
1234,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.091,uM,=,-1.0409586076789064,0,c1ccccc1
1235,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(O)c1c(O)cccc1CCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"2-(8-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)-6-hydroxybenzoic acid",0.0134,uM,=,-1.8728952016351923,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
1236,1881813,10.1016/j.ejmech.2018.09.067,,,,Inhibition of human recombinant acetylcholinesterase using acetylthiocholine as substrate after 30 mins by spectrophotometric analysis,O=C(NNC(=S)Nc1ccc(Cl)c(Cl)c1)c1ccccc1O,"4-(3,4-Dichlorophenyl)-1-(2-hydroxybenzoyl)-3-thiosemicarbazide",0.52,uM,=,-0.2839966563652008,0,O=C(NNC(=S)Nc1ccccc1)c1ccccc1
1237,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4C)CC3)ccc2n1C,N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine,2.8,uM,=,0.4471580313422192,1,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
1238,967407,10.1016/j.bmc.2013.05.001,,,,Inhibition of human AchE using acetylthiocholine iodide as substrate incubated for 20 mins prior to substrate addition measured for 1 hr by Ellman's method,CN(C)CCCN(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1,"N1,N1-bis(1H-benzo[d]imidazol-2-yl)-N3,N3-dimethylpropane-1,3-diamine",59.68,uM,=,1.7758288144646124,1,c1ccc2[nH]c(Nc3nc4ccccc4[nH]3)nc2c1
1239,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-Hydroxy-2,5,7,8-tetramethyl-N-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)chroman-2-carboxamide",0.69,uM,=,-0.1611509092627447,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
1240,305184,10.1016/j.bmcl.2004.10.067,,,,Inhibitory concentration against Acetylcholinesterase activity,COC1=CC(=O)[C@]2(C)[C@]3(O)Cc4c(cc(-c5cc(OC)c(OC)c(OC)c5)oc4=O)O[C@]3(C)CC[C@]2(O)C1(C)C,"4a,12a-dihydroxy-3-methoxy-4,4,6a,12b-tetramethyl-9-(3,4,5-trimethoxyphenyl)-1,4a,5,6,6a,12,12a,12b-octahydro-4H,11H-benzo[f]pyrano[4,3-b]chromene-1,11-dione",0.42,uM,=,-0.3767507096020995,0,O=C1C=CCC2CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC3C12
1241,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,CC(C)(c1ccc(-c2cnc3[nH]c4cnc(C#N)cc4c3c2)cc1)N1CCCCC1,"3-(4-(2-(Piperidin-1-yl)propan-2-yl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.507,uM,=,-0.294992040666664,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
1242,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cccc(CCCCCCCCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(octane-1,8-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",0.19,uM,=,-0.721246399047171,0,c1ccc(CCCCCCCCc2cccc[nH+]2)[nH+]c1
1243,2245163,10.1016/j.bmc.2022.116660,,,,Inhibition of Human AChE by Ellman's method,CCCCC1OC(=O)c2cc(OCc3ccc(CN4CCCCC4)c(O)c3)ccc21,3-butyl-6-((3'-hydroxy-4'-(piperidin-1-ylmethyl)benzyl)oxy)isobenzofuran-1(3H)-one,0.0409999999999999,uM,=,-1.3872161432802643,0,O=C1OCc2ccc(OCc3ccc(CN4CCCCC4)cc3)cc21
1244,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2cccc(Br)c2)ccc1O,(E)-N-(2-((3-bromophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,13.07,uM,=,1.1162755875805443,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
1245,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc(-c3ccccc3)cc2)c1,Methyl-carbamic acid 3-({[3-(biphenyl-4-yloxy)-propyl]-methyl-amino}-methyl)-phenyl ester,0.0546,uM,=,-1.2628073572952627,0,c1ccc(CNCCCOc2ccc(-c3ccccc3)cc2)cc1
1246,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),O=[N+]([O-])C1C(Cc2c[nH]cn2)NC2(c3ccccc3-c3nc4ccccc4nc32)C1c1ccccn1,"5'-(1H-imidazol-4-ylmethyl)-4'-nitro-3'-(2-pyridyl)spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",17.04,uM,=,1.2314695904306814,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)nc1
1247,1465704,10.1016/j.bmcl.2015.02.015,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate after 15 mins by Ellman spectrophotometric method,COc1cc2oc(-c3ccc(OCC(=O)NCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,"N-(5-((6-chloro-1,2,3,4-tetrahydroanthracen-9-yl)amino)pentyl)-2-(4-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",0.0069,uM,=,-2.161150909262745,0,O=C(COc1ccc(-c2cc(=O)c3ccccc3o2)cc1)NCCCCCNc1c2c(nc3ccccc13)CCCC2
1248,2263808,10.1016/j.bmc.2020.115895,,,,Inhibition of AChE (unknown origin),O=C1/C(=C/c2ccc(OCCN3CCCCC3)cc2)Oc2ccccc21,2-(4-(2-(piperidin-1-yl)ethoxy)benzylidene)benzofuran-3(2H)-one,0.348,uM,=,-0.4584207560534191,0,O=C1/C(=C/c2ccc(OCCN3CCCCC3)cc2)Oc2ccccc21
1249,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,COC(=O)CC[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@@H](OC(C)=O)[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3=O,methyl lucidenate E2,17.14,uM,=,1.2340108175871791,1,O=C1C[C@H]2CCCCC2C2=C1C1C(=O)CCC1CC2=O
1250,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(C=C2Cc3cc(OC)c(OC)cc3C2=O)cc1,"2-[[4-(diethylaminomethyl)phenyl]methylene]-5,6-dimethoxy-indan-1-one",0.253,uM,=,-0.5968794788241821,0,O=C1C(=Cc2ccccc2)Cc2ccccc21
1251,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,CN(CCCOc1ccc([N+](=O)[O-])cc1)C(=O)c1cnc(CC(=O)c2ccccc2)nc1,N-methyl-N-(3-(4-nitrophenoxy)propyl)-2-(2-oxo-2-phenylethyl)pyrimidine-5-carboxamide,9.94,uM,=,0.9973863843973132,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
1252,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCCC[n+]2ccccc2)cc1,"1,10-bis(pyridinium)decane dibromide",0.4,uM,=,-0.3979400086720376,0,c1cc[n+](CCCCCCCCCC[n+]2ccccc2)cc1
1253,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,COc1ccc(-c2nc(SC)n(C(=O)N(C)C)n2)cc1,"3-(4-Methoxy-phenyl)-5-methylsulfanyl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.8,uM,=,-0.0969100130080563,0,c1ccc(-c2nc[nH]n2)cc1
1254,1875190,10.1016/j.ejmech.2019.111785,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins prior to substrate addition measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.00559,uM,=,-2.252588192113577,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1255,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,COc1ccc(C(=O)COc2cccc([N+](C)(C)Cc3ccccc3)c2)cc1OC.[Br-],"Benzyl-{3-[2-(3,4-dimethoxy-phenyl)-2-oxo-ethoxy]-phenyl}-dimethyl-ammonium bromide",0.33,uM,=,-0.4814860601221125,0,O=C(COc1cccc([NH2+]Cc2ccccc2)c1)c1ccccc1
1256,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(OC)c3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-amino-3-methoxyphenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.0685,uM,=,-1.1643094285075744,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
1257,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCNc3c4c(nc5ccccc35)CCCC4)c2c1,"N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
1258,2054941,10.1016/j.ejmech.2020.112743,,,,Inhibition of recombinant human AChE using ATCI as substrate incubated for 5 mins followed by substrate addition and measured after 5 mins by spectrophotometric based Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.006,uM,=,-2.2218487496163566,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1259,1724020,10.1016/j.ejmech.2017.05.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured over 5 mins by Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN[C@@H]1N2.O=C(O)c1ccccc1O,Physostigmine salicylic acid,14.5,uM,=,1.1613680022349748,1,c1ccc2c(c1)N[C@H]1NCCC21.c1ccccc1
1260,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccc(Cl)cc32)cc1,2-Chloro-10H-phenoselenazin-10-yl-(4-methoxyphenyl)-methanone,5.8,uM,=,0.7634279935629373,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
1261,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-Hydroxy-2,5,7,8-tetramethyl-N-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)chroman-2-carboxamide",0.1437,uM,=,-0.8425432318657744,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
1262,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCN(C)C,(E)-3-(4-(3-(dimethylamino)propoxy)-3-methoxyphenyl)-N-phenylacrylamide,33.86,uM,=,1.5296869537729163,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
1263,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1cc(CCC(=O)NCCC2CCN(Cc3ccccc3)CC2)ccc1O,N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)propanamide,5.32,uM,=,0.7259116322950482,1,O=C(CCc1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1264,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CN1,"(4aS,6aR,7aR,9aR,10S,11R,12aS,12bS,14aR,14bR)-10-[1-(dimethylamino)ethyl]-11-hydroxy-3-isopropyl-9a,12a,14b-trimethyl-1,2,4a,5,6,9,9a,10,11,12,12a,12b,13,14,14a,14bhexadecahydro-8H-cyclopenta[5,6]cyclopropa[1,8a]naphtho[2,1-f]quinazolin-8-one",3.108,uM,=,0.4924810101288767,1,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4CNC=N[C@H]4CC[C@@]34C[C@@]124
1265,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccc(OC)cc2)=CC1=O)Cc1ccc(OC)cc1,"2,5-bis{6-[ethyl(4-methoxybenzyl)amino]hexylamino}-[1,4]-benzoquinone",0.0511,uM,=,-1.2915790998652872,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
1266,305184,10.1016/j.bmcl.2004.10.067,,,,Inhibitory concentration against Acetylcholinesterase activity,COc1ccc(-c2cc3c(c(=O)o2)C[C@@]2(O)[C@@]4(C)C(=O)[C@@]5(OC)C(=O)O[C@]4(CC[C@@]2(C)O3)C5(C)C)cc1,"13-hydroxy-16-methoxy-8-(4-methoxyphenyl)-4,14,19,19-tetramethyl-5,9,18-trioxapentacyclo[14.2.1.01,14.04,13.06,11]nonadeca-6(11),7-diene-10,15,17-trione",0.23,uM,=,-0.6382721639824072,0,O=C1O[C@@]23CCC4Oc5cc(-c6ccccc6)oc(=O)c5CC4C2C(=O)C1C3
1267,2052542,10.1016/j.ejmech.2019.111958,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3o2)cc1,"2-(4-((Ethyl(methyl)carbamoyl)oxy)phenyl)-4-oxo-4H-chromene-5,7-diyl bis(ethyl(methyl)carbamate)",9.2,uM,=,0.9637878273455552,1,O=c1cc(-c2ccccc2)oc2ccccc12
1268,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3c(Cl)cc(Cl)cc13)CCC2,"5,7-dichloro-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",13.1,uM,=,1.1172712956557642,1,c1ccc2nc3c(cc2c1)CCC3
1269,27788,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in monkey red blood cell,Nc1c2c(nc3ccccc13)CCC(O)C2,"9-Amino-1,2,3,4-tetrahydro-acridin-2-ol",2.3,uM,=,0.3617278360175928,1,c1ccc2nc3c(cc2c1)CCCC3
1270,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,O=C(/C=C/c1ccc(O)c(O)c1)NCCC1CCN(Cc2ccccc2)CC1,"(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,4-dihydroxyphenyl)acrylamide",1.45,uM,=,0.1613680022349748,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1271,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc4ccccc4n3)CC1)C2,"5,6-dimethoxy-2-((1-(quinolin-2-ylmethyl)piperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",8.43,uM,=,0.9258275746247424,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccc3ccccc3n2)CC1
1272,305079,10.1021/jm0493461,,,,Inhibitory concentration against human acetylcholinesterase,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(1,2,3,4-tetrahydro-acridin-9-yl)-heptane-1,7-diamine (bis(7)-Tacrine)",0.0005899999999999,uM,=,-3.229147988357856,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
1273,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COCC[n+]1ccc(CCC(=O)c2cc3cc(OC)c(OC)cc3s2)cc1,"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(2-methoxy-ethyl)-pyridinium",0.03,uM,=,-1.5228787452803376,0,O=C(CCc1cc[nH+]cc1)c1cc2ccccc2s1
1274,2258882,10.6019/CHEMBL5212743,,,,"Selectivity interaction (PSP Principial panel 20118+ (panel of GPCRs, transporter, and ion channels)) EUB0000283b ACHE",C[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc4cnccc4c3)ccc2[nH]1,NVS-MLLT-1,0.25,uM,=,-0.6020599913279624,0,O=C(Nc1ccc2[nH]c(CN3CCCC3)nc2c1)c1ccc2cnccc2c1
1275,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(C(F)(F)F)cc1)CC2.[Br-],"8-methoxy-2-(4-(trifluoromethyl)phenyl)-3,4-dihydroisoquinolinium bromide",1.94,uM,=,0.287801729930226,1,C1=[N+](c2ccccc2)CCc2ccccc21
1276,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[3-(benzylmethylamino)propoxy]xanthen-9-one,2.68,uM,=,0.4281347940287888,1,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
1277,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4cccnc4oc3c2)c1,"3-((methyl(3-(5-oxo-5H-chromeno[2,3-b]pyridin-8-yloxy)propyl)amino)methyl)phenyl hexylcarbamate",0.042,uM,=,-1.3767507096020994,0,O=c1c2ccc(OCCCNCc3ccccc3)cc2oc2ncccc12
1278,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1ccccc1CN(C)CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1,3-{7-[(2-methoxybenzyl)methylamino]heptyloxy}xanthen-9-one,2.18,uM,=,0.3384564936046048,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
1279,1455127,10.1016/j.bmc.2014.07.053,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins before substrate addition by Ellman method,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.0007,uM,=,-3.154901959985743,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
1280,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccccc1Br)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(2-brombenzyl)berberine bromide,1.7,uM,=,0.2304489213782739,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
1281,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2ccc(F)cc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccc(F)cc1,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis [(E)-4-fluoro phenylmethylidene]tetrahydro-4''(1H)-pyridinone",19.84,uM,=,1.29754166781816,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
1282,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCCOC[n+]1ccn(C(C)(C)C)c1/C=N/O.[Cl-],3-tert-Butyl-1-but-3-ynyloxymethyl-2-(hydroxyimino-methyl)-3H-imidazol-1-ium chloride,339.0,uM,=,2.530199698203082,1,c1c[nH+]c[nH]1
1283,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCC3CC[N+](C)(CC(=O)OC(C)(C)C)CC3)sc2cc1OC.[Br-],"1-tert-Butoxycarbonylmethyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-piperidinium bromide",0.079,uM,=,-1.1023729087095586,0,O=C(CCC1CC[NH2+]CC1)c1cc2ccccc2s1
1284,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C2\COC/C(=C\c3ccc(C(OCC)OCC)cc3)C2=O)cc1,"3,5-Bis-(4-diethoxymethyl-benzylidene)-tetrahydro-pyran-4-one",41.22,uM,=,1.6151079874431942,1,O=C1/C(=C/c2ccccc2)COC/C1=C\c1ccccc1
1285,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc2c(c1)CCCc1c-2nc2ccccc2c1N,"3-Methoxy-6,7-dihydro-5H-13-aza-benzo[3,4]cyclohepta[1,2-b]naphthalen-8-ylamine",68.8,uM,=,1.8375884382355112,1,c1ccc2c(c1)CCCc1cc3ccccc3nc1-2
1286,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)CC(CC1CCN(CCNc3c4c(nc5cc(Cl)ccc35)CCCC4)CC1)C2.Cl.Cl.Cl,"6-Chloro-9-[(2-{4-[(5,6-dimethoxyindan-2-yl)methyl]piperidin-1-yl}ethyl)amino]-1,2,3,4-tetrahydroacridine dihydrochloride",0.0026,uM,=,-2.5850266520291822,0,c1ccc2c(c1)CC(CC1CCN(CCNc3c4c(nc5ccccc35)CCCC4)CC1)C2
1287,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.041,uM,=,-1.3872161432802643,0,c1ccccc1
1288,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,O=C(Nc1cccc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)n1)Nc1cccc2c1C1CCCCN1C2=O,"(+/-)-1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(6-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)pyridin-2-yl)urea",0.133,uM,=,-0.8761483590329142,0,O=C(Nc1cccc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)n1)Nc1cccc2c1C1CCCCN1C2=O
1289,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CC[C@@]2(C)c3cc(OC(=O)NC(C)c4ccccc4)ccc3C[C@@H]12,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl 1-phenylethylcarbamate",1.33,uM,=,0.1238516409670858,1,O=C(NCc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1C2
1290,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N/O)Nc1ccc[n+](Cc2ccccc2C[n+]2cccc(NC(=O)/C=N/O)c2)c1.[Br-].[Br-],"1,1'-(1,2-phenylenebis(methylene))bis(3-(2-(hydroxyimino)acetamido)pyridinium)dibromide",1700.0,uM,=,3.230448921378274,1,c1cc[n+](Cc2ccccc2C[n+]2ccccc2)cc1
1291,1891538,10.1016/j.bmcl.2019.04.002,,,,Inhibition of AChE in erythrocytes (unknown origin) pre-incubated for 20 mins before acetylthiocholine substrate addition and measured over 30 mins by DTNB dye based spectrophotometry,Brc1ccc(-c2nnn3c2C2c4ccccc4CCN2Cc2ccccc2-3)cc1,"16-(4-bromophenyl)-5,6,8,16b-tetrahydro benzo[5,6][1,2,3]triazolo[5',1':3,4][1,4]diazepino[2,1-a]isoquinoline",0.25,uM,=,-0.6020599913279624,0,c1ccc(-c2nnn3c2C2c4ccccc4CCN2Cc2ccccc2-3)cc1
1292,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3ccc(Cl)cc13)CCCC2,"7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.743,uM,=,-0.1290111862394247,0,c1ccc2nc3c(cc2c1)CCCC3
1293,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CC2CCCC2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclopentylmethyl)-4-piperidyl]propan-1-one,0.069,uM,=,-1.1611509092627446,0,O=C(CCC1CCN(CC2CCCC2)CC1)c1ccccc1
1294,28313,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.12-0.41,CNCCc1cccc(OC(=O)N(C)C)c1,Dimethyl-carbamic acid 3-(2-methylamino-ethyl)-phenyl ester,0.28,uM,=,-0.5528419686577808,0,c1ccccc1
1295,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Fc1ccc(CN2CCC(Nc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)s3)CC2)c(Cl)c1,"1-(2-Chloro-4-fluorobenzyl)-N-[4,5-bis(4-chlorophenyl)-thiazol-2-yl]piperidin-4-ylamine",0.37,uM,=,-0.431798275933005,0,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
1296,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,Cc1ccc(C2c3ccc4ccccc4c3Oc3nc4c(c(N)c32)CCCC4)cc1,"rac-7-(p-Tolyl)-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",0.4,uM,=,-0.3979400086720376,0,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
1297,1718383,10.1016/j.ejmech.2017.08.051,,,,Inhibition of AChE in human erythrocytes acetylthiocholine iodide as substrate by Ellman's spectrophotometry,COc1cc2c(cc1OC)C(=O)C(CC1CCN(CCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)CC1)C2,"2-((1-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.00027,uM,=,-3.5686362358410126,0,O=C1c2ccccc2CC1CC1CCN(CCCNc2c3c(nc4ccccc24)CCCC3)CC1
1298,28462,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 13.6-27.3,C#CCNC(C)Cc1cccc(OC(=O)N(C)CCC)c1,Methyl-propyl-carbamic acid 3-(2-prop-2-ynylamino-propyl)-phenyl ester,19.1,uM,=,1.2810333672477277,1,c1ccccc1
1299,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCSC(=S)N(C)C)ccc12,2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)ethyldimethylcarbamodithioate,10.59,uM,=,1.024895960107485,1,O=c1ccc2ccccc2o1
1300,2015826,10.1016/j.bmcl.2020.127370,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by UV-vis spectrophotometry based Ellman's method,CCn1cc(CNCc2c[nH]nc2-c2ccc(-c3ccccc3)cc2)cn1,1-(3-(biphenyl-4-yl)-1H-pyrazol-4-yl)-N-((1-ethyl-1H-pyrazol-4-yl)methyl)methanamine,0.35,uM,=,-0.4559319556497244,0,c1ccc(-c2ccc(-c3n[nH]cc3CNCc3cn[nH]c3)cc2)cc1
1301,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,"N4-(phenethyl)-N2-propylquinazoline-2,4-diamine",7.2,uM,=,0.8573324964312685,1,c1ccc(CCNc2ncnc3ccccc23)cc1
1302,28453,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.89-2.50,C#CCNC1CCc2c(OC(=O)N(C)CC)cccc21.Cl,Ethyl-methyl-carbamic acid 1-prop-2-ynylamino-indan-4-yl ester hydrochloride,2.15,uM,=,0.3324384599156053,1,c1ccc2c(c1)CCC2
1303,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(F)cc13)CCCC2,"7-fluoro-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.978,uM,=,-0.0096611452123985,0,c1ccc2nc3c(cc2c1)CCCC3
1304,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,"2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one",2.91,uM,=,0.4638929889859073,1,O=c1cc(-c2ccccc2)oc2ccccc12
1305,826907,10.1021/ml200313p,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 120 mins before substrate addition by Ellman's method,CN(CCCOc1ccc2c(=O)c3cccnc3oc2c1)Cc1cccc(OC(=O)NCCCCCCCN2CCOCC2)c1,(7-Morpholin-4-yl-heptyl)carbamic acid 3-({methyl-[3-(10-oxo-10H-9-oxa-1-azaanthracen-7-yloxy)propyl]amino]methyl}phenyl ester,0.139,uM,=,-0.8569851997459049,0,O=C(NCCCCCCCN1CCOCC1)Oc1cccc(CNCCCOc2ccc3c(=O)c4cccnc4oc3c2)c1
1306,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,C/C=C1/C(=O)C[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](N(C)C)CC[C@@]45C[C@@]35CC[C@]12C,Cyclobuxophylline K,58.2,uM,=,1.7649229846498886,1,C=C1C(=O)CC2C1CC[C@@]13C[C@@]14CCCC[C@@H]4CC[C@@H]23
1307,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1CNc2cc3onc(CCC4CCN(Cc5ccccc5)CC4)c3cc2C1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-7,8-dihydroisoxazolo[4,5-g]quinolin-6(5H)-one",0.0004799999999999,uM,=,-3.318758762624413,0,O=C1CNc2cc3onc(CCC4CCN(Cc5ccccc5)CC4)c3cc2C1
1308,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Cc1ccc2[nH]c(-c3ccc(OCCN(C)C)cc3)nc2c1,"N,N-dimethyl-2-(4-(5-methyl-1H-benzo[d]imidazol-2-yl)phenoxy)ethanamine",12.34,uM,=,1.0913151596972228,1,c1ccc(-c2nc3ccccc3[nH]2)cc1
1309,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccccc3C#N)cc12.[Br-],2-(2-cyanophenyl)-8-methoxyisoquinolinium bromide,1.75,uM,=,0.2430380486862944,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
1310,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C1Cc2cc(N3C(=O)c4ccccc4C3=O)ccc2CN1C(=O)c1ccccc1,"2-(2-benzoyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-6-yl)isoindoline-1,3-dione",0.0655999999999999,uM,=,-1.1830961606243398,0,O=C1Cc2cc(N3C(=O)c4ccccc4C3=O)ccc2CN1C(=O)c1ccccc1
1311,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCOC(=O)/C=C/c1ccc(OCCCCCCN(CC)CC)c(OC)c1,(E)-ethyl-3-(4-((6-(diethylamino)hexyl)oxy)-3-methoxyphenyl)acrylate,1.94,uM,=,0.287801729930226,1,c1ccccc1
1312,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccccc1C(C)NS(N)(=O)=O,N-(1-(2-Methoxyphenyl)ethyl)sulfamide,2.685e-05,uM,=,-4.571055709964425,0,c1ccccc1
1313,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(Cl)c1.[I-],(E)-2-(2-Chloro-4-(diethylamino)styryl)-1-methyl quinolinium iodide,0.6,uM,=,-0.2218487496163563,0,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
1314,347063,10.1016/j.bmcl.2006.01.067,,,,Inhibition of AChE activity,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.59,uM,=,-0.2291479883578558,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1315,2261427,10.1016/j.ejmech.2022.114606,,,,Binding affinity to AChE (unknown origin) assessed as inhibition constant using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1cccc2c1CCCC2NS(=O)(=O)NC(=O)OCc1ccccc1,benzyl N-[(5-methoxytetralin-1-yl)sulfamoyl]carbamate,0.0002089999999999,uM,=,-3.679853713888946,0,O=C(NS(=O)(=O)NC1CCCc2ccccc21)OCc1ccccc1
1316,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(CCc1ccccc1)N1c2ccccc2Sc2ccc(Cl)cc21,1-(2-Chloro-10H-phenothiazin-10-yl)-3-phenylpropan-1-one,7.9,uM,=,0.8976270912904415,1,O=C(CCc1ccccc1)N1c2ccccc2Sc2ccccc21
1317,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,Cc1cccc(C(=O)N2Cc3cc(NC(=O)c4ccccc4)ccc3CC2=O)c1,"N-(2-(3-methylbenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",2.621e-05,uM,=,-4.581532979053399,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
1318,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1ccccc1,"(2'S,3R,7a'R)-6-chloro-2'-((3E,5E)-3,5-dibenzylidene-4-oxopiperidine-1-carbonyl)-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",15.72,uM,=,1.196452541703389,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
1319,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1C=CN(Cc3ccccc3)C=C1C(C)=O)CC2,"2-((3-Acetyl-1-benzyl-1,4-dihydropyridin-4-yl)methyl)-6,7-dimethoxy-3,4-dihydronaphthalen-1(2H)-one",0.924,uM,=,-0.0343280287798932,0,O=C1c2ccccc2CCC1CC1C=CN(Cc2ccccc2)C=C1
1320,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCCOc1ccc2c(c1)C/C(=C\c1ccc(CN(C)Cc3ccccc3)cc1)C2=O,2-{4-[(Benzylmethylamino)methyl]benzylidene}-5-(4-diethylaminobutoxy)indan-1-one,3.95,uM,=,0.5965970956264602,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
1321,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,CCCCCCCC/C=C\CCCCCCCC(=O)OCCCc1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1,7-demethoxyegonol oleate,3.1,uM,=,0.4913616938342727,1,c1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1
1322,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3C)cc1C(N)=O)C2.[Br-],"(+/-)-4-[(5,6-Dimethoxy-1-oxo-indan-2-yl)methyl]-1-(o-tolylmethyl)pyridin-1-ium-3-carboxamide Bromide",0.678,uM,=,-0.1687703061329366,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
1323,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12,(2-(1-benzylpiperidin-4-yl)benzofuran-3-yl)(phenyl)methanone,41.27,uM,=,1.615634468877416,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
1324,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1ccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1,(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(4-methoxyphenyl)acrylamide,5.76,uM,=,0.7604224834232121,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
1325,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,COc1ccc(-c2ccc(OCC(=O)NCCCN3CCN(C)CC3)cc2)cc1,"2-((4'-Methoxy-[1,1'-biphenyl]-4-yl)oxy)-N-(3-(4-methylpiperazin-1-yl)propyl)acetamide",190.0,uM,=,2.278753600952829,1,O=C(COc1ccc(-c2ccccc2)cc1)NCCCN1CCNCC1
1326,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3cc(F)ccc13)CCCC2,"6-Fluoro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.087,uM,=,-1.0604807473813815,0,c1ccc2nc3c(cc2c1)CCCC3
1327,1797688,10.1021/acs.jnatprod.8b00378,,,,Inhibition of human AChE using acetylthiocholine as substrate,C[C@H]1COc2c1c(=O)oc(=O)c1c3c(ccc21)C(C)(C)CCC3,"4,9,9-Trimethyl-4,5,9,10,11,12-hexahydrofuro[3,2-c]naphtho[2,1-e]oxepine-1,3-dione",3.213,uM,=,0.5069107255515181,1,O=c1oc(=O)c2c3c(ccc2c2c1CCO2)CCCC3
1328,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccc(OC)c(C(C)NS(N)(=O)=O)c1,"N-(1-(2,5-Dimethoxyphenyl)ethyl)sulfamide",2.685e-05,uM,=,-4.571055709964425,0,c1ccccc1
1329,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,CCN(CCCOc1ccc2c(C)c(C)c(=O)oc2c1)Cc1cccc(F)c1,"7-(3-(ethyl(3-fluorobenzyl)amino)propoxy)-3,4-dimethyl-2H-chromen-2-one",1.2,uM,=,0.0791812460476248,1,O=c1ccc2ccc(OCCCNCc3ccccc3)cc2o1
1330,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc2c(cc1OC)C(=O)C(CCCCCCc1cccc(OC)[n+]1C)C2.O=S(=O)([O-])C(F)(F)F,"2-(6-(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)hexyl)-6-methoxy-1-methylpyridinium trifluoromethanesulfonate",0.1,uM,=,-1.0,0,O=C1c2ccccc2CC1CCCCCCc1cccc[nH+]1
1331,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCOC2N3C)cc1,"(4-Isopropyl-phenyl)-carbamic acid (S)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",3.86,uM,=,0.5865873046717549,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCOC1N2
1332,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1ccc2c(c1)C(=O)/C(=C/C1CCN(Cc3ccccc3)CC1)C2,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-6-methoxy-2,3-dihydro-1H-inden-1-one",0.342,uM,=,-0.4659738939438649,0,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
1333,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CC[C@@]2(C)c3cc(OC(=O)NC)ccc3C[C@@H]12,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl methylcarbamate",0.038,uM,=,-1.42021640338319,0,c1ccc2c(c1)C[C@H]1NCCC21
1334,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccc(C)cc2)C[C@@H](c2ccc(Cl)cc2)N(c2ccc(C)cc2)[C@@H]1c1ccc(Cl)cc1,"(2R,6S)-ethyl 2,6-bis(4-chlorophenyl)-1-p-tolyl-4-(p-tolylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",5390.0,uM,=,3.7315887651867374,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
1335,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1[N+](=O)[O-],3-{7-[methyl-(2-nitrobenzyl)amino]heptyloxy}xanthen-9-on,413.0,uM,=,2.615950051656401,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
1336,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(-c3ccccc3)cc2)CC1c1ccc([N+](=O)[O-])cc1,"1-(3-([1,1'-Biphenyl]-4-yl)-5-(4-nitrophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1556.0,uM,=,3.1920095926536702,1,c1ccc(-c2ccc(C3=NNC(c4ccccc4)C3)cc2)cc1
1337,1276071,10.1021/jm401047q,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman's method,COc1cc2[se]n(CCC3CCN(Cc4ccccc4)CC3)c(=O)c2cc1OC,"2-[2-(1-Benzylpiperidin-4-yl)ethyl]-5,6-dimethoxybenzo[d][1,2]-selenazol-3(2H)-one",0.097,uM,=,-1.0132282657337552,0,O=c1c2ccccc2[se]n1CCC1CCN(Cc2ccccc2)CC1
1338,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCCCN3CCOCC3)nn2)cc1,N-(3-morpholinopropyl)-6-phenylpyridazin-3-amine,410.0,uM,=,2.6127838567197355,1,c1ccc(-c2ccc(NCCCN3CCOCC3)nn2)cc1
1339,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1cc(OC)cc(OC)c1)c1ccc(=O)[nH]c1C2,"(1R,9R)-1-{[1-(3,5-Dimethoxy-phenyl)-methylidene]-amino}-13-eth-(E)-ylidene-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.029,uM,=,-1.537602002101044,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
1340,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,N#CC1=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C([N+](=O)[O-])C12c1ccccc1-c1nc3ccc([N+](=O)[O-])cc3nc12,"2'-amino-1'-benzyl-6'-(benzylamino)-5',8-dinitro-1'H-spiro[indeno[1,2-b]quinoxaline-11,4'-pyridine]-3'-carbonitrile",4.4,uM,=,0.6434526764861874,1,C1=CC2(C=C(NCc3ccccc3)N1Cc1ccccc1)c1ccccc1-c1nc3ccccc3nc12
1341,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl 4-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)butanoate",0.01654,uM,=,-1.781464494783472,0,O=C(CCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
1342,1993976,10.1016/j.bmc.2020.115324,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 60 mins followed by substrate addition and measured for 5 mins by Ellman's method,CN(C)C(=O)Oc1ccc(C(O)CNC2CCCCC2)cc1.Cl,4-(2-(cyclohexylamino)-1-hydroxyethyl)phenyl dimethylcarbamate Hydrochloride,266.0,uM,=,2.424881636631067,1,c1ccc(CCNC2CCCCC2)cc1
1343,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccccc4C)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(2-Methylbenzyl)-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]piperidine-4-carboxamide",1.34,uM,=,0.1271047983648076,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
1344,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,Nc1c2c(nc3c1C(c1ccc(O)cc1)c1ccc4ccccc4c1O3)CCCC2,"rac-4-(8-Amino-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-7-yl)phenol",7.83,uM,=,0.8937617620579434,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
1345,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,"6-Hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox)",186.4,uM,=,2.270445908017962,1,c1ccc2c(c1)CCCO2
1346,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3nc4ccccc4o3)cc1C(N)=O)C2.[Br-],"1-(1,3-Benzoxazol-2-ylmethyl)-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]pyridin-1-ium-3-carboxamide bromide",9.267,uM,=,0.966939163021113,1,O=C1c2ccccc2CC1Cc1cc[n+](Cc2nc3ccccc3o2)cc1
1347,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCNC1=CC(=O)C(NCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis{4-[ethyl(2-methoxybenzyl)amino]butylamino}-[1,4]-benzoquinone",0.0136,uM,=,-1.8664610916297824,0,O=C1C=C(NCCCCNCc2ccccc2)C(=O)C=C1NCCCCNCc1ccccc1
1348,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(Cc1ccccc1)N1c2ccccc2[Se]c2ccccc21,1-(10H-phenoselenazin-10-yl)-2-phenylethanone,6.4,uM,=,0.8061799739838872,1,O=C(Cc1ccccc1)N1c2ccccc2[Se]c2ccccc21
1349,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCCC(C)n1cc(C(=O)C(F)(F)F)cn1,"2,2,2-trifluoro-1-(1-(pentan-2-yl)-1H-pyrazol-4-yl)ethanone",0.0083699999999999,uM,=,-2.07727454200674,0,c1cn[nH]c1
1350,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4ccc(-c5nnn[nH]5)cc4)[nH]3)ccc21,"(S)-3-[1-(4-Fluorophenyl)-5-(1H-tetrazol-5-yl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine",251.67,uM,=,2.4008314491162253,1,c1ccc(C2OCc3cc(-c4nnc(-c5ccc(-c6nnn[nH]6)cc5)[nH]4)ccc32)cc1
1351,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3Cl)CC1)C2,"2-((1-(2-chlorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.097,uM,=,-1.0132282657337552,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1352,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C/C(=O)C2CCc3ccccc3C2=O)cc1,"2-[3-(4-Diethoxymethyl-phenyl)-acryloyl]-3,4-dihydro-2Hnaphthalen-1-one",76.93,uM,=,1.886095732437748,1,O=C(/C=C/c1ccccc1)C1CCc2ccccc2C1=O
1353,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1c(O)cc(C2Oc3cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c3C(=O)[C@@H]2O)cc1O,"(3R)-2-(3,5-dihydroxy-4-methoxyphenyl)-6-((E)-3,7-dimethylocta-2,6-dienyl)-3,5,7-trihydroxychroman-4-one",15.6,uM,=,1.1931245983544616,1,O=C1CC(c2ccccc2)Oc2ccccc21
1354,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCN(C)CCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@H](C1)C2.Cl.Cl.Cl,Huprine-Tacrine Heterodimer,0.00032,uM,=,-3.494850021680094,0,C1=C[C@@H]2Cc3nc4ccccc4c(NCCCNCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@H](C1)C2
1355,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCCN(Cc4cccc(F)c4)C3)cc2oc1=O,"(+/-)-7-((1-(3-fluorobenzyl)piperidin-3-yl)methoxy)-3,4-dimethyl-2H-chromen-2-one",1.2,uM,=,0.0791812460476248,1,O=c1ccc2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2o1
1356,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@@]1(C)CO[C@H](C1)O2,"(+)-(5S)-5-methyl-4,5-dihydro-2,5-methano-1,3-benzodioxepin-7-yl N-(o-Tolyl)-carbamate",0.038,uM,=,-1.42021640338319,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CO[C@H](C1)O2
1357,1497677,10.1021/acs.jnatprod.5b00057,,,,Inhibition of human erythrocytes acetylcholinesterase after 30 mins using S-acetylthiocholine iodide substrate by spectrophotometry based Ellman method,CCC(C)C(=O)[C@]12C(=O)[C@]3(CC=C(C)C)C[C@H](CC=C(C)C)[C@@]1(C)CC[C@@H](C(C)(C)O)OC2=C(CC=C(C)C)C3=O,"(1R,6S,9R,10S,13S)-6-(2-hydroxypropan-2-yl)-9-methyl-1,3,13-tris(3-methylbut-2-en-1-yl)-10-(2-methylbutanoyl)-5-oxatricyclo[7.2.2.0^{4,10}]tridec-3-ene-2,11-dione",37.2,uM,=,1.5705429398818975,1,O=C1C=C2OCCCC3CCC1C(=O)C23
1358,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(NCCc1c[nH]c2ccccc12)c1ccc[n+](Cc2ccccc2F)c1.[Br-],3-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-(2-fluorobenzyl)pyridin-1-ium bromide,28.6,uM,=,1.4563660331290431,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc[n+](Cc2ccccc2)c1
1359,1507558,10.1016/j.bmcl.2015.05.002,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.3,uM,=,-0.5228787452803376,0,c1ccc2nc3c(cc2c1)CCCC3
1360,28628,10.1021/jm970210v,,,,Inhibition of human acetylcholinesterase from erythrocytes (RBC),CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C=O)C12,"Phenyl-carbamic acid (S)-8-formyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.7804,uM,=,-0.1076827392775195,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
1361,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CN1CCN(Cc2ccc(CNCCN3CCNC3=C(C#N)C#N)o2)CC1,2-[1-(2-{[5-(4-Methyl-piperazin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile,4.5,uM,=,0.6532125137753437,1,C=C1NCCN1CCNCc1ccc(CN2CCNCC2)o1
1362,2055647,10.1016/j.ejmech.2020.112766,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 5 mins by Ellman's method,CCCCN[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCC1CCN(Cc2ccccc2)CC1,(S)-N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-2-butylamino-3-(1H-indol-3-yl)-propionamide,25.4,uM,=,1.404833716619938,1,O=C(CCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
1363,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)C(=O)C(CC1CCN(CCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)CC1)C2.Cl.Cl.Cl,"6-Chloro-9-[(3-{4-[(5,6-Dimethoxy-1-oxoindan-2-yl)methyl]piperidin-1-yl}propyl)amino]-1,2,3,4-tetrahydroacridine dihydrochloride",0.00027,uM,=,-3.5686362358410126,0,O=C1c2ccccc2CC1CC1CCN(CCCNc2c3c(nc4ccccc24)CCCC3)CC1
1364,579492,10.1016/j.bmcl.2009.05.087,,,,Inhibition of human AChE-induced amyloid beta (1-40) aggregation by thioflavin T fluorescence-based assay,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@@H](C)c2ccccc2OC)=CC1=O)[C@H](C)c1ccccc1OC,"2-(6-(ethyl((R)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)-5-(6-(ethyl((S)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",11.0,uM,=,1.0413926851582251,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
1365,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,CCCCN(CCCC)CCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,"N,N-dibutyl-6-(4-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)phenoxy)hexan-1-amine",3.85,uM,=,0.5854607295085007,1,c1ccc(CC2NCCc3ccccc32)cc1
1366,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,"(+/-)-1-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)pyridin-2-yl)urea",0.0114,uM,=,-1.9430951486635275,0,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O
1367,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(R)-2-amino-N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.0069,uM,=,-2.161150909262745,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
1368,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,CN(C)c1ccc(C2NC(=S)Nc3nc4c(c(N)c32)CCCC4)cc1,"5-amino-4-(4-(dimethylamino)phenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",24.1,uM,=,1.3820170425748683,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
1369,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(CN(C)Cc4ccc(C)cc4)cc3)c(=O)oc2cc1OC,"6,7-dimethoxy-3-(4-{[(4-methylbenzyl)methylamino]methyl}phenyl)chromen-2-one",0.31,uM,=,-0.5086383061657274,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
1370,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,CN(C)c1ccc(/C=N/c2ccc3oc(=O)ccc3c2)cc1,6-[(4-(Dimethylamino)benzylidene)amino]-2H-chromen-2-one,0.041,uM,=,-1.3872161432802643,0,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1
1371,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCOC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-prop-2-ynyloxymethyl-3H-imidazol-1-ium chloride,21.8,uM,=,1.3384564936046048,1,c1c[nH+]c[nH]1
1372,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CCN(CC)CCOc1ccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)cc1,(2-(4-(7-(benzyl(methyl)amino)heptyloxy)phenyl)benzofuran-3-yl)(4-(2-(diethylamino)ethoxy)phenyl)methanone,78.0,uM,=,1.8920946026904804,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
1373,1641224,,,,,AChE/BuChE Inhibition Assay: The cholinesterase assays were performed using colorimetric method reported by Ellman. The appearance of product was monitored at 412 nm for 5 min using a spectrophotometer. The reaction rates were compared and the percent inhibition due to the presence of test compounds was calculated. Inhibition curve was obtained for each compound. The linear regression parameters were determined and the IC50 values extrapolated.,Fc1ccc(C[n+]2ccc(CCNc3nc4ccc(F)cc4s3)cc2)cc1,"US9255091, 4d",0.269,uM,=,-0.570247719997592,0,c1ccc(C[n+]2ccc(CCNc3nc4ccccc4s3)cc2)cc1
1374,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,COc1ccc2[nH]c3ccncc3c2c1,"8-methoxy-5H-pyrido[4,3-b]indole",49.6,uM,=,1.6954816764901974,1,c1ccc2c(c1)[nH]c1ccncc12
1375,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1cc(C#N)c(NCCCCC2CCN(Cc3ccccc3)CC2)nc1Cl,"2-((4-(1-Benzylpiperidin-4-yl)butyl)amino)-6-chloropyridine-3,5-dicarbonitrile",0.013,uM,=,-1.8860566476931635,0,c1ccc(CN2CCC(CCCCNc3ccccn3)CC2)cc1
1376,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccc(Br)cc1)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(4-Bromophenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",34.56,uM,=,1.5385737338068557,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
1377,28323,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.54-0.56,C#CCNC1CCc2ccc(OC(=O)N(C)c3ccccc3)cc21.Cl,Methyl-phenyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,0.55,uM,=,-0.2596373105057561,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)CCC2
1378,2223705,10.1039/D1MD00046B,,,,Inhibition of AChE in human serum by Ellman's method,OCCCCCCCCc1ccc(CN2CCCCC2)c(O)c1,5-(8-Hydroxyoctyl)-2-[(piperidin-1-yl)methyl]phenol,30.0,uM,=,1.4771212547196624,1,c1ccc(CN2CCCCC2)cc1
1379,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(/C=C/c1ccc(O)cc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide,1.01,uM,=,0.0043213737826425,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1380,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)chroman-2-carboxamide",0.2838,uM,=,-0.5469876088785448,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
1381,1278501,10.1016/j.bmc.2013.09.050,,,,Inhibition of human erythrocytic AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.285,uM,=,-0.5451551399914898,0,c1ccc2nc3c(cc2c1)CCCC3
1382,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(Cl)c3)CC2)nc1-c1ccccc1,Ethyl 2-(4-((4-amino-3-chlorophenyl)sulfonyl)piperazin-1-yl)-4-methyl-6-phenylpyrimidine-5-carboxylate,0.07912,uM,=,-1.101713721410877,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
1383,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)cinnamamide,0.411,uM,=,-0.3861581781239308,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1384,1278097,10.1016/j.bmcl.2013.10.034,,,,Inhibition of human AChE using acetylthiocholine chloride as substrate preincubated for 15 mins by Ellman's method,COc1cc2[se]n(CCCCCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c2cc1OC,"5,6-dimethoxy-2-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)benzo[d][1,2]selenazol-3(2H)-one",0.01513,uM,=,-1.820161071976813,0,O=c1c2ccccc2[se]n1CCCCCCNc1c2c(nc3ccccc13)CCCC2
1385,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1Cc2cc3ccc(=O)oc3cc2O1,Nodakenin,68.0,uM,=,1.8325089127062364,1,O=c1ccc2cc3c(cc2o1)O[C@@H](CO[C@H]1CCCCO1)C3
1386,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)/C(=N\NC(=O)CCNC(=O)C(C)c1ccc(CC(C)C)cc1)C(CC1CCN(Cc3ccccc3)CC1)C2,"N-[3-[(2Z)-2-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]hydrazino]-3-oxo-propyl]-2-(4-isobutylphenyl)propanamide",4.85,uM,=,0.6857417386022636,1,O=C(Cc1ccccc1)NCCC(=O)N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1387,744973,10.1016/j.bmcl.2010.12.093,,,,Inhibition of human serum AChE,O=C1C=C(NCCCNCc2cc3ccccc3o2)C(=O)C=C1NCCCNCc1cc2ccccc2o1,"2,5-bis(3-(benzofuran-2-ylmethylamino)propylamino)cyclohexa-2,5-diene-1,4-dione",21.8,uM,=,1.3384564936046048,1,O=C1C=C(NCCCNCc2cc3ccccc3o2)C(=O)C=C1NCCCNCc1cc2ccccc2o1
1388,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)CCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccc1O,,0.00294,uM,=,-2.5316526695878427,0,O=C(CCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccccc1
1389,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(CN2CCC(CCN3C(=O)c4ccc([N+](=O)[O-])cc4C3=O)CC2)cc1,"2-{2-[1-(4-Methoxy-benzyl)-piperidin-4-yl]-ethyl}-5-nitro-isoindole-1,3-dione",0.44,uM,=,-0.3565473235138126,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
1390,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCC[n+]2cccc3ccccc32)cc1,1-(8-(pyridinium-1-yl)octyl)quinoliniumdibromide,0.27,uM,=,-0.5686362358410126,0,c1cc[n+](CCCCCCCC[n+]2cccc3ccccc32)cc1
1391,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,COc1ccc(N2C(=O)C3CN(C)C4(C(=O)c5ccccc5C4=O)C3C2=O)cc1,"5'-(4-Methoxyphenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",0.78,uM,=,-0.1079053973095195,0,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
1392,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(Br)cc13)CCCCC2,"2-bromo-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",13.8,uM,=,1.1398790864012365,1,c1ccc2nc3c(cc2c1)CCCCC3
1393,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3)cc1C#N)C2.[Br-],"(+/-)-1-Benzyl-4-[(5,6-dimethoxy-1-oxo-indan-2-yl)methyl]pyridin-1-ium-3-carbonitrile Bromide",0.00292,uM,=,-2.5346171485515816,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
1394,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(CN2CCC(Nc3nc(-c4ccc(OC)cc4)c(-c4ccc(OC)cc4)s3)CC2)cc1,"4-Methoxybenzyl-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]-piperidin-4-ylamine",0.77,uM,=,-0.1135092748275181,0,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
1395,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.123,uM,=,-0.910094888560602,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
1396,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC(C)=CCOc1c2ccoc2cc2oc(=O)ccc12,Isoimperatorin,69.00000000000001,uM,=,1.838849090737256,1,O=c1ccc2cc3ccoc3cc2o1
1397,2288317,10.1016/j.ejmech.2022.114806,,,,Inhibition of human AChE using ATC and BTC iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by DTNB reagent based assay,Cc1ccc(-c2noc(-c3cccc(OCC4CCN(Cc5ccccc5Cl)CC4)c3)n2)cn1,"5-(3-((1-(2-chlorobenzyl)piperidin-4-yl)methoxy)phenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole",0.57,uM,=,-0.2441251443275086,0,c1ccc(CN2CCC(COc3cccc(-c4nc(-c5cccnc5)no4)c3)CC2)cc1
1398,1276071,10.1021/jm401047q,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman's method,COc1cc2c(cc1OC)[Se](=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O,"2-[2-(1-Benzylpiperidin-4-yl)ethyl]-5,6-dimethoxybenzo[d][1,2]-selenazol-3(2H)-one 1-Oxide",0.163,uM,=,-0.7878123955960422,0,O=C1c2ccccc2[Se](=O)N1CCC1CCN(Cc2ccccc2)CC1
1399,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1ccc(C(=O)NCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc1.Cl.[Br-],"N,N,N-triethyl-2-(4-(((6-(2-(1,2,3,4-tetrahydroacridin-9-yl)-hydrazino)-6-oxohexyl)amino)carbonyl)phenoxy)ethanammonium bromide hydrochloride",0.00761,uM,=,-2.1186153432294272,0,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
1400,1539619,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 8,CO[P@]1(=O)OC[C@H]2COC(=O)C2=C(C)O1,cyclophostin,0.04,uM,=,-1.3979400086720375,0,O=C1OC[C@@H]2CO[PH](=O)OC=C12
1401,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,O=C(Nc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)s1)C1CCN(Cc2cc(F)cc(F)c2)CC1,"1-(3,5-Difluorobenzyl)-N-[4,5-bis(4-chlorophenyl)thiazol-2-yl]piperidine-4-carboxamide",0.64,uM,=,-0.1938200260161128,0,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
1402,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(CCCOc2ccc3c(=O)c4ccccc4oc3c2)C(C)C)c1,Butyl-carbamic acid 3-({isopropyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.1,uM,=,-1.0,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
1403,1635358,10.1016/j.ejmech.2016.09.078,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by Ellman's method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3cc(OCCNC(=O)/C=C/c4cc(F)cc(F)c4)ccc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-6-yloxy)ethyl)-3-(3,5-difluorophenyl)acrylamide",0.00716,uM,=,-2.1450869776921446,0,O=C(/C=C/c1ccccc1)NCCOc1ccc2oc(=O)c(-c3ccc(CNCc4ccccc4)cc3)cc2c1
1404,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cc1ccc(-[n+]2ccc3c4ccccc4n(C)c3c2)cc1,"9-methyl-2-(p-tolyl)pyrido[3,4-b]indol-2-ium",0.3,uM,=,-0.5228787452803376,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
1405,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(C2=NN(C(C)=O)C(c3ccc(-c4ccccc4)cc3)C2)cc(OC)c1OC,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1947.0,uM,=,3.289365951520032,1,c1ccc(C2=NNC(c3ccc(-c4ccccc4)cc3)C2)cc1
1406,1454788,10.1016/j.ejmech.2014.07.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric analysis,Cl.O=C(NCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,"N-{4-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]butyl}-5-(4-chlorophenyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-9-carboxamide dihydrochloride",0.0141999999999999,uM,=,-1.8477116556169435,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)NCCC3
1407,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],"9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium chloride",0.04,uM,=,-1.3979400086720375,0,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
1408,28450,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.7-2.5,C#CCN(C)[C@H](C)Cc1cccc(OC(=O)N(C)CCCCCC)c1,(R)-Hexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,2.0,uM,=,0.3010299956639812,1,c1ccccc1
1409,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)cc1,(E)-4-(3-(4-benzylpiperazin-1-yl)-3-oxoprop-1-en-1-yl)phenyl ethyl(methyl)carbamate,14.8,uM,=,1.1702617153949575,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
1410,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CN1CCN(c2nccc(NCc3ccccc3)n2)CC1,N-benzyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine,24.9,uM,=,1.3961993470957363,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
1411,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CC(CCC)OC[n+]1ccn(C)c1/C=N/O.[Cl-],1-(1-Ethynyl-butoxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,8.27,uM,=,0.9175055095525466,1,c1c[nH+]c[nH]1
1412,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Oc1cc(O)cc(Oc2cc(O)c(O)c3c2Oc2c(O)cc(Oc4c(O)cc(Oc5c(O)cc(O)c6c5Oc5c(O)cc(O)cc5O6)cc4O)cc2O3)c1,Dieckol,5.69,uM,=,0.7551122663950712,1,c1ccc(Oc2cccc3c2Oc2ccc(Oc4ccc(Oc5cccc6c5Oc5ccccc5O6)cc4)cc2O3)cc1
1413,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(CN(C)Cc4ccccc4C)cc3)c(=O)oc2cc1OC,"6,7-dimethoxy-3-(4-{[(2-methylbenzyl)methylamino]methyl}phenyl)chromen-2-one",0.366,uM,=,-0.4365189146055893,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
1414,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)C2N3C)cc1,"(4-Isopropyl-phenyl)-carbamic acid (S)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.76,uM,=,-0.1191864077192086,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
1415,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,7-bis(4-tert.butylpyridinium)-hept-1,7-diyl dibromide",0.016,uM,=,-1.7958800173440752,0,c1cc[n+](CCCCCCC[n+]2ccccc2)cc1
1416,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(OCCN[N+]3(C)CCN(c4ccc(/C=C5\Cc6cc(OC)c(OC)cc6C5=O)cc4)CC3)cc1)C2.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(-((2,3-dihydro-5,6-dimethoxy-1H-inden-1-one-2-(4-ethoxybenzylidine-2-yl))-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one bromide",24.0,uM,=,1.380211241711606,1,O=C1/C(=C/c2ccc(OCCN[NH+]3CCN(c4ccc(/C=C5\Cc6ccccc6C5=O)cc4)CC3)cc2)Cc2ccccc21
1417,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-Phenyl-5-(4-(pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazole",0.341,uM,=,-0.4672456210075022,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
1418,28452,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.85-3.26,C#CCNC1CCc2ccc(OC(=O)NCCC)cc21.Cl,Propyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,2.38,uM,=,0.3765769570565119,1,c1ccc2c(c1)CCC2
1419,2223705,10.1039/D1MD00046B,,,,Inhibition of AChE in human serum by Ellman's method,CCN(CCCCCCCCc1cccc(OC)c1)Cc1ccccc1OC,N-ethyl-N-(2-methoxybenzyl)-8-(3-methoxyphenyl)octan-1-amine,5.65,uM,=,0.7520484478194386,1,c1ccc(CCCCCCCCNCc2ccccc2)cc1
1420,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N@@+](C)([O-])[C@@H]1N2C.Cl,"5-(2-Ethyl-phenylcarbamoyloxy)-1-hydroxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",0.125,uM,=,-0.9030899869919436,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+][C@@H]1N2
1421,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCc1cc(=NCCC2CCN(Cc3ccccc3)CC2)[nH]nc1-c1ccccc1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-5-ethyl-6-phenylpyridazin-3-amine,0.027,uM,=,-1.5686362358410126,0,c1ccc(CN2CCC(CCN=c3ccc(-c4ccccc4)n[nH]3)CC2)cc1
1422,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccc(Cl)cc2)C[C@@H](c2ccc(OC)cc2)N(c2ccc(Cl)cc2)[C@@H]1c1ccc(OC)cc1,"(2R,6S)-ethyl 1-(4-chlorophenyl)-4-(4-chlorophenylamino)-2,6-bis(4-methoxyphenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate",380.0,uM,=,2.57978359661681,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
1423,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,"2,7-bis(6-(ethyl(2-methoxybenzyl)amino)hexyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone",0.00037,uM,=,-3.431798275933005,0,O=C1c2ccc3c4c(ccc(c24)C(=O)N1CCCCCCNCc1ccccc1)C(=O)N(CCCCCCNCc1ccccc1)C3=O
1424,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCCC2)cc1O,rac-2-(3-Hydroxy-4-methoxyphenyl)-2-(pyrrolidin-1-yl)acetonitrile,394.0,uM,=,2.595496221825574,1,c1ccc(CN2CCCC2)cc1
1425,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,O=C(Nc1ccccc1)OC1CCN(C2Cc3ccccc3C2)CC1,"1-(2,3-dihydro-1H-inden-2-yl)piperidin-4-yl phenylcarbamate",19.2,uM,=,1.2833012287035497,1,O=C(Nc1ccccc1)OC1CCN(C2Cc3ccccc3C2)CC1
1426,2019674,10.1039/d0md00009d,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by Ellman's method,Cc1cc(S(=O)(=O)Nc2cnccn2)c(C(C)C)cc1O,4-hydroxy-2-isopropyl-5-methyl-N-pyrazin-2-yl-benzenesulfonamide,7.34,uM,=,0.8656960599160706,1,O=S(=O)(Nc1cnccn1)c1ccccc1
1427,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,COP(=O)(OC)OC=C(Cl)Cl,"Phosphoric acid 2,2-dichloro-vinyl ester dimethyl ester",0.627,uM,=,-0.2027324591692835,0,
1428,29401,10.1016/0960-894X(96)00337-X,,,,In vitro inhibitory activity against Acetylcholinesterase (AChE).,C/C=C1\C2C=C(C(F)(F)F)CC1(N)c1ccc(O)nc1C2,"1-Amino-13-eth-(E)-ylidene-11-trifluoromethyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.4,uM,=,-0.3979400086720376,0,C=C1C2C=CCC1c1cccnc1C2
1429,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2cccc([N+](=O)[O-])c2)C(=O)/C(=C/c2cccc([N+](=O)[O-])c2)C1,"(3E,5E)-1-Acryloyl-3,5-bis(3-nitrophenylmethylidene)piperidin-4-one",9.76,uM,=,0.9894498176666918,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
1430,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2F)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1-(2-fluorobenzyl)piperidin-4-yl)ethoxy)thiazole-5-carboxamide,7.8,uM,=,0.8920946026904804,1,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
1431,1853673,10.1016/j.ejmech.2019.06.041,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition measured for 15 mins by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",3.03,uM,=,0.481442628502305,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1432,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCN(C)CC4)cc3)C2)cc1OC,"1-(5-(4-(4-Methylpiperazin-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",6.5,uM,=,0.8129133566428556,1,c1ccc(C2=NNC(c3ccc(N4CCNCC4)cc3)C2)cc1
1433,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1.Cl,Methyl-carbamic acid 3-({methyl-[7-(9-oxo-9H-xanthen-3-yloxy)-heptyl]-amino}-methyl)-phenyl ester hydrochloride,0.00032,uM,=,-3.494850021680094,0,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
1434,1735876,10.1021/acs.jnatprod.7b00892,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate pretreated for 15 mins followed by substrate addition and measured by DTNB reagent based assay,Oc1ccc(-c2oc3cc(O)c4c5c3c2-c2cc(O)cc(O)c2[C@H](c2ccc(O)cc2)[C@@H]5[C@H](c2ccc(O)cc2)[C@@H]4c2cc(O)cc(O)c2)cc1,Vateriferol,8.4,uM,=,0.9242792860618816,1,c1ccc(-c2oc3ccc4c5c3c2-c2ccccc2[C@H](c2ccccc2)[C@@H]5[C@H](c2ccccc2)[C@@H]4c2ccccc2)cc1
1435,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1c(/C=N/Nc2ccc(C(F)(F)F)cc2)coc2cc3oc(-c4cccc(F)c4)cc3cc12,"2-(3-fluorophenyl)-6-((2-(4-(trifluoromethyl)phenyl)hydrazineylidene)methyl)-5H-furo[3,2-g]chromen-5-one",7.6,uM,=,0.8808135922807914,1,O=c1c(/C=N/Nc2ccccc2)coc2cc3oc(-c4ccccc4)cc3cc12
1436,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCNCCCNCCCNc1c3c(nc4ccccc14)CCCC3)c1cc(N)ccc21.[Cl-],"3,8-diamino-6-phenyl-5-(3-(3-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propylamino)propylamino)propyl)phenanthridinium",0.00149,uM,=,-2.826813731587726,0,c1ccc(-c2c3ccccc3c3ccccc3[n+]2CCCNCCCNCCCNc2c3c(nc4ccccc24)CCCC3)cc1
1437,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[12-(benzylmethylamino)dodecyloxy]xanthen-9-one,908.0,uM,=,2.958085848521085,1,O=c1c2ccccc2oc2cc(OCCCCCCCCCCCCNCc3ccccc3)ccc12
1438,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,Brc1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1,"3-(4-Bromophenyl)-6-(furan-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1
1439,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Cl.Clc1ccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)cc1,"9-(2-(4-((1-(4-Chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",7.03,uM,=,0.846955325019824,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
1440,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,N-(4-(phenethylamino)quinazolin-2-yl)acetamide,7.0,uM,=,0.8450980400142568,1,c1ccc(CCNc2ncnc3ccccc23)cc1
1441,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCCCNC(=O)Oc1ccc2c(c1)C1(C)CCN(CC)C2C1,"Hexyl-carbamic acid 9-ethyl-1-methyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.133,uM,=,-0.8761483590329142,0,c1ccc2c(c1)C1CCNC2C1
1442,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccccc1CN(C)CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(C)Cc1ccccc1OC,6-[(2-Methoxy-benzyl)-methyl-amino]-hexanoic acid [8-({6-[(2-methoxy-benzyl)-methyl-amino]-hexanoyl}-methyl-amino)-octyl]-methyl-amide,0.104,uM,=,-0.9829666607012196,0,O=C(CCCCCNCc1ccccc1)NCCCCCCCCNC(=O)CCCCCNCc1ccccc1
1443,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.016,uM,=,-1.7958800173440752,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1444,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=c1c2ccccc2[se]n1-c1ccccc1,2-Phenyl-benzo[d]isoselenazol-3-one (Ebselen),6.2,uM,=,0.7923916894982539,1,O=c1c2ccccc2[se]n1-c1ccccc1
1445,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(NCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,"(S)-N-(2-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)-2-amino-3-(1H-indole-3-yl)propylamide dihydrochloride",5.7,uM,=,0.7558748556724915,1,O=C(CCc1c[nH]c2ccccc12)NCCNc1c2c(nc3ccccc13)CCCC2
1446,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C/C(=C\CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3=O)CO,Lucidadiol,31.03,uM,=,1.4917817755841658,1,O=C1C[C@H]2CCCCC2C2=C1C1CCCC1CC2
1447,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1N2C,"ethyl-carbamic acid (3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.082,uM,=,-1.0861861476162833,0,c1ccc2c(c1)N[C@H]1OCCC21
1448,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCOC(=O)c1cc2c(N)c3c(nc2nc1C)CCC3,"Ethyl 5-Amino-2-methyl-7,8-dihydro-6H-cyclopenta[b][1,8]-naphthyridine-3-carboxylate",2.1,uM,=,0.3222192947339193,1,c1cnc2nc3c(cc2c1)CCC3
1449,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CNc2ccc(N3CCOCC3)c(F)c2)c1,(E)-3-((3-fluoro-4-morpholinophenylamino)methyl)-2-hydroxy-5-methylbenzaldehyde oxime,3269.0,uM,=,3.514414920580369,1,c1ccc(CNc2ccc(N3CCOCC3)cc2)cc1
1450,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCC4)cc2c1,"N1-(Benzofuran-2-ylmethyl)-N7-(2,3-dihydro-1H-cyclopenta[b]-quinolin-9-yl)heptane-1,7-diamine",0.0108,uM,=,-1.9665762445130504,0,c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCC4)cc2c1
1451,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccc(Cl)cc2)CC1)c1ccc2c(c1)CCN2,"3-[1-(4-Chloro-benzyl)-piperidin-4-yl]-1-(2,3-dihydro-1H-indol-5-yl)-propan-1-one",6.36,uM,=,0.8034571156484139,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
1452,2198746,10.1039/d2md00087c,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 sec for 3 mins by DTNB-based UV analysis,CCCCCCCNC(=O)Oc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCN2CCCCC2)cc1,4-((5-(Diethylcarbamoyl)-1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazol-2-yl)methyl)phenyl heptylcarbamate,10.12,uM,=,1.0051805125037805,1,c1ccc(Cc2nc3ccccc3n2CCN2CCCCC2)cc1
1453,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(Cl)cc(Cl)c4c(N)c3C(C1)C2,"5,7-dichloro-15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00139,uM,=,-2.856985199745905,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
1454,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1,"N1-(quinolin-4-yl)-N9-(1,2,3,4-tetrahydroacridin-9-yl)nonane-1,9-diamine",0.038,uM,=,-1.42021640338319,0,c1ccc2c(NCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1
1455,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3c1C(c1ccccc1)NC(=S)N3)CCCC2,"5-amino-4-phenyl-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",10.8,uM,=,1.0334237554869496,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
1456,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"N-{7-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]heptyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.111,uM,=,-0.9546770212133424,0,O=C(CC1CCc2ccccc2O1)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
1457,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1ccc(C[n+]2ccc(COc3ccc4c(C)cc(=O)oc4c3)cc2)cc1.[Br-],4-(((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)-1-(4-methylbenzyl)pyridin-1-ium bromide,0.25,uM,=,-0.6020599913279624,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
1458,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-2-amino-N-(2-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.16,uM,=,-0.7958800173440752,0,O=C(CCc1c[nH]c2ccccc12)NCCNc1c2c(nc3ccccc13)CCCC2
1459,1331163,10.1039/C1MD00221J,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured after 10 mins by Ellman's method,COc1ccc(C(=O)Nc2cc3ccccc3oc2=O)cc1,4-methoxy-N-(2-oxo-2H-chromen-3-yl)benzamide,69.47,uM,=,1.841797298874356,1,O=C(Nc1cc2ccccc2oc1=O)c1ccccc1
1460,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccncc2)=CC1=O)Cc1ccncc1,"2,5-bis{6-[ethyl(pyridin-4-ylmethyl)amino]hexylamino}-[1,4]-benzoquinone",0.192,uM,=,-0.7166987712964504,0,O=C1C=C(NCCCCCCNCc2ccncc2)C(=O)C=C1NCCCCCCNCc1ccncc1
1461,1335299,10.1021/jm400970m,,,,Inhibition of AChE (unknown origin),c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-(2,2'-disulfanediylbis(ethane-2,1-diyl))bis(1,2,3,4-tetrahydroacridin-9-amine)",0.00504,uM,=,-2.2975694635544746,0,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
1462,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,COC(=O)C1=C(C)O[P@](=O)(OC)CC[C@H]1COCc1ccccc1,"(2S,6R)-6-Benzyloxymethyl-2-methoxy-4-methyl-2-oxo-6,7-dihydro-2lambda*5*-[1,3,2]dioxaphosphepine-5-carboxylic acid methyl ester",6.0,uM,=,0.7781512503836436,1,O=[PH]1CC[C@@H](COCc2ccccc2)C=CO1
1463,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCCCOc1ccc(/C=C/C(=O)Nc2ccccc2)cc1OC,(E)-3-(4-((5-(diethylamino)pentyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,18.98,uM,=,1.278296208091274,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
1464,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,CCN(CCCCCCOc1ccc2c(C)c(C)c(=O)oc2c1)Cc1ccccc1.Cl,"7-(6-(N-Benzyl-N-ethylamino)hexyloxy)-3,4-dimethyl-2H-chromen-2-one hydrochloride",0.44,uM,=,-0.3565473235138126,0,O=c1ccc2ccc(OCCCCCCNCc3ccccc3)cc2o1
1465,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccccc1NCC1CCN(Cc2ccccc2)CC1,N-((1-benzylpiperidin-4-yl)methyl)-2-methoxyaniline,0.157,uM,=,-0.8041003475907662,0,c1ccc(CN2CCC(CNc3ccccc3)CC2)cc1
1466,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1ccc(N2CCN(C(=O)/C=C/c3ccc(O)c(OC)c3)CC2)cc1,(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-(4-methoxyphenyl)piperazin-1-yl)prop-2-en-1-one,12.05,uM,=,1.080987046910887,1,O=C(/C=C/c1ccccc1)N1CCN(c2ccccc2)CC1
1467,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3c1C(c1cccc(Br)c1)NC(=S)N3)CCCC2,"5-amino-4-(3-bromophenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",0.0373,uM,=,-1.4282911681913124,0,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
1468,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccc(F)cc4)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(4-Fluorobenzyl)-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]piperidine-4-carboxamide",1.16,uM,=,0.0644579892269184,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
1469,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc(F)c3)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(3-fluorobenzyl)pyridin-1-ium bromide",0.0029,uM,=,-2.537602002101044,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
1470,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,Oc1nc2ccccc2n1CCNCc1ccc(CN2CCCCC2)o1,"1-{2-[(5-Piperidin-1-ylmethyl-furan-2-ylmethyl)-amino]-ethyl}-1,3-dihydro-benzoimidazol-2-one",1.2,uM,=,0.0791812460476248,1,c1ccc2c(c1)ncn2CCNCc1ccc(CN2CCCCC2)o1
1471,28908,10.1021/jm00095a008,,,,"In vitro acetyl cholinesterase (AChE-I) inhibitory activity, ability to reverse the cholinergic deficit characteristic of AD",Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.18,uM,=,-0.744727494896694,0,c1ccc2nc3c(cc2c1)CCCC3
1472,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(Br)cc(/C=N/O)c3O)CC1)CC2,"5-bromo-3-((4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",568.0,uM,=,2.754348335711019,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1
1473,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCCCCCCCCCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(hexadecylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.00531,uM,=,-2.274905478918531,0,O=c1c2ccccc2nc2n1CCC2
1474,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,CC1(C)C[C@@H](c2ccccc2)C(CN2C(=O)c3ccccc3C2=O)=NO1,"(S)-2-((6,6-dimethyl-4-phenyl-5,6-dihydro-4H-1,2-oxazin-3-yl)methyl)isoindoline-1,3-dione",65.32,uM,=,1.8150461760646304,1,O=C1c2ccccc2C(=O)N1CC1=NOCC[C@H]1c1ccccc1
1475,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1ccc2c(c1)C1CCN(CC)C1C2,"1-ethyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl butylcarbamate",1.076,uM,=,0.0318122713303703,1,c1ccc2c(c1)CC1NCCC21
1476,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.055,uM,=,-1.259637310505756,0,c1ccc2nc3c(cc2c1)CCCC3
1477,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc3ccccc3c2)nn1C(=O)N(C)C,"5-Methylsulfanyl-3-naphthalen-2-yl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.05,uM,=,-1.3010299956639813,0,c1ccc2cc(-c3nc[nH]n3)ccc2c1
1478,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N\O)Nc1ccc[n+](CCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],"1,1'-(butane-1,4-diyl)bis(3-((Z)-2-(hydroxyimino)acetamido)pyridinium)dibromide",1060.0,uM,=,3.0253058652647704,1,c1cc[n+](CCCC[n+]2ccccc2)cc1
1479,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2)=CC1=O)Cc1ccccc1,"2,5-bis[6-(benzylethylamino)hexylamino]-[1,4]-benzoquinone",0.0733,uM,=,-1.134896025358872,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
1480,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCCCCCCCNC(=O)C4(C)CCc5c(C)c(O)c(C)c(C)c5O4)c2c1)CCCC3,"6-hydroxy-N-(8-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)-2,5,7,8-tetramethylchroman-2-carboxamide",3.48,uM,=,0.541579243946581,1,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
1481,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)ccc1N1CCN(C)CC1.[I-],(E)-2-(3-Methoxy-4-(4-methylpiperazin-1-yl)styryl)-1-methyl quinolinium iodide,2.1,uM,=,0.3222192947339193,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccc(N2CCNCC2)cc1
1482,1662079,10.1016/j.ejmech.2017.02.039,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine chloride as substrate measured after 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,"(E)-1-(4-benzylpiperidin-1-yl)-3-(4-(4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy)-3-methoxyphenyl)prop-2-en-1-one",3.82,uM,=,0.5820633629117087,1,O=C(/C=C/c1ccc(OCCCCN2CCc3ccccc3C2)cc1)N1CCC(Cc2ccccc2)CC1
1483,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1c[nH]c2ccccc12,3-(1-Benzoyl-1H-pyrrol-3-ylmethylene)-1-benzyl-piperidin-4-one,8.0,uM,=,0.9030899869919436,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1c[nH]c2ccccc12
1484,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(Br)cc1F)CC2.[Br-],"2-(4-bromo-2-fluorophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.29,uM,=,0.1105897102992489,1,C1=[N+](c2ccccc2)CCc2ccccc21
1485,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc(F)cc2)cc1,S-4-fluorobenzyl 4-methylbenzenthiosulfonate,0.3125,uM,=,-0.5051499783199059,0,O=S(=O)(SCc1ccccc1)c1ccccc1
1486,2261370,10.1016/j.ejmech.2022.114606,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 5 mins by Ellman's method,CN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NCCCCCCCCCN2CCOCC2)c1,(9-Morpholin-4-yl-nonyl)-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0089,uM,=,-2.050609993355087,0,O=C(NCCCCCCCCCN1CCOCC1)Oc1cccc(CNCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1
1487,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CN(CCCCCOc1ccc(-c2cc3ccccc3o2)cc1)Cc1ccccc1,[5-(4-Benzofuran-2-yl-phenoxy)pentyl]benzylmethylamine,215.0,uM,=,2.3324384599156054,1,c1ccc(CNCCCCCOc2ccc(-c3cc4ccccc4o3)cc2)cc1
1488,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc(CCCCCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(pentane-1,5-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",0.1,uM,=,-1.0,0,c1ccc(CCCCCc2cccc[nH+]2)[nH+]c1
1489,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)CC2,"2-{4-[(Benzylmethylamino)methyl]benzylidene}-7-methoxy-3,4-dihydro-2H-naphthalen-1-one",5.38,uM,=,0.7307822756663892,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)CCc2ccccc21
1490,2224364,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins by Ellman's method,O=C1CCC(O)c2c(O)cccc21,"4,5-dihydroxy-3,4-dihydronaphthalen-1(2H)-one",1082.2012787519666,uM,=,3.0343080427684304,1,O=C1CCCc2ccccc21
1491,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,Cc1ccc2nc3c(c(NCc4ccccc4)c2c1)CCCC3,"Benzyl-(7-methyl-1,2,3,4-tetrahydro-acridin-9-yl)-amine",3.7,uM,=,0.568201724066995,1,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
1492,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)NC3CCN(Cc4ccccc4)CC3)cn2)cc1,N-(1-benzylpiperidin-4-yl)-2-(2-(4-methoxyphenyl)-2-oxoethyl)pyrimidine-5-carboxamide,28.0,uM,=,1.4471580313422192,1,O=C(Cc1ncc(C(=O)NC2CCN(Cc3ccccc3)CC2)cn1)c1ccccc1
1493,1827463,10.1016/j.ejmech.2018.10.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by Ellman's method,Cc1c(C)c2ccc(OCC3CCN(Cc4cccc(OCCCO)c4)CC3)cc2oc1=O,"7-({1-[3-(3-Hydroxypropoxy)benzyl]piperidin-4-yl}methoxy)-3,4-dimethyl-2H-chromen-2-one",0.84,uM,=,-0.0757207139381183,0,O=c1ccc2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2o1
1494,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2,"3-(3-(4-Benzylpiperidin-1-yl)propoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",4.3,uM,=,0.6334684555795865,1,O=c1oc2cc(OCCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2
1495,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)N(CCC1CCN(Cc2ccccc2)CC1)c1ccncc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-pyridin-4-yl-acetamide,0.108,uM,=,-0.9665762445130504,0,c1ccc(CN2CCC(CCNc3ccncc3)CC2)cc1
1496,2261370,10.1016/j.ejmech.2022.114606,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 5 mins by Ellman's method,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[7-(9-oxo-9H-xanthen-3-yloxy)-heptyl]-amino}-methyl)-phenyl ester,0.0516,uM,=,-1.2873502983727887,0,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
1497,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccccc3I)cc12.[Br-],2-(2-iodophenyl)-8-methoxyisoquinolinium bromide,2.06,uM,=,0.3138672203691534,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
1498,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1cc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2cc(OC)c3c(c2)OCO3)cc(OC)c1OC,SID470313,0.46,uM,=,-0.3372421683184259,0,c1ccc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2ccc3c(c2)OCO3)cc1
1499,471590,10.1016/j.bmc.2007.12.048,,,,Inhibition of AChE,c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1,1-[3-(4-hexahydro-1-pyridinylmethylphenoxy)propyl]hexahydropyridine,3.2,uM,=,0.505149978319906,1,c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1
1500,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,"1-{4-[2-(2,4-Dichloro-phenyl)-2-[1,2,4]triazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-4-isopropyl-piperazine",21.573,uM,=,1.3339105434729788,1,c1ccc([C@@]2(Cn3cncn3)OC[C@H](COc3ccc(N4CCNCC4)cc3)O2)cc1
1501,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,CCC[N+]1(C)CCN(c2ccc(/C=C3\Cc4cc(OC)c(OC)cc4C3=O)cc2)CC1.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-propyl-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one bromide",2.15,uM,=,0.3324384599156053,1,O=C1/C(=C/c2ccc(N3CC[NH2+]CC3)cc2)Cc2ccccc21
1502,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,C[n+]1c(-c2ccccc2)cn2cc(C(N)=O)ccc21.[I-],"6-carbamoyl-1-methyl-2-phenylimidazo[1,2-a]pyridin-1-ium",9.5,uM,=,0.9777236052888478,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
1503,2093130,10.1016/j.ejmech.2020.112718,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate measured after 30 mins by Ellman's method,C=CC(C)(C)c1cc([C@@H]2CC(=O)c3c(O)cc(O)c(CC=C(C)C)c3O2)c(O)cc1O,"2(S)-5'-(1''',1'''-Dimethylallyl)-8-(3'',3''-dimethylallyl)-2',4',5,7-tetrahydroxyflavanone",28.98,uM,=,1.4620983811351558,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
1504,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CC2CCN(CCCOc3ccc4c5c(c(=O)oc4c3)CCCC5)CC2)c1,"3-(3-(4-(3-Methoxybenzyl)piperidin-1-yl)propoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",4.9,uM,=,0.6901960800285137,1,O=c1oc2cc(OCCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2
1505,410400,10.1021/jm060945c,,,,Inhibition of human erythrocyte AChE,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2NS(C)(=O)=O,"N-{3-amino-7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2,4,6,8,10,14-hexaen-17-yl}methanesulfonamide",0.0405,uM,=,-1.3925449767853315,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
1506,534772,10.1021/jm800564y,,,,Inhibition of human erythrocyte AchE by Ellman's method,O=C(NCc1ccccc1)O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2OC(=O)c1ccccc1,Isosorbide-2-(benzylcarbamate)-5-benzoate,221.0,uM,=,2.3443922736851106,1,O=C(NCc1ccccc1)O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2OC(=O)c1ccccc1
1507,1837068,10.1016/j.ejmech.2019.07.040,,,,Inhibition of human AChE,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCC2,"7-(3-(Piperidin-1-yl)propoxy)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one",5.4,uM,=,0.7323937598229685,1,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCC2
1508,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCC[C@@H](O)C4)cc3)cc12,"(R)-3-(4-((3-Hydroxypiperidin-1-yl)methyl)phenyl)-9H-pyrrolo-[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.708,uM,=,-0.149966742310231,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
1509,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.926,uM,=,-0.0333890133180656,0,c1ccc2nc3c(cc2c1)CCCC3
1510,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(NCCCCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3,"(10-Morpholin-4-yldecyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.0283999999999999,uM,=,-1.5466816599529625,0,c1ccc2c(NCCCCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3
1511,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(C#N)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-kyanbenzyl)berberine bromide,1.7,uM,=,0.2304489213782739,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
1512,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine,0.13,uM,=,-0.8860566476931633,0,c1ccc(COc2ccccc2)cc1
1513,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,COc1ccc(C(=O)CCc2ccc([N+](C)(C)C)cc2)cc1OC.[Br-],"{4-[3-(3,4-Dimethoxy-phenyl)-3-oxo-propyl]-phenyl}-trimethyl-ammonium bromide",3.0,uM,=,0.4771212547196624,1,O=C(CCc1ccccc1)c1ccccc1
1514,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccccc1)Cc1ccccc1,1-Benzoyl-3-{2-[2-(benzyl-methyl-amino)-ethoxy]-ethyl}-thiourea,0.12,uM,=,-0.9208187539523752,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccccc1
1515,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,CCN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1,"2-[6-[Ethyl(phenylmethyl)amino]hexyl]-1H-isoindole-1,3(2H)-dione",3.7,uM,=,0.568201724066995,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
1516,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCNc3noc4ccccc34)CC2)cc1,Benzo[d]isoxazol-3-yl-[2-(1-benzyl-piperidin-4-yl)-ethyl]-amine,0.81,uM,=,-0.0915149811213502,0,c1ccc(CN2CCC(CCNc3noc4ccccc34)CC2)cc1
1517,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)-2-(propylamino)acetamide",0.31,uM,=,-0.5086383061657274,0,O=c1c2ccccc2nc2n1CCC2
1518,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.0335,uM,=,-1.4749551929631548,0,c1ccc2nc3c(cc2c1)CCCC3
1519,1508181,10.1016/j.bmc.2015.01.031,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CC1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2,"6,7,10,11-Tetrahydro-9-methyl-12-{{12-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]dodecyl}amino}-7,11-methanocycloocta[b]quinoline",0.00366,uM,=,-2.436518914605589,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
1520,2263808,10.1016/j.bmc.2020.115895,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C2\Oc3cc(OCCN4CCCC4)ccc3C2=O)cc(OC)c1OC,"(Z)-6-(2-(pyrrolidin-1-yl)ethoxy)-2-(3,4,5-trimethoxybenzylidene)benzofuran-3(2H)-one",0.643,uM,=,-0.1917890270757779,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCN3CCCC3)ccc21
1521,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COC(=O)/C(=N\Nc1ccccc1)C(=O)C(F)(F)F,"Methyl(2Z)-4,4,4-trifluoro-3-oxo-2-(2-phenylhydrazinylidene)butanoate",20.1,uM,=,1.3031960574204888,1,c1ccccc1
1522,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,OCc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2[nH]1,(5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1H-indol-2-yl)methanol,13.6,uM,=,1.1335389083702174,1,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
1523,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1ccc(N(C)C)cc1)c1ccc(=O)[nH]c1C2,"(1R,9R)-1-{[1-(4-Dimethylamino-phenyl)-methylidene]-amino}-13-eth-(E)-ylidene-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.031,uM,=,-1.5086383061657274,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
1524,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,CSc1ccc(C2SCC(=O)N2c2ccc3oc(=O)ccc3c2)cc1,2-[4-(Methylthio)phenyl]-3-(2-oxo-2H-chromen-6-yl)thiazolidin-4-one,0.311,uM,=,-0.5072396109731625,0,O=C1CSC(c2ccccc2)N1c1ccc2oc(=O)ccc2c1
1525,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(C3CCCCC3)C(=O)C2C12C(=O)c1ccccc1C2=O,"5'-Cyclohexyl-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",4.12,uM,=,0.6148972160331346,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1C1CCCCC1
1526,2215548,10.1016/j.ejmech.2022.114397,,,,Inhibition of AChE (unknown origin) by spectrophotometric based Ellman's method,COc1ccc(CCc2cc(=O)c3c(o2)[C@H]2O[C@H]2[C@@H](O)[C@H]3OC)cc1,"(1aS,2S,3S,7bS)-2-hydroxy-3-methoxy-6-(4-methoxyphenethyl)-2,3-dihydro-1aH-oxireno[2,3-h]chromen-4(7bH)-one",155.6,uM,=,2.1920095926536702,1,O=c1cc(CCc2ccccc2)oc2c1CC[C@@H]1O[C@H]21
1527,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1nn(S(=O)(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1-c1nsc(Nc2ccccc2)n1,"{3-[1-(3,5-Bis-trifluoromethyl-benzenesulfonyl)-3-methyl-1H-pyrazol-4-yl]-[1,2,4]thiadiazol-5-yl}-phenyl-amine",2.6,uM,=,0.414973347970818,1,O=S(=O)(c1ccccc1)n1cc(-c2nsc(Nc3ccccc3)n2)cn1
1528,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2cccc([N+](=O)[O-])c2C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-4-nitro-isoindole-1,3-dione",0.009,uM,=,-2.0457574905606752,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
1529,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCOC(=O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)NCCC1CCN(Cc2ccccc2)CC1,N-carboxybenzyl-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-ethyl,4.99,uM,=,0.69810054562339,1,O=C(CNC(=O)OCc1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1530,28329,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.27-1.86,CN(C)C(=O)Oc1ccc2c(c1)C(N)CCC2,"Dimethyl-carbamic acid 8-amino-5,6,7,8-tetrahydro-naphthalen-2-yl ester",1.48,uM,=,0.1702617153949573,1,c1ccc2c(c1)CCCC2
1531,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)C=C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[2-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-2-oxo-ethylidene]-1-methyl-piperidinium bromide",0.52,uM,=,-0.2839966563652008,0,O=C(C=C1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
1532,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCCNc3c4c(nc5cccc(Cl)c35)CCCC4)c2c1,"6-(8-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
1533,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCC[n+]1cc(C(F)(F)F)ccc1OC.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"1,1'-(propane-1,3-diyl)bis(2-methoxy-5-(trifluoromethyl)pyridinium)trifluoromethanesulfonate",10.5,uM,=,1.021189299069938,1,c1cc[n+](CCC[n+]2ccccc2)cc1
1534,762161,10.1016/j.ejmech.2011.04.038,,,,Inhibition of AChE by Ellman's method,Cl.O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc(F)cc1,"4-fluoro-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]-benzamide hydrochloride",0.000809,uM,=,-3.092051478387728,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
1535,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cn1cc(C(=O)NCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)c2ccccc21,"1H-methylindole-3-carboxylic acid [7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)-heptyl]-amide",0.0109,uM,=,-1.9625735020593764,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1c[nH]c2ccccc12
1536,1337582,10.1021/np400978x,,,,Inhibition of human AChE by spectrophotometry,CC[C@H]1[C@@H]2OC(=O)[C@@](C)(O)[C@@H]2[C@@]23CC[C@@H]([C@@H]4C[C@H](C)C(=O)O4)N2CCCC[C@H]13,Sessilistemonamine B,17.1,uM,=,1.2329961103921538,1,O=C1CC[C@@H]([C@@H]2CC[C@@]34[C@H](CCCCN23)C[C@@H]2OC(=O)C[C@@H]24)O1
1537,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,COc1cccc(CNC2CCN(Cc3ccccc3)C2)c1OC,"1-Benzyl-N-(2,3-dimethoxybenzyl)pyrrolidin-3-amine",4.383,uM,=,0.6417714706539592,1,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
1538,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{6-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",0.0941,uM,=,-1.026410376572743,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
1539,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,c1ccc(CCCCCNc2c3c(nc4ccccc24)CCCC3)nc1,"N-[5-(pyridin-2-yl)pentyl]-1,2,3,4-tetrahydroacridin-9-amine",0.15,uM,=,-0.8239087409443188,0,c1ccc(CCCCCNc2c3c(nc4ccccc24)CCCC3)nc1
1540,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCCCN(C)C,(E)-3-(4-((8-(dimethylamino)octyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,8.95,uM,=,0.951823035315912,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
1541,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1cc(OCC[N+](CC)(CC)CC)c(C(=O)NCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc1OCC[N+](CC)(CC)CC.Cl.[Br-].[Br-].[Br-],"N,N,N-triethyl-2-(5-(((6-(2-(1,2,3,4-tetrahydroacridin-9-yl)-hydrazino)-6-oxohexyl)amino)carbonyl)-2,3-bis((2-triethylammonio)ethoxy)phenoxy)ethanammonium tribromide hydrochloride",0.0232,uM,=,-1.6345120151091004,0,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
1542,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,Cc1c(OC(=O)N(C)C)c2c(c[n+]1C)COC(C)(C)OC2.[Br-],"1,5-Dihydro-3,3,7,8-tetramethyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",500.0,uM,=,2.6989700043360187,1,c1cc2c(c[nH+]1)COCOC2
1543,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),COc1ccc(-[n+]2ccc3c4ccccc4n(C)c3c2)cc1,"2-(4-methoxyphenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.3,uM,=,-0.5228787452803376,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
1544,2288317,10.1016/j.ejmech.2022.114806,,,,Inhibition of human AChE using ATC and BTC iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by DTNB reagent based assay,Cc1ccc(-c2noc(-c3cccc(OCC4CCN(Cc5ccc(F)cc5)CC4)c3)n2)cn1,"5-(3-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)phenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole",2.99,uM,=,0.4756711883244297,1,c1ccc(CN2CCC(COc3cccc(-c4nc(-c5cccnc5)no4)c3)CC2)cc1
1545,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1ccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c(OC)c1OC,"3-{7-[methyl-(2,3,4-trimethoxybenzyl)amino]-heptyloxy}xanthen-9-one",155.0,uM,=,2.1903316981702914,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
1546,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCc3cc[n+](Cc4ccc(F)cc4)cc3)c2c1.[Br-],1-(4-fluorobenzyl)-4-(3-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-3-oxo propyl)pyridin-1-ium bromide,0.58,uM,=,-0.2365720064370627,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)NCCc1c[nH]c2ccccc12
1547,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)CC(CC1CCN(CCNc3c4c(nc5ccccc35)CCCC4)CC1)C2.Cl.Cl,"9-[(2-{4-[(5,6-Dimethoxyindan-2-yl)methyl]piperidin-1-yl}ethyl)amino]-1,2,3,4-tetrahydroacridine dihydrochloride",0.00513,uM,=,-2.289882634888184,0,c1ccc2c(c1)CC(CC1CCN(CCNc3c4c(nc5ccccc35)CCCC4)CC1)C2
1548,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cccc(CN2CCN(C(=O)/C=C/c3ccc(O)c(OC)c3)CC2)c1,(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-(3-methoxybenzyl)piperazin-1-yl)prop-2-en-1-one,15.18,uM,=,1.1812717715594616,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
1549,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1ccc2nc3c(c(Nc4ccccc4)c2c1)CCCC3,"7-methyl-N-phenyl-1,2,3,4-tetrahydroacridin-9-amine",3.7,uM,=,0.568201724066995,1,c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1
1550,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-9-{{5-[3-(3,4-dihydro-5-phenyl-2H-pyrano[3,2-c]quinolin-9-yl)propanamido]pentyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.00964,uM,=,-2.015922966097169,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCNc1c2c(nc3ccccc13)CCCC2
1551,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,O=C(CNCc1cc(F)cc(F)c1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-((3,5-difluorobenzyl)amino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.00761,uM,=,-2.1186153432294272,0,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
1552,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1,"N-(2-benzoyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",0.0005099999999999,uM,=,-3.292429823902064,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
1553,744973,10.1016/j.bmcl.2010.12.093,,,,Inhibition of human serum AChE,O=C1C=C(NCCCNCc2ccc(-c3nc4ccccc4s3)cc2)C(=O)C=C1NCCCNCc1ccc(-c2nc3ccccc3s2)cc1,"2,5-bis(3-(4-(benzo[d]thiazol-2-yl)benzylamino)propylamino)cyclohexa-2,5-diene-1,4-dione",31.4,uM,=,1.4969296480732148,1,O=C1C=C(NCCCNCc2ccc(-c3nc4ccccc4s3)cc2)C(=O)C=C1NCCCNCc1ccc(-c2nc3ccccc3s2)cc1
1554,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COC(=O)c1ccc(COc2c(OC)ccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1.[Br-],9-O-(4-methyloxykarbonyOberberine bromide,2.6,uM,=,0.414973347970818,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
1555,27788,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in monkey red blood cell,Nc1c2c(nc3ccccc13)CC(O)CC2,"9-Amino-1,2,3,4-tetrahydro-acridin-3-ol",0.759,uM,=,-0.1197582241045196,0,c1ccc2nc3c(cc2c1)CCCC3
1556,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc(-[n+]2ccc3cccc(OC)c3c2)c1.[Br-],8-Methoxy-2-(3-methoxyphenyl)isoquinolin-2-ium bromide,6.9,uM,=,0.8388490907372553,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
1557,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,O=C(CF)c1cnn(C2CCCC2)c1,1-(1-cyclopentyl-1H-pyrazol-4-yl)-2-fluoroethan-1-one,1.31,uM,=,0.1172712956557642,1,c1cnn(C2CCCC2)c1
1558,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,COc1cc2c(cc1OC)[C@]1(O)C(=O)c3ccc4c(c3O[C@@H]1CO2)C=CC(C)(C)O4,"7a-Hydroxy-9,10-dimethoxy-1,1-dimethyl-13,13a-dihydro-1H,7aH-pyrano[2,3-c;6,5-f']dichromen-7-one (tephrosin)",127.18,uM,=,2.1044188206475947,1,O=C1c2ccc3c(c2O[C@@H]2COc4ccccc4C12)C=CCO3
1559,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.02,uM,=,-1.6989700043360187,0,c1ccc2nc3c(cc2c1)CCCC3
1560,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,CC(=O)C1=CN(Cc2ccccc2C)C=CC1CC1Cc2cc(C)c(C)cc2C1=O,"2-[[3-Acetyl-1-(o-tolylmethyl)-4H-pyridin-4-yl]methyl]-5,6-dimethyl-indan-1-one",0.653,uM,=,-0.185086818724926,0,O=C1c2ccccc2CC1CC1C=CN(Cc2ccccc2)C=C1
1561,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)CCCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccc1O,,0.00548,uM,=,-2.261219441515631,0,O=C(CCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccccc1
1562,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,O/N=C/c1ncc(CCCCCNc2c3c(nc4ccccc24)CCCC3)cc1O,"2-[1-(hydroxyimino)methyl]-5-{5-[(1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}pyridin-3-ol",0.163,uM,=,-0.7878123955960422,0,c1cncc(CCCCCNc2c3c(nc4ccccc24)CCCC3)c1
1563,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/C=C/c1ccc(N(C)C)cc1)c1ccc(=O)[nH]c1C2,"(1R,9R)-1-[3-(4-Dimethylamino-phenyl)-prop-2-enylideneamino]-13-eth-(E)-ylidene-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.04,uM,=,-1.3979400086720375,0,C=C1[C@H]2C=CC[C@]1(/N=C/C=C/c1ccccc1)c1ccc(=O)[nH]c1C2
1564,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CCCC(O)C2)o1,2-[1-(2-{[5-(3-Hydroxy-piperidin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile,0.37,uM,=,-0.431798275933005,0,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
1565,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1ccc2[nH]cc(CCNC(=O)c3ccc(CN(C)Cc4cccc(Cl)c4)cc3)c2c1,4-{[(3-Chlorobenzyl)(methyl)amino]methyl}-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]benzamide,5.6,uM,=,0.7481880270062004,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
1566,2263808,10.1016/j.bmc.2020.115895,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C2\Oc3cc(OCCN4CCCCC4)ccc3C2=O)cc(OC)c1OC,"(Z)-6-(2-(piperidin-1-yl)ethoxy)-2-(3,4,5-trimethoxybenzylidene)benzofuran-3(2H)-one",0.422,uM,=,-0.3746875490383261,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCN3CCCCC3)ccc21
1567,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=c1cc(-c2ccc(OCCCCN3CCc4ccccc4C3)cc2)oc2cc(OCCCCN3CCc4ccccc4C3)cc(O)c12,"7-(4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy)-2-(4-(4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one",0.59,uM,=,-0.2291479883578558,0,O=c1cc(-c2ccc(OCCCCN3CCc4ccccc4C3)cc2)oc2cc(OCCCCN3CCc4ccccc4C3)ccc12
1568,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,Cc1cc2nc3c(nc2cc1C)C1(C(C#N)=C(N)N2CCCNC2=C1[N+](=O)[O-])c1ccccc1-3,"6'-amino-7,8-dimethyl-9'-nitro-1',2',3',4'-tetrahydrospiro[indeno[1,2-b]quinoxaline-11,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",5.7,uM,=,0.7558748556724915,1,C1=CC2(C=C3NCCCN13)c1ccccc1-c1nc3ccccc3nc12
1569,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCC[n+]1cccc2ccccc21,"1,1'-but-1,4-diyl-bis(quinolinium)dibromide",38.0,uM,=,1.57978359661681,1,c1ccc2c(c1)ccc[n+]2CCCC[n+]1cccc2ccccc21
1570,2164642,10.1021/acs.jmedchem.1c01748,,,,Inhibition of recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells using acetylthiocholine iodide as substrate measured for 6 mins by Ellman's method,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1.[Cl-].[Cl-],4-[(E)-(hydroxyimino)methyl]-1-[({4-[(E)-(hydroxyimino)methyl]pyridinium-1-yl}methoxy)methyl]pyridinium dichloride (toxogonin),640.0,uM,=,2.806179973983887,1,c1cc[n+](COC[n+]2ccccc2)cc1
1571,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,Cc1[nH]c(C)c(/C=C2\CN(Cc3ccccc3)CCC2=O)c1C=O,"4-(1-Benzyl-4-oxo-piperidin-3-ylidenemethyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde",30.0,uM,=,1.4771212547196624,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cc[nH]c1
1572,513727,10.1016/j.bmc.2008.07.009,,,,Inhibition of AchE,Cc1ccc(C2CC(c3cccc(O)c3)=Nc3ccccc3S2)cc1,"2-(4''-Methylphenyl)-4-(3'-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepine",49.4,uM,=,1.6937269489236468,1,c1ccc(C2=Nc3ccccc3SC(c3ccccc3)C2)cc1
1573,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,COc1ccc2c(c1)c(/C=C1\CN(Cc3ccccc3)CCC1=O)cn2C(=O)c1ccccc1,3-(1-Benzoyl-5-methoxy-1H-indol-3-ylmethylene)-1-benzyl-piperidin-4-one,80.0,uM,=,1.9030899869919435,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12
1574,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccc(F)cc2)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1-(4-fluorobenzyl)piperidin-4-yl)ethoxy)thiazole-5-carboxamide,4.5,uM,=,0.6532125137753437,1,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
1575,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc(C(=O)CCc2cc[n+](Cc3cccc(Cl)c3)cc2C(C)=O)cc1OC.[Br-],"3-Acetyl-1-(3-chlorobenzyl)-4-(3-(3,4-dimethoxyphenyl)-3-oxopropyl)pyridinium bromide",0.1435,uM,=,-0.8431480989299889,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccccc1
1576,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2[se]n(-c3ccc(CN4CCCCC4)cc3)c(=O)c2cc1OC,"5,6-Dimethoxy-2-(4-(piperidin-1-ylmethyl)phenyl)benzo[d][1,2]selenazol-3(2H)-one",1.44,uM,=,0.1583624920952496,1,O=c1c2ccccc2[se]n1-c1ccc(CN2CCCCC2)cc1
1577,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-hexyl-7-methoxytacrine hydrochloride,0.1,uM,=,-1.0,0,c1ccc2nc3c(cc2c1)CCCC3
1578,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0203,uM,=,-1.6925039620867872,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1579,1508181,10.1016/j.bmc.2015.01.031,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{12-[(1,2,3,4-tetrahydroacridin-9-yl)amino]dodecyl}amino}-7,11-methanocycloocta[b]quinoline",0.0019199999999999,uM,=,-2.7166987712964503,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
1580,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCCCC[n+]1ccn(C(C)(C)C)c1/C=N/O.[Cl-],3-tert-Butyl-1-hex-5-ynyl-2-(hydroxyimino-methyl)-3H-imidazol-1-ium chloride,76.6,uM,=,1.884228769632604,1,c1c[nH+]c[nH]1
1581,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cccc2c1C(=O)/C(=C/C1CCN(Cc3ccc4c(c3)OCO4)CC1)C2,"(E)-2-((1-(benzo[d][1,3]dioxol-5-ylmethyl)piperidin-4-yl)methylene)-7-methoxy-2,3-dihydro-1H-inden-1-one",11.135,uM,=,1.046690221370057,1,O=C1/C(=C/C2CCN(Cc3ccc4c(c3)OCO4)CC2)Cc2ccccc21
1582,462117,10.1021/jm7009364,,,,Inhibition of human AchE,COc1ccccc1CNCCCCCCNCCSSCCNCCCCCCNCc1ccccc1OC,"N-(2-Methoxy-benzyl)-N'-(2-{2-[6-(2-methoxy-benzylamino)-hexylamino]-ethyldisulfanyl}-ethyl)-hexane-1,6-diamine (BHC, Benextramine)",7.24,uM,=,0.859738566197147,1,c1ccc(CNCCCCCCNCCSSCCNCCCCCCNCc2ccccc2)cc1
1583,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCOc1ccc(/C=C/C(=O)Nc2ccccc2)cc1OC,(E)-3-(4-(2-(diethylamino)ethoxy)-3-methoxyphenyl)-N-phenylacrylamide,41.06,uM,=,1.613418945034573,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
1584,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCNC(=O)c4sc(-c5ccnc(NC(=O)C6CC6)c5)nc4OC)c2c1)CCCC3,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-methoxy-N-(2-((7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)thiazole-5-carboxamide",0.023,uM,=,-1.6382721639824072,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1
1585,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3C)cc1C(C)=O)C2.[Br-],"(+/-)-2-[[3-Acetyl-1-(o-tolylmethyl)pyridin-1-ium-4-yl]methyl]-5,6-dimethoxy-indan-1-one Bromide",0.0088,uM,=,-2.055517327849832,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
1586,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=c1c(-c2ccc(OCCCCN3CCc4ccccc4C3)cc2)coc2cc(OCCCCN3CCc4ccccc4C3)cc(O)c12,"7-(4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy)-3-(4-(4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one",8.1,uM,=,0.9084850188786496,1,O=c1c(-c2ccc(OCCCCN3CCc4ccccc4C3)cc2)coc2cc(OCCCCN3CCc4ccccc4C3)ccc12
1587,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCCOc1ccc2c(C)cc(=O)oc2c1.O=S(=O)([O-])C(F)(F)F,2-methoxy-1-(4-(4-methyl-2-oxo-2H-chromen-7-yloxy)butyl)-5-(trifluoromethyl)pyridinium trifluoromethanesulfonate,1.11,uM,=,0.0453229787866574,1,O=c1ccc2ccc(OCCCC[n+]3ccccc3)cc2o1
1588,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CN1CCN(c2ccc(/C=C/c3ccc4ccccc4[n+]3C)cc2)CC1.[I-],(E)-1-Methyl-2-(4-(4-methylpiperazin-1-yl)styryl)quinolinium iodide,1.4,uM,=,0.1461280356782379,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccc(N2CCNCC2)cc1
1589,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Brc1ccc(/C=C2/CNCC3=C2N=C2SC=C(c4ccc5ccccc5c4)N2C3c2ccc(Br)cc2)cc1,"(E)-9-(4-bromobenzylidene)-5-(4-bromophenyl)-3-(naphthalen-2-yl)-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",0.73,uM,=,-0.1366771398795441,0,C1=C(c2ccc3ccccc3c2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
1590,1871369,10.1016/j.bmcl.2018.12.011,,,,Inhibition of AchE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 20 secs for 20 times by Ellman's assay,O=C(O)CC1(CC(=O)c2cc(O)ccc2O)C=C(CO)CCC1,Patchiene A,26.0,uM,=,1.414973347970818,1,O=C(CC1C=CCCC1)c1ccccc1
1591,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(NCC2CCN(Cc3ccccc3)CC2)cc1OC,"N-((1-benzylpiperidin-4-yl)methyl)-3,4-dimethoxyaniline",0.145,uM,=,-0.8386319977650252,0,c1ccc(CN2CCC(CNc3ccccc3)CC2)cc1
1592,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3c(F)c(F)c(F)c(F)c3F)cn2)cc1,2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-methyl-N-(3-(perfluorophenoxy)propyl)pyrimidine-5-carboxamide,5.14,uM,=,0.7109631189952758,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
1593,462117,10.1021/jm7009364,,,,Inhibition of human AchE,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [3-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-amide",0.00025,uM,=,-3.6020599913279625,0,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2
1594,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(/C=C/c1ccc(O)cc1O)NCCC1CCN(Cc2ccccc2)CC1,"(E)-N-(2-(1-Benzylpiperidin-4-yl)ethyl)-3-(2,4-dihydroxyphenyl)acrylamide",0.99,uM,=,-0.00436480540245,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1595,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CCCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4cccnc4oc3c2)c1,Heptyl-carbamic acid 3-({methyl-[3-(10-oxo-10H-9-oxa-1-aza-anthracen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.042,uM,=,-1.3767507096020994,0,O=c1c2ccc(OCCCNCc3ccccc3)cc2oc2ncccc12
1596,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCOC(=O)/C=C/c1ccc(OCCCCCCCCN(CC)CC)c(OC)c1,(E)-ethyl-3-(4-((8-(diethylamino)octyl)oxy)-3-methoxyphenyl)acrylate,1.56,uM,=,0.1931245983544616,1,c1ccccc1
1597,579492,10.1016/j.bmcl.2009.05.087,,,,Inhibition of human AChE-induced amyloid beta (1-40) aggregation by thioflavin T fluorescence-based assay,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis(6-((2-methoxybenzyl)(ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",28.3,uM,=,1.4517864355242902,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
1598,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,c1ccc(COc2ccc(CCOCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2)cc1,"N-{5'-[4''-(Benzyloxyphenethyloxy]pentyl}-1,2,3,4-tetrahydroacridin-9-amine",0.454,uM,=,-0.342944147142896,0,c1ccc(COc2ccc(CCOCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2)cc1
1599,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1sc(-c2ccnc(NC(=O)C3CCC3)c2)nc1OCC1CC1,"2-(2-(cyclobutanecarboxamido)pyridin-4-yl)-4-(cyclopropylmethoxy)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)thiazole-5-carboxamide",0.2951999999999999,uM,=,-0.5298836468489961,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1sc(-c2ccnc(NC(=O)C3CCC3)c2)nc1OCC1CC1
1600,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(Cc3ccccc3)C1N2Cc1ccccc1,"Methyl-carbamic acid (R)-1,8-dibenzyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",3.56,uM,=,0.5514499979728752,1,c1ccc(CN2CCC3c4ccccc4N(Cc4ccccc4)C32)cc1
1601,28466,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.2-6.4,C#CCN(C)[C@@H](C)Cc1cccc(OC(=O)N(C)CCCCCC)c1,(S)-Hexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,3.4,uM,=,0.5314789170422551,1,c1ccccc1
1602,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCNc1c2c(nc3ccccc13)CCCC2,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-methoxy-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)thiazole-5-carboxamide",0.0064,uM,=,-2.193820026016113,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1
1603,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2ccc(Cl)cc2)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(4-Chlorophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",22.24,uM,=,1.3471347829100198,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
1604,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(C1CCCCC1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,Cyclohexanecarboxylic acid [2-(1-benzyl-piperidin-4-yl)-ethyl]-phenyl-amide,9.4,uM,=,0.9731278535996988,1,O=C(C1CCCCC1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
1605,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(9-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)nonyl)-3-(1H-indol-3-yl)propanamide",0.0044,uM,=,-2.356547323513813,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
1606,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cc1ccc2c(c1)c1cc[n+](-c3ccccc3)cc1n2C,"6,9-dimethyl-2-phenyl-pyrido[3,4-b]indol-2-ium",0.42,uM,=,-0.3767507096020995,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
1607,1507873,10.1016/j.bmc.2015.05.027,,,,Inhibition of human acetylcholinesterase incubated for 60 mins using ATChI substrate by DTNB dye based UV-visible spectrophotometry,O=C(C[n+]1ccc(/C=N/O)cc1)Nc1nc(-c2ccccc2)cs1.[Cl-],4-((Hydroxyimino)methyl)-1-(2-oxo-2-(4-phenylthiazol-2-ylamino)ethyl)pyridinium chloride,990.0,uM,=,2.99563519459755,1,O=C(C[n+]1ccccc1)Nc1nc(-c2ccccc2)cs1
1608,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)N3CCN(Cc4ccccc4)CC3)cn2)cc1,2-(5-(4-benzylpiperazine-1-carbonyl)pyrimidin-2-yl)-1-(4-methoxyphenyl)ethan-1-one,17.3,uM,=,1.2380461031287957,1,O=C(Cc1ncc(C(=O)N2CCN(Cc3ccccc3)CC2)cn1)c1ccccc1
1609,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,COc1ccccc1NC(=S)NCCN(C)C,1-(2-(Dimethylamino)ethyl)-3-(2-methoxyphenyl)thiourea,120.0,uM,=,2.0791812460476247,1,c1ccccc1
1610,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3)cc1)C2.[Br-],"(E)-1-benzyl-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)pyridin-1-ium bromide",0.0034,uM,=,-2.468521082957745,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
1611,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCCCCOc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(6-diethylaminohexyloxy)indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
1612,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3cccc(C)c3)cc1C(C)=O)C2.[Br-],"(+/-)-2-[[3-Acetyl-1-(m-tolylmethyl)pyridin-1-ium-4-yl]methyl]-5,6-dimethoxy-indan-1-one Bromide",0.014,uM,=,-1.853871964321762,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
1613,2200852,10.1016/j.ejmech.2020.112860,,,,Inhibition of AChE (unknown origin),CC(=O)O[C@@H]1C[C@@]2(C)Oc3cc(C)oc(=O)c3C[C@@H]2[C@@]2(C)C=CC(=O)C(C)(C)[C@H]12,Asperversin G,13.6,uM,=,1.1335389083702174,1,O=C1C=CC2[C@@H](CCC3Oc4ccoc(=O)c4C[C@@H]32)C1
1614,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,OCc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,(3-(2-morpholinoethylamino)-6-phenylpyridazin-4-yl)methanol,440.0,uM,=,2.6434526764861874,1,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1
1615,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCCCCCNCc3ccccc3)cc2oc1=O.Cl,"7-(5-(N-Benzyl)pentyloxy)-3,4-dimethyl-2H-chromen-2-one hydrochloride",0.3,uM,=,-0.5228787452803376,0,O=c1ccc2ccc(OCCCCCNCc3ccccc3)cc2o1
1616,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3ccc(=O)oc3c2)c1,3-((methyl(3-(2-oxo-2H-chromen-7-yloxy)propyl)amino)methyl)phenyl hexylcarbamate,0.013,uM,=,-1.8860566476931635,0,O=c1ccc2ccc(OCCCNCc3ccccc3)cc2o1
1617,1842255,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc2oc(-c3ccc(NCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,"2-(4-(2-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)ethylamino)phenyl)-5,6,7-trimethoxy-4H-chromen-4-one",0.00163,uM,=,-2.7878123955960423,0,O=c1cc(-c2ccc(NCCNc3c4c(nc5ccccc35)CCCC4)cc2)oc2ccccc12
1618,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,COC(=O)[C@H](C)CC(=O)C[C@@H](C)[C@H]1C[C@@H]2OC(C)(C)O[C@H]3C[C@H]4C(C)(C)C(=O)CC[C@]4(C)C4=C3[C@@]2(C)[C@]1(C)CC4=O,"methyl 7beta,15alpha-isopropylidenedioxy-3,11,23-trioxo-5alpha-lanost-8-en-26-oate",18.35,uM,=,1.2636360685881085,1,O=C1CCC2C3=C4C5C(CC[C@@H]5OCO[C@H]4C[C@H]2C1)CC3=O
1619,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"N-{6-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]hexyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.275,uM,=,-0.5606673061697374,0,O=C(CC1CCc2ccccc2O1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
1620,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0141,uM,=,-1.85078088734462,0,c1ccc2c(c1)N[C@H]1NCCC21
1621,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1ccc(OC)cc1OC)c1ccc(=O)[nH]c1C2,"1-{[1-(2,4-Dimethoxy-phenyl)-methylidene]-amino}-13-ethylidene-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.084,uM,=,-1.0757207139381184,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
1622,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3Br)cc1)C2.[Br-],"(E)-1-(2-bromobenzyl)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)pyridin-1-ium bromide",0.0038,uM,=,-2.42021640338319,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
1623,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(CC)C(=O)/C=C/c1ccc(OC(=O)N(C)C)c(OC)c1,(E)-4-(3-(diethylamino)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl dimethylcarbamate,13.1,uM,=,1.1172712956557642,1,c1ccccc1
1624,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1cc(C#N)c(NC2CCN(Cc3ccccc3)CC2)nc1NC1CCN(Cc2ccccc2)CC1,"2,6-bis((1-benzylpiperidin-4-yl)amino)pyridine-3,5-dicarbonitrile",7.3,uM,=,0.8633228601204559,1,c1ccc(CN2CCC(Nc3cccc(NC4CCN(Cc5ccccc5)CC4)n3)CC2)cc1
1625,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OC1CCN(Cc2ccccc2)CC1,4-((1-Benzylpiperidin-4-yl)oxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methylthiazole-5-carboxamide,73.0,uM,=,1.863322860120456,1,O=C(Nc1cc(-c2nc(OC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
1626,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CN1c2ccc(OC(=O)NC3CCCCC3)cc2[C@]2(C)CCN(CCc3ccccc3)[C@H]12,"3alpha,8-dimethyl-1-phenethyl-1,2,3,3alpha,8,8alpha-hexahydropyrrolo[2,3-b]indol-5-ylcyclohexylcarbamate",0.022,uM,=,-1.6575773191777938,0,O=C(NC1CCCCC1)Oc1ccc2c(c1)C1CCN(CCc3ccccc3)[C@@H]1N2
1627,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1N2C,"o-tolyl-carbamic acid (3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.013,uM,=,-1.8860566476931635,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@@H]1N2
1628,513727,10.1016/j.bmc.2008.07.009,,,,Inhibition of AchE,Oc1cccc(C2=Nc3ccccc3SC(c3cccs3)C2)c1,"2-(Thien-2''-yl)-4-(3'-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepine",5.9,uM,=,0.7708520116421442,1,c1ccc(C2=Nc3ccccc3SC(c3cccs3)C2)cc1
1629,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,Cc1ccccc1CNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-((2-methylbenzyl)amino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-7-yl)acetamide",0.119,uM,=,-0.9244530386074692,0,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
1630,1837068,10.1016/j.ejmech.2019.07.040,,,,Inhibition of human AChE,C#CCN(C)Cc1cc2cc(OCCCN3CCCCC3)ccc2n1C,N-Methyl-N-((1-methyl-5-(3-(piperidin-1-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine,0.53,uM,=,-0.2757241303992109,0,c1cc2cc(OCCCN3CCCCC3)ccc2[nH]1
1631,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3[C@H](C1)C2.Cl.Cl.Cl.Cl,"(-)-(7S,11S)-3-Chloro-12-((7-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl)amino)-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinoline dihydrochloride",0.00204,uM,=,-2.690369832574101,0,C1=C[C@@H]2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@H](C1)C2
1632,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12,(4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine,6.9071,uM,=,0.8392957437046855,1,c1ccc(CNCc2cccc3ccccc23)cc1
1633,28165,10.1016/s0960-894x(02)00482-1,,,,In vitro inhibition of human recombinant AChE.,COc1cc2cc(C(=O)CCC3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC,"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-piperidinium",0.008,uM,=,-2.096910013008056,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
1634,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,Fc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,4-(benzofuran-2-yl)-1-(4-fluorobenzyl)piperidine,21.3,uM,=,1.3283796034387378,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
1635,1455127,10.1016/j.bmc.2014.07.053,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins before substrate addition by Ellman method,COc1cc(CCC(=O)/C=C/c2ccc(CNc3c4c(nc5cc(Cl)ccc35)CC3CC(C)=CC4C3)cc2)cc(CN(C)C)c1O,"1-{4-{[(3-chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]methyl}phenyl}-5-[3-(dimethylamino)methyl-4-hydroxy-5-methoxyphenyl]pent-1-en-3-one",0.0211,uM,=,-1.6757175447023074,0,O=C(/C=C/c1ccc(CNc2c3c(nc4ccccc24)CC2CC=CC3C2)cc1)CCc1ccccc1
1636,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCOCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,5-bis(4-tert.butylpyridinium)-3-oxapent-1,5-diyl dibromide",19.0,uM,=,1.2787536009528289,1,c1cc[n+](CCOCC[n+]2ccccc2)cc1
1637,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-N-methyl-2-(2-(2-((4-((1,2,3,4-tetrahydroacridin-9-yl)amino)butyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0231,uM,=,-1.6363880201078556,0,O=C(CNCCCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
1638,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(CC1CCN(Cc2ccc(F)cc2)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12,2-(1-(4-Fluorobenzyl)piperidin-4-yl)-N-(6-(pyridin-3-yl)-1H-indazol-3-yl)acetamide,0.518,uM,=,-0.2856702402547669,0,O=C(CC1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12
1639,1525144,10.1016/j.bmcl.2015.06.047,,,,Inhibition of human AChE,COc1ccc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)CC[C@@H](OC(C)=O)C(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc1,(+)-Arisugacin D,3.5,uM,=,0.5440680443502757,1,O=c1oc(-c2ccccc2)cc2c1CC1C(CCC3CCCCC31)O2
1640,28451,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.7-6.4,C#CCNC1CCc2cccc(OC(=O)N(C)C)c21.Cl,Dimethyl-carbamic acid 3-prop-2-ynylamino-indan-4-yl ester hydrochloride,2.5,uM,=,0.3979400086720376,1,c1ccc2c(c1)CCC2
1641,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,Cc1ccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)cc1,(2-{4-[7-(benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-p-tolylmethanone,10.5,uM,=,1.021189299069938,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
1642,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCCCC2)cc(OC)c1OC,"rac-2-(3,4,5-Trimethoxyphenyl)-2-(piperidin-1-yl)acetonitrile",381.0,uM,=,2.5809249756756194,1,c1ccc(CN2CCCCC2)cc1
1643,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,CN(C)CCN=C(S)Nc1cccc(Cl)c1,SID17414785,140.0,uM,=,2.146128035678238,1,c1ccccc1
1644,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CC(C)C(C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],"1-(1,2-Dimethyl-but-3-ynyloxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride",12.7,uM,=,1.1038037209559568,1,c1c[nH+]c[nH]1
1645,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,"2-(7-(Benzyl(methyl)amino)heptyl)isoindoline-1,3-dione hydrochloride",0.997,uM,=,-0.0013048416883442,0,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
1646,642381,10.1021/jm100329q,,,,Inhibition of human erythrocyte AChE by Ellman's reaction,Cl.Cl.Cl.Oc1c(CNCCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(Cl)c2cccnc12,"5-Chloro-7-{[9-(1,2,3,4-tetrahydroacridin-9-ylamino)nonylamino]methyl}quinolin-8-ol Dihydrochloride",0.001,uM,=,-3.0,0,c1cnc2cc(CNCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc2c1
1647,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1ccc2c(N)c3c(nc2c1)CCCC3.Cl,"6-methyl-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.072,uM,=,-1.1426675035687317,0,c1ccc2nc3c(cc2c1)CCCC3
1648,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NC)c1,Methyl-carbamic acid 3-({ethyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.00056,uM,=,-3.2518119729938,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
1649,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,Cc1c(OC(=O)N(C)C)c2c(c[n+]1C)COC(C)OC2.[Br-],"1,5-Dihydro-3,7,8-trimethyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",150.0,uM,=,2.1760912590556813,1,c1cc2c(c[nH+]1)COCOC2
1650,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1ccc(OC)c(C2=NN(C(C)=O)C(c3ccc(-c4ccccc4)cc3)C2)c1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1705.0,uM,=,3.2317243833285167,1,c1ccc(C2=NNC(c3ccc(-c4ccccc4)cc3)C2)cc1
1651,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CCN(CC)CCOc1cccc(/C=C2\COc3ccccc3C2=O)c1,(E)-3-(3-(2-(diethylamino)ethoxy)benzylidene)chroman-4-one,30.3,uM,=,1.481442628502305,1,O=C1/C(=C/c2ccccc2)COc2ccccc21
1652,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(O)cc1)N1CCN(c2ccccn2)CC1,N'-(4-Hydroxybenzylidene)-4-(pyridin-2-yl)piperazine-1-carbohydrazide,4.81,uM,=,0.6821450763738317,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
1653,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12c1ccccc1-c1nc3ccc([N+](=O)[O-])cc3nc12,"5-amino-8,8'-dinitro-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,11'-indeno[1,2-b]quinoxaline]-6-carbonitrile",6.5,uM,=,0.8129133566428556,1,C1=CC2(C=C3NCCN13)c1ccccc1-c1nc3ccccc3nc12
1654,28317,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.28-0.32,COc1ccc(N(C)C(=O)Oc2ccc3c(c2)C(N)CC3)cc1.Cl,(4-Methoxy-phenyl)-methyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,0.3,uM,=,-0.5228787452803376,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)CCC2
1655,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,CO[P@]1(=O)CC[C@H]2COC(=O)C2=C(C)O1,"(6R,8aR)-6-Methoxy-4-methyl-6-oxo-6,7,8,8a-tetrahydro-1H-2,5-dioxa-6lambda*5*-phospha-azulen-3-one",30.0,uM,=,1.4771212547196624,1,O=C1OC[C@@H]2CC[PH](=O)OC=C12
1656,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1,"N-(6-((2,3-Dihydro-1H-cyclopenta[b]quinolin-9-yl)amino)hexyl)-benzofuran-2-carboxamide",0.545,uM,=,-0.2636034977233575,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1
1657,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccccc1CN1CCC(CNc2nc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3)s2)CC1,"N-[(1-(2-Methylbenzyl)piperidin-4-yl)methyl]-4,5-bis(4-chlorophenyl)thiazol-2-ylamine",0.87,uM,=,-0.0604807473813814,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
1658,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1cc(-c2ccc(Cl)cc2)nc2nc(-c3ccccc3)cc(C(F)(F)F)c12,"2-(4-Chlorophenyl)-7-phenyl-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",0.52,uM,=,-0.2839966563652008,0,c1ccc(-c2ccc3ccc(-c4ccccc4)nc3n2)cc1
1659,28628,10.1021/jm970210v,,,,Inhibition of human acetylcholinesterase from erythrocytes (RBC),CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(C)C1N2,"Methyl-carbamic acid (R)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",2.1935,uM,=,0.3411376387409639,1,c1ccc2c(c1)NC1NCCC21
1660,573639,10.1021/np800671p,,,,Inhibition of AChE by spectrophotometry,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",73.9,uM,=,1.8686444383948253,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1661,2019674,10.1039/d0md00009d,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by Ellman's method,Cc1cc(S(=O)(=O)Nc2ccccc2O)c(C(C)C)cc1O,4-hydroxy-N-(2-hydroxyphenyl)-2-isopropyl-5-methyl-benzenesulfonamide,8.74,uM,=,0.9415114326344032,1,O=S(=O)(Nc1ccccc1)c1ccccc1
1662,2198746,10.1039/d2md00087c,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 sec for 3 mins by DTNB-based UV analysis,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.188,uM,=,-0.7258421507363202,0,c1ccc2nc3c(cc2c1)CCCC3
1663,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-propyl-7-methoxytacrine hydrochloride,9.2,uM,=,0.9637878273455552,1,c1ccc2nc3c(cc2c1)CCCC3
1664,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCc2ccccc2CSCc2ccc(CN(C)C)o2)o1,{5-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanylmethyl)-benzylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,9.0,uM,=,0.9542425094393248,1,c1coc(CSCc2ccccc2CSCc2ccco2)c1
1665,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3cc(OCCNC(=O)CCc4ccc(F)c(F)c4)ccc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-6-yloxy)ethyl)-3-(3,4-difluorophenyl)propanamide",2.77,uM,=,0.4424797690644485,1,O=C(CCc1ccccc1)NCCOc1ccc2oc(=O)c(-c3ccc(CNCc4ccccc4)cc3)cc2c1
1666,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(2-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-methoxythiazole-5-carboxamide",0.0021,uM,=,-2.6777807052660805,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1
1667,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=[N+]([O-])c1ccc2nc3c(c(N4CCOCC4)c2c1)CCCC3,"4-(7-Nitro-1,2,3,4-tetrahydroacridin-9-yl)morpholine",1.217,uM,=,0.085290578230065,1,c1ccc2c(N3CCOCC3)c3c(nc2c1)CCCC3
1668,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1,HI-6,667.8,uM,=,2.824646414718352,1,c1cc[n+](COC[n+]2ccccc2)cc1
1669,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCN1C(=O)c2ccc(-c3ccc4c(c3)C(=O)N(CCCCCCN(CC)Cc3ccccc3OC)C4=O)cc2C1=O)Cc1ccccc1OC,"2,2'-Bis-{6-[ethyl-(2-methoxybenzyl)amino]hexyl}-[5,5']biisoindolyl-1,3,1',3'-tetraone",0.014,uM,=,-1.853871964321762,0,O=C1c2ccc(-c3ccc4c(c3)C(=O)N(CCCCCCNCc3ccccc3)C4=O)cc2C(=O)N1CCCCCCNCc1ccccc1
1670,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.05012,uM,=,-1.2999889376778877,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1671,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCCCNc1c2c(nc3cc(Cl)cc(Cl)c13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-8-(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-ylamino)octanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
1672,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-isoindole-1,3-dione",0.08,uM,=,-1.0969100130080565,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
1673,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(CN2CCC(CCC(=O)c3ccc4c(c3)CCN4)CC2)cc1,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(4-methoxy-benzyl)-piperidin-4-yl]-propan-1-one",13.3,uM,=,1.1238516409670858,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
1674,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccc(F)c(F)c2)CC1,"2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1-(3,4-difluorobenzyl)piperidin-4-yl)ethoxy)thiazole-5-carboxamide",42.8,uM,=,1.631443769013172,1,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
1675,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCOC(=O)c1ccc2nc(-c3cccnc3)c3c(c2c1)N(Cc1ccccc1)CCC3,"Ethyl 1-benzyl-1,2,3,4-tetrahydro-5-(3-pyridyl)benzo[h][1,6]naphthyridine-9-carboxylate",1.06,uM,=,0.0253058652647702,1,c1ccc(CN2CCCc3c(-c4cccnc4)nc4ccccc4c32)cc1
1676,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCC1CCN(Cc2ccccc2)CC1)C(=O)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-methyl-benzamide HCl,0.17,uM,=,-0.7695510786217261,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1ccccc1
1677,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-],benzethonium hydrochloride,2.246,uM,=,0.351409751925439,1,c1ccc(C[NH2+]CCOCCOc2ccccc2)cc1
1678,1761987,10.1016/j.ejmech.2018.01.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by DTNB addition for 5 mins and subsequent addition of substrate measured after 3 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.1168,uM,=,-0.9325571572236192,0,c1ccc2nc3c(cc2c1)CCCC3
1679,751131,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes BChE,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(Heptylphysostigmine(-))Heptyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.005,uM,=,-2.3010299956639813,0,c1ccc2c(c1)N[C@H]1NCCC21
1680,2224364,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins by Ellman's method,O=C1CCC(O)c2cccc(O)c21,"4, 8-dihydroxy-3,4-dihydro-2H-naphthalen-1-one",569910.6682291104,uM,=,5.755806786662671,1,O=C1CCCc2ccccc21
1681,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(CNCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc12,"N1-((7-Methoxybenzofuran-2-yl)methyl)-N6-(1,2,3,4-tetrahydroacridin-9-yl)hexane-1,6-diamine",0.0153,uM,=,-1.815308569182401,0,c1ccc2oc(CNCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1
1682,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3ccc(=O)oc3c2)c1,Methyl-carbamic acid 3-({methyl-[3-(2-oxo-2H-chromen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0057,uM,=,-2.2441251443275085,0,O=c1ccc2ccc(OCCCNCc3ccccc3)cc2o1
1683,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCOCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"3-(2-(1H-indol-3-yl)ethoxy)-N-(5-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)pentyl)propanamide",0.0015,uM,=,-2.8239087409443187,0,O=C(CCOCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
1684,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Nc1cccc2n1cc(-c1ccc(OC(=O)N(C)C)cc1)[n+]2C.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-1-methyl-5-(3-methylureido)imidazo[1,2-a]pyridin-1-ium",1.35,uM,=,0.1303337684950061,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
1685,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),O=[N+]([O-])C1C(Cc2c[nH]cn2)NC2(c3ccccc3-c3nc4ccccc4nc32)C1c1ccco1,"3'-(2-furyl)-5'-(1H-imidazol-4-ylmethyl)-4'-nitro-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",14.24,uM,=,1.1535099893008376,1,c1coc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)c1
1686,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)O)ccc1OCCCCCCN1CCCC1,(E)-3-(3-methoxy-4-((6-(pyrrolidin-1-yl)hexyl)oxy)phenyl)acrylicacid,69.91,uM,=,1.844539302129008,1,c1ccc(OCCCCCCN2CCCC2)cc1
1687,2261371,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method,CNC(=O)Oc1cccc(CN(C)CCCCCCOc2ccc3c(c2)O/C(=C\c2cc(OC)c(OC)c(OC)c2)C3=O)c1,"[3-[[methyl-[6-[(2Z)-3-oxo-2-[(3,4,5-trimethoxyphenyl)methylene]benzofuran-6-yl]oxyhexyl]amino]methyl]phenyl]N-methylcarbamate",0.00052,uM,=,-3.283996656365201,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCNCc3ccccc3)ccc21
1688,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,CC(C)(C)OC(=O)n1cc(/C=C2\CN(Cc3ccccc3)CCC2=O)c2ccccc21,3-(1-Benzyl-4-oxo-piperidin-3-ylidenemethyl)-indole-1-carboxylic acid tert-butyl ester,30.0,uM,=,1.4771212547196624,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1c[nH]c2ccccc12
1689,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)OCC[N+](C)(C)CCCCCCCCCCCC[N+](C)(C)CCOC(=O)[C@]3(C)CCC[C@@]4(C)[C@@H]5CC[C@@]6(C)C[C@]5(CC[C@@H]43)CC6=O)(CC1=O)C2.[Br-].[Br-],,2.2,uM,=,0.3424226808222063,1,O=C1C[C@]23CC[C@@H]4C(C(=O)OCC[NH2+]CCCCCCCCCCCC[NH2+]CCOC(=O)C5CCCC6[C@@H]5CC[C@@]57CC(=O)C(CC[C@@H]65)C7)CCCC4[C@@H]2CCC1C3
1690,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"N-{8-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]octyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.0698,uM,=,-1.1561445773768388,0,O=C(CC1CCc2ccccc2O1)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
1691,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2C(=O)OC)cc1,"4'-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-biphenyl-2-carboxylic acid methyl ester",0.2405999999999999,uM,=,-0.6187043769961741,0,O=C1N(Cc2ccc(-c3ccccc3)cc2)C=NC12CCCC2
1692,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.15,uM,=,-0.8239087409443188,0,c1ccc2nc3c(cc2c1)CCCC3
1693,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCNC(=O)CCc1c[nH]c2ccccc12)CCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(3-{[3-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-methyl-amino}-propyl)-3-(1H-indol-3-yl)-propionamide",0.0029,uM,=,-2.537602002101044,0,O=C(CCc1c[nH]c2ccccc12)NCCCNCCCNc1c2c(nc3ccccc13)CCCC2
1694,1837068,10.1016/j.ejmech.2019.07.040,,,,Inhibition of human AChE,COc1ccccc1CN1CCN(CCCCCOc2cccc3[nH]c4ccccc4c23)CC1,4-[5-[4-[(2-methoxyphenyl)methyl]piperazin-1-yl]pentoxy]-9H-carbazole,2.4,uM,=,0.380211241711606,1,c1ccc(CN2CCN(CCCCCOc3cccc4[nH]c5ccccc5c34)CC2)cc1
1695,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,Nc1ccc2nc3c(c(N)c2c1)CCCC3,"5,6,7,8-Tetrahydro-acridine-2,9-diamine",3.8,uM,=,0.5797835966168101,1,c1ccc2nc3c(cc2c1)CCCC3
1696,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.14,uM,=,-0.8538719643217619,0,c1ccc2nc3c(cc2c1)CCCC3
1697,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CNC(NCCNCc1ccc(CN(C(C)C)C(C)C)o1)=C(C#N)C#N,2-{[2-({5-[(Diisopropylamino)-methyl]-furan-2-ylmethyl}-amino)-ethylamino]-methylamino-methylene}-malononitrile,2.1,uM,=,0.3222192947339193,1,c1ccoc1
1698,1500569,10.1039/C4MD00069B,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins by Ellmans method,Cc1ccc2[nH]c3c(c2c1)CN(CCCCCCN1CCc2[nH]c4ccc(C)cc4c2C1)CC3,"1,6-bis(8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)hexane",0.19,uM,=,-0.721246399047171,0,c1ccc2c3c([nH]c2c1)CCN(CCCCCCN1CCc2[nH]c4ccccc4c2C1)C3
1699,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"4'-(4-((Ethyl)(2-methoxybenzyl)amino)butoxy)-5,6,7-trimethoxyflavone",0.08,uM,=,-1.0969100130080565,0,O=c1cc(-c2ccc(OCCCCNCc3ccccc3)cc2)oc2ccccc12
1700,1442760,10.1016/j.bmcl.2014.10.055,,,,Inhibition of human acetylcholinesterase by Ellman's method,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1.[Cl-].[Cl-],4-[(E)-(hydroxyimino)methyl]-1-[({4-[(E)-(hydroxyimino)methyl]pyridinium-1-yl}methoxy)methyl]pyridinium dichloride (toxogonin),2210.0,uM,=,3.3443922736851106,1,c1cc[n+](COC[n+]2ccccc2)cc1
1701,462117,10.1021/jm7009364,,,,Inhibition of human AchE,Clc1cccc(Cl)c1CO/N=C/c1cc[n+](CCC[n+]2ccc(/C=N/OCc3c(Cl)cccc3Cl)cc2)cc1.[Br-].[Br-],"(E,E)-1,3-bis[4-[[(2,6-dichlorobenzyloxyl)imino]methyl]pyridinium]propane. dibromide",6.0,uM,=,0.7781512503836436,1,C(=N/OCc1ccccc1)\c1cc[n+](CCC[n+]2ccc(/C=N/OCc3ccccc3)cc2)cc1
1702,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CNc2ccnc(N3CCCC3)n2)cc1,N-benzyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine,8.7,uM,=,0.9395192526186184,1,c1ccc(CNc2ccnc(N3CCCC3)n2)cc1
1703,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1ccc(-c2cn3c(C)cccc3[n+]2C)cc1.[I-],"1,5-dimethyl-2-(4-(methylcarbamoyloxy)phenyl)imidazo[1,2-a]pyridin-1-ium",4.0,uM,=,0.6020599913279624,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
1704,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,O/N=C/c1nccc(CCCCCNc2c3c(nc4ccccc24)CCCC3)c1O,"2-[(hydroxyimino)methyl]-4-{5-[(1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}pyridin-3-ol",0.077,uM,=,-1.1135092748275182,0,c1ccc2c(NCCCCCc3ccncc3)c3c(nc2c1)CCCC3
1705,1768646,10.1016/j.bmc.2018.01.029,,,,Inhibition of AChE (unknown origin),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.22,uM,=,-0.6575773191777937,0,c1ccc2c(c1)N[C@H]1NCCC21
1706,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COC(=O)c1c(O)cccc1CCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"methyl 2-(8-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)-6-hydroxybenzoate",0.00281,uM,=,-2.55129368009492,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
1707,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),COc1ccc([C@@H]2c3[nH]c4ccccc4c3C[C@H]3C(=O)N(CCC4CCN(Cc5ccccc5)CC4)CC(=O)N23)cc1,"(2R,8S)-6-[2-(1-benzyl-4-piperidyl)ethyl]-2-(4-methoxyphenyl)-3,6,17-triazatetracyclo[8.7.0.0^3,8.0^11,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione",0.015,uM,=,-1.8239087409443189,0,O=C1[C@@H]2Cc3c([nH]c4ccccc34)[C@@H](c3ccccc3)N2C(=O)CN1CCC1CCN(Cc2ccccc2)CC1
1708,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cccc(C#N)[n+]1C.F[B-](F)(F)F,2-cyano-6-methoxy-1-methylpyridinium tetrafluoroborate,18.0,uM,=,1.255272505103306,1,c1cc[nH+]cc1
1709,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Fc1ccc2[nH]c3ccncc3c2c1,"8-fluoro-5H-pyrido[4,3-b]indole",11.4,uM,=,1.0569048513364727,1,c1ccc2c(c1)[nH]c1ccncc12
1710,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(3-(1-(4-fluorobenzyl)piperidin-4-yl)propoxy)thiazole-5-carboxamide,0.31,uM,=,-0.5086383061657274,0,O=C(Nc1cc(-c2nc(OCCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
1711,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=c1cc(-c2ccc(OCCCCN3CCC(Cc4ccccc4)CC3)cc2)oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)cc(O)c12,7-(4-(4-benzylpiperidin-1-yl)butoxy)-2-(4-(4-(4-benzylpiperidin-1-yl)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one,0.67,uM,=,-0.1739251972991735,0,O=c1cc(-c2ccc(OCCCCN3CCC(Cc4ccccc4)CC3)cc2)oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc12
1712,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)/C(=N\NC(=O)C(NC(=O)C(C)c1ccc(CC(C)C)cc1)C(C)C)C(CC1CCN(Cc3ccccc3)CC1)C2,"N-[(Z)-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]amino]-2-[2-(4-isobutylphenyl)propanoylamino]-3-methyl-butanamide",0.4,uM,=,-0.3979400086720376,0,O=C(Cc1ccccc1)NCC(=O)N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1713,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1,"N-((1,2,3,4-Tetrahydroacridin-9-ylamino)methyl)benzofuran-2-carboxamide",0.424,uM,=,-0.3726341434072674,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1
1714,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2cc(OC)c(OC)c(OC)c2)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(7-{3-oxo-2-[1-(3,4,5-trimethoxy-phenyl)-meth-(Z)-ylidene]-2,3-dihydro-benzofuran-6-yloxy}-heptyl)-amino]-methyl}-phenyl ester",0.52,uM,=,-0.2839966563652008,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
1715,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)CCC2,"2,3-Dihydro-1H-cyclopenta[b]quinolin-9-ylamine",0.056,uM,=,-1.2518119729937995,0,c1ccc2nc3c(cc2c1)CCC3
1716,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2oc(CNCCCCCCNc3c4c(nc5ccccc35)CCC4)cc2c1,"N1-(Benzofuran-2-ylmethyl)-N6-(2,3-dihydro-1H-cyclopenta[b]-quinolin-9-yl)hexane-1,6-diamine",0.047,uM,=,-1.3279021420642825,0,c1ccc2oc(CNCCCCCCNc3c4c(nc5ccccc35)CCC4)cc2c1
1717,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCOCC2)cc1O,rac-2-(3-Hydroxy-4-methoxyphenyl)-2-(morpholin-1-yl)acetonitrile,363.0,uM,=,2.5599066250361124,1,c1ccc(CN2CCOCC2)cc1
1718,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1ccc(NC(=O)CNC(=O)/C=C/c2ccc(O)c(OC)c2)cc1,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-((4-methoxyphenyl)amino)-2-oxoethyl)acrylamide,17.29,uM,=,1.2377949932739225,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
1719,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CCNc2ccnc(N3CCSCC3)n2)cc1,N-phenethyl-2-thiomorpholinopyrimidin-4-amine,26.4,uM,=,1.421603926869831,1,c1ccc(CCNc2ccnc(N3CCSCC3)n2)cc1
1720,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(C)C1N2C,"Methyl-carbamic acid (R)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",9.89,uM,=,0.9951962915971796,1,c1ccc2c(c1)NC1NCCC21
1721,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,Nc1c2c(nc3c1C(c1ccccc1)c1ccc4ccccc4c1O3)CCCC2,"rac-7-Phenyl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",0.3,uM,=,-0.5228787452803376,0,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
1722,1842255,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc2oc(-c3ccc(NCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,"2-(4-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propylamino)phenyl)-5,6,7-trimethoxy-4H-chromen-4-one",0.0019,uM,=,-2.721246399047171,0,O=c1cc(-c2ccc(NCCCNc3c4c(nc5ccccc35)CCCC4)cc2)oc2ccccc12
1723,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CN(Cc1ccccc1)Cc1ccc(/C=C2\Cc3ccc(OCCCCN4CCCCC4)cc3C2=O)cc1,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(4-piperidin-1-yl-butoxy)indan-1-one,0.18,uM,=,-0.744727494896694,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccc(OCCCCN3CCCCC3)cc21
1724,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-Acetamido-3-(1H-indol-3-yl)-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)propanamide",0.153,uM,=,-0.8153085691824012,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
1725,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1ccc(-c2cn3c(NC(=O)c4ccccc4)cccc3[n+]2C)cc1.[Cl-],"5-benzamido-2-(4-(dimethylcarbamoyloxy)phenyl)-1-methylimidazo[1,2-a]pyridin-1-ium",0.2,uM,=,-0.6989700043360187,0,O=C(Nc1cccc2[nH+]c(-c3ccccc3)cn12)c1ccccc1
1726,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2ccccc2F)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1,5-(2-(Cyclopropanecarboxamido)isonicotinamido)-N-((1-(2-fluorobenzyl)piperidin-4-yl)methyl)nicotinamide,1.755,uM,=,0.2442771208018428,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
1727,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Clc1ccc2c(NCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(6-chloro-1,2,3,4-tetrahydro-acridin-9-yl)-heptane-1,7-diamine",7.000000000000001e-05,uM,=,-4.154901959985743,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
1728,462117,10.1021/jm7009364,,,,Inhibition of human AchE,COc1cc2cc(-c3ccc(CN(C)Cc4ccccc4)cc3)c(=O)oc2cc1OC,"3-{4-[(Benzyl-methyl-amino)-methyl]-phenyl}-6,7-dimethoxy-chromen-2-one",0.0445,uM,=,-1.3516399890190685,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
1729,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(Cc4cc(F)ccc4F)CC3)nc12,"3-(4-(2,5-Difluorobenzyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide",12.62,uM,=,1.1010593549081156,1,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1nc2ccccc2s1
1730,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(Cl)c1,3-{7-[(3-chlorobenzyl)methylamino]-heptyloxy}xanthen-9-one,594.0,uM,=,2.773786444981193,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
1731,2198746,10.1039/d2md00087c,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 sec for 3 mins by DTNB-based UV analysis,CCCCCCCNC(=O)Oc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCCCN2CCCCC2)cc1,4-((5-(Diethylcarbamoyl)-1-(4-(piperidin-1-yl)butyl)-1H-benzo[d]imidazol-2-yl)methyl)phenyl heptylcarbamate,2.148,uM,=,0.332034277027518,1,c1ccc(Cc2nc3ccccc3n2CCCCN2CCCCC2)cc1
1732,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cc2nc3c(c(N)c2cc1OC)CCCC3,"6,7-Dimethoxy-1,2,3,4-tetrahydro-acridin-9-ylamine",5.2,uM,=,0.7160033436347992,1,c1ccc2nc3c(cc2c1)CCCC3
1733,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(Cc4ccccn4)CC3)cc1)C2.[Cl-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-((pyridine-2-yl)methyl)-4-methylpiperazinium)-1-yl)benzylidine]-1H-inden-1-one chloride",0.38,uM,=,-0.4202164033831898,0,O=C1/C(=C/c2ccc(N3CC[NH+](Cc4ccccn4)CC3)cc2)Cc2ccccc21
1734,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccccc2CCN1CCC1CCN(Cc2ccccc2)CC1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-3,4-dihydro-2H-isoquinolin-1-one",1.0,uM,=,0.0,0,O=C1c2ccccc2CCN1CCC1CCN(Cc2ccccc2)CC1
1735,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.00369,uM,=,-2.43297363384094,0,O=C(CC1CCc2ccccc2O1)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
1736,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]cc(CCNC(=O)Cn3cc(CN4CC[C@@]56C=C[C@H](O)C[C@@H]5Oc5c(OC)ccc(c56)C4)nn3)c2c1,,5.412000000000001,uM,=,0.7333577879255855,1,O=C(Cn1cc(CN2CC[C@@]34C=CCC[C@@H]3Oc3cccc(c34)C2)nn1)NCCc1c[nH]c2ccccc12
1737,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,CCCN(CCC)CCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,"6-(4-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)phenoxy)-N,N-dipropylhexan-1-amine",3.46,uM,=,0.5390760987927766,1,c1ccc(CC2NCCc3ccccc32)cc1
1738,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)[C@@H]1C2,"(3aS,8aR)-1-benzyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl heptylcarbamate",0.506,uM,=,-0.2958494831602009,0,c1ccc(CN2CCC3c4ccccc4C[C@H]32)cc1
1739,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Fc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c(F)c1,"2-(2,4-Difluorophenyl)-5-(4-(pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazole",0.054,uM,=,-1.2676062401770314,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
1740,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cn1c2ccccc2c2cc[n+](-c3ccc(Br)cc3)cc21,"2-(4-bromophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.3,uM,=,-0.5228787452803376,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
1741,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=[N+]([O-])c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-(4-Nitrophenyl)-5-(4-(pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazole",0.2189999999999999,uM,=,-0.6595558851598817,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
1742,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,O=C1/C(=C/c2ccc(N3CCCC3)cc2)CC/C1=C\c1ccc(N2CCCC2)cc1,"2,5-Bis-(4-pyrrolidin-1-yl-benzylidene)-cyclopentanone",66.43,uM,=,1.822364252441549,1,O=C1/C(=C/c2ccc(N3CCCC3)cc2)CC/C1=C\c1ccc(N2CCCC2)cc1
1743,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc2c(c1OC)C(=O)CC2CCC1CCN(Cc2ccccc2)CC1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-6,7-dimethoxy-2,3-dihydro-1H-inden-1-one",0.008,uM,=,-2.096910013008056,0,O=C1CC(CCC2CCN(Cc3ccccc3)CC2)c2ccccc21
1744,1668099,10.1016/j.bmcl.2017.04.006,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition by Ellman's method,Clc1ccc2c(NCc3ccccn3)c3c(nc2c1)CCCC3,"6-chloro-N-(pyridin-2-ylmethyl)-1,2,3,4-tetrahydroacridin-9-amine",0.09,uM,=,-1.0457574905606752,0,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)nc1
1745,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,N#CC(c1ccc(O)cc1)N1CCCCC1,SID14720769,93.0,uM,=,1.9684829485539352,1,c1ccc(CN2CCCCC2)cc1
1746,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,COC(=O)C(C)CC(=O)C[C@@H](C)[C@H]1C[C@H](O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O,methyl ganoderate A,30.26,uM,=,1.480868923687168,1,O=C1CCC2C3=C(CC[C@H]2C1)C1CCCC1CC3=O
1747,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,OCCN1CCN(c2nccc(NCc3ccccc3)n2)CC1,2-[4-(4-(Benzylamino)pyrimidin-2-yl)piperazin-1-yl]ethanol,26.4,uM,=,1.421603926869831,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
1748,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccc(C#N)cc4)CC3)sc2-c2ccc(C)cc2)cc1,"1-(4-Cyanobenzyl)-N-[4,5-bis(p-tolyl)thiazol-2-yl]piperidine-4-carboxamide",1.28,uM,=,0.1072099696478683,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
1749,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CN1c2ccc(OC(=O)Nc3ccccc3)cc2[C@]2(C)CCNC12,"Phenyl-carbamic acid (S)-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0138,uM,=,-1.8601209135987635,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
1750,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,Cn1ncc2c1-c1sccc1C2NC(=O)CN1CCN(Cc2ccccc2F)CC1,"2-[4-(2-Fluorobenzyl)piperazin-1-yl]-N-(1-methyl-1,4-dihydrothieno[3',2':4,5]cyclopenta[1,2-c]pyrazol-4-yl)acetamide",1.32,uM,=,0.1205739312058498,1,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cn[nH]c2-c2sccc21
1751,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2cccc(Br)c2)CC1)N1CCN(CCCc2c[nH]c3ccc(F)cc23)CC1,2-(4-(3-bromobenzoyl)piperazin-1-yl)-1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)ethanone,37.3,uM,=,1.5717088318086876,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
1752,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(phenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(phenylmethylidene)-1''-N-acrolylpiperidin-4''-one,8.74,uM,=,0.9415114326344032,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
1753,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=c1c(-c2ccc(OCCCCN3CCCCC3)cc2)coc2cc(OCCCCN3CCCCC3)cc(O)c12,5-hydroxy-7-(4-(piperidin-1-yl)butoxy)-3-(4-(4-(piperidin-1-yl)butoxy)phenyl)-4H-chromen-4-one,0.81,uM,=,-0.0915149811213502,0,O=c1c(-c2ccc(OCCCCN3CCCCC3)cc2)coc2cc(OCCCCN3CCCCC3)ccc12
1754,2260019,10.1016/j.ejmech.2020.112872,,,,Inhibition of human AchE by spectrophotometric analysis,O=c1c(NCCCCc2c3c(nc4cc(Cl)ccc24)CCCC3)c(NCCCCc2c3c(nc4ccc(Cl)cc24)CCCC3)c1=O,"3-[4-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)butylamino]-4-[4-(7-chloro-1,2,3,4-tetrahydroacridin-9-yl)butylamino]cyclobut-3-ene-1,2-dione",0.002,uM,=,-2.6989700043360187,0,O=c1c(NCCCCc2c3c(nc4ccccc24)CCCC3)c(NCCCCc2c3c(nc4ccccc24)CCCC3)c1=O
1755,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1F,"2-(5-(2,4-diFluorobenzylamino)pentyl)isoindoline-1,3-dione",0.258,uM,=,-0.5883802940367698,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
1756,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,Cc1cccc(C(=O)Nc2ccc3c(c2)CN(C(=O)c2cccc(C)c2)C(=O)C3)c1,"3-Methyl-N-(2-(3-methylbenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",1.352e-05,uM,=,-4.869023308394383,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
1757,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(NCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3,"(7-Morpholin-4-yl-heptyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.0445,uM,=,-1.3516399890190685,0,c1ccc2c(NCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3
1758,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2cccc4ccccc24)C3=O)c1,"Methyl-carbamic acid 3-({methyl-[7-(2-naphthalen-1-ylmethylene-3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-amino}-methyl)-phenyl ester",0.00209,uM,=,-2.679853713888946,0,O=C1/C(=C/c2cccc3ccccc23)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
1759,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,COC(=O)c1cc2c(N)c3c(nc2nc1C)CCCCC3,"Methyl 5-Amino-2-methyl-7,8,9,10-tetrahydro-6H-cyclohepta-[b][1,8]naphthyridine-3-carboxylate",2.0,uM,=,0.3010299956639812,1,c1cnc2nc3c(cc2c1)CCCCC3
1760,430853,10.1021/jm0503289,,,,Inhibition of human brain AchE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-3-(1H-indol-3-yl)-propionamide",7e-05,uM,=,-4.154901959985743,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
1761,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2cccc(F)c2)ccc1O,(E)-N-(2-((3-fluorophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,22.12,uM,=,1.3447851226326606,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
1762,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1cc[nH]c1,1-Benzyl-3-(1H-pyrrol-3-ylmethylene)-piperidin-4-one,6.0,uM,=,0.7781512503836436,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cc[nH]c1
1763,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCCCOc1ccc2c(c1)CC/C(=C\c1ccc(CN(C)Cc3ccccc3)cc1)C2=O,"2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(5-diethylaminopentyloxy)-3,4-dihydro-2H-naphthalen-1-one",0.056,uM,=,-1.2518119729937995,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)CCc2ccccc21
1764,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methyl-4-(3-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)propoxy)thiazole-5-carboxamide",0.168,uM,=,-0.7746907182741372,0,O=C(Nc1cc(-c2nc(OCCCc3cn(CCNc4c5c(nc6ccccc46)CCCC5)nn3)cs2)ccn1)C1CC1
1765,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](C/C=C\C[n+]2ccc(C(C)(C)C)cc2)cc1.[Cl-].[Cl-],"1,4-bis(4-tert.butylpyridinium)-but-(2Z)-ene-1,4-diyl dichloride",2.0,uM,=,0.3010299956639812,1,C(=C\C[n+]1ccccc1)\C[n+]1ccccc1
1766,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,Cc1ccccc1C1N(C)Cc2cc(O)ccc2N1C,"1,3-Dimethyl-2-o-tolyl-1,2,3,4-tetrahydroquinazolin-6-ol",143.4,uM,=,2.1565491513317814,1,c1ccc(C2NCc3ccccc3N2)cc1
1767,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,COC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-1-methoxymethyl-3-methyl-3H-imidazol-1-ium chloride,134.0,uM,=,2.127104798364808,1,c1c[nH+]c[nH]1
1768,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC1CCN(c2nccc(NCCc3ccccc3)n2)CC1,2-(4-methylpiperidin-1-yl)-N-phenethylpyrimidin-4-amine,8.8,uM,=,0.9444826721501688,1,c1ccc(CCNc2ccnc(N3CCCCC3)n2)cc1
1769,327131,10.1021/jm050746d,,,,Inhibition of human AChE,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccc(O)cc12,"6-(1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(5-hydroxy-1H-indol-3-yl)-ethyl]-amide",0.00045,uM,=,-3.3467874862246565,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
1770,28456,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 11.9-128,C#CCNC1CCc2ccc(OC(=O)N(C)CC)cc21.Cl,Ethyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,47.0,uM,=,1.6720978579357175,1,c1ccc2c(c1)CCC2
1771,1724027,10.1016/j.ejmech.2017.05.019,,,,Inhibition of human brain cortex AChE,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN[C@@H]1N2.O=C(O)c1ccccc1O,Physostigmine salicylic acid,0.031,uM,=,-1.5086383061657274,0,c1ccc2c(c1)N[C@H]1NCCC21.c1ccccc1
1772,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1cccc(-c2cn3c(C(F)(F)F)cccc3[n+]2C)c1.[Cl-],"2-(3-(dimethylcarbamoyloxy)phenyl)-1-methyl-5-(trifluoromethyl)imidazo[1,2-a]pyridin-1-ium",33.6,uM,=,1.526339277389844,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
1773,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,c1ccc2c(c1)[nH]c1ccncc12,"5H-Pyrido[4,3-b]indole",21.4,uM,=,1.3304137733491908,1,c1ccc2c(c1)[nH]c1ccncc12
1774,1994861,10.1016/j.bmcl.2020.127075,,,,Inhibition of human AchE,COc1cc(C2C3=C(CCCC3=O)NC3=C2C(=O)CCC3)ccc1OCc1ccc(F)cc1,"9-[4-[(4-fluorophenyl)methoxy]-3-methoxy-phenyl]-2,3,4,5,6,7,9,10-octahydroacridine-1,8-dione",125.0,uM,=,2.096910013008056,1,O=C1CCCC2=C1C(c1ccc(OCc3ccccc3)cc1)C1=C(CCCC1=O)N2
1775,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1cccc(C(=O)N2c3ccccc3[Se]c3ccc(Cl)cc32)c1,2-Chloro-10H-phenoselenazin-10-yl-(3-methoxyphenyl)-methanone,5.9,uM,=,0.7708520116421442,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
1776,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCN(C)C,(E)-3-(4-(2-(dimethylamino)ethoxy)-3-methoxyphenyl)-N-phenylacrylamide,23.2,uM,=,1.3654879848908996,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
1777,597529,10.1021/jm901296p,,,,Inhibition of human recombinant AChE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(CCCN1CCCCC1)C2,"((4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-[3-(1-piperidinyl)propyl]-6Hbenzofuro[3a,3,2-ef][2]benzazepin-6-ol",0.35,uM,=,-0.4559319556497244,0,C1=C[C@@]23CCN(CCCN4CCCCC4)Cc4cccc(c42)O[C@H]3CC1
1778,2213907,10.1016/j.ejmech.2021.113949,,,,Inhibition of human AChE,c1ccc2c(c1)CN1Cc3cc(OCCCN4CCCCC4)ccc3N=C21,"8-(3-(piperidin-1-yl)propoxy)-10,12-dihydroisoindolo[1,2-b]quinazoline",0.142,uM,=,-0.8477116556169436,0,c1ccc2c(c1)CN1Cc3cc(OCCCN4CCCCC4)ccc3N=C21
1779,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCc3cc[n+](CC4CC4)cc3)sc2cc1OC.[Br-],"1-Cyclopropylmethyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium bromide",0.11,uM,=,-0.958607314841775,0,O=C(CCc1cc[n+](CC2CC2)cc1)c1cc2ccccc2s1
1780,28307,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes,C#CCN(C)[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21.Cl,Ethyl-methyl-carbamic acid 3-(methyl-prop-2-ynyl-amino)-indan-5-yl ester hydrochloride,1200.0,uM,=,3.0791812460476247,1,c1ccc2c(c1)CCC2
1781,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,CN(Cc1ccnc(NC(=O)Nc2cccc3c2C2CCCCN2C3=O)c1)Cc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1,"(+/-)-1-(4-((Methyl((1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)pyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)urea",0.0586,uM,=,-1.2321023839819094,0,O=C(Nc1cc(CNCc2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O
1782,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(-c2ccccc2)n[nH]c1=NCCC1CCN(Cc2ccccc2)CC1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-4-methyl-6-phenylpyridazin-3-amine,0.32,uM,=,-0.494850021680094,0,c1ccc(CN2CCC(CCN=c3ccc(-c4ccccc4)n[nH]3)CC2)cc1
1783,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Cc1ccc2c(c1)c1cnccc1n2CCC(=O)N1c2ccccc2Sc2ccccc21,"3-(8-methyl-5H-pyrido[4,3-b]indol-5-yl)-1-(10H-phenothiazin-10-yl)propan-1-one",0.51,uM,=,-0.2924298239020636,0,O=C(CCn1c2ccccc2c2cnccc21)N1c2ccccc2Sc2ccccc21
1784,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(NCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,"(S)-2-amino-3-(1H-indol-3-yl)-N-(5-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)pentyl)propanamide dihydrochloride",0.62,uM,=,-0.2076083105017461,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
1785,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)c3cc[n+](Cc4ccccc4F)cc3)c2c1.[Br-],1-(2-fluorobenzyl)-4-((2-(5-methoxy-1H-indol-3-yl)ethyl)carbamoyl)pyridi-n-1-ium bromide,3.3,uM,=,0.5185139398778875,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
1786,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,COCCNC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](C)c1.[I-],"[3-(2-Methoxyethylcarbamoyl)-1-methyl-quinolin-1-ium-5-yl]-N,N-dimethylcarbamate iodide",0.02,uM,=,-1.6989700043360187,0,c1ccc2[nH+]cccc2c1
1787,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(6-(6-methoxy-1-methylpyridinium-2-yl)hexyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",0.15,uM,=,-0.8239087409443188,0,c1ccc(CCCCCC[NH+]2CCc3ccccc3C2)[nH+]c1
1788,1465704,10.1016/j.bmcl.2015.02.015,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate after 15 mins by Ellman spectrophotometric method,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0136,uM,=,-1.8664610916297824,0,c1ccc2nc3c(cc2c1)CCCC3
1789,2247136,10.1021/acs.jmedchem.1c02150,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 240 sec by Ellman's method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2,,0.321,uM,=,-0.4934949675951279,0,C1=C[C@H]2Cc3nc4ccccc4cc3[C@@H](C1)C2
1790,1331163,10.1039/C1MD00221J,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured after 10 mins by Ellman's method,O=C(Nc1cc2ccccc2oc1=O)c1ccc(Cl)c(Cl)c1,"3-(3',4'-Dichlorobenzamide)coumarin",15.01,uM,=,1.1763806922432705,1,O=C(Nc1cc2ccccc2oc1=O)c1ccccc1
1791,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,CC1(C)CNC2=C([N+](=O)[O-])C3(C(=O)c4ccc(Br)c5c(Br)ccc3c45)C(C#N)=C(N)N2C1,"6'-amino-5,6-dibromo-3',3'-dimethyl-9'-nitro-2-oxo-1',2',3',4'-tetrahydro-2H-spiro[acenaphthylene-1,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",5.98,uM,=,0.7767011839884109,1,O=C1c2cccc3cccc(c23)C12C=CN1CCCNC1=C2
1792,327131,10.1021/jm050746d,,,,Inhibition of human AChE,O=C(CCCCCNc1c2c(nc3cccc(Cl)c13)CCCC2)NCCc1c[nH]c2ccccc12,"6-(8-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",0.00087,uM,=,-3.0604807473813813,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
1793,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COC(=O)c1ccccc1C[n+]1ccc(CC2Cc3cc(OC)c(OC)cc3C2=O)c(C(=O)Oc2c(Cl)cc(Cl)cc2Cl)c1.[Br-],"(2,4,6-Trichlorophenyl) 4-[(5,6-dimethoxy-1-oxo-indan-2-yl)methyl]-1-[(2-methoxycarbonylphenyl)methyl]pyridin-1-ium-3-carboxylate bromide",0.0693,uM,=,-1.1592667653881932,0,O=C(Oc1ccccc1)c1c[n+](Cc2ccccc2)ccc1CC1Cc2ccccc2C1=O
1794,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CCN(CC)CCOc1cccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)c1,(2-{4-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-[3-(2-diethylaminoethoxy)phenyl]methanone,37.1,uM,=,1.569373909615046,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
1795,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(CCC2C(=O)Nc3ccccc3C2=O)CC1,"3-[2-(1-Methyl-piperidin-4-yl)-ethyl]-1H-quinoline-2,4-dione",0.0042,uM,=,-2.3767507096021,0,O=C1Nc2ccccc2C(=O)C1CCC1CCNCC1
1796,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2,"3-(1-Benzyl-piperidin-4-yl)-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.1,uM,=,-1.0,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
1797,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(Cl)cc1)N1CCN(c2ccccn2)CC1,N'-(4-Chlorobenzylidene)-4-(pyridin-2-yl)piperazine-1-carbohydrazide,3.42,uM,=,0.534026106056135,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
1798,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,O=[N+]([O-])c1ccc2nc3c(c(NCc4ccccc4)c2c1)CCCC3,"Benzyl-(7-nitro-1,2,3,4-tetrahydro-acridin-9-yl)-amine",1.6,uM,=,0.2041199826559248,1,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
1799,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1,5-Benzylidene-2-[(2-oxo-2H-chromen-6-yl)imino]thiazolidin-4-one,0.0940999999999999,uM,=,-1.026410376572743,0,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1
1800,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)O[C@@H]1N2C,"(2-Ethyl-phenyl)-carbamic acid 2,3a,8-trimethyl-3,3a,8,8a-tetrahydro-2H-isoxazolo[5,4-b]indol-5-yl ester",0.065,uM,=,-1.1870866433571443,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNO[C@@H]1N2
1801,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccc([N+](=O)[O-])cc12,"6'-amino-5,9'-dinitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",1.15,uM,=,0.0606978403536116,1,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
1802,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,Cl.N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CC=CCC2)o1,"2-[1-(2-{[5-(3,6-Dihydro-2H-pyridin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile, Di-hydrochloride",0.095,uM,=,-1.0222763947111522,0,C=C1NCCN1CCNCc1ccc(CN2CC=CCC2)o1
1803,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,c1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1,2-{4-[2-(Piperidin-1-yl)ethoxy]phenyl}-1H-benzo[d]-imidazole,1.03,uM,=,0.0128372247051722,1,c1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1
1804,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Fc1ccc2c(NCCCCCCCNc3c4c(nc5cc(F)ccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(6-fluoro-1,2,3,4-tetrahydro-acridin-9-yl)-heptane-1,7-diamine",0.0006,uM,=,-3.2218487496163566,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
1805,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1,"N-(5-((1-benzylpiperidin-4-yl)carbamoyl)pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide",0.358,uM,=,-0.4461169733561256,0,O=C(NC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1
1806,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CC(C)c1ccc(NC(=O)OCC2CCCN(C3Cc4ccccc4C3)C2)cc1,"(1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl (4-isopropylphenyl)carbamate",18.7,uM,=,1.271841606536499,1,O=C(Nc1ccccc1)OCC1CCCN(C2Cc3ccccc3C2)C1
1807,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(Br)cc13)CCCC2,"7-bromo-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",4.79,uM,=,0.6803355134145632,1,c1ccc2nc3c(cc2c1)CCCC3
1808,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccc(C#N)cc3)CC2)cc(C(C)(C)C)c1O,"(E)-N-(2-(1-(4-cyanobenzyl)piperidin-4-yl)ethyl)-3-(3,5-ditert-butyl-4-hydroxyphenyl)acrylamide",2.78,uM,=,0.4440447959180762,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1809,945319,10.1016/j.bmcl.2012.11.083,,,,Inhibition of AChE (unknown origin),C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.045,uM,=,-1.3467874862246565,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
1810,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccc(C)cc3)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)-1-(4-methylbenzyl)pyridinium bromide",0.556,uM,=,-0.2549252084179425,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
1811,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccc(F)cc2)cc1.[Br-],4-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-(4-fluorobenzyl)pyridin-1-ium bromide,3.4,uM,=,0.5314789170422551,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
1812,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,COP(=O)(OC)O/C(C)=C1\CCOC1=O,(E)-Dimethyl 1-(2-oxodihydrofuran-3(2H)-ylidene)ethylphosphate,70.0,uM,=,1.845098040014257,1,C=C1CCOC1=O
1813,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCCc1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1,"7-demethoxyegonol-9(Z),12(Z)linoleate",2.7,uM,=,0.4313637641589873,1,c1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1
1814,28628,10.1021/jm970210v,,,,Inhibition of human acetylcholinesterase from erythrocytes (RBC),CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(C)C1N2Cc1ccccc1,"Methyl-carbamic acid (R)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",2.8475,uM,=,0.454463732751138,1,c1ccc(CN2c3ccccc3C3CCNC32)cc1
1815,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1OC)CCCC3,"ethyl 5-amino-2-methyl-4-(2-methoxyphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.234,uM,=,-0.6307841425898572,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
1816,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NCCCCCCCCN2CCOCC2)c1,(8-Morpholin-4-yl-octyl)-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0273999999999999,uM,=,-1.562249437179612,0,O=C(NCCCCCCCCN1CCOCC1)Oc1cccc(CNCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1
1817,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(F)cc1)CC2.[Br-],"2-(4-fluorophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.99,uM,=,0.2988530764097066,1,C1=[N+](c2ccccc2)CCc2ccccc21
1818,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc([N+](=O)[O-])cc3)CC1)C2,"5,6-Dimethoxy-2-[1-(4-nitro-benzyl)-piperidin-4-ylmethyl]-indan-1-one",1.91,uM,=,0.2810333672477275,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1819,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccccc2CCC1CC1CCN(c2ccccc2)CC1,"2-((1-phenylpiperidin-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one",2.1,uM,=,0.3222192947339193,1,O=C1c2ccccc2CCC1CC1CCN(c2ccccc2)CC1
1820,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CNC(=O)Oc1ccc2c(c1)c1c(n2C)/C(=N\CCc2ccccc2)CC1,"Methyl-carbamic acid 4-methyl-3-[(Z)-phenethylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.16,uM,=,-0.7958800173440752,0,c1ccc(CC/N=C2/CCc3c2[nH]c2ccccc32)cc1
1821,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,C(=C/C1CCN(Cc2ccccc2)CC1)\c1noc2ccccc12,3-[(E)-2-(1-Benzyl-piperidin-4-yl)-vinyl]-benzo[d]isoxazole,0.21,uM,=,-0.6777807052660807,0,C(=C/C1CCN(Cc2ccccc2)CC1)\c1noc2ccccc12
1822,462117,10.1021/jm7009364,,,,Inhibition of human AchE,Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCNCCCNCCCNc1c3c(nc4ccccc14)CCCC3)c1cc(N)ccc21,"3,8-Diamino-6-phenyl-5-(3-{3-[3-(1,2,3,4-tetrahydro-acridin-9-ylamino)-propylamino]-propylamino}-propyl)-phenanthridinium",0.00155,uM,=,-2.8096683018297086,0,c1ccc(-c2c3ccccc3c3ccccc3[n+]2CCCNCCCNCCCNc2c3c(nc4ccccc24)CCCC3)cc1
1823,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(Cl)cc2)nn1C(=O)N(C)C,"3-(4-Chloro-phenyl)-5-methylsulfanyl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.1,uM,=,-1.0,0,c1ccc(-c2nc[nH]n2)cc1
1824,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cccc2oc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)cc(=O)c12,N-(2-(1-benzylpiperidin-4-yl)ethyl)-5-methoxy-4-oxo-4H-chromene-2-carboxamide,0.87,uM,=,-0.0604807473813814,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
1825,1842289,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 60 mins followed by substrate addition by Ellman's method,C#CCN(C)C(C)Cc1cccc(OC(=O)N(C)CCCCCC)c1,Hexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,2.0,uM,=,0.3010299956639812,1,c1ccccc1
1826,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCCCCCCCCOc1ccc(/C=C/C(=O)Nc2ccccc2)cc1OC,(E)-3-(4-((10-(diethylamino)decyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,14.92,uM,=,1.17376882313665,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
1827,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Oc1ccc(C2CC(c3ccccc3O)=Nc3ccccc3S2)cc1,"2-[2-(4-hydroxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4-yl]phenol",4.1,uM,=,0.6127838567197355,1,c1ccc(C2=Nc3ccccc3SC(c3ccccc3)C2)cc1
1828,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CN(CCOc1ccc2c3c(c(=O)oc2c1)CCCC3)Cc1ccccc1,"3-(2-(Benzyl(methyl)amino)ethoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",2.8,uM,=,0.4471580313422192,1,O=c1oc2cc(OCCNCc3ccccc3)ccc2c2c1CCCC2
1829,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2cccc3ccccc23)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1cccc2ccccc12,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(naphthalen-1-ylmethylene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",5.81,uM,=,0.7641761323903307,1,O=C1/C(=C/c2cccc3ccccc23)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1cccc2ccccc12
1830,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)OC/C(=C/c2cc(O)c(O)c(O)c2)C3=O)c1,"3-((methyl(7-(4-oxo-3-(3,4,5-trihydroxybenzylidene)chroman-7-yloxy)heptyl)amino)methyl)phenyl methylcarbamate",0.00981,uM,=,-2.0083309926200514,0,O=C1/C(=C\c2ccccc2)COc2cc(OCCCCCCCNCc3ccccc3)ccc21
1831,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,C/N=C1/CCc2c1n(C)c1cc(Cl)c(OC(=O)NC)cc21,"Methyl-carbamic acid 6-chloro-4-methyl-3-[(Z)-methylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.67,uM,=,-0.1739251972991735,0,N=C1CCc2c1[nH]c1ccccc21
1832,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,Clc1ccccc1CNc1ccnc(NC2CCN(Cc3ccccc3)CC2)n1,"N2-(1-Benzylpiperidin-4-yl)-N4-(2-chlorobenzyl)pyrimidine-2,4-diamine",7.7,uM,=,0.8864907251724818,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
1833,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.054,uM,=,-1.2676062401770314,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1834,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1C.F[B-](F)(F)F,2-methoxy-1-methyl-5-(trifluoromethyl)pyridinium tetrafluoroborate,31.0,uM,=,1.4913616938342726,1,c1cc[nH+]cc1
1835,28477,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 28.1-58.3,CCN(C)C(=O)Oc1ccc2c(c1)C(NC)CC2.Cl,Ethyl-methyl-carbamic acid 3-methylamino-indan-5-yl ester hydrochloride,38.6,uM,=,1.586587304671755,1,c1ccc2c(c1)CCC2
1836,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C/c2nnc(-c3ccc(C(F)(F)F)cc3)o2)ccc1O,"2-methoxy-4-(2-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)vinyl)phenol",6.8e-05,uM,=,-4.167491087293763,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
1837,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(Br)n3)CC1)C2,"2-((1-((6-bromopyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",1.98,uM,=,0.2966651902615311,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
1838,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2Cc3ccsc3C2=NN1CCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(4-(4-((1-(phenylsulfonyl)-1H-indol-4-yl)methyl)piperazin-1-yl)butyl)-2,4,4a,5-tetrahydro-3H-thieno[3',2':4,5]cyclopenta[1,2-c]pyridazin-3-one",3.55,uM,=,0.5502283530550941,1,O=C1CC2Cc3ccsc3C2=NN1CCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
1839,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCc2cccc(CSCc3ccc(CN(C)C)o3)c2)o1,{5-[3-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanylmethyl)-benzylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,1.5,uM,=,0.1760912590556812,1,c1cc(CSCc2ccco2)cc(CSCc2ccco2)c1
1840,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,COc1ccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)cc1.Cl,"9-(2-(4-((1-(4-Methoxyphenyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",2.3,uM,=,0.3617278360175928,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
1841,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,COc1ccc2c(c1)c1c[n+](C)ccc1n2CCC(=O)N1c2ccccc2Sc2ccccc21.[I-],"8-methoxy-2-methyl-5-(3-oxo-3-(10H-phenothiazin-10-yl)propyl)-5H-pyrido[4,3-b]indol-2-ium iodide",5.3,uM,=,0.724275869600789,1,O=C(CCn1c2ccccc2c2c[nH+]ccc21)N1c2ccccc2Sc2ccccc21
1842,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c3ccccc32)cc1,"1-[(4-methoxyphenyl)methyl]-4-oxo-N-{8-[(1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-1,4-dihydroquinoline-3-carboxamide",0.768,uM,=,-0.114638779968488,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
1843,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,FC(F)(F)c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-(4-(Pyridin-2-yl)piperazin-1-yl)-5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazole",0.182,uM,=,-0.7399286120149252,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
1844,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,O=C(Nc1ccccc1)OCC1CCCN(Cc2ccccc2)C1,(1-benzylpiperidin-3-yl)methyl phenylcarbamate,67.1,uM,=,1.826722520168992,1,O=C(Nc1ccccc1)OCC1CCCN(Cc2ccccc2)C1
1845,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=c1ccc2cc(/N=C/c3ccc(Cl)cc3)ccc2o1,6-[(4-Chlorobenzylidene)amino]-2H-chromen-2-one,0.0789,uM,=,-1.1029229967905796,0,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1
1846,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4ccccc4F)[nH]3)ccc21,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(2-fluorophenyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",187.51,uM,=,2.2730244338184646,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
1847,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3Sc3ccccc32)cc1,(4-methoxyphenyl)(10H-phenothiazin-10-yl)methanone,6.3,uM,=,0.7993405494535817,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
1848,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Oc1cc(O)cc(Oc2c(O)cc(O)c3c2Oc2c(O)cc(O)cc2O3)c1,Eckol,10.03,uM,=,1.001300933020418,1,c1ccc(Oc2cccc3c2Oc2ccccc2O3)cc1
1849,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,O=C(c1cccc(Cl)c1Cl)n1nc(OCCN2CCCCC2)c2ccccc21,"(2,3-dichlorophenyl)(3-(2-piperidinoethoxy)indazol-1-yl)ketone",10.5,uM,=,1.021189299069938,1,O=C(c1ccccc1)n1nc(OCCN2CCCCC2)c2ccccc21
1850,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1,"1,3-Bis-(3-imidazolidin-2-yl-phenyl)-urea",0.59,uM,=,-0.2291479883578558,0,O=C(Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1
1851,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C2\CN(C)C/C(=C\c3ccc(C(OCC)OCC)cc3)C2=O)cc1,"3,5-Bis[4-(diethoxymethyl)benzylidene]-1-methyl-piperidin-4-one",0.042,uM,=,-1.3767507096020994,0,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
1852,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1.[Cl-].[Cl-],4-(aminocarbonyl)-1-({[1-chloro-2-[(E)-(hydroxyimino)methyl]pyridinium-1(2H)-yl]methoxy}methyl)pyridinium chloride,203.0,uM,=,2.307496037913213,1,c1cc[n+](COC[n+]2ccccc2)cc1
1853,2200872,10.1016/j.ejmech.2020.112860,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 20 mins by DTNB reagent based spectrophotometric method,CCOC1(c2cc(O)ccc2O)C=C(CC/C=C(\C)CCC=C(C)C)C(=O)O1,Dayaolingzhiol E,7.37,uM,=,0.8674674878590515,1,O=C1C=CC(c2ccccc2)O1
1854,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CN(C)c1ccc(/C=C/C(=O)C2CCc3ccccc3C2=O)cc1,"2-[3-(4-Dimethylamino-2-nitro-phenyl)-acryloyl]-3,4-dihydro-2H-naphthalen-1-one",39.44,uM,=,1.5959369062691735,1,O=C(/C=C/c1ccccc1)C1CCc2ccccc2C1=O
1855,28165,10.1016/s0960-894x(02)00482-1,,,,In vitro inhibition of human recombinant AChE.,COc1cc2c(cc1OC)C(=O)C(CC1CC[N+](C)(Cc3ccccc3)CC1)C2,"1-Benzyl-4-(5,6-dimethoxy-1-oxo-indan-2-ylmethyl)-1-methyl-piperidinium",0.025,uM,=,-1.6020599913279625,0,O=C1c2ccccc2CC1CC1CC[NH+](Cc2ccccc2)CC1
1856,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(N4CCN(C)CC4)c2c1)CCCC3,"7-Methyl-9-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydroacridine",0.44,uM,=,-0.3565473235138126,0,c1ccc2c(N3CCNCC3)c3c(nc2c1)CCCC3
1857,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(NCCCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3,"(9-Morpholin-4-ylnonyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.034,uM,=,-1.4685210829577449,0,c1ccc2c(NCCCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3
1858,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1,"(2-(7-(Benzylamino)heptyl)isoindoline-1,3-dione",0.303,uM,=,-0.518557371497695,0,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
1859,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(c3ccc(Cl)cc3)C(=O)C2C12C(=O)c1ccccc1C2=O,"5'-(4-Chlorophenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",27.86,uM,=,1.4449811120879448,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
1860,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,"N4-(3,4-dimethoxyphenethyl)-N2-ethylquinazoline-2,4-diamine",7.5,uM,=,0.8750612633917001,1,c1ccc(CCNc2ncnc3ccccc23)cc1
1861,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,CCCC1OCc2c[n+](C)c(C)c(OC(=O)N(C)C)c2CO1.[Br-],"1,5-Dihydro-3-propyl-7,8-dimethyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",140.0,uM,=,2.146128035678238,1,c1cc2c(c[nH+]1)COCOC2
1862,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",1.03,uM,=,0.0128372247051722,1,c1ccc2nc3c(cc2c1)CCCC3
1863,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.005,uM,=,-2.3010299956639813,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1864,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(NCCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3,"(8-Morpholin-4-yloctyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.0165,uM,=,-1.7825160557860935,0,c1ccc2c(NCCCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3
1865,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2cc(O)ccc2o1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-6-hydroxy-4-oxo-4H-chromene-2-carboxamide,0.091,uM,=,-1.0409586076789064,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
1866,1653858,10.1016/j.ejmech.2016.11.050,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by spectrophotometry based Ellman method,COc1cccc(C2c3ccc4cccnc4c3Oc3nc4c(c(N)c32)CCCC4)c1,"7-(3-Methoxyphenyl)-9,10,11,12-tetrahydro-7H-pyrano[2,3-b:5,6-h']diquinolin-8-amine",0.75,uM,=,-0.1249387366082999,0,c1ccc(C2c3cc4c(nc3Oc3c2ccc2cccnc32)CCCC4)cc1
1867,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.016,uM,=,-1.7958800173440752,0,c1ccc2c(c1)N[C@H]1NCCC21
1868,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3c(Cl)cccc13)C1CCC2C1,"8-chloro-10-azatetracyclo[10.2.1.02,11.04,9]pentadeca-2,4,6,8,10-pentaen-3-amine",0.0843,uM,=,-1.0741724253752576,0,c1ccc2nc3c(cc2c1)C1CCC3C1
1869,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,COc1ccc(C2NC(=S)Nc3nc4c(c(N)c32)CCCC4)cc1,"5-amino-4-(4-methoxyphenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",7.64,uM,=,0.8830933585756899,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
1870,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(OC)c(CN2CCC(c3oc4ccccc4c3C(=O)c3ccccc3)CC2)c1,"(2-(1-(2,5-dimethoxybenzyl)piperidin-4-yl)benzofuran-3-yl)(phenyl)methanone",58.19,uM,=,1.7648483571934108,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
1871,573639,10.1021/np800671p,,,,Inhibition of AChE by spectrophotometry,C[C@]1(CO)CCC[C@]2(C)[C@H]1C[C@H](O)[C@@]13C[C@@H](CC[C@@H]21)[C@]1(C)O[C@@H]13,sideroxol,14.5,uM,=,1.1613680022349748,1,C1CC[C@@H]2CC[C@@]34C[C@@H](CC[C@H]3C2C1)C1O[C@@H]14
1872,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CCn1c2ccccc2c2cc(/C=C/c3cc(N4CCOCC4)c4ccccc4[n+]3C)ccc21.[I-],(E)-2-(2-(9-Ethyl-9H-carbazol-3-yl)vinyl)-1-methyl-4-(morpholin-4-yl)quinolinium iodide,2.3,uM,=,0.3617278360175928,1,C(=C/c1cc(N2CCOCC2)c2ccccc2[nH+]1)\c1ccc2[nH]c3ccccc3c2c1
1873,28936,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase activity from octopus brain,CCCCSC(=O)OCC[N+](C)(C)C.[Cl-],(2-Butylsulfanylcarbonyloxy-ethyl)-trimethyl-ammonium chloride,1000.0,uM,=,3.0,1,
1874,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NC(=O)C3CCN(Cc4cc(F)cc(F)c4)CC3)sc2-c2ccc(C)cc2)cc1,"1-(3,5-Difluorobenzyl)-N-[4,5-bis(p-tolyl)thiazol-2-yl]-piperidine-4-carboxamide",2.5,uM,=,0.3979400086720376,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
1875,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCCCCCCN(C)Cc3ccccc3)cc2oc1=O,"7-(6-(N-Benzyl-N-methylamino)hexyloxy)-3,4-dimethyl-2H-chromen-2-one",0.34,uM,=,-0.4685210829577448,0,O=c1ccc2ccc(OCCCCCCNCc3ccccc3)cc2o1
1876,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@H]2O1,"Phenyl-carbamic acid 2,4a,9-trimethyl-2,3,4,4a,9,9a-hexahydro-1-oxa-2,9-diaza-fluoren-6-yl ester",0.13,uM,=,-0.8860566476931633,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNO[C@@H]1N2
1877,1459232,10.1016/j.ejmech.2014.07.013,,,,Inhibition of AChE (unknown origin),COc1cc2oc(-c3ccc(CN4CCCC4)cc3)cc(=O)c2cc1OC,"6,7-Dimethoxy-2-[4-(pyrrolidin-1-ylmethyl)-phenyl]-4Hchromen-4-one",0.034,uM,=,-1.4685210829577449,0,O=c1cc(-c2ccc(CN3CCCC3)cc2)oc2ccccc12
1878,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCc3cc[n+](Cc4ccccc4)cc3)sc2cc1OC,"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium",0.0046,uM,=,-2.337242168318426,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1cc2ccccc2s1
1879,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCn3cc(CCCCN4CC[C@@]56C=C[C@H](O)C[C@@H]5Oc5c(OC)ccc(c56)C4)nn3)c2c1,,0.018,uM,=,-1.744727494896694,0,O=C(CCCCn1cc(CCCCN2CC[C@@]34C=CCC[C@@H]3Oc3cccc(c34)C2)nn1)NCCc1c[nH]c2ccccc12
1880,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(Cc1cccc(/C=N/O)c1O)CC2,"3-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",907.8,uM,=,2.9579901784068303,1,c1ccc(CN2CCc3ccccc3C2c2ccccc2)cc1
1881,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1,N-Hydroxy-4-(2-benzyloxyacridin-9-ylamino)benzamide,2.64,uM,=,0.421603926869831,1,c1ccc(COc2ccc3nc4ccccc4c(Nc4ccccc4)c3c2)cc1
1882,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,1-[(2-Chloro-phenyl)-diphenyl-methyl]-1H-imidazole,19.41,uM,=,1.2880255353883627,1,c1ccc(C(c2ccccc2)(c2ccccc2)n2ccnc2)cc1
1883,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCNCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-N'-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]heptane-1,7-diamine",0.00044,uM,=,-3.356547323513813,0,c1ccc2c(c1)CCC(CCNCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2
1884,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCCN2c1ccccc1,"3-(1-benzylpiperidin-4-yl)-1-(1-phenyl-1,2,3,4-tetrahydroquinolin-6-yl)propan-1-one",0.054,uM,=,-1.2676062401770316,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCCN2c1ccccc1
1885,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)/C(=N\N)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one hydrazone",0.19,uM,=,-0.721246399047171,0,N=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1886,1279629,10.1021/ml400304w,,,,Inhibition of acetylcholinesterase (unknown origin),Cc1cccc2c3c(ccc12)C1=C(C(=O)C3=O)[C@@H](C)CO1,"(R)-1,6-dimethyl-1,2-dihydrophenanthro[1,2-b]furan-10,11-dione",1.0,uM,=,0.0,0,O=C1C(=O)c2c(ccc3ccccc23)C2=C1CCO2
1887,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1[N+](=O)[O-])CCCC3,"ethyl 5-amino-2-methyl-4-(2-nitrophenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.338,uM,=,-0.4710832997223452,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
1888,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccc(C)cc2)N(c2ccccc2)[C@@H]1c1ccc(C)cc1,"(2R,6S)-methyl 1-phenyl-4-(phenylamino)-2,6-dip-tolyl-1,2,5,6-tetrahydropyridine-3-carboxylate",5730.0,uM,=,3.75815462196739,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
1889,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c(cn1)[nH]c1ccccc12,"N-(6-((1,2,3,4-Tetrahydroacridin-9-yl)amino)hexyl)-9Hpyrido[3,4-b]indoe-3-carboxamide",0.0917999999999999,uM,=,-1.0371573187987575,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c(cn1)[nH]c1ccccc12
1890,1885291,10.1016/j.bmc.2019.06.033,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,O=C(Cc1cc(=O)oc2cc(O)ccc12)NCCCNCCNCCCNc1c2c(nc3ccccc13)CCCC2,"2-(7-hydroxy-2-oxo-2H-chromen-4-yl)-N-(3-(2-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propylamino)ethylamino)propyl)acetamide",0.038,uM,=,-1.42021640338319,0,O=C(Cc1cc(=O)oc2ccccc12)NCCCNCCNCCCNc1c2c(nc3ccccc13)CCCC2
1891,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,O=c1c2ccccc2nc2n1CCC2,"2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one",62.5,uM,=,1.7958800173440752,1,O=c1c2ccccc2nc2n1CCC2
1892,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCNc1c2c(nc3c(Cl)cccc13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-6-(5-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
1893,751131,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes BChE,CCN(CC)C(C)C(=O)N1c2ccccc2Sc2ccccc21.Cl,2-(diethylamino)-1-(10H-phenothiazin-10-yl)propan-1-one hydrochloride,3.37,uM,=,0.5276299008713387,1,c1ccc2c(c1)Nc1ccccc1S2
1894,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3cccc(Cl)c3)cc1C(N)=O)C2.[Br-],"(+/-)-1-[(3-Chlorophenyl)methyl]-4-[(5,6-dimethoxy-1-oxo-indan-2-yl)methyl]pyridin-1-ium-3-carboxamide Bromide",0.041,uM,=,-1.3872161432802643,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
1895,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCN1CCCC1,(E)-3-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-N-phenylacrylamide,35.13,uM,=,1.5456781497920256,1,O=C(/C=C/c1ccc(OCCN2CCCC2)cc1)Nc1ccccc1
1896,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,CN[C@H]1CCC2=CC3=CC[C@]4(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]4(C)[C@@H]3CC[C@H]2C1(C)C,buxaminol C,40.0,uM,=,1.6020599913279625,1,C1=C2CCCC[C@@H]2CC[C@@H]2C1=CCC1CCCC12
1897,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC(C)C,"4-Isobutoxy-N-methyl-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0492,uM,=,-1.3080348972326397,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nccs2)ccn1
1898,2059377,10.1016/j.bmc.2021.116074,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,10.9,uM,=,1.0374264979406236,1,c1ccccc1
1899,2288317,10.1016/j.ejmech.2022.114806,,,,Inhibition of human AChE using ATC and BTC iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by DTNB reagent based assay,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.044,uM,=,-1.3565473235138126,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1900,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)CC/C(=C/c2cc(O)c(O)c(O)c2)C3=O)c1,"3-((methyl(7-(5-oxo-6-(3,4,5-trihydroxybenzylidene)-5,6,7,8-tetrahydronaphthalen-2-yloxy)heptyl)amino)methyl)phenyl methylcarbamate",0.00494,uM,=,-2.306273051076353,0,O=C1/C(=C\c2ccccc2)CCc2cc(OCCCCCCCNCc3ccccc3)ccc21
1901,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,CC1(C)CCN(Cc2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1,"3-(4-((4,4-Dimethylpiperidin-1-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.011,uM,=,-1.958607314841775,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
1902,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1C=CN(Cc3ccccc3)C=C1C(C)=O)CC2,"2-((3-Acetyl-1-benzyl-1,4-dihydropyridin-4-yl)methyl)-6,7-dimethoxy-3,4-dihydronaphthalen-1(2H)-one",0.173,uM,=,-0.7619538968712046,0,O=C1c2ccccc2CCC1CC1C=CN(Cc2ccccc2)C=C1
1903,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,COc1ccc(C2c3ccc4ccccc4c3Oc3nc4c(c(N)c32)CCCC4)c(OC)c1,"rac-7-(2,4-Dimethoxyphenyl)-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",0.37,uM,=,-0.431798275933005,0,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
1904,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Oc1ccc(CNC2CCN(Cc3ccccc3)C2)c(O)c1,"4-(((1-Benzylpyrrolidin-3-yl)amino)methyl)benzene-1,3-diol",1.5219999999999998,uM,=,0.1824146524345539,1,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
1905,2054941,10.1016/j.ejmech.2020.112743,,,,Inhibition of recombinant human AChE using ATCI as substrate incubated for 5 mins followed by substrate addition and measured after 5 mins by spectrophotometric based Ellman's method,O=c1c2cc(Cl)ccc2oc2ccc(OCCCCCN3CCCCCC3)cc12,2-(5-(Azepan-1-yl)pentyloxy)-7-chloro-9H-xanthen-9-one,0.12,uM,=,-0.9208187539523752,0,O=c1c2ccccc2oc2ccc(OCCCCCN3CCCCCC3)cc12
1906,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,COc1ccc2cc(C(=O)N[C@@H](CCC(=O)NCCC3CCN(Cc4ccccc4)CC3)C(=O)O)ccc2c1,N-[6-Methoxy-2-naphthoyl]-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-OH,15.2,uM,=,1.1818435879447726,1,O=C(CCCNC(=O)c1ccc2ccccc2c1)NCCC1CCN(Cc2ccccc2)CC1
1907,28464,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.0-15.2,C#CCN[C@H]1CCc2ccc(OC(=O)N(C)CCC)cc21.Cl,Methyl-propyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,8.5,uM,=,0.9294189257142929,1,c1ccc2c(c1)CCC2
1908,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCCCCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-dodecyl-7-methoxytacrine hydrochloride,1.0,uM,=,0.0,0,c1ccc2nc3c(cc2c1)CCCC3
1909,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1n[nH]c2ccccc12,"1H-indazole-3-carboxylic acid [7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)-heptyl]-amide",0.095,uM,=,-1.0222763947111522,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1n[nH]c2ccccc12
1910,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1.[Cl-].[Cl-],4-[(E)-(hydroxyimino)methyl]-1-[({4-[(E)-(hydroxyimino)methyl]pyridinium-1-yl}methoxy)methyl]pyridinium dichloride (toxogonin),577.0,uM,=,2.761175813155732,1,c1cc[n+](COC[n+]2ccccc2)cc1
1911,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{5-[(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",8.02,uM,=,0.9041743682841636,1,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
1912,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)cc1,2-Chloro-[10-(4-methoxybenzoyl)]-10H-phenothiazine,5.9,uM,=,0.7708520116421442,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
1913,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,Cc1ccc(C2C3=C(CC(C)(C)CC3=O)Nc3nc4c(c(N)c32)CCCC4)cc1,"11-Amino-3,3-dimethyl-12-p-tolyl-3,4,5,7,8,9,10,12-octahydro-2H-dibenzo[b,g][1,8]naphthyridin-1-one",0.67,uM,=,-0.1739251972991735,0,O=C1CCCC2=C1C(c1ccccc1)c1cc3c(nc1N2)CCCC3
1914,526512,10.1021/np060268p,,,,Inhibition of human AChE by Ellman's assay,COc1ccc2c(=O)oc3c(OC)cc(CCN(C)C)c4c(=O)oc1c2c34,"{1-(2-dimethylaminoethyl)-3,8-dimethoxychromeno[5,4,3-cde]chromene-5,10-dione}",0.54,uM,=,-0.2676062401770315,0,O=c1oc2cccc3c(=O)oc4cccc1c4c23
1915,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCCCC2)ccc1O,SID7975408,448.0,uM,=,2.651278013998144,1,c1ccc(CN2CCCCC2)cc1
1916,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCN1CCN(Cc2ccccc2)CC1,"2-(2-(4-benzylpiperazin-1-yl)ethyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",0.17,uM,=,-0.7695510786217261,0,O=C1CC2CCc3ccsc3C2=NN1CCN1CCN(Cc2ccccc2)CC1
1917,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccc(C)cc2)C(=O)[C@@]2(C1)[C@H](c1ccc(C)cc1)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(4-methylphenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(4-methylphenylmethylidene)-1''-N-acrolylpiperidin-4''-one,7.49,uM,=,0.8744818176994665,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
1918,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CCCN1Cc2cc(O)ccc2N(C)C1c1ccccc1,"1-Methyl-2-phenyl-3-n-propyl-1,2,3,4-tetrahydroquinazolin-6-ol",279.3,uM,=,2.4460709357010053,1,c1ccc(C2NCc3ccccc3N2)cc1
1919,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),CC(C)n1c2ccccc2c2cc[n+](-c3ccccc3)cc21,"9-isopropyl-2-phenyl-pyrido[3,4-b]indol-2-ium",0.54,uM,=,-0.2676062401770315,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
1920,1797688,10.1021/acs.jnatprod.8b00378,,,,Inhibition of human AChE using acetylthiocholine as substrate,Cc1coc2c1c(=O)oc(=O)c1c3c(ccc12)C(C)(C)CCC3,"4,9,9-Trimethyl-9,10,11,12-tetrahydrofuro[3,2-c]naphtho[2,1-e]oxepine-1,3-dione",3.312,uM,=,0.5200903281128425,1,O=c1oc(=O)c2c3c(ccc2c2occc12)CCCC3
1921,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCCCCCN(C)Cc1ccc(OC)c(OC)c1,"1-(12-((3,4-dimethoxybenzyl)(methyl)amino)dodecyl)-5-methoxy-1H-indole-3-carbaldehyde",44.96,uM,=,1.6528263025610046,1,c1ccc(CNCCCCCCCCCCCCn2ccc3ccccc32)cc1
1922,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2Cl)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(2-chlorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(2-chlorophenylmethylidene)hexahydro-1H-pyrrolizine,13.64,uM,=,1.13481437032046,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
1923,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2c4ccccc4cc4ccccc24)C3=O)c1,"Methyl-carbamic acid 3-({[7-(2-anthracen-9-ylmethylene-3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-methyl-amino}-methyl)-phenyl ester",0.0790999999999999,uM,=,-1.1018235165023236,0,O=C1/C(=C/c2c3ccccc3cc3ccccc23)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
1924,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCCCC2)cc1OC,SID3717638,45.0,uM,=,1.6532125137753435,1,c1ccc(CN2CCCCC2)cc1
1925,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCC4)oc12,"N-(7-(2,3-Dihydro-1H-cyclopenta[b]quinolin-9-ylamino)heptyl)-7-methoxybenzofuran-2-carboxamide",0.993,uM,=,-0.0030507515046188,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1
1926,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCC[n+]2ccccc2)cc1,"1,4-bis(pyridinium)-butane dibromide",505.0,uM,=,2.7032913781186614,1,c1cc[n+](CCCC[n+]2ccccc2)cc1
1927,1337582,10.1021/np400978x,,,,Inhibition of human AChE by spectrophotometry,CC[C@H]1[C@H]2OC(=O)[C@](C)(O)[C@H]2[C@]23CC[C@@H]([C@@H]4C[C@@H](C)C(=O)O4)N2CCCC[C@@H]13,Sessilistemoamine E,9.1,uM,=,0.9590413923210936,1,O=C1CC[C@@H]([C@@H]2CC[C@]34[C@@H](CCCCN23)C[C@H]2OC(=O)C[C@H]24)O1
1928,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1ccc2c(c1)C(=O)/C(=C/C1CCN(Cc3ccc4c(c3)OCO4)CC1)C2,"(E)-2-((1-(benzo[d][1,3]dioxol-5-ylmethyl)piperidin-4-yl)methylene)-6-methoxy-2,3-dihydro-1H-inden-1-one",25.195,uM,=,1.4013143626917874,1,O=C1/C(=C/C2CCN(Cc3ccc4c(c3)OCO4)CC2)Cc2ccccc21
1929,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1Cc1ccc(CN2CCN(Cc3ccccc3)CC2)cc1,"2-(4-((4-benzylpiperazin-1-yl)methyl)benzyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",3.65,uM,=,0.5622928644564748,1,O=C1CC2CCc3ccsc3C2=NN1Cc1ccc(CN2CCN(Cc3ccccc3)CC2)cc1
1930,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCN1CCCCC1,(E)-3-(3-methoxy-4-((5-(piperidin-1-yl)pentyl)oxy)phenyl)-N-phenylacrylamide,4.8,uM,=,0.6812412373755872,1,O=C(/C=C/c1ccc(OCCCCCN2CCCCC2)cc1)Nc1ccccc1
1931,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3ccc(Cl)cc3Cl)C(=O)[C@@]3(C2)[C@H](c2ccc(Cl)cc2Cl)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,"(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(2,4-dichlorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(2,4-dichlorophenyl)pyrrolidine",4.42,uM,=,0.6454222693490919,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
1932,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)chroman-2-carboxamide",0.69,uM,=,-0.1611509092627447,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
1933,28160,10.1016/S0960-894X(97)10025-7,,,,Compound was tested in vitro for inhibitory activity against Acetylcholinesterase,Nc1c2c(nc3ccccc13)-c1ccccc1C2,"11H-Indeno[1,2-b]quinolin-10-ylamine",0.676,uM,=,-0.170053304058364,0,c1ccc2c(c1)Cc1cc3ccccc3nc1-2
1934,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CCNc2ccnc(N3CCCC3)n2)cc1,N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine,9.8,uM,=,0.9912260756924948,1,c1ccc(CCNc2ccnc(N3CCCC3)n2)cc1
1935,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1,"N-(7-(7,8,9,10-Tetrahydro-6H-cyclohepta[b]quinolin-11-ylamino)heptyl)benzofuran-2-carboxamide",0.323,uM,=,-0.4907974776688971,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1
1936,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1CCN1C(=O)c2ccccc2C1=O,"2-[2-(2-butyl-4-oxo-1,3-diazaspiro[4,4]non-1-en-3-yl)ethyl]isoin-dole-1,3-dione",0.2308,uM,=,-0.6367641955163061,0,O=C1c2ccccc2C(=O)N1CCN1C=NC2(CCCC2)C1=O
1937,762161,10.1016/j.ejmech.2011.04.038,,,,Inhibition of AChE by Ellman's method,Cl.O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1ccc(F)cc1,"4-fluoro-N-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-benzamide hydrochloride",0.000815,uM,=,-3.088842391260024,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
1938,1525144,10.1016/j.bmcl.2015.06.047,,,,Inhibition of human AChE,COc1cc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc(OC)c1OC,"4a,12a-Dihydroxy-4,4,6a,12b-tetramethyl-9-(3,4,5-trimethoxy-phenyl)-4a,6,6a,12,12a,12b-hexahydro-4H,5H-7,10-dioxa-benzo[a]anthracene-1,11-dione",0.0076,uM,=,-2.1191864077192086,0,O=C1C=CCC2CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC3C12
1939,489450,10.1021/jm800577j,,,,Inhibition of human recombinant AChE by Ellman's method,Clc1ccc2c(NCCCNCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3,"N-[3-(9H-Carbazol-4-yloxy)propyl]-N'-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)propane-1,3-diamine",0.00215,uM,=,-2.6675615400843946,0,c1ccc2c(NCCCNCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3
1940,1500569,10.1039/C4MD00069B,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins by Ellmans method,Cc1ccc2[nH]c3c(c2c1)CN(CCCCCCCN1CCc2[nH]c4ccc(C)cc4c2C1)CC3,"1,7-bis(8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)heptane",0.69,uM,=,-0.1611509092627447,0,c1ccc2c3c([nH]c2c1)CCN(CCCCCCCN1CCc2[nH]c4ccccc4c2C1)C3
1941,1922071,10.1016/j.bmc.2018.12.030,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,c1ccc(CN2CCC(Cn3cc(CNc4ncnc5ccccc45)nn3)CC2)cc1,"N-((1-((1-Benzylpiperidin-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl)quinazolin-4-amine",4.22,uM,=,0.6253124509616739,1,c1ccc(CN2CCC(Cn3cc(CNc4ncnc5ccccc45)nn3)CC2)cc1
1942,1978343,10.1016/j.bmcl.2019.126888,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1CN(/N=C/c2ccc(-c3ccccc3[N+](=O)[O-])o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-1-((5-(2-nitrophenyl)furan-2-yl)methyleneamino)imidazolidine-2,4-dione",0.0342,uM,=,-1.465973893943865,0,O=C1CN(/N=C/c2ccc(-c3ccccc3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1
1943,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN2CCN(CCCCOc3ccc4c(c3)oc(=O)c3ccccc34)CC2)c1,3-(4-(4-(3-Methoxybenzyl)piperazin-1-yl)butoxy)-6H-benzo[c]chromen-6-one,21.3,uM,=,1.3283796034387378,1,O=c1oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12
1944,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccccc2C(F)(F)F)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-oxo-2-((2-(trifluoromethyl)phenyl)amino)ethyl)acrylamide,15.15,uM,=,1.1804126328383238,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
1945,2261397,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human AChE,C#CCN(C)C1CCc2cccc(OC(=O)N(C)C)c21,"[3-[methyl(prop-2-ynyl)amino]indan-4-yl]N,N-dimethylcarbamate",730.0,uM,=,2.863322860120456,1,c1ccc2c(c1)CCC2
1946,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-nonyl-7-methoxytacrine hydrochloride,1.6,uM,=,0.2041199826559248,1,c1ccc2nc3c(cc2c1)CCCC3
1947,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,1.68,uM,=,0.2253092817258628,1,c1ccccc1
1948,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccc(F)cc1)C(=O)C(F)(F)F,"Ethyl(2Z)-4,4,4-trifluoro-2-[2-(4-fluorophenyl)hydrazinylidene]-3-oxobutanoate",2.67,uM,=,0.4265112613645752,1,c1ccccc1
1949,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccc(F)cc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1ccc(F)cc1,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(4-fluorobenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",22.32,uM,=,1.3486941902655412,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
1950,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,COc1ccc(NC(=S)NCCN2CCCCC2)cc1,1-(4-Methoxyphenyl)-3-(2-(piperidin-1-yl)ethyl)thiourea,120.0,uM,=,2.0791812460476247,1,S=C(NCCN1CCCCC1)Nc1ccccc1
1951,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,Cl.Cl.Nc1ccc(O)c(Cn2cccn2)c1,2-((1H-pyrazol-1-yl)methyl)-4-aminophenol dihydrochloride,844.5,uM,=,2.926599653907028,1,c1ccc(Cn2cccn2)cc1
1952,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.33,uM,=,-0.4814860601221125,0,c1ccc2nc3c(cc2c1)CCCC3
1953,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1cccc(OC)c1C(C)NS(=O)(=O)NC(=O)OCc1ccccc1,"Benzyl N-(1-(2,6-dimethoxyphenyl)ethyl)sulfamoylcarbamate",2.685e-05,uM,=,-4.571055709964425,0,O=C(NS(=O)(=O)NCc1ccccc1)OCc1ccccc1
1954,1790748,10.1039/C7MD00143F,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured for 20 mins by Ellman's assay,Nc1c2c(nc3cc(Cl)ccc13)C[C@H]1C=C(CCCCn3cc(CO)nn3)C[C@H]2C1,,0.00043,uM,=,-3.3665315444204134,0,C1=C(CCCCn2ccnn2)C[C@H]2C[C@H]1Cc1nc3ccccc3cc12
1955,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3,"3-Methyl-1,2-dihydro-benzo[j]aceanthrylene",22.683,uM,=,1.3557004927818816,1,c1cc2c3c(c4ccc5ccccc5c4cc3c1)CC2
1956,28622,10.1021/jm010949b,,,,In vitro inhibitory concentration against acetylcholinesterase of human erythrocytes,CC1=CC2CC(C1)Cc1nc3ccccc3c(N)c12.Cl,"(+/-)15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,15-hexaen-3-amine hydrochloride",0.436,uM,=,-0.3605135107314139,0,C1=CC2CC(C1)Cc1nc3ccccc3cc12
1957,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CN1CCN(c2ccc(/C=C/c3cc(N4CCN(C)CC4)c4ccccc4[n+]3C)cc2)CC1.[I-],(E)-1-Methyl-4-(4-Methylpiperazin-1-yl)-2-(4-(4-methylpiperazin-1-yl)styryl)quinolinium iodide,2.5,uM,=,0.3979400086720376,1,C(=C/c1cc(N2CCNCC2)c2ccccc2[nH+]1)\c1ccc(N2CCNCC2)cc1
1958,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2cc(O)c(O)c(O)c2)C3=O)c1,"3-((methyl(7-(3-oxo-2-(3,4,5-trihydroxybenzylidene)-2,3-dihydrobenzofuran-6-yloxy)heptyl)amino)methyl)phenyl methylcarbamate",0.00052,uM,=,-3.283996656365201,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
1959,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,O=[N+]([O-])c1ccc2c(NCc3ccccc3)c3c(nc2c1)CCCC3,"Benzyl-(6-nitro-1,2,3,4-tetrahydro-acridin-9-yl)-amine",4.8,uM,=,0.6812412373755872,1,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
1960,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2cccc(C)c2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-oxo-2-(m-tolylamino)ethyl)acrylamide,18.91,uM,=,1.2766915288450398,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
1961,510556,10.1021/np800305b,,,,Inhibition of acetylcholinesterase,CC(C)=CC(=O)N[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C([C@H](C)N(C)C)=CC[C@@H]32)[C@H]1O,"(20S)-20-(N,N-dimethylamino)-3beta-(N-senecoylamino)-5alpha-pregn-16-en-4beta-ol",48.5,uM,=,1.6857417386022635,1,C1=CC2CC[C@@H]3C4CCCC[C@@H]4CC[C@H]3[C@@H]2C1
1962,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,4.45,uM,=,0.6483600109809317,1,c1ccccc1
1963,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4cccc([N+](=O)[O-])c4)[nH]3)ccc21,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(3-nitrophenyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",138.23,uM,=,2.140602308020332,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
1964,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,O=C(c1ccccc1Cl)n1nc(OCCN2CCCC2)c2ccccc21,(2-chlorophenyl)(3-(2-(1-pyrrolidinyl)ethoxy)indazol-1-yl)ketone,9.7,uM,=,0.9867717342662448,1,O=C(c1ccccc1)n1nc(OCCN2CCCC2)c2ccccc21
1965,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,Cl.Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine hydrochloride",0.136,uM,=,-0.8664610916297825,0,c1ccc2nc3c(cc2c1)CCCC3
1966,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(7-(6-methoxy-1-methylpyridinium-2-yl)heptyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",0.11,uM,=,-0.958607314841775,0,c1ccc(CCCCCCC[NH+]2CCc3ccccc3C2)[nH+]c1
1967,1834120,10.1021/acs.jnatprod.8b00592,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by Ellman's method,COc1cc2c(cc1O)C(Cc1ccc(O)c(Oc3cc(CC4c5cc(O)c(OC)cc5CCN4C)ccc3OC)c1)N(C)CC2,Berbostrejdine,66.0,uM,=,1.8195439355418688,1,c1cc(CC2NCCc3ccccc32)cc(Oc2cccc(CC3NCCc4ccccc43)c2)c1
1968,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CC(C)NC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](C)c1.[I-],"[3-(Isopropylcarbamoyl)-1-methyl-quinolin-1-ium-5-yl]-N,N-dimethylcarbamate iodide",0.058,uM,=,-1.2365720064370629,0,c1ccc2[nH+]cccc2c1
1969,1581164,10.1021/acs.jnatprod.5b00877,,,,Inhibition AChE (unknown origin) using ATCI as substrate assessed as hydrolysis of ATCI after 10 mins measured every 1 min for 10 times,COc1c(CC=C(C)C)c(O)cc2c1C[C@H](c1ccc(O)c(CC=C(C)C)c1O)CO2,licoricidin,15.5,uM,=,1.1903316981702914,1,c1ccc([C@@H]2COc3ccccc3C2)cc1
1970,28166,10.1016/s0960-894x(02)00482-1,,,,In vitro inhibition of human recombinant AChE.,CC1=C[C@H]2Cc3[nH]c(=O)ccc3[C@]3(C1)NCCC[C@H]23,Huperzine B,0.03,uM,=,-1.5228787452803376,0,O=c1ccc2c([nH]1)C[C@@H]1C=CC[C@]23NCCC[C@H]13
1971,826907,10.1021/ml200313p,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 120 mins before substrate addition by Ellman's method,CN(CCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NCCCCCc2ccccc2)c1,(5-Phenylpentyl)carbamic acid 3-({methyl-[3-(2-oxo-2H-chromen-7-yloxy)propyl]amino]-methyl}phenyl ester,0.0749,uM,=,-1.1255181823005336,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3ccc(=O)oc3c2)c1
1972,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CNCc1cc(N)ccc1O.Cl.Cl,4-amino-2-((methylamino)methyl)phenol dihydrochloride,333.5,uM,=,2.523095838252568,1,c1ccccc1
1973,510556,10.1021/np800305b,,,,Inhibition of acetylcholinesterase,C[C@@H]([C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](N)CC[C@]4(C)[C@H]3CC[C@]12C)N(C)C,chonemorphine,28.0,uM,=,1.4471580313422192,1,C1CC[C@@H]2CC[C@H]3[C@@H]4CCCC4CC[C@@H]3C2C1
1974,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=S(=O)(Nc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1)c1ccccc1,N-{3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazol-6-yl}-benzenesulfonamide,0.014,uM,=,-1.853871964321762,0,O=S(=O)(Nc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1)c1ccccc1
1975,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,Cc1cccc(C(=O)N2Cc3cc(NC(=O)c4cccc(Cl)c4)ccc3CC2=O)c1,"3-Chloro-N-(2-(3-methylbenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",1.441e-05,uM,=,-4.841336019186011,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
1976,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.178,uM,=,-0.749579997691106,0,c1ccc2nc3c(cc2c1)CCCC3
1977,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(6-(4-((1-(phenylsulfonyl)-1H-indol-4-yl)methyl)piperazin-1-yl)hexyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",9.8,uM,=,0.9912260756924948,1,O=C1CC2CCc3ccsc3C2=NN1CCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
1978,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CN(C)C(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"(S)-5-Dimethylcarbamoyloxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",0.97,uM,=,-0.0132282657337551,0,c1ccc2c(c1)NC1NCCC21
1979,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN1CCCc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21,"3-(1-benzylpiperidin-4-yl)-1-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)propan-1-one",0.024,uM,=,-1.619788758288394,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCCN2
1980,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,Clc1ccc2c(NCCCCCCCNc3c4c(nc5cc(Cl)ccc35)-c3ccccc3C4)c3c(nc2c1)CCCC3,"N1-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)-N7-(7-chloro-11H-indeno[1,2-b]quinolin-10-yl)heptane-1,7-diamine",0.0121,uM,=,-1.91721462968355,0,c1ccc2c(c1)Cc1c-2nc2ccccc2c1NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
1981,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(Cc2ccc3ccccc3c2)CC1,4-Methyl-1-naphthalen-2-ylmethyl-piperidine,2.9,uM,=,0.4623979978989561,1,c1ccc2cc(CN3CCCCC3)ccc2c1
1982,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),C/C(=C\C1=CCN(C(=O)CCc2ccccc2)C(=O)C1)N1C(=O)c2ccccc2C1=O,"2-(1-(2-oxo-1-(3-phenylpropanoyl)-1,2,3,6-tetrahydropyridin-4-yl)prop-1-en-2-yl)isoindoline-1,3-dione",0.05526,uM,=,-1.2575891194195077,0,O=C1c2ccccc2C(=O)N1C=CC1=CCN(C(=O)CCc2ccccc2)C(=O)C1
1983,28159,10.1021/jm00161a008,,,,"Compound was tested for the rate of EPMP-inhibited acetylcholinesterase reactivation, OX is the anionic (oximate) form of added test compound",CCN(CC)CCS/C(=N\O)c1nc(C(C)(C)C)no1,"3-tert-Butyl-N-hydroxy-[1,2,4]oxadiazole-5-carboximidothioic acid 2-diethylamino-ethyl ester",390.0,uM,=,2.591064607026499,1,c1ncon1
1984,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(F)c3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-amino-3-fluorophenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.1006,uM,=,-0.9974020192800914,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
1985,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCCC[n+]1cc(C(F)(F)F)ccc1OC.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"1,1'-(pentane-1,5-diyl)bis(2-methoxy-5-(trifluoromethyl)pyridinium)trifluoromethanesulfonate",22.0,uM,=,1.3424226808222062,1,c1cc[n+](CCCCC[n+]2ccccc2)cc1
1986,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,CCC1OCc2c[n+](C)c(C)c(OC(=O)N(C)C)c2CO1.[Br-],"1,5-Dihydro-3-ethyl-7,8-dimethyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",280.0,uM,=,2.4471580313422194,1,c1cc2c(c[nH+]1)COCOC2
1987,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1ccc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc1O,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3-hydroxy-4-methoxyphenyl)acrylamide,1.66,uM,=,0.220108088040055,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
1988,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.022,uM,=,-1.6575773191777938,0,c1ccccc1
1989,751129,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes AChE,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.022,uM,=,-1.6575773191777938,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
1990,2215089,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) using ATCI as substrate incubated for 30 mins by Ellman's method,CCn1c2ccccc2c2cc(/C=C/c3ccc(NC(=S)NCCN4CCCC4)cc3)ccc21,1-(4-(2-(9-ethyl-9H-carbazol-3-yl)vinyl)phenyl)-3-(2-(pyrrolidin-1-yl)ethyl)thiourea,2.64,uM,=,0.421603926869831,1,S=C(NCCN1CCCC1)Nc1ccc(/C=C/c2ccc3[nH]c4ccccc4c3c2)cc1
1991,751130,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human plasma AChE,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.19,uM,=,-0.721246399047171,0,c1ccc2nc3c(cc2c1)CCCC3
1992,1978343,10.1016/j.bmcl.2019.126888,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-1-((5-(4-nitrophenyl)furan-2-yl)methyleneamino)imidazolidine-2,4-dione",0.0464,uM,=,-1.3334820194451191,0,O=C1CN(/N=C/c2ccc(-c3ccccc3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1
1993,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCC(C)CC4)cc3)C2)cc1OC,"1-(5-(4-(4-Methylpiperidin-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",77.4,uM,=,1.8887409606828929,1,c1ccc(C2=NNC(c3ccc(N4CCCCC4)cc3)C2)cc1
1994,526512,10.1021/np060268p,,,,Inhibition of human AChE by Ellman's assay,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.18,uM,=,0.0718820073061253,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
1995,529395,10.1021/np9905719,,,,Inhibition of AChE by microplate assay,CO[C@@H]1[C@@H](O)[C@H]2c3cc4c(cc3CN3CC=C([C@H]1O)[C@H]23)OCO4,ungiminorine,86.0,uM,=,1.934498451243568,1,C1=C2CCC[C@H]3c4cc5c(cc4CN(C1)[C@H]23)OCO5
1996,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cccc(CCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(ethane-1,2-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",1.1,uM,=,0.041392685158225,1,c1ccc(CCc2cccc[nH+]2)[nH+]c1
1997,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)ccoc3c2)c1,Propyl-carbamic acid 3-({methyl-[3-(4-oxo-4H-chromen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.25,uM,=,-0.6020599913279624,0,O=c1ccoc2cc(OCCCNCc3ccccc3)ccc12
1998,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc(Cc3ccccc3)cc2)c1,3-(((3-(4-benzylphenoxy)propyl)(methyl)amino)methyl)phenyl methylcarbamate,0.0247,uM,=,-1.6073030467403342,0,c1ccc(CNCCCOc2ccc(Cc3ccccc3)cc2)cc1
1999,2247136,10.1021/acs.jmedchem.1c02150,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 240 sec by Ellman's method,O=C(Nc1ccc(OC(F)(F)F)cc1)NC1CCN(C(=O)CCNc2c3c(nc4cc(Cl)ccc24)CCCC3)CC1,"1-{1-{3-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-propanoyl}piperidin-4-yl}-3-[4-(trifluoromethoxy)phenyl]urea",0.0145,uM,=,-1.8386319977650247,0,O=C(Nc1ccccc1)NC1CCN(C(=O)CCNc2c3c(nc4ccccc24)CCCC3)CC1
2000,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCNCc1cccc(Cl)c1,"2-(5-(3-Chlorobenzylamino)pentyl)isoindoline-1,3-dione",0.16,uM,=,-0.7958800173440752,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
2001,2114062,10.1016/j.bmcl.2021.128100,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by DTNB-reagent based Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c3C(C1)C2.Cl.Cl,,0.0121,uM,=,-1.91721462968355,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1
2002,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CNc2ccnc(N3CCOCC3)n2)cc1,N-benzyl-2-morpholinopyrimidin-4-amine,14.0,uM,=,1.146128035678238,1,c1ccc(CNc2ccnc(N3CCOCC3)n2)cc1
2003,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1ccc2c(c1)c(CC(=O)N/N=C1\c3cc(OC)c(OC)cc3CC1CC1CCN(Cc3ccccc3)CC1)c(C)n2C(=O)c1ccc(Cl)cc1,"N-[(Z)-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]amino]-2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetamide",0.51,uM,=,-0.2924298239020636,0,O=C(Cc1cn(C(=O)c2ccccc2)c2ccccc12)N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2004,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccccc4F)cc3)ccc12.[Br-],1-(2-Fluorobenzyl)-4-(((4-methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)pyridin-1-ium bromide,0.0653,uM,=,-1.1850868187249262,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
2005,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CN(C)C(=O)Oc1cccc2c1cc(C(=O)NCCOCCO)c[n+]2C.COS(=O)(=O)[O-],5-((dimethylcarbamoyl)oxy)-3-((2-(2-hydroxyethoxy)ethyl)carbamoyl)-1-methylquinolin-1-ium methyl sulfate,0.037,uM,=,-1.431798275933005,0,c1ccc2[nH+]cccc2c1
2006,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4cccc(F)c4)cc3)ccc12.[Br-],1-(3-Fluorobenzyl)-4-(((4-methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)pyridin-1-ium bromide,0.0416,uM,=,-1.3809066693732572,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
2007,2019674,10.1039/d0md00009d,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by Ellman's method,Cc1cc(S(=O)(=O)NCc2ccccn2)c(C(C)C)cc1O,4-hydroxy-2-isopropyl-5-methyl-N-(2-pyridylmethyl)benzenesulfonamide,6.99,uM,=,0.8444771757456815,1,O=S(=O)(NCc1ccccn1)c1ccccc1
2008,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,COC(=O)CC1=NO[C@@H]2CCCC[C@@H]2[C@H]1c1ccccc1,"methyl 2-((4S,4aR)-4-phenyl-4a,5,6,7,8,8a-hexahydro-4H-benzo[e][1,2]oxazin-3-yl)acetate",35.12,uM,=,1.5455545072340648,1,C1=NO[C@@H]2CCCC[C@@H]2[C@H]1c1ccccc1
2009,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCCCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1.Cl,Methyl-carbamic acid 3-({methyl-[10-(9-oxo-9H-xanthen-3-yloxy)-decyl]-amino}-methyl)-phenyl ester hydrochloride,0.0218,uM,=,-1.6615435063953952,0,O=c1c2ccccc2oc2cc(OCCCCCCCCCCNCc3ccccc3)ccc12
2010,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,Rivastigmine tartrate,19.8,uM,=,1.2966651902615312,1,c1ccccc1
2011,775052,10.1016/j.ejmech.2011.09.001,,,,Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,COc1cc2nc(Cl)nc(NCCCNC(=O)CCCCC3CCSS3)c2cc1OC,"rac-N-(3-(2-chloro-6,7-dimethoxyquinazolin-4-ylamino)propyl)-5-(1,2-dithiolan-3-yl)pentanamide",192.0,uM,=,2.2833012287035497,1,O=C(CCCCC1CCSS1)NCCCNc1ncnc2ccccc12
2012,1549817,10.1016/j.bmc.2016.01.031,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,I.ICC1CN=C(Nc2ccccn2)S1,"(5-Iodomethyl-4,5-dihydrothiazol-2-yl)pyridin-2-ylamine hydroiodide",71.0,uM,=,1.8512583487190752,1,c1ccc(NC2=NCCS2)nc1
2013,2261397,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human AChE,O=C1CCOc2cc(OCCCCCSC(=S)N3CCCCC3)ccc21,5-(4-oxochroman-7-yl)oxypentyl piperidine-1-carbodithioate,0.1,uM,=,-1.0,0,O=C1CCOc2cc(OCCCCCSC(=S)N3CCCCC3)ccc21
2014,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCN(Cc5ccccc5)CC4)cc3)C2)cc1OC,"1-(5-(4-(4-Benzylpiperazin-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",62.8,uM,=,1.797959643737196,1,c1ccc(CN2CCN(c3ccc(C4CC(c5ccccc5)=NN4)cc3)CC2)cc1
2015,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2cccc(Cl)c2)CC1)N1CCN(CCCc2c[nH]c3ccc(F)cc23)CC1,2-(4-(3-chlorobenzoyl)piperazin-1-yl)-1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)ethanone,18.4,uM,=,1.2648178230095364,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
2016,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(Cc4ccccc4F)CC3)nc12,3-(4-(2-Fluorobenzyl)piperazin-1-yl)-N-(4-methylbenzo[d]-thiazol-2-yl)propanamide,5.22,uM,=,0.7176705030022621,1,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1nc2ccccc2s1
2017,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,COc1ccc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc1OC,"9-(3,4-Dimethoxy-phenyl)-4a,12a-dihydroxy-4,4,6a,12b-tetramethyl-4a,6,6a,12,12a,12b-hexahydro-4H,5H-7,10-dioxa-benzo[a]anthracene-1,11-dione",0.001,uM,=,-3.0,0,O=C1C=CCC2CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC3C12
2018,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CN1CC[C@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)C12,"Phenyl-carbamic acid (R)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",3.5,uM,=,0.5440680443502757,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
2019,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(F)c3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-acetamido-3-fluorophenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.0919,uM,=,-1.0366844886138886,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
2020,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,CCCCC[N+]1(C)CCN(c2ccc(/C=C3\Cc4cc(OC)c(OC)cc4C3=O)cc2)CC1.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-pentyl-4-methylpiperazinium-1-yl)berizylidine]-1H-inden-1-one bromide",0.54,uM,=,-0.2676062401770315,0,O=C1/C(=C/c2ccc(N3CC[NH2+]CC3)cc2)Cc2ccccc21
2021,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2C#N)cc1,"4'-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-biphenyl-2-carbonitrile",0.0825,uM,=,-1.083546051450075,0,O=C1N(Cc2ccc(-c3ccccc3)cc2)C=NC12CCCC2
2022,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,C[C@@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,"(2R,2'R)-N,N'-(3,3'-(3,3'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)bis(propane-3,1-diyl))bis(azanediyl)bis(propane-3,1-diyl))bis(2-(2-fluorobiphenyl-4-yl)propanamide)",27.8,uM,=,1.4440447959180762,1,O=C(Cc1ccc(-c2ccccc2)cc1)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccc(-c3ccccc3)cc2)=CC1=O
2023,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1c2c(nc3nc(-c4ccccc4)cc(C(F)(F)F)c13)CCCC2,"2-Phenyl-4-(trifluoromethyl)-6,7,8,9-tetrahydrobenzo[b][1,8]-naphthyridin-5-amine",0.35,uM,=,-0.4559319556497244,0,c1ccc(-c2ccc3cc4c(nc3n2)CCCC4)cc1
2024,1278501,10.1016/j.bmc.2013.09.050,,,,Inhibition of human erythrocytic AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman method,O=C1/C(=C/c2ccc(F)cc2)COc2cc(OCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc21,"(E)-3-(4-Fluorobenzylidene)-7-(6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyloxy)chroman-4-one",0.1052999999999999,uM,=,-0.9775716288145136,0,O=C1/C(=C/c2ccccc2)COc2cc(OCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc21
2025,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(OC)c3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-((4-acetamido-3-methoxyphenyl)sulfonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.07916,uM,=,-1.1014942144656414,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
2026,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-2-amino-N-(5-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)pentyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.076,uM,=,-1.1191864077192086,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
2027,1668099,10.1016/j.bmcl.2017.04.006,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition by Ellman's method,COc1ccc(CCNc2c3c(nc4cc(Cl)ccc24)CCCC3)cc1OC,"6-chloro-N-(3,4-dimethoxyphenethyl)-1,2,3,4-tetrahydroacridin-9-amine",0.6,uM,=,-0.2218487496163563,0,c1ccc(CCNc2c3c(nc4ccccc24)CCCC3)cc1
2028,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(/C=C2/S/C(=N/c3ccc4oc(=O)ccc4c3)NC2=O)cc1,5-(4-Methoxybenzylidene)-2-[(2-oxo-2H-chromen-6-yl)imino]thiazolidin-4-one,0.0498,uM,=,-1.3027706572402824,0,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1
2029,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COC(=O)/C(=N\Nc1ccc(OC)cc1)C(=O)C(F)(F)F,"Methyl(2Z)-4,4,4-trifluoro-2-[2-(4-methoxyphenyl)hydrazinylidene]-3-oxobutanoate",30.3,uM,=,1.481442628502305,1,c1ccccc1
2030,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCN1CCCC1,(E)-3-(3-methoxy-4-(4-(pyrrolidin-1-yl)butoxy)phenyl)-N-phenylacrylamide,24.35,uM,=,1.3864989655506532,1,O=C(/C=C/c1ccc(OCCCCN2CCCC2)cc1)Nc1ccccc1
2031,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=[N+]([O-])c1ccc2c(Nc3ccccc3)c3c(nc2c1)CCCC3,"6-nitro-N-phenyl-1,2,3,4-tetrahydroacridin-9-amine",4.8,uM,=,0.6812412373755872,1,c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1
2032,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CCNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-N-ethyl-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0452,uM,=,-1.3448615651886178,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
2033,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,Cl.Cl.Nc1ccc(O)c(CN2CCCCC2)c1,4-amino-2-(piperidin-1-ylmethyl)phenol dihydrochloride,456.0,uM,=,2.6589648426644352,1,c1ccc(CN2CCCCC2)cc1
2034,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.0104,uM,=,-1.98296666070122,0,O=C(CC1CCc2cc(OCc3ccccc3)ccc2O1)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
2035,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1ccc2cc([C@H](C)C(=O)N/N=C3\c4cc(OC)c(OC)cc4CC3CC3CCN(Cc4ccccc4)CC3)ccc2c1,"(2S)-N-[(Z)-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]amino]-2-(6-methoxy-2-naphthyl)propanamide",0.15,uM,=,-0.8239087409443188,0,O=C(Cc1ccc2ccccc2c1)N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2036,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1cc(OCC[N+](CC)(CC)CC)c(C(=O)NCCCCCC(=O)NNc2c3c(nc4cc(Cl)ccc24)CCCC3)cc1OCC[N+](CC)(CC)CC.[Br-].[Br-].[Br-],"2-(5-(((6-(2-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-6-oxohexyl)amino)carbonyl)-2,3-bis((2-triethylammonio)-ethoxy)phenoxy)-N,N,N-triethylethanammonium tribromidehydrochloride",0.00654,uM,=,-2.184422251675733,0,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
2037,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1ccc(-[n+]2ccc3cccc(OC)c3c2)cc1.[Br-],8-Methoxy-2-(4-methoxyphenyl)isoquinolin-2-ium bromide,0.14,uM,=,-0.8538719643217619,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
2038,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(NCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,"(S)-2-amino-3-(1H-indol-3-yl)-N-(6-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)propanamide dihydrochloride",0.94,uM,=,-0.0268721464003013,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
2039,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,C[n+]1c(/C=C/c2ccc(N3CCOCC3)cc2)ccc2ccccc21.[I-],(E)-1-Methyl-2-(4-morpholinostyryl)quinolin-1-ium Iodide,2.4,uM,=,0.380211241711606,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccc(N2CCOCC2)cc1
2040,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,CC(C)N(CCOc1ccc(-c2nc3cc(Cl)ccc3[nH]2)cc1)C(C)C,N-{2-[4-(5-Chloro-1H-benzo[d]imidazol-2-yl)phenoxy]ethyl}-N-isopropylpropan-2-amine,3.68,uM,=,0.5658478186735176,1,c1ccc(-c2nc3ccccc3[nH]2)cc1
2041,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1ccc2c(Nc3ccccc3)c3c(nc2c1)CCCC3,"6-methyl-N-phenyl-1,2,3,4-tetrahydroacridin-9-amine",0.75,uM,=,-0.1249387366082999,0,c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1
2042,642381,10.1021/jm100329q,,,,Inhibition of human erythrocyte AChE by Ellman's reaction,Cl.Cl.Oc1c(CNCCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)ccc2cccnc12,"7-{[9-(1,2,3,4-Tetrahydroacridin-9-ylamino)nonylamino]methyl}-quinolin-8-ol Dihydrochloride",0.0055,uM,=,-2.2596373105057563,0,c1cnc2cc(CNCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc2c1
2043,28605,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 5.5-45.9,C#CCN(C)C1CCc2ccc(OC(=O)N(C)C)cc21.Cl,Dimethyl-carbamic acid 3-(methyl-prop-2-ynyl-amino)-indan-5-yl ester hydrochloride,12.9,uM,=,1.110589710299249,1,c1ccc2c(c1)CCC2
2044,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(Cc4ccccc4Cl)CC3)cc1)C2.[Cl-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-(2-chlorobenzyl)-4-methylpiperazinium-1-yl)benzylidinel-1H-inden-1-one chloride",0.48,uM,=,-0.3187587626244128,0,O=C1/C(=C/c2ccc(N3CC[NH+](Cc4ccccc4)CC3)cc2)Cc2ccccc21
2045,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccc(F)cc1,5-(4-Fluorobenzylidene)-2-[(2-oxo-2H-chromen-6-yl)imino]thiazolidin-4-one,0.216,uM,=,-0.6655462488490691,0,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1
2046,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(5-((1,2,3,4-tetrahydroacridin-9-yl)amino)pentyl)chroman-2-carboxamide",0.2153,uM,=,-0.6669559701765128,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
2047,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cccc2c(=O)cc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)[nH]c12,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-2-carboxamide",1.64,uM,=,0.2148438480476978,1,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2[nH]1
2048,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,c1ccc(CCCCCSc2c3c(nc4ccccc24)CCCC3)nc1,"9-{[5-(Pyridin-2-yl)pentyl]sulfanyl}-1,2,3,4-tetrahydroacridine",130.0,uM,=,2.113943352306837,1,c1ccc(CCCCCSc2c3c(nc4ccccc24)CCCC3)nc1
2049,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C(CNc1ccc2oc(=O)ccc2c1)N1CCN(c2ccccc2)CC1,6-[(2-Oxo-2-(4-phenylpiperazin-1-yl)ethyl)amino]-2H-chromen-2-one,0.08,uM,=,-1.0969100130080565,0,O=C(CNc1ccc2oc(=O)ccc2c1)N1CCN(c2ccccc2)CC1
2050,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COC(=O)/C(=N\Nc1ccc(C)cc1)C(=O)C(F)(F)F,"Methyl(2Z)-4,4,4-trifluoro-2-[2-(4-methylphenyl)hydrazinylidene]-3-oxobutanoate",28.3,uM,=,1.4517864355242902,1,c1ccccc1
2051,2266747,10.1021/acs.jmedchem.0c01664,,,,Inhibition of AChe (unknown origin),CN1c2ccc(OC(=O)Nc3ccncc3)cc2[C@]2(C)CCO[C@H]12,"(3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl pyridin-4-ylcarbamate",7.0,uM,=,0.8450980400142568,1,O=C(Nc1ccncc1)Oc1ccc2c(c1)C1CCO[C@@H]1N2
2052,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccc([N+](=O)[O-])cc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5-nitro-isoindole-1,3-dione",0.0125,uM,=,-1.9030899869919435,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
2053,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,Oc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1O,"N-{5'-[3'',4''-(Dihydroxy)phenethyloxy]pentyl}-1,2,3,4-tetrahydroacridin-9-amine",0.542,uM,=,-0.266000713461613,0,c1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
2054,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc([N+](=O)[O-])cc3)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(4-nitrobenzyl)pyridin-1-ium bromide",0.0595,uM,=,-1.2254830342714504,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
2055,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4cccc(Br)c4)cc3)ccc12.[Br-],1-(3-Bromobenzyl)-4-(((4-methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)pyridin-1-ium bromide,0.1286,uM,=,-0.8907590314117968,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
2056,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc2nc3c(c(N4CCOCC4)c2cc1OC)CCCC3,"4-(6,7-Dimethoxy-1,2,3,4-tetrahydroacridin-9-yl)morpholine",0.062,uM,=,-1.207608310501746,0,c1ccc2c(N3CCOCC3)c3c(nc2c1)CCCC3
2057,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCCCN(C)Cc1cccc(O)c1,1-(10-((3-hydroxybenzyl)(methyl)amino)hexyl)-5-methoxy-1H-indo1e-3-carbaldehyde,4.52,uM,=,0.6551384348113821,1,c1ccc(CNCCCCCCCCCCn2ccc3ccccc32)cc1
2058,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1cccc(C(=O)N2c3ccccc3[Se]c3ccccc32)c1,(3-Methoxyphenyl)-(10H-phenoselenazin-10-yl)methanone,6.2,uM,=,0.7923916894982539,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
2059,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1cccc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)c1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3-methoxyphenyl)acrylamide,0.75,uM,=,-0.1249387366082999,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2060,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,[6-Hydroxy-2-(4-hydroxy-phenyl)-benzo[b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone,0.4,uM,=,-0.3979400086720376,0,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccccc2)sc2ccccc12
2061,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCCCOc1ccc2c(C)cc(=O)oc2c1.O=S(=O)([O-])C(F)(F)F,2-methoxy-1-(5-(4-methyl-2-oxo-2H-chromen-7-yloxy)pentyl)-5-(trifluoromethyl)pyridinium trifluoromethanesulfonate,1.03,uM,=,0.0128372247051722,1,O=c1ccc2ccc(OCCCCC[n+]3ccccc3)cc2o1
2062,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4)cc(O)c3c2=O)cc1)Cc1ccccc1,7-(4-(benzyl(ethyl)amino)butoxy)-3-(4-(4-(benzyl(ethyl)amino)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one,2.1,uM,=,0.3222192947339193,1,O=c1c(-c2ccc(OCCCCNCc3ccccc3)cc2)coc2cc(OCCCCNCc3ccccc3)ccc12
2063,2185041,10.1016/j.ejmech.2021.113278,,,,Inhibition of human AchE using acetylthiocholine iodide as substrate by Ellman colorimetric assay,COc1cc(/C=C/c2nnc(-c3ccc(C(F)(F)F)cc3)o2)ccc1O,"2-methoxy-4-(2-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)vinyl)phenol",0.068,uM,=,-1.1674910872937636,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
2064,1337582,10.1021/np400978x,,,,Inhibition of human AChE by spectrophotometry,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.55,uM,=,-0.2596373105057561,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
2065,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,C[n+]1c(/C=C/c2ccc(Cl)cc2)ccc2ccccc21.[I-],(E)-2-(4-Chlorostyryl)-1-methyl quinolinium iodide,4.4,uM,=,0.6434526764861874,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
2066,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CN1c2ccc(OC(=O)Nc3ccccc3)cc2[C@]2(C)CC[N+](C)(C)C12.[Br-],"(3aS)-1,1,3a,8-tetramethyl-5-(phenylcarbamoyloxy)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium bromide",0.0254,uM,=,-1.595166283380062,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+]C1N2
2067,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccncc1)CCCC3,"Ethyl Ester 5-Amino-1,4,6,7,8,9-hexahydro-2-methyl-4-(4'-pyridyl)benzo[b][1,8]naphthyridine-3-carboxylic Acid",0.223,uM,=,-0.6516951369518393,0,C1=CC(c2ccncc2)c2cc3c(nc2N1)CCCC3
2068,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCCOc1ccc(/C=C/C(=O)Nc2ccccc2)cc1OC,(E)-3-(4-(4-(diethylamino)butoxy)-3-methoxyphenyl)-N-phenylacrylamide,41.63,uM,=,1.6194064108867774,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
2069,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=C(Cl)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(Cl)C1=O)Cc1ccccc1OC,"2,5-bis{6-[ethyl(2-methoxybenzyl)amino]hexylamino}-3,6-dichloro-[1,4]-benzoquinone",0.0030499999999999,uM,=,-2.515700160653214,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
2070,1783503,10.1016/j.ejmech.2018.01.007,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(Cc1c[nH]c2ccc(Br)cc12)NCCC1CCN(Cc2ccccc2)CC1,N-[2-(1-Benzyl-piperidin-4-yI)-ethyl]-2-(5-bromo-1H-indol-3-yl)-acetamide,1.41,uM,=,0.1492191126553798,1,O=C(Cc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
2071,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COC(=O)c1c(CCCCCCCCNc2c3c(nc4ccc(OC)cc24)CCCC3)cccc1OC,"methyl 2-methoxy-6-(8-((7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)benzoate",1.26,uM,=,0.1003705451175629,1,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
2072,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,O=C(c1cccc(F)c1F)n1nc(OCCN2CCCC2)c2ccccc21,"(2,3-difluorophenyl)(3-(2-(1-pyrrolidinyl)ethoxy)indazol-1-yl)ketone",11.0,uM,=,1.0413926851582251,1,O=C(c1ccccc1)n1nc(OCCN2CCCC2)c2ccccc21
2073,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Clc1ccc2[nH]c(-c3ccc(OCCN4CCCC4)cc3)nc2c1,5-Chloro-2-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-1H-benzo[d]imidazole,1.4,uM,=,0.1461280356782379,1,c1ccc2[nH]c(-c3ccc(OCCN4CCCC4)cc3)nc2c1
2074,1632485,10.1016/j.ejmech.2016.08.016,,,,Inhibition of human recombinant AChE preincubated for 5 mins followed by acetylthiocholine iodide substrate addition measured after 5 mins by Ellman's method,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21,"N-(3-(4-(1-(phenylsulfonyl)-1H-indol-4-yl)piperazin-1-yl)propyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0096999999999999,uM,=,-2.0132282657337552,0,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21
2075,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)/C=C/c3cc[n+](Cc4cccc(F)c4)cc3)c2c1.[Br-],1-(3-fluorobenzyl)-4-(3-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-3-oxoprop-1-en-1-yl)pyridin-1-ium bromide,0.11,uM,=,-0.958607314841775,0,O=C(/C=C/c1cc[n+](Cc2ccccc2)cc1)NCCc1c[nH]c2ccccc12
2076,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCN1CCCCC1,(E)-3-(3-methoxy-4-((6-(piperidin-1-yl)hexyl)oxy)phenyl)-N-phenylacrylamide,0.71,uM,=,-0.1487416512809247,0,O=C(/C=C/c1ccc(OCCCCCCN2CCCCC2)cc1)Nc1ccccc1
2077,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc(C(=O)CCc2cc[n+](Cc3cccc(Cl)c3)cc2C(=O)O)cc1OC.[Br-],"3-Carboxy-1-(3-chlorobenzyl)-4-(3-(3,4-dimethoxyphenyl)-3-oxopropyl)pyridinium bromide",0.0181,uM,=,-1.7423214251308154,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccccc1
2078,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CCSCC2)o1,2-(1-{2-[(5-Thiomorpholin-4-ylmethyl-furan-2-ylmethyl)-amino]-ethyl}-imidazolidin-2-ylidene)-malononitrile,1.5,uM,=,0.1760912590556812,1,C=C1NCCN1CCNCc1ccc(CN2CCSCC2)o1
2079,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,CC[n+]1ccc(CCC(=O)c2cc3cc(OC)c(OC)cc3s2)cc1.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-ethyl-pyridinium bromide",0.28,uM,=,-0.5528419686577808,0,O=C(CCc1cc[nH+]cc1)c1cc2ccccc2s1
2080,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c3ccccc32)cc1,"1-[(4-methoxyphenyl)methyl]-4-oxo-N-{5-[(1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}-1,4-dihydroquinoline-3-carboxamide",0.293,uM,=,-0.5331323796458906,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
2081,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,CC1(C)CNC2=C([N+](=O)[O-])C3(C(=O)Nc4ccccc43)C(C#N)=C(N)N2C1,"6'-amino-3',3'-dimethyl-9'-nitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",1.25,uM,=,0.0969100130080564,1,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
2082,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2,"Methyl-carbamic acid (S)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0567,uM,=,-1.2464169411070931,0,c1ccc2c(c1)NC1NCCC21
2083,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CC(C)=CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-((3-methylbut-2-en-1-yl)amio)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.0259,uM,=,-1.586700235918748,0,O=c1c2ccccc2nc2n1CCC2
2084,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NC(=O)C3CCN(Cc4c(F)cccc4Cl)CC3)sc2-c2ccc(C)cc2)cc1,"1-(2-Chloro-6-fluorobenzyl)-N-[4,5-bis(p-tolyl)thiazol-2-yl]-piperidine-4-carboxamide",2.88,uM,=,0.4593924877592308,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
2085,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,C[C@@H]1C[C@H](C)CN(Cc2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)C1,"3-(4-(((3R,5S)-3,5-Dimethylpiperidin-1-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carbonitrile",4.1,uM,=,0.6127838567197355,1,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
2086,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)[C@@H]1C2,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl propylcarbamate",0.154,uM,=,-0.8124792791635369,0,c1ccc2c(c1)C[C@H]1NCCC21
2087,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,NS(=O)(=O)c1ccc(NC(=S)NNc2c3c(nc4ccccc24)CCCC3)cc1,"N-(4-sulfamoylphenyl)-2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazine-1-carbothioamide",0.961,uM,=,-0.0172766123314546,0,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccccc1
2088,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)CCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1,N1-dimethyl-N9-(1,2,3,4-tetrahydroacridin-9-yl)nonane-1,9-diamine",0.071,uM,=,-1.1487416512809248,0,c1ccc2nc3c(cc2c1)CCCC3
2089,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)NCCC(=O)Nc2ccccc2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(3-oxo-3-(phenylamino)propyl)acrylamide,14.75,uM,=,1.1687920203141815,1,O=C(/C=C/c1ccccc1)NCCC(=O)Nc1ccccc1
2090,2052542,10.1016/j.ejmech.2019.111958,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,CON(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)OC)cc3o2)cc1,5-Hydroxy-2-(4-((methoxy(methyl)carbamoyl)oxy)phenyl)-4-oxo-4H-chromen-7-yl methoxy(methyl)carbamate,10.2,uM,=,1.0086001717619175,1,O=c1cc(-c2ccccc2)oc2ccccc12
2091,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccc(F)cc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-fluorobenzoyl)piperazin-1-yl)ethanone,39.4,uM,=,1.5954962218255742,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
2092,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(OC)c(OC)c1)CCCC3,"Ethyl Ester 5-Amino-4-(3',4'-dimethoxyphenyl)-1,4,6,7,8,9-hexahydro-2-methyl-benzo[b][1,8]naphthyridine-3-carboxylic acid",0.045,uM,=,-1.3467874862246565,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
2093,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(-c3ccccc3)cc2)CC1c1ccc2ccccc2c1,"1-(3-([1,1'-Biphenyl]-4-yl)-5-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.799,uM,=,-0.0974532206860085,0,c1ccc(-c2ccc(C3=NNC(c4ccc5ccccc5c4)C3)cc2)cc1
2094,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCOC(=O)c1cc2c(N)c3c(nc2nc1C)CCCC3,"ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.78,uM,=,-0.1079053973095195,0,c1cnc2nc3c(cc2c1)CCCC3
2095,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)cc1OC,"2-Chloro-10H-phenothiazin-10-yl-(3,4-dimethoxyphenyl)-methanone",6.4,uM,=,0.8061799739838872,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
2096,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3cccc(C(F)(F)F)c3)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)-1-(3-(trifluoromethyl)benzyl)pyridinium bromide",0.3075,uM,=,-0.5121548798885645,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
2097,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(C)C,"(E)-4-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl dimethylcarbamate",17.9,uM,=,1.252853030979893,1,O=C(/C=C/c1ccccc1)N1CCc2ccccc2C1
2098,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3sccc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1,"2-(4-(4-benzylpiperazin-1-yl)butyl)-4,4a,5,6-tetrahydrothieno[2,3-h]cinnolin-3(2H)-one",0.86,uM,=,-0.0655015487564322,0,O=C1CC2CCc3sccc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1
2099,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCCN(C)Cc1ccc(O)cc1,1-(9-((4-hydroxybenzyl)(methyl)amino)nonyl)-5-methoxy-1H-indo1e-3-carbaldehyde,6.23,uM,=,0.7944880466591696,1,c1ccc(CNCCCCCCCCCn2ccc3ccccc32)cc1
2100,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCOC(=O)/C=C/c1ccc(OCCCCCCN2CCCC2)c(OC)c1,(E)-ethyl-3-(3-methoxy-4-((6-(pyrrolidin-1-yl)hexyl)oxy)phenyl)acrylate,5.05,uM,=,0.7032913781186614,1,c1ccc(OCCCCCCN2CCCC2)cc1
2101,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,NCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1-(1,2,3,4-tetrahydroacridin-9-yl)nonane-1,9-diamine",0.131,uM,=,-0.8827287043442358,0,c1ccc2nc3c(cc2c1)CCCC3
2102,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1ccc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc1OC,"(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,4-dimethoxyphenyl)acrylmide",0.26,uM,=,-0.585026652029182,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2103,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccccc3F)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-1-(2-fluorobenzyl)-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium bromide",0.043,uM,=,-1.3665315444204136,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
2104,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1OC)CC(CC1CCN(CCNc3c4c(nc5cc(Cl)ccc35)CC3C=C(C)CC4C3)CC1)C2.Cl.Cl,"(-)-3-chloro-N-(2-(4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)ethyl)-9-methyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinolin-12-amine Dihydrochloride",0.013,uM,=,-1.8860566476931635,0,C1=CC2Cc3nc4ccccc4c(NCCN4CCC(CC5Cc6ccccc6C5)CC4)c3C(C1)C2
2105,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCCC1,"2-(4-(pyrrolidin-1-yl)butyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",1.16,uM,=,0.0644579892269184,1,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCCC1
2106,1276071,10.1021/jm401047q,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman's method,COc1cc2[se]n(CCCC3CCN(Cc4ccccc4)CC3)c(=O)c2cc1OC,"2-[3-(1-Benzylpiperidin-4-yl)propyl]-5,6-dimethoxybenzo[d][1,2]-selenazol-3(2H)-one",0.231,uM,=,-0.6363880201078557,0,O=c1c2ccccc2[se]n1CCCC1CCN(Cc2ccccc2)CC1
2107,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3cccc(Cl)c13)CCCC2,"8-chloro-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.0334,uM,=,-1.4762535331884354,0,c1ccc2nc3c(cc2c1)CCCC3
2108,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)[C@@H]1C2,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl butylcarbamate",0.09,uM,=,-1.0457574905606752,0,c1ccc2c(c1)C[C@H]1NCCC21
2109,2261346,10.1016/j.ejmech.2022.114606,,,,Inhibition of AChE (unknown origin),CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1O2,"(-)-(3aS)-3a-methyl-2,3,3a,8a-tetrahydrofuro[2,3-b]benzofuran-5-yl N-Ethylcarbamate",0.036,uM,=,-1.4436974992327127,0,c1ccc2c(c1)O[C@H]1OCCC21
2110,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2cccnc2)=CC1=O)Cc1cccnc1,"2,5-bis{6-[ethyl(pyridin-3-ylmethyl)amino]hexylamino}-[1,4]-benzoquinone",0.133,uM,=,-0.8761483590329142,0,O=C1C=C(NCCCCCCNCc2cccnc2)C(=O)C=C1NCCCCCCNCc1cccnc1
2111,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,c1ccc(COc2ccc(CCOCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2OCc2ccccc2)cc1,"N-{5'-[3'',4''-(Dibenzyloxy)phenethyloxy]pentyl}-1,2,3,4-tetrahydroacridin-9-amine",0.506,uM,=,-0.2958494831602009,0,c1ccc(COc2ccc(CCOCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2OCc2ccccc2)cc1
2112,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCNCc1ccc2nc(-c3cccnc3)c3c(c2c1)NCCC3,"N-{{1,2,3,4-tetrahydro-5-(3-pyridyl)benzo[h][1,6]naphthyridin-9-yl}methyl}ethanamine",15.8,uM,=,1.1986570869544226,1,c1cncc(-c2nc3ccccc3c3c2CCCN3)c1
2113,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-chlorobenzoyl)piperazin-1-yl)ethanone,35.2,uM,=,1.546542663478131,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
2114,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,COc1cc(N)c(Cl)cc1C(=O)NCCNCc1ccc(CN(C)C)o1,4-Amino-5-chloro-N-{2-[(5-dimethylaminomethyl-furan-2-ylmethyl)-amino]-ethyl}-2-methoxy-benzamide,3.1,uM,=,0.4913616938342727,1,O=C(NCCNCc1ccco1)c1ccccc1
2115,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,"(S)-5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chroman-4-one",2045.0,uM,=,3.3106933123433606,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
2116,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CN1C/C(=C/c2ccc(N3CCCC3)cc2)C(=O)/C(=C/c2ccc(N3CCCC3)cc2)C1,"1-Methyl-3,5-bis[4-(pyrrolidinyl)benzylidene]piperidin-4-one",2.78,uM,=,0.4440447959180762,1,O=C1/C(=C\c2ccc(N3CCCC3)cc2)CNC/C1=C\c1ccc(N2CCCC2)cc1
2117,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Fc1ccc2[nH]c3c(c2c1)CN(Cc1ccccc1)CC3,"2-benzyl-8-fluoro-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole",17.6,uM,=,1.24551266781415,1,c1ccc(CN2CCc3[nH]c4ccccc4c3C2)cc1
2118,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,COc1cc2c(cc1OC)C(NC(=O)CN1CCN(Cc3ccccc3)CC1)c1cnn(C)c1-2,"2-(4-Benzylpiperazin-1-yl)-N-(6,7-dimethoxy-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-4-yl)acetamide",1.84,uM,=,0.2648178230095365,1,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2ccccc2-c2[nH]ncc21
2119,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCC3C)cc1)NCC2,"6,7-dimethoxy-1-(4-((6-(2-methylpyrrolidin-1-yl)hexyl)oxy)benzyl)-1,2,3,4-tetrahydroisoquinoline",4.5,uM,=,0.6532125137753437,1,c1ccc2c(c1)CCNC2Cc1ccc(OCCCCCCN2CCCC2)cc1
2120,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1725.0,uM,=,3.236789099409293,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
2121,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(c2)O/C(=C\c2cc(O)c(O)c(O)c2)C3=O)c1,"3-((methyl(3-(3-oxo-2-(3,4,5-trihydroxybenzylidene)-2,3-dihydrobenzofuran-6-yloxy)propyl)amino)methyl)phenyl methylcarbamate",0.00299,uM,=,-2.5243288116755704,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCNCc3ccccc3)ccc21
2122,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,CC1(C)CC(=O)C2=C(C1)Nc1nc3c(c(N)c1C2c1ccncc1)CCCC3,"11-Amino-3,3-dimethyl-12-pyridin-4-yl-3,4,5,7,8,9,10,12-octahydro-2H-dibenzo[b,g][1,8]naphthyridin-1-one",2.8,uM,=,0.4471580313422192,1,O=C1CCCC2=C1C(c1ccncc1)c1cc3c(nc1N2)CCCC3
2123,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCC[n+]2ccccc2)cc1,"1,9-di(1-pyridiniumyl)nonane; dibromide",2.0,uM,=,0.3010299956639812,1,c1cc[n+](CCCCCCCCC[n+]2ccccc2)cc1
2124,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CNC(=O)Oc1cccc2c1SCC1CCN(C)C21,"Methyl-carbamic acid 1-methyl-1,2,3,3a,4,9b-hexahydro-5-thia-1-aza-cyclopenta[a]naphthalen-6-yl ester",0.00811,uM,=,-2.090979145788844,0,c1ccc2c(c1)SCC1CCNC21
2125,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CCN(CC)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((diethylamino)methyl)phenol dihydrochloride,48.3,uM,=,1.683947130751512,1,c1ccccc1
2126,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)/C=C/c3cc[n+](Cc4ccc(F)cc4)cc3)c2c1.[Br-],1-(4-fluorobenzyl)-4-(3-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-3-oxoprop-1-en-1-yl)pyridin-1-ium bromide,0.21,uM,=,-0.6777807052660807,0,O=C(/C=C/c1cc[n+](Cc2ccccc2)cc1)NCCc1c[nH]c2ccccc12
2127,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,COc1cc2nc3ccccc3c(Nc3ccc(C(=O)NO)cc3)c2c(OC)c1OC,"N-Hydroxy-4-(1,2,3-trimethoxyacridin-9-ylamino)benzamide",0.64,uM,=,-0.1938200260161128,0,c1ccc(Nc2c3ccccc3nc3ccccc23)cc1
2128,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cccc(CCCCCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(pentane-1,5-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",0.11,uM,=,-0.958607314841775,0,c1ccc(CCCCCc2cccc[nH+]2)[nH+]c1
2129,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)-c1ccccc1NCC2,"6,7-Dihydro-5H-benzo[2,3]azepino[4,5-b]quinolin-8-ylamine",69.4,uM,=,1.841359470454855,1,c1ccc2c(c1)NCCc1cc3ccccc3nc1-2
2130,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,C[C@]12CC[C@H](O)[C@@](C)(CO)C1C[C@H](O)[C@@]1(C)Oc3cc(-c4ccccn4)oc(=O)c3C(=O)C21,"3,6-Dihydroxy-4-hydroxymethyl-4,6a,12b-trimethyl-9-pyridin-2-yl-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-7,10-dioxa-benzo[a]anthracene-11,12-dione",101.0,uM,=,2.004321373782642,1,O=C1c2c(cc(-c3ccccn3)oc2=O)OC2CCC3CCCCC3C12
2131,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,COc1cc2c(cc1OC)C(NC(=O)CN1CCN(Cc3ccccc3F)CC1)c1cnn(-c3ccccc3)c1-2,"2-[4-(2-Fuorobenzyl)piperazin-1-yl]-N-(6,7-dimethoxy-1-phenyl-1,4-dihydroindeno[1,2-c]pyrazol-4-yl)acetamide",2.43,uM,=,0.3856062735983122,1,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2ccccc2-c2c1cnn2-c1ccccc1
2132,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccc3c(c2)OCO3)N(c2ccccc2)[C@@H]1c1ccc2c(c1)OCO2,"(2R,6S)-methyl 2,6-di(benzo[d][1,3]dioxol-5-yl)-1-phenyl-4-(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",3270.0,uM,=,3.514547752660286,1,C1=C(Nc2ccccc2)C[C@@H](c2ccc3c(c2)OCO3)N(c2ccccc2)[C@@H]1c1ccc2c(c1)OCO2
2133,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(CCCC2Cc3ccccc3C2=O)CC1,2-[3-(1-Methyl-piperidin-4-yl)-propyl]-indan-1-one,0.0015,uM,=,-2.8239087409443187,0,O=C1c2ccccc2CC1CCCC1CCNCC1
2134,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,Cc1ccccc1CN1CCC(C)CC1,4-Methyl-1-(2-methyl-benzyl)-piperidine,0.01,uM,=,-2.0,0,c1ccc(CN2CCCCC2)cc1
2135,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,CCc1nc(C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,"1-Ethyl-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)-hexyl)-9H-pyrido[3,4-b]indole-3-carboxamide",0.0982,uM,=,-1.0078885122130503,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c(cn1)[nH]c1ccccc12
2136,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1cc(/C=N/NC(=O)N2CCN(c3ccccn3)CC2)cc(OC)c1OC,"4-(Pyridin-2-yl)-N'-(3,4,5-trimethoxybenzylidene)piperazine-1-carbohydrazide",5.69,uM,=,0.7551122663950712,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
2137,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c3ccccc32)cc1,"1-[(4-methoxyphenyl)methyl]-4-oxo-N-{6-[(1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}-1,4-dihydroquinoline-3-carboxamide",0.194,uM,=,-0.712198270069774,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
2138,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCN(C)Cc1ccc(O)cc1,1-(7-((4-hydroxybenzyl)(methyl)amino)heptyl)-5-methoxy-1H-indo1e-3-carbaldehyde,1.61,uM,=,0.2068258760318497,1,c1ccc(CNCCCCCCCn2ccc3ccccc32)cc1
2139,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCOCC2)cc1OC,"rac-2-(3,4-Dimethoxyphenyl)-2-(morpholin-1-yl)acetonitrile",54.0,uM,=,1.7323937598229686,1,c1ccc(CN2CCOCC2)cc1
2140,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(Cc1ccccc1)Cc1ccc(/C=C2\Cc3ccc(OC)cc3C2=O)cc1,2-{4-[(Benzylethylamino)methyl]benzylidene}-6-methoxyindan-1-one,4.93,uM,=,0.69284691927723,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
2141,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN2CCN(CCCOc3ccc4c5c(c(=O)oc4c3)CCCC5)CC2)c1,"3-(3-(4-(3-Methoxybenzyl)piperazin-1-yl)propoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",6.2,uM,=,0.7923916894982539,1,O=c1oc2cc(OCCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2
2142,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCCC4)oc12,"7-Methoxy-N-(6-((7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)amino)hexyl)benzofuran-2-carboxamide",0.0322999999999999,uM,=,-1.4907974776688973,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1
2143,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Cc1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,1-Benzyl-N-(4-methylbenzyl)pyrrolidin-3-amine,6.392,uM,=,0.805636766305935,1,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
2144,1676712,10.1021/acs.jmedchem.7b01083,,,,Reactivation of organophosphate inhibited human erythrocyte AChE assessed as organophosphate IC50 using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addition measured for 3 mins by Ellman's method,COc1ccc(CN(CC(=O)NCc2ccccc2)C(=O)CCCCCn2ccnc2/C=N/O)cc1,N-p-Methoxybenzyl-N-[2-(benzylamino)-2-oxoethyl]-(6-(2-hydroxyiminomethyl-1H-imidazol-1-yl))hexanamide,180.0,uM,=,2.255272505103306,1,O=C(CN(Cc1ccccc1)C(=O)CCCCCn1ccnc1)NCc1ccccc1
2145,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.009,uM,=,-2.0457574905606752,0,c1ccc2nc3c(cc2c1)CCCC3
2146,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Cc1cccc2nc3c(c(N)c12)CCCO3,"5-Methyl-3,4-dihydro-2H-1-oxa-9-aza-anthracen-10-ylamine",0.15,uM,=,-0.8239087409443188,0,c1ccc2nc3c(cc2c1)CCCO3
2147,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,N/C(=N\O)c1nc(CCCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,"N',3-dihydroxy-6-{5-[(1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}pyridine-2-carboximidamide",0.26,uM,=,-0.585026652029182,0,c1ccc(CCCCCNc2c3c(nc4ccccc24)CCCC3)nc1
2148,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-9-{{6-[3-(3,4-dihydro-5-phenyl-2H-pyrano[3,2-c]quinolin-9-yl)propanamido]hexyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.0111,uM,=,-1.9546770212133424,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
2149,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2[nH]c(C(=O)NCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2c1,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-6-methoxy-4-oxo-1,4-dihydroquinoline-2-carboxamide",0.88,uM,=,-0.0555173278498313,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2[nH]1
2150,900878,10.1007/s00044-011-9581-9,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 min prior to substrate addition measured after 20 min by Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0472446593216419,uM,=,-1.3256472783342546,0,c1ccc2c(c1)N[C@H]1NCCC21
2151,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,5-bis(4-tert.butylpyridinium)-pent-1,5-diyl dibromide",24.0,uM,=,1.380211241711606,1,c1cc[n+](CCCCC[n+]2ccccc2)cc1
2152,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)ccc1OC(C)=O,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-ethoxy-3-methoxyphenyl)acrylamide,0.339,uM,=,-0.4698003017969178,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2153,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)[C@@H]1C2,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl heptylcarbamate",0.058,uM,=,-1.2365720064370629,0,c1ccc2c(c1)C[C@H]1NCCC21
2154,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1cc(OCC[N+](CC)(CC)CC)cc(C(=O)NCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)c1.Cl.[Br-].[Br-],"N,N,N-triethyl-2-(3-(((6-(2-(1,2,3,4-tetrahydroacridin-9-yl)-hydrazino)-6-oxohexyl)amino)carbonyl)-5-((2-triethylammonio)-ethoxy)phenoxy)ethanammonium dibromide hydrochloride",0.0158,uM,=,-1.8013429130455774,0,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
2155,2073679,10.1021/acs.jmedchem.0c00756,,,,Inhibition of recombinant human AChE using ATC as substrate by DTNB-reagent based Ellman's method,COCCn1cnc2cc(NC(=O)c3ccccc3)cc(C(=O)NCc3cc(F)cc(F)c3)c21,"5-benzamido-N-(3,5-difluorobenzyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-7-carboxamide",0.12,uM,=,-0.9208187539523752,0,O=C(Nc1cc(C(=O)NCc2ccccc2)c2[nH]cnc2c1)c1ccccc1
2156,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CCC/N=C1/CCc2c1n(C)c1ccc(OC(=O)NC)cc21,"Methyl-carbamic acid 4-methyl-3-[(Z)-propylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",3.84,uM,=,0.5843312243675308,1,N=C1CCc2c1[nH]c1ccccc21
2157,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N+](C)(C)C1N2C.[Br-],"(3aS)-1,1,3a,8-tetramethyl-5-(methylcarbamoyloxy)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium bromide",0.0261,uM,=,-1.583359492661719,0,c1ccc2c(c1)NC1[NH2+]CCC21
2158,745140,10.1021/jm101299d,,,,Inhibition of human recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,[Br-].[Br-].c1cc(C[N+]23CCC(CC2)CC3)cc(-c2cccc(C[N+]34CCC(CC3)CC4)c2)c1,"1,1'-[Biphenyl-3,3'-diylbis(methylene)]bis(quinuclidinium)bromide",0.62,uM,=,-0.2076083105017461,0,c1cc(C[N+]23CCC(CC2)CC3)cc(-c2cccc(C[N+]34CCC(CC3)CC4)c2)c1
2159,1842234,10.1016/j.bmc.2019.01.025,,,,Inhibition of human acetylcholinesterase,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.03,uM,=,-1.5228787452803376,0,c1ccc2nc3c(cc2c1)CCCC3
2160,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3cccc(OC)c3)cn2)cc1,N-(3-(3-methoxyphenoxy)propyl)-2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-methylpyrimidine-5-carboxamide,44.9,uM,=,1.6522463410033232,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
2161,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,O/N=C\c1cccc[n+]1COCCOC[n+]1ccccc1/C=N/O.[Cl-].[Cl-],2-[1-(2-{2-[2-hydroxy-(E)-1-methenylimino]-1-pyridiniumylmethoxy}ethoxymethyl)-2-pyridiniumyl]-(E)-1-iminomethen-1-ol,339.6,uM,=,2.530967681571916,1,c1cc[n+](COCCOC[n+]2ccccc2)cc1
2162,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(-c2ccccc2)cc1)CCCC3,"Ethyl Ester 5-Amino-4-(4'-biphenyl)-1,4,6,7,8,9-hexahydro-2-methyl-benzo[b][1,8]naphthyridine-3-carboxylic Acid",0.071,uM,=,-1.1487416512809248,0,C1=CC(c2ccc(-c3ccccc3)cc2)c2cc3c(nc2N1)CCCC3
2163,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(NCCN4CCN(Cc5ccccc5)CC4)c2c1)CCCC3,"N-(2-(4-benzylpiperazin-1-yl)ethyl)-7-methyl-1,2,3,4-tetrahydroacridin-9-amine",6.381,uM,=,0.8048887446223915,1,c1ccc(CN2CCN(CCNc3c4c(nc5ccccc35)CCCC4)CC2)cc1
2164,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCCCN1CCCC1,(E)-3-(3-methoxy-4-((8-(pyrrolidin-1-yl)octyl)oxy)phenyl)-N-phenylacrylamide,2.91,uM,=,0.4638929889859073,1,O=C(/C=C/c1ccc(OCCCCCCCCN2CCCC2)cc1)Nc1ccccc1
2165,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C(/C=C/c1ccc(F)cc1)c1cc(I)c(Br)cc1O,1-(4-bromo-2-hydroxy-5-iodophenyl)-3-(4-fluorophenyl)prop-2-en-1-one,0.01098,uM,=,-1.9593976598859268,0,O=C(/C=C/c1ccccc1)c1ccccc1
2166,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12,"3-(4-(Piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carbonitrile",0.333,uM,=,-0.4775557664936801,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
2167,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)Cc6cccc(C(F)(F)F)c6)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"20S-[m-(trifluoromethyl)benzylamino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.003,uM,=,-2.5228787452803374,0,O=C1CC2C(CC[C@@H]2CNCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
2168,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NCC3CCN(Cc4ccccc4C(F)(F)F)CC3)sc2-c2ccc(OC)cc2)cc1,"N-[(1-(2-Trifluoromethylbenzyl)piperidin-4-yl)methyl]-4,5-bis(4-methoxyphenyl)thiazol-2-ylamine",0.69,uM,=,-0.1611509092627447,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
2169,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12,"(-)-Phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",1.56,uM,=,0.1931245983544616,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
2170,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccc(OC)cc1)C(=O)C(F)(F)F,"Ethyl(2Z)-4,4,4-trifluoro-2-[2-(4-methoxyphenyl)hydrazinylidene]-3-oxobutanoate",4.62,uM,=,0.6646419755561255,1,c1ccccc1
2171,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC1CCCCC1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-cyclohexyl-thiourea,1.4,uM,=,0.1461280356782379,1,S=C(NCCOCCNCc1ccccc1)NC1CCCCC1
2172,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCc3ccc(CN(C)Cc4ccc(C#N)cc4)cc3)cc2oc1=O.Cl,"4-(((N-(4-(3,4-Dimethyl-2H-2-oxochromen-7-yl)oxymethyl)benzyl)-N-methylamino)methyl)benzonitrile hydrochloride",3.9,uM,=,0.5910646070264992,1,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
2173,1632485,10.1016/j.ejmech.2016.08.016,,,,Inhibition of human recombinant AChE preincubated for 5 mins followed by acetylthiocholine iodide substrate addition measured after 5 mins by Ellman's method,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21,"N-(5-(4-(1-(phenylsulfonyl)-1H-indol-4-yl)piperazin-1-yl)pentyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0182,uM,=,-1.739928612014925,0,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21
2174,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-2-amino-N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.0063,uM,=,-2.2006594505464183,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
2175,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Oc1ccc(/C=N\C2CCN(Cc3ccccc3)C2)c(O)c1,"4-(((1-Benzylpyrrolidin-3-yl)imino)methyl)benzene-1,3-diol",3.679,uM,=,0.565729787831127,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
2176,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(Cc2cccc3ccccc23)CC1,4-Methyl-1-naphthalen-1-ylmethyl-piperidine,0.22,uM,=,-0.6575773191777937,0,c1ccc2c(CN3CCCCC3)cccc2c1
2177,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.04,uM,=,-1.3979400086720375,0,c1ccc2c(c1)N[C@H]1NCCC21
2178,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2,"3-(3-(4-Benzylpiperazin-1-yl)propoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",0.9,uM,=,-0.0457574905606751,0,O=c1oc2cc(OCCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2
2179,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(Cl)cc1)CC2.[Br-],"2-(4-chlorophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",0.32,uM,=,-0.494850021680094,0,C1=[N+](c2ccccc2)CCc2ccccc21
2180,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,FC(F)(F)c1ccc(/C=N\C2CCN(Cc3ccccc3)C2)cc1,N-(1-Benzylpyrrolidin-3-yl)-1-(4-(trifluoromethyl)phenyl)methanimine,1.039,uM,=,0.0166155475571774,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
2181,1765157,10.1021/acs.jmedchem.8b00592,,,,Inhibition of human recombinant AChE by spectrophotometry based Ellman's assay,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1.[Cl-].[Cl-],4-(aminocarbonyl)-1-({[1-chloro-2-[(E)-(hydroxyimino)methyl]pyridinium-1(2H)-yl]methoxy}methyl)pyridinium chloride,54.0,uM,=,1.7323937598229686,1,c1cc[n+](COC[n+]2ccccc2)cc1
2182,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"o-Tolyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.01,uM,=,-2.0,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
2183,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CCNc2nc(NC(C)=O)nc3ccccc23)cc1OC,"N-(4-((3,4-dimethoxyphenethyl)amino)quinazolin-2-yl)acetamide",7.4,uM,=,0.8692317197309762,1,c1ccc(CCNc2ncnc3ccccc23)cc1
2184,751129,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes AChE,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,Diethyl-(1-methyl-2-phenothiazin-10-yl-ethyl)-amine,0.26,uM,=,-0.585026652029182,0,c1ccc2c(c1)Nc1ccccc1S2
2185,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,"[1,4']Bipiperidinyl-1'-carboxylic acid (S)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester",1.827,uM,=,0.2617385473525377,1,O=C1Cc2cc3n(c(=O)c2CO1)Cc1cc2cc(OC(=O)N4CCC(N5CCCCC5)CC4)ccc2nc1-3
2186,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C/c2nnc(-c3ccc(OC(F)(F)F)cc3)o2)ccc1O,"2-methoxy-4-(2-(5-(4-(trifluoromethoxy)phenyl)-1,3,4-oxadiazol-2-yl)vinyl)phenol",9.2e-05,uM,=,-4.036212172654444,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
2187,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCSCc2ccc(CN(C)C)o2)o1,{5-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.5,uM,=,-0.3010299956639812,0,c1coc(CSCCSCc2ccco2)c1
2188,2222235,10.1021/acsmedchemlett.2c00001,,,,Inhibition of recombinant human AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2oc1=O.Cl,"(+/-)-3,4-Dimethyl-7-[(N-benzylpiperidin-3-yl)methoxy]-2H-chromen-2-one hydrochloride",1.4,uM,=,0.1461280356782379,1,O=c1ccc2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2o1
2189,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,COc1ccc(C(=O)CCc2ccc([N+](C)(C)Cc3ccccc3)cc2)cc1OC.[Br-],"Benzyl-{4-[3-(3,4-dimethoxy-phenyl)-3-oxo-propyl]-phenyl}-dimethyl-ammonium bromide",1.3,uM,=,0.1139433523068367,1,O=C(CCc1ccc([NH2+]Cc2ccccc2)cc1)c1ccccc1
2190,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1CC(=O)c1ccc(Cl)cc1,"2-butyl-3-[2-(4-chlorophenyl)-2-oxoethyl]-1,3-diazaspiro[4,4]non-1-en-4-one",0.2864,uM,=,-0.5430269863641821,0,O=C(CN1C=NC2(CCCC2)C1=O)c1ccccc1
2191,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,[O-][S+]1CCN(c2nccc(NCc3ccccc3)n2)CC1,4-[4-(benzylamino)pyrimidin-2-yl]thiomorpholine-1-oxide,12.6,uM,=,1.100370545117563,1,c1ccc(CNc2ccnc(N3CC[SH+]CC3)n2)cc1
2192,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Brc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-6-bromo-benzo[d]isoxazole,0.05,uM,=,-1.3010299956639813,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
2193,28474,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 224-1012,C#CCNC1CCc2cccc(OC(=O)N(C)CC)c21.Cl,Ethyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-4-yl ester hydrochloride,525.0,uM,=,2.720159303405957,1,c1ccc2c(c1)CCC2
2194,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,CCN1CCN(c2ccc(C3CC(c4ccc(OC)cc4)=NN3C(C)=O)cc2)CC1,"1-(5-(4-(4-Ethylpiperazin-1-yl)phenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",221.2,uM,=,2.344785122632661,1,c1ccc(C2=NNC(c3ccc(N4CCNCC4)cc3)C2)cc1
2195,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CNC(=O)Oc1cccc(C(C)N(C)C)c1.Cl,Dimethyl-[1-(3-methylcarbamoyloxy-phenyl)-ethyl]-ammonium chloride,0.1,uM,=,-1.0,0,c1ccccc1
2196,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,Cl.O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)OCCO2,"3-(1-Benzyl-piperidin-4-yl)-1-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-propan-1-one hydrochloride",0.03,uM,=,-1.5228787452803376,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)OCCO2
2197,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2oc(-c3ccc(CN(C)Cc4ccccc4)cc3)cc(=O)c2cc1OC,"2-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxychromen-4-one",3.1,uM,=,0.4913616938342727,1,O=c1cc(-c2ccc(CNCc3ccccc3)cc2)oc2ccccc12
2198,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(F)cc3)cc12.[Br-],2-(4-Fluorophenyl)-8-methoxyisoquinolin-2-ium bromide,0.67,uM,=,-0.1739251972991735,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
2199,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1ccc2nc3c(c(N)c2c1)CCCC3.Cl,"7-methyl-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",15.5,uM,=,1.1903316981702914,1,c1ccc2nc3c(cc2c1)CCCC3
2200,28595,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 31.2-202,C#CCNC1CCc2ccc(OC(=O)N(CC)CCCC)cc21.Cl,Butyl-ethyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,72.4,uM,=,1.859738566197147,1,c1ccc2c(c1)CCC2
2201,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(CN(C)CCCCCOc2ccc3ccc(=O)oc3c2)c1,3-((Methyl-(5-((2-oxo-2H-chromen-7-yl)oxy)pentyl)amino)-methyl)phenyl Heptylcarbamate,0.0113,uM,=,-1.9469215565165805,0,O=c1ccc2ccc(OCCCCCNCc3ccccc3)cc2o1
2202,1978343,10.1016/j.bmcl.2019.126888,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1CN(/N=C/c2ccc(-c3cccc([N+](=O)[O-])c3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-1-((5-(3-nitrophenyl)furan-2-yl)methyleneamino)imidazolidine-2,4-dione",0.29,uM,=,-0.5376020021010439,0,O=C1CN(/N=C/c2ccc(-c3ccccc3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1
2203,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCC(C#N)CC4)cc3)cc12,"3-(4-((4-Cyanopiperidin-1-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",2.69,uM,=,0.4297522800024079,1,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
2204,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(F)c3)CC1)C2,"2-((1-(3-fluorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.054,uM,=,-1.2676062401770316,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2205,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(C(F)(F)F)cc2)nn1C(=O)N(C)C,"5-Methylsulfanyl-3-(4-trifluoromethyl-phenyl)-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.5,uM,=,-0.3010299956639812,0,c1ccc(-c2nc[nH]n2)cc1
2206,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Clc1ccc2c(Nc3ccccc3)c3c(nc2c1)CCCC3,"6-chloro-N-phenyl-1,2,3,4-tetrahydroacridin-9-amine",0.17,uM,=,-0.7695510786217261,0,c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1
2207,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-3-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)-N-(4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl)propanamide",0.00975,uM,=,-2.0109953843014634,0,O=C(CCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
2208,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)C1N2Cc1ccccc1,"Methyl-carbamic acid (S)-1,8-dibenzyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",1.09,uM,=,0.0374264979406236,1,c1ccc(CN2CCC3c4ccccc4N(Cc4ccccc4)C32)cc1
2209,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1,N-(5-((1-benzylpiperidin-4-yl)methoxy)pyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide,0.0026,uM,=,-2.5850266520291822,0,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1
2210,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCN=c3[nH]nc(-c4ccccc4)c4ccccc34)CC2)cc1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-4-phenylphthalazin-1-amine,0.44,uM,=,-0.3565473235138126,0,c1ccc(CN2CCC(CCN=c3[nH]nc(-c4ccccc4)c4ccccc34)CC2)cc1
2211,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(C=C2Cc3ccccc3C2=O)cc1,2-[[4-(diethylaminomethyl)phenyl]methylene]indan-1-one,1.31,uM,=,0.1172712956557642,1,O=C1C(=Cc2ccccc2)Cc2ccccc21
2212,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,"N1-(Benzofuran-2-ylmethyl)-N7-(1,2,3,4-tetrahydroacridin-9-yl)-heptane-1,7-diamine",0.00086,uM,=,-3.065501548756432,0,c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1
2213,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCCCC[n+]2ccc3ccccc3c2)cc1,1-(11-(pyridinium-1-yl)undecyl)isoquinoliniumdibromide,0.03,uM,=,-1.5228787452803376,0,c1cc[n+](CCCCCCCCCCC[n+]2ccc3ccccc3c2)cc1
2214,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,C=CC[N+]1(C)CCN(c2ccc(/C=C3\Cc4cc(OC)c(OC)cc4C3=O)cc2)CC1.[Cl-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-(2-propen-1-yl-4-methylpiperazinium-1-yl)benzylidinel-1H-inden-1-one chloride",0.43,uM,=,-0.3665315444204134,0,O=C1/C(=C/c2ccc(N3CC[NH2+]CC3)cc2)Cc2ccccc21
2215,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCOc1ccc2c(c1)C/C(=C\c1ccc(CN(C)Cc3ccccc3)cc1)C2=O,2-{4-[(Benzylmethylamino)methyl]benzylidene}-5-(3-diethylaminopropoxy)indan-1-one,1.61,uM,=,0.2068258760318497,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
2216,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,C=CC[n+]1ccc(CCC(=O)c2cc3cc(OC)c(OC)cc3s2)cc1.[Br-],"1-Allyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium bromide",0.54,uM,=,-0.2676062401770315,0,O=C(CCc1cc[nH+]cc1)c1cc2ccccc2s1
2217,452431,10.1021/jm701225u,,,,Inhibition of human serum recombinant AChE by Ellman's method,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)C(=O)NCCNc1c2c(nc3ccccc13)CCCC2,"N1,N2-bis(2-(5,6,7,8-tetrahydroacridin-9-ylamino)ethyl)oxalamide",0.00665,uM,=,-2.1771783546968955,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)C(=O)NCCNc1c2c(nc3ccccc13)CCCC2
2218,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccc(OC)c(OC)c3)CC2)cc1OC,"(2-(1-(3,4-dimethoxybenzyl)piperidin-4-yl)benzofuran-3-yl)(3,4-dimethoxyphenyl)methanone",67.96,uM,=,1.832253370197008,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
2219,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCNC(=O)NCCSCc2ccc(CN(C)C)o2)o1,"1,3-Bis-[2-(5-dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-urea",48.0,uM,=,1.6812412373755872,1,O=C(NCCSCc1ccco1)NCCSCc1ccco1
2220,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,[O-]c1cc2c3c(c1)c1cc4c(cc1c[n+]3CC2)OCO4,"2-hydroxy-4,5-dihydro-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridin-6-ylium",3.85,uM,=,0.5854607295085007,1,c1cc2c3c(c1)c1cc4c(cc1c[n+]3CC2)OCO4
2221,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccc(F)c(F)c3)CC2)cc(C(C)(C)C)c1O,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(3,4-difluorobenzyl)piperidin-4-yl)piperidin-4-yl)ethyl)acrylamide",1.62,uM,=,0.2095150145426309,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2222,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)Nc1ccccn1)Cc1ccccc1,1-(2-(2-(benzyl(methyl)amino)ethoxy)ethyl)-3-(pyridin-2-yl)thiourea,4.0,uM,=,0.6020599913279624,1,S=C(NCCOCCNCc1ccccc1)Nc1ccccn1
2223,28936,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase activity from octopus brain,CC[N+](C)(C)c1cccc(O)c1.[Cl-],Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium chloride,0.5,uM,=,-0.3010299956639812,0,c1ccccc1
2224,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31[C@H](O)CN(C)C2,11-Hydroxygalantamine,1.61,uM,=,0.2068258760318497,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
2225,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(Br)cc1)N1CCN(c2ccccn2)CC1,N'-(4-Bromobenzylidene)-4-(pyridin-2-yl)piperazine-1-carbohydrazide,0.489,uM,=,-0.3106911408763798,0,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
2226,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCC[n+]2ccccc2)cc1,"1,7-bis(pyridinium)-heptane dibromide",241.0,uM,=,2.3820170425748683,1,c1cc[n+](CCCCCCC[n+]2ccccc2)cc1
2227,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2cccc(O)c21,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-7-hydroxy-2,3-dihydro-1H-inden-1-one",0.636,uM,=,-0.1965428843515861,0,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
2228,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2cc(O)ccc2o1,N-(1-benzylpiperidin-4-yl)-6-hydroxy-4-oxo-4H-chromene-2-carboxamide,2.36,uM,=,0.3729120029701065,1,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
2229,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCCCNC(=O)C4(C)CCc5c(C)c(O)c(C)c(C)c5O4)c2c1)CCCC3,"6-hydroxy-N-(4-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)butyl)-2,5,7,8-tetramethylchroman-2-carboxamide",7.21,uM,=,0.857935264719429,1,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
2230,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CCCC3,"ethyl 5-amino-2-methyl-4-(3-nitrophenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.191,uM,=,-0.7189666327522725,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
2231,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc(CCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(ethane-1,2-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",0.81,uM,=,-0.0915149811213502,0,c1ccc(CCc2cccc[nH+]2)[nH+]c1
2232,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,"N*4*-(6-Chloro-2-methoxy-acridin-9-yl)-N*1*,N*1*-diethyl-pentane-1,4-diamine",2.667,uM,=,0.4260230156898761,1,c1ccc2nc3ccccc3cc2c1
2233,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CCOc1nn(-c2cccc(OCc3ccccc3)c2)c(=O)o1,"3-(3-Benzyloxy-phenyl)-5-ethoxy-3H-[1,3,4]oxadiazol-2-one",0.75,uM,=,-0.1249387366082999,0,O=c1ocnn1-c1cccc(OCc2ccccc2)c1
2234,1497677,10.1021/acs.jnatprod.5b00057,,,,Inhibition of human erythrocytes acetylcholinesterase after 30 mins using S-acetylthiocholine iodide substrate by spectrophotometry based Ellman method,C=C(C)[C@H]1CC[C@@](C)(O)[C@@H](C2=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(C(=O)C(C)C)=C2O)C1,Hyphenrone J,25.4,uM,=,1.404833716619938,1,O=C1C=CC(C2CCCCC2)=CC1
2235,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(Cc4ccc(C(C)(C)C)cc4)CC3)nc12,3-(4-(4-(tert-Butyl)benzyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,40.0,uM,=,1.6020599913279625,1,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1nc2ccccc2s1
2236,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2,"3-(2-(4-Benzylpiperidin-1-yl)ethoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",8.1,uM,=,0.9084850188786496,1,O=c1oc2cc(OCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2
2237,1922071,10.1016/j.bmc.2018.12.030,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(Cc1cn(CC3CCN(Cc4ccccc4)CC3)nn1)C2,"2-((1-((1-Benzylpiperidin-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",4.92,uM,=,0.6919651027673603,1,O=C1c2ccccc2CC1Cc1cn(CC2CCN(Cc3ccccc3)CC2)nn1
2238,813758,10.1016/j.bmcl.2012.02.057,,,,Inhibition of AChE by Ellman's method,CC[C@H]1C[C@@H]2CN3CCc4c([nH]c5cc([C@H]6C[C@H]7C(C(=O)OC)[C@H](Cc8c6[nH]c6ccccc86)N(C)C[C@H]7CC)ccc45)[C@](C(=O)OC)(C2)[C@H]13,"19,20-dihydroervahanine A",0.071,uM,=,-1.1487416512809248,0,c1ccc2c3c([nH]c2c1)[C@@H](c1ccc2c4c([nH]c2c1)C1C[C@@H]2CC[C@@H]1N(CC4)C2)C[C@@H]1CCN[C@@H](C3)C1
2239,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1c(/N=C/c2ccccc2O)cc2c(c1N)C(C)(C)CC2(C)C,"2-[(7-Amino-1,1,3,3,6-pentamethyl-indan-5-ylimino)-methyl]-phenol",16.0,uM,=,1.2041199826559248,1,C(=N/c1ccc2c(c1)CCC2)\c1ccccc1
2240,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,O=C1/C(=C/c2ccc(OCCCN3CCN(Cc4ccccc4)CC3)cc2)COc2ccccc21,(E)-3-(4-(3-(4-benzylpiperazin-1-yl)propoxy)benzylidene)chroman-4-one,4.72,uM,=,0.6739419986340878,1,O=C1/C(=C/c2ccc(OCCCN3CCN(Cc4ccccc4)CC3)cc2)COc2ccccc21
2241,1580946,10.1021/acsmedchemlett.6b00099,,,,Inhibition of AchE (unknown origin),COc1cc2c(cc1OC)C(=O)C(CC1CCN(CC3CCCCC3)CC1)C2,"2-(1-Cyclohexylmethyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.009,uM,=,-2.0457574905606752,0,O=C1c2ccccc2CC1CC1CCN(CC2CCCCC2)CC1
2242,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(1,2,3,4-tetrahydro-acridin-9-yl)-octane-1,8-diamine",0.0016,uM,=,-2.7958800173440754,0,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
2243,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),O=[N+]([O-])C1C(Cc2c[nH]cn2)NC2(c3ccccc3-c3nc4ccccc4nc32)C1c1ccc(Br)cc1,"3'-(4-bromophenyl)-5'-(1H-imidazol-4-ylmethyl)-4'-nitro-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",16.25,uM,=,1.2108533653148932,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
2244,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2[se]n(-c3ccc(OCCN4CCCCC4)cc3)c(=O)c2cc1OC,"5,6-Dimethoxy-2-(4-(2-(piperidin-1-yl)ethoxy)phenyl)benzo[d][1,2]selenazol-3(2H)-one",0.45,uM,=,-0.3467874862246563,0,O=c1c2ccccc2[se]n1-c1ccc(OCCN2CCCCC2)cc1
2245,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc(-c3oc4ccccc4c3C(=O)c3ccc(C)cc3)cc2)c1,Methylcarbamic acid 3-{[methyl-(7-{4-[3-(4-methylbenzoyl)benzofuran-2-yl]phenoxy}heptyl)-amino]methyl}phenyl ester,0.34,uM,=,-0.4685210829577448,0,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
2246,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(Cc4cccc5ccccc45)CC3)nc12,N-(4-Methylbenzo[d]thiazol-2-yl)-3-(4-(naphthalen-1-ylmethyl)piperazin-1-yl)propanamide,19.33,uM,=,1.286231854028553,1,O=C(CCN1CCN(Cc2cccc3ccccc23)CC1)Nc1nc2ccccc2s1
2247,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN(C)S(=O)(=O)NC1CCc2ccc(O)cc2C1,"3-(7-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylsulfamide",0.0369699999999999,uM,=,-1.4321505494268931,0,c1ccc2c(c1)CCCC2
2248,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CC[N+](C)(CCc4ccccc4)C2N3C)cc1.[Br-],"(3aS)-5-(4-isopropylphenylcarbamoyloxy)-1,3a,8-trimethyl-1-phenethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium bromide",0.3,uM,=,-0.5228787452803376,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH+](CCc3ccccc3)C1N2
2249,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,COc1ccc(C(=O)COc2ccc([N+](C)(C)Cc3ccccc3)cc2)cc1OC.[Br-],"Benzyl-{4-[2-(3,4-dimethoxy-phenyl)-2-oxo-ethoxy]-phenyl}-dimethyl-ammonium bromide",10.0,uM,=,1.0,1,O=C(COc1ccc([NH2+]Cc2ccccc2)cc1)c1ccccc1
2250,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(Cn1nc2ncccc2c1NC(=O)Cn1nc2ncccc2c1NC(=O)CN1CCN(Cc2ccccc2)CC1)Nc1[nH]nc2ncccc12,"N-(2-(2-((2H-pyrazolo[3,4-b]pyridin-3-yl)amino)-2-oxoethyl)-2H-pyrazolo[3,4-b]pyridin-3-yl)-2-(3-(2-(4-benzylpiperazin-1-yl)acetamido)-2H-pyrazolo[3,4-b]pyridin-2-yl)acetamide",18.04,uM,=,1.2562365332059229,1,O=C(Cn1nc2ncccc2c1NC(=O)Cn1nc2ncccc2c1NC(=O)CN1CCN(Cc2ccccc2)CC1)Nc1[nH]nc2ncccc12
2251,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,Brc1ccc([N+]2=Cc3ccccc3CC2)cc1.[Br-],"2-(4-bromophenyl)-3,4-dihydroisoquinolinium bromide",10.5,uM,=,1.021189299069938,1,C1=[N+](c2ccccc2)CCc2ccccc21
2252,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccc(Cl)cc2)c2ccccc12,1-Benzyl-3-[1-(4-chloro-benzoyl)-1H-indol-3-ylmethylene]-piperidin-4-one,50.0,uM,=,1.6989700043360187,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12
2253,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCCCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,9-bis(4-tert.butylpyridinium)-non-1,9-diyl dibromide",0.037,uM,=,-1.431798275933005,0,c1cc[n+](CCCCCCCCC[n+]2ccccc2)cc1
2254,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(OCCCN(C)C(=O)c2cnc(CC(=O)c3ccc(OC)cc3)nc2)cc1,N-(3-(4-methoxyphenoxy)propyl)-2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-methylpyrimidine-5-carboxamide,9.82,uM,=,0.9921114877869496,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
2255,2238682,10.1021/acs.jmedchem.2c01338,,,,Inhibition of AChE (unknown origin),O=C1OCc2cc(-c3ccc(-c4ccc(CO)cc4)s3)ccc21,5-(5-(4-(Hydroxymethyl)phenyl)thiophen-2-yl)isobenzofuran-1(3H)-one,8.0,uM,=,0.9030899869919436,1,O=C1OCc2cc(-c3ccc(-c4ccccc4)s3)ccc21
2256,1510773,10.1021/acs.jmedchem.5b00434,,,,Inhibition of human AChE,CSc1nc(-c2ccc(OC(F)(F)F)cc2)nn1C(=O)N(C)C,"5-Methylsulfanyl-3-(4-trifluoromethoxy-phenyl)-[1,2,4]triazole-1-carboxylic acid dimethylamide",200.0,uM,=,2.3010299956639813,1,c1ccc(-c2nc[nH]n2)cc1
2257,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2C)=CC1=O)Cc1ccccc1C,"2,5-bis{6-[ethyl(2-methylbenzyl)amino]hexylamino}-[1,4]-benzoquinone",0.0719,uM,=,-1.1432711096171173,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
2258,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C([N+](=O)[O-])C12C(=O)Nc1ccc(F)cc12,"2'-amino-1'-benzyl-6'-(benzylamino)-5-fluoro-5'-nitro-2-oxo-1'H-spiro[indoline-3,4'-pyridine]-3'-carbonitrile",3.54,uM,=,0.5490032620257879,1,O=C1Nc2ccccc2C12C=CN(Cc1ccccc1)C(NCc1ccccc1)=C2
2259,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N-(8-aminooctyl)-5,6,7,8-tetrahydroacridin-9-amine",0.089,uM,=,-1.0506099933550872,0,c1ccc2nc3c(cc2c1)CCCC3
2260,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCCCCNc3c4c(nc5ccccc35)CCCC4)c2c1,"N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-8-(1,2,3,4-tetrahydroacridin-9-ylamino)octanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
2261,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,"3,5,7-Trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chromen-4-one",0.012,uM,=,-1.9208187539523751,0,O=c1cc(-c2ccccc2)oc2ccccc12
2262,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCc1cn(CCNc2c3c(nc4cc(Cl)ccc24)CCCC3)nn1,"4-(2-((1-(2-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)ethoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methylthiazole-5-carboxamide",0.0121,uM,=,-1.91721462968355,0,O=C(Nc1cc(-c2nc(OCCOCc3cn(CCNc4c5c(nc6ccccc46)CCCC5)nn3)cs2)ccn1)C1CC1
2263,2261363,10.1016/j.ejmech.2022.114606,,,,Inhibition of human AChE,CCC(C)(C)NCC(O)c1cc(O)cc(OC(=O)N(C)C)c1,"[3-[2-(1,1-dimethylpropylamino)-1-hydroxy-ethyl]-5-hydroxy-phenyl]N,N-dimethylcarbamate",20.0,uM,=,1.3010299956639813,1,c1ccccc1
2264,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-8-(1,2,3,4-tetrahydroacridin-9-ylamino)octanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
2265,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC(O)C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-1-hydroxy-3-oxo-propyl]-1-methyl-piperidinium bromide",0.219,uM,=,-0.6595558851598816,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
2266,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,COc1ccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)cc1,(2-{4-[7-(benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-(4-methoxyphenyl)-methanone,281.0,uM,=,2.44870631990508,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
2267,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCNCc1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,"N-{{5-(4-chlorophenyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridin-9-yl}methyl}ethanamine",0.556,uM,=,-0.2549252084179425,0,c1ccc(-c2nc3ccccc3c3c2CCCN3)cc1
2268,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"(S)-5-Butylcarbamoyloxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",0.152,uM,=,-0.8181564120552274,0,c1ccc2c(c1)NC1NCCC21
2269,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)N(CCC1CCN(Cc2ccccc2)CC1)c1cccc(F)c1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-(3-fluoro-phenyl)-acetamide,0.065,uM,=,-1.1870866433571443,0,c1ccc(CN2CCC(CCNc3ccccc3)CC2)cc1
2270,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCNCc1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,"N-{{1-benzyl-5-(4-chlorophenyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridin-9-yl}methyl}ethanamine",0.942,uM,=,-0.0259490972071226,0,c1ccc(CN2CCCc3c(-c4ccccc4)nc4ccccc4c32)cc1
2271,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1/C(=C/c2ccc[nH]2)CN(Cc2ccccc2)C/C1=C\c1ccc[nH]1,"1-Benzyl-3,5-bis-(1H-pyrrol-2-ylmethylene)-piperidin-4-one",18.0,uM,=,1.255272505103306,1,O=C1/C(=C/c2ccc[nH]2)CN(Cc2ccccc2)C/C1=C\c1ccc[nH]1
2272,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NCCc1c[nH]c2ccccc12,"6-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
2273,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC(=O)N1CCN(c2nccc(NCCc3ccccc3)n2)CC1,1-[4-(4-(Phenethylamino)pyrimidin-2-yl)piperazin-1-yl]ethanone,19.9,uM,=,1.2988530764097066,1,c1ccc(CCNc2ccnc(N3CCNCC3)n2)cc1
2274,513727,10.1016/j.bmc.2008.07.009,,,,Inhibition of AchE,Oc1cccc(C2=Nc3ccccc3SC(c3ccc(Cl)cc3)C2)c1,"2-(4''-Chlorophenyl)-4-(3'-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepine",18.8,uM,=,1.2741578492636798,1,c1ccc(C2=Nc3ccccc3SC(c3ccccc3)C2)cc1
2275,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.538,uM,=,-0.2692177243336108,0,c1ccc2c(c1)N[C@H]1NCCC21
2276,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,C[C@@H](c1ccc2c(c1)oc(=O)c1ccccc12)N(C)C.Cl,(S)-3-(1-(Dimethylamino)ethyl)-6H-benzo[c]chromen-6-one hydrochloride,7.9,uM,=,0.8976270912904415,1,O=c1oc2ccccc2c2ccccc12
2277,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(/C=C2\Cc3ccccc3C2=O)CC1,2-(1-Methyl-piperidin-4-ylmethylene)-indan-1-one,0.0084,uM,=,-2.0757207139381184,0,O=C1/C(=C/C2CCNCC2)Cc2ccccc21
2278,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3ccccc13)CCCC2O,"9-Amino-1,2,3,4-tetrahydro-acridin-1-ol ; Maleate",0.164,uM,=,-0.7851561519523022,0,c1ccc2nc3c(cc2c1)CCCC3
2279,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0176,uM,=,-1.75448733218585,0,c1ccc2nc3c(cc2c1)CCCC3
2280,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCC(=O)NCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"9-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-N-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]nonanamide",0.00623,uM,=,-2.2055119533408303,0,O=C(CCC1CCc2ccccc2O1)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
2281,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(5-(6-methoxy-1-methylpyridinium-2-yl)pentyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",0.5,uM,=,-0.3010299956639812,0,c1ccc(CCCCC[NH+]2CCc3ccccc3C2)[nH+]c1
2282,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)cc(OC)c1,"6-chloro-N-(8-(3,5-dimethoxyphenyl)octyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0050999999999999,uM,=,-2.292429823902064,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
2283,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(C=C2Cc3cc(OC)ccc3C2=O)cc1,2-[[4-(diethylaminomethyl)phenyl]methylene]-5-methoxy-indan-1-one,0.505,uM,=,-0.2967086218813386,0,O=C1C(=Cc2ccccc2)Cc2ccccc21
2284,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1C.F[B-](F)(F)F,2-methoxy-1-methyl-5-(trifluoromethyl)pyridinium tetrafluoroborate,23.0,uM,=,1.3617278360175928,1,c1cc[nH+]cc1
2285,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(OC)c(OC)c2)cc1,"N-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-(3,4-dimethoxyphenyl)acetamide",3.22,uM,=,0.5078558716958309,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
2286,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCCNc3c4c(nc5cc(Cl)cc(Cl)c35)CCCC4)c2c1,"6-(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-ylamino)-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)hexanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
2287,2247136,10.1021/acs.jmedchem.1c02150,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 240 sec by Ellman's method,CC(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,1-(1-acetylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea,115.0,uM,=,2.060697840353612,1,O=C(Nc1ccccc1)NC1CCNCC1
2288,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CN(C)CCOc1cccc(/C=C2\COc3ccccc3C2=O)c1,(E)-3-(3-(2-(dimethylamino)ethoxy)benzylidene)chroman-4-one,1.41,uM,=,0.1492191126553798,1,O=C1/C(=C/c2ccccc2)COc2ccccc21
2289,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(CC1CCN(Cc3ccc(O)c(/C=N/O)c3)CC1)CC2,"5-((4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",393.3,uM,=,2.5947239464097467,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1
2290,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)Nc1ccc2c(c1)CNC(=O)C2,"2-Methoxy-N-(3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",0.926,uM,=,-0.0333890133180657,0,O=C1Cc2ccc(NC(=O)c3ccccc3)cc2CN1
2291,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,COc1ccc([C@@H]2[C@H]3CSCN3C3(C(=O)c4ccccc4C3=O)[C@]23CSc2ccccc2C3=O)cc1,"(6'R,7'S,7a'S)-7'-(4-Methoxyphenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",1.1,uM,=,0.041392685158225,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
2292,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN(C)CCCCOc2ccc3c4c(c(=O)oc3c2)CCCC4)c1,"3-(4-((3-Methoxybenzyl)(methyl)amino)butoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",1.7,uM,=,0.2304489213782739,1,O=c1oc2cc(OCCCCNCc3ccccc3)ccc2c2c1CCCC2
2293,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)[C@@H]1C2,"Hexyl-carbamic acid (3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-indeno[2,1-b]pyrrol-5-yl ester",0.045,uM,=,-1.3467874862246565,0,c1ccc2c(c1)C[C@H]1NCCC21
2294,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCC5(CC4)COC5)cc3)cc12,"3-(4-((2-Oxa-7-azaspiro[3.5]nonan-7-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carbonitrile",2.42,uM,=,0.3838153659804312,1,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCC5(CC4)COC5)cc3)cc12
2295,2082243,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE (unknown origin) by DTNB reagent based Ellman's method,CCc1ccc(NC(=O)COc2c(Cl)cc(Cl)cc2S(=O)(=O)N2CCN(C(=O)c3ccco3)CC2)cc1,"2-(2,4-dichloro-6-(4-(furan-2-carbonyl)piperazin-1-ylsulfonyl)phenoxy)-N-(4-ethylphenyl)acetamide",5.54,uM,=,0.7435097647284298,1,O=C(COc1ccccc1S(=O)(=O)N1CCN(C(=O)c2ccco2)CC1)Nc1ccccc1
2296,28473,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 22.2-56.8,CCN(C)C(=O)Oc1cccc(CCN)c1,Ethyl-methyl-carbamic acid 3-(2-amino-ethyl)-phenyl ester,35.5,uM,=,1.5502283530550942,1,c1ccccc1
2297,462117,10.1021/jm7009364,,,,Inhibition of human AchE,Cc1c(C)c2ccc(OCc3cccc(Cl)c3)cc2oc1=O,"7-(3-Chloro-benzyloxy)-3,4-dimethyl-chromen-2-one",3.39,uM,=,0.5301996982030822,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
2298,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1ccc2c(c1)C/C(=C\C1CCN(Cc3ccccc3)CC1)C2=O,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-5-methoxy-2,3-dihydro-1H-inden-1-one",0.043,uM,=,-1.3665315444204136,0,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
2299,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,C[n+]1ccccc1/C=N/O.[Cl-],2-Pyridine aldoxime methohalide,996.0,uM,=,2.998259338423699,1,c1cc[nH+]cc1
2300,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccc2c(c1)C(=O)c1ccccc1-2)Cc1ccccc1,N-(2-(2-(benzyl(methyl)amino)ethoxy)ethylcarbamothioyl)-9-oxo-9H-fluorene-2-carboxamide,0.03,uM,=,-1.5228787452803376,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccc2c(c1)C(=O)c1ccccc1-2
2301,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,C[C@@]12CC[C@@H]3[C@]4(CC[C@H]5[C@@]3(C)CCC[C@@]5(C)C(=O)OCC[N+](C)(C)CCCCCCCCC[N+](C)(C)CCOC(=O)[C@]3(C)CCC[C@@]5(C)[C@@H]6CC[C@@]7(C)C[C@]6(CC[C@@H]53)C[C@H]7OC(=O)CCCCCCCCC(=O)O[C@@H]1C4)C2.[Br-].[Br-],,5.0,uM,=,0.6989700043360189,1,O=C1CCCCCCCCC(=O)O[C@@H]2C[C@]34CC[C@@H]5C(CCCC5[C@@H]3CCC2C4)C(=O)OCC[NH2+]CCCCCCCCC[NH2+]CCOC(=O)C2CCCC3[C@@H]2CC[C@]24CC(CC[C@@H]32)[C@@H](C4)O1
2302,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,C(=C/C[n+]1ccccc1)\C[n+]1ccccc1.[Br-].[Br-],"(E)-1,4-bis(pyridinium)-but-2-ene dibromide",2290.0,uM,=,3.359835482339888,1,C(=C/C[n+]1ccccc1)\C[n+]1ccccc1
2303,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NCC3CCN(Cc4ccccc4C(F)(F)F)CC3)sc2-c2ccc(C)cc2)cc1,"N-[(1-(2-Trifluoromethylbenzyl)piperidin-4-yl)methyl]-4,5-bis(p-tolyl)thiazol-2-ylamine",0.4,uM,=,-0.3979400086720376,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
2304,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,8-bis(4-tert.butylpyridinium)-oct-1,8-diyl dibromide",0.005,uM,=,-2.3010299956639813,0,c1cc[n+](CCCCCCCC[n+]2ccccc2)cc1
2305,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc(C#N)cc[n+]1C.F[B-](F)(F)F,4-cyano-2-methoxy-1-methylpyridinium tetrafluoroborate,51.0,uM,=,1.7075701760979365,1,c1cc[nH+]cc1
2306,28165,10.1016/s0960-894x(02)00482-1,,,,In vitro inhibition of human recombinant AChE.,C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3c(c2)CCO3)CC1,"1-Benzyl-4-[3-(2,3-dihydro-benzofuran-5-yl)-3-oxo-propyl]-1-methyl-piperidinium",0.017,uM,=,-1.769551078621726,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccc2c(c1)CCO2
2307,597529,10.1021/jm901296p,,,,Inhibition of human recombinant AChE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(CCCCCCCCN1C(=O)c3ccccc3S1(=O)=O)C2.O=C(O)/C=C/C(=O)O,"N-saccharinohexyl-galanthamine fumarate(2-[6-[(4aS,6R,8aS)-4a,5,9,10-tetrahydro-6-hydroxy-3-methoxy-6H-benzofuro[3a,3,2-ef][2]benzazepin-11(12H)-yl]hexyl]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide",0.05,uM,=,-1.3010299956639813,0,O=C1c2ccccc2S(=O)(=O)N1CCCCCCCCN1CC[C@@]23C=CCC[C@@H]2Oc2cccc(c23)C1
2308,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cc1n(C)cc[n+]1COC(C)C(C)(C)C.[Cl-],"2,3-Dimethyl-1-(1,2,2-trimethyl-propoxymethyl)-3H-imidazol-1-ium chloride",33.0,uM,=,1.5185139398778875,1,c1c[nH+]c[nH]1
2309,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2cccc([N+](=O)[O-])c2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1cccc([N+](=O)[O-])c1,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis [(E)-3-nitro phenylmethylidene]tetrahydro-4''(1H)-pyridinone",5.99,uM,=,0.7774268223893114,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2310,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C/c2nnc(-c3ccc(F)cc3F)o2)ccc1O,"4-(2-(5-(2,4-difluorophenyl)-1,3,4-oxadiazol-2-yl)vinyl)-2-methoxyphenol",0.00019,uM,=,-3.721246399047171,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
2311,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,COc1ccccc1C1c2ccc3ccccc3c2Oc2nc3c(c(N)c21)CCCC3,"rac-7-(2-Methoxyphenyl)-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",4.53,uM,=,0.6560982020128319,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
2312,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C(CNc1ccc(F)cc1)Nc1ccc2oc(=O)ccc2c1,2-(4-fluorophenylamino)-N-(2-oxo-2H-chromen-6-yl)acetamide,0.062,uM,=,-1.207608310501746,0,O=C(CNc1ccccc1)Nc1ccc2oc(=O)ccc2c1
2313,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,CC(=O)c1c[n+](Cc2cccc(Cl)c2)ccc1CC1Cc2cc(O)ccc2C1=O.[Br-],"3-Acetyl-1-(3-chlorobenzyl)-4-((5-hydroxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)pyridinium bromide",0.1165,uM,=,-0.9336740746379624,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
2314,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccc(C)cc2)C[C@@H](c2ccccc2)N(c2ccc(C)cc2)[C@@H]1c1ccccc1,"(2R,6S)-ethyl 2,6-diphenyl-1-p-tolyl-4-(p-tolylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",5180.0,uM,=,3.714329759745233,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
2315,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3NC12,"Phenyl-carbamic acid (S)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0407999999999999,uM,=,-1.3893398369101202,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
2316,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(NCCN4CCN(C)CC4)c2c1)CCCC3,"7-Methyl-N-(2-(4-methylpiperazin-1-yl)ethyl)-1,2,3,4-tetrahydroacridin-9-amine",0.974,uM,=,-0.0114410431213844,0,c1ccc2c(NCCN3CCNCC3)c3c(nc2c1)CCCC3
2317,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1,4-Amino-N-(1-benzyl-piperidin-4-yl)-5-chloro-2-methoxy-benzamide,0.89,uM,=,-0.0506099933550872,0,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1
2318,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.Cl.O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"6-Chloro-9-{{8-[5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-9-carboxamido]octyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.00703,uM,=,-2.153044674980176,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
2319,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,CN(CCCCCCCOc1ccc(-c2cc3ccccc3o2)cc1)Cc1ccccc1,[7-(4-Benzofuran-2-yl-phenoxy)hephtyl]benzylmethylamine,32.6,uM,=,1.513217600067939,1,c1ccc(CNCCCCCCCOc2ccc(-c3cc4ccccc4o3)cc2)cc1
2320,1908427,10.1016/j.bmcl.2019.126754,,,,Inhibition of AChE (unknown origin) by Ellman's method,Oc1ccc2[nH]c3c(c2c1)C[PH](Cc1cccc2ccccc12)(c1ccccc1)CC3,"2-Naphthalen-1-ylmethyl-2-phenyl-2,3,4,5-tetrahydro-1H-2lambda5-phosphinino[4,3-b]indol-8-ol",2.604,uM,=,0.4156409798961543,1,c1ccc([PH]2(Cc3cccc4ccccc34)CCc3[nH]c4ccccc4c3C2)cc1
2321,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-amino-3-(1H-indol-3-yl)-N-(6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)propanamide dihydrochloride",0.12,uM,=,-0.9208187539523752,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
2322,2289119,10.1016/j.ejmech.2022.114841,,,,Inhibition of AChE in human SH-SY5Ycells assessed as reduction AChE activity using acetylthiocholine as substrate incubated for 24 hrs by DTNB based Ellman's method,Cl.Oc1cccc2ccc(/C=C/C3=CCN(Cc4ccccc4C(F)(F)F)CC3)nc12,"(E)-2-(2-(1-(2-(trifluoromethyl)benzyl)-1,2,3,6-tetrahydropyridin-4-yl)vinyl)quinolin-8-ol hydrochloride",161.0,uM,=,2.206825876031849,1,C1=C(/C=C/c2ccc3ccccc3n2)CCN(Cc2ccccc2)C1
2323,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1cc(-c2ccc(F)cc2)nc2nc(-c3ccccc3)cc(C(F)(F)F)c12,"2-(4-Fluorophenyl)-7-phenyl-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",6.58,uM,=,0.8182258936139555,1,c1ccc(-c2ccc3ccc(-c4ccccc4)nc3n2)cc1
2324,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3cnccc13)CCCC2,"6,7,8,9-Tetrahydro-benzo[b][1,7]naphthyridin-5-ylamine",2.6,uM,=,0.414973347970818,1,c1cc2cc3c(nc2cn1)CCCC3
2325,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(CN2CCC(Nc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)s3)CC2)cc1,"4-Methoxybenzyl-N-[4,5-bis(4-chlorophenyl)thiazol-2-yl]-piperidin-4-ylamine",1.12,uM,=,0.0492180226701816,1,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
2326,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc2[nH]ccc12,"N-(5-((1-benzylpiperidin-4-yl)methoxy)pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide",0.0039,uM,=,-2.408935392973501,0,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc2[nH]ccc12
2327,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(C(F)(F)F)c3)CC1)C2,"6-dimethoxy-2-((1-(3-(trifluoromethyl)benzyl)piperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",2.12,uM,=,0.3263358609287514,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2328,28160,10.1016/S0960-894X(97)10025-7,,,,Compound was tested in vitro for inhibitory activity against Acetylcholinesterase,Nc1c2c(nc3ccccc13)-c1ccccc1CS2,5H-6-Thia-12-aza-benzo[a]anthracen-7-ylamine,18.58,uM,=,1.2690457096576229,1,c1ccc2c(c1)CSc1cc3ccccc3nc1-2
2329,28165,10.1016/s0960-894x(02)00482-1,,,,In vitro inhibition of human recombinant AChE.,C[N@+]1(Cc2ccccc2)CC[C@H](CCC(=O)c2ccc3c(c2)CCO3)CC1,"1-Benzyl-4-[3-(2,3-dihydro-benzofuran-5-yl)-3-oxo-propyl]-1-methyl-piperidinium",0.066,uM,=,-1.1804560644581312,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccc2c(c1)CCO2
2330,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(Br)cc1Br)CC2.[Br-],"2-(2,4-dibromophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",3.72,uM,=,0.5705429398818975,1,C1=[N+](c2ccccc2)CCc2ccccc21
2331,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN(C)CCCCOc2ccc3c(c2)oc(=O)c2ccccc23)c1,3-(4-((3-Methoxybenzyl)(methyl)amino)butoxy)-6H-benzo[c]chromen-6-one,8.3,uM,=,0.919078092376074,1,O=c1oc2cc(OCCCCNCc3ccccc3)ccc2c2ccccc12
2332,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccc(Br)cc1)C(=O)C(F)(F)F,"Ethyl(2Z)-4,4,4-trifluoro-2-[2-(4-bromophenyl)hydrazinylidene]-3-oxobutanoate",1.36,uM,=,0.1335389083702175,1,c1ccccc1
2333,1790738,10.1039/C7MD00143F,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured for 5 mins by Ellman's assay,Cn1c2nc3ccccc3c-2c(NCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)c2ccccc21,"5-methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5H-indolo[2,3-b]quinolin-11-amine",0.00095,uM,=,-3.0222763947111524,0,c1ccc2c(NCCCCCCCCNc3c4c5ccccc5nc-4[nH]c4ccccc34)c3c(nc2c1)CCCC3
2334,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(-c3ccccc3)cc2)CC1c1ccc(C(=O)O)cc1,"4-(3-([1,1'-Biphenyl]-4-yl)-1-acetyl-4,5-dihydro-1H-pyrazol-5-yl)benzoic acid",1541.0,uM,=,3.1878026387184195,1,c1ccc(-c2ccc(C3=NNC(c4ccccc4)C3)cc2)cc1
2335,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3cccc(Cl)c3)cc1C(C)=O)CC2.[Br-],"3-Acetyl-1-(3-chlorobenzyl)-4-((6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium bromide",0.021,uM,=,-1.6777807052660807,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
2336,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccc(Cl)cc1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(4-chloro-benzoyl)-thiourea,0.03,uM,=,-1.5228787452803376,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccccc1
2337,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1ccc2c(N)c3c(nc2c1)CCCC3,"6-Methyl-1,2,3,4-tetrahydro-acridin-9-ylamine",0.1,uM,=,-1.0,0,c1ccc2nc3c(cc2c1)CCCC3
2338,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c4c(c(=O)oc3c2)CCCC4)c1,"3-((Methyl(3-((6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy)propyl)amino)methyl)phenyl Heptylcarbamate",0.0216,uM,=,-1.665546248849069,0,O=c1oc2cc(OCCCNCc3ccccc3)ccc2c2c1CCCC2
2339,305373,10.1021/jm049156q,,,,Inhibition of Acetylcholinesterase,COc1ccccc1CN(C)CCCN(C)CCCNCCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21,"3,8-Diamino-5-{3-[3-({3-[(2-methoxy-benzyl)-methyl-amino]-propyl}-methyl-amino)-propylamino]-propyl}-6-phenyl-phenanthridinium",0.952,uM,=,-0.0213630516155256,0,c1ccc(CNCCCNCCCNCCC[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
2340,1837068,10.1016/j.ejmech.2019.07.040,,,,Inhibition of human AChE,O=C(c1ccc(OCCCc2c[nH]cn2)cc1)C1CC1,Cyclopropyl-{4-[3-(1H-imidazol-4-yl)-propoxy]-phenyl}-methanone,86.1,uM,=,1.9350031514536548,1,O=C(c1ccc(OCCCc2c[nH]cn2)cc1)C1CC1
2341,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccc(F)cc1)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(4-Fluorophenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",19.8,uM,=,1.2966651902615312,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
2342,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCC(=O)NCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-N-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]octanamide",0.00794,uM,=,-2.100179497572904,0,O=C(CCC1CCc2ccccc2O1)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
2343,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-],3-Dimethylcarbamoyloxy-1-methyl-pyridinium bromide,0.36,uM,=,-0.4436974992327127,0,c1cc[nH+]cc1
2344,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,CSc1ccc(/C=C2/S/C(=N/c3ccc4oc(=O)ccc4c3)NC2=O)cc1,5-[4-(Methylthio)benzylidene]-2-[(2-oxo-2H-chromen-6-yl)imino]thiazolidin-4-one,0.1507,uM,=,-0.8218867476853682,0,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1
2345,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),CCC1=CC2Cc3nc4cc(Cl)ccc4c(NCCN4CCC(CC5Cc6cc(OC)c(OC)cc6C5)CC4)c3C(C1)C2.Cl.Cl,"(-)-36a-3-chloro-N-(2-(4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)ethyl)-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinolin-12-amine dihydrochloride",0.0286,uM,=,-1.543633966870957,0,C1=CC2Cc3nc4ccccc4c(NCCN4CCC(CC5Cc6ccccc6C5)CC4)c3C(C1)C2
2346,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.043,uM,=,-1.3665315444204136,0,c1ccc2c(c1)N[C@H]1NCCC21
2347,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,NC(=O)c1cc[n+](C/C=C/C[n+]2ccc(/C=N/O)cc2)cc1.[Br-].[Br-],(E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide,566.0,uM,=,2.7528164311882715,1,C(=C/C[n+]1ccccc1)\C[n+]1ccccc1
2348,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=c1[nH]c2ccccc2c(=O)n1CCC1CCN(Cc2ccccc2)CC1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-quinazoline-2,4-dione",0.0042,uM,=,-2.3767507096021,0,O=c1[nH]c2ccccc2c(=O)n1CCC1CCN(Cc2ccccc2)CC1
2349,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1.[I-],(E)-2-[4-(Diethylamino)styryl]-1-methyl quinolinium iodide,0.4,uM,=,-0.3979400086720376,0,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
2350,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2ccc(Cl)cc2Cl)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccc(Cl)cc1Cl,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-2,4-dichloro phenylmethylidene]tetrahydro-4''(1H)-pyridinone",4.11,uM,=,0.6138418218760693,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2351,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)c2ccc(CNc3c4c(nc5cc(Cl)ccc35)CC3C=C(C)CC4C3)cc2)ccc1O,,0.0249,uM,=,-1.6038006529042637,0,O=C(NCc1ccccc1)c1ccc(CNc2c3c(nc4ccccc24)CC2C=CCC3C2)cc1
2352,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(NCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3,"(6-Morpholin-4-ylhexyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.0689,uM,=,-1.161780778092374,0,c1ccc2c(NCCCCCCN3CCOCC3)c3c(nc2c1)CCCC3
2353,2275466,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) by Ellman's method,C[n+]1ccc2c(c1)[nH]c1ccccc12,2-Methyl-9H-beta-carbolin-2-ium,4.1,uM,=,0.6127838567197355,1,c1ccc2c(c1)[nH]c1c[nH+]ccc12
2354,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cccc(C(F)(F)F)[n+]1C.F[B-](F)(F)F,2-methoxy-1-methyl-6-(trifluoromethyl)pyridinium tetrafluoroborate,46.0,uM,=,1.662757831681574,1,c1cc[nH+]cc1
2355,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CNC(=O)/C=C/c3ccc(O)c(OC)c3)c2c1,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-2-oxoethyl)acrylamide,0.96,uM,=,-0.0177287669604316,0,O=C(/C=C/c1ccccc1)NCC(=O)NCCc1c[nH]c2ccccc12
2356,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,C[n+]1c(/C=C/c2ccc(F)cc2)ccc2ccccc21.[I-],GNF-Pf-3892,2.4,uM,=,0.380211241711606,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
2357,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(Br)cc2)C[C@@H](c2ccc(OC)cc2)N(c2ccc(Br)cc2)[C@@H]1c1ccc(OC)cc1,"(2R,6S)-methyl 1-(4-bromophenyl)-4-(4-bromophenylamino)-2,6-bis(4-methoxyphenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate",2160.0,uM,=,3.334453751150931,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
2358,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,"N2-isopropyl-N4-(phenethyl)quinazoline-2,4-diamine",7.2,uM,=,0.8573324964312685,1,c1ccc(CCNc2ncnc3ccccc23)cc1
2359,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,COC[n+]1c(/C=N/O)n(C)c2ccccc21.[Cl-],2-(Hydroxyimino-methyl)-1-methoxymethyl-3-methyl-3H-benzoimidazol-1-ium chloride,198.0,uM,=,2.296665190261531,1,c1ccc2[nH+]c[nH]c2c1
2360,1580946,10.1021/acsmedchemlett.6b00099,,,,Inhibition of AchE (unknown origin),COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.007,uM,=,-2.154901959985743,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2361,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CN(C)C(=O)Oc1cccc2c1cc(C(=O)NC1CCCCC1)c[n+]2C.[I-],"[3-(Cyclohexylcarbamoyl)-1-methyl-quinolin-1-ium-5-yl]-N,N-dimethylcarbamate iodide",0.02,uM,=,-1.6989700043360187,0,O=C(NC1CCCCC1)c1c[nH+]c2ccccc2c1
2362,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](/C=C2\C=CC3=CC/C(=C\[n+]4ccc(C(C)(C)C)cc4)C=C3C2)cc1.[Br-].[Br-],"1,1'-bis(4-tert.butylpyridinium)-naphtyl-3,6-dimethylenyl dibromide",0.024,uM,=,-1.619788758288394,0,C1=C/C(=C\[n+]2ccccc2)CC2=C/C(=C/[n+]3ccccc3)CC=C12
2363,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-],"3-(dimethylcarbamoyloxy)-N,N,N-trimethylbenzenaminium methyl sulfate",69.1,uM,=,1.8394780473741985,1,c1ccccc1
2364,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccccc2Cl)C(=O)[C@@]2(C1)[C@H](c1ccccc1Cl)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(2-chlorophenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(2-chlorophenylmethylidene)-1''-N-acrolylpiperidin-4''-one,5.12,uM,=,0.7092699609758308,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
2365,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,Cc1ccc([C@@H]2CN(C)C3(C(=O)c4ccccc4C3=O)[C@]23CSc2ccccc2C3=O)cc1,"(3'R,4'S)-1'-Methyl-4'-(p-tolyl)dispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",6.6,uM,=,0.8195439355418687,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
2366,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl,"6-chloro-N-[6-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)hexyl]-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.00074,uM,=,-3.130768280269024,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
2367,2185046,10.1016/j.ejmech.2021.113278,,,,Inhibition of human AchE preincubated for 6 mins followed by substrate addition using acetylthiocholine iodide as substrate by DTNB reagent based Ellman method,COc1ccc(/C=C/C(=O)Nc2cc[n+](Cc3ccc(F)cc3)cc2)cc1OC.[Br-],"4-(3-(3,4-dimethoxyphenyl)acrylamido)-1-(4-fluorobenzyl)pyridin-1-ium Bromide",0.0086,uM,=,-2.065501548756432,0,O=C(/C=C/c1ccccc1)Nc1cc[n+](Cc2ccccc2)cc1
2368,462138,10.1021/jm7009364,,,,Inhibition of human AchE-induced amyloid beta aggregation,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],"3-(3,8-diamino-6-phenyl-5-phenanthridiniumyl)propyl(diethyl)methylammonium",12.6,uM,=,1.100370545117563,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
2369,751130,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human plasma AChE,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(Heptylphysostigmine(-))Heptyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",22.0,uM,=,1.3424226808222062,1,c1ccc2c(c1)N[C@H]1NCCC21
2370,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2ccc4ccccc4c2)C3=O)c1,"3-((methyl(7-(2-(naphthalen-2-ylmethylene)-3-oxo-2,3-dihydrobenzofuran-6-yloxy)heptyl)amino)methyl)phenyl methylcarbamate",0.00209,uM,=,-2.679853713888946,0,O=C1/C(=C/c2ccc3ccccc3c2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
2371,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@@]2(C)CCO[C@H]2O3)cc1,"(+)-(3aR)-3a-methyl-2,3,3a,8a-Tetrahydrofuro[2,3-b]benzofuran-5-yl N-(p-Isopropylphenyl)carbamate",6.7,uM,=,0.8260748027008264,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@H]1O2
2372,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2ccccc2F)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1F,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis [(E)-2-fluoro phenylmethylidene]tetrahydro-4''(1H)-pyridinone",34.37,uM,=,1.5361795321372254,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2373,1471266,10.1016/j.ejmech.2015.03.040,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins prior to substrate addition measured after 60 to 180 secs by Ellman method,Cc1c(C)c2ccc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc2oc1=O,"3,4-Dimethyl-7-(2-(4-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperazin-1-yl)ethoxy)-2H-chromen-2-one",0.01611,uM,=,-1.792904459580782,0,O=c1ccc2ccc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc2o1
2374,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1Cc2c(ccc3c(CCC4CCN(Cc5ccccc5)CC4)noc23)N1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-6,8-dihydro-isoxazolo[5,4-e]indol-7-one",0.0036,uM,=,-2.4436974992327127,0,O=C1Cc2c(ccc3c(CCC4CCN(Cc5ccccc5)CC4)noc23)N1
2375,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCc3ccc(CN(C)CCCC(F)F)cc3)cc2oc1=O,"7-((4-(((4,4-difluorobutyl)(methyl)amino)methyl)benzyl)oxy)-3,4-dimethyl-2H-chromen-2-one",1.5,uM,=,0.1760912590556812,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
2376,1274971,10.1016/j.ejmech.2013.09.050,,,,Inhibition of acetylcholinesterase (unknown origin) by Ellman's method,NC(=O)c1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazole-6-carboxylic acid amide,0.0008,uM,=,-3.096910013008056,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
2377,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCCCCCN1CCCCC1,(E)-3-(3-methoxy-4-((10-(piperidin-1-yl)decyl)oxy)phenyl)-N-phenylacrylamide,11.11,uM,=,1.0457140589408676,1,O=C(/C=C/c1ccc(OCCCCCCCCCCN2CCCCC2)cc1)Nc1ccccc1
2378,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN(C)C)cc1)NCC2,"6-(4-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)phenoxy)-N,N-dimethylhexan-1-amine",7.13,uM,=,0.8530895298518656,1,c1ccc(CC2NCCc3ccccc32)cc1
2379,749399,10.1016/j.bmcl.2009.04.089,,,,Inhibition of human recombinant AChE preincubated for 30 mins before DTNB substrate addition by spectrophotometric assay based Ellman's method,C[C@H](Cc1ccccc1)NC(=O)Oc1cccc([C@H](C)N(C)C)c1.Cl,3-((S)-1-(dimethylamino)ethyl)phenyl(R)-1-phenylpropan-2-ylcarbamate hydrochloride,0.404,uM,=,-0.393618634889395,0,O=C(NCCc1ccccc1)Oc1ccccc1
2380,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(CCc2ccccc2)CC1,4-Methyl-1-phenethyl-piperidine,0.18,uM,=,-0.744727494896694,0,c1ccc(CCN2CCCCC2)cc1
2381,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1ccccc1,N-Benzoyl-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-ethyl,0.85,uM,=,-0.0705810742857072,0,O=C(CCCNC(=O)c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2382,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,CC#CC(C)(C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],"1-(1,1-Dimethyl-but-2-ynyloxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride",175.0,uM,=,2.2430380486862944,1,c1c[nH+]c[nH]1
2383,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCc3ccc(CN(C)Cc4ccccc4)cc3)cc2oc1=O.Cl,"7-(4-(N-Benzyl-N-methylaminomethyl)benzyloxy)-3,4-dimethyl-2H-chromen-2-one hydrochloride",0.45,uM,=,-0.3467874862246563,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
2384,1849549,10.1016/j.bmc.2019.07.001,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Nc1cccc(Cl)c1Oc1ccc(CNc2ccc(O)cc2)cc1,4-((4-(2-Amino-6-chlorophenoxy)benzyl)amino)phenol,8.81,uM,=,0.944975908412048,1,c1ccc(NCc2ccc(Oc3ccccc3)cc2)cc1
2385,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N\O)Nc1ccc[n+](CCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],"1,1'-(propane-1,3-diyl)bis(3-((Z)-2-(hydroxyimino)acetamido)pyridinium)dibromide",1070.0,uM,=,3.0293837776852097,1,c1cc[n+](CCC[n+]2ccccc2)cc1
2386,28622,10.1021/jm010949b,,,,In vitro inhibitory concentration against acetylcholinesterase of human erythrocytes,CCC1=CC2CC(C1)Cc1nc3ccccc3c(N)c12.Cl,"(+/-)15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,15-hexaen-3-amine hydrochloride",0.0769,uM,=,-1.114073660198569,0,C1=CC2CC(C1)Cc1nc3ccccc3cc12
2387,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccccc2F)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1ccccc1F,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(2-fluorobenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",29.51,uM,=,1.4699692094999597,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2388,1442760,10.1016/j.bmcl.2014.10.055,,,,Inhibition of human acetylcholinesterase by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CCCCCCn1ccnc1/C=N/O)CC2,"1-(6-(6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)hexyl)-1H-imidazole-2-carbaldehyde oxime",870.0,uM,=,2.9395192526186187,1,c1ccc(C2c3ccccc3CCN2CCCCCCn2ccnc2)cc1
2389,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,COc1ccc2[nH]cc(/C=C3\CN(Cc4ccccc4)CCC3=O)c2c1,3-(1-Benzoyl-1H-pyrrol-3-ylmethylene)-1-benzyl-piperidin-4-one,6.0,uM,=,0.7781512503836436,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1c[nH]c2ccccc12
2390,347063,10.1016/j.bmcl.2006.01.067,,,,Inhibition of AChE activity,COc1ccc(CC2=[N+](C)CCc3cc(OC)c(OC)cc32)cc1OC,"1-(3,4-dimethoxy-benzyl)-6,7-dimethoxy-2-methyl-3,4-dihydro-isoquinolinium",5.5,uM,=,0.7403626894942439,1,c1ccc(CC2=[NH+]CCc3ccccc32)cc1
2391,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccc(Cl)cc2)C[C@@H](c2ccccc2)N(c2ccc(Cl)cc2)[C@@H]1c1ccccc1,"(2R,6S)-ethyl 1-(4-chlorophenyl)-4-(4-chlorophenylamino)-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate",4600.0,uM,=,3.6627578316815743,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
2392,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CNc2ccnc(N3CCSCC3)n2)cc1,N-benzyl-2-thiomorpholinopyrimidin-4-amine,23.2,uM,=,1.3654879848908996,1,c1ccc(CNc2ccnc(N3CCSCC3)n2)cc1
2393,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCC(N4CCCCC4)CC3)ccc12,"2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)ethyl[1,4'-bipiperidine]-1'-carbodithioate",1.16,uM,=,0.0644579892269184,1,O=c1ccc2ccc(OCCSC(=S)N3CCC(N4CCCCC4)CC3)cc2o1
2394,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),C[n+]1ccc2c3ccccc3n(CCc3ccccc3)c2c1,"2-methyl-9-(2-phenylethyl)pyrido[3,4-b]indol-2-ium",0.0005,uM,=,-3.3010299956639813,0,c1ccc(CCn2c3ccccc3c3cc[nH+]cc32)cc1
2395,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)CCCCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccc1O,,0.00435,uM,=,-2.3615107430453626,0,O=C(CCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccccc1
2396,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)Nc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,N-{3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazol-6-yl}-acetamide,0.0028,uM,=,-2.552841968657781,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
2397,1776929,10.1016/j.bmcl.2018.07.019,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate by UV-visible spectrophotometric Ellman's method,COc1ccc(-c2ccccc2/C=C2/Cc3cc(OC)ccc3C2=O)cc1,"5-Methoxy-2-((4'-methoxy-[1,1'-biphenyl]-2-yl)methylene)-2,3-dihydro-1H-inden-1-one",0.0212,uM,=,-1.6736641390712486,0,O=C1/C(=C\c2ccccc2-c2ccccc2)Cc2ccccc21
2398,2076989,10.1039/d1md00105a,,,,Inhibition of human AChE,O=c1ccoc2ccc(OCCCCCN3CCOCC3)cc12,6-(5-morpholinopentyloxy)-4H-chromen-4-one,96.2,uM,=,1.983175072037813,1,O=c1ccoc2ccc(OCCCCCN3CCOCC3)cc12
2399,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCN3CCc4ccccc4C3)CC2)cc1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1,2,3,4-tetrahydro-isoquinoline",1.6,uM,=,0.2041199826559248,1,c1ccc(CN2CCC(CCN3CCc4ccccc4C3)CC2)cc1
2400,2244091,10.1016/j.ejmech.2022.114152,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.099,uM,=,-1.00436480540245,0,c1ccc2nc3c(cc2c1)CCCC3
2401,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),COc1cc2occ(-c3ccc(N4CCCC4)cc3)c(=O)c2cc1OC,"6,7-dimethoxy-3-(4-(pyrrolidin-1-yl)phenyl)-4H-chromen-4-one",1.63,uM,=,0.2121876044039577,1,O=c1c(-c2ccc(N3CCCC3)cc2)coc2ccccc12
2402,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1c(F)c[n+](CCCCOc2ccc3c(C)cc(=O)oc3c2)cc1F.O=S(=O)([O-])C(F)(F)F,"3,5-difluoro-4-methoxy-1-(4-(4-methyl-2-oxo-2H-chromen-7-yloxy)butyl)pyridinium trifluoromethanesulfonate",0.69,uM,=,-0.1611509092627447,0,O=c1ccc2ccc(OCCCC[n+]3ccccc3)cc2o1
2403,347063,10.1016/j.bmcl.2006.01.067,,,,Inhibition of AChE activity,COc1ccc(C(O)c2nccc3cc(OC)c(OC)cc23)cc1OC,"(6,7-dimethoxyisoquinolin-1-yl)(3,4-dimethoxyphenyl)methanol",10.73,uM,=,1.030599721965951,1,c1ccc(Cc2nccc3ccccc23)cc1
2404,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(4-((1,2,3,4-tetrahydroacridin-9-yl)amino)butyl)chroman-2-carboxamide",0.535,uM,=,-0.2716462179787715,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
2405,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,O=C(Cc1cc(=O)oc2cc(O)ccc12)NCCCNc1c2c(nc3ccccc13)CCCC2,"2-(7-hydroxy-2-oxo-2H-chromen-4-yl)-N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)acetamide",0.277,uM,=,-0.5575202309355514,0,O=C(Cc1cc(=O)oc2ccccc12)NCCCNc1c2c(nc3ccccc13)CCCC2
2406,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"5-Hydroxy-4'-(3-((ethyl)(2-Methoxybenzyl)amino)propoxy)-6,7-dimethoxyflavone",0.9,uM,=,-0.0457574905606751,0,O=c1cc(-c2ccc(OCCCNCc3ccccc3)cc2)oc2ccccc12
2407,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.1,uM,=,-1.0,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
2408,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,CN(C)CCCCN1N=C2c3sccc3CCC2CC1=O,"2-(4-(dimethylamino)butyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",6.36,uM,=,0.8034571156484139,1,O=C1CC2CCc3ccsc3C2=NN1
2409,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2cc(Cl)cc(Cl)c2)C3=O)c1,"Methyl-carbamic acid 3-[({7-[2-(3,5-dichloro-benzylidene)-3-oxo-2,3-dihydro-benzofuran-6-yloxy]-heptyl}-methyl-amino)-methyl]-phenyl ester",44.6,uM,=,1.649334858712142,1,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
2410,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1c(N)nc(NCCC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-Amino-6-((2-(1-benzylpiperidin-4-yl)ethyl)amino)-4-phenylpyridine-3,5-dicarbonitrile",0.39,uM,=,-0.4089353929735008,0,c1ccc(CN2CCC(CCNc3cc(-c4ccccc4)ccn3)CC2)cc1
2411,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1ccc(F)cc1,"2-(4-Fluorophenyl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-ol",143.4,uM,=,2.1565491513317814,1,c1ccc(C2NCc3ccccc3N2)cc1
2412,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,CC(=O)c1ccc(N2CCN(CCC(=O)Nc3nc4c(C)cccc4s3)CC2)cc1,3-(4-(4-Acetylphenyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,3.82,uM,=,0.5820633629117087,1,O=C(CCN1CCN(c2ccccc2)CC1)Nc1nc2ccccc2s1
2413,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCC[n+]2ccccc2)cc1,"1,8-bis(pyridinium)octane dibromide",31.0,uM,=,1.4913616938342726,1,c1cc[n+](CCCCCCCC[n+]2ccccc2)cc1
2414,1757796,10.1016/j.ejmech.2017.06.048,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method,c1ccc2c(NCCCCC[Se]CCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"Bis[5-(1',2',3',4'-tetrahydroacridin-9'-ylamino)pentyl]selenide",0.00225,uM,=,-2.6478174818886377,0,c1ccc2c(NCCCCC[Se]CCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
2415,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1cccc(Br)c1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(3-brombenzyl)berberine bromide,2.7,uM,=,0.4313637641589873,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
2416,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,C[C@]12CCNC1Nc1ccc(OC(=O)Nc3ccccc3)cc12,"Phenyl-carbamic acid (R)-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.231,uM,=,-0.6363880201078557,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
2417,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CC(C)n1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-isopropyl-1H-pyrazol-4-yl)ethan-1-one",0.869,uM,=,-0.0609802235513335,0,c1cn[nH]c1
2418,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCCCCCOC(=O)[C@@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1ccccc1,N-Benzoyl-D-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-n-hexyl,0.89,uM,=,-0.0506099933550872,0,O=C(CCCNC(=O)c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2419,959848,10.1016/j.bmcl.2013.02.103,,,,Inhibition of AChE (unknown origin) by Ellman method,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,3-(2-(4-benzylpiperazin-1-yl)acetyl)-7-methoxy-2H-chromen-2-one,1.76,uM,=,0.2455126678141498,1,O=C(CN1CCN(Cc2ccccc2)CC1)c1cc2ccccc2oc1=O
2420,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2cccc(F)c2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1,5-(2-(Cyclopropanecarboxamido)isonicotinamido)-N-((1-(3-fluorobenzyl)piperidin-4-yl)methyl)nicotinamide,2.388,uM,=,0.3780343224573315,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
2421,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1ccc[nH]1,1-Benzyl-3-(1H-pyrrol-2-ylmethylene)-piperidin-4-one,11.0,uM,=,1.0413926851582251,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1ccc[nH]1
2422,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCCCCCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,11-bis(4-tert.butylpyridinium)-undec-1,11-diyl dibromide",0.026,uM,=,-1.585026652029182,0,c1cc[n+](CCCCCCCCCCC[n+]2ccccc2)cc1
2423,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCOCC3)cc1)NCC2,"4-(6-(4-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)phenoxy)hexyl)morpholine",35.48,uM,=,1.5499836111596887,1,c1ccc2c(c1)CCNC2Cc1ccc(OCCCCCCN2CCOCC2)cc1
2424,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(/C=C/c1ccc(O)c(O)c1)NCCC1CCN(Cc2ccccc2)CC1,"(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,4-dihydroxyphenyl)acrylamide",1.75,uM,=,0.2430380486862944,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2425,28936,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase activity from octopus brain,CCCCCSC(=O)OCC[N+](C)(C)C.[Cl-],Trimethyl-(2-pentylsulfanylcarbonyloxy-ethyl)-ammonium chloride,50.0,uM,=,1.6989700043360187,1,
2426,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(Cl)c3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-((4-acetamido-3-chlorophenyl)sulfonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.04733,uM,=,-1.324863495532006,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
2427,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,Nc1ccc2c(c1)CNC(=O)C2,"7-amino-1,2-dihydroisoquinolin-3(4H)-one",1.36,uM,=,0.1335389083702174,1,O=C1Cc2ccccc2CN1
2428,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,C[C@]12CC[C@H](O)[C@@](C)(CO)C1C[C@H](O)[C@@]1(C)Oc3cc(-c4cccnc4)oc(=O)c3C(=O)C21,"3,6-Dihydroxy-4-hydroxymethyl-4,6a,12b-trimethyl-9-pyridin-3-yl-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-7,10-dioxa-benzo[a]anthracene-11,12-dione",35.0,uM,=,1.5440680443502757,1,O=C1c2c(cc(-c3cccnc3)oc2=O)OC2CCC3CCCCC3C12
2429,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCC(=O)NCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"7-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-N-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]heptanamide",0.0038,uM,=,-2.42021640338319,0,O=C(CCC1CCc2ccccc2O1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
2430,462138,10.1021/jm7009364,,,,Inhibition of human AchE-induced amyloid beta aggregation,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [3-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-amide",45.0,uM,=,1.6532125137753435,1,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2
2431,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,O=C(Nc1cc(COCc2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,"(+/-)-1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(((1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)methyl)pyridin-2-yl)urea",0.0208,uM,=,-1.6819366650372385,0,O=C(Nc1cc(COCc2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O
2432,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,"N,1-Dibenzylpyrrolidin-3-amine",1.126,uM,=,0.0515383905153273,1,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
2433,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NCC3CCN(Cc4c(F)cccc4Cl)CC3)sc2-c2ccc(OC)cc2)cc1,"N-[(1-(2-Chloro-6-fluorobenzyl)piperidin-4-yl)methyl]-4,5-bis(4-methoxyphenyl)thiazol-2-ylamine",0.36,uM,=,-0.4436974992327127,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
2434,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,COc1cc(CCCOC(=O)Nc2ccccc2)cc2cc(-c3ccc4c(c3)OCO4)oc12,N-phenylegonolcarbamate,4.5,uM,=,0.6532125137753437,1,O=C(Nc1ccccc1)OCCCc1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1
2435,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"20S-(dimethylamino)-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
2436,1335299,10.1021/jm400970m,,,,Inhibition of AChE (unknown origin),O=C(CCCOc1cccc2[nH]c3ccccc3c12)NCCCNc1c2c(nc3ccccc13)CCCC2,"4-(9H-carbazol-4-yloxy)-N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)butanamide",0.00215,uM,=,-2.6675615400843946,0,O=C(CCCOc1cccc2[nH]c3ccccc3c12)NCCCNc1c2c(nc3ccccc13)CCCC2
2437,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,Cc1ccccc1CN1CCC(CCNC(=O)/C=C/c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)CC1,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(2-methylbenzyl)piperidin-4-yl)ethyl)acrylamide",2.51,uM,=,0.3996737214810381,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2438,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CN1CC[C@@]2(C)c3cc(OC(=O)NCc4ccccc4)ccc3N(C)C12,"(S)-5-Benzylcarbamoyloxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",0.4599999999999999,uM,=,-0.3372421683184259,0,O=C(NCc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
2439,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(Nc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1)c1ccccc1,N-{3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazol-6-yl}-benzamide,0.0094,uM,=,-2.026872146400301,0,O=C(Nc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1)c1ccccc1
2440,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc[n+]1C.F[B-](F)(F)F,2-methoxy-1-methylpyridinium tetrafluoroborate,37.0,uM,=,1.568201724066995,1,c1cc[nH+]cc1
2441,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CC1CCCCN1Cc1ccc(CNCCN2CCNC2=C(C#N)C#N)o1,2-[1-(2-{[5-(2-Methyl-piperidin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile,0.54,uM,=,-0.2676062401770315,0,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
2442,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2ccc(Cl)cc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccc(Cl)cc1,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-4-chloro phenylmethylidene]tetrahydro-4''(1H)-pyridinone",3.36,uM,=,0.5263392773898441,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2443,1589694,10.1016/j.bmc.2016.07.005,,,,Inhibition of hemoglobin free erythrocyte ghost human AChE using acetylcholine iodide as substrate measured for 1 hr by spectrophotometry based Ellman method,NC(=O)c1cc[n+](CCC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],1-(3-(4-carbamoylpyridinium-1-yl)propyl)-3-(2-(hydroxyimino)acetamido)pyridinium dibromide,1670.0,uM,=,3.222716471147584,1,c1cc[n+](CCC[n+]2ccccc2)cc1
2444,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,COc1ccc2c3c1O[C@H]1CC(O)CC[C@@]31CCN(C)C2,Galantamine,0.61,uM,=,-0.2146701649892329,0,c1cc2c3c(c1)O[C@H]1CCCC[C@@]31CCNC2
2445,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(Cc3ccccc3)nn2)cc1.Cl,"9-(2-(4-((1-Benzyl-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",1.05,uM,=,0.021189299069938,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(Cc3ccccc3)nn2)cc1
2446,1437257,10.1016/j.bmcl.2014.10.049,,,,Inhibition of AChE (unknown origin) by Ellman's method,O=C1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc21,"1,8-Dihydroxy-3-hydroxymethyl-anthraquinone",68.0237287185479,uM,=,1.8326604340875363,1,O=C1c2ccccc2C(=O)c2ccccc21
2447,1718355,10.1016/j.ejmech.2017.08.051,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured over 5 mins by UV-Vis spectrophotometric analysis,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0057,uM,=,-2.2441251443275085,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2448,28160,10.1016/S0960-894X(97)10025-7,,,,Compound was tested in vitro for inhibitory activity against Acetylcholinesterase,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.254,uM,=,-0.595166283380062,0,c1ccc2nc3c(cc2c1)CCCC3
2449,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(/C=C2\Cc3ccccc3C2=O)cc1,(2E)-2-[[4-(diethylaminomethyl)phenyl]methylene]indan-1-one,0.612,uM,=,-0.2132485778544388,0,O=C1/C(=C/c2ccccc2)Cc2ccccc21
2450,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,"1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole",18.659,uM,=,1.2708883646988325,1,c1ccc(COC(Cn2ccnc2)c2ccccc2)cc1
2451,1765157,10.1021/acs.jmedchem.8b00592,,,,Inhibition of human recombinant AChE by spectrophotometry based Ellman's assay,O/N=C/c1nc(CCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,"2-[1-(hydroxyimino)methyl]-6-{4-[(1,2,3,4-tetrahydroacridin-9-yl)amino]butyl}pyridin-3-ol",0.25,uM,=,-0.6020599913279624,0,c1ccc(CCCCNc2c3c(nc4ccccc24)CCCC3)nc1
2452,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Oc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"4-(5-(4-(Pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazol-2-yl)phenol",1.18,uM,=,0.0718820073061253,1,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
2453,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc2nc3c(c(N)c2c1)CCCC3.Cl,"7-methoxy-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",10.0,uM,=,1.0,1,c1ccc2nc3c(cc2c1)CCCC3
2454,1525143,10.1016/j.bmcl.2015.06.047,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.35,uM,=,-0.4559319556497244,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
2455,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)C12,"Phenyl-carbamic acid (S)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.022,uM,=,-1.6575773191777938,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
2456,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CC1CCCC(C)N1Cc1ccc(CNCCN2CCNC2=C(C#N)C#N)o1,"2-[1-(2-{[5-(2,6-Dimethyl-piperidin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile",4.5,uM,=,0.6532125137753437,1,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
2457,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCOC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)C(=O)CC3,"Ethyl 1-benzyl-5-(4-chlorophenyl)-1,2,3,4-tetrahydro-2-oxobenzo[h][1,6]naphthyridine-9-carboxylate",4.15,uM,=,0.6180480967120927,1,O=C1CCc2c(-c3ccccc3)nc3ccccc3c2N1Cc1ccccc1
2458,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2[C@@H]1c1ccc(OC)cc1)CCCC3,"(S)-ethyl 5-amino-4-(4-methoxyphenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.378,uM,=,-0.4225082001627747,0,C1=C[C@@H](c2ccccc2)c2cc3c(nc2N1)CCCC3
2459,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCOC2O3)cc1,"(4-Isopropyl-phenyl)-carbamic acid(S)-3a-methyl-2,3,3a,8a-tetrahydro-benzo[b]furo[3,2-d]furan-5-yl ester",0.027,uM,=,-1.5686362358410126,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCOC1O2
2460,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3cccc(Cl)c3)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-1-(3-chlorobenzyl)-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium bromide",0.071,uM,=,-1.1487416512809248,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
2461,2076989,10.1039/d1md00105a,,,,Inhibition of human AChE,O=c1ccoc2ccc(OCCCN3CCCCCC3)cc12,6-(3-(azepan-1-yl)propoxy)-4H-chromen-4-one,10.6,uM,=,1.0253058652647702,1,O=c1ccoc2ccc(OCCCN3CCCCCC3)cc12
2462,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccccc1C)CC2.[Br-],"8-methoxy-2-o-tolyl-3,4-dihydroisoquinolinium bromide",3.07,uM,=,0.4871383754771864,1,C1=[N+](c2ccccc2)CCc2ccccc21
2463,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN1CCC(CCN2C(=O)c3ccc([N+](=O)[O-])cc3C2=O)CC1,"2-[2-(1-Methyl-piperidin-4-yl)-ethyl]-5-nitro-isoindole-1,3-dione",6.8,uM,=,0.8325089127062363,1,O=C1c2ccccc2C(=O)N1CCC1CCNCC1
2464,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,"5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one",3.42,uM,=,0.534026106056135,1,O=c1cc(-c2ccccc2)oc2ccccc12
2465,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2cccc(F)c2)CC1)c1ccc2c(c1)CCN2,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(3-fluoro-benzyl)-piperidin-4-yl]-propan-1-one",0.016,uM,=,-1.7958800173440752,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
2466,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2cc(O)ccc2o1,N-(3-(1-benzylpiperidin-4-yl)propyl)-6-hydroxy-4-oxo-4H-chromene-2-carboxamide,0.023,uM,=,-1.6382721639824072,0,O=C(NCCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
2467,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{4-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]butyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",0.0896,uM,=,-1.0476919903378747,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
2468,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,CC1(C)CCCN(Cc2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)C1,"3-(4-((3,3-Dimethylpiperidin-1-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",3.33,uM,=,0.5224442335063199,1,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
2469,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,CC(=O)c1c[n+](Cc2ccccc2C)ccc1CC1Cc2cc(C)c(C)cc2C1=O.[Br-],"(+/-)-2-[[3-Acetyl-1-(o-tolylmethyl)pyridin-1-ium-4-yl]methyl]-5,6-dimethyl-indan-1-one Bromide",0.0277,uM,=,-1.5575202309355514,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
2470,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,O=C(Nc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)s1)C1CCN(Cc2ccccc2C(F)(F)F)CC1,"1-(2-Trifluoromethylbenzyl)-N-[4,5-bis(4-chlorophenyl)-thiazol-2-yl]piperidine-4-carboxamide",2.77,uM,=,0.4424797690644485,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
2471,28623,10.1021/jm00394a014,,,,Inhibitory activity against acetylcholinesterase in human blood,CCCN1CCCC(c2cccc(OC(=O)NC(C)C)c2)C1,Isopropyl-carbamic acid 3-(1-propyl-piperidin-3-yl)-phenyl ester,10.0,uM,=,1.0,1,c1ccc(C2CCCNC2)cc1
2472,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCN(C)Cc1ccc(O)cc1,1-(8-((4-hydroxybenzyl)(methyl)amino)octyl)-5-methoxy-1H-indole-3-carbaldehyde,2.06,uM,=,0.3138672203691534,1,c1ccc(CNCCCCCCCCn2ccc3ccccc32)cc1
2473,1837068,10.1016/j.ejmech.2019.07.040,,,,Inhibition of human AChE,COc1ccc2nc3c(c(NCCCCCCCCNC(=S)NC45CC6CC(CC(C6)C4)C5)c2c1)CCCC3,"1-Adamantan-1-yl-3-[8-(7-methoxy-1,2,3,4-tetrahydro-acridin-9-ylamino)-octyl]-thiourea",1.6,uM,=,0.2041199826559248,1,S=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)NC12CC3CC(CC(C3)C1)C2
2474,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CCSc1nc(-c2ccc(OC)cc2)nn1C(=O)N(C)c1ccccc1,"5-Ethylsulfanyl-3-(4-methoxy-phenyl)-[1,2,4]triazole-1-carboxylic acid methyl-phenyl-amide",1.1,uM,=,0.041392685158225,1,O=C(Nc1ccccc1)n1cnc(-c2ccccc2)n1
2475,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(N4CCN(c5c6c(nc7ccc(C)cc57)CCCC6)CC4)c2c1)CCCC3,"1,4-Bis(7-methyl-1,2,3,4-tetrahydroacridin-9-yl)piperazine",0.521,uM,=,-0.2831622767004755,0,c1ccc2c(N3CCN(c4c5c(nc6ccccc46)CCCC5)CC3)c3c(nc2c1)CCCC3
2476,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,CCN1CCc2sc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2C1,"3-(5-Ethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.259,uM,=,-0.5867002359187482,0,c1cc2c(cn1)[nH]c1ncc(-c3cc4c(s3)CCNC4)cc12
2477,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1,"(4-Isopropyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.05,uM,=,-1.3010299956639813,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
2478,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccccc2OC)C(=O)/C(=C/c2ccccc2OC)C1,"(3E,5E)-1-Acryloyl-3,5-bis(2-methoxyphenylmethylidene)piperidin-4-one",8.72,uM,=,0.9405164849325672,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
2479,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(Br)cc1,"3-(4-bromobenzyl)-2-butyl-1,3-diazaspiro[4,4]non-1-en-4-one",0.07,uM,=,-1.154901959985743,0,O=C1N(Cc2ccccc2)C=NC12CCCC2
2480,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)N(Cc1ccccc1)CCCC2,"3-(1-Benzyl-piperidin-4-yl)-1-(1-benzyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",3.14,uM,=,0.4969296480732149,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)N(Cc1ccccc1)CCCC2
2481,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)CCCC/C=C/CNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccc1O,,0.00441,uM,=,-2.3555614105321614,0,O=C(CCCC/C=C/CNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccccc1
2482,1626872,10.1016/j.bmc.2016.10.016,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins followed by substrate addition measured after 20 mins by UV-Vis spectrophotometric analysis,S=C1/C(=C/c2ccccc2)Oc2ccccc21,(Z)-2-(Benzylidene)benzofuran-3(2H)-thione,6.39,uM,=,0.8055008581584001,1,S=C1/C(=C/c2ccccc2)Oc2ccccc21
2483,1635002,10.1016/j.ejmech.2016.09.037,,,,Inhibition of human AChE pretreated for 20 mins followed by acetylthiocholine iodide substrate addition measured for 5 mins by Ellman's method,O=C1NCCCc2c1c1ccccc1n2CCc1ccccc1,"6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one",12.6,uM,=,1.100370545117563,1,O=C1NCCCc2c1c1ccccc1n2CCc1ccccc1
2484,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCCOC[n+]1ccn(C)c1C.[Cl-],"1-But-3-ynyloxymethyl-2,3-dimethyl-3H-imidazol-1-ium chloride",27.0,uM,=,1.4313637641589874,1,c1c[nH+]c[nH]1
2485,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,S=C(NCCN1CCCCC1)Nc1cccc(Cl)c1,1-(3-Chlorophenyl)-3-(2-(piperidin-1-yl)ethyl)thiourea,190.0,uM,=,2.278753600952829,1,S=C(NCCN1CCCCC1)Nc1ccccc1
2486,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1cc(-c2ccccc2)nc2nc(-c3ccccc3)cc(C(F)(F)F)c12,"2,7-Diphenyl-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",7.1,uM,=,0.8512583487190752,1,c1ccc(-c2ccc3ccc(-c4ccccc4)nc3n2)cc1
2487,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccc(F)cc2)CC1)N1CCN(CCCc2c[nH]c3ccc(F)cc23)CC1,1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-fluorobenzoyl)piperazin-1-yl)ethanone,3.4,uM,=,0.5314789170422551,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
2488,2211577,10.1021/acs.jnatprod.1c01155,,,,Inhibition of AChE in human Erythrocyte incubated for 20 mins by Ellman reagent based spectrophotometry,C=C(C)[C@]1(O)CC[C@@]2(C)C3=Cc4c(cc(-c5cccnc5)oc4=O)O[C@]3(C)[C@@H](O)C[C@@H]2[C@@]12CCC(=O)OC2,Pileotin B,13.9,uM,=,1.1430148002540952,1,O=C1CC[C@]2(CCCC3C4=Cc5c(cc(-c6cccnc6)oc5=O)OC4CC[C@@H]32)CO1
2489,2059377,10.1016/j.bmc.2021.116074,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc2c(cc1OC)/C(=C/c1ccc(O)c(N3CCCCC3)c1)OC2=O,"(Z)-3-(4-hydroxy-3-(piperidin-1-yl)benzylidene)-5,6-dimethoxyisobenzofuran-1(3H)-one",0.000616,uM,=,-3.2104192878355744,0,O=C1O/C(=C\c2cccc(N3CCCCC3)c2)c2ccccc21
2490,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(-n4cnc5ccccc54)cc3)C2)cc1OC,"1-(5-(4-(1H-Benzo[d]imidazol-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",319.2,uM,=,2.504062882678692,1,c1ccc(C2=NNC(c3ccc(-n4cnc5ccccc54)cc3)C2)cc1
2491,28298,10.1021/jm00015a002,,,,In vitro inhibition of Acetylcholinesterase from human erythrocytes,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.17,uM,=,-0.7695510786217261,0,c1ccc2nc3c(cc2c1)CCCC3
2492,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(C(=O)NC(=S)NCCOCCN(C)Cc2ccccc2)cc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(4-methoxy-benzoyl)-thiourea,0.026,uM,=,-1.585026652029182,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccccc1
2493,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,S=C(NCc1ccccc1)NNc1c2c(nc3ccccc13)CCCC2,"N-benzyl-2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazine-1-carbothioamide",0.218,uM,=,-0.6615435063953952,0,S=C(NCc1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
2494,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCc1cn(CCNc2c3c(nc4cc(Cl)ccc24)CCCC3)nn1,"4-(2-(1-(2-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)ethoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methylthiazole-5-carboxamide",0.0387,uM,=,-1.4122890349810886,0,O=C(Nc1cc(-c2nc(OCCc3cn(CCNc4c5c(nc6ccccc46)CCCC5)nn3)cs2)ccn1)C1CC1
2495,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCN(Cc3ccc(F)cc3)CC2)ccc1O,(E)-1-(4-(4-fluorobenzyl)piperazin-1-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one,14.54,uM,=,1.162564406523019,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
2496,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Cl.NS(=O)(=O)c1ccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)cc1,"4-(4-((4-((2-(1,2,3,4-Tetrahydroacridin-9-yl)hydrazono)methyl)phenoxy)methyl)-1H-1,2,3-triazol-1-yl)benzenesulfonamide Hydrochloride",1.11,uM,=,0.0453229787866574,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
2497,1776929,10.1016/j.bmcl.2018.07.019,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate by UV-visible spectrophotometric Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.00687,uM,=,-2.163043262940449,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2498,2264452,10.1039/d1md00394a,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate preincubated for 15 mins followed by substrate addition and measured after 5 mins by DTNB reagent based Ellman's method,O=c1c(/C=N/Nc2ccc(C(F)(F)F)cc2)coc2c1ccc1oc(-c3ccc(Cl)cc3)cc12,"8-(4-chlorophenyl)-3-((2-(4-(trifluoromethyl)phenyl)hydrazineylidene)methyl)-4H-furo[2,3-h]chromen-4-one",5.0,uM,=,0.6989700043360189,1,O=c1c(/C=N/Nc2ccccc2)coc2c1ccc1oc(-c3ccccc3)cc12
2499,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,Cl.Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine hydrochloride",0.093,uM,=,-1.031517051446065,0,c1ccc2nc3c(cc2c1)CCCC3
2500,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(1,2,3,4-tetrahydro-acridin-9-yl)-heptane-1,7-diamine (bis(7)-Tacrine)",0.00081,uM,=,-3.09151498112135,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
2501,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)NCCC(=O)Nc2ccc(Cl)cc2)ccc1O,(E)-N-(3-((4-chlorophenyl)amino)-3-oxopropyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,5.32,uM,=,0.7259116322950482,1,O=C(/C=C/c1ccccc1)NCCC(=O)Nc1ccccc1
2502,1807943,10.1016/j.ejmech.2019.07.051,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry analysis,NC12CC3CC(F)(CC(C1)c1cc(NC(=O)CCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)ccc13)C2,"N-(7-Amino-9-fluoro-7H-5,6,8,9,10,11-hexahydro-5,9:7,11-dimethanobenzo[9]annulen-2-yl)-4-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]butanamide",0.0003,uM,=,-3.522878745280338,0,O=C(CCCNc1c2c(nc3ccccc13)CCCC2)Nc1ccc2c(c1)C1CC3CC(CC2C3)C1
2503,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3cccc(Cl)c13)CCCC2,"8-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.039,uM,=,-1.408935392973501,0,c1ccc2nc3c(cc2c1)CCCC3
2504,683819,10.1016/j.ejmech.2010.08.025,,,,Inhibition of human AChE by Ellman method,O=C(NP(=O)(NN1CCOCC1)NN1CCOCC1)c1ccccc1,"N-Benzoyl-N',N''-bis(4-aminomorpholine)phosphoric triamide",18620.0,uM,=,4.269979676645324,1,O=C(NP(=O)(NN1CCOCC1)NN1CCOCC1)c1ccccc1
2505,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,COc1cc(/C=N\C2CCN(Cc3ccccc3)C2)cc(OC)c1OC,"N-(1-Benzylpyrrolidin-3-yl)-1-(3,4,5-trimethoxyphenyl)methanimine",7.792999999999999,uM,=,0.8917046762391827,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
2506,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4cccc(F)c4)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(3-Fluorobenzyl)-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]piperidine-4-carboxamide",0.57,uM,=,-0.2441251443275086,0,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
2507,28622,10.1021/jm010949b,,,,In vitro inhibitory concentration against acetylcholinesterase of human erythrocytes,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.26,uM,=,-0.585026652029182,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
2508,1539620,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 6,COC(=O)C1=C(C)OP(=O)(OC)CCC1,"2-Methoxy-7-methyl-2-oxo-2,3,4,5-tetrahydro-2lambda*5*-[1,2]oxaphosphepine-6-carboxylic acid methyl ester",26.0,uM,=,1.414973347970818,1,O=[PH]1CCCC=CO1
2509,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,CCOC(=O)c1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2[nH]1,Ethyl 5-(3-(1-benzylpiperidin-4-yl)propoxy)-1H-indole-2-carboxylate,9.6,uM,=,0.9822712330395684,1,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
2510,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(CC4CCCO4)CC3)nc12,(+/-)-N-(4-Methylbenzo[d]thiazol-2-yl)-3-(4-((tetrahydrofuran-2-yl)methyl)piperazin-1-yl)propanamide,7.91,uM,=,0.8981764834976765,1,O=C(CCN1CCN(CC2CCCO2)CC1)Nc1nc2ccccc2s1
2511,462117,10.1021/jm7009364,,,,Inhibition of human AchE,O=C(CCCCCCNc1c2c(nc3cc(Cl)cc(Cl)c13)CCCC2)NCCc1c[nH]c2ccccc12,"7-(6,8-dichloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",8e-06,uM,=,-5.096910013008056,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
2512,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,Cc1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1,"N2-(1-Benzylpiperidin-4-yl)-N4-(4-methylbenzyl)pyrimidine-2,4-diamine",12.9,uM,=,1.110589710299249,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
2513,28613,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 7.33-61.5,CCNC(=O)Oc1ccc2c(c1)C(N)CC2.Cl,Ethyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,17.7,uM,=,1.2479732663618066,1,c1ccc2c(c1)CCC2
2514,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(C)cc(C)c4c(N)c3C(C1)C2,"15-ethyl-5,7-dimethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00496,uM,=,-2.3045183235098023,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
2515,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,Cc1ccccc1NC(=O)Oc1ccc2c(c1)C1(C)CCOC1O2,"o-Tolyl-carbamic acid 3a-methyl-2,3,3a,8a-tetrahydro-benzo[b]furo[3,2-d]furan-5-yl ester",0.023,uM,=,-1.6382721639824072,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCOC1O2
2516,2164642,10.1021/acs.jmedchem.1c01748,,,,Inhibition of recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells using acetylthiocholine iodide as substrate measured for 6 mins by Ellman's method,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1.[Cl-].[Cl-],4-(aminocarbonyl)-1-({[1-chloro-2-[(E)-(hydroxyimino)methyl]pyridinium-1(2H)-yl]methoxy}methyl)pyridinium chloride,55.0,uM,=,1.740362689494244,1,c1cc[n+](COC[n+]2ccccc2)cc1
2517,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCN(C)C,(E)-3-(4-((5-(dimethylamino)pentyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,33.02,uM,=,1.5187770689267748,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
2518,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",14.0,uM,=,1.146128035678238,1,c1ccc2c(c1)N[C@H]1NCCC21
2519,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)c3cc[n+](Cc4ccc(F)cc4)cc3)c2c1.[Br-],1-(4-fluorobenzyl)-4-((2-(5-methoxy-1H-indol-3-yl)ethyl)carbamoyl)pyridin-1-ium bromide,5.1,uM,=,0.7075701760979364,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
2520,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCc2c[nH]c3ccc(F)cc23)CC1,2-(4-(4-chlorobenzoyl)piperazin-1-yl)-1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)ethanone,22.3,uM,=,1.3483048630481609,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
2521,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1c[nH]c2ccccc12,"1H-indole-3-carboxylic acid [7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-amide",0.036,uM,=,-1.4436974992327127,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1c[nH]c2ccccc12
2522,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCCN3CCCCC3)nn2)cc1,(6-Phenyl-pyridazin-3-yl)-(2-piperidin-1-yl-ethyl)-amine,13.0,uM,=,1.1139433523068367,1,c1ccc(-c2ccc(NCCN3CCCCC3)nn2)cc1
2523,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-amino-3-(1H-indol-3-yl)-N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)propanamide dihydrochloride",0.58,uM,=,-0.2365720064370627,0,O=C(CCc1c[nH]c2ccccc12)NCCCNc1c2c(nc3ccccc13)CCCC2
2524,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1ccc(C#N)cc1)c1ccc(=O)[nH]c1C2,"4-{[13-Ethylidene-11-methyl-5-oxo-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-1-ylimino]-methyl}-benzonitrile",0.022,uM,=,-1.6575773191777938,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
2525,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)c(O)c2)cc1,"N-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-(3,4-dihydroxyphenyl)acetamide",7.26,uM,=,0.8609366207000937,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
2526,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN(C)CCOc2ccc3c(c2)oc(=O)c2ccccc23)c1,3-(2-((3-Methoxybenzyl)(methyl)amino)ethoxy)-6H-benzo[c]chromen-6-one,18.4,uM,=,1.2648178230095364,1,O=c1oc2cc(OCCNCc3ccccc3)ccc2c2ccccc12
2527,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Fc1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,1-Benzyl-N-(4-fluorobenzyl)pyrrolidin-3-amine,0.149,uM,=,-0.826813731587726,0,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
2528,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3[C@@H](C1)C2.Cl.Cl.Cl.Cl,"(+)-(7R,11R)-3-Chloro-12-((7-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl)amino)-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinoline dihydrochloride",0.0115,uM,=,-1.9393021596463884,0,C1=C[C@H]2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@@H](C1)C2
2529,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1ccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)c(OC)c1,"(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(2,4-dimethoxyphenyl)acrylamide",8.73,uM,=,0.9410142437055696,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
2530,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN1CCCc2ccc(C(=O)CCC3CCN(Cc4ccccc4)CC3)cc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-methyl-1,2,3,4-tetrahydro-quinolin-7-yl)-propan-1-one",0.036,uM,=,-1.4436974992327127,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCC2
2531,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3cccc(F)c3)cc12.[Br-],2-(3-Fluorophenyl)-8-methoxyisoquinolin-2-ium bromide,9.13,uM,=,0.960470777534299,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
2532,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CCNC(=O)Oc1ccc2c(c1)[C@@]1(C)CO[C@H](C1)O2,"(-)-(5S)-5-mthyl-4,5-dihydro-2,5-methano-1,3-benzodioxepin-7-yl N-Ethylcarbamate",0.61,uM,=,-0.2146701649892329,0,c1ccc2c(c1)O[C@H]1CC2CO1
2533,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccccc2F)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-((1-(2-fluorobenzyl)piperidin-4-yl)methoxy)-N-methylthiazole-5-carboxamide,9.0,uM,=,0.9542425094393248,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
2534,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,O=C(CC[C@@H](NC(=O)c1ccccc1)C(=O)O)NCCC1CCN(Cc2ccccc2)CC1,N-Benzoyl-D-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-OH,20.0,uM,=,1.3010299956639813,1,O=C(CCCNC(=O)c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2535,1894671,10.1016/j.ejmech.2019.05.062,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured upto 5 mins by Ellman's method,Cl.c1ccc(CCCCN2CCCc3[nH]c4ccccc4c3C2)cc1,"2-(4-phenylbutyl)-1,2,3,4,5,6-hexahydroazepino[4,3-b]indole hydrochloride",20.0,uM,=,1.3010299956639813,1,c1ccc(CCCCN2CCCc3[nH]c4ccccc4c3C2)cc1
2536,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)cc3)CC2)nc1-c1ccccc1,Ethyl 2-(4-((4-acetamidophenyl)sulfonyl)piperazin-1-yl)-4-methyl-6-phenylpyrimidine-5-carboxylate,0.1178,uM,=,-0.9288547095489172,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
2537,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(Cl)cc2)nn1C(=O)N1CCCCC1,"[3-(4-Chloro-phenyl)-5-methylsulfanyl-[1,2,4]triazol-1-yl]-piperidin-1-yl-methanone",0.026,uM,=,-1.585026652029182,0,O=C(N1CCCCC1)n1cnc(-c2ccccc2)n1
2538,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN(C)S(=O)(=O)N[C@H]1CCc2cc(O)ccc2C1,"(S)-3-(6-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylsulfamide",0.02787,uM,=,-1.5548630312866958,0,c1ccc2c(c1)CCCC2
2539,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C)CC3)cc1)C2,"2,3-Dihydro-5,6-dimethoxy-2-(4-(4-methylpiperazin-1-yl)benzylidene]-1H-inden-1-one",0.32,uM,=,-0.494850021680094,0,O=C1/C(=C/c2ccc(N3CCNCC3)cc2)Cc2ccccc21
2540,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,O=C(CCn1c2ccccc2c2cnccc21)N1c2ccccc2Sc2ccccc21,"1-(10H-phenothiazin-10-yl)-3-(5H-pyrido[4,3-b]indol-5-yl)propan-1-one",2.3,uM,=,0.3617278360175928,1,O=C(CCn1c2ccccc2c2cnccc21)N1c2ccccc2Sc2ccccc21
2541,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CC2CCN(CCCOc3ccc4c(c3)oc(=O)c3ccccc34)CC2)c1,3-(3-(4-(3-Methoxybenzyl)piperidin-1-yl)propoxy)-6H-benzo[c]chromen-6-one,18.5,uM,=,1.2671717284030135,1,O=c1oc2cc(OCCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12
2542,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2.Cl,(+/-)-huprine Y-HCl,0.00069,uM,=,-3.161150909262745,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
2543,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,CC1Cc2nc3nc(-c4ccccc4)cc(C(F)(F)F)c3c(N)c2C1,"7-Methyl-2-phenyl-4-(trifluoromethyl)-7,8-dihydro-6Hcyclopenta[b][1,8]-naphthyridin-5-amine",9.37,uM,=,0.9717395908877784,1,c1ccc(-c2ccc3cc4c(nc3n2)CCC4)cc1
2544,2198763,10.1039/d2md00087c,,,,Pseudo-irreversible inhibition of human AChE using acetylthiocholineiodide as substrate preincubated for 20 to 60 mins followed by substrate addition and measured for 5 mins by DTNB reagent based Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,1.5,uM,=,0.1760912590556812,1,c1ccccc1
2545,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1OC,(E)-4-(3-(4-benzylpiperidin-1-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl ethyl(methyl)carbamate,17.3,uM,=,1.2380461031287957,1,O=C(/C=C/c1ccccc1)N1CCC(Cc2ccccc2)CC1
2546,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)CCCCCCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccc1O,,0.0019399999999999,uM,=,-2.712198270069774,0,O=C(CCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccccc1
2547,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,Cc1c(OC(=O)N(C)C)c2c(c[n+]1C)COC(C(C)C)OC2.[Br-],"1,5-Dihydro-3-isopropyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",260.0,uM,=,2.414973347970818,1,c1cc2c(c[nH+]1)COCOC2
2548,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)Nc1cccc2ccccc12)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-naphthalen-1-yl-thiourea,10.0,uM,=,1.0,1,S=C(NCCOCCNCc1ccccc1)Nc1cccc2ccccc12
2549,967407,10.1016/j.bmc.2013.05.001,,,,Inhibition of human AchE using acetylthiocholine iodide as substrate incubated for 20 mins prior to substrate addition measured for 1 hr by Ellman's method,CC1CCCCN1c1nc2ccccc2[nH]1,2-(2-Methylpiperidin-1-yl)-1H-benzo[d]imidazole,88.92,uM,=,1.948999454026953,1,c1ccc2[nH]c(N3CCCCC3)nc2c1
2550,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),CCN(CC)CCCCOc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1,7-(4-(diethylamino)butoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one,0.1,uM,=,-1.0,0,O=c1c(-c2ccccc2)coc2ccccc12
2551,1331163,10.1039/C1MD00221J,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured after 10 mins by Ellman's method,Cc1ccc(C(=O)Nc2cc3ccccc3oc2=O)cc1,SID24811901,18.38,uM,=,1.2643455070500924,1,O=C(Nc1cc2ccccc2oc1=O)c1ccccc1
2552,972045,10.1016/j.bmcl.2013.04.081,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylcholine iodide as substrate preincubated for 15 mins prior to substrate addition by spectrophotometric analysis,COc1c2occc2cc2ccc(=O)oc12,"9-Methoxy-furo[3,2-g]chromen-7-one",0.76,uM,=,-0.1191864077192086,0,O=c1ccc2cc3ccoc3cc2o1
2553,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1c(F)c[n+](CCC[n+]2cc(F)c(OC)c(F)c2)cc1F.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"1,1'-(propane-1,3-diyl)bis(3,5-difluoro-4-methoxypyridinium)trifluoromethanesulfonate",21.0,uM,=,1.3222192947339193,1,c1cc[n+](CCC[n+]2ccccc2)cc1
2554,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCOCC2)ccc1O,SID850139,409.2,uM,=,2.6119356250401227,1,c1ccc(CN2CCOCC2)cc1
2555,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(OC)c3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-((4-amino-3-methoxyphenyl)sulfonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.08558,uM,=,-1.067627717852086,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
2556,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(-c2cn3ccccc3[n+]2C)c1.[I-],"1-methyl-2-(3-(methylcarbamoyloxy)phenyl)imidazo[1,2-a]pyridin-1-ium",0.35,uM,=,-0.4559319556497244,0,c1ccc(-c2cn3ccccc3[nH+]2)cc1
2557,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-methoxyindan-1-one,0.63,uM,=,-0.2006594505464183,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
2558,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,O=C(Cc1cc(=O)oc2cc(O)ccc12)NCCNc1c2c(nc3ccccc13)CCCC2,"N1-[2-(1,2,3,4-Tetrahydroacridin-9-ylamino)ethyl]-2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetamide",2.91,uM,=,0.4638929889859073,1,O=C(Cc1cc(=O)oc2ccccc12)NCCNc1c2c(nc3ccccc13)CCCC2
2559,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,FC(F)(F)Oc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-(4-(Pyridin-2-yl)piperazin-1-yl)-5-(4-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole",0.089,uM,=,-1.0506099933550872,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
2560,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1ccc2[nH]cc(CCNC(=O)c3ccc(CN(C)Cc4ccccc4)cc3)c2c1,4-{[Benzyl(methyl)amino]methyl}-N-[2-(5-methoxy-1Hindol-3-yl)ethyl]benzamide,6.1,uM,=,0.785329835010767,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
2561,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,CCN1CCN(CCC(=O)Nc2nc3c(C)cccc3s2)CC1,3-(4-Ethylpiperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)-propanamide,20.58,uM,=,1.3134453704264142,1,O=C(CCN1CCNCC1)Nc1nc2ccccc2s1
2562,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1c(F)c[n+](CCC[n+]2cc(F)c(OC)c(F)c2)cc1F.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"1,1'-(propane-1,3-diyl)bis(3,5-difluoro-4-methoxypyridinium)trifluoromethanesulfonate",28.0,uM,=,1.4471580313422192,1,c1cc[n+](CCC[n+]2ccccc2)cc1
2563,1675783,10.1016/j.ejmech.2017.03.062,,,,Inhibition of human plasma AChE using acetyl-(beta-methyl)thiocholine as substrate pretreated for 30 mins followed by substrate addition after 25 mins by spectrophotometric method,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCC(C)[C@@H]2C3C)cc1,4'-Isopropylphenserine; Cymserine,0.76,uM,=,-0.1191864077192086,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCC[C@@H]1C2
2564,28628,10.1021/jm970210v,,,,Inhibition of human acetylcholinesterase from erythrocytes (RBC),CN1CC[C@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(Cc3ccccc3)C12,"Phenyl-carbamic acid (R)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",11.223,uM,=,1.0501089629178677,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2Cc1ccccc1
2565,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CC1CCN(Cc3cc(C)cc(/C=N/O)c3O)CC1)CC2,"3-((4-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxy-5-methylbenzaldehyde oxime",524.7,uM,=,2.719911064198339,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3c3ccccc3)CC2)cc1
2566,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCCCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(decylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.0241,uM,=,-1.6179829574251317,0,O=c1c2ccccc2nc2n1CCC2
2567,430856,10.1021/jm0503289,,,,Inhibition of human AChE-induced beta amyloid peptide(1-40) aggregation by thioflavin T-based fluorometric assay,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)-heptyl]-2-(1H-indol-3-yl)-acetamide",7.0,uM,=,0.8450980400142568,1,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
2568,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COC[n+]2ccn(C)c2/C=N/O)c1/C=N/O,2-(3-{2-[2-hydroxy-(E)-1-methenylimino]-1-methyl-1H-imidazol-3-ium-3-ylmethoxymethyl}-1-methyl-1H-imidazol-3-ium-2-yl)-(E)-1-iminomethen-1-ol,7.8,uM,=,0.8920946026904804,1,c1c[n+](COC[n+]2cc[nH]c2)c[nH]1
2569,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,C[C@@]12CCNC1Nc1ccc(OC(=O)Nc3ccccc3)cc12,"Phenyl-carbamic acid (S)-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0221,uM,=,-1.6556077263148894,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
2570,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(CCN(C(C)C)C(C)C)CC3)nc12,3-(4-(2-(Diisopropylamino)ethyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,0.24,uM,=,-0.619788758288394,0,O=C(CCN1CCNCC1)Nc1nc2ccccc2s1
2571,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCNC(=O)CCc1c[nH]c2ccccc12)CCCNc1c2c(nc3ccccc13)CCCC2,"N-(3-{[3-(1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-methyl-amino}-propyl)-3-(1H-indol-3-yl)-propionamide",0.147,uM,=,-0.8326826652518239,0,O=C(CCc1c[nH]c2ccccc12)NCCCNCCCNc1c2c(nc3ccccc13)CCCC2
2572,1339402,10.1016/j.bmc.2014.02.046,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins prior to substrate challenge measured after 15 mins by Ellman's method,COc1cc2[nH]c(=O)c(C(=O)NCC3CCN(Cc4ccccc4)CC3)c(O)c2cc1OC,"N-((1-Benzylpiperidin-4-yl)methyl)-4-hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydroquinoline-3-carboxamide",0.23,uM,=,-0.6382721639824072,0,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cc2ccccc2[nH]c1=O
2573,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1ncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)o1,"5-(3-(4-(Piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridin-6-yl)oxazole",0.323,uM,=,-0.4907974776688971,0,c1ncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)o1
2574,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1ccc([C@H]2OC[C@H]3[C@@H]2C(=O)O[C@@H]3c2ccc3c(c2)OCO3)cc1OC,"Ciquitin C; O-methylstyraxin; (+)-(7S,7'S,8R,8'S)-7-(3,4-methylenedioxyphenyl)-7'-(3',4'-dimethoxyphenyl-9'-oxo-8,8'-dioxabicyclo[3.3.0]octane",2.229,uM,=,0.3481100684802377,1,O=C1O[C@H](c2ccc3c(c2)OCO3)[C@H]2CO[C@H](c3ccccc3)[C@@H]12
2575,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1c(O)cc(C2CC(=O)c3c(cc(O)c(C/C=C(\C)CCC=C(C)C)c3O)O2)cc1O,"6-Geranyl-3',5,5',7-tetrahydroxy-4'-methoxyflavanone",22.9,uM,=,1.359835482339888,1,O=C1CC(c2ccccc2)Oc2ccccc21
2576,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl.Cl.Cl,"(+/-)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-((10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl)amino)-7,11-methanocycloocta[b]quinoline dihydrochloride",0.00419,uM,=,-2.377785977033705,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
2577,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(C2Cc3ccccc3C2=O)CC1,2-(1-Methyl-piperidin-4-yl)-indan-1-one,3.3,uM,=,0.5185139398778875,1,O=C1c2ccccc2CC1C1CCNCC1
2578,683819,10.1016/j.ejmech.2010.08.025,,,,Inhibition of human AChE by Ellman method,O=P(O)(NN1CCCCC1)Oc1ccccc1,Phenyl-N-(4-aminopiperidine)phosphate,5490.0,uM,=,3.739572344450092,1,O=[PH](NN1CCCCC1)Oc1ccccc1
2579,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0247,uM,=,-1.6073030467403342,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2580,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(benzylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.231,uM,=,-0.6363880201078557,0,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
2581,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCC(c4ccccc4)CC3)cc1)NCC2,"6,7-dimethoxy-1-(4-((6-(4-phenylpiperidin-1-yl)hexyl)oxy)benzyl)-1,2,3,4-tetrahydroisoquinoline",9.33,uM,=,0.9698816437465,1,c1ccc(C2CCN(CCCCCCOc3ccc(CC4NCCc5ccccc54)cc3)CC2)cc1
2582,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,COC(=O)C(CC1=C(c2ccccc2)CC(C)(C)ON1C(C)=O)C(=O)OC,"Dimethyl[(2-acetyl-6,6-dimethyl-4-phenyl-5,6-dihydro-2H-1,2-oxazin-3-yl)methyl]malonate",12.0,uM,=,1.0791812460476249,1,C1=C(c2ccccc2)CCON1
2583,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CO[C@@H](C2)O3)cc1,"(-)-(5R)-5-methyl-4,5-dihydro-2,5-methano-1,3-benzodioxepin-7-yl N-(p-Isopropylphenyl)carbamate",3.43,uM,=,0.5352941200427705,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CO[C@@H](C1)O2
2584,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2cnc(NCN3CCCCC3)nn2)cc1,"6-phenyl-N-(piperidin-1-ylmethyl)-1,2,4-triazin-3-amine",60.0,uM,=,1.7781512503836436,1,c1ccc(-c2cnc(NCN3CCCCC3)nn2)cc1
2585,1443169,10.1016/j.ejmech.2014.09.081,,,,Inhibition of human erythrocyte AChE preincubated for 15 mins by Ellman's method,CCN(CC)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,"(E)-2-(4-(diethylamino)benzylidene)-5-methoxy-6-(2-(piperidin-1-yl)ethoxy)-2,3-dihydro-1H-inden-1-one",0.5364,uM,=,-0.2705112308204387,0,O=C1/C(=C/c2ccccc2)Cc2ccc(OCCN3CCCCC3)cc21
2586,956356,10.1016/j.ejmech.2013.01.056,,,,Inhibition of AChE (unknown origin),c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(1,2,3,4-tetrahydro-acridin-9-yl)-heptane-1,7-diamine (bis(7)-Tacrine)",0.0004,uM,=,-3.397940008672037,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
2587,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2oc(C(=O)NCCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2cc1OC,"N-(3-(1-benzylpiperidin-4-yl)propyl)-6,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide",0.11,uM,=,-0.958607314841775,0,O=C(NCCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
2588,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Clc1ccc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc2c1,4-{2-[4-(5-Chloro-1H-benzo[d]imidazol-2-yl)phenoxy]ethyl}morpholine,9.73,uM,=,0.988112840268352,1,c1ccc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc2c1
2589,1980351,10.1016/j.ejmech.2019.02.005,,,,Inhibition of human AChE,COc1ccc(C2c3c(nc4c(c3N)CCCC4)Oc3ccc4ccccc4c32)cc1OC,"rac-14-(3',4'-Dimethoxyphenyl)-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amine",0.083,uM,=,-1.080921907623926,0,c1ccc(C2c3cc4c(nc3Oc3ccc5ccccc5c32)CCCC4)cc1
2590,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)N1Cc2cc(NC(=O)c3cccc(Cl)c3)ccc2CC1=O,"3-Chloro-N-(2-(2-methoxybenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",1.0949999999999998e-05,uM,=,-4.960585880823863,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
2591,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,CN(Cc1ccc(COc2ccc3c(CO)cc(=O)oc3c2)cc1)Cc1cccc(F)c1,7-((4-(((3-fluorobenzyl)(methyl)amino)methyl)benzyl)oxy)-4-(hydroxymethyl)-2H-chromen-2-one,0.33,uM,=,-0.4814860601221125,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
2592,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,CN(CCCN1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1)c1ccccc1,"N-(2-{4-[3-(methylanilino)propyl]piperazino}ethyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.0848,uM,=,-1.0716041477432865,0,c1ccc(NCCCN2CCN(CCNc3c4c(nc5ccccc35)CCCC4)CC2)cc1
2593,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,COc1cc(C2c3ccc4ccccc4c3Oc3nc4c(c(N)c32)CCCC4)ccc1O,"rac-4-(8-Amino-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-7-yl)-2-methoxyphenol",0.33,uM,=,-0.4814860601221125,0,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
2594,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cccc2n1cc(-c1cccc(OC(=O)N(C)C)c1)[n+]2C.[Cl-],"2-(3-(dimethylcarbamoyloxy)phenyl)-1,5-dimethylimidazo[1,2-a]pyridin-1-ium",24.0,uM,=,1.380211241711606,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
2595,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)N(Cc1ccccc1)CC2,"1-(1-Benzyl-2,3-dihydro-1H-indol-6-yl)-3-(1-benzyl-piperidin-4-yl)-propan-1-one",0.853,uM,=,-0.0690509688324769,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)N(Cc1ccccc1)CC2
2596,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),O=c1c2ccccc2nc2n1C(C1CN=Cc3[nH]c4ccccc4c31)CC2O,Nigellastrine II,40.46,uM,=,1.607025878434786,1,O=c1c2ccccc2nc2n1C(C1CN=Cc3[nH]c4ccccc4c31)CC2
2597,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1cccc(COc2c(OC)ccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)c1.[Br-],9-O-(3-methoxybenzyl)berberine bromide,3.5,uM,=,0.5440680443502757,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
2598,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2cc3c(cc21)OCO3,"(E)-6-((1-benzylpiperidin-4-yl)methylene)-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-one",0.755,uM,=,-0.1220530483708117,0,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2cc3c(cc21)OCO3
2599,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCNc1nc(NCc2ccccc2)c2ccccc2n1,"N4-(Benzyl)-N2-ethylquinazoline-2,4-diamine",7.5,uM,=,0.8750612633917001,1,c1ccc(CNc2ncnc3ccccc23)cc1
2600,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,C[n+]1ccccc1C=NO,2-(Hydroxyimino-methyl)-1-methyl-pyridinium,878.0,uM,=,2.9434945159061026,1,c1cc[nH+]cc1
2601,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2c(=O)cc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)oc2c1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-7-methoxy-4-oxo-4H-chromene-2-carboxamide,0.033,uM,=,-1.4814860601221125,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
2602,2196164,10.1016/j.ejmech.2022.114117,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate measured after 30 mins by Ellman's method,C[C@H]1CN2C(=O)[C@]34Cc5c([nH]c6c7c(ccc56)OC(C)(C)CC7=O)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4,Mangrovamide C,58.0,uM,=,1.7634279935629371,1,O=C1CCOc2ccc3c4c([nH]c3c21)C[C@@H]1C[C@]23CCCN2C(=O)[C@@]1(C4)NC3=O
2603,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NCCCCCCN2CCOCC2)c1,(6-Morpholin-4-yl-hexyl)-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0211,uM,=,-1.6757175447023074,0,O=C(NCCCCCCN1CCOCC1)Oc1cccc(CNCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1
2604,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1.Cl,Methyl-carbamic acid 3-({methyl-[9-(9-oxo-9H-xanthen-3-yloxy)-nonyl]-amino}-methyl)-phenyl ester hydrochloride,0.0116999999999999,uM,=,-1.9318141382538383,0,O=c1c2ccccc2oc2cc(OCCCCCCCCCNCc3ccccc3)ccc12
2605,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(F)cc(F)c4c(N)c3C(C1)C2,"15-ethyl-5,7-difluoro-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00176,uM,=,-2.75448733218585,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
2606,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,NC(=O)Cc1nc(NCCc2ccccc2)c2ccccc2n1,2-((4-(Phenethylamino)quinazolin-2-yl)amino)acetamide,7.3,uM,=,0.8633228601204559,1,c1ccc(CCNc2ncnc3ccccc23)cc1
2607,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1nnc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)o1,"2-(3-(4-(Piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridin-6-yl)-1,3,4-oxadiazole",0.45,uM,=,-0.3467874862246563,0,c1nnc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)o1
2608,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCC(=O)N1CCN(C(=O)CCCCCN(CC)Cc2ccccc2OC)CC1)Cc1ccccc1OC,6-[Ethyl-(2-methoxybenzyl)amino]-1-(4-{6-[ethyl-(2-methoxybenzyl) amino] hexanoyl}piperazin-1-yl)hexan-1-one,0.0257,uM,=,-1.5900668766687054,0,O=C(CCCCCNCc1ccccc1)N1CCN(C(=O)CCCCCNCc2ccccc2)CC1
2609,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CC[C@@]2(C)c3cc(OC(=O)NC(C)(C)C)ccc3C[C@@H]12,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl tert-butylcarbamate",12.487,uM,=,1.0964581117174534,1,c1ccc2c(c1)C[C@H]1NCCC21
2610,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(-n2cc(COc3ccc4ccc(=O)oc4c3)nn2)c1,"3-(4-(((2-oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)phenyl Heptylcarbamate",0.702,uM,=,-0.1536628878701947,0,O=c1ccc2ccc(OCc3cn(-c4ccccc4)nn3)cc2o1
2611,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2oc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2cc1OC,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-6,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide",0.046,uM,=,-1.337242168318426,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
2612,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,CCN(CCC(=O)NCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCCCC1,"N1-[4-(1,2,3,4-Tetrahydroacridin-9-ylamino)butyl]-3-[cyclohexyl(ethyl)amino]propanamide",0.0942,uM,=,-1.0259490972071226,0,O=C(CCNC1CCCCC1)NCCCCNc1c2c(nc3ccccc13)CCCC2
2613,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccccc12,"5-amino-8-nitro-2'-oxo-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,3'-indoline]-6-carbonitrile",4.85,uM,=,0.6857417386022636,1,O=C1Nc2ccccc2C12C=CN1CCNC1=C2
2614,28471,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.8-27.5,C#CCN(C)[C@@H](C)Cc1cccc(OC(=O)N(C)C2CCCCC2)c1,(S)-Cyclohexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,6.3,uM,=,0.7993405494535817,1,O=C(NC1CCCCC1)Oc1ccccc1
2615,2129875,10.1021/acsmedchemlett.1c00363,,,,Antagonist activity at human muscarinic acetylcholine M4 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization relative to control,Fc1ccccc1-c1ccc(N[C@H]2C[C@@H]3CN(CC4CCOCC4)C[C@@H]3C2)nn1,"(3aR,5s,6aS)-N-(6-(2-fluorophenyl)pyridazin-3-yl)-2-((tetrahydro-2H-pyran-4-yl)methyl)octahydrocyclopenta[c]pyrrol-5-amine",0.0017,uM,=,-2.7695510786217263,0,c1ccc(-c2ccc(N[C@H]3C[C@@H]4CN(CC5CCOCC5)C[C@@H]4C3)nn2)cc1
2616,1443169,10.1016/j.ejmech.2014.09.081,,,,Inhibition of human erythrocyte AChE preincubated for 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0116999999999999,uM,=,-1.9318141382538383,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2617,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,N#CC(C#N)=C1Nc2ccccc2N1CCNCc1ccc(CN2CCCCC2)o1,"2-(1-{2-[(5-Piperidin-1-ylmethyl-furan-2-ylmethyl)-amino]-ethyl}-1,3-dihydro-benzoimidazol-2-ylidene)-malononitrile",0.073,uM,=,-1.136677139879544,0,C=C1Nc2ccccc2N1CCNCc1ccc(CN2CCCCC2)o1
2618,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCCCCN3CCc4ccccc4C3)nn2)cc1,"[4-(3,4-Dihydro-1H-isoquinolin-2-yl)-butyl]-(6-phenyl-pyridazin-3-yl)-amine",15.0,uM,=,1.1760912590556811,1,c1ccc(-c2ccc(NCCCCN3CCc4ccccc4C3)nn2)cc1
2619,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CN1c2ccc(OC(=O)Nc3ccccc3)cc2[C@]2(C)CC[N@@+](C)([O-])[C@H]12.Cl,"1-Hydroxy-1,3a,8-trimethyl-5-phenylcarbamoyloxy-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium: Hydrochloride",0.2,uM,=,-0.6989700043360187,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+][C@@H]1N2
2620,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,CCOc1ccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3ccc([N+](=O)[O-])cc3)cn2)cc1,2-(2-(4-ethoxyphenyl)-2-oxoethyl)-N-methyl-N-(3-(4-nitrophenoxy)propyl)pyrimidine-5-carboxamide,6.4,uM,=,0.8061799739838872,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
2621,28629,10.1021/jm981101z,,,,Inhibitory concentration against acetylcholinesterase (AChE) from human erythrocytes,CN(CCCCCNc1ccc(-c2ccccc2)nn1)Cc1ccccc1.Cl,"N-Benzyl-N-methyl-N'-(6-phenyl-pyridazin-3-yl)-pentane-1,5-diamine hydrochloride",0.93,uM,=,-0.0315170514460648,0,c1ccc(CNCCCCCNc2ccc(-c3ccccc3)nn2)cc1
2622,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCCNC(=O)c4sc(-c5ccnc(NC(=O)C6CC6)c5)nc4OC)c2c1)CCCC3,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-methoxy-N-(3-((7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)thiazole-5-carboxamide",0.038,uM,=,-1.42021640338319,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1
2623,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2F)CC1)c1ccc2c(c1)NCCCC2,"3-[1-(2-Fluoro-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.331,uM,=,-0.4801720062242812,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
2624,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCc2ccc(-c3ccc(CSCc4ccc(CN(C)C)o4)cc3)cc2)o1,{5-[4'-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanylmethyl)-biphenyl-4-ylmethylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.18,uM,=,-0.744727494896694,0,c1coc(CSCc2ccc(-c3ccc(CSCc4ccco4)cc3)cc2)c1
2625,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,Nc1c2c(nc3cc(Br)ccc13)CCCC2,"6-Bromo-1,2,3,4-tetrahydro-acridin-9-ylamine",0.066,uM,=,-1.1804560644581312,0,c1ccc2nc3c(cc2c1)CCCC3
2626,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(Cn2cc(COc3ccc4ccc(=O)oc4c3)nn2)c1,"3-((4-(((2-Oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)phenyl Heptylcarbamate",1.044,uM,=,0.0187004986662433,1,O=c1ccc2ccc(OCc3cn(Cc4ccccc4)nn3)cc2o1
2627,2245163,10.1016/j.bmc.2022.116660,,,,Inhibition of Human AChE by Ellman's method,CCCCC1OC(=O)c2cc(OCc3ccc(CN4CCOCC4)c(O)c3)ccc21,3-butyl-6-((3'-hydroxy-4'-(morpholinomethyl)benzyl)oxy)isobenzofuran-1(3H)-one,3.32,uM,=,0.5211380837040362,1,O=C1OCc2ccc(OCc3ccc(CN4CCOCC4)cc3)cc21
2628,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccc(Cl)cc2Cl)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1ccc(Cl)cc1Cl,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(2,4-dichlorobenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",3.33,uM,=,0.5224442335063199,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2629,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,COc1cccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)c1,(2-{4-[7-(benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-(3-methoxyphenyl)-methanone,127.0,uM,=,2.103803720955957,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
2630,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,C[C@@H]1[C@@H]2CC[C@@H]3C(=CC[C@]4(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]34C)C=C2CC[C@@H]1N(C)C,31-demethylbuxaminol,25.8,uM,=,1.4116197059632305,1,C1=C2CCCC[C@@H]2CC[C@@H]2C1=CCC1CCCC12
2631,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COC(=O)Nc1ccc2n(c1)cc(-c1ccccc1)[n+]2C.[Cl-],"6-(methoxycarbonylamino)-1-methyl-2-phenylimidazo[1,2-a]pyridin-1-ium",50.0,uM,=,1.6989700043360187,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
2632,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cccc(N2CCN(C(=O)/C=C/c3ccc(O)c(OC)c3)CC2)c1,(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-(3-methoxyphenyl)piperazin-1-yl)prop-2-en-1-one,9.91,uM,=,0.9960736544852752,1,O=C(/C=C/c1ccccc1)N1CCN(c2ccccc2)CC1
2633,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CN1CCN(C2CCN(C(=O)COc3ccc(-c4ccccc4)cc3)CC2)CC1,"2-([1,1'-Biphenyl]-4-yloxy)-1-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)ethanone",10.0,uM,=,1.0,1,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCNCC2)CC1
2634,2114062,10.1016/j.bmcl.2021.128100,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by DTNB-reagent based Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c3C(C1)C2.Cl.Cl,,0.0226999999999999,uM,=,-1.6439741428068773,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1
2635,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(F)ccc4c(N)c3C(C1)C2,"(+)-15-ethyl-7-fluoro-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00211,uM,=,-2.6757175447023074,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
2636,2213907,10.1016/j.ejmech.2021.113949,,,,Inhibition of human AChE,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCCCC1=N2,"2-(3-(piperidin-1-yl)propoxy)-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazoline",0.82,uM,=,-0.0861861476162833,0,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCCCC1=N2
2637,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccc(Cl)cc2Cl)C(=O)[C@@]2(C1)[C@H](c1ccc(Cl)cc1Cl)CN(C)[C@]21C(=O)Nc2ccccc21,"(+/-)-1-Methyl-4-(2,4-dichlorophenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(2,4-dichlorophenylmethylidene)-1''-N-acrolylpiperidin-4''-one",6.14,uM,=,0.7881683711411677,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
2638,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-4-(1H-indol-3-yl)-butyramide",0.0003,uM,=,-3.522878745280338,0,O=C(CCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
2639,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1OC,"(4-((benzyl(methyl)amino)methyl)phenyl)(3,4-dimethoxyphenyl)methanone",0.46,uM,=,-0.3372421683184259,0,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
2640,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Cc1cc2c(c(C)c1CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)[C@@H](C)[C@H]2O,"(2S,3R)-pteroside C",9.17,uM,=,0.9623693356700213,1,O=C1CCc2ccc(CCO[C@H]3CCCCO3)cc21
2641,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,O=S1(=O)CCN(c2nccc(NCc3ccccc3)n2)CC1,"4-[4-(benzylamino)pyrimidin-2-yl]thiomorpholine-1,1-dioxide",24.2,uM,=,1.383815365980431,1,O=S1(=O)CCN(c2nccc(NCc3ccccc3)n2)CC1
2642,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(CCCOc2ccc3c(=O)c4ccccc4oc3c2)C(C)C)c1,3-((isopropyl(3-(9-oxo-9H-xanthen-3-yloxy)propyl)amino)methyl)phenyl hexylcarbamate,0.17,uM,=,-0.7695510786217261,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
2643,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-((methyl(10-(9-oxo-9H-xanthen-3-yloxy)decyl)amino)methyl)phenyl methylcarbamate,0.0218,uM,=,-1.6615435063953952,0,O=c1c2ccccc2oc2cc(OCCCCCCCCCCNCc3ccccc3)ccc12
2644,28309,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.012-0.014,CN(C)C(=O)Oc1cccc2c1CCC2N(C)C.Cl,Dimethyl-carbamic acid 1-dimethylamino-indan-4-yl ester hydrochloride,0.013,uM,=,-1.8860566476931635,0,c1ccc2c(c1)CCC2
2645,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccc(Cl)cc1Cl)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(2,4-Dichlorophenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",19.48,uM,=,1.2895889525425968,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
2646,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,COc1ccc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc1,"4a,12a-Dihydroxy-9-(4-methoxy-phenyl)-4,4,6a,12b-tetramethyl-4a,6,6a,12,12a,12b-hexahydro-4H,5H-7,10-dioxa-benzo[a]anthracene-1,11-dione",0.026,uM,=,-1.585026652029182,0,O=C1C=CCC2CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC3C12
2647,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1cc(C#N)c(NC2CCN(Cc3ccccc3)CC2)nc1Cl,"2-((1-Benzylpiperidin-4-yl)amino)-6-chloropyridine-3,5-dicarbonitrile",5.35,uM,=,0.7283537820212285,1,c1ccc(CN2CCC(Nc3ccccn3)CC2)cc1
2648,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccccc1C(=O)OCC)C(=O)C(F)(F)F,"Ethyl 2-[(2Z)-2-(1-ethoxy-4,4,4-trifluoro-1,3-dioxobutan-2-ylidene)hydrazinyl]benzoate",0.481,uM,=,-0.3178549236261682,0,c1ccccc1
2649,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2,"3-(1-Benzyl-piperidin-4-yl)-1-(2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.02,uM,=,-1.6989700043360187,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
2650,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCCSCc2ccc(CN(C)C)o2)o1,{5-[3-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-propylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.33,uM,=,-0.4814860601221125,0,c1coc(CSCCCSCc2ccco2)c1
2651,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,(E)-4-(3-(4-benzylpiperidin-1-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl diphenylcarbamate,32.1,uM,=,1.506505032404872,1,O=C(/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)cc1)N1CCC(Cc2ccccc2)CC1
2652,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)cc2oc1=O,"3,4-dimethyl-7-((1-(3-(trifluoromethyl)benzyl)piperidin-4-yl)methoxy)-2H-chromen-2-one",0.47,uM,=,-0.3279021420642826,0,O=c1ccc2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2o1
2653,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[4-(9-oxo-9H-xanthen-3-yloxy)-butyl]-amino}-methyl)-phenyl ester,0.037,uM,=,-1.431798275933005,0,O=c1c2ccccc2oc2cc(OCCCCNCc3ccccc3)ccc12
2654,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,CC(C)Cc1cc(N)c2c(C(F)(F)F)cc(-c3ccccc3)nc2n1,"2-Isobutyl-7-phenyl-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",19.09,uM,=,1.2808059283936668,1,c1ccc(-c2ccc3cccnc3n2)cc1
2655,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,CS(=O)(=O)[O-].CS(=O)(=O)[O-].NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1,(E)-1-(((4-carbamoylpyridinium-1-yl)methoxy)methyl)-2-((hydroxyimino)methyl)pyridinium methanesulfonate,636.0,uM,=,2.803457115648414,1,c1cc[n+](COC[n+]2ccccc2)cc1
2656,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(CCCN(C)C)CC3)nc12,3-(4-(3-(Dimethylamino)propyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,0.41,uM,=,-0.3872161432802645,0,O=C(CCN1CCNCC1)Nc1nc2ccccc2s1
2657,2273297,10.1039/D1MD00217A,,,,Inhibition of AChE (unknown origin),COc1cc(CO)ccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,vanilloloside,4.55,uM,=,0.6580113966571124,1,c1ccc(O[C@H]2CCCCO2)cc1
2658,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCCCCCN(C)Cc1cccc(O)c1,1-(12-((3-hydroxybenzyl)(methyl)amino)dodecyl)-5-methoxy-1H-indo1e-3-carbaldehyde,76.52,uM,=,1.8837749613552583,1,c1ccc(CNCCCCCCCCCCCCn2ccc3ccccc32)cc1
2659,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc([N+](=O)[O-])c3)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(3-nitrobenzyl)pyridin-1-ium bromide",0.0036,uM,=,-2.4436974992327127,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
2660,1641224,,,,,AChE/BuChE Inhibition Assay: The cholinesterase assays were performed using colorimetric method reported by Ellman. The appearance of product was monitored at 412 nm for 5 min using a spectrophotometer. The reaction rates were compared and the percent inhibition due to the presence of test compounds was calculated. Inhibition curve was obtained for each compound. The linear regression parameters were determined and the IC50 values extrapolated.,COc1ccc2nc(NCCc3cc[n+](Cc4ccccc4)cc3)sc2c1,"US9255091, 4a",0.186,uM,=,-0.7304870557820837,0,c1ccc(C[n+]2ccc(CCNc3nc4ccccc4s3)cc2)cc1
2661,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,COC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](C)c1.[I-],5-(dimethylcarbamoyloxy)-3-(methoxycarbonyl)-1-methylquinolinium iodide,0.02,uM,=,-1.6989700043360187,0,c1ccc2[nH+]cccc2c1
2662,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0189,uM,=,-1.723538195826756,0,c1ccc2c(c1)N[C@H]1NCCC21
2663,28150,10.1021/jm00043a012,,,,Evaluated for the in vitro inhibition of the Acetylcholinesterase (AChE) from human erythrocytes,C(=C\C1CCN(Cc2ccccc2)CC1)\c1noc2ccccc12,3-[(Z)-2-(1-Benzyl-piperidin-4-yl)-vinyl]-benzo[d]isoxazole,0.21,uM,=,-0.6777807052660807,0,C(=C\C1CCN(Cc2ccccc2)CC1)\c1noc2ccccc12
2664,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CNc2ccc(Cn3cncn3)cc2)c1,"(E)-3-((4-((1H-1,2,4-triazol-1-yl)methyl)phenylamino)methyl)-2-hydroxy-5-methylbenzaldehyde oxime",3255.0,uM,=,3.512550992904211,1,c1ccc(CNc2ccc(Cn3cncn3)cc2)cc1
2665,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2F)CC1)c1ccc2c(c1)CCN2,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(2-fluoro-benzyl)-piperidin-4-yl]-propan-1-one",0.043,uM,=,-1.3665315444204136,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
2666,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),O=C(O)C1=Nc2ccccc2CN1,"2-Carboxyl-3,4-dihydroquinazoline",344.8,uM,=,2.537567257152676,1,C1=Nc2ccccc2CN1
2667,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CCCCCCCNC(=O)Oc1cccc2c1OCC1CCN(C)C21,"Heptyl-carbamic acid 1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalen-6-yl ester",0.0203,uM,=,-1.692503962086787,0,c1ccc2c(c1)OCC1CCNC21
2668,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCCCCC[n+]1cccc2ccccc21,"1,1'-oct-1,8-diyl-bis(quinolinium)dibromide",0.08,uM,=,-1.0969100130080565,0,c1ccc2c(c1)ccc[n+]2CCCCCCCC[n+]1cccc2ccccc21
2669,1718355,10.1016/j.ejmech.2017.08.051,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured over 5 mins by UV-Vis spectrophotometric analysis,COc1cc2c(cc1OC)C(=O)/C(=C/C1CCN(Cc3cc(N=[N+]=[N-])c4ccccc4n3)CC1)C2,"(E)2-((1-((4-Azidoquinolin-2-yl)methyl)piperidin-4-yl)methylene)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",4.88,uM,=,0.6884198220027107,1,O=C1/C(=C/C2CCN(Cc3ccc4ccccc4n3)CC2)Cc2ccccc21
2670,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,Cc1ccc2c(c1)C1(C(=O)N2)C(C#N)=C(N)N2CCNC2=C1[N+](=O)[O-],"5-amino-5'-methyl-8-nitro-2'-oxo-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,3'-indoline]-6-carbonitrile",3.86,uM,=,0.5865873046717549,1,O=C1Nc2ccccc2C12C=CN1CCNC1=C2
2671,1337582,10.1021/np400978x,,,,Inhibition of human AChE by spectrophotometry,CC[C@H]1[C@H](C[C@H](C)C(=O)OC)O[C@]23CC[C@@H]([C@@H]4C[C@H](C)C(=O)O4)N2CCCC[C@H]13,Stichoneurine F,71.5,uM,=,1.8543060418010808,1,O=C1CC[C@@H]([C@@H]2CC[C@]34OCC[C@H]3CCCCN24)O1
2672,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Brc1ccc(/C=N\C2CCN(Cc3ccccc3)C2)cc1,N-(1-Benzylpyrrolidin-3-yl)-1-(4-bromophenyl)methanimine,1.3030000000000002,uM,=,0.1149444157125847,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
2673,2114062,10.1016/j.bmcl.2021.128100,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by DTNB-reagent based Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2.Cl,(+/-)-huprine Y-HCl,0.00164,uM,=,-2.785156151952302,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
2674,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,C=CC[N+](C)(C)c1ccc(CCC(=O)CCc2ccc([N+](C)(C)CC=C)cc2)cc1.[Br-].[Br-],"1,5-bis(4-isopropylphenyl)pentan-3-one",0.03,uM,=,-1.5228787452803376,0,O=C(CCc1ccccc1)CCc1ccccc1
2675,1584962,10.1021/acs.jmedchem.6b00078,,,,Inhibition of AChE (unknown origin),Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,"5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide",0.93,uM,=,-0.0315170514460648,0,c1ccc(Nc2nccc(Nc3ccc4c[nH]nc4c3)n2)cc1
2676,1507558,10.1016/j.bmcl.2015.05.002,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CN(Cc1ccccc1)Cc1ccc(/C=C2\Cc3ccc(OCCCCCN4CCC(c5ccccc5)CC4)cc3C2=O)cc1,"(E)-2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-[(5-(4-phenylpiperidin-1-yl)pentyloxy)]-2,3-dihydro-1H-inden-1-one",62.0,uM,=,1.792391689498254,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccc(OCCCCCN3CCC(c4ccccc4)CC3)cc21
2677,327131,10.1021/jm050746d,,,,Inhibition of human AChE,COc1ccc2[nH]cc(CCNC(=O)CCCCCCNc3c4c(nc5cc(Cl)cc(Cl)c35)CCCC4)c2c1,"7-(6,8-dichloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide",4e-05,uM,=,-4.3979400086720375,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
2678,2211577,10.1021/acs.jnatprod.1c01155,,,,Inhibition of AChE in human Erythrocyte incubated for 20 mins by Ellman reagent based spectrophotometry,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.27,uM,=,-0.5686362358410126,0,c1ccc2nc3c(cc2c1)CCCC3
2679,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.05,uM,=,-1.3010299956639813,0,c1ccc2nc3c(cc2c1)CCCC3
2680,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccccc2F)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(3-(1-(2-fluorobenzyl)piperidin-4-yl)propoxy)thiazole-5-carboxamide,1.32,uM,=,0.1205739312058498,1,O=C(Nc1cc(-c2nc(OCCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
2681,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccc(F)cc1,"2-(7-(4-Fluorobenzylamino)heptyl)isoindoline-1,3-dione",0.437,uM,=,-0.3595185630295782,0,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
2682,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(NCCCCCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1,"N1-phenyl-N12-(1,2,3,4-tetrahydroacridin-9-yl)dodecane-1,12-diamine",0.261,uM,=,-0.583359492661719,0,c1ccc(NCCCCCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
2683,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,Brc1ccc(-[n+]2ccc3ccccc3c2)cc1.[Br-],2-(4-Bromophenyl)isoquinolin-2-ium bromide,2.39,uM,=,0.3783979009481377,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
2684,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,Cc1ccccc1NC(=O)Oc1ccc2c(c1)C1(C)COC(C1)O2,"o-Tolyl-carbamic acid 1-methyl-8,10-dioxa-tricyclo[7.2.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.056,uM,=,-1.2518119729937995,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1COC(C1)O2
2685,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,COc1ccc(C(CN(C)c2ccc(NCc3cc(C)cc(/C=N/O)c3O)cc2)C2(O)CCCCC2)cc1,(E)-2-hydroxy-3-((4-((2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)(methyl)amino)phenylamino)methyl)-5-methylbenzaldehyde oxime,1256.0,uM,=,3.0989896394011773,1,c1ccc(CNc2ccc(NCC(c3ccccc3)C3CCCCC3)cc2)cc1
2686,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,O=C1C(=O)N(Cc2ccc(Br)cc2)c2ccc(Br)cc21,"5-bromo-1-(4-bromobenzyl)indoline-2,3-dione",0.08913,uM,=,-1.0499760934766735,0,O=C1C(=O)N(Cc2ccccc2)c2ccccc21
2687,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Cc1ccc(/C=N/NC(=O)N2CCN(c3ccccn3)CC2)cc1,N'-(4-Methylbenzylidene)-4-(pyridine-2-yl)piperazine-1-carbohydrazide,4.78,uM,=,0.6794278966121189,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
2688,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,O=C(Nc1cc(Cl)nc(Cl)c1)OCCCCCNCc1c[nH]c2ccccc12,"5-(((1H-indol-3-yl)methyl)amino)pentyl-(2,6-dichloropyridin-4-yl)carbamate",0.648,uM,=,-0.1884249941294066,0,O=C(Nc1ccncc1)OCCCCCNCc1c[nH]c2ccccc12
2689,28624,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in human red blood cell,Nc1c2c(nc3ccccc13)CCCC2O,"9-Amino-1,2,3,4-tetrahydro-acridin-1-ol ; Maleate",0.702,uM,=,-0.1536628878701947,0,c1ccc2nc3c(cc2c1)CCCC3
2690,452431,10.1021/jm701225u,,,,Inhibition of human serum recombinant AChE by Ellman's method,c1ccc2c(NCCOCCOCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N-(2-(2-(2-(5,6,7,8-tetrahydroacridin-9-ylamino)ethoxy)ethoxy)ethyl)-5,6,7,8-tetrahydroacridin-9-amine",0.0197,uM,=,-1.705533773838407,0,c1ccc2c(NCCOCCOCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
2691,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(OC1Cc2c(O)cc(O)cc2OC1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,"2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate",28.0,uM,=,1.4471580313422192,1,O=C(OC1Cc2ccccc2OC1c1ccccc1)c1ccccc1
2692,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OC(F)(F)F)cc23)cc1,N-Hydroxy-4-(2-trifluoromethoxyacridin-9-ylamino)benzamide,3.65,uM,=,0.5622928644564748,1,c1ccc(Nc2c3ccccc3nc3ccccc23)cc1
2693,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)Nc1cccc2n1cc(-c1cccc(OC(=O)N(C)C)c1)[n+]2C.[Cl-],"5-acetamido-2-(3-(dimethylcarbamoyloxy)phenyl)-1-methylimidazo[1,2-a]pyridin-1-ium",2.5,uM,=,0.3979400086720376,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
2694,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(OC)cc2)C[C@@H](c2ccc(C)cc2)N(c2ccc(OC)cc2)[C@@H]1c1ccc(C)cc1,"(2R,6S)-methyl 1-(4-methoxyphenyl)-4-(4-methoxyphenylamino)-2,6-dip-tolyl-1,2,5,6-tetrahydropyridine-3-carboxylate",5840.0,uM,=,3.7664128471124,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
2695,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cc2c(cc1O)C(=O)/C(=C/C1CCN(Cc3ccccc3)CC1)C2,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-6-hydroxy-5-methoxy-2,3-dihydro-1H-inden-1-one",1.54,uM,=,0.1875207208364631,1,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
2696,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,"2-(5-(Benzyl(methyl)amino)pentyl)isoindoline-1,3-dione hydrochloride",0.361,uM,=,-0.4424927980943421,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
2697,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,Cc1ccccc1CN1CCC(CNC(=O)c2cncc(NC(=O)c3ccnc(NC(=O)C4CC4)c3)c2)CC1,5-(2-(Cyclopropanecarboxamido)isonicotinamido)-N-((1-(2-methylbenzyl)piperidin-4-yl)methyl)nicotinamide,4.093,uM,=,0.6120417446452695,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
2698,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CC(C)N1Cc2cc(O)ccc2N(C)C1c1ccccc1,"3-iso-Propyl-1-methyl-2-phenyl-1,2,3,4-tetrahydroquinazolin-6-ol",253.0,uM,=,2.403120521175818,1,c1ccc(C2NCc3ccccc3N2)cc1
2699,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,4-(benzofuran-2-yl)-1-(4-methoxybenzyl)piperidine,92.81,uM,=,1.9675947726718896,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
2700,2114062,10.1016/j.bmcl.2021.128100,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by DTNB-reagent based Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c3C(C1)C2.Cl.Cl,,0.0116999999999999,uM,=,-1.9318141382538383,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1
2701,744973,10.1016/j.bmcl.2010.12.093,,,,Inhibition of human serum AChE,O=C1C=C(NCCCCCCNCc2ccc(-c3nc4ccccc4s3)cc2)C(=O)C=C1NCCCCCCNCc1ccc(-c2nc3ccccc3s2)cc1,"2,5-bis(6-(4-(benzo[d]thiazol-2-yl)benzylamino)hexylamino)cyclohexa-2,5-diene-1,4-dione",0.305,uM,=,-0.5157001606532141,0,O=C1C=C(NCCCCCCNCc2ccc(-c3nc4ccccc4s3)cc2)C(=O)C=C1NCCCCCCNCc1ccc(-c2nc3ccccc3s2)cc1
2702,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Butyl-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.036,uM,=,-1.4436974992327127,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
2703,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3ccccc3F)C(=O)[C@@]3(C2)[C@H](c2ccccc2F)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(2-fluorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(2-fluorophenyl)pyrrolidine,6.18,uM,=,0.7909884750888159,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
2704,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,C[n+]1ccc2c(c1)c1ccccc1n2CCC(=O)N1c2ccccc2Sc2ccccc21.[I-],"2-methyl-5-(3-oxo-3-(10H-phenothiazin-10-yl)propyl)-5H-pyrido[4,3-b]indol-2-ium iodide",2.2,uM,=,0.3424226808222063,1,O=C(CCn1c2ccccc2c2c[nH+]ccc21)N1c2ccccc2Sc2ccccc21
2705,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,"2-(6-((2-Fluorobenzyl)(methyl)amino)hexyl)isoindoline-1,3-dione hydrochloride",1.992,uM,=,0.2992893340876799,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
2706,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCN(CCCC(F)F)CC3)cc2oc1=O,"7-((1-(4,4-difluorobutyl)piperidin-4-yl)methoxy)-3,4-dimethyl-2H-chromen-2-one",1.2,uM,=,0.0791812460476248,1,O=c1ccc2ccc(OCC3CCNCC3)cc2o1
2707,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccc(F)c(F)c2)CC1,"2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-((1-(3,4-difluorobenzyl)piperidin-4-yl)methoxy)-N-methylthiazole-5-carboxamide",80.0,uM,=,1.9030899869919435,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
2708,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(Cl)cc(/C=N/O)c3O)CC1)CC2,"5-chloro-3-((4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",636.7,uM,=,2.803934849863842,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1
2709,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,C[n+]1ccccc1C=NO.[I-],2-(Hydroxyimino-methyl)-1-methyl-pyridinium iodide,995.7,uM,=,2.9981285071282664,1,c1cc[nH+]cc1
2710,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CC1,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-(cyclopropylmethoxy)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)thiazole-5-carboxamide",0.3116,uM,=,-0.5064025509994731,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CC1
2711,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCN(C)Cc1cccc(O)c1,1-(8-((3-hydroxybenzyl)(methyl)amino)hexyl)-5-methoxy-1H-indole-3-carbaldehyde,2.6,uM,=,0.414973347970818,1,c1ccc(CNCCCCCCCCn2ccc3ccccc32)cc1
2712,305184,10.1016/j.bmcl.2004.10.067,,,,Inhibitory concentration against Acetylcholinesterase activity,COc1ccc(-c2cc3c(c(=O)o2)C[C@@]2(O)[C@@]4(C)CCC(=O)OC(C)(C)[C@@]4(O)CC[C@@]2(C)O3)cc1,"13a-hydroxy-10-(4-methoxyphenyl)-5,5,5a,7a,13b-pentamethyl-1,2,3,5a,6,7,7a,13,13a,13b-decahydro-5H,12H-oxepino[4,3-f]pyrano[4,3-b]chromene-3,12-dione",2.5,uM,=,0.3979400086720376,1,O=C1CCC2C(CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC32)CO1
2713,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(4-((1,2,3,4-tetrahydroacridin-9-yl)amino)butyl)chroman-2-carboxamide",0.95,uM,=,-0.0222763947111522,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
2714,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CN1CCN(CCCNC(=O)COc2ccc(I)cc2)CC1,2-(4-iodophenoxy)-N-(3-(4-methylpiperazin-1-yl)propyl)acetamide,138.0,uM,=,2.1398790864012365,1,O=C(COc1ccccc1)NCCCN1CCNCC1
2715,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCNc3ccc(-c4ccccc4)nn3)CC2)cc1,[2-(1-Benzyl-piperidin-4-yl)-ethyl]-(6-phenyl-pyridazin-3-yl)-amine,0.12,uM,=,-0.9208187539523752,0,c1ccc(CN2CCC(CCNc3ccc(-c4ccccc4)nn3)CC2)cc1
2716,1668099,10.1016/j.bmcl.2017.04.006,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition by Ellman's method,COc1ccc(CNc2c3c(nc4cc(Cl)ccc24)CCCC3)cc1OC,"6-chloro-N-(3,4-dimethoxybenzyl)-1,2,3,4-tetrahydroacridin-9-amine",0.8,uM,=,-0.0969100130080563,0,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
2717,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1cccc(C[n+]2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2)c1.[Br-],4-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-(3-methylbenzyl)pyridin-1-ium bromide,2.7,uM,=,0.4313637641589873,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
2718,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2oc(C(=O)NCC3CCN(Cc4ccccc4)CC3)cc(=O)c2c1,N-((1-benzylpiperidin-4-yl)methyl)-6-methoxy-4-oxo-4H-chromene-2-carboxamide,3.61,uM,=,0.557507201905658,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
2719,430856,10.1021/jm0503289,,,,Inhibition of human AChE-induced beta amyloid peptide(1-40) aggregation by thioflavin T-based fluorometric assay,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-3-(1H-indol-3-yl)-propionamide",6.0,uM,=,0.7781512503836436,1,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
2720,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](CC3CCCCC3)cc1C(C)=O)C2=O.[I-],"3-Acetyl-1-(cyclohexylmethyl)-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium iodide",0.21,uM,=,-0.6777807052660807,0,O=C1c2ccccc2CCC1Cc1cc[n+](CC2CCCCC2)cc1
2721,2185504,10.1016/j.bmc.2021.116143,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's colorimetric method,Oc1cc2c(cc1O)-c1cc3ccc(O)c(O)c3c[n+]1CC2.[Br-],"2,3,9,10-Tetrahydroxy-5,6-dihydro-isoquino[3,2-a]isoquinolinylium bromide",2.3,uM,=,0.3617278360175928,1,c1ccc2c(c1)CC[n+]1cc3ccccc3cc1-2
2722,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(F)cc23)cc1,N-Hydroxy-4-(2-fluoroacridin-9-ylamino)benzamide,0.6,uM,=,-0.2218487496163563,0,c1ccc(Nc2c3ccccc3nc3ccccc23)cc1
2723,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CCCSc1nc(-c2ccc(Cl)cc2)nn1C(=O)N(C)C,"3-(4-Chloro-phenyl)-5-propylsulfanyl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.3,uM,=,-0.5228787452803376,0,c1ccc(-c2nc[nH]n2)cc1
2724,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCCCOc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(5-diethylaminopentyloxy)indan-1-one,0.19,uM,=,-0.721246399047171,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
2725,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,CCCCCCCCC1OCc2c[n+](C)c(C)c(OC(=O)N(C)C)c2CO1.[Br-],"1,5-Dihydro-3-octyl-7,8-dimethyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",1.3,uM,=,0.1139433523068367,1,c1cc2c(c[nH+]1)COCOC2
2726,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0308,uM,=,-1.5114492834995557,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2727,2221647,10.1016/j.bmcl.2022.128602,,,,Inhibition of AChE (unknown origin),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@]1(C)N2C,Physostigmine,0.0279999999999999,uM,=,-1.5528419686577808,0,c1ccc2c(c1)NC1NCCC21
2728,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCCCN(C)Cc1ccc(O)cc1,1-(10-((4-hydroxybenzyl)(methyl)amino)decyl)-5-methoxy-1H-indole-3-carbaldehyde,0.6,uM,=,-0.2218487496163563,0,c1ccc(CNCCCCCCCCCCn2ccc3ccccc32)cc1
2729,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,Cl.Cl.Nc1ccc(O)c(CN2CCOCC2)c1,4-amino-2-(morpholinomethyl)phenol dihydrochloride,270.6,uM,=,2.432327792261604,1,c1ccc(CN2CCOCC2)cc1
2730,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CCCCNC(=O)Oc1ccc2c(c1Br)c1c(n2C)/C(=N\C)CC1,"Butyl-carbamic acid 8-bromo-4-methyl-3-[(Z)-methylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",3.17,uM,=,0.5010592622177514,1,N=C1CCc2c1[nH]c1ccccc21
2731,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3ccc(Cl)cc3)C(=O)[C@@]3(C2)[C@H](c2ccc(Cl)cc2)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(4-chlorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(4-chlorophenyl)pyrrolidine,6.14,uM,=,0.7881683711411677,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
2732,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,CCN1CCN(c2ccc(C3CC(c4ccc(OC)c(OC)c4)=NN3C(C)=O)cc2)CC1,"1-(5-(4-(4-Ethylpiperazin-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",47.9,uM,=,1.6803355134145632,1,c1ccc(C2=NNC(c3ccc(N4CCNCC4)cc3)C2)cc1
2733,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,COc1ccc(NCc2ccc3c(c2)C(=O)C(=O)N3C(=O)c2ccccc2)cc1,"1-benzoyl-5-((4-methoxyphenylamino)methyl)indoline-2,3-dione",0.1698,uM,=,-0.7700623140920662,0,O=C1C(=O)N(C(=O)c2ccccc2)c2ccc(CNc3ccccc3)cc21
2734,1663576,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE (unknown origin),COC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](C)c1,5-(dimethylcarbamoyloxy)-3-(methoxycarbonyl)-1-methylquinolinium,0.02,uM,=,-1.6989700043360187,0,c1ccc2[nH+]cccc2c1
2735,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(F)c[n+]1C.F[B-](F)(F)F,5-fluoro-2-methoxy-1-methylpyridinium tetrafluoroborate,16.0,uM,=,1.2041199826559248,1,c1cc[nH+]cc1
2736,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,COc1ccccc1/C=C1\CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C(=C\c2ccccc2OC)C1=O,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-2-methoxy phenylmethylidene]tetrahydro-4''(1H)-pyridinones",15.86,uM,=,1.200303182981585,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2737,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(NCCc1c[nH]c2ccccc12)c1ccc[n+](Cc2ccccc2)c1.[Br-],3-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-benzylpyridin-1-ium bromide,30.5,uM,=,1.484299839346786,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc[n+](Cc2ccccc2)c1
2738,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3F)CC1)C2,"2-((1-(2-fluorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.032,uM,=,-1.494850021680094,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2739,1671088,10.1016/j.bmc.2017.03.058,,,,Inhibition of human AChE using acetylthiocholine as substrate by spectrophotometric analysis,CSP(C)(=O)OC1CCCCC1,O-cyclohexyl S-methyl methylphosphonothioate,70.0,uM,=,1.845098040014257,1,C1CCCCC1
2740,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,N#Cc1ccc2[nH]cc(CCC(=O)NCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c2c1,"N-[6-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-3-(5-cyano-1H-indol-3-yl)-propionamide",0.0007,uM,=,-3.154901959985743,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
2741,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccc(Br)cc3)CC2)cc(C(C)(C)C)c1O,"(E)-N-(2-(1-(4-bromobenzyl)piperidin-4-yl)ethyl)-3-(3,5-ditert-butyl-4-hydroxyphenyl)acrylamide",3.81,uM,=,0.5809249756756193,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2742,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=C(/C=C/c1ccc(OCCCCN2CCC(Cc3ccccc3)CC2)cc1)c1c(O)cc(OCCCCN2CCC(Cc3ccccc3)CC2)cc1O,"1-(4-(4-(4-benzylpiperidin-1-yl)butoxy)-2,6-dihydroxyphenyl)-3-(4-(4-(4-benzylpiperidin-1-yl)butoxy)phenyl)prop-2-en-1-one",11.9,uM,=,1.0755469613925308,1,O=C(/C=C/c1ccc(OCCCCN2CCC(Cc3ccccc3)CC2)cc1)c1ccc(OCCCCN2CCC(Cc3ccccc3)CC2)cc1
2743,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CN(CCCCCCCOc1ccc2c(c1)O/C(=C\c1cccc3ccccc13)C2=O)Cc1cccc(O)c1,6-{7-[(3-Hydroxy-benzyl)-methyl-amino]-heptyloxy}-2-[1-naphthalen-1-yl-meth-(Z)-ylidene]-benzofuran-3-one,49600.0,uM,=,4.695481676490197,1,O=C1/C(=C/c2cccc3ccccc23)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
2744,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,CC(=O)n1cc(/C=C2\CN(Cc3ccccc3)CCC2=O)c2ccccc21,3-(1-Acetyl-1H-indol-3-ylmethylene)-1-benzyl-piperidin-4-one,11.0,uM,=,1.0413926851582251,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1c[nH]c2ccccc12
2745,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)Cc6ccccc6C(F)(F)F)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"20S-[o-(trifluoromethyl)benzylamino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.011,uM,=,-1.958607314841775,0,O=C1CC2C(CC[C@@H]2CNCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
2746,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CCCCOC[n+]1ccn(C)c1/C=N/O.[Cl-],1-Butoxymethyl-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,27.5,uM,=,1.4393326938302626,1,c1c[nH+]c[nH]1
2747,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,CN(Cc1ccc(C(=O)NCCc2c[nH]c3ccccc23)cc1)Cc1ccccc1Cl,N-[2-(1H-Indol-3-yl)ethyl]-4-{[(2-chlorobenzyl)(methyl)-amino]methyl}benzamide,3.8,uM,=,0.5797835966168101,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
2748,2261374,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc(-c3cc4ccccc4oc3=O)cc2)c1,3-((methyl(7-(4-(2-oxo-2H-chromen-3-yl)phenoxy)heptyl)amino)methyl)phenyl methylcarbamate,0.0012,uM,=,-2.920818753952376,0,O=c1oc2ccccc2cc1-c1ccc(OCCCCCCCNCc2ccccc2)cc1
2749,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCNCc1cccc(Cl)c1,"2-(6-(3-Chlorobenzylamino)hexyl)isoindoline-1,3-dione",2.008,uM,=,0.3027637084729817,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
2750,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,"N2-Ethyl-N4-(phenethyl)quinazoline-2,4-diamine",7.6,uM,=,0.8808135922807914,1,c1ccc(CCNc2ncnc3ccccc23)cc1
2751,28320,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.45-1.8,CN(C)C(=O)Oc1ccc2c(c1)C(N)CC2.Cl,Dimethyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,0.76,uM,=,-0.1191864077192086,0,c1ccc2c(c1)CCC2
2752,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,COc1cc2c(cc1OC)[C@@H]1C(=O)c3ccc4c(c3O[C@@H]1CO2)C=CC(C)(C)O4,"(7aS,13aS)-13,13a-Dihydro-9,10-dimethoxy-3,3-dimethyl-3H-bis[1]benzopyrano [3,4-b:6',5'-3]pyran-7(7aH)-one",126.7,uM,=,2.102776614883441,1,O=C1c2ccc3c(c2O[C@@H]2COc4ccccc4[C@H]12)C=CCO3
2753,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(NCCN4CCCCC4)c2c1)CCCC3,"7-Methyl-N-(2-(piperidin-1-yl)ethyl)-1,2,3,4-tetrahydroacridin-9-amine",2.542,uM,=,0.4051755462179893,1,c1ccc2c(NCCN3CCCCC3)c3c(nc2c1)CCCC3
2754,410400,10.1021/jm060945c,,,,Inhibition of human erythrocyte AChE,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2NC=O,"N-{3-amino-7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2,4,6,8,10,14-hexaen-17-yl}formamide",0.098,uM,=,-1.0087739243075051,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
2755,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1Cc2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-4H-isoquinoline-1,3-dione",0.023,uM,=,-1.6382721639824072,0,O=C1Cc2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
2756,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCNC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,"5-(4-chlorophenyl)-N-ethyl-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-9-carboxamide",0.065,uM,=,-1.1870866433571443,0,c1ccc(-c2nc3ccccc3c3c2CCCN3)cc1
2757,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0145,uM,=,-1.8386319977650247,0,c1ccc2nc3c(cc2c1)CCCC3
2758,2215548,10.1016/j.ejmech.2022.114397,,,,Inhibition of AChE (unknown origin) by spectrophotometric based Ellman's method,COc1ccc(CCc2cc(=O)c3c(o2)[C@H]2O[C@H]2[C@@H](O)[C@H]3OC)cc1O,"(1aS,2S,3S,7bS)-2-hydroxy-6-(3-hydroxy-4-methoxyphenethyl)-3-methoxy-2,3-dihydro-1aH-oxireno[2,3-h]chromen-4(7bH)-one",441.6,uM,=,2.6450290647211427,1,O=c1cc(CCc2ccccc2)oc2c1CC[C@@H]1O[C@H]21
2759,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,O=c1c2ccccc2[se]n1-c1ccc(OCCN2CCCCC2)cc1,"2-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)benzo[d][1,2]selenazol-3(2H)-one",10.93,uM,=,1.0386201619497029,1,O=c1c2ccccc2[se]n1-c1ccc(OCCN2CCCCC2)cc1
2760,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(4-(6-methoxy-1-methylpyridinium-2-yl)butyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",5.5,uM,=,0.7403626894942439,1,c1ccc(CCCC[NH+]2CCc3ccccc3C2)[nH+]c1
2761,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccc2oc(-c3ccc(CN(C)Cc4ccccc4)cc3)cc(=O)c2c1,2-{4-[(benzylmethylamino)methyl]phenyl}-6-methoxychromen-4-one,18.1,uM,=,1.2576785748691846,1,O=c1cc(-c2ccc(CNCc3ccccc3)cc2)oc2ccccc12
2762,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCN(C(C)C)CC3)ccc12,2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)ethyl 4-isopropylpiperazine-1-carbodithioate,1.99,uM,=,0.2988530764097066,1,O=c1ccc2ccc(OCCSC(=S)N3CCNCC3)cc2o1
2763,1443169,10.1016/j.ejmech.2014.09.081,,,,Inhibition of human erythrocyte AChE preincubated for 15 mins by Ellman's method,COc1cc2c(cc1OCCN1CCCCC1)C(=O)/C(=C/c1ccc(N(C)C)cc1)C2,"(E)-2-(4-(dimethylamino)benzylidene)-5-methoxy-6-(2-(piperidin-1-yl)ethoxy)-2,3-dihydro-1H-inden-1-one",0.2851,uM,=,-0.54500278269054,0,O=C1/C(=C/c2ccccc2)Cc2ccc(OCCN3CCCCC3)cc21
2764,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1ccc2c(c1)C1CCN(CCC)C1C2,"1-propyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl hexylcarbamate",0.546,uM,=,-0.2628073572952627,0,c1ccc2c(c1)CC1NCCC21
2765,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,COc1ccc(C2N(C)Cc3cc(O)ccc3N2C)cc1,"2-(4-Methoxyphenyl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-ol",103.8,uM,=,2.016197353512439,1,c1ccc(C2NCc3ccccc3N2)cc1
2766,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccccc2)ccc1O,(E)-N-(2-((phenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,21.94,uM,=,1.3412366232386923,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
2767,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3c1C(c1ccc(Cl)cc1)NC(=S)N3)CCCC2,"5-amino-4-(4-chlorophenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",5.28,uM,=,0.7226339225338123,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
2768,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0082,uM,=,-2.086186147616284,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2769,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CCCn1c2c(c3c(Br)c(OC(=O)NC)ccc31)CC/C2=N/CC,"Methyl-carbamic acid 8-bromo-3-[(Z)-ethylimino]-4-propyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.23,uM,=,-0.6382721639824072,0,N=C1CCc2c1[nH]c1ccccc21
2770,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2cccc([N+](=O)[O-])c2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(3-nitrophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(3-nitrophenylmethylidene)hexahydro-1H-pyrrolizine,26.6,uM,=,1.424881636631067,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
2771,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)OCC[N+](C)(C)Cc3ccccc3)(CC1=O)C2.[Br-],,30.0,uM,=,1.4771212547196624,1,O=C1C[C@]23CC[C@@H]4C(C(=O)OCC[NH2+]Cc5ccccc5)CCCC4[C@@H]2CCC1C3
2772,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,COc1cccc(-c2nnc3sc(-c4ccoc4)nn23)c1,"6-(Furan-3-yl)-3-(3-methoxyphenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1
2773,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,2-(4-Methylpiperidin-1-yl)-N-(naphth-1-ylmethyl)pyrimidin-4-amine,25.8,uM,=,1.4116197059632305,1,c1ccc2c(CNc3ccnc(N4CCCCC4)n3)cccc2c1
2774,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNc1c2c(nc3cc(OC)ccc13)CCCC2,"Heptyl-(6-methoxy-1,2,3,4-tetrahydro-acridin-9-yl)-amine",0.46,uM,=,-0.3372421683184259,0,c1ccc2nc3c(cc2c1)CCCC3
2775,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccccc2F)ccc1O,(E)-N-(2-((2-fluorophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,17.23,uM,=,1.2362852774480284,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
2776,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc2c(c1)CCc1c-2nc2ccccc2c1N,"3-Methoxy-5,6-dihydro-benzo[c]acridin-7-ylamine",47.0,uM,=,1.6720978579357175,1,c1ccc2c(c1)CCc1cc3ccccc3nc1-2
2777,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),O=C(/C=C/c1ccc(N2CCCCC2)cc1)c1sccc1Cl,(2E)-1-(3-Chlorothiophen-2-yl)-3-(4-piperidin-1-ylphenyl)prop-2-en-1-one,0.16,uM,=,-0.7958800173440752,0,O=C(/C=C/c1ccc(N2CCCCC2)cc1)c1cccs1
2778,1922071,10.1016/j.bmc.2018.12.030,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,c1ccc(CN2CCC(Cn3cc(CSc4nc5ccccc5[nH]4)nn3)CC2)cc1,"2-(((1-((1-Benzylpiperidin-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-1H-benzo[d]imidazole",7.33,uM,=,0.865103974641128,1,c1ccc(CN2CCC(Cn3cc(CSc4nc5ccccc5[nH]4)nn3)CC2)cc1
2779,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(=O)N(C)[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4[C@]5(C)CSC(C(C)C)=N[C@H]5CC[C@@]45C[C@@]35C(=O)C[C@]12C,"N-[(1S)-1-[(1R,3R,6R,7S,8R,10S,11S,14R,15S,20S)-8-hydroxy-6,10,15-trimethyl-4-oxo-18-(propan-2-yl)-17-thia-19-azahexacyclo[12.8.0.0^{1,3}.0^{3,11}.0^{6,10}.0^{15,20}]docos-18-en-7-yl]ethyl]-N-methylacetamide",0.298,uM,=,-0.5257837359237448,0,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
2780,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCCCC2)cc1OC,(E)-2-Methoxy-4-(3-oxo-3-(piperidin-1-yl)prop-1-en-1-yl)phenyl ethyl(methyl)carbamate,10.7,uM,=,1.0293837776852095,1,O=C(/C=C/c1ccccc1)N1CCCCC1
2781,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cccc2n1cc(-c1ccc(OC(=O)N(C)C)cc1)[n+]2C.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-1,5-dimethylimidazo[1,2-a]pyridin-1-ium",1.3,uM,=,0.1139433523068367,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
2782,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3ccc(=O)oc3c2)c1,Butyl-carbamic acid 3-({methyl-[3-(2-oxo-2H-chromen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.014,uM,=,-1.853871964321762,0,O=c1ccc2ccc(OCCCNCc3ccccc3)cc2o1
2783,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]c(CCNC(=O)Cn3cc(CCCCN4CCc5cc(OC)c(OC)cc5C4CCCN4C(=O)c5ccccc5C4=O)nn3)cc2c1,"2-(4-(4-(1-(3-(1,3-dioxoisoindolin-2-yl)propyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-1H-1,2,3-triazol-1-yl)-N-(2-(5-methoxy-1H-indol-2-yl)ethyl)acetamide",173.9,uM,=,2.2402995820027125,1,O=C(Cn1cc(CCCCN2CCc3ccccc3C2CCCN2C(=O)c3ccccc3C2=O)nn1)NCCc1cc2ccccc2[nH]1
2784,28318,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.32-0.98,C#CCNC(C)Cc1cccc(OC(=O)N(C)C)c1,Dimethyl-carbamic acid 3-(2-prop-2-ynylamino-propyl)-phenyl ester,0.54,uM,=,-0.2676062401770315,0,c1ccccc1
2785,798011,10.1016/j.bmc.2011.12.042,,,,Inhibition of AChE,COc1ccccc1NCc1cc(=O)oc2cc3oc4ccccc4c3cc12,"4-((2-methoxyphenylamino)methyl)-2H-benzofuro[3,2-g]chromen-2-one",0.19,uM,=,-0.721246399047171,0,O=c1cc(CNc2ccccc2)c2cc3c(cc2o1)oc1ccccc13
2786,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CCC)[C@@H]1C2,"(3aS,8aR)-3a-methyl-1-propyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl heptylcarbamate",0.093,uM,=,-1.031517051446065,0,c1ccc2c(c1)C[C@H]1NCCC21
2787,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,COc1cc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)ccc1O,(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,8.32,uM,=,0.920123326290724,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
2788,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccccc2C)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-oxo-2-(o-tolylamino)ethyl)acrylamide,16.27,uM,=,1.2113875529368587,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
2789,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(-c3ccccc3)cc2)CC1c1ccc2c(c1)OCO2,"1-(3-([1,1'-Biphenyl]-4-yl)-5-(benzo[d][1,3]dioxol-5-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.988,uM,=,-0.0052430554123718,0,c1ccc(-c2ccc(C3=NNC(c4ccc5c(c4)OCO5)C3)cc2)cc1
2790,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1cccc(F)c1)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(3-Fluorophenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",12.24,uM,=,1.0877814178095424,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
2791,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccccc1,"N-Phenyl-2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazine-1-carbothioamide",0.61,uM,=,-0.2146701649892329,0,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccccc1
2792,1586651,10.1016/j.bmcl.2016.05.046,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay,O=C(CCCCCCCCc1ccc(O)c(O)c1)c1c(O)cccc1O,malabaricone C,1.94,uM,=,0.287801729930226,1,O=C(CCCCCCCCc1ccccc1)c1ccccc1
2793,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl,"N-[6-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)hexyl]-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.00089,uM,=,-3.050609993355087,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
2794,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(10-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)decyl)-3-(1H-indol-3-yl)propanamide",0.0219,uM,=,-1.6595558851598815,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
2795,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"N-(8-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)-5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-9-carboxamide",0.00703,uM,=,-2.153044674980176,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
2796,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(c2)O/C(=C\c2cccc4ccccc24)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(3-{2-[1-naphthalen-1-yl-meth-(Z)-ylidene]-3-oxo-2,3-dihydro-benzofuran-6-yloxy}-propyl)-amino]-methyl}-phenyl ester",6.86,uM,=,0.8363241157067517,1,O=C1/C(=C/c2cccc3ccccc23)Oc2cc(OCCCNCc3ccccc3)ccc21
2797,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,CN(C)CCOc1ccc(-c2nc3cc(Cl)ccc3[nH]2)cc1,"2-[4-(5-Chloro-1H-benzo[d]imidazol-2-yl)phenoxy]-N,N-dimethylethanamine",8.02,uM,=,0.9041743682841636,1,c1ccc(-c2nc3ccccc3[nH]2)cc1
2798,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.459,uM,=,-0.3381873144627387,0,c1ccc2nc3c(cc2c1)CCCC3
2799,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Clc1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,1-Benzyl-N-(4-chlorobenzyl)pyrrolidin-3-amine,0.178,uM,=,-0.749579997691106,0,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
2800,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1c[nH]c2ccccc12,"1H-indole-3-carboxylic acid [8-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-octyl]-amide",0.046,uM,=,-1.337242168318426,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1c[nH]c2ccccc12
2801,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Clc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-(4-Chlorophenyl)-5-(4-(pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazole",0.102,uM,=,-0.9913998282380824,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
2802,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccc(F)cc2)C[C@@H](c2ccc(Cl)cc2)N(c2ccc(F)cc2)[C@@H]1c1ccc(Cl)cc1,"(2R,6S)-ethyl 2,6-bis(4-chlorophenyl)-1-(4-fluorophenyl)-4-(4-fluorophenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",550.0,uM,=,2.740362689494244,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
2803,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc([N+](=O)[O-])c[n+]1C.F[B-](F)(F)F,2-methoxy-1-methyl-5-nitropyridinium tetrafluoroborate,7.5,uM,=,0.8750612633917001,1,c1cc[nH+]cc1
2804,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2cccc(Cl)c2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1,"N-(5-(((1-(3-chlorobenzyl)piperidin-4-yl)methyl)carbamoyl)pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide",1.306,uM,=,0.1159431769390551,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1
2805,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCN(C)C,(E)-3-(4-(4-(dimethylamino)butoxy)-3-methoxyphenyl)-N-phenylacrylamide,100.5,uM,=,2.002166061756508,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
2806,1978343,10.1016/j.bmcl.2019.126888,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1cccc(-c2ccc(/C=N/N3CC(=O)N(CCC4CCN(Cc5ccccc5)CC4)C3=O)o2)c1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-1-((5-(3-methoxyphenyl)furan-2-yl)methyleneamino)imidazolidine-2,4-dione",0.047,uM,=,-1.3279021420642825,0,O=C1CN(/N=C/c2ccc(-c3ccccc3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1
2807,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,"N4-(3,4-dimethoxyphenethyl)-N2-propylquinazoline-2,4-diamine",7.0,uM,=,0.8450980400142568,1,c1ccc(CCNc2ncnc3ccccc23)cc1
2808,2057880,10.1016/j.ejmech.2020.113124,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.048,uM,=,-1.3187587626244128,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2809,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),Cc1ccc(C2C([N+](=O)[O-])C(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1,"5'-(1H-imidazol-4-ylmethyl)-4'-nitro-3'-(p-tolyl)spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",2.02,uM,=,0.3053513694466238,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
2810,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1c(F)c[n+](C)cc1F.O=S(=O)([O-])C(F)(F)F,"N-Methyl-3,5-difluoro-4-methoxypyridinium Trifluoromethanesulfonate",54.0,uM,=,1.7323937598229686,1,c1cc[nH+]cc1
2811,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(-n4cncn4)cc3)C2)cc1OC,"1-(5-(4-(1H-1,2,4-Triazol-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",955.3,uM,=,2.9801397777457543,1,c1ccc(C2=NNC(c3ccc(-n4cncn4)cc3)C2)cc1
2812,1704268,10.1016/j.bmc.2017.05.045,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.6,uM,=,-0.2218487496163563,0,c1ccc2nc3c(cc2c1)CCCC3
2813,1331163,10.1039/C1MD00221J,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured after 10 mins by Ellman's method,O=C(Nc1cc2ccccc2oc1=O)c1ccc([N+](=O)[O-])cc1,4-nitro-N-(2-oxo-2H-chromen-3-yl)benzamide,12.89,uM,=,1.110252917353403,1,O=C(Nc1cc2ccccc2oc1=O)c1ccccc1
2814,751131,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes BChE,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(CCc4ccccc4)[C@@H]2N3C)cc1,"3alpha,8-dimethyl-1-phenethyl-1,2,3,3alpha,8,8alpha-hexahydropyrrolo[2,3-b]indol-5-yl 4-isopropylphenylcarbamate",0.006,uM,=,-2.2218487496163566,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN(CCc3ccccc3)[C@@H]1N2
2815,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCCCCCCSC(=O)OCC[N+](C)(C)C.[Cl-],(2-Heptylsulfanylcarbonyloxy-ethyl)-trimethyl-ammonium chloride,50.0,uM,=,1.6989700043360187,1,
2816,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(N)c2c1)CCCC3,7-methoxytacrine,10.0,uM,=,1.0,1,c1ccc2nc3c(cc2c1)CCCC3
2817,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2cc3cc4c(=O)c(/C=N/Nc5ccc(C(F)(F)F)cc5)coc4cc3o2)cc1,"2-(4-methoxyphenyl)-6-((2-(4-(trifluoromethyl)phenyl)hydrazineylidene)methyl)-5H-furo[3,2-g]chromen-5-one",5.4,uM,=,0.7323937598229685,1,O=c1c(/C=N/Nc2ccccc2)coc2cc3oc(-c4ccccc4)cc3cc12
2818,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccccc2)CN(Cc2ccc3ccccc3c2)C/C1=C\c1ccccc1,"(3E,5E)-3,5-dibenzylidene-1-(naphthalen-2-ylmethyl)piperidin-4-one",1.93,uM,=,0.2855573090077737,1,O=C1/C(=C/c2ccccc2)CN(Cc2ccc3ccccc3c2)C/C1=C\c1ccccc1
2819,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1,"(4-Isopropyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.76,uM,=,-0.1191864077192086,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
2820,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(C(=O)CNCC2CCN(Cc3ccccc3)CC2)cc(C(C)(C)C)c1O,"2-(((1-Benzylpiperidin-4-yl)methyl)amino)-1-(3,5-di-tertbutyl-4-hydroxyphenyl)ethan-1-one",2.44,uM,=,0.3873898263387294,1,O=C(CNCC1CCN(Cc2ccccc2)CC1)c1ccccc1
2821,1790738,10.1039/C7MD00143F,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured for 5 mins by Ellman's assay,Cn1c2nc3ccccc3c-2c(NCCCCCCNc2c3c(nc4ccccc24)CCCC3)c2ccccc21,"N1-(5-methyl-5H-indolo[2,3-b]quinolin-11-yl)-N6-(1,2,3,4-tetrahydroacridin-9-yl)hexane-1,6-diamine",0.00125,uM,=,-2.903089986991944,0,c1ccc2c(NCCCCCCNc3c4c5ccccc5nc-4[nH]c4ccccc34)c3c(nc2c1)CCCC3
2822,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCOC(=O)c1cc2c(N)c3c(nc2nc1C)CCCCCC3,"Ethyl 5-Amino-2-methyl-6,7,8,9,10,11-hexahydrocycloocta-[b][1,8]naphthyridine-3-carboxylate",1.8,uM,=,0.255272505103306,1,c1cnc2nc3c(cc2c1)CCCCCC3
2823,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3cccc(Cl)c3)cc1C(C)=O)C2.[Br-],"(+/-)-2-[[3-Acetyl-1-[(3-chlorophenyl)methyl]pyridin-1-ium-4-yl]-methyl]-5,6-dimethoxy-indan-1-one Bromide",0.00327,uM,=,-2.485452247339714,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
2824,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(Cl)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-chlorbenzyl)berberine bromide,2.5,uM,=,0.3979400086720376,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
2825,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Cc1cc2c(c(C)c1CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)C(C)(C)[C@H]2O,(3R)-Pteroside D,27.4,uM,=,1.437750562820388,1,O=C1CCc2ccc(CCO[C@H]3CCCCO3)cc21
2826,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCCCOc1ccc2c(C)cc(=O)oc2c1.O=S(=O)([O-])C(F)(F)F,2-methoxy-1-(5-(4-methyl-2-oxo-2H-chromen-7-yloxy)pentyl)-5-(trifluoromethyl)pyridinium trifluoromethanesulfonate,0.72,uM,=,-0.1426675035687315,0,O=c1ccc2ccc(OCCCCC[n+]3ccccc3)cc2o1
2827,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(O)CCC1CCN(CC2CCCCC2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-ol,1.03,uM,=,0.0128372247051722,1,c1ccc(CCCC2CCN(CC3CCCCC3)CC2)cc1
2828,969870,10.1016/j.bmcl.2013.05.092,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C,Propentofylline,6.4,uM,=,0.8061799739838872,1,O=c1[nH]c(=O)c2[nH]cnc2[nH]1
2829,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)CCN6C(=O)c7ccccc7C6=O)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"2-{2-[[16alpha-hydroxy-4beta,14alpha-dimethyl-11-oxo-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-20S-yl](methyl)amino]ethyl}-1H-isoindole-1,3(2H)-dione",0.07,uM,=,-1.154901959985743,0,O=C1c2ccccc2C(=O)N1CCNC[C@H]1CCC2C1CC(=O)[C@@]13C[C@@]14CC[C@@H]1N=CSCC1[C@@H]4CC[C@@H]23
2830,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CCN(CC)C(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"(S)-5-Diethylcarbamoyloxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",40.0,uM,=,1.6020599913279625,1,c1ccc2c(c1)NC1NCCC21
2831,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,C[C@H]1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)OCC[N+](C)(C)C)[C@@H]2CC[C@]1(Cl)C3.[I-],,34.0,uM,=,1.5314789170422551,1,C1CC[C@H]2CC[C@]34CCC(CC[C@H]3C2C1)C4
2832,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCCN(CCCO)C3)cc2oc1=O,"7-{[1-(3-Hydroxypropyl)piperidin-3-yl]methoxy}-3,4-dimethyl-2H-chromen-2-one",1.1,uM,=,0.041392685158225,1,O=c1ccc2ccc(OCC3CCCNC3)cc2o1
2833,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3ncccc13)OCCC2,"3,4-Dihydro-2H-1-oxa-8,9-diaza-anthracen-10-ylamine",6.262,uM,=,0.7967130632808964,1,c1cnc2nc3c(cc2c1)CCCO3
2834,1766084,10.1021/acs.jnatprod.8b00461,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by Ellman's method,CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C(C(C)(C)C(=O)O)C4=CC(=O)O[C@](O)(C[C@]12C)[C@@]43C,Colocynthenin A,2.6,uM,=,0.414973347970818,1,O=C1C=C2C=CC[C@H]3C4CCCC4CC(O1)C23
2835,28330,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.28-3.30,C#CCNC1CCc2ccc(OC(=O)N(C)Cc3ccccc3)cc21.Cl,Benzyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,1.78,uM,=,0.250420002308894,1,O=C(NCc1ccccc1)Oc1ccc2c(c1)CCC2
2836,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,CC[C@H](C)C(=O)OCCCc1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1,"(S)-3-(2-(benzo[d][1,3]dioxol-5-yl)benzofuran-5-yl)propyl 2-methylbutanoate",6.1,uM,=,0.785329835010767,1,c1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1
2837,1298092,10.1016/j.ejmech.2014.02.045,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCCCOc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1)Cc1ccccc1,7-((6-(Benzyl(ethyl)amino)hexyl)oxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one,5.8,uM,=,0.7634279935629373,1,O=c1c(-c2ccccc2)coc2cc(OCCCCCCNCc3ccccc3)ccc12
2838,1735876,10.1021/acs.jnatprod.7b00892,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate pretreated for 15 mins followed by substrate addition and measured by DTNB reagent based assay,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",13.9,uM,=,1.1430148002540952,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
2839,1620689,10.1021/acs.jmedchem.6b00967,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,O=C(COc1ccccc1)N1CCN(C2CCN(Cc3ccccc3)CC2)CC1,1-(1-benzyl-4-piperidinyl)-4-(phenoxyacetyl)piperazine,43.0,uM,=,1.6334684555795866,1,O=C(COc1ccccc1)N1CCN(C2CCN(Cc3ccccc3)CC2)CC1
2840,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(I)cc3)cc12.[Br-],2-(4-iodophenyl)-8-methoxyisoquinolinium bromide,0.72,uM,=,-0.1426675035687315,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
2841,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CC(C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-(1-methyl-prop-2-ynyloxymethyl)-3H-imidazol-1-ium chloride,11.9,uM,=,1.0755469613925308,1,c1c[nH+]c[nH]1
2842,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(C)CCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-((methyl(5-(9-oxo-9H-xanthen-3-yloxy)pentyl)amino)methyl)phenyl hexylcarbamate,0.1,uM,=,-1.0,0,O=c1c2ccccc2oc2cc(OCCCCCNCc3ccccc3)ccc12
2843,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCCC(C)n1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-(pentan-2-yl)-1H-pyrazol-4-yl)ethan-1-one",0.158,uM,=,-0.8013429130455774,0,c1cn[nH]c1
2844,1776929,10.1016/j.bmcl.2018.07.019,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate by UV-visible spectrophotometric Ellman's method,COc1ccc2c(c1)C/C(=C/c1ccccc1-c1ccc3nc(N)ccc3c1)C2=O,"2-(2-(2-Aminoquinolin-6-yl)benzylidene)-5-methoxy-2,3-dihydro-1H-inden-1-one",0.0147,uM,=,-1.832682665251824,0,O=C1/C(=C\c2ccccc2-c2ccc3ncccc3c2)Cc2ccccc21
2845,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CNc3ccc(-c4ccccc4)nn3)CC2)cc1,N-((1-benzylpiperidin-4-yl)methyl)-6-phenylpyridazin-3-amine,56.0,uM,=,1.7481880270062005,1,c1ccc(CN2CCC(CNc3ccc(-c4ccccc4)nn3)CC2)cc1
2846,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,C[C@]12CC[C@H](O)[C@@](C)(CO)C1C[C@H](O)[C@@]1(C)Oc3cc(-c4ccccc4)oc(=O)c3C(=O)C21,"3,6-Dihydroxy-4-hydroxymethyl-4,6a,12b-trimethyl-9-phenyl-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-7,10-dioxa-benzo[a]anthracene-11,12-dione",99.0,uM,=,1.99563519459755,1,O=C1c2c(cc(-c3ccccc3)oc2=O)OC2CCC3CCCCC3C12
2847,1786413,10.1039/C7MD00449D,,,,Inhibition of human serum AChE,Fc1ccc2c(C3CCN(CCN4CCCCC4)CC3)noc2c1,6-fluoro-3-(1-(2-(piperidin-1-yl)ethyl)piperidin-4-yl)benzo[d]isoxazole,2.22,uM,=,0.3463529744506387,1,c1ccc2c(C3CCN(CCN4CCCCC4)CC3)noc2c1
2848,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(F)cc2)C[C@@H](c2ccc(F)cc2)N(c2ccc(F)cc2)[C@@H]1c1ccc(F)cc1,"(2R,6S)-methyl 1,2,6-tris(4-fluorophenyl)-4-(4-fluorophenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",3200.0,uM,=,3.505149978319906,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
2849,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cccc[n+]1C.F[B-](F)(F)F,2-methoxy-1-methylpyridinium tetrafluoroborate,46.0,uM,=,1.662757831681574,1,c1cc[nH+]cc1
2850,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCc1cc(N2CCC=N2)ccc1C(=O)O/N=C(\N)c1ccc(C(F)(F)F)cc1,"N'-(4-(4,5-dihydro-1H-pyrazol-1-yl)-2-propylbenzoyloxy)-4-(trifluoromethyl)benzimidamide",13.0,uM,=,1.1139433523068367,1,O=C(ON=Cc1ccccc1)c1ccc(N2CCC=N2)cc1
2851,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CC/N=C1/CCc2c1n(C)c1ccc(OC(=O)NC)c(Cl)c21,"Methyl-carbamic acid 8-chloro-3-[(Z)-ethylimino]-4-methyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.16,uM,=,-0.7958800173440752,0,N=C1CCc2c1[nH]c1ccccc21
2852,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,C[Si](C)(C)c1cccc(C(=O)C(F)(F)F)c1,ZIFROSILONE,0.0929,uM,=,-1.0319842860063582,0,c1ccccc1
2853,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1cccc2c1C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O,"4-Amino-2-[2-(1-benzyl-piperidin-4-yl)-ethyl]-isoindole-1,3-dione",0.011,uM,=,-1.958607314841775,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
2854,1276071,10.1021/jm401047q,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.534,uM,=,-0.2724587429714435,0,c1ccc2nc3c(cc2c1)CCCC3
2855,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(CCN1CCOCC1)Nc1n[nH]c2ncccc12,"3-Morpholino-N-(1H-pyrazolo[3,4-b]pyridin-3-yl)propanamide",0.275,uM,=,-0.5606673061697374,0,O=C(CCN1CCOCC1)Nc1n[nH]c2ncccc12
2856,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(c1ccccc1)c1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O,"5-Benzoyl-2-[2-(1-benzyl-piperidin-4-yl)-ethyl]-isoindole-1,3-dione",0.0024,uM,=,-2.619788758288394,0,O=C(c1ccccc1)c1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O
2857,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3ccc(Cl)cc13)OCCC2,"6-Chloro-3,4-dihydro-2H-1-oxa-9-aza-anthracen-10-ylamine",9.81,uM,=,0.9916690073799486,1,c1ccc2nc3c(cc2c1)CCCO3
2858,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2[se]n(-c3ccc(CN4CCCC4)cc3)c(=O)c2cc1OC,"5,6-Dimethoxy-2-(4-(pyrrolidin-1-ylmethyl)phenyl)benzo[d][1,2]selenazol-3(2H)-one",4.31,uM,=,0.6344772701607315,1,O=c1c2ccccc2[se]n1-c1ccc(CN2CCCC2)cc1
2859,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)ccc1O,(E)-1-(4-benzylpiperazin-1-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one,13.34,uM,=,1.1251558295805302,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
2860,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CC(=O)Nc1cc(-c2nc(OCC3CC3)c(C(=O)NCCCNc3c4c(nc5ccccc35)CCCC4)s2)ccn1,"2-(2-acetamidopyridin-4-yl)-4-(cyclopropylmethoxy)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)thiazole-5-carboxamide",0.3936,uM,=,-0.4049449102406961,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1sc(-c2ccncc2)nc1OCC1CC1
2861,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccccc3C)cc12.[Br-],8-Methoxy-2-(o-toly)isoquinolin-2-ium bromide,2.89,uM,=,0.4608978427565479,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
2862,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2oc(CN(CCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4ccccc4o3)cc2c1,"N1,N1-Bis(benzofuran-2-ylmethyl)-N6-(2,3-dihydro-1Hcyclopenta[b]quinolin-9-yl)hexane-1,6-diamine",2.07,uM,=,0.3159703454569177,1,c1ccc2oc(CN(CCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4ccccc4o3)cc2c1
2863,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,COc1ccc2[nH]cc(CCCN3CCN(C(=O)CN4CCN(C(=O)c5cccc(F)c5)CC4)CC3)c2c1,2-(4-(3-fluorobenzoyl)piperazin-1-yl)-1-(4-(3-(5-methoxy-1H-indol-3-yl)propyl)piperazin-1-yl)ethanone,37.3,uM,=,1.5717088318086876,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
2864,1849549,10.1016/j.bmc.2019.07.001,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1cccc(NCc2ccc(Oc3c(N)cccc3Cl)cc2)c1,N-(4-(2-amino-6-chlorophenoxy)benzyl)-3-methoxyaniline,5.65,uM,=,0.7520484478194386,1,c1ccc(NCc2ccc(Oc3ccccc3)cc2)cc1
2865,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CNC(NCCNCc1ccc(CN(C)C)o1)=C(C#N)C#N,2-({2-[(5-Dimethylaminomethyl-furan-2-ylmethyl)-amino]-ethylamino}-methylamino-methylene)-malononitrile,0.63,uM,=,-0.2006594505464183,0,c1ccoc1
2866,2076989,10.1039/d1md00105a,,,,Inhibition of human AChE,O=c1ccoc2ccc(OCCCCCN3CCCC3)cc12,6-(5-(pyrrolidin-1-yl)pentyloxy)-4H-chromen-4-one,7.2,uM,=,0.8573324964312685,1,O=c1ccoc2ccc(OCCCCCN3CCCC3)cc12
2867,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(c3ccccc3)C(=O)C2C12C(=O)c1ccccc1C2=O,"2'-Methyl-5'-phenyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",69.8,uM,=,1.8438554226231607,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
2868,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc(OC)c1OC,"(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)acrylamide",0.234,uM,=,-0.6307841425898572,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
2869,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccc(Cl)cc2Cl)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,"(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(2,4-dichlorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(2,4-dichloro phenylmethylidene)hexahydro-1H-pyrrolizine",6.96,uM,=,0.8426092396105621,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
2870,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Oc1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,4-(((1-Benzylpyrrolidin-3-yl)amino)methyl)phenol,1.7480000000000002,uM,=,0.2425414282983843,1,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
2871,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(NCCN4CCOCC4)c2c1)CCCC3,"7-Methyl-N-(2-morpholinoethyl)-1,2,3,4-tetrahydroacridin-9-amine",0.131,uM,=,-0.8827287043442358,0,c1ccc2c(NCCN3CCOCC3)c3c(nc2c1)CCCC3
2872,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N\O)Nc1ccc[n+](CCCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],"1,1'-(pentane-1,5-diyl)bis(3-((Z)-2-(hydroxyimino)acetamido)pyridinium)dibromide",1790.0,uM,=,3.2528530309798933,1,c1cc[n+](CCCCC[n+]2ccccc2)cc1
2873,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),CC(C)=CCC/C(C)=C/Cc1c(O)ccc2cc(-c3cc(O)cc(O)c3CC=C(C)C)oc12,mulberrofuran D,23.05,uM,=,1.362670929725667,1,c1ccc(-c2cc3ccccc3o2)cc1
2874,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)C2(C)COC(C2)O3)cc1,"(4-Isopropyl-phenyl)-carbamic acid 1-methyl-8,10-dioxa-tricyclo[7.2.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",4.3,uM,=,0.6334684555795865,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1COC(C1)O2
2875,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,CC(=O)N1OC(C)(C)CC(c2ccccc2)=C1CN1C(=O)c2ccccc2C1=O,"2-[(2-Acetyl-6,6-dimethyl-4-phenyl-5,6-dihydro-2H-1,2-oxazin-3-yl)methyl]-1H-isoindole-1,3(2H)-dione",2.5,uM,=,0.3979400086720376,1,O=C1c2ccccc2C(=O)N1CC1=C(c2ccccc2)CCON1
2876,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1cc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)ccn1,"3-(4-(Piperidin-1-ylmethyl)phenyl)-6-(pyridin-4-yl)-9H-pyrrolo-[2,3-b:5,4-c']dipyridine",0.777,uM,=,-0.1095789811990857,0,c1cc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)ccn1
2877,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21,10H-Phenoselenazin-10-yl-(phenyl)methanone,5.4,uM,=,0.7323937598229685,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
2878,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,CN1CCN(c2c3c(nc4ccc([N+](=O)[O-])cc24)CCCC3)CC1,"9-(4-Methylpiperazin-1-yl)-7-nitro-1,2,3,4-tetrahydroacridine",0.245,uM,=,-0.6108339156354675,0,c1ccc2c(N3CCNCC3)c3c(nc2c1)CCCC3
2879,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(Br)cc2)CC1c1ccc(-c2ccccc2)cc1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(4-bromophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.903,uM,=,-0.0443122496864941,0,c1ccc(C2=NNC(c3ccc(-c4ccccc4)cc3)C2)cc1
2880,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,O=C(Nc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)s1)C1CCN(Cc2ccc(F)cc2Cl)CC1,"1-(2-Chloro-4-fluorobenzyl)-N-[4,5-bis(4-chlorophenyl)-thiazol-2-yl]piperidine-4-carboxamide",3.7,uM,=,0.568201724066995,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
2881,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,Ethylestrenol,6.504,uM,=,0.8131805325860118,1,C1=C2CC[C@@H]3[C@H](CCC4CCC[C@H]43)[C@H]2CCC1
2882,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(c3ccc(Br)cc3)C(=O)C2C12C(=O)c1ccccc1C2=O,"5'-(4-Bromophenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",73.32,uM,=,1.8652224562901791,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
2883,462117,10.1021/jm7009364,,,,Inhibition of human AchE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-3-(1H-indol-3-yl)-propionamide",6e-05,uM,=,-4.221848749616356,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
2884,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CCC(C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-(1-methyl-but-3-ynyloxymethyl)-3H-imidazol-1-ium chloride,8.72,uM,=,0.9405164849325672,1,c1c[nH+]c[nH]1
2885,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.15,uM,=,-0.8239087409443188,0,c1ccc2c(c1)N[C@H]1NCCC21
2886,2245163,10.1016/j.bmc.2022.116660,,,,Inhibition of Human AChE by Ellman's method,CCCCC1OC(=O)c2cc(OCc3ccc(CN(CC)CC)c(O)c3)ccc21,3-butyl-6-((3'-hydroxy-4'-((diethylamino)methyl)benzyl)oxy)isobenzofuran-1(3H)-one,0.35,uM,=,-0.4559319556497244,0,O=C1OCc2ccc(OCc3ccccc3)cc21
2887,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,CN1CCN(C(C#N)c2ccc3c(c2)OCO3)CC1,"rac-2-(3,4-Dioxymethylenphenyl)-2-(4-methylpiperazin-1-yl)acetonitrile",275.3,uM,=,2.4398062113933303,1,c1cc2c(cc1CN1CCNCC1)OCO2
2888,2247136,10.1021/acs.jmedchem.1c02150,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 240 sec by Ellman's method,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCCC(=O)N4CCC(NC(=O)Nc5ccc(OC(F)(F)F)cc5)CC4)c3[C@H](C1)C2,"(-)-(7S,11S)-1-{1-{5-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]pentanoyl}-piperidin-4-yl}-3-[4-(trifluoromethoxy)phenyl]urea",0.0019399999999999,uM,=,-2.712198270069774,0,O=C(Nc1ccccc1)NC1CCN(C(=O)CCCCNc2c3c(nc4ccccc24)C[C@H]2C=CC[C@@H]3C2)CC1
2889,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,N#Cc1ccc(CN2CCC(Nc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)s3)CC2)cc1,"4-Cyanobenzyl-N-[4,5-bis(4-chlorophenyl)thiazol-2-yl]-piperidin-4-ylamine",1.02,uM,=,0.0086001717619175,1,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
2890,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1,(2-Morpholin-4-yl-ethyl)-(6-phenyl-pyridazin-3-yl)-amine (2HCl),1000.0,uM,=,3.0,1,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1
2891,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CN(C)CCOc1ccc(/C=C2\COc3ccccc3C2=O)cc1,(E)-3-(4-(2-(dimethylamino)ethoxy)benzylidene)chroman-4-one,0.657,uM,=,-0.1824346304402192,0,O=C1/C(=C/c2ccccc2)COc2ccccc21
2892,1274971,10.1016/j.ejmech.2013.09.050,,,,Inhibition of acetylcholinesterase (unknown origin) by Ellman's method,CCn1c(=O)n(C)s/c1=N\CCC1CCN(Cc2ccccc2)CC1,"5-(2-(1-benzylpiperidin-4-yl)ethylimino)-4-ethyl-2-methyl-1,2,4-thiadiazolidin-3-one",0.14,uM,=,-0.8538719643217619,0,O=c1[nH]s/c(=N\CCC2CCN(Cc3ccccc3)CC2)[nH]1
2893,1922071,10.1016/j.bmc.2018.12.030,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2ncnc(NCc3cn(CC4CCN(Cc5ccccc5)CC4)nn3)c2cc1OC,"N-((1-((1-Benzylpiperidin-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl)-6,7-dimethoxyquinazolin-4-amine",3.94,uM,=,0.5954962218255742,1,c1ccc(CN2CCC(Cn3cc(CNc4ncnc5ccccc45)nn3)CC2)cc1
2894,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,"2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-[3,4,5-trihydroxy-6-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxymethyl)-tetrahydro-pyran-2-yloxy]-chromen-4-one",0.012,uM,=,-1.9208187539523751,0,O=c1c(O[C@H]2CCC[C@@H](CO[C@H]3CCCCO3)O2)c(-c2ccccc2)oc2ccccc12
2895,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,C=CC[N+](C)(C)c1ccccc1OC.[Br-],Allyl-(2-methoxy-phenyl)-dimethyl-ammonium bromide,1.0,uM,=,0.0,0,c1ccccc1
2896,2264452,10.1039/d1md00394a,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate preincubated for 15 mins followed by substrate addition and measured after 5 mins by DTNB reagent based Ellman's method,COc1ccc(-c2cc3cc4c(=O)c(C=O)coc4cc3o2)cc1,"2-(4-methoxyphenyl)-5-oxo-5H-furo[3,2-g]chromene-6-carbaldehyde",10.0,uM,=,1.0,1,O=c1ccoc2cc3oc(-c4ccccc4)cc3cc12
2897,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl.Cl.Cl.Cl,"(+/-)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-((9-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]nonyl)amino)-7,11-methanocycloocta[b]quinoline dihydrochloride",0.00326,uM,=,-2.486782399932061,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
2898,1790738,10.1039/C7MD00143F,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured for 5 mins by Ellman's assay,Cn1c2nc3ccccc3c-2c(NCCCCNc2c3c(nc4ccccc24)CCCC3)c2ccccc21,"N1-(5-methyl-5H-indolo[2,3-b]quinolin-11-yl)-N4-(1,2,3,4-tetrahydroacridin-9-yl)butane-1,4-diamine",0.053,uM,=,-1.275724130399211,0,c1ccc2c(NCCCCNc3c4c5ccccc5nc-4[nH]c4ccccc34)c3c(nc2c1)CCCC3
2899,2164642,10.1021/acs.jmedchem.1c01748,,,,Inhibition of recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells using acetylthiocholine iodide as substrate measured for 6 mins by Ellman's method,OC[C@H]1O[C@@H](OCCCCc2cn(CCCc3ccc(O)c(/C=N/O)n3)nn2)[C@H](O)[C@@H](O)[C@@H]1O,"(E)-3-hydroxy-6-(3-(4-(4-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)butyl)-1H-1,2,3-triazol-1-yl)propyl)picolinaldehyde oxime",1600.0,uM,=,3.204119982655925,1,c1ccc(CCCn2cc(CCCCO[C@H]3CCCCO3)nn2)nc1
2900,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),COc1cccc(C2C([N+](=O)[O-])C(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)c1,"5'-(1H-imidazol-4-ylmethyl)-3'-(3-methoxyphenyl)-4'-nitro-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",9.2,uM,=,0.9637878273455552,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
2901,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1,"N-(7-((2,3-Dihydro-1H-cyclopenta[b]quinolin-9-yl)amino)heptyl)-benzofuran-2-carboxamide",0.0486,uM,=,-1.3133637307377066,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1
2902,2215278,10.1016/j.bmc.2022.116742,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2nc3c(c(N)c2c1)C1CC=CC(C3)C1,,2.63,uM,=,0.4199557484897578,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
2903,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCN3CCCCC3)nc2)cc1,5-phenyl-N-(piperidin-1-ylmethyl)pyridin-2-amine,13.0,uM,=,1.1139433523068367,1,c1ccc(-c2ccc(NCN3CCCCC3)nc2)cc1
2904,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4ccccc4o3)cc2c1,"N1,N1-Bis(benzofuran-2-ylmethyl)-N7-(7,8,9,10-tetrahydro-6Hcyclohepta[b]quinolin-11-yl)heptane-1,7-diamine",0.2,uM,=,-0.6989700043360187,0,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4ccccc4o3)cc2c1
2905,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,Clc1ccc2c(c1)Nc1ccccc1[Se]2,2-Chloro-10H-phenoselenazine,6.3,uM,=,0.7993405494535817,1,c1ccc2c(c1)Nc1ccccc1[Se]2
2906,2261397,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human AChE,C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21.C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21,Ladostigil,1000.0,uM,=,3.0,1,c1ccc2c(c1)CCC2.c1ccc2c(c1)CCC2
2907,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCOc1ccc2c(C)cc(=O)oc2c1.O=S(=O)([O-])C(F)(F)F,2-methoxy-1-(3-(4-methyl-2-oxo-2H-chromen-7-yloxy)propyl)-5-(trifluoromethyl)pyridinium trifluoromethanesulfonate,3.6,uM,=,0.5563025007672873,1,O=c1ccc2ccc(OCCC[n+]3ccccc3)cc2o1
2908,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(CCN2C(=O)c3ccccc3C2=O)CC1,"2-[2-(1-Methyl-piperidin-4-yl)-ethyl]-isoindole-1,3-dione",0.0009,uM,=,-3.0457574905606752,0,O=C1c2ccccc2C(=O)N1CCC1CCNCC1
2909,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccc(Cl)cc4)ccc3N(C)C12,"(S)-5-(4-Chloro-phenylcarbamoyloxy)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",1.7999999999999998,uM,=,0.255272505103306,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
2910,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCCNC(=NC#N)NCCSCc2ccc(CN(C)C)o2)o1,N-((5-Ethylsulfanylmethyl-furan-2-ylmethyl)-dimethyl-amine)l-N-[1-(((5-Ethylsulfanylmethyl-furan-2-ylmethyl)-dimethyl-amine)amino)-2-cynovinyl]amine,0.29,uM,=,-0.5376020021010439,0,N=C(NCCSCc1ccco1)NCCSCc1ccco1
2911,1849549,10.1016/j.bmc.2019.07.001,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Nc1cccc(Cl)c1Oc1ccc(CNc2cccc(O)c2)cc1,3-((4-(2-amino-6-chlorophenoxy)benzyl)amino)phenol,7.23,uM,=,0.8591382972945308,1,c1ccc(NCc2ccc(Oc3ccccc3)cc2)cc1
2912,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,O=C(NCCCCCc1ccccc1)Oc1cccc(Cn2cc(COc3ccc4ccc(=O)oc4c3)nn2)c1,"3-((4-(((2-Oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)phenyl(5-Phenylpentyl)carbamate",0.922,uM,=,-0.0352690789463706,0,O=C(NCCCCCc1ccccc1)Oc1cccc(Cn2cc(COc3ccc4ccc(=O)oc4c3)nn2)c1
2913,2123405,10.1016/j.ejmech.2021.113735,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.018,uM,=,-1.744727494896694,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2914,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,CCN(Cc1ccccc1)Cc1ccc(-c2cc3cc(OC)c(OC)cc3oc2=O)cc1,"3-{4-[(benzylethylamino)methyl]phenyl}-6,7-dimethoxychromen-2-one",0.0183,uM,=,-1.7375489102695705,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
2915,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)CCCc1ccccc1-2,"6,7-Dihydro-5H-8-aza-benzo[3,4]cyclohepta[1,2-b]naphthalen-13-ylamine",38.2,uM,=,1.582063362911709,1,c1ccc2c(c1)CCCc1nc3ccccc3cc1-2
2916,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,Cl.Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine hydrochloride",0.205,uM,=,-0.6882461389442457,0,c1ccc2nc3c(cc2c1)CCCC3
2917,2245163,10.1016/j.bmc.2022.116660,,,,Inhibition of Human AChE by Ellman's method,CCCCC1OC(=O)c2cc(OCc3ccc(CN4CCCC4)c(O)c3)ccc21,3-butyl-6-((3'-hydroxy-4'-(pyrrolidin-1-ylmethyl)benzyl)oxy)isobenzofuran-1(3H)-one,3.92,uM,=,0.5932860670204573,1,O=C1OCc2ccc(OCc3ccc(CN4CCCC4)cc3)cc21
2918,462117,10.1021/jm7009364,,,,Inhibition of human AchE,CCN(CCCCCC(=O)N1CCC(C2CCN(C(=O)CCCCCN(CC)Cc3ccccc3OC)CC2)CC1)Cc1ccccc1OC,"6-[ethyl-(2-methoxy-benzyl)-amino]-1-(1'-{6-[ethyl-(2-methoxy-benzyl)-amino]-hexanoyl}-[4,4']bipiperidinyl-1-yl)-hexan-1-one",0.0033,uM,=,-2.4814860601221125,0,O=C(CCCCCNCc1ccccc1)N1CCC(C2CCN(C(=O)CCCCCNCc3ccccc3)CC2)CC1
2919,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CO[C@@H](C1)O2,"(+)-(5R)-5-methyl-4,5-dihydro-2,5-methano-1,3-benzodioxepin-7-yl N-Ethylcarbamate",2.42,uM,=,0.3838153659804312,1,c1ccc2c(c1)O[C@@H]1CC2CO1
2920,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccc(Cl)cc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1ccc(Cl)cc1,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(4-chlorobenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",3.36,uM,=,0.5263392773898441,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
2921,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(C(=O)c2ccccc2)CC1,(4-Methyl-piperidin-1-yl)-phenyl-methanone,10.0,uM,=,1.0,1,O=C(c1ccccc1)N1CCCCC1
2922,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC(C)C1CCN(c2nccc(NCc3ccccc3)n2)CC1,N-Benzyl-2-(4-isopropylpiperidin-1-yl)pyrimidin-4-amine,14.2,uM,=,1.1522883443830565,1,c1ccc(CNc2ccnc(N3CCCCC3)n2)cc1
2923,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2cc(O)ccc21,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-5-hydroxy-2,3-dihydro-1H-inden-1-one",2.16,uM,=,0.3344537511509309,1,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
2924,2261382,10.1016/j.ejmech.2022.114606,,,,Inhibition of human whole red blood cells AChE using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CC(=O)N1CC[C@@]2(O)c3cc(OC(=O)Nc4ccccc4)ccc3N[C@@H]12,"[(3aS,8bR)-3-acetyl-8b-hydroxy-1,2,3a,4-tetrahydropyrrolo[2,3-b]indol-7-yl]N-phenylcarbamate",0.25,uM,=,-0.6020599913279624,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
2925,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,COc1ccccc1CNCCCCCCNC1=CC(=O)C(NCCCCCCNCc2ccccc2OC)=CC1=O,"2,5-bis[6-(2-methoxybenzylamino)hexylamino]-[1,4]-benzoquinone",0.123,uM,=,-0.910094888560602,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
2926,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,Cn1ncc2c1-c1c(Br)sc(Br)c1C2NC(=O)CN1CCN(Cc2ccccc2F)CC1,"N-(5,7-Dibromo-1-methyl-1,4-dihydrothieno[3',4':4,5]cyclopenta[1,2-c]pyrazol-4-yl)-2-[4-(2-fluoro-benzyl)piperazine]acetamide",0.88,uM,=,-0.0555173278498313,0,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cscc2-c2[nH]ncc21
2927,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl.O,Donepezil hydrochloride monohydrate,0.03,uM,=,-1.5228787452803376,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2928,2263067,10.1021/acs.jmedchem.2c01299,,,,Inhibition of acetylcholinesterase (unknown origin),Cn1ccc2cc(-c3cnc4ccc(C(=O)N5CCCCC5)cc4n3)ccc2c1=O,2-Methyl-6-(7-(piperidine-1-carbonyl)quinoxalin-2-yl)isoquinolin-1(2H)-one,5.4,uM,=,0.7323937598229685,1,O=C(c1ccc2ncc(-c3ccc4c(=O)[nH]ccc4c3)nc2c1)N1CCCCC1
2929,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc2c(cc1OC)C(=O)C(CCCCCCc1cccc(OC)[n+]1C)C2.O=S(=O)([O-])C(F)(F)F,"2-(6-(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)hexyl)-6-methoxy-1-methylpyridinium trifluoromethanesulfonate",0.07,uM,=,-1.154901959985743,0,O=C1c2ccccc2CC1CCCCCCc1cccc[nH+]1
2930,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CN2CCC(n3c(=O)[nH]c4cc(Cl)ccc43)CC2)c1,"(E)-3-((4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)methyl)-2-hydroxy-5-methylbenzaldehyde oxime",1905.0,uM,=,3.279894980011638,1,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccccc2)CC1
2931,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(CCc1ccccc1)N1c2ccccc2[Se]c2ccc(Cl)cc21,1-(2-Chloro-10H-phenoselenazin-10-yl)-3-phenylpropan-1-one,6.3,uM,=,0.7993405494535817,1,O=C(CCc1ccccc1)N1c2ccccc2[Se]c2ccccc21
2932,1455127,10.1016/j.bmc.2014.07.053,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins before substrate addition by Ellman method,COc1cc(CCC(=O)/C=C/CCCNc2c3c(nc4cc(Cl)ccc24)CC2CC(C)=CC3C2)ccc1O,"8-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]-1-(4-hydroxy-3-methoxyphenyl)oct-4-en-3-one",0.0067,uM,=,-2.1739251972991736,0,O=C(/C=C/CCCNc1c2c(nc3ccccc13)CC1CC=CC2C1)CCc1ccccc1
2933,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(CCN1CCCCC1)Nc1n[nH]c2ncccc12,"3-(Piperidin-1-yl)-N-(1H-pyrazolo[3,4-b]pyridin-3-yl)propanamide",0.6579999999999999,uM,=,-0.1817741063860445,0,O=C(CCN1CCCCC1)Nc1n[nH]c2ncccc12
2934,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(Cc1ccc(O)c(/C=N/O)c1)CC2,"5-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",559.3,uM,=,2.747644819328248,1,c1ccc(CN2CCc3ccccc3C2)cc1
2935,28298,10.1021/jm00015a002,,,,In vitro inhibition of Acetylcholinesterase from human erythrocytes,CN1C(=O)Cc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc21.CS(=O)(=O)O,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-7-methyl-5,7-dihydro-isoxazolo[4,5-f]indol-6-one; compound with methanesulfonic acid",0.0004799999999999,uM,=,-3.318758762624413,0,O=C1Cc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc2N1
2936,2052542,10.1016/j.ejmech.2019.111958,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,CON(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)OC)cc(OC(=O)N(C)OC)cc3o2)cc1,"2-(4-((Methoxy(methyl)carbamoyl)oxy)phenyl)-4-oxo-4H-chromene-5,7-diyl bis(methoxy(methyl)carbamate)",12.7,uM,=,1.1038037209559568,1,O=c1cc(-c2ccccc2)oc2ccccc12
2937,750449,10.1016/j.bmcl.2009.04.128,,,,Inhibition of AChE,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,Dimebolin,45.0,uM,=,1.6532125137753435,1,c1cncc(CCn2c3c(c4ccccc42)CNCC3)c1
2938,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(5-(4-((1-(phenylsulfonyl)-1H-indol-4-yl)methyl)piperazin-1-yl)pentyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",4.44,uM,=,0.6473829701146199,1,O=C1CC2CCc3ccsc3C2=NN1CCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
2939,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCN(C)Cc1cccc(O)c1,1-(7-((3-hydroxybenzyl)(methyl)amino)hexyl)-5-methoxy-1H-indole-3-carbaldehyde,5.54,uM,=,0.7435097647284298,1,c1ccc(CNCCCCCCCn2ccc3ccccc32)cc1
2940,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCCc3ccsc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1,"2-(4-(4-benzylpiperazin-1-yl)butyl)-2,4,4a,5,6,7-hexahydro-3H-thieno[3',2':6,7]cyclohepta[1,2-c]pyridazin-3-one",1.23,uM,=,0.0899051114393979,1,O=C1CC2CCCc3ccsc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1
2941,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,Oc1cccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)c1,"3-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)phenol",0.0192,uM,=,-1.7166987712964503,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
2942,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)C(=O)C(CC1CCN(CCNc3c4c(nc5cc(Cl)ccc35)CCCC4)CC1)C2.Cl.Cl.Cl,"6-Chloro-9-[(2-{4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidin-1-yl}ethyl)amino]-1,2,3,4-tetrahydroacridine dihydrochloride",0.00067,uM,=,-3.1739251972991736,0,O=C1c2ccccc2CC1CC1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1
2943,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c3ccccc32)cc1,"1-[(4-methoxyphenyl)methyl]-4-oxo-N-{4-[(1,2,3,4-tetrahydroacridin-9-yl)amino]butyl}-1,4-dihydroquinoline-3-carboxamide",0.491,uM,=,-0.3089185078770315,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
2944,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,CN(CCCC(F)F)Cc1ccc(COc2ccc3c(CO)cc(=O)oc3c2)cc1,"7-((4-(((4,4-difluorobutyl)(methyl)amino)methyl)benzyl)oxy)-4-(hydroxymethyl)-2H-chromen-2-one",0.55,uM,=,-0.2596373105057561,0,O=c1ccc2ccc(OCc3ccccc3)cc2o1
2945,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C([N+](=O)[O-])C12C(=O)Nc1ccccc12,"2'-amino-1'-benzyl-6'-(benzylamino)-5'-nitro-2-oxo-1'H-spiro[indoline-3,4'-pyridine]-3'-carbonitrile",3.96,uM,=,0.5976951859255123,1,O=C1Nc2ccccc2C12C=CN(Cc1ccccc1)C(NCc1ccccc1)=C2
2946,793322,10.1021/jm200853t,,,,Inhibition of cerebral human recombinant AchE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 10 mins measured after 15 mins of substrate addition by Ellman's method,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2n1C,N-{[5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1-methyl-1Hindol-2-yl]methyl}-N-methylprop-2-yn-1-amine,0.38,uM,=,-0.4202164033831898,0,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
2947,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1cc2ccc(OCc3ccc(CN(C)Cc4ccccc4)cc3)cc2oc1=O.Cl,7-(4-(N-Benzyl-N-methylaminomethyl)benzyloxy)-3-methyl-2H-chromen-2-one hydrochloride,0.5,uM,=,-0.3010299956639812,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
2948,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3C)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(2-methylbenzyl)pyridin-1-ium bromide",0.0058,uM,=,-2.2365720064370627,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
2949,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(1,2,3,4-tetrahydro-acridin-9-yl)-hexane-1,6-diamine",0.0014,uM,=,-2.853871964321762,0,c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
2950,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCc1cc(=NCCC2CCN(Cc3ccccc3)CC2)[nH]nc1-c1ccccc1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-6-phenyl-5-propylpyridazin-3-amine,0.061,uM,=,-1.214670164989233,0,c1ccc(CN2CCC(CCN=c3ccc(-c4ccccc4)n[nH]3)CC2)cc1
2951,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0099,uM,=,-2.00436480540245,0,c1ccc2nc3c(cc2c1)CCCC3
2952,751131,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes BChE,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,Diethyl-(1-methyl-2-phenothiazin-10-yl-ethyl)-amine,0.3,uM,=,-0.5228787452803376,0,c1ccc2c(c1)Nc1ccccc1S2
2953,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCc3noc4cc(N5CCOCC5)ccc34)CC2)cc1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-6-morpholin-4-yl-benzo[d]isoxazole,0.0008,uM,=,-3.096910013008056,0,c1ccc(CN2CCC(CCc3noc4cc(N5CCOCC5)ccc34)CC2)cc1
2954,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=c1c2ccccc2ncn1CCC1CCN(Cc2ccccc2)CC1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-3H-quinazolin-4-one,1.2,uM,=,0.0791812460476248,1,O=c1c2ccccc2ncn1CCC1CCN(Cc2ccccc2)CC1
2955,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(c3ccc([N+](=O)[O-])cc3)C(=O)C2C12C(=O)c1ccccc1C2=O,"2'-Methyl-5'-(4-nitrophenyl)-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",6.6,uM,=,0.8195439355418687,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
2956,573639,10.1021/np800671p,,,,Inhibition of AChE by spectrophotometry,C=C1C[C@]23C[C@H]1CC[C@H]2[C@]1(C)CCC[C@](C)(CO)[C@@H]1C[C@@H]3O,7-epi candicandiol,22.8,uM,=,1.3579348470004535,1,C=C1C[C@@]23CC[C@H]4CCCCC4[C@@H]2CC[C@@H]1C3
2957,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,N#Cc1ccccc1CN1CCC(C(=O)Nc2nc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3)s2)CC1,"1-(2-Cyanobenzyl)-N-[4,5-bis(4-chlorophenyl)thiazol-2-yl]-piperidine-4-carboxamide",1.77,uM,=,0.2479732663618066,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
2958,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl,"N-[8-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)octyl]-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.00138,uM,=,-2.8601209135987635,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
2959,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(Nc1ccccc1)c1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O,"2-(2-(1-benzylpiperidin-4-yl)ethyl)-1,3-dioxo-N-phenylisoindoline-5-carboxamide",0.0022,uM,=,-2.657577319177794,0,O=C(Nc1ccccc1)c1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O
2960,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12C(=O)c1ccc(Br)c3c(Br)ccc2c13,"6'-amino-5,6-dibromo-9'-nitro-2-oxo-1',2',3',4'-tetrahydro-2H-spiro[acenaphthylene-1,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",6.71,uM,=,0.8267225201689921,1,O=C1c2cccc3cccc(c23)C12C=CN1CCCNC1=C2
2961,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-5-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)-N-(4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl)pentanamide",0.0983,uM,=,-1.0074464821678644,0,O=C(CCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
2962,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),O=[N+]([O-])C1C(Cc2c[nH]cn2)NC2(c3ccccc3-c3nc4ccccc4nc32)C1c1ccccc1,"5'-(1H-imidazol-4-ylmethyl)-4'-nitro-3'-phenyl-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",11.8,uM,=,1.0718820073061257,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
2963,1641224,,,,,AChE/BuChE Inhibition Assay: The cholinesterase assays were performed using colorimetric method reported by Ellman. The appearance of product was monitored at 412 nm for 5 min using a spectrophotometer. The reaction rates were compared and the percent inhibition due to the presence of test compounds was calculated. Inhibition curve was obtained for each compound. The linear regression parameters were determined and the IC50 values extrapolated.,COc1ccc2nc(NCCc3cc[n+](Cc4ccc(F)cc4)cc3)sc2c1,"US9255091, 4b",0.223,uM,=,-0.6516951369518393,0,c1ccc(C[n+]2ccc(CCNc3nc4ccccc4s3)cc2)cc1
2964,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),O=c1c2ccccc2nc2n1C(c1cncc3[nH]c4ccccc4c13)CC2O,Nigellastrine I,70.5,uM,=,1.8481891169913989,1,O=c1c2ccccc2nc2n1C(c1cncc3[nH]c4ccccc4c13)CC2
2965,1983599,10.1016/j.bmcl.2019.126880,,,,Inhibition of human AChE using acetylthiocholine chloride as substrate peincubated for 15 mins followed by substrate addition measured at 1 min interval by Ellman's method,C#CCNc1c2c(nc3ccccc13)CCCC2,"N-(prop-2-ynyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0507,uM,=,-1.294992040666664,0,c1ccc2nc3c(cc2c1)CCCC3
2966,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CN(Cc1ccccc1)Cc1ccc(/C=C2\Cc3ccccc3C2=O)cc1,2-{4-[(Benzylmethylamino)methyl]benzylidene}indan-1-one,11.7,uM,=,1.0681858617461617,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
2967,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CC1CCN(Cc3ccc(O)c(/C=N/O)c3)CC1)CC2,"3-((4-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-4-hydroxybenzaldehyde oxime",233.7,uM,=,2.368658712392227,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3c3ccccc3)CC2)cc1
2968,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,O=C(CNCCCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"N-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-7-yl)-2-((3-phenylpropyl)amino)acetamide",0.00409,uM,=,-2.388276691992658,0,O=C(CNCCCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
2969,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](Cc2ccccc2C[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,1'-bis(4-tert.butylpyridinium)-1,2-phenyldimethylenyl dibromide",10.0,uM,=,1.0,1,c1cc[n+](Cc2ccccc2C[n+]2ccccc2)cc1
2970,2281428,10.1016/j.ejmech.2021.113492,,,,Inhibition of human recombinant AchE,CCCCCCCCCCCC1=CC(=O)C=CC1=O,"3-undecyl-1,4-benzoquinone",7.91,uM,=,0.8981764834976765,1,O=C1C=CC(=O)C=C1
2971,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,Oc1cc(/C=N/c2c3c(nc4ccccc24)CCCC3)cc(O)c1O,"(E)-N-(3',4',5'-Trihydroxybenzylidene)-1,2,3,4-tetrahydroacridin-9-amine",1.04,uM,=,0.0170333392987803,1,C(=N/c1c2c(nc3ccccc13)CCCC2)\c1ccccc1
2972,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)[C@@H]1C2,"Hexyl-carbamic acid (3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-indeno[2,1-b]pyrrol-5-yl ester",0.02,uM,=,-1.6989700043360187,0,c1ccc2c(c1)C[C@H]1NCCC21
2973,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCCCCCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(dodecylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.0367,uM,=,-1.435333935747911,0,O=c1c2ccccc2nc2n1CCC2
2974,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc2c(CNc3ccnc(N4CCCC4)n3)cccc2c1,N-(naphthalen-1-ylmethyl)-2-(pyrrolidin-1-yl)pyrimidin-4-amine,5.5,uM,=,0.7403626894942439,1,c1ccc2c(CNc3ccnc(N4CCCC4)n3)cccc2c1
2975,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2oc(C(=O)OCC3CCN(Cc4ccccc4)CC3)cc(=O)c2cc1OC,"(1-Benzylpiperidin-4-yl)methyl 6,7-dimethoxy-4-oxo-4H-chromene-2-carboxylate",0.3,uM,=,-0.5228787452803376,0,O=C(OCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
2976,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1cccc(C2CC(c3cc(F)ccc3F)=NN2c2ccc(S(N)(=O)=O)cc2)c1OC,"4-(3-(2,5-difluorophenyl)-5-(2,3-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
2977,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1C2,"(3aS,8aR)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl hexylcarbamate",0.01,uM,=,-2.0,0,c1ccc2c(c1)C[C@H]1NCCC21
2978,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCO[C@H]1N2C,"methyl-carbamic acid (3aR,8aR)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.056,uM,=,-1.2518119729937995,0,c1ccc2c(c1)N[C@@H]1OCCC21
2979,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(C2CCN(C(=O)COc3ccc(-c4ccc(OC)cc4)cc3)CC2)CC1,"1-(4-(4-Ethylpiperazin-1-yl)piperidin-1-yl)-2-((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)ethanone",18.0,uM,=,1.255272505103306,1,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCNCC2)CC1
2980,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4ccccc4I)[nH]3)ccc21,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(2-iodophenyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",310.31,uM,=,2.4917957713135914,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
2981,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1,2-(1-{2-[(5-Piperidin-1-ylmethyl-furan-2-ylmethyl)-amino]-ethyl}-imidazolidin-2-ylidene)-malononitrile,0.03,uM,=,-1.5228787452803376,0,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
2982,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1ccc2onc(CCC3CCN(Cc4ccccc4)CC3)c2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5-methyl-benzo[d]isoxazole,0.0078,uM,=,-2.10790539730952,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
2983,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.061,uM,=,-1.214670164989233,0,c1ccc2c(c1)N[C@H]1NCCC21
2984,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CC(c1cc(O)cc2oc(=O)c3ccccc3c12)N(C)C.Cl,(+/-)-1-(1-(Dimethylamino)ethyl)-3-hydroxy-6H-benzo[c]chromen-6-one hydrochloride,33.1,uM,=,1.5198279937757189,1,O=c1oc2ccccc2c2ccccc12
2985,2261407,10.1016/j.ejmech.2022.114606,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured upto 180 secs by Ellman's method,Cc1c(Cl)c(=O)oc2cc(OCCCCSC(=S)N3CCCCC3C)ccc12,4-(3-chloro-4-methyl-2-oxo-chromen-7-yl)oxybutyl 2-methylpiperidine-1-carbodithioate,0.0068,uM,=,-2.167491087293764,0,O=c1ccc2ccc(OCCCCSC(=S)N3CCCCC3)cc2o1
2986,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,FC(F)(F)c1ccc(CN2CCN(c3nccc(NCc4ccccc4)n3)CC2)cc1,N-Benzyl-2-[4-(4-trifluoromethylbenzyl)piperazin-1-yl]pyrimidin-4-amine,28.8,uM,=,1.4593924877592308,1,c1ccc(CNc2ccnc(N3CCN(Cc4ccccc4)CC3)n2)cc1
2987,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)Cc6ccc(C(F)(F)F)cc6)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"20S-[p-(trifluoromethyl)benzylamino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.003,uM,=,-2.5228787452803374,0,O=C1CC2C(CC[C@@H]2CNCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
2988,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1cc(=O)oc2cc(OCc3ccc(CN(C)Cc4ccc(C#N)cc4)cc3)ccc12.Cl,4-(((N-(4-(4-Methyl-2H-2-oxochromen-7-yl)oxymethyl)benzyl)-N-methylamino)methyl)benzonitrile hydrochloride,8.5,uM,=,0.9294189257142929,1,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
2989,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3c(Cl)cc(Cl)cc13)CCCC2,"5,7-dichloro-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",4.34,uM,=,0.6374897295125107,1,c1ccc2nc3c(cc2c1)CCCC3
2990,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc(C[n+]2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2)cc1.[Br-],4-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-(4-methylbenzyl)pyridin-1-ium bromide,5.7,uM,=,0.7558748556724915,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
2991,2156182,10.1021/acs.jnatprod.1c00400,,,,Inhibition of AChE (unknown origin),COc1c(-c2ccc(O)cc2)cc2oc3cc(O)c(O)cc3c2c1O,Peniterphenyl A,16.0,uM,=,1.2041199826559248,1,c1ccc(-c2ccc3c(c2)oc2ccccc23)cc1
2992,751129,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes AChE,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,4.15,uM,=,0.6180480967120927,1,c1ccccc1
2993,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(/C=C2\Cc3cc(OC)ccc3C2=O)cc1,(2E)-2-[[4-(diethylaminomethyl)phenyl]methylene]-5-methoxy-indan-1-one,0.113,uM,=,-0.9469215565165804,0,O=C1/C(=C/c2ccccc2)Cc2ccccc21
2994,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccc2oc(=O)c(-c3ccc(CN(C)Cc4ccccc4)cc3)cc2c1,3-{4-[(benzylmethylamino)methyl]phenyl}-6-methoxychromen-2-one,0.163,uM,=,-0.7878123955960422,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
2995,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.011,uM,=,-1.958607314841775,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
2996,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(NCC(=O)Nc2ccc3oc(=O)ccc3c2)cc1,2-(4-methoxyphenylamino)-N-(2-oxo-2H-chromen-6-yl)acetamide,0.0552,uM,=,-1.258060922270801,0,O=C(CNc1ccccc1)Nc1ccc2oc(=O)ccc2c1
2997,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1cccc2c1CC[C@H](NC(=O)N(C)C)C2,"(S)-3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylurea",0.0198999999999999,uM,=,-1.7011469235902934,0,c1ccc2c(c1)CCCC2
2998,2261363,10.1016/j.ejmech.2022.114606,,,,Inhibition of human AChE,O=C(Oc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1)N1CCCCC1,[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]piperidine-1-carboxylate,62.5,uM,=,1.7958800173440752,1,O=C(Oc1ccc2c(=O)cc(-c3ccccc3)oc2c1)N1CCCCC1
2999,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1Cc2ccccc2CN1CCC1CCN(Cc2ccccc2)CC1,"2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1,4-dihydro-2H-isoquinolin-3-one",0.017,uM,=,-1.769551078621726,0,O=C1Cc2ccccc2CN1CCC1CCN(Cc2ccccc2)CC1
3000,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCC1=C(C)Cc2c1nc1ccccc1c2N,3-Butyl-2-methyl-1H-cyclopenta[b]quinolin-9-ylamine,25.0,uM,=,1.3979400086720375,1,C1=Cc2nc3ccccc3cc2C1
3001,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,CC1(C)CNC2=C([N+](=O)[O-])C3(C(=O)Nc4ccc([N+](=O)[O-])cc43)C(C#N)=C(N)N2C1,"6'-amino-3',3'-dimethyl-5,9'-dinitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",1.54,uM,=,0.1875207208364631,1,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
3002,813758,10.1016/j.bmcl.2012.02.057,,,,Inhibition of AChE by Ellman's method,CC[C@H]1C[C@@H]2C[C@H]3c4[nH]c5cc([C@@H]6C[C@H]7C(C(=O)OC)[C@@H](Cc8c6[nH]c6ccccc86)N(C)C[C@H]7CC)ccc5c4CCN(C2)[C@@H]13,"19,20-dihydrotabernamine",0.227,uM,=,-0.6439741428068773,0,c1ccc2c3c([nH]c2c1)[C@H](c1ccc2c4c([nH]c2c1)[C@@H]1C[C@H]2CC[C@@H]1N(CC4)C2)C[C@@H]1CCN[C@H](C3)C1
3003,2224411,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 5 mins by Ellman's method,CCC1C/C(=C\c2cc(OC)c(OC)c(OC)c2Br)C(=O)c2ccccc21,"2-(2-bromo-3,4,5-trimethoxybenzylidene)-4-ethyl-3,4-dihydronaphthalen-1(2H)-one",0.045,uM,=,-1.3467874862246565,0,O=C1/C(=C/c2ccccc2)CCc2ccccc21
3004,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](Cc2ccccc2C[n+]2ccccc2)cc1,"1,1'-bis(pyridinium)-1,2-phenyldimethylene dibromide",636.0,uM,=,2.803457115648414,1,c1cc[n+](Cc2ccccc2C[n+]2ccccc2)cc1
3005,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2,"3-(1HiIndol-3-yl)-N-[5-(1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-propionamide",0.07,uM,=,-1.154901959985743,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
3006,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NCC3CCN(Cc4ccccc4C)CC3)sc2-c2ccc(C)cc2)cc1,"N-[(1-(2-Methylbenzyl)piperidin-4-yl)methyl]-4,5-bis(ptolyl)thiazol-2-ylamine",0.5,uM,=,-0.3010299956639812,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
3007,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccc2oc(=O)c(-c3cccc(CN(C)Cc4ccccc4)c3)cc2c1,3-{3-[(benzylmethylamino)methyl]phenyl}-6-methoxychromen-2-one,0.303,uM,=,-0.518557371497695,0,O=c1oc2ccccc2cc1-c1cccc(CNCc2ccccc2)c1
3008,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Cc1ccc2[nH]c3c(c2c1)CN(Cc1ccccc1)CC3,"2-benzyl-8-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole",35.1,uM,=,1.545307116465824,1,c1ccc(CN2CCc3[nH]c4ccccc4c3C2)cc1
3009,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(CCC)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Butyl-carbamic acid 3-({[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-propyl-amino}-methyl)-phenyl ester,0.07,uM,=,-1.154901959985743,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
3010,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(c3ccc(F)cc3)C(=O)C2C12C(=O)c1ccccc1C2=O,"5'-(4-Fluorophenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",50.12,uM,=,1.7000110623221123,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
3011,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,"N,N'-(3,3'-(3,3'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)bis(propane-3,1-diyl))bis(azanediyl)bis(propane-3,1-diyl))bis(2-(2-(2,6-dichlorophenylamino)phenyl)acetamide)",15.4,uM,=,1.187520720836463,1,O=C(Cc1ccccc1Nc1ccccc1)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2ccccc2)=CC1=O
3012,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Fc1ccc2c(NCCCCCCCCNc3c4c(nc5cc(F)ccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(6-fluoro-1,2,3,4-tetrahydro-acridin-9-yl)-octane-1,8-diamine",0.0007,uM,=,-3.154901959985743,0,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
3013,1586651,10.1016/j.bmcl.2016.05.046,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay,O=C(CCCCCCCCc1ccc(O)cc1)c1c(O)cccc1O,malabaricone B,1.84,uM,=,0.2648178230095365,1,O=C(CCCCCCCCc1ccccc1)c1ccccc1
3014,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,COc1ccc(C2CC(=O)c3ccc4c(c3O2)C=CC(C)(C)O4)cc1,Dorspoinsettifolin,91.07,uM,=,1.959375336575843,1,O=C1CC(c2ccccc2)Oc2c1ccc1c2C=CCO1
3015,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1,"(2-(6-(Benzylamino)hexyl)isoindoline-1,3-dione",2.105,uM,=,0.3232521001716871,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
3016,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CC1CCCCC1OC[n+]1ccn(C)c1/C=N/O.[Cl-],1-(2-Ethynyl-cyclohexyloxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,20.3,uM,=,1.307496037913213,1,c1c[n+](COC2CCCCC2)c[nH]1
3017,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCOC1N2C,"Ethyl-carbamic acid (S)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.082,uM,=,-1.0861861476162833,0,c1ccc2c(c1)NC1OCCC21
3018,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@@]1(C)CCO[C@H]1O2,"(+)-(3aR)-3a-methyl-2,3,3a,8a-Tetrahydrofuro[2,3-b]benzofuran-5-yl N-(o-Tolyl)carbamate",0.036,uM,=,-1.4436974992327127,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@H]1O2
3019,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,Cc1cc2nc3c(nc2cc1C)C1(C(C#N)=C(N)N2CC(C)(C)CNC2=C1[N+](=O)[O-])c1ccccc1-3,"6'-amino-3',3',7,8-tetramethyl-9'-nitro-1',2',3',4'-tetrahydrospiro[indeno[1,2-b]quinoxaline-11,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",4.0,uM,=,0.6020599913279624,1,C1=CC2(C=C3NCCCN13)c1ccccc1-c1nc3ccccc3nc12
3020,858577,10.1016/j.bmc.2012.09.040,,,,Inhibition of human AChE by Ellman's method,COc1cc2c(cc1OC)-c1cc3ccc(OC)c(OC)c3c[n+]1CC2.O.[Cl-],Palmatine chloride hydrate,1.69,uM,=,0.2278867046136735,1,c1ccc2c(c1)CC[n+]1cc3ccccc3cc1-2
3021,1935994,10.1021/acs.jnatprod.8b00705,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 5 mins by spectrophotometric analysis,COc1cc(O)c2c(c1)C1=C(c3c(O)c(O)cc(C)c3-c3cc(OC)cc(O)c3C(=O)O)C(=O)C(O)=CC1(C)OC2=O,(+)-Bialternacin E,15.5,uM,=,1.1903316981702914,1,O=C1C=CC2OC(=O)c3ccccc3C2=C1c1ccccc1-c1ccccc1
3022,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,Cc1ccc(C2N(C)Cc3cc(O)ccc3N2C)cc1,"1,3-Dimethyl-2-p-tolyl-1,2,3,4-tetrahydroquinazolin-6-ol",109.9,uM,=,2.0409976924234905,1,c1ccc(C2NCc3ccccc3N2)cc1
3023,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccc(F)cc1F,"2-(8-(2,4-diFluorobenzylamino)octyl)isoindoline-1,3-dione",0.578,uM,=,-0.2380721615794709,0,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1
3024,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCOC(=O)c1ccc2nc(-c3cccnc3)c3c(c2c1)NCCC3,"Ethyl 5-(3-pyridyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-9-carboxylate",22.8,uM,=,1.3579348470004535,1,c1cncc(-c2nc3ccccc3c3c2CCCN3)c1
3025,1776929,10.1016/j.bmcl.2018.07.019,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate by UV-visible spectrophotometric Ellman's method,COc1ccc2c(c1)C/C(=C/c1ccccc1-c1ccc3ccccc3c1)C2=O,"5-Methoxy-2-(2-(naphthalen-2-yl)benzylidene)-2,3-dihydro-1H-inden-1-one",0.0324,uM,=,-1.489454989793388,0,O=C1/C(=C\c2ccccc2-c2ccc3ccccc3c2)Cc2ccccc21
3026,529395,10.1021/np9905719,,,,Inhibition of AChE by microplate assay,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.98,uM,=,-0.0087739243075051,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
3027,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(10-((1,2,3,4-tetrahydroacridin-9-yl)amino)decyl)chroman-2-carboxamide",0.4533,uM,=,-0.3436142809413122,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3028,1834120,10.1021/acs.jnatprod.8b00592,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,SID144205156,0.033,uM,=,-1.4814860601221125,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
3029,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(C)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-methylbenzyl)berberine bromide,75.8,uM,=,1.8796692056320536,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
3030,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1,"4'-(4-(Benzyl(ethyl)amino)butoxy)-5,6,7-trimethoxyflavone",1.36,uM,=,0.1335389083702175,1,O=c1cc(-c2ccc(OCCCCNCc3ccccc3)cc2)oc2ccccc12
3031,826913,10.1021/ml200313p,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 90 mins before substrate addition by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,1.535,uM,=,0.1861083798132052,1,c1ccccc1
3032,2244091,10.1016/j.ejmech.2022.114152,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,c1ccc2c(NCCN3CCOCC3)c3c(nc2c1)CCCC3,"N-(2-morpholinoethyl)-1,2,3,4-tetrahydroacridin-9-amine",0.093,uM,=,-1.0315170514460648,0,c1ccc2c(NCCN3CCOCC3)c3c(nc2c1)CCCC3
3033,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(C2=NNC(NCN3CCCCC3)=NC2)cc1,"6-phenyl-N-(piperidin-1-ylmethyl)-2,5-dihydro-1,2,4-triazin-3-amine",47.0,uM,=,1.6720978579357175,1,c1ccc(C2=NNC(NCN3CCCCC3)=NC2)cc1
3034,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-phenylmethylidene]tetrahydro-4''(1H)-pyridinones",17.49,uM,=,1.2427898094786765,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
3035,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1cccc(Cl)c1,"N-(2-benzoyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-chlorobenzamide",1.323e-05,uM,=,-4.878440155812499,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
3036,1274974,10.1016/j.ejmech.2013.09.050,,,,Inhibition of acetylcholinesterase (unknown origin),CCOC(=O)C1=C(C)Oc2nc3c(c(N)c2C1c1ccc(OC)cc1)CCCC3,"ethyl 5-amino-4-(4-methoxyphenyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrano[2,3-b]quinoline-3-carboxylate",0.8679999999999999,uM,=,-0.0614802748235081,0,C1=CC(c2ccccc2)c2cc3c(nc2O1)CCCC3
3037,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.00753,uM,=,-2.1232050237992994,0,c1ccc2nc3c(cc2c1)CCCC3
3038,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN(C)C(=O)NC1CCc2cc(O)ccc2C1,"3-(6-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylurea",0.00716,uM,=,-2.1450869776921446,0,c1ccc2c(c1)CCCC2
3039,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3cccc(C)c3)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)-1-(3-methylbenzyl)pyridinium bromide",0.1105,uM,=,-0.9566377219788704,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
3040,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),c1ccc2c(c1)CN1CCCC1=N2,"1,2,3,9-Tetrahydro-pyrrolo[2,1-b]quinazoline",2.37,uM,=,0.3747483460101038,1,c1ccc2c(c1)CN1CCCC1=N2
3041,29401,10.1016/0960-894X(96)00337-X,,,,In vitro inhibitory activity against Acetylcholinesterase (AChE).,NC12CC(C(F)(F)F)=CC(Cc3nc(O)ccc31)/C2=C\C(F)(F)F,"1-Amino-13-[2,2,2-trifluoro-eth-(E)-ylidene]-11-trifluoromethyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",3.0,uM,=,0.4771212547196624,1,C=C1C2C=CCC1c1cccnc1C2
3042,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1,N-(1-Benzylpyrrolidin-3-yl)-1-phenylmethanimine,4.121,uM,=,0.6150026145245883,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
3043,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,CC#CC(C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-(1-methyl-but-2-ynyloxymethyl)-3H-imidazol-1-ium chloride,144.0,uM,=,2.1583624920952498,1,c1c[nH+]c[nH]1
3044,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1c(F)c[n+](CCCCCOc2ccc3c(C)cc(=O)oc3c2)cc1F.O=S(=O)([O-])C(F)(F)F,"3,5-difluoro-4-methoxy-1-(5-(4-methyl-2-oxo-2H-chromen-7-yloxy)pentyl)pyridinium trifluoromethanesulfonate",0.48,uM,=,-0.3187587626244128,0,O=c1ccc2ccc(OCCCCC[n+]3ccccc3)cc2o1
3045,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,(E)-2-Methoxy-4-(3-oxo-3-(piperidin-1-yl)prop-1-en-1-yl)phenyl diphenylcarbamate,27.2,uM,=,1.434568904034199,1,O=C(/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)cc1)N1CCCCC1
3046,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCNC1N2,"Methyl-carbamic acid (S)-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0109,uM,=,-1.9625735020593764,0,c1ccc2c(c1)NC1NCCC21
3047,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1ccc2nc3c(c(N)c2c1)CCC3.Cl,"7-methyl-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",10.0,uM,=,1.0,1,c1ccc2nc3c(cc2c1)CCC3
3048,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCC3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-piperidinium bromide",0.008,uM,=,-2.096910013008056,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
3049,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1ccc(-c2cn3c(C(F)(F)F)cccc3[n+]2C)cc1.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-1-methyl-5-(trifluoromethyl)imidazo[1,2-a]pyridin-1-ium",10.0,uM,=,1.0,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
3050,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,CCN(CCCCCCNC1=CC(=O)C(C)=C(C)C1=O)Cc1ccccc1OC,"5-(6-(ethyl(2-methoxybenzyl)amino)hexylamino)-2,3-dimethylcyclohexa-2,5-diene-1,4-dione",0.029,uM,=,-1.537602002101044,0,O=C1C=CC(=O)C(NCCCCCCNCc2ccccc2)=C1
3051,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.01,uM,=,-2.0,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3052,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,4-bis(4-tert.butylpyridinium)-but-1,4-diyl dibromide",3.7,uM,=,0.568201724066995,1,c1cc[n+](CCCC[n+]2ccccc2)cc1
3053,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl 5-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)pentanoate",0.00108,uM,=,-2.96657624451305,0,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
3054,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc2nc3c(c(N)c2c1)CCCCC3.Cl,"2-methoxy-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",17.6,uM,=,1.24551266781415,1,c1ccc2nc3c(cc2c1)CCCCC3
3055,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CCC)[C@@H]1C2,"(3aS,8aR)-3a-methyl-1-propyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl hexylcarbamate",0.062,uM,=,-1.207608310501746,0,c1ccc2c(c1)C[C@H]1NCCC21
3056,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12.O=C(O)C(O)C(O)C(=O)O,"Phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester; compound with 2,3-dihydroxy-succinic acid",0.024,uM,=,-1.619788758288394,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
3057,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,CC(C(=O)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O)c1ccc(-c2ccccc2)c(F)c1,"N-(3-(3-(1,4-dioxo-1,4-dihydronaphthalen-2-ylamino)propylamino)propyl)-2-(2-fluorobiphenyl-4-yl)propanamide",107.0,uM,=,2.0293837776852097,1,O=C(Cc1ccc(-c2ccccc2)cc1)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O
3058,2261999,10.1016/j.bmc.2022.117030,,,,Inhibition of human recombinant AChE using S-acetylthiocholine as substrate by DTNB reagent based spectrophotometric analysis,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",1.18,uM,=,0.0718820073061253,1,c1ccc2nc3c(cc2c1)CCCC3
3059,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@@]1(C)CCO[C@H]1N2C,"(+)-(3aR)-3a,8-dimethyl-2,3,3a,8a-tetrahydrofuro[2,3-b]indol-5-yl N-(2'-Methylphenyl)carbamate",0.142,uM,=,-0.8477116556169436,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@H]1N2
3060,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccc(F)cc3F)CC2)cc(C(C)(C)C)c1O,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(2,4-difluorobenzyl)piperidin-4-yl)ethyl)acrylamide",1.78,uM,=,0.250420002308894,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3061,430856,10.1021/jm0503289,,,,Inhibition of human AChE-induced beta amyloid peptide(1-40) aggregation by thioflavin T-based fluorometric assay,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],"3-(3,8-diamino-6-phenyl-5-phenanthridiniumyl)propyl(diethyl)methylammonium",13.0,uM,=,1.1139433523068367,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
3062,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)Nc1ccc2c(c1)CN(C(=O)c1cccc(Cl)c1)C(=O)C2,"N-(2-(3-chlorobenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)-2-methoxybenzamide",1.672e-05,uM,=,-4.776763726897003,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
3063,1331163,10.1039/C1MD00221J,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured after 10 mins by Ellman's method,Cc1ccc(C(=O)Nc2cc3cc(C)ccc3oc2=O)cc1,4-methyl-N-(6-methyl-2-oxo-2H-chromen-3-yl)benzamide,41.37,uM,=,1.6166855208955122,1,O=C(Nc1cc2ccccc2oc1=O)c1ccccc1
3064,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCCC3C)cc1)NCC2,"6,7-dimethoxy-1-(4-((6-(2-methylpiperidin-1-yl)hexyl)oxy)benzyl)-1,2,3,4-tetrahydroisoquinoline",2.2,uM,=,0.3424226808222063,1,c1ccc2c(c1)CCNC2Cc1ccc(OCCCCCCN2CCCCC2)cc1
3065,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,c1ccc2oc(C3CCNCC3)cc2c1,4-(benzofuran-2-yl)piperidine,61.18,uM,=,1.78660947264866,1,c1ccc2oc(C3CCNCC3)cc2c1
3066,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(-c2ccccc2)nnc1NCCN1CCCCC1,4-methyl-6-phenyl-N-(2-(piperidin-1-yl)ethyl)pyridazin-3-amine,5.4,uM,=,0.7323937598229685,1,c1ccc(-c2ccc(NCCN3CCCCC3)nn2)cc1
3067,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,CCN(CC)CCOc1ccc(-c2nc3cc(Cl)ccc3[nH]2)cc1,"2-[4-(5-Chloro-1H-benzo[d]imidazol-2-yl)phenoxy]-N,N-diethylethanamine",8.75,uM,=,0.9420080530223132,1,c1ccc(-c2nc3ccccc3[nH]2)cc1
3068,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1ccc2nc3c(c(N)c2c1)CCCCC3.Cl,"2-methyl-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",22.5,uM,=,1.3521825181113625,1,c1ccc2nc3c(cc2c1)CCCCC3
3069,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCCC[n+]2cccc3ccccc32)cc1,1-(10-(pyridinium-1-yl)decyl)quinoliniumdibromide,0.005,uM,=,-2.3010299956639813,0,c1cc[n+](CCCCCCCCCC[n+]2cccc3ccccc32)cc1
3070,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-N-methyl-2-(2-(2-((8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0152,uM,=,-1.818156412055228,0,O=C(CNCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
3071,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)N(C)CCC1CCN(Cc2ccccc2)CC1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-methyl-acetamide,0.66,uM,=,-0.1804560644581313,0,c1ccc(CN2CCCCC2)cc1
3072,1525144,10.1016/j.bmcl.2015.06.047,,,,Inhibition of human AChE,COc1cc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc(OC)c1O,(+)-Territrem C,0.0068,uM,=,-2.167491087293764,0,O=C1C=CCC2CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC3C12
3073,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,N#Cc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazole-6-carbonitrile,0.101,uM,=,-0.9956786262173574,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
3074,1275666,10.1021/jm400990p,,,,Inhibition of human AChE,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1.[Cl-].[Cl-],4-(aminocarbonyl)-1-({[1-chloro-2-[(E)-(hydroxyimino)methyl]pyridinium-1(2H)-yl]methoxy}methyl)pyridinium chloride,66.0,uM,=,1.8195439355418688,1,c1cc[n+](COC[n+]2ccccc2)cc1
3075,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(F)cc1)N1CCN(c2ccccn2)CC1,N'-(4-Fluorobenzylidene)-4-(pyridin-2-yl)piperazine-1-carbohydrazide,1.87,uM,=,0.2718416065364989,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
3076,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCOCC[n+]1cccc2ccccc21,"1,1'-(2,2'-oxybis(ethane-2,1-diyl))diquinolinium bromide",35.0,uM,=,1.5440680443502757,1,c1ccc2c(c1)ccc[n+]2CCOCC[n+]1cccc2ccccc21
3077,1766084,10.1021/acs.jnatprod.8b00461,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,SID144205156,0.4,uM,=,-0.3979400086720376,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
3078,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCCC[n+]2ccc3ccccc3c2)cc1,1-(10-(pyridinium-1-yl)decyl)isoquinoliniumdibromide,0.02,uM,=,-1.6989700043360187,0,c1cc[n+](CCCCCCCCCC[n+]2ccc3ccccc3c2)cc1
3079,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(/C=C/c1cccc(O)c1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-Benzylpiperidin-4-yl)ethyl)-3-(3-hydroxyphenyl)acrylamide,1.12,uM,=,0.0492180226701816,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3080,967407,10.1016/j.bmc.2013.05.001,,,,Inhibition of human AchE using acetylthiocholine iodide as substrate incubated for 20 mins prior to substrate addition measured for 1 hr by Ellman's method,c1ccc2[nH]c(N3CCCCC3)nc2c1,2-(Piperidin-1-yl)-1H-benzo[d]imidazole,59.2,uM,=,1.7723217067229198,1,c1ccc2[nH]c(N3CCCCC3)nc2c1
3081,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3ccccc3c2)c1,3-((methyl(3-(naphthalen-2-yloxy)propyl)amino)methyl)phenyl methylcarbamate,0.0825999999999999,uM,=,-1.0830199526796178,0,c1ccc(CNCCCOc2ccc3ccccc3c2)cc1
3082,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)C1N2C,"Methyl-carbamic acid 1-benzyl-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.33,uM,=,-0.4814860601221125,0,c1ccc(CN2CCC3c4ccccc4NC32)cc1
3083,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,COc1ccc(C(=O)N2CCN(CC(=O)N3CCN(CCCc4c[nH]c5ccc(F)cc45)CC3)CC2)cc1,1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-methoxybenzoyl)piperazin-1-yl)ethanone,14.4,uM,=,1.1583624920952498,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
3084,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2cccc([N+](=O)[O-])c2)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-N-methyl-4-((1-(3-nitrobenzyl)piperidin-4-yl)methoxy)thiazole-5-carboxamide,6.0,uM,=,0.7781512503836436,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
3085,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-],3-Dimethylcarbamoyloxy-1-methyl-pyridinium bromide,0.35,uM,=,-0.4559319556497244,0,c1cc[nH+]cc1
3086,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCCc3noc4ccccc34)CC2)cc1,3-[3-(1-Benzyl-piperidin-4-yl)-propyl]-benzo[d]isoxazole,0.9,uM,=,-0.0457574905606751,0,c1ccc(CN2CCC(CCCc3noc4ccccc34)CC2)cc1
3087,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,CN(Cc1ccccc1)Cc1ccc(C(=O)NCCc2c[nH]c3ccc(O)cc23)cc1,4-{[Benzyl(methyl)amino]methyl}-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide,4.2,uM,=,0.6232492903979004,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
3088,642381,10.1021/jm100329q,,,,Inhibition of human erythrocyte AChE by Ellman's reaction,Cc1ccc2ccc(CNCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c(O)c2n1.Cl.Cl,"2-Methyl-7-{[8-(1,2,3,4-tetrahydroacridin-9-ylamino)octylamino]methyl}quinolin-8-ol Dihydrochloride",0.0005,uM,=,-3.3010299956639813,0,c1cnc2cc(CNCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc2c1
3089,2185014,10.1016/j.ejmech.2021.113278,,,,Inhibition of AchE (unknown origin) using acetylcholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured after 10 mins by DTNB reagent based Ellman's method,COC(=O)/C=C/c1ccc(OCCCCCN2CCN(CC(=O)Nc3c4c(nc5ccccc35)CCCC4)CC2)c(OC)c1,"Methyl(3-(3-methoxy-4-((5-(4-(2-oxo-2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)piperazin-1-yl)pentyl)oxy)phenyl)acrylate",0.0617,uM,=,-1.2097148359667582,0,O=C(CN1CCN(CCCCCOc2ccccc2)CC1)Nc1c2c(nc3ccccc13)CCCC2
3090,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1ccccc1CN(C)CCCOc1ccc2c(=O)c3ccccc3oc2c1,3-{3-[(2-methoxybenzyl)methylamino]propoxy}xanthen-9-one,3.4,uM,=,0.5314789170422551,1,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
3091,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc([N+]2=Cc3c(cccc3OC)CC2)c1.[Br-],"8-methoxy-2-(3-methoxyphenyl)-3,4-dihydroisoquinolinium bromide",5.23,uM,=,0.7185016888672743,1,C1=[N+](c2ccccc2)CCc2ccccc21
3092,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC(C)(O)C(=O)Cc1cc2ccc(=O)oc2cc1O,Peucedanone,180.0,uM,=,2.255272505103306,1,O=c1ccc2ccccc2o1
3093,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,COc1ccccc1CNCCCCCCNC(=O)c1cc(Cl)nc(Cl)c1,"2,6-Dichloro-N-(6-((2-methoxybenzyl)amino)hexyl)isonicotinamide",8.3,uM,=,0.919078092376074,1,O=C(NCCCCCCNCc1ccccc1)c1ccncc1
3094,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,O=C(/C=C/c1ccc([N+](=O)[O-])cc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-nitrophenyl)acrylamide,0.337,uM,=,-0.4723700991286613,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3095,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3c1CCCC3)CCCC2,"1,2,3,4,5,6,7,8-Octahydro-acridin-9-ylamine",0.36,uM,=,-0.4436974992327127,0,c1c2c(nc3c1CCCC3)CCCC2
3096,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(Nc1cccc2c1C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O)c1ccccc1,"N-{2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}-benzamide",0.34,uM,=,-0.4685210829577448,0,O=C(Nc1cccc2c1C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O)c1ccccc1
3097,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1ccc(OC)c(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,"3-{7-[(2,5-dimethoxybenzyl)methylamino]heptyloxy}xanthen-9-one",127.0,uM,=,2.103803720955957,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
3098,1442181,10.1021/jm501195e,,,,Inhibition of AChE (unknown origin),CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1,"(4-Isopropyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.75,uM,=,-0.1249387366082999,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
3099,1922071,10.1016/j.bmc.2018.12.030,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1Cc1cn(CC2CCN(Cc3ccccc3)CC2)nn1,"2-((1-((1-Benzylpiperidin-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl)isoindoline-1,3-dione",4.9,uM,=,0.6901960800285137,1,O=C1c2ccccc2C(=O)N1Cc1cn(CC2CCN(Cc3ccccc3)CC2)nn1
3100,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CCNC(=O)Oc1cccc2c1OCC1CCN(C)C21,"Ethyl-carbamic acid 1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalen-6-yl ester",0.42,uM,=,-0.3767507096020995,0,c1ccc2c(c1)OCC1CCNC21
3101,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Brc1ccc(/C=C2/CNCC3=C2N=C2SC=C(c4ccccc4)N2C3c2ccc(Br)cc2)cc1,"(E)-9-(4-bromobenzylidene)-5-(4-bromophenyl)-3-phenyl-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",1.48,uM,=,0.1702617153949573,1,C1=C(c2ccccc2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
3102,1641224,,,,,AChE/BuChE Inhibition Assay: The cholinesterase assays were performed using colorimetric method reported by Ellman. The appearance of product was monitored at 412 nm for 5 min using a spectrophotometer. The reaction rates were compared and the percent inhibition due to the presence of test compounds was calculated. Inhibition curve was obtained for each compound. The linear regression parameters were determined and the IC50 values extrapolated.,COc1ccc2nc(NCCc3cc[n+](Cc4c(F)cccc4F)cc3)sc2c1,"US9255091, 4c",0.203,uM,=,-0.6925039620867871,0,c1ccc(C[n+]2ccc(CCNc3nc4ccccc4s3)cc2)cc1
3103,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{9-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]nonyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.00789,uM,=,-2.10292299679058,0,O=C(CC1CCc2cc(OCc3ccccc3)ccc2O1)NCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3104,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,NC(=O)Cc1nc(NCc2ccccc2)c2ccccc2n1,2-((4-(Benzylamino)quinazolin-2-yl)amino)acetamide,7.2,uM,=,0.8573324964312685,1,c1ccc(CNc2ncnc3ccccc23)cc1
3105,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cccc(F)c4c(N)c3C(C1)C2,"15-ethyl-5-fluoro-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.0295,uM,=,-1.530177984021837,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
3106,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C/c2nnc(-c3ccc(Cl)cc3Cl)o2)ccc1O,"4-(2-(5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)vinyl)-2-methoxyphenol",0.00022,uM,=,-3.657577319177794,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
3107,2224411,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 5 mins by Ellman's method,COc1cc(/C=C2\CCc3cc([N+](=O)[O-])ccc3C2=O)c(Br)c(OC)c1OC,"2-(2-bromo-3,4,5-trimethoxybenzylidene)-6-nitro-3,4-dihydronaphthalen-1(2H)-one",0.57,uM,=,-0.2441251443275086,0,O=C1/C(=C/c2ccccc2)CCc2ccccc21
3108,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,CC(=O)c1c[n+](Cc2ccccc2C)ccc1CC1Cc2cc(C)ccc2C1=O.[Br-],(+/-)-2-[[3-Acetyl-1-(o-tolylmethyl)pyridin-1-ium-4-yl]methyl]-5-methyl-indan-1-one Bromide,0.091,uM,=,-1.0409586076789064,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
3109,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl.Cl,Huprine-Tacrine Heterodimer,0.00033,uM,=,-3.4814860601221125,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
3110,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,"2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-[3,4,5-trihydroxy-6-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxymethyl)-tetrahydro-pyran-2-yloxy]-chromen-4-one",113.3,uM,=,2.0542299098633974,1,O=c1c(O[C@H]2CCC[C@@H](CO[C@H]3CCCCO3)O2)c(-c2ccccc2)oc2ccccc12
3111,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCC(C)(C)SC(=O)OCC[N+](C)(C)C.[Cl-],"[2-(1,1-Dimethyl-propylsulfanylcarbonyloxy)-ethyl]-trimethyl-ammonium chloride",40.0,uM,=,1.6020599913279625,1,
3112,972045,10.1016/j.bmcl.2013.04.081,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylcholine iodide as substrate preincubated for 15 mins prior to substrate addition by spectrophotometric analysis,O=c1ccc2cc3ccoc3cc2o1,"Furo[3,2-g]chromen-7-one",6.48,uM,=,0.8115750058705934,1,O=c1ccc2cc3ccoc3cc2o1
3113,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COC(=O)Nc1cccc2n1cc(-c1ccc(OC(=O)N(C)C)cc1)[n+]2C.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-5-(methoxycarbonylamino)-1-methylimidazo[1,2-a]pyridin-1-ium",1.1,uM,=,0.041392685158225,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
3114,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1ccc2[nH]cc(CCNC(=O)c3ccc(CN(C)Cc4ccccc4OC)cc3)c2c1,N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-4-{[(2-methoxybenzyl)(methyl)amino]methyl}benzamide,5.4,uM,=,0.7323937598229685,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
3115,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CCCCc2ccc(C(=O)CCC3CCN(Cc4ccccc4)CC3)cc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-ethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.376,uM,=,-0.4248121550723389,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
3116,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(Br)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-brombenzyl)berberine bromide,3.3,uM,=,0.5185139398778875,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
3117,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,Cc1cccc(C(=O)Nc2ccc3c(c2)CN(C(=O)c2cccc(Cl)c2)C(=O)C3)c1,"N-(2-(3-chlorobenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-methylbenzamide",2.0940000000000003e-05,uM,=,-4.6790233226571765,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
3118,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(Br)cc3Br)cc12.[Br-],"2-(2,4-Dibromophenyl)-8-methoxyisoquinolin-2-ium bromide",0.57,uM,=,-0.2441251443275086,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
3119,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCNc1c2c(nc3ccccc13)CCCC2,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-methoxy-N-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)thiazole-5-carboxamide",0.0063,uM,=,-2.2006594505464183,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1
3120,2266926,10.1016/j.ejmech.2020.113102,,,,Inhibition of AChE (unknown origin),COc1cccc([C@@H]2[C@H](Cc3c[nH]c4ccccc34)NC3(C(=O)Nc4ccccc43)[C@@]23Cc2cc(OC)c(OC)cc2C3=O)c1,"(2R,4'S,5'S)-5'-((1H-indol-3-yl)methyl)-5,6-dimethoxy-4'-(3-methoxyphenyl)dispiro[indene-2,3'-pyrrolidine-2',3''-indoline]-1,2''(3H)-dione",2.31,uM,=,0.3636119798921443,1,O=C1Nc2ccccc2C12N[C@@H](Cc1c[nH]c3ccccc13)[C@@H](c1ccccc1)[C@]21Cc2ccccc2C1=O
3121,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](Cc2ccc3ccc(C[n+]4ccccc4)cc3c2)cc1,"1,1'-bis(pyridinium)-naphtyl-3,6-dimethylene dibromide",0.2,uM,=,-0.6989700043360187,0,c1cc[n+](Cc2ccc3ccc(C[n+]4ccccc4)cc3c2)cc1
3122,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-],3-Dimethylcarbamoyloxy-1-methyl-pyridinium bromide,40.0,uM,=,1.6020599913279625,1,c1cc[nH+]cc1
3123,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCCCCOc1ccc(/C=C/C(=O)O)cc1OC,(E)-3-(4-((6-(diethylamino)hexyl)oxy)-3-methoxyphenyl)acrylicacid,2.67,uM,=,0.4265112613645752,1,c1ccccc1
3124,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1OC,"(E)-4-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl ethyl(methyl)carbamate",10.6,uM,=,1.0253058652647702,1,O=C(/C=C/c1ccccc1)N1CCc2ccccc2C1
3125,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,O=C(N1CCCCC1)n1nc(-c2ccc(Cl)cc2)nc1SCC(F)(F)F,"[3-(4-Chloro-phenyl)-5-(2,2,2-trifluoro-ethylsulfanyl)-[1,2,4]triazol-1-yl]-piperidin-1-yl-methanone",0.3,uM,=,-0.5228787452803376,0,O=C(N1CCCCC1)n1cnc(-c2ccccc2)n1
3126,1783503,10.1016/j.ejmech.2018.01.007,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,Cc1[nH]c2ccccc2c1CC(=O)NCCC1CCN(Cc2ccccc2)CC1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl] -2-(2-methyl-1H-indol-3-yl)-acetamide,7.27,uM,=,0.8615344108590378,1,O=C(Cc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
3127,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,Cc1ccc(C(=O)N2CCN(CC(=O)N3CCN(CCCc4c[nH]c5ccc(F)cc45)CC3)CC2)cc1,1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-methylbenzoyl)piperazin-1-yl)ethanone,3.6,uM,=,0.5563025007672873,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
3128,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3cccc(Cl)c13)OCCC2,"5-Chloro-3,4-dihydro-2H-1-oxa-9-aza-anthracen-10-ylamine",0.313,uM,=,-0.5044556624535516,0,c1ccc2nc3c(cc2c1)CCCO3
3129,2277647,10.1021/acs.jmedchem.2c01150,,,,Inhibition of human AchE by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(OCCN3CCCCC3)cc1)C2,"(2E)-5,6-dimethoxy-2-[[4-[2-(1-piperidyl)ethoxy]phenyl]methylene]indan-1-one",0.3,uM,=,-0.5228787452803376,0,O=C1/C(=C/c2ccc(OCCN3CCCCC3)cc2)Cc2ccccc21
3130,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccc(Br)cc1,5-(4-Bromrobenzylidene)-2-[(2-oxo-2H-chromen-6-yl)imino]thiazolidin-4-one,0.2764,uM,=,-0.5584619612978392,0,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1
3131,1671094,10.1016/j.bmc.2017.03.058,,,,Inhibition of human AChE using p-nitrophenyl acetate as substrate measured for 30 secs by spectrophotometric analysis,CCOP(=O)(OCC)Oc1ccc([N+](=O)[O-])cc1,Phosphoric acid diethyl ester 4-nitro-phenyl ester,0.01,uM,=,-2.0,0,c1ccccc1
3132,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCN(Cc3cccc(F)c3)CC2)ccc1O,(E)-1-(4-(3-fluorobenzyl)piperazin-1-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one,13.13,uM,=,1.1182647260894794,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
3133,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,O=C(O)c1c(O)cccc1CCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"2-hydroxy-6-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)benzoic acid",0.184,uM,=,-0.7351821769904636,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
3134,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCOCCOCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-3,6-dioxaoctyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.0479,uM,=,-1.3196644865854368,0,O=C(CC1CCc2ccccc2O1)NCCOCCOCCNc1c2c(nc3ccccc13)CCCC2
3135,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(Cc1ccccc1)C(=O)/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)c(OC)c1,(E)-4-(3-(benzyl(ethyl)amino)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl diphenylcarbamate,28.1,uM,=,1.44870631990508,1,O=C(/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)cc1)NCc1ccccc1
3136,877957,10.1021/jm3015519,,,,Inhibition of human AChE,COc1cc2c(cc1OC)C(c1ccccc1)N(CCCc1ccc(O)c(/C=N/O)n1)CC2,"6-(3-(6,7-Dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)propyl)-3-hydroxypicolinaldehyde oxime",260.0,uM,=,2.414973347970818,1,c1ccc(C2c3ccccc3CCN2CCCc2ccccn2)cc1
3137,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccc(F)cc1,"2-(6-(4-Fluorobenzylamino)hexyl)isoindoline-1,3-dione",3.167,uM,=,0.5006480633719119,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
3138,1635002,10.1016/j.ejmech.2016.09.037,,,,Inhibition of human AChE pretreated for 20 mins followed by acetylthiocholine iodide substrate addition measured for 5 mins by Ellman's method,O=C1NCCCc2c1c1ccccc1n2CCc1ccc(F)cc1,"6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one",10.0,uM,=,1.0,1,O=C1NCCCc2c1c1ccccc1n2CCc1ccccc1
3139,462138,10.1021/jm7009364,,,,Inhibition of human AchE-induced amyloid beta aggregation,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-3-(1H-indol-3-yl)-propionamide",9.0,uM,=,0.9542425094393248,1,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3140,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,COC(=O)c1cc2c(N)c3c(nc2nc1C)CCC3,"Methyl 5-Amino-2-methyl-7,8-dihydro-6H-cyclopenta-[b][1,8]naphthyridine-3-carboxylate",1.9,uM,=,0.2787536009528289,1,c1cnc2nc3c(cc2c1)CCC3
3141,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc(OC(F)(F)F)cc2)cc1,S-4-(trifluoromethoxy)benzyl 4-methylbenzenthiosulfonate,0.1294,uM,=,-0.8880657236673184,0,O=S(=O)(SCc1ccccc1)c1ccccc1
3142,2290720,10.1021/acs.jmedchem.2c01933,,,,Inhibition of acetyl cholinesterase (unknown origin),CC(C)C[C@@H](NC(=O)C1(C(F)(F)F)CCCCC1)C(=O)Nc1nnc(Cc2ccc(C#N)cc2)s1,"N-[(1R)-1-[[5-((4-Cyanophenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]1-3-methyl-butyl)-1-(trifluoromethyl)cydohexanecarboxamide",7.61,uM,=,0.8813846567705729,1,O=C(CNC(=O)C1CCCCC1)Nc1nnc(Cc2ccccc2)s1
3143,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2[C@H]1c1ccc(OC)cc1)CCCC3,"(R)-ethyl 5-amino-4-(4-methoxyphenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.036,uM,=,-1.4436974992327127,0,C1=C[C@H](c2ccccc2)c2cc3c(nc2N1)CCCC3
3144,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc([N+](=O)[O-])cc1,"2-butyl-3-(4-nitrobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one",0.1354,uM,=,-0.8683813356508745,0,O=C1N(Cc2ccccc2)C=NC12CCCC2
3145,305005,10.1021/jm049113+,,,,Inhibitory concentration against Acetylcholinesterase; (range = 2-20 uM),COc1ccc(CCN2CC(=O)N(CCc3ccccn3)CC2=O)cc1OC,"1-[2-(3,4-Dimethoxy-phenyl)-ethyl]-4-(2-pyridin-2-yl-ethyl)-piperazine-2,5-dione",20.0,uM,=,1.3010299956639813,1,O=C1CN(CCc2ccccn2)C(=O)CN1CCc1ccccc1
3146,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)C(=O)C(CC1CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC1)C2.Cl.Cl,"9-[(3-{4-[(5,6-Dimethoxy-1-oxoindan-2-yl)methyl]piperidin-1-yl}propyl)amino]-1,2,3,4-tetrahydroacridine dihydrochloride",0.00088,uM,=,-3.055517327849832,0,O=C1c2ccccc2CC1CC1CCN(CCCNc2c3c(nc4ccccc24)CCCC3)CC1
3147,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCn1c(=O)c2cc3c(=O)n(CCCCCCN(CC)Cc4ccccc4OC)c(=O)c3cc2c1=O)Cc1ccccc1OC,"2,6-Bis-{6-[ethyl-(2-methoxybenzyl)amino]hexyl}pyrrolo[3,4-f]isoindole-1,3,5,7-tetraone",0.0077,uM,=,-2.113509274827518,0,O=c1c2cc3c(=O)n(CCCCCCNCc4ccccc4)c(=O)c3cc2c(=O)n1CCCCCCNCc1ccccc1
3148,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.156,uM,=,0.0629578340845102,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
3149,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CCC1,"4-(cyclobutylmethoxy)-N-methyl-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.1553,uM,=,-0.8088285442714415,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CCC3)cs2)ccn1
3150,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(Cc1cccc(/C=N/O)c1O)CC2,"3-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",1265.0,uM,=,3.1020905255118367,1,c1ccc(CN2CCc3ccccc3C2)cc1
3151,28322,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.50-0.53,CNC1CCc2cccc(OC(=O)N(C)C)c21.Cl,Dimethyl-carbamic acid 3-methylamino-indan-4-yl ester hydrochloride,0.51,uM,=,-0.2924298239020636,0,c1ccc2c(c1)CCC2
3152,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CC1=C[C@@H]2Cc3nc4cc(F)ccc4c(N)c3[C@H](C1)C2,"(-)-7-fluoro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00458,uM,=,-2.339134521996131,0,C1=C[C@@H]2Cc3nc4ccccc4cc3[C@H](C1)C2
3153,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,COC(=O)C1=C(C)OP(=O)(OC)CCC1,"2-Methoxy-7-methyl-2-oxo-2,3,4,5-tetrahydro-2lambda*5*-[1,2]oxaphosphepine-6-carboxylic acid methyl ester",7.0,uM,=,0.8450980400142568,1,O=[PH]1CCCC=CO1
3154,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CN(Cc1ccccc1)Cc1ccc(/C=C2\Cc3ccc(OCCCCCN4CCCCC4)cc3C2=O)cc1,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(5-piperidin-1-yl-pentyloxy)indan-1-one,0.2,uM,=,-0.6989700043360187,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccc(OCCCCCN3CCCCC3)cc21
3155,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CN(C)Cc1ccc(CSCCCCCCCCCSCc2ccc(CN(C)C)o2)o1,{5-[9-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-nonylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.46,uM,=,-0.3372421683184259,0,c1coc(CSCCCCCCCCCSCc2ccco2)c1
3156,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,O=C(/C=C/c1ccc(O)cc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide,2.2,uM,=,0.3424226808222063,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3157,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)CCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1,N1-dimethyl-N8-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine",0.047,uM,=,-1.3279021420642825,0,c1ccc2nc3c(cc2c1)CCCC3
3158,28156,10.1021/jm00161a008,,,,Reactivation of human acetylcholinesterase,CCN(CC)CCS/C(=N\O)c1nc(Cc2ccccc2)no1,"3-Benzyl-N-hydroxy-[1,2,4]oxadiazole-5-carboximidothioic acid 2-diethylamino-ethyl ester",30.0,uM,=,1.4771212547196624,1,c1ccc(Cc2ncon2)cc1
3159,1276071,10.1021/jm401047q,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman's method,COc1cc2[se]n(CCCCC3CCN(Cc4ccccc4)CC3)c(=O)c2cc1OC,"2-[4-(1-Benzylpiperidin-4-yl)butyl]-5,6-dimethoxybenzo[d][1,2]-selenazol-3(2H)-one",0.103,uM,=,-0.9871627752948278,0,O=c1c2ccccc2[se]n1CCCCC1CCN(Cc2ccccc2)CC1
3160,28628,10.1021/jm970210v,,,,Inhibition of human acetylcholinesterase from erythrocytes (RBC),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C=O,"Methyl-carbamic acid (S)-8-formyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.3875,uM,=,-0.4117282931576709,0,c1ccc2c(c1)NC1NCCC21
3161,1444262,10.1016/j.bmcl.2014.12.006,,,,Inhibition of AChE (unknown origin) assessed as reduction in acetylthiocholine iodide hydrolysis after 15 mins by Ellman method,O=S(=O)(CCCN1CCN(Cc2ccccc2)CC1)NCCNc1cccc2ccccc12,3-(4-benzylpiperazin-1-yl)-N-(2-(naphthalen-1-ylamino)ethyl)propane-1-sulfonamide,0.16,uM,=,-0.7958800173440752,0,O=S(=O)(CCCN1CCN(Cc2ccccc2)CC1)NCCNc1cccc2ccccc12
3162,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCCCO.O=S(=O)([O-])C(F)(F)F,1-(5-hydroxypentyl)-2-methoxy-5-(trifluoromethyl)pyridinium trifluoromethanesulfonate,131.0,uM,=,2.1172712956557644,1,c1cc[nH+]cc1
3163,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCCCCCCCC[n+]1cccc2ccccc21,"1,11-di(1-quinoliniumyl)undecane; dibromide",0.01,uM,=,-2.0,0,c1ccc2c(c1)ccc[n+]2CCCCCCCCCCC[n+]1cccc2ccccc21
3164,826907,10.1021/ml200313p,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 120 mins before substrate addition by Ellman's method,CN(CCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NCCCCCCCN2CCOCC2)c1,(7-Morpholin-4-yl-heptyl)carbamic acid 3-({methyl-[3-(2-oxo-2H-chromen-7-yloxy)propyl]amino]methyl}phenyl ester,0.119,uM,=,-0.9244530386074692,0,O=C(NCCCCCCCN1CCOCC1)Oc1cccc(CNCCCOc2ccc3ccc(=O)oc3c2)c1
3165,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NCCc1c[nH]c2ccccc12,"7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
3166,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,O=C(CC[C@H](NC(=O)c1ccccc1)C(=O)O)NCCC1CCN(Cc2ccccc2)CC1,N-Benzoyl-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-OH,0.76,uM,=,-0.1191864077192086,0,O=C(CCCNC(=O)c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3167,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,C[C@]12CC[C@H](O)[C@@](C)(CO)C1C[C@H](O)[C@@]1(C)Oc3cc(-c4ccc(Cl)nc4)oc(=O)c3C(=O)C21,"9-(6-Chloro-pyridin-3-yl)-3,6-dihydroxy-4-hydroxymethyl-4,6a,12b-trimethyl-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-7,10-dioxa-benzo[a]anthracene-11,12-dione",80.0,uM,=,1.9030899869919435,1,O=C1c2c(cc(-c3cccnc3)oc2=O)OC2CCC3CCCCC3C12
3168,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2ccc(F)cc2)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(4-Fluorophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",23.32,uM,=,1.3677285460869766,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
3169,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc(F)c[n+]1C.F[B-](F)(F)F,5-fluoro-2-methoxy-1-methylpyridinium tetrafluoroborate,17.0,uM,=,1.230448921378274,1,c1cc[nH+]cc1
3170,28319,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.44-0.49,CN(C)C(=O)Oc1cccc2c1C(N)CC2.Cl,Dimethyl-carbamic acid 3-amino-indan-4-yl ester hydrochloride,0.46,uM,=,-0.3372421683184259,0,c1ccc2c(c1)CCC2
3171,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12,3-(3-(4-Benzylpiperazin-1-yl)propoxy)-6H-benzo[c]chromen-6-one,0.8,uM,=,-0.0969100130080563,0,O=c1oc2cc(OCCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12
3172,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCOCC[n+]2ccccc2)cc1,"1,5-bis(pyridinium)-3-oxapentane dibromide",2010.0,uM,=,3.303196057420489,1,c1cc[n+](CCOCC[n+]2ccccc2)cc1
3173,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CCN(CCOc1ccc(/C=C2\COc3ccccc3C2=O)cc1)Cc1ccccc1,(E)-3-(4-(2-(benzyl(ethyl)amino)ethoxy)benzylidene)chroman-4-one,22.3,uM,=,1.3483048630481609,1,O=C1/C(=C/c2ccc(OCCNCc3ccccc3)cc2)COc2ccccc21
3174,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(C)c1cc(-c2ccccc2)n[nH]c1=NCCC1CCN(Cc2ccccc2)CC1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-4-isopropyl-6-phenylpyridazin-3-amine,0.43,uM,=,-0.3665315444204134,0,c1ccc(CN2CCC(CCN=c3ccc(-c4ccccc4)n[nH]3)CC2)cc1
3175,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC(=O)N1CCN(c2nccc(NCc3ccccc3)n2)CC1,1-[4-(4-(Benzylamino)pyrimidin-2-yl)piperazin-1-yl]ethanone,16.6,uM,=,1.2201080880400552,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
3176,2213907,10.1016/j.ejmech.2021.113949,,,,Inhibition of human AChE,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCC1=N2,"7-(3-(piperidin-1-yl)propoxy)-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline",1.1,uM,=,0.041392685158225,1,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCC1=N2
3177,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3ccc(C(F)(F)F)cc3)cn2)cc1,2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-methyl-N-(3-(4-(trifluoromethyl)phenoxy)propyl)pyrimidine-5-carboxamide,29.8,uM,=,1.4742162640762553,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
3178,489450,10.1021/jm800577j,,,,Inhibition of human recombinant AChE by Ellman's method,Clc1ccc2c(NCCCNCCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3,"N-[4-(9H-Carbazol-4-yloxy)butyl]-N'-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)propane-1,3-diamine",0.00165,uM,=,-2.7825160557860937,0,c1ccc2c(NCCCNCCCCOc3cccc4[nH]c5ccccc5c34)c3c(nc2c1)CCCC3
3179,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CNc1nc(NCc2ccccc2)c2ccccc2n1,"N4-Benzyl-N2-methylquinazoline-2,4-diamine",8.0,uM,=,0.9030899869919436,1,c1ccc(CNc2ncnc3ccccc23)cc1
3180,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(1,2,3,4-tetrahydro-acridin-9-yl)-heptane-1,7-diamine (bis(7)-Tacrine)",0.0002,uM,=,-3.6989700043360174,0,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
3181,1671084,10.1016/j.bmc.2017.03.058,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 30 secs by Ellman's method,CCO[P@](=O)(SCC)c1ccccc1,"(S)-O,S-diethylphenylphosphonothioate",8.0,uM,=,0.9030899869919436,1,c1ccccc1
3182,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,CC(=O)Nc1ccc2nc3c(c(N4CCOCC4)c2c1)CCCC3,"N-(9-morpholino-5,6,7,8-tetrahydroacridin-2-yl)acetamide",1.11,uM,=,0.0453229787866574,1,c1ccc2c(N3CCOCC3)c3c(nc2c1)CCCC3
3183,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CC1CCN(Cc3cc(Cl)cc(/C=N/O)c3O)CC1)CC2,"5-chloro-3-((4-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",940.8,uM,=,2.973497308732063,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3c3ccccc3)CC2)cc1
3184,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccccc4C#N)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(2-Cyanobenzyl)-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]piperidine-4-carboxamide",2.8,uM,=,0.4471580313422192,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
3185,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,"N,N'-(3,3'-(3,3'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)bis(propane-3,1-diyl))bis(azanediyl)bis(propane-3,1-diyl))bis(2-(4-isobutylphenyl)propanamide)",0.6,uM,=,-0.2218487496163563,0,O=C(Cc1ccccc1)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2)=CC1=O
3186,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,Ranitidine,0.65,uM,=,-0.1870866433571444,0,c1ccoc1
3187,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,O=c1c2ccccc2[se]n1-c1ccc(CN2CCCCC2)cc1,"2-(4-(Piperidin-1-ylmethyl)phenyl)benzo[d][1,2]selenazol-3(2H)-one",10.85,uM,=,1.0354297381845483,1,O=c1c2ccccc2[se]n1-c1ccc(CN2CCCCC2)cc1
3188,1539620,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 6,CCOP1(=O)CCCC(C(=O)OC)=C(C)O1,"Methyl 2-ethoxy-7-methyl-2,3,4,5-tetrahydro-1,2-oxaphosphepine-6-carboxylate 2-oxide",8.9,uM,=,0.9493900066449128,1,O=[PH]1CCCC=CO1
3189,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc(C(F)(F)F)[n+]1C.F[B-](F)(F)F,2-methoxy-1-methyl-6-(trifluoromethyl)pyridinium tetrafluoroborate,36.0,uM,=,1.5563025007672873,1,c1cc[nH+]cc1
3190,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)C(O)C(O)C(=O)O,"o-Tolyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester; compound with 2,3-dihydroxy-succinic acid",0.01,uM,=,-2.0,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
3191,749399,10.1016/j.bmcl.2009.04.089,,,,Inhibition of human recombinant AChE preincubated for 30 mins before DTNB substrate addition by spectrophotometric assay based Ellman's method,C[C@@H](c1cccc(OC(=O)N(C)[C@@H](C)Cc2ccccc2)c1)N(C)C.Cl,3-((S)-1-(dimethylamino)ethyl)phenylmethyl((S)-1-phenylpropan-2-yl)carbamate hydrochloride,0.131,uM,=,-0.8827287043442358,0,O=C(NCCc1ccccc1)Oc1ccccc1
3192,1500569,10.1039/C4MD00069B,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins by Ellmans method,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,"N,N'-(3,3'-(3,3'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)bis(propane-3,1-diyl))bis(azanediyl)bis(propane-3,1-diyl))bis(2-(2-(2,6-dichlorophenylamino)phenyl)acetamide)",0.6,uM,=,-0.2218487496163563,0,O=C(Cc1ccccc1Nc1ccccc1)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2ccccc2)=CC1=O
3193,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,COc1ccc2nc3c(c(NCCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,"(S)-2-amino-3-(1H-indol-3-yl)-N-(7-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)propanamide dihydrochloride",0.98,uM,=,-0.0087739243075051,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3194,791001,10.1016/j.bmcl.2011.09.030,,,,Inhibition of human erythrocyte AChE incubated for 12 mins before addition of acetylthiocholine iodide substrate by spectrophotometric analysis,C#CCOP(C)(=O)OC(C(F)(F)F)C(F)(F)F,"rac-Methyl-phosphonic acid prop-2-ynyl ester 2,2,2-trifluoro-1-trifluoromethyl-ethyl ester",65.00000000000001,uM,=,1.812913356642856,1,
3195,2263808,10.1016/j.bmc.2020.115895,,,,Inhibition of AChE (unknown origin),COc1ccc(/C=C2\Oc3cc(OCCN4CCCCC4)ccc3C2=O)cc1,(Z)-2-(4-methoxybenzylidene)-6-(2-(piperidin-1-yl)ethoxy)benzofuran-3(2H)-one,0.845,uM,=,-0.0731432910503076,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCN3CCCCC3)ccc21
3196,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)OCC[N+](C)(C)CCCCCCCCCC[N+](C)(C)CCOC(=O)[C@]3(C)CCC[C@@]4(C)[C@@H]5CC[C@@]6(C)C[C@]5(CC[C@@H]43)CC6=O)(CC1=O)C2.[Br-].[Br-],,88.0,uM,=,1.944482672150169,1,O=C1C[C@]23CC[C@@H]4C(C(=O)OCC[NH2+]CCCCCCCCCC[NH2+]CCOC(=O)C5CCCC6[C@@H]5CC[C@@]57CC(=O)C(CC[C@@H]65)C7)CCCC4[C@@H]2CCC1C3
3197,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1CC2C(=O)N(c3cccc(F)c3)C(=O)C2C12C(=O)c1ccccc1C2=O,"5'-(3-Fluorophenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",80.11,uM,=,1.9036867317365025,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
3198,1458076,10.1016/j.bmcl.2014.05.040,,,,Inhibition of AChE (unknown origin) using ACh chloride as substrate preincubated for 15 mins before substrate addition by Ellman method,COC(=O)C(CC1=C(c2ccc(Cl)cc2)CC(C)(C)ON1C(C)=O)C(=O)OC,"Dimethyl{[2-acetyl-4-(4-chlorophenyl)-6,6-dimethyl-5,6-dihydro-2H-1,2-oxazin-3-yl]methyl}malonate",46.76,uM,=,1.6698745024898023,1,C1=C(c2ccccc2)CCON1
3199,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc(C(C)(C)C)cc2)cc1,S-4-tert-butylbenzyl 4-methylbenzenthiosulfonate,0.1766,uM,=,-0.7530093007584502,0,O=S(=O)(SCc1ccccc1)c1ccccc1
3200,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-amino-3-(1H-indol-3-yl)-N-(7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)propanamide dihydrochloride",0.12,uM,=,-0.9208187539523752,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3201,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,"N4-(3,4-dimethoxybenzyl)-N2-propylquinazoline-2,4-diamine",5.6,uM,=,0.7481880270062004,1,c1ccc(CNc2ncnc3ccccc23)cc1
3202,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)NCCc2c[nH]c3ccccc23)ccc1O,(E)-N-(2-((2-(1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,1.42,uM,=,0.1522883443830564,1,O=C(/C=C/c1ccccc1)NCC(=O)NCCc1c[nH]c2ccccc12
3203,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CN(C)c1ccc(/C=C2/CCC/C(=C\c3ccc(N(C)C)cc3[N+](=O)[O-])C2=O)c([N+](=O)[O-])c1,"2,6-Bis-(4-dimethylamino-2-nitro-benzylidene)-cyclohexanone",45.29,uM,=,1.6560023206829573,1,O=C1/C(=C\c2ccccc2)CCC/C1=C\c1ccccc1
3204,1978343,10.1016/j.bmcl.2019.126888,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(-c2ccc(/C=N/N3CC(=O)N(CCC4CCN(Cc5ccccc5)CC4)C3=O)o2)cc1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-1-((5-(4-methoxyphenyl)furan-2-yl)methyleneamino)imidazolidine-2,4-dione",0.108,uM,=,-0.9665762445130504,0,O=C1CN(/N=C/c2ccc(-c3ccccc3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1
3205,304927,10.1021/jm049510k,,,,Inhibitory concentration against human Acetylcholinesterase,CN(CCCNc1c2c(nc3ccccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2,"N-Methyl-N'-(1,2,3,4-tetrahydro-acridin-9-yl)-N-[3-(1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-propane-1,3-diamine",0.0003,uM,=,-3.522878745280338,0,c1ccc2c(NCCCNCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
3206,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CNc3noc4ccccc34)CC2)cc1,Benzo[d]isoxazol-3-yl-(1-benzyl-piperidin-4-ylmethyl)-amine,0.32,uM,=,-0.494850021680094,0,c1ccc(CN2CCC(CNc3noc4ccccc34)CC2)cc1
3207,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(4-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)butyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.15,uM,=,-0.8239087409443188,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3208,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=c1[nH]c2cc(Cl)ccc2c(=O)n1CCC1CCN(Cc2ccccc2)CC1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-7-chloro-1H-quinazoline-2,4-dione",0.0045,uM,=,-2.3467874862246565,0,O=c1[nH]c2ccccc2c(=O)n1CCC1CCN(Cc2ccccc2)CC1
3209,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methyl-4-(2-((1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)ethoxy)thiazole-5-carboxamide",0.0447,uM,=,-1.3496924768680636,0,O=C(Nc1cc(-c2nc(OCCOCc3cn(CCNc4c5c(nc6ccccc46)CCCC5)nn3)cs2)ccn1)C1CC1
3210,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.128,uM,=,-0.8927900303521317,0,c1ccc2nc3c(cc2c1)CCCC3
3211,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(C2CCN(C(=O)COc3ccc4c(c3)CCC4=O)CC2)CC1,"5-(2-(4-(4-ethylpiperazin-1-yl)piperidin-1-yl)-2-oxoethoxy)-2,3-dihydro-1H-inden-1-one",4.9,uM,=,0.6901960800285137,1,O=C1CCc2cc(OCC(=O)N3CCC(N4CCNCC4)CC3)ccc21
3212,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{6-[(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",10.0,uM,=,1.0,1,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
3213,471590,10.1016/j.bmc.2007.12.048,,,,Inhibition of AChE,OC1CCN(Cc2ccc(OCCCN3CCCCC3)cc2)CC1,1-[4-(3-Piperidin-1-yl-propoxy)-benzyl]-piperidin-4-ol,2.3,uM,=,0.3617278360175928,1,c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1
3214,28156,10.1021/jm00161a008,,,,Reactivation of human acetylcholinesterase,CCN(CC)CC/N=C(\NO)c1nc(-c2ccccc2)no1,"N-(2-Diethylamino-ethyl)-N'-hydroxy-3-phenyl-[1,2,4]oxadiazole-5-carboxamidine",260.0,uM,=,2.414973347970818,1,c1ccc(-c2ncon2)cc1
3215,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccc([N+](=O)[O-])cc13)CCCC2,"7-Nitro-1,2,3,4-tetrahydro-acridin-9-ylamine",3.0,uM,=,0.4771212547196624,1,c1ccc2nc3c(cc2c1)CCCC3
3216,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)Nc1ccc2c(c1)CN(C(=O)c1cccc(C)c1)C(=O)C2,"2-Methoxy-N-(2-(3-methylbenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",2.5920000000000003e-05,uM,=,-4.586365002801444,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
3217,466877,10.1021/jm070154q,,,,Inhibition of human recombinant AChE-induced amyloid beta aggregation by thioflavin T fluorescence method,CC[C@@]1(c2cccc(O)c2)CCCCN(CCCCCCCCCCN2CCCC[C@@](CC)(c3cccc(O)c3)C2)C1,"N,N'-(1',10'-decylene)-bis-(-)-nor-MEP",5.8,uM,=,0.7634279935629373,1,c1ccc(C2CCCCN(CCCCCCCCCCN3CCCCC(c4ccccc4)C3)C2)cc1
3218,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CC(C)(C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],"1-(1,1-Dimethyl-prop-2-ynyloxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride",24.2,uM,=,1.383815365980431,1,c1c[nH+]c[nH]1
3219,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CCCCCCCCOC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-octyloxymethyl-3H-imidazol-1-ium chloride,9.5,uM,=,0.9777236052888478,1,c1c[nH+]c[nH]1
3220,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,O=C(CCCCCCNc1c2c(nc3cccc(Cl)c13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-7-(8-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)heptanamide",8e-06,uM,=,-5.096910013008056,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
3221,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Cl.O=[N+]([O-])c1cccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)c1,"9-(2-(4-((1-(3-Nitrophenyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",1.46,uM,=,0.1643528557844371,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
3222,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.019,uM,=,-1.7212463990471711,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3223,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1Cc2cc3onc(CCC4CCN(Cc5ccccc5)CC4)c3cc2N1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5,7-dihydro-isoxazolo[5,4-f]indol-6-one",0.00095,uM,=,-3.0222763947111524,0,O=C1Cc2cc3onc(CCC4CCN(Cc5ccccc5)CC4)c3cc2N1
3224,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,CO[C@@H]1C=C[C@@]23c4cc5c(cc4CN(C[C@@H]2O)[C@H]3C1)OCO5,(+)-haemanthamine,452.0,uM,=,2.655138434811382,1,C1=C[C@]23CCN(Cc4cc5c(cc42)OCO5)[C@H]3CC1
3225,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCOc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(3-diethylaminopropoxy)indan-1-one,1.32,uM,=,0.1205739312058498,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
3226,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,N#CC(c1ccc2c(c1)OCO2)N1CCCC1,"rac-2-(3,4-Dioxymethylenphenyl)-2-(pyrrolidin-1-yl)acetonitrile",51.0,uM,=,1.7075701760979365,1,c1cc2c(cc1CN1CCCC1)OCO2
3227,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,"N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N-[(E)-1-(methylamino)-2-nitrovinyl]amine",5.6146,uM,=,0.749318821331103,1,c1cscn1
3228,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCN(C)CC2)cc1OC,"rac-2-(3,4-Dimethoxyphenyl)-2-(4-methylpiperazin-1-yl)acetonitrile",379.0,uM,=,2.578639209968072,1,c1ccc(CN2CCNCC2)cc1
3229,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cccc(CN2CCC(CCC(=O)c3ccc4c(c3)NCCCC4)CC2)c1,"3-[1-(3-Methoxy-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.847,uM,=,-0.0721165896692931,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
3230,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NCCCCCCCCCN2CCOCC2)c1,(9-Morpholin-4-yl-nonyl)-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0293,uM,=,-1.5331323796458909,0,O=C(NCCCCCCCCCN1CCOCC1)Oc1cccc(CNCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1
3231,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNc1c2c(nc3cc(C)ccc13)CCCC2,"Heptyl-(6-methyl-1,2,3,4-tetrahydro-acridin-9-yl)-amine",0.13,uM,=,-0.8860566476931633,0,c1ccc2nc3c(cc2c1)CCCC3
3232,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCCCCCN3Cc4ccccc4CN3)nn2)cc1,"N-(5-(3,4-dihydrophthalazin-2(1H)-yl)pentyl)-6-phenylpyridazin-3-amine",10.0,uM,=,1.0,1,c1ccc(-c2ccc(NCCCCCN3Cc4ccccc4CN3)nn2)cc1
3233,1882796,10.1016/j.bmc.2018.11.015,,,,Inhibition of acetylcholinesterase (unknown origin),O=C(O)c1ccccc1O,2-Hydroxy-benzoic acid,346.0,uM,=,2.5390760987927767,1,c1ccccc1
3234,1676712,10.1021/acs.jmedchem.7b01083,,,,Reactivation of organophosphate inhibited human erythrocyte AChE assessed as organophosphate IC50 using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addition measured for 3 mins by Ellman's method,CCCCN(CC(=O)NCc1ccccc1)C(=O)CCCCCn1cc[n+](C)c1/C=N\O.[I-],N-Butyl-N-[2-(benzylamino)-2-oxoethyl]-(6-N-(1-Me-2-hydroxyiminomethyl-1H-imidazolium))hexanamide Iodide,50.0,uM,=,1.6989700043360187,1,O=C(CCCCCn1cc[nH+]c1)NCC(=O)NCc1ccccc1
3235,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C[C@H](CC[C@H](O)[C@](C)(O)CO)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@]12C,Ganodermanontriol,22.31,uM,=,1.3484995702838378,1,O=C1CCC2C3=CCC4CCCC4C3=CC[C@H]2C1
3236,1684524,10.1016/j.ejmech.2017.03.050,,,,Inhibition of recombinant human AChE expressed in HEK293F cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman's method,COc1ccc(NC(=S)NCCN2CCOCC2)cc1Cl,1-(3-Chloro-4-methoxyphenyl)-3-(2-morpholinoethyl)thiourea,14.0,uM,=,1.146128035678238,1,S=C(NCCN1CCOCC1)Nc1ccccc1
3237,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN(CCN(C)C)Cc3ccccc3)cc2)cc1OC,"(4-{[Benzyl-(2-dimethylaminoethyl)amino]methyl}-phenyl)-(3,4-dimethoxyphenyl)methanone",8.64,uM,=,0.9365137424788932,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
3238,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(c1ccc([N+](=O)[O-])cc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-4-nitro-N-phenyl-benzamide,0.0054,uM,=,-2.2676062401770314,0,O=C(c1ccccc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
3239,785863,10.1016/j.bmcl.2011.08.042,,,,Inhibition of human recombinant AChE after 5 mins using spectrophotometer by Ellman's method,C=CCCCNc1c2c(nc3ccc(OC)cc13)CCCC2,"9-amino-7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridine",2.2,uM,=,0.3424226808222063,1,c1ccc2nc3c(cc2c1)CCCC3
3240,29401,10.1016/0960-894X(96)00337-X,,,,In vitro inhibitory activity against Acetylcholinesterase (AChE).,CC1=CC2Cc3nc(O)ccc3C(N)(C1)/C2=C/C(F)(F)F,"1-Amino-13-eth-(E)-ylidene-11-trifluoromethyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",2.0,uM,=,0.3010299956639812,1,C=C1C2C=CCC1c1cccnc1C2
3241,28160,10.1016/S0960-894X(97)10025-7,,,,Compound was tested in vitro for inhibitory activity against Acetylcholinesterase,Nc1cc(-c2ccccc2)nc2ccccc12,2-Phenyl-quinolin-4-ylamine,11.48,uM,=,1.0599418880619549,1,c1ccc(-c2ccc3ccccc3n2)cc1
3242,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,CCOP(=S)(OCC)Oc1cc(C)nc(C(C)C)n1,"O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate",1.9,uM,=,0.2787536009528289,1,c1cncnc1
3243,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC(O)C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-1-hydroxy-3-oxo-propyl]-1-methyl-piperidinium bromide",0.043,uM,=,-1.3665315444204136,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
3244,745140,10.1021/jm101299d,,,,Inhibition of human recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCC3)cc2)cc(-c2cccc(C[n+]3ccc(N4CCCCC4)cc3)c2)c1,4-hexahydro-1-pyridinyl-1-{3-[3-(4-hexahydro-1-pyridinyl-1-pyridiniumylmethyl)phenyl]benzyl}pyridinium bromide,0.06,uM,=,-1.2218487496163564,0,c1cc(C[n+]2ccc(N3CCCCC3)cc2)cc(-c2cccc(C[n+]3ccc(N4CCCCC4)cc3)c2)c1
3245,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCN(CCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NC)c1,Methyl-carbamic acid 3-({[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-propyl-amino}-methyl)-phenyl ester,0.004,uM,=,-2.397940008672037,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
3246,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1ccc(-c2cn3ccccc3[n+]2C)cc1.[I-],"1-methyl-2-(4-(methylcarbamoyloxy)phenyl)imidazo[1,2-a]pyridin-1-ium",19.5,uM,=,1.290034611362518,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
3247,1298092,10.1016/j.ejmech.2014.02.045,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCOc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1)Cc1ccccc1OC,"3-(4-(4-(Ethyl(2-methoxybenzyl)amino)butoxy)phenyl)-5,7-dihydroxy-4H-chromen-4-one",3.88,uM,=,0.5888317255942073,1,O=c1c(-c2ccc(OCCCCNCc3ccccc3)cc2)coc2ccccc12
3248,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),Cc1ccccc1C1C([N+](=O)[O-])C(Cc2c[nH]cn2)NC12c1ccccc1-c1nc3ccccc3nc12,"5'-(1H-imidazol-4-ylmethyl)-4'-nitro-3'-(o-tolyl)spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",10.02,uM,=,1.000867721531227,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
3249,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,C#CCOc1ccc(/C=N/Nc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"9-(2-(4-(Prop-2-yn-1-yloxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",2.73,uM,=,0.436162647040756,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccccc1
3250,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12,3-(2-(4-Benzylpiperidin-1-yl)ethoxy)-6H-benzo[c]chromen-6-one,20.0,uM,=,1.3010299956639813,1,O=c1oc2cc(OCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12
3251,1632485,10.1016/j.ejmech.2016.08.016,,,,Inhibition of human recombinant AChE preincubated for 5 mins followed by acetylthiocholine iodide substrate addition measured after 5 mins by Ellman's method,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21,"N-(7-(4-(1-(phenylsulfonyl)-1H-indol-4-yl)piperazin-1-yl)heptyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0062,uM,=,-2.207608310501746,0,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21
3252,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCN1C(=O)c2cccc3cccc(c23)C1=O)Cc1ccccc1OC,"2-{6-[Ethyl-(2-methoxybenzyl)amino]hexyl}benzo[de]isoquinoline-1,3-dione",0.0535,uM,=,-1.2716462179787715,0,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCNCc1ccccc1
3253,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CN(C)c1cccc(OC(=O)Nc2ccccc2)c1,3-(dimethylamino)phenyl phenylcarbamate,2.5,uM,=,0.3979400086720376,1,O=C(Nc1ccccc1)Oc1ccccc1
3254,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2oc(C(=O)NC3CCN(Cc4ccccc4)CC3)cc(=O)c2c1,N-(1-benzylpiperidin-4-yl)-6-methoxy-4-oxo-4H-chromene-2-carboxamide,0.97,uM,=,-0.0132282657337551,0,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
3255,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4ccc(Cl)cc4)[nH]3)ccc21,"(S)-3-{5-[5-(4-Chlorophenyl)-4H-1,2,4-triazol-3-yl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",6.71,uM,=,0.8267225201689921,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
3256,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1c(/C=N/O)[n+](C)c2ccccc21.[Cl-],"2-(Hydroxyimino-methyl)-1,3-dimethyl-3H-benzoimidazol-1-ium chloride",123.0,uM,=,2.089905111439398,1,c1ccc2[nH+]c[nH]c2c1
3257,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.00233,uM,=,-2.632644078973981,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3258,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),O=[N+]([O-])C1C(Cc2c[nH]cn2)NC2(c3ccccc3-c3nc4ccccc4nc32)C1c1ccc(Cl)cc1,"3'-(4-chlorophenyl)-5'-(1H-imidazol-4-ylmethyl)-4'-nitro-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",18.24,uM,=,1.2610248339923973,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
3259,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Fc1ccc(CN2CCC(CNc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)s3)CC2)c(C(F)(F)F)c1,"N-[(1-(4-Fluoro-2-trifluoromethylbenzyl)piperidin-4-yl)-methyl]-4,5-bis(4-chlorophenyl)thiazol-2-ylamine",1.24,uM,=,0.093421685162235,1,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
3260,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3ccc(Cl)cc13)C1CCC2C1,"6-chloro-10-azatetracyclo[10.2.1.02,11.04,9]pentadeca-2,4,6,8,10-pentaen-3-amine",1.1,uM,=,0.041392685158225,1,c1ccc2nc3c(cc2c1)C1CCC3C1
3261,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CNc2nc(CC(N)=O)nc3ccccc23)cc1OC,"2-((4-((3,4-Dimethoxybenzyl)amino)quinazolin-2-yl)amino)acetamide",7.4,uM,=,0.8692317197309762,1,c1ccc(CNc2ncnc3ccccc23)cc1
3262,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,CN(CCC(=O)NCCCNc1c2c(nc3ccccc13)CCCC2)C1CCCCC1,"N1-[3-(1,2,3,4-Tetrahydroacridin-9-ylamino)propyl]-3-[cyclohexyl(methyl)amino]propanamide",0.398,uM,=,-0.4001169279263121,0,O=C(CCNC1CCCCC1)NCCCNc1c2c(nc3ccccc13)CCCC2
3263,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(Cc1ccccc1OC)C(=O)CCCCCNC1=CC(=O)C(NCCCCCC(=O)N(CC)Cc2ccccc2OC)=CC1=O,"6-(4-{5-[ethyl(2-methoxybenzyl)carbamoyl]pentylamino}-3,6-dioxocyclohexa-1,4-dienylamino)hexanoic acid ethyl(2-methoxybenzyl)amide",11.6,uM,=,1.0644579892269186,1,O=C(CCCCCNC1=CC(=O)C(NCCCCCC(=O)NCc2ccccc2)=CC1=O)NCc1ccccc1
3264,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CCc3nccc4ccccc34)CC2)cc1,1-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-isoquinoline,0.22,uM,=,-0.6575773191777937,0,c1ccc(CN2CCC(CCc3nccc4ccccc34)CC2)cc1
3265,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1ccc2c(=O)c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3oc2c1,3-[7-(benzylmethylamino)heptyloxy]-6-methoxyxanthen-9-one,7.84,uM,=,0.8943160626844384,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
3266,28165,10.1016/s0960-894x(02)00482-1,,,,In vitro inhibition of human recombinant AChE.,C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3c(c2)OCO3)CC1,"4-(3-Benzo[1,3]dioxol-5-yl-3-oxo-propyl)-1-benzyl-1-methyl-piperidinium",0.24,uM,=,-0.619788758288394,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccc2c(c1)OCO2
3267,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,C[n+]1c(/C=C/c2ccccc2)ccc2ccccc21.[I-],(E)-1-Methyl-2-styrylquinolin-1-ium Iodide,4.3,uM,=,0.6334684555795865,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
3268,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CN(C)Cc1ccc(CSCCCCCCCCSCc2ccc(CN(C)C)o2)o1,{5-[8-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-octylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.47,uM,=,-0.3279021420642826,0,c1coc(CSCCCCCCCCSCc2ccco2)c1
3269,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCCC3)cc1)NCC2,"6,7-dimethoxy-1-(4-((6-(piperidin-1-yl)hexyl)oxy)benzyl)-1,2,3,4-tetrahydroisoquinoline",2.14,uM,=,0.3304137733491908,1,c1ccc2c(c1)CCNC2Cc1ccc(OCCCCCCN2CCCCC2)cc1
3270,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCNC1=CC(=O)C(NCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis{2-[ethyl(2-methoxybenzyl)amino]ethylamino}-[1,4]-benzoquinone",0.0615,uM,=,-1.2111248842245832,0,O=C1C=C(NCCNCc2ccccc2)C(=O)C=C1NCCNCc1ccccc1
3271,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{2-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]ethyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",0.0745,uM,=,-1.1278437272517072,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
3272,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(C2(c3cc(C)c(O)c(C)c3)CCCCC2)cc(C)c1O,"4-[1-(4-hydroxy-3,5-dimethylphenyl)cyclohexyl]-2,6-dimethylphenol",15.0,uM,=,1.1760912590556811,1,c1ccc(C2(c3ccccc3)CCCCC2)cc1
3273,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1cc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)cnn1,"3-(4-(Piperidin-1-ylmethyl)phenyl)-6-(pyridazin-4-yl)-9H-pyrrolo-[2,3-b:5,4-c']dipyridine",1.037,uM,=,0.0157787563890409,1,c1cc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)cnn1
3274,2208331,10.1016/j.bmc.2021.116560,,,,Inhibition of human acetylcholinesterase,C=C1c2[nH]c3ccc(OC)cc3c2C2[C@@H](CC)C1CCN2C,Uleine,279.0,uM,=,2.4456042032735974,1,C=C1c2[nH]c3ccccc3c2C2CC1CCN2
3275,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(CCN(C)C)CC3)nc12,3-(4-(2-(Dimethylamino)ethyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,0.48,uM,=,-0.3187587626244128,0,O=C(CCN1CCNCC1)Nc1nc2ccccc2s1
3276,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)/C(=N\NC(=O)c1ccccc1OC(C)=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"[2-[[(Z)-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]amino]carbamoyl]phenyl]acetate",0.046,uM,=,-1.337242168318426,0,O=C(N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1)c1ccccc1
3277,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CCNc2nc(CC(N)=O)nc3ccccc23)cc1OC,"2-((4-((3,4-Dimethoxyphenethyl)amino)quinazolin-2-yl)amino)acetamide",12.5,uM,=,1.0969100130080565,1,c1ccc(CCNc2ncnc3ccccc23)cc1
3278,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCc2ccc(CN(C)C)o2)o1,[5-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanylmethyl)-furan-2-ylmethyl]-dimethyl-amine,44.0,uM,=,1.6434526764861874,1,c1coc(CSCc2ccco2)c1
3279,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1C=CN(Cc3ccccc3)C=C1C(C)=O)CC2,"2-((3-Acetyl-1-benzyl-1,4-dihydropyridin-4-yl)methyl)-6,7-dimethoxy-3,4-dihydronaphthalen-1(2H)-one",0.415,uM,=,-0.3819519032879073,0,O=C1c2ccccc2CCC1CC1C=CN(Cc2ccccc2)C=C1
3280,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccc(Cl)cc1,"N-(4-chlorophenyl)-2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazine-1-carbothioamide",0.786,uM,=,-0.104577453960592,0,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccccc1
3281,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,Ranitidine,2.3,uM,=,0.3617278360175928,1,c1ccoc1
3282,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,Cc1cccc(CN2CCC(CNC(=O)c3cncc(NC(=O)c4ccnc(NC(=O)C5CC5)c4)c3)CC2)c1,5-(2-(Cyclopropanecarboxamido)isonicotinamido)-N-((1-(3-methylbenzyl)piperidin-4-yl)methyl)nicotinamide,6364.0,uM,=,3.803730170974544,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
3283,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1N2C,"methyl-carbamic acid (3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.027,uM,=,-1.5686362358410126,0,c1ccc2c(c1)N[C@H]1OCCC21
3284,305184,10.1016/j.bmcl.2004.10.067,,,,Inhibitory concentration against Acetylcholinesterase activity,COc1ccc(-c2cc3c(c(=O)o2)C[C@@]2(O)[C@@]4(C)CCC(=O)C(C)(C)[C@@]4(O)CC[C@@]2(C)O3)cc1,"4a,12a-dihydroxy-9-(4-methoxyphenyl)-4,4,6a,12b-tetramethyl-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromene-3,11-dione",0.06,uM,=,-1.2218487496163564,0,O=C1CCC2C(CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC32)C1
3285,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3cccc(Cl)c3)CC2)cc(C(C)(C)C)c1O,"(E)-N-(2-(1-(3-chlorobenzyl)piperidin-4-yl)ethyl)-3-(3,5-ditert-butyl-4-hydroxyphenyl)acrylamide",2.54,uM,=,0.404833716619938,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3286,1461400,10.1016/j.bmcl.2014.12.071,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate by Ellman method,O=C1N[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1,"(3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)piperidin-2-one",46.0,uM,=,1.662757831681574,1,O=C1N[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1
3287,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1ccc(C2CC(c3ccc(-c4ccccc4)cc3)=NN2C(C)=O)cc1OC,"1-(3-([1,1'-Biphenyl]-4-yl)-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1426.0,uM,=,3.154119525515847,1,c1ccc(-c2ccc(C3=NNC(c4ccccc4)C3)cc2)cc1
3288,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N(CC)Cc2ccccc2)cc1OC,(E)-4-(3-(benzyl(ethyl)amino)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl ethyl(methyl)carbamate,20.7,uM,=,1.3159703454569178,1,O=C(/C=C/c1ccccc1)NCc1ccccc1
3289,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Cc1cc2c(c(C)c1CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)[C@H](C)C2,(2R)-pterosin B 14-O-beta-D-glucopyranoside,2.55,uM,=,0.4065401804339551,1,O=C1CCc2ccc(CCO[C@H]3CCCCO3)cc21
3290,2215314,10.1016/j.bmc.2022.116742,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by Ellman's method,Clc1ccc2c(NCCCNCC34CC5CC(CC(C5)C3)C4)ccnc2c1,"N1-(1-adamantylmethyl)-N3-(7-chloro-4-quinolinyl)-1,3-propanediamine",0.5,uM,=,-0.3010299956639812,0,c1ccc2c(NCCCNCC34CC5CC(CC(C5)C3)C4)ccnc2c1
3291,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CC)[C@@H]1C2,"(3aS,8aR)-1-ethyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl heptylcarbamate",0.381,uM,=,-0.4190750243243807,0,c1ccc2c(c1)C[C@H]1NCC[C@@H]21
3292,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCOC(=O)c1cc2c(N)c3c(nc2nc1C)CCCCC3,"Ethyl 5-Amino-2-methyl-7,8,9,10-tetrahydro-6H-cyclohepta-[b][1,8]naphthyridine-3-carboxylate",2.0,uM,=,0.3010299956639812,1,c1cnc2nc3c(cc2c1)CCCCC3
3293,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1ccncc1,"1,3-Dimethyl-2-(pyridin-4-yl)-1,2,3,4-tetrahydroquinazolin-6-ol",242.4,uM,=,2.384532615494249,1,c1ccc2c(c1)CNC(c1ccncc1)N2
3294,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,Cc1ccc(S(=O)(=O)N2[C@H](C)CCC[C@@H]2C)cc1,"1-(4-methyl benzene)-sulfonyl-cis-2,6-dimethylpiperidine",0.368,uM,=,-0.4341521813264823,0,O=S(=O)(c1ccccc1)N1CCCCC1
3295,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccccc3Br)cc12.[Br-],2-(2-bromophenyl)-8-methoxyisoquinolinium bromide,5.23,uM,=,0.7185016888672743,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
3296,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,Cl.O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,3-(1-Benzyl-piperidin-4-yl)-1-phenyl-propan-1-one hydrochloride,0.305,uM,=,-0.5157001606532141,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
3297,430853,10.1021/jm0503289,,,,Inhibition of human brain AchE,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)-heptyl]-2-(1H-indol-3-yl)-acetamide",0.00012,uM,=,-3.9208187539523753,0,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3298,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CN1CCN(Cc2ccccc2)CC1,"2-[(4-benzylpiperazin-1-yl)methyl]-2H,3H,4H,4aH,5H,6H-thieno[3,2-h]cinnolin-3-one",13.6,uM,=,1.1335389083702174,1,O=C1CC2CCc3ccsc3C2=NN1CN1CCN(Cc2ccccc2)CC1
3299,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCNCCOCCOCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-N'-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]-3,6-dioxaoctane-1,8-diamine",0.00835,uM,=,-2.078313524516398,0,c1ccc2c(c1)CCC(CCNCCOCCOCCNc1c3c(nc4ccccc14)CCCC3)O2
3300,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,O=C1/C(=C\c2ccc(N3CCCC3)cc2)CNC/C1=C\c1ccc(N2CCCC2)cc1,"3,5-Bis-(4-pyrrolidin-1-yl-benzylidene)-piperidin-4-one",9.52,uM,=,0.9786369483844743,1,O=C1/C(=C\c2ccc(N3CCCC3)cc2)CNC/C1=C\c1ccc(N2CCCC2)cc1
3301,1795973,10.1016/j.ejmech.2018.09.031,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method,C#CCNc1nc(NCCCCC2CCN(Cc3ccccc3)CC2)c(C#N)cc1C#N,"2-(4-(1-benzylpiperidin-4-yl)butylamino)-6-(prop-2-ynylamino)pyridine-3,5-dicarbonitrile",0.001,uM,=,-3.0,0,c1ccc(CN2CCC(CCCCNc3ccccn3)CC2)cc1
3302,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),Cc1ccc2cc(C3CC(c4cc(Cl)sc4Cl)=NN3)c(Cl)nc2c1,"2-Chloro-3-[3-(2,5-dichlorothiophen-3-yl)-4,5-dihydro-1Hpyrazol-5-yl]-7-methylquinoline",0.15,uM,=,-0.8239087409443188,0,c1ccc2ncc(C3CC(c4ccsc4)=NN3)cc2c1
3303,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccccc2)CC1,4-((1-Benzylpiperidin-4-yl)methoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)thiazole-5-carboxamide,1.5,uM,=,0.1760912590556812,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
3304,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,"3,5,7-Trihydroxy-2-phenyl-chromen-4-one",0.012,uM,=,-1.9208187539523751,0,O=c1cc(-c2ccccc2)oc2ccccc12
3305,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,C/N=c1\c(O)c(O)\c1=N/CCNCc1ccc(CN2CCCCC2)o1,"3-Methylamino-4-{2-[(5-piperidin-1-ylmethyl-furan-2-ylmethyl)-amino]-ethylamino}-cyclobut-3-ene-1,2-dione",9.3,uM,=,0.9684829485539352,1,N=c1cc/c1=N\CCNCc1ccc(CN2CCCCC2)o1
3306,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,O=C1COCCN1c1ccc(NCc2cc(Cl)cc(/C=N/O)c2O)cc1,(E)-5-chloro-2-hydroxy-3-((4-(3-oxomorpholino)phenylamino)methyl)benzaldehyde oxime,4177.0,uM,=,3.620864475265121,1,O=C1COCCN1c1ccc(NCc2ccccc2)cc1
3307,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCOC1N2C,"o-Tolyl-carbamic acid (S)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.013,uM,=,-1.8860566476931635,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCOC1N2
3308,2055837,10.1016/j.ejmech.2020.112761,,,,Inhibition of recombinant human AChE,COc1ccc2cc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)ccc2c1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-6-methoxy-2-naphthamide,0.17,uM,=,-0.7695510786217261,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2c1
3309,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2n1C,N-{[5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1-methyl-1Hindol-2-yl]methyl}-N-methylprop-2-yn-1-amine,3.4,uM,=,0.5314789170422551,1,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
3310,1589180,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 60 mins followed by substrate addition by Ellman's method,CCCCCCc1ccc(NC(=O)Oc2cccc(CN(C)CCCOc3ccc4ccc(=O)oc4c3)c2)cc1,3-((Methyl(3-((2-oxo-2H-chromen-7-yl)oxy)propyl)amino)-methyl)phenyl(4-Hexylphenyl)carbamate,3.8,uM,=,0.5797835966168101,1,O=C(Nc1ccccc1)Oc1cccc(CNCCCOc2ccc3ccc(=O)oc3c2)c1
3311,833863,10.1021/np2009626,,,,Inhibition of human AChE pre-incubated for 10 mins before acetylthiocholine iodide substrate addition,CC(=O)Oc1cccc2nc3c(OC(C)=O)ccc(C/C=C(\C)CCC=C(C)C)c3nc12,diacetylgeranylphenazinediol,2.01,uM,=,0.3031960574204888,1,c1ccc2nc3ccccc3nc2c1
3312,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(Cl)c3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-acetamido-3-chlorophenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.08762,uM,=,-1.0573967511578437,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
3313,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,COc1cc(/C=C/c2cc(N3CCN(C)CC3)c3ccccc3[n+]2C)ccc1N1CCN(C)CC1.[I-],(E)-2-(3-Methoxy-4-(4-methylpiperazin-1-yl)styryl)-1-methyl-4-(4-methylpiperazin-1-yl)quinolinium iodide,4.2,uM,=,0.6232492903979004,1,C(=C/c1cc(N2CCNCC2)c2ccccc2[nH+]1)\c1ccc(N2CCNCC2)cc1
3314,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CNc2ccnc(N3CCN(C4CCCCC4)CC3)n2)cc1,N-Benzyl-2-(4-cyclohexylpiperazin-1-yl)pyrimidin-4-amine,22.9,uM,=,1.359835482339888,1,c1ccc(CNc2ccnc(N3CCN(C4CCCCC4)CC3)n2)cc1
3315,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CCC(OC[n+]1ccn(C)c1/C=N/O)C(C)(C)C.[Cl-],"1-(1-Ethyl-2,2-dimethyl-propoxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride",24.0,uM,=,1.380211241711606,1,c1c[nH+]c[nH]1
3316,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1cccc(C2CC(c3cc(F)cc(F)c3)=NN2c2ccc(S(N)(=O)=O)cc2)c1OC,"4-(3-(3,5-difluorophenyl)-5-(2,3-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
3317,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,O/N=C/c1cc(Cl)cc(CNc2ncccc2OCc2ccccc2)c1O,(E)-3-((3-(benzyloxy)pyridin-2-ylamino)methyl)-5-chloro-2-hydroxybenzaldehyde oxime,826.0,uM,=,2.9169800473203824,1,c1ccc(CNc2ncccc2OCc2ccccc2)cc1
3318,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CCN(CCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1cccc(OC(=O)NC)c1,3-((ethyl(5-(9-oxo-9H-xanthen-3-yloxy)pentyl)amino)methyl)phenyl methylcarbamate,0.00082,uM,=,-3.086186147616284,0,O=c1c2ccccc2oc2cc(OCCCCCNCc3ccccc3)ccc12
3319,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CCN(CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1OC,3-{7-[ethyl-(2-methoxybenzyl)amino]heptyloxy}xanthen-9-one,3.15,uM,=,0.4983105537896005,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
3320,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1.[Cl-].[Cl-],4-(aminocarbonyl)-1-({[1-chloro-2-[(E)-(hydroxyimino)methyl]pyridinium-1(2H)-yl]methoxy}methyl)pyridinium chloride,89.0,uM,=,1.9493900066449128,1,c1cc[n+](COC[n+]2ccccc2)cc1
3321,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2cccc3ccccc23)C(=O)/C(=C/c2cccc3ccccc23)C1,"(3E,5E)-1-acryloyl-3,5-bis(naphthalen-1-ylmethylene)piperidin-4-one",13.84,uM,=,1.141136090120739,1,O=C1/C(=C/c2cccc3ccccc23)CNC/C1=C\c1cccc2ccccc12
3322,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O,"N-{5-Chloro-4-[(4-chloro-phenyl)-cyano-methyl]-2-methyl-phenyl}-2-hydroxy-3,5-diiodo-benzamide",2.951,uM,=,0.4699692094999594,1,O=C(Nc1ccc(Cc2ccccc2)cc1)c1ccccc1
3323,327131,10.1021/jm050746d,,,,Inhibition of human AChE,O=C(CCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NCCc1c[nH]c2ccccc12,"7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",0.0001,uM,=,-4.0,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
3324,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CCN(CC)CCCCCCOc1ccc(/C=C2\COc3ccccc3C2=O)cc1,(E)-3-(4-((6-(diethylamino)hexyl)oxy)benzylidene)chroman-4-one,1.85,uM,=,0.2671717284030138,1,O=C1/C(=C/c2ccccc2)COc2ccccc21
3325,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1,"N4-Benzyl-N2-(1-benzylpiperidin-4-yl)pyrimidine-2,4-diamine",12.4,uM,=,1.0934216851622351,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
3326,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),Cc1ccc(NCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3oc12,"4-methyl-1-((2-((1S,9aR)-octahydro-2H-quinolizin-1-yl)ethyl)amino)-9H-xanthen-9-one",0.14,uM,=,-0.8538719643217619,0,O=c1c2ccccc2oc2cccc(NCC[C@@H]3CCCN4CCCC[C@H]34)c12
3327,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,Cc1c(OC(=O)N(C)C)c2c(c[n+]1C)COC(C(C)(C)C)OC2.[Br-],"1,5-Dihydro-3-tert-butyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",110.0,uM,=,2.041392685158225,1,c1cc2c(c[nH+]1)COCOC2
3328,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2[se]n(-c3ccc(CCN4CCCC4)cc3)c(=O)c2cc1OC,"5,6-Dimethoxy-2-(4-(2-(pyrrolidin-1-yl)ethyl)phenyl)benzo[d][1,2]selenazol-3(2H)-one",13.94,uM,=,1.1442627737619906,1,O=c1c2ccccc2[se]n1-c1ccc(CCN2CCCC2)cc1
3329,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),COc1ccc([C@@H]2N[C@@H](C(=O)O)Cc3c2n(C)c2ccccc32)cc1OC,"(1S,3R)-1-(3,4-dimethoxyphenyl)-9-methyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-3-carboxylic acid",2.5,uM,=,0.3979400086720376,1,c1ccc([C@@H]2NCCc3c2[nH]c2ccccc32)cc1
3330,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,CN(Cc1ccc(C(=O)NCCc2c[nH]c3ccccc23)cc1)Cc1cccc(Cl)c1,N-[2-(1H-Indol-3-yl)ethyl]-4-{[(3-chlorobenzyl)(methyl)-amino]methyl}benzamide,5.1,uM,=,0.7075701760979364,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
3331,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,c1ccc2c(c1)c1cnccc1n2CCCCCCCCCn1c2ccccc2c2cnccc21,"1,9-bis(5H-pyrido[4,3-b]indol-5-yl)nonane",0.08,uM,=,-1.0969100130080565,0,c1ccc2c(c1)c1cnccc1n2CCCCCCCCCn1c2ccccc2c2cnccc21
3332,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCN(CC)CCCCOc1ccc(/C=C/C(=O)c2c(O)cc(OCCCCN(CC)CC)cc2O)cc1,"1-(4-(4-(diethylamino)butoxy)-2,6-dihydroxyphenyl)-3-(4-(4-(diethylamino)butoxy)phenyl)prop-2-en-1-one",4.7,uM,=,0.6720978579357175,1,O=C(/C=C/c1ccccc1)c1ccccc1
3333,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,Cc1ccc(N2C(=O)C3CN(C)C4(C(=O)c5ccccc5C4=O)C3C2=O)cc1,"2'-Methyl-5'-(p-tolyl)-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",7.34,uM,=,0.8656960599160706,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
3334,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3ccccc13)OCCC2,"3,4-Dihydro-2H-1-oxa-9-aza-anthracen-10-ylamine",0.266,uM,=,-0.575118363368933,0,c1ccc2nc3c(cc2c1)CCCO3
3335,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3ccc(Cl)cc13)CCCC2,"7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",3.68,uM,=,0.5658478186735176,1,c1ccc2nc3c(cc2c1)CCCC3
3336,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)CCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1,N1-dimethyl-N7-(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine",0.052,uM,=,-1.2839966563652008,0,c1ccc2nc3c(cc2c1)CCCC3
3337,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCCCC[n+]1cccc2ccccc21,"1,1'-pent-1,5-diyl-bis(quinolinium)dibromide",4.0,uM,=,0.6020599913279624,1,c1ccc2c(c1)ccc[n+]2CCCCC[n+]1cccc2ccccc21
3338,1984129,10.1021/acs.jmedchem.9b01617,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated for 60 mins followed by substrate addition by Ellman's method,C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21,Ethyl-methyl-carbamic acid 3-((R)-prop-2-ynylamino)-indan-5-yl ester,31.8,uM,=,1.5024271199844328,1,c1ccc2c(c1)CCC2
3339,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCCCCCCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-tridecyl-7-methoxytacrine hydrochloride,100.0,uM,=,2.0,1,c1ccc2nc3c(cc2c1)CCCC3
3340,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCN(Cc4ccccc4)CC3)cc1)NCC2,"1-(4-((6-(4-benzylpiperazin-1-yl)hexyl)oxy)benzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline",5.59,uM,=,0.7474118078864233,1,c1ccc(CN2CCN(CCCCCCOc3ccc(CC4NCCc5ccccc54)cc3)CC2)cc1
3341,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[8-(benzylmethylamino)octyloxy]xanthen-9-one,10.3,uM,=,1.0128372247051722,1,O=c1c2ccccc2oc2cc(OCCCCCCCCNCc3ccccc3)ccc12
3342,2057880,10.1016/j.ejmech.2020.113124,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 10 mins by Ellman's method,Cn1c(=O)sc2cc(C(=O)CCN3CCN(Cc4ccccc4)CC3)ccc21,3-Methyl-6-[3-(4-benzylpiperazin-1-yl)propanoyl]benzothiazol-2(3H)-one,0.46,uM,=,-0.3372421683184259,0,O=C(CCN1CCN(Cc2ccccc2)CC1)c1ccc2[nH]c(=O)sc2c1
3343,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,O/N=C/c1cc(Cl)cc(CNc2ccc(N3CCOCC3)c(F)c2)c1O,(E)-5-chloro-3-((3-fluoro-4-morpholinophenylamino)methyl)-2-hydroxybenzaldehyde oxime,5917.0,uM,=,3.772101569277012,1,c1ccc(CNc2ccc(N3CCOCC3)cc2)cc1
3344,305005,10.1021/jm049113+,,,,Inhibitory concentration against Acetylcholinesterase; (range = 2-20 uM),CCN(CC)CCN1CC(=O)N(CCc2ccccc2)CC1=O,"1-(2-Diethylamino-ethyl)-4-phenethyl-piperazine-2,5-dione",20.0,uM,=,1.3010299956639813,1,O=C1CN(CCc2ccccc2)C(=O)CN1
3345,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1F,"2-(6-(2-Fluorobenzylamino)hexyl)isoindoline-1,3-dione",0.941,uM,=,-0.0264103765727431,0,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
3346,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),CN(C)Cc1c(O)c(O)c(O)c2c(=O)cc(-c3ccccc3)oc12,"5,6,7-Trihydroxy-8-(dimethylamino)-2-phenyl-4Hchromen-4-one",81.99,uM,=,1.913760886412323,1,O=c1cc(-c2ccccc2)oc2ccccc12
3347,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(Cc1cc(Cl)cc(/C=N/O)c1O)CC2,"5-chloro-3-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",1207.0,uM,=,3.081707270097349,1,c1ccc(CN2CCc3ccccc3C2c2ccccc2)cc1
3348,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1c[nH]c2ccccc12,N-[Indole-3-carbonyl]-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-ethyl,1.9,uM,=,0.2787536009528289,1,O=C(CCCNC(=O)c1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
3349,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(CN(C)CCCCCOc2ccc3c4c(c(=O)oc3c2)CCCC4)c1,"3-((methyl(5-(6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yloxy)pentyl)amino)methyl)phenyl heptylcarbamate",0.0183,uM,=,-1.7375489102695705,0,O=c1oc2cc(OCCCCCNCc3ccccc3)ccc2c2c1CCCC2
3350,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN(C)CCCOc2ccc3c(c2)oc(=O)c2ccccc23)c1,3-(3-((3-Methoxybenzyl)(methyl)amino)propoxy)-6H-benzo[c]chromen-6-one,20.9,uM,=,1.320146286111054,1,O=c1oc2cc(OCCCNCc3ccccc3)ccc2c2ccccc12
3351,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C/C(=C\CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)C3=CC[C@]12C)CO,ganoderol B,26.78,uM,=,1.4278105726759902,1,C1=C2C(=CCC3CCCC23)C2CCCC[C@@H]2C1
3352,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1ccc2c(c1)C[C@@H](NC(=O)N(C)C)CC2,"(S)-3-(7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylurea",0.02241,uM,=,-1.649558143464939,0,c1ccc2c(c1)CCCC2
3353,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CN(CCCCCCCOc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(OCCN3CCOCC3)cc2)cc1)Cc1ccccc1,(2-{4-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-[4-(2-morpholinoethoxy)-phenyl]methanone,39.0,uM,=,1.591064607026499,1,O=C(c1ccc(OCCN2CCOCC2)cc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
3354,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(Cc4cccc(Br)c4)CC3)cc1)C2.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-1-[(4-(3-bromobenzyl)-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one bromide",1.99,uM,=,0.2988530764097066,1,O=C1/C(=C/c2ccc(N3CC[NH+](Cc4ccccc4)CC3)cc2)Cc2ccccc21
3355,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1c2c(nc3nc(-c4ccccc4)cc(C(F)(F)F)c13)CCCCCC2,"2-Phenyl-4-(trifluoromethyl)-6,7,8,9,10,11-hexahydrocycloocta[b][1,8]-naphthyridin-5-amine",7.69,uM,=,0.8859263398014311,1,c1ccc(-c2ccc3cc4c(nc3n2)CCCCCC4)cc1
3356,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,CC(C)(C)OC(=O)N1Cc2[nH]c3ccccc3c2C[C@H]1C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-tert-Butyl-3-((6-((1,2,3,4-tetrahydroacridin-9-yl)-amino)hexyl)carbamoyl)-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate",0.187,uM,=,-0.728158393463501,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1
3357,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1C=CN(Cc3cccc(Cl)c3)C=C1C(N)=O)C2,"1-[(3-Chlorophenyl)methyl]-4-[(5,6-dimethoxy-1-oxo-indan-2-yl)methyl]-4H-pyridine-3-carboxamide",26.95,uM,=,1.4305587695227575,1,O=C1c2ccccc2CC1CC1C=CN(Cc2ccccc2)C=C1
3358,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2oc1=O,"7-((1-benzylpiperidin-4-yl)methoxy)-3,4-dimethyl-2H-chromen-2-one",0.38,uM,=,-0.4202164033831898,0,O=c1ccc2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2o1
3359,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,O=C1C[C@@H](c2ccc(O)c(O)c2)Oc2cc(O)cc(O)c21,"(S)-2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-chroman-4-one",1663.8,uM,=,3.221101119961505,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
3360,1632485,10.1016/j.ejmech.2016.08.016,,,,Inhibition of human recombinant AChE preincubated for 5 mins followed by acetylthiocholine iodide substrate addition measured after 5 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.131,uM,=,-0.8827287043442358,0,c1ccc2nc3c(cc2c1)CCCC3
3361,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCCCCCCCCCCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,12-Bis-(4-tert-butylpyridinium)dodecane dibromide",0.007,uM,=,-2.154901959985743,0,c1cc[n+](CCCCCCCCCCCC[n+]2ccccc2)cc1
3362,1539619,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 8,COC(=O)C1=C(C)OP(=O)(OC)CCC1,"2-Methoxy-7-methyl-2-oxo-2,3,4,5-tetrahydro-2lambda*5*-[1,2]oxaphosphepine-6-carboxylic acid methyl ester",12.0,uM,=,1.0791812460476249,1,O=[PH]1CCCC=CO1
3363,1454788,10.1016/j.ejmech.2014.07.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric analysis,O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"N-(8-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)-5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-9-carboxamide",0.0193,uM,=,-1.714442690992226,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
3364,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12c1ccccc1-c1nc3ccccc3nc12,"5-amino-8-nitro-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,11'-indeno[1,2-b]quinoxaline]-6-carbonitrile",6.4,uM,=,0.8061799739838872,1,C1=CC2(C=C3NCCN13)c1ccccc1-c1nc3ccccc3nc12
3365,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.412,uM,=,-0.3851027839668654,0,c1ccc2nc3c(cc2c1)CCCC3
3366,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2,"3-(4-(4-Benzylpiperazin-1-yl)butoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",6.4,uM,=,0.8061799739838872,1,O=c1oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2
3367,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COCc2cccc3ccccc23)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-(naphthalen-1-ylmethoxymethyl)-3H-imidazol-1-ium chloride,3.8,uM,=,0.5797835966168101,1,c1ccc2c(COC[n+]3cc[nH]c3)cccc2c1
3368,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1c(Cl)nc(NCCCCC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-((4-(1-Benzylpiperidin-4-yl)butyl)amino)-6-chloro-4-phenylpyridine-3,5-dicarbonitrile",0.031,uM,=,-1.5086383061657274,0,c1ccc(CN2CCC(CCCCNc3cc(-c4ccccc4)ccn3)CC2)cc1
3369,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(c4ccccn4)CC3)nc12,N-(4-Methylbenzo[d]thiazol-2-yl)-3-(4-(pyridin-2-yl)-piperazin-1-yl)propanamide,17.23,uM,=,1.2362852774480284,1,O=C(CCN1CCN(c2ccccn2)CC1)Nc1nc2ccccc2s1
3370,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2Cl)CC1)c1ccc2c(c1)CCN2,"3-[1-(2-Chloro-benzyl)-piperidin-4-yl]-1-(2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.076,uM,=,-1.1191864077192086,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
3371,775052,10.1016/j.ejmech.2011.09.001,,,,Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,COc1cccc(C(C)N(C)CCCNC(=O)CCCCC2CCSS2)c1,"5-(1,2-dithiolan-3-yl)-N-(3-((1-(3-methoxyphenyl)ethyl)(methyl)amino)propyl)pentanamide",74.10000000000001,uM,=,1.869818207979328,1,O=C(CCCCC1CCSS1)NCCCNCc1ccccc1
3372,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{2-[(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino]ethyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",2.64,uM,=,0.421603926869831,1,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
3373,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3ccccc3)C(=O)[C@@]3(C2)[C@H](c2ccccc2)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(phenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(phenyl)pyrrolidine,2.63,uM,=,0.4199557484897578,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
3374,1584962,10.1021/acs.jmedchem.6b00078,,,,Inhibition of AChE (unknown origin),CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,"5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide",5.87,uM,=,0.7686381012476144,1,O=C1Nc2ccccc2/C1=C/c1ccc[nH]1
3375,1786413,10.1039/C7MD00449D,,,,Inhibition of human serum AChE,Fc1ccc2c(C3CCN(CCN4CCCC4)CC3)noc2c1,6-fluoro-3-(1-(2-(pyrrolidin-1-yl)ethyl)piperidin-4-yl)benzo[d]isoxazole,3.29,uM,=,0.5171958979499743,1,c1ccc2c(C3CCN(CCN4CCCC4)CC3)noc2c1
3376,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)cc3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-acetamidophenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.13205,uM,=,-0.8792615944570572,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
3377,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CC(C)c1ccc(NC(=O)OC2CCN(C3Cc4ccccc4C3)CC2)cc1,"1-(2,3-dihydro-1H-inden-2-yl)piperidin-4-yl (4-isopropylphenyl)carbamate",2.3080000000000003,uM,=,0.3632358044836938,1,O=C(Nc1ccccc1)OC1CCN(C2Cc3ccccc3C2)CC1
3378,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCC(Cc5ccccc5)CC4)cc3)C2)cc1OC,"1-(5-(4-(4-Benzylpiperidin-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",20.1,uM,=,1.3031960574204888,1,c1ccc(CC2CCN(c3ccc(C4CC(c5ccccc5)=NN4)cc3)CC2)cc1
3379,1935994,10.1021/acs.jnatprod.8b00705,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 5 mins by spectrophotometric analysis,COc1cc(O)c(C(C)=O)c(-c2c(C)cc(O)c3oc4c(O)cc(C)c(-c5cc(OC)cc(O)c5C(=O)O)c4c23)c1,Bialternacin D,68.3,uM,=,1.8344207036815323,1,c1ccc(-c2cccc3oc4cccc(-c5ccccc5)c4c23)cc1
3380,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1c(/C=N/Nc2ccc(C(F)(F)F)cc2)coc2c1ccc1oc(-c3ccc(Cl)cc3)cc12,"8-(4-chlorophenyl)-3-((2-(4-(trifluoromethyl)phenyl)hydrazineylidene)methyl)-4H-furo[2,3-h]chromen-4-one",5.4,uM,=,0.7323937598229685,1,O=c1c(/C=N/Nc2ccccc2)coc2c1ccc1oc(-c3ccccc3)cc12
3381,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccccc2CCCC1CC1CCN(c2ccccc2)CC1,"6-((1-phenylpiperidin-4-yl)methyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one",15.0,uM,=,1.1760912590556811,1,O=C1c2ccccc2CCCC1CC1CCN(c2ccccc2)CC1
3382,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1ccc([C@H]2Oc3cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c3C(=O)[C@@H]2O)cc1O,4'-O-methyldiplacol,31.9,uM,=,1.5037906830571812,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
3383,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,C=CC[N+](C)(C)c1ccccc1O.[Br-],Allyl-(2-hydroxy-phenyl)-dimethyl-ammonium bromide,1.85,uM,=,0.2671717284030138,1,c1ccccc1
3384,1567401,10.1016/j.bmc.2016.04.002,,,,Inhibition of AChE (unknown origin) using acetylcholine iodate as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1ccc2c(c1)CCC(NC(=O)N(C)C)C2,"3-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-1,1-dimethylurea",0.01638,uM,=,-1.7856861025756003,0,c1ccc2c(c1)CCCC2
3385,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccc(Cl)cc21,2-Chloro-(10H-phenoselenazin-10-yl)-(phenyl)methanone,6.0,uM,=,0.7781512503836436,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
3386,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(Cc1cc(Br)cc(/C=N/O)c1O)CC2,"5-bromo-3-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",895.8,uM,=,2.952211058108669,1,c1ccc(CN2CCc3ccccc3C2c2ccccc2)cc1
3387,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,O=C(CCn1c2ccncc2c2cc(F)ccc21)N1c2ccccc2Sc2ccccc21,"3-(8-fluoro-5H-pyrido[4,3-b]indol-5-yl)-1-(10H-phenothiazin-10-yl)propan-1-one",6.2,uM,=,0.7923916894982539,1,O=C(CCn1c2ccccc2c2cnccc21)N1c2ccccc2Sc2ccccc21
3388,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(Nc3ccc(-c4ccccc4)nn3)CC2)cc1,N-(1-benzylpiperidin-4-yl)-6-phenylpyridazin-3-amine,65.0,uM,=,1.812913356642856,1,c1ccc(CN2CCC(Nc3ccc(-c4ccccc4)nn3)CC2)cc1
3389,1586651,10.1016/j.bmcl.2016.05.046,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.08,uM,=,-1.0969100130080565,0,c1ccc2c(c1)N[C@H]1NCCC21
3390,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,COS(=O)(=O)[O-].C[N+](C)(C)c1cccc(OC(=O)Nc2ccccc2)c1,"N,N,N-trimethyl-3-(phenylcarbamoyloxy)benzenaminium methyl sulfate",1.875,uM,=,0.2730012720637376,1,O=C(Nc1ccccc1)Oc1ccccc1
3391,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,6.5,uM,=,0.8129133566428556,1,c1ccccc1
3392,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N@@+](C)([O-])[C@@H]1N2C.Cl,"1-Hydroxy-1,3a,8-trimethyl-5-o-tolylcarbamoyloxy-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium: Hydrochloride",0.18,uM,=,-0.744727494896694,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+][C@@H]1N2
3393,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COC(=O)C[N+]1(C)CCC(CCC(=O)c2cc3cc(OC)c(OC)cc3s2)CC1.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methoxycarbonylmethyl-1-methyl-piperidinium bromide",0.054,uM,=,-1.2676062401770316,0,O=C(CCC1CC[NH2+]CC1)c1cc2ccccc2s1
3394,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccccc3)CC2)cc1OC,"(2-(1-(3,4-dimethoxybenzyl)piperidin-4-yl)benzofuran-3-yl)(phenyl)methanone",45.31,uM,=,1.6561940621791855,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
3395,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=c1cc(-c2ccc(OCCCCN3CCN(Cc4ccccc4)CC3)cc2)oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)cc(O)c12,7-(4-(4-benzylpiperazin-1-yl)butoxy)-2-(4-(4-(4-benzylpiperazin-1-yl)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one,1.0,uM,=,0.0,0,O=c1cc(-c2ccc(OCCCCN3CCN(Cc4ccccc4)CC3)cc2)oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc12
3396,1776929,10.1016/j.bmcl.2018.07.019,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate by UV-visible spectrophotometric Ellman's method,COc1ccc2c(c1)C/C(=C/c1ccccc1-c1ccccc1)C2=O,"2-([1,1'-Biphenyl]-2-ylmethylene)-5-methoxy-2,3-dihydro-1H-inden-1-one",0.0298,uM,=,-1.5257837359237447,0,O=C1/C(=C\c2ccccc2-c2ccccc2)Cc2ccccc21
3397,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccc2c(c1)C(=O)c1ccccc1C2=O)Cc1ccccc1,"N-(2-(2-(benzyl(methyl)amino)ethoxy)ethylcarbamothioyl)-9,10-dioxo-9,10-dihydroanthracene-2-carboxamide",0.006,uM,=,-2.2218487496163566,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
3398,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,CN1CCN(CCC(=O)Nc2n[nH]c3ncccc23)CC1,"3-(4-Methylpiperazin-1-yl)-N-(1H-pyrazolo[3,4-bjpyridin-3-yl)propanamide",0.8440000000000001,uM,=,-0.0736575533743449,0,O=C(CCN1CCNCC1)Nc1n[nH]c2ncccc12
3399,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(-c3ccccc3)cc2)CC1c1ccccc1,"1-(3-([1,1'-Biphenyl]-4-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1328.0,uM,=,3.1231980750319988,1,c1ccc(-c2ccc(C3=NNC(c4ccccc4)C3)cc2)cc1
3400,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,COc1ccc([C@@H]2CN(C)C3(C(=O)c4ccccc4C3=O)[C@]23CSc2ccccc2C3=O)cc1,"(3'R,4'S)-4'-(4-Methoxyphenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",1.16,uM,=,0.0644579892269184,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
3401,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCn1c(=O)c(=O)n(CCCCCCN(CC)Cc2ccccc2OC)c2ccccc21)Cc1ccccc1OC,"1,4-bis(6-(ethyl(2-methoxybenzyl)amino)hexyl)quinoxaline-2,3(1H,4H)-dione",0.00141,uM,=,-2.8507808873446203,0,O=c1c(=O)n(CCCCCCNCc2ccccc2)c2ccccc2n1CCCCCCNCc1ccccc1
3402,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccc(C)cc1)C(=O)C(F)(F)F,"Ethyl(2Z)-4,4,4-trifluoro-2-[2-(4-methylphenyl)hydrazinylidene]-3-oxobutanoate",7.32,uM,=,0.8645110810583919,1,c1ccccc1
3403,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2[N+](=O)[O-])=CC1=O)Cc1ccccc1[N+](=O)[O-],"2,5-bis{6-[ethyl(2-nitrobenzyl)amino]hexylamino}-[1,4]-benzoquinone",2.31,uM,=,0.3636119798921443,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3404,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CCCN(CCC)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((dipropylamino)methyl)phenol dihydrochloride,131.1,uM,=,2.117602691690084,1,c1ccccc1
3405,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccc(Br)cc4)cc3)ccc12.[Br-],1-(4-Bromobenzyl)-4-(((4-methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)pyridin-1-ium bromide,0.2175,uM,=,-0.6625407387093438,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
3406,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccc(Cl)cc2)N(c2ccccc2)[C@@H]1c1ccc(Cl)cc1,"(2R,6S)-methyl 2,6-bis(4-chlorophenyl)-1-phenyl-4-(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",880.0,uM,=,2.9444826721501687,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
3407,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCC(=O)N1Cc2ccc3c4c(ccc(c24)C1)CN(C(=O)CCCCCN(CC)Cc1ccccc1OC)C3)Cc1ccccc1OC,"1,1'-(benzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl)bis(6-(ethyl(2-methoxybenzyl)amino)hexan-1-one)",0.00483,uM,=,-2.316052869248488,0,O=C(CCCCCNCc1ccccc1)N1Cc2ccc3c4c(ccc(c24)C1)CN(C(=O)CCCCCNCc1ccccc1)C3
3408,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{7-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",0.0517,uM,=,-1.2865094569060576,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
3409,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4ccccc4N)[nH]3)ccc21,"(S)-2-(5-{1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl}-4H-1,2,4-triazol-3-yl)aniline",359.72,uM,=,2.5559645847414223,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
3410,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OC(=O)N(C)C,(E)-2-Methoxy-4-(3-oxo-3-(piperidin-1-yl)prop-1-en-1-yl)phenyl dimethylcarbamate,9.1,uM,=,0.9590413923210936,1,O=C(/C=C/c1ccccc1)N1CCCCC1
3411,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Fc1cc(F)cc(CN2CCC(CNc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)s3)CC2)c1,"N-[(1-(3,5-Difluorobenzyl)piperidin-4-yl)methyl]-4,5-bis(4-chlorophenyl)thiazol-2-ylamine",0.63,uM,=,-0.2006594505464183,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
3412,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,O=C(Nc1ccccc1)OCC1CCN(Cc2ccccc2)CC1,(1-benzylpiperidin-4-yl)methyl phenylcarbamate,7.31,uM,=,0.8639173769578604,1,O=C(Nc1ccccc1)OCC1CCN(Cc2ccccc2)CC1
3413,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)c1ccccc1O,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester; compound with 2-hydroxy-benzoic acid",0.028,uM,=,-1.5528419686577808,0,c1ccc2c(c1)N[C@H]1NCCC21.c1ccccc1
3414,1801064,10.1016/j.ejmech.2018.07.033,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured for 1 min by Ellman's assay,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.1148,uM,=,-0.9400581119380452,0,c1ccc2nc3c(cc2c1)CCCC3
3415,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1CSC(c2ccc(F)cc2)N1c1ccc2oc(=O)ccc2c1,2-(4-Fluorophenyl)-3-(2-oxo-2H-chromen-6-yl)thiazolidin-4-one,0.102,uM,=,-0.9913998282380824,0,O=C1CSC(c2ccccc2)N1c1ccc2oc(=O)ccc2c1
3416,471590,10.1016/j.bmc.2007.12.048,,,,Inhibition of AChE,OCC1CCN(Cc2ccc(OCCCN3CCCCC3)cc2)CC1,(1-(4-(3-(piperidin-1-yl)propoxy)benzyl)piperidin-4-yl)methanol,1.1,uM,=,0.041392685158225,1,c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1
3417,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C2\CN(Cc3ccccc3)C/C(=C\c3ccc(C(OCC)OCC)cc3)C2=O)cc1,"1-Benzyl-3,5-bis[4-(diethoxymethyl)benzylidene]piperidin-4-one",27.54,uM,=,1.4399639359209049,1,O=C1/C(=C/c2ccccc2)CN(Cc2ccccc2)C/C1=C\c1ccccc1
3418,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,CCN(CCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1OC,"2-[3-[[(2-Methoxyphenyl)methyl]ethylamino]propyl]-1H-isoindole-1,3(2H)-dione",4.5,uM,=,0.6532125137753437,1,O=C1c2ccccc2C(=O)N1CCCNCc1ccccc1
3419,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(C)cc2)nn1C(=O)N(C)C,"5-Methylsulfanyl-3-p-tolyl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.8,uM,=,-0.0969100130080563,0,c1ccc(-c2nc[nH]n2)cc1
3420,28596,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 33.2-96.7,C#CCNC1CCc2cccc(OC(=O)N(C)CCC)c21.Cl,Methyl-propyl-carbamic acid 3-prop-2-ynylamino-indan-4-yl ester hydrochloride,45.8,uM,=,1.6608654780038692,1,c1ccc2c(c1)CCC2
3421,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1cccc2ccccc12,"1,3-Dimethyl-2-(naphthalen-1-yl)-1,2,3,4-tetrahydroquinazolin-6-ol",341.7,uM,=,2.5336449787987627,1,c1ccc2c(c1)CNC(c1cccc3ccccc13)N2
3422,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,Oc1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1O,"N-[3',4'-(Dihidroxy)phenyl)methyl]-1,2,3,4-tetrahydroacridin-9-amine",0.1,uM,=,-1.0,0,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
3423,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccccc1)C1CCCCC1,1-Benzoyl-3-{2-[2-(cyclohexyl-methyl-amino)-ethoxy]-ethyl}-thiourea,0.013,uM,=,-1.8860566476931635,0,O=C(NC(=S)NCCOCCNC1CCCCC1)c1ccccc1
3424,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,Oc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1,"N-[5'-(4''-Hydroxyphenethyloxy)pentyl]-1,2,3,4-tetrahydroacridin-9-amine",0.142,uM,=,-0.8477116556169436,0,c1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
3425,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.041,uM,=,-1.3872161432802643,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3426,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1ccc2nc3c(c(N)c2c1)CCCC3,"7-Methyl-1,2,3,4-tetrahydro-acridin-9-ylamine",8.1,uM,=,0.9084850188786496,1,c1ccc2nc3c(cc2c1)CCCC3
3427,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CC1S/C(=N/c2ccc(C3CCCCC3)cc2)NC1=O)Nc1ccc(OC(F)(F)F)cc1,2-[2-(4-Cyclohexyl-phenylimino)-4-oxo-thiazolidin-5-yl]-N-(4-trifluoromethoxy-phenyl)-acetamide,2.9,uM,=,0.4623979978989561,1,O=C(CC1S/C(=N/c2ccc(C3CCCCC3)cc2)NC1=O)Nc1ccccc1
3428,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,Cc1nc(C(=O)NCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,"1-Methyl-N-(4-((1,2,3,4-tetrahydroacridin-9-yl)amino)-butyl)-9H-pyrio[3, 4-b]indole-3-carboxamide",0.325,uM,=,-0.4881166390211256,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c(cn1)[nH]c1ccccc12
3429,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)c(O)c2)cc1,"N-(4-((benzyl(methyl)amino)methyl)phenyl)-2-(3,4-dihydroxyphenyl)acetamide",4.63,uM,=,0.6655809910179531,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
3430,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(Cc1cc(Br)cc(/C=N/O)c1O)CC2,"5-bromo-3-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxybenzaldehyde oxime",956.7,uM,=,2.980775773962621,1,c1ccc(CN2CCc3ccccc3C2)cc1
3431,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.3,uM,=,-0.5228787452803376,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
3432,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,COc1cc(CNC2CCN(Cc3ccccc3)C2)cc(OC)c1OC,"1-Benzyl-N-(3,4,5-trimethoxybenzyl)pyrrolidin-3-amine",3.125,uM,=,0.494850021680094,1,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
3433,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@H](C1)C2.Cl,SID535370,0.00043,uM,=,-3.3665315444204134,0,C1=C[C@@H]2Cc3nc4ccccc4cc3[C@H](C1)C2
3434,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,Cc1ccccc1/C=C1\CN(C(=O)[C@@H]2CCN(C)[C@]23C(=O)Nc2ccccc23)C[C@]2(C1=O)[C@H](c1ccccc1C)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(2-methylphenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(2-methylphenyl)pyrrolidine,9.43,uM,=,0.9745116927373284,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
3435,28448,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.66-3.14,CN(C)C(=O)Oc1ccc2c(c1)C(N(C)C)CC2.Cl,Dimethyl-carbamic acid 3-dimethylamino-indan-5-yl ester hydrochloride,2.15,uM,=,0.3324384599156053,1,c1ccc2c(c1)CCC2
3436,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,CC(CC(=O)C[C@@H](C)[C@H]1C[C@H](O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC3)C(=O)O,ganolucidic acid A,22.97,uM,=,1.361160995195026,1,O=C1CCC2C3=C(CC[C@H]2C1)C1CCCC1CC3=O
3437,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccccc2F)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(2-bromobenzoyl)piperazin-1-yl)ethanone,20.2,uM,=,1.305351369446624,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
3438,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1cccc3ccccc13)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(Naphthalen-1-yl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",16.48,uM,=,1.216957207361097,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1cccc3ccccc13)[C@@]21CSc2ccccc2C1=O
3439,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCc3cc[n+](Cc4cccc(F)c4)cc3)c2c1.[Br-],1-(3-fluorobenzyl)-4-(3-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-3-oxo propyl)pyridin-1-ium bromide,0.44,uM,=,-0.3565473235138126,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)NCCc1c[nH]c2ccccc12
3440,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Cc1ccc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc2c1,4-(2-(4-(5-methyl-1H-benzo[d]imidazol-2-yl)phenoxy)ethyl)morpholine,12.92,uM,=,1.1112625136590653,1,c1ccc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc2c1
3441,826907,10.1021/ml200313p,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 120 mins before substrate addition by Ellman's method,CN(CCCOc1ccc2c(=O)c3cccnc3oc2c1)Cc1cccc(OC(=O)NCCCCCc2ccccc2)c1,(5-Phenylpentyl)carbamic acid 3-({methyl-[3-(10-oxo-10H-9-oxa-1-azaanthracen-7-yloxy)propyl]amino]methyl}phenyl ester,0.0895,uM,=,-1.048176964684088,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3c(=O)c4cccnc4oc3c2)c1
3442,28609,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 6.02-21.4,CCN(C)C(=O)Oc1cccc2c1C(N)CC2.Cl,Ethyl-methyl-carbamic acid 3-amino-indan-4-yl ester hydrochloride,10.5,uM,=,1.021189299069938,1,c1ccc2c(c1)CCC2
3443,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,Brc1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1,"N2-(1-Benzylpiperidin-4-yl)-N4-(4-bromobenzyl)pyrimidine-2,4-diamine",9.9,uM,=,0.99563519459755,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
3444,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,O=[N+]([O-])c1ccc(/C=N\C2CCN(Cc3ccccc3)C2)cc1,N-(1-Benzylpyrrolidin-3-yl)-1-(4-nitrophenyl)methanimine,2.461,uM,=,0.3911116137028025,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
3445,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"4'-(3-((Ethyl)(2-methoxybenzyl)amino)propoxy)-5,6,7-trimethoxyflavone",0.2,uM,=,-0.6989700043360187,0,O=c1cc(-c2ccc(OCCCNCc3ccccc3)cc2)oc2ccccc12
3446,2164642,10.1021/acs.jmedchem.1c01748,,,,Inhibition of recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells using acetylthiocholine iodide as substrate measured for 6 mins by Ellman's method,OC[C@H]1O[C@@H](OCCCCc2cn(CCCCc3ccc(O)c(/C=N/O)n3)nn2)[C@H](O)[C@@H](O)[C@@H]1O,"(E)-3-hydroxy-6-(4-(4-(4-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)butyl)-1H-1,2,3-triazol-1-yl)butyl)picolinaldehyde oxime",580.0,uM,=,2.7634279935629373,1,c1ccc(CCCCn2cc(CCCCO[C@H]3CCCCO3)nn2)nc1
3447,1837068,10.1016/j.ejmech.2019.07.040,,,,Inhibition of human AChE,COc1cc2c(cc1OC)-c1cc(OCCN3CCCCC3)nc(=O)n1CC2,"9,10-dimethoxy-2-[2-(1-piperidyl)ethoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one",5.0,uM,=,0.6989700043360189,1,O=c1nc(OCCN2CCCCC2)cc2n1CCc1ccccc1-2
3448,555178,10.1016/j.bmcl.2008.05.039,,,,Inhibition of AchE,O=c1c2ccccc2nc2n1CCC2,"2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one",82.5,uM,=,1.916453948549925,1,O=c1c2ccccc2nc2n1CCC2
3449,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CC(C)c1ccc([C@@H]2CN(C)C3(C(=O)c4ccccc4C3=O)[C@]23CSc2ccccc2C3=O)cc1,"(3'R,4'S)-4'-(4-Isopropylphenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",19.8,uM,=,1.2966651902615312,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
3450,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Clc1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1,5-Chloro-2-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-1H-benzo[d]imidazole,0.13,uM,=,-0.8860566476931633,0,c1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1
3451,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,CCN(CCC(=O)NCCCNc1c2c(nc3ccccc13)CCCC2)C1CCCCC1,"N1-[3-(1,2,3,4-Tetrahydroacridin-9-ylamino)propyl]-3-[cyclohexyl(ethyl)amino]propanamide",0.0263,uM,=,-1.5800442515102422,0,O=C(CCNC1CCCCC1)NCCCNc1c2c(nc3ccccc13)CCCC2
3452,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN2CCN(CCOc3ccc4c(c3)oc(=O)c3ccccc34)CC2)c1,3-(2-(4-(3-Methoxybenzyl)piperazin-1-yl)ethoxy)-6H-benzo[c]chromen-6-one,11.4,uM,=,1.0569048513364727,1,O=c1oc2cc(OCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12
3453,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,COC1=CC(=O)C(N2CCC(C3CCN(Cc4ccccc4OC)CC3)CC2)=CC1=O,"2-methoxy-5-(1'-(2-methoxybenzyl)-4,4'-bipiperidin-1-yl)cyclohexa-2,5-diene-1,4-dione",24.4,uM,=,1.3873898263387294,1,O=C1C=CC(=O)C(N2CCC(C3CCN(Cc4ccccc4)CC3)CC2)=C1
3454,1626872,10.1016/j.bmc.2016.10.016,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins followed by substrate addition measured after 20 mins by UV-Vis spectrophotometric analysis,COc1ccc(/C=C2\Oc3ccccc3C2=O)cc1,4'-Methoxy-aurone,1.26,uM,=,0.1003705451175629,1,O=C1/C(=C/c2ccccc2)Oc2ccccc21
3455,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,O=C(NCCCCCc1ccccc1)Oc1ccc(Cn2cc(COc3ccc4ccc(=O)oc4c3)nn2)cc1,"4-((4-(((2-Oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)phenyl(5-Phenylpentyl)carbamate",0.255,uM,=,-0.5934598195660449,0,O=C(NCCCCCc1ccccc1)Oc1ccc(Cn2cc(COc3ccc4ccc(=O)oc4c3)nn2)cc1
3456,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCCCCCCNC(=O)C4(C)CCc5c(C)c(O)c(C)c(C)c5O4)c2c1)CCCC3,"6-hydroxy-N-(7-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)-2,5,7,8-tetramethylchroman-2-carboxamide",6.72,uM,=,0.8273692730538252,1,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3457,27788,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in monkey red blood cell,Nc1c2c(nc3ccccc13)CCCC2O,"9-Amino-1,2,3,4-tetrahydro-acridin-1-ol ; Maleate",0.954,uM,=,-0.0204516252959049,0,c1ccc2nc3c(cc2c1)CCCC3
3458,28628,10.1021/jm970210v,,,,Inhibition of human acetylcholinesterase from erythrocytes (RBC),CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(Cc3ccccc3)C12,"Phenyl-carbamic acid (S)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.2453,uM,=,-0.6103024517936143,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2Cc1ccccc1
3459,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)cc2)cc1,N-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-(4-hydroxyphenyl)acetamide,6.5,uM,=,0.8129133566428556,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
3460,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccccc4)cc3)ccc12.[Br-],1-Benzyl-4-(((4-methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)pyridin-1-ium bromide,0.352,uM,=,-0.453457336521869,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
3461,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[11-(benzylmethylamino)undecyloxy]xanthen-9-one,626.0,uM,=,2.7965743332104296,1,O=c1c2ccccc2oc2cc(OCCCCCCCCCCCNCc3ccccc3)ccc12
3462,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Clc1ccc(/C=C2/CNCC3=C2N=C2SC=C(c4ccc5ccccc5c4)N2C3c2ccc(Cl)cc2)cc1,"(E)-9-(4-chlorobenzylidene)-5-(4-chlorophenyl)-3-(naphthalen-2-yl)-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",1.35,uM,=,0.1303337684950061,1,C1=C(c2ccc3ccccc3c2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
3463,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1ccc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2cc(OC)c(OC)c(OC)c2)cc1OC,(+)-magnolin,0.903,uM,=,-0.0443122496864941,0,c1ccc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2ccccc2)cc1
3464,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COC(=O)c1cccc(CN2CCC(CC3Cc4cc(OC)c(OC)cc4C3=O)CC2)n1,"Methyl 6-((4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)methyl)picolinate",5.78,uM,=,0.761927838420529,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
3465,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CN(C)CCCOc1cccc(/C=C2\COc3ccccc3C2=O)c1,(E)-3-(3-(3-(dimethylamino)propoxy)benzylidene)chroman-4-one,25.72,uM,=,1.4102709642521845,1,O=C1/C(=C/c2ccccc2)COc2ccccc21
3466,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1ccc2c(c1)CC/C(=C\c1ccc(CN(C)Cc3ccccc3)cc1)C2=O,"2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-methoxy-3,4-dihydro-2H-naphthalen-1-one",0.11,uM,=,-0.958607314841775,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)CCc2ccccc21
3467,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](CCC[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,3-bis(4-tert.butylpyridinium)-prop-1,3-diyl dibromide",14.0,uM,=,1.146128035678238,1,c1cc[n+](CCC[n+]2ccccc2)cc1
3468,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=c1c(-c2ccc(OCCCCN3CCN(Cc4ccccc4)CC3)cc2)coc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)cc(O)c12,7-(4-(4-benzylpiperazin-1-yl)butoxy)-3-(4-(4-(4-benzylpiperazin-1-yl)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one,25.1,uM,=,1.3996737214810382,1,O=c1c(-c2ccc(OCCCCN3CCN(Cc4ccccc4)CC3)cc2)coc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc12
3469,1508181,10.1016/j.bmc.2015.01.031,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CC1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2,"6,7,10,11-Tetrahydro-9-methyl-12-{{10-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}amino}-7,11-methanocycloocta[b]quinoline",0.00148,uM,=,-2.8297382846050425,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
3470,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CNc3n[nH]c4ccccc34)CC2)cc1,N-((1-benzylpiperidin-4-yl)methyl)-1H-indazol-3-amine,0.12,uM,=,-0.9208187539523752,0,c1ccc(CN2CCC(CNc3n[nH]c4ccccc34)CC2)cc1
3471,2264466,10.1039/d1md00394a,,,,Inhibition of human AchE expressed in human HEK293 cells using acetylthiocholine as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 8 mins by DTNB based Ellman's spectrophotometric method,COc1ccc2[nH]cc(CCNC(=O)CN(CCCCC3CCN(Cc4ccccc4)CC3)C(=O)c3cc(=O)c4ccccc4o3)c2c1,N-(4-(1-benzylpiperidin-4-yl)butyl)-N-(2-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-4-oxo-4H-chromene-2-carboxamide,2.0,uM,=,0.3010299956639812,1,O=C(CN(CCCCC1CCN(Cc2ccccc2)CC1)C(=O)c1cc(=O)c2ccccc2o1)NCCc1c[nH]c2ccccc12
3472,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3ccccc3Cl)C(=O)[C@@]3(C2)[C@H](c2ccccc2Cl)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(2-chlorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(2-chlorophenyl)pyrrolidine,5.19,uM,=,0.7151673578484579,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
3473,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1ccc([C@H]2OC(=O)[C@H]3[C@@H]2C(=O)O[C@@H]3c2ccc3c(c2)OCO3)cc1OC,"Ciquitin D; O-methyl-4,8-dioxopiperitol; (+)-(7S,7'S,8S,8'S)-7-(3',4'-methylenedioxyphenyl)-7'-(3',4'-dimethoxyphenyl)-9,9'-dioxo-8,8'-dioxabicyclo[3.3.0]octane",0.158,uM,=,-0.8013429130455774,0,O=C1O[C@H](c2ccc3c(c2)OCO3)[C@H]2C(=O)O[C@H](c3ccccc3)[C@@H]12
3474,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)ccc1OC(=O)N(C)C,(E)-4-(3-(4-benzylpiperazin-1-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl dimethylcarbamate,23.5,uM,=,1.3710678622717365,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
3475,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2ccccc2Cl)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(2-Chlorophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",10.11,uM,=,1.0047511555910011,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
3476,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1,(E)-4-(3-(4-benzylpiperidin-1-yl)-3-oxoprop-1-en-1-yl)phenyl ethyl(methyl)carbamate,27.1,uM,=,1.4329692908744058,1,O=C(/C=C/c1ccccc1)N1CCC(Cc2ccccc2)CC1
3477,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCC(CC)n1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-(pentan-3-yl)-1H-pyrazol-4-yl)ethan-1-one",0.0352,uM,=,-1.453457336521869,0,c1cn[nH]c1
3478,2261999,10.1016/j.bmc.2022.117030,,,,Inhibition of human recombinant AChE using S-acetylthiocholine as substrate by DTNB reagent based spectrophotometric analysis,CC(C)c1ccc(COc2ccc3[nH]c(=O)oc(=O)c3c2)cc1,"6-{(4-(Propan-2-yl)phenyl]methoxy}-2H-3,1-benzoxazine-2,4(1H)-dione",55.0,uM,=,1.740362689494244,1,O=c1[nH]c2ccc(OCc3ccccc3)cc2c(=O)o1
3479,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(Cl)cc3)CC1)C2,"2-((1-(4-chlorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",2.86,uM,=,0.456366033129043,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3480,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,Cc1nc2ccc(C(=O)CCC3CCN(Cc4ccccc4)CC3)cc2s1.Cl,3-(1-Benzyl-piperidin-4-yl)-1-(2-methyl-benzothiazol-6-yl)-propan-1-one hydrochloride,0.0068,uM,=,-2.167491087293764,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2ncsc2c1
3481,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1CCCCN1CCC1CCN(Cc2ccccc2)CC1,1-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-piperidin-2-one,0.27,uM,=,-0.5686362358410126,0,O=C1CCCCN1CCC1CCN(Cc2ccccc2)CC1
3482,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(F)cc2)C[C@@H](c2ccccc2)N(c2ccc(F)cc2)[C@@H]1c1ccccc1,"(2R,6S)-methyl 1-(4-fluorophenyl)-4-(4-fluorophenylamino)-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate",15120.0,uM,=,4.179551791165188,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
3483,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,(4-Methyl-6-phenyl-pyridazin-3-yl)-(2-morpholin-4-yl-ethyl)-amine,85.0,uM,=,1.9294189257142929,1,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1
3484,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCCCCCN(C)C,(E)-3-(4-((10-(dimethylamino)decyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,9.93,uM,=,0.9969492484953812,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
3485,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,O=C(Nc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)s1)C1CCN(Cc2cccc(F)c2)CC1,"1-(3-Fluorobenzyl)-N-[4,5-bis(4-chlorophenyl)thiazol-2-yl]-piperidine-4-carboxamide",0.65,uM,=,-0.1870866433571444,0,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
3486,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1c(NCCC2CCN(Cc3ccccc3)CC2)nc(NCCC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2,6-bis((2-(1-benzylpiperidin-4-yl)ethyl)amino)-4-phenylpyridine-3,5-dicarbonitrile",9.77,uM,=,0.989894563718773,1,c1ccc(CN2CCC(CCNc3cc(-c4ccccc4)cc(NCCC4CCN(Cc5ccccc5)CC4)n3)CC2)cc1
3487,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCc2ccc(CSCc3ccc(CN(C)C)o3)cc2)o1,{5-[4-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanylmethyl)-benzylsulfanylmethyl]-furan-2-ylmethyl}-dimethyl-amine,0.26,uM,=,-0.585026652029182,0,c1coc(CSCc2ccc(CSCc3ccco3)cc2)c1
3488,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3cc([N+](=O)[O-])ccc13)CCCC2,"6-Nitro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.028,uM,=,-1.5528419686577808,0,c1ccc2nc3c(cc2c1)CCCC3
3489,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,CN(CCCCCCCCCCCCn1cc(C=O)c2cc(O)ccc21)Cc1cccc(O)c1,5-hydroxy-1-(12-((3-hydroxybenzyl)(methyl)amino)dodecyl)-1H-indole-3-carbaldehyde,177.49,uM,=,2.2491738894071123,1,c1ccc(CNCCCCCCCCCCCCn2ccc3ccccc32)cc1
3490,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)C(O)C(O)C(=O)O,"(2-Ethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester; compound with 2,3-dihydroxy-succinic acid",0.01,uM,=,-2.0,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
3491,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,Cc1ccc(/C=C2/CNCC3=C2N=C2SC=C(c4ccc(Br)cc4)N2C3c2ccc(C)cc2)cc1,"(E)-3-(4-bromophenyl)-9-(4-methylbenzylidene)-5-(p-tolyl)-6,7,8,9-tetrahydro-5H-pyrido[4,3-d]thiazolo[3,2-a]pyrimidin-7-ium",2.27,uM,=,0.3560258571931227,1,C1=C(c2ccccc2)N2C(=NC3=C(CNC/C3=C/c3ccccc3)C2c2ccccc2)S1
3492,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1c(N)nc(NCCCCC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-Amino-6-((4-(1-benzylpiperidin-4-yl)butyl)amino)-4-phenylpyridine-3,5-dicarbonitrile",0.12,uM,=,-0.9208187539523752,0,c1ccc(CN2CCC(CCCCNc3cc(-c4ccccc4)ccn3)CC2)cc1
3493,2213904,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin),O=c1c2ccccc2nc2n1CCC2O,SID24823936,76.6,uM,=,1.884228769632604,1,O=c1c2ccccc2nc2n1CCC2
3494,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CC)[C@@H]1C2,"(3aS,8aR)-1-ethyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl hexylcarbamate",0.208,uM,=,-0.6819366650372385,0,c1ccc2c(c1)C[C@H]1NCC[C@@H]21
3495,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCN1CCCC1,(E)-3-(3-methoxy-4-((5-(pyrrolidin-1-yl)pentyl)oxy)phenyl)-N-phenylacrylamide,6.21,uM,=,0.7930916001765802,1,O=C(/C=C/c1ccc(OCCCCCN2CCCC2)cc1)Nc1ccccc1
3496,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)C2(C)CCOC2O3)cc1,"(4-Isopropyl-phenyl)-carbamic acid 3a-methyl-2,3,3a,8a-tetrahydro-benzo[b]furo[3,2-d]furan-5-yl ester",2.65,uM,=,0.4232458739368078,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCOC1O2
3497,1589694,10.1016/j.bmc.2016.07.005,,,,Inhibition of hemoglobin free erythrocyte ghost human AChE using acetylcholine iodide as substrate measured for 1 hr by spectrophotometry based Ellman method,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1.[Cl-].[Cl-],4-[(E)-(hydroxyimino)methyl]-1-[({4-[(E)-(hydroxyimino)methyl]pyridinium-1-yl}methoxy)methyl]pyridinium dichloride (toxogonin),910.0,uM,=,2.959041392321093,1,c1cc[n+](COC[n+]2ccccc2)cc1
3498,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-2-(2-(2-((2-((7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)-N-methylthiazole-5-carboxamide",0.0306999999999999,uM,=,-1.5128616245228137,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
3499,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1ccc(-c2cn3ccccc3[n+]2C)cc1.Cc1ccc(S(=O)(=O)[O-])cc1,"2-(4-(dimethylcarbamoyloxy)phenyl)-1-methylimidazo[1,2-a]pyridin-1-ium",17.1,uM,=,1.2329961103921538,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1.c1ccccc1
3500,744973,10.1016/j.bmcl.2010.12.093,,,,Inhibition of human serum AChE,COc1cc(CNCCCCCCNC2=CC(=O)C(NCCCCCCNCc3ccc(O)c(OC)c3)=CC2=O)ccc1O,"2,5-bis(6-(4-hydroxy-3-methoxybenzylamino)hexylamino)cyclohexa-2,5-diene-1,4-dione",0.102,uM,=,-0.9913998282380824,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3501,2114062,10.1016/j.bmcl.2021.128100,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by DTNB-reagent based Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.32,uM,=,-0.494850021680094,0,c1ccc2nc3c(cc2c1)CCCC3
3502,745140,10.1021/jm101299d,,,,Inhibition of human recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.11,uM,=,-0.958607314841775,0,c1ccc2nc3c(cc2c1)CCCC3
3503,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]-Quinolin-12-Amine",0.00032,uM,=,-3.494850021680094,0,C1=CC2Cc3nc4ccccc4cc3[C@@H](C1)C2
3504,1797688,10.1021/acs.jnatprod.8b00378,,,,Inhibition of human AChE using acetylthiocholine as substrate,Cc1cccc2c1ccc1c3c(c(=O)oc(=O)c12)[C@@H](C)CO3,"4,9-Dimethyl-4,5-dihydrofuro-[3,2-c]naphtho[2,1-e]oxepine-1,3-dione",10.132,uM,=,1.0056951811185104,1,O=c1oc(=O)c2c(ccc3ccccc32)c2c1CCO2
3505,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc(F)cc3)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(4-fluorobenzyl)pyridin-1-ium bromide",0.0040999999999999,uM,=,-2.3872161432802645,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
3506,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(C(F)(F)F)cc1)N1CCN(c2ccccn2)CC1,4-(Pyridin-2-yl)-N'-(4-(trifluoromethyl)benzylidene)piperazine-1-carbohydrazide,1.32,uM,=,0.1205739312058498,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
3507,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,C[n+]1ccccc1/C=N/O.[Cl-],2-Pyridine aldoxime methohalide,366.0,uM,=,2.5634810853944106,1,c1cc[nH+]cc1
3508,1718355,10.1016/j.ejmech.2017.08.051,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured over 5 mins by UV-Vis spectrophotometric analysis,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.23,uM,=,-0.6382721639824072,0,c1ccc2nc3c(cc2c1)CCCC3
3509,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)cc(OCCCCN(CC)Cc4ccccc4)cc3o2)cc1)Cc1ccccc1,7-(4-(benzyl(ethyl)amino)butoxy)-2-(4-(4-(benzyl(ethyl)amino)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one,0.36,uM,=,-0.4436974992327127,0,O=c1cc(-c2ccc(OCCCCNCc3ccccc3)cc2)oc2cc(OCCCCNCc3ccccc3)ccc12
3510,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)chroman-2-carboxamide",0.0235,uM,=,-1.6289321377282635,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3511,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,CN(CCC(=O)NCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCCCC1,"N1-[4-(1,2,3,4-Tetrahydroacridin-9-ylamino)butyl]-3-[cyclohexyl(methyl)amino]propanamide",0.104,uM,=,-0.9829666607012196,0,O=C(CCNC1CCCCC1)NCCCCNc1c2c(nc3ccccc13)CCCC2
3512,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCOCC2)cc(OC)c1OC,"rac-2-(3,4,5-Trimethoxyphenyl)-2-(morpholin-1-yl)acetonitrile",389.0,uM,=,2.589949601325708,1,c1ccc(CN2CCOCC2)cc1
3513,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,O=C(Nc1cc(Cl)nc(Cl)c1)OCCCCCNCc1ccccc1,"5-(benzylamino)pentyl-(2,6-dichloropyridin-4-yl)carbamate",0.153,uM,=,-0.8153085691824012,0,O=C(Nc1ccncc1)OCCCCCNCc1ccccc1
3514,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,COc1cccc2nc3c(c(N)c12)CCCO3,"5-Methoxy-3,4-dihydro-2H-1-oxa-9-aza-anthracen-10-ylamine",0.606,uM,=,-0.2175273758337138,0,c1ccc2nc3c(cc2c1)CCCO3
3515,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,Clc1ccc2c(c1)Nc1ccccc1S2,SID57287863,7.4,uM,=,0.8692317197309762,1,c1ccc2c(c1)Nc1ccccc1S2
3516,1724026,10.1016/j.ejmech.2017.05.019,,,,Inhibition of human AChE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.07,uM,=,0.0293837776852096,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
3517,28594,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 3.87-11.9,CCN(C)C(=O)Oc1ccc2c(c1)C(N)CCC2,"Ethyl-methyl-carbamic acid 8-amino-5,6,7,8-tetrahydro-naphthalen-2-yl ester",6.22,uM,=,0.7937903846908188,1,c1ccc2c(c1)CCCC2
3518,2247136,10.1021/acs.jmedchem.1c02150,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 240 sec by Ellman's method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCC(=O)N4CCC(NC(=O)Nc5ccc(OC(F)(F)F)cc5)CC4)c3[C@@H](C1)C2,"(-)-(7R,11R)-1-{1-{5-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]pentanoyl}-piperidin-4-yl}-3-[4-(trifluoromethoxy)phenyl]urea",1.66,uM,=,0.220108088040055,1,O=C(Nc1ccccc1)NC1CCN(C(=O)CCCCNc2c3c(nc4ccccc24)C[C@@H]2C=CC[C@H]3C2)CC1
3519,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCN1CCCCC1,(E)-3-(3-methoxy-4-(2-(piperidin-1-yl)ethoxy)phenyl)-N-phenylacrylamide,19.4,uM,=,1.287801729930226,1,O=C(/C=C/c1ccc(OCCN2CCCCC2)cc1)Nc1ccccc1
3520,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCNC1=CC(=O)C(NCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis{3-[ethyl(2-methoxybenzyl)amino]propylamino}-[1,4]-benzoquinone",0.00225,uM,=,-2.6478174818886377,0,O=C1C=C(NCCCNCc2ccccc2)C(=O)C=C1NCCCNCc1ccccc1
3521,1783503,10.1016/j.ejmech.2018.01.007,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,Cn1cc(CC(=O)NCCC2CCN(Cc3ccccc3)CC2)c2ccccc21,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-2-(1-methyI-1H-indol-3-yI)-acetamide,1.42,uM,=,0.1522883443830564,1,O=C(Cc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
3522,1443169,10.1016/j.ejmech.2014.09.081,,,,Inhibition of human erythrocyte AChE preincubated for 15 mins by Ellman's method,CCCN(C)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,"(E)-5-methoxy-2-(4-(methyl(propyl)amino)benzylidene)-6-(2-(piperidin-1-yl)ethoxy)-2,3-dihydro-1H-inden-1-one",0.3902,uM,=,-0.4087127349415007,0,O=C1/C(=C/c2ccccc2)Cc2ccc(OCCN3CCCCC3)cc21
3523,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2cccc(Br)c2)CC1,4-((1-(3-Bromobenzyl)piperidin-4-yl)methoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methylthiazole-5-carboxamide,394.0,uM,=,2.595496221825574,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
3524,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NC(=O)C3CCN(Cc4ccc([N+](=O)[O-])cc4)CC3)sc2-c2ccc(C)cc2)cc1,"1-(4-Nitrobenzyl)-N-[4,5-bis(p-tolyl)thiazol-2-yl]piperidine-4-carboxamide",2.32,uM,=,0.3654879848908996,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
3525,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(OC)c(CN2CCC(c3oc4ccccc4c3C(=O)c3ccc(OC)c(OC)c3)CC2)c1,"(2-(1-(2,5-dimethoxybenzyl)piperidin-4-yl)benzofuran-3-yl)(3,4-dimethoxyphenyl)methanone",55.41,uM,=,1.7435881501599038,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
3526,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Oc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazol-6-ol,0.026,uM,=,-1.585026652029182,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
3527,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2,"3-(2-(4-Benzylpiperazin-1-yl)ethoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",1.3,uM,=,0.1139433523068367,1,O=c1oc2cc(OCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2
3528,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)chroman-2-carboxamide",6.97,uM,=,0.8432327780980095,1,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3529,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,O=C(NO)c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1,"N-Hydroxy-4-(5,6,7,8-tetrahydroacridin-9-ylamino)benzamide",1.97,uM,=,0.2944662261615929,1,c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1
3530,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(Cc1ccccc1)N1c2ccccc2[Se]c2ccc(Cl)cc21,1-(2-chloro-10H-phenoselenazin-10-yl)-2-phenylethanone,6.5,uM,=,0.8129133566428556,1,O=C(Cc1ccccc1)N1c2ccccc2[Se]c2ccccc21
3531,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(CCC)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-(((3-(9-oxo-9H-xanthen-3-yloxy)propyl)(propyl)amino)methyl)phenyl hexylcarbamate,0.4,uM,=,-0.3979400086720376,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
3532,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,CC(C)=CCC/C(C)=C/Cc1c(O)cc2c(c1O)C(=O)C[C@@H](c1ccc(O)c(O)c1)O2,diplacone,7.2,uM,=,0.8573324964312685,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
3533,28292,10.1021/jm010491d,,,,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)O[C@@H]1N2C,"Methyl-carbamic acid 2,4a,9-trimethyl-2,3,4,4a,9,9a-hexahydro-1-oxa-2,9-diaza-fluoren-6-yl ester",0.15,uM,=,-0.8239087409443188,0,c1ccc2c(c1)N[C@H]1ONCCC21
3534,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCCCCCCOc1ccc(/C=C/C(=O)O)cc1OC,(E)-3-(4-((8-(diethylamino)octyl)oxy)-3-methoxyphenyl)acrylicacid,3.18,uM,=,0.5024271199844327,1,c1ccccc1
3535,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)N2CCN(c3ccc(C)cc3)CC2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-(p-tolyl)piperazin-1-yl)prop-2-en-1-one,19.48,uM,=,1.2895889525425968,1,O=C(/C=C/c1ccccc1)N1CCN(c2ccccc2)CC1
3536,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)N1Cc2cc(NC(=O)c3ccccc3)ccc2CC1=O,"N-(2-(2-methoxybenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",1.893e-05,uM,=,-4.722849386036203,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
3537,642381,10.1021/jm100329q,,,,Inhibition of human erythrocyte AChE by Ellman's reaction,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.35,uM,=,-0.4559319556497244,0,c1ccc2nc3c(cc2c1)CCCC3
3538,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,CC(=O)c1c[n+](Cc2ccccc2C)ccc1CC1Cc2cc(OCC(F)(F)F)ccc2C1=O.[Br-],"3-Acetyl-1-(2-methylbenzyl)-4-((1-oxo-5-(2,2,2-trifluoroethoxy)-2,3-dihydro-1H-inden-2-yl)methyl)pyridinium bromide",0.0371,uM,=,-1.430626090384954,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
3539,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ccc(NCCCN3CCc4ccccc4C3)nn2)cc1,"N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)propyl)-6-phenylpyridazin-3-amine",35.0,uM,=,1.5440680443502757,1,c1ccc(-c2ccc(NCCCN3CCc4ccccc4C3)nn2)cc1
3540,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccccc3F)cc12.[Br-],2-(2-Fluorophenyl)-8-methoxyisoquinolin-2-ium bromide,2.55,uM,=,0.4065401804339551,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
3541,1871369,10.1016/j.bmcl.2018.12.011,,,,Inhibition of AchE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 20 secs for 20 times by Ellman's assay,C/C(=C/CC[C@H](CO)c1cc2cc(O)c(O)cc2o1)CO,Ganocapenoid C,28.6,uM,=,1.4563660331290431,1,c1ccc2occc2c1
3542,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2.Cl,(+)-Huprine Y,0.0136,uM,=,-1.8664610916297824,0,C1=C[C@H]2Cc3nc4ccccc4cc3[C@@H](C1)C2
3543,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COCC(C)(C)C)c1/C=N/O.[Cl-],"1-(2,2-Dimethyl-propoxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride",8.4,uM,=,0.9242792860618816,1,c1c[nH+]c[nH]1
3544,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCC3)cc1)NCC2,"6,7-dimethoxy-1-(4-((6-(pyrrolidin-1-yl)hexyl)oxy)benzyl)-1,2,3,4-tetrahydroisoquinoline",2.98,uM,=,0.4742162640762553,1,c1ccc2c(c1)CCNC2Cc1ccc(OCCCCCCN2CCCC2)cc1
3545,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,COc1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)C2N3C)cc1,"(S)-5-(4-Methoxy-phenylcarbamoyloxy)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",1.7,uM,=,0.2304489213782739,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
3546,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,C[C@@H]([C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4C(=CC[C@@H]5N=C(C(C)(C)C)OC[C@]54C)C[C@H]3C(=O)C[C@]12C)N(C)C,"(4aS,7aR,9aR,10S,11R,12aS,12bR,14bS)-3-tert-butyl-10-[1-(dimethylamino)ethyl]-11-hydroxy-9a,12a,14b-trimethyl-1,4a,5,7,7a,9,9a,10,11,12,12a,12b,13,14,14a,14b-hexadecahydro-8H-indeno[5'',4'':4',5']cyclohepta[1',2':3,4]benzo[1,2-d][1,3]oxazin-8-one",0.351,uM,=,-0.4546928835341759,0,O=C1CC2CCCC2[C@@H]2CC[C@@H]3C(=CC[C@@H]4N=COCC43)C[C@@H]12
3547,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1,"N1-(quinolin-4-yl)-N8-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine",0.0088,uM,=,-2.055517327849832,0,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1
3548,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(Cc1cc(C)cc(/C=N/O)c1O)CC2,"3-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxy-5-methylbenzaldehyde oxime",1124.0,uM,=,3.0507663112330423,1,c1ccc(CN2CCc3ccccc3C2c2ccccc2)cc1
3549,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc(CCCCCCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(hexane-1,6-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",0.07,uM,=,-1.154901959985743,0,c1ccc(CCCCCCc2cccc[nH+]2)[nH+]c1
3550,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"3-(1H-indol-3-yl)-N-(7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)propanamide",6e-05,uM,=,-4.221848749616356,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3551,2261437,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition measured after 6 mins by Ellman's method,CC[C@@]1(c2cccc(OC(=O)Nc3ccccc3)c2)CCCCN(C)C1,Meserine,0.274,uM,=,-0.5622494371796121,0,O=C(Nc1ccccc1)Oc1cccc(C2CCCCNC2)c1
3552,1852486,10.1016/j.ejmech.2019.05.020,,,,Inhibition of recombinant human AChE,COc1ccc2[nH]c3nc4c(c(N)c3c2c1)CCCC4,"9-methoxy-2,3,4,6-tetrahydro-1H-indolo[2,3-b]quinolin-11-amine",1.5,uM,=,0.1760912590556812,1,c1ccc2c(c1)[nH]c1nc3c(cc12)CCCC3
3553,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.025,uM,=,-1.6020599913279625,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3554,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"o-Tolyl-carbamic acid (S)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.01,uM,=,-2.0,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
3555,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1,"N-(8-(3,5-dimethoxyphenyl)octyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0472,uM,=,-1.3260580013659122,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
3556,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(/C=C2\Cc3cc(OC)c(OC)cc3C2=O)cc1,"(E)-2-{4-[(Diethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",0.063,uM,=,-1.2006594505464183,0,O=C1/C(=C/c2ccccc2)Cc2ccccc21
3557,28476,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 26.2-5898,C#CCNC1CCc2ccc(OC(=O)N(C)CC)cc2C1,"Ethyl-methyl-carbamic acid 7-prop-2-ynylamino-5,6,7,8-tetrahydro-naphthalen-2-yl ester",204.0,uM,=,2.3096301674258988,1,c1ccc2c(c1)CCCC2
3558,1586651,10.1016/j.bmcl.2016.05.046,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay,O=C(CCCCCCCCc1ccc(O)c(O)c1)c1c(O)ccc(C(CCCCCCCCc2ccc(O)c(O)c2)c2c(O)cccc2O)c1O,Maingayone A,12.66,uM,=,1.1024337056813365,1,O=C(CCCCCCCCc1ccccc1)c1cccc(C(CCCCCCCCc2ccccc2)c2ccccc2)c1
3559,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)heptyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.08,uM,=,-1.0969100130080565,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3560,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,"2-(5-((2-Fluorobenzyl)(methyl)amino)pentyl)isoindoline-1,3-dione hydrochloride",0.525,uM,=,-0.2798406965940431,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
3561,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccccc2[N+](=O)[O-])CC1c1ccc(-c2ccccc2)cc1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(2-nitrophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.052,uM,=,-1.2839966563652008,0,c1ccc(C2=NNC(c3ccc(-c4ccccc4)cc3)C2)cc1
3562,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,COc1ccc(-c2nc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc3c2[nH]c2ccccc23)cc1,"1-(4-Methoxyphenyl)-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)-9H-pyrido[3,4-b]indole-3-carboxamide",0.149,uM,=,-0.826813731587726,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c([nH]c3ccccc32)c(-c2ccccc2)n1
3563,1842303,10.1016/j.bmc.2019.01.025,,,,Inhibition of human acetylcholinesterase by Ellman's method,Cc1cc(=O)oc2ccc(OC/C=C/CCn3cnc4c(N5CCCCC5)ncnc43)cc12,4-methyl-6-(5-(6-(piperidin-1-yl)-9H-purin-9-yl)pent-2-enyloxy)-2H-chromen-2-one,11.94,uM,=,1.0770043267933502,1,O=c1ccc2cc(OC/C=C/CCn3cnc4c(N5CCCCC5)ncnc43)ccc2o1
3564,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(OC)cc1)CCCC3,"ethyl 5-amino-2-methyl-4-(4-methoxyphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.105,uM,=,-0.978810700930062,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
3565,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1cccc(C)c1)CC2.[Br-],"8-methoxy-2-m-tolyl-3,4-dihydroisoquinolinium bromide",2.89,uM,=,0.4608978427565479,1,C1=[N+](c2ccccc2)CCc2ccccc21
3566,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C#N)c[n+]1C.F[B-](F)(F)F,5-cyano-2-methoxy-1-methylpyridinium tetrafluoroborate,43.0,uM,=,1.6334684555795866,1,c1cc[nH+]cc1
3567,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.4351,uM,=,-0.361410916707283,0,c1ccc2nc3c(cc2c1)CCCC3
3568,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)c3cc[n+](Cc4cccc(F)c4)cc3)c2c1.[Br-],1-(3-fluorobenzyl)-4-((2-(5-methoxy-1H-indol-3-yl)ethyl)carbamoyl)pyridi-n-1-ium bromide,3.8,uM,=,0.5797835966168101,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
3569,1507873,10.1016/j.bmc.2015.05.027,,,,Inhibition of human acetylcholinesterase incubated for 60 mins using ATChI substrate by DTNB dye based UV-visible spectrophotometry,COc1ccc(-c2csc(NC(=O)C[n+]3ccc(/C=N/O)cc3)n2)cc1.[I-],4-((Hydroxyimino)methyl)-1-(2-(4-(4-methoxyphenyl)thiazol-2-ylamino)-2-oxoethyl)pyridinium iodide,1660.0,uM,=,3.220108088040055,1,O=C(C[n+]1ccccc1)Nc1nc(-c2ccccc2)cs1
3570,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Cl-].[Cl-].c1cc[n+](COC[n+]2ccccc2)cc1,"1,3-bis(pyridinium)-2-oxapropane dichloride",1770.0,uM,=,3.247973266361807,1,c1cc[n+](COC[n+]2ccccc2)cc1
3571,788347,10.1016/j.bmcl.2011.08.106,,,,Inhibition of acetylcholinesterase,CCCOCCn1c(=O)nc(NC2CCC(O)CC2)c2nnc(-c3ccc(OC)nc3)cc21,"8-(4-hydroxycyclohexylamino)-3-(6-methoxypyridin-3-yl)-5-(2-propoxyethyl)pyridazino[4,3-d]pyrimidin-6(5H)-one",5.6,uM,=,0.7481880270062004,1,O=c1nc(NC2CCCCC2)c2nnc(-c3cccnc3)cc2[nH]1
3572,28480,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 3.18-5.07,C#CCC1CCCc2ccc(OC(=O)N(C)C)cc21,"Dimethyl-carbamic acid 8-prop-2-ynyl-5,6,7,8-tetrahydro-naphthalen-2-yl ester",3.94,uM,=,0.5954962218255742,1,c1ccc2c(c1)CCCC2
3573,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1c[nH]c2ccc(OCc3ccccc3)cc12,3-(1-Benzoyl-1H-pyrrol-3-ylmethylene)-1-benzyl-piperidin-4-one,25.0,uM,=,1.3979400086720375,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1c[nH]c2ccc(OCc3ccccc3)cc12
3574,28146,10.1021/jm990971t,,,,Inhibitory activity against human erythrocyte acetylcholinesterase,Cc1ccc2c(NCc3ccccc3)c3c(nc2c1)CCCC3,"Benzyl-(6-methyl-1,2,3,4-tetrahydro-acridin-9-yl)-amine",0.75,uM,=,-0.1249387366082999,0,c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1
3575,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2[se]n(-c3ccc(OCCCN4CCCCC4)cc3)c(=O)c2cc1OC,"5,6-Dimethoxy-2-(4-(3-(piperidin-1-yl)propoxy)phenyl)benzo[d][1,2]selenazol-3(2H)-one",5.15,uM,=,0.7118072290411911,1,O=c1c2ccccc2[se]n1-c1ccc(OCCCN2CCCCC2)cc1
3576,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1-(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine",0.319,uM,=,-0.4962093169428189,0,c1ccc2nc3c(cc2c1)CCCC3
3577,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN1CCCCc2ccc(C(=O)CCC3CCN(Cc4ccccc4)CC3)cc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-methyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.081,uM,=,-1.0915149811213505,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
3578,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl,"6-chloro-N-[8-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)octyl]-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",0.00132,uM,=,-2.87942606879415,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
3579,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2cccc(OC)c2)=CC1=O)Cc1cccc(OC)c1,"2,5-bis{6-[ethyl(3-methoxybenzyl)amino]hexylamino}-[1,4]-benzoquinone",0.0138,uM,=,-1.8601209135987635,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3580,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2,"3-(4-(4-Benzylpiperidin-1-yl)butoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",9.2,uM,=,0.9637878273455552,1,O=c1oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2
3581,28624,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in human red blood cell,Nc1c2c(nc3ccccc13)CCC(O)C2,"9-Amino-1,2,3,4-tetrahydro-acridin-2-ol",1.61,uM,=,0.2068258760318497,1,c1ccc2nc3c(cc2c1)CCCC3
3582,327131,10.1021/jm050746d,,,,Inhibition of human AChE,COc1ccc2[nH]cc(CCNC(=O)CCCCCCNc3c4c(nc5ccccc35)CCCC4)c2c1,"7-(1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-5-metoxy-3-yl)-ethyl]-amide",0.00065,uM,=,-3.1870866433571443,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
3583,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,C(=C\C[n+]1cccc2ccccc21)\C[n+]1cccc2ccccc21.[Cl-].[Cl-],"(Z)-1,1'-(but-2-ene-1,4-diyl)diquinolinium chloride",2.0,uM,=,0.3010299956639812,1,C(=C\C[n+]1cccc2ccccc21)\C[n+]1cccc2ccccc21
3584,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,C#CCNCc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2[nH]1,N-((5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine,4.9,uM,=,0.6901960800285137,1,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
3585,1511340,10.1016/j.bmc.2015.07.029,,,,Inhibition of AChE (unknown origin) assessed as enzyme-mediated Amyloid beta peptide (1 to 42) aggregation incubated for 5 hrs by thioflavin-T based fluorometric assay,CN(C)c1ccc(C(=O)NCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]benzamide hydrochloride",12.1,uM,=,1.08278537031645,1,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
3586,858577,10.1016/j.bmc.2012.09.040,,,,Inhibition of human AChE by Ellman's method,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],"9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium chloride",0.61,uM,=,-0.2146701649892329,0,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
3587,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCCCN(Cc3cccc(F)c3)C(C)C)cc2oc1=O,"7-(3-((3-fluorobenzyl)(isopropyl)amino)propoxy)-3,4-dimethyl-2H-chromen-2-one",0.91,uM,=,-0.0409586076789063,0,O=c1ccc2ccc(OCCCNCc3ccccc3)cc2o1
3588,1924573,10.1021/acsmedchemlett.6b00122,,,,Inhibition of ACES (unknown origin),Cc1c([C@@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,"US9018211, 2A",9.94,uM,=,0.9973863843973132,1,O=C1OCc2cc(CCN3CCN(CCc4ccc5c(c4)COC5=O)CC3)ccc21
3589,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,Galanthamine hydrogenbromide,3.8,uM,=,0.5797835966168101,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
3590,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2Cc1ccccc1,"Methyl-carbamic acid (S)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.161,uM,=,-0.7931741239681502,0,c1ccc(CN2c3ccccc3C3CCNC32)cc1
3591,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,CCN(CCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1,"2-[4-[Ethyl(phenylmethyl)amino]butyl]-1H-isoindole-1,3(2H)-dione",0.68,uM,=,-0.1674910872937636,0,O=C1c2ccccc2C(=O)N1CCCCNCc1ccccc1
3592,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c3ccccc32)cc1,"1-[(4-methoxyphenyl)methyl]-4-oxo-N-{2-[(1,2,3,4-tetrahydroacridin-9-yl)amino]ethyl}-1,4-dihydroquinoline-3-carboxamide",0.187,uM,=,-0.728158393463501,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
3593,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0008,uM,=,-3.096910013008056,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
3594,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCOC(=O)/C=C/c1ccc(OCCCCCCN2CCCCC2)c(OC)c1,(E)-ethyl-3-(3-methoxy-4-((6-(piperidin-1-yl)hexyl)oxy)phenyl)acrylate,2.65,uM,=,0.4232458739368078,1,c1ccc(OCCCCCCN2CCCCC2)cc1
3595,1765157,10.1021/acs.jmedchem.8b00592,,,,Inhibition of human recombinant AChE by spectrophotometry based Ellman's assay,O/N=C/c1ccccn1,Pyridine-2-carbaldehyde oxime,560.0,uM,=,2.7481880270062,1,c1ccncc1
3596,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)CC(CC1CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC1)C2.Cl.Cl,"9-[(3-{4-[(5,6-dimethoxyindan-2-yl)methyl]piperidin-1-yl}propyl)amino]-1,2,3,4-tetrahydroacridine dihydrochloride",0.00216,uM,=,-2.6655462488490693,0,c1ccc2c(c1)CC(CC1CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC1)C2
3597,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cc2c(cc1OC)C(=O)C(CC1CCN(c3ccccc3)CC1)C2,"5,6-dimethoxy-2-((1-phenylpiperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",0.0057,uM,=,-2.2441251443275085,0,O=C1c2ccccc2CC1CC1CCN(c2ccccc2)CC1
3598,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,COc1cccc(C(=O)N2CCN(CC(=O)N3CCN(CCCc4c[nH]c5ccc(F)cc45)CC3)CC2)c1,1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(3-methoxybenzoyl)piperazin-1-yl)ethanone,19.4,uM,=,1.287801729930226,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
3599,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,COCCN1CCN(c2nccc(NCc3ccccc3)n2)CC1,N-Benzyl-2-[4-(2-methoxyethyl)piperazin-1-yl]pyrimidin-4-amine,26.7,uM,=,1.4265112613645752,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
3600,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.3,uM,=,0.1139433523068367,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
3601,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COC(=O)c1c[n+](Cc2cccc(Cl)c2)ccc1CCC(=O)c1ccc(OC)c(OC)c1.[Br-],"1-(3-chlorobenzyl)-4-(3-(3,4-dimethoxyphenyl)-3-oxopropyl)-3-(methoxycarbonyl)pyridinium bromide",0.171,uM,=,-0.7670038896078462,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccccc1
3602,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCN(CC2Cc3ccccc3C2=O)CC1,2-(4-Methyl-piperazin-1-ylmethyl)-indan-1-one,0.094,uM,=,-1.0268721464003014,0,O=C1c2ccccc2CC1CN1CCNCC1
3603,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2SCC(=O)N2c2ccc3oc(=O)ccc3c2)cc1,2-(4-Methoxyphenyl)-3-(2-oxo-2H-chromen-6-yl)thiazolidin-4-one,0.0711,uM,=,-1.1481303992702336,0,O=C1CSC(c2ccccc2)N1c1ccc2oc(=O)ccc2c1
3604,2022983,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin),CC1=C[C@@H]2Cc3[nH]c(=O)ccc3[C@]3(C1)NCCC[C@H]23,Huperzine B,2.57,uM,=,0.4099331233312945,1,O=c1ccc2c([nH]1)C[C@H]1C=CC[C@]23NCCC[C@H]13
3605,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,N#CC(c1ccc2c(c1)OCO2)N1CCCCC1,"rac-2-(3,4-Dioxymethylenphenyl)-2-(piperidin-1-yl)acetonitrile",61.4,uM,=,1.7881683711411678,1,c1cc2c(cc1CN1CCCCC1)OCO2
3606,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCCC2,"3-(1-Benzyl-piperidin-4-yl)-1-(1,2,3,4,5,6-hexahydro-benzo[b]azocin-9-yl)-propan-1-one",0.127,uM,=,-0.8961962790440431,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCCC2
3607,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc(C#N)cc2)ccc1O,(E)-N-(2-((4-cyanophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,17.43,uM,=,1.2412973871099933,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
3608,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2Cc1ccc2ccc(C[n+]3cccc4ccccc43)cc2c1,"1,1'-(naphthalene-2,7-diylbis(methylene))diquinolinium dibromide",0.8,uM,=,-0.0969100130080563,0,c1ccc2c(c1)ccc[n+]2Cc1ccc2ccc(C[n+]3cccc4ccccc43)cc2c1
3609,1278501,10.1016/j.bmc.2013.09.050,,,,Inhibition of human erythrocytic AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman method,COc1ccc(/C=C2\COc3cc(OCCCCCCNc4c5c(nc6ccccc46)CCCC5)ccc3C2=O)cc1,"(E)-3-(4-Methoxybenzylidene)-7-(6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyloxy)chroman-4-one",0.1568,uM,=,-0.8046539416515803,0,O=C1/C(=C/c2ccccc2)COc2cc(OCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc21
3610,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccc(OC)cc2)C[C@@H](c2ccccc2)N(c2ccc(OC)cc2)[C@@H]1c1ccccc1,"(2R,6S)-ethyl 1-(4-methoxyphenyl)-4-(4-methoxyphenylamino)-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate",2250.0,uM,=,3.3521825181113627,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
3611,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CCOC(OCC)c1ccc(/C=C2\CC/C(=C\c3ccc(C(OCC)OCC)cc3)C2=O)cc1,"2,5-Bis-(4-diethoxymethyl-benzylidene)-cyclopentanone",76.64,uM,=,1.884455496070488,1,O=C1/C(=C/c2ccccc2)CC/C1=C\c1ccccc1
3612,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CN1CCN(c2nccc(NCCc3ccccc3)n2)CC1,2-(4-methylpiperazin-1-yl)-N-phenethylpyrimidin-4-amine,20.4,uM,=,1.3096301674258988,1,c1ccc(CCNc2ccnc(N3CCNCC3)n2)cc1
3613,969870,10.1016/j.bmcl.2013.05.092,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,O=c1[nH]c(=O)c2nc[nH]c2[nH]1,"3,7-Dihydro-purine-2,6-dione",9.0,uM,=,0.9542425094393248,1,O=c1[nH]c(=O)c2nc[nH]c2[nH]1
3614,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COCC[N+]1(C)CCC(CCC(=O)c2cc3cc(OC)c(OC)cc3s2)CC1.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(2-methoxy-ethyl)-1-methyl-piperidinium bromide",0.053,uM,=,-1.275724130399211,0,O=C(CCC1CC[NH2+]CC1)c1cc2ccccc2s1
3615,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),O=C1[C@@H]2Cc3c([nH]c4ccccc34)[C@@H](c3ccc4c(c3)OCO4)N2C(=O)CN1CCC1CCN(Cc2ccccc2)CC1,"(6R,12aS)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4-yl)ethyl)-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione",0.032,uM,=,-1.494850021680094,0,O=C1[C@@H]2Cc3c([nH]c4ccccc34)[C@@H](c3ccc4c(c3)OCO4)N2C(=O)CN1CCC1CCN(Cc2ccccc2)CC1
3616,28624,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in human red blood cell,Nc1c2c(nc3ccccc13)C(O)CCC2,"9-Amino-1,2,3,4-tetrahydro-acridin-4-ol",0.521,uM,=,-0.2831622767004755,0,c1ccc2nc3c(cc2c1)CCCC3
3617,462117,10.1021/jm7009364,,,,Inhibition of human AchE,COc1ccccc1CNCCCNCCCNCCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21,"3,8-diamino-5-(3-{3-[3-(2-methoxy-benzylamino)-propylamino]-propylamino}-propyl)-6-phenyl-phenanthridinium",0.952,uM,=,-0.0213630516155256,0,c1ccc(CNCCCNCCCNCCC[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
3618,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),Cc1ccc2cc(C3CC(c4sccc4Cl)=NN3)c(Cl)nc2c1,"2-Chloro-3-[3-(3-chlorothiophen-2-yl)-4,5-dihydro-1Hpyrazol-5-yl]-7-methylquinoline",0.2,uM,=,-0.6989700043360187,0,c1csc(C2=NNC(c3cnc4ccccc4c3)C2)c1
3619,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(Cl)cc1Cl)CC2.[Br-],"2-(2,4-dichlorophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.04,uM,=,0.0170333392987803,1,C1=[N+](c2ccccc2)CCc2ccccc21
3620,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CCC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2ccc4ccccc4c2)C3=O)c1,"Propionic acid 3-{[methyl-(7-{2-[1-naphthalen-2-yl-meth-(Z)-ylidene]-3-oxo-2,3-dihydro-benzofuran-6-yloxy}-heptyl)-amino]-methyl}-phenyl ester",2.09,uM,=,0.320146286111054,1,O=C1/C(=C/c2ccc3ccccc3c2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
3621,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12c1ccccc1-c1nc3ccc([N+](=O)[O-])cc3nc12,"6'-amino-8,9'-dinitro-1',2',3',4'-tetrahydrospiro[indeno[1,2-b]quinoxaline-11,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",3.9,uM,=,0.5910646070264992,1,C1=CC2(C=C3NCCCN13)c1ccccc1-c1nc3ccccc3nc12
3622,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,CCN(CCC(=O)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1)C1CCCCC1,"3-[cyclohexyl(ethyl)amino]-1-{4-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]piperazino}-1-propanone",0.00497,uM,=,-2.303643611266668,0,O=C(CCNC1CCCCC1)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1
3623,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3)cc1)C2.[Br-],"(+/-)-2-[(1-Benzylpyridin-1-ium-4-yl)methyl]-5,6-dimethoxy-indan-1-one Bromide",0.0365,uM,=,-1.4377071355435254,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
3624,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(Cc2ccccc2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(1-benzyl-4-piperidyl)propan-1-one,0.0085,uM,=,-2.070581074285707,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
3625,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3Cl)cc1C(C)=O)C2.[Br-],"(+/-)-2-[[3-Acetyl-1-[(2-chlorophenyl)methyl]pyridin-1-ium-4-yl]-methyl]-5,6-dimethoxy-indan-1-one Bromide",0.018,uM,=,-1.744727494896694,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
3626,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(/C=C/C=C2\Cc3ccccc3C2=O)CC1,2-[3-(1-Methyl-piperidin-4-yl)-allylidene]-indan-1-one,0.003,uM,=,-2.5228787452803374,0,O=C1/C(=C/C=C/C2CCNCC2)Cc2ccccc21
3627,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(OC(F)(F)F)cc1)N1CCN(c2ccccn2)CC1,4-(Pyridin-2-yl)-N'-(4-(trifluoromethoxy)benzylidene)piperazine-1-carbohydrazide,2.91,uM,=,0.4638929889859073,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
3628,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCCCCCSC(=S)N3CCCCC3)ccc12,6-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)hexylpiperidine-1-carbodithioate,0.61,uM,=,-0.2146701649892329,0,O=c1ccc2ccc(OCCCCCCSC(=S)N3CCCCC3)cc2o1
3629,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)-c1cc(Br)ccc1CC2,"2-bromo-5,6-dihydrobenzo[c]acridin-7-amine",144.1,uM,=,2.1586639808139894,1,c1ccc2c(c1)CCc1cc3ccccc3nc1-2
3630,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC(C)(C)C,"N-methyl-4-(neopentyloxy)-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.1029,uM,=,-0.9875846252375672,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nccs2)ccn1
3631,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1ccc(CN(C)Cc2ccc(-c3cc4cc(OC)c(OC)cc4oc3=O)cc2)cc1,"6,7-dimethoxy-3-(4-{[(4-methoxybenzyl)methylamino]methyl}phenyl)chromen-2-one",2.26,uM,=,0.3541084391474008,1,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
3632,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,Cc1cccc(C(=O)c2c(-c3cccc(OCCCCCCCN(C)Cc4ccccc4)c3)oc3ccccc23)c1,(2-{3-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-m-tolylmethanone,102.0,uM,=,2.008600171761917,1,O=C(c1ccccc1)c1c(-c2cccc(OCCCCCCCNCc3ccccc3)c2)oc2ccccc12
3633,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,CN(Cc1ccccc1)Cc1ccc(COc2ccc3ccc(=O)[nH]c3c2)cc1.Cl,7-(4-(N-Benzyl-N-methylaminomethyl)benzyloxy)-2H-quinolin-2-one hydrochloride,1.5,uM,=,0.1760912590556812,1,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2[nH]1
3634,1913605,10.1021/acs.jmedchem.9b01099,,,,Inhibition of AChE (unknown origin),Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)ccn1,4-(4-(4-Fluorophenyl)-2-(piperidin-4-yl)thiazol-5-yl)-N-(2-methylpyridin-4-yl)pyrimidin-2-amine,0.4,uM,=,-0.3979400086720376,0,c1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(Nc3ccncc3)n2)cc1
3635,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccc(Cl)cc1,3-{7-[(4-chlorobenzyl)methylamino]-heptyloxy}xanthen-9-one,1050.0,uM,=,3.0211892990699383,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
3636,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cnn(-c3ccccc3)c2-c2c(Br)sc(Br)c21,"N-(5,7-Dibromo-1-phenyl-1,4-dihydrothieno[3',4':4,5]cyclopenta[1,2-c]pyrazol-4-yl)-2-(4-benzylpiperazine)acetamide",0.87,uM,=,-0.0604807473813814,0,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cscc2-c2c1cnn2-c1ccccc1
3637,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(Cc1cc(C)cc(/C=N/O)c1O)CC2,"3-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-2-hydroxy-5-methylbenzaldehyde oxime",1058.0,uM,=,3.024485667699167,1,c1ccc(CN2CCc3ccccc3C2)cc1
3638,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccccc12,"6'-amino-9'-nitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",1.02,uM,=,0.0086001717619175,1,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
3639,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,CCN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1OC,"2-(6-(ethyl(2-methoxybenzyl)amino)hexyl)isoindoline-1,3-dione",0.59,uM,=,-0.2291479883578558,0,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
3640,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1cccs1,"1,3-Dimethyl-2-(thiophen-2-yl)-1,2,3,4-tetrahydroquinazolin-6-ol",225.8,uM,=,2.353723937588949,1,c1csc(C2NCc3ccccc3N2)c1
3641,1724020,10.1016/j.ejmech.2017.05.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured over 5 mins by Ellman's method,O=C(O)C(F)(F)F.O=C1CC[C@@]2(C=CNC3=C2C2=NCCc4c[nH]c(c42)C3=O)C=C1Br,"(+)-Discorhabdin G 2,2,2-trifluoroacetic acid",116.0,uM,=,2.0644579892269186,1,O=C1C=C[C@]2(C=CNC3=C2C2=NCCc4c[nH]c(c42)C3=O)CC1
3642,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3ccc(F)cc3)C(=O)[C@@]3(C2)[C@H](c2ccc(F)cc2)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(4-fluorophenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(4-fluorophenyl)pyrrolidine,2.35,uM,=,0.3710678622717362,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
3643,493238,10.1021/jm8009684,,,,Inhibition of human recombinant AChE-induced amyloid beta (1-40) aggregation by thioflavin T formation assay,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,"2,7-bis(6-(ethyl(2-methoxybenzyl)amino)hexyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone",8.13,uM,=,0.9100905455940682,1,O=C1c2ccc3c4c(ccc(c24)C(=O)N1CCCCCCNCc1ccccc1)C(=O)N(CCCCCCNCc1ccccc1)C3=O
3644,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=[N+]([O-])c1ccc2nc3c(c(Nc4[nH]nc5ncccc45)c2c1)CCCC3,"7-Nitro-N-(1H-pyrazolo[3,4-b]pyridin-3-yl)-1,2,3,4-tetrahydroacridin-9-amine",0.299,uM,=,-0.5243288116755703,0,c1ccc2c(Nc3[nH]nc4ncccc34)c3c(nc2c1)CCCC3
3645,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C[C@H](CC[C@H](O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)C3=CC[C@]12C,Lucidumol B,16.27,uM,=,1.2113875529368587,1,C1=C2C(=CCC3CCCC23)C2CCCC[C@@H]2C1
3646,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(F)n3)CC1)C2,"2-((1-((6-fluoropyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.195,uM,=,-0.7099653886374819,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
3647,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,c1ccc2c(c1)Cc1c-2nc2ccccc2c1NCCCCCCCNc1c2c(nc3ccccc13)-c1ccccc1C2,"N,N'-Bis-(11H-indeno[1,2-b]quinolin-10-yl)heptane-1,7-diamine",0.455,uM,=,-0.3419886033428876,0,c1ccc2c(c1)Cc1c-2nc2ccccc2c1NCCCCCCCNc1c2c(nc3ccccc13)-c1ccccc1C2
3648,2055647,10.1016/j.ejmech.2020.112766,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 5 mins by Ellman's method,CCCCN[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCC1CCCN(Cc2ccccc2)CC1,(S)-N-[2-(1-Benzyl-azepan-4-yl)-ethyl]-2-butylamino-3-(1H-indol-3-yl)-propionamide,16.0,uM,=,1.2041199826559248,1,O=C(CCc1c[nH]c2ccccc12)NCCC1CCCN(Cc2ccccc2)CC1
3649,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(F)c3)CC2)nc1-c1ccccc1,Ethyl 2-(4-((4-acetamido-3-fluorophenyl)sulfonyl)piperazin-1-yl)-4-methyl-6-phenylpyrimidine-5-carboxylate,0.09743,uM,=,-1.011307297450183,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
3650,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),CC1c2[nH]c3ccccc3c2CCN1C(=O)/C=C/c1ccc(O)c(O)c1,"3-(3,4-dihydroxyphenyl)-1-(1-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)prop-2-en-1-one",21.0,uM,=,1.3222192947339193,1,O=C(/C=C/c1ccccc1)N1CCc2c([nH]c3ccccc23)C1
3651,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC3CCN(Cc4ccc(C)cc4)CC3)sc2-c2ccc(OC)cc2)cc1,"4-Methylbenzyl-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]-piperidin-4-ylamine",0.83,uM,=,-0.0809219076239261,0,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
3652,938311,10.1016/j.bmcl.2012.11.064,,,,Inhibition of human recombinant AChE measured for 1 min by Ellman's method,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1OC,"N'-(3,4-Dimethoxybenzylidene)-2-(4-benzylpiperidin-1-yl)acetohydrazide",62.8,uM,=,1.797959643737196,1,O=C(CN1CCC(Cc2ccccc2)CC1)N/N=C/c1ccccc1
3653,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccc([N+](=O)[O-])cc12,"5-amino-5',8-dinitro-2'-oxo-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,3'-indoline]-6-carbonitrile",3.24,uM,=,0.5105450102066121,1,O=C1Nc2ccccc2C12C=CN1CCNC1=C2
3654,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C1Cc2ccc(NC(=O)c3ccccc3)cc2CN1,"N-(3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",1.3199999999999998,uM,=,0.1205739312058498,1,O=C1Cc2ccc(NC(=O)c3ccccc3)cc2CN1
3655,28163,10.1021/jm00122a035,,,,Reversible inhibition of acetylcholinesterase (AChE) by 50 % in human erythrocytes ,C#CC(CC)OC[n+]1ccn(C)c1/C=N/O.[Cl-],1-(1-Ethyl-prop-2-ynyloxymethyl)-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,7.81,uM,=,0.8926510338773003,1,c1c[nH+]c[nH]1
3656,1718355,10.1016/j.ejmech.2017.08.051,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured over 5 mins by UV-Vis spectrophotometric analysis,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cc(N)c4ccccc4n3)CC1)C2,"2-((1-((4-Aminoquinolin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.71,uM,=,-0.1487416512809247,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccc3ccccc3n2)CC1
3657,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Brc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-(4-Bromophenyl)-5-(4-(pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazole",0.074,uM,=,-1.1307682802690238,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
3658,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,"2-(5-((3-Chlorobenzyl)(methyl)amino)pentyl)isoindoline-1,3-dione hydrochloride",0.537,uM,=,-0.2700257143004443,0,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1
3659,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),CC(C)=CCC/C(C)=C/CC/C(C)=C\Cc1c(O)cc(O)c(CC=C(C)C)c1-c1cc2ccc(O)cc2o1,Morusalfuran B,13.92,uM,=,1.1436392352745433,1,c1ccc(-c2cc3ccccc3o2)cc1
3660,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1ccc(Cl)cc1,"2-(4-Chlorophenyl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-o",235.6,uM,=,2.372175286115064,1,c1ccc(C2NCc3ccccc3N2)cc1
3661,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-Phenyl-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",12.86,uM,=,1.1092409685882032,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
3662,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)N(C)c1cccc2n1cc(-c1ccc(OC(=O)N(C)C)cc1)[n+]2C.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-1-methyl-5-(N-methylacetamido)imidazo[1,2-a]pyridin-1-ium",24.5,uM,=,1.3891660843645326,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
3663,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,"N4-(3,4-dimethoxyphenethyl)-N2-methylquinazoline-2,4-diamine",8.5,uM,=,0.9294189257142929,1,c1ccc(CCNc2ncnc3ccccc23)cc1
3664,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ncccc3C)CC1)C2,"5,6-Dimethoxy-2-((1-((6-methylpyridin-2-yl)methyl)piperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",0.113,uM,=,-0.9469215565165804,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
3665,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)CCc6ccccc6)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"20S-[methyl(2-phenylethyl)amino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1CC2C(CC[C@@H]2CNCCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
3666,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CO[C@@H](C1)O2,"(-)-(5R)-5-methyl-4,5-dihydro-2,5-methano-1,3-benzodioxepin-7-yl N-(o-Tolyl)-carbamate",0.097,uM,=,-1.0132282657337552,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CO[C@@H](C1)O2
3667,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3cccc(C)c3)cc1Br)C2=O.[Br-],2-[[3-Bromo-1-(m-tolylmethyl)pyridin-1-ium-4-yl]methyl]-6-methoxy-tetralin-1-one bromide,0.0165,uM,=,-1.7825160557860935,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
3668,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CN(CCCCCCOc1ccc(/C=C2\COc3ccccc3C2=O)cc1)Cc1ccccc1,(E)-3-(4-(6-(benzyl(methyl)amino)hexyl)oxy)benzylidene)chroman-4-one,40.9,uM,=,1.611723308007342,1,O=C1/C(=C/c2ccc(OCCCCCCNCc3ccccc3)cc2)COc2ccccc21
3669,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CC(C)c1ccc(N2C(=O)C3CN(C)C4(C(=O)c5ccccc5C4=O)C3C2=O)cc1,"5'-(4-Isopropylphenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",12.24,uM,=,1.0877814178095424,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
3670,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1,"(E)-4-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-3-oxoprop-1-en-1-yl)phenyl ethyl(methyl)carbamate",6.8,uM,=,0.8325089127062363,1,O=C(/C=C/c1ccccc1)N1CCc2ccccc2C1
3671,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1cccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c1OC,"2-(2,3-Dimethoxyphenyl)-5-(4-(pyridine-2-yl)piperazine-1-yl)-1,3,4-oxadiazole",1.19,uM,=,0.0755469613925307,1,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
3672,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.087,uM,=,-1.0604807473813815,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3673,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.029,uM,=,-1.537602002101044,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
3674,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,C[C@]12CC[C@H](O)[C@@](C)(CO)C1C[C@H](O)[C@@]1(C)Oc3cc(-c4ccncc4)oc(=O)c3C(=O)C21,"3,6-Dihydroxy-4-hydroxymethyl-4,6a,12b-trimethyl-9-pyridin-4-yl-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-7,10-dioxa-benzo[a]anthracene-11,12-dione",7.9,uM,=,0.8976270912904415,1,O=C1c2c(cc(-c3ccncc3)oc2=O)OC2CCC3CCCCC3C12
3675,877957,10.1021/jm3015519,,,,Inhibition of human AChE,COc1cc2c(cc1OC)C(c1ccccc1)N(CCCCCc1ccnc(/C=N/O)c1O)CC2,"4-(5-(6,7-Dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)pentyl)-3-hydroxypicolinaldehyde oxime",320.0,uM,=,2.505149978319906,1,c1ccc(C2c3ccccc3CCN2CCCCCc2ccncc2)cc1
3676,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,c1ccc(CN2CCC(Nc3nccc(NCc4ccc5c(c4)OCO5)n3)CC2)cc1,"N4-(Benzo[d][1,3]dioxol-5-ylmethyl)-N2-(1-benzylpiperidin-4-yl)pyrimidine-2,4-diamine",12.6,uM,=,1.100370545117563,1,c1ccc(CN2CCC(Nc3nccc(NCc4ccc5c(c4)OCO5)n3)CC2)cc1
3677,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],"3-(3,8-diamino-6-phenyl-5-phenanthridiniumyl)propyl(diethyl)methylammonium",7.14,uM,=,0.8536982117761743,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
3678,1993993,10.1016/j.bmcl.2020.126985,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2csc(NC(=O)CCN3CCCC3)n2)cc1,N-(4-(4-methoxyphenyl)thiazol-2-yl)-3-(pyrrolidin-1-yl)propanamide,0.51,uM,=,-0.2924298239020636,0,O=C(CCN1CCCC1)Nc1nc(-c2ccccc2)cs1
3679,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(CN2CCC(CNc3nsc4ccccc34)CC2)cc1,N-((1-benzylpiperidin-4-yl)methyl)benzo[d]isothiazol-3-amine,0.099,uM,=,-1.00436480540245,0,c1ccc(CN2CCC(CNc3nsc4ccccc34)CC2)cc1
3680,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,CCN(CCCN1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1)C1CCCCC1,"N-(2-{4-[3-(cyclohexyl(ethyl)amino)propyl]piperazino}ethyl)-(1,2,3,4-tetrahydroacridin-9-yl)amine",0.194,uM,=,-0.712198270069774,0,c1ccc2c(NCCN3CCN(CCCNC4CCCCC4)CC3)c3c(nc2c1)CCCC3
3681,1500569,10.1039/C4MD00069B,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins by Ellmans method,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis(6-((2-methoxybenzyl)(ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",15.4,uM,=,1.187520720836463,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3682,28290,10.1016/S0960-894X(01)81088-X,,,,Concentration required to inhibit acetylcholinesterase isolated from human erythrocytes,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.128,uM,=,-0.8927900303521317,0,c1ccc2c(c1)N[C@H]1NCCC21
3683,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,CC1(C)C=Cc2cc3ccc(=O)oc3cc2O1,"8,8-Dimethyl-8H-pyrano[3,2-g]chromen-2-one",150.0,uM,=,2.1760912590556813,1,O=c1ccc2cc3c(cc2o1)OCC=C3
3684,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)cc3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-aminophenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.07189,uM,=,-1.143331516388465,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
3685,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(CC2=Cc3ccccc3C2)CC1,4-(1H-Inden-2-ylmethyl)-1-methyl-piperidine,4.4,uM,=,0.6434526764861874,1,C1=C(CC2CCNCC2)Cc2ccccc21
3686,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccccc2)cc1,SID417440,0.5174,uM,=,-0.2861735756194754,0,O=S(=O)(SCc1ccccc1)c1ccccc1
3687,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN(C)CCCOc2ccc3c4c(c(=O)oc3c2)CCCC4)c1,"3-(3-((3-Methoxybenzyl)(methyl)amino)propoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",2.7,uM,=,0.4313637641589873,1,O=c1oc2cc(OCCCNCc3ccccc3)ccc2c2c1CCCC2
3688,2261346,10.1016/j.ejmech.2022.114606,,,,Inhibition of AChE (unknown origin),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.028,uM,=,-1.5528419686577808,0,c1ccc2c(c1)N[C@H]1NCCC21
3689,744973,10.1016/j.bmcl.2010.12.093,,,,Inhibition of human serum AChE,COc1cc(CNCCCNC2=CC(=O)C(NCCCNCc3ccc(O)c(OC)c3)=CC2=O)ccc1O,"2,5-bis(3-(4-hydroxy-3-methoxybenzylamino)propylamino)cyclohexa-2,5-diene-1,4-dione",0.198,uM,=,-0.7033348097384688,0,O=C1C=C(NCCCNCc2ccccc2)C(=O)C=C1NCCCNCc1ccccc1
3690,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Fc1ccc(/C=N\C2CCN(Cc3ccccc3)C2)cc1,N-(1-Benzylpyrrolidin-3-yl)-1-(4-fluorophenyl)methanimine,1.0659999999999998,uM,=,0.0277572046905533,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
3691,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCCNc1ccc(-c2ccccc2)nn1)Cc1ccccc1,"N1-benzyl-N1-methyl-N4-(6-phenylpyridazin-3-yl)butane-1,4-diamine",11.0,uM,=,1.0413926851582251,1,c1ccc(CNCCCCNc2ccc(-c3ccccc3)nn2)cc1
3692,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Cl-].[Cl-].c1ccc2c(c1)ccc[n+]2COC[n+]1cccc2ccccc21,"1,1'-prop-2-oxa-1,3-diyl-bis(quinolinium) dichloride",418.0,uM,=,2.621176281775035,1,c1ccc2c(c1)ccc[n+]2COC[n+]1cccc2ccccc21
3693,1791401,10.1039/C7MD00457E,,,,Inhibition of AChE (unknown origin),CCN(CC)c1ccc(/C=C/c2cc(N3CCCCC3)c3ccccc3n2)cc1,"N,N-diethyl-4-(2-(4-(piperidin-1-yl)quinolin-2-yl)vinyl)aniline",64.1,uM,=,1.8068580295188168,1,C(=C/c1cc(N2CCCCC2)c2ccccc2n1)\c1ccccc1
3694,1443169,10.1016/j.ejmech.2014.09.081,,,,Inhibition of human erythrocyte AChE preincubated for 15 mins by Ellman's method,CNc1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,"(E)-5-methoxy-2-(4-(methylamino)benzylidene)-6-(2-(piperidin-1-yl)ethoxy)-2,3-dihydro-1H-inden-1-one",0.3011,uM,=,-0.5212892444872407,0,O=C1/C(=C/c2ccccc2)Cc2ccc(OCCN3CCCCC3)cc21
3695,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cc2c(cc1O)C/C(=C\C1CCN(Cc3ccccc3)CC1)C2=O,"(E)-2-((1-benzylpiperidin-4-yl)methylene)-5-hydroxy-6-methoxy-2,3-dihydro-1H-inden-1-one",1.54,uM,=,0.1875207208364631,1,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
3696,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2,SID11112431,1.33,uM,=,0.1238516409670858,1,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
3697,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,O=C(c1cnn(C2CCCC2)c1)C(F)F,"1-(1-cyclopentyl-1H-pyrazol-4-yl)-2,2-difluoroethan-1-one",0.244,uM,=,-0.6126101736612706,0,c1cnn(C2CCCC2)c1
3698,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,N#CC(c1ccc2c(c1)OCO2)N1CCOCC1,"rac-2-(3,4-Dioxymethylenphenyl)-2-(morpholin-1-yl)acetonitrile",58.0,uM,=,1.7634279935629371,1,c1cc2c(cc1CN1CCOCC1)OCO2
3699,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3c1CCCO3)CCC2,"1,2,3,6,7,8-Hexahydro-5-oxa-4-aza-cyclopenta[b]naphthalen-9-ylamine",1.12,uM,=,0.0492180226701816,1,c1c2c(nc3c1CCCO3)CCC2
3700,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,COc1ccccc1CN(C)CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,"4'-(4-((2-Methoxybenzyl)(methyl)amino)butoxy)-5,6,7-trimethoxyflavone",0.5,uM,=,-0.3010299956639812,0,O=c1cc(-c2ccc(OCCCCNCc3ccccc3)cc2)oc2ccccc12
3701,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cc(C(C)N(C)C)cc2oc(=O)c3ccccc3c12.Cl,(+/-)-3-(1-(Dimethylamino)ethyl)-1-methoxy-6H-benzo[c]chromen-6-one hydrochloride,2.8,uM,=,0.4471580313422192,1,O=c1oc2ccccc2c2ccccc12
3702,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),COc1ccc2c3ccnc(C)c3n(CC3CC(c4ccccc4)=NO3)c2c1,"5-[(7-methoxy-1-methyl-pyrido[3,4-b]indol-9-yl)methyl]-3-phenyl-4,5-dihydroisoxazole",11.0,uM,=,1.0413926851582251,1,c1ccc(C2=NOC(Cn3c4ccccc4c4ccncc43)C2)cc1
3703,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CC#CCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-((methyl(4-(9-oxo-9H-xanthen-3-yloxy)but-2-ynyl)amino)methyl)phenyl methylcarbamate,0.21,uM,=,-0.6777807052660807,0,O=c1c2ccccc2oc2cc(OCC#CCNCc3ccccc3)ccc12
3704,1663551,10.1021/acs.jmedchem.7b00702,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3)cc1C(C)=O)C2.[Br-],"(+/-)-2-[(3-Acetyl-1-benzyl-pyridin-1-ium-4-yl)methyl]-5,6-dimethoxy-indan-1-one Bromide",0.018,uM,=,-1.744727494896694,0,O=C1c2ccccc2CC1Cc1cc[n+](Cc2ccccc2)cc1
3705,1852470,10.1016/j.ejmech.2019.05.020,,,,Inhibition of AChE (unknown origin),C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2n1C,N-{[5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1-methyl-1Hindol-2-yl]methyl}-N-methylprop-2-yn-1-amine,0.35,uM,=,-0.4559319556497244,0,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
3706,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,COc1ccccc1CN(CCCCCCNC1=CC(=O)C(NCCCCCCN(Cc2ccccc2OC)C(C)C)=CC1=O)C(C)C,"2,5-bis{6-[isopropyl(2-methoxybenzyl)amino]hexylamino}-[1,4]-benzoquinone",0.0129,uM,=,-1.889410289700751,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3707,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cccc(NC(=O)CCNC(=O)/C=C/c2ccc(O)c(OC)c2)c1,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(3-((3-methoxyphenyl)amino)-3-oxopropyl)acrylamide,2.41,uM,=,0.3820170425748684,1,O=C(/C=C/c1ccccc1)NCCC(=O)Nc1ccccc1
3708,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,[Br-].c1ccc(C[n+]2ccc3[nH]c4ccccc4c3c2)cc1,"2-benzyl-5H-pyrido[4,3-b]indol-2-ium bromide",8.6,uM,=,0.9344984512435676,1,c1ccc(C[n+]2ccc3[nH]c4ccccc4c3c2)cc1
3709,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccccc2C)C(=O)/C(=C/c2ccccc2C)C1,"(3E,5E)-1-Acryloyl-3,5-bis(2-methylphenylmethylidene)piperidin-4-one",17.39,uM,=,1.2402995820027125,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
3710,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccc(C(C)NS(N)(=O)=O)cc1OC,"N-(1-(3,4-Dimethoxyphenyl)ethyl)sulfamide",2.685e-05,uM,=,-4.571055709964425,0,c1ccccc1
3711,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccccc2CC1CC1CCN(c2ccccc2)CC1,"2-((1-phenylpiperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",0.15,uM,=,-0.8239087409443188,0,O=C1c2ccccc2CC1CC1CCN(c2ccccc2)CC1
3712,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)CCCC/C=C/CCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccc1O,,0.00564,uM,=,-2.248720896016658,0,O=C(CCCC/C=C/CCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccccc1
3713,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4ccc(O)cc4)[nH]3)ccc21,"(S)-4-(5-{1-[3-(Dimethylamino)propyl]-1-(4-fluoro phenyl)-1,3-dihydroisobenzofuran-5-yl}-4H-1,2,4-triazol-3-yl)phenol",387.56,uM,=,2.5883389472339537,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
3714,28600,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 4.7-15.6,CCCN(C)C(=O)Oc1cccc(CCN)c1,Methyl-propyl-carbamic acid 3-(2-amino-ethyl)-phenyl ester,7.8,uM,=,0.8920946026904804,1,c1ccccc1
3715,2266926,10.1016/j.ejmech.2020.113102,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1OC)C(=O)[C@]1(C2)[C@H](c2ccccc2OC)[C@H](Cc2c[nH]c3ccccc23)NC12C(=O)Nc1ccccc12,"(2R,4'S,5'S)-5'-((1H-indol-3-yl)methyl)-5,6-dimethoxy-4'-(2-methoxyphenyl)dispiro[indene-2,3'-pyrrolidine-2',3''-indoline]-1,2''(3H)-dione",2.76,uM,=,0.4409090820652177,1,O=C1Nc2ccccc2C12N[C@@H](Cc1c[nH]c3ccccc13)[C@@H](c1ccccc1)[C@]21Cc2ccccc2C1=O
3716,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)CCCCCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccc1O,,0.00077,uM,=,-3.113509274827518,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccccc1
3717,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CNc2nc(NC(C)C)nc3ccccc23)cc1OC,"N4-(3,4-dimethoxybenzyl)-N2-isopropylquinazoline-2,4-diamine",6.8,uM,=,0.8325089127062363,1,c1ccc(CNc2ncnc3ccccc23)cc1
3718,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3c(F)cccc3F)cc12.[Br-],"2-(2,6-Difluoropheny1)-8-methoxyisoquinolin-2-ium bromide",2.7,uM,=,0.4313637641589873,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
3719,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1OC)CC(CC1CCN(CCCNc3c4c(nc5cc(Cl)ccc35)CC3C=C(C)CC4C3)CC1)C2.Cl.Cl,"(+/-)-3-chloro-N-(3-(4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)propyl)-9-methyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinolin-12-amine Dihydrochloride",0.00537,uM,=,-2.2700257143004445,0,C1=CC2Cc3nc4ccccc4c(NCCCN4CCC(CC5Cc6ccccc6C5)CC4)c3C(C1)C2
3720,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CCN(CC)CCCCOc1ccc(/C=C2\COc3ccccc3C2=O)cc1,(E)-3-(4-(4-(diethylamino)butoxy)benzylidene)chroman-4-one,14.1,uM,=,1.14921911265538,1,O=C1/C(=C/c2ccccc2)COc2ccccc21
3721,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1c(F)c[n+](CCCOc2ccc3c(C)cc(=O)oc3c2)cc1F.O=S(=O)([O-])C(F)(F)F,"3,5-difluoro-4-methoxy-1-(3-(4-methyl-2-oxo-2H-chromen-7-yloxy)propyl)pyridinium trifluoromethanesulfonate",1.9,uM,=,0.2787536009528289,1,O=c1ccc2ccc(OCCC[n+]3ccccc3)cc2o1
3722,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CC(c1cc(O)c2c(c1)oc(=O)c1ccccc12)N(C)C.Cl,(+/-)-3-(1-(Dimethylamino)ethyl)-1-hydroxy-6H-benzo[c]chromen-6-one hydrochloride,18.9,uM,=,1.276461804173244,1,O=c1oc2ccccc2c2ccccc12
3723,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-phenyl-acetamide,0.052,uM,=,-1.2839966563652008,0,c1ccc(CN2CCC(CCNc3ccccc3)CC2)cc1
3724,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(Cc1c[nH]c2ccc(Br)cc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"2-(5-bromo-1H-indol-3-yl)-N-[7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-acetamide",0.0006,uM,=,-3.2218487496163566,0,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3725,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C[C@H](CCC(=O)O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1C[C@@H]3O,Lucidenic acid N,25.91,uM,=,1.413467412985825,1,O=C1CC2CCC(=O)C2C2=C1C1CCCC[C@@H]1CC2
3726,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3ccccc3)cc1C(C)=O)CC2.[Br-],"3-Acetyl-1-benzyl-4-((6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium bromide",0.024,uM,=,-1.619788758288394,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
3727,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,N-(2-chloro-5-(S-2-fluoroethyl)thiophenyl)-N'-(3-thiomethylphenyl)-N'-methyl guanidine,1.14,uM,=,0.0569048513364725,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
3728,2261999,10.1016/j.bmc.2022.117030,,,,Inhibition of human recombinant AChE using S-acetylthiocholine as substrate by DTNB reagent based spectrophotometric analysis,O=c1[nH]c2ccc(OCc3ccc(F)cc3)cc2c(=O)o1,"6-[(4-Fluorophenyl)methoxy]-2H-3,1-benzoxazine-2,4(1H)-dione",76.2,uM,=,1.8819549713396004,1,O=c1[nH]c2ccc(OCc3ccccc3)cc2c(=O)o1
3729,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,CCN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(OC)c(OC)c2)cc1,"{4-[(Benzylethylamino)methyl]phenyl}-(3,4-dimethoxyphenyl)methanone",0.57,uM,=,-0.2441251443275086,0,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
3730,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc(Br)c3)cc1)C2.[Br-],"(E)-1-(3-bromobenzyl)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)pyridin-1-ium bromide",0.0052,uM,=,-2.283996656365201,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
3731,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCN(Cc5ccccc5)CC4)cc3)C2)cc1,"1-(5-(4-(4-Benzylpiperazin-1-yl)phenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",100.2,uM,=,2.000867721531227,1,c1ccc(CN2CCN(c3ccc(C4CC(c5ccccc5)=NN4)cc3)CC2)cc1
3732,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.Cl.O=C(NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"6-Chloro-9-{{6-[5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-9-carboxamido]hexyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.0192,uM,=,-1.7166987712964503,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
3733,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,COc1cc(OC)c(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,Barbigerone,121.6,uM,=,2.084933574936716,1,O=c1c(-c2ccccc2)coc2c3c(ccc12)OCC=C3
3734,1331163,10.1039/C1MD00221J,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured after 10 mins by Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.16,uM,=,-0.7958800173440752,0,c1ccc2c(c1)N[C@H]1NCCC21
3735,1565849,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CCCCCCCNC(=O)Oc1ccc2c(c1)CN(C)C(c1ccc(F)cc1)N2C,"2-(4-Fluorophenyl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-yl n-heptylcarbamate",1.61,uM,=,0.2068258760318497,1,c1ccc(C2NCc3ccccc3N2)cc1
3736,2261363,10.1016/j.ejmech.2022.114606,,,,Inhibition of human AChE,CCN1/C(=C/C(C)=O)Sc2ccc(OC(=O)OCCOCCNC(=O)c3cc4c(OC(=O)N(C)C)cccc4[n+](C)c3)cc21.COS(=O)(=O)[O-],"[(2Z)-2-acetonylidene-3-ethyl-1,3-benzothiazol-5-yl]2-[2-[[5-(dimethylcarbamoyloxy)-1-methyl-quinolin-1-ium-3-carbonyl]amino]ethoxy]ethyl carbonate methyl sulfate",0.0814,uM,=,-1.0893755951107988,0,C=C1Nc2cc(OC(=O)OCCOCCNC(=O)c3c[nH+]c4ccccc4c3)ccc2S1
3737,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(C4CCCCC4)CC3)nc12,3-(4-Cyclohexylpiperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,10.91,uM,=,1.0378247505883418,1,O=C(CCN1CCN(C2CCCCC2)CC1)Nc1nc2ccccc2s1
3738,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=C(Br)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(Br)C1=O)Cc1ccccc1OC,"2,5-bis{6-[ethyl(2-methoxybenzyl)amino]hexylamino}-3,6-dibromo-[1,4]-benzoquinone",0.00266,uM,=,-2.575118363368933,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3739,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,Cc1cc2nc3c(nc2cc1C)C1(C(C#N)=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C1[N+](=O)[O-])c1ccccc1-3,"2'-amino-1'-benzyl-6'-(benzylamino)-7,8-dimethyl-5'-nitro-1'H-spiro[indeno[1,2-b]quinoxaline-11,4'-pyridine]-3'-carbonitrile",5.8,uM,=,0.7634279935629373,1,C1=CC2(C=C(NCc3ccccc3)N1Cc1ccccc1)c1ccccc1-c1nc3ccccc3nc12
3740,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2C(=O)OC(C)(C)C)cc1,"4'-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-biphenyl-2-carboxylic acid tert-butyl ester",0.2688,uM,=,-0.5705707356182124,0,O=C1N(Cc2ccc(-c3ccccc3)cc2)C=NC12CCCC2
3741,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,Clc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,4-(benzofuran-2-yl)-1-(4-chlorobenzyl)piperidine,98.55,uM,=,1.993656628615462,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
3742,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(-c2ccc(Cl)cc2)nnc1NCCN1CCOCC1,[6-(4-Chloro-phenyl)-4-methyl-pyridazin-3-yl]-(2-morpholin-4-yl-ethyl)-amine (2HCl),34.0,uM,=,1.5314789170422551,1,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1
3743,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(5-((1,2,3,4-tetrahydroacridin-9-yl)amino)pentyl)chroman-2-carboxamide",0.62,uM,=,-0.2076083105017461,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3744,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1cccn1C(=O)c1ccccc1,3-(1-Benzoyl-1H-pyrrol-2-ylmethylene)-1-benzyl-piperidin-4-one,30.0,uM,=,1.4771212547196624,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cccn1C(=O)c1ccccc1
3745,579488,10.1016/j.bmcl.2009.05.087,,,,Inhibition of human recombinant AChE preincubated 20 mins before substrate addition by Ellman method,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@@H](C)c2ccccc2OC)=CC1=O)[C@H](C)c1ccccc1OC,"2-(6-(ethyl((R)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)-5-(6-(ethyl((S)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",0.0003599999999999,uM,=,-3.4436974992327127,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3746,2222235,10.1021/acsmedchemlett.2c00001,,,,Inhibition of recombinant human AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2oc1=O,"(+)-3,4-Dimethyl-7-[(N-benzylpiperidin-3-yl)methoxy]-2H-chromen-2-one",1.3,uM,=,0.1139433523068367,1,O=c1ccc2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2o1
3747,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1.[Br-],4-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-benzylpyridin-1-ium bromide,4.2,uM,=,0.6232492903979004,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
3748,2215309,10.1016/j.bmc.2022.116742,,,,"Inhibition of recombinant human AChE using Amplex red, acetylthiocholine as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by microplate fluorescence reader analysis",C#CCOc1cccc(-c2cc(-c3ccc(OCCN4CCOCC4)cc3)nc(C)n2)c1,4-(2-(4-(2-methyl-6-(3-(prop-2-yn-1-yloxy)phenyl)pyrimidin-4-yl)phenoxy)ethyl)morpholine,0.00954,uM,=,-2.020451625295905,0,c1ccc(-c2cc(-c3ccc(OCCN4CCOCC4)cc3)ncn2)cc1
3749,28615,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 7.81-39.2,C#CCNC1CCc2ccc(OC(=O)N(C)CCCCCC)cc21.Cl,Hexyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,15.7,uM,=,1.1958996524092338,1,c1ccc2c(c1)CCC2
3750,2261371,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method,CNC(=O)Oc1cccc(CN(C)CCCCCCOc2ccc(C(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)c(O)c2)c1,"[3-[[6-[3-hydroxy-4-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]phenoxy]hexyl-methyl-amino]methyl]phenyl]N-methylcarbamate",0.00133,uM,=,-2.876148359032914,0,O=C(/C=C/c1ccccc1)c1ccc(OCCCCCCNCc2ccccc2)cc1
3751,2295739,10.1016/j.bmc.2023.117256,,,,Inhibition of AChE (unknown origin),CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,2.07,uM,=,0.3159703454569177,1,c1ccccc1
3752,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2ccccc2NCN1CCC1CCN(Cc2ccccc2)CC1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-2,3-dihydro-1H-quinazolin-4-one",0.8,uM,=,-0.0969100130080563,0,O=C1c2ccccc2NCN1CCC1CCN(Cc2ccccc2)CC1
3753,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCC3CC[N+](C)(CC4CCCCO4)CC3)sc2cc1OC.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-1-(tetrahydro-pyran-2-ylmethyl)-piperidinium bromide",0.028,uM,=,-1.5528419686577808,0,O=C(CCC1CC[NH+](CC2CCCCO2)CC1)c1cc2ccccc2s1
3754,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCOC(=O)[C@@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1ccccc1,N-Benzoyl-D-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-ethyl,0.5,uM,=,-0.3010299956639812,0,O=C(CCCNC(=O)c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3755,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCN1CCc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-propyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.022,uM,=,-1.6575773191777938,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
3756,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(O)cc1O)N1CCN(c2ccccn2)CC1,"N'-(2,4-Dihydroxybenzylidene)-4-(pyridine-2-yl)piperazine-1-carbohydrazide",4.68,uM,=,0.670245853074124,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
3757,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N/O)Nc1ccc[n+](CC[n+]2cccc(NC(=O)/C=N/O)c2)c1.[Br-].[Br-],"1,1'-(ethane-1,2-diyl)bis(3-(2-(hydroxyimino)acetamido)pyridinium)dibromide",2530.0,uM,=,3.403120521175818,1,c1cc[n+](CC[n+]2ccccc2)cc1
3758,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccccc1C(=O)N1Cc2ccc(N3C(=O)c4ccccc4C3=O)cc2CC1=O,"2-(2-(2-methoxybenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-6-yl)isoindoline-1,3-dione",0.08165,uM,=,-1.088043810927313,0,O=C1Cc2cc(N3C(=O)c4ccccc4C3=O)ccc2CN1C(=O)c1ccccc1
3759,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CC[N+](C)(C)c1cccc(O)c1.[Cl-],Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium chloride,0.1999999999999999,uM,=,-0.6989700043360189,0,c1ccccc1
3760,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCN1CCCCC1,(E)-3-(3-methoxy-4-(4-(piperidin-1-yl)butoxy)phenyl)-N-phenylacrylamide,7.14,uM,=,0.8536982117761743,1,O=C(/C=C/c1ccc(OCCCCN2CCCCC2)cc1)Nc1ccccc1
3761,785863,10.1016/j.bmcl.2011.08.042,,,,Inhibition of human recombinant AChE after 5 mins using spectrophotometer by Ellman's method,CCCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2,"N-heptyl-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine",0.27,uM,=,-0.5686362358410126,0,c1ccc2nc3c(cc2c1)CCCC3
3762,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)cc2)cc1,N-(4-((benzyl(methyl)amino)methyl)phenyl)-2-(4-hydroxyphenyl)acetamide,3.24,uM,=,0.5105450102066121,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
3763,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(c2)O/C(=C\c2cc(OC)c(OC)c(OC)c2)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(3-{3-oxo-2-[1-(3,4,5-trimethoxy-phenyl)-meth-(Z)-ylidene]-2,3-dihydro-benzofuran-6-yloxy}-propyl)-amino]-methyl}-phenyl ester",2.99,uM,=,0.4756711883244297,1,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCNCc3ccccc3)ccc21
3764,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCC(C)n1cc(C(=O)C(F)(F)F)cn1,"1-(1-(sec-butyl)-1H-pyrazol-4-yl)-2,2,2-trifluoroethanone",0.00884,uM,=,-2.053547734986927,0,c1cn[nH]c1
3765,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,C=CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(allylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.0665999999999999,uM,=,-1.176525770829699,0,O=c1c2ccccc2nc2n1CCC2
3766,2048979,10.1016/j.bmcl.2020.127609,,,,Inhibition of human recombinant AChE,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.084,uM,=,-1.0757207139381184,0,c1ccc2nc3c(cc2c1)CCCC3
3767,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,Oc1ccc(CNCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1O,"N-[6'-(3'',4''-dihydroxybenzyl)amino]hexyl-1,2,3,4-tetrahydroacridin-9-amine",0.029,uM,=,-1.537602002101044,0,c1ccc(CNCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
3768,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,C/N=C1/CCc2c1n(C)c1ccc(OC(=O)NC)c(Cl)c21,"Methyl-carbamic acid 8-chloro-4-methyl-3-[(Z)-methylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.23,uM,=,-0.6382721639824072,0,N=C1CCc2c1[nH]c1ccccc21
3769,1465704,10.1016/j.bmcl.2015.02.015,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate after 15 mins by Ellman spectrophotometric method,COc1cc2oc(-c3cccc(OCC(=O)NCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3)cc(=O)c2c(OC)c1OC,"N-(6-((6-chloro-1,2,3,4-tetrahydroanthracen-9-yl)amino)hexyl)-2-(3-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",0.0325,uM,=,-1.4881166390211256,0,O=C(COc1cccc(-c2cc(=O)c3ccccc3o2)c1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
3770,938311,10.1016/j.bmcl.2012.11.064,,,,Inhibition of human recombinant AChE measured for 1 min by Ellman's method,CCOc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,N'-(4-Ethoxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide,81.4,uM,=,1.9106244048892007,1,O=C(CN1CCN(Cc2ccccc2)CC1)N/N=C/c1ccccc1
3771,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc3ccccc3c2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}naphthalen-2-yl-methanone,19.6,uM,=,1.292256071356476,1,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc2ccccc2c1
3772,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCCCCCN(C)Cc1ccc(O)cc1,1-(12-((4-hydroxybenzyl)(methyl)amino)dodecyl)-5-methoxy-1H-indole-3-carbaldehyde,60.61,uM,=,1.78254428401001,1,c1ccc(CNCCCCCCCCCCCCn2ccc3ccccc32)cc1
3773,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CC(C)c1ccc(NC(=O)OC2CCCN(C3Cc4ccccc4C3)C2)cc1,"1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl (4-isopropylphenyl)carbamate",7.914,uM,=,0.8983960459300089,1,O=C(Nc1ccccc1)OC1CCCN(C2Cc3ccccc3C2)C1
3774,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Cl.O=[N+]([O-])c1ccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)cc1,"9-(2-(4-((1-(4-Nitrophenyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",1.05,uM,=,0.021189299069938,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
3775,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(C2CCN(C(=O)COc3ccc(-c4ccccc4)cc3)CC2)CC1,"2-([1,1'-Biphenyl]-4-yloxy)-1-[4-(4-ethyl-1-piperazinyl)-1-piperidinyl]-ethanone",31.0,uM,=,1.4913616938342726,1,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCNCC2)CC1
3776,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COC(=O)/C(=N\Nc1ccccc1[N+](=O)[O-])C(=O)C(F)(F)F,"Methyl(2Z)-4,4,4-trifluoro-2-[2-(2-nitrophenyl)hydrazinylidene]-3-oxobutanoate",20.9,uM,=,1.320146286111054,1,c1ccccc1
3777,1849549,10.1016/j.bmc.2019.07.001,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.04,uM,=,-1.3979400086720375,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3778,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,C[C@@H]([C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4[C@]5(C)COC(C(C)(C)F)=N[C@H]5CC[C@@]45C[C@@]35C(=O)C[C@]12C)N(C)C,"20S-(dimethylamino)-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-(1-fluoro-1-methylethyl)-5',6'-dihydro-4alphaH-[1',3']oxazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.744,uM,=,-0.1284270644541213,0,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4COC=N[C@H]4CC[C@@]34C[C@@]124
3779,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CCC(C)n1cc(C(=O)C(F)F)cn1,"1-(1-(sec-butyl)-1H-pyrazol-4-yl)-2,2-difluoroethan-1-one",0.0859,uM,=,-1.0660068361687576,0,c1cn[nH]c1
3780,749399,10.1016/j.bmcl.2009.04.089,,,,Inhibition of human recombinant AChE preincubated for 30 mins before DTNB substrate addition by spectrophotometric assay based Ellman's method,C[C@H](Cc1ccccc1)N(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.Cl,3-((S)-1-(dimethylamino)ethyl)phenylmethyl((R)-1-phenylpropan-2-yl)carbamate hydrochloride,0.302,uM,=,-0.5199930570428494,0,O=C(NCCc1ccccc1)Oc1ccccc1
3781,462117,10.1021/jm7009364,,,,Inhibition of human AchE,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(OC)cc1)CCCC3,"ethyl 5-amino-2-methyl-4-(4-methoxyphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.045,uM,=,-1.3467874862246565,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
3782,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccccc2)CC1,4-((1-Benzylpiperidin-4-yl)methoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methylthiazole-5-carboxamide,8.0,uM,=,0.9030899869919436,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
3783,2093130,10.1016/j.ejmech.2020.112718,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate measured after 30 mins by Ellman's method,CC(C)=CCc1c(O)cc(O)c2c1O[C@H](c1ccccc1)CC2=O,"(S)-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-2,3-dihydrochromen-4-one",0.0064,uM,=,-2.193820026016113,0,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
3784,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)CCCCC2,"7,8,9,10-Tetrahydro-6H-cyclohepta[b]quinolin-11-ylamine",0.039,uM,=,-1.408935392973501,0,c1ccc2nc3c(cc2c1)CCCCC3
3785,1551032,10.1021/acs.jnatprod.5b00830,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate assessed as substrate hydrolysis preincubated for 20 mins followed by substrate addition measured after 30 mins by Ellman's assay,CCC(C)C(=O)[C@@H]1C(=O)[C@]2(CC=C(C)C)OC(=O)[C@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)C/C=C/C(C)(C)O)C2=O,Hyperuralone D,7.1,uM,=,0.8512583487190752,1,O=C1OC2C(=O)CCCCC1C2=O
3786,28468,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.35-4.98,CN(C)C(=O)Oc1ccc2c(c1)CC(N)CC2,"Dimethyl-carbamic acid 7-amino-5,6,7,8-tetrahydro-naphthalen-2-yl ester",3.24,uM,=,0.5105450102066121,1,c1ccc2c(c1)CCCC2
3787,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cccc(C[n+]2ccc(COc3ccc4c(C)cc(=O)oc4c3)cc2)c1.[Br-],4-(((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)-1-(3-methylbenzyl)pyridin-1-ium bromide,0.0836,uM,=,-1.0777937225609835,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
3788,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CC1=CC2Cc3nc4cc(F)cc(F)c4c(N)c3C(C1)C2,"5,7-difluoro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.0022,uM,=,-2.657577319177794,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
3789,321162,10.1021/jm058225d,,,,Inhibitory concentration against acetylcholinesterase,CN(C)C(=O)Oc1ccc2c(c1)C=CCN(C)[C@@H]2CCOc1ccc([N+](=O)[O-])cc1,"Dimethyl-carbamic acid (R)-2-methyl-1-[2-(4-nitro-phenoxy)-ethyl]-2,3-dihydro-1H-benzo[c]azepin-7-yl ester",0.014,uM,=,-1.853871964321762,0,C1=Cc2ccccc2[C@@H](CCOc2ccccc2)NC1
3790,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1ccc(OC)c(C2CC(c3cc(F)cc(F)c3)=NN2c2ccc(S(N)(=O)=O)cc2)c1,"4-(3-(3,5-difluorophenyl)-5-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
3791,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)/C(=N\NC(=O)C(C)c1ccc(CC(C)C)cc1)C(CC1CCN(Cc3ccccc3)CC1)C2,"N-[(Z)-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]amino]-2-(4-isobutylphenyl)propanamide",0.015,uM,=,-1.8239087409443189,0,O=C(Cc1ccccc1)N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3792,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.1719,uM,=,-0.7647241233129476,0,c1ccc2nc3c(cc2c1)CCCC3
3793,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methyl-4-(2-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)ethoxy)thiazole-5-carboxamide",0.269,uM,=,-0.570247719997592,0,O=C(Nc1cc(-c2nc(OCCc3cn(CCNc4c5c(nc6ccccc46)CCCC5)nn3)cs2)ccn1)C1CC1
3794,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Oc1ccc(/C=N\C2CCN(Cc3ccccc3)C2)cc1,4-(((1-Benzylpyrrolidin-3-yl)imino)methyl)phenol,5.627999999999999,uM,=,0.750354088762708,1,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
3795,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl.Cl,Huprine-Tacrine Heterodimer,0.0005,uM,=,-3.3010299956639813,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
3796,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)cc(-c4ccccc4)oc3c2)c1,3-((methyl(3-(4-oxo-2-phenyl-4H-chromen-7-yloxy)propyl)amino)methyl)phenyl hexylcarbamate,0.068,uM,=,-1.1674910872937636,0,O=c1cc(-c2ccccc2)oc2cc(OCCCNCc3ccccc3)ccc12
3797,462117,10.1021/jm7009364,,,,Inhibition of human AchE,C/N=C1/CCc2c1n(C)c1ccc(OC(=O)N(C)C)c(Br)c21,"Dimethyl-carbamic acid 8-bromo-4-methyl-3-[(Z)-methylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",0.06,uM,=,-1.2218487496163564,0,N=C1CCc2c1[nH]c1ccccc21
3798,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(=NCCC2CCN(Cc3ccccc3)CC2)[nH]nc1-c1ccccc1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-5-methyl-6-phenylpyridazin-3-amine,0.021,uM,=,-1.6777807052660807,0,c1ccc(CN2CCC(CCN=c3ccc(-c4ccccc4)n[nH]3)CC2)cc1
3799,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1/C(CCC1CCN(CC2CCCCC2)CC1)=N/O,(E)1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one oxime,0.024,uM,=,-1.619788758288394,0,N=C(CCC1CCN(CC2CCCCC2)CC1)c1ccccc1
3800,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc2c(N)c3c(nc2c1)CCCC3,"6-Methoxy-1,2,3,4-tetrahydro-acridin-9-ylamine",0.35,uM,=,-0.4559319556497244,0,c1ccc2nc3c(cc2c1)CCCC3
3801,28144,10.1021/jm9800494,,,,Anticholinesterase activity against erythrocyte acetylcholinesterase (AChE) in humans.,C[C@@]12CCN(Cc3ccccc3)C1N(Cc1ccccc1)c1ccc(OC(=O)Nc3ccccc3)cc12,"Phenyl-carbamic acid (S)-1,8-dibenzyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",41.13,uM,=,1.6141587095091752,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN(Cc3ccccc3)C1N2Cc1ccccc1
3802,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[8-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-octyl]-3-(1H-indol-3-yl)-propionamide",0.0005,uM,=,-3.3010299956639813,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3803,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CN(CCCCCCCOc1ccc(-c2oc3ccccc3c2C(=O)c2c3ccccc3cc3ccccc23)cc1)Cc1ccccc1,Anthracen-9-yl-(2-{4-[7-(benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)methanone,67.7,uM,=,1.830588668685144,1,O=C(c1c2ccccc2cc2ccccc12)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
3804,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc(/C=N/O)c(O)c(CN2CCC(CN3CCc4cc(OC)c(OC)cc4C3c3ccccc3)CC2)c1,"3-((4-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxy-5-methoxybenzaldehyde oxime",543.4,uM,=,2.735119634081872,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3c3ccccc3)CC2)cc1
3805,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)cc1OC,(E)-4-(3-(4-benzylpiperazin-1-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl diethylcarbamate,16.8,uM,=,1.2253092817258628,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
3806,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.175,uM,=,-0.7569619513137056,0,c1ccc2c(c1)N[C@H]1NCCC21
3807,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(N(CCC2CCN(Cc3ccccc3)CC2)C(C)=O)cc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-(4-methoxy-phenyl)-acetamide,0.7,uM,=,-0.1549019599857432,0,c1ccc(CN2CCC(CCNc3ccccc3)CC2)cc1
3808,1454788,10.1016/j.ejmech.2014.07.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric analysis,Cl.O=C(NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,"N-{3-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-5-(4-chlorophenyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-9-carboxamide dihydrochloride",6e-06,uM,=,-5.221848749616356,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)NCCC3
3809,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccc(Cl)cc2)CC1,4-((1-(4-Chlorobenzyl)piperidin-4-yl)methoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-N-methylthiazole-5-carboxamide,82.0,uM,=,1.9138138523837167,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
3810,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.021,uM,=,-1.6777807052660807,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3811,1471266,10.1016/j.ejmech.2015.03.040,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins prior to substrate addition measured after 60 to 180 secs by Ellman method,Cc1c(Cl)c(=O)oc2cc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,"3-Chloro-4-methyl-7-(2-(4-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperazin-1-yl)ethoxy)-2H-chromen-2-one",0.02437,uM,=,-1.6131444708152758,0,O=c1ccc2ccc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc2o1
3812,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[6-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-4-(1H-indol-3-yl)-butyramide",0.0005,uM,=,-3.3010299956639813,0,O=C(CCCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
3813,2050396,10.1016/j.bmc.2020.115826,,,,Inhibition of human AchE expressed in HEK293 cells using acetylthiocholine as substrate by Ellman's method,CS[C@@H](Cn1nnc2cc(C#Cc3ccc(-n4ccnc4CO)cc3)ccc21)N(O)C=O,"(S)-N-hydroxy-N-(2-(5-((4((2-(hydroxymethyl)-1H-imidazol-1-yl)methyl)phenyl)ethynyl)-1H-benzo[d][1,2,3]triazol-1-y1)-1-(methylthio)ethyl)formamide",15.0,uM,=,1.1760912590556811,1,C(#Cc1ccc2[nH]nnc2c1)c1ccc(-n2ccnc2)cc1
3814,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one hydrochloride",0.032,uM,=,-1.494850021680094,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3815,28622,10.1021/jm010949b,,,,In vitro inhibitory concentration against acetylcholinesterase of human erythrocytes,CCC1=CC2Cc3nc4ccccc4c(N)c3C(C1)C2.Cl,"(+/-) 15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine hydrochloride",0.0378,uM,=,-1.422508200162775,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
3816,1935994,10.1021/acs.jnatprod.8b00705,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 5 mins by spectrophotometric analysis,C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,SID144205156,4.3,uM,=,0.6334684555795865,1,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
3817,1288736,10.1016/j.bmc.2013.12.066,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2[se]n(-c3ccc(OCCCCN4CCCCC4)cc3)c(=O)c2cc1OC,"5,6-Dimethoxy-2-(4-(4-(piperidin-1-yl)butoxy)phenyl)benzo[d][1,2]selenazol-3(2H)-one",3.41,uM,=,0.5327543789924978,1,O=c1c2ccccc2[se]n1-c1ccc(OCCCCN2CCCCC2)cc1
3818,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl 6-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)hexanoate",0.01072,uM,=,-1.9698052146432488,0,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
3819,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Cc1ccc2[nH]c3cc[n+](C)cc3c2c1.[I-],"2,8-dimethyl-5H-pyrido[4,3-b]indol-2-ium iodide",9.1,uM,=,0.9590413923210936,1,c1ccc2c(c1)[nH]c1cc[nH+]cc12
3820,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,O=C(c1cccc(Cl)c1Cl)n1nc(OCCCN2CCCCC2)c2ccccc21,"(2,3-dichlorophenyl)(3-(3-piperidinopropoxy)indazol-1-yl)ketone",17.0,uM,=,1.230448921378274,1,O=C(c1ccccc1)n1nc(OCCCN2CCCCC2)c2ccccc21
3821,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[7-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)-heptyl]-2-(1H-indol-3-yl)-acetamide",0.0002,uM,=,-3.6989700043360174,0,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3822,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=c1ccc2cc(/N=C/c3ccc(F)cc3)ccc2o1,6-[(4-Flurobenzylidene)amino]-2H-chromen-2-one,0.226,uM,=,-0.645891560852599,0,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1
3823,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CC(C)(C)c1cccc(C(=O)C(F)F)c1,"1-(3-(tert-butyl)phenyl)-2,2-difluoroethan-1-one",0.00869,uM,=,-2.0609802235513337,0,c1ccccc1
3824,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.08,uM,=,-1.0969100130080565,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
3825,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,COc1ccc(C(CN(C)c2ccc(NCc3cc(Cl)cc(/C=N/O)c3O)cc2)C2(O)CCCCC2)cc1,(E)-5-chloro-2-hydroxy-3-((4-((2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)(methyl)amino)phenylamino)methyl)benzaldehyde oxime,2505.0,uM,=,3.3988077302032647,1,c1ccc(CNc2ccc(NCC(c3ccccc3)C3CCCCC3)cc2)cc1
3826,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1F,"2-(8-(2-Fluorobenzylamino)octyl)isoindoline-1,3-dione",0.545,uM,=,-0.2636034977233575,0,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1
3827,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,COc1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1,"6-(Furan-3-yl)-3-(4-methoxyphenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1
3828,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCO[C@@H]2N3C)cc1,"(4-isopropyl-phenyl)-carbamic acid (3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",3.86,uM,=,0.5865873046717549,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@@H]1N2
3829,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,COc1ccc(CC(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1O,N-(4-((benzyl(methyl)amino)methyl)phenyl)-2-(3-hydroxy-4-methoxyphenyl)acetamide,3.04,uM,=,0.4828735836087537,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
3830,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1c(Cl)nc(NCCCC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-((3-(1-Benzylpiperidin-4-yl)propyl)amino)-6-chloro-4-phenylpyridine-3,5-dicarbonitrile",3.86,uM,=,0.5865873046717549,1,c1ccc(CN2CCC(CCCNc3cc(-c4ccccc4)ccn3)CC2)cc1
3831,28467,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.2-6.9,C#CCNC(C)Cc1cccc(OC(=O)N(C)C2CCCCC2)c1,Cyclohexyl-methyl-carbamic acid 3-(2-prop-2-ynylamino-propyl)-phenyl ester,3.6,uM,=,0.5563025007672873,1,O=C(NC1CCCCC1)Oc1ccccc1
3832,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"Ethyl-carbamic acid (S)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.094,uM,=,-1.0268721464003014,0,c1ccc2c(c1)NC1NCCC21
3833,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,"2-(8-((2-Fluorobenzyl)(methyl)amino)octyl)isoindoline-1,3-dione hydrochloride",0.644,uM,=,-0.1911141326401879,0,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1
3834,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1c(F)c[n+](CCCCCOc2ccc3c(C)cc(=O)oc3c2)cc1F.O=S(=O)([O-])C(F)(F)F,"3,5-difluoro-4-methoxy-1-(5-(4-methyl-2-oxo-2H-chromen-7-yloxy)pentyl)pyridinium trifluoromethanesulfonate",0.47,uM,=,-0.3279021420642826,0,O=c1ccc2ccc(OCCCCC[n+]3ccccc3)cc2o1
3835,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN(CCOCCNC(=O)NCc1ccccc1)CC1CCCCC1,1-Benzyl-3-{2-[2-(cyclohexylmethyl-ethyl-amino)-ethoxy]-ethyl}-urea,10.0,uM,=,1.0,1,O=C(NCCOCCNCC1CCCCC1)NCc1ccccc1
3836,2056084,10.1016/j.ejmech.2020.112751,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method,CCCNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1,"4-(cyclopropylmethoxy)-N-propyl-2-(2-(2-((2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)amino)acetamido)pyridin-4-yl)thiazole-5-carboxamide",0.0049,uM,=,-2.309803919971486,0,O=C(CNCCNc1c2c(nc3ccccc13)CCCC2)Nc1cc(-c2nc(OCC3CC3)cs2)ccn1
3837,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4cccnc4oc3c2)c1,Heptyl-carbamic acid 3-({methyl-[3-(10-oxo-10H-9-oxa-1-aza-anthracen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.013,uM,=,-1.8860566476931635,0,O=c1c2ccc(OCCCNCc3ccccc3)cc2oc2ncccc12
3838,1861945,10.1016/j.ejmech.2019.111596,,,,Inhibition of human erythrocytes AChE assessed as reduction in 5-thio-2-nitrobenzoate anion formation using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0121,uM,=,-1.91721462968355,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3839,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-9-{{4-[3-(3,4-dihydro-5-phenyl-2H-pyrano[3,2-c]quinolin-9-yl)propanamido]butyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.0166,uM,=,-1.779891911959945,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCNc1c2c(nc3ccccc13)CCCC2
3840,2185046,10.1016/j.ejmech.2021.113278,,,,Inhibition of human AchE preincubated for 6 mins followed by substrate addition using acetylthiocholine iodide as substrate by DTNB reagent based Ellman method,COc1ccc(/C=C/C(=O)Nc2cc[n+](Cc3cccc(F)c3)cc2)cc1OC.[Br-],"4-(3-(3,4-dimethoxyphenyl)acrylamido)-1-(3-fluorobenzyl)pyridin-1-ium Bromide",0.0192,uM,=,-1.7166987712964503,0,O=C(/C=C/c1ccccc1)Nc1cc[n+](Cc2ccccc2)cc1
3841,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,CC(=O)O[C@H]1C[C@@H]2C(=CC[C@]3(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]23C)C[C@@]23O[C@@H]2[C@H]2OC[C@](C)([C@H]2NC(=O)c2ccccc2)[C@H]13,O2-natafuranamine,3.0,uM,=,0.4771212547196624,1,O=C(N[C@@H]1C2CO[C@@H]1[C@H]1O[C@]13CC1=CCC4CCCC4[C@@H]1CC[C@@H]23)c1ccccc1
3842,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CC(C)c1ccc(NC(=O)OCC2CCN(C3Cc4ccccc4C3)CC2)cc1,"(1-(2,3-dihydro-1H-inden-2-yl)piperidin-4-yl)methyl (4-isopropylphenyl)carbamate",4.083,uM,=,0.6109793799229971,1,O=C(Nc1ccccc1)OCC1CCN(C2Cc3ccccc3C2)CC1
3843,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,CCCCOC(=O)C(C)CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@@H](OC(C)=O)[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3=O,"n-butyl 12beta-acetoxy-3beta-hydroxy-7,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oate",9.4,uM,=,0.9731278535996988,1,O=C1C[C@H]2CCCCC2C2=C1C1C(=O)CCC1CC2=O
3844,579492,10.1016/j.bmcl.2009.05.087,,,,Inhibition of human AChE-induced amyloid beta (1-40) aggregation by thioflavin T fluorescence-based assay,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@H](C)c2ccccc2OC)=CC1=O)[C@H](C)c1ccccc1OC,"2,5-bis(6-(ethyl((R)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",9.34,uM,=,0.9703468762300934,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
3845,2055647,10.1016/j.ejmech.2020.112766,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 5 mins by Ellman's method,CCCCN[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCC1CCN(CC2CCN(C)CC2)CC1,(S)-2-Butylamino-3-(1H-indol-3-yl)-N-{2-[1-(1-methyl-piperidin-4-ylmethyl)-piperidin-4-yl]-ethyl}-propionamide,29.7,uM,=,1.4727564493172125,1,O=C(CCc1c[nH]c2ccccc12)NCCC1CCN(CC2CCNCC2)CC1
3846,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.02,uM,=,-1.6989700043360187,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3847,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CNC(=O)Oc1cccc2c1CCC1CCN(C)C21,"Methyl-carbamic acid 1-methyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indol-6-yl ester",0.0173,uM,=,-1.7619538968712043,0,c1ccc2c(c1)CCC1CCNC21
3848,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(S)-2-amino-N-(8-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)-3-(1H-indol-3-yl)propanamide dihydrochloride",0.05,uM,=,-1.3010299956639813,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
3849,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(OC)c3)CC2)nc1-c1ccccc1,Ethyl 2-(4-((4-amino-3-methoxyphenyl)sulfonyl)piperazin-1-yl)-4-methyl-6-phenylpyrimidine-5-carboxylate,0.08465,uM,=,-1.072373037555046,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
3850,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,COc1ccccc1CN(C)[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4[C@]5(C)CSC(C(C)C)=N[C@H]5CC[C@@]45C[C@@]35C(=O)C[C@]12C,"20S-[(2-methoxybenzyl)(methyl)amino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.006,uM,=,-2.2218487496163566,0,O=C1CC2C(CC[C@@H]2CNCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
3851,347063,10.1016/j.bmcl.2006.01.067,,,,Inhibition of AChE activity,COc1cc2ccnc(C(O)c3ccccc3OC)c2cc1OC,"(6,7-dimethoxyisoquinolin-1-yl)(2-methoxyphenyl)methanol",6.94,uM,=,0.8413594704548549,1,c1ccc(Cc2nccc3ccccc23)cc1
3852,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2cccc(O)c2[nH]1,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-8-hydroxy-4-oxo-1,4-dihydroquinoline-2-carboxamide",1.15,uM,=,0.0606978403536116,1,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2[nH]1
3853,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Ethyl-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.013,uM,=,-1.8860566476931635,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
3854,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1cc(OCC[N+](CC)(CC)CC)cc(C(=O)NCCCCCC(=O)NNc2c3c(nc4cc(Cl)ccc24)CCCC3)c1.[Br-].[Br-],"2-(3-(((6-(2-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-6-oxohexyl)amino)carbonyl)-5-((2-triethylammonio)ethoxy)phenoxy)-N,N,N-triethylethanammonium dibromide hydrochloride",0.00675,uM,=,-2.170696227168975,0,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
3855,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CN(CCCCCCCOc1ccc(-c2oc3ccccc3c2C(=O)c2cccc3ccccc23)cc1)Cc1ccccc1,(2-{4-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)naphthalen-1yl-methanone,101.0,uM,=,2.004321373782642,1,O=C(c1cccc2ccccc12)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
3856,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]cc(CCNC(=O)Cn3cc(CN4CCc5cc(OC)c(OC)cc5C4CCCN4C(=O)c5ccccc5C4=O)nn3)c2c1,"2-(4-((1-(3-(1,3-dioxoisoindolin-2-yl)propyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)acetamide",39.9,uM,=,1.6009728956867482,1,O=C(Cn1cc(CN2CCc3ccccc3C2CCCN2C(=O)c3ccccc3C2=O)nn1)NCCc1c[nH]c2ccccc12
3857,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1ccccc1/C=C1\CN(C(=O)[C@@H]2CCN(C)[C@]23C(=O)Nc2ccccc23)C[C@]2(C1=O)[C@H](c1ccccc1OC)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(2-methoxyphenylmethylidene)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(2-methoxyphenyl)pyrrolidine,4.73,uM,=,0.6748611407378116,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@@]2(C1)[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
3858,1993994,10.1016/j.bmcl.2020.126985,,,,Inhibition of AChE (unknown origin) using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1ccc(CCC(=O)Nc2nc(-c3cc4ccccc4oc3=O)cs2)cc1OC,"3-(3,4-dimethoxyphenyl)-N-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)propanamide",0.74,uM,=,-0.1307682802690238,0,O=C(CCc1ccccc1)Nc1nc(-c2cc3ccccc3oc2=O)cs1
3859,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3Cl)CC2)cc(C(C)(C)C)c1O,"(E)-N-(2-(1-(2-chlorobenzyl)piperidin-4-yl)ethyl)-3-(3,5-ditert-butyl-4-hydroxyphenyl)acrylamide",2.44,uM,=,0.3873898263387294,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3860,1783503,10.1016/j.ejmech.2018.01.007,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,Cn1cc(C(=O)NCCC2CCN(Cc3ccccc3)CC2)c2ccccc21,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1-(1-methyI-1H-indol-3-yI)-formamide,6.11,uM,=,0.7860412102425542,1,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1c[nH]c2ccccc12
3861,2200872,10.1016/j.ejmech.2020.112860,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 20 mins by DTNB reagent based spectrophotometric method,COC/C(C=O)=C\CCC1=CC(c2cc(O)ccc2O)OC1=O,Oregonensin B,8.52,uM,=,0.9304395947667,1,O=C1C=CC(c2ccccc2)O1
3862,1335299,10.1021/jm400970m,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,"(E)-3-(4-Hydroxy-3-methoxyphenyl)-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]acrylamide",0.01164,uM,=,-1.9340470196861304,0,O=C(/C=C/c1ccccc1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
3863,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc(C(=O)CCc2cc[n+](Cc3cccc(F)c3)cc2C#N)cc1OC.[Br-],"3-Cyano-4-(3-(3,4-dimethoxyphenyl)-3-oxopropyl)-1-(3-fluorobenzyl)pyridinium bromide",0.011,uM,=,-1.958607314841775,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccccc1
3864,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CN(CCCOc1ccc2cc(-c3ccccc3)c(=O)oc2c1)Cc1cccc(OC(=O)NCCCCCc2ccccc2)c1,3-((Methyl-(3-((2-oxo-3-phenyl-2H-chromen-7-yl)oxy)propyl)-amino)methyl)phenyl(5-Phenylpentyl)carbamate,0.125,uM,=,-0.9030899869919436,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3cc(-c4ccccc4)c(=O)oc3c2)c1
3865,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccc(F)cc2)C(=O)[C@@]2(C1)[C@H](c1ccc(F)cc1)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(4-fluorophenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(4-fluorophenylmethylidene)-1''-N-acrolylpiperidin-4''-one,7.8,uM,=,0.8920946026904804,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
3866,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(C(F)(F)F)cc3)cc12.[Br-],8-methoxy-2-(4-(trifluoromethyl)phenyl)isoquinolinium bromide,0.69,uM,=,-0.1611509092627447,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
3867,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cccc(CN2CCC(CCC(=O)c3ccc4c(c3)CCN4)CC2)c1,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(3-methoxy-benzyl)-piperidin-4-yl]-propan-1-one",2.68,uM,=,0.4281347940287888,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
3868,1715588,10.1016/j.bmc.2018.05.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval by Ellman's method,O=C(Cc1cc(=O)oc2cc(O)ccc12)NCCCCCCCNC(=O)c1cccc2c(=O)c3ccccc3[nH]c12,"N-(7-(2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetamido)heptyl)-9-oxo-9,10-dihydroacridine-4-carboxamide",5.85,uM,=,0.7671558660821804,1,O=C(Cc1cc(=O)oc2ccccc12)NCCCCCCCNC(=O)c1cccc2c(=O)c3ccccc3[nH]c12
3869,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,CC(=O)O[C@H]1[C@H]2c3cc4c(cc3CN3CCC(=C[C@@H]1O)[C@H]23)OCO4,"acetic acid (1S,2S,12bS,12cS)-2-hydroxy-1,2,4,5,12b,12c-hexahydro-7H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridin-1-yl ester",0.96,uM,=,-0.0177287669604316,0,C1=C2CCN3Cc4cc5c(cc4[C@H](CC1)[C@@H]23)OCO5
3870,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CN(CCCOc1ccc2c3c(c(=O)oc2c1)CCCC3)Cc1cccc(OC(=O)NCCCCCc2ccccc2)c1,"3-((Methyl(3-((6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy)propyl)amino)methyl)phenyl(5-Phenylpentyl)carbamate",0.0899,uM,=,-1.0462403082667713,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3c4c(c(=O)oc3c2)CCCC4)c1
3871,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN3CCOCC3)cc2)cc1OC,"(3,4-Dimethoxyphenyl)-(4-morpholin-4-ylmethylphenyl)methanone",345.0,uM,=,2.537819095073274,1,O=C(c1ccccc1)c1ccc(CN2CCOCC2)cc1
3872,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,CC1(C)CNC2=C([N+](=O)[O-])C3(C(=O)Nc4ccc(F)cc43)C(C#N)=C(N)N2C1,"6'-amino-5-fluoro-3',3'-dimethyl-9'-nitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",1.07,uM,=,0.0293837776852096,1,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
3873,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,"2-(8-((3-Chlorobenzyl)(methyl)amino)octyl)isoindoline 1,3-dione hydrochloride",1.044,uM,=,0.0187004986662433,1,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1
3874,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCN1CCCCc2ccc(C(=O)CCC3CCN(Cc4ccccc4)CC3)cc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-propyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",1.33,uM,=,0.1238516409670858,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
3875,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,Oc1ccc(/C=N/c2c3c(nc4ccccc24)CCCC3)cc1,"(E)-N-(4'-Hydroxybenzylidene)-1,2,3,4-tetrahydroacridin-9-amine",1.475,uM,=,0.1687920203141818,1,C(=N/c1c2c(nc3ccccc13)CCCC2)\c1ccccc1
3876,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(CCCCc1cn(CC(=O)NCCc3c[nH]c4ccccc34)nn1)C2,,0.138,uM,=,-0.8601209135987634,0,O=C(Cn1cc(CCCCN2CC[C@@]34C=CCC[C@@H]3Oc3cccc(c34)C2)nn1)NCCc1c[nH]c2ccccc12
3877,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,"1-(4-((3,4-Dimethoxyphenethyl)amino)quinazolin-2-yl)urea",8.7,uM,=,0.9395192526186184,1,c1ccc(CCNc2ncnc3ccccc23)cc1
3878,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC(C)N1CCN(c2nccc(NCc3ccccc3)n2)CC1,N-Benzyl-2-(4-isopropylpiperazin-1-yl)pyrimidin-4-amine,25.0,uM,=,1.3979400086720375,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
3879,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1)CCCC3,"ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.12,uM,=,-0.9208187539523752,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
3880,1589694,10.1016/j.bmc.2016.07.005,,,,Inhibition of hemoglobin free erythrocyte ghost human AChE using acetylcholine iodide as substrate measured for 1 hr by spectrophotometry based Ellman method,NC(=O)c1cc[n+](CC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],1-(2-(4-carbamoylpyridinium-1-yl)ethyl)-3-(2-(hydroxyimino)acetamido)pyridinium dibromide,1870.0,uM,=,3.271841606536499,1,c1cc[n+](CC[n+]2ccccc2)cc1
3881,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,CN(Cc1ccccc1)Cc1ccc(COc2ccc3ccc(=O)oc3c2)cc1,7-(4-(N-Benzyl-N-methylaminomethyl)benzyloxy)-2H-chromen-2-one,0.95,uM,=,-0.0222763947111522,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
3882,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCCCC1,"2-(4-(piperidin-1-yl)butyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",2.09,uM,=,0.320146286111054,1,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCCCC1
3883,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)c3c(nc2c1)CCCCC3,"N,N'-Bis-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)-octane-1,8-diamine",0.0016,uM,=,-2.7958800173440754,0,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)c3c(nc2c1)CCCCC3
3884,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccccc2OC)C(=O)[C@@]2(C1)[C@H](c1ccccc1OC)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(2-methoxyphenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(2-methoxyphenylmethylidene)-1''-N-acrolylpiperidin-4''-one,4.1,uM,=,0.6127838567197355,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
3885,28160,10.1016/S0960-894X(97)10025-7,,,,Compound was tested in vitro for inhibitory activity against Acetylcholinesterase,Nc1c2c(nc3ccccc13)-c1ccccc1CC2,"5,6-Dihydro-benzo[c]acridin-7-ylamine",2.98,uM,=,0.4742162640762553,1,c1ccc2c(c1)CCc1cc3ccccc3nc1-2
3886,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1ccc(Cn2cc(COc3ccc4ccc(=O)oc4c3)nn2)cc1,"4-((4-(((2-Oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)phenyl Heptylcarbamate",0.214,uM,=,-0.6695862266508091,0,O=c1ccc2ccc(OCc3cn(Cc4ccccc4)nn3)cc2o1
3887,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(NCCO)c2c1)CCCC3,"2-(7-methyl-1,2,3,4-tetrahydroacridin-9-yl)aminoethan-1-ol",0.18,uM,=,-0.744727494896694,0,c1ccc2nc3c(cc2c1)CCCC3
3888,2261352,10.1016/j.ejmech.2022.114606,,,,Inhibition of human erythrocyte AChE using acetyl-(beta-methyl)thiocholine as substrate by enzymatic assay,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"o-Tolyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0103,uM,=,-1.987162775294828,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
3889,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc(C)cc3)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(4-methylbenzyl)pyridin-1-ium bromide",0.0186,uM,=,-1.7304870557820835,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
3890,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(F)ccc4c(N)c3C(C1)C2,"(+)-15-ethyl-7-fluoro-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00379,uM,=,-2.421360790031928,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
3891,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2cccc(F)c2)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(3-Fluorophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",24.56,uM,=,1.39022836246913,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
3892,813756,10.1016/j.bmcl.2012.02.057,,,,Inhibition of human AChE by Ellman's method,COc1ccc2c3c([nH]c2c1)C(C)=NCC3,"7-Methoxy-1-methyl-2,9-dihydro-1H-beta-carboline",23.7,uM,=,1.374748346010104,1,C1=NCCc2c1[nH]c1ccccc21
3893,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc(-c2ccc(Cl)cc2)nnc1NCCN1CCCCC1,6-(4-chlorophenyl)-4-methyl-N-(2-(piperidin-1-yl)ethyl)pyridazin-3-amine,1.3,uM,=,0.1139433523068367,1,c1ccc(-c2ccc(NCCN3CCCCC3)nn2)cc1
3894,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1c2c(nc3nc(-c4ccccc4)cc(C(F)(F)F)c13)CCC2,"2-Phenyl-4-(trifluoromethyl)-7,8-dihydro-6H-cyclopenta[b][1,8]naphthyridin-5-amine",8.05,uM,=,0.9057958803678684,1,c1ccc(-c2ccc3cc4c(nc3n2)CCC4)cc1
3895,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(CC2Cc3ccccc3C2=O)CC1,2-(4-Methyl-piperidin-1-ylmethyl)-indan-1-one,0.48,uM,=,-0.3187587626244128,0,O=C1c2ccccc2CC1CN1CCCCC1
3896,900878,10.1007/s00044-011-9581-9,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 min prior to substrate addition measured after 20 min by Ellman's method,COc1ccc2c(OC)c3ccoc3nc2c1OC,"4,7,8-Trimethoxy-furo[2,3-b]quinoline",33.193808960366724,uM,=,1.521057090177686,1,c1ccc2nc3occc3cc2c1
3897,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc12,"7-Methoxy-N-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)-benzofuran-2-carboxamide",0.0442,uM,=,-1.354577730650908,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1
3898,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,Cc1ccc2[nH]c3ccncc3c2c1,8-methyl-gama-carboline,35.4,uM,=,1.549003262025788,1,c1ccc2c(c1)[nH]c1ccncc12
3899,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,Cn1cc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)cn1,"6-(1-Methyl-1H-pyrazol-4-yl)-3-(4-(piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine",0.874,uM,=,-0.0584885673655969,0,c1cc(-c2cnc3[nH]c4cnc(-c5cn[nH]c5)cc4c3c2)ccc1CN1CCCCC1
3900,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(OC)c3)CC2)nc1-c1ccc(OC)cc1,Ethyl 2-(4-((4-acetamido-3-methoxyphenyl)sulfonyl)piperazin-1-yl)-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate,0.07925,uM,=,-1.1010007291102109,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
3901,28598,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 4.50-28.6,C#CCNC1CCc2ccc(OC(=O)NCC)cc21.Cl,Ethyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,13.7,uM,=,1.136720567156407,1,c1ccc2c(c1)CCC2
3902,799823,10.1021/jm200691d,,,,Inhibition of human recombinant AChE-induced amyloid beta (1-40) aggregation assessed as fibril formation after 24 hrs by thioflavin T-based fluorometric assay,CCN(CCCCCCNC1=CC(=O)c2ccccc2C1=O)Cc1ccccc1OC,"2-(6-(ethyl(2-methoxybenzyl)amino)hexylamino)naphthalene-1,4-dione",45.0,uM,=,1.6532125137753435,1,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)c2ccccc21
3903,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)cinnamamide,0.45,uM,=,-0.3467874862246563,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
3904,2247136,10.1021/acs.jmedchem.1c02150,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 240 sec by Ellman's method,O=C(Nc1ccc(OC(F)(F)F)cc1)NC1CCN(C(=O)CCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)CC1,"1-{1-{5-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-pentanoyl}piperidin-4-yl}-3-[4-(trifluoromethoxy)phenyl]urea",0.0129,uM,=,-1.889410289700751,0,O=C(Nc1ccccc1)NC1CCN(C(=O)CCCCNc2c3c(nc4ccccc24)CCCC3)CC1
3905,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,C=CC[N+](C)(C)c1ccc(CCC(=O)CCc2ccc([N+](C)(C)CC=C)cc2)cc1,"1,5-di[4-allyl(dimethyl)ammoniumphenyl]-3-pentanone",0.008,uM,=,-2.096910013008056,0,O=C(CCc1ccccc1)CCc1ccccc1
3906,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CN1C(=O)C2CN(C)C3(C(=O)c4ccccc4C3=O)C2C1=O,"2',5'-Dimethyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",2.1,uM,=,0.3222192947339193,1,O=C1NC(=O)C2C1CNC21C(=O)c2ccccc2C1=O
3907,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1nc(N)ncc1-c1nnnn1-c1ccc(-c2ccccc2)cc1,5-(1-Biphenyl-4-yl-1H-tetrazol-5-yl)-4-methyl-pyrimidin-2-ylamine,27.0,uM,=,1.4313637641589874,1,c1ccc(-c2ccc(-n3nnnc3-c3cncnc3)cc2)cc1
3908,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.03,uM,=,-1.5228787452803376,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3909,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=c1c(O)c(-c2ccc(Cl)cc2)oc2cc(F)c(I)cc12,2-(4-chlorophenyl)-7-fluoro-3-hydroxy-6-iodo-4H-chromen-4-one,0.00345,uM,=,-2.462180904926726,0,O=c1cc(-c2ccccc2)oc2ccccc12
3910,28156,10.1021/jm00161a008,,,,Reactivation of human acetylcholinesterase,CCN(CC)CCS/C(=N\O)c1nc(-c2ccccc2)no1,"N-Hydroxy-3-phenyl-[1,2,4]oxadiazole-5-carboximidothioic acid 2-diethylamino-ethyl ester",6.0,uM,=,0.7781512503836436,1,c1ccc(-c2ncon2)cc1
3911,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COC(=O)c1c(O)cccc1CCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"methyl 2-hydroxy-6-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)benzoate",0.017,uM,=,-1.769551078621726,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
3912,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,O=C(c1cnn(C2CCCC2)c1)C(F)(F)F,"1-(1-cyclopentyl-1H-pyrazol-4-yl)-2,2,2-trifluoroethanone",0.00611,uM,=,-2.213958789757446,0,c1cnn(C2CCCC2)c1
3913,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CN(C)Cc1ccc(CSCCN/C=C(/NCCSCc2ccc(CN(C)C)o2)[N+](=O)[O-])o1,N-((5-Ethylsulfanylmethyl-furan-2-ylmethyl)-dimethyl-amine)l-N-[1-(((5-Ethylsulfanylmethyl-furan-2-ylmethyl)-dimethyl-amine)amino)-2-nitrovinyl]amine,0.074,uM,=,-1.1307682802690238,0,C(=C/NCCSCc1ccco1)\NCCSCc1ccco1
3914,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.045,uM,=,-1.3467874862246565,0,c1ccccc1
3915,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCC4)oc12,"N-(6-((2,3-Dihydro-1H-cyclopenta[b]quinolin-9-yl)amino)hexyl)-7-methoxybenzofuran-2-carboxamide",1.685,uM,=,0.2265999052073574,1,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1
3916,775052,10.1016/j.ejmech.2011.09.001,,,,Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,O=C(CCCCc1cccs1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-5-(thiophen-2-yl)pentanamide",0.00266,uM,=,-2.575118363368933,0,O=C(CCCCc1cccs1)NCCCNc1c2c(nc3ccccc13)CCCC2
3917,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(CN1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2ncccc12,"2-(4-Benzylpiperazin-1-yl)-N-(1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide",0.301,uM,=,-0.5214335044061567,0,O=C(CN1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2ncccc12
3918,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,O=C(Cc1cc(=O)oc2cc(O)ccc12)N/N=C1\SCC(=O)N1c1c2c(nc3ccccc13)CCCC2,"2-(7-hydroxy-2-oxo-2H-chromen-4-yl)-N'-(4-oxo-3-(1,2,3,4-tetrahydroacridin-9-yl)thiazolidin-2-ylidene)acetohydrazide",15.7,uM,=,1.1958996524092338,1,O=C(Cc1cc(=O)oc2ccccc12)N/N=C1\SCC(=O)N1c1c2c(nc3ccccc13)CCCC2
3919,1276880,10.1016/j.bmcl.2013.09.091,,,,Inhibition of human recombinant AChE by Ellman's assay,CC1=C(CC(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)CC3=C(C)/C(=C\c4ccc([S+](C)[O-])cc4)c4ccc(F)cc43)=CC2=O)c2cc(F)ccc2/C1=C/c1ccc([S+](C)[O-])cc1,"N,N'-(3,3'-(3,3'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)bis(propane-3,1-diyl))bis(azanediyl)bis(propane-3,1-diyl))bis(2-(5-fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetamide)",9.54,uM,=,0.9795483747040952,1,O=C(CC1=C/C(=C\c2ccccc2)c2ccccc21)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)CC2=C/C(=C\c3ccccc3)c3ccccc32)=CC1=O
3920,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,O=C(Nc1ccc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)cn1)Nc1cccc2c1C1CCCCN1C2=O,"(+/-)-1-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(5-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)pyridin-2-yl)urea",0.0008,uM,=,-3.096910013008056,0,O=C(Nc1ccc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)cn1)Nc1cccc2c1C1CCCCN1C2=O
3921,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,N#Cc1ccc(C(=O)n2cc(/C=C3\CN(Cc4ccccc4)CCC3=O)c3ccccc32)cc1,4-[3-(1-Benzyl-4-oxo-piperidin-3-ylidenemethyl)-indole-1-carbonyl]-benzonitrile,20.0,uM,=,1.3010299956639813,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12
3922,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1ccc2c(CCNC(=O)c3ccc(CN(C)Cc4cccc(Cl)c4)cc3)c[nH]c2c1,4-{[(3-Chlorobenzyl)(methyl)amino]methyl}-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]benzamide,2.1,uM,=,0.3222192947339193,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
3923,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(C)c3)CC1)C2,"5,6-Dimethoxy-2-[1-(3-methyl-benzyl)-piperidin-4-ylmethyl]-indan-1-one",0.088,uM,=,-1.055517327849831,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3924,1586651,10.1016/j.bmcl.2016.05.046,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay,O=C(CCCCCCCCc1ccccc1)c1c(O)cccc1O,"1-(2,6-dihydroxyphenyl)-9-phenylnonan-1-one",1.31,uM,=,0.1172712956557642,1,O=C(CCCCCCCCc1ccccc1)c1ccccc1
3925,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)cc(-c4ccccc4)oc3c2)c1,Methyl-carbamic acid 3-({methyl-[3-(4-oxo-2-phenyl-4H-chromen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0057,uM,=,-2.2441251443275085,0,O=c1cc(-c2ccccc2)oc2cc(OCCCNCc3ccccc3)ccc12
3926,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc(Cl)cc2)cc1,S-4-chlorobenzyl 4-methylbenzenthiosulfonate,0.4782,uM,=,-0.320390428220244,0,O=S(=O)(SCc1ccccc1)c1ccccc1
3927,463671,10.1016/j.bmcl.2007.09.100,,,,Inhibition of human recombinant AChE by Ellman method,CCN(Cc1ccccc1)Cc1ccc(-c2cc3cc(OCCNC(=O)Cc4cc(F)cc(F)c4)ccc3oc2=O)cc1,"N-(2-(3-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-oxo-2H-chromen-6-yloxy)ethyl)-2-(3,5-difluorophenyl)acetamide",0.551,uM,=,-0.2588484011482149,0,O=C(Cc1ccccc1)NCCOc1ccc2oc(=O)c(-c3ccc(CNCc4ccccc4)cc3)cc2c1
3928,1298092,10.1016/j.ejmech.2014.02.045,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4OC)cc(O)c3c2=O)cc1)Cc1ccccc1OC,7-(4-(Ethyl(2-methoxybenzyl)amino)butoxy)-3-(4-(4-(ethyl(2-methoxybenzyl)amino)butoxy)phenyl)-5-hydroxy-4H-chromen-4-one,0.35,uM,=,-0.4559319556497244,0,O=c1c(-c2ccc(OCCCCNCc3ccccc3)cc2)coc2cc(OCCCCNCc3ccccc3)ccc12
3929,1834120,10.1021/acs.jnatprod.8b00592,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by Ellman's method,COc1cc2c(cc1OC)-c1cc3ccc(OC)c(OC)c3c[n+]1CC2,SID11112538,1.7,uM,=,0.2304489213782739,1,c1ccc2c(c1)CC[n+]1cc3ccccc3cc1-2
3930,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,O=C(COc1ccc(-c2ccccc2)cc1)NCCCN1CCCCC1,2-(4-Biphenylyloxy)-N-[3-(1-piperidinyl)propyl]-acetamide,57.0,uM,=,1.7558748556724917,1,O=C(COc1ccc(-c2ccccc2)cc1)NCCCN1CCCCC1
3931,1783503,10.1016/j.ejmech.2018.01.007,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(CCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1,N-(2-(1-Benzylpiperidin-4-yl)ethyl)-3-(1H-indol-3-yl)propanamide,5.95,uM,=,0.7745169657285496,1,O=C(CCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
3932,2185041,10.1016/j.ejmech.2021.113278,,,,Inhibition of human AchE using acetylthiocholine iodide as substrate by Ellman colorimetric assay,COc1cc(/C=C/c2nnc(-c3ccc(OC(F)(F)F)cc3)o2)ccc1O,"2-methoxy-4-(2-(5-(4-(trifluoromethoxy)phenyl)-1,3,4-oxadiazol-2-yl)vinyl)phenol",0.092,uM,=,-1.0362121726544449,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
3933,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(OC)n1.[I-],(E)-2-(2-(6-(Diethylamino)-2-methoxy pyridine-3-yl)vinyl)e1emethyl quinolinium iodide,1.0,uM,=,0.0,0,C(=C/c1ccc2ccccc2[nH+]1)\c1cccnc1
3934,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN(C)Cc3cccc(C)c3)cc2)cc1OC,"(3,4-Dimethoxyphenyl)-(4-{[methyl-(3-methylbenzyl)amino]methyl}phenyl)methanone",1.65,uM,=,0.2174839442139062,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
3935,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cccc(N(CCC2CCN(Cc3ccccc3)CC2)C(C)=O)c1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-(3-methoxy-phenyl)-acetamide,0.046,uM,=,-1.337242168318426,0,c1ccc(CN2CCC(CCNc3ccccc3)CC2)cc1
3936,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2ccc(Cl)c(Cl)c2)C3=O)c1,"Methyl-carbamic acid 3-[({7-[2-(3,4-dichloro-benzylidene)-3-oxo-2,3-dihydro-benzofuran-6-yloxy]-heptyl}-methyl-amino)-methyl]-phenyl ester",0.008,uM,=,-2.096910013008056,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
3937,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1,"3-[4-(4-Methyl-piperazin-1-yl)-phenyl]-9H-dipyrido[2,3-b:4',3'-d]pyrrole-6-carbonitrile",0.018,uM,=,-1.744727494896694,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(N4CCNCC4)cc3)cc12
3938,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,CC1(C)CC(=O)C2=C(C1)Nc1nc3c(c(N)c1C2c1ccc(F)cc1)CCCC3,"11-Amino-12-(4-fluoro-phenyl)-3,3-dimethyl-3,4,5,7,8,9,10,12-octahydro-2H-dibenzo[b,g][1,8]naphthyridin-1-one",1.6,uM,=,0.2041199826559248,1,O=C1CCCC2=C1C(c1ccccc1)c1cc3c(nc1N2)CCCC3
3939,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Cc1ccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)cc1.Cl,"9-(2-(4-((1-(p-Tolyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",3.75,uM,=,0.5740312677277188,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
3940,2261363,10.1016/j.ejmech.2022.114606,,,,Inhibition of human AChE,CNC(=O)Oc1cccc2c1CCC1C2CCN1CCC1CCCCC1,"[3-(2-cyclohexylethyl)-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl]N-methylcarbamate",0.058,uM,=,-1.2365720064370629,0,c1ccc2c(c1)CCC1C2CCN1CCC1CCCCC1
3941,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]-Quinolin-12-Amine",0.0231,uM,=,-1.6363880201078556,0,C1=CC2Cc3nc4ccccc4cc3[C@@H](C1)C2
3942,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cn1c2ccccc2c2cc[n+](-c3ccc(I)cc3)cc21,"2-(4-iodophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.3,uM,=,-0.5228787452803376,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
3943,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Nc1nn(-c2c3c(nc4ccc([N+](=O)[O-])cc24)CCCC3)c2ncccc12,"1-(7-Nitro-1,2,3,4-tetrahydroacridin-9-yl)-1H-pyrazolo[3,4-b]pyridin-3-amine",0.0559999999999999,uM,=,-1.2518119729937995,0,c1cnc2c(c1)cnn2-c1c2c(nc3ccccc13)CCCC2
3944,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(C)cc1)CC2.[Br-],"8-methoxy-2-p-tolyl-3,4-dihydroisoquinolinium bromide",0.53,uM,=,-0.2757241303992109,0,C1=[N+](c2ccccc2)CCc2ccccc21
3945,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),COc1ccc(C2C([N+](=O)[O-])C(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1,"5'-(1H-imidazol-4-ylmethyl)-3'-(4-methoxyphenyl)-4'-nitro-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",2.05,uM,=,0.3117538610557542,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
3946,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNc1c2c(nc3cc(F)ccc13)CCCC2,"(6-Fluoro-1,2,3,4-tetrahydro-acridin-9-yl)-heptyl-amine",0.045,uM,=,-1.3467874862246565,0,c1ccc2nc3c(cc2c1)CCCC3
3947,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,C[n+]1ccccc1/C=N/O.[Cl-],2-Pyridine aldoxime methohalide,1190.0,uM,=,3.0755469613925306,1,c1cc[nH+]cc1
3948,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(Cl)cc2)nn1C(=O)N(C)c1ccccc1,"3-(4-Chloro-phenyl)-5-methylsulfanyl-[1,2,4]triazole-1-carboxylic acid methyl-phenyl-amide",1.4,uM,=,0.1461280356782379,1,O=C(Nc1ccccc1)n1cnc(-c2ccccc2)n1
3949,28737,10.1021/jm00084a015,,,,Inhibition of human acetylcholinesterase-I,CN(C)Cc1ccc(CSCC/N=C/NCCSCc2ccc(CN(C)C)o2)o1.Cl,"N,N'-Bis-[2-(5-dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-formamidine: Trihydrochloride salt",3.0,uM,=,0.4771212547196624,1,C(=N/CCSCc1ccco1)\NCCSCc1ccco1
3950,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,C[C@@H]([C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4[C@]5(C)COC(C(F)(C(F)(F)F)C(F)(F)F)=N[C@H]5CC[C@@]45C[C@@]35C(=O)C[C@]12C)N(C)C,"20S-(dimethylamino)-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-heptafluoroisobutyl)-5',6'-dihydro-4alphaH-[1',3']oxazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",3.003,uM,=,0.4775553321989811,1,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4COC=N[C@H]4CC[C@@]34C[C@@]124
3951,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,CCCCCC[N+]1(C)CCN(c2ccc(/C=C3\Cc4cc(OC)c(OC)cc4C3=O)cc2)CC1.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-1-[(4-hexyl-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one bromide",4.25,uM,=,0.6283889300503115,1,O=C1/C(=C/c2ccc(N3CC[NH2+]CC3)cc2)Cc2ccccc21
3952,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(C)cc2)nn1C(=O)N(C)c1ccccc1,"5-Methylsulfanyl-3-p-tolyl-[1,2,4]triazole-1-carboxylic acid methyl-phenyl-amide",2.4,uM,=,0.380211241711606,1,O=C(Nc1ccccc1)n1cnc(-c2ccccc2)n1
3953,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccc(O)cc12,"N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-8-(1,2,3,4-tetrahydroacridin-9-ylamino)octanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
3954,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,COc1ccc2nc3c(c(N)c2c1)CCCC3,7-methoxytacrine,15.0,uM,=,1.1760912590556811,1,c1ccc2nc3c(cc2c1)CCCC3
3955,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,Cc1c(C(C)C)c(=O)on1C(=O)N1CCC[C@H](C)C1,4-Isopropyl-3-methyl-2-((S)-3-methyl-piperidine-1-carbonyl)-2H-isoxazol-5-one,17.0,uM,=,1.230448921378274,1,O=C(N1CCCCC1)n1ccc(=O)o1
3956,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccc(NC(=S)NCCOCCN(C)Cc2cccc([N+](=O)[O-])c2)cc1OC,"1-(3,4-Dimethoxy-phenyl)-3-(2-{2-[methyl-(3-nitro-benzyl)-amino]-ethoxy}-ethyl)-thiourea",1.5,uM,=,0.1760912590556812,1,S=C(NCCOCCNCc1ccccc1)Nc1ccccc1
3957,2245163,10.1016/j.bmc.2022.116660,,,,Inhibition of Human AChE by Ellman's method,CCCCC1OC(=O)c2cc(OCc3ccc(CN4CCN(C)CC4)c(O)c3)ccc21,3-butyl-6-((3'-hydroxy-4'-((4-methylpiperazin-1-ylmethyl)benzyl)oxy)isobenzofuran-1(3H)-one,23.76,uM,=,1.375846436309156,1,O=C1OCc2ccc(OCc3ccc(CN4CCNCC4)cc3)cc21
3958,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CCCCN(C)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((butyl(methyl)amino)methyl)phenol dihydrochloride,125.2,uM,=,2.097604328874411,1,c1ccccc1
3959,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,Clc1ccccc1-c1nnc2sc(-c3ccoc3)nn12,"3-(2-Chlorophenyl)-6-(furan-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1
3960,2265037,10.1016/j.bmcl.2022.128976,,,,Inhibition of AChE (unknown origin) by Ellman's method,COc1cc2c(cc1OC)/C(=N\NC(=O)C(CC(C)C)NC(=O)C(C)c1ccc(CC(C)C)cc1)C(CC1CCN(Cc3ccccc3)CC1)C2,"N-[(Z)-[2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-ylidene]amino]-2-[2-(4-isobutylphenyl)propanoylamino]-4-methyl-pentanamide",0.35,uM,=,-0.4559319556497244,0,O=C(Cc1ccccc1)NCC(=O)N/N=C1\c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
3961,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc(C(F)(F)F)cc2)cc1,S-4-(trifluoromethyl)benzyl 4-methylbenzenthiosulfonate,0.0866,uM,=,-1.0624821079826534,0,O=S(=O)(SCc1ccccc1)c1ccccc1
3962,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,C#CCN(CCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1,"2-(3-(Benzyl(prop-2-yn-1-yl)amino)propyl)isoindoline-1,3-dione",1.2,uM,=,0.0791812460476248,1,O=C1c2ccccc2C(=O)N1CCCNCc1ccccc1
3963,1702964,10.1016/j.ejmech.2017.04.054,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"N-(4-(ethyl(2-methoxybenzyl)amino)butyl)-2-(4-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",0.063,uM,=,-1.2006594505464183,0,O=C(COc1ccc(-c2cc(=O)c3ccccc3o2)cc1)NCCCCNCc1ccccc1
3964,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCCN(CCCC(F)F)C3)cc2oc1=O,"7-((1-(4,4-difluorobutyl)piperidin-3-yl)methoxy)-3,4-dimethyl-2H-chromen-2-one",0.48,uM,=,-0.3187587626244128,0,O=c1ccc2ccc(OCC3CCCNC3)cc2o1
3965,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1cc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc(OC)c1OC,"2-(3,4,5-Trimethoxyphenyl)-5-(4-(pyridine-2-yl)piperazine-1-yl)-1,3,4-oxadiazole",0.222,uM,=,-0.6536470255493614,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
3966,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C=CCOc1ccc(/C=N/[C@@]23CC(C)=C[C@@H](Cc4[nH]c(=O)ccc42)/C3=C\C)cc1,"(1R,9R)-1-{[1-(4-Allyloxy-phenyl)-methylidene]-amino}-13-eth-(E)-ylidene-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.031,uM,=,-1.5086383061657274,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
3967,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CC2CCN(CCCCOc3ccc4c(c3)oc(=O)c3ccccc34)CC2)c1,3-(4-(4-(3-Methoxybenzyl)piperidin-1-yl)butoxy)-6H-benzo[c]chromen-6-one,27.4,uM,=,1.437750562820388,1,O=c1oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12
3968,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,CC1c2[nH]c3ccccc3c2C[C@@H](C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)N1C(=O)OC(C)(C)C,"(3S)-tert-Butyl-1-methyl-3-((6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)carbamoyl)-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate",0.526,uM,=,-0.2790142558462609,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1
3969,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CCC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]-Quinolin-12-Amine",0.00075,uM,=,-3.1249387366083,0,C1=CC2Cc3nc4ccccc4cc3[C@@H](C1)C2
3970,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(C(C)(C)C)CC3)nc12,3-(4-(tert-Butyl)piperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,0.81,uM,=,-0.0915149811213502,0,O=C(CCN1CCNCC1)Nc1nc2ccccc2s1
3971,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(O)c1.[I-],(E)-2-(4-(Diethylamino)-2-hydroxystyryl)-1-methyl quinolinium iodide,1.5,uM,=,0.1760912590556812,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
3972,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CC/N=C1/CCc2c1n(C)c1ccc(OC(=O)NC)cc21,"Methyl-carbamic acid 3-[(Z)-ethylimino]-4-methyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",5.68,uM,=,0.7543483357110189,1,N=C1CCc2c1[nH]c1ccccc21
3973,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)oc12,"N-(7-(7,8,9,10-Tetrahydro-6H-cyclohepta[b]quinolin-11-ylamino)heptyl)-7-methoxybenzofuran-2-carboxamide",0.416,uM,=,-0.3809066693732573,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1
3974,1525144,10.1016/j.bmcl.2015.06.047,,,,Inhibition of human AChE,COc1ccc(-c2cc3c(c(=O)o2)C[C@H]2[C@@](C)(CC[C@@]4(O)C(C)(C)C(=O)CC[C@]24C)O3)cc1,(+)-Arisugacin C,2.5,uM,=,0.3979400086720376,1,O=C1CCC2C(CCC3Oc4cc(-c5ccccc5)oc(=O)c4C[C@@H]32)C1
3975,1807953,10.1016/j.ejmech.2019.07.051,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate incubated for 5 mins,COc1ccc2nc3c(c(NCCCCCNC(=S)NC45CC6CC(CC(C6)C4)C5)c2c1)CCCC3,"1-Adamantan-1-yl-3-[5-(7-methoxy-1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-thiourea",0.47,uM,=,-0.3279021420642826,0,S=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)NC12CC3CC(CC(C3)C1)C2
3976,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1C(F)(F)F)CCCC3,"ethyl 5-amino-2-methyl-4-(2-(trifluoromethyl)phenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.226,uM,=,-0.645891560852599,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
3977,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CSc1nc(-c2ccc(OC(F)(F)F)cc2)nn1C(=O)N(C)C,"5-Methylsulfanyl-3-(4-trifluoromethoxy-phenyl)-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.8,uM,=,-0.0969100130080563,0,c1ccc(-c2nc[nH]n2)cc1
3978,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00078,uM,=,-3.10790539730952,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
3979,858577,10.1016/j.bmc.2012.09.040,,,,Inhibition of human AChE by Ellman's method,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-],"1,2-Dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridin-12-ium",1.54,uM,=,0.1875207208364631,1,c1ccc2c(c1)c[nH+]c1c3cc4c(cc3ccc21)OCO4
3980,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(-c3ccccc3)cc2)CC1c1ccccc1[N+](=O)[O-],"1-(3-([1,1'-Biphenyl]-4-yl)-5-(2-nitrophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.64,uM,=,-0.1938200260161128,0,c1ccc(-c2ccc(C3=NNC(c4ccccc4)C3)cc2)cc1
3981,1292090,10.1016/j.ejmech.2013.12.008,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CCNC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,"1-Benzyl-5-(4-chlorophenyl)-N-ethyl-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-9-carboxamide",0.801,uM,=,-0.0963674839157623,0,c1ccc(CN2CCCc3c(-c4ccccc4)nc4ccccc4c32)cc1
3982,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1ccccc1OS(=O)(=O)[O-])c1ccc(=O)[nH]c1C2.[Na+],"sodium (2-{N-[(1R,9R,13E)-13-ethylidene-11-methyl-5-oxo-6-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,10-trien-1-yl]carboximidoyl}phenyl) sulfate",0.041,uM,=,-1.3872161432802643,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
3983,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1c(N)nc(NCCCC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-Amino-6-((3-(1-benzylpiperidin-4-yl)propyl)amino)-4-phenylpyridine-3,5-dicarbonitrile",0.24,uM,=,-0.619788758288394,0,c1ccc(CN2CCC(CCCNc3cc(-c4ccccc4)ccn3)CC2)cc1
3984,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4cccc(OC)c4o3)oc12,"N1,N1-Bis((7-methoxybenzofuran-2-yl)methyl)-N7-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)heptane-1,7-diamine",0.199,uM,=,-0.7011469235902933,0,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4ccccc4o3)cc2c1
3985,1497001,10.1016/j.ejmech.2015.02.063,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,CCN(CCCCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,"4'-(6-((Ethyl)(2-methoxybenzyl)amino)hexyloxy)-5,6,7-trimethoxyflavone",0.43,uM,=,-0.3665315444204134,0,O=c1cc(-c2ccc(OCCCCCCNCc3ccccc3)cc2)oc2ccccc12
3986,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,CCCCOC(=O)CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O,n-Butyl lucidenate A,12.26,uM,=,1.0884904701823963,1,O=C1CCC2C3=C(CC[C@H]2C1)C1CCCC1CC3=O
3987,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),CC(C)=CCCC1(C)C=Cc2c(ccc3cc(-c4cc(O)cc(O)c4CC=C(C)C)oc23)O1,Mulberrufen D2,4.61,uM,=,0.6637009253896482,1,C1=Cc2c(ccc3cc(-c4ccccc4)oc23)OC1
3988,28465,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 2.2-10.1,C#CCNC1CCc2ccc(OC(=O)N(C)C)cc2C1,"Dimethyl-carbamic acid 7-prop-2-ynylamino-5,6,7,8-tetrahydro-naphthalen-2-yl ester",4.1,uM,=,0.6127838567197355,1,c1ccc2c(c1)CCCC2
3989,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1cc(C#N)c(NCCC2CCN(Cc3ccccc3)CC2)nc1N,"2-Amino-6-((2-(1-benzylpiperidin-4-yl)ethyl)amino)pyridine-3,5-dicarbonitrile",0.22,uM,=,-0.6575773191777937,0,c1ccc(CN2CCC(CCNc3ccccn3)CC2)cc1
3990,28621,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 91.8-732,C#CCN(C)C(C)Cc1cccc(OC(=O)N(C)CC)c1,Ethyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,234.0,uM,=,2.369215857410143,1,c1ccccc1
3991,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)c1,"N-(8-(3-methoxyphenyl)octyl)-1,2,3,4-tetrahydroacridin-9-amine",0.04,uM,=,-1.3979400086720375,0,c1ccc(CCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
3992,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COC[n+]2ccccc2/C=N/O)c1/C=N/O.[Cl-].[Cl-],2-(1-{2-[2-hydroxy-(E)-1-methenylimino]-1-methyl-1H-imidazol-3-ium-3-ylmethoxymethyl}-2-pyridiniumyl)-(E)-1-iminomethen-1-ol,38.0,uM,=,1.57978359661681,1,c1cc[n+](COC[n+]2cc[nH]c2)cc1
3993,1278501,10.1016/j.bmc.2013.09.050,,,,Inhibition of human erythrocytic AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman method,COc1ccc(/C=C2\COc3cc(OCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)ccc3C2=O)cc1,"(E)-3-(4-methoxybenzylidene)-7-(8-(1,2,3,4-tetrahydroacridin-9-ylamino)octyloxy)chroman-4-one",0.1216,uM,=,-0.9150664250632838,0,O=C1/C(=C/c2ccccc2)COc2cc(OCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc21
3994,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,O/N=C/c1cc[n+](CCC[n+]2ccc(-c3ccccc3)cc2)cc1.[Br-].[Br-],"4-Hydroxyiminomethyl-4'-phenyl-1,1'-(prop-1,3-diyl)-bispyridinium dibromide",112.0,uM,=,2.049218022670181,1,c1ccc(-c2cc[n+](CCC[n+]3ccccc3)cc2)cc1
3995,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(NCC2CCN(Cc3ccccc3)CC2)cc1,N-((1-benzylpiperidin-4-yl)methyl)-4-methoxyaniline,0.165,uM,=,-0.7825160557860937,0,c1ccc(CN2CCC(CNc3ccccc3)CC2)cc1
3996,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
3997,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1OC,"(E)-4-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl diethylcarbamate",15.7,uM,=,1.1958996524092338,1,O=C(/C=C/c1ccccc1)N1CCc2ccccc2C1
3998,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2ccc(Br)cc2)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(4-Bromophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",28.34,uM,=,1.4523998459114416,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
3999,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(Cc2cc(Cl)cc(/C=N/O)c2O)CC1,"(E)-5-chloro-3-((4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",4148.0,uM,=,3.6178387477170033,1,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccccc2)CC1
4000,1539619,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 8,CO[P@]1(=O)OC[C@@H]2COC(=O)C2=C(C)O1,trans-cyclophostin,0.035,uM,=,-1.4559319556497243,0,O=C1OC[C@H]2CO[PH](=O)OC=C12
4001,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(CCO)CC3)cc1)C2.[Cl-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-(2-hydroxyethyl)-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one chloride",1.1,uM,=,0.041392685158225,1,O=C1/C(=C/c2ccc(N3CC[NH2+]CC3)cc2)Cc2ccccc21
4002,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,CCCCCCCCCC(C)C1OCc2c[n+](C)c(C)c(OC(=O)N(C)C)c2CO1.[Br-],"1,5-Dihydro-3-(1-methyldecyl)-7,8-dimethyl-9-dimethylaminocarbamoyloxy-[1,3]-dioxepino-[5,6-c]-pyridinium bromide",0.46,uM,=,-0.3372421683184259,0,c1cc2c(c[nH+]1)COCOC2
4003,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,"1-(2,4-Dichloro-phenyl)-2-imidazol-1-yl-ethanone O-(2,4-dichloro-benzyl)-oxime",4.6465,uM,=,0.6671259414859892,1,c1ccc(CO/N=C(\Cn2ccnc2)c2ccccc2)cc1
4004,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)c3cc[n+](Cc4ccc(OC(=O)N(C)C)cc4)cc3)c2c1.[Br-],1-(4-((dimethylcarbamoyl)oxy)benzyl)-4-((2-(5-methoxy-1H-indol-3-yl)ethyl)carbamoyl)pyridin-1-ium bromide,1.3,uM,=,0.1139433523068367,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
4005,2224411,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.059,uM,=,-1.2291479883578558,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4006,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1cccc(CN(C)Cc2ccc(C(=O)NCCc3c[nH]c4ccc(OC)cc34)cc2)c1,N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-4-{[(3-methoxybenzyl)(methyl)amino]methyl}benzamide,6.8,uM,=,0.8325089127062363,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
4007,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)N(CCC1CCN(Cc2ccccc2)CC1)c1ccc(F)cc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-(4-fluoro-phenyl)-acetamide,0.205,uM,=,-0.6882461389442457,0,c1ccc(CN2CCC(CCNc3ccccc3)CC2)cc1
4008,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CC(C)(C)OC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1,"(2R,6S)-tert-butyl 1,2,6-triphenyl-4-(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",2790.0,uM,=,3.4456042032735974,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
4009,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,CN(Cc1ccccc1)Cc1ccc(COc2ccc3c(CO)cc(=O)oc3c2)cc1.Cl,7-(4-(N-Benzyl-N-methylaminomethyl)benzyloxy)-4-(hydroxymethyl)-2H-chromen-2-one hydrochloride,0.12,uM,=,-0.9208187539523752,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
4010,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCCN2,"3-(1-benzylpiperidin-4-yl)-1-(1,2,3,4-tetrahydroquinolin-6-yl)propan-1-one",0.054,uM,=,-1.2676062401770316,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCCN2
4011,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,1.7,uM,=,0.2304489213782739,1,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
4012,1508181,10.1016/j.bmc.2015.01.031,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2,"3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-{{12-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]dodecyl}amino}-7,11-methanocycloocta[b]quinoline",0.00346,uM,=,-2.460923901207224,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4013,1673532,10.1021/acs.jmedchem.7b01760,,,,Inhibition of human erythrocyte AChE using ATC iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's method,CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCCCN2CCCCC2)cc1,"2-(4-Ethoxybenzyl)-N,N-diethyl-1-(4-(piperidin-1-yl)butyl)-1H-benzo[d]imidazole-5-carboxamide",60.1,uM,=,1.7788744720027396,1,c1ccc(Cc2nc3ccccc3n2CCCCN2CCCCC2)cc1
4014,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(Cl)cc13)CCCCC2,"2-chloro-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",8.6,uM,=,0.9344984512435676,1,c1ccc2nc3c(cc2c1)CCCCC3
4015,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=C(/C=C/c1ccc(OCCCCN2CCCC2)cc1)c1c(O)cc(OCCCCN2CCCC2)cc1O,"1-(2,6-dihydroxy-4-(4-(pyrrolidin-1-yl)butoxy)phenyl)-3-(4-(4-(pyrrolidin-1-yl)butoxy)phenyl)prop-2-en-1-one",3.2,uM,=,0.505149978319906,1,O=C(/C=C/c1ccc(OCCCCN2CCCC2)cc1)c1ccc(OCCCCN2CCCC2)cc1
4016,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3Cl)CC2)c1)c1ccnc(NC(=O)C2CC2)c1,N-(5-((1-(2-chlorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)-2-(cyclopropanecarboxamido)isonicotinamide,0.0816,uM,=,-1.0883098412461387,0,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1
4017,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCc3cc[n+](Cc4ccc([N+](=O)[O-])o4)cc3)sc2cc1OC.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(5-nitro-furan-2-ylmethyl)-pyridinium",0.0045,uM,=,-2.3467874862246565,0,O=C(CCc1cc[n+](Cc2ccco2)cc1)c1cc2ccccc2s1
4018,1539619,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 8,CCOP1(=O)CCCC(C(=O)OC)=C(C)O1,"Methyl 2-ethoxy-7-methyl-2,3,4,5-tetrahydro-1,2-oxaphosphepine-6-carboxylate 2-oxide",7.5,uM,=,0.8750612633917001,1,O=[PH]1CCCC=CO1
4019,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1ccc(OC)c(C2CC(c3cc(F)ccc3F)=NN2c2ccc(S(N)(=O)=O)cc2)c1,"4-(3-(2,5-difluorophenyl)-5-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
4020,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,CN(Cc1ccc(C#N)cc1)Cc1ccc(COc2ccc3ccc(=O)oc3c2)cc1.Cl,4-(((N-(4-(2H-2-Oxochromen-7-yl)oxymethyl)benzyl)-N-methylamino)methyl)benzonitrile hydrochloride,6.0,uM,=,0.7781512503836436,1,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
4021,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,O=c1c2ccc(OCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2oc2ncccc12,"7-[7-(1,2,3,4-Tetrahydroacridin-9-ylamino)heptyloxy]-9-oxa-1-azaanthracen-10-one",0.283,uM,=,-0.5482135644757098,0,O=c1c2ccc(OCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2oc2ncccc12
4022,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCC3CC[N+](C)(Cc4ccc([N+](=O)[O-])o4)CC3)sc2cc1OC.[Br-],"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-1-(5-nitro-furan-2-ylmethyl)-piperidinium bromide",0.032,uM,=,-1.494850021680094,0,O=C(CCC1CC[NH+](Cc2ccco2)CC1)c1cc2ccccc2s1
4023,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NC3CCN(Cc4ccccc4)CC3)sc2-c2ccc(C)cc2)cc1,"1-Benzyl-N-[4,5-bis(p-tolyl)thiazol-2-yl]piperidin-4-ylamine",1.28,uM,=,0.1072099696478683,1,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
4024,466877,10.1021/jm070154q,,,,Inhibition of human recombinant AChE-induced amyloid beta aggregation by thioflavin T fluorescence method,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],"3-(3,8-diamino-6-phenyl-5-phenanthridiniumyl)propyl(diethyl)methylammonium",12.8,uM,=,1.1072099696478683,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
4025,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccccc32)cc1,(4-Methoxyphenyl)-(10H-phenoselenazin-10-yl)methanone,4.6,uM,=,0.6627578316815741,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
4026,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2[nH]c(C(=O)NCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2cc1OC,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-6,7-dimethoxy-4-oxo-1,4-dihydroquinoline-2-carboxamide",0.17,uM,=,-0.7695510786217261,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2[nH]1
4027,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COCc2ccccc2)c1/C=N/O.[Cl-],1-Benzyloxymethyl-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,56.0,uM,=,1.7481880270062005,1,c1ccc(COC[n+]2cc[nH]c2)cc1
4028,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,FC(F)(F)c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,1-Benzyl-N-(4-(trifluoromethyl)benzyl)pyrrolidin-3-amine,0.128,uM,=,-0.8927900303521317,0,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
4029,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.015,uM,=,-1.8239087409443189,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4030,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl.Cl,Huprine-Tacrine Heterodimer,0.00045,uM,=,-3.3467874862246565,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4031,28625,10.1021/jm950771r,,,,Inhibitory activity against Acetylcholinesterase,CCCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"(S)-1,3a,8-Trimethyl-5-octylcarbamoyloxy-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-1-ium",0.11,uM,=,-0.958607314841775,0,c1ccc2c(c1)NC1NCCC21
4032,2245163,10.1016/j.bmc.2022.116660,,,,Inhibition of Human AChE by Ellman's method,CCCCC1OC(=O)c2cc(OCc3ccc(CN(C)C)c(O)c3)ccc21,3-butyl-6-((3'-hydroxy-4'-((dimethylamino)methyl)benzyl)oxy)isobenzofuran-1(3H)-one,8.78,uM,=,0.9434945159061026,1,O=C1OCc2ccc(OCc3ccccc3)cc21
4033,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,COc1ccc(-c2cc3ccc(OCCCN(C)Cc4cccc(OC(=O)NCCCCCc5ccccc5)c4)cc3oc2=O)cc1,3-(((3-((3-(4-Methoxyphenyl)-2-oxo-2H-chromen-7-yl)oxy)propyl)(methyl)amino)methyl)phenyl(5-Phenylpentyl)carbamate,0.312,uM,=,-0.5058454059815573,0,O=C(NCCCCCc1ccccc1)Oc1cccc(CNCCCOc2ccc3cc(-c4ccccc4)c(=O)oc3c2)c1
4034,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CN(CCCCOc1ccc2c(c1)oc(=O)c1ccccc12)Cc1ccccc1,3-(4-(Benzyl(methyl)amino)butoxy)-6H-benzo[c]chromen-6-one,1.1,uM,=,0.041392685158225,1,O=c1oc2cc(OCCCCNCc3ccccc3)ccc2c2ccccc12
4035,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2,"N-(2-benzoyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)-2-methoxybenzamide",2.938e-05,uM,=,-4.531948208545763,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
4036,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,O[C@H]1[C@H]2c3cc4c(cc3CN3CCC(=C[C@@H]1O)[C@H]23)OCO4,"(1S,2S,12bS,12cS)-1,2,4,5,12b,12c-hexahydro-7H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol",155.0,uM,=,2.1903316981702914,1,C1=C2CCN3Cc4cc5c(cc4[C@H](CC1)[C@@H]23)OCO5
4037,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,Oc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,4-((4-(benzofuran-2-yl)piperidin-1-yl)methyl)phenol,34.89,uM,=,1.5427009694481109,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
4038,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2ncccc12,"3-(4-Benzylpiperazin-1-yl)-N-(1H-pyrazolo[3,4-b]pyridin-3-yl)propanamide",0.034,uM,=,-1.4685210829577449,0,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2ncccc12
4039,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCCC3)ccc12,2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)ethyl pyrrolidine-1-carbodithioate,0.89,uM,=,-0.0506099933550872,0,O=c1ccc2ccc(OCCSC(=S)N3CCCC3)cc2o1
4040,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1C=CN(Cc3cccc(Cl)c3)C=C1C(N)=O)C2,"1-[(3-Chlorophenyl)methyl]-4-[(5,6-dimethoxy-1-oxo-indan-2-yl)methyl]-4H-pyridine-3-carboxamide",5.339,uM,=,0.7274599208579089,1,O=C1c2ccccc2CC1CC1C=CN(Cc2ccccc2)C=C1
4041,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3cccc(F)c13)OCCC2,"5-Fluoro-3,4-dihydro-2H-1-oxa-9-aza-anthracen-10-ylamine",0.335,uM,=,-0.4749551929631547,0,c1ccc2nc3c(cc2c1)CCCO3
4042,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,Cl.Cl.Nc1ccc(O)c(Cn2ccnc2)c1,2-((1H-imidazol-1-yl)methyl)-4-aminophenol dihydrochloride,482.5,uM,=,2.683497317679812,1,c1ccc(Cn2ccnc2)cc1
4043,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCOc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(2-diethylaminoethoxy)indan-1-one,1.53,uM,=,0.1846914308175988,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
4044,787087,10.1016/j.ejmech.2011.09.038,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate by Ellman's assay,Nc1c2c(nc3c1cc(-c1ccccc1)n3-c1ccccc1)CCCC2,"1,2-Diphenyl-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinolin-4-amine",45.5,uM,=,1.6580113966571124,1,c1ccc(-c2cc3cc4c(nc3n2-c2ccccc2)CCCC4)cc1
4045,787787,10.1016/j.bmcl.2011.04.042,,,,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@]12C,ganodermanondiol,25.08,uM,=,1.3993275321586789,1,O=C1CCC2C3=CCC4CCCC4C3=CC[C@H]2C1
4046,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(CCc1ccccc1)N1c2ccccc2Sc2ccccc21,1-(10H-phenothiazin-10-yl)-3-phenylpropan-1-one,7.1,uM,=,0.8512583487190752,1,O=C(CCc1ccccc1)N1c2ccccc2Sc2ccccc21
4047,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),C#CCn1c2cc(OC)ccc2c2ccnc(C)c21,"7-methoxy-1-methyl-9-prop-2-ynyl-pyrido[3,4-b]indole",1.9,uM,=,0.2787536009528289,1,c1ccc2c(c1)[nH]c1cnccc12
4048,28444,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.32-2.23,C#CCN(C)C(C)Cc1cccc(OC(=O)N(C)C)c1,Dimethyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,1.64,uM,=,0.2148438480476978,1,c1ccccc1
4049,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CC(C)CCSC(=O)OCC[N+](C)(C)C.[Cl-],Trimethyl-[2-(3-methyl-butylsulfanylcarbonyloxy)-ethyl]-ammonium chloride,50.0,uM,=,1.6989700043360187,1,
4050,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCCCCNC(=O)Oc1ccc2c(c1)C1CCN(C)C2C1,"Heptyl-carbamic acid 9-methyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.143,uM,=,-0.8446639625349383,0,c1ccc2c(c1)C1CCNC2C1
4051,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1Cl,3-{7-[(2-chlorobenzyl)methylamino]-heptyloxy}xanthen-9-one,433.0,uM,=,2.6364878963533656,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
4052,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,CN1CCN(Cc2ccc3c(c2)C(=O)C(=O)N3C(=O)c2ccccc2)CC1,"1-benzoyl-5-((4-methylpiperazin-1-yl)methyl)indoline-2,3-dione",0.04786,uM,=,-1.3200273057225815,0,O=C1C(=O)N(C(=O)c2ccccc2)c2ccc(CN3CCNCC3)cc21
4053,762161,10.1016/j.ejmech.2011.04.038,,,,Inhibition of AChE by Ellman's method,Cl.O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc(F)cc1,"4-fluoro-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]-benzamide hydrochloride",0.000784,uM,=,-3.1056839373155616,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
4054,1507873,10.1016/j.bmc.2015.05.027,,,,Inhibition of human acetylcholinesterase incubated for 60 mins using ATChI substrate by DTNB dye based UV-visible spectrophotometry,CCOC(=O)Cc1csc(NC(=O)C[n+]2ccc(/C=N/O)cc2)n1.[Cl-],1-(2-(4-(2-Ethoxy-2-oxoethyl)thiazol-2-ylamino)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium chloride,2270.0,uM,=,3.356025857193123,1,O=C(C[n+]1ccccc1)Nc1nccs1
4055,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2c4ccccc4cc4ccccc24)C3=O)c1,"Methyl-carbamic acid 3-({[7-(2-anthracen-9-ylmethylene-3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-methyl-amino}-methyl)-phenyl ester",79.1,uM,=,1.8981764834976764,1,O=C1/C(=C/c2c3ccccc3cc3ccccc23)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
4056,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Fc1ccc(CN2CCC(CNc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)s3)CC2)c(Cl)c1,"N-[(1-(2-Chloro-4-fluorobenzyl)piperidin-4-yl)methyl]-4,5-bis(4-chlorophenyl)thiazol-2-ylamine",0.52,uM,=,-0.2839966563652008,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
4057,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COCC2CCCc3ccccc32)c1/C=N/O.[Cl-],"2-(Hydroxyimino-methyl)-3-methyl-1-(1,2,3,4-tetrahydro-naphthalen-1-ylmethoxymethyl)-3H-imidazol-1-ium chloride",56.0,uM,=,1.7481880270062005,1,c1ccc2c(c1)CCCC2COC[n+]1cc[nH]c1
4058,1842289,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 60 mins followed by substrate addition by Ellman's method,C#CCN(C)C(C)Cc1cccc(OC(=O)N(C)CCCCCC)c1,Hexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,3.4,uM,=,0.5314789170422551,1,c1ccccc1
4059,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCNc3c4c(nc5ncccc35)CCCCC4)c3c(nc2c1)CCCCC3,"N1-(7,8,9,10-tetrahydro-6H-cyclohepta[b][1,8]naphthyridin-5-yl)-N6-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)hexane-1,6-diamine",0.0025,uM,=,-2.6020599913279625,0,c1ccc2c(NCCCCCCNc3c4c(nc5ncccc35)CCCCC4)c3c(nc2c1)CCCCC3
4060,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1cccc(C(=O)N2c3ccccc3Sc3ccccc32)c1,SID17508097,6.2,uM,=,0.7923916894982539,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
4061,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(O)cc3)c2O)O1,"1-(5-Hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3-(4-hydroxy-phenyl)-propenone",17.14,uM,=,1.2340108175871791,1,O=C(/C=C/c1ccccc1)c1ccc2c(c1)C=CCO2
4062,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,CCCC[N+]1(C)CCN(c2ccc(/C=C3\Cc4cc(OC)c(OC)cc4C3=O)cc2)CC1.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-butyl-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one bromide",0.54,uM,=,-0.2676062401770315,0,O=C1/C(=C/c2ccc(N3CC[NH2+]CC3)cc2)Cc2ccccc21
4063,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CN(CCCOc1ccc2c(c1)oc(=O)c1ccccc12)Cc1ccccc1,3-(3-(Benzyl(methyl)amino)propoxy)-6H-benzo[c]chromen-6-one,8.5,uM,=,0.9294189257142929,1,O=c1oc2cc(OCCCNCc3ccccc3)ccc2c2ccccc12
4064,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{7-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.00543,uM,=,-2.2652001704111533,0,O=C(CC1CCc2ccccc2O1)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
4065,798011,10.1016/j.bmc.2011.12.042,,,,Inhibition of AChE,COc1cc2oc(=O)c(OCCCCOc3cc(O)cc(N(C)C)c3)c(C)c2cc1OC,"3-(4-(3-(dimethylamino)-5-hydroxyphenoxy)butoxy)-6,7-dimethoxy-4-methyl-2H-chromen-2-one",0.000236,uM,=,-3.627087997029893,0,O=c1oc2ccccc2cc1OCCCCOc1ccccc1
4066,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,c1ccc(CN2CCc3[nH]c4ccccc4c3C2)cc1,SID92764010,20.4,uM,=,1.3096301674258988,1,c1ccc(CN2CCc3[nH]c4ccccc4c3C2)cc1
4067,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,O=C(CNCc1ccccc1[N+](=O)[O-])Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-((2-nitrobenzyl)amino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-7-yl)acetamide",0.0306999999999999,uM,=,-1.5128616245228137,0,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
4068,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1cccc(Cl)c1,"2-(8-(3-Chlorobenzylamino)octyl)isoindoline-1,3-dione",0.686,uM,=,-0.1636758842932482,0,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1
4069,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cccc(CN2CCC(CCC(=O)c3ccc4c(c3)CCN4)CC2)c1,"1-(2,3-Dihydro-1H-indol-5-yl)-3-[1-(3-methyl-benzyl)-piperidin-4-yl]-propan-1-one",0.05,uM,=,-1.3010299956639813,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
4070,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc(/C=N/O)c(O)c(CN2CCC(CN3CCc4cc(OC)c(OC)cc4C3)CC2)c1,"3-((4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxy-5-methoxybenzaldehyde oxime",847.9,uM,=,2.928344635264862,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1
4071,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{5-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",0.18,uM,=,-0.744727494896694,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
4072,1834120,10.1021/acs.jnatprod.8b00592,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by Ellman's method,COc1cc2c3cc1Oc1c(O)c(OC)cc4c1[C@@H](Cc1ccc(O)c(c1)Oc1ccc(cc1)C[C@@H]3N(C)CC2)N(C)CC4,(+)-obamegine,97.0,uM,=,1.9867717342662448,1,c1cc2cc(c1)Oc1ccc(cc1)C[C@@H]1NCCc3ccc(cc31)Oc1cccc3c1[C@@H](C2)NCC3
4073,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCOc1ccc2c(c1)C/C(=C\c1ccc(CN(C)Cc3ccccc3)cc1)C2=O,2-{4-[(Benzylmethylamino)methyl]benzylidene}-5-(2-diethylaminoethoxy)indan-1-one,2.9,uM,=,0.4623979978989561,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
4074,28301,10.1016/0960-894X(95)00371-Y,,,,In vitro inhibitory activity against Acetylcholinesterase from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCN4CCOCC4)ccc3N(C)[C@@H]12,"(2-Morpholin-4-yl-ethyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.7,uM,=,-0.1549019599857432,0,O=C(NCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
4075,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,COC(=O)C1=C(C)OP(=O)(OC)CC1,"2-Methoxy-6-methyl-2-oxo-3,4-dihydro-2H-2lambda*5*-[1,2]oxaphosphinine-5-carboxylic acid methyl ester",5.0,uM,=,0.6989700043360189,1,O=[PH]1CCC=CO1
4076,1766084,10.1021/acs.jnatprod.8b00461,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by Ellman's method,CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C(C(C)(C)C(=O)O)/C(=C\C(=O)O)[C@]3(C)C(=O)C[C@]12C,Colocynthenin C,3.1,uM,=,0.4913616938342727,1,C=C1C=CC[C@@H]2C1C(=O)CC1CCCC12
4077,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),COc1ccc(C2CC(c3cc(F)cc(F)c3)=NN2c2ccc(S(N)(=O)=O)cc2)cc1OC,"4-(3-(3,5-difluorophenyl)-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide",0.00636,uM,=,-2.196542884351586,0,c1ccc(C2=NN(c3ccccc3)C(c3ccccc3)C2)cc1
4078,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,CC[C@H](C)C(=O)OCCCc1cc(OC)c2oc(-c3ccc4c(c3)OCO4)cc2c1,"(S)-3-(2-(benzo[d][1,3]dioxol-5-yl)-7-methoxybenzofuran-5-yl)propyl 2-methylbutanoate",5.9,uM,=,0.7708520116421442,1,c1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1
4079,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,"5-[4-(1-Methyl-cyclohexylmethoxy)-benzyl]-thiazolidine-2,4-dione (ciglitazone)",15.026,uM,=,1.1768433845037387,1,O=C1NC(=O)C(Cc2ccc(OCC3CCCCC3)cc2)S1
4080,1632706,10.1016/j.ejmech.2016.08.006,,,,Inhibition of acetylcholinesterase (unknown origin),CCOC(=O)C1=C(C)Oc2nc3c(c(N)c2C1c1ccc(OC)cc1)CCCC3,"ethyl 5-amino-4-(4-methoxyphenyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrano[2,3-b]quinoline-3-carboxylate",0.182,uM,=,-0.7399286120149252,0,C1=CC(c2ccccc2)c2cc3c(nc2O1)CCCC3
4081,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)Nc1ccc2c(c1)C(=O)N(CCC1CCN(Cc3ccccc3)CC1)C2=O,"N-{2-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl}-acetamide",0.0028,uM,=,-2.552841968657781,0,O=C1c2ccccc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
4082,1718675,10.1021/acs.jnatprod.7b00301,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c1O[C@H]1C[C@H](O)CC[C@@]31CCN(C)C2,3-epi-Lycoramine,57.9,uM,=,1.7626785637274365,1,c1cc2c3c(c1)O[C@H]1CCCC[C@@]31CCNC2
4083,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccccc2)c1,3-((methyl(3-phenoxypropyl)amino)methyl)phenyl methylcarbamate,0.0795999999999999,uM,=,-1.0990869322623311,0,c1ccc(CNCCCOc2ccccc2)cc1
4084,1632485,10.1016/j.ejmech.2016.08.016,,,,Inhibition of human recombinant AChE preincubated for 5 mins followed by acetylthiocholine iodide substrate addition measured after 5 mins by Ellman's method,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21,"N-(8-(4-(1-(phenylsulfonyl)-1H-indol-4-yl)piperazin-1-yl)octyl)-1,2,3,4-tetrahydroacridin-9-amine",0.0013,uM,=,-2.886056647693163,0,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21
4085,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(Cc4ccccc4)CC3)cc1)C2.[Cl-],"2,3-Dihydro-5,6-dimethoxy-2-1-[(4-benzyl-4-methylpiperazinium-1-yl)benzylidinel-1H-inden-1-one chloride",0.37,uM,=,-0.431798275933005,0,O=C1/C(=C/c2ccc(N3CC[NH+](Cc4ccccc4)CC3)cc2)Cc2ccccc21
4086,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.53,uM,=,-0.2757241303992109,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4087,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.52,uM,=,-0.2839966563652008,0,c1ccc2nc3c(cc2c1)CCCC3
4088,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,Cc1cc(C)c(C(=O)n2nc(OCCN3CCCCC3)c3ccccc32)c(C)c1,"(2,4,6-trimethylphenyl)(3-(2-piperidinoethoxy)indazol-1-yl)ketone",11.6,uM,=,1.0644579892269186,1,O=C(c1ccccc1)n1nc(OCCN2CCCCC2)c2ccccc21
4089,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CC2CCCCCC2)CC1,1-(4-amino-5-chloro-2-methoxyphenyl)-3-(1-(cycloheptylmethyl)piperidin-4-yl)propan-1-one,0.057,uM,=,-1.2441251443275083,0,O=C(CCC1CCN(CC2CCCCCC2)CC1)c1ccccc1
4090,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3C)CC1)C2,"5,6-Dimethoxy-2-[1-(2-methyl-benzyl)-piperidin-4-ylmethyl]-indan-1-one",0.243,uM,=,-0.6143937264016879,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4091,579488,10.1016/j.bmcl.2009.05.087,,,,Inhibition of human recombinant AChE preincubated 20 mins before substrate addition by Ellman method,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@@H](C)c2ccccc2OC)=CC1=O)[C@@H](C)c1ccccc1OC,"2,5-bis(6-(ethyl((S)-1-(2-methoxyphenyl)ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",0.00403,uM,=,-2.3946949538588904,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
4092,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,Brc1cccc(-c2nnc3sc(-c4ccoc4)nn23)c1,"3-(3-Bromophenyl)-6-(furan-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",0.344,uM,=,-0.4634415574284699,0,c1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1
4093,1661208,10.1016/j.bmc.2017.02.017,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellmans method,CC1(C)CNC2=C([N+](=O)[O-])C3(C(C#N)=C(N)N2C1)c1ccccc1-c1nc2ccccc2nc13,"6'-amino-3',3'-dimethyl-9'-nitro-1',2',3',4'-tetrahydrospiro[indeno[1,2-b]quinoxaline-11,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",4.3,uM,=,0.6334684555795865,1,C1=CC2(C=C3NCCCN13)c1ccccc1-c1nc3ccccc3nc12
4094,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0132,uM,=,-1.8794260687941504,0,c1ccc2nc3c(cc2c1)CCCC3
4095,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1Cc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc2N1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5,7-dihydro-isoxazolo[4,5-f]indol-6-one",0.00033,uM,=,-3.4814860601221125,0,O=C1Cc2cc3c(CCC4CCN(Cc5ccccc5)CC4)noc3cc2N1
4096,642168,10.1016/j.bmc.2010.05.022,,,,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2C,"o-Tolyl-carbamic acid (S)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0103,uM,=,-1.987162775294828,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
4097,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,CN(Cc1ccccc1)Cc1ccc(-c2cc3cc(N)ccc3oc2=O)cc1,6-amino-3-{4-[(benzylmethylamino)methyl]phenyl}-chromen-2-one,0.281,uM,=,-0.5512936800949201,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
4098,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1c2c(nc3nc(-c4ccccc4)cc(C(F)(F)F)c13)-c1ccccc1CC2,"10-phenyl-8-(trifluoromethyl)-5,6-dihydronaphtho[1,2-b][1,8]naphthyridin-7-amine",23.14,uM,=,1.3643633546157308,1,c1ccc(-c2ccc3cc4c(nc3n2)-c2ccccc2CC4)cc1
4099,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(C2CCN(C(=O)COc3ccc(I)cc3)CC2)CC1,1-(4-(4-Ethylpiperazin-1-yl)piperidin-1-yl)-2-(4-iodophenoxy)ethanone,20.0,uM,=,1.3010299956639813,1,O=C(COc1ccccc1)N1CCC(N2CCNCC2)CC1
4100,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1Nc2ccccc2CN1CCC1CCN(Cc2ccccc2)CC1,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-3,4-dihydro-1H-quinazolin-2-one",0.013,uM,=,-1.8860566476931635,0,O=C1Nc2ccccc2CN1CCC1CCN(Cc2ccccc2)CC1
4101,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1,Obidoxime,2169.0,uM,=,3.336259552014193,1,c1cc[n+](COC[n+]2ccccc2)cc1
4102,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3C(F)(F)F)CC1)C2,"6-dimethoxy-2-((1-(2-(trifluoromethyl)benzyl)piperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",4.87,uM,=,0.6875289612146344,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4103,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(CN(CCO)Cc4ccccc4)cc3)c(=O)oc2cc1OC,"3-(4-{[benzyl-(2-hydroxyethyl)amino]methyl}phenyl)-6,7-dimethoxychromen-2-one",0.0493,uM,=,-1.30715308072277,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
4104,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCc1ccc(SC(=O)OCC[N+](C)(C)C)cc1.[Cl-],[2-(4-Ethyl-phenylsulfanylcarbonyloxy)-ethyl]-trimethyl-ammonium chloride,500.0,uM,=,2.6989700043360187,1,c1ccccc1
4105,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCN)O2,2-(2-aminoethyl)-7-methoxy-2-methylchroman-6-ol,101.0,uM,=,2.004321373782642,1,c1ccc2c(c1)CCCO2
4106,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1ccccc1CN(C)Cc1ccc(C(=O)NCCc2c[nH]c3ccccc23)cc1,N-[2-(1H-Indol-3-yl)ethyl]-4-{[(2-methoxybenzyl)(methyl)-amino]methyl}benzamide,4.7,uM,=,0.6720978579357175,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
4107,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCC(O)CC3)cc1)NCC2,"1-(6-(4-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)phenoxy)hexyl)piperidin-4-ol",9.59,uM,=,0.9818186071706636,1,c1ccc2c(c1)CCNC2Cc1ccc(OCCCCCCN2CCCCC2)cc1
4108,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,N#Cc1ccccc1CNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-((2-cyanobenzyl)amino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-7-yl)acetamide",0.0168,uM,=,-1.7746907182741372,0,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
4109,1553281,10.1016/j.bmc.2016.02.023,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by spectrophotometric-based Ellman's method,O=c1oc2cc(OCCNC3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2,"3-(2-((1-Benzylpiperidin-4-yl)amino)ethoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",1.37,uM,=,0.1367205671564068,1,O=c1oc2cc(OCCNC3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2
4110,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCc3cc[n+](Cc4ccccc4F)cc3)c2c1.[Br-],1-(2-fluorobenzyl)-4-(3-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-3-oxo propyl)pyridin-1-ium bromide,0.53,uM,=,-0.2757241303992109,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)NCCc1c[nH]c2ccccc12
4111,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCNc3c4c(nc5ccccc35)CCCC4)c(=O)c3ccccc32)cc1,"1-[(4-methoxyphenyl)methyl]-4-oxo-N-{3-[(1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-1,4-dihydroquinoline-3-carboxamide",0.129,uM,=,-0.889410289700751,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
4112,1335188,10.1016/j.ejmech.2014.03.042,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,O=C(c1ccc(CN2CCC(CCO)CC2)cc1)c1ccc(O)c(F)c1,3-Fluoro-4-hydroxyphenyl-4-[4-(2-hydroxyethyl)piperidin-1-ylmethyl]phenylmethanone,2.32,uM,=,0.3654879848908996,1,O=C(c1ccccc1)c1ccc(CN2CCCCC2)cc1
4113,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,8.1,uM,=,0.9084850188786496,1,c1ccccc1
4114,305005,10.1021/jm049113+,,,,Inhibitory concentration against Acetylcholinesterase; (range = 2-20 uM),CCN(CC)CCCN1CC(=O)N(C2CC2)CC1=O,"1-Cyclopropyl-4-(3-diethylamino-propyl)-piperazine-2,5-dione",20.0,uM,=,1.3010299956639813,1,O=C1CN(C2CC2)C(=O)CN1
4115,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCNc1ccc(-c2ccccc2)nn1)Cc1ccccc1,"N1-benzyl-N1-methyl-N3-(6-phenylpyridazin-3-yl)propane-1,3-diamine",13.0,uM,=,1.1139433523068367,1,c1ccc(CNCCCNc2ccc(-c3ccccc3)nn2)cc1
4116,2272284,10.1016/j.bmc.2021.116270,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate incubated for 20 mins by DTNB reagent based Ellman's method,C/C=C1/CN2CCc3c([nH]c4ccccc34)[C@@H]2CC1/C(=C\C(=O)OC)OC,Geissoschizine methyl ether,10.103924524885436,uM,=,1.0044900934312608,1,C=C1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1
4117,2261346,10.1016/j.ejmech.2022.114606,,,,Inhibition of AChE (unknown origin),CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCO[C@@H]2O3)cc1,"(-)-(3aS)-3a-methyl-2,3,3a,8a-Tetrahydrofuro[2,3-b]benzofuran-5-yl N-(p-Isopropylphenyl)carbamate",2.65,uM,=,0.4232458739368078,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@@H]1O2
4118,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc2c(cc1OC)C[N+](C)(CCCCCc1cccc(OC)[n+]1C)CC2.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,7-dimethoxy-2-(5-(6-methoxy-1-methylpyridinium-2-yl)pentyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium trifluoromethanesulfonate",0.46,uM,=,-0.3372421683184259,0,c1ccc(CCCCC[NH+]2CCc3ccccc3C2)[nH+]c1
4119,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCC[n+]2ccc3ccccc3c2)cc1,1-(8-(pyridinium-1-yl)octyl)isoquinoliniumdibromide,0.14,uM,=,-0.8538719643217619,0,c1cc[n+](CCCCCCCC[n+]2ccc3ccccc3c2)cc1
4120,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4cccnc4oc3c2)c1,Butyl-carbamic acid 3-({methyl-[3-(10-oxo-10H-9-oxa-1-aza-anthracen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0089,uM,=,-2.050609993355087,0,O=c1c2ccc(OCCCNCc3ccccc3)cc2oc2ncccc12
4121,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCC(O)CC4)cc3)cc12,"3-(4-((4-Hydroxypiperidin-1-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.378,uM,=,-0.4225082001627747,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
4122,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1cc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,(+)-syringaresinol dimethyl ether,0.616,uM,=,-0.2104192878355745,0,c1ccc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2ccccc2)cc1
4123,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1cc2cc(-c3ccc(CN(C)Cc4ccccc4)cc3)c(=O)oc2cc1OC,"3-{4-[(Benzyl-methyl-amino)-methyl]-phenyl}-6,7-dimethoxy-chromen-2-one",0.044,uM,=,-1.3565473235138126,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
4124,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)chroman-2-carboxamide",0.26,uM,=,-0.585026652029182,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
4125,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(-c3nnc(-c4ccc(F)cc4)[nH]3)ccc21,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(4-fluorophenyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",260.63,uM,=,2.416024404026534,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
4126,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccc(Cl)cc2Cl)C(=O)/C(=C/c2ccc(Cl)cc2Cl)C1,"(3E,5E)-1-acryloyl-3,5-bis(2,4-dichlorobenzylidene)piperidin-4-one",15.75,uM,=,1.1972805581256194,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
4127,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1cccc(Cl)c1,"2-(7-(3-Chlorobenzylamino)heptyl)isoindoline-1,3-dione",0.651,uM,=,-0.186419011431808,0,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
4128,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(Br)cc2)C[C@@H](c2ccc(C)cc2)N(c2ccc(Br)cc2)[C@@H]1c1ccc(C)cc1,"(2R,6S)-methyl 1-(4-bromophenyl)-4-(4-bromophenylamino)-2,6-dip-tolyl-1,2,5,6-tetrahydropyridine-3-carboxylate",2480.0,uM,=,3.3944516808262164,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
4129,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCN1CCCC1,(E)-3-(3-methoxy-4-(3-(pyrrolidin-1-yl)propoxy)phenyl)-N-phenylacrylamide,37.14,uM,=,1.5698418994037615,1,O=C(/C=C/c1ccc(OCCCN2CCCC2)cc1)Nc1ccccc1
4130,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1OC)CC(CC1CCN(CCCNc3c4c(nc5cc(Cl)ccc35)CC3C=C(C)CC4C3)CC1)C2.Cl.Cl,"(+/-)-3-chloro-N-(3-(4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)propyl)-9-methyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinolin-12-amine Dihydrochloride",0.00261,uM,=,-2.583359492661719,0,C1=CC2Cc3nc4ccccc4c(NCCCN4CCC(CC5Cc6ccccc6C5)CC4)c3C(C1)C2
4131,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3c(Cl)cccc13)CCCC2,"5-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0689,uM,=,-1.161780778092374,0,c1ccc2nc3c(cc2c1)CCCC3
4132,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1c(F)c[n+](CCCCOc2ccc3c(C)cc(=O)oc3c2)cc1F.O=S(=O)([O-])C(F)(F)F,"3,5-difluoro-4-methoxy-1-(4-(4-methyl-2-oxo-2H-chromen-7-yloxy)butyl)pyridinium trifluoromethanesulfonate",0.53,uM,=,-0.2757241303992109,0,O=c1ccc2ccc(OCCCC[n+]3ccccc3)cc2o1
4133,1653858,10.1016/j.ejmech.2016.11.050,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by spectrophotometry based Ellman method,Cc1ccc(C2c3ccc4cccnc4c3Oc3nc4c(c(N)c32)CCCC4)cc1,"7-(p-Tolyl)-9,10,11,12-tetrahydro-7H-pyrano[2,3-b:5,6-h']diquinolin-8-amine",2.85,uM,=,0.4548448600085102,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2cccnc32)CCCC4)cc1
4134,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(CCCCc1cn(CCCC(=O)NCCc3c[nH]c4ccccc34)nn1)C2,,0.12,uM,=,-0.9208187539523752,0,O=C(CCCn1cc(CCCCN2CC[C@@]34C=CCC[C@@H]3Oc3cccc(c34)C2)nn1)NCCc1c[nH]c2ccccc12
4135,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)N2CCN(c3ccc(Cl)cc3)CC2)ccc1O,(E)-1-(4-(4-chlorophenyl)piperazin-1-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one,11.15,uM,=,1.0472748673841794,1,O=C(/C=C/c1ccccc1)N1CCN(c2ccccc2)CC1
4136,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,COc1cccc(C2NC(=S)Nc3nc4c(c(N)c32)CCCC4)c1,"5-amino-4-(3-methoxyphenyl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",3.05,uM,=,0.4842998393467858,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
4137,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)O)ccc1OCCCCCCN1CCCCC1,(E)-3-(3-methoxy-4-((6-(piperidin-1-yl)hexyl)oxy)phenyl)acrylicacid,45.55,uM,=,1.658488381309017,1,c1ccc(OCCCCCCN2CCCCC2)cc1
4138,1821776,10.1016/j.bmcl.2019.03.024,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by spectrophotometry based Ellman's method,COc1ccc(/C=C/C(=O)c2ccc3c(c2O)C=CC(C)(C)O3)cc1,"(E)-1-(5-Hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3-(4-methoxy-phenyl)-propenone",74.71,uM,=,1.873378736409141,1,O=C(/C=C/c1ccccc1)c1ccc2c(c1)C=CCO2
4139,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2cccc(Br)c2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(3-bromobenzoyl)piperazin-1-yl)ethanone,23.0,uM,=,1.3617278360175928,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
4140,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]cc(CCNC(=O)Cn3cc(CCCCN4CC[C@@]56C=C[C@H](O)C[C@@H]5Oc5c(OC)ccc(c56)C4)nn3)c2c1,,0.023,uM,=,-1.6382721639824072,0,O=C(Cn1cc(CCCCN2CC[C@@]34C=CCC[C@@H]3Oc3cccc(c34)C2)nn1)NCCc1c[nH]c2ccccc12
4141,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1c(F)cccc1F)CC2.[Br-],"2-(2,6-difluorophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.29,uM,=,0.1105897102992489,1,C1=[N+](c2ccccc2)CCc2ccccc21
4142,2244080,10.1016/j.ejmech.2022.114152,,,,Inhibition of C-terminal 6His-tagged human recombinant AChE (32 to 614 residues) expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,Cc1ccc2nc3c(c(NCCCl)c2c1)CCCC3,"N-(2-chloroethyl)-7-methyl-1,2,3,4-tetrahydroacridin-9-amine",0.763,uM,=,-0.1174754620451195,0,c1ccc2nc3c(cc2c1)CCCC3
4143,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)N(c1ccccc1)CCC2,"3-(1-benzylpiperidin-4-yl)-1-(1-phenyl-1,2,3,4-tetrahydroquinolin-7-yl)propan-1-one",1.49,uM,=,0.173186268412274,1,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)N(c1ccccc1)CCC2
4144,2213907,10.1016/j.ejmech.2021.113949,,,,Inhibition of human AChE,c1ccc2c(c1)CCCN1Cc3cc(OCCCN4CCCCC4)ccc3N=C21,"11-[3-(1-piperidyl)propoxy]-5,6,7,9-tetrahydroquinazolino[2,3-a][2]benzazepine",0.535,uM,=,-0.2716462179787715,0,c1ccc2c(c1)CCCN1Cc3cc(OCCCN4CCCCC4)ccc3N=C21
4145,813756,10.1016/j.bmcl.2012.02.057,,,,Inhibition of human AChE by Ellman's method,COc1ccc2c(ccc[n+]2C)c1.[I-],6-Methoxy-1-methyl quinolinium iodide,49.73,uM,=,1.6966184592322249,1,c1ccc2[nH+]cccc2c1
4146,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(OC)c(CN2CCC(c3cc4ccccc4o3)CC2)c1,"4-(benzofuran-2-yl)-1-(2,5-dimethoxybenzyl)piperidine",23.9,uM,=,1.3783979009481375,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
4147,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c([nH]c3ccccc32)c(-c2ccccc2)n1,"1-Phenyl-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)-hexyl)-9H-pyrido[3,4-b]indole-3-carboxamide",0.159,uM,=,-0.7986028756795485,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c([nH]c3ccccc32)c(-c2ccccc2)n1
4148,2215296,10.1016/j.bmc.2022.116742,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's method,O=c1cc(/N=N/N=P(CCP(=N/N=N/c2cc(=O)oc3ccccc23)(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)c2ccccc2o1,4-[[[2-[[(2-oxochromen-4-yl)iminohydrazono]-diphenyllambda5-phosphanyl]ethyl-diphenyl-lambda5-phosphanylidene]amino]azo]chromen-2-one,0.03496,uM,=,-1.4564285760376343,0,O=c1cc(/N=N/N=P(CCP(=N/N=N/c2cc(=O)oc3ccccc23)(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)c2ccccc2o1
4149,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1c(F)ccc[n+]1C.F[B-](F)(F)F,3-fluoro-2-methoxy-1-methylpyridinium tetrafluoroborate,110.0,uM,=,2.041392685158225,1,c1cc[nH+]cc1
4150,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CNc2ccc(S(=O)(=O)Nc3nccs3)cc2)c1,(E)-4-(2-hydroxy-3-((hydroxyimino)methyl)-5-methylbenzylamino)-N-(thiazol-2-yl)benzenesulfonamide,5149.0,uM,=,3.711722891827234,1,O=S(=O)(Nc1nccs1)c1ccc(NCc2ccccc2)cc1
4151,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,O=C(CCn1c2ccccc2c2c[n+](Cc3ccccc3)ccc21)N1c2ccccc2Sc2ccccc21.[Br-],"2-benzyl-5-(3-oxo-3-(10H-phenothiazin-10-yl)propyl)-5H-pyrido[4,3-b]indol-2-ium bromide",2.2,uM,=,0.3424226808222063,1,O=C(CCn1c2ccccc2c2c[n+](Cc3ccccc3)ccc21)N1c2ccccc2Sc2ccccc21
4152,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,Clc1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)-c3ccccc3C4)c3c(nc2c1)CCCC3,"N-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-N'-(11H-indeno[1,2-b]quinolin-10-yl)heptane-1,7-diamine",0.00105,uM,=,-2.9788107009300617,0,c1ccc2c(c1)Cc1c-2nc2ccccc2c1NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
4153,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0003,uM,=,-3.522878745280338,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
4154,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,Cc1nc(C(=O)NCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,"1-Methyl-N-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)-9H-pyrido[3,4-b]indole-3-carboxamide",0.153,uM,=,-0.8153085691824012,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c(cn1)[nH]c1ccccc12
4155,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,0.06,uM,=,-1.2218487496163564,0,c1ccccc1
4156,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-amino-3-(1H-indol-3-yl)-N-(8-(1,2,3,4-tetrahydroacridin-9-ylamino)octyl)propanamide dihydrochloride",0.076,uM,=,-1.1191864077192086,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
4157,1565849,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CCCCCCCNC(=O)Oc1ccc2c(c1)CN(C)C(c1cc[nH]c1)N2C,"1,3-Dimethyl-2-(1H-pyrrol-3-yl)-1,2,3,4-tetrahydroquinazolin-6-yl n-heptylcarbamate",0.852,uM,=,-0.0695604052332999,0,c1ccc2c(c1)CNC(c1cc[nH]c1)N2
4158,552872,10.1021/jm8001313,,,,Inhibition of human erythrocyte AChE by Ellman's assay,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one hydrochloride",0.0116,uM,=,-1.9355420107730816,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4159,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccn3)CC1)C2,"5,6-dimethoxy-2-((1-(pyridin-2-ylmethyl)piperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1-one",0.147,uM,=,-0.8326826652518239,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
4160,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/c1ccc(O)c(OCC)c1)c1ccc(=O)[nH]c1C2,"(1R,9R)-1-{[1-(3-Ethoxy-4-hydroxy-phenyl)-methylidene]-amino}-13-eth-(E)-ylidene-11-methyl-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.025,uM,=,-1.6020599913279625,0,C=C1[C@H]2C=CC[C@]1(/N=C/c1ccccc1)c1ccc(=O)[nH]c1C2
4161,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3cccc(F)c13)CCCC2,"8-Fluoro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.078,uM,=,-1.1079053973095196,0,c1ccc2nc3c(cc2c1)CCCC3
4162,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,COc1ccc(C(=O)N2CCN(CC(=O)N3CCN(CCCc4c[nH]c5ccccc45)CC3)CC2)cc1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-methoxybenzoyl)piperazin-1-yl)ethanone,25.1,uM,=,1.3996737214810382,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
4163,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2cccc(Cl)c2)ccc1O,(E)-N-(2-((3-chlorophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,5.68,uM,=,0.7543483357110189,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
4164,1822343,10.1021/acs.jmedchem.9b00017,,,,Inhibition of AChE in human erythrocytes preincubated for 60 mins followed by substrate addition by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,0.92,uM,=,-0.0362121726544447,0,c1ccccc1
4165,751131,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes BChE,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.047,uM,=,-1.3279021420642825,0,c1ccc2nc3c(cc2c1)CCCC3
4166,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,O=C1C(=O)N(Cc2ccccc2[N+](=O)[O-])c2ccc(Br)cc21,"5-bromo-1-(2-nitrobenzyl)indoline-2,3-dione",0.263,uM,=,-0.5800442515102421,0,O=C1C(=O)N(Cc2ccccc2)c2ccccc21
4167,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CN(Cc1ccccc1)Cc1ccc(/C=C2\CCc3cc(OCCCCCN4CCCCC4)ccc3C2=O)cc1,"2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(5-piperidin-1-yl-pentyloxy)-3,4-dihydro-2H-naphthalen-1-one",0.052,uM,=,-1.2839966563652008,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)CCc2cc(OCCCCCN3CCCCC3)ccc21
4168,2261346,10.1016/j.ejmech.2022.114606,,,,Inhibition of AChE (unknown origin),CN1c2ccc(OC(=O)NCC3CCCCC3)cc2[C@]2(C)CCN(CCc3ccccc3)[C@H]12,"3alpha,8-dimethyl-1-phenethyl-1,2,3,3alpha,8,8alpha-hexahydropyrrolo[2,3-b]indol-5-ylcyclohexylmethylcarbamate",2.5,uM,=,0.3979400086720376,1,O=C(NCC1CCCCC1)Oc1ccc2c(c1)C1CCN(CCc3ccccc3)[C@@H]1N2
4169,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.032,uM,=,-1.494850021680094,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4170,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN(C)CCOc2ccc3c4c(c(=O)oc3c2)CCCC4)c1,"3-(2-((3-Methoxybenzyl)(methyl)amino)ethoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",6.0,uM,=,0.7781512503836436,1,O=c1oc2cc(OCCNCc3ccccc3)ccc2c2c1CCCC2
4171,1834120,10.1021/acs.jnatprod.8b00592,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by Ellman's method,CCN(CC)Cc1cc2cc(c1O)Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@@H](C2)N(C)CC3,Bersavine,68.0,uM,=,1.8325089127062364,1,c1cc2cc(c1)Oc1ccc(cc1)C[C@@H]1NCCc3ccc(cc31)Oc1cccc3c1[C@@H](C2)NCC3
4172,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CCN(C)C(=O)Oc1cc(C(C)N(C)C)cc2oc(=O)c3ccccc3c12.Cl,(+/-)-3-(1-(Dimethylamino)ethyl)-6-oxo-6H-benzo[c]chromen-1-yl ethyl(methyl)carbamate hydrochloride,39.7,uM,=,1.5987905067631152,1,O=c1oc2ccccc2c2ccccc12
4173,2019674,10.1039/d0md00009d,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by Ellman's method,Cc1ccc(C(C)C)cc1O,5-Isopropyl-2-methyl-phenol,283.6,uM,=,2.452706226511029,1,c1ccccc1
4174,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CCCCCCOC[n+]1ccn(C)c1/C=N/O.[Cl-],1-Hexyloxymethyl-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,25.0,uM,=,1.3979400086720375,1,c1c[nH+]c[nH]1
4175,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(C[C@H]2Cc3ccccc3C2=O)CC1,2-(1-Methyl-piperidin-4-ylmethyl)-indan-1-one,0.0077,uM,=,-2.113509274827518,0,O=C1c2ccccc2C[C@@H]1CC1CCNCC1
4176,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(c2)O/C(=C\c2ccc4ccccc4c2)C3=O)c1,"Methyl-carbamic acid 3-{[methyl-(3-{2-[1-naphthalen-2-yl-meth-(Z)-ylidene]-3-oxo-2,3-dihydro-benzofuran-6-yloxy}-propyl)-amino]-methyl}-phenyl ester",3.41,uM,=,0.5327543789924978,1,O=C1/C(=C/c2ccc3ccccc3c2)Oc2cc(OCCCNCc3ccccc3)ccc21
4177,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,CC1CCc2c(nc3nc(-c4ccccc4)cc(C(F)(F)F)c3c2N)C1,"8-Methyl-2-phenyl-4-(trifluoromethyl)-6,7,8,9-tetrahydrobenzo[b][1,8]-naphthyridin-5-amine",3.25,uM,=,0.5118833609788744,1,c1ccc(-c2ccc3cc4c(nc3n2)CCCC4)cc1
4178,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc(/C=C/c2cc(=O)oc3c2ccc2oc(-c4cccc(Cl)c4)cc23)cc(OC)c1,"8-(3-chlorophenyl)-4-(3,5-dimethoxystyryl)-2H-furo[2,3-h]chromen-2-one",1.8,uM,=,0.255272505103306,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
4179,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3cc(Cl)ccc13)C1CCC2C1,"7-chloro-10-azatetracyclo[10.2.1.02,11.04,9]pentadeca-2,4,6,8,10-pentaen-3-amine",0.0045,uM,=,-2.3467874862246565,0,c1ccc2nc3c(cc2c1)C1CCC3C1
4180,2213907,10.1016/j.ejmech.2021.113949,,,,Inhibition of human AChE,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCCC1=N2,"2-(3-(piperidin-1-yl)propoxy)-7,8,9,11-tetrahydro-6H-pyrido[2,1-b]quinazoline",0.225,uM,=,-0.6478174818886375,0,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCCC1=N2
4181,932823,10.1007/s00044-012-0353-y,,,,Inhibition of AChE (unknown origin),CC(C)=CCC/C(C)=C/Cc1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)c(O)cc1O,"5'-geranyl-5,7,2',4'-tetrahydroxyflavone",16.21,uM,=,1.209783014848515,1,O=c1cc(-c2ccccc2)oc2ccccc12
4182,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1cccc2nc3c(c(N)c12)CCCCC3.Cl,"1-methyl-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",0.255,uM,=,-0.5934598195660449,0,c1ccc2nc3c(cc2c1)CCCCC3
4183,28458,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 12.6-74.0,C#CCNC(C)Cc1cccc(OC(=O)N(C)CC)c1,Ethyl-methyl-carbamic acid 3-(2-prop-2-ynylamino-propyl)-phenyl ester,33.9,uM,=,1.530199698203082,1,c1ccccc1
4184,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,CC(C)OP(=O)(F)OC(C)C,Phosphorofluoridic acid diisopropyl ester,0.12,uM,=,-0.9208187539523752,0,
4185,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(CC1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12,2-(1-Benzylpiperidin-4-yl)-N-(6-(pyridin-3-yl)-1H-indazol-3-yl)acetamide,0.509,uM,=,-0.2932822176632412,0,O=C(CC1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12
4186,305184,10.1016/j.bmcl.2004.10.067,,,,Inhibitory concentration against Acetylcholinesterase activity,COc1ccc(-c2cc3c(c(=O)o2)C[C@@]2(O)[C@@]4(C)C=CC(=O)C(C)(C)[C@@]4(O)CC[C@@]2(C)O3)cc1,"4a,12a-dihydroxy-9-(4-methoxyphenyl)-4,4,6a,12b-tetramethyl-3,4a,5,6,6a,12,12a,12b-octahydro-4H,11H-benzo[f]pyrano[4,3-b]chromene-3,11-dione",0.09,uM,=,-1.0457574905606752,0,O=C1C=CC2C(CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC32)C1
4187,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)ccoc3c2)c1,Methyl-carbamic acid 3-({methyl-[3-(4-oxo-4H-chromen-7-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0089,uM,=,-2.050609993355087,0,O=c1ccoc2cc(OCCCNCc3ccccc3)ccc12
4188,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,COc1ccccc1/C=C1\CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C(=C\c2ccccc2OC)C1=O,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(2-methoxybenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",14.52,uM,=,1.161966616364075,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
4189,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1,"(S)-N-(6-((1,2,3,4-Tetrahydroacridin-9-yl)amino)hexyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide",0.0632,uM,=,-1.1992829217176149,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1
4190,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(=O)(=O)c1cc(Cl)ccc1Cl,"1-(2,5-dichloro benzene)-sulfonyl-cis-2,6-dimethyl piperidine",0.09,uM,=,-1.0457574905606752,0,O=S(=O)(c1ccccc1)N1CCCCC1
4191,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,C[n+]1ccc2[nH]c3ccc(F)cc3c2c1.[I-],"8-fluoro-2-methyl-5H-pyrido[4,3-b]indol-2-ium iodide",1.9,uM,=,0.2787536009528289,1,c1ccc2c(c1)[nH]c1cc[nH+]cc12
4192,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCCNc3c4c(nc5ccccc35)CCCC4)c2c1,"6-(1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4193,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CC(C)(C)c1cccc(C(=O)CF)c1,1-(3-(tert-butyl)phenyl)-2-fluoroethan-1-one,0.715,uM,=,-0.1456939581989194,0,c1ccccc1
4194,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(CN(CCCCCCNc3c4c(nc5ccccc35)CCCC4)Cc3cc4cccc(OC)c4o3)oc12,"N1,N1-Bis(7-methoxybenzofuran-2-yl)methyl)-N6-(1,2,3,4-tetrahydroacridin-9-yl)hexane-1,6-diamine",0.26,uM,=,-0.585026652029182,0,c1ccc2oc(CN(CCCCCCNc3c4c(nc5ccccc35)CCCC4)Cc3cc4ccccc4o3)cc2c1
4195,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12C(=O)c1cccc3cccc2c13,"5'-amino-8'-nitro-2-oxo-2',3'-dihydro-1'H,2H-spiro[acenaphthylene-1,7'-imidazo[1,2-a]pyridine]-6'-carbonitrile",7.08,uM,=,0.850033257689769,1,O=C1c2cccc3cccc(c23)C12C=CN1CCNC1=C2
4196,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3nc(CN4CCCCC4)cs3)cc12,"3-(4-(Piperidin-1-ylmethyl)thiazol-2-yl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carbonitrile",0.018,uM,=,-1.744727494896694,0,c1cc2c(cn1)[nH]c1ncc(-c3nc(CN4CCCCC4)cs3)cc12
4197,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(F)cc1)CCCC3,"ethyl 5-amino-4-(4-fluorophenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.193,uM,=,-0.7144426909922262,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
4198,1549817,10.1016/j.bmc.2016.01.031,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Br.BrCC1CN=C(Nc2ccccn2)S1,"(5-Bromomethyl-4,5-dihydrothiazol-2-yl)pyridin-2-ylamine hydrobromide",110.0,uM,=,2.041392685158225,1,c1ccc(NC2=NCCS2)nc1
4199,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CCNC(=O)Oc1ccc2c(c1)C1(C)COC(C1)O2,"Ethyl-carbamic acid 1-methyl-8,10-dioxa-tricyclo[7.2.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.83,uM,=,-0.0809219076239261,0,c1ccc2c(c1)OC1CC2CO1
4200,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cccc(NC(=O)CNC(=O)/C=C/c2ccc(O)c(OC)c2)c1,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-((3-methoxyphenyl)amino)-2-oxoethyl)acrylamide,2.42,uM,=,0.3838153659804312,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
4201,1553281,10.1016/j.bmc.2016.02.023,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by spectrophotometric-based Ellman's method,Cc1cc(=O)oc2cc(CNCCC3CCN(Cc4ccccc4)CC3)ccc12,7-(((2-(1-Benzylpiperidin-4-yl)ethyl)amino)methyl)-4-methyl-2H-chromen-2-one,0.067,uM,=,-1.1739251972991736,0,O=c1ccc2ccc(CNCCC3CCN(Cc4ccccc4)CC3)cc2o1
4202,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,O=C(NO)c1ccc(Nc2ccnc3ccccc23)cc1,N-Hydroxy-4-(quinolin-4-ylamino)benzamide,0.83,uM,=,-0.0809219076239261,0,c1ccc(Nc2ccnc3ccccc23)cc1
4203,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3F)CC2)cc(C(C)(C)C)c1O,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(2-fluorobenzyl)piperidin-4-yl)ethyl)acrylamide",0.75,uM,=,-0.1249387366082999,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4204,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,COc1ccccc1C1N(C)Cc2cc(O)ccc2N1C,"2-(2-Methoxyphenyl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-ol",192.8,uM,=,2.285107029566812,1,c1ccc(C2NCc3ccccc3N2)cc1
4205,665090,10.1016/j.bmcl.2010.08.044,,,,Inhibition of human recombinant AChE after 5 mins,CCCCNc1c2c(nc3ccc(OC)cc13)CCCC2.Cl,N-n-butyl-7-methoxytacrine hydrochloride,21.0,uM,=,1.3222192947339193,1,c1ccc2nc3c(cc2c1)CCCC3
4206,510556,10.1021/np800305b,,,,Inhibition of acetylcholinesterase,CN[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C(=O)[C@@H](NC(=O)C=C(C)C)CC[C@]4(C)[C@H]3CC[C@]12C,epipachysamine-E-5-en-4-one,9.9,uM,=,0.99563519459755,1,O=C1CCCC2C1=CC[C@H]1[C@@H]3CCCC3CC[C@H]21
4207,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3c1C(c1ccc4c(c1)OCO4)NC(=S)N3)CCCC2,"5-amino-4-(benzo[d][1,3]dioxol-5-yl)-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",8.18,uM,=,0.912753303671323,1,S=C1Nc2nc3c(cc2C(c2ccc4c(c2)OCO4)N1)CCCC3
4208,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Oc1ccc(-c2cn3c(NC=O)cccc3[n+]2C)cc1.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-5-formamido-1-methylimidazo[1,2-a]pyridin-1-ium",1.2,uM,=,0.0791812460476248,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
4209,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCCCNc3c4c(nc5ccccc35)CCCC4)c2c1,"7-(1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-5-metoxy-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4210,2114062,10.1016/j.bmcl.2021.128100,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by DTNB-reagent based Ellman's method,COc1ccc2nc3c(c(N)c2c1)C1CC(C)=CC(C3)C1.Cl,(+/-)-2-methoxyhuprine hydrochloride,2.63,uM,=,0.4199557484897578,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
4211,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc([N+](=O)[O-])cc1)CCCC3,"ethyl 5-amino-2-methyl-4-(4-nitrophenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.309,uM,=,-0.5100415205751654,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
4212,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12,3-(2-(4-Benzylpiperazin-1-yl)ethoxy)-6H-benzo[c]chromen-6-one,0.9,uM,=,-0.0457574905606751,0,O=c1oc2cc(OCCN3CCN(Cc4ccccc4)CC3)ccc2c2ccccc12
4213,1299163,10.1039/C3MD00041A,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride by spectrophotometry,Cn1ncc2c1-c1sccc1C2NC(=O)CN1CCN(Cc2ccccc2)CC1,"2-(4-Benzylpiperazine)-N-(1-methyl-1,4-dihydrothieno[3',2':4,5]cyclopenta[1,2-c]pyrazol-4-yl)acetamide",0.93,uM,=,-0.0315170514460648,0,O=C(CN1CCN(Cc2ccccc2)CC1)NC1c2cn[nH]c2-c2sccc21
4214,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCC[n+]2ccccc2)cc1,"1,5-bis(pyridinium)-pentane dibromide",1270.0,uM,=,3.103803720955957,1,c1cc[n+](CCCCC[n+]2ccccc2)cc1
4215,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CN(Cc1ccccc1)Cc1ccc(NC(=O)/C=C/c2ccc(O)c(O)c2)cc1,"(E)-N-(4-((benzyl(methyl)amino)methyl)phenyl)-3-(3,4-dihydroxyphenyl)acrylamide",5.42,uM,=,0.7339992865383869,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
4216,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(c4ncccn4)CC3)nc12,N-(4-Methylbenzo[d]thiazol-2-yl)-3-(4-(pyrimidin-2-yl)-piperazin-1-yl)propanamide,30.02,uM,=,1.4774106879072515,1,O=C(CCN1CCN(c2ncccn2)CC1)Nc1nc2ccccc2s1
4217,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[4-(benzylmethylamino)butoxy]xanthen-9-one,6.25,uM,=,0.7958800173440752,1,O=c1c2ccccc2oc2cc(OCCCCNCc3ccccc3)ccc12
4218,2185005,10.1016/j.ejmech.2021.113278,,,,Inhibition of human AchE preincubated for 20 mins followed by substrate addition using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc2nc3c(c(NCCCCCCCCN(CC(=O)Nc4ccc5ccccc5c4)C(=O)/C=C/c4ccc(O)c(OC)c4)c2c1)CCCC3,"3-(4-hydroxy-3-methoxyphenyl)-N-(8-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)octyl)-N-(2-(naphthalen-2-ylamino)-2-oxoethyl)acrylamide",0.0222,uM,=,-1.6536470255493614,0,O=C(CN(CCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C(=O)/C=C/c1ccccc1)Nc1ccc2ccccc2c1
4219,613426,10.1016/j.bmc.2010.01.063,,,,Inhibition of human AChE by modified Ellman's spectrophotometric method,COC(=O)C1=C(C)O[P@@](=O)(OC)CC[C@H]1COCc1ccccc1,"(2R,6R)-6-Benzyloxymethyl-2-methoxy-4-methyl-2-oxo-6,7-dihydro-2lambda*5*-[1,3,2]dioxaphosphepine-5-carboxylic acid methyl ester",35.0,uM,=,1.5440680443502757,1,O=[PH]1CC[C@@H](COCc2ccccc2)C=CO1
4220,1842234,10.1016/j.bmc.2019.01.025,,,,Inhibition of human acetylcholinesterase,COc1ccc2[nH]cc(CCNC(=O)CN(CCC3CCN(Cc4ccccc4)CC3)C(=O)/C=C/c3ccc(O)c(OC)c3)c2c1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-(2-(5-methoxy-1H-indol-3-yl)ethylamino)-2-oxoethyl)acrylamide,0.0306999999999999,uM,=,-1.5128616245228137,0,O=C(CN(CCC1CCN(Cc2ccccc2)CC1)C(=O)/C=C/c1ccccc1)NCCc1c[nH]c2ccccc12
4221,811771,10.1016/j.bmc.2012.02.044,,,,Inhibition of human erythrocyte AChE assessed as acetylthiocholine iodide hydrolysis after 10 mins preincubation by spectrophotometry,COc1cc([C@@H]2CC(=O)c3c(cc(O)c(C/C=C(\C)CCC=C(C)C)c3O)O2)ccc1O,3'-O-methyldiplacone,109.2,uM,=,2.0382226383687185,1,O=C1C[C@@H](c2ccccc2)Oc2ccccc21
4222,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(Cl)cc13)CCCC2,"7-chloro-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",1.94,uM,=,0.287801729930226,1,c1ccc2nc3c(cc2c1)CCCC3
4223,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)ccoc3c2)c1,3-((methyl(3-(4-oxo-4H-chromen-7-yloxy)propyl)amino)methyl)phenyl hexylcarbamate,0.021,uM,=,-1.6777807052660807,0,O=c1ccoc2cc(OCCCNCc3ccccc3)ccc12
4224,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc(SC)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-methylthiobenzyl)berberine bromide,2.6,uM,=,0.414973347970818,1,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
4225,1620689,10.1021/acs.jmedchem.6b00967,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCSc1nc2sc3c(c2c(=O)n1-c1ccccc1)CCN(Cc1ccccc1)C3,GNF-Pf-5524,5.1,uM,=,0.7075701760979364,1,O=c1c2c3c(sc2ncn1-c1ccccc1)CN(Cc1ccccc1)CC3
4226,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1OC,"4-(benzofuran-2-yl)-1-(3,4-dimethoxybenzyl)piperidine",52.78,uM,=,1.722469385884031,1,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1
4227,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCCCC[n+]2ccccc2)cc1,"1,11-di(1-pyridiniumyl)undecane; dibromide",0.7,uM,=,-0.1549019599857432,0,c1cc[n+](CCCCCCCCCCC[n+]2ccccc2)cc1
4228,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(C)cc(/C=N/O)c3O)CC1)CC2,"3-((4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxy-5-methylbenzaldehyde oxime",417.5,uM,=,2.620656479819621,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1
4229,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,COc1ccccc1-c1nnc2sc(-c3ccoc3)nn12,"6-(Furan-3-yl)-3-(2-methoxyphenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(-c2nnc3sc(-c4ccoc4)nn23)cc1
4230,28617,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 8.6-49.9,C#CCN(CC)C1CCc2ccc(OC(=O)N(C)C)cc21.Cl,Dimethyl-carbamic acid 3-(ethyl-prop-2-ynyl-amino)-indan-5-yl ester hydrochloride,17.9,uM,=,1.252853030979893,1,c1ccc2c(c1)CCC2
4231,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccccc2Cl)ccc1O,(E)-N-(2-((2-chlorophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,5.72,uM,=,0.7573960287930241,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
4232,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(=O)(=O)c1cccc([N+](=O)[O-])c1,"1-(3-nitro benzene)-sulfonyl-cis-2,6-dimethylpiperidine",0.192,uM,=,-0.7166987712964504,0,O=S(=O)(c1ccccc1)N1CCCCC1
4233,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccc(Br)cc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(4-bromobenzoyl)piperazin-1-yl)ethanone,35.7,uM,=,1.5526682161121932,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
4234,1801959,10.1016/j.ejmech.2018.08.016,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by DTNB reagent based assay,CCN(CC)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((diethylamino)methyl)phenol dihydrochloride,17.8,uM,=,1.250420002308894,1,c1ccccc1
4235,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,O=C(NCCCCCCNCc1c[nH]c2ccccc12)c1cc(Cl)nc(Cl)c1,"N-(6-(((1H-indol-3-yl)methyl)amino)hexyl)-2,6-dichloroisonicotinamide",8.85,uM,=,0.9469432706978256,1,O=C(NCCCCCCNCc1c[nH]c2ccccc12)c1ccncc1
4236,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,O=c1ccc2ccc(O)cc2o1,7-Hydroxy-chromen-2-one,29000.0,uM,=,4.462397997898956,1,O=c1ccc2ccccc2o1
4237,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1cccc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)c1,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3-methoxyphenyl)acrylamide,0.69,uM,=,-0.1611509092627447,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4238,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,Cc1nc(C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,"1-Methyl-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)-hexyl)-9H-pyrido[3,4-b]indole-3-carboxamide",0.0925999999999999,uM,=,-1.0333890133180657,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c(cn1)[nH]c1ccccc12
4239,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,COc1cc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc(OC)c1OC,"N2-(1-Benzylpiperidin-4-yl)-N4-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine",10.3,uM,=,1.0128372247051722,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
4240,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1ccc([C@H]2O[C@@H](O)[C@H]3[C@@H]2C(=O)O[C@@H]3c2cc(OC)c3c(c2)OCO3)cc1OC,"Ciquitin A; (+)-(7S,7'S,8S,8'S,9R)-9-hydroxy-7-[(3'-methoxy-4',5'-methylenedioxyphenyl-7'-(3,4-dimethoxyphenyl)]-9'-oxo-8,8'-dioxabicyclo[3.3.0]octane",0.003,uM,=,-2.5228787452803374,0,O=C1O[C@H](c2ccc3c(c2)OCO3)[C@H]2CO[C@H](c3ccccc3)[C@@H]12
4241,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1,N-((1-benzylpiperidin-4-yl)methyl)-5-(2-(cyclopropanecarboxamido)isonicotinamido)nicotinamide,1.102,uM,=,0.0421815945157662,1,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1
4242,28619,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 9.46-68.1,C#CCNCCc1cccc(OC(=O)N(C)CC)c1,Ethyl-methyl-carbamic acid 3-(2-prop-2-ynylamino-ethyl)-phenyl ester,30.2,uM,=,1.4800069429571507,1,c1ccccc1
4243,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccc(OC)cc3)CC2)cc1,(2-(1-(4-methoxybenzyl)piperidin-4-yl)benzofuran-3-yl)(4-methoxyphenyl)methanone,59.73,uM,=,1.776192514747072,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
4244,28618,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 8.99-49.4,CCN(C)C(=O)Oc1ccc2c(c1)C(N)CC2.Cl,Ethyl-methyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,19.0,uM,=,1.2787536009528289,1,c1ccc2c(c1)CCC2
4245,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[7-(9-oxo-9H-xanthen-3-yloxy)-heptyl]-amino}-methyl)-phenyl ester,0.32,uM,=,-0.494850021680094,0,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
4246,1565849,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.032,uM,=,-1.494850021680094,0,c1ccc2c(c1)N[C@H]1NCCC21
4247,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)ccc1O,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,0.39,uM,=,-0.4089353929735008,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4248,763955,10.1016/j.ejmech.2011.07.004,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,Clc1ccc2c(NCCCCCCCOc3cccc(-c4cc5ccccc5o4)c3)c3c(nc2c1)CCCC3,"[7-(3-Benzofuran-2-yl-phenoxy)heptyl]-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amine",0.258,uM,=,-0.5883802940367698,0,c1cc(OCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(-c2cc3ccccc3o2)c1
4249,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCN1CCCC1,(E)-3-(3-methoxy-4-((6-(pyrrolidin-1-yl)hexyl)oxy)phenyl)-N-phenylacrylamide,1.11,uM,=,0.0453229787866574,1,O=C(/C=C/c1ccc(OCCCCCCN2CCCC2)cc1)Nc1ccccc1
4250,751131,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human erythrocytes BChE,CN(C)CC(C)(C)c1cccc(OC(=O)NCCCCN2CCOCC2)c1,"[4-(4-morpholinyl)butyl]carbamic acid-3-(1,1-dimethyl-2-dimethylaminoethyl)phenylester",0.009,uM,=,-2.0457574905606752,0,O=C(NCCCCN1CCOCC1)Oc1ccccc1
4251,28327,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.99-1.20,CNC1CCc2ccc(OC(=O)N(C)C)cc21.Cl,Dimethyl-carbamic acid 3-methylamino-indan-5-yl ester hydrochloride,1.07,uM,=,0.0293837776852096,1,c1ccc2c(c1)CCC2
4252,1497677,10.1021/acs.jnatprod.5b00057,,,,Inhibition of human erythrocytes acetylcholinesterase after 30 mins using S-acetylthiocholine iodide substrate by spectrophotometry based Ellman method,CC(C)=CC[C@]12C[C@@H]3[C@@H]4[C@@H](O)C(C)(C)[C@@H](C(C)C)CC4(C1=O)C(=O)[C@](C(=O)c1ccccc1)(C2=O)C3(C)C,"(3R,5R,6S,7R,9R,11S)-9-benzoyl-5-hydroxy-4,4,8,8-tetramethyl-11-(3-methylbut-2-en-1-yl)-3-(propan-2-yl)tetracyclo[7.3.1.1^{7,11}.0^{1,6}]tetradecane-10,12,13-trione",26.4,uM,=,1.421603926869831,1,O=C1C2C[C@H]3C[C@@](C(=O)c4ccccc4)(C2=O)C(=O)C12CCCC[C@@H]32
4253,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,C=CCNC(=S)NNc1c2c(nc3ccccc13)CCCC2,"N-allyl-2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazine-1-carbothioamide",5.77,uM,=,0.7611758131557314,1,c1ccc2nc3c(cc2c1)CCCC3
4254,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cc(C(C)N(C)C)c2c(c1)oc(=O)c1ccccc12.Cl,(+/-)-1-(1-(Dimethylamino)ethyl)-3-methoxy-6H-benzo[c]chromen-6-one hydrochloride,15.1,uM,=,1.1789769472931697,1,O=c1oc2ccccc2c2ccccc12
4255,462117,10.1021/jm7009364,,,,Inhibition of human AchE,C#CCN[C@@H]1CCc2cc(Cl)c(OC(=O)N(C)CCC)cc21,"(R)-6-chloro-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl methyl(propyl)carbamate",43.9,uM,=,1.6424645202421213,1,c1ccc2c(c1)CCC2
4256,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,CN(Cc1ccccc1)Cc1ccc(COc2ccc3c(C(F)F)cc(=O)oc3c2)cc1,7-((4-((benzyl(methyl)amino)methyl)benzyl)oxy)-4-(difluoromethyl)-2H-chromen-2-one,0.56,uM,=,-0.2518119729937995,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
4257,28624,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in human red blood cell,Nc1c2c(nc3ccccc13)CC(O)CC2,"9-Amino-1,2,3,4-tetrahydro-acridin-3-ol",0.623,uM,=,-0.2055119533408304,0,c1ccc2nc3c(cc2c1)CCCC3
4258,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.002,uM,=,-2.6989700043360187,0,c1ccccc1
4259,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,1-(4-(Benzylamino)quinazolin-2-yl)urea,8.3,uM,=,0.919078092376074,1,c1ccc(CNc2ncnc3ccccc23)cc1
4260,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc4cccc(O)c4n3)CC1)C2,"2-((1-((8-hydroxyquinolin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",29.8,uM,=,1.4742162640762553,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccc3ccccc3n2)CC1
4261,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,Cc1ccc(/C=C2\CN(C(=O)C[C@H]3C[C@H]4CCCN4[C@]34C(=O)Nc3ccccc34)C[C@@]3(C[C@H]4CCCN4[C@@]34C(=O)Nc3ccccc34)C2=O)cc1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(4-methylphenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(4-methylphenylmethylidene)hexahydro-1H-pyrrolizine,19.59,uM,=,1.2920344359947364,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
4262,1278501,10.1016/j.bmc.2013.09.050,,,,Inhibition of human erythrocytic AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman method,COc1ccc(/C=C2\COc3cc(OCCCCCNc4c5c(nc6ccccc46)CCCC5)ccc3C2=O)cc1,"(E)-3-(4-Methoxybenzylidene)-7-(5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyloxy)chroman-4-one",0.098,uM,=,-1.0087739243075051,0,O=C1/C(=C/c2ccccc2)COc2cc(OCCCCCNc3c4c(nc5ccccc35)CCCC4)ccc21
4263,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2cc(=O)c3ccc(OCCN4CCOCC4)cc3o2)cc1,2-(4-methoxyphenyl)-7-(2-morpholinoethoxy)-4H-chromen-4-one,0.011,uM,=,-1.958607314841775,0,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCOCC3)ccc12
4264,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(C2CCN(C(=O)COc3ccc(-c4ccccc4F)cc3)CC2)CC1,"1-(4-(4-Ethylpiperazin-1-yl)piperidin-1-yl)-2-((2'-fluoro-[1,1'-biphenyl]-4-yl)oxy)ethanone",19.0,uM,=,1.2787536009528289,1,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCNCC2)CC1
4265,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CC[C@H](C)C1=N[C@H]2CC=C3C[C@H]4C(=O)C[C@]5(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]5(C)[C@@H]4CC[C@H]3[C@]2(C)CN1,"(4aS,7aR,9aR,10S,11R,12aS,12bR,14aR,14bR)-10-[1-(dimethylamino)ethyl]-11-hydroxy-9a,12a,14b-trimethyl-3-[(1S)-1-methylpropyl]-2,4a,5,7,7a,9,9a,10,11,12,12a,12b, 13,14,14a,14b-hexadecahydroindeno[5',4':4,5]cyclohepta[1,2-f]quinazolin-8(1H)-one",3.832,uM,=,0.5834255004065068,1,O=C1CC2CCCC2[C@@H]2CC[C@@H]3C(=CC[C@@H]4N=CNCC43)C[C@@H]12
4266,1454788,10.1016/j.ejmech.2014.07.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric analysis,Cl.O=C(NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,"N-{5-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}-5-(4-chlorophenyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-9-carboxamide dihydrochloride",0.0141999999999999,uM,=,-1.8477116556169435,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)NCCC3
4267,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(7-(4-((1-(phenylsulfonyl)-1H-indol-4-yl)methyl)piperazin-1-yl)heptyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",4.56,uM,=,0.658964842664435,1,O=C1CC2CCc3ccsc3C2=NN1CCCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
4268,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,C[n+]1ccc2c(c1)c1ccccc1n2CCCCCCCCCn1c2ccccc2c2c[n+](C)ccc21.[I-].[I-],"1,9-bis(2-methyl-5H-2lamda4-pyrido[4,3-b]indol-5-yl)nonane diiodide",0.00033,uM,=,-3.4814860601221125,0,c1ccc2c(c1)c1c[nH+]ccc1n2CCCCCCCCCn1c2ccccc2c2c[nH+]ccc21
4269,1849549,10.1016/j.bmc.2019.07.001,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1cc(NCc2ccc(Oc3c(N)cccc3Cl)cc2)cc(OC)c1OC,"N-(4-(2-amino-6-chlorophenoxy)benzyl)-3,4,5-trimethoxyaniline",1.32,uM,=,0.1205739312058498,1,c1ccc(NCc2ccc(Oc3ccccc3)cc2)cc1
4270,1718355,10.1016/j.ejmech.2017.08.051,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured over 5 mins by UV-Vis spectrophotometric analysis,COc1cc2c(cc1OC)C(=O)/C(=C/C1CCN(Cc3cc(N)c4ccccc4n3)CC1)C2,"(E)-2-((1-((4-Aminoquinolin-2-yl)methyl)piperidin-4-yl)methylene)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.014,uM,=,-1.853871964321762,0,O=C1/C(=C/C2CCN(Cc3ccc4ccccc4n3)CC2)Cc2ccccc21
4271,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,Cl.N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CCCCCC2)o1,"2-(1-{2-[(5-Azepan-1-ylmethyl-furan-2-ylmethyl)-amino]-ethyl}-imidazolidin-2-ylidene)-malononitrile, Di-hydrochloride",0.12,uM,=,-0.9208187539523752,0,C=C1NCCN1CCNCc1ccc(CN2CCCCCC2)o1
4272,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,Brc1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,1-Benzyl-N-(4-bromobenzyl)pyrrolidin-3-amine,0.133,uM,=,-0.8761483590329142,0,c1ccc(CNC2CCN(Cc3ccccc3)C2)cc1
4273,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,CN(CCCCCCCOc1ccc2c(=O)c3ccccc3oc2c1)Cc1ccccc1,3-[7-(benzylmethylamino)-heptyloxy]xanthen-9-one,2.82,uM,=,0.450249108319361,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
4274,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2c(=O)cc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)[nH]c2c1,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-7-methoxy-4-oxo-1,4-dihydroquinoline-2-carboxamide",0.45,uM,=,-0.3467874862246563,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2[nH]1
4275,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2cccc3ccccc23)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(naphthalen-1-ylphenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(naphthalen-1-ylphenylmethyliden)hexahydro-1H-pyrrolizine,20.63,uM,=,1.3144992279731516,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2cccc3ccccc23)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
4276,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CCCCCN(C)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((methyl(pentyl)amino)methyl)phenol dihydrochloride,805.1,uM,=,2.905849826642319,1,c1ccccc1
4277,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)OCC3=O)c1,"Methyl-carbamic acid 3-({methyl-[7-(3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-amino}-methyl)-phenyl ester",1610.0,uM,=,3.206825876031849,1,O=C1COc2cc(OCCCCCCCNCc3ccccc3)ccc21
4278,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1cccc(Cl)c1,"2-(3-Chlorophenyl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-ol",242.4,uM,=,2.384532615494249,1,c1ccc(C2NCc3ccccc3N2)cc1
4279,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4C(=CC[C@@H]5N=C(C(C)C)OC[C@]54C)C[C@H]3C(=O)C[C@]12C,"(4aS,7aR,9aR,10S,11R,12aS,12bR,14aR,14bS)-11-hydroxy-3-isopropyl-9a,12a,14btrimethyl-10-[1-(methylamino)ethyl]-1,4a,5,7,7a,9,9a,10,11,12,12a,12b,13,14,14a,14bhexadecahydro-8H-indeno[5'',4'':4',5']cyclohepta[1',2':3,4]benzo[1,2-d][1,3]oxazin-8-one",0.517,uM,=,-0.2865094569060575,0,O=C1CC2CCCC2[C@@H]2CC[C@@H]3C(=CC[C@@H]4N=COCC43)C[C@@H]12
4280,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccccc2)C(=O)/C(=C/c2ccccc2)C1,"1-Acryloyl-3,5-dibenzylidene-piperidin-4-one",17.68,uM,=,1.2474822606770544,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
4281,2222235,10.1021/acsmedchemlett.2c00001,,,,Inhibition of recombinant human AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2oc1=O,"(+)-3,4-Dimethyl-7-[(N-benzylpiperidin-3-yl)methoxy]-2H-chromen-2-one",1.6,uM,=,0.2041199826559248,1,O=c1ccc2ccc(OCC3CCCN(Cc4ccccc4)C3)cc2o1
4282,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1ccc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc1OC,"(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,4-dimethoxyphenyl)acrylmide",0.526,uM,=,-0.2790142558462609,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4283,1724020,10.1016/j.ejmech.2017.05.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured over 5 mins by Ellman's method,O=C([O-])C(F)(F)F.O=C1C2=C3C4=[N+](CCc5c[nH]c1c54)[C@@H]1C(=O)C=C4S[C@@H](C[C@@]43[C@H]1O)N2,1R-hydroxydiscorhabdin D,158.0,uM,=,2.198657086954422,1,O=C1C2=C3C4=[N+](CCc5c[nH]c1c54)[C@H]1C[C@@]34C[C@@H](N2)SC4=CC1=O
4284,2073679,10.1021/acs.jmedchem.0c00756,,,,Inhibition of recombinant human AChE using ATC as substrate by DTNB-reagent based Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",7.12,uM,=,0.8524799936368563,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4285,430856,10.1021/jm0503289,,,,Inhibition of human AChE-induced beta amyloid peptide(1-40) aggregation by thioflavin T-based fluorometric assay,O=C(CCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-4-(1H-indol-3-yl)-butyramide",2.0,uM,=,0.3010299956639812,1,O=C(CCCc1c[nH]c2ccccc12)NCCCCCNc1c2c(nc3ccccc13)CCCC2
4286,2088319,10.1016/j.ejmech.2020.112282,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition by Ellman's method,CC(C)c1ccc(NC(=O)OCC2CCCN(Cc3ccccc3)C2)cc1,(1-benzylpiperidin-3-yl)methyl (4-isopropylphenyl)carbamate,15.1,uM,=,1.1789769472931697,1,O=C(Nc1ccccc1)OCC1CCCN(Cc2ccccc2)C1
4287,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],"3-(3,8-diamino-6-phenyl-5-phenanthridiniumyl)propyl(diethyl)methylammonium",32.3,uM,=,1.509202522331103,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
4288,1671088,10.1016/j.bmc.2017.03.058,,,,Inhibition of human AChE using acetylthiocholine as substrate by spectrophotometric analysis,CSP(C)(=O)OC(C)C(C)(C)C,"O-3,3-dimethylbutan-2-yl S-methyl methylphosphonothioate",720.0,uM,=,2.8573324964312685,1,
4289,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,O=C(COc1ccc(I)cc1)NCCCN1CCCCC1,2-(4-iodophenoxy)-N-(3-(piperidin-1-yl)propyl)acetamide,13.0,uM,=,1.1139433523068367,1,O=C(COc1ccccc1)NCCCN1CCCCC1
4290,28606,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 5.6-11.9,C#CCN(C)[C@H](C)Cc1cccc(OC(=O)N(C)C2CCCCC2)c1,(R)-Cyclohexyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,7.9,uM,=,0.8976270912904415,1,O=C(NC1CCCCC1)Oc1ccccc1
4291,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Brc1ccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)cc1.Cl,"9-(2-(4-((1-(4-Bromophenyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)hydrazinyl)-1,2,3,4-tetrahydroacridine Hydrochloride",12.8,uM,=,1.1072099696478683,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
4292,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,Cc1ccc2c(c1)C1(C(=O)N2)C(C#N)=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C1[N+](=O)[O-],"2'-amino-1'-benzyl-6'-(benzylamino)-5-methyl-5'-nitro-2-oxo-1'H-spiro[indoline-3,4'-pyridine]-3'-carbonitrile",3.71,uM,=,0.5693739096150459,1,O=C1Nc2ccccc2C12C=CN(Cc1ccccc1)C(NCc1ccccc1)=C2
4293,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,O=C(Nc1ccc(CN2CCOCC2)cc1C(=O)C(=O)N1C(=O)CCC1=O)c1ccccc1,"N-(2-(2-(2,5-dioxopyrrolidin-1-yl)-2-oxoacetyl)-4-(morpholinomethyl)phenyl)benzamide",0.22908,uM,=,-0.6400128255587084,0,O=C(Nc1ccc(CN2CCOCC2)cc1C(=O)C(=O)N1C(=O)CCC1=O)c1ccccc1
4294,2275466,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) by Ellman's method,CC(C)n1c2ccccc2c2cc[n+](-c3ccccc3)cc21,"9-isopropyl-2-phenyl-pyrido[3,4-b]indol-2-ium",3.1,uM,=,0.4913616938342727,1,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
4295,2224364,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins by Ellman's method,O=C1CC(O)C(O)c2c(O)cccc21,"3,4,5-trihydroxy-3,4-dihydronaphthalen-1(2H)-one",1408.7547458926342,uM,=,3.1488353921324315,1,O=C1CCCc2ccccc21
4296,462117,10.1021/jm7009364,,,,Inhibition of human AchE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-[5-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-3-(1H-indol-3-yl)-propionamide",2e-05,uM,=,-4.698970004336019,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
4297,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Oc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c(O)c1,"4-(5-(4-(Pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazol-2-yl)benzene-1,3-diol",1.34,uM,=,0.1271047983648076,1,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
4298,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCCCCC[n+]2cccc3ccccc32)cc1,1-(12-(pyridinium-1-yl)dodecyl)quinoliniumdibromide,0.0047,uM,=,-2.3279021420642825,0,c1cc[n+](CCCCCCCCCCCC[n+]2cccc3ccccc32)cc1
4299,616422,10.1016/j.bmcl.2010.01.034,,,,Inhibition of human erythrocyte AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCC[n+]2ccccc2)cc1,"1,6-bis(pyridinium)hexane dibromide",63.0,uM,=,1.7993405494535817,1,c1cc[n+](CCCCCC[n+]2ccccc2)cc1
4300,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,CC(=O)c1cc[n+](CCC[n+]2ccc(/C=N/O)cc2)cc1.[Br-].[Br-],"4-Hydroxyiminomethyl-4'-methylcarbonyl-1,1'-(prop-1,3-diyl)-bispyridinium dibromide",105.0,uM,=,2.0211892990699383,1,c1cc[n+](CCC[n+]2ccccc2)cc1
4301,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,COc1ccccc1CN(C)CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(C)Cc1ccccc1OC.Cl.Cl,Caproctamine HCl,0.17,uM,=,-0.7695510786217261,0,O=C(CCCCCNCc1ccccc1)NCCCCCCCCNC(=O)CCCCCNCc1ccccc1
4302,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1cc(-c2cccc(F)c2)nc2nc(-c3ccccc3)cc(C(F)(F)F)c12,"2-(3-Fluorophenyl)-7-phenyl-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",7.03,uM,=,0.846955325019824,1,c1ccc(-c2ccc3ccc(-c4ccccc4)nc3n2)cc1
4303,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2oc3cc(Br)c(I)cc3c(=O)c2O)cc1,7-bromo-3-hydroxy-6-iodo-2-(4-methoxyphenyl)-4H-chromen-4-one,0.02899,uM,=,-1.5377517846450026,0,O=c1cc(-c2ccccc2)oc2ccccc12
4304,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCNc1c2c(nc3cc(Cl)cc(Cl)c13)CCCC2)NCCc1c[nH]c2ccccc12,"6-(6,8-dichloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4305,462117,10.1021/jm7009364,,,,Inhibition of human AchE,Clc1cccc(Cl)c1CO/N=C/c1cc[n+](CCCc2ccccc2)cc1,"4-[(2,6-Dichloro-benzyloxyimino)-methyl]-1-(3-phenyl-propyl)-pyridinium",0.18,uM,=,-0.744727494896694,0,C(=N/OCc1ccccc1)\c1cc[n+](CCCc2ccccc2)cc1
4306,1861945,10.1016/j.ejmech.2019.111596,,,,Inhibition of human erythrocytes AChE assessed as reduction in 5-thio-2-nitrobenzoate anion formation using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc(CN2CCC(CCC(=O)c3cc(Cl)c(N)cc3OC)CC2)ccc1O,1-(4-amino-5-chloro-2-methoxyphenyl)-3-{1-[(4-hydroxy-3-methoxyphenyl)methyl]piperidin-4-yl}propan-1-one,0.535,uM,=,-0.2716462179787715,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
4307,2112551,10.1016/j.ejmech.2021.113385,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCOC(=O)/C(=N\Nc1ccccc1)C(=O)C(F)(F)F,"Ethyl(2Z)-4,4,4-trifluoro-3-oxo-2-(2-phenylhydrazinylidene)butanoate",3.22,uM,=,0.5078558716958309,1,c1ccccc1
4308,1768646,10.1016/j.bmc.2018.01.029,,,,Inhibition of AChE (unknown origin),CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,"2-{3-[4-(3-Chloro-phenyl)-piperazin-1-yl]-propyl}-5-ethyl-4-(2-phenoxy-ethyl)-2,4-dihydro-[1,2,4]triazol-3-one",1.037,uM,=,0.0157787563890409,1,O=c1n(CCOc2ccccc2)cnn1CCCN1CCN(c2ccccc2)CC1
4309,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),CCN(CC)C(=O)Oc1ccc(-c2cc(=O)c3c(O)c(O)c(O)cc3o2)cc1,"4-(5,6,7-Trihydroxy-4-oxo-4H-chromen-2-yl)phenyl diethylcarbamate",1.2,uM,=,0.0791812460476248,1,O=c1cc(-c2ccccc2)oc2ccccc12
4310,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,CC1(C)CC(=O)C2=C(C1)Nc1nc3c(c(N)c1C2c1ccccc1)CCCC3,"11-Amino-3,3-dimethyl-12-phenyl-3,4,5,7,8,9,10,12-octahydro-2H-dibenzo[b,g][1,8]naphthyridin-1-one",0.71,uM,=,-0.1487416512809247,0,O=C1CCCC2=C1C(c1ccccc1)c1cc3c(nc1N2)CCCC3
4311,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)c1ccc(-c2c3cc(O)c(=O)cc-3oc3cc(O)c(O)cc23)cc1,"9-(4-Dimethylamino-phenyl)-2,6,7-trihydroxy-xanthen-3-one",22.0,uM,=,1.3424226808222062,1,O=c1ccc2c(-c3ccccc3)c3ccccc3oc-2c1
4312,28293,10.1021/jm00095a008,,,,In vitro acetyl cholinesterase (AChE-I) inhibitory activity to determine its ability to reverse the cholinergic deficit characteristic of AD,CN(C)Cc1ccc(CSCCNc2cccc(F)c2C#N)o1,2-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethylamino]-6-fluoro-benzonitrile,2.1,uM,=,0.3222192947339193,1,c1ccc(NCCSCc2ccco2)cc1
4313,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),COc1cc2oc3cccc(O)c3c(=O)c2c(O)c1CN(C)C,"2-((dimethylamino)methyl)-1,8-dihydroxy-3-methoxy-9H-xanthen-9-one",100.0,uM,=,2.0,1,O=c1c2ccccc2oc2ccccc12
4314,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(CC3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophen-2-ylmethyl)-1-methyl-piperidinium bromide",10.0,uM,=,1.0,1,c1ccc(C[NH+]2CCC(Cc3cc4ccccc4s3)CC2)cc1
4315,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,CCN(CC)CCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,"6-(4-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)phenoxy)-N,N-diethylhexan-1-amine",4.99,uM,=,0.69810054562339,1,c1ccc(CC2NCCc3ccccc32)cc1
4316,471590,10.1016/j.bmc.2007.12.048,,,,Inhibition of AChE,OCCC1CCN(Cc2ccc(OCCCN3CCCCC3)cc2)CC1,2-(1-(4-(3-(piperidin-1-yl)propoxy)benzyl)piperidin-4-yl)ethanol,0.35,uM,=,-0.4559319556497244,0,c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1
4317,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)cc3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-((4-acetamidophenyl)sulfonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.08879,uM,=,-1.0516359440116307,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
4318,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,Oc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCNC2,norsanguinine,1.43,uM,=,0.1553360374650617,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4319,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCC1(O)c2nc3ccccc3c(N)c2CC1C,"9-Amino-3-butyl-2-methyl-2,3-dihydro-1H-cyclopenta[b]quinolin-3-ol",91.0,uM,=,1.9590413923210936,1,c1ccc2nc3c(cc2c1)CCC3
4320,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),CCN(CC)CCOc1ccc2c(=O)cc(-c3ccc(OC)cc3)oc2c1,7-(2-(diethylamino)ethoxy)-2-(4-methoxyphenyl)-4H-chromen-4-one,0.0271,uM,=,-1.5670307091255942,0,O=c1cc(-c2ccccc2)oc2ccccc12
4321,1348251,10.1016/j.bmcl.2014.03.058,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCN(c4ccccc4)CC3)cc1)NCC2,"6,7-dimethoxy-1-(4-((6-(4-phenylpiperazin-1-yl)hexyl)oxy)benzyl)-1,2,3,4-tetrahydroisoquinoline",16.33,uM,=,1.212986184736668,1,c1ccc(N2CCN(CCCCCCOc3ccc(CC4NCCc5ccccc54)cc3)CC2)cc1
4322,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc(C#N)[n+]1C.F[B-](F)(F)F,2-cyano-6-methoxy-1-methylpyridinium tetrafluoroborate,14.0,uM,=,1.146128035678238,1,c1cc[nH+]cc1
4323,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccc(F)cc1F,"2-(7-(2,4-diFluorobenzylamino)heptyl)isoindoline-1,3-dione",0.381,uM,=,-0.4190750243243807,0,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
4324,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,NC(=O)c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12,"3-(4-(Piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carboxamide",0.217,uM,=,-0.6635402661514705,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
4325,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,C[n+]1c(/C=C/c2ccc(O)cc2)ccc2ccccc21.[I-],SID49674183,1.8,uM,=,0.255272505103306,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
4326,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CC1,"20S-(dimethylamino)-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{6'-isopropyl-2'alpha,3',4',5'-tetrahydropyridino[2',3':3,4]}-5alpha,9betapregnan-11-one",0.618,uM,=,-0.2090115249111841,0,O=C1CC2CCCC2[C@@H]2CC[C@H]3C4CCC=N[C@H]4CC[C@@]34C[C@@]124
4327,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC12CCC(c3c1nc1ccccc1c3N)C2(C)C,"9-Amino-1,4-methano-1,2,3,4-tetrahydro-4,11,11-trimethylacridine",110.0,uM,=,2.041392685158225,1,c1ccc2nc3c(cc2c1)C1CCC3C1
4328,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,COc1ccc(-c2cc(N)c3c(C(F)(F)F)cc(-c4ccccc4)nc3n2)cc1,"2-(4-Methoxyphenyl)-7-phenyl-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",8.24,uM,=,0.9159272116971158,1,c1ccc(-c2ccc3ccc(-c4ccccc4)nc3n2)cc1
4329,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,C=CC(=O)N1C/C(=C\c2ccc(Cl)cc2)C(=O)/C(=C/c2ccc(Cl)cc2)C1,"1-Acryloyl-3,5-bis-(4-chloro-benzylidene)-piperidin-4-one",22.04,uM,=,1.3432115901797474,1,O=C1/C(=C/c2ccccc2)CNC/C1=C\c1ccccc1
4330,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1ccc2c(N)c3c(nc2c1)CCC3.Cl,"6-methyl-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",0.347,uM,=,-0.4596705252091262,0,c1ccc2nc3c(cc2c1)CCC3
4331,2114059,10.1016/j.bmc.2021.116194,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured by Ellman's method,Cc1ccc(S(=O)(=O)SCc2ccc([N+](=O)[O-])cc2)cc1,S-4-nitrobenzyl 4-methylbenzenthiosulfonate,0.2123,uM,=,-0.6730500058340012,0,O=S(=O)(SCc1ccccc1)c1ccccc1
4332,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,CC1N[C@H](C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)Cc2c1[nH]c1ccccc21,"(3S)-1-Methyl-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide",0.203,uM,=,-0.6925039620867871,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1
4333,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Clc1ccc(-c2nc(NC3CCN(Cc4ccccc4)CC3)sc2-c2ccc(Cl)cc2)cc1,"1-Benzyl-N-[4,5-bis(4-chlorophenyl)thiazol-2-yl]piperidin-4-ylamine",1.38,uM,=,0.1398790864012364,1,c1ccc(CN2CCC(Nc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
4334,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.008,uM,=,-2.096910013008056,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4335,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(Cc4ccccc4Br)CC3)cc1)C2.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-1-[(4-(2-bromobenzyl)-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one bromide",0.54,uM,=,-0.2676062401770315,0,O=C1/C(=C/c2ccc(N3CC[NH+](Cc4ccccc4)CC3)cc2)Cc2ccccc21
4336,785863,10.1016/j.bmcl.2011.08.042,,,,Inhibition of human recombinant AChE after 5 mins using spectrophotometer by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.5,uM,=,-0.3010299956639812,0,c1ccc2nc3c(cc2c1)CCCC3
4337,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccccc1)CC2.[Br-],"8-methoxy-2-phenyl-3,4-dihydroisoquinolinium bromide",1.62,uM,=,0.2095150145426309,1,C1=[N+](c2ccccc2)CCc2ccccc21
4338,471590,10.1016/j.bmc.2007.12.048,,,,Inhibition of AChE,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.16,uM,=,-0.7958800173440752,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4339,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCC4)Cc3cc4ccccc4o3)cc2c1,"N1,N1-Bis(benzofuran-2-ylmethyl)-N7-(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine",0.117,uM,=,-0.9318141382538384,0,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCC4)Cc3cc4ccccc4o3)cc2c1
4340,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CCC2c3cc(OC(=O)NC)ccc3CC21,"1-ethyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl methylcarbamate",0.253,uM,=,-0.5968794788241821,0,c1ccc2c(c1)CC1NCCC21
4341,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN1CC[C@@H](C(=O)N2C/C(=C\c3cccc4ccccc34)C(=O)[C@@]3(C2)[C@H](c2cccc4ccccc24)CN(C)[C@]32C(=O)Nc3ccccc32)[C@@]12C(=O)Nc1ccccc12,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-N-methylpyrrolo)-5''-(1-naphthyl)tetrahydro-4''-(1H)-pyridinone-1-methyl-4-(1-naphthyl)pyrrolidine,4.93,uM,=,0.69284691927723,1,O=C([C@@H]1CCN[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2cccc3ccccc23)C(=O)[C@@]2(C1)[C@H](c1cccc3ccccc13)CN[C@]21C(=O)Nc2ccccc21
4342,1586651,10.1016/j.bmcl.2016.05.046,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay,O=C(CCCCCCCCc1ccc(O)c(O)c1)c1c(O)ccc(C(CCCCCCCCc2ccc(O)cc2)c2c(O)cccc2O)c1O,Maingayone B,30.67,uM,=,1.4867137759824856,1,O=C(CCCCCCCCc1ccccc1)c1cccc(C(CCCCCCCCc2ccccc2)c2ccccc2)c1
4343,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CNC(=O)Oc1ccccc1OC(C)C,propoxur,0.59,uM,=,-0.2291479883578558,0,c1ccccc1
4344,410400,10.1021/jm060945c,,,,Inhibition of human erythrocyte AChE,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2.Cl,(+/-)-huprine Y-HCl,0.00078,uM,=,-3.10790539730952,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
4345,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl.Cl.Cl.Cl,"(+/-)-3-chloro-6,7,10,11-tetrahydro-9-methyl-12-((7-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl)amino)-7,11-methanocycloocta[b]quinoline dihydrochloride",0.0040199999999999,uM,=,-2.39577394691553,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4346,633730,10.1021/jm901902w,,,,Inhibition of AChE in human erythrocytes by Ellman's method,COC(=O)c1cc2c(N)c3c(nc2nc1C)CCCC3,"Methyl 5-Amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate",1.0,uM,=,0.0,0,c1cnc2nc3c(cc2c1)CCCC3
4347,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"3-(1H-indol-3-yl)-N-(6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)propanamide",2e-05,uM,=,-4.698970004336019,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
4348,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,SID11110929,1.45,uM,=,0.1613680022349748,1,c1ccc2c(c1)c[nH+]c1c3cc4c(cc3ccc21)OCO4
4349,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NCC3CCN(Cc4ccccc4C)CC3)sc2-c2ccc(OC)cc2)cc1,"N-[(1-(2-Methylbenzyl)piperidin-4-yl)methyl]-4,5-bis(4-methoxyphenyl)thiazol-2-ylamine",0.59,uM,=,-0.2291479883578558,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
4350,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCN(C)C,(E)-3-(4-((6-(dimethylamino)hexyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,8.4,uM,=,0.9242792860618816,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
4351,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)CCCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1,N1-dimethyl-N12-(1,2,3,4-tetrahydroacridin-9-yl)dodecane-1,12-diamine",0.264,uM,=,-0.5783960731301689,0,c1ccc2nc3c(cc2c1)CCCC3
4352,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCC4)c3c(nc2c1)CCC3,"N,N'-Bis-(2,3-dihydro-1H-cyclopenta[b]quinolin-9-yl)-octane-1,8-diamine",0.022,uM,=,-1.6575773191777938,0,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCC4)c3c(nc2c1)CCC3
4353,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CC(O)C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-1-hydroxy-3-oxo-propyl]-1-methyl-piperidinium bromide",0.19,uM,=,-0.721246399047171,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
4354,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccc(F)cc4)cc3)ccc12.[Br-],1-(4-Fluorobenzyl)-4-(((4-methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)pyridin-1-ium bromide,0.0368999999999999,uM,=,-1.4329736338409398,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
4355,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCc3cc[n+](Cc4ccc(F)cc4)cc3)sc2cc1OC,"4-[3-(5,6-Dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(4-fluoro-benzyl)-pyridinium",0.0026,uM,=,-2.5850266520291822,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1cc2ccccc2s1
4356,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,CC(C)OC[n+]1ccn(C)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-1-isopropoxymethyl-3-methyl-3H-imidazol-1-ium chloride,49.0,uM,=,1.6901960800285136,1,c1c[nH+]c[nH]1
4357,2164642,10.1021/acs.jmedchem.1c01748,,,,Inhibition of recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells using acetylthiocholine iodide as substrate measured for 6 mins by Ellman's method,C[n+]1ccccc1C=NO,2-(Hydroxyimino-methyl)-1-methyl-pyridinium,560.0,uM,=,2.7481880270062,1,c1cc[nH+]cc1
4358,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc3c(c2)OCO3)CC1c1ccc(-c2ccccc2)cc1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(benzo[d][1,3]dioxol-5-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.913,uM,=,-0.039529222465701,0,c1ccc(-c2ccc(C3CC(c4ccc5c(c4)OCO5)=NN3)cc2)cc1
4359,1350422,10.1016/j.bmc.2014.03.023,,,,Inhibition of hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,O=C(/C=N\O)Nc1ccc[n+](CCCCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],"1,1'-(hexane-1,6-diyl)bis(3-((Z)-2-(hydroxyimino)acetamido)pyridinium)dibromide",1430.0,uM,=,3.155336037465062,1,c1cc[n+](CCCCCC[n+]2ccccc2)cc1
4360,1629468,10.1016/j.bmcl.2016.11.065,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as reduction in formation of 5-thio-2-nitrobenzoate from acetylthiocholine iodide preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccc(Br)cc2)CN(Cc2ccc3ccccc3c2)C/C1=C\c1ccc(Br)cc1,"(3E,5E)-3,5-bis(4-bromobenzylidene)-1-(naphthalen-2-ylmethyl)piperidin-4-one",0.83,uM,=,-0.0809219076239261,0,O=C1/C(=C/c2ccccc2)CN(Cc2ccc3ccccc3c2)C/C1=C\c1ccccc1
4361,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCNC(=O)Oc1cccc(CN(CC)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-((ethyl(3-(9-oxo-9H-xanthen-3-yloxy)propyl)amino)methyl)phenyl hexylcarbamate,0.16,uM,=,-0.7958800173440752,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
4362,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(ethylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.557,uM,=,-0.254144804826271,0,O=c1c2ccccc2nc2n1CCC2
4363,1765157,10.1021/acs.jmedchem.8b00592,,,,Inhibition of human recombinant AChE by spectrophotometry based Ellman's assay,O/N=C/c1nc(CCCCNc2c3c(nc4ccc(Cl)cc24)CCCC3)ccc1O,"6-(4-((7-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)butyl)-3-hydroxypicolinaldehyde oxime",2.3,uM,=,0.3617278360175928,1,c1ccc(CCCCNc2c3c(nc4ccccc24)CCCC3)nc1
4364,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethoxy)thiazole-5-carboxamide",0.3,uM,=,-0.5228787452803376,0,O=C(Nc1cc(-c2nc(OCCNc3c4c(nc5ccccc35)CCCC4)cs2)ccn1)C1CC1
4365,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc(C(C)(C)C)c1O,"(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)acrylamide",2.23,uM,=,0.3483048630481606,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4366,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Fc1ccc2c(NCCCCCCNc3c4c(nc5cc(F)ccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(6-fluoro-1,2,3,4-tetrahydro-acridin-9-yl)-hexane-1,6-diamine",0.0009,uM,=,-3.0457574905606752,0,c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
4367,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,Cc1ccccc1/C=C1\CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C(=C\c2ccccc2C)C1=O,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-2-methylpheylmethylidene]tetrahydro-4''(1H)-pyridinones",12.47,uM,=,1.0958664534785427,1,O=C1/C(=C/c2ccccc2)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
4368,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-((methyl(9-(9-oxo-9H-xanthen-3-yloxy)nonyl)amino)methyl)phenyl methylcarbamate,0.0116999999999999,uM,=,-1.9318141382538383,0,O=c1c2ccccc2oc2cc(OCCCCCCCCCNCc3ccccc3)ccc12
4369,2050396,10.1016/j.bmc.2020.115826,,,,Inhibition of human AchE expressed in HEK293 cells using acetylthiocholine as substrate by Ellman's method,CS[C@@H](Cn1nnc2cc(C#Cc3ccc(N4C[C@H](O)[C@@H](O)C4)cc3)ccc21)N(O)C=O,"N-((S)-2-(5-((4-(((3S,4S)-3,4-dihydroxypyrrolidin-1-ylmethyl)phenyl)ethynyl)-1H-benzo[d][1,2,3]triazol-1-y1)-1-(methylthio)ethyl)-N-hydroxyformamide",22.0,uM,=,1.3424226808222062,1,C(#Cc1ccc2[nH]nnc2c1)c1ccc(N2CCCC2)cc1
4370,2019674,10.1039/d0md00009d,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by Ellman's method,Cc1cc(S(=O)(=O)NN)c(C(C)C)cc1O,4-hydroxy-2-isopropyl-5-methyl-benzenesulfonohydrazide,9.24,uM,=,0.9656719712201068,1,c1ccccc1
4371,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1,"(S)-N-(6-((1,2,3,4-Tetrahydroacridin-9-yl)amino)hexyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide",0.022,uM,=,-1.6575773191777938,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1
4372,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CC1=CC2Cc3nc4cccc(F)c4c(N)c3C(C1)C2,"(rac)5-fluoro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.0354,uM,=,-1.450996737974212,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
4373,29411,10.1021/jm031004s,,,,Inhibitory concentration against acetylcholinesterase,CCSc1nc(-c2ccc(Cl)cc2)nn1C(=O)N(C)C,"3-(4-Chloro-phenyl)-5-ethylsulfanyl-[1,2,4]triazole-1-carboxylic acid dimethylamide",0.056,uM,=,-1.2518119729937995,0,c1ccc(-c2nc[nH]n2)cc1
4374,2288317,10.1016/j.ejmech.2022.114806,,,,Inhibition of human AChE using ATC and BTC iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by DTNB reagent based assay,Cc1ccc(-c2noc(-c3cccc(OCC4CCN(Cc5ccccc5F)CC4)c3)n2)cn1,"5-(3-((1-(2-fluorobenzyl)piperidin-4-yl)methoxy)phenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole",0.29,uM,=,-0.5376020021010439,0,c1ccc(CN2CCC(COc3cccc(-c4nc(-c5cccnc5)no4)c3)CC2)cc1
4375,1807943,10.1016/j.ejmech.2019.07.051,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry analysis,FC12CC3CC(NCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)(CC(C1)c1ccccc13)C2,"N-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-N'-(9-fluoro-7H-5,6,8,9,10,11-hexahydro-5,9:7,11-dimethanobenzo[9]annulen-7-yl)-1,4-butanediamine",0.002,uM,=,-2.6989700043360187,0,c1ccc2c(c1)C1CC3CC2CC(NCCCCNc2c4c(nc5ccccc25)CCCC4)(C3)C1
4376,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc(C(=O)c3ccccc3)cc2)c1,3-(((3-(4-benzoylphenoxy)propyl)(methyl)amino)methyl)phenyl methylcarbamate,0.0054,uM,=,-2.2676062401770314,0,O=C(c1ccccc1)c1ccc(OCCCNCc2ccccc2)cc1
4377,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCNc1c2c(nc3ccc(F)cc13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-6-(7-fluoro-1,2,3,4-tetrahydroacridin-9-ylamino)hexanamide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4378,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,Cc1cccc(C(=O)Nc2ccc3c(c2)CNC(=O)C3)c1,"3-Methyl-N-(3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",0.7909999999999999,uM,=,-0.1018235165023234,0,O=C1Cc2ccc(NC(=O)c3ccccc3)cc2CN1
4379,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],"9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium chloride",0.774,uM,=,-0.1112590393171073,0,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
4380,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,C=CC[N+](C)(C)c1cccc(O)c1.[Br-],Allyl-(3-hydroxy-phenyl)-dimethyl-ammonium bromide,3.0,uM,=,0.4771212547196624,1,c1ccccc1
4381,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.062,uM,=,-1.207608310501746,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4382,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl.Cl,Huprine-Tacrine Heterodimer,0.00034,uM,=,-3.468521082957745,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4383,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,c1ccc2[nH]c(-c3ccc(OCCN4CCCC4)cc3)nc2c1,2-{4-[2-(Pyrrolidin-1-yl)ethoxy]phenyl}-1H-benzo[d]-imidazole,2.13,uM,=,0.3283796034387377,1,c1ccc2[nH]c(-c3ccc(OCCN4CCCC4)cc3)nc2c1
4384,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,CCc1ccc(N2C(=O)C3CN(C)C4(C(=O)c5ccccc5C4=O)C3C2=O)cc1,"5'-(4-Ethylphenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",44.56,uM,=,1.6489451821656724,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
4385,2223705,10.1039/D1MD00046B,,,,Inhibition of AChE in human serum by Ellman's method,OCCCCCCCCc1ccc(CN2CCCC2)c(O)c1,5-(8-Hydroxyoctyl)-2-[(pyrrolidine-1-yl)methyl]phenol,47.6,uM,=,1.677606952720493,1,c1ccc(CN2CCCC2)cc1
4386,305502,10.1021/jm049782n,,,,Inhibitory concentration against human serum acetylcholinesterase activity,CNC(=O)Oc1cccc2c1OCC1CCN(C)C21,"Methyl-carbamic acid 1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalen-6-yl ester",0.03,uM,=,-1.5228787452803376,0,c1ccc2c(c1)OCC1CCNC21
4387,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,Cl.O=C(O)c1ccc(-n2cc(COc3ccc(/C=N/Nc4c5c(nc6ccccc46)CCCC5)cc3)nn2)cc1,"4-(4-((4-((2-(1,2,3,4-Tetrahydroacridin-9-yl)hydrazono)methyl)phenoxy)methyl)-1H-1,2,3-triazol-1-yl)benzoic acid Hydrochloride",4.03,uM,=,0.6053050461411095,1,C(=N/Nc1c2c(nc3ccccc13)CCCC2)\c1ccc(OCc2cn(-c3ccccc3)nn2)cc1
4388,28447,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.64-7.91,C#CCNC1CCc2ccc(OC(=O)N(C)C)cc21.Cl,Dimethyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,2.9,uM,=,0.4623979978989561,1,c1ccc2c(c1)CCC2
4389,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.374,uM,=,-0.4271283977995198,0,c1ccc2nc3c(cc2c1)CCCC3
4390,2170777,10.1021/acs.jmedchem.1c00048,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1ccc2nc3c(c(N)c2c1)CCCC3,7-methoxytacrine,8.0,uM,=,0.9030899869919436,1,c1ccc2nc3c(cc2c1)CCCC3
4391,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc(C)cc2)CC1c1ccc(-c2ccccc2)cc1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.845,uM,=,-0.0731432910503076,0,c1ccc(C2=NNC(c3ccc(-c4ccccc4)cc3)C2)cc1
4392,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,CCN(CCCCCCNC1=CC(=O)c2ncccc2C1=O)Cc1ccccc1OC,"6-(6-(ethyl(2-methoxybenzyl)amino)hexylamino)quinoline-5,8-dione",0.0278999999999999,uM,=,-1.5543957967264026,0,O=C1C(NCCCCCCNCc2ccccc2)=CC(=O)c2ncccc21
4393,717112,10.1021/np100416v,,,,Inhibition of human erythrocytes acetylcholinesterase after 15 mins,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",2.6,uM,=,0.414973347970818,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4394,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccccc3C)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)-1-(2-methylbenzyl)pyridinium bromide",0.01,uM,=,-2.0,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
4395,1586613,10.1021/acsmedchemlett.5b00483,,,,Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman method,COc1cc2c(cc1OC)C(=O)/C(=C/C1CCN(Cc3ccccc3)CC1)C2,"2-[1-(1-Benzyl-piperidin-4-yl)-meth-(E)-ylidene]-5,6-dimethoxy-indan-1-one",0.058,uM,=,-1.2365720064370629,0,O=C1/C(=C/C2CCN(Cc3ccccc3)CC2)Cc2ccccc21
4396,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1cnc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)cn1,"3-(4-(Piperidin-1-ylmethyl)phenyl)-6-(pyrazin-2-yl)-9H-pyrrolo-[2,3-b:5,4-c']dipyridine",1.213,uM,=,0.083860800866573,1,c1cnc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)cn1
4397,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2nnc(NCN3CCCCC3)s2)cc1,"5-phenyl-N-(piperidin-1-ylmethyl)-1,3,4-thiadiazol-2-amine",54.0,uM,=,1.7323937598229686,1,c1ccc(-c2nnc(NCN3CCCCC3)s2)cc1
4398,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(=O)(=O)c1ccccc1[N+](=O)[O-],"1-(2-nitro benzene)-sulfonyl-cis-2,6-dimethylpiperidine",0.185,uM,=,-0.7328282715969863,0,O=S(=O)(c1ccccc1)N1CCCCC1
4399,1807943,10.1016/j.ejmech.2019.07.051,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry analysis,FC12CC3CC(NCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)(CC(C1)c1ccccc13)C2,"N-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-N'-(9-fluoro-7H-5,6,8,9,10,11-hexahydro-5,9:7,11-dimethanobenzo[9]annulen-7-yl)-1,5-pentanediamine",0.0014,uM,=,-2.853871964321762,0,c1ccc2c(c1)C1CC3CC2CC(NCCCCCNc2c4c(nc5ccccc25)CCCC4)(C3)C1
4400,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCCCC[n+]2ccc3ccccc3c2)cc1,1-(9-(pyridinium-1-yl)nonyl)isoquinoliniumdibromide,0.04,uM,=,-1.3979400086720375,0,c1cc[n+](CCCCCCCCC[n+]2ccc3ccccc3c2)cc1
4401,2294017,10.1016/j.ejmech.2018.08.015,,,,Inhibition of human erythrocyte AChE incubated for 10 mins by Ellman's method,CN1CCc2c(c3ccccc3n2Cc2ccccc2C(=O)NCCO[N+](=O)[O-])C1,"2-(2-((2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl)benzamido)ethyl nitrate",14.8,uM,=,1.1702617153949575,1,c1ccc(Cn2c3c(c4ccccc42)CNCC3)cc1
4402,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12,"6-(1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4403,1724020,10.1016/j.ejmech.2017.05.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured over 5 mins by Ellman's method,O=C(O)C(F)(F)F.O=C1C=C2S[C@H]3C[C@]2(C=C1Br)C1=C(N3)C(=O)c2[nH]cc3c2C1=NCC3,Discorhabdin B,49.4,uM,=,1.6937269489236468,1,O=C1C=C[C@@]23C[C@@H](NC4=C2C2=NCCc5c[nH]c(c52)C4=O)SC3=C1
4404,497902,10.1021/jm801292b,,,,Inhibition of human serum AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc(OC)c1)CCCC3,"ethyl 5-amino-2-methyl-4-(3-methoxyphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.058,uM,=,-1.2365720064370629,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
4405,700949,10.1016/j.bmc.2010.12.021,,,,Inhibition of human recombinant AChE by modified Ellman's method,O/N=C/c1cc[n+](CCC[n+]2ccc(/C=N/O)cc2)cc1.[Br-].[Br-],"1,3-bis(4-hydroxyiminomethylpyridinium)-propane dibromide",167.0,uM,=,2.222716471147584,1,c1cc[n+](CCC[n+]2ccccc2)cc1
4406,969870,10.1016/j.bmcl.2013.05.092,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,Cn1c(=O)c2c(ncn2C)n(C)c1=O,"1,3,7-Trimethyl-3,7-dihydro-purine-2,6-dione",7.25,uM,=,0.8603380065709937,1,O=c1[nH]c(=O)c2[nH]cnc2[nH]1
4407,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),COc1ccc2c(c1)[nH]c1c(C(C)=O)nccc12,arenarine C,4.0,uM,=,0.6020599913279624,1,c1ccc2c(c1)[nH]c1cnccc12
4408,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)nc3)cc12,"3-(6-(Piperidin-1-ylmethyl)pyridin-3-yl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carbonitrile",0.187,uM,=,-0.728158393463501,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)nc3)cc12
4409,305200,10.1021/jm049515h,,,,Inhibition of recombinant human AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)OC/C(=C\c2cc(OC)c(OC)c(OC)c2)C3=O)c1,"Methyl-carbamic acid 3-[(methyl-{7-[4-oxo-3-(3,4,5-trimethoxy-benzylidene)-chroman-7-yloxy]-heptyl}-amino)-methyl]-phenyl ester",9.81,uM,=,0.9916690073799486,1,O=C1/C(=C/c2ccccc2)COc2cc(OCCCCCCCNCc3ccccc3)ccc21
4410,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(O)C3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[(5,6-dimethoxy-benzo[b]thiophen-2-yl)-hydroxy-methyl]-1-methyl-piperidinium bromide",19.58,uM,=,1.291812687467119,1,c1ccc(C[NH+]2CCC(Cc3cc4ccccc4s3)CC2)cc1
4411,28161,10.1021/jm00122a034,,,,Concentration required to inhibit 50% of acetylcholinesterase (AChE) in human erythrocyte(RBC).,Cn1cc[n+](COCCCc2ccccc2)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-methyl-1-(3-phenyl-propoxymethyl)-3H-imidazol-1-ium chloride,21.2,uM,=,1.3263358609287514,1,c1ccc(CCCOC[n+]2cc[nH]c2)cc1
4412,28634,10.1021/jm00084a015,,,,The compound was evaluated for the inhibition of human Acetylcholinesterase,CN(C)Cc1ccc(CSCCNc2cc(NCCSCc3ccc(CN(C)C)o3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N,N'-Bis-[2-(5-dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-benzene-1,3-diamine",0.028,uM,=,-1.5528419686577808,0,c1cc(NCCSCc2ccco2)cc(NCCSCc2ccco2)c1
4413,430856,10.1021/jm0503289,,,,Inhibition of human AChE-induced beta amyloid peptide(1-40) aggregation by thioflavin T-based fluorometric assay,O=C(Cc1c[nH]c2ccc(Br)cc12)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"2-(5-bromo-1H-indol-3-yl)-N-[7-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-acetamide",15.0,uM,=,1.1760912590556811,1,O=C(Cc1c[nH]c2ccccc12)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
4414,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(C(=O)c2c(C3CCN(Cc4cc(OC)ccc4OC)CC3)oc3ccccc23)cc1,"(2-(1-(2,5-dimethoxybenzyl)piperidin-4-yl)benzofuran-3-yl)(4-methoxyphenyl)methanone",60.98,uM,=,1.7851874200293618,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
4415,555909,10.1021/jm8002747,,,,Inhibition of human recombinant AchE after 20 mins by Ellman's method,Cc1cccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)c1,(2-{4-[7-(benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-m-tolylmethanone,127.0,uM,=,2.103803720955957,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
4416,1468485,10.1016/j.ejmech.2015.01.058,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins before substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"6-hydroxy-2,5,7,8-tetramethyl-N-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)chroman-2-carboxamide",0.2265,uM,=,-0.6449317936511493,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
4417,1522395,10.1016/j.ejmech.2015.08.052,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2cccc(F)c2)cc1.[Br-],4-((2-(1H-indol-3-yl)ethyl)carbamoyl)-1-(3-fluorobenzyl)pyridin-1-ium bromide,3.9,uM,=,0.5910646070264992,1,O=C(NCCc1c[nH]c2ccccc12)c1cc[n+](Cc2ccccc2)cc1
4418,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccc(Cl)cc2)C(=O)[C@@]2(C1)[C@H](c1ccc(Cl)cc1)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(4-chlorophenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(4-chlorophenylmethylidene)-1''-N-acrolylpiperidin-4''-one,8.4,uM,=,0.9242792860618816,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
4419,785863,10.1016/j.bmcl.2011.08.042,,,,Inhibition of human recombinant AChE after 5 mins using spectrophotometer by Ellman's method,CCCCCCNc1c2c(nc3ccc(OC)cc13)CCCC2,"N-hexyl-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine",0.1,uM,=,-1.0,0,c1ccc2nc3c(cc2c1)CCCC3
4420,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN(CCO)Cc3ccccc3)cc2)cc1OC,"(4-{[Benzyl-(2-hydroxyethyl)amino]methyl}phenyl)-(3,4-dimethoxyphenyl)methanone",1.41,uM,=,0.1492191126553798,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
4421,1565848,10.1021/acs.jmedchem.5b01674,,,,Inhibition of human acetylcholinesterase using acetylcholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's spectrophotometric method,CN1Cc2cc(O)ccc2N(C)C1c1c(Cl)cccc1Cl,"2-(2,6-Dichlorophenyl)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-6-ol",13.5,uM,=,1.130333768495006,1,c1ccc(C2NCc3ccccc3N2)cc1
4422,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,O=C1C(=O)N(C(=O)c2ccccc2)c2ccc(CN3CCCCC3)cc21,"1-benzoyl-5-(piperidin-1-ylmethyl)indoline-2,3-dione",0.07943,uM,=,-1.100015437450609,0,O=C1C(=O)N(C(=O)c2ccccc2)c2ccc(CN3CCCCC3)cc21
4423,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)cc(OC)c1O.[I-],"(E)-2-(4-Hydroxy-3,5-dimethoxystyryl)-1-methylquinolin-1-ium Iodide",1.7,uM,=,0.2304489213782739,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
4424,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CCCC1CNc1ccc(-c2ccccc2)nn1,N-((1-ethylpyrrolidin-2-yl)methyl)-6-phenylpyridazin-3-amine,62.0,uM,=,1.792391689498254,1,c1ccc(-c2ccc(NCC3CCCN3)nn2)cc1
4425,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,COC(=O)C1=C(Nc2ccc(Cl)cc2)C[C@@H](c2ccc(F)cc2)N(c2ccc(Cl)cc2)[C@@H]1c1ccc(F)cc1,"(2R,6S)-methyl 1-(4-chlorophenyl)-4-(4-chlorophenylamino)-2,6-bis(4-fluorophenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate",710.0,uM,=,2.8512583487190755,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
4426,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](Cc2ccc(C[n+]3ccc(C(C)(C)C)cc3)cc2)cc1.[Br-].[Br-],"1,1'-bis(4-tert.butylpyridinium)-1,4-phenyldimethylenyl dibromide",0.3,uM,=,-0.5228787452803376,0,c1cc[n+](Cc2ccc(C[n+]3ccccc3)cc2)cc1
4427,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCN(CCCCOc1ccc(/C=C/C(=O)c2c(O)cc(OCCCCN(CC)Cc3ccccc3OC)cc2O)cc1)Cc1ccccc1OC,"1-(4-(4-(ethyl(2-methoxybenzyl)amino)butoxy)-2,6-dihydroxyphenyl)-3-(4-(4-(ethyl(2-methoxybenzyl)amino)butoxy)phenyl)prop-2-en-1-one",1.3,uM,=,0.1139433523068367,1,O=C(/C=C/c1ccc(OCCCCNCc2ccccc2)cc1)c1ccc(OCCCCNCc2ccccc2)cc1
4428,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCC[n+]1cc(C(F)(F)F)ccc1OC.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"1,1'-(propane-1,3-diyl)bis(2-methoxy-5-(trifluoromethyl)pyridinium)trifluoromethanesulfonate",3.6,uM,=,0.5563025007672873,1,c1cc[n+](CCC[n+]2ccccc2)cc1
4429,785863,10.1016/j.bmcl.2011.08.042,,,,Inhibition of human recombinant AChE after 5 mins using spectrophotometer by Ellman's method,C=CC(CBr)Nc1c2c(nc3ccc(OC)cc13)CCCC2,"N-(1-bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine",89.1,uM,=,1.9498777040368749,1,c1ccc2nc3c(cc2c1)CCCC3
4430,2288317,10.1016/j.ejmech.2022.114806,,,,Inhibition of human AChE using ATC and BTC iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by DTNB reagent based assay,Cc1ccc(-c2noc(-c3cccc(OCC4CCN(Cc5cccc(F)c5)CC4)c3)n2)cn1,"5-(3-((1-(3-fluorobenzyl)piperidin-4-yl)methoxy)phenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole",0.38,uM,=,-0.4202164033831898,0,c1ccc(CN2CCC(COc3cccc(-c4nc(-c5cccnc5)no4)c3)CC2)cc1
4431,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,C/N=C1/CCc2c1n(C)c1ccc(OC(=O)NCc3ccccc3)c(Br)c21,"Benzyl-carbamic acid 8-bromo-4-methyl-3-[(Z)-methylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",4.19,uM,=,0.6222140229662954,1,N=C1CCc2c1[nH]c1ccc(OC(=O)NCc3ccccc3)cc21
4432,1718675,10.1021/acs.jnatprod.7b00301,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)CC[C@@]31CCN(C)C2,Lycoramine,20.07,uM,=,1.3025473724874856,1,c1cc2c3c(c1)O[C@H]1CCCC[C@@]31CCNC2
4433,462117,10.1021/jm7009364,,,,Inhibition of human AchE,COc1ccccc1CN(C)CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(C)Cc1ccccc1OC,6-[(2-Methoxy-benzyl)-methyl-amino]-hexanoic acid [8-({6-[(2-methoxy-benzyl)-methyl-amino]-hexanoyl}-methyl-amino)-octyl]-methyl-amide,0.17,uM,=,-0.7695510786217261,0,O=C(CCCCCNCc1ccccc1)NCCCCCCCCNC(=O)CCCCCNCc1ccccc1
4434,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,C=CCC[N+](C)(C)c1ccccc1O.[Br-],But-3-enyl-(2-hydroxy-phenyl)-dimethyl-ammonium bromide,10.0,uM,=,1.0,1,c1ccccc1
4435,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,CN(Cc1ccc(COc2ccc3c(CO)cc(=O)oc3c2)cc1)Cc1cccc(Cl)c1.Cl,7-(4-(N-(3-Chlorobenzyl)-N-methylaminomethyl)benzyloxy)-4-(hydroxymethyl)-2H-chromen-2-one hydrochloride,0.33,uM,=,-0.4814860601221125,0,O=c1ccc2ccc(OCc3ccc(CNCc4ccccc4)cc3)cc2o1
4436,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.Cl.O=C(NCCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"6-Chloro-9-{{10-[5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-9-carboxamido]decyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.05,uM,=,-1.3010299956639813,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
4437,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)N(C)CCCOc3ccc([N+](=O)[O-])cc3)cn2)cc1OC,"2-(2-(3,4-dimethoxyphenyl)-2-oxoethyl)-N-methyl-N-(3-(4-nitrophenoxy)propyl)pyrimidine-5-carboxamide",3.79,uM,=,0.5786392099680724,1,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccccc1
4438,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCC(C)CSC(=O)OCC[N+](C)(C)C.[Cl-],Trimethyl-[2-(2-methyl-butylsulfanylcarbonyloxy)-ethyl]-ammonium chloride,1000.0,uM,=,3.0,1,
4439,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(CN(C)Cc4ccccc4[N+](=O)[O-])cc3)c(=O)oc2cc1OC,"6,7-dimethoxy-3-(4-{[(2-nitrobenzyl)methylamino]methyl}phenyl)-chromen-2-one",0.987,uM,=,-0.0056828473303632,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
4440,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)C(=O)c6ccccc6)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"N-{16alpha-hydroxy-4beta,14alpha-dimethyl-11-oxo-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-20S-yl}-N-methylbenzamide",0.043,uM,=,-1.3665315444204136,0,O=C(NC[C@H]1CCC2C1CC(=O)[C@@]13C[C@@]14CC[C@@H]1N=CSCC1[C@@H]4CC[C@@H]23)c1ccccc1
4441,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,c1ccc2c(c1)Nc1ccccc1[Se]2,10H-Phenoselenazine,5.6,uM,=,0.7481880270062004,1,c1ccc2c(c1)Nc1ccccc1[Se]2
4442,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,C=CC[N+](C)(C)c1cccc(OC(C)=O)c1.[Br-],(3-Acetoxy-phenyl)-allyl-dimethyl-ammonium bromide,1.0,uM,=,0.0,0,c1ccccc1
4443,1339402,10.1016/j.bmc.2014.02.046,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins prior to substrate challenge measured after 15 mins by Ellman's method,O=C(NCC1CCN(Cc2ccccc2)CC1)c1c(O)c2cc(O)c(O)cc2[nH]c1=O,"N-((1-Benzylpiperidin-4-yl)methyl)-4,6,7-trihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide",0.98,uM,=,-0.0087739243075051,0,O=C(NCC1CCN(Cc2ccccc2)CC1)c1cc2ccccc2[nH]c1=O
4444,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,CCN(Cc1ccccc1)Cc1cccc(-c2coc3cc(OC)c(OC)cc3c2=O)c1,"3-{3-[(benzylethylamino)-methyl]-phenyl}-6,7-dimethoxychromen-4-one",1.59,uM,=,0.2013971243204514,1,O=c1c(-c2cccc(CNCc3ccccc3)c2)coc2ccccc12
4445,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,c1ccc(CCNc2ccnc(N3CCOCC3)n2)cc1,2-morpholino-N-phenethylpyrimidin-4-amine,19.7,uM,=,1.294466226161593,1,c1ccc(CCNc2ccnc(N3CCOCC3)n2)cc1
4446,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cccc(CN2CCC(CCC(=O)c3ccc4c(c3)NCCCC4)CC2)c1,"3-[1-(3-Methyl-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.224,uM,=,-0.6497519816658371,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
4447,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc(C[n+]2cccc3ccccc32)c(C[n+]2cccc3ccccc32)c1,"1,1'-(phenylene-1,2-dimethylenyl)-bis(quinolinium)dibromide",35.0,uM,=,1.5440680443502757,1,c1ccc(C[n+]2cccc3ccccc32)c(C[n+]2cccc3ccccc32)c1
4448,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,Nc1ccc2oc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2c1,6-Amino-N-(2-(1-benzylpiperidin-4-yl)ethyl)-4-oxo-4H-chromene-2-carboxamide,0.041,uM,=,-1.3872161432802643,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
4449,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2)CC1,4-(2-(1-Benzylpiperidin-4-yl)ethoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)thiazole-5-carboxamide,0.73,uM,=,-0.1366771398795441,0,O=C(Nc1cc(-c2nc(OCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
4450,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccccc32)cc1OC,"(3,4-Dimethoxyphenyl)-(10H-phenoselenazin-10-yl)methanone",5.1,uM,=,0.7075701760979364,1,O=C(c1ccccc1)N1c2ccccc2[Se]c2ccccc21
4451,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCNC(=O)Oc1cccc(CN(CC)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Butyl-carbamic acid 3-({ethyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.0086,uM,=,-2.065501548756432,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
4452,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1ccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1OC,"(E)-N-(4-((Benzyl(methyl)amino)methyl)phenyl)-3-(3,4-dimethoxyphenyl)acrylamide",3.98,uM,=,0.5998830720736879,1,O=C(/C=C/c1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
4453,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1ccc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc1,(E)-N-(2-(1-Benzylpiperidin-4-yl)ethyl)-3-(4-methoxyphenyl)acrylamide,0.49,uM,=,-0.3098039199714864,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4454,1970373,10.1016/j.bmcl.2019.126789,,,,Inhibition of AChE (unknown origin),Cc1cccc(C2C([N+](=O)[O-])C(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)c1,"5'-(1H-imidazol-4-ylmethyl)-3'-(m-tolyl)-4'-nitro-spiro[indeno[1,2-b]quinoxaline-11,2'-pyrrolidine]",7.8,uM,=,0.8920946026904804,1,c1ccc(C2CC(Cc3c[nH]cn3)NC23c2ccccc2-c2nc4ccccc4nc23)cc1
4455,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1OC,(E)-4-(3-(4-benzylpiperidin-1-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl diethylcarbamate,19.7,uM,=,1.294466226161593,1,O=C(/C=C/c1ccccc1)N1CCC(Cc2ccccc2)CC1
4456,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2Cc3ccsc3C2=NN1CCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,"2-(6-(4-(((1-(phenylsulfonyl-1H-indol-4-yl)methyppiperazin-lAhexyl)-2,4,4a,5-tetrahydro-3H-thieno[3',2':4,5]cyclopenta[1,2-c]pyridazin-3-one",9.18,uM,=,0.9628426812012424,1,O=C1CC2Cc3ccsc3C2=NN1CCCCCCN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
4457,462117,10.1021/jm7009364,,,,Inhibition of human AchE,C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21,Ethyl-methyl-carbamic acid 3-((R)-prop-2-ynylamino)-indan-5-yl ester,52.4,uM,=,1.7193312869837267,1,c1ccc2c(c1)CCC2
4458,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1cc(/C=C/c2nnc(-c3ccc(Cl)cc3)o2)ccc1O,"4-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)vinyl)-2-methoxyphenol",0.000334,uM,=,-3.4762535331884354,0,C(=C/c1nnc(-c2ccccc2)o1)\c1ccccc1
4459,1740532,10.1016/j.ejmech.2018.06.044,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine as substrate pretreated for 20 mins followed by substrate addition by Ellman's method,Cc1ccc(C2NC(=S)Nc3nc4c(c(N)c32)CCCC4)cc1,"5-amino-4-p-tolyl-3,4,6,7,8,9-hexahydropyrimido[4,5-b]quinoline-2(1H)-thione",23.8,uM,=,1.376576957056512,1,S=C1Nc2nc3c(cc2C(c2ccccc2)N1)CCCC3
4460,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{7-[(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",1.53,uM,=,0.1846914308175988,1,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
4461,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,[Br-].[Br-].c1ccc2c(c1)ccc[n+]2CCC[n+]1cccc2ccccc21,"1,1'-prop-1,3-diyl-bis(quinolinium)dibromide",9.0,uM,=,0.9542425094393248,1,c1ccc2c(c1)ccc[n+]2CCC[n+]1cccc2ccccc21
4462,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1cc2oc3cc(OCCCCCCCN(C)Cc4ccccc4)ccc3c(=O)c2cc1OC,"6-[7-(benzylmethylamino)heptyloxy]-2,3-dimethoxyxanthen-9-one",2.32,uM,=,0.3654879848908996,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
4463,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-((methyl(8-(9-oxo-9H-xanthen-3-yloxy)octyl)amino)methyl)phenyl methylcarbamate,0.0068,uM,=,-2.167491087293764,0,O=c1c2ccccc2oc2cc(OCCCCCCCCNCc3ccccc3)ccc12
4464,1508181,10.1016/j.bmc.2015.01.031,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CC1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2,"6,7,10,11-Tetrahydro-9-methyl-12-{{12-[(1,2,3,4-tetrahydroacridin-9-yl)amino]dodecyl}amino}-7,11-methanocycloocta[b]quinoline",0.0101,uM,=,-1.9956786262173567,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4465,2022983,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin),CCCCCCCCCCCCCCCCc1cc[n+](C)cc1C(=O)[O-],Platisidine B,2600.0,uM,=,3.414973347970818,1,c1cc[nH+]cc1
4466,28626,10.1016/s0960-894x(00)00218-3,,,,Inhibitory activity against Acetylcholinesterase,COc1ccc(-c2cc3c(c(=O)o2)C(=O)C2[C@@]4(C)CC[C@H](O)[C@@](C)(CO)C4C[C@H](O)[C@@]2(C)O3)cc1OC,"9-(3,4-Dimethoxy-phenyl)-3,6-dihydroxy-4-hydroxymethyl-4,6a,12b-trimethyl-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-7,10-dioxa-benzo[a]anthracene-11,12-dione",58.0,uM,=,1.7634279935629371,1,O=C1c2c(cc(-c3ccccc3)oc2=O)OC2CCC3CCCCC3C12
4467,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc(-c2ncc(NCN3CCCCC3)nn2)cc1,"3-phenyl-N-(piperidin-1-ylmethyl)-1,2,4-triazin-6-amine",57.0,uM,=,1.7558748556724917,1,c1ccc(-c2ncc(NCN3CCCCC3)nn2)cc1
4468,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1,(+/-)-Spiro-[2.3']-oxindole-spiro[3.3'']-1''-carbonyl(spiro[2.3']oxindole-hexahydro-1H-pyrrolizine)-5''-(phenylmethylidene)tetrahydro-4''-(1H)-pyridinone-4-(phenylmethylidene)hexahydro-1H-pyrrolizine,19.65,uM,=,1.2933625547114456,1,O=C(C[C@H]1C[C@H]2CCCN2[C@]12C(=O)Nc1ccccc12)N1C/C(=C\c2ccccc2)C(=O)[C@]2(C[C@H]3CCCN3[C@@]23C(=O)Nc2ccccc23)C1
4469,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,CCN(CC)Cc1ccc(NC(=O)c2ccccc2)c(C(=O)C(=O)N(CC)CC)c1,N-(2-(2-(diethylamino)-2-oxoacetyl)-4-((diethylamino)methyl)phenyl)benzamide,0.04467,uM,=,-1.3499840475281617,0,O=C(Nc1ccccc1)c1ccccc1
4470,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,O/N=C/c1nc(CCCCCSc2c3c(nc4ccccc24)CCCC3)ccc1O,"2-[1-(hydroxyimino)methyl]-6-[5-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)pentyl]pyridin-3-ol",307.0,uM,=,2.4871383754771865,1,c1ccc(CCCCCSc2c3c(nc4ccccc24)CCCC3)nc1
4471,793257,10.1016/j.bmc.2011.09.061,,,,Inhibition of AChE,COc1cc2c(cc1OC)C(=O)C(Oc1ccc(CN3CCCC3)cc1)C2,"5,6-Dimethoxy-2-(4-pyrrolidin-1-ylmethyl-phenoxy)-indan-1-one",0.05,uM,=,-1.3010299956639813,0,O=C1c2ccccc2CC1Oc1ccc(CN2CCCC2)cc1
4472,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1ccc2oc(C(=O)NCCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2c1,N-(3-(1-benzylpiperidin-4-yl)propyl)-6-methoxy-4-oxo-4H-chromene-2-carboxamide,0.37,uM,=,-0.431798275933005,0,O=C(NCCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
4473,28153,10.1021/jm000980y,,,,Inhibition of acetylcholinesterase isolated from Human erythrocytes.,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00032,uM,=,-3.494850021680094,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
4474,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[5-(9-oxo-9H-xanthen-3-yloxy)-pentyl]-amino}-methyl)-phenyl ester,0.00082,uM,=,-3.086186147616284,0,O=c1c2ccccc2oc2cc(OCCCCCNCc3ccccc3)ccc12
4475,2158896,10.1016/j.ejmech.2021.114044,,,,Inhibition of AChE (unknown origin),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCOC1N2C,"Methyl-carbamic acid (S)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.004,uM,=,-2.397940008672037,0,c1ccc2c(c1)NC1OCCC21
4476,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(Cl)cc13)CCC2,"7-chloro-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",1.58,uM,=,0.1986570869544226,1,c1ccc2nc3c(cc2c1)CCC3
4477,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-6-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)-N-(4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl)hexanamide",0.15325,uM,=,-0.8145995168095473,0,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
4478,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,Cc1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1,5-methyl-2-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1H-benzo[d]imidazole,0.39,uM,=,-0.4089353929735008,0,c1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1
4479,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,"N-{9-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]nonyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.0578,uM,=,-1.238072161579471,0,O=C(CC1CCc2ccccc2O1)NCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
4480,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CNC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](Cc2ccccc2)c1.[Br-],"[1-Benzyl-3-(methylcarbamoyl)quinolin-1-ium-5-yl]-N,N-dimethylcarbamate bromide",1.16,uM,=,0.0644579892269184,1,c1ccc(C[n+]2cccc3ccccc32)cc1
4481,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CC2CC2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclopropylmethyl)-4-piperidyl]propan-1-one,0.937,uM,=,-0.0282604091122217,0,O=C(CCC1CCN(CC2CC2)CC1)c1ccccc1
4482,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2occ(-c3ccc(CN(C)Cc4ccccc4)cc3)c(=O)c2cc1OC,"3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxychromen-4-one",1.23,uM,=,0.0899051114393979,1,O=c1c(-c2ccc(CNCc3ccccc3)cc2)coc2ccccc12
4483,1465527,10.1016/j.bmc.2015.01.045,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's assay,CN(CCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,"2-(7-((2-Fluorobenzyl)(methyl)amino)heptyl)isoindoline-1,3-dione hydrochloride",0.625,uM,=,-0.2041199826559248,0,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1
4484,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(I)cc1)CC2.[Br-],"2-(4-iodophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.01,uM,=,0.0043213737826425,1,C1=[N+](c2ccccc2)CCc2ccccc21
4485,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccc(F)cc2)CC1)c1ccc2c(c1)NCCCC2,"3-[1-(4-Fluoro-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.393,uM,=,-0.4056074496245733,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
4486,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.Cl.O=C(NCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"6-Chloro-9-{{9-[5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-9-carboxamido]nonyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.0249,uM,=,-1.6038006529042637,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
4487,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1ccc(-c2cc3c(ccc4c(/C=C/c5cc(OC)cc(OC)c5)cc(=O)oc43)o2)cc1,"4-(3,5-dimethoxystyryl)-8-(4-methoxyphenyl)-2H-furo[2,3-h]chromen-2-one",1.8,uM,=,0.255272505103306,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
4488,749399,10.1016/j.bmcl.2009.04.089,,,,Inhibition of human recombinant AChE preincubated for 30 mins before DTNB substrate addition by spectrophotometric assay based Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,2.615,uM,=,0.4174716932032931,1,c1ccccc1
4489,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cccc(CN(C)Cc2ccc(-c3cc4cc(OC)c(OC)cc4oc3=O)cc2)c1,"6,7-dimethoxy-3-(4-{[(3-methoxybenzyl)methylamino]methyl}phenyl)chromen-2-one",0.714,uM,=,-0.1463017882238256,0,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
4490,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,CCN(CC)CCCCN1N=C2c3sccc3CCC2CC1=O,"2-(4-(diethylamino)butyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",2.93,uM,=,0.4668676203541094,1,O=C1CC2CCc3ccsc3C2=NN1
4491,856751,10.1016/j.ejmech.2012.10.045,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,CCN(CC)Cc1cccc(C(=O)c2c(-c3ccc(OCCCCCCCN(C)Cc4ccccc4)cc3)oc3ccccc23)c1,(2-{4-[7-(Benzylmethylamino)heptyloxy]phenyl}benzofuran-3-yl)-[3-(diethylaminomethyl)-phenyl]methanone,53.0,uM,=,1.7242758696007892,1,O=C(c1ccccc1)c1c(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
4492,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccccc2)CC1,4-(3-(1-Benzylpiperidin-4-yl)propoxy)-2-(2-(cyclopropanecarboxamido)pyridin-4-yl)thiazole-5-carboxamide,0.38,uM,=,-0.4202164033831898,0,O=C(Nc1cc(-c2nc(OCCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
4493,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccccc1Br)CC2.[Br-],"2-(2-bromophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.5,uM,=,0.1760912590556812,1,C1=[N+](c2ccccc2)CCc2ccccc21
4494,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)CCCc6ccccc6)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"20S-[methyl(3-phenylpropyl)amino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4alphaH-thiazine[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.076,uM,=,-1.1191864077192086,0,O=C1CC2C(CC[C@@H]2CNCCCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
4495,1278106,10.1016/j.bmcl.2013.10.043,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,[Br-].[Br-].c1cc[n+](CCCCCCC[n+]2cccc3ccccc32)cc1,1-(7-(pyridinium-1-yl)heptyl)quinoliniumdibromide,0.54,uM,=,-0.2676062401770315,0,c1cc[n+](CCCCCCC[n+]2cccc3ccccc32)cc1
4496,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CCCN1CCN(c2nccc(NCc3ccccc3)n2)CC1,N-Benzyl-2-(4-propylpiperazin-1-yl)pyrimidin-4-amine,15.3,uM,=,1.1846914308175989,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
4497,2261374,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc(-c3cc(=O)c4ccccc4o3)cc2)c1,[3-[[methyl-[7-[4-(4-oxochromen-2-yl)phenoxy]heptyl]amino]methyl]phenyl]N-methylcarbamate,0.00073,uM,=,-3.136677139879544,0,O=c1cc(-c2ccc(OCCCCCCCNCc3ccccc3)cc2)oc2ccccc12
4498,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CN(C)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((dimethylamino)methyl)phenol dihydrochloride,1536.5,uM,=,3.186532564592397,1,c1ccccc1
4499,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{8-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",0.119,uM,=,-0.9244530386074692,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
4500,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1O)CCC(C)(CCNCCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-N'-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]nonane-1,9-diamine",0.00027,uM,=,-3.5686362358410126,0,c1ccc2c(c1)CCC(CCNCCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2
4501,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2cccc(C#N)c2)ccc1O,(E)-N-(2-((3-cyanophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,16.01,uM,=,1.2043913319192998,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
4502,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)cc(OC)c1OC.[I-],"(E)-1-Methyl-2-(3,4,5-trimethoxystyryl)quinolin-1-ium Iodide",1.6,uM,=,0.2041199826559248,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccccc1
4503,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(Cc2ccccc2)CC1,1-Benzyl-4-methyl-piperidine,0.0053,uM,=,-2.275724130399211,0,c1ccc(CN2CCCCC2)cc1
4504,2076989,10.1039/d1md00105a,,,,Inhibition of human AChE,O=c1ccoc2ccc(OCCCCN3CCCCC3)cc12,6-(4-(piperidin-1-yl)butoxy)-4H-chromen-4-one,5.58,uM,=,0.7466341989375788,1,O=c1ccoc2ccc(OCCCCN3CCCCC3)cc12
4505,2057657,10.1021/acs.jmedchem.0c01775,,,,Inhibition of recombinant human AChE using acetylthiocholineiodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cc(CNC(=O)Cc2cn(CCCCC3=CC4Cc5nc6cc(Cl)ccc6c(N)c5C(C3)C4)nn2)ccc1O,,0.00106,uM,=,-2.9746941347352296,0,O=C(Cc1cn(CCCCC2=CC3Cc4nc5ccccc5cc4C(C2)C3)nn1)NCc1ccccc1
4506,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1[C@@H]1CCCCN1C2=O,"(+)-(S)-1-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)pyridin-2-yl)urea",0.0136999999999999,uM,=,-1.863279432843593,0,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1[C@@H]1CCCCN1C2=O
4507,813756,10.1016/j.bmcl.2012.02.057,,,,Inhibition of human AChE by Ellman's method,COc1ccc2c(ccc[n+]2Cc2ccccc2)c1.[I-],1-benzyl-6-methoxy quinolinium iodide,5.29,uM,=,0.7234556720351858,1,c1ccc(C[n+]2cccc3ccccc32)cc1
4508,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(=O)(=O)c1ccc(Cl)cc1,"1-(4-chloro benzene)-sulfonyl-cis-2,6-dimethylpiperidine",0.318,uM,=,-0.4975728800155673,0,O=S(=O)(c1ccccc1)N1CCCCC1
4509,1718675,10.1021/acs.jnatprod.7b00301,,,,Inhibition of AChE (unknown origin),COc1cc2c(cc1OC)[C@@H]1[C@H](O)[C@@H](OC)C=C3CCN(C2)[C@H]31,galanthine,6.1,uM,=,0.785329835010767,1,C1=C2CCN3Cc4ccccc4[C@H](CC1)[C@@H]23
4510,1589694,10.1016/j.bmc.2016.07.005,,,,Inhibition of hemoglobin free erythrocyte ghost human AChE using acetylcholine iodide as substrate measured for 1 hr by spectrophotometry based Ellman method,NC(=O)c1cc[n+](CCCC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],1-(3-(4-carbamoylpyridinium-1-yl)butyl)-3-(2-(hydroxyimino)acetamido)pyridinium dibromide,1560.0,uM,=,3.1931245983544616,1,c1cc[n+](CCCC[n+]2ccccc2)cc1
4511,2294033,10.1016/j.ejmech.2018.08.093,,,,Inhibition of AChE (unknown origin),COc1ccc2c(c1)[nH]c1c(C)nccc12,7-Methoxy-1-methyl-9H-beta-carboline,11.3,uM,=,1.0530784434834195,1,c1ccc2c(c1)[nH]c1cnccc12
4512,1993976,10.1016/j.bmc.2020.115324,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 60 mins followed by substrate addition and measured for 5 mins by Ellman's method,CN(C)C(=O)Oc1cccc(C(O)CNC2CCCCC2)c1.Cl,3-(2-(cyclohexylamino)-1-hydroxyethyl)phenyl dimethylcarbamate Hydrochloride,792.0,uM,=,2.898725181589493,1,c1ccc(CCNC2CCCCC2)cc1
4513,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CC(C)Cn1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-isobutyl-1H-pyrazol-4-yl)ethan-1-one",11.0,uM,=,1.0413926851582251,1,c1cn[nH]c1
4514,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1cc(-c2ccccc2Br)nc2nc(-c3ccccc3)cc(C(F)(F)F)c12,"2-(2-Bromophenyl)-7-phenyl-5-(trifluoromethyl)-1,8-naphthyridin-4-amine",0.89,uM,=,-0.0506099933550872,0,c1ccc(-c2ccc3ccc(-c4ccccc4)nc3n2)cc1
4515,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,S=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12,"N-(2-(1H-indol-3-yl)ethyl)-6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexanethioamide",5e-09,uM,=,-8.301029995663981,0,S=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4516,1842245,10.1016/j.bmc.2019.01.025,,,,Inhibition of human acetylcholinesterase using acetylthiocholine as substrate pretreated followed by substrate addition and measured after 15 mins by Ellman's method,O=C(/C=C/c1ccc(OCc2ccccc2)cc1)NCCNc1c2c(nc3ccccc13)CCCC2,"3-(4-(benzyloxy)phenyl)-N-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)acrylamide",0.0606,uM,=,-1.2175273758337135,0,O=C(/C=C/c1ccc(OCc2ccccc2)cc1)NCCNc1c2c(nc3ccccc13)CCCC2
4517,2273297,10.1039/D1MD00217A,,,,Inhibition of AChE (unknown origin),COc1cc([C@@H](O)[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Oc2ccc(CCCO)cc2OC)ccc1O,Camellignanoside A,0.75,uM,=,-0.1249387366082999,0,c1ccc(C[C@H](CO[C@H]2CCCCO2)Oc2ccccc2)cc1
4518,1852470,10.1016/j.ejmech.2019.05.020,,,,Inhibition of AChE (unknown origin),OC(CNCc1cccc(OCc2ccccc2)c1)Cn1cc(Br)c2cc(Br)ccc21,"1-(3-(benzyloxy)benzylamino)-3-(3,5-dibromo-1H-indol-1-yl)propan-2-ol",9.1,uM,=,0.9590413923210936,1,c1ccc(COc2cccc(CNCCCn3ccc4ccccc43)c2)cc1
4519,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(Nc1cncc(OCC2CCN(Cc3ccc(F)cc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1,2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide,0.001,uM,=,-3.0,0,O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1
4520,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,CN(CCCCOc1ccc2c3c(c(=O)oc2c1)CCCC3)Cc1ccccc1,"3-(4-(Benzyl(methyl)amino)butoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",1.0,uM,=,0.0,0,O=c1oc2cc(OCCCCNCc3ccccc3)ccc2c2c1CCCC2
4521,1565223,10.1016/j.ejmech.2016.02.049,,,,Inhibition of human AChE assessed as hydrolytic activity using acetylthiocholine iodide as substrate measured for 15 mins by Ellmans assay,COc1nc(Oc2ccc(C(=O)OCC(C)N(C)C)cc2)nc(Oc2ccc(C(=O)OCC(C)N(C)C)cc2)n1,"bis(2-(dimethylamino)propyl) 4,4'-(6-methoxy-1,3,5-triazine-2,4-diyl)bis(oxy)dibenzoate",110.5,uM,=,2.0433622780211294,1,c1ccc(Oc2ncnc(Oc3ccccc3)n2)cc1
4522,2022980,10.1016/j.bmc.2020.115820,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition and measured every 30 secs for 1 hr by Ellman's method,C/C=C1\C2C=C(C)CC1(NCC(=O)OC)c1ccc(=O)[nH]c1C2,Huperserine E,6.71,uM,=,0.8267225201689921,1,C=C1C2C=CCC1c1ccc(=O)[nH]c1C2
4523,342264,10.1021/jm050578p,,,,Anticholinesterase activity against human erythrocyte AChE,CCNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCO[C@H]1O2,"(+)-(3aR)-3a-methyl-2,3,3a,8a-Tetrahydrofuro[2,3-b]benzofuran-5-yl N-Ethylcarbamate",0.486,uM,=,-0.3133637307377066,0,c1ccc2c(c1)O[C@@H]1OCCC21
4524,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",3.39,uM,=,0.5301996982030822,1,c1ccc2c(c1)N[C@H]1NCCC21
4525,1431531,10.1016/j.bmc.2014.08.035,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 6 mins by spectrophotometric method,CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-tert-Butyl(3-(1H-indol-3-yl)-1-oxo-1-((6-((1,2,3,4-tetrahydro-acridin-9-yl)amino)hexyl)amino)propan-2-yl)carbamate",0.116,uM,=,-0.9355420107730816,0,O=C(CCc1c[nH]c2ccccc12)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
4526,1890173,10.1016/j.ejmech.2019.02.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured over 2 mins by UV-Vis spectrophotometric analysis based Ellman's method,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCNc1c2c(nc3ccccc13)CCCC2,"(S)-2-amino-3-(1H-indol-3-yl)-N-(4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl)propanamide dihydrochloride",1.3,uM,=,0.1139433523068367,1,O=C(CCc1c[nH]c2ccccc12)NCCCCNc1c2c(nc3ccccc13)CCCC2
4527,938311,10.1016/j.bmcl.2012.11.064,,,,Inhibition of human recombinant AChE measured for 1 min by Ellman's method,CCOc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,N'-(4-Ethoxybenzylidene)-2-(4-benzylpiperidin-1-yl)acetohydrazide,53.1,uM,=,1.725094521081469,1,O=C(CN1CCC(Cc2ccccc2)CC1)N/N=C/c1ccccc1
4528,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,C[C@@H]([C@H]1CC[C@@]2(C)[C@@H]3CC[C@@H]4C(=CC3=CC[C@]12C)CC[C@H](N(C)C)C4(C)C)N(C)C,buxamine A,80.0,uM,=,1.9030899869919435,1,C1=C2CCCC[C@@H]2CC[C@@H]2C1=CCC1CCCC12
4529,1454788,10.1016/j.ejmech.2014.07.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric analysis,Cl.O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,"N-{8-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-5-(4-chlorophenyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-9-carboxamide dihydrochloride",0.00206,uM,=,-2.6861327796308467,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)NCCC3
4530,1455386,10.1016/j.bmc.2014.05.032,,,,Inhibition of AChE (unknown origin),Cc1cc(=O)oc2cc(OCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,"2-(4-(2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)ethyl)piperazin-1-yl)-N-(1,2,3,4-tetrahydroacridin-9-yl)acetamide",0.092,uM,=,-1.0362121726544449,0,O=C(CN1CCN(CCOc2ccc3ccc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2
4531,1758305,10.1016/j.ejmech.2017.07.055,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccccc4Br)cc3)ccc12.[Br-],1-(2-Bromobenzyl)-4-(((4-methyl-2-oxo-2H-chromen-7-yl)oxy)methyl)pyridin-1-ium bromide,0.0780999999999999,uM,=,-1.1073489661226998,0,O=c1ccc2ccc(OCc3cc[n+](Cc4ccccc4)cc3)cc2o1
4532,1551032,10.1021/acs.jnatprod.5b00830,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate assessed as substrate hydrolysis preincubated for 20 mins followed by substrate addition measured after 30 mins by Ellman's assay,CC(C)=CC[C@H]1C[C@@]2(CC=C(C)C)C(=O)O[C@@](CC=C(C)C)(C(=O)[C@@H](C(=O)C(C)C)[C@]1(C)C/C=C/C(C)(C)O)C2=O,Hyperuralone C,9.6,uM,=,0.9822712330395684,1,O=C1OC2C(=O)CCCCC1C2=O
4533,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2cc(O)c(O)cc2o1,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-6,7-dihydroxy-4-oxo-4H-chromene-2-carboxamide",4.13,uM,=,0.615950051656401,1,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
4534,28936,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase activity from octopus brain,CCc1ccc(SC(=O)OCC[N+](C)(C)C)cc1.[Cl-],[2-(4-Ethyl-phenylsulfanylcarbonyloxy)-ethyl]-trimethyl-ammonium chloride,50.0,uM,=,1.6989700043360187,1,c1ccccc1
4535,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(Cc1ccccc1)N1c2ccccc2Sc2ccccc21,1-(10H-phenothiazin-10-yl)-2-phenylethanone,7.4,uM,=,0.8692317197309762,1,O=C(Cc1ccccc1)N1c2ccccc2Sc2ccccc21
4536,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,"N3-(2-morpholinoethyl)-6-phenylpyridazine-3,4-diamine",270.0,uM,=,2.431363764158988,1,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1
4537,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)CCCN6C(=O)c7ccccc7C6=O)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"2-{3-[[16alpha-hydroxy-4beta,14alpha-dimethyl-11-oxo-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-20S-yl](methyl)amino]propyl}-1H-isoindole-1,3(2H)-dione",0.014,uM,=,-1.853871964321762,0,O=C1c2ccccc2C(=O)N1CCCNC[C@H]1CCC2C1CC(=O)[C@@]13C[C@@]14CC[C@@H]1N=CSCC1[C@@H]4CC[C@@H]23
4538,1861135,10.1016/j.ejmech.2019.07.053,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylcholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured after 5 mins by Ellman's method,COc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1OC,"N-[5'-(3'',4''-Dimethoxyphenethyloxy)pentyl]-1,2,3,4-tetrahydroacridin-9-amine",0.168,uM,=,-0.7746907182741372,0,c1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
4539,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,Cl.Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine hydrochloride",0.5,uM,=,-0.3010299956639812,0,c1ccc2nc3c(cc2c1)CCCC3
4540,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1ccc([C@H]2O[C@@H](O)[C@H]3[C@@H]2C(=O)O[C@@H]3c2ccc(OC)c(OC)c2)cc1OC,"Ciquitin B; (+)-(7S,7'S,8S,8'S,9R)-9-hydroxy-7-(3,4-dimethoxyphenyl)-7'-(3',4'-dimethoxyphenyl)-9'-oxo-8,8'-dioxabicyclo[3.3.0]-octane",0.0279999999999999,uM,=,-1.5528419686577808,0,O=C1O[C@H](c2ccccc2)[C@H]2CO[C@H](c3ccccc3)[C@@H]12
4541,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C(NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,"N-(7-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)-5-(4-chlorophenyl)-3,4-dihydro-2H-pyrano[3,2-c]quinoline-9-carboxamide",0.0183,uM,=,-1.7375489102695705,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3
4542,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)Nc3ccncc3)cn2)cc1,2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-(pyridin-4-yl)pyrimidine-5-carboxamide,17.9,uM,=,1.252853030979893,1,O=C(Cc1ncc(C(=O)Nc2ccncc2)cn1)c1ccccc1
4543,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1ccc2[nH]cc(CCNC(=O)c3ccc(CN(C)Cc4ccccc4Cl)cc3)c2c1,4-{[(2-Chlorobenzyl)(methyl)amino]methyl}-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]benzamide,2.6,uM,=,0.414973347970818,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
4544,1290205,10.1016/j.bmc.2014.01.010,,,,Inhibition of AChE (unknown origin) using 2-nitrobenzoate-5-mercaptothiocholine as substrate after 15 to 60 mins by microplate assay,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",3.2,uM,=,0.505149978319906,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4545,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1Cl)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(2-Chlorophenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",33.16,uM,=,1.520614521878236,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
4546,450173,10.1021/jm070536w,,,,Inhibition of human recombinant AChE by Ellman's method,CC(C)C1=N[C@H]2CC=C3C[C@H]4C(=O)C[C@]5(C)[C@@H]([C@H](C)N(C)C)[C@H](OC(=O)C(C)(C)C)C[C@@]5(C)[C@@H]4CC[C@H]3[C@]2(C)CO1,"(4aS,7aR,9aR,10S,11R,12aS,12bR,14aR,14bS)-10-[1-(dimethylamino)ethyl]-3-isopropyl-9a,12a,14b-trimethyl-8-oxo-4a,5,7,7a,8,9,9a,10,11,12,12a,12b,13,14,14a,14bhexadecahydro-1H-indeno[5'',4'':4',5']cyclohepta[1',2':3,4]benzo[1,2-d][1,3]oxazin-11-yl 2,2-dimethylpropanoate",0.839,uM,=,-0.0762380391712997,0,O=C1CC2CCCC2[C@@H]2CC[C@@H]3C(=CC[C@@H]4N=COCC43)C[C@@H]12
4547,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,NCCCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1-(1,2,3,4-tetrahydroacridin-9-yl)dodecane-1,12-diamine",0.18,uM,=,-0.744727494896694,0,c1ccc2nc3c(cc2c1)CCCC3
4548,1501999,10.1021/acs.jmedchem.5b00599,,,,Inhibition of human recombinant AChE by spectrophotometric Ellman's method,Cc1c(C)c2ccc(OCCCN(C)Cc3ccccc3)cc2oc1=O.Cl,"7-(3-(N-Benzyl-N-methylamino)propyloxy)-3,4-dimethyl-2H-chromen-2-one hydrochloride",1.0,uM,=,0.0,0,O=c1ccc2ccc(OCCCNCc3ccccc3)cc2o1
4549,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CNc2ccc(-n3cccn3)cc2)c1,(E)-3-((4-(1H-pyrazol-1-yl)phenylamino)methyl)-2-hydroxy-5-methylbenzaldehyde oxime,3183.0,uM,=,3.502836638621003,1,c1ccc(CNc2ccc(-n3cccn3)cc2)cc1
4550,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1cccc(Br)c1)[C@@]21CSc2ccccc2C1=O,"(6'R,7'S,7a'S)-7'-(3-Bromophenyl)-7',7a'-dihydro-1'H,3'H-dispiro[indene-2,5'-pyrrolo[1,2-c]thiazole-6',3''-thiochromane]-1,3,4''-trione",38.34,uM,=,1.583652108542044,1,O=C1c2ccccc2C(=O)C12N1CSC[C@@H]1[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
4551,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(I)cc1F)CC2.[Br-],"2-(2-fluoro-4-iodophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",1.06,uM,=,0.0253058652647702,1,C1=[N+](c2ccccc2)CCc2ccccc21
4552,471590,10.1016/j.bmc.2007.12.048,,,,Inhibition of AChE,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,Decamethonium,5.9,uM,=,0.7708520116421442,1,
4553,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,Cl.Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine hydrochloride",1.026,uM,=,0.0111473607757974,1,c1ccc2nc3c(cc2c1)CCCC3
4554,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(/C=C/C(=O)c2cc(I)c(Cl)cc2O)cc1,1-(4-chloro-2-hydroxy-5-iodophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one,0.01172,uM,=,-1.931072388317928,0,O=C(/C=C/c1ccccc1)c1ccccc1
4555,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[7-(9-oxo-9H-xanthen-3-yloxy)-heptyl]-amino}-methyl)-phenyl ester,0.00032,uM,=,-3.494850021680094,0,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
4556,305079,10.1021/jm0493461,,,,Inhibitory concentration against human acetylcholinesterase,Cc1c(Cl)nc2ccccc2c1C(=O)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"2-Chloro-3-methyl-quinoline-4-carboxylic acid [7-(1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-amide",0.003,uM,=,-2.5228787452803374,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccnc2ccccc12
4557,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCOCC4)cc3)cc12,"3-(4-(Morpholinomethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridine-6-carbonitrile",13.3,uM,=,1.1238516409670858,1,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCOCC4)cc3)cc12
4558,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CCCCCCCNC(=O)Oc1cccc(CN(C)CCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Heptyl-carbamic acid 3-({methyl-[4-(9-oxo-9H-xanthen-3-yloxy)-butyl]-amino}-methyl)-phenyl ester,0.1,uM,=,-1.0,0,O=c1c2ccccc2oc2cc(OCCCCNCc3ccccc3)ccc12
4559,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccc(Cl)cc1,5-(4-Chlorobenzylidene)-2-[(2-oxo-2H-chromen-6-yl)imino]thiazolidin-4-one,0.1735,uM,=,-0.7607005208731075,0,O=C1N/C(=N\c2ccc3oc(=O)ccc3c2)S/C1=C/c1ccccc1
4560,977210,10.1016/j.bmc.2013.06.065,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins before substrate addition by Ellman's method,CCN(CC)CCOc1ccc(-c2nc3cc(C)ccc3[nH]2)cc1,"N,N-diethyl-2-(4-(5-methyl-1H-benzo[d]imidazol-2-yl)phenoxy)ethanamine",50.98,uM,=,1.7073998311332488,1,c1ccc(-c2nc3ccccc3[nH]2)cc1
4561,488359,10.1021/jm701575k,,,,Inhibition of human acetylcholinesterase,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.031,uM,=,-1.5086383061657274,0,c1ccccc1
4562,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,COc1ccc(NC(=S)NNc2c3c(nc4ccccc24)CCCC3)cc1,"N-(4-methoxyphenyl)-2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazine-1-carbothioamide",0.293,uM,=,-0.5331323796458906,0,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccccc1
4563,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,CC1(C)CNC2=C([N+](=O)[O-])C3(C(=O)c4cccc5cccc3c45)C(C#N)=C(N)N2C1,"6'-amino-3',3'-dimethyl-9'-nitro-2-oxo-1',2',3',4'-tetrahydro-2H-spiro[acenaphthylene-1,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",7.71,uM,=,0.887054378050957,1,O=C1c2cccc3cccc(c23)C12C=CN1CCCNC1=C2
4564,1439748,10.1021/np500412f,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as inhibition of acetylcholine hydrolysis after 30 mins by Ellmann's method,C/C=C1\[C@H]2C=C(C)C[C@]1(N[C@H]1OC(=O)C3=C4CC(C)(C)C[C@H]4[C@@H](C)[C@@H](O)C[C@]31O)c1ccc(=O)[nH]c1C2,Huptremule B,2.17,uM,=,0.3364597338485295,1,C=C1[C@H]2C=CC[C@]1(N[C@H]1OC(=O)C3=C4CCC[C@H]4CCCC31)c1ccc(=O)[nH]c1C2
4565,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1cccc([N+](=O)[O-])c1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(3-nitro-benzoyl)-thiourea,0.015,uM,=,-1.8239087409443189,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccccc1
4566,28597,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 33.4-148,CCN(C)C(=O)Oc1ccc2c(c1)CC(N)CC2,"Ethyl-methyl-carbamic acid 7-amino-5,6,7,8-tetrahydro-naphthalen-2-yl ester",79.6,uM,=,1.900913067737669,1,c1ccc2c(c1)CCCC2
4567,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc(F)cc2)ccc1O,(E)-N-(2-((4-fluorophenyl)amino)-2-oxoethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,12.93,uM,=,1.111598524880394,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
4568,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4cc(F)cc(F)c4)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(3,5-Difluorobenzyl)-N-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]piperidine-4-carboxamide",2.45,uM,=,0.3891660843645325,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
4569,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3F)cc1)C2.[Br-],"(E)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)-1-(2-fluorobenzyl)pyridin-1-ium bromide",0.0008,uM,=,-3.096910013008056,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
4570,27788,10.1021/jm9602266,,,,Inhibition of Acetylcholinesterase in monkey red blood cell,Nc1c2c(nc3ccccc13)C(O)CCC2,"9-Amino-1,2,3,4-tetrahydro-acridin-4-ol",0.476,uM,=,-0.3223930472795068,0,c1ccc2nc3c(cc2c1)CCCC3
4571,1589175,10.1021/acs.jmedchem.6b00609,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 120 mins followed by substrate addition by Ellman's method,CCCCCCCNC(=O)Oc1ccc(-n2cc(COc3ccc4ccc(=O)oc4c3)nn2)cc1,"4-(4-(((2-Oxo-2H-chromen-7-yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)phenyl Heptylcarbamate",157.5,uM,=,2.197280558125619,1,O=c1ccc2ccc(OCc3cn(-c4ccccc4)nn3)cc2o1
4572,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,COc1ccccc1CN(C)CCCCCCNC1=CC(=O)C(NCCCCCCN(C)Cc2ccccc2OC)=CC1=O,"2,5-bis{6-[(2-methoxybenzyl)methylamino]hexylamino}-[1,4]-benzoquinone",0.0778,uM,=,-1.109020403010311,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
4573,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1ccc2c(c1)CN(CCCOc1ccc3c(=O)c4ccccc4oc3c1)CC2.Cl,"Methyl-carbamic acid 2-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-1,2,3,4-tetrahydro-isoquinolin-7-yl ester hydrochloride",0.0124,uM,=,-1.9065783148377649,0,O=c1c2ccccc2oc2cc(OCCCN3CCc4ccccc4C3)ccc12
4574,1507873,10.1016/j.bmc.2015.05.027,,,,Inhibition of human acetylcholinesterase incubated for 60 mins using ATChI substrate by DTNB dye based UV-visible spectrophotometry,CCOC(=O)c1csc(NC(=O)C[n+]2ccc(/C=N/O)cc2)n1.[Cl-],1-(2-(4-(Ethoxycarbonyl)thiazol-2-ylamino)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridiniumchloride,2490.0,uM,=,3.3961993470957363,1,O=C(C[n+]1ccccc1)Nc1nccs1
4575,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CC[N+](C)(Cc4ccc(Br)cc4)CC3)cc1)C2.[Br-],"2,3-Dihydro-5,6-dimethoxy-2-[4-(4-(4-bromobenzyl)-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one bromide",2.55,uM,=,0.4065401804339551,1,O=C1/C(=C/c2ccc(N3CC[NH+](Cc4ccccc4)CC3)cc2)Cc2ccccc21
4576,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNc1c2c(nc3ccc(C)cc13)CCCC2,"Heptyl-(7-methyl-1,2,3,4-tetrahydro-acridin-9-yl)-amine",0.39,uM,=,-0.4089353929735008,0,c1ccc2nc3c(cc2c1)CCCC3
4577,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(Cc2cccnc2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(3-pyridylmethyl)-4-piperidyl]propan-1-one,0.045,uM,=,-1.3467874862246565,0,O=C(CCC1CCN(Cc2cccnc2)CC1)c1ccccc1
4578,2031693,10.1016/j.ejmech.2020.112193,,,,Inhibition of recombinant human C-terminal 6His-tagged AChE (Glu32 to Leu614 residues) expressed in CHO cells using acetylthiocholine iodide as substrate preincubated for 5 mins measured after 15 mins by DTNB reagent based assay,c1ccc2nc3ccccc3cc2c1,Acridine,6.84,uM,=,0.8350561017201162,1,c1ccc2nc3ccccc3cc2c1
4579,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(Heptylphysostigmine(-))Heptyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.009,uM,=,-2.0457574905606752,0,c1ccc2c(c1)N[C@H]1NCCC21
4580,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,Nc1c2c(nc3nc(-c4ccccc4)cc(C(F)(F)F)c13)CCCCC2,"2-Phenyl-4-(trifluoromethyl)-7,8,9,10-tetrahydro-6Hcyclohepta[b][1,8]-naphthyridin-5-amine",10.13,uM,=,1.0056094453602804,1,c1ccc(-c2ccc3cc4c(nc3n2)CCCCC4)cc1
4581,1984636,10.1021/acs.jnatprod.9b00759,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 2 mins by Ellman's method,COc1ccc([C@H](O)[C@H](N)C(=O)O)cc1OC,"(3S)-hydroxy-3',4'-dimethoxy-L-phenylalanine",0.001,uM,=,-3.0,0,c1ccccc1
4582,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccc(C)cc2)N(c2ccccc2)[C@@H]1c1ccc(C)cc1,"(2R,6S)-ethyl 1-phenyl-4-(phenylamino)-2,6-dip-tolyl-1,2,5,6-tetrahydropyridine-3-carboxylate",5580.0,uM,=,3.746634198937578,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
4583,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc(OC)c2c(=O)cc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)oc2c1,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-5,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide",0.32,uM,=,-0.494850021680094,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
4584,1861945,10.1016/j.ejmech.2019.111596,,,,Inhibition of human erythrocytes AChE assessed as reduction in 5-thio-2-nitrobenzoate anion formation using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition by Ellman's method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(Cc2ccc(O)c(O)c2)CC1,"1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-[(3,4-dihydroxyphenyl)methyl]-4-piperidyl]propan-1-one",0.1379,uM,=,-0.8604357338241503,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
4585,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(F)c3)CC2)nc1-c1ccc(OC)c(OC)c1,"Ethyl 2-(4-((4-acetamido-3-fluorophenyl)sulfonyl)piperazin-1-yl)-4-(3,4-dimethoxyphenyl)-6-methylpyrimidine-5-carboxylate",0.0765199999999999,uM,=,-1.116225038644742,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
4586,2261407,10.1016/j.ejmech.2022.114606,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured upto 180 secs by Ellman's method,Cc1c(Cl)c(=O)oc2cc(OCCCCSC(=S)N3C(C)CCCC3C)ccc12,"4-(3-chloro-4-methyl-2-oxo-chromen-7-yl)oxybutyl 2,6-dimethylpiperidine-1-carbodithioate",0.114,uM,=,-0.9430951486635274,0,O=c1ccc2ccc(OCCCCSC(=S)N3CCCCC3)cc2o1
4587,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1cc2c(cc1OC)C(=O)C(CCCCCCCc1cccc(OC)[n+]1C)C2.O=S(=O)([O-])C(F)(F)F,"2-(7-(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)heptyl)-6-methoxy-1-methylpyridinium trifluoromethanesulfonate",0.27,uM,=,-0.5686362358410126,0,O=C1c2ccccc2CC1CCCCCCCc1cccc[nH+]1
4588,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Methyl-carbamic acid 3-({methyl-[6-(9-oxo-9H-xanthen-3-yloxy)-hexyl]-amino}-methyl)-phenyl ester,0.0014,uM,=,-2.853871964321762,0,O=c1c2ccccc2oc2cc(OCCCCCCNCc3ccccc3)ccc12
4589,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,CC[N+](C)(C)c1cccc(O)c1.[Br-],Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium bromide,3.96,uM,=,0.5976951859255123,1,c1ccccc1
4590,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),Cn1c2ccccc2c2cc[n+](-c3ccc(Br)cc3)cc21,"2-(4-bromophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",9.0,uM,=,0.9542425094393248,1,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
4591,2122761,10.1016/j.ejmech.2021.113663,,,,Inhibition of human recombinant AChE preincubated for 1 min in presence of DNTB followed by addition of acetylthiocholine iodide substrate and measured after 20 mins by Ellman's method,O=C(NCCC1CCN(Cc2cccc(Cl)c2)CC1)c1cncc(NC(=O)c2cccc(NC(=O)C3CC3)c2)c1,N-(2-(1-(3-chlorobenzyl)piperidin-4-yl)ethyl)-5-(2-(cyclopropanecarboxamido)isonicotinamido)nicotinamide,4.392,uM,=,0.6426623314420354,1,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2cccc(NC(=O)C3CC3)c2)c1
4592,1556949,10.1039/C5MD00274E,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 60 to 300 sec by Ellman's method,O=C(c1ccccc1)N1c2ccccc2Sc2ccc(Cl)cc21,10-Benzoyl-2-chloro-10H-phenothiazine,9.9,uM,=,0.99563519459755,1,O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21
4593,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccccc3Cl)cc1C(N)=O)C2=O.[Br-],"3-Carbamoyl-1-(2-chlorobenzyl)-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)pyridinium bromide",0.3788,uM,=,-0.4215900296687641,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
4594,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)CCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1,N1-dimethyl-N10-(1,2,3,4-tetrahydroacridin-9-yl)decane-1,10-diamine",0.045,uM,=,-1.3467874862246565,0,c1ccc2nc3c(cc2c1)CCCC3
4595,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,COc1ccccc1CNCCCCCOC(=O)Nc1cc(Cl)nc(Cl)c1,"5-(((2-methoxyphenyl)methyl)amino)pentyl-(2,6-dichloropyridin-4-yl)carbamate",6.16,uM,=,0.7895807121644255,1,O=C(Nc1ccncc1)OCCCCCNCc1ccccc1
4596,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CC1CCN(CC2CCCCC2)CC1,1-Cyclohexylmethyl-4-methyl-piperidine,0.0089,uM,=,-2.050609993355087,0,C1CCC(CN2CCCCC2)CC1
4597,1837068,10.1016/j.ejmech.2019.07.040,,,,Inhibition of human AChE,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2n1C,N-{[5-(3-(1-Benzylpiperidin-4-yl)propoxy)-1-methyl-1Hindol-2-yl]methyl}-N-methylprop-2-yn-1-amine,0.81,uM,=,-0.0915149811213502,0,c1ccc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)cc1
4598,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(CCC(=O)NCCC2CCN(Cc3ccccc3)CC2)cc(C(C)(C)C)c1O,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanamide",3.42,uM,=,0.534026106056135,1,O=C(CCc1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4599,2275464,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c([nH]c2c1N)C(C)NCC3,"7-methoxy-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-8-amine",2.0,uM,=,0.3010299956639812,1,c1ccc2c3c([nH]c2c1)CNCC3
4600,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl.Cl.Cl,"(+/-)-(7S,11S)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-({7-[(1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}amino)-7,11-methanocycloocta[b]quinoline Dihydrochloride",0.00189,uM,=,-2.723538195826756,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4601,839486,10.1016/j.ejmech.2012.09.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman method,N#Cc1c(N)nc(NC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-Amino-6-((1-benzylpiperidin-4-yl)amino)-4-phenylpyridine-3,5-dicarbonitrile",8.8,uM,=,0.9444826721501688,1,c1ccc(CN2CCC(Nc3cc(-c4ccccc4)ccn3)CC2)cc1
4602,452431,10.1021/jm701225u,,,,Inhibition of human serum recombinant AChE by Ellman's method,O=C(CCCNc1c2c(nc3ccccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2,"1,7-bis(5,6,7,8-tetrahydroacridin-9-ylamino)heptan-4-one",0.00183,uM,=,-2.7375489102695707,0,O=C(CCCNc1c2c(nc3ccccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2
4603,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3c(Br)cc(Br)cc13)CCCC2,"5,7-dibromo-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",5.18,uM,=,0.714329759745233,1,c1ccc2nc3c(cc2c1)CCCC3
4604,699906,10.1016/j.bmcl.2010.11.051,,,,Inhibition of human recombinant AChE,CC(C)(C)c1cc[n+](C/C=C/C[n+]2ccc(C(C)(C)C)cc2)cc1.[Br-].[Br-],"1,4-bis(4-tert.butylpyridinium)-but-(2E)-ene-1,4-diyl dibromide",3.4,uM,=,0.5314789170422551,1,C(=C/C[n+]1ccccc1)\C[n+]1ccccc1
4605,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCN(C)CC2)ccc1O,rac-2-(4-Hydroxy-3-methoxyphenyl)-2-(4-methylpiperazin-1-yl)acetonitrile,340.2,uM,=,2.5317343092765503,1,c1ccc(CN2CCNCC2)cc1
4606,2215309,10.1016/j.bmc.2022.116742,,,,"Inhibition of recombinant human AChE using Amplex red, acetylthiocholine as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins by microplate fluorescence reader analysis",C#CCOc1ccc(-c2cc(-c3ccc(OCCN4CCOCC4)cc3)nc(N)n2)cc1,4-(4-(2-morpholinoethoxy)phenyl)-6-(4-(prop-2-ynyloxy)phenyl)pyrimidin-2-amine,0.03046,uM,=,-1.5162701009999762,0,c1ccc(-c2cc(-c3ccc(OCCN4CCOCC4)cc3)ncn2)cc1
4607,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2ccc(Br)cc2)CC1)N1CCN(CCCc2c[nH]c3ccc(F)cc23)CC1,2-(4-(4-bromobenzoyl)piperazin-1-yl)-1-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)ethanone,39.4,uM,=,1.5954962218255742,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
4608,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ncc(C)cc3C)CC1)C2,"2-((1-((3,5-dimethylpyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one",0.814,uM,=,-0.0893755951107988,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccn2)CC1
4609,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc2ccccc2c1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(napht-2-yl)berberine bromide,1.5,uM,=,0.1760912590556812,1,c1ccc2cc(COc3cccc4cc5[n+](cc34)CCc3cc4c(cc3-5)OCO4)ccc2c1
4610,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccc(C(C)NS(=O)(=O)NC(=O)OCc2ccccc2)cc1OC,"Benzyl N-(1-(3,4-dimethoxyphenyl)ethyl)sulfamoylcarbamate",2.685e-05,uM,=,-4.571055709964425,0,O=C(NS(=O)(=O)NCc1ccccc1)OCc1ccccc1
4611,1501472,10.1016/j.bmc.2015.04.019,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as AChI hydrolysis using AChI and DTNB as substrate by Ellman's method,COc1ccc(OC)c(C(C)NS(=O)(=O)NC(=O)OCc2ccccc2)c1,"Benzyl N-(1-(2,5-dimethoxyphenyl)ethyl)sulfamoylcarbamate",2.685e-05,uM,=,-4.571055709964425,0,O=C(NS(=O)(=O)NCc1ccccc1)OCc1ccccc1
4612,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,O=C(Nc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)s1)C1CCN(Cc2ccc(OC(F)(F)F)cc2)CC1,"1-(4-Trifluoromethoxybenzyl)-N-[4,5-bis(4-chlorophenyl)-thiazol-2-yl]piperidine-4-carboxamide",1.38,uM,=,0.1398790864012364,1,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
4613,28306,10.1016/s0960-894x(01)00703-x,,,,In vitro inhibitory activity against human recombinant AChE,COc1ccc(C(=O)CCc2cccc([N+](C)(C)Cc3ccccc3)c2)cc1OC.[Br-],"Benzyl-{3-[3-(3,4-dimethoxy-phenyl)-3-oxo-propyl]-phenyl}-dimethyl-ammonium bromide",1.04,uM,=,0.0170333392987803,1,O=C(CCc1cccc([NH2+]Cc2ccccc2)c1)c1ccccc1
4614,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,Cc1cccc2sc(NC(=O)CCN3CCN(C(C)C)CC3)nc12,3-(4-lsopropylpiperazin-1-yl)-N-(4-methylbenzo[d]thiazol-2-yl)propanamide,2.75,uM,=,0.4393326938302626,1,O=C(CCN1CCNCC1)Nc1nc2ccccc2s1
4615,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1,"2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-((1-(3,4-dichlorobenzyl)piperidin-4-yl)methoxy)-N-methylthiazole-5-carboxamide",97.0,uM,=,1.9867717342662448,1,O=C(Nc1cc(-c2nc(OCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
4616,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Fc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,"2-(4-Fluorophenyl)-5-(4-(pyridin-2-yl)piperazin-1-yl)-1,3,4-oxadiazole",0.136,uM,=,-0.8664610916297825,0,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
4617,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(C)(=O)=O,"cis-2,6-dimethyl-1-methyl sulfonyl piperidine",0.075,uM,=,-1.1249387366083,0,C1CCNCC1
4618,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(CCCCc1cn(CCCCC(=O)NCCc3c[nH]c4ccccc34)nn1)C2,,0.031,uM,=,-1.5086383061657274,0,O=C(CCCCn1cc(CCCCN2CC[C@@]34C=CCC[C@@H]3Oc3cccc(c34)C2)nn1)NCCc1c[nH]c2ccccc12
4619,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,O=C1/C(=C/c2ccc(O)cc2)COc2ccccc21,SID49677398,99.9,uM,=,1.9995654882259823,1,O=C1/C(=C/c2ccccc2)COc2ccccc21
4620,1617977,10.1016/j.ejmech.2016.05.055,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,COc1ccc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)c(OC)c1,"(E)-N-(2-(1-Benzylpiperidin-4-yl)ethyl)-3-(2,4-dimethoxyphenyl)acrylamide",0.63,uM,=,-0.2006594505464183,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4621,833863,10.1021/np2009626,,,,Inhibition of human AChE pre-incubated for 10 mins before acetylthiocholine iodide substrate addition,CC(C)=CCC/C(C)=C/Cc1ccc(O)c2nc3cccc(O)c3nc12,geranylphenazinediol,2.62,uM,=,0.4183012913197454,1,c1ccc2nc3ccccc3nc2c1
4622,2048534,10.1016/j.bmc.2020.115721,,,,Inhibition of human AChE by Ellman's method,FC(F)(F)Oc1ccc(/C=N\C2CCN(Cc3ccccc3)C2)cc1,N-(1-Benzylpyrrolidin-3-yl)-1-(4-(trifluoromethoxy)phenyl)methanimine,0.8640000000000001,uM,=,-0.0634862575211066,0,C(=N\C1CCN(Cc2ccccc2)C1)\c1ccccc1
4623,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,CN(CCCOc1ccc([N+](=O)[O-])cc1)C(=O)c1cnc(CC(=O)c2cccs2)nc1,N-methyl-N-(3-(4-nitrophenoxy)propyl)-2-(2-oxo-2-(thiophen-2-yl)ethyl)pyrimidine-5-carboxamide,0.88,uM,=,-0.0555173278498313,0,O=C(NCCCOc1ccccc1)c1cnc(CC(=O)c2cccs2)nc1
4624,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc(C(C#N)N2CCN(C)CC2)cc1O,rac-2-(3-Hydroxy-4-methoxyphenyl)-2-(4-methylpiperazin-1-yl)acetonitrile,350.1,uM,=,2.5441921107650325,1,c1ccc(CN2CCNCC2)cc1
4625,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(C)C(=O)Nc1cccc2n1cc(-c1ccc(OC(=O)N(C)C)cc1)[n+]2C.[Cl-],"2-(4-(dimethylcarbamoyloxy)phenyl)-5-(3,3-dimethylureido)-1-methylimidazo[1,2-a]pyridin-1-ium",1.6,uM,=,0.2041199826559248,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
4626,514381,10.1016/j.bmc.2008.07.005,,,,Inhibition of human erythrocyte AChE by Ellman's method,CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(OC)cc1)CCCC3,"ethyl 5-amino-2-methyl-4-(4-methoxyphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate",0.11,uM,=,-0.958607314841775,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
4627,900249,10.1007/s00044-011-9695-0,,,,Inhibition of AChE (unknown origin) after 10 min by Ellmans method,CC1CCc2nc3nc(-c4ccccc4)cc(C(F)(F)F)c3c(N)c2C1,"7-Methyl-2-phenyl-4-(trifluoromethyl)-6,7,8,9-tetrahydrobenzo[b][1,8]-naphthyridin-5-amine",0.51,uM,=,-0.2924298239020636,0,c1ccc(-c2ccc3cc4c(nc3n2)CCCC4)cc1
4628,28307,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes,CC(c1cccc(OC(=O)N(C)C)c1)N(C)C,Dimethyl-carbamic acid 3-(1-dimethylamino-ethyl)-phenyl ester,0.03,uM,=,-1.5228787452803376,0,c1ccccc1
4629,2224411,10.1016/j.ejmech.2021.113964,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 5 mins by Ellman's method,COc1ccc(/C=C2\CCc3cc([N+](=O)[O-])ccc3C2=O)c(Cl)c1OC,"2-(2-chloro-3,4-dimethoxybenzylidene)-6-nitro-3,4-dihydronaphthalen-1(2H)-one",2.92,uM,=,0.4653828514484183,1,O=C1/C(=C/c2ccccc2)CCc2ccccc21
4630,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2cc(O)ccc2[nH]1,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-6-hydroxy-4-oxo-1,4-dihydroquinoline-2-carboxamide",0.3,uM,=,-0.5228787452803376,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2[nH]1
4631,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1ccc(S(=O)(=O)N(Cc2ccccc2)c2ccc(N)cc2O)cc1,N-(4-Amino-2-hydroxy-phenyl)-N-benzyl-4-methyl-benzenesulfonamide,2.5,uM,=,0.3979400086720376,1,O=S(=O)(c1ccccc1)N(Cc1ccccc1)c1ccccc1
4632,1834527,10.1039/C9MD00030E,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCN(c5ccccc5)CC4)cc3)C2)cc1OC,"1-(5-(4-(4-Phenylpiperazin-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",294.9,uM,=,2.469674772551798,1,c1ccc(C2=NNC(c3ccc(N4CCN(c5ccccc5)CC4)cc3)C2)cc1
4633,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc(/C=C/c2cc(=O)oc3c2ccc2oc(-c4ccc(F)cc4)cc23)cc(OC)c1,"4-(3,5-dimethoxystyryl)-8-(4-fluorophenyl)-2H-furo[2,3-h]chromen-2-one",1.8,uM,=,0.255272505103306,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
4634,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,CN(CCCOc1ccc([N+](=O)[O-])cc1)C(=O)c1cnc(CC(=O)c2ccc3c(c2)OCO3)nc1,"2-(2-(benzo[d][1,3]dioxol-5-yl)-2-oxoethyl)-N-methyl-N-(3-(4-nitrophenoxy)propyl)pyrimidine-5-carboxamide",0.99,uM,=,-0.00436480540245,0,O=C(Cc1ncc(C(=O)NCCCOc2ccccc2)cn1)c1ccc2c(c1)OCO2
4635,833863,10.1021/np2009626,,,,Inhibition of human AChE pre-incubated for 10 mins before acetylthiocholine iodide substrate addition,Oc1cccc2nc3c(O)cccc3nc12,"1,6-phenazinediol",4.52,uM,=,0.6551384348113821,1,c1ccc2nc3ccccc3nc2c1
4636,1739898,10.1016/j.ejmech.2018.05.057,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by Ellman's method,CN(C)C(=O)Oc1cccc2c1cc(C(=O)NCCOCCOCCN1C(=O)c3ccccc3C1=O)c[n+]2C.O=S(=O)([O-])C(F)(F)F,"5-{(dimethylcarbamoyl)oxy)-3-((2-(2-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)ethoxy)ethyl)carbamoyl}-1-methyl-quinolin-1-ium triflate",0.006,uM,=,-2.2218487496163566,0,O=C(NCCOCCOCCN1C(=O)c2ccccc2C1=O)c1c[nH+]c2ccccc2c1
4637,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,C[C@@H]([C@H]1[C@H](O)C[C@@]2(C)[C@@H]3C=C[C@H]4C(C)(C)[C@@H](N(C)C)[C@H](O)C[C@@]45C[C@@]35CC[C@]12C)N(C)C,cyclonataminol,22.9,uM,=,1.359835482339888,1,C1=C[C@H]2C3CCCC3CC[C@]23C[C@@]32CCCC[C@H]12
4638,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OCc1ccc([N+](=O)[O-])cc1)CCc1cc2c(cc1-3)OCO2.[Br-],9-O-(4-nitrobenyl)berberine bromide,0.99,uM,=,-0.00436480540245,0,c1ccc(COc2cccc3cc4[n+](cc23)CCc2cc3c(cc2-4)OCO3)cc1
4639,762161,10.1016/j.ejmech.2011.04.038,,,,Inhibition of AChE by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.00316,uM,=,-2.500312917381596,0,c1ccc2nc3c(cc2c1)CCCC3
4640,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCC4)c3c(nc2c1)CCC3,"N,N'-Bis-(2,3-dihydro-1H-cyclopenta[b]quinolin-9-yl)-hexane-1,6-diamine",0.115,uM,=,-0.9393021596463884,0,c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCC4)c3c(nc2c1)CCC3
4641,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,"2a-[2-(4-Methyl-pyrazin-1-yl)-ethyl]-2a,3,4,5-tetrahydro-1H-benzo[cd]indol-2-one",1.344,uM,=,0.1283992687178064,1,O=C(NC[C@H]1CN[C@@H]2Cc3c[nH]c4cccc(c34)[C@H]2C1)OCc1ccccc1
4642,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Cc1cccc2nc3c(c(N)c12)CCCC3,"8-Methyl-1,2,3,4-tetrahydro-acridin-9-ylamine",0.099,uM,=,-1.00436480540245,0,c1ccc2nc3c(cc2c1)CCCC3
4643,2261403,10.1016/j.ejmech.2022.114606,,,,Inhibition of recombinant human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 45 to 90 mins by Ellman's method,CN(CCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NC2CCCC2)c1,[3-[[methyl-[3-(2-oxochromen-7-yl)oxypropyl]amino]methyl]phenyl]N-cyclopentylcarbamate,0.521,uM,=,-0.2831622767004755,0,O=C(NC1CCCC1)Oc1cccc(CNCCCOc2ccc3ccc(=O)oc3c2)c1
4644,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1ncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)s1,"5-(3-(4-(Piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']-dipyridin-6-yl)thiazole",0.496,uM,=,-0.3045183235098025,0,c1ncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)s1
4645,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-methoxy-N-(6-((1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)thiazole-5-carboxamide",0.022,uM,=,-1.6575773191777938,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1
4646,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,CC1CCN(Cc2ccc(CNCCN3CCNC3=C(C#N)C#N)o2)CC1,2-[1-(2-{[5-(4-Methyl-piperidin-1-ylmethyl)-furan-2-ylmethyl]-amino}-ethyl)-imidazolidin-2-ylidene]-malononitrile,0.29,uM,=,-0.5376020021010439,0,C=C1NCCN1CCNCc1ccc(CN2CCCCC2)o1
4647,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/C(=C/c1ccccc1)CCCCC)c1ccc(=O)[nH]c1C2,"13-Ethylidene-11-methyl-1-[2-[1-phenyl-methylidene]-heptylideneamino]-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.051,uM,=,-1.2924298239020635,0,C=C1[C@H]2C=CC[C@]1(/N=C/C=C/c1ccccc1)c1ccc(=O)[nH]c1C2
4648,2071578,10.1021/acs.jmedchem.0c00528,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,"N-{6-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide",0.011,uM,=,-1.958607314841775,0,O=C(CC1CCc2cc(OCc3ccccc3)ccc2O1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
4649,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc2c(c1)CCC(Cc1cc[n+](Cc3ccc(Cl)cc3)cc1C(C)=O)C2=O.[Br-],"3-Acetyl-4-((6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)-1-(4-chlorobenzyl)pyridinium bromide",0.568,uM,=,-0.2456516642889811,0,O=C1c2ccccc2CCC1Cc1cc[n+](Cc2ccccc2)cc1
4650,587673,10.1016/j.ejmech.2009.04.042,,,,Inhibition of human serum AChE by Ellman's assay,C[C@@H]1CCC[C@H](C)N1S(=O)(=O)c1ccccc1,"1-benzene sulfonyl-cis-2,6-dimethyl piperidine",0.392,uM,=,-0.4067139329795427,0,O=S(=O)(c1ccccc1)N1CCCCC1
4651,305786,10.1021/jm049309+,,,,Inhibitory concentration against human erythrocyte Acetylcholinesterase,CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N+](C)([O-])[C@@H]1N2C.Cl,CHF-2819,0.125,uM,=,-0.9030899869919436,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+][C@@H]1N2
4652,1724020,10.1016/j.ejmech.2017.05.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured over 5 mins by Ellman's method,O=C(O)C(F)(F)F.O=C1C2=C(C3=NCCc4c[nH]c1c43)C1(C=CN2)C=C(Br)C(O)C(Br)=C1,"(-)-3-dihydro-7,8-dehydro discorhabdin C 2,2,2-trifluoroacetic acid",152.0,uM,=,2.1818435879447726,1,O=C1C2=C(C3=NCCc4c[nH]c1c43)C1(C=CCC=C1)C=CN2
4653,785863,10.1016/j.bmcl.2011.08.042,,,,Inhibition of human recombinant AChE after 5 mins using spectrophotometer by Ellman's method,COc1ccc2nc3c(c(N4CCCCCN(c5c6c(nc7ccc(OC)cc57)CCCC6)CCCCC4)c2c1)CCCC3,"9,9'-di-(pentane-1,5-diyldiimino)-di-(7-methoxy-1,2,3,4-tetrahydroacridine)",4.6,uM,=,0.6627578316815741,1,c1ccc2c(N3CCCCCN(c4c5c(nc6ccccc46)CCCC5)CCCCC3)c3c(nc2c1)CCCC3
4654,410400,10.1021/jm060945c,,,,Inhibition of human erythrocyte AChE,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.205,uM,=,-0.6882461389442457,0,c1ccc2nc3c(cc2c1)CCCC3
4655,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,"3,4,6-trichloro-2-(2,3,5-trichloro-6-hydroxybenzyl)phenol (hexachlorophene)",3.0149,uM,=,0.4792729117768569,1,c1ccc(Cc2ccccc2)cc1
4656,28475,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 252-806,C#CCN(C)C1CCc2cccc(OC(=O)N(C)CC)c21.Cl,Ethyl-methyl-carbamic acid 3-(methyl-prop-2-ynyl-amino)-indan-4-yl ester hydrochloride,439.0,uM,=,2.6424645202421213,1,c1ccc2c(c1)CCC2
4657,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3ccc(Br)cc3)cc12.[Br-],2-(4-bromophenyl)-8-methoxyisoquinolinium bromide,0.19,uM,=,-0.721246399047171,0,c1ccc(-[n+]2ccc3ccccc3c2)cc1
4658,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CN2CCN(CCCCOc3ccc4c5c(c(=O)oc4c3)CCCC5)CC2)c1,"3-(4-(4-(3-Methoxybenzyl)piperazin-1-yl)butoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",8.7,uM,=,0.9395192526186184,1,O=c1oc2cc(OCCCCN3CCN(Cc4ccccc4)CC3)ccc2c2c1CCCC2
4659,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.00346,uM,=,-2.460923901207224,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4660,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,COc1ccc(-c2nc(NC(=O)C3CCN(Cc4c(F)cccc4Cl)CC3)sc2-c2ccc(OC)cc2)cc1,"1-(2-Chloro-6-fluorobenzyl)-N-[4,5-bis(4-methoxyphenyl)-thiazol-2-yl]piperidine-4-carboxamide",0.41,uM,=,-0.3872161432802645,0,O=C(Nc1nc(-c2ccccc2)c(-c2ccccc2)s1)C1CCN(Cc2ccccc2)CC1
4661,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCCC2)ccc1O,rac-2-(4-Hydroxy-3-methoxyphenyl)-2-(pyrrolidin-1-yl)acetonitrile,358.2,uM,=,2.554125581513013,1,c1ccc(CN2CCCC2)cc1
4662,462117,10.1021/jm7009364,,,,Inhibition of human AchE,O=C(O)CCCC[C@@H]1CCSS1,N-Phenyl-thiophene-2-carboxamidine,0.001,uM,=,-3.0,0,C1CSSC1
4663,1898859,10.1016/j.ejmech.2019.01.030,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate by Ellman's assay,COc1cc(C(=O)n2nc(OCCN3CCCC3)c3ccccc32)cc(OC)c1OC,"(3,4,5-trimethoxyphenyl)(3-(2-(1-pyrrolidinyl)ethoxy)indazol-1-yl)ketone",11.6,uM,=,1.0644579892269186,1,O=C(c1ccccc1)n1nc(OCCN2CCCC2)c2ccccc21
4664,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,CCN(CC)CCCCCCCOc1ccc2c(c1)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)cc1)C2,2-{4-[(Benzylmethylamino)methyl]benzylidene}-6-(7-diethylaminoheptyloxy)indan-1-one,0.51,uM,=,-0.2924298239020636,0,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
4665,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,Cc1cc(/C=N/O)c(O)c(CNc2ccc(N3CCOCC3=O)cc2)c1,(E)-2-hydroxy-5-methyl-3-((4-(3-oxomorpholino)phenylamino)methyl)benzaldehyde oxime,5305.0,uM,=,3.72468538823736,1,O=C1COCCN1c1ccc(NCc2ccccc2)cc1
4666,1549912,10.1021/acs.jmedchem.5b01119,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,COc1cccc2cc(CN(CCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4cccc(OC)c4o3)oc12,"N1-(2,3-Dihydro-1H-cyclopenta[b]quinolin-9-yl)-N6,N6-bis((7-methoxybenzofuran-2-yl)methyl)hexane-1,6-diamine",7.495,uM,=,0.8747716371842983,1,c1ccc2oc(CN(CCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4ccccc4o3)cc2c1
4667,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)NCC(=O)Nc2ccc(C)cc2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-oxo-2-(p-tolylamino)ethyl)acrylamide,12.62,uM,=,1.1010593549081156,1,O=C(/C=C/c1ccccc1)NCC(=O)Nc1ccccc1
4668,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)C(O)C(O)C(=O)O,"ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester 2,3-dihydroxy-succinic acid",6.5,uM,=,0.8129133566428556,1,c1ccccc1
4669,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1/C(=C/c2cc[nH]c2)CN(Cc2ccccc2)C/C1=C\c1cc[nH]c1,"1-Benzyl-3,5-bis-(1H-pyrrol-3-ylmethylene)-piperidin-4-one",6.0,uM,=,0.7781512503836436,1,O=C1/C(=C/c2cc[nH]c2)CN(Cc2ccccc2)C/C1=C\c1cc[nH]c1
4670,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCNC(=O)Oc1cccc(CN(C)CCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,Propyl-carbamic acid 3-({methyl-[3-(9-oxo-9H-xanthen-3-yloxy)-propyl]-amino}-methyl)-phenyl ester,0.028,uM,=,-1.5528419686577808,0,O=c1c2ccccc2oc2cc(OCCCNCc3ccccc3)ccc12
4671,1442760,10.1016/j.bmcl.2014.10.055,,,,Inhibition of human acetylcholinesterase by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CCCCCn1ccnc1/C=N/O)CC2,"1-(5-(6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)pentyl)-1H-imidazole-2-carbaldehyde oxime",930.0,uM,=,2.9684829485539352,1,c1ccc(C2c3ccccc3CCN2CCCCCn2ccnc2)cc1
4672,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)OCC1CCN(CC2CCCCC2)CC1,[1-(Cyclohexylmethyl)-4-piperidyl]methyl 4-amino-5-chloro-2-methoxybenzoate,2.72,uM,=,0.4345689040341987,1,O=C(OCC1CCN(CC2CCCCC2)CC1)c1ccccc1
4673,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCCCCSC(=S)N3CCCCC3)ccc12,5-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)pentylpiperidine-1-carbodithioate,0.21,uM,=,-0.6777807052660807,0,O=c1ccc2ccc(OCCCCCSC(=S)N3CCCCC3)cc2o1
4674,2117704,10.1016/j.ejmech.2021.113541,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured after 7 mins by Ellman's method,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccccc3)CC2)cc1,(2-(1-(4-methoxybenzyl)piperidin-4-yl)benzofuran-3-yl)(phenyl)methanone,97.13,uM,=,1.9873533887357937,1,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12
4675,1864124,10.1016/j.ejmech.2019.05.080,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's spectrophotometric method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",2.77,uM,=,0.4424797690644485,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4676,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2oc3cc(CN(C)Cc4ccccc4)ccc3c(=O)c2cc1OC,"6-[(benzylmethylamino)methyl]-2,3-dimethoxyxanthen-9-one",30.3,uM,=,1.481442628502305,1,O=c1c2ccccc2oc2cc(CNCc3ccccc3)ccc12
4677,1731300,10.1016/j.ejmech.2017.12.084,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's method,COc1ccc(C(=O)CCC2C=CN(Cc3cccc(Cl)c3)C=C2C#N)cc1OC,"1-(3-chlorobenzyl)-4-(3-(3,4-dimethoxyphenyl)-3-oxopropyl)-1,4-dihydropyridine-3-carbonitrile",0.923,uM,=,-0.0347982989740879,0,O=C(CCC1C=CN(Cc2ccccc2)C=C1)c1ccccc1
4678,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,Cc1ccccc1/C=C1\CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C(=C\c2ccccc2C)C1=O,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(2-methylbenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",11.2,uM,=,1.0492180226701815,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
4679,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1cc(C(C#N)N2CCN(C)CC2)cc(OC)c1OC,"rac-2-(3,4,5-Trimethoxyphenyl)-2-(4-methylpiperazin-1-yl)acetonitrile",406.0,uM,=,2.6085260335771943,1,c1ccc(CN2CCNCC2)cc1
4680,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,(E)-4-(3-(4-benzylpiperazin-1-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl diphenylcarbamate,28.7,uM,=,1.4578818967339924,1,O=C(/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)cc1)N1CCN(Cc2ccccc2)CC1
4681,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)NC(=O)c1ccc(-c2ccccc2)cc1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(biphenyl-4-carbonyl)-thiourea,0.23,uM,=,-0.6382721639824072,0,O=C(NC(=S)NCCOCCNCc1ccccc1)c1ccc(-c2ccccc2)cc1
4682,1442760,10.1016/j.bmcl.2014.10.055,,,,Inhibition of human acetylcholinesterase by Ellman's method,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1,HI-6,1360.0,uM,=,3.133538908370217,1,c1cc[n+](COC[n+]2ccccc2)cc1
4683,1699069,10.1016/j.ejmech.2017.02.034,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1c[nH]c2ccccc12,N-[Indole-3-carbonyl]-L-Glu[NH-2-(1-benzylpiperidin-4-yl)ethyl]-O-n-hexyl,3.04,uM,=,0.4828735836087537,1,O=C(CCCNC(=O)c1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
4684,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,C[N+](C)(C)CCOC(=O)Sc1ccccc1.[Cl-],Trimethyl-(2-phenylsulfanylcarbonyloxy-ethyl)-ammonium chloride,1000.0,uM,=,3.0,1,c1ccccc1
4685,305601,10.1021/jm0496741,,,,Inhibitory concentration against Acetylcholinesterase from human erythrocytes,CCC1=CC2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl.Cl,Huprine-Tacrine Heterodimer,0.00082,uM,=,-3.086186147616284,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4686,2293981,10.1016/j.ejmech.2018.05.004,,,,Inhibition of AChE (unknown origin),Cc1ccc(NCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,"4-methyl-1-((2-((1S,9aR)-octahydro-2H-quinolizin-1-yl)ethyl)amino)-9H-thioxanthen-9-one",5.2,uM,=,0.7160033436347992,1,O=c1c2ccccc2sc2cccc(NCC[C@@H]3CCCN4CCCC[C@H]34)c12
4687,2059377,10.1016/j.bmc.2021.116074,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc2c(cc1OC)/C(=C/c1ccc(N3CCCCC3)c(O)c1)OC2=O,"(Z)-3-(3-hydroxy-4-(piperidin-1-yl)benzylidene)-5,6-dimethoxyisobenzofuran-1(3H)-one",0.05,uM,=,-1.3010299956639813,0,O=C1O/C(=C\c2ccc(N3CCCCC3)cc2)c2ccccc21
4688,2053696,10.1016/j.ejmech.2020.112593,,,,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],"9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium chloride",17.4,uM,=,1.2405492482825995,1,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
4689,938311,10.1016/j.bmcl.2012.11.064,,,,Inhibition of human recombinant AChE measured for 1 min by Ellman's method,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,N'-(4-Methoxybenzylidene)-2-(4-benzylpiperidin-1-yl)acetohydrazide,73.5,uM,=,1.866287339084195,1,O=C(CN1CCC(Cc2ccccc2)CC1)N/N=C/c1ccccc1
4690,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),CCCCCCCCc1ccc(O)cc1,4-Octyl-phenol,11.471,uM,=,1.059601279762754,1,c1ccccc1
4691,1521647,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 60 mins by Ellman assay,CC(C)(C)c1cccc(C(=O)C(F)(F)F)c1,"1-(3-tert-Butyl-phenyl)-2,2,2-trifluoro-ethanone",0.005,uM,=,-2.3010299956639813,0,c1ccccc1
4692,1720304,10.1016/j.ejmech.2017.09.022,,,,Inhibition of human serum AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured for 3 mins by Ellman's method,O=C(NCCCCCCNCc1ccccc1)c1cc(Cl)nc(Cl)c1,"N-(6-(benzylamino)hexyl)-2,6-dichloroisonicotinamide",3.17,uM,=,0.5010592622177514,1,O=C(NCCCCCCNCc1ccccc1)c1ccncc1
4693,1697195,10.1016/j.bmcl.2017.09.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 15 mins by Ellman's method,C#CCN[C@@H]1CCc2ccccc21,(R)-Indan-1-yl-prop-2-ynyl-amine,0.019,uM,=,-1.7212463990471711,0,c1ccc2c(c1)CCC2
4694,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3cnccc13)OCCC2,"3,4-Dihydro-2H-1-oxa-7,9-diaza-anthracen-10-ylamine",0.042,uM,=,-1.3767507096020994,0,c1cc2cc3c(nc2cn1)OCCC3
4695,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1cc(OC)c(OC)cc1Br,"3-(2-bromo-4,5-dimethoxybenzyl)-2-butyl-1,3-diazaspiro[4,4]non-1-en-4-one",0.0825,uM,=,-1.083546051450075,0,O=C1N(Cc2ccccc2)C=NC12CCCC2
4696,28299,10.1016/S0960-894X(00)80545-4,,,,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,Nc1c2c(nc3cccc(Cl)c13)CCCC2,"8-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0094,uM,=,-2.026872146400301,0,c1ccc2nc3c(cc2c1)CCCC3
4697,29096,10.1021/jm00057a007,,,,Inhibition of guinea pig acetylcholinesterase,N#CC(C#N)=C1NCCN1CCNCc1ccc(CN2CCOCC2)o1,2-(1-{2-[(5-Morpholin-4-ylmethyl-furan-2-ylmethyl)-amino]-ethyl}-imidazolidin-2-ylidene)-malononitrile,11.0,uM,=,1.0413926851582251,1,C=C1NCCN1CCNCc1ccc(CN2CCOCC2)o1
4698,451097,10.1021/jm070859s,,,,Inhibition of human Acetylcholinesterase,CC[N+](CC)(CC)CCOc1ccc(C(=O)NCCCCCC(=O)NNc2c3c(nc4cc(Cl)ccc24)CCCC3)cc1.[Br-],"2-(4-(((6-(2-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-6-oxohexyl)amino)carbonyl)phenoxy)-N,N,N-triethylethanammoniumbromide hydrochloride",0.00544,uM,=,-2.26440110030182,0,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
4699,990755,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method,COc1ccc([N+](=O)[O-])c[n+]1C.F[B-](F)(F)F,2-methoxy-1-methyl-5-nitropyridinium tetrafluoroborate,35.0,uM,=,1.5440680443502757,1,c1cc[nH+]cc1
4700,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C1c2cccnc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1,"6-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-pyrrolo[3,4-b]pyridine-5,7-dione",0.013,uM,=,-1.8860566476931635,0,O=C1c2cccnc2C(=O)N1CCC1CCN(Cc2ccccc2)CC1
4701,1677343,10.1021/acs.jmedchem.7b01086,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.355,uM,=,-0.4497716469449059,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4702,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN1CCc2cc(C(=O)CCC3CCN(Cc4ccccc4)CC3)ccc21,"3-(1-Benzyl-piperidin-4-yl)-1-(1-methyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one",0.01,uM,=,-2.0,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2
4703,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc(C(=O)c3ccccc3)cc2)c1.Cl,Methyl-carbamic acid 3-({[3-(4-benzoyl-phenoxy)-propyl]-methyl-amino}-methyl)-phenyl ester hydrochloride,0.0054,uM,=,-2.2676062401770314,0,O=C(c1ccccc1)c1ccc(OCCCNCc2ccccc2)cc1
4704,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCOc2ccc3ccccc3c2)c1.Cl,Methyl-carbamic acid 3-({methyl-[3-(naphthalen-2-yloxy)-propyl]-amino}-methyl)-phenyl ester hydrochloride,0.0825999999999999,uM,=,-1.0830199526796178,0,c1ccc(CNCCCOc2ccc3ccccc3c2)cc1
4705,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCNC(=S)Nc1ccc(OC(F)(F)F)cc1)Cc1ccccc1,1-{2-[2-(Benzyl-methyl-amino)-ethoxy]-ethyl}-3-(4-trifluoromethoxy-phenyl)-thiourea,1.0,uM,=,0.0,0,S=C(NCCOCCNCc1ccccc1)Nc1ccccc1
4706,1443169,10.1016/j.ejmech.2014.09.081,,,,Inhibition of human erythrocyte AChE preincubated for 15 mins by Ellman's method,CCCN(CCC)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,"(E)-2-(4-(dipropylamino)benzylidene)-5-methoxy-6-(2-(piperidin-1-yl)ethoxy)-2,3-dihydro-1H-inden-1-one",0.9542,uM,=,-0.0203605877770926,0,O=C1/C(=C/c2ccccc2)Cc2ccc(OCCN3CCCCC3)cc21
4707,1459232,10.1016/j.ejmech.2014.07.013,,,,Inhibition of AChE (unknown origin),O=c1cc(-c2ccc(CN3CCCCC3)cc2)oc2ccccc12,2-(4-(piperidin-1-ylmethyl)phenyl)-4H-chromen-4-one,0.055,uM,=,-1.259637310505756,0,O=c1cc(-c2ccc(CN3CCCCC3)cc2)oc2ccccc12
4708,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CC(=O)Nc1cccc2n1cc(-c1ccc(OC(=O)N(C)C)cc1)[n+]2C.[Cl-],"5-acetamido-2-(4-(dimethylcarbamoyloxy)phenyl)-1-methylimidazo[1,2-a]pyridin-1-ium",0.7,uM,=,-0.1549019599857432,0,c1ccc(-c2cn3ccccc3[nH+]2)cc1
4709,1338681,10.1016/j.ejmech.2014.03.067,,,,Inhibition of AChE (unknown origin) by Ellman colorimetric method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.1,uM,=,0.041392685158225,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4710,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),Cc1cc2c(c(C)c1CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)[C@H](C)[C@H]2O,"(2R,3R)-pteroside C",3.77,uM,=,0.5763413502057929,1,O=C1CCc2ccc(CCO[C@H]3CCCCO3)cc21
4711,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cccc(CCCCCCCCc2cccc(OC)[n+]2C)[n+]1C.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F,"6,6'-(octane-1,8-diyl)bis(2-methoxy-1-methylpyridinium)trifluoromethanesulfonate",0.18,uM,=,-0.744727494896694,0,c1ccc(CCCCCCCCc2cccc[nH+]2)[nH+]c1
4712,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccc(F)cc1F)N1CCN(c2ccccn2)CC1,"N'-(2,4-Difluorobenzylidene)-4-(pyridine-2-yl)piperazine-1-carbohydrazide",0.682,uM,=,-0.166215625343521,0,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
4713,1590871,10.1016/j.bmcl.2016.06.070,,,,Inhibition of human AChE assessed as acetylthiocholine hydrolysis preincubated for 10 mins followed by addition of substrate measured after 2 mins by spectrophotometric method,Cc1c(OC(=O)N(C)C)c2c(c[n+]1C)COCOC2.[Br-],"1,5-Dihydro-7,8-dimethyl-9-dimethylaminocarbamoyloxy-[1,3]dioxepino-[5,6-c]-pyridinium bromide",130.0,uM,=,2.113943352306837,1,c1cc2c(c[nH+]1)COCOC2
4714,1338714,10.1016/j.ejmech.2014.03.044,,,,Inhibition of recombinant human AChE by Ellman's method,O/N=C/c1nc(CCCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,"2-[(1E)-(hydroxyimino)methyl]-6-{5-[(1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}pyridin-3-ol",0.26,uM,=,-0.585026652029182,0,c1ccc(CCCCCNc2c3c(nc4ccccc24)CCCC3)nc1
4715,1525143,10.1016/j.bmcl.2015.06.047,,,,Inhibition of AChE (unknown origin),C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.005,uM,=,-2.3010299956639813,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
4716,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(Cc2ccncc2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(4-pyridylmethyl)-4-piperidyl]propan-1-one,0.121,uM,=,-0.91721462968355,0,O=C(CCC1CCN(Cc2ccncc2)CC1)c1ccccc1
4717,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1ccc(-c2cn3c(NC(C)=O)cccc3[n+]2C)cc1.[I-],"5-acetamido-1-methyl-2-(4-(methylcarbamoyloxy)phenyl)imidazo[1,2-a]pyridin-1-ium",1.1,uM,=,0.041392685158225,1,c1ccc(-c2cn3ccccc3[nH+]2)cc1
4718,1469747,10.1021/jm501501a,,,,Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccc(OC(=O)N(C)C)c5ncccc45)CC3)ccc2n1C,5-((4-(3-((1-Methyl-2-((methyl(prop-2-yn-1-yl)amino)methyl)-1H-indol-5-yl)oxy)propyl)piperidin-1-yl)methyl)quinolin-8-yl dimethylcarbamate,8.4,uM,=,0.9242792860618816,1,c1cc(CN2CCC(CCCOc3ccc4[nH]ccc4c3)CC2)c2cccnc2c1
4719,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N(Cc2ccccc2)C(NCc2ccccc2)=C([N+](=O)[O-])C12C(=O)c1cccc3cccc2c13,"2'-amino-1'-benzyl-6'-(benzylamino)-5'-nitro-2-oxo-1'H,2H-spiro[acenaphthylene-1,4'-pyridine]-3'-carbonitrile",5.96,uM,=,0.7752462597402364,1,O=C1c2cccc3cccc(c23)C12C=CN(Cc1ccccc1)C(NCc1ccccc1)=C2
4720,2193766,10.1039/d2md00042c,,,,Inhibition of human serum recombinant AChE using acetylthiocholine iodide as a substrate incubated for 20 mins by DTNB reagent based Ellman's method,CCN(CC)Cc1ccc(/C=C2/Cc3cc(OC)ccc3C2=O)cc1,(2Z)-2-[[4-(diethylaminomethyl)phenyl]methylene]-5-methoxy-indan-1-one,1.15,uM,=,0.0606978403536116,1,O=C1/C(=C\c2ccccc2)Cc2ccccc21
4721,305005,10.1021/jm049113+,,,,Inhibitory concentration against Acetylcholinesterase; (range = 2-20 uM),CC1CCCCN1CCCN1CC(=O)N(CCc2ccc(F)cc2)CC1=O,"1-[2-(4-Fluoro-phenyl)-ethyl]-4-[3-(2-methyl-piperidin-1-yl)-propyl]-piperazine-2,5-dione",20.0,uM,=,1.3010299956639813,1,O=C1CN(CCc2ccccc2)C(=O)CN1CCCN1CCCCC1
4722,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2cc([N+](=O)[O-])ccc2o1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-6-nitro-4-oxo-4H-chromene-2-carboxamide,0.021,uM,=,-1.6777807052660807,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
4723,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)CCCCCC2,"6,7,8,9,10,11-Hexahydro-cycloocta[b]quinolin-12-ylamine",9.1,uM,=,0.9590413923210936,1,c1ccc2nc3c(cc2c1)CCCCCC3
4724,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2oc(C(=O)OCCC3CCN(Cc4ccccc4)CC3)cc(=O)c2cc1OC,"2-(1-Benzylpiperidin-4-yl)ethyl 6,7-dimethoxy-4-oxo-4H-chromene-2-carboxylate",0.056,uM,=,-1.2518119729937995,0,O=C(OCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
4725,958767,10.1016/j.bmcl.2013.03.027,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 15 mins prior to substrate addition measured after 30 mins by Ellman's method,O=C1/C(=C/c2ccccc2Cl)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2cc(Cl)ccc23)C/C1=C\c1ccccc1Cl,"(2'S,3R,7a'R)-2'-((3E,5E)-3,5-bis(2-chlorobenzylidene)-4-oxopiperidine-1-carbonyl)-6-chloro-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one",5.08,uM,=,0.7058637122839193,1,O=C1/C(=C/c2ccccc2)CN(C(=O)[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1ccccc1
4726,1585842,10.1039/C6MD00053C,,,,Inhibition of human erythrocytes acetylcholinesterase preincubated for 5 mins followed by addition of acetylthiocholine iodide as substrate measured after 60 to 120 mins by Ellmans method,COc1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)ccc1O,(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide,0.729,uM,=,-0.1372724716820254,0,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4727,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,COc1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1OC,"N2-(1-Benzylpiperidin-4-yl)-N4-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamine",9.9,uM,=,0.99563519459755,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
4728,882269,10.1016/j.ejmech.2012.06.038,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by Ellman's method,Nc1c2c(nc3c1C(c1ccc([N+](=O)[O-])cc1)c1ccc4ccccc4c1O3)CCCC2,"rac-7-(4-Nitrophenyl)-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amine",5.74,uM,=,0.7589118923979735,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2ccccc32)CCCC4)cc1
4729,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1ccc2c(CCNC(=O)c3ccc(CN(C)Cc4ccccc4)cc3)c[nH]c2c1,4-{[Benzyl(methyl)amino]methyl}-N-[2-(6-methoxy-1Hindol-3-yl)ethyl]benzamide,4.1,uM,=,0.6127838567197355,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
4730,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2cccc(Cl)c2)CC1)c1ccc2c(c1)NCCCC2,"3-[1-(3-Chloro-benzyl)-piperidin-4-yl]-1-(2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-propan-1-one",0.333,uM,=,-0.4775557664936801,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2
4731,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCc3cc[n+](CC4CCC4)cc3)sc2cc1OC.[Br-],"1-Cyclobutylmethyl-4-[3-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium bromide",0.04,uM,=,-1.3979400086720375,0,O=C(CCc1cc[n+](CC2CCC2)cc1)c1cc2ccccc2s1
4732,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@@H](C1)C2.Cl.Cl.Cl,"(+)-(7R,11R)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-({7-[(1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}amino)-7,11-methanocycloocta[b]quinoline Dihydrochloride",0.00684,uM,=,-2.164943898279884,0,C1=C[C@H]2Cc3nc4ccccc4c(NCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3[C@@H](C1)C2
4733,831932,10.1016/j.ejmech.2012.06.051,,,,Inhibition of human recombinant AChE using acetylthiocholine substrate preincubated for 5 mins before substrate addition by Ellman's method,O=C(CCNCCNc1c2c(nc3ccccc13)CCCC2)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1,"3-{[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]amino}-1-{4-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]piperazino}-1-propanone",0.00449,uM,=,-2.3477536589966768,0,O=C(CCNCCNc1c2c(nc3ccccc13)CCCC2)N1CCN(CCNc2c3c(nc4ccccc24)CCCC3)CC1
4734,29413,10.1021/jm00081a023,,,,Inhibition of acetylcholinesterase activity,CN1CCC(=C2Cc3ccccc3C2=O)CC1,2-(1-Methyl-piperidin-4-ylidene)-indan-1-one,1.2,uM,=,0.0791812460476248,1,O=C1C(=C2CCNCC2)Cc2ccccc21
4735,2295738,10.1016/j.bmc.2023.117256,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins followed by substrate addition and measured for 5 mins by Ellman's spectrophotometric method,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1,"2-(4-(4-benzylpiperazin-1-yl)butyl)-4,4a,5,6-tetrahydrothieno[3,2-h]cinnolin-3(2H)-one",0.756,uM,=,-0.1214782044987934,0,O=C1CC2CCc3ccsc3C2=NN1CCCCN1CCN(Cc2ccccc2)CC1
4736,1842234,10.1016/j.bmc.2019.01.025,,,,Inhibition of human acetylcholinesterase,COc1ccc2[nH]cc(CCNC(=O)CN(CCCC3CCN(Cc4ccccc4)CC3)C(=O)/C=C/c3ccc(O)c(OC)c3)c2c1,N-(3-(1-benzylpiperidin-4-yl)propyl)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-(2-(5-methoxy-1H-indol-3-yl)ethylamino)-2-oxoethyl)acrylamide,0.0261999999999999,uM,=,-1.5816987086802543,0,O=C(CN(CCCC1CCN(Cc2ccccc2)CC1)C(=O)/C=C/c1ccccc1)NCCc1c[nH]c2ccccc12
4737,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1,N'-Benzylidene-4-(pyridin-2-yl)piperazine-1-carbohydrazide,3.62,uM,=,0.5587085705331657,1,O=C(N/N=C/c1ccccc1)N1CCN(c2ccccn2)CC1
4738,714889,10.1021/np100494u,,,,Inhibition of AChE by Ellman's method,C[C@@H]([C@H]1[C@H](O)C[C@@]2(C)[C@@H]3C[C@H](O)[C@H]4[C@]5(C)CO[C@]4(C=C[C@@H]5NC(=O)c4ccccc4)CC3=CC[C@]12C)N(C)C,O10-natafuranamine,8.5,uM,=,0.9294189257142929,1,O=C(N[C@H]1C=C[C@@]23CC4=CCC5CCCC5[C@@H]4CC[C@H]2C1CO3)c1ccccc1
4739,2116201,10.1016/j.bmc.2021.116355,,,,Inhibition of recombinant human AChE expressed in HEK293 cells by Ellman's method,C[n+]1ccc2c(c1)c1cc(F)ccc1n2CCC(=O)N1c2ccccc2Sc2ccccc21.[I-],"8-fluoro-2-methyl-5-(3-oxo-3-(10H-phenothiazin-10-yl)propyl)-5H-pyrido[4,3-b]indol-2-ium iodide",2.6,uM,=,0.414973347970818,1,O=C(CCn1c2ccccc2c2c[nH+]ccc21)N1c2ccccc2Sc2ccccc21
4740,1653858,10.1016/j.ejmech.2016.11.050,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by spectrophotometry based Ellman method,Nc1c2c(nc3c1C(c1ccccc1)c1ccc4cccnc4c1O3)CCCC2,"7-Phenyl-9,10,11,12-tetrahydro-7H-pyrano[2,3-b:5,6-h']diquinolin-8-amine",1.73,uM,=,0.2380461031287954,1,c1ccc(C2c3cc4c(nc3Oc3c2ccc2cccnc32)CCCC4)cc1
4741,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,"3,4-di-O-caffeoylquinic acid",2.14,uM,=,0.3304137733491908,1,O=C(/C=C/c1ccccc1)O[C@@H]1CCCC[C@H]1OC(=O)/C=C/c1ccccc1
4742,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cc1cccc2nc3c(c(N)c12)CCC3.Cl,"8-methyl-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",0.415,uM,=,-0.3819519032879073,0,c1ccc2nc3c(cc2c1)CCC3
4743,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(CCCNC(=O)COc2ccc(-c3ccc(OC)cc3)cc2)CC1,"N-(3-(4-Ethylpiperazin-1-yl)propyl)-2-((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)acetamide",110.0,uM,=,2.041392685158225,1,O=C(COc1ccc(-c2ccccc2)cc1)NCCCN1CCNCC1
4744,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Clc1ccc2c(NCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c3c(nc2c1)CCCC3,"N,N'-Bis-(6-chloro-1,2,3,4-tetrahydro-acridin-9-yl)-octane-1,8-diamine",0.0003,uM,=,-3.522878745280338,0,c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3
4745,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CC1CCN(Cc3cc(Br)cc(/C=N/O)c3O)CC1)CC2,"5-bromo-3-((4-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-2-hydroxybenzaldehyde oxime",977.4,uM,=,2.990072334692153,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3c3ccccc3)CC2)cc1
4746,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2cc(Cl)cc(Cl)c2)C3=O)c1,"Methyl-carbamic acid 3-[({7-[2-(3,5-dichloro-benzylidene)-3-oxo-2,3-dihydro-benzofuran-6-yloxy]-heptyl}-methyl-amino)-methyl]-phenyl ester",0.0446,uM,=,-1.350665141287858,0,O=C1/C(=C/c2ccccc2)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
4747,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,"1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile",73.3,uM,=,1.865103974641128,1,c1ccc(C2OCc3ccccc32)cc1
4748,811246,10.1021/jm200840c,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior substrate addition measured after 5 mins by spectrophotometry,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCN(C)CCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3C(C1)C2.Cl,"{3-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}[3-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)propyl]methylamine hydrochloride",0.00031,uM,=,-3.508638306165728,0,C1=CC2Cc3nc4ccccc4c(NCCCNCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4749,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,COc1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1,"N2-(1-Benzylpiperidin-4-yl)-N4-(4-methoxybenzyl)pyrimidine-2,4-diamine",9.4,uM,=,0.9731278535996988,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
4750,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1c(F)c[n+](CCCOc2ccc3c(C)cc(=O)oc3c2)cc1F.O=S(=O)([O-])C(F)(F)F,"3,5-difluoro-4-methoxy-1-(3-(4-methyl-2-oxo-2H-chromen-7-yloxy)propyl)pyridinium trifluoromethanesulfonate",1.7,uM,=,0.2304489213782739,1,O=c1ccc2ccc(OCCC[n+]3ccccc3)cc2o1
4751,2221647,10.1016/j.bmcl.2022.128602,,,,Inhibition of AChE (unknown origin),CN1c2ccccc2C(NCCCCCCC(=O)CCCCNc2c3c(nc4ccccc24)CCCC3)c2ccc(Cl)cc2S1(=O)=O,"11-((3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino)-1-((1,2,3,4-tetrahydroacridin-9-yl)amino)undecan-5-one",0.16,uM,=,-0.7958800173440752,0,O=C(CCCCCCNC1c2ccccc2NS(=O)(=O)c2ccccc21)CCCCNc1c2c(nc3ccccc13)CCCC2
4752,2082795,10.1016/j.ejmech.2021.113286,,,,Inhibition of human AChE assessed as decrease in enzyme activity incubated for 30 mins by Ellman's method,O=S(=O)(Nc1nccs1)c1ccc(NCc2cc(Cl)cc(/C=N/O)c2O)cc1,(E)-4-(5-chloro-2-hydroxy-3-((hydroxyimino)methyl)benzylamino)-N-(thiazol-2-yl)benzenesulfonamide,4275.0,uM,=,3.630936119064192,1,O=S(=O)(Nc1nccs1)c1ccc(NCc2ccccc2)cc1
4753,462117,10.1021/jm7009364,,,,Inhibition of human AchE,Cc1c(N2CCN(C)CC2)nc2ccccc2c1C(=O)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"3-Methyl-2-(4-methyl-piperazin-1-yl)-quinoline-4-carboxylic acid [7-(1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-amide",0.0040999999999999,uM,=,-2.3872161432802645,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(N2CCNCC2)nc2ccccc12
4754,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CCCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1.Cl,Methyl-carbamic acid 3-({methyl-[8-(9-oxo-9H-xanthen-3-yloxy)-octyl]-amino}-methyl)-phenyl ester hydrochloride,0.0068,uM,=,-2.167491087293764,0,O=c1c2ccccc2oc2cc(OCCCCCCCCNCc3ccccc3)ccc12
4755,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12C(=O)c1ccc(Br)c3c(Br)ccc2c13,"5'-amino-5,6-dibromo-8'-nitro-2-oxo-2',3'-dihydro-1'H,2H-spiro[acenaphthylene-1,7'-imidazo[1,2-a]pyridine]-6'-carbonitrile",6.37,uM,=,0.8041394323353505,1,O=C1c2cccc3cccc(c23)C12C=CN1CCNC1=C2
4756,2304347,10.1016/j.ejmech.2020.112666,,,,Inhibition of AChE (unknown origin),CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,SID11111527,22.2,uM,=,1.3463529744506386,1,c1ccccc1
4757,28291,10.1016/s0960-894x(02)00483-3,,,,Concentration required for the inhibition of acetylcholinesterase,COc1cc2cc(C(=O)CCCCC3CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC.[Br-],"1-Benzyl-4-[5-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-5-oxo-pentyl]-1-methyl-piperidinium bromide",0.11,uM,=,-0.958607314841775,0,O=C(CCCCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
4758,28629,10.1021/jm981101z,,,,Inhibitory concentration against acetylcholinesterase (AChE) from human erythrocytes,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.095,uM,=,-1.0222763947111522,0,c1ccc2nc3c(cc2c1)CCCC3
4759,508688,10.1021/np000441w,,,,Inhibition of AChE by spectrophotometry,COc1cc(OCC=C(C)C)c2ccc(=O)oc2c1,7-methoxy-5-prenyloxycoumarin,240.0,uM,=,2.380211241711606,1,O=c1ccc2ccccc2o1
4760,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]c(-c3ccccc3)nc2c1,3-(1-benzylpiperidin-4-yl)-1-(2-phenyl-1H-benzo[d]imidazol-5-yl)propan-1-one,0.033,uM,=,-1.4814860601221125,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]c(-c3ccccc3)nc2c1
4761,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1cc2c(cc1OC)C(=O)C(CCCCCc1cccc(OC)[n+]1C)C2.O=S(=O)([O-])C(F)(F)F,"2-(5-(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)pentyl)-6-methoxy-1-methylpyridinium trifluoromethanesulfonate",0.12,uM,=,-0.9208187539523752,0,O=C1c2ccccc2CC1CCCCCc1cccc[nH+]1
4762,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2cc[n+](-c3cccc(C#N)c3)cc12.[Br-],2-(3-Cyanophenyl)-8-methoxyisoquinolin-2-ium bromide,3.41,uM,=,0.5327543789924978,1,c1ccc(-[n+]2ccc3ccccc3c2)cc1
4763,1525953,10.1021/acs.jmedchem.5b01325,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1ccc2nc3c(c(NCCCCCCNC(=O)C4(C)CCc5c(C)c(O)c(C)c(C)c5O4)c2c1)CCCC3,"6-hydroxy-N-(6-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-2,5,7,8-tetramethylchroman-2-carboxamide",6.61,uM,=,0.8202014594856403,1,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)C1CCc2ccccc2O1
4764,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1[C@H]1CCCCN1C2=O,"(-)-(R)-1-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)pyridin-2-yl)urea",0.0095,uM,=,-2.0222763947111524,0,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1[C@H]1CCCCN1C2=O
4765,459365,10.1021/np0702077,,,,Inhibition of AChE by Ellman method,COc1ccc2c3c1O[C@H]1C[C@H](O)C=C[C@@]31[C@H](O)CN(C)C2,Epinorgalantamine,9.01,uM,=,0.9547247909790628,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4766,1683700,10.1016/j.ejmech.2017.02.045,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate pretreated for 6 mins followed by substrate addition measured up to 180 sec by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc(Br)cc3)cc1)C2.[Br-],"(E)-1-(4-bromobenzyl)-4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)pyridin-1-ium bromide",0.0697,uM,=,-1.1567672219019909,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)Cc2ccccc21
4767,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,O=C(/C=C/c1ccc(OCCCCN2CCCCC2)cc1)c1c(O)cc(OCCCCN2CCCCC2)cc1O,"1-(2,6-dihydroxy-4-(4-(piperidin-1-yl)butoxy)phenyl)-3-(4-(4-(piperidin-1-yl)butoxy)phenyl)prop-2-en-1-one",5.1,uM,=,0.7075701760979364,1,O=C(/C=C/c1ccc(OCCCCN2CCCCC2)cc1)c1ccc(OCCCCN2CCCCC2)cc1
4768,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1cc(C#N)c(NCCCC2CCN(Cc3ccccc3)CC2)nc1Cl,"2-((3-(1-Benzylpiperidin-4-yl)propyl)amino)-6-chloropyridine-3,5-dicarbonitrile",0.054,uM,=,-1.2676062401770316,0,c1ccc(CN2CCC(CCCNc3ccccn3)CC2)cc1
4769,2032523,10.1016/j.ejmech.2020.112265,,,,Inhibition of human erythrocytes AChE using acetylcholine iodide as substrate incubated for 15 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,"(E)-4-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl diphenylcarbamate",30.5,uM,=,1.484299839346786,1,O=C(/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)cc1)N1CCc2ccccc2C1
4770,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),COc1ccc(C(=O)N2Cc3ccc(N4C(=O)c5ccccc5C4=O)cc3CC2=O)cc1,"2-(2-(4-methoxybenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-6-yl)isoindoline-1,3-dione",0.0818499999999999,uM,=,-1.08698131625204,0,O=C1Cc2cc(N3C(=O)c4ccccc4C3=O)ccc2CN1C(=O)c1ccccc1
4771,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,CCN(CCCCCCCCCCCCn1cc(C=O)c2cc(OC)ccc21)Cc1cccc(O)c1,1-(12-(ethyl(3-methoxybenzyl)amino)dodecyl)-5-methoxy-1H-indole-3-carbaldehyde,42.49,uM,=,1.6282867310895144,1,c1ccc(CNCCCCCCCCCCCCn2ccc3ccccc32)cc1
4772,1932474,10.1021/acs.jmedchem.6b00426,,,,Inhibition of human erythrocyte AChE using ATCI as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman assay,Cc1ccc(-c2nc(NCC3CCN(Cc4cc(F)cc(F)c4)CC3)sc2-c2ccc(C)cc2)cc1,"N-[(1-(3,5-Difluorobenzyl)piperidin-4-yl)methyl]-4,5-bis(ptolyl)thiazol-2-ylamine",0.3,uM,=,-0.5228787452803376,0,c1ccc(CN2CCC(CNc3nc(-c4ccccc4)c(-c4ccccc4)s3)CC2)cc1
4773,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc(/C=C/c2cc(=O)oc3c2ccc2oc(-c4ccc(Cl)cc4)cc23)cc(OC)c1,"8-(4-chlorophenyl)-4-(3,5-dimethoxystyryl)-2H-furo[2,3-h]chromen-2-one",1.8,uM,=,0.255272505103306,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
4774,1454788,10.1016/j.ejmech.2014.07.021,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric analysis,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.0059,uM,=,-2.229147988357856,0,c1ccc2nc3c(cc2c1)CCCC3
4775,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CN(C)c1ccc(/C=C2\CCc3ccccc3C2=O)c([N+](=O)[O-])c1,"2-(4-Dimethylamino-2-nitro-benzylidene)-3,4-dihydro-2Hnaphthalen-1-one",79.31,uM,=,1.899327949877654,1,O=C1/C(=C/c2ccccc2)CCc2ccccc21
4776,1332182,10.1039/C2MD20165H,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate by visible spectrophotometry,CC[N+](CC)(CC)CCOCCOCCOC(=O)[C@]1(C)CCC[C@@]2(C)[C@@H]3CC[C@@]4(C)C[C@]3(CC[C@@H]21)CC4=O.[Br-],,80.0,uM,=,1.9030899869919435,1,O=C1C[C@]23CC[C@@H]4CCCCC4[C@@H]2CCC1C3
4777,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2oc(-c3cccc(CN(C)Cc4ccccc4)c3)cc(=O)c2cc1OC,"2-{3-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxychromen-4-one",2.27,uM,=,0.3560258571931227,1,O=c1cc(-c2cccc(CNCc3ccccc3)c2)oc2ccccc12
4778,28303,10.1021/jm00039a013,,,,In vitro inhibitory activity against human acetylcholinesterase,CCCCCCNC(=O)Oc1ccc2c(c1)C1CCN(C)C2C1,"Hexyl-carbamic acid 9-methyl-9-aza-tricyclo[6.3.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.072,uM,=,-1.1426675035687317,0,c1ccc2c(c1)C1CCNC2C1
4779,1801925,10.1016/j.ejmech.2018.08.016,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine as substrate measured for 1 min,CCCCCCN(C)Cc1cc(N)ccc1O.Cl.Cl,4-amino-2-((hexyl(methyl)amino)methyl)phenol dihydrochloride,1053.5,uM,=,3.0226345399441192,1,c1ccccc1
4780,2082220,10.1016/j.ejmech.2021.113224,,,,Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(OC)c3)CC2)nc1-c1ccccc1,Ethyl 2-(4-((4-acetamido-3-methoxyphenyl)sulfonyl)piperazin-1-yl)-4-methyl-6-phenylpyrimidine-5-carboxylate,0.0789899999999999,uM,=,-1.1024278861742696,0,O=S(=O)(c1ccccc1)N1CCN(c2nccc(-c3ccccc3)n2)CC1
4781,606474,10.1016/j.bmc.2009.08.017,,,,Inhibition of human AChE by Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(/N=C/C=C/c1ccccc1)c1ccc(=O)[nH]c1C2,"13-Ethylidene-11-methyl-1-[3-phenyl-prop-2-enylideneamino]-6-aza-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,10-trien-5-one",0.024,uM,=,-1.619788758288394,0,C=C1[C@H]2C=CC[C@]1(/N=C/C=C/c1ccccc1)c1ccc(=O)[nH]c1C2
4782,1707150,10.1016/j.bmcl.2017.07.013,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate by Ellman's method,Cc1ccc2c(c1)C(=O)C(=O)N2Cc1ccc(Br)cc1,"1-(4-bromobenzyl)-5-methylindoline-2,3-dione",0.20417,uM,=,-0.69000807121882,0,O=C1C(=O)N(Cc2ccccc2)c2ccccc21
4783,462117,10.1021/jm7009364,,,,Inhibition of human AchE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)O/C(=C\c2cccc4ccccc24)C3=O)c1,"Methyl-carbamic acid 3-({methyl-[7-(2-naphthalen-1-ylmethylene-3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-amino}-methyl)-phenyl ester",2.76,uM,=,0.4409090820652177,1,O=C1/C(=C/c2cccc3ccccc23)Oc2cc(OCCCCCCCNCc3ccccc3)ccc21
4784,1473459,10.1016/j.ejmech.2015.01.027,,,,Inhibition of human recombinant AChE after 5 mins by Ellman's method,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccc(F)cc1F,"2-(6-(2,4-diFluorobenzylamino)hexyl)isoindoline-1,3-dione",1.596,uM,=,0.2030328870147106,1,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1
4785,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2c(nc3ccccc13)-c1ccccc1CCC2,"6,7-Dihydro-5H-13-aza-benzo[3,4]cyclohepta[1,2-b]naphthalen-8-ylamine",166.1,uM,=,2.220369632451394,1,c1ccc2c(c1)CCCc1cc3ccccc3nc1-2
4786,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCC(=O)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-phenyl-propionamide,0.83,uM,=,-0.0809219076239261,0,c1ccc(CN2CCC(CCNc3ccccc3)CC2)cc1
4787,1765157,10.1021/acs.jmedchem.8b00592,,,,Inhibition of human recombinant AChE by spectrophotometry based Ellman's assay,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1,Obidoxime,640.0,uM,=,2.806179973983887,1,c1cc[n+](COC[n+]2ccccc2)cc1
4788,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,CN(Cc1ccccc1)Cc1ccc(C(=O)NCCc2c[nH]c3ccccc23)cc1,N-[2-(1H-Indol-3-yl)ethyl]-4-{[benzyl(methyl)amino]methyl}-benzamide,1.9,uM,=,0.2787536009528289,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
4789,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CNC(=O)Oc1cccc(CN(C)CCCCCCCOc2ccc3c(c2)OCC3=O)c1,"Methyl-carbamic acid 3-({methyl-[7-(3-oxo-2,3-dihydro-benzofuran-6-yloxy)-heptyl]-amino}-methyl)-phenyl ester",1.61,uM,=,0.2068258760318497,1,O=C1COc2cc(OCCCCCCCNCc3ccccc3)ccc21
4790,28293,10.1021/jm00095a008,,,,In vitro acetyl cholinesterase (AChE-I) inhibitory activity to determine its ability to reverse the cholinergic deficit characteristic of AD,CN(C)Cc1ccc(CSCCNc2nnccc2[N+](=O)[O-])o1,[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-(4-nitro-pyridazin-3-yl)-amine,0.47,uM,=,-0.3279021420642826,0,c1cnnc(NCCSCc2ccco2)c1
4791,1978343,10.1016/j.bmcl.2019.126888,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1ccccc1-c1ccc(/C=N/N2CC(=O)N(CCC3CCN(Cc4ccccc4)CC3)C2=O)o1,"3-(2-(1-benzylpiperidin-4-yl)ethyl)-1-((5-(2-methoxyphenyl)furan-2-yl)methyleneamino)imidazolidine-2,4-dione",0.0904,uM,=,-1.0438315695246367,0,O=C1CN(/N=C/c2ccc(-c3ccccc3)o2)C(=O)N1CCC1CCN(Cc2ccccc2)CC1
4792,1447982,10.1021/jm5008648,,,,Inhibition of human recombinant AChE pre-incubated for 5 mins before acetylthiocholine substrate addition by Ellman's method,O=C(Cc1cc(=O)oc2cc(O)ccc12)NCCCCNc1c2c(nc3ccccc13)CCCC2,"2-(7-hydroxy-2-oxo-2H-chromen-4-yl)-N-(4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl)acetamide",0.0154,uM,=,-1.812479279163537,0,O=C(Cc1cc(=O)oc2ccccc12)NCCCCNc1c2c(nc3ccccc13)CCCC2
4793,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CN1CCN(CCCNC(=O)COc2ccc(-c3ccccc3)cc2)CC1,"2-([1,1'Biphenyl]-4-yloxy)-N-(3-(4-methylpiperazin-1-yl)propyl)acetamide",115.0,uM,=,2.060697840353612,1,O=C(COc1ccc(-c2ccccc2)cc1)NCCCN1CCNCC1
4794,2102746,10.1016/j.bmc.2021.116385,,,,Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method,COc1cc(/C=C/C(=O)N2CCN(Cc3cccc(Cl)c3)CC2)ccc1O,(E)-1-(4-(3-chlorobenzyl)piperazin-1-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one,15.43,uM,=,1.1883659260631485,1,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccccc2)CC1
4795,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,O=C1CCN(Cc2ccccc2)C/C1=C\c1ccn(C(=O)c2ccccc2)c1,3-(1-Benzoyl-1H-pyrrol-3-ylmethylene)-1-benzyl-piperidin-4-one,30.0,uM,=,1.4771212547196624,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1ccn(C(=O)c2ccccc2)c1
4796,2207446,10.1021/acs.jmedchem.2c01003,,,,Inhibition of human recombinant AChe using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.06,uM,=,-1.2218487496163564,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4797,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]c(CCNC(=O)CCCn3cc(CCCCN4CCc5cc(OC)c(OC)cc5C4CCCN4C(=O)c5ccccc5C4=O)nn3)cc2c1,"4-(4-(4-(1-(3-(1,3-dioxoisoindolin-2-yl)propyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-1H-1,2,3-triazol-1-yl)-N-(2-(5-methoxy-1H-indol-2-yl)ethyl)butanamide",158.6,uM,=,2.200303182981585,1,O=C(CCCn1cc(CCCCN2CCc3ccccc3C2CCCN2C(=O)c3ccccc3C2=O)nn1)NCCc1cc2ccccc2[nH]1
4798,1556092,10.1016/j.bmc.2016.02.019,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as reduction of DTNB to TNB preincubated for 20 mins followed by addition of substrate by Ellman's kinetic method,N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccc(F)cc12,"6'-amino-5-fluoro-9'-nitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile",0.42,uM,=,-0.3767507096020995,0,O=C1Nc2ccccc2C12C=CN1CCCNC1=C2
4799,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c2c1,"6-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4800,2164306,10.1021/acs.jmedchem.1c01784,,,,Inhibition of human recombinant AChE by Ellman's spectrophotometric assay,Cc1c(C)c2ccc(OCC3CCN(CCCO)CC3)cc2oc1=O,"7-{[1-(3-Hydroxypropyl)piperidin-4-yl]methoxy}-3,4-dimethyl-2H-chromen-2-one",0.89,uM,=,-0.0506099933550872,0,O=c1ccc2ccc(OCC3CCNCC3)cc2o1
4801,956785,10.1016/j.ejmech.2013.01.060,,,,Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry,Fc1ccccc1Cc1nnc2sc(-c3ccoc3)nn12,"3-(2-Fluorobenzyl)-6-(furan-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole",1.78,uM,=,0.250420002308894,1,c1ccc(Cc2nnc3sc(-c4ccoc4)nn23)cc1
4802,28164,10.1021/jm00007a005,,,,Concentration required to inhibit 50% of Acetylcholinesterase obtained from human erythrocytes was determined in vitro,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.267,uM,=,-0.5734887386354247,0,c1ccc2nc3c(cc2c1)CCCC3
4803,1470629,10.1021/acs.jmedchem.5b00115,,,,Inhibition of human erythrocyte AChE pre-incubated for 5 mins before acetylthiocholine iodide substrate by Ellman' method,COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CCC2CCCCC2)CC1,1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylethyl)-4-piperidyl]propan-1-one,0.222,uM,=,-0.6536470255493614,0,O=C(CCC1CCN(CCC2CCCCC2)CC1)c1ccccc1
4804,2063858,10.1016/j.bmc.2016.09.044,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate preincubated with enzyme for 15 mins followed by substrate addition by Ellman's method,CN1C[C@@H](c2cccc(Br)c2)[C@@]2(CSc3ccccc3C2=O)C12C(=O)c1ccccc1C2=O,"(3'R,4'S)-4'-(3-Bromophenyl)-1'-methyldispiro[indene-2,2'-pyrrolidine-3',3''-thiochromane]-1,3,4''-trione",19.8,uM,=,1.2966651902615312,1,O=C1c2ccccc2C(=O)C12NC[C@@H](c1ccccc1)[C@@]21CSc2ccccc2C1=O
4805,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCOCC2)CC1,"2-([1,1'-Biphenyl]-4-yloxy)-1-(4-morpholinopiperidin-1-yl)ethan-1-one",93.0,uM,=,1.9684829485539352,1,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCOCC2)CC1
4806,1797236,10.1021/acs.jmedchem.8b01060,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay,CCN1CCN(C2CCN(C(=O)COc3ccc(-c4ccc([N+](=O)[O-])cc4)cc3)CC2)CC1,1-(4-(4-ethylpiperazin-1-yl)piperidin-1-yl)-2-(4'-nitrobiphenyl-4-yloxy)ethanone,2.1,uM,=,0.3222192947339193,1,O=C(COc1ccc(-c2ccccc2)cc1)N1CCC(N2CCNCC2)CC1
4807,960980,10.1021/ml4000996,,,,Inhibition of acetyl cholinesterase (unknown origin),CN(C)C(=O)[C@H]1C[C@@H]1c1ccc(-c2ncn(C)c2Sc2ccc(Cl)cn2)cc1,"(1S,2S)-2-(4-(5-((5-Chloropyridin-2-yl)thio)-1-methyl-1H-imidazol-4-yl)phenyl)-N,N-dimethylcyclopropanecarboxamide",1.63,uM,=,0.2121876044039577,1,c1ccc(Sc2[nH]cnc2-c2ccc(C3CC3)cc2)nc1
4808,1990435,10.1021/acs.jnatprod.0c00306,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition and measured after 30 mins by Ellman's method,CC(C)=CC[C@H]1C[C@]2(CC=C(C)C)C(=O)[C@]3(CC=C(C)C)O[C@@]1(C(=O)C(C)C)[C@@]2(O)C(C)(C)C3=O,Garcinielliptin oxide,20.7,uM,=,1.3159703454569178,1,O=C1CC2C3CCC2C(=O)C1O3
4809,2200852,10.1016/j.ejmech.2020.112860,,,,Inhibition of AChE (unknown origin),COc1ccc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)CC[C@@H](O)C(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc1,Arisugacin J,0.64,uM,=,-0.1938200260161128,0,O=c1oc(-c2ccccc2)cc2c1CC1C(CCC3CCCCC31)O2
4810,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3cccc(Cl)c13)CCCCC2,"1-chloro-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride",223.0,uM,=,2.3483048630481607,1,c1ccc2nc3c(cc2c1)CCCCC3
4811,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,N#Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,3-(2-Morpholin-4-yl-ethylamino)-6-phenyl-pyridazine-4-carbonitrile (2HCl 2H2O),100.0,uM,=,2.0,1,c1ccc(-c2ccc(NCCN3CCOCC3)nn2)cc1
4812,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,COc1cc(/C=C/C(=O)Nc2ccccc2)ccc1OCCCCCCCCCCN1CCCC1,(E)-3-(3-methoxy-4-((10-(pyrrolidin-1-yl)decyl)oxy)phenyl)-N-phenylacrylamide,13.52,uM,=,1.1309766916056172,1,O=C(/C=C/c1ccc(OCCCCCCCCCCN2CCCC2)cc1)Nc1ccccc1
4813,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-n2nnnc2C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1,"2-butyl-3-[2'-(1-trityl-tetrazol-5-yl)biphenyl-4-ylmethyl]-1,3-diaza spiro[4,4]non-1-en-4-one",0.3835,uM,=,-0.4162346317150002,0,O=C1N(Cc2ccc(-c3ccccc3-n3nnnc3C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2)C=NC12CCCC2
4814,2129521,10.1016/j.bmc.2021.116269,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CCCCn3cc(CN4CC[C@@]56C=C[C@H](O)C[C@@H]5Oc5c(OC)ccc(c56)C4)nn3)c2c1,,1.002,uM,=,0.0008677215312269,1,O=C(CCCCn1cc(CN2CC[C@@]34C=CCC[C@@H]3Oc3cccc(c34)C2)nn1)NCCc1c[nH]c2ccccc12
4815,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,C#CCN(C)Cc1ccc(C(=O)c2ccc(OC)c(OC)c2)cc1,"(3,4-Dimethoxyphenyl)-{4-[(methylprop-2-ynylamino)-methyl]phenyl}methanone",27.2,uM,=,1.434568904034199,1,O=C(c1ccccc1)c1ccccc1
4816,29414,10.1021/jm0109356,,,,Inhibitory concentration required against acetylcholinesterase activity,COc1ccc(C(=O)n2cc(/C=C3\CN(Cc4ccccc4)CCC3=O)c3ccccc32)cc1,1-Benzyl-3-[1-(4-methoxy-benzoyl)-1H-indol-3-ylmethylene]-piperidin-4-one,70.0,uM,=,1.845098040014257,1,O=C1CCN(Cc2ccccc2)C/C1=C\c1cn(C(=O)c2ccccc2)c2ccccc12
4817,305184,10.1016/j.bmcl.2004.10.067,,,,Inhibitory concentration against Acetylcholinesterase activity,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.09,uM,=,-1.0457574905606752,0,c1ccc2nc3c(cc2c1)CCCC3
4818,1783503,10.1016/j.ejmech.2018.01.007,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by Ellman's method,O=C(CCCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-4-(1H-indol-3-yI)-butyramide,1.26,uM,=,0.1003705451175629,1,O=C(CCCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
4819,739672,10.1016/j.bmcl.2011.02.047,,,,Inhibition of human erythrocyte recombinant AChE by modified Ellman's method,C(=C/C[n+]1cccc2ccccc21)\C[n+]1cccc2ccccc21.[Br-].[Br-],"1,1'-(but-2-ene-1,4-diyl)diquinolinium bromide",6.0,uM,=,0.7781512503836436,1,C(=C/C[n+]1cccc2ccccc21)\C[n+]1cccc2ccccc21
4820,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,[2-(1-Benzyl-piperidin-4-yl)-ethyl]-ethyl-phenyl-amine,12.0,uM,=,1.0791812460476249,1,c1ccc(CN2CCC(CCNc3ccccc3)CC2)cc1
4821,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=C(c1ccncc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1,N-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-N-phenyl-isonicotinamide,0.064,uM,=,-1.193820026016113,0,O=C(c1ccncc1)N(CCC1CCN(Cc2ccccc2)CC1)c1ccccc1
4822,2087078,10.1016/j.ejmech.2020.112180,,,,Inhibition of AChE in human erythrocytes by Ellman's method,CCN(CCCCOc1ccc(C2CC(=O)c3c(O)cc(OCCCCN(CC)Cc4ccccc4OC)cc3O2)cc1)Cc1ccccc1OC,7-(4-(ethyl(2-methoxybenzyl)amino)butoxy)-2-(4-(4-(ethyl(2-methoxybenzyl)amino)butoxy)phenyl)-5-hydroxychroman-4-one,4.3,uM,=,0.6334684555795865,1,O=C1CC(c2ccc(OCCCCNCc3ccccc3)cc2)Oc2cc(OCCCCNCc3ccccc3)ccc21
4823,1906456,10.1016/j.ejmech.2019.111651,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by Ellman's method,COc1ccc(/C=N/c2ccc3oc(=O)ccc3c2)cc1,6-[(4-Methoxybenzylidene)amino]-2H-chromen-2-one,0.1351,uM,=,-0.8693446509779694,0,O=c1ccc2cc(/N=C/c3ccccc3)ccc2o1
4824,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.07238,uM,=,-1.1403814212278194,0,c1ccc2nc3c(cc2c1)CCCC3
4825,1672445,10.1016/j.bmcl.2017.05.050,,,,Inhibition of AChE (unknown origin) using acetylcholine as substrate preincubated for 15 mins followed by substrate addition measured every minute by spectrophotometric analysis,COc1ccccc1N1C(=O)C2CN(C)C3(C(=O)c4ccccc4C3=O)C2C1=O,"5'-(2-Methoxyphenyl)-2'-methyl-2',3',3a',6a'-tetrahydro-4'H-spiro[indene-2,1'-pyrrolo[3,4-c]pyrrole]-1,3,4',6'(5'H)-tetraone",11.12,uM,=,1.0461047872460387,1,O=C1C2CNC3(C(=O)c4ccccc4C3=O)C2C(=O)N1c1ccccc1
4826,613840,10.1016/j.bmc.2010.01.071,,,,Inhibition of human recombinant AChE preincubated for 20 mins before substrate addition by Ellman's method,COc1ccc2c(c1)C/C(=C\c1ccc(CN(C)Cc3ccccc3)cc1)C2=O,2-Chloro-5-(S-2-fluoroethyl)thioaniline,28.7,uM,=,1.4578818967339924,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Cc2ccccc21
4827,1889410,10.1016/j.ejmech.2018.12.063,,,,Inhibition of human recombinant AChE using ATCh as substrate preincubated for 20 mins followed by substrate addition and measured for 3 mins by Ellman method,O=C(Nc1cc(CCc2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,"(+/-)-1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(2-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)ethyl)pyridin-2-yl)urea",0.0236,uM,=,-1.6270879970298933,0,O=C(Nc1cc(CCc2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O
4828,2198746,10.1039/d2md00087c,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 sec for 3 mins by DTNB-based UV analysis,CCN(CC)C(=O)c1ccc2c(c1)nc(Cc1ccc(OC(=O)N3CCC3)cc1)n2CCC(C)C,4-((5-(Diethylcarbamoyl)-1-isopentyl-1H-benzo[d]imidazol-2-yl)methyl)phenyl azetidine-1-carboxylate,0.711,uM,=,-0.1481303992702337,0,O=C(Oc1ccc(Cc2nc3ccccc3[nH]2)cc1)N1CCC1
4829,28457,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 12.0-19.1,C#CCN(C)C1CCc2c(OC(=O)N(C)CC)cccc21.Cl,Ethyl-methyl-carbamic acid 1-(methyl-prop-2-ynyl-amino)-indan-4-yl ester hydrochloride,14.9,uM,=,1.173186268412274,1,c1ccc2c(c1)CCC2
4830,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"(6-Chloro-1,2,3,4-tetrahydro-acridin-9-yl)-heptyl-amine",0.013,uM,=,-1.8860566476931635,0,c1ccc2nc3c(cc2c1)CCCC3
4831,1884186,10.1016/j.ejmech.2019.02.076,,,,Inhibition of human AChE,CC[C@@H](CN1CCCC1=O)C(=O)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)C[C@H]1C=C(C)C[C@@H]2C1,,0.0042,uM,=,-2.3767507096021,0,O=C(CCN1CCCC1=O)NCCCCCCCNc1c2c(nc3ccccc13)C[C@H]1C=CC[C@@H]2C1
4832,1465704,10.1016/j.bmcl.2015.02.015,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate after 15 mins by Ellman spectrophotometric method,COc1cc2oc(-c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,"N-(6-((6-chloro-1,2,3,4-tetrahydroanthracen-9-yl)amino)hexyl)-2-(4-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenoxy)acetamide",0.0216,uM,=,-1.665546248849069,0,O=C(COc1ccc(-c2cc(=O)c3ccccc3o2)cc1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
4833,1348974,10.1021/jm5000613,,,,Inhibition of human recombinant AchE using acetylthiocholine iodide as substrate incubated for 5 mins prior to substrate addition measured after 5 mins by Ellman method,COc1cccc(CN(C)Cc2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2)c1,N-[2-(1H-Indol-3-yl)ethyl]-4-{[(3-methoxybenzyl)(methyl)-amino]methyl}benzamide,3.8,uM,=,0.5797835966168101,1,O=C(NCCc1c[nH]c2ccccc12)c1ccc(CNCc2ccccc2)cc1
4834,327131,10.1021/jm050746d,,,,Inhibition of human AChE,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12,"7-(1,2,3,4-tetrahydro-acridin-9-ylamino)-heptanoic acid [2-(1H-indol-3-yl)-ethyl]-amide",0.0005,uM,=,-3.3010299956639813,0,O=C(CCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4835,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,COc1ccccc1CN(C)CCCN(C)CCCNCCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[Cl-],"3,8-diamino-5-(3-(3-((3-((2-methoxybenzyl)(methyl)amino)propyl)(methyl)amino)propylamino)propyl)-6-phenylphenanthridinium",0.894,uM,=,-0.0486624812040823,0,c1ccc(CNCCCNCCCNCCC[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
4836,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCCCCNc1ccc(-c2ccccc2)nn1)Cc1ccccc1,"N1-benzyl-N1-methyl-N5-(6-phenylpyridazin-3-yl)pentane-1,5-diamine",0.74,uM,=,-0.1307682802690238,0,c1ccc(CNCCCCCNc2ccc(-c3ccccc3)nn2)cc1
4837,1646248,10.1016/j.ejmech.2016.12.003,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate after 25 mins by Ellmann method,CCN(CC)CCCCCCCCOc1ccc(/C=C/C(=O)Nc2ccccc2)cc1OC,(E)-3-(4-((8-(diethylamino)octyl)oxy)-3-methoxyphenyl)-N-phenylacrylamide,1.36,uM,=,0.1335389083702175,1,O=C(/C=C/c1ccccc1)Nc1ccccc1
4838,1539620,10.1016/j.bmc.2015.10.044,,,,Inhibition of human AChE at pH 6,COP1(=O)OCCC(C(=O)OC(C)(C)C)=C(C)O1,"tert-Butyl 2-methoxy-4-methyl-6,7-dihydro-1,3,2-dioxaphosphepine-5-carboxylate 2-oxide",6.1,uM,=,0.785329835010767,1,O=[PH]1OC=CCCO1
4839,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1,N-(2-(1-benzylpiperidin-4-yl)ethyl)-4-oxo-4H-chromene-2-carboxamide,0.11,uM,=,-0.958607314841775,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccccc2o1
4840,2260121,10.1016/j.ejmech.2020.112960,,,,Inhibition of AChE (unknown origin) incubated for 20 mins by Ellman's method,C=C[C@H]1COC(=O)C2=CN3CCc4c([nH]c5cccc(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c45)[C@@H]3C[C@H]21,Rhynchophylloside J,21.07586400903141,uM,=,1.3237853876461585,1,O=C1OCC[C@@H]2C[C@H]3c4[nH]c5cccc(O[C@H]6CCCCO6)c5c4CCN3C=C12
4841,2280502,10.1016/j.bmc.2022.117146,,,,Inhibition of human erythrocyte AChE using ATCI and BTCI as substrate preincubated for 5 mins followed by substrate addition and measured after 3 mins by DTNB-reagent based Ellman's method,COc1ccc2c(c1)c(C=O)cn2CCCCCCCCCN(C)Cc1cccc(O)c1,1-(9-((3-hydroxybenzyl)(methyl)amino)hexyl)-5-methoxy-1H-indole-3-carbaldehyde,5.19,uM,=,0.7151673578484579,1,c1ccc(CNCCCCCCCCCn2ccc3ccccc32)cc1
4842,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,C[C@@H]1CCC[C@H](C)N1Cc1ccc(-c2cnc3[nH]c4cnc(C#N)cc4c3c2)cc1,"3-(4-(((2R,6S)-2,6-Dimethylpiperidin-1-yl)methyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile",0.135,uM,=,-0.8696662315049939,0,c1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCCCC4)cc3)cc12
4843,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{3-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",0.0419,uM,=,-1.3777859770337046,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
4844,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,O=[N+]([O-])c1ccc2nc3c(c(Nc4ccccc4)c2c1)CCCC3,"7-nitro-N-phenyl-1,2,3,4-tetrahydroacridin-9-amine",1.6,uM,=,0.2041199826559248,1,c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1
4845,1442181,10.1021/jm501195e,,,,Inhibition of AChE (unknown origin),CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,3.03,uM,=,0.481442628502305,1,c1ccccc1
4846,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CC2CCN(CCCCOc3ccc4c5c(c(=O)oc4c3)CCCC5)CC2)c1,"3-(4-(4-(3-Methoxybenzyl)piperidin-1-yl)butoxy)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one",13.7,uM,=,1.136720567156407,1,O=c1oc2cc(OCCCCN3CCC(Cc4ccccc4)CC3)ccc2c2c1CCCC2
4847,2110044,10.1016/j.ejmech.2021.113434,,,,Inhibition of human recombinant AChE assessed as reduction in cholinesterase activity using acetylthiocholine iodide as substrate by Ellman's method,Cl.Nc1c2c(nc3ccc(F)cc13)CCC2,"7-fluoro-1H,2H,3H-cyclopenta[b]quinolin-9-amine hydrochloride",0.662,uM,=,-0.1791420105603,0,c1ccc2nc3c(cc2c1)CCC3
4848,1698978,10.1016/j.ejmech.2017.02.042,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)ccc1N1CCOCC1.[I-],(E)-2-(3-Methoxy-4-morpholinostyryl)-1-methylquinolin-1-ium Iodide,1.9,uM,=,0.2787536009528289,1,C(=C/c1ccc2ccccc2[nH+]1)\c1ccc(N2CCOCC2)cc1
4849,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCCCCCCNc1c2c(nc3cc([N+](=O)[O-])ccc13)CCCC2,"Heptyl-(6-nitro-1,2,3,4-tetrahydro-acridin-9-yl)-amine",0.29,uM,=,-0.5376020021010439,0,c1ccc2nc3c(cc2c1)CCCC3
4850,2088471,10.1016/j.ejmech.2020.112368,,,,Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method,O=C(CN1CCN(C(=O)c2cccc(Cl)c2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1,1-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)-2-(4-(3-chlorobenzoyl)piperazin-1-yl)ethanone,32.4,uM,=,1.510545010206612,1,O=C(CN1CCN(C(=O)c2ccccc2)CC1)N1CCN(CCCc2c[nH]c3ccccc23)CC1
4851,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Cc1cc2onc(CCC3CCN(Cc4ccccc4)CC3)c2cc1C,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5,6-dimethyl-benzo[d]isoxazole",0.0058,uM,=,-2.2365720064370627,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
4852,28149,10.1021/jm010914b,,,,In vitro inhibition of human erythrocyte Acetylcholinesterase.,CNC(=O)Oc1cccc(CN(C)CC#CCOc2ccc3c(=O)c4ccccc4oc3c2)c1.Cl,Methyl-carbamic acid 3-({methyl-[4-(9-oxo-9H-xanthen-3-yloxy)-but-2-ynyl]-amino}-methyl)-phenyl ester hydrochloride,0.21,uM,=,-0.6777807052660807,0,O=c1c2ccccc2oc2cc(OCC#CCNCc3ccccc3)ccc12
4853,450032,10.1016/j.bmc.2007.07.014,,,,Inhibition of human serum AChE by Ellman colorimetric assay,CCCCC1=NC2(CCCC2)C(=O)N1Cc1cc2c(cc1C)OCO2,"2-butyl-3-(6-methylbenzo[1,3]dioxole-5-ylmethyl)-1,3-diazaspiro [4,4]non-1-en-4-one",0.2315,uM,=,-0.635449004646028,0,O=C1N(Cc2ccc3c(c2)OCO3)C=NC12CCCC2
4854,1827463,10.1016/j.ejmech.2018.10.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by Ellman's method,Cc1c(C)c2ccc(OCC3CCN(Cc4cccc(CO[N+](=O)[O-])c4)CC3)cc2oc1=O,"3-[(4-{[(3,4-Dimethyl-2-oxo-2H-chromen-7-yl)oxy]methyl}piperidin-1-yl)methyl]benzyl nitrate",1.3,uM,=,0.1139433523068367,1,O=c1ccc2ccc(OCC3CCN(Cc4ccccc4)CC3)cc2o1
4855,28296,10.1021/jm970141k,,,,Inhibition of Acetylcholinesterase from human red blood cells,CCCCSC(=O)OCC[N+](C)(C)C.[Cl-],(2-Butylsulfanylcarbonyloxy-ethyl)-trimethyl-ammonium chloride,500.0,uM,=,2.6989700043360187,1,
4856,1626872,10.1016/j.bmc.2016.10.016,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins followed by substrate addition measured after 20 mins by UV-Vis spectrophotometric analysis,CC(C)Cc1ccc(/C=C2\Oc3ccccc3C2=O)cc1,(Z)-2-(4-Isobutylbenzylidene)benzofuran-3(2H)-one,0.98,uM,=,-0.0087739243075051,0,O=C1/C(=C/c2ccccc2)Oc2ccccc21
4857,29400,10.1016/0960-894X(96)00072-8,,,,Inhibition of acetylcholinesterase.,C/N=C1/CCc2c1n(C)c1ccc(OC(=O)NC)cc21,"Methyl-carbamic acid 4-methyl-3-[(Z)-methylimino]-1,2,3,4-tetrahydro-cyclopenta[b]indol-7-yl ester",3.36,uM,=,0.5263392773898441,1,N=C1CCc2c1[nH]c1ccccc21
4858,773729,10.1021/np200308j,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method,CCCCCCCC/C=C\CCCCCCCC(=O)OCCCc1cc(OC)c2oc(-c3ccc4c(c3)OCO4)cc2c1,egonol oleate,1.8,uM,=,0.255272505103306,1,c1ccc2oc(-c3ccc4c(c3)OCO4)cc2c1
4859,499943,10.1016/j.ejmech.2008.02.035,,,,Inhibition of human recombinant AChE by Ellman's method,COc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1F,{4-[(Benzylmethylamino)methyl]phenyl}-(3-fluoro-4-methoxyphenyl)methanone,1.57,uM,=,0.1958996524092337,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
4860,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(CC1CCN(Cc3cc(F)cc(/C=N/O)c3O)CC1)CC2,"3-((4-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)piperidin-1-yl)methyl)-5-fluoro-2-hydroxybenzaldehyde oxime",684.5,uM,=,2.8353734524700087,1,c1ccc(CN2CCC(CN3CCc4ccccc4C3c3ccccc3)CC2)cc1
4861,1849549,10.1016/j.bmc.2019.07.001,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1ccc(NCc2ccc(Oc3c(N)cccc3Cl)cc2)cc1,N-(4-(2-amino-6-chlorophenoxy)benzyl)-4-methoxyaniline,5.24,uM,=,0.7193312869837267,1,c1ccc(NCc2ccc(Oc3ccccc3)cc2)cc1
4862,750271,10.1016/j.ejmech.2011.02.073,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate by spectroscopic Ellmans method,CC(C)C1=N[C@H]2CC[C@]34C[C@]35C(=O)C[C@]3(C)[C@@H]([C@H](C)N(C)Cc6ccccc6)[C@H](O)C[C@@]3(C)[C@@H]5CC[C@H]4[C@]2(C)CS1,"20S-[benzyl(methyl)amino]-16alpha-hydroxy-4beta,14alpha-dimethyl-9,19-cyclo-{2'-isopropyl-5',6'-dihydro-4'alphaH-[1',3']thiazino[4',5':3,4]}-5alpha,9beta-pregnan-11-one",0.007,uM,=,-2.154901959985743,0,O=C1CC2C(CC[C@@H]2CNCc2ccccc2)[C@@H]2CC[C@H]3C4CSC=N[C@H]4CC[C@@]34C[C@@]124
4863,1839122,10.1016/j.ejmech.2019.02.012,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate pre-incubated for 20 mins before substrate addition and measured for 180 secs by spectrophotometry based Ellman's method,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccc(Br)cc1,"N-(4-bromophenyl)-2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazine-1-carbothioamide",0.571,uM,=,-0.243363891754152,0,S=C(NNc1c2c(nc3ccccc13)CCCC2)Nc1ccccc1
4864,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,SID144205156,5.28,uM,=,0.7226339225338123,1,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
4865,1500179,10.1021/acs.jmedchem.5b00464,,,,Inhibition of human acetylcholine esterase by horseradish peroxidase-coupled fluorescence assay,c1ncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)cn1,"3-(4-(Piperidin-1-ylmethyl)phenyl)-6-(pyrimidin-5-yl)-9H-pyrrolo-[2,3-b:5,4-c']dipyridine",0.266,uM,=,-0.575118363368933,0,c1ncc(-c2cc3c(cn2)[nH]c2ncc(-c4ccc(CN5CCCCC5)cc4)cc23)cn1
4866,1800949,10.1016/j.ejmech.2018.07.026,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition and measured for 5 mins by Ellman's method,COc1cc2nc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)cc(OC)c2cc1OC,"N-(2-(1-benzylpiperidin-4-yl)ethyl)-4,6,7-trimethoxyquinoline-2-carboxamide",0.62,uM,=,-0.2076083105017461,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2n1
4867,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(8-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)-3-(5-phenyl-3,4-dihydro-2H-pyrano[3,2-c]quinolin-9-yl)propanamide",0.014,uM,=,-1.853871964321762,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
4868,2215328,10.1016/j.bmc.2022.116742,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 45 mins followed by substrate addition by DTNB reagent based Ellman's method,CC1(C)CCCC2(C)OC(=O)C=C12,DL-dihydroactinidiolide,0.03003,uM,=,-1.5224446678010188,0,O=C1C=C2CCCCC2O1
4869,2288317,10.1016/j.ejmech.2022.114806,,,,Inhibition of human AChE using ATC and BTC iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by DTNB reagent based assay,Cc1ccc(-c2noc(-c3cccc(OCC4CCN(Cc5ccccc5)CC4)c3)n2)cn1,"5-(3-((1-benzylpiperidin-4-yl)methoxy)phenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole",0.74,uM,=,-0.1307682802690238,0,c1ccc(CN2CCC(COc3cccc(-c4nc(-c5cccnc5)no4)c3)CC2)cc1
4870,1758439,10.1016/j.ejmech.2017.07.077,,,,Inhibition of human erythrocytic AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 180 secs by spectrophotometric analysis,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(OC)c(O)c2)cc1,N-(4-((benzyl(ethyl)amino)methyl)phenyl)-2-(3-hydroxy-4-methoxyphenyl)acetamide,2.76,uM,=,0.4409090820652177,1,O=C(Cc1ccccc1)Nc1ccc(CNCc2ccccc2)cc1
4871,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,COc1cccc(CC2CCN(CCOc3ccc4c(c3)oc(=O)c3ccccc34)CC2)c1,3-(2-(4-(3-Methoxybenzyl)piperidin-1-yl)ethoxy)-6H-benzo[c]chromen-6-one,29.3,uM,=,1.4668676203541096,1,O=c1oc2cc(OCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12
4872,578532,10.1021/jm900859q,,,,Inhibition of AChE in human erythrocytes by Ellman's method,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-9-{{8-[3-(3,4-dihydro-5-phenyl-2H-pyrano[3,2-c]quinolin-9-yl)propanamido]octyl}amino}-1,2,3,4-tetrahydroacridine Dihydrochloride",0.014,uM,=,-1.853871964321762,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2
4873,1842270,10.1016/j.bmc.2019.01.025,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccc(O)cc12,"6-(1,2,3,4-tetrahydro-acridin-9-ylamino)-hexanoic acid [2-(5-hydroxy-1H-indol-3-yl)-ethyl]-amide",5e-09,uM,=,-8.301029995663981,0,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12
4874,1807943,10.1016/j.ejmech.2019.07.051,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry analysis,NC12CC3CC(F)(CC(C1)c1cc(NC(=O)CCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)ccc13)C2,"N-(7-Amino-9-fluoro-7H-5,6,8,9,10,11-hexahydro-5,9:7,11-dimethanobenzo[9]annulen-2-yl)-5-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]pentanamide",0.0025,uM,=,-2.6020599913279625,0,O=C(CCCCNc1c2c(nc3ccccc13)CCCC2)Nc1ccc2c(c1)C1CC3CC(CC2C3)C1
4875,2050170,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE by Ellman's method,O=C(CCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,"(E)-4-((9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl 3-(4,4a-dihydro-1H-pyrido[3,4-b]indol-2(3H,9H,9aH)-yl)propanoate",0.00093,uM,=,-3.0315170514460648,0,O=C(CCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1
4876,1508181,10.1016/j.bmc.2015.01.031,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 20 mins prior to substrate addition by Ellman's method,CC1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2,"6,7,10,11-Tetrahydro-9-methyl-12-{{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}amino}-7,11-methanocycloocta[b]quinoline",0.00646,uM,=,-2.189767482004916,0,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
4877,751130,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human plasma AChE,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,Diethyl-(1-methyl-2-phenothiazin-10-yl-ethyl)-amine,260.0,uM,=,2.414973347970818,1,c1ccc2c(c1)Nc1ccccc1S2
4878,1875190,10.1016/j.ejmech.2019.111785,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins prior to substrate addition measured after 5 mins by Ellman's method,Cc1ccc2oc(-c3ccc(OCCCCCCN4CCCCCC4)cc3)cc(=O)c2c1,2-(4-(6-(Azepan-1-yl)hexyloxy)phenyl)-6-methyl-4H-chromen-4-one,0.48,uM,=,-0.3187587626244128,0,O=c1cc(-c2ccc(OCCCCCCN3CCCCCC3)cc2)oc2ccccc12
4879,1732010,10.1016/j.ejmech.2018.01.055,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method,Cc1cc(=O)oc2cc(OCCCSC(=S)N3CCCCC3)ccc12,3-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)propylpiperidine-1-carbodithioate,0.29,uM,=,-0.5376020021010439,0,O=c1ccc2ccc(OCCCSC(=S)N3CCCCC3)cc2o1
4880,1363503,10.1016/j.ejmech.2014.06.034,,,,Inhibition of AChE (unknown origin) after 5 mins by Ellman's method,CN1C/C(=C/c2ccc(N(C)C)cc2[N+](=O)[O-])C(=O)/C(=C/c2ccc(N(C)C)cc2[N+](=O)[O-])C1,"3,5-Bis[4-(dimethylamino)2-nitro-benzylidene]-1-methylpiperidin-4-one",0.057,uM,=,-1.2441251443275083,0,O=C1/C(=C\c2ccccc2)CNC/C1=C\c1ccccc1
4881,2281430,10.1016/j.ejmech.2021.113492,,,,Inhibition of AChE (unknown origin),O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N-(6-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)hexyl)-3-(5-phenyl-3,4-dihydro-2H-pyrano[3,2-c]quinolin-9-yl)propanamide",0.0111,uM,=,-1.9546770212133424,0,O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
4882,446304,10.1021/jm070559a,,,,Inhibition of human recombinant acetylcholinesterase,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)CCc2ccccc2OC)=CC1=O)CCc1ccccc1OC,"2,5-bis(6-{ethyl[2-(2-methoxyphenyl)ethyl]amino}hexylamino)-[1,4]-benzoquinone",0.0173,uM,=,-1.7619538968712043,0,O=C1C=C(NCCCCCCNCCc2ccccc2)C(=O)C=C1NCCCCCCNCCc1ccccc1
4883,2261346,10.1016/j.ejmech.2022.114606,,,,Inhibition of AChE (unknown origin),Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1O2,"(-)-(3aS)-3a-methyl-2,3,3a,8a-Tetrahydrofuro[2,3-b]benzofuran-5-yl N-(o-Tolyl)carbamate",0.023,uM,=,-1.6382721639824072,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCO[C@@H]1O2
4884,980915,10.1016/j.ejmech.2013.06.021,,,,Inhibition of purified human erythrocyte AChE using acetylcholine as substrate by Ellman's method,N#Cc1c(Cl)nc(NC2CCN(Cc3ccccc3)CC2)c(C#N)c1-c1ccccc1,"2-((1-Benzylpiperidin-4-yl)amino)-6-chloro-4-phenylpyridine-3,5-dicarbonitrile",9.43,uM,=,0.9745116927373284,1,c1ccc(CN2CCC(Nc3cc(-c4ccccc4)ccn3)CC2)cc1
4885,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,COc1ccccc1CN1CCC(N2CCC(NC3=CC(=O)c4ccccc4C3=O)CC2)CC1,"2-(1'-(2-Methoxybenzyl)-1,4'-bipiperidin-4-ylamino)naphthalene-1,4-dione",17.2,uM,=,1.235528446907549,1,O=C1C=C(NC2CCN(C3CCN(Cc4ccccc4)CC3)CC2)C(=O)c2ccccc21
4886,1654045,10.1016/j.ejmech.2016.12.005,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured for 60 to 300 secs by Ellman's method,CNc1nc(NCCc2ccccc2)c2ccccc2n1,"N2-Methyl-N4-(phenethyl)quinazoline-2,4-diamine",8.7,uM,=,0.9395192526186184,1,c1ccc(CCNc2ncnc3ccccc23)cc1
4887,1627946,10.1016/j.ejmech.2016.07.052,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured up to 3 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(C)cc3)CC1)C2,"5,6-Dimethoxy-2-[1-(4-methyl-benzyl)-piperidin-4-ylmethyl]-indan-1-one",0.127,uM,=,-0.8961962790440431,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4888,1439748,10.1021/np500412f,,,,Inhibition of acetylcholinesterase (unknown origin) assessed as inhibition of acetylcholine hydrolysis after 30 mins by Ellmann's method,C/C=C1\[C@H]2C=C(C)C[C@]1(N[C@H]1OC(=O)C3=C4CC(C)(C)C[C@H]4[C@@H](C)[C@@H](O)C[C@]31OC)c1ccc(=O)[nH]c1C2,Huptremule A,0.99,uM,=,-0.00436480540245,0,C=C1[C@H]2C=CC[C@]1(N[C@H]1OC(=O)C3=C4CCC[C@H]4CCCC31)c1ccc(=O)[nH]c1C2
4889,1784114,10.1021/acsmedchemlett.7b00463,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition measured after 2 mins by Ellman's method,CCOC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,"Ethyl 2-(2-(cyclopropanecarboxamido)pyridin-4-yl)-4-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethoxy)thiazole-5-carboxylate",0.31,uM,=,-0.5086383061657274,0,O=C(Nc1cc(-c2nc(OCCNc3c4c(nc5ccccc35)CCCC4)cs2)ccn1)C1CC1
4890,745140,10.1021/jm101299d,,,,Inhibition of human recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay,COc1cc2c(cc1OC)CN(c1cc[n+](Cc3ccc(C[n+]4ccc(N5CCCCC5)cc4)cc3)cc1)CC2.[Br-].[Br-],"4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-1-{4-[(4-piperidin-1-ylpyridinium-1-yl)methyl]benzyl}pyridiniumbromide",0.062,uM,=,-1.207608310501746,0,c1ccc2c(c1)CCN(c1cc[n+](Cc3ccc(C[n+]4ccc(N5CCCCC5)cc4)cc3)cc1)C2
4891,347063,10.1016/j.bmcl.2006.01.067,,,,Inhibition of AChE activity,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,"1-(3,4-Dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline (Papaverine)",24.33,uM,=,1.3861421089308186,1,c1ccc(Cc2nccc3ccccc23)cc1
4892,900795,10.1007/s00044-010-9373-7,,,,Inhibition of acetylcholinesterase (unknown origin),CNCOc1cccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1,3-(7-(methyl(3-((methylamino)methoxy)benzyl)amino)heptyloxy)-9H-xanthen-9-one,0.00032,uM,=,-3.494850021680094,0,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
4893,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,Nc1c2ccccc2nc2c1cnc1cc(Cl)ccc12,"3-Chloro-dibenzo[b,h][1,6]naphthyridin-7-ylamine",1000.0,uM,=,3.0,1,c1ccc2nc3c(cnc4ccccc43)cc2c1
4894,833863,10.1021/np2009626,,,,Inhibition of human AChE pre-incubated for 10 mins before acetylthiocholine iodide substrate addition,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.012,uM,=,-1.9208187539523751,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
4895,28310,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.025-0.027,CCN(C)C(=O)Oc1cccc2c1CCC2N.Cl,Ethyl-methyl-carbamic acid 1-amino-indan-4-yl ester hydrochloride,0.026,uM,=,-1.585026652029182,0,c1ccc2c(c1)CCC2
4896,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc(/C=C/c2cc(=O)oc3c2ccc2oc(-c4ccc(C)cc4)cc23)cc(OC)c1,"4-(3,5-dimethoxystyryl)-8-(p-tolyl)-2H-furo[2,3-h]chromen-2-one",1.8,uM,=,0.255272505103306,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
4897,493234,10.1021/jm8009684,,,,Inhibition of human recombinant AChE by Ellman's assay,CCN(CCCCCCN1CCN(CCCCCCN(CC)Cc2ccccc2OC)C1=O)Cc1ccccc1OC,"1,3-Bis-{6-[ethyl-(2-methoxybenzyl)amino]hexyl}imidazolidin-2-one",0.0724,uM,=,-1.1402614338028532,0,O=C1N(CCCCCCNCc2ccccc2)CCN1CCCCCCNCc1ccccc1
4898,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc(/C=C/c2cc(=O)oc3c2ccc2oc(-c4cccc(F)c4)cc23)cc(OC)c1,"4-(3,5-dimethoxystyryl)-8-(3-fluorophenyl)-2H-furo[2,3-h]chromen-2-one",1.8,uM,=,0.255272505103306,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
4899,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2ccc3ccccc3c2)CC1c1ccc(-c2ccccc2)cc1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",0.068,uM,=,-1.1674910872937636,0,c1ccc(-c2ccc(C3CC(c4ccc5ccccc5c4)=NN3)cc2)cc1
4900,990754,10.1016/j.bmcl.2013.09.008,,,,Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method,COc1ccc(C(F)(F)F)c[n+]1CCCCCO.O=S(=O)([O-])C(F)(F)F,1-(5-hydroxypentyl)-2-methoxy-5-(trifluoromethyl)pyridinium trifluoromethanesulfonate,98.0,uM,=,1.9912260756924949,1,c1cc[nH+]cc1
4901,969870,10.1016/j.bmcl.2013.05.092,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.16,uM,=,-0.7958800173440752,0,c1ccc2nc3c(cc2c1)CCCC3
4902,1507382,10.1016/j.bmc.2015.06.005,,,,Inhibition of human acetylcholinesterase using ATCI/DTNB as substrate preincubated for 30 mins followed by substrate addition measured for 60 mins by Ellman method,CCOC(=O)C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1,"(2R,6S)-ethyl 1,2,6-triphenyl-4-(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate",2950.0,uM,=,3.469822015978163,1,C1=C(Nc2ccccc2)C[C@@H](c2ccccc2)N(c2ccccc2)[C@@H]1c1ccccc1
4903,2213869,10.1016/j.ejmech.2021.113949,,,,Inhibition of AChE (unknown origin) incubated for 20 mins by TLC analysis,O=c1c2ccccc2nc2n1CC[C@@H]2[C@@H]1CCCN1,Peganumine D,5.71,uM,=,0.756636108245848,1,O=c1c2ccccc2nc2n1CC[C@@H]2[C@@H]1CCCN1
4904,2261346,10.1016/j.ejmech.2022.114606,,,,Inhibition of AChE (unknown origin),CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12,"(-)-Phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.024,uM,=,-1.619788758288394,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
4905,1758984,10.1016/j.ejmech.2017.09.008,,,,Inhibition of human AChE pre-incubated for 6 mins before ATCI substrate addition and measured after 12 mins by DTNB reagent dependent UV-Vis spectrophotometry based Ellman's method,CCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"2-(butylamino)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b]quinazolin-7-yl)acetamide",0.0212,uM,=,-1.6736641390712486,0,O=c1c2ccccc2nc2n1CCC2
4906,1439641,10.1016/j.bmc.2014.08.016,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide substrate incubated for 15 mins by spectrophotometry based Ellman's method,O=c1oc2cc(OCCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12,3-(3-(4-Benzylpiperidin-1-yl)propoxy)-6H-benzo[c]chromen-6-one,4.1,uM,=,0.6127838567197355,1,O=c1oc2cc(OCCCN3CCC(Cc4ccccc4)CC3)ccc2c2ccccc12
4907,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,Fc1ccc(CN2CCN(c3nccc(NCc4ccccc4)n3)CC2)cc1,N-Benzyl-2-[4-(4-fluorobenzyl)piperazin-1-yl]pyrimidin-4-amine,21.6,uM,=,1.334453751150931,1,c1ccc(CNc2ccnc(N3CCN(Cc4ccccc4)CC3)n2)cc1
4908,1553281,10.1016/j.bmc.2016.02.023,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by spectrophotometric-based Ellman's method,Cc1c(Cl)c(=O)oc2cc(OCCNC3CCN(Cc4ccccc4)CC3)ccc12,7-(2-((1-Benzylpiperidin-4-yl)amino)ethoxy)-3-chloro-4-methyl-2H-chromen-2-one,1.82,uM,=,0.2600713879850748,1,O=c1ccc2ccc(OCCNC3CCN(Cc4ccccc4)CC3)cc2o1
4909,2195557,10.1039/d2md00262k,,,,Inhibition of human acetylcholinesterase using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method,CC(=O)N1N=C(c2cccc3ccccc23)CC1c1ccc(-c2ccccc2)cc1,"1-(5-([1,1'-Biphenyl]-4-yl)-3-(naphthalen-1-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone",1015.0,uM,=,3.006466042249232,1,c1ccc(-c2ccc(C3CC(c4cccc5ccccc45)=NN3)cc2)cc1
4910,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CN(CCOCCCNC(=S)NC(=O)c1ccccc1)Cc1ccccc1,1-Benzoyl-3-{3-[2-(benzyl-methyl-amino)-ethoxy]-propyl}-thiourea,1.1,uM,=,0.041392685158225,1,O=C(NC(=S)NCCCOCCNCc1ccccc1)c1ccccc1
4911,1790870,10.1039/C7MD00199A,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 to 3 mins time interval by Ellman's method,CCN(CC)CCOc1ccc(/C=C2\COc3ccccc3C2=O)cc1,(E)-3-(4-(2-(diethylamino)ethoxy)benzylidene)chroman-4-one,3.29,uM,=,0.5171958979499743,1,O=C1/C(=C/c2ccccc2)COc2ccccc21
4912,1511667,10.1016/j.bmc.2015.06.051,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method,Cc1cccc(-c2nnc(-c3ccc4c(c3)CO[C@@]4(CCCN(C)C)c3ccc(F)cc3)[nH]2)c1,"(S)-3-{1-(4-Fluorophenyl)-5-[5-(m-tolyl)-4H-1,2,4-triazol-3-yl]-1,3-dihydroisobenzofuran-1-yl}-N,N-dimethylpropan-1-amine",133.23,uM,=,2.124602027893338,1,c1ccc(-c2nnc(-c3ccc4c(c3)COC4c3ccccc3)[nH]2)cc1
4913,2089390,10.1016/j.ejmech.2020.112415,,,,Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method,COc1cccc2c1C=[N+](c1ccc(Br)cc1)CC2.[Br-],"2-(4-bromophenyl)-8-methoxy-3,4-dihydroisoquinolinium bromide",0.28,uM,=,-0.5528419686577808,0,C1=[N+](c2ccccc2)CCc2ccccc21
4914,2086996,10.1016/j.ejmech.2020.112140,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0139999999999999,uM,=,-1.853871964321762,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
4915,28154,10.1016/S0960-894X(00)80267-X,,,,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,Nc1c2c(nc3c1CCCO3)CCCC2,"3,4,5,6,7,8-Hexahydro-2H-1-oxa-9-aza-anthracen-10-ylamine",0.455,uM,=,-0.3419886033428876,0,c1c2c(nc3c1CCCO3)CCCC2
4916,2204620,10.1016/j.bmcl.2022.128873,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate by DTNB reagent based Ellman's method,COc1ccc(C(=O)Cc2ncc(C(=O)NCc3cccs3)cn2)cc1,2-(2-(4-methoxyphenyl)-2-oxoethyl)-N-(thiophen-2-ylmethyl)pyrimidine-5-carboxamide,30.7,uM,=,1.4871383754771863,1,O=C(Cc1ncc(C(=O)NCc2cccs2)cn1)c1ccccc1
4917,1763446,10.1016/j.ejmech.2018.02.083,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 2 mins time interval by Ellman's method,COc1ccc(Cn2cc(C(=O)NCCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c(=O)c3ccccc32)cc1,"N-{3-[(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide",2.24,uM,=,0.3502480183341628,1,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cn(Cc2ccccc2)c2ccccc2c1=O
4918,2215094,10.1016/j.ejmech.2022.114242,,,,Inhibition of AChE (unknown origin) incubated for 30 mins by Ellman's method,COc1cc(/C=C/c2cc(=O)oc3c2ccc2oc(-c4cc(OC)cc(OC)c4)cc23)cc(OC)c1,"8-(3,5-dimethoxyphenyl)-4-(3,5-dimethoxystyryl)-2H-furo[2,3-h]chromen-2-one",2.8,uM,=,0.4471580313422192,1,O=c1cc(/C=C/c2ccccc2)c2ccc3oc(-c4ccccc4)cc3c2o1
4919,1693521,10.1016/j.bmc.2017.06.041,,,,Inhibition of human AChE using acetylthiocholine as substrate preincubated for 30 mins followed by substrate addition measured every 5 mins for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(c1ccccc1)N(Cc1cc(F)cc(/C=N/O)c1O)CC2,"3-((6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-5-fluoro-2-hydroxybenzaldehyde oxime",754.7,uM,=,2.877774349991398,1,c1ccc(CN2CCc3ccccc3C2c2ccccc2)cc1
4920,1757775,10.1016/j.ejmech.2017.07.006,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C(Nc1ccc2c(c1)CN(C(=O)c1cccc(Cl)c1)C(=O)C2)c1cccc(Cl)c1,"3-Chloro-N-(2-(3-chlorobenzoyl)-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide",1.415e-05,uM,=,-4.849243560139691,0,O=C(Nc1ccc2c(c1)CN(C(=O)c1ccccc1)C(=O)C2)c1ccccc1
4921,431877,10.1016/j.bmc.2006.09.026,,,,Inhibition of human erythrocyte AchE,COc1cccc(CN(C)CCCCCCCOc2ccc3c(=O)c4ccccc4oc3c2)c1OC,"3-{7-[(2,3-dimethoxybenzyl)methylamino]heptyloxy}xanthen-9-one",138.0,uM,=,2.1398790864012365,1,O=c1c2ccccc2oc2cc(OCCCCCCCNCc3ccccc3)ccc12
4922,1994861,10.1016/j.bmcl.2020.127075,,,,Inhibition of human AchE,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.1,uM,=,-1.0,0,c1ccc2nc3c(cc2c1)CCCC3
4923,444935,10.1021/jm070100g,,,,Inhibition of human recombinant AChE,COc1cc2cc(-c3ccc(CN(C)Cc4ccc([N+](=O)[O-])cc4)cc3)c(=O)oc2cc1OC,"6,7-dimethoxy-3-(4-{[(4-nitrobenzyl)methylamino]methyl}phenyl)-chromen-2-one",24.6,uM,=,1.390935107103379,1,O=c1oc2ccccc2cc1-c1ccc(CNCc2ccccc2)cc1
4924,742791,10.1016/j.bmc.2011.02.030,,,,Inhibition of human AChE incubated with compounf for 5 mins before addition of substrate acetylthiocholine iodide by Ellman's method,CC(C)(C)OC(=O)N1CCN(c2nccc(NCc3ccccc3)n2)CC1,tert-Butyl 4-[4-(Benzylamino)pyrimidin-2-yl]piperazine-1-carboxylate,18.8,uM,=,1.2741578492636798,1,c1ccc(CNc2ccnc(N3CCNCC3)n2)cc1
4925,1288744,10.1016/j.bmc.2014.01.002,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,C=CC(=O)N1C/C(=C\c2ccccc2C)C(=O)[C@@]2(C1)[C@H](c1ccccc1C)CN(C)[C@]21C(=O)Nc2ccccc21,(+/-)-1-Methyl-4-(2-methylphenyl)pyrrolo-(spiro[2.3']oxindole)-spiro[3.3'']-5''-(2-methylphenylmethylidene)-1''-N-acrolylpiperidin-4''-one,3.97,uM,=,0.5987905067631151,1,O=C1/C(=C/c2ccccc2)CNC[C@@]12[C@H](c1ccccc1)CN[C@]21C(=O)Nc2ccccc21
4926,2034410,10.1016/j.bmc.2020.115940,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate incubated for 10 mins by Ellman's method,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2cccc(F)c2)CC1,2-(2-(Cyclopropanecarboxamido)pyridin-4-yl)-4-(3-(1-(3-fluorobenzyl)piperidin-4-yl)propoxy)thiazole-5-carboxamide,3.0,uM,=,0.4771212547196624,1,O=C(Nc1cc(-c2nc(OCCCC3CCN(Cc4ccccc4)CC3)cs2)ccn1)C1CC1
4927,2014474,10.1016/j.ejmech.2019.111707,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Cc1cccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c1,"2-(4-(Pyridin-2-yl)piperazin-1-yl)-5-(m-tolyl)-1,3,4-oxadiazole",5.24,uM,=,0.7193312869837267,1,c1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1
4928,774691,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34,Benzo[def]chrysene,28.0,uM,=,1.4471580313422192,1,c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34
4929,633769,10.1016/j.ejmech.2009.12.038,,,,Inhibition of AChE,CCN1CC[C@@]2(C)c3cc(OC(=O)NCc4ccccc4)ccc3C[C@@H]12,"(3aS,8aR)-1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrol-5-yl benzylcarbamate",0.069,uM,=,-1.1611509092627446,0,O=C(NCc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1C2
4930,799817,10.1021/jm200691d,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method,NCCCCCCNC1=CC(=O)c2ccccc2C1=O,"2-(6-Aminohexylamino)naphthalene-1,4-dione",64.5,uM,=,1.809559714635268,1,O=C1C=CC(=O)c2ccccc21
4931,942479,10.1016/j.bmc.2013.01.066,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide substrate by Ellman's method based spectrophotometry,O=C1/C(=C/c2cccc3ccccc23)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1cccc2ccccc12,"(+/-)-1''-Carbonyl(spiro[2.3']oxindole-hexahydro-1Hpyrrolizine)-3'',5''-bis[(E)-naphthylmethylidene]tetrahydro-4''(1H)-pyridinone",6.76,uM,=,0.829946695941636,1,O=C1/C(=C/c2cccc3ccccc23)CN(C(=O)C[C@H]2C[C@H]3CCCN3[C@]23C(=O)Nc2ccccc23)C/C1=C\c1cccc2ccccc12
4932,2247136,10.1021/acs.jmedchem.1c02150,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 240 sec by Ellman's method,O=C(Nc1ccc(OC(F)(F)F)cc1)NC1CCN(C(=O)CCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)CC1,"1-{1-{4-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-butanoyl}piperidin-4-yl}-3-[4-(trifluoromethoxy)phenyl]urea",0.00271,uM,=,-2.567030709125594,0,O=C(Nc1ccccc1)NC1CCN(C(=O)CCCNc2c3c(nc4ccccc24)CCCC3)CC1
4933,2088239,10.1016/j.ejmech.2020.112257,,,,Inhibition of recombinant human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrophotometry based Ellman's method,COc1cc(/C=C/C(=O)N2CCN(c3ccccc3)CC2)ccc1O,(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-phenylpiperazin-1-yl)prop-2-en-1-one,29.34,uM,=,1.467460109507264,1,O=C(/C=C/c1ccccc1)N1CCN(c2ccccc2)CC1
4934,1801971,10.1016/j.ejmech.2018.08.005,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3cccc([N+](=O)[O-])c3)CC2)cc(C(C)(C)C)c1O,"(E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(1-(4-nitrobenzyl)piperidin-4-yl)ethyl)acrylamide",3.46,uM,=,0.5390760987927766,1,O=C(/C=C/c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
4935,827686,10.1016/j.bmcl.2012.05.077,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 5 mins by DTNB method,Clc1cccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)c1,"N2-(1-Benzylpiperidin-4-yl)-N4-(3-chlorobenzyl)pyrimidine-2,4-diamine",7.7,uM,=,0.8864907251724818,1,c1ccc(CNc2ccnc(NC3CCN(Cc4ccccc4)CC3)n2)cc1
4936,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1cccc(F)c1,1-Fluoro-3-methyl-benzene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
4937,1627472,10.1016/j.bmc.2016.11.002,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,COc1ccc(/C=C/C(=O)c2cccc(OC(=O)N(C)C)c2)cc1,(E)-3-(3-(4-Methoxyphenyl)acryloyl)phenyl dimethylcarbamate,8.05,uM,=,0.9057958803678684,1,O=C(/C=C/c1ccccc1)c1ccccc1
4938,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,Cc1ccccc1CN1CCC(C(=O)NCCc2c[nH]c3ccccc23)CC1,N-(2-(1H-Indol-3-yl)ethyl)-1-(2-methylbenzyl)piperidine-4-carboxamide,3.56,uM,=,0.5514499979728752,1,O=C(NCCc1c[nH]c2ccccc12)C1CCN(Cc2ccccc2)CC1
4939,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2Cc1ccccc1,"(3aS,8aR)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate",0.1608,uM,=,-0.7937139555875675,0,c1ccc(CN2c3ccccc3C3CCN[C@@H]32)cc1
4940,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=C(CCO[N+](=O)[O-])NCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(3'-(nitrooxy)propanoyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine",0.093,uM,=,-1.031517051446065,0,c1ccc2nc3c(cc2c1)CCCC3
4941,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,CCN(CC)Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O,"(Z)-2-(4-((diethylamino)methyl)-3-hydroxybenzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",0.7,uM,=,-0.1549019599857432,0,O=C1/C(=C/c2ccccc2)Oc2ccccc21
4942,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",C=CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CC(C)(C)CC3,"US9284330, S4",1.055,uM,=,0.0232524596337114,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
4943,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,C=C(C)[C@H](O)CC[C@]1(C)[C@@H](CC=C(C)C)C[C@@]2(CC=C(C)C)C(=O)[C@]1(C(=O)C(C)C)C(=O)C1=C2O[C@@H](C(C)(C)O)C1,15-epi-Hyperforatin I,25.07,uM,=,1.3991543339582164,1,O=C1C2=C(OCC2)C2CCCC1C2=O
4944,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4c(nc5ccc(Cl)cc35)CCCC4)cc12,"US8841453, 16",0.0014299999999999,uM,=,-2.844663962534938,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
4945,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCCSc1nc2nc3c(c(N)c2s1)C1CC(C)=CC(C3)C1,"(+/-)-11-Amino-2-thiopropyl-5,6,9,10-tetrahydro-thiazolo[4,5-b]-8-methyl-6,10-methanocycloocta[e]pyridine",7.689999999999999,uM,=,0.885926339801431,1,C1=CC2Cc3nc4ncsc4cc3C(C1)C2
4946,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CCN(CC)CCCCCOc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(5-diethylaminopentyloxy)phenyl]methanone,0.144,uM,=,-0.8416375079047503,0,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
4947,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)C3CCN(Cc4ccccc4)CC3)c2c1,1-Benzyl-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)piperidine-4-carboxamide,12.22,uM,=,1.0870712059065355,1,O=C(NCCc1c[nH]c2ccccc12)C1CCN(Cc2ccccc2)CC1
4948,1984714,10.1021/acs.jnatprod.9b00561,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by spectrophotometric based Ellman's method,COc1c2c(cc3c1OCO3)[C@]13C=C[C@H](OC)C[C@@H]1[N@](C2)C[C@H]3OC(=O)c1ccccc1[N+](=O)[O-],11-O-(2-Nitrobenzoyl)ambelline,54.0,uM,=,1.7323937598229686,1,O=C(O[C@@H]1C[N@@]2Cc3cc4c(cc3[C@@]13C=CCC[C@H]23)OCO4)c1ccccc1
4949,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,C#CCN(Cc1ccc(O)c2ncccc12)C(C#N)CCC1CCN(Cc2ccccc2)CC1,rac-4-(1-benzylpiperidin-4-yl)-2-(((8-hydroxyquinolin-5-yl)methyl)(prop-2-ynyl)amino)butanenitrile,0.35,uM,=,-0.4559319556497244,0,c1ccc(CN2CCC(CCCNCc3cccc4ncccc34)CC2)cc1
4950,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cl.O.c1ccc(CN2CCC(CCN=c3cc4c(n[nH]3)-c3ccccc3C4)CC2)cc1,"[2-(1-Benzyl-piperidin-4-yl)-ethyl]-(5H-indeno[1,2-c]pyridazin-3-yl)-amine dihydrochloride hydrate",0.074,uM,=,-1.1307682802690238,0,c1ccc(CN2CCC(CCN=c3cc4c(n[nH]3)-c3ccccc3C4)CC2)cc1
4951,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@@H](C1)C2,"US9238626, (+)-(Ib) HCl",2.93,uM,=,0.4668676203541094,1,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)C[C@@H]1C=CC[C@H]2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
4952,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,COc1ccc2[nH]c3c(C)[n+](C)ccc3c2c1,"6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium",0.8,uM,=,-0.0969100130080563,0,c1ccc2c(c1)[nH]c1c[nH+]ccc12
4953,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=C(CO/N=[N+](\[O-])N1CCCC1)NCCCCNc1c2c(nc3ccccc13)CCCC2,"O2-[2-(N-delta-(1,2,3,4-tetrahydroacridine)-delta-aminobutylamino)-2-oxoethyl]-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate",0.0507,uM,=,-1.294992040666664,0,O=C(CON=[NH+]N1CCCC1)NCCCCNc1c2c(nc3ccccc13)CCCC2
4954,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=C(CO[N+](=O)[O-])NCCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-delta-(2'-(nitrooxy)acetyl)-delta-aminobutylamino]-1,2,3,4-tetrahydroacridine",0.0226,uM,=,-1.645891560852599,0,c1ccc2nc3c(cc2c1)CCCC3
4955,1984714,10.1021/acs.jnatprod.9b00561,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by spectrophotometric based Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.7,uM,=,0.2304489213782739,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
4956,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,C=C[C@H]1[C@@H](/C(=C/O)C(=O)OC)C[C@H]2c3[nH]c4ccccc4c3CCN2[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,"methyl(Z)-2-[(2S,3S,4S,12bS)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3-vinyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxy-prop-2-enoate",1.9,uM,=,0.2787536009528289,1,c1ccc2c3c([nH]c2c1)[C@@H]1CCC[C@H](O[C@H]2CCCCO2)N1CC3
4957,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CCc1cccc(CC)c1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(2,6-Diethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.69,uM,=,-0.1611509092627447,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
4958,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,CCN(CC)CCS/C(=N\O)C(=O)c1ccc(Br)cc1.Cl,2-(4-Bromo-phenyl)-N-hydroxy-2-oxo-thioacetimidic acid 2-diethylamino-ethyl ester hydrochloride,210.0,uM,=,2.322219294733919,1,c1ccccc1
4959,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2,"US9238626, (+/-)-(Ic) HCl",0.0076,uM,=,-2.1191864077192086,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
4960,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(-c2ccccc2)cc1)NCC1CCN(Cc2ccccc2)CC1,"2-([1,1'-Biphenyl]-4-yloxy)-N-((1-benzylpiperidin-4-yl)methyl)acetamide",1.7,uM,=,0.2304489213782739,1,O=C(COc1ccc(-c2ccccc2)cc1)NCC1CCN(Cc2ccccc2)CC1
4961,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCN(CC)CCCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(6-(Diethylamino)hexyloxy)phenyl)-3-phenylprop-2-en-1-one,50.44,uM,=,1.702775077901044,1,O=C(/C=C/c1ccccc1)c1ccccc1
4962,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1Cc1ccccc1-2,"8-(3-(Piperidin-1-yl)propoxy)isoindolo[1,2-b]quinazolin-10(12H)-one",0.142,uM,=,-0.8477116556169436,0,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1Cc1ccccc1-2
4963,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Heptyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.211,uM,=,-0.6757175447023074,0,c1ccc2c(c1)CC1NCCC21
4964,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,c1ccc2c(CNc3ccnc(N4CCN(C5CCCCC5)CC4)n3)cccc2c1,2-(4-Cyclohexylpiperazin-1-yl)-N-(naphth-1-ylmethyl)pyrimidin-4-amine,8.0,uM,=,0.9030899869919436,1,c1ccc2c(CNc3ccnc(N4CCN(C5CCCCC5)CC4)n3)cccc2c1
4965,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)c(C)c1,"(2,4-Dimethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.014,uM,=,-1.853871964321762,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
4966,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",COC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1)CSCC3,"US9284330, S22",0.45,uM,=,-0.3467874862246563,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCSC3
4967,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1cccc(CNC2CCN(Cc3ccccc3)CC2)c1OC,"1-Benzyl-N-(2,3-dimethoxybenzyl)piperidin-4-amine",2.2,uM,=,0.3424226808222063,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
4968,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC(C)N1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,2-(4-Isopropylpiperazin-1-yl)-N-(naphth-1-ylmethyl)pyrimidin-4-amine,15.8,uM,=,1.1986570869544226,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
4969,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CCCCCn1nc(OCc2ccc(OC)cc2)c2cc([N+](=O)[O-])ccc21,3-(4-Methoxybenzyloxy)-5-nitro-1-pentylindazole,9.7,uM,=,0.9867717342662448,1,c1ccc(COc2n[nH]c3ccccc23)cc1
4970,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,COc1c(C(=O)CCC2CCN(Cc3ccccc3)CC2)cc(Cl)c2[nH]ccc12,3-(1-Benzyl-4-piperidyl)-1-(7-chloro-4-methoxy-1H-indol-5-yl)propan-1-one,0.0203999999999999,uM,=,-1.6903698325741012,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]ccc2c1
4971,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CC(C)(C)c1cccc(C(=O)CF)c1,1-(3-(tert-butyl)phenyl)-2-fluoroethan-1-one,0.578,uM,=,-0.2380721615794709,0,c1ccccc1
4972,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CCc3ccccc3)C1N2C,"o-Tolyl-carbamic acid (S)-3a,8-dimethyl-1-phenethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.55,uM,=,-0.2596373105057561,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN(CCc3ccccc3)C1N2
4973,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(Cl)cc1[N+](=O)[O-])NCCN1CCN(Cc2ccccc2)CC1,N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2-(4-chloro-2-nitrophenoxy)acetamide,0.0008,uM,=,-3.096910013008056,0,O=C(COc1ccccc1)NCCN1CCN(Cc2ccccc2)CC1
4974,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccc(O)cc1,4-Methyl-phenol,4.9,uM,=,0.6901960800285137,1,c1ccccc1
4975,1335303,10.1021/jm400970m,,,,Inhibition of AChE (unknown origin) assessed as inhibition of ROS production,O=C(CCCOc1cccc2[nH]c3ccccc3c12)NCCCNc1c2c(nc3ccccc13)CCCC2,"4-(9H-carbazol-4-yloxy)-N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)butanamide",23.0,uM,=,1.3617278360175928,1,O=C(CCCOc1cccc2[nH]c3ccccc3c12)NCCCNc1c2c(nc3ccccc13)CCCC2
4976,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Oc1ccc(CNC2CCN(Cc3ccccc3)CC2)c(O)c1,"4-(((1-Benzylpiperidin-4-yl)amino)methyl)benzene-1,3-diol",2.3,uM,=,0.3617278360175928,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
4977,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,"6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine",0.00718,uM,=,-2.1438755557577,0,c1ccc2nc3c(cc2c1)CCCC3
4978,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1cc2c(c(OC)c1OC)C(=O)C(C)C2,"5,6,7-Trimethoxy-2-methyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
4979,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,C=C(C)[C@@H](O)CC[C@]1(C)[C@@H](CC=C(C)C)C[C@]23C[C@@H](C(C)(C)O)OC2=C(CC=C(C)C)C(=O)[C@@]1(C(=O)C(C)C)C3=O,32-epi-Hyperforatin E,9.13,uM,=,0.960470777534299,1,O=C1C=C2OCC[C@@]23CCCC1C3=O
4980,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.035,uM,=,-1.4559319556497243,0,c1ccc2c(c1)N[C@H]1NCCC21
4981,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CN(C)CCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(5-(Dimethylamino)pentyloxy)phenyl)-3-phenylprop-2-en-1-one,13.07,uM,=,1.1162755875805443,1,O=C(/C=C/c1ccccc1)c1ccccc1
4982,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCOCC3)c(O)c1)O2,"(Z)-2-(3-hydroxy-4-(morpholinomethyl)benzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",6.0,uM,=,0.7781512503836436,1,O=C1/C(=C/c2ccc(CN3CCOCC3)cc2)Oc2ccccc21
4983,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cl.Cl.c1ccc(CN2CCC(CCSc3ccc(-c4ccccc4)nn3)CC2)cc1,3-[2-(1-Benzyl-piperidin-4-yl)-ethylsulfanyl]-6-phenyl-pyridazine dihydrochloride,0.47,uM,=,-0.3279021420642826,0,c1ccc(CN2CCC(CCSc3ccc(-c4ccccc4)nn3)CC2)cc1
4984,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)CCC3CC[N+](C)(Cc4ccccc4)CC3)n(C)c2cc1OC,"1-Benzyl-4-[3-(5,6-dimethoxy-1-methyl-1H-indol-2-yl)-3-oxo-propyl]-1-methyl-piperidinium",0.12,uM,=,-0.9208187539523752,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2[nH]1
4985,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OC(C)C)C(c2ccccc2F)c2c(nc3c(c2N)CC(C)(C)CC3)N1,"US9284330, S7",1.377,uM,=,0.1389339402569236,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
4986,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(Nc3ccc(F)cc3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-N'-(4-fluoro-phenyl)-4,6-dinitro-benzene-1,3-diamine",0.68,uM,=,-0.1674910872937636,0,c1ccc(Nc2cccc(NCCSCc3ccco3)c2)cc1
4987,2268546,10.1021/acs.jmedchem.1c00683,,,,Inhibition of AChE (unknown origin),CCN(C)C(=O)Oc1ccc2c(c1)C=CC(C)N(C)C2CCOc1ccc([N+](=O)[O-])cc1,"2,3-dimethyl-1-(2-(4-nitrophenoxy)ethyl)-2,3-dihydro-1H-benzo[c]azepin-7-yl ethyl(methyl)carbamate",0.014,uM,=,-1.853871964321762,0,C1=Cc2ccccc2C(CCOc2ccccc2)NC1
4988,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1C2,"Heptyl-carbamic acid 1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.114,uM,=,-0.9430951486635274,0,c1ccc2c(c1)CC1NCCC21
4989,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CN(CCC1CCN(Cc2ccccc2)CC1)Cc1c[nH]c2ccccc12,N-((1H-Indol-3-yl)methyl)-2-(1-benzylpiperidin-4-yl)-N-methylethan-1-amine,33.89,uM,=,1.5300715688373785,1,c1ccc(CN2CCC(CCNCc3c[nH]c4ccccc34)CC2)cc1
4990,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CN(C)CCOC(=O)/C=C/c1ccc2occ(C(=O)Nc3ccc(Cl)cc3)c(=O)c2c1,2-(Dimethylamino)ethyl (E)-3-(3-((4-chlorophenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,9.32,uM,=,0.9694159123539814,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
4991,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1cc2c(cc1O)C(=O)C(C)C2,6-Hydroxy-5-methoxy-2-methyl-indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
4992,28162,10.1021/jm00122a035,,,,Concentration of compound that reversibly inhibits acetylcholinesterase (AChE) by 50 %,C#CCCCC[n+]1ccn(C)c1/C=N/O.[Cl-],1-Hex-5-ynyl-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride,8.5,uM,=,0.9294189257142929,1,c1c[nH+]c[nH]1
4993,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,Cc1ccccc1CN1CCC(CC(=O)NCCc2c[nH]c3ccccc23)CC1,N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-2-(1-(2-methylbenzyl)piperidin-4-yl)acetamide,1.54,uM,=,0.1875207208364631,1,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12
4994,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,COc1cccc(C)c1,1-Methoxy-3-methyl-benzene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
4995,28308,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.008-0.012,CN(C)C(=O)Oc1cccc2c1CCC2N.Cl,Dimethyl-carbamic acid 1-amino-indan-4-yl ester hydrochloride,0.009,uM,=,-2.0457574905606752,0,c1ccc2c(c1)CCC2
4996,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)OC[C@@H]1CCN(C)[C@H]21,"Methyl-carbamic acid 1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalen-7-yl ester",0.03,uM,=,-1.5228787452803376,0,c1ccc2c(c1)OC[C@@H]1CCN[C@H]21
4997,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2,"(3aS,8aS)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate",0.0567,uM,=,-1.2464169411070931,0,c1ccc2c(c1)N[C@H]1NCCC21
4998,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccccc1F,1-Fluoro-2-methyl-benzene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
4999,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Oc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)cc1,4-(((1-Benzylpiperidin-4-yl)imino)methyl)phenol,4.8,uM,=,0.6812412373755872,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5000,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cl.Cl.c1ccc(CN2CCC(CCNc3ccc(-c4ccccc4)nn3)CC2)cc1,[2-(1-Benzyl-piperidin-4-yl)-ethyl]-(6-phenyl-pyridazin-3-yl)-amine dihydrochloride hydrate,0.14,uM,=,-0.8538719643217619,0,c1ccc(CN2CCC(CCNc3ccc(-c4ccccc4)nn3)CC2)cc1
5001,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Clc1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,SID47202393,0.85,uM,=,-0.0705810742857072,0,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5002,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.15,uM,=,-0.8239087409443188,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
5003,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(Cl)cc1[N+](=O)[O-])NCC1CCN(Cc2ccccc2)CC1,N-((1-Benzylpiperidin-4-yl)methyl)-2-(4-chloro-2-nitrophenoxy)acetamide,0.122,uM,=,-0.9136401693252518,0,O=C(COc1ccccc1)NCC1CCN(Cc2ccccc2)CC1
5004,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CCc1cc[n+](CC3CC3)cc1)C2,"1-Cyclopropylmethyl-4-[3-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium",0.11,uM,=,-0.958607314841775,0,O=C(CCc1cc[n+](CC2CC2)cc1)C1Cc2ccccc2S1
5005,751132,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human plasma BChE,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",4.15,uM,=,0.6180480967120927,1,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5006,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2cc(O)c(O)cc2o1,"6,7-Dihydroxy-4-oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)-amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.0065,uM,=,-2.1870866433571443,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5007,1500860,10.1016/j.bmc.2015.04.080,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as substrate hydrolysis by spectrophotometric/Ellman method,CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@@]3(C)C[C@@]4(O)CC[C@H]5C(C)(C)[C@@H](OC(C)=O)CC[C@]5(C)[C@H]4CC[C@@H]32)C1(C)C,"3beta,21alpha-diacetoxyserratan-14beta-ol",0.91,uM,=,-0.0409586076789063,0,C1CC[C@@H]2CCC3CC4CC[C@H]5CCCCC5[C@H]4CC[C@@H]3C2C1
5008,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)C2N3Cc2ccccc2)cc1,"(4-Isopropyl-phenyl)-carbamic acid (S)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",13.0,uM,=,1.1139433523068367,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2Cc1ccccc1
5009,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCl)c3C(C1)C2,"(+/-)-N-(2-chloroethyl)-3-chloro-6,7,10,11-tetrahydro-12-ylamino-9-methyl-7,11-methanocyclooctan[b]-quinoline",0.0433,uM,=,-1.3635121036466344,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5010,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCN(CCC)CCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(3-(Dipropylamino)propoxy)phenyl)-3-phenylprop-2-en-1-one,24.63,uM,=,1.3914644118391033,1,O=C(/C=C/c1ccccc1)c1ccccc1
5011,1840498,10.1016/j.ejmech.2019.02.008,,,,Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition and measured at 1 min time interval by Ellman's method relative to control,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.4,uM,=,-0.3979400086720376,0,c1ccc2nc3c(cc2c1)CCCC3
5012,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00184,uM,=,-2.735182176990464,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5013,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2c(c1)CN1CCc3c([nH]c4ccccc34)C1=N2,Rutaecarpene,3.4,uM,=,0.5314789170422551,1,c1ccc2c(c1)CN1CCc3c([nH]c4ccccc34)C1=N2
5014,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2occ(C(=O)Nc3ccc(C)cc3)c(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(4-oxo-3-((4-methylphenyl)carbamoyl)-4H-chromen-6-yl)acrylate,8.99,uM,=,0.9537596917332288,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5015,2022945,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's coupled enzyme assay,C[C@@H]1CC[C@H]2[C@H](C(=O)c3c(O)c([C@@]4(O)CC[C@@H](O)[C@H]5O[C@H]54)cn(O)c3=O)[C@H](C)C=C[C@@H]2C1,N-hydroxyapiosporamide,39.0,uM,=,1.591064607026499,1,O=C(c1cc(C2CCC[C@H]3O[C@@H]23)c[nH]c1=O)[C@@H]1CC=C[C@@H]2CCCC[C@H]21
5016,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(4-oxo-4-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)butyl)-benzamide",0.241,uM,=,-0.6179829574251317,0,O=C(CCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5017,2162543,10.1016/j.ejmech.2021.114045,,,,Inhibition of recombinant AChE in human erythrocytes using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.00739,uM,=,-2.1313555616051745,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5018,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(C)[C@@H]1N2C,"(3aR,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate",9.887,uM,=,0.9950645341561416,1,c1ccc2c(c1)N[C@H]1NCCC21
5019,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1,"4-Oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.0175,uM,=,-1.7569619513137056,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5020,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,8-Bis(isoquinolinium)-oct-1,8-diyl dibromide",0.005,uM,=,-2.3010299956639813,0,c1ccc2c[n+](CCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1
5021,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 15",0.0038,uM,=,-2.42021640338319,0,O=C(NCCCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5022,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(N)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-benzene-1,3-diamine",0.083,uM,=,-1.080921907623926,0,c1ccc(NCCSCc2ccco2)cc1
5023,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,CCCCCN1CCCN=C1/C=N/O.Cl,"1-Pentyl-1,4,5,6-tetrahydropyrimidine-2-carbaldehyde Oxime Hydrochloride",21.0,uM,=,1.3222192947339193,1,C1=NCCCN1
5024,2185017,10.1016/j.ejmech.2021.113278,,,,Inhibition of human AchE preincubated for 6 mins followed by substrate addition and measured upto 3 mins using acetylthiocholine iodide as substrate by Ellman's method,COc1cc(/C=C/C(=O)OCCCCCN(C)Cc2cccc(OC(=O)N(C)C)c2)ccc1O,5-((3-((dimethylcarbamoyl)oxy)benzyl)(methyl)amino)pentyl-3-(4-hydroxy-3-methoxyphenyl)acrylate,0.0197,uM,=,-1.705533773838407,0,O=C(/C=C/c1ccccc1)OCCCCCNCc1ccccc1
5025,2022945,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's coupled enzyme assay,C[C@@H]1CC[C@H]2[C@H](C(=O)c3c4c(cn(O)c3=O)[C@@]3(O)CC[C@H](O)[C@H](O4)[C@@H]3O)[C@H](C)C=C[C@@H]2C1,Arthpyrone A,47.0,uM,=,1.6720978579357175,1,O=C(c1c2c(c[nH]c1=O)C1CCC[C@@H](C1)O2)[C@@H]1CC=C[C@@H]2CCCC[C@H]21
5026,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=C(CO/N=[N+](\[O-])N1CCCC1)NCCCNc1c2c(nc3ccccc13)CCCC2,"O2-[2-(N-gamma-(1,2,3,4-tetrahydroacridine)-gamma-aminopropylamino)-2-oxoethyl]-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate",0.0355,uM,=,-1.449771646944906,0,O=C(CON=[NH+]N1CCCC1)NCCCNc1c2c(nc3ccccc13)CCCC2
5027,2079760,10.1016/j.ejmech.2020.113059,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate peincubated for 5 mins followed by substrate addition by DTNB-reagent based Ellman's method,CCN(C)C(=O)Oc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1,3-[[2-(6-fluoro-1H-indol-3-yl)ethylamino]methyl]phenyl N-ethyl-N-methylcarbamate,16.5,uM,=,1.2174839442139065,1,c1ccc(CNCCc2c[nH]c3ccccc23)cc1
5028,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccc(N)cc1,p-Tolylamine,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5029,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,COc1cc2nc3c(c(N)c2cc1OC)C1CC(C)=CC(C3)C1,"(+/-)-12-Amino-2,3-dimethoxy-9-methyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline",11.7,uM,=,1.0681858617461617,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5030,28601,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 42.5-45.9,C#CCNC1CCc2c(Cl)cc(OC(=O)N(C)CCC)cc21.Cl,Methyl-propyl-carbamic acid 7-chloro-3-prop-2-ynylamino-indan-5-yl ester hydrochloride,43.9,uM,=,1.6424645202421213,1,c1ccc2c(c1)CCC2
5031,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)C(=O)C(C1CC[N+](C)(Cc3ccccc3)CC1)=C2,"1-Benzyl-4-(5,6-dimethoxy-1-oxo-1H-inden-2-yl)-1-methyl-piperidinium",0.25,uM,=,-0.6020599913279624,0,O=C1C(C2CC[NH+](Cc3ccccc3)CC2)=Cc2ccccc21
5032,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,O=C(CCCCC1CCSS1)NCCCCNc1c2c(nc3ccccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [4-(1,2,3,4-tetrahydro-acridin-9-ylamino)-butyl]-amide",0.0352,uM,=,-1.453457336521869,0,O=C(CCCCC1CCSS1)NCCCCNc1c2c(nc3ccccc13)CCCC2
5033,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCNC2N3C)cc1,"(4-Isopropyl-phenyl)-carbamic acid (S)-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.324,uM,=,-0.4894549897933878,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
5034,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCO)c3C(C1)C2,"(+/-)-N-(2-Hydroxyethyl)-3-chloro-6,7,10,11-tetrahydro-12-ylamino-9-methyl-7,11-methanocyclooctan[b]-quinoline",0.00966,uM,=,-2.0150228735845066,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5035,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2,"US9238626, (+/-)-(Ia) HCl",0.0044,uM,=,-2.356547323513813,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5036,973813,10.1021/np4003355,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 8 mins by Ellman's spectrophotometric method,C=C[C@@H]1[C@H]2C=C(C)C[C@]1(NC)c1ccc(=O)[nH]c1C2,N-demethylhuperzinine,15.0,uM,=,1.1760912590556811,1,O=c1ccc2c([nH]1)C[C@@H]1C=CCC2C1
5037,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CCC[N+](C)(CC#N)CC3)sc2cc1OC,"1-Cyanomethyl-4-(5,6-dimethoxy-benzo[b]thiophene-2-carbonyl)-1-methyl-azepanium",1.0,uM,=,0.0,0,O=C(c1cc2ccccc2s1)C1CCC[NH2+]CC1
5038,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CN(C)Cc1cc2c(cc1OC(=O)Nc1ccccc1)[C@]1(C)CCN(C)[C@@H]1N2C,"Phenyl-carbamic acid 6-dimethylaminomethyl-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.7804,uM,=,-0.1076827392775195,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5039,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,CCCCCN1CC(C)(C)CN=C1/C=N/O.Cl,"5,5-Dimethyl-1-pentyl-1,4,5,6-tetrahydropyrimidine-2-carbaldehyde Oxime Hydrochloride",89.0,uM,=,1.9493900066449128,1,C1=NCCCN1
5040,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4c(nc5ccc(Cl)cc35)CCCC4)cc12,"US8841453, 13",3.2806,uM,=,0.5159532805588786,1,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5041,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(CCC(=O)NCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3-(3,4,5-trimethoxyphenyl)-N-(3-oxo-3-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-propyl)propanamide",0.135,uM,=,-0.8696662315049939,0,O=C(CCc1ccccc1)NCCC(=O)NNc1c2c(nc3ccccc13)CCCC2
5042,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1cccc(COc2ccc3c(C)c(C)c(=O)oc3c2)c1,"3,4-Dimethyl-7-(3-methyl-benzyloxy)-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5043,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1cc(=O)c2ccccc2o1,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-decyl}-4-oxo-4H-chromene-2-carboxamide hydrochloride",0.0003,uM,=,-3.522878745280338,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5044,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccc(C(F)(F)F)cc1)CC(C)CC3,"US9284330, S1",0.768,uM,=,-0.114638779968488,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5045,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,Cl.O/N=C/C1=NCCN1Cc1ccccc1,"1-benzyl-4,5-dihydro-1H-imidazole-2-carbaldehyde oxime hydrochloride",44.0,uM,=,1.6434526764861874,1,C1=NCCN1Cc1ccccc1
5046,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,Cc1cc(Br)cc(C)c1OCC(=O)NCC1CCN(Cc2ccccc2)CC1,"N-((1-Benzylpiperidin-4-yl)methyl)-2-(4-bromo-2,6-dimethylphenoxy)acetamide",0.595,uM,=,-0.2254830342714504,0,O=C(COc1ccccc1)NCC1CCN(Cc2ccccc2)CC1
5047,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-],"3-(dimethylcarbamoyloxy)-N,N,N-trimethylbenzenaminium methyl sulfate",0.0421,uM,=,-1.3757179041643317,0,c1ccccc1
5048,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)[C@@H]1N2C,"Methyl-carbamic acid 1-benzyl-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",1.5,uM,=,0.1760912590556812,1,c1ccc(CN2CCC3c4ccccc4N[C@H]32)cc1
5049,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,C[n+]1ccc2c(c1)[nH]c1ccc(O)cc12,6-hydroxy-2-methyl-9H-beta-carbolin-2-ium,4.2,uM,=,0.6232492903979004,1,c1ccc2c(c1)[nH]c1c[nH+]ccc12
5050,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",COC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CSC3,"US9284330, S15",0.729,uM,=,-0.1372724716820254,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CSC3
5051,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(2-oxo-2-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)ethyl)-benzamide",0.0516,uM,=,-1.2873502983727887,0,O=C(CNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5052,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CCc1cc[n+](Cc3ccsc3)cc1)C2,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-thiophen-3-ylmethyl-pyridinium",0.006,uM,=,-2.2218487496163566,0,O=C(CCc1cc[n+](Cc2ccsc2)cc1)C1Cc2ccccc2S1
5053,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC(=O)N1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,1-[4-(4-[Benzhydrylamino]pyrimidin-2-yl)piperazin-1-yl]ethanone,29.0,uM,=,1.462397997898956,1,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1
5054,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=CC2Cc3nc4cc(Cl)ccc4c(NCc4ccc(CNC(=O)c5cc(O)c6c(c5)C(=O)c5cccc(O)c5C6=O)cc4)c3C(C1)C2,"US9238626, (+/-)-(Ie) HCl",0.0182,uM,=,-1.739928612014925,0,O=C(NCc1ccc(CNc2c3c(nc4ccccc24)CC2C=CCC3C2)cc1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5055,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1cc(OC)c2c(=O)cc(C(=O)NCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc2c1.Cl,"5,7-Dimethoxy-4-oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.0023,uM,=,-2.638272163982407,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5056,1500860,10.1016/j.bmc.2015.04.080,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as substrate hydrolysis by spectrophotometric/Ellman method,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2,SID11112431,0.1,uM,=,-1.0,0,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
5057,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CCC[N+](C)(CCOc4ccccc4)CC3)sc2cc1OC,"4-(5,6-Dimethoxy-benzo[b]thiophene-2-carbonyl)-1-methyl-1-(2-phenoxy-ethyl)-azepanium",0.39,uM,=,-0.4089353929735008,0,O=C(c1cc2ccccc2s1)C1CCC[NH+](CCOc2ccccc2)CC1
5058,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCN1CC[C@@]2(C)c3cc(OC(=O)NC(C)(C)C)ccc3CC12,"(+/-)-tert-Butyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",12.487,uM,=,1.0964581117174534,1,c1ccc2c(c1)CC1NCCC21
5059,1655757,10.1016/j.ejmech.2016.12.048,,,,Inhibition of acetylcholinesterase isolated from human red blood cells using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Oc1cc(O)cc(CCc2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)c1,"5-(4-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)phenethyl)benzene-1,3-diol",1.3,uM,=,0.1139433523068367,1,c1ccc(CCc2ccc(Nc3c4c(nc5ccccc35)CCCC4)cc2)cc1
5060,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCC1=N2,"7-(3-(piperidin-1-yl)propoxy)-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline",0.0339,uM,=,-1.469800301796918,0,c1cc2c(cc1OCCCN1CCCCC1)CN1CCCC1=N2
5061,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@@]2(CC=C(C)C)C(=O)[C@]1(C(=O)C(C)C)C(=O)C1=C2O[C@@H](C(C)(C)O)[C@@H]1O,Hyperforatin K,11.26,uM,=,1.0515383905153275,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5062,2275467,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) incubated for 40 mins by Ellman's method,Cc1ccc([N+]2=Cc3c(c4ccccc4n3C)CC2)cc1,"9-methyl-2-(p-tolyl)-3,4-dihydropyrido[3,4-b]indol-2-ium",1.5,uM,=,0.1760912590556812,1,C1=[N+](c2ccccc2)CCc2c1[nH]c1ccccc21
5063,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CCN(CC)CCCCCCOc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(6-diethylaminohexyloxy)phenyl]methanone,0.257,uM,=,-0.5900668766687055,0,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
5064,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccccc1C(F)(F)F)NCCN1CCN(Cc2ccccc2)CC1,N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2-(2-(trifluoromethyl)phenoxy)acetamide,0.136,uM,=,-0.8664610916297825,0,O=C(COc1ccccc1)NCCN1CCN(Cc2ccccc2)CC1
5065,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCCCCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(12-Morpholin-4-yl-dodecyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.07,uM,=,-1.154901959985743,0,O=C(NCCCCCCCCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5066,2050183,10.1016/j.bmcl.2020.127659,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 4.5 mins followed by substrate addition measured after 2.5 mins by Ellman's method,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCC2,"7-(3-(Piperidin-1-yl)propoxy)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one",0.05,uM,=,-1.3010299956639813,0,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCC2
5067,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,"(+/-)-N-{10-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]decyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.00761,uM,=,-2.1186153432294272,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5068,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CC(C)Cn1cc(C(=O)C(F)(F)F)cn1,"2, 2, 2-trifluoro-1-(1-isobutyl-1H-pyrazol-4-yl)ethan-1-one",0.591,uM,=,-0.2284125191187446,0,c1cn[nH]c1
5069,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C=C(NCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,"2-[3-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl-amino)propyl]-amino-1,4-naphthoquinone",0.0054,uM,=,-2.2676062401770314,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5070,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Clc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)c(Cl)c1,"N-(1-benzylpiperidin-4-yl)-1-(2,4-dichlorophenyl)methanimine",1.3,uM,=,0.1139433523068367,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5071,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,O=[N+]([O-])c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,1-Benzyl-N-(4-nitrobenzyl)piperidin-4-amine,0.72,uM,=,-0.1426675035687315,0,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5072,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C=O)[C@@H]12,"(3aS,8aR)-8-formyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate",0.33,uM,=,-0.4814860601221125,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5073,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.2,uM,=,-0.6989700043360187,0,c1ccc2c(c1)N[C@H]1NCCC21
5074,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(9-Morpholin-4-yl-nonyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.06,uM,=,-1.2218487496163564,0,O=C(NCCCCCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5075,1549987,10.1016/j.ejmech.2015.12.024,,,,Inhibition of human acetylcholine esterase preincubated for 10 mins followed by the addition of 550 uM of acetylcholine iodide as substrate measured after 20 mins by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",2.01,uM,=,0.3031960574204888,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5076,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(NCc3ccccc3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-Benzyl-N'-[2-(5-dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-benzene-1,3-diamine",0.69,uM,=,-0.1611509092627447,0,c1ccc(CNc2cccc(NCCSCc3ccco3)c2)cc1
5077,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C(NCCNc2c3c(nc4ccccc24)CCCC3)=CC(=O)c2c(O)cccc21,"5-hydroxy-2-(2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethylamino)naphthalene-1,4-dione",0.0247,uM,=,-1.6073030467403342,0,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5078,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,CCOCC[n+]1ccc(CCC(=O)C2Cc3cc(OC)c(OC)cc3S2)cc1,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(2-ethoxy-ethyl)-pyridinium",0.007,uM,=,-2.154901959985743,0,O=C(CCc1cc[nH+]cc1)C1Cc2ccccc2S1
5079,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccc2c(c1)OCO2,"4-(3-Benzo[1,3]dioxol-5-yl-3-oxo-propyl)-1-benzyl-pyridinium",0.24,uM,=,-0.619788758288394,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)c1ccc2c(c1)OCO2
5080,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(NC(=O)CN3CCCCC3)cc2)cc1,N-(4-{4-[(Benzylmethylamino)methyl]benzoyl}phenyl)-2-piperidin-1-yl-acetamide,0.55,uM,=,-0.2596373105057561,0,O=C(CN1CCCCC1)Nc1ccc(C(=O)c2ccc(CNCc3ccccc3)cc2)cc1
5081,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CCN3CCCC3)CC2)cc1,1-[bis(4-fluoro-phenyl)-methyl]-4-(2-pyrrolidin-1-ylethyl)-piperazine,0.021,uM,=,-1.6777807052660807,0,c1ccc(C(c2ccccc2)N2CCN(CCN3CCCC3)CC2)cc1
5082,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"ethyl-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.094,uM,=,-1.0268721464003014,0,c1ccc2c(c1)N[C@H]1NCCC21
5083,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)CCNc1cc(NCCSCc2ccc(CN(C)C)o2)c([N+](=O)[O-])cc1[N+](=O)[O-],"N-(2-Dimethylamino-ethyl)-N'-[2-(5-dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-benzene-1,3-diamine",0.52,uM,=,-0.2839966563652008,0,c1ccc(NCCSCc2ccco2)cc1
5084,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1cccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)c1C,"(2,3-Dimethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.023,uM,=,-1.6382721639824072,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5085,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",COCCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1Cl)CC(C)(C)CC3,"US9284330, S9",0.919,uM,=,-0.0366844886138887,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5086,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3ccc(C)cc3)cc(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(4-oxo-2-((4-methylphenyl)carbamoyl)-4H-chromen-6-yl)acrylate,9.87,uM,=,0.9943171526696368,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5087,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1OC)CC(C)CC3,"US9284330, S27",0.178,uM,=,-0.7495799976911061,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5088,1432884,10.1021/np500558b,,,,Inhibition of AChE (unknown origin) assessed as inhibition of acetylcholine hydrolysis preincubated for 15 mins by Ellman method,CNc1ccccc1-c1nc(C(=O)OC)cs1,Anithiactin A,63.0,uM,=,1.7993405494535817,1,c1ccc(-c2nccs2)cc1
5089,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccccc1C,o-Xylene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5090,646813,10.1038/nchembio.307,,,,Inhibition of AChE,O=C(CCCN1C(=O)c2ccccc2C1=O)N1CCCCCC1,"2-(4-(azepan-1-yl)-4-oxobutyl)isoindoline-1,3-dione",0.5,uM,=,-0.3010299956639812,0,O=C(CCCN1C(=O)c2ccccc2C1=O)N1CCCCCC1
5091,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,CCCCN1CCCN=C1/C=N/O.Cl,"1-Butyl-1,4,5,6-tetrahydropyrimidine-2-carbaldehyde Oxime Hydrochloride",157.0,uM,=,2.1958996524092336,1,C1=NCCCN1
5092,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,COCCN1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,2-[4-(2-Methoxyethyl)piperazin-1-yl]-N-(naphth-1-ylmethyl)pyrimidin-4-amine,11.7,uM,=,1.0681858617461617,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
5093,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,Cc1cc2cc3n(c(=O)c2cn1)CCc1c-3[nH]c2ccccc12,,22.0,uM,=,1.3424226808222062,1,O=c1c2cnccc2cc2n1CCc1c-2[nH]c2ccccc12
5094,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4ncccc4c(N)c3C(C1)C2,"(+/-)-11-Amino-8-ethyl-5,6,9,10-tetrahydro-6,10-methanocyclooctabenzo[b][1,8]naphthyridine",0.8550000000000001,uM,=,-0.0680338852718273,0,C1=CC2Cc3nc4ncccc4cc3C(C1)C2
5095,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,Clc1ccc2c(c1)CN1CCCCCC1=N2,"2-Chloro-6,7,8,9,10,12-hexahydro-azepino[2,1-b]quinazoline",0.5,uM,=,-0.3010299956639812,0,c1ccc2c(c1)CN1CCCCCC1=N2
5096,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCCC2,"2-(3-(Piperidin-1-yl)propoxy)-8,9-dihydro-6H-pyrido[2,1-b]quinazolin-11(7H)-one",0.225,uM,=,-0.6478174818886375,0,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCCC2
5097,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1cc2cc[n+](C)c3c2c(c1OC)C(Br)OC3=O,"7-Bromo-5,6-dimethoxy-1-methyl-9-oxo-7H,9H-8-oxa-1-azonia-phenalene",105.0,uM,=,2.0211892990699383,1,O=C1OCc2cccc3cc[nH+]c1c23
5098,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN1c2ccccc2C(n2nnc3ccccc32)c2ccccc21,"9-(1H-benzo[d][1,2,3]triazol-1-yl)-10-methyl-9,10-dihydroacridine",12.4,uM,=,1.0934216851622351,1,c1ccc2c(c1)Nc1ccccc1C2n1nnc2ccccc21
5099,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4ccccc4C)CC3)c2c1,N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-2-(1-(2-methylbenzyl)piperidin-4-yl)acetamide,3.6,uM,=,0.5563025007672873,1,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12
5100,2261362,10.1016/j.ejmech.2022.114606,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by spectrophotometry,CCOC(=O)c1cc2c(OC(=O)N(C)C)cccc2[n+](C)c1.O=C([O-])C(F)(F)F,"ethyl 5-(dimethylcarbamoyloxy)-1-methyl-quinolin-1-ium-3-carboxylate 2,2,2-trifluoroacetate",0.007,uM,=,-2.154901959985743,0,c1ccc2[nH+]cccc2c1
5101,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,Clc1cccc2c1CN1CCCCCC1=N2,"1-Chloro-6,7,8,9,10,12-hexahydro-azepino[2,1-b]quinazoline",1.7,uM,=,0.2304489213782739,1,c1ccc2c(c1)CN1CCCCCC1=N2
5102,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,Clc1ccc2c(c1)N=C1CCCCCN1C2,"3-Chloro-6,7,8,9,10,12-hexahydro-azepino[2,1-b]quinazoline",0.158,uM,=,-0.8013429130455774,0,c1ccc2c(c1)CN1CCCCCC1=N2
5103,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,COc1cc(C)cc(OC)c1OC,"1,2,3-Trimethoxy-5-methyl-benzene",4.9,uM,=,0.6901960800285137,1,c1ccccc1
5104,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,C#CCCCCCCN1CCc2cc(OC)c(OC)cc2C1c1cccc([N+](=O)[O-])c1,"1-(3-nitrophenyl)-6,7-dimethoxy-2-(oct-7-ynyl)-1,2,3,4-tetrahydroisoquinoline",8.079999999999998,uM,=,0.907411360774586,1,c1ccc(C2NCCc3ccccc32)cc1
5105,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2cc(O)ccc2o1,"6-Hydroxy-4-oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)-amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.008,uM,=,-2.096910013008056,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5106,590772,10.1021/jm901123n,,,,Inhibition of human recombinant AChE by Ellman's method,CCN(CCCNC1=CC(=O)C(NCCCNC(=O)CCCCC2CCSS2)=CC1=O)Cc1ccccc1OC,"5-[1,2]Dithiolan-3-yl-pentanoic acid [3-(4-{3-[ethyl-(2-methoxy-benzyl)-amino]-propylamino}-3,6-dioxo-cyclohexa-1,4-dienylamino)-propyl]-amide",0.19,uM,=,-0.721246399047171,0,O=C(CCCCC1CCSS1)NCCCNC1=CC(=O)C(NCCCNCc2ccccc2)=CC1=O
5107,28315,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.18-0.32,C#CCNCCc1cccc(OC(=O)N(C)C)c1,Dimethyl-carbamic acid 3-(2-prop-2-ynylamino-ethyl)-phenyl ester,0.22,uM,=,-0.6575773191777937,0,c1ccccc1
5108,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,Cc1cccc(CN2CCC(CC(=O)NCCc3c[nH]c4ccccc34)CC2)c1,N-(2-(1H-Indol-3-yl)ethyl)-2-(1-(3-methylbenzyl)piperidin-4-yl)acetamide,4.63,uM,=,0.6655809910179531,1,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12
5109,1431108,10.1016/j.bmcl.2014.10.025,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)C[C@@H]4C=C(C)C[C@H]5C4)c3[C@@H](C1)C2,"(+)-N,N'-bis[(7R,11R)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocyclo-octa[b]quinolin-12-yl]-1,12-dodecanediamine",0.431,uM,=,-0.3655227298392684,0,C1=C[C@H]2Cc3nc4ccccc4c(NCCCCCCCCCCCCNc4c5c(nc6ccccc46)C[C@@H]4C=CC[C@H]5C4)c3[C@@H](C1)C2
5110,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(10-Morpholin-4-yl-decyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.04,uM,=,-1.3979400086720375,0,O=C(NCCCCCCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5111,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Heptyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.036,uM,=,-1.4436974992327127,0,c1ccc2c(c1)CC1NCCC21
5112,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC(C)C1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,N-Benzhydryl-2-(4-isopropylpiperidin-1-yl)pyrimidin-4-amine,42.5,uM,=,1.6283889300503116,1,c1ccc(C(Nc2ccnc(N3CCCCC3)n2)c2ccccc2)cc1
5113,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCOCC[n+]3ccc4ccccc4c3)ccc2c1,"1,5-Bis(isoquinolinium)-3-oxapent-1,5-diyl dibromide",1310.0,uM,=,3.1172712956557644,1,c1ccc2c[n+](CCOCC[n+]3ccc4ccccc4c3)ccc2c1
5114,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,CCOc1cc2c(cc1OCC)C(=O)C(C)C2,"5,6-Diethoxy-2-methyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5115,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,Cc1ccc(NC(=O)c2cc(=O)c3cc(/C=C/C(=O)O)ccc3o2)cc1,(E)-3-(4-Oxo-2-((4-methylphenyl)carbamoyl)-4H-chromen-6-yl)acrylic acid,5.1,uM,=,0.7075701760979364,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5116,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,Cc1ccc(NC(=O)c2cc(=O)c3cc(/C=C/C(=O)OCCN(C)C)ccc3o2)cc1,2-(Dimethylamino)ethyl (E)-3-(4-oxo-2-((4-methylphenyl)carbamoyl)-4H-chromen-6-yl)acrylate,0.21,uM,=,-0.6777807052660807,0,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5117,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Cl-].[Cl-].c1ccc2c[n+](COC[n+]3ccc4ccccc4c3)ccc2c1,"1,3-Bis(isoquinolinium)-2-oxaprop-1,3-diyl dichloride",2.0,uM,=,0.3010299956639812,1,c1ccc2c[n+](COC[n+]3ccc4ccccc4c3)ccc2c1
5118,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,c1ccc(CN2CCC(CCc3n[nH]c4ccccc34)CC2)cc1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-indazole,0.12,uM,=,-0.9208187539523752,0,c1ccc(CN2CCC(CCc3n[nH]c4ccccc34)CC2)cc1
5119,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)CC[C@@H]1CCN(C)[C@H]21,"(3aR,9bS)-1-methyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indol-7-yl methylcarbamate",0.0173,uM,=,-1.7619538968712043,0,c1ccc2c(c1)CC[C@@H]1CCN[C@H]21
5120,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CC)C1C2,"(+/-)-Propyl-carbamic acid 1-ethyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",2.192,uM,=,0.3408405498123316,1,c1ccc2c(c1)CC1NCC[C@@H]21
5121,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,COc1ccc(C)cc1OC,"1,2-Dimethoxy-4-methyl-benzene",4.9,uM,=,0.6901960800285137,1,c1ccccc1
5122,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,CCCCC/N=C(/C=N/O)N(C)C.Cl,"2-(Hydroxyimino)-N,N-dimethyl-N'-pentylacetimidamide Hydrochloride Salt",13.0,uM,=,1.1139433523068367,1,
5123,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12,N-(2-(1H-indol-3-yl)ethyl)-2-(1-benzylpiperidin-4-yl)acetamide,3.8,uM,=,0.5797835966168101,1,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12
5124,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C(Cl)=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,"2-chloro-3-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propylamino)naphthalene-1,4-dione",0.038,uM,=,-1.42021640338319,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5125,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)N(C)c2nc3c(c(N)c2C1c1ccccc1Cl)CC(C)(C)CC3,"US9284330, S37",1.86,uM,=,0.2695129442179163,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5126,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,C#CCCCCCCN1CCc2cc(OC)c(OC)cc2C1c1ccc([N+](=O)[O-])cc1,"1-(4-nitrophenyl)-6,7-dimethoxy-2-(oct-7-ynyl)-1,2,3,4-tetrahydroisoquinoline",2.92,uM,=,0.4653828514484183,1,c1ccc(C2NCCc3ccccc32)cc1
5127,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,Cc1ccc(NC(=O)c2cc(=O)c3cc(/C=C/C(=O)OCCN(C)C)ccc3o2)cc1C,"2-(Dimethylamino)ethyl (E)-3-(2-((3,4-dimethylphenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate",0.21,uM,=,-0.6777807052660807,0,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5128,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12,"(-)-Phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0221,uM,=,-1.6556077263148894,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5129,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCCCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(8-oxo-8-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)octyl)-benzamide",0.00524,uM,=,-2.280668713016273,0,O=C(CCCCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5130,1984714,10.1021/acs.jnatprod.9b00561,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by spectrophotometric based Ellman's method,COc1c2c(cc3c1OCO3)[C@]13C=C[C@H](OC)C[C@@H]1[N@](C2)C[C@H]3OC(=O)c1ccccc1C,11-O-(2-Methylbenzoyl)ambelline,55.0,uM,=,1.740362689494244,1,O=C(O[C@@H]1C[N@@]2Cc3cc4c(cc3[C@@]13C=CCC[C@H]23)OCO4)c1ccccc1
5131,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,FC(F)(F)Oc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)cc1,N-(1-benzylpiperidin-4-yl)-1-(4-(trifluoromethoxy)phenyl)methanimine,1.0,uM,=,0.0,0,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5132,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)O[C@@]12CCN(C(C)=O)[C@@H]1N(C(C)=O)c1ccc(OC(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 7",0.03681,uM,=,-1.4340341825533334,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5133,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CO[C@H]1C[C@H]2C(=C[C@@H]1OC(=O)c1cc([N+](=O)[O-])ccc1Cl)[C@H]1CN2Cc2cc3c(cc21)OCO3,,3.18,uM,=,0.5024271199844327,1,O=C(O[C@H]1C=C2[C@H]3CN(Cc4cc5c(cc43)OCO5)[C@H]2CC1)c1ccccc1
5134,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CC(C)n1cc(C(=O)C(F)(F)F)cn1,"2,2,2-trifluoro-1-(1-isopropyl-1H-pyrazol-4-yl)ethanone",0.0775,uM,=,-1.1106982974936896,0,c1cn[nH]c1
5135,2271719,10.1016/j.ejmech.2020.112787,,,,Inhibition of human AChE using acetylcholine as substrate incubated for 5 mins followed by substrate addition by Ellman's method,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCCC1CCN(Cc3ccccc3F)CC1)O2,"N-(2-(1-(2-fluorobenzyl)piperidin-4-yl)ethyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide",0.54,uM,=,-0.2676062401770315,0,O=C(NCCC1CCN(Cc2ccccc2)CC1)C1CCc2ccccc2O1
5136,973813,10.1021/np4003355,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 8 mins by Ellman's spectrophotometric method,CC1=C[C@H]2Cc3[nH]c(=O)ccc3[C@@]3(C1)[C@@H]2[C@H](Cl)CCN3C,Casuarinine C,20.9,uM,=,1.320146286111054,1,O=c1ccc2c([nH]1)C[C@@H]1C=CC[C@]23NCCC[C@H]13
5137,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(3-oxo-3-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)propyl)-benzamide",0.0892,uM,=,-1.0496351456238768,0,O=C(CCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5138,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1cccc(C)c1,m-Xylene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5139,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3cccc(Cl)c3)cc(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(2-((3-chlorophenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,4.45,uM,=,0.6483600109809317,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5140,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Oc1ccccc1/C=N/C1CCN(Cc2ccccc2)CC1,2-(((1-Benzylpiperidin-4-yl)imino)methyl)phenol,2.8,uM,=,0.4471580313422192,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5141,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc(F)c1)CC(C)(C)CC3,"US9284330, S33",1.836,uM,=,0.2638726768652236,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5142,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(OCCCN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)cc1,"1-{1-[3-(4-{4-[(Benzylmethylamino)methyl]benzoyl}phenoxy)propyl]piperidin-4-yl}-1,3-dihydrobenzoimidazol-2-one",0.068,uM,=,-1.1674910872937636,0,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc(OCCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)cc1
5143,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,COc1c(C(=O)CCC2CCN(CC3CCCCC3)CC2)cc(Cl)c2c1ccn2Cc1ccccc1,1-(1-Benzyl-7-chloro-4-methoxy-indol-5-yl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one,0.2606,uM,=,-0.5840255886234341,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2c(ccn2Cc2ccccc2)c1
5144,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCN(CC)CCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(2-(Diethylamino)ethoxy)phenyl)-3-phenylprop-2-en-1-one,7.63,uM,=,0.8825245379548805,1,O=C(/C=C/c1ccccc1)c1ccccc1
5145,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3cccc(O)c3)cc2oc1=O,"7-(3-Hydroxy-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5146,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCCN(CCC1CCCCCC1)Cc1cn(OC(=O)N(C)C)c2ccccc12,3-((Butyl(2-cycloheptylethyl)amino)methyl)-1H-indol-1-yl dimethylcarbamate,0.1519,uM,=,-0.8184422261372136,0,c1ccc2c(CNCCC3CCCCCC3)c[nH]c2c1
5147,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,COc1ccc(OCC(=O)NCCN2CCN(Cc3ccccc3)CC2)cc1,N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2-(4-methoxyphenoxy)acetamide,0.3,uM,=,-0.5228787452803376,0,O=C(COc1ccccc1)NCCN1CCN(Cc2ccccc2)CC1
5148,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,O=C(CCCCC1CCSS1)NCCCCCNc1c2c(nc3ccccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [5-(1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-amide",0.0384,uM,=,-1.4156687756324693,0,O=C(CCCCC1CCSS1)NCCCCCNc1c2c(nc3ccccc13)CCCC2
5149,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)CC3CCCC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC,"1-Benzyl-4-[2-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-2-oxo-ethyl]-1-methyl-azocanium",0.11,uM,=,-0.958607314841775,0,O=C(CC1CCCC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
5150,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,CCc1cccc(CC)c1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(2,6-Diethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",1.5,uM,=,0.1760912590556812,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5151,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,COc1ccc2c(c1)c1ccnc(C)c1n2C,"6-methoxy-1,9-dimethyl-9H-pyrido[3,4-b]indole",11.8,uM,=,1.0718820073061257,1,c1ccc2c(c1)[nH]c1cnccc12
5152,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3c(c2)OCCO3)CC1,"1-Benzyl-4-[3-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-3-oxo-propyl]-1-methyl-piperidinium",0.1,uM,=,-1.0,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccc2c(c1)OCCO2
5153,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl]benzamide hydrochloride",0.075,uM,=,-1.1249387366083,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5154,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CN1CC[C@@]2(C)c3cc(OC(=O)NC(C)(C)C)ccc3N(C)[C@@H]12,"(-)-tert-Butyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",32.0,uM,=,1.505149978319906,1,c1ccc2c(c1)N[C@H]1NCCC21
5155,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4oc(C)c(C)c4c(N)c3C(C1)C2,"(+/-)-9-Amino-7-methyl-2,3-dimethylfuro[2,3-b]-4,5,8,9-tetrahydro-5,9-methanocyclo octan[e]pyridine",4.78,uM,=,0.6794278966121189,1,C1=CC2Cc3nc4occc4cc3C(C1)C2
5156,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CCCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(-)-Octyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.015,uM,=,-1.8239087409443189,0,c1ccc2c(c1)N[C@H]1NCCC21
5157,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNS(=O)(=O)c4cn[nH]c4)c3C(C1)C2,"N-(9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]nonyl)-1H-pyrazole-4-sulfonamide",0.0024,uM,=,-2.619788758288394,0,O=S(=O)(NCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1cn[nH]c1
5158,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",C#CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc(F)c1)CC(C)(C)CC3,"US9284330, S35",1.792,uM,=,0.2533380053261064,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5159,1823693,10.1021/acs.jmedchem.9b01012,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured after 2.5 mins by DTNB reagent based spectrometric method,CN1c2ccc(OC(=O)NCCCCCCN3CCCCC3)cc2CN2CCc3ccccc3C21,"13-Methyl-5,8,13,13a-tetrahydro-6H-isoquinolino[1,2-b]-quinazolin-10-yl-[6-(piperidin-1-yl)hexyl]carbamate",1.2,uM,=,0.0791812460476248,1,O=C(NCCCCCCN1CCCCC1)Oc1ccc2c(c1)CN1CCc3ccccc3C1N2
5160,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1cccc(O)c1,3-Methyl-phenol,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5161,1982755,10.1021/acsmedchemlett.9b00656,,,,Inhibition of human AChE using acetylthiocholineiodide as substrate measured for every 30 sec for 5 mins by Ellman's method,COc1cc2cc(NC(=O)[C@H]3CCC[C@@H](NCc4ccccc4)C3)c(=O)oc2cc1OC,"cis-3-(Benzylamino)cyclohexanecarboxylic acid(6,7-dimethoxy-2-oxo-2H-chromen-3-yl)-amide",0.38,uM,=,-0.4202164033831898,0,O=C(Nc1cc2ccccc2oc1=O)[C@H]1CCC[C@@H](NCc2ccccc2)C1
5162,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,C#CCN(Cc1ccc2cccc(O)c2n1)C(C#N)CC1CCN(Cc2ccccc2)CC1,3-(1-Benzylpiperidin-4-yl)-2-(((8-hydroxyquinolin-2-yl)methyl)(prop-2-yn-1-yl)amino)propanenitrile,3.3,uM,=,0.5185139398778875,1,c1ccc(CN2CCC(CCNCc3ccc4ccccc4n3)CC2)cc1
5163,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C(Cl)=C(NCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,"2-Chloro-3-[3-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl-amino)-propyl]amino-1,4-naphthoquinone",0.00894,uM,=,-2.0486624812040826,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5164,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,CC(C)CC/N=C(/C=N/O)N(C)C.Cl,"2-(Hydroxyimino)-N'-isopentyl-N,N-dimethylacetimidamide Hydrochloride Salt",17.0,uM,=,1.230448921378274,1,
5165,1432884,10.1021/np500558b,,,,Inhibition of AChE (unknown origin) assessed as inhibition of acetylcholine hydrolysis preincubated for 15 mins by Ellman method,CNc1ccccc1-c1nc(C(=O)O)cs1,Anithiactin C,68.0,uM,=,1.8325089127062364,1,c1ccc(-c2nccs2)cc1
5166,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",COC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1ccccc1)CC(C)(C)CC3,"US9284330, S6",0.893,uM,=,-0.0491485411114535,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5167,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCN(CCC)CCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(5-(Dipropylamino)pentyloxy)phenyl)-3-phenylprop-2-en-1-one,29.48,uM,=,1.469527479187014,1,O=C(/C=C/c1ccccc1)c1ccccc1
5168,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=[N+]([O-])OCCNCCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(2'-(nitrooxy)ethyl)-gamma-aminobutylamino]-1,2,3,4-tetrahydroacridine",0.0111,uM,=,-1.9546770212133424,0,c1ccc2nc3c(cc2c1)CCCC3
5169,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCC(CC)n1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-(pentan-3-yl)-1H-pyrazol-4-yl)ethan-1-one",0.0288,uM,=,-1.5406075122407692,0,c1cn[nH]c1
5170,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.03,uM,=,-1.5228787452803376,0,c1ccc2c(c1)N[C@H]1NCCC21
5171,1675804,10.1016/j.ejmech.2017.03.062,,,,Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine chloride as substrate after 5 mins by spectrophotometric method,COc1ccc2nc3c(c(NCCCCCCCNC(=S)NC45CC6CC(CC(C6)C4)C5)c2c1)CCCC3,"1-Adamantan-1-yl-3-[7-(7-methoxy-1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-thiourea",3.47,uM,=,0.5403294747908738,1,S=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)NC12CC3CC(CC(C3)C1)C2
5172,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1cc(C)c(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)c(C)c1,"(2,4,6-Trimethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",1.3,uM,=,0.1139433523068367,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5173,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C(F)(F)F)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CC(C)(C)CC3,"US9284330, S23",0.54,uM,=,-0.2676062401770315,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5174,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)cc(O)c4)c3C(C1)C2,"N-(9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]nonyl)-3,5-dihydroxybenzamide",0.00257,uM,=,-2.5900668766687054,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccccc1
5175,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COC(=O)c1ccc(C[n+]2ccc(CCC(=O)C3Cc4cc(OC)c(OC)cc4S3)cc2)cc1,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(4-methoxycarbonyl-benzyl)-pyridinium",1.0,uM,=,0.0,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)C1Cc2ccccc2S1
5176,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,O=C(NCCc1c[nH]c2ccccc12)C1CCN(Cc2ccccc2)CC1,N-(2-(1H-Indol-3-yl)ethyl)-1-benzylpiperidine-4-carboxamide,7.85,uM,=,0.8948696567452525,1,O=C(NCCc1c[nH]c2ccccc12)C1CCN(Cc2ccccc2)CC1
5177,28599,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 4.6-25.8,C#CCN[C@H]1CCc2ccc(OC(=O)N(C)CCCC)cc21.Cl,Butyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,9.3,uM,=,0.9684829485539352,1,c1ccc2c(c1)CCC2
5178,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1ccc(COc2ccc3c(C)c(C)c(=O)oc3c2)cc1,"3,4-Dimethyl-7-(4-methyl-benzyloxy)-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5179,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN1c2ccccc2C(n2cncn2)c2ccccc21,"10-methyl-9-(1H-1,2,4-triazol-1-yl)-9,10-dihydroacridine",18.8,uM,=,1.2741578492636798,1,c1ccc2c(c1)Nc1ccccc1C2n1cncn1
5180,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.0451,uM,=,-1.3458234581220394,0,c1ccc2nc3c(cc2c1)CCCC3
5181,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,Cc1nc2ccccn2c(=O)c1CCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,"3-(2-{4-[bis(4-fluoro-phenyl)-methyl]piperazine-1-yl}-ethyl)-2-methyl-pyrido[1,2-a]pyrimidin-4-one",3.2037,uM,=,0.5056518412309912,1,O=c1c(CCN2CCN(C(c3ccccc3)c3ccccc3)CC2)cnc2ccccn12
5182,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(5-Morpholin-4-yl-pentyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",7.6,uM,=,0.8808135922807914,1,O=C(NCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5183,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2occ(C(=O)Nc3ccc(Cl)cc3)c(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(3-((4-chlorophenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,7.68,uM,=,0.885361220031512,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5184,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]-Quinolin-12-Amine",0.0011,uM,=,-2.958607314841775,0,C1=CC2Cc3nc4ccccc4cc3[C@@H](C1)C2
5185,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Fc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)cc1,N-(1-benzylpiperidin-4-yl)-1-(4-fluorophenyl)methanimine,2.9,uM,=,0.4623979978989561,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5186,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,Cl.O/N=C/C1=NCCCN1Cc1ccc(Cl)cc1Cl,"1-(2,4-Dichlorobenzyl)-1,4,5,6-tetrahydropyrimidine-2-carbaldehyde Oxime Hydrochloride",9.0,uM,=,0.9542425094393248,1,C1=NCCCN1Cc1ccccc1
5187,2275467,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) incubated for 40 mins by Ellman's method,Cc1ccc(-[n+]2ccc3c4ccccc4n(C)c3c2)cc1,"9-methyl-2-(p-tolyl)pyrido[3,4-b]indol-2-ium",0.24,uM,=,-0.619788758288394,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
5188,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CC[N+](C)(Cc4ccccc4)CCC3OC)sc2cc1OC,"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophene-2-carbonyl)-5-methoxy-1-methyl-azepanium",0.12,uM,=,-0.9208187539523752,0,O=C(c1cc2ccccc2s1)C1CCC[NH+](Cc2ccccc2)CC1
5189,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,CCN(CC)CCS/C(=N\O)C(=O)c1ccc(C#N)cc1.Cl,2-(4-Cyano-phenyl)-N-hydroxy-2-oxo-thioacetimidic acid 2-diethylamino-ethyl ester hydrochloride,180.0,uM,=,2.255272505103306,1,c1ccccc1
5190,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,COC(=O)C1=CO[C@@H](C)[C@H]2C[n+]3ccc4c([nH]c5ccccc54)c3C[C@H]12,Serpentine,0.78,uM,=,-0.1079053973095195,0,C1=C[C@H]2Cc3c4[nH]c5ccccc5c4cc[n+]3C[C@@H]2CO1
5191,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,c1ccc(CN2CCC(COc3noc4ccccc34)CC2)cc1,3-(1-Benzyl-piperidin-4-ylmethoxy)-benzo[d]isoxazole,2.6,uM,=,0.414973347970818,1,c1ccc(CN2CCC(COc3noc4ccccc34)CC2)cc1
5192,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CCC)C1C2,"(-)Hexyl-carbamic acid 1-propyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.546,uM,=,-0.2628073572952627,0,c1ccc2c(c1)CC1NCC[C@@H]21
5193,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2,"o-Tolyl-carbamic acid (S)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.04,uM,=,-1.3979400086720375,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
5194,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4cc(OC)c(OC)cc4c(N)c3C(C1)C2,"(+/-)-12-Amino-2,3-dimethoxy-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline",5.1,uM,=,0.7075701760979364,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5195,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CSc1n[nH]c2nc3c(c(N)c12)C1CC(C)=CC(C3)C1,"(+/-)-9-Amino-1-(methylthio)-1H-pyrazolo[3,4-b]-3,4,7,8-tetrahydro-6-methyl-4,8-methanocycloocta[e]pyridine",50.0,uM,=,1.6989700043360187,1,C1=CC2Cc3nc4[nH]ncc4cc3C(C1)C2
5196,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(NN)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-(5-hydrazino-2,4-dinitro-phenyl)-amine",0.076,uM,=,-1.1191864077192086,0,c1ccc(NCCSCc2ccco2)cc1
5197,1549348,10.1016/j.bmc.2016.01.010,,,,Inhibition of human AChE using ATC as substrate preincubated for 5 mins followed by substrate addition measured after 2 mins by Ellman's assay,CC(C)NCc1cccc2[nH]c3ccccc3c12,N-((9H-carbazol-4-yl)methyl)propan-2-amine,18.0,uM,=,1.255272505103306,1,c1ccc2c(c1)[nH]c1ccccc12
5198,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,COc1ccc2nc3c(c(NCCNC4=C(Cl)C(=O)c5ccccc5C4=O)c2c1)CCCC3,"2-Chloro-3-[2-(7-methoxy-1,2,3,4-tetrahydroacridin-9-yl-amino)-ethyl]amino-1,4-naphthoquinone",1.37,uM,=,0.1367205671564068,1,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5199,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(NCc3cccnc3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-N'-pyridin-3-ylmethyl-benzene-1,3-diamine",0.31,uM,=,-0.5086383061657274,0,c1cncc(CNc2cccc(NCCSCc3ccco3)c2)c1
5200,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CN(C)CCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(3-(Dimethylamino)propoxy)phenyl)-3-phenylprop-2-en-1-one,10.47,uM,=,1.0199466816788425,1,O=C(/C=C/c1ccccc1)c1ccccc1
5201,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,"(+/-)-N-{5-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]pentyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.00107,uM,=,-2.9706162223147903,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5202,1982755,10.1021/acsmedchemlett.9b00656,,,,Inhibition of human AChE using acetylthiocholineiodide as substrate measured for every 30 sec for 5 mins by Ellman's method,COc1cc2cc(NC(=O)[C@H]3CCC[C@@H](NCc4ccccc4)C3)c(=O)oc2cc1OC,"cis-3-(Benzylamino)cyclohexanecarboxylic acid(6,7-dimethoxy-2-oxo-2H-chromen-3-yl)-amide",0.0365,uM,=,-1.4377071355435254,0,O=C(Nc1cc2ccccc2oc1=O)[C@H]1CCC[C@@H](NCc2ccccc2)C1
5203,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2.Cl,(+)-Huprine Y,0.321,uM,=,-0.4934949675951279,0,C1=C[C@H]2Cc3nc4ccccc4cc3[C@@H](C1)C2
5204,849809,10.1016/j.bmc.2012.07.045,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate preincubated for 15 mins by Ellman's method,CN(C)c1ccccc1CNCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1-(2-(Dimethylamino)benzyl)-N9-(1,2,3,4-tetrahydroacridin-9-yl)nonane-1,9-diamine",0.00352,uM,=,-2.453457336521869,0,c1ccc(CNCCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
5205,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,C=[N+]1N=C(CCC2CCN(Cc3ccccc3)CC2)c2ccccc21,{3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-isoindol-1-yl}-methylene-amine,0.34,uM,=,-0.4685210829577448,0,C=[N+]1N=C(CCC2CCN(Cc3ccccc3)CC2)c2ccccc21
5206,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(NCc3ccccn3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-N'-pyridin-2-ylmethyl-benzene-1,3-diamine",1.3,uM,=,0.1139433523068367,1,c1ccc(CNc2cccc(NCCSCc3ccco3)c2)nc1
5207,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,O=C(Nc1ccccc1Cl)Oc1ccc2c(c1)CCCN2Cc1ccccc1,"2-Chlorophenylcarbamic Acid 1-Benzyl-1,2,3,4-tetrahydroquinolin-6-yl Ester",3.31,uM,=,0.5198279937757188,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)CCCN2Cc1ccccc1
5208,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,"N,1-dibenzylpiperidin-4-amine",1.7,uM,=,0.2304489213782739,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5209,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,O=C(CCCCC1CCSS1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [6-(1,2,3,4-tetrahydro-acridin-9-ylamino)-hexyl]-amide",0.0301,uM,=,-1.5214335044061569,0,O=C(CCCCC1CCSS1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
5210,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3ccccc3)cc2oc1=O,"7-Benzyloxy-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5211,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1cc2ccsc2s1,"(S)-hexyl 5-(2-(1-benzylpiperidin-4-yl)ethylamino)-5-oxo-2-(thieno[2,3-b]thiophene-2-carboxamido)pentanoate",0.3,uM,=,-0.5228787452803376,0,O=C(CCCNC(=O)c1cc2ccsc2s1)NCCC1CCN(Cc2ccccc2)CC1
5212,2022945,10.1016/j.bmc.2020.115820,,,,Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's coupled enzyme assay,CO[C@]1(c2cn(O)c(=O)c(C(=O)[C@H]3[C@@H]4CC[C@@H](C)C[C@H]4C=C[C@H]3C)c2O)CC[C@@H](O)[C@H]2O[C@H]21,Arthpyrone C,0.81,uM,=,-0.0915149811213502,0,O=C(c1cc(C2CCC[C@H]3O[C@@H]23)c[nH]c1=O)[C@@H]1CC=C[C@@H]2CCCC[C@H]21
5213,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Clc1ccc(CNC2CCN(Cc3ccccc3)CC2)c(Cl)c1,"1-Benzyl-N-(2,4-dichlorobenzyl)piperidin-4-amine",0.62,uM,=,-0.2076083105017461,0,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5214,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,CN1C(=O)Cc2cc3onc(CCC4CCN(Cc5ccccc5)CC4)c3cc21,"3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5-methyl-5,7-dihydro-isoxazolo[5,4-f]indol-6-one",0.0004799999999999,uM,=,-3.318758762624413,0,O=C1Cc2cc3onc(CCC4CCN(Cc5ccccc5)CC4)c3cc2N1
5215,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00107,uM,=,-2.9706162223147903,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5216,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(Cl)cc1)NCC1CCN(Cc2ccccc2)CC1,N-((1-Benzylpiperidin-4-yl)methyl)-2-(4-chlorophenoxy)acetamide,1.68,uM,=,0.2253092817258628,1,O=C(COc1ccccc1)NCC1CCN(Cc2ccccc2)CC1
5217,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCCCC3)c(O)c1)O2,"(Z)-2-(3-hydroxy-4-(piperidin-1-ylmethyl)benzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",0.0371,uM,=,-1.430626090384954,0,O=C1/C(=C/c2ccc(CN3CCCCC3)cc2)Oc2ccccc21
5218,1431108,10.1016/j.bmcl.2014.10.025,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)C[C@@H]4C=C(C)C[C@H]5C4)c3[C@@H](C1)C2,"(+)-N,N'-bis[(7R,11R)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl]-1,8-octanediamine",0.0725,uM,=,-1.1396619934290064,0,C1=C[C@H]2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)C[C@@H]4C=CC[C@H]5C4)c3[C@@H](C1)C2
5219,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,"(+/-)-N-{6-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]hexyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.00152,uM,=,-2.818156412055228,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5220,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cc12,"US8841453, 19",0.0256,uM,=,-1.5917600346881504,0,O=C(NCCCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5221,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1ccc2cc(C(=O)CCC3CC[N+](C)(Cc4ccccc4)CC3)ccc2c1,1-Benzyl-4-[3-(6-methoxy-naphthalen-2-yl)-3-oxo-propyl]-1-methyl-piperidinium,0.05,uM,=,-1.3010299956639813,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccc2ccccc2c1
5222,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,Nc1ccc2c(c1)c(OCc1ccccc1)nn2Cc1ccccc1,5-Amino-1-benzyl-3-benzyloxyindazole,8.6,uM,=,0.9344984512435676,1,c1ccc(COc2nn(Cc3ccccc3)c3ccccc23)cc1
5223,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCCC(C)n1cc(C(=O)C(F)(F)F)cn1,"2,2,2-trifluoro-1-(1-(pentan-2-yl)-1H-pyrazol-4-yl)ethanone",0.00715,uM,=,-2.1456939581989194,0,c1cn[nH]c1
5224,2275467,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) incubated for 40 mins by Ellman's method,Cn1c2c(c3ccccc31)CC[N+](c1ccc(I)cc1)=C2,"2-(4-iodophenyl)-9-methyl-3,4-dihydropyrido[3,4-b]indol-2-ium",1.5,uM,=,0.1760912590556812,1,C1=[N+](c2ccccc2)CCc2c1[nH]c1ccccc21
5225,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OC2CCC2)C(c2ccccc2F)c2c(nc3c(c2N)CC(C)(C)CC3)N1,"US9284330, S8",0.757,uM,=,-0.1209041204999272,0,O=C(OC1CCC1)C1=CNc2nc3c(cc2C1c1ccccc1)CCCC3
5226,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OC(C)C)C(c2ccccc2Cl)c2c(nc3c(c2N)CC(C)(C)CC3)N1,"US9284330, S31",3.03,uM,=,0.481442628502305,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5227,744971,10.1016/j.bmcl.2010.12.041,,,,Inhibition of AChE-induced amyloid beta aggregation,COc1cc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc(OC)c1OC,"4a,12a-Dihydroxy-4,4,6a,12b-tetramethyl-9-(3,4,5-trimethoxy-phenyl)-4a,6,6a,12,12a,12b-hexahydro-4H,5H-7,10-dioxa-benzo[a]anthracene-1,11-dione",0.006,uM,=,-2.2218487496163566,0,O=C1C=CCC2CCC3Oc4cc(-c5ccccc5)oc(=O)c4CC3C12
5228,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4ccc[nH]c4=O)c3C(C1)C2,"N-(9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]nonyl)-2-oxo-1,2-dihydropyridine-3-carboxamide",0.00182,uM,=,-2.7399286120149253,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc[nH]c1=O
5229,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,CN(C)Cc1cc2c(cc1OC(=O)Nc1ccccc1)[C@]1(C)CCN(C)[C@@H]1N2C,"Phenyl-carbamic acid 6-dimethylaminomethyl-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",2.5,uM,=,0.3979400086720376,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5230,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,COc1ccc2[nH]c3c[n+](C)ccc3c2c1,6-methoxy-2-methyl-9H-beta-carbolin-2-ium,2.2,uM,=,0.3424226808222063,1,c1ccc2c(c1)[nH]c1c[nH+]ccc12
5231,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1ccc2c(c1OC)CC(C)C2=O,"4,5-Dimethoxy-2-methyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5232,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CN1CC[C@@]2(C)c3cc(OC(=O)NC(C)(C)C)ccc3N(C)[C@@H]12,"(-)-tert-Butyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",23.0,uM,=,1.3617278360175928,1,c1ccc2c(c1)N[C@H]1NCCC21
5233,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,9-di(2-isoquinoliniumyl)nonane; dibromide",0.04,uM,=,-1.3979400086720375,0,c1ccc2c[n+](CCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1
5234,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,COc1ccc2nc3c(c(NCCNC4=CC(=O)c5c(O)cccc5C4=O)c2c1)CCCC3,"5-hydroxy-2-(2-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)ethylamino)naphthalene-1,4-dione",0.651,uM,=,-0.186419011431808,0,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5235,2231701,10.1016/j.bmcl.2022.128574,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate incubated for 15 mins by DTNB reagent based Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,8.8,uM,=,0.9444826721501688,1,c1ccccc1
5236,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,"2-[2-(1,2,3,4-Tetrahydroacridin-9-yl-amino)ethyl]amino-1,4-naphthoquinone",0.0143,uM,=,-1.844663962534938,0,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5237,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=[N+]([O-])OCCCNCCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(3'-(nitrooxy)propyl)-gamma-aminobutylamino]-1,2,3,4-tetrahydroacridine",0.0056,uM,=,-2.2518119729938,0,c1ccc2nc3c(cc2c1)CCCC3
5238,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 1",0.03377,uM,=,-1.4714689393645886,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5239,1812363,10.1016/j.bmc.2018.12.023,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 secs for 1 hr by Ellman's assay,COc1ccc(-c2cc(=O)c3cc(OC)c(O)c([C@@H]4CCC(=O)N4)c3o2)cc1,S-(+)-leucoflavonine,68.0,uM,=,1.8325089127062364,1,O=C1CC[C@@H](c2cccc3c(=O)cc(-c4ccccc4)oc23)N1
5240,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CCc3ccccc3)[C@@H]1N2C,"Methyl-carbamic acid 3a,8-dimethyl-1-phenethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.15,uM,=,-0.8239087409443188,0,c1ccc(CCN2CCC3c4ccccc4N[C@H]32)cc1
5241,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,COc1cc2c(cc1OC)C(c1cccc([N+](=O)[O-])c1)N(CCCCCCc1cn(CCNc3c4c(nc5cc(Cl)ccc35)CC3C=C(C)CC4C3)nn1)CC2,"(+/-)-3-chloro-6,7,10,11-tetrahydro-N-(2-(4-(6-(3,4-dihydro-6,7-dimethoxy-1-(3-nitrophenyl)isoquinolin-2(1H)-yl)hexyl)-1H-1,2,3-triazol-1-yl)-9-methyl)-12-amino-6,10-methanocycloocta[b]quinoline",0.00395,uM,=,-2.40340290437354,0,C1=CC2Cc3nc4ccccc4c(NCCn4cc(CCCCCCN5CCc6ccccc6C5c5ccccc5)nn4)c3C(C1)C2
5242,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,C=CCC1(O)OCc2c(OC)c(OC)cc3ccnc1c23,"9-Allyl-5,6-dimethoxy-7H,9H-8-oxa-1-aza-phenalen-9-ol",174.14578824970135,uM,=,2.24091297542341,1,c1cc2c3c(nccc3c1)COC2
5243,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,C=C(C)[C@@H](O)CC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C3=C(O[C@H](C(C)(C)O)C3)[C@@]1(C(=O)C(C)C)C2=O,Hyperforatin A,10.72,uM,=,1.0301947853567512,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5244,1500860,10.1016/j.bmc.2015.04.080,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as substrate hydrolysis by spectrophotometric/Ellman method,COc1ccc(C(=O)O[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]4(C)C[C@@]5(O)[C@H](CC[C@@H]43)[C@@]3(C)CC[C@@H](O)C(C)(C)[C@@H]3C[C@@H]5O)[C@@]2(C)C(=O)O)cc1O,"3beta,14alpha,15alpha,21beta-tetrahydroxyserratan-24-oic acid-3beta-yl-(4'-methoxy-5'-hydroxybenzoate)",9.98,uM,=,0.9991305412873712,1,O=C(O[C@H]1CCC2[C@@H](CCC3CC4CC[C@H]5CCCCC5[C@H]4CC[C@@H]32)C1)c1ccccc1
5245,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 10",0.18644,uM,=,-0.729460905739452,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5246,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]benzamide hydrochloride",0.019,uM,=,-1.7212463990471711,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5247,29407,10.1016/s0960-894x(02)00017-3,,,,In vitro inhibitory activity against acetylcholinesterase,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,0.6,uM,=,-0.2218487496163563,0,c1ccccc1
5248,714885,10.1016/j.bmc.2010.07.034,,,,Inhibition of human acetylcholine esterase,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],(3-Dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium,4.3e-05,uM,=,-4.366531544420414,0,c1ccccc1
5249,1982755,10.1021/acsmedchemlett.9b00656,,,,Inhibition of human AChE using acetylthiocholineiodide as substrate measured for every 30 sec for 5 mins by Ellman's method,COc1cc2cc(NC(=O)[C@@H]3CCC[C@H](NCc4ccccc4)C3)c(=O)oc2cc1OC,"(-)-Cis-3-(benzylamino)-N-(6,7-dimethoxy-2-oxo-chromen-3-yl)cyclohexanecarboxamide",0.0192,uM,=,-1.7166987712964503,0,O=C(Nc1cc2ccccc2oc1=O)[C@@H]1CCC[C@H](NCc2ccccc2)C1
5250,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(8-Morpholin-4-yl-octyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.08,uM,=,-1.0969100130080565,0,O=C(NCCCCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5251,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(Heptylphysostigmine(-))Heptyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.29,uM,=,-0.5376020021010439,0,c1ccc2c(c1)N[C@H]1NCCC21
5252,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,C[n+]1c2ccccc2c(-c2ccc(N)cc2)c2ccccc21.F[B-](F)(F)F,9-(4-aminophenyl)-10-methylacridinium tetrafluoroborate,7.62,uM,=,0.8819549713396005,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5253,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,"(+/-)-N-{9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]nonyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.0036,uM,=,-2.4436974992327127,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5254,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CC(C)n1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-isopropyl-1H-pyrazol-4-yl)ethan-1-one",0.802,uM,=,-0.0958256317158364,0,c1cn[nH]c1
5255,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,Cl.O/N=C/C1=NCCCN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1,"1-(3,5-Bis(trifluoromethyl)benzyl)-1,4,5,6-tetrahydropyrimidine-2-carbaldehyde Oxime Hydrochloride",45.0,uM,=,1.6532125137753435,1,C1=NCCCN1Cc1ccccc1
5256,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,C=C[C@H]1C[N+]2=C(C[C@@H]1/C(=C\OC)C(=O)OC)c1[nH]c3cccc(OC)c3c1CC2,"methyl(E)-3-methoxy-2-[(2S,3R)-8-methoxy-3-vinyl-2,3,4,6,7,12-hexahydro-1H-indolo[2,3-a]quinolizin-5-ium-2-yl]prop-2-enoate",4.1,uM,=,0.6127838567197355,1,c1ccc2c3c([nH]c2c1)C1=[N+](CCCC1)CC3
5257,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CCc1cc[n+](Cc3coc([N+](=O)[O-])c3)cc1)C2.[I-],"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(5-nitro-furan-3-ylmethyl)-pyridinium",0.0045,uM,=,-2.3467874862246565,0,O=C(CCc1cc[n+](Cc2ccoc2)cc1)C1Cc2ccccc2S1
5258,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CN(C)CCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(4-(Dimethylamino)butoxy)phenyl)-3-phenylprop-2-en-1-one,8.95,uM,=,0.951823035315912,1,O=C(/C=C/c1ccccc1)c1ccccc1
5259,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[8-(1,2,3,4-tetrahydroacridin-9-ylamino)octyl]benzamide hydrochloride",0.077,uM,=,-1.1135092748275182,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5260,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)[C@@H]1N2C,"Methyl-carbamic acid 1-benzyl-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.33,uM,=,-0.4814860601221125,0,c1ccc(CN2CCC3c4ccccc4N[C@H]32)cc1
5261,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2,"(3aS,8aS)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl o-tolylcarbamate",0.04,uM,=,-1.3979400086720375,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5262,1729471,10.1021/acs.jnatprod.7b00847,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate pretreated for 20 mins followed by substrate addition measured after 30 mins by Ellman's method,CO[C@H]1O[C@@](C)(c2nccc3cc4c(cc23)OCO4)c2ccc3c(c21)OCO3,(-)-Mucroniferanine D,28.3,uM,=,1.4517864355242902,1,c1cc2cc3c(cc2c(C2OCc4c2ccc2c4OCO2)n1)OCO3
5263,1982755,10.1021/acsmedchemlett.9b00656,,,,Inhibition of human AChE using acetylthiocholineiodide as substrate measured for every 30 sec for 5 mins by Ellman's method,COc1cc2cc(NC(=O)CCCNCc3ccccc3)c(=O)oc2cc1OC,"4-(benzylamino)-N-(6,7-dimethoxy-2H-2-oxochromen-3-yl)butyramide",0.748,uM,=,-0.1260984021355386,0,O=C(CCCNCc1ccccc1)Nc1cc2ccccc2oc1=O
5264,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)C1N2Cc1ccccc1,"o-Tolyl-carbamic acid (S)-1,8-dibenzyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",1.76,uM,=,0.2455126678141498,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN(Cc3ccccc3)C1N2Cc1ccccc1
5265,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,Nc1c2c(nc3cc(Cl)ccc13)CC(CNC(=O)CCCCC1CCSS1)CC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid (9-amino-6-chloro-1,2,3,4-tetrahydro-acridin-3-ylmethyl)-amide",1.09,uM,=,0.0374264979406236,1,O=C(CCCCC1CCSS1)NCC1CCc2cc3ccccc3nc2C1
5266,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1cc(CNC2CCN(Cc3ccccc3)CC2)cc(OC)c1OC,"1-Benzyl-N-(3,4,5-trimethoxybenzyl)piperidin-4-amine",2.2,uM,=,0.3424226808222063,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5267,1500860,10.1016/j.bmc.2015.04.080,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as substrate hydrolysis by spectrophotometric/Ellman method,CCCC[C@@H](O)/C=C/C=C/C(=O)O,"(2E,4E,6R)-6-hydroxydeca-2,4-dienoic acid",0.22,uM,=,-0.6575773191777937,0,
5268,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Fc1ccc(CNC2CCN(Cc3ccccc3)CC2)c(F)c1,"1-Benzyl-N-(2,4-difluorobenzyl)piperidin-4-amine",0.71,uM,=,-0.1487416512809247,0,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5269,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CCc1cc[n+](CC3CCC3)cc1)C2,"1-Cyclobutylmethyl-4-[3-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium",0.04,uM,=,-1.3979400086720375,0,O=C(CCc1cc[n+](CC2CCC2)cc1)C1Cc2ccccc2S1
5270,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,O=C(CCN1CCCC1)Nc1ccc2c(c1)CN1CCc3c([nH]c4ccccc34)C1=N2,,0.029,uM,=,-1.537602002101044,0,O=C(CCN1CCCC1)Nc1ccc2c(c1)CN1CCc3c([nH]c4ccccc34)C1=N2
5271,1814688,10.1016/j.ejmech.2019.111737,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,O=C(/C=C/c1ccc(OCCCCCCN2CCCC2)cc1)c1ccc(OCCCCCCN2CCCC2)cc1O,(E)-1-(2-hydroxy-4-((6-(pyrrolidin-1-yl)hexyl)oxy)phenyl)-3-(4-((6-(pyrrolidin-1-yl)hexyl)oxy)phenyl)prop-2-en-1-one,0.78,uM,=,-0.1079053973095195,0,O=C(/C=C/c1ccc(OCCCCCCN2CCCC2)cc1)c1ccc(OCCCCCCN2CCCC2)cc1
5272,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CCN(CC)CCCCCCCOc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(7-diethylaminoheptyloxy)phenyl]methanone,0.81,uM,=,-0.0915149811213502,0,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
5273,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,O=C(CCC1CCN(CC2CCCCC2)CC1)c1cc(Cl)c2[nH]ccc2c1,1-(7-Chloro-1H-indol-5-yl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one,0.0288,uM,=,-1.5406075122407692,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2[nH]ccc2c1
5274,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,O=C(CN1CCCCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,"3-(2-N-Piperidyl-acetamino)-7,8-dehydrorutaecarpine",0.01,uM,=,-2.0,0,O=C(CN1CCCCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1
5275,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,CCN(Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O)Cc1ccccc1N(C)C,"(Z)-2-(4-(((2-(dimethylamino)benzyl)(ethyl)amino)methyl)-3-hydroxybenzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",6.69,uM,=,0.8254261177678232,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Oc2ccccc21
5276,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CN(CCC1CCCCCC1)Cc1c[nH]c2ccccc12,N-((1H-Indol-3-yl)methyl)-2-cycloheptyl-N-methylethan-1-amine,25.2,uM,=,1.4014005407815442,1,c1ccc2c(CNCCC3CCCCCC3)c[nH]c2c1
5277,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CCCNc1cc(NCCSCc2ccc(CN(C)C)o2)c([N+](=O)[O-])cc1[N+](=O)[O-],"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-N'-propyl-benzene-1,3-diamine",0.26,uM,=,-0.585026652029182,0,c1ccc(NCCSCc2ccco2)cc1
5278,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,CCCC/N=C(/C=N/O)N(C)C.Cl,"N'-butyl-2-(hydroxyimino)-N,N-dimethylacetimidamide hydrochloride",54.0,uM,=,1.7323937598229686,1,
5279,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCCC3)c(O)c1)O2,"(Z)-2-(3-hydroxy-4-(pyrrolidin-1-ylmethyl)benzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",1.32,uM,=,0.1205739312058498,1,O=C1/C(=C/c2ccc(CN3CCCC3)cc2)Oc2ccccc21
5280,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,c1ccc2c(c1)CN1CCCCCCCC1=N2,"6,7,8,9,10,11,12,13-Octahydro-5,12a-diaza-cyclonona[b]naphthalene",13.51,uM,=,1.1306553490220306,1,c1ccc2c(c1)CN1CCCCCCCC1=N2
5281,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1cc2ccnc3c2c(c1OC)COC3(CC(O)CO)OC,"3-(5,6,9-Trimethoxy-7H,9H-8-oxa-1-aza-phenalen-9-yl)-propane-1,2-diol",95.483371732132,uM,=,1.979927746518261,1,c1cc2c3c(nccc3c1)COC2
5282,849809,10.1016/j.bmc.2012.07.045,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate preincubated for 15 mins by Ellman's method,CN(C)c1ccccc1CNCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1-(2-(Dimethylamino)benzyl)-N7-(1,2,3,4-tetrahydroacridin-9-yl)heptane-1,7-diamine",0.00518,uM,=,-2.285670240254767,0,c1ccc(CNCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
5283,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CN(C)CCOC(=O)/C=C/c1ccc2occ(C(=O)Nc3ccccc3)c(=O)c2c1,2-(Dimethylamino)ethyl (E)-3-(4-oxo-3-(phenylcarbamoyl)-4H-chromen-6-yl)acrylate,3.69,uM,=,0.5670263661590603,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5284,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CN(C)CCCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(6-(Dimethylamino)hexyloxy)phenyl)-3-phenylprop-2-en-1-one,14.24,uM,=,1.1535099893008376,1,O=C(/C=C/c1ccccc1)c1ccccc1
5285,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,OCCN1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,2-[4-(4-[(Naphth-1-ylmethyl)amino]pyrimidin-2-yl)piperazin-1-yl]ethanol,9.8,uM,=,0.9912260756924948,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
5286,2275467,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) incubated for 40 mins by Ellman's method,Cn1c2ccccc2c2cc[n+](-c3ccc(Br)cc3)cc21,"2-(4-bromophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.24,uM,=,-0.619788758288394,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
5287,28604,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 5.5-10.2,CCCN(C)C(=O)Oc1ccc2c(c1)C(N)CC2.Cl,Methyl-propyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,7.3,uM,=,0.8633228601204559,1,c1ccc2c(c1)CCC2
5288,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=[N+]([O-])OCCNCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(2'-(nitrooxy)ethyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine",0.01,uM,=,-2.0,0,c1ccc2nc3c(cc2c1)CCCC3
5289,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCC[n+]3ccc4ccccc4c3)ccc2c1,"1,3-Bis(isoquinolinium)-prop-1,3-diyl dibromide",446.0,uM,=,2.649334858712142,1,c1ccc2c[n+](CCC[n+]3ccc4ccccc4c3)ccc2c1
5290,1521690,10.1039/C4MD00225C,,,,Inhibition of AChE from human erythrocytes,CC[N+]1(Cc2ccccc2[N+](=O)[O-])CCCCCn2c(C)cc(=O)n(c2=O)CCCCC[N+](CC)(Cc2ccccc2[N+](=O)[O-])CCCCCn2c(=O)cc(C)n(c2=O)CCCCC1.[Br-].[Br-],,0.13,uM,=,-0.8860566476931633,0,O=c1ccn2c(=O)n1CCCCC[NH+](Cc1ccccc1)CCCCCn1c(=O)ccn(c1=O)CCCCC[NH+](Cc1ccccc1)CCCCC2
5291,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC(=O)N1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,1-[4-(4-[(Naphth-1-ylmethyl)amino]pyrimidin-2-yl)piperazin-1-yl]ethanone,13.8,uM,=,1.1398790864012365,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
5292,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4oc(C)c(C)c4c(N)c3C(C1)C2,"(+/-)-9-Amino-7-ethyl-2,3-dimethylfuro[2,3-b]-4,5,8,9-tetrahydro-5,9-methanocyclo octan[e]pyridine",6.45,uM,=,0.8095597146352678,1,C1=CC2Cc3nc4occc4cc3C(C1)C2
5293,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3ccc(Cl)cc3)cc2oc1=O,"7-(4-Chloro-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5294,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,CC(C)=CC[C@H]1C[C@@]2(CC=C(C)C)C(=O)[C@](C(=O)C(C)C)(C(=O)C3=C2O[C@H](C(C)(C)O)C3)[C@]1(C)CCC(=O)C(C)C,Hyperforatin H,10.88,uM,=,1.0366288953621612,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5295,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCC(=O)Nc4cn[nH]c4)c3C(C1)C2,"9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]-N-(1H-pyrazol-4-yl)nonanamide",0.00239,uM,=,-2.6216020990518625,0,O=C(CCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)Nc1cn[nH]c1
5296,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CCCCCOc1nn(CCCCC)c2ccc([N+](=O)[O-])cc12,5-Nitro-1-(pentyl)-3-(pentyloxy)indazole,4.2,uM,=,0.6232492903979004,1,c1ccc2[nH]ncc2c1
5297,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)[C@@H]1N2C,"Methyl-carbamic acid 1-benzyl-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.19,uM,=,-0.721246399047171,0,c1ccc(CN2CCC3c4ccccc4N[C@H]32)cc1
5298,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,7-Bis(isoquinolinium)-hept-1,7-diyl dibromide",0.5,uM,=,-0.3010299956639812,0,c1ccc2c[n+](CCCCCCC[n+]3ccc4ccccc4c3)ccc2c1
5299,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Cc1cc(-c2c3ccccc3[n+](C)c3ccccc23)cc(C)c1C.F[B-](F)(F)F,"10-methyl-9-(3,4,5-trimethylphenyl)acridinium tetrafluoroborate",60.1,uM,=,1.7788744720027396,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5300,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCN1CC[C@@]2(C)c3cc(OC(=O)NCc4ccccc4)ccc3CC12,"(+/-)-Benzyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.069,uM,=,-1.1611509092627446,0,O=C(NCc1ccccc1)Oc1ccc2c(c1)C1CCNC1C2
5301,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.031,uM,=,-1.5086383061657274,0,c1ccc2c(c1)N[C@H]1NCCC21
5302,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1cc2c(cc1OC)C(=O)C(C)C2,"5,6-Dimethoxy-2-methyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5303,973813,10.1021/np4003355,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 8 mins by Ellman's spectrophotometric method,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,Huperzine A,0.125,uM,=,-0.9030899869919436,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
5304,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,O=C(O)/C=C/c1ccc2oc(C(=O)Nc3ccccc3)cc(=O)c2c1,(E)-3-(4-Oxo-2-(phenylcarbamoyl)-4H-chromen-6-yl)acrylic acid,5.99,uM,=,0.7774268223893114,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5305,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"o-Tolyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.04,uM,=,-1.3979400086720375,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5306,1729471,10.1021/acs.jnatprod.7b00847,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate pretreated for 20 mins followed by substrate addition measured after 30 mins by Ellman's method,c1cc2cc3c(cc2c([C@H]2Oc4ccc5c(c4O2)OCO5)n1)OCO3,(-)-Mucroniferanine C,78.1,uM,=,1.8926510338773004,1,c1cc2cc3c(cc2c([C@H]2Oc4ccc5c(c4O2)OCO5)n1)OCO3
5307,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1ccccc1COc1ccc2c(C)c(C)c(=O)oc2c1,"3,4-Dimethyl-7-(2-methyl-benzyloxy)-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5308,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCc1ccccc1-2,"10-(3-(piperidin-1-yl)propoxy)-5H-isoquinolino[1,2-b]quinazolin-8(6H)-one",0.216,uM,=,-0.6655462488490691,0,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCc1ccccc1-2
5309,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(OCCCCCCN3CCCCC3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(6-piperidin-1-ylhexyloxy)phenyl]methanone,0.21,uM,=,-0.6777807052660807,0,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc(OCCCCCCN2CCCCC2)cc1
5310,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2c(O)cc(O)cc2o1,"5,7-Dihydroxy-4-oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)-amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.0023,uM,=,-2.638272163982407,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5311,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,c1ccc(CN2CCC(CCc3nsc4ccccc34)CC2)cc1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isothiazole,0.099,uM,=,-1.00436480540245,0,c1ccc(CN2CCC(CCc3nsc4ccccc34)CC2)cc1
5312,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1,N-(1-benzylpiperidin-4-yl)-1-phenylmethanimine,2.1,uM,=,0.3222192947339193,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5313,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)C)c(O)c1)O2,"(Z)-2-(4-((dimethylamino)methyl)-3-hydroxybenzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",24.3,uM,=,1.385606273598312,1,O=C1/C(=C/c2ccccc2)Oc2ccccc21
5314,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CCc1cc[n+](Cc3ccccc3)cc1)C2,"1-Benzyl-4-[3-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium",0.0046,uM,=,-2.337242168318426,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)C1Cc2ccccc2S1
5315,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@H](C1)C2,"(-)-(7S,11S)-huprine H3",0.00074,uM,=,-3.130768280269024,0,C1=C[C@@H]2Cc3nc4ccccc4cc3[C@H](C1)C2
5316,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,Clc1cccc2c1N=C1CCCCCN1C2,"4-Chloro-6,7,8,9,10,12-hexahydro-azepino[2,1-b]quinazoline",1.5,uM,=,0.1760912590556812,1,c1ccc2c(c1)CN1CCCCCC1=N2
5317,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCN(C)CC3)c(O)c1)O2,"(Z)-2-(3-hydroxy-4-((4-methylpiperazin-1-yl)methyl)benzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",14.0,uM,=,1.146128035678238,1,O=C1/C(=C/c2ccc(CN3CCNCC3)cc2)Oc2ccccc21
5318,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,C#CCN(Cc1ccc2cccc(O)c2n1)CC1CCN(Cc2ccccc2)CC1,2-((((1-Benzylpiperidin-4-yl)methyl)(prop-2-yn-1-yl)amino)methyl)quinolin-8-ol,9.7,uM,=,0.9867717342662448,1,c1ccc(CN2CCC(CNCc3ccc4ccccc4n3)CC2)cc1
5319,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCNC1N2,"o-Tolyl-carbamic acid (S)-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.285,uM,=,-0.5451551399914898,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
5320,2261355,10.1016/j.ejmech.2022.114606,,,,Inhibition of human erythrocyte AChE using acetyl-(beta-methyl)thiocholine as substrate by Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCO[C@@H]1N2C,"methyl-carbamic acid (3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-5-yl ester",0.004,uM,=,-2.397940008672037,0,c1ccc2c(c1)N[C@H]1OCCC21
5321,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(Nc3ccccc3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-N'-phenyl-benzene-1,3-diamine",0.64,uM,=,-0.1938200260161128,0,c1ccc(Nc2cccc(NCCSCc3ccco3)c2)cc1
5322,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,COc1ccc2c(c1)c1cc[n+](C)cc1n2C,"6-methoxy-2,9-dimethyl-9H-beta-carbolin-2-ium",1.3,uM,=,0.1139433523068367,1,c1ccc2c(c1)[nH]c1c[nH+]ccc12
5323,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,"(+/-)-N-{7-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]heptyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.00318,uM,=,-2.4975728800155674,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5324,1551243,10.1021/acs.jnatprod.5b00600,,,,Inhibition of human acetylcholinesterase after 30 mins by microplate reader-based Ellman's method,CC[C@H]1O[C@@H]2O[C@H](/C=C/C=C/C=C/c3oc(=O)cc(OC/C=C(\C)C(=O)OC)c3C)[C@H](O)[C@]2(C)[C@@]1(C)O,Avertoxin B,14.9,uM,=,1.173186268412274,1,O=c1cccc(/C=C/C=C/C=C/[C@@H]2CC3CCO[C@@H]3O2)o1
5325,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,c1ccc(CN2CCC(CCCc3noc4ccccc34)CC2)cc1,3-[3-(1-Benzyl-piperidin-4-yl)-propyl]-benzo[d]isoxazole,0.009,uM,=,-2.0457574905606752,0,c1ccc(CN2CCC(CCCc3noc4ccccc34)CC2)cc1
5326,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Fc1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,SID47202111,1.2,uM,=,0.0791812460476248,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5327,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00069,uM,=,-3.161150909262745,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5328,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCC2,"7-(3-(Piperidin-1-yl)propoxy)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one",1.1,uM,=,0.041392685158225,1,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCC2
5329,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,C=C(C)[C@H](O)CC[C@]1(C)[C@@H](CC=C(C)C)C[C@@]2(CC=C(C)C)C(=O)[C@]1(C(=O)C(C)C)C(=O)C1=C2O[C@H](C(C)(C)O)C1,Hyperforatin I,26.43,uM,=,1.4220971631317103,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5330,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=[N+]([O-])OCCCCCCNCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(6'-(nitrooxy)hexyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine",0.0063,uM,=,-2.2006594505464183,0,c1ccc2nc3c(cc2c1)CCCC3
5331,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCN(CC)CCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(3-(Diethylamino)propoxy)phenyl)-3-phenylprop-2-en-1-one,22.51,uM,=,1.35237549500052,1,O=C(/C=C/c1ccccc1)c1ccccc1
5332,2275467,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) incubated for 40 mins by Ellman's method,Cn1c2c(c3ccccc31)CC[N+](c1ccc(Br)cc1)=C2,"2-(4-bromophenyl)-9-methyl-3,4-dihydropyrido[3,4-b]indol-2-ium",1.5,uM,=,0.1760912590556812,1,C1=[N+](c2ccccc2)CCc2c1[nH]c1ccccc21
5333,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2,"US9238626, (+/-)-(Id) HCl",0.0174,uM,=,-1.7594507517174005,0,O=C(NCCCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5334,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCC(C)n1cc(C(=O)CF)cn1,1-(1-(sec-butyl)-1H-pyrazol-4-yl)-2-fluoroethan-1-one,16.9,uM,=,1.2278867046136734,1,c1cn[nH]c1
5335,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",25.0,uM,=,1.3979400086720375,1,c1ccc2c(c1)N[C@H]1NCCC21
5336,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1cc2oc(C(=O)NCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc(=O)c2cc1OC.Cl,"6,7-Dimethoxy-4-oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.0018,uM,=,-2.744727494896694,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5337,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN1c2ccccc2C(N2CCSCC2)c2ccccc21,"4-(10-methyl-9,10-dihydroacridin-9-yl)thiomorpholine",11.8,uM,=,1.0718820073061257,1,c1ccc2c(c1)Nc1ccccc1C2N1CCSCC1
5338,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,CCN(CC)CCS/C(=N\O)C(=O)c1ccc(OC)cc1,N-Hydroxy-2-(4-methoxy-phenyl)-2-oxo-thioacetimidic acid 2-diethylamino-ethyl ester,260.0,uM,=,2.414973347970818,1,c1ccccc1
5339,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,C[n+]1ccccc1C=NO,2-(Hydroxyimino-methyl)-1-methyl-pyridinium,340.0,uM,=,2.531478917042256,1,c1cc[nH+]cc1
5340,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(Cc2ccccc2)cc1)NCCN1CCN(Cc2ccccc2)CC1,2-(4-Benzylphenoxy)-N-(2-(4-benzylpiperazin-1-yl)ethyl)acetamide,0.993,uM,=,-0.0030507515046188,0,O=C(COc1ccc(Cc2ccccc2)cc1)NCCN1CCN(Cc2ccccc2)CC1
5341,1875660,10.1021/acs.jmedchem.8b01954,,,,Inhibition of human recombinant acetylcholinesterase expressed in HEK-293 cells using AMTch as substrate after 30 mins by spectrophotometric method,Cc1cc(N2CCCCC2)nc2ccccc12,SID24829278,0.84,uM,=,-0.0757207139381183,0,c1ccc2nc(N3CCCCC3)ccc2c1
5342,2162543,10.1016/j.ejmech.2021.114045,,,,Inhibition of recombinant AChE in human erythrocytes using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman's method,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc(C(=O)CCC5CCN(Cc6ccccc6)CC5)cc4)CC3)c2c1,3-(4-(4-(4-(3-(1-Benzylpiperidin-4-yl)propanoyl)phenyl)piperazin-1-yl)butyl)-1H-indole-5-carbonitrile,0.00058,uM,=,-3.2365720064370627,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc(N2CCN(CCCCc3c[nH]c4ccccc34)CC2)cc1
5343,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,Cc1ccc2c(c1)C(=O)C(C)C2,"2,6-Dimethyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5344,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CC1C=CC[N+](C)(Cc3ccccc3)CC1)C2,"1-Benzyl-4-[2-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-2-oxo-ethyl]-1-methyl-2,3,4,7-tetrahydro-1H-azepinium",0.75,uM,=,-0.1249387366082999,0,O=C(CC1C=CC[NH+](Cc2ccccc2)CC1)C1Cc2ccccc2S1
5345,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,COC(C)(C)/C=C/C[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C3=C(O[C@@H](C(C)(C)O)C3)[C@@]1(C(=O)C(C)C)C2=O,Hyperforatin D,7.17,uM,=,0.8555191556678001,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5346,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1ccc2oc(C(=O)NCCCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cc(=O)c2c1.Cl,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-decyl}-6-methoxy-4-oxo-4H-chromene-2-carboxamide hydrochloride",0.0001,uM,=,-4.0,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5347,1852472,10.1016/j.ejmech.2019.05.020,,,,Inhibition of recombinant human AChE using acetylthiocholine as substrate by UV-visible absorption method,COc1ccc(CNC(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1OC,"1-benzoyl-N-(3,4-dimethoxybenzyl)piperidine-4-carboxamide",0.00411,uM,=,-2.3861581781239307,0,O=C(NCc1ccccc1)C1CCN(C(=O)c2ccccc2)CC1
5348,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1cc2oc(C(=O)NCCCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cc(=O)c2cc1OC.Cl,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-decyl}-6,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide hydrochloride",0.0002,uM,=,-3.6989700043360174,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5349,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,COc1cccc(COc2ccc3c(C)c(C)c(=O)oc3c2)c1,"7-(3-Methoxy-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5350,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@@H](C1)C2.Cl,"(+)-N-{9-[((7R,11R)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]nonyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",2.93,uM,=,0.4668676203541094,1,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)C[C@@H]1C=CC[C@H]2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5351,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)SC[C@@H]1CCN(C)[C@H]21,"(3aR,9bS)-1-methyl-1,2,3,3a,4,9b-hexahydrothiochromeno[4,3-b]pyrrol-7-yl methylcarbamate",0.00811,uM,=,-2.090979145788844,0,c1ccc2c(c1)SC[C@@H]1CCN[C@H]21
5352,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,COc1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1,"(-)-(4-Methoxy-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.35,uM,=,-0.4559319556497244,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5353,28602,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 5.24-30.8,C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CCC)cc21.Cl,Methyl-propyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,10.8,uM,=,1.0334237554869496,1,c1ccc2c(c1)CCC2
5354,1729471,10.1021/acs.jnatprod.7b00847,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate pretreated for 20 mins followed by substrate addition measured after 30 mins by Ellman's method,CC1(c2nccc3cc4c(cc23)OCO4)OC(O)c2c1ccc1c2OCO1,Mucroniferanine F,12.2,uM,=,1.0863598306747482,1,c1cc2cc3c(cc2c(C2OCc4c2ccc2c4OCO2)n1)OCO3
5355,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1cc(F)ccc1[N+](=O)[O-])NCC1CCN(Cc2ccccc2)CC1,N-((1-Benzylpiperidin-4-yl)methyl)-2-(5-fluoro-2-nitrophenoxy)acetamide,0.103,uM,=,-0.9871627752948278,0,O=C(COc1ccccc1)NCC1CCN(Cc2ccccc2)CC1
5356,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(OCCCCCN3CCCCC3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(5-piperidin-1-ylpentyloxy)phenyl]methanone,0.143,uM,=,-0.8446639625349383,0,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc(OCCCCCN2CCCCC2)cc1
5357,2233511,10.1016/j.bmcl.2022.128722,,,,Inhibition of AChE (unknown origin) using acetylcholine iodide as substrate incubated for 10 mins by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",117.91089844468516,uM,=,2.0715539485695653,1,c1ccc2nc3c(cc2c1)CCCC3
5358,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1cc2ccnc3c2c(c1OC)COC3(O)CC(O)CO,"3-(9-Hydroxy-5,6-dimethoxy-7H,9H-8-oxa-1-aza-phenalen-9-yl)-propane-1,2-diol",108.99310270236118,uM,=,2.0373990158022584,1,c1cc2c3c(nccc3c1)COC2
5359,590772,10.1021/jm901123n,,,,Inhibition of human recombinant AChE by Ellman's method,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCNC(=O)CCCCC2CCSS2)=CC1=O)Cc1ccccc1OC,"5-[1,2]Dithiolan-3-yl-pentanoic acid [6-(4-{6-[ethyl-(2-methoxy-benzyl)-amino]-hexylamino}-3,6-dioxo-cyclohexa-1,4-dienylamino)-hexyl]-amide",0.1,uM,=,-1.0,0,O=C(CCCCC1CCSS1)NCCCCCCNC1=CC(=O)C(NCCCCCCNCc2ccccc2)=CC1=O
5360,28479,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 3.18-17.9,CCN(C)C(=O)Oc1ccc2c(c1)[C@H](N)CC2.Cl,Ethyl-methyl-carbamic acid 3-amino-indan-5-yl ester hydrochloride,6.14,uM,=,0.7881683711411677,1,c1ccc2c(c1)CCC2
5361,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCCN(CCCC)CCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(2-(Dibutylamino)ethoxy)phenyl)-3-phenylprop-2-en-1-one,252.96,uM,=,2.403051852588134,1,O=C(/C=C/c1ccccc1)c1ccccc1
5362,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OC(C)C)C(c2cccc(F)c2)c2c(nc3c(c2N)CC(C)(C)CC3)N1,"US9284330, S2",0.558,uM,=,-0.2533658010624212,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5363,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]benzamide hydrochloride",0.357,uM,=,-0.4473317838878068,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5364,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2occ(C(=O)Nc3ccc(OC)cc3)c(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(3-((4-methoxyphenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,5.43,uM,=,0.7347998295888469,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5365,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,Cc1ccc(C)c(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)c1,"(2,5-Dimethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.026,uM,=,-1.585026652029182,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5366,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(O)c(CN(C)C)c1)O2,"(Z)-2-(4-hydroxy-3-(piperidin-1-ylmethyl)benzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",0.51,uM,=,-0.2924298239020636,0,O=C1/C(=C/c2ccccc2)Oc2ccccc21
5367,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,Cn1c2ccc(O)cc2c2cc[n+](C)cc21,"6-hydroxy-2,9-dimethyl-9H-beta-carbolin-2-ium",1.8,uM,=,0.255272505103306,1,c1ccc2c(c1)[nH]c1c[nH+]ccc12
5368,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Cc1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,1-Benzyl-N-(4-methylbenzyl)piperidin-4-amine,3.7,uM,=,0.568201724066995,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5369,2259357,10.6019/CHEMBL5212743,,,,"Selectivity interaction (NIBR principial panel (12 GPCRs, 3 nuclear receptors, 3 transporters, and 7 other enzymes)) EUB0000254b ACHE",Cc1c(Nc2ccc(S(=O)(=O)N3CCN(C)CC3)cc2F)nc2ccc(Nc3cnn(C4CC4)c3)cn2c1=O,NVS-BPTF-C,5.5,uM,=,0.7403626894942439,1,O=c1cc(Nc2ccc(S(=O)(=O)N3CCNCC3)cc2)nc2ccc(Nc3cnn(C4CC4)c3)cn12
5370,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCC(CC)n1cc(C(=O)CF)cn1,2-fluoro-1-(1-(pentan-3-yl)-1H-pyrazol-4-yl)ethan-1-one,5.29,uM,=,0.7234556720351858,1,c1cn[nH]c1
5371,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3c(c2)CCCCO3)CC1,"1-Benzyl-1-methyl-4-[3-oxo-3-(2,3,4,5-tetrahydro-benzo[b]oxepin-7-yl)-propyl]-piperidinium",0.139,uM,=,-0.8569851997459049,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccc2c(c1)CCCCO2
5372,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN1c2ccccc2C(N2CCOCC2)c2ccccc21,"4-(10-methyl-9,10-dihydroacridin-9-yl)morpholine",12.3,uM,=,1.089905111439398,1,c1ccc2c(c1)Nc1ccccc1C2N1CCOCC1
5373,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,CCN(CC)CCCOc1ccc2nc3n(c(=O)c2c1)CCCCC3,"2-(3-(Diethylamino)propoxy)-7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",12.1,uM,=,1.08278537031645,1,O=c1c2ccccc2nc2n1CCCCC2
5374,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCC[N+](C)(CCCc1c[nH]c2ccccc12)CCC1CCCCCC1.[I-],N-(3-(1H-Indol-3-yl)propyl)-N-(2-cycloheptylethyl)-N-methylbutan-1-aminium iodide,23.203,uM,=,1.3655441400294694,1,c1ccc2c(CCC[NH2+]CCC3CCCCCC3)c[nH]c2c1
5375,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(CCC(=O)NCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3-(3,4,5-trimethoxyphenyl)-N-(4-oxo-4-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-butyl)propanamide",0.0721,uM,=,-1.142064735280571,0,O=C(CCc1ccccc1)NCCCC(=O)NNc1c2c(nc3ccccc13)CCCC2
5376,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,CCCCN1CC(C)(C)CN=C1/C=N/O.Cl,"1-Butyl-5,5-dimethyl-1,4,5,6-tetrahydropyrimidine-2-carbaldehyde Oxime Hydrochloride",93.0,uM,=,1.9684829485539352,1,C1=NCCCN1
5377,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4oc(C5CC5)nc4c(N)c3C(C1)C2,"(+/-)-9-Amino-1-cyclopropyl-oxazolo[4,5-b]-6-ethyl-3,4,7,8-tetrahydro-6,10-methano cycloocta[e]pyridine",50.0,uM,=,1.6989700043360187,1,C1=CC2Cc3nc4oc(C5CC5)nc4cc3C(C1)C2
5378,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CN1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,N-Benzhydryl-2-(methylpiperazin-1-yl)pyrimidin-4-amine,13.7,uM,=,1.136720567156407,1,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1
5379,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CO[C@H]1C[C@H]2C(=C[C@@H]1OC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)[C@H]1CN2Cc2cc3c(cc21)OCO3,,13.06,uM,=,1.115943176939055,1,O=C(O[C@H]1C=C2[C@H]3CN(Cc4cc5c(cc43)OCO5)[C@H]2CC1)c1ccccc1
5380,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4c(nc5ccc(Cl)cc35)CCCC4)cc12,"US8841453, 17",0.007,uM,=,-2.154901959985743,0,O=C(NCCCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5381,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2,"CHEMBL2011499::US9238626, (+)-Huprine Y HCl",0.0136,uM,=,-1.8664610916297824,0,C1=C[C@H]2Cc3nc4ccccc4cc3[C@@H](C1)C2
5382,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccccc1C(=O)O[C@H]1CN2Cc3cc4c(cc3[C@]13C=C[C@@H](O)C[C@H]23)OCO4,11-O-(2-Methoxybenzoyl)haemanthamine,90.0,uM,=,1.954242509439325,1,O=C(O[C@H]1CN2Cc3cc4c(cc3[C@]13C=CCC[C@H]23)OCO4)c1ccccc1
5383,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1,"di(2,2'-(decane-1,10-diyl)diisoquinolinium)di bromide",0.05,uM,=,-1.3010299956639813,0,c1ccc2c[n+](CCCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1
5384,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1cc2c(cc1OC(=O)Nc1ccccc1)[C@]1(C)CCN(C)[C@@H]1N2C,"Phenyl-carbamic acid 1,3a,6,8-tetramethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.26,uM,=,-0.585026652029182,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5385,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN[C@@H]1N2C,"Methyl-carbamic acid 3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.023,uM,=,-1.6382721639824072,0,c1ccc2c(c1)N[C@H]1NCCC21
5386,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OC(C)C)C(c2cccc(Cl)c2)c2c(nc3c(c2N)CC(C)(C)CC3)N1,"US9284330, S32",6.918,uM,=,0.8399805576783427,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5387,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCCC(C)n1cc(C(=O)CF)cn1,2-fluoro-1-(1-(pentan-2-yl)-1H-pyrazol-4-yl)ethan-1-one,24.2,uM,=,1.383815365980431,1,c1cn[nH]c1
5388,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cl.Cl.O.c1ccc(CN2CCC(CCNc3cc4c(nn3)-c3ccccc3CC4)CC2)cc1,"[2-(1-Benzyl-piperidin-4-yl)-ethyl]-(5,6-dihydro-benzo[h]cinnolin-3-yl)-amine dihydrochloride hydrate",0.19,uM,=,-0.721246399047171,0,c1ccc(CN2CCC(CCNc3cc4c(nn3)-c3ccccc3CC4)CC2)cc1
5389,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,CCCCN1CCC(CCC(=O)c2ccc3[nH]ccc3c2)CC1,3-(1-Butyl-4-piperidyl)-1-(1H-indol-5-yl)propan-1-one,0.716,uM,=,-0.1450869776921444,0,O=C(CCC1CCNCC1)c1ccc2[nH]ccc2c1
5390,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1cccc2c1CC(C)C2=O,4-Methoxy-2-methyl-indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5391,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCN(CC)CCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(5-(Diethylamino)pentyloxy)phenyl)-3-phenylprop-2-en-1-one,34.14,uM,=,1.5332635167787148,1,O=C(/C=C/c1ccccc1)c1ccccc1
5392,936734,10.1016/j.bmc.2012.10.045,,,,Inhibition of acetylcholinesterase (unknown origin),CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,0.7,uM,=,-0.1549019599857432,0,c1ccccc1
5393,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4cc(Cl)ccc4c(NCCN=[N+]=[N-])c3C(C1)C2,"(+/-)-N-(2-azidoethyl)-3-chloro-6,7,10,11-tetrahydro-12-ylamino-9-ethyl-7,11-methanocyclooctan[b]-quinoline",0.0137,uM,=,-1.863279432843593,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5394,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,C[C@H](c1cccc(OC(=O)N(C)C)c1)N1CCCCC1,(R)-3-(1-(piperidin-1-yl)ethyl)phenyl dimethylcarbamate,0.032,uM,=,-1.494850021680094,0,c1ccc(CN2CCCCC2)cc1
5395,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN[C@@H]1N2C,"Methyl-carbamic acid 3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.021,uM,=,-1.6777807052660807,0,c1ccc2c(c1)N[C@H]1NCCC21
5396,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CC[N+](C)(Cc4ccccc4)CCC3O)sc2cc1OC,"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophene-2-carbonyl)-5-hydroxy-1-methyl-azepanium",0.043,uM,=,-1.3665315444204136,0,O=C(c1cc2ccccc2s1)C1CCC[NH+](Cc2ccccc2)CC1
5397,28304,10.1021/jm00086a011,,,,In vitro inhibitory activity against human Acetylcholinesterase,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CC)C1C2,"(+/-)-Heptyl-carbamic acid 1-ethyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.381,uM,=,-0.4190750243243807,0,c1ccc2c(c1)CC1NCC[C@@H]21
5398,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(6-Morpholin-4-yl-hexyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.93,uM,=,-0.0315170514460648,0,O=C(NCCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5399,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Hexyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.045,uM,=,-1.3467874862246565,0,c1ccc2c(c1)CC1NCCC21
5400,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CC)C1C2,"(+/-)-Hexyl-carbamic acid 1-ethyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.208,uM,=,-0.6819366650372385,0,c1ccc2c(c1)CC1NCC[C@@H]21
5401,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,COc1ccc2nc3c(c(NCCCNC4=CC(=O)c5ccccc5C4=O)c2c1)CCCC3,"2-[3-(7-Methoxy-1,2,3,4-tetrahydroacridin-9-yl-amino)propyl]-amino-1,4-naphthoquinone",6.15,uM,=,0.7888751157754168,1,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5402,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12,"(-)-Phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.036,uM,=,-1.4436974992327127,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5403,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccc(F)cc1,1-Fluoro-4-methyl-benzene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5404,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,COc1c(C(=O)CCC2CCN(CC3CCCCC3)CC2)cc(Cl)c2[nH]ccc12,1-(7-Chloro-4-methoxy-1H-indol-5-yl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one,0.0914,uM,=,-1.0390538042661686,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2[nH]ccc2c1
5405,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(CCc2ccccc2)cc1)NCC1CCN(Cc2ccccc2)CC1,N-((1-Benzylpiperidin-4-yl)methyl)-2-(4-phenethylphenoxy)acetamide,0.135,uM,=,-0.8696662315049939,0,O=C(COc1ccc(CCc2ccccc2)cc1)NCC1CCN(Cc2ccccc2)CC1
5406,936734,10.1016/j.bmc.2012.10.045,,,,Inhibition of acetylcholinesterase (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.3,uM,=,-0.5228787452803376,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5407,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1cc2c(cc1OC(C)C)CC(C)C2=O,5-Isopropoxy-6-methoxy-2-methyl-indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5408,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,CCN(CC)CCCOc1ccc2nc3n(c(=O)c2c1)CCc1ccccc1-3,"10-(3-(diethylamino)propoxy)-5H-isoquinolino[1,2-b]quinazolin-8(6H)-one",0.669,uM,=,-0.1745738822321768,0,O=c1c2ccccc2nc2n1CCc1ccccc1-2
5409,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)[C@@H]1N2Cc1ccccc1,"(3aS,8aR)-1,8-dibenzyl-3a-methyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate",3.56,uM,=,0.5514499979728752,1,c1ccc(CN2CCC3c4ccccc4N(Cc4ccccc4)[C@H]32)cc1
5410,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,Cc1cc(Br)cc(C)c1OCC(=O)NCCN1CCN(Cc2ccccc2)CC1,"N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2-(4-bromo-2,6-dimethylphenoxy)acetamide",0.09,uM,=,-1.0457574905606752,0,O=C(COc1ccccc1)NCCN1CCN(Cc2ccccc2)CC1
5411,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.45,uM,=,-0.3467874862246563,0,c1ccc2nc3c(cc2c1)CCCC3
5412,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,O=C(CF)c1cnn(C2CCCC2)c1,1-(1-cyclopentyl-1H-pyrazol-4-yl)-2-fluoroethan-1-one,2.5,uM,=,0.3979400086720376,1,c1cnn(C2CCCC2)c1
5413,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCN(CC)CCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(4-(diethylamino)butoxy)phenyl)-3-phenylprop-2-en-1-one,23.21,uM,=,1.3656751404559178,1,O=C(/C=C/c1ccccc1)c1ccccc1
5414,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CN1c2ccccc2C(n2cnc([N+](=O)[O-])n2)c2ccccc21,"10-methyl-9-(3-nitro-1H-1,2,4-triazol-1-yl)-9,10-dihydroacridine",16.7,uM,=,1.2227164711475833,1,c1ccc2c(c1)Nc1ccccc1C2n1cncn1
5415,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,CC[N+](C)(CC)CCS/C(=N\O)C(=O)c1ccc(F)cc1.[Cl-],Diethyl-{2-[2-(4-fluoro-phenyl)-N-hydroxy-2-oxo-acetimidoylsulfanyl]-ethyl}-methyl-ammonium chloride,720.0,uM,=,2.8573324964312685,1,c1ccccc1
5416,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1cc(F)ccc1[N+](=O)[O-])NCCN1CCN(Cc2ccccc2)CC1,N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2(5-fluoro-2-nitrophenoxy)acetamide,0.0028,uM,=,-2.552841968657781,0,O=C(COc1ccccc1)NCCN1CCN(Cc2ccccc2)CC1
5417,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(6-oxo-6-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)hexyl)-benzamide",0.0182,uM,=,-1.739928612014925,0,O=C(CCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5418,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3cc(F)cc(F)c3)cc2oc1=O,"7-(3,5-Difluoro-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5419,2231701,10.1016/j.bmcl.2022.128574,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate incubated for 15 mins by DTNB reagent based Ellman's method,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)CC)cc3o2)cc1,2-(4-((Ethyl(methyl)carbamoyl)oxy)phenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl ethyl(methyl)carbamate,7.9,uM,=,0.8976270912904415,1,O=c1cc(-c2ccccc2)oc2ccccc12
5420,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,Cc1c2c(cc[n+]1C)c1cc(O)ccc1n2C,"6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium",1.9,uM,=,0.2787536009528289,1,c1ccc2c(c1)[nH]c1c[nH+]ccc12
5421,28325,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.76-1.05,C#CCNC1CCc2ccc(OC(=O)N(C)c3ccc(OC)cc3)cc21.Cl,(4-Methoxy-phenyl)-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,0.86,uM,=,-0.0655015487564322,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)CCC2
5422,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1,N-(naphth-1-ylmethyl)-2-(piperazin-1-yl)pyrimidin-4-amine,17.5,uM,=,1.2430380486862944,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
5423,1521690,10.1039/C4MD00225C,,,,Inhibition of AChE from human erythrocytes,CC[N+]1(Cc2ccccc2[N+](=O)[O-])CCCCCn2c(C)c3c(=O)n(c2=O)CCCCC[N+](CC)(Cc2ccccc2[N+](=O)[O-])CCCCCn2c(C)c(c(=O)n(c2=O)CCCCC1)C3.[Br-].[Br-],,4.0,uM,=,0.6020599913279624,1,O=c1c2cn3c(=O)n1CCCCC[NH+](Cc1ccccc1)CCCCCn1cc(c(=O)n(c1=O)CCCCC[NH+](Cc1ccccc1)CCCCC3)C2
5424,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4oc(C5CCC5)nc4c(N)c3C(C1)C2,"(+/-)-9-Amino-1-cyclobutyl-oxazolo[4,5-b]-6-methyl-3,4,7,8-tetrahydro-6,10-methano cycloocta[e]pyridine",27.1,uM,=,1.4329692908744058,1,C1=CC2Cc3nc4oc(C5CCC5)nc4cc3C(C1)C2
5425,1729471,10.1021/acs.jnatprod.7b00847,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate pretreated for 20 mins followed by substrate addition measured after 30 mins by Ellman's method,COC1c2c(ccc3c2OCO3)-c2ccc3cc4c(cc3c2N1C)OCO4,8-methoxydihydrosanguinarine,96.8,uM,=,1.9858753573083936,1,c1cc2c(c3c1OCO3)CNc1c-2ccc2cc3c(cc12)OCO3
5426,2079760,10.1016/j.ejmech.2020.113059,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate peincubated for 5 mins followed by substrate addition by DTNB-reagent based Ellman's method,CCN(C)C(=O)Oc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1.O=C(O)/C=C/C(=O)O,3-[[2-(6-fluoro-1H-indol-3-yl)ethylamino]methyl]phenylN-ethyl-N-methylcarbamate fumaric acid,17.555,uM,=,1.24440083380137,1,c1ccc(CNCCc2c[nH]c3ccccc23)cc1
5427,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccccc1C(F)(F)F)NCC1CCN(Cc2ccccc2)CC1,N-((1-Benzylpiperidin-4-yl)methyl)-2-(2-(trifluoromethyl)phenoxy)acetamide,0.767,uM,=,-0.115204636051019,0,O=C(COc1ccccc1)NCC1CCN(Cc2ccccc2)CC1
5428,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCCN(CCOc1cccc2c(OC(=O)N(C)C)cccc12)CCC1CCCCCC1,5-(2-(Butyl(2-cycloheptylethyl)amino)ethoxy)naphthalen-1-yl dimethylcarbamate,0.0479,uM,=,-1.3196644865854368,0,c1ccc2c(OCCNCCC3CCCCCC3)cccc2c1
5429,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,Cl.O/N=C/C1=NCCCN1Cc1ccccc1,"1-benzyl-1,4,5,6-tetrahydropyrimidine-2-carbaldehyde oxime hydrochloride",28.0,uM,=,1.4471580313422192,1,C1=NCCCN1Cc1ccccc1
5430,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CCNC(=O)Oc1ccc2c(c1)C1(C)COC(O2)O1,"Ethyl-carbamic acid 1-methyl-8,10,12-trioxa-tricyclo[7.2.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",0.3875,uM,=,-0.4117282931576709,0,c1ccc2c(c1)OC1OCC2O1
5431,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC(C)C1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,2-(4-Isopropylpiperidin-1-yl)-N-(naphth-1-ylmethyl)pyrimidin-4-amine,16.7,uM,=,1.2227164711475833,1,c1ccc2c(CNc3ccnc(N4CCCCC4)n3)cccc2c1
5432,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0268,uM,=,-1.5718652059712113,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5433,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2,"US9238626, (+/-)-(Ib) HCl",0.0036,uM,=,-2.4436974992327127,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5434,2027088,10.1021/acs.jmedchem.6b01178,,,,Inhibition of AChE in human erythrocyte hemo-lyzates pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CN(CCCCCCCCNc3c4c(nc5ccccc35)CCCC4)C(=O)/C=C/c3ccc(O)c(OC)c3)c2c1,"(E)-3-(4-Hydroxy-3-methoxyphenyl)-N-(2-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-N-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)acrylamide",0.0437,uM,=,-1.359518563029578,0,O=C(CN(CCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C(=O)/C=C/c1ccccc1)NCCc1c[nH]c2ccccc12
5435,1984714,10.1021/acs.jnatprod.9b00561,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by spectrophotometric based Ellman's method,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.063,uM,=,-1.2006594505464183,0,c1ccc2c(c1)N[C@H]1NCCC21
5436,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CN(C)C1CCC(CCN(CCCc2c[nH]c3ccccc23)CCC2CCCCCC2)CC1,"4-(2-((3-(1H-Indol-3-yl)propyl)(2-cycloheptylethyl)amino)ethyl)-N,N-dimethylcyclohexan-1-amine",8.573,uM,=,0.9331328237267345,1,c1ccc2c(CCCN(CCC3CCCCCC3)CCC3CCCCC3)c[nH]c2c1
5437,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,12-di(2-isoquinoliniumyl)dodecane; dibromide",137.0,uM,=,2.1367205671564067,1,c1ccc2c[n+](CCCCCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1
5438,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",C=CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc(F)c1)CC(C)(C)CC3,"US9284330, S34",1.78,uM,=,0.250420002308894,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5439,28446,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.57-2.08,C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)C)cc21.Cl,Dimethyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,1.8,uM,=,0.255272505103306,1,c1ccc2c(c1)CCC2
5440,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@H](C1)C2,"CHEMBL1994202::US9238626, (-)-Huprine Y HCl",0.00043,uM,=,-3.3665315444204134,0,C1=C[C@@H]2Cc3nc4ccccc4cc3[C@H](C1)C2
5441,28449,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 1.67-3.57,C#CCN[C@H]1CCc2ccc(OC(=O)N(C)C)cc21.Cl,Dimethyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,2.25,uM,=,0.3521825181113625,1,c1ccc2c(c1)CCC2
5442,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.8,uM,=,-0.0969100130080563,0,c1ccc2nc3c(cc2c1)CCCC3
5443,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,COc1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1,"(-)-(4-Methoxy-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.23,uM,=,-0.6382721639824072,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5444,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1cc(OC)c2c(=O)cc(C(=O)NCCCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)oc2c1.Cl,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-decyl}-5,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide hydrochloride",0.00035,uM,=,-3.4559319556497243,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5445,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CCOC(=O)C1=CN(C)c2cccc(OC(=O)N(C)C)c2C1,"ethyl 5-(dimethylcarbamoyloxy)-1-methyl-1,4-dihydroquinoline-3-carboxylate",0.007,uM,=,-2.154901959985743,0,C1=CNc2ccccc2C1
5446,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4cc(Cl)ccc4c(NCCO)c3C(C1)C2,"(+/-)-N-(2-Hydroxyethyl)-3-chloro-6,7,10,11-tetrahydro-12-ylamino-9-ethyl-7,11-methanocyclooctan[b]-quinoline",0.00675,uM,=,-2.170696227168975,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5447,1627472,10.1016/j.bmc.2016.11.002,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CN(C)C(=O)Oc1cccc(C(=O)/C=C/c2ccc(O)cc2)c1,(E)-3-(3-(4-Hydroxyphenyl)acryloyl)phenyl dimethylcarbamate,0.87,uM,=,-0.0604807473813814,0,O=C(/C=C/c1ccccc1)c1ccccc1
5448,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3ccc(F)c(F)c3)cc2oc1=O,"7-(3,4-Difluoro-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5449,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CC(C)(C)CC3,"US9284330, S30",5.96,uM,=,0.7752462597402364,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5450,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CC(C)(C)c1cccc(C(=O)C(F)(F)F)c1,"1-(3-tert-Butyl-phenyl)-2,2,2-trifluoro-ethanone",0.0146,uM,=,-1.8356471442155629,0,c1ccccc1
5451,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=[N+]([O-])c1ccc2c(c1)c(OCc1ccccc1)nn2Cc1ccccc1,SID517573,7.3,uM,=,0.8633228601204559,1,c1ccc(COc2nn(Cc3ccccc3)c3ccccc23)cc1
5452,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 8",0.26968,uM,=,-0.5691512604870844,0,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5453,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCCc1ccccc1-2,"11-(3-(Piperidin-1-yl)propoxy)-6,7-dihydrobenzo[3,4]azepino[2,1-b]quinazolin-9(5H)-one",0.535,uM,=,-0.2716462179787715,0,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCCc1ccccc1-2
5454,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2ccc(F)cc2[N+](=O)[O-])o1,[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-(4-fluoro-2-nitro-phenyl)-amine,0.65,uM,=,-0.1870866433571444,0,c1ccc(NCCSCc2ccco2)cc1
5455,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,1.9,uM,=,0.2787536009528289,1,c1ccccc1
5456,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(Heptylphysostigmine(-))Heptyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.022,uM,=,-1.6575773191777938,0,c1ccc2c(c1)N[C@H]1NCCC21
5457,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCC(C)n1cc(C(=O)C(F)F)cn1,"1-(1-(sec-butyl)-1H-pyrazol-4-yl)-2,2-difluoroethan-1-one",0.11,uM,=,-0.958607314841775,0,c1cn[nH]c1
5458,2233511,10.1016/j.bmcl.2022.128722,,,,Inhibition of AChE (unknown origin) using acetylcholine iodide as substrate incubated for 10 mins by Ellman's method,CCC(c1ccc(O)c(OC)c1)c1cccc(O)c1O,"3-(1-(4-Hydroxy-3-methoxyphenyl)propyl)benzen-1,2-diol",5.66,uM,=,0.7528164311882715,1,c1ccc(Cc2ccccc2)cc1
5459,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4cc(Cl)ccc4c(O)c3C(C1)C2,"(+/-)-3-Chloro-12-hydroxy-6,7,10,11-tetrahydro-9-methyl-7,11-ethanocyclooctan[b]quinoline",14.7,uM,=,1.1673173347481762,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5460,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])o1,"[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-(2,4-dinitro-phenyl)-amine",0.2,uM,=,-0.6989700043360187,0,c1ccc(NCCSCc2ccco2)cc1
5461,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CCN3CCCCC3)CC2)cc1,1-[bis(4-fluoro-phenyl)-methyl]-4-(2-piperidin-1-yl-ethyl)-piperazine,0.1263,uM,=,-0.8985966494446693,0,c1ccc(C(c2ccccc2)N2CCN(CCN3CCCCC3)CC2)cc1
5462,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1ccc2c(CCC3CCN(Cc4ccccc4)CC3)noc2c1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-6-methoxy-benzo[d]isoxazole,0.0083,uM,=,-2.0809219076239263,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
5463,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,COC(C)(C)/C=C/C[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C3=C(O[C@H](C(C)(C)O)C3)[C@@]1(C(=O)C(C)C)C2=O,15-epi-Hyperforatin D,3.98,uM,=,0.5998830720736879,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5464,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc([N+](=O)[O-])cc1)NCCN1CCN(Cc2ccccc2)CC1,N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2-(4-nitrophenoxy)acetamide,0.042,uM,=,-1.3767507096020994,0,O=C(COc1ccccc1)NCCN1CCN(Cc2ccccc2)CC1
5465,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,COP(=O)(OC)OC=C(Cl)Cl,"Phosphoric acid 2,2-dichloro-vinyl ester dimethyl ester",2.31,uM,=,0.3636119798921443,1,
5466,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,COc1ccc2nc3c(c(NCCCNC4=CC(=O)c5c(O)cccc5C4=O)c2c1)CCCC3,"5-hydroxy-2-(3-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)propylamino)naphthalene-1,4-dione",0.348,uM,=,-0.4584207560534191,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5467,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CCCN1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,N-Benzhydryl-2-(4-propylpiperazin-1-yl)pyrimidin-4-amine,14.6,uM,=,1.1643528557844371,1,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1
5468,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C(O[C@H]1CN2Cc3cc4c(cc3[C@]13C=C[C@@H](O)C[C@H]23)OCO4)c1cccc([N+](=O)[O-])c1,11-O-(3-Nitrobenzoyl)haemanthamine,4.0,uM,=,0.6020599913279624,1,O=C(O[C@H]1CN2Cc3cc4c(cc3[C@]13C=CCC[C@H]23)OCO4)c1ccccc1
5469,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cl.Cl.O.c1ccc(CN2CCC(CCOc3ccc(-c4ccccc4)nn3)CC2)cc1,3-[2-(1-Benzyl-piperidin-4-yl)-ethoxy]-6-phenyl-pyridazine dihydrochloride hydrate,0.71,uM,=,-0.1487416512809247,0,c1ccc(CN2CCC(CCOc3ccc(-c4ccccc4)nn3)CC2)cc1
5470,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",C#CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CC(C)(C)CC3,"US9284330, S36",1.928,uM,=,0.2851070295668119,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5471,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,O=C(CCCCC1CCSS1)NCCNc1c2c(nc3ccccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [2-(1,2,3,4-tetrahydro-acridin-9-ylamino)-ethyl]-amide",0.097,uM,=,-1.0132282657337552,0,O=C(CCCCC1CCSS1)NCCNc1c2c(nc3ccccc13)CCCC2
5472,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,"(+/-)-N-{11-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]undecyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.0174,uM,=,-1.7594507517174005,0,O=C(NCCCCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5473,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)OC(C)(C)C,(S)-hexyl 5-(2-(1-benzylpiperidin-4-yl)ethylamino)-2-(tert-butoxycarbonylamino)-5-oxopentanoate,0.95,uM,=,-0.0222763947111522,0,c1ccc(CN2CCCCC2)cc1
5474,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,11-di(2-isoquinoliniumyl)undecane; dibromide",0.1,uM,=,-1.0,0,c1ccc2c[n+](CCCCCCCCCCC[n+]3ccc4ccccc4c3)ccc2c1
5475,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(5-oxo-5-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)pentyl)-benzamide",0.017,uM,=,-1.769551078621726,0,O=C(CCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5476,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,C=CCN1CC[C@@]2(C)c3cc(OC(=O)NC)ccc3N(C)[C@@H]12,"Methyl-carbamic acid 1-allyl-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.045,uM,=,-1.3467874862246565,0,c1ccc2c(c1)N[C@H]1NCCC21
5477,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4cc(Cl)ccc4c(Cl)c3C(C1)C2,"(+/-)-3,12-Dichloro-6,7,10,11-tetrahydro-9-methyl-7,11-ethanocyclooctan[b]quinoline",22.4,uM,=,1.3502480183341627,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5478,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3ccc(OC)cc3)cc(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(2-((4-methoxyphenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,1.14,uM,=,0.0569048513364725,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5479,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=C(CCO[N+](=O)[O-])NCCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-delta-(3'-(nitrooxy)propanoyl)-delta-aminopropylamino]-1,2,3,4-tetrahydroacridine",0.0457,uM,=,-1.3400837999301498,0,c1ccc2nc3c(cc2c1)CCCC3
5480,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,COc1ccc(-c2c3ccccc3[n+](C)c3ccccc23)cc1.F[B-](F)(F)F,9-(4-methoxyphenyl)-10-methylacridinium tetrafluoroborate,13.7,uM,=,1.136720567156407,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5481,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,O=C(CCc1c[nH]c2ccccc12)NC1CCN(Cc2ccccc2)CC1,N-(1-Benzylpiperidin-4-yl)-3-(1H-indol-3-yl)propanamide,8.32,uM,=,0.920123326290724,1,O=C(CCc1c[nH]c2ccccc12)NC1CCN(Cc2ccccc2)CC1
5482,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCCN(CCC1CCCCCC1)Cc1ccc(OC(=O)N(C)C)c2ccccc12,4-((Butyl(2-cycloheptylethyl)amino)methyl)naphthalen-1-yl dimethylcarbamate,0.1012,uM,=,-0.9948194874962196,0,c1ccc2c(CNCCC3CCCCCC3)cccc2c1
5483,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,CCN1CCN(Cc2ccc(/C=C3\Oc4cc(OC)c(OC)cc4C3=O)cc2O)CC1,"(Z)-2-(4-((4-ethylpiperazin-1-yl)methyl)-3-hydroxybenzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",32.1,uM,=,1.506505032404872,1,O=C1/C(=C/c2ccc(CN3CCNCC3)cc2)Oc2ccccc21
5484,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,C[Si](C)(C)c1cccc(C(=O)C(F)(F)F)c1,ZIFROSILONE,0.285,uM,=,-0.5451551399914898,0,c1ccccc1
5485,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCN=[N+]=[N-])c3C(C1)C2,"(+/-)-N-(2-azidoethyl)-3-chloro-6,7,10,11-tetrahydro-12-ylamino-9-methyl-7,11-methanocyclooctan[b]-quinoline",0.00869,uM,=,-2.0609802235513337,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5486,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,c1ccc(COc2nn(Cc3ccccc3)c3ccccc23)cc1,1-Benzyl-3-benzyloxyindazole,2.9,uM,=,0.4623979978989561,1,c1ccc(COc2nn(Cc3ccccc3)c3ccccc23)cc1
5487,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C(NCCCNc2c3c(nc4ccccc24)CCCC3)=CC(=O)c2c(O)cccc21,"5-hydroxy-2-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propylamino)naphthalene-1,4-dione",0.103,uM,=,-0.9871627752948278,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5488,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=[N+]([O-])c1ccc2c(c1)c(OCc1ccc3ccccc3c1)nn2Cc1ccccc1,1-Benzyl-3-(2-naphthylmethoxy)-5-nitroindazole,6.3,uM,=,0.7993405494535817,1,c1ccc(Cn2nc(OCc3ccc4ccccc4c3)c3ccccc32)cc1
5489,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,CC1Cc2cc3c(cc2C1=O)OCO3,"6-Methyl-6,7-dihydro-indeno[5,6-d][1,3]dioxol-5-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2cc3c(cc21)OCO3
5490,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc(Cl)c1)CC(C)(C)CC3,"US9284330, S5",0.77,uM,=,-0.1135092748275181,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5491,1984714,10.1021/acs.jnatprod.9b00561,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by spectrophotometric based Ellman's method,COc1c2c(cc3c1OCO3)[C@]13C=C[C@H](OC)C[C@@H]1[N@](C2)C[C@H]3OC(=O)c1cccc([N+](=O)[O-])c1,11-O-(3-Nitrobenzoyl)ambelline,48.0,uM,=,1.6812412373755872,1,O=C(O[C@@H]1C[N@@]2Cc3cc4c(cc3[C@@]13C=CCC[C@H]23)OCO4)c1ccccc1
5492,1549348,10.1016/j.bmc.2016.01.010,,,,Inhibition of human AChE using ATC as substrate preincubated for 5 mins followed by substrate addition measured after 2 mins by Ellman's assay,CCN(Cc1cccc2[nH]c3cc(Cl)ccc3c12)C(=O)/C=C/c1ccc(O)c(OC)c1,N-Ethyl-3-(4-hydroxy-3-methoxyphenyl)-N-((7-chloro-9H-carbazol-4-yl)methyl)acrylamide,6.9,uM,=,0.8388490907372553,1,O=C(/C=C/c1ccccc1)NCc1cccc2[nH]c3ccccc3c12
5493,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccccc1,Toluene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5494,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(2-Ethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.01,uM,=,-2.0,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5495,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](Cc3ccc4ccc(C[n+]5ccc6ccccc6c5)cc4c3)ccc2c1,"1,10-Bis(isoquinolinium)-naphtyl-3,6-dimethylenyldibromide",0.3,uM,=,-0.5228787452803376,0,c1ccc2c[n+](Cc3ccc4ccc(C[n+]5ccc6ccccc6c5)cc4c3)ccc2c1
5496,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CN(C)CCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,1-(4-(2-(dimethylamino)ethoxy)phenyl)-3-phenylprop-2-en-1-one,4.68,uM,=,0.670245853074124,1,O=C(/C=C/c1ccccc1)c1ccccc1
5497,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,6-Bis(isoquinolinium)-hex-1,6-diyl dibromide",0.3,uM,=,-0.5228787452803376,0,c1ccc2c[n+](CCCCCC[n+]3ccc4ccccc4c3)ccc2c1
5498,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,C=CCC1(OC)OCc2c(OC)c(OC)cc3ccnc1c23,"9-Allyl-5,6,9-trimethoxy-7H,9H-8-oxa-1-aza-phenalene",99.62428094260116,uM,=,1.998365199811572,1,c1cc2c3c(nccc3c1)COC2
5499,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(NC(=O)CCCCN3CCCCC3)cc2)cc1,5-Piperidin-1-ylpentanoic acid(4-{4-[(benzylmethylamino)methyl]benzoyl}phenyl)amide,0.217,uM,=,-0.6635402661514705,0,O=C(CCCCN1CCCCC1)Nc1ccc(C(=O)c2ccc(CNCc3ccccc3)cc2)cc1
5500,2153545,10.1021/acs.jnatprod.1c00980,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,COc1cc2c[n+]3c(cc2c(CO)c1OC)-c1c(cc2c(c1OC)OCO2)CC3,Alborine,20.0,uM,=,1.3010299956639813,1,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
5501,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1ccc2c(c1OC)C(=O)C(C)C2,"6,7-Dimethoxy-2-methyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5502,28295,10.1021/jm00108a019,,,,In vitro concentration of compound required for reversibly inhibiting 50% of human anticholinesterase activity,CN(CCn1cc[n+](C)c1/C=N/O)S(C)(=O)=O.[Cl-],2-(Hydroxyimino-methyl)-3-[2-(methanesulfonyl-methyl-amino)-ethyl]-1-methyl-3H-imidazol-1-ium chloride,6.8,uM,=,0.8325089127062363,1,c1c[nH+]c[nH]1
5503,2231701,10.1016/j.bmcl.2022.128574,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate incubated for 15 mins by DTNB reagent based Ellman's method,CCN(C)C(=O)Oc1ccc(C2CC(=O)c3c(O)cc(OC(=O)N(C)CC)cc3O2)cc1,2-(4-((ethyl(methyl)carbamoyl)oxy)phenyl)-5-hydroxy-4-oxochroman-7-yl ethyl(methyl)carbamate,9.7,uM,=,0.9867717342662448,1,O=C1CC(c2ccccc2)Oc2ccccc21
5504,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCCN(CCCc1c[nH]c2ccccc12)CCC1CCN(Cc2ccccc2)CC1,N-(3-(1H-Indol-3-yl)propyl)-N-(2-(1-benzylpiperidin-4-yl)ethyl)butan-1-amine,7.837,uM,=,0.8941498467679221,1,c1ccc(CN2CCC(CCNCCCc3c[nH]c4ccccc34)CC2)cc1
5505,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,COc1c(C(=O)CCC2CCN(Cc3ccccc3)CC2)cc(Cl)c2[nH]c([Si](C)(C)C)cc12,3-(1-Benzyl-4-piperidyl)-1-(7-chloro-4-methoxy-2-trimethylsilyl-1H-indol-5-yl)propan-1-one,0.275,uM,=,-0.5606673061697374,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]ccc2c1
5506,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Propyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.154,uM,=,-0.8124792791635369,0,c1ccc2c(c1)CC1NCCC21
5507,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CC(O)C1CC[N+](C)(Cc3ccccc3)CC1)C2,"1-Benzyl-4-[3-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-1-hydroxy-3-oxo-propyl]-1-methyl-piperidinium",0.19,uM,=,-0.721246399047171,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)C1Cc2ccccc2S1
5508,28311,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.045-0.057,C#CCNC1CCc2c(OC(=O)N(C)C)cccc21.Cl,Dimethyl-carbamic acid 1-prop-2-ynylamino-indan-4-yl ester hydrochloride,0.053,uM,=,-1.275724130399211,0,c1ccc2c(c1)CCC2
5509,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(Cc3ccccc3)[C@@H]12,"(3aS,8aR)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate",0.2453,uM,=,-0.6103024517936143,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2Cc1ccccc1
5510,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,FC(F)(F)Oc1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,1-Benzyl-N-(4-(trifluoromethoxy)benzyl)piperidin-4-amine,0.59,uM,=,-0.2291479883578558,0,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5511,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,CN(C(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C)c1ccccc1,"Methyl-phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.69,uM,=,-0.1611509092627447,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5512,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CN(C)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3ccc(Cl)cc3)cc(=O)c2c1,(E)-2-(dimethylamino)ethyl 3-(2-(4-chlorophenylcarbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,1.22,uM,=,0.0863598306747482,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5513,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(Nc3ccccc3C#N)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"2-{5-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethylamino]-2,4-dinitro-phenylamino}-benzonitrile",0.63,uM,=,-0.2006594505464183,0,c1ccc(Nc2cccc(NCCSCc3ccco3)c2)cc1
5514,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(Heptylphysostigmine(-))Heptyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.125,uM,=,-0.9030899869919436,0,c1ccc2c(c1)N[C@H]1NCCC21
5515,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cl.Cl.O.c1ccc(CN2CCC(CCNc3cc4ccc5ccccc5c4nn3)CC2)cc1,Benzo[h]cinnolin-3-yl-[2-(1-benzyl-piperidin-4-yl)-ethyl]-amine dihydrochloride hydrate,0.19,uM,=,-0.721246399047171,0,c1ccc(CN2CCC(CCNc3cc4ccc5ccccc5c4nn3)CC2)cc1
5516,28304,10.1021/jm00086a011,,,,In vitro inhibitory activity against human Acetylcholinesterase,CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CCC)C1C2.Cc1ccc(C(=O)OC(C(=O)O)C(OC(=O)c2ccc(C)cc2)C(=O)O)cc1.O,"(+/-)-Hexyl-carbamic acid 3a-methyl-1-propyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.062,uM,=,-1.207608310501746,0,O=C(OCCOC(=O)c1ccccc1)c1ccccc1.c1ccc2c(c1)CC1NCCC21
5517,436796,10.1021/np0700568,,,,Inhibition of AChE by Ellman method,C[C@H]1C=C2N3CC[C@@H](O)C24[C@H](CC(=O)[C@H]4C[C@H](O)C3)C1,2-alpha-11-alpha-dihydroxyfawcettidine,27.9,uM,=,1.4456042032735976,1,O=C1C[C@@H]2CCC=C3N4CCC[C@H]1C32CCC4
5518,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1,N-Benzhydryl-2-(piperazin-1-yl)pyrimidin-4-amine,31.3,uM,=,1.4955443375464486,1,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1
5519,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CCC[N+](C)(CC4CCCCO4)CC3)sc2cc1OC,"4-(5,6-Dimethoxy-benzo[b]thiophene-2-carbonyl)-1-methyl-1-(tetrahydro-pyran-2-ylmethyl)-azepanium",0.028,uM,=,-1.5528419686577808,0,O=C(c1cc2ccccc2s1)C1CCC[NH+](CC2CCCCO2)CC1
5520,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CCc1cc[n+](Cc3ccc(F)cc3)cc1)C2,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(4-fluoro-benzyl)-pyridinium",0.0026,uM,=,-2.5850266520291822,0,O=C(CCc1cc[n+](Cc2ccccc2)cc1)C1Cc2ccccc2S1
5521,28326,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.79-0.93,C#CCN(C)CCc1cccc(OC(=O)N(C)C)c1,Dimethyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-ethyl]-phenyl ester,0.85,uM,=,-0.0705810742857072,0,c1ccccc1
5522,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,CC(=O)[C@@]12C(=O)C(CC=C(C)C)=C3O[C@H](C(C)(C)O)C[C@]3(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,Hyperforatin F,8.75,uM,=,0.9420080530223132,1,O=C1C=C2OCC[C@@]23CCCC1C3=O
5523,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Oc1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,4-(((1-Benzylpiperidin-4-yl)amino)methyl)phenol,4.0,uM,=,0.6020599913279624,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5524,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCCN(CCc1c[nH]c2cc(O)ccc12)CCC1CCCCCC1,3-(2-(Butyl(2-cycloheptylethyl)amino)ethyl)-1H-indol-6-ol,70.639,uM,=,1.849044542529366,1,c1ccc2c(CCNCCC3CCCCCC3)c[nH]c2c1
5525,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C=C(NCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,"2-[2-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl-amino)ethyl]-amino-1,4-naphthoquinone",0.0019299999999999,uM,=,-2.714442690992226,0,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5526,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CN(C)C(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(-)-Dimethyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.31,uM,=,-0.5086383061657274,0,c1ccc2c(c1)N[C@H]1NCCC21
5527,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Hexyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.02,uM,=,-1.6989700043360187,0,c1ccc2c(c1)CC1NCCC21
5528,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis(6-((2-methoxybenzyl)(ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",0.00155,uM,=,-2.8096683018297086,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
5529,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CCCCCNc1cc(NCCSCc2ccc(CN(C)C)o2)c([N+](=O)[O-])cc1[N+](=O)[O-],"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-N'-pentyl-benzene-1,3-diamine",1.2,uM,=,0.0791812460476248,1,c1ccc(NCCSCc2ccco2)cc1
5530,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1ccc2oc(C(=O)NCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc(=O)c2c1.Cl,"6-Methoxy-4-oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)-amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.000775,uM,=,-3.11069829749369,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5531,1842238,10.1016/j.bmc.2019.01.025,,,,Inhibition of human Acetylcholinesterase using acetylthiocholine as substrate preincubated for 20 mins followed by substrate addition by Ellman's method,c1ccc2c(NCc3ccc(-c4ccc(CNc5c6c(nc7ccccc57)CCCC6)cc4)cc3)c3c(nc2c1)CCCC3,"N,N'-(biphenyl-4,4'-diylbis(methylene))bis(1,2,3,4-tetrahydroacridin-9-amine)",0.00361,uM,=,-2.4424927980943423,0,c1ccc2c(NCc3ccc(-c4ccc(CNc5c6c(nc7ccccc57)CCCC6)cc4)cc3)c3c(nc2c1)CCCC3
5532,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cc12,"US8841453, 4",0.0077,uM,=,-2.113509274827518,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5533,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,CCC[n+]1ccc(CCC(=O)C2Cc3cc(OC)c(OC)cc3S2)cc1,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-propyl-pyridinium",2.57,uM,=,0.4099331233312945,1,O=C(CCc1cc[nH+]cc1)C1Cc2ccccc2S1
5534,1655757,10.1016/j.ejmech.2016.12.048,,,,Inhibition of acetylcholinesterase isolated from human red blood cells using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,Oc1cc(O)cc(/C=C/c2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)c1,"(E)-5-(4-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)styryl)benzene-1,3-diol",8.8,uM,=,0.9444826721501688,1,C(=C/c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1)\c1ccccc1
5535,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1cc(O)c2c(=O)cc(C(=O)NCCCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)oc2c1.Cl,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-decyl}-5-hydroxy-7-methoxy-4-oxo-4H-chromene-2-carboxamide hydrochloride",3.5000000000000004e-05,uM,=,-4.455931955649724,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5536,973813,10.1021/np4003355,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 8 mins by Ellman's spectrophotometric method,CC1=C[C@H]2Cc3[nH]c(=O)ccc3[C@@]3(C1)[C@@H]2[C@H](C)CN3C,Casuarinine I,12.1,uM,=,1.08278537031645,1,O=c1ccc2c([nH]1)C[C@@H]1C=CC[C@]23NCC[C@H]13
5537,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,c1ccc2c(c1)c(OCC1CCCCC1)nn2CC1CCCCC1,3-(Cyclohexylmethoxy)-1-(cyclohexylmethyl)indazole,7.1,uM,=,0.8512583487190752,1,c1ccc2c(c1)c(OCC1CCCCC1)nn2CC1CCCCC1
5538,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=C(CO[N+](=O)[O-])NCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(2'-(nitrooxy)acetyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine",0.0282,uM,=,-1.5497508916806388,0,c1ccc2nc3c(cc2c1)CCCC3
5539,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CCN(CC)CC(=O)Nc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1,N-(4-{4-[(Benzylmethylamino)methyl]benzoyl}phenyl)-2-diethylaminoacetamide,0.21,uM,=,-0.6777807052660807,0,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
5540,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.033,uM,=,-1.4814860601221125,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5541,1500860,10.1016/j.bmc.2015.04.080,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as substrate hydrolysis by spectrophotometric/Ellman method,C[C@@]12CC[C@@H]3[C@](C)(CC[C@H](OC(=O)CCc4ccc(O)cc4)[C@]3(C)C(=O)O)[C@H]1CC[C@H]1C(=CC[C@@H]3[C@]1(C)CC[C@@H](O)[C@]3(C)CO)C2,"3beta,21beta,29-trihydroxyserrat-14-en-3beta-yl p-dihydrocoumarate",1.69,uM,=,0.2278867046136735,1,O=C(CCc1ccccc1)O[C@H]1CCC2[C@@H](CCC3CC4=CC[C@H]5CCCCC5[C@H]4CC[C@@H]32)C1
5542,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCN(CCC)CCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(2-(Dipropylamino)ethoxy)phenyl)-3-phenylprop-2-en-1-one,64.55,uM,=,1.809896246602439,1,O=C(/C=C/c1ccccc1)c1ccccc1
5543,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,Fascaplysin,1.5,uM,=,0.1760912590556812,1,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21
5544,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1cc2cccnc2s1,"(S)-hexyl 5-(2-(1-benzylpiperidin-4-yl)ethylamino)-5-oxo-2-(thieno[2,3-b]pyridine-2-carboxamido)pentanoate",0.44,uM,=,-0.3565473235138126,0,O=C(CCCNC(=O)c1cc2cccnc2s1)NCCC1CCN(Cc2ccccc2)CC1
5545,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,Galanthamine hydrogenbromide,3.2,uM,=,0.505149978319906,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5546,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc(C(F)(F)F)c1)CC(C)(C)CC3,"US9284330, S3",1.125,uM,=,0.0511525224473812,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5547,28304,10.1021/jm00086a011,,,,In vitro inhibitory activity against human Acetylcholinesterase,CCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Butyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.09,uM,=,-1.0457574905606752,0,c1ccc2c(c1)CC1NCCC21
5548,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CO[C@H]1C[C@H]2C(=C[C@@H]1OC(=O)c1ccc(C)c([N+](=O)[O-])c1)[C@H]1CN2Cc2cc3c(cc21)OCO3,2-O-(4-methyl-3-nitrobenzoyl)-3-O-methylpancracine,4.32,uM,=,0.6354837468149122,1,O=C(O[C@H]1C=C2[C@H]3CN(Cc4cc5c(cc43)OCO5)[C@H]2CC1)c1ccccc1
5549,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCc4ccc(CNC(=O)c5cc(O)c6c(c5)C(=O)c5cccc(O)c5C6=O)cc4)c3C(C1)C2.Cl,"(+/-)-N-{4-{[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]methyl}benzyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.0182,uM,=,-1.739928612014925,0,O=C(NCc1ccc(CNc2c3c(nc4ccccc24)CC2C=CCC3C2)cc1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5550,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CN(C)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3cccc(Cl)c3)cc(=O)c2c1,(E)-2-(dimethylamino)ethyl 3-(2-(3-chlorophenylcarbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,5.92,uM,=,0.7723217067229198,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5551,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc([N+](=O)[O-])cc1)NCC1CCN(Cc2ccccc2)CC1,N-((1-Benzylpiperidin-4-yl)methyl)-2-(4-nitrophenoxy)acetamide,0.509,uM,=,-0.2932822176632412,0,O=C(COc1ccccc1)NCC1CCN(Cc2ccccc2)CC1
5552,28304,10.1021/jm00086a011,,,,In vitro inhibitory activity against human Acetylcholinesterase,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(Cc3ccccc3)C1C2,"(+/-)-Heptyl-carbamic acid 1-benzyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.506,uM,=,-0.2958494831602009,0,c1ccc(CN2CCC3c4ccccc4CC32)cc1
5553,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,CC(C)=CCC1=C2O[C@H](C(C)(C)O)C[C@@]23C[C@H](CC=C(C)C)[C@@](C)(CCC(=O)C(C)C)[C@@](C(=O)C(C)C)(C1=O)C3=O,Hyperforatin G,24.26,uM,=,1.384890796530554,1,O=C1C=C2OCC[C@@]23CCCC1C3=O
5554,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,"2-[3-(1,2,3,4-Tetrahydroacridin-9-yl-amino)propyl]amino-1,4-naphthoquinone",0.0537,uM,=,-1.2700257143004443,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5555,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,COc1ccc(COc2nn(CCN(C(C)C)C(C)C)c3ccc([N+](=O)[O-])cc23)cc1,1-(2-Diisopropylaminoethyl)-3-(4-methoxybenzyloxy)-5-nitroindazole,91.0,uM,=,1.9590413923210936,1,c1ccc(COc2n[nH]c3ccccc23)cc1
5556,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,CCN(CC)CCCOc1ccc2nc3n(c(=O)c2c1)CCCc1ccccc1-3,"11-(3-(Diethylamino)propoxy)-6,7-dihydrobenzo[3,4]azepino[2,1-b]quinazolin-9(5H)-one",4.2,uM,=,0.6232492903979004,1,O=c1c2ccccc2nc2n1CCCc1ccccc1-2
5557,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,COc1c(C(=O)CCC2CCN(CC3CCCCC3)CC2)cc(Cl)c2c1ccn2C,1-(7-Chloro-4-methoxy-1-methyl-indol-5-yl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one,0.0844,uM,=,-1.0736575533743449,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2[nH]ccc2c1
5558,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,CC(C)N(CCS/C(=N\O)C(=O)c1ccc(Cl)cc1)C(C)C.Cl,2-(4-Chloro-phenyl)-N-hydroxy-2-oxo-thioacetimidic acid 2-diisopropylamino-ethyl ester hydrochloride,330.0,uM,=,2.5185139398778875,1,c1ccccc1
5559,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,CC1Cc2ccc(F)cc2C1=O,6-Fluoro-2-methyl-indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5560,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCN1CC[C@H]2c3cc(OC(=O)NC)ccc3CC21,"(+/-)-Methyl-carbamic acid 1-ethyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.253,uM,=,-0.5968794788241821,0,c1ccc2c(c1)CC1NCC[C@@H]21
5561,1521690,10.1039/C4MD00225C,,,,Inhibition of AChE from human erythrocytes,CC[N+]1(Cc2ccccc2[N+](=O)[O-])CCCCCC[N+](CC)(Cc2ccccc2[N+](=O)[O-])CCCCCn2c(=O)cc(C)n(c2=O)CCCCC1.[Br-].[Br-],"7,14-diethyl-21-methyl-7,14-bis(2-nitrobenzyl)-23,24-dioxo-1,20-diaza-7,14-diazoniabicyclo[18.3.1]tetracos-21-ene bromide",0.059,uM,=,-1.2291479883578558,0,O=c1ccn2c(=O)n1CCCCC[NH+](Cc1ccccc1)CCCCCC[NH+](Cc1ccccc1)CCCCC2
5562,2215336,10.1016/j.bmc.2022.116742,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition and measured for 12 mins by DTNB reagent based Ellman's method,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,"3-(4-benzylpiperazin-1-yl)-N-(9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-7-yl)propanamide",3.29,uM,=,0.5171958979499743,1,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1ccc2nc3n(c(=O)c2c1)CCC3
5563,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3=CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC,"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophene-2-carbonyl)-1-methyl-1,2,3,6-tetrahydro-pyridinium",0.52,uM,=,-0.2839966563652008,0,O=C(C1=CC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
5564,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,Cc1c2[nH]c3ccc(O)cc3c2cc[n+]1C,"6-hydroxy-1,2-dimethyl-9H-beta-carbolin-2-ium",1.0,uM,=,0.0,0,c1ccc2c(c1)[nH]c1c[nH+]ccc12
5565,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,O=c1ccoc2ccc(Oc3ccccc3)cc12,6-phenoxy-4H-chromen-4-one,3.0,uM,=,0.4771212547196624,1,O=c1ccoc2ccc(Oc3ccccc3)cc12
5566,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,CCN(CC)CCCOc1ccc2nc3n(c(=O)c2c1)CCCC3,"2-(3-(Diethylamino)propoxy)-8,9-dihydro-6H-pyrido[2,1-b]quinazolin-11(7H)-one",1.5,uM,=,0.1760912590556812,1,O=c1c2ccccc2nc2n1CCCC2
5567,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=[N+]([O-])OCCCCCCNCCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(6'-(nitrooxy)hexyl)-gamma-aminobutylamino]-1,2,3,4-tetrahydroacridine",0.0181,uM,=,-1.7423214251308154,0,c1ccc2nc3c(cc2c1)CCCC3
5568,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,COc1ccc(NC(=O)c2coc3ccc(/C=C/C(=O)O)cc3c2=O)cc1,(E)-3-(3-((4-Methoxyphenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylic acid,8.7,uM,=,0.9395192526186184,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5569,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(3-Morpholin-4-yl-propyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",3.8,uM,=,0.5797835966168101,1,O=C(NCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5570,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1cccs1,(S)-hexyl 5-(2-(1-benzylpiperidin-4-yl)ethylamino)-5-oxo-2-(thiophene-2-carboxamido)pentanoate,0.5,uM,=,-0.3010299956639812,0,O=C(CCCNC(=O)c1cccs1)NCCC1CCN(Cc2ccccc2)CC1
5571,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Cc1cc(-c2c3ccccc3[n+](C)c3ccccc23)cc(C)c1O.F[B-](F)(F)F,"9-(4-hydroxy-3,5-dimethylphenyl)-10-methylacridinium tetrafluoroborate",49.8,uM,=,1.6972293427597176,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5572,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,CCN(CC)CCCOc1ccc2nc3n(c(=O)c2c1)CCC3,"7-(3-(Diethylamino)propoxy)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one",1.2,uM,=,0.0791812460476248,1,O=c1c2ccccc2nc2n1CCC2
5573,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(CCC(=O)NCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3-(3,4,5-trimethoxyphenyl)-N-(5-oxo-5-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-pentyl)propanamide",0.059,uM,=,-1.2291479883578558,0,O=C(CCc1ccccc1)NCCCCC(=O)NNc1c2c(nc3ccccc13)CCCC2
5574,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,C=C(C)[C@H](O)CC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C3=C(O[C@H](C(C)(C)O)C3)[C@@]1(C(=O)C(C)C)C2=O,32-epi-Hyperforatin A,19.6,uM,=,1.292256071356476,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5575,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCCN(CCC1CCCCCC1)Cc1cc2ccccc2cc1O,3-((Butyl(2-cycloheptylethyl)amino)methyl)naphthalen-2-ol,18.623,uM,=,1.2700496432671604,1,c1ccc2cc(CNCCC3CCCCCC3)ccc2c1
5576,1826274,10.1039/C8MD00384J,,,,Inhibition of AChE (unknown origin),O=C(/C=C/c1ccc([N+](=O)[O-])cc1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,"3-(4-nitrophenyl)-N-(6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)acrylamide",0.0027,uM,=,-2.5686362358410126,0,O=C(/C=C/c1ccccc1)NCCCCCCNc1c2c(nc3ccccc13)CCCC2
5577,28614,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 7.5-19.5,C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CCCC)cc21.Cl,Butyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,11.6,uM,=,1.0644579892269186,1,c1ccc2c(c1)CCC2
5578,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)C2N3)cc1,"(4-Isopropyl-phenyl)-carbamic acid (S)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",2.02,uM,=,0.3053513694466238,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
5579,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(Nc3ncccc3[N+](=O)[O-])c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-4,6-dinitro-N'-(3-nitro-pyridin-2-yl)-benzene-1,3-diamine",0.65,uM,=,-0.1870866433571444,0,c1ccc(Nc2cccc(NCCSCc3ccco3)c2)nc1
5580,1500860,10.1016/j.bmc.2015.04.080,,,,Inhibition of AChE (unknown origin) using acetylthiocholine as substrate assessed as substrate hydrolysis by spectrophotometric/Ellman method,CC1(C)C(=O)CC[C@@]2(C)[C@H]1CC[C@@]1(C)CC3=CC(=O)[C@H]4C(C)(C)[C@H](O)CC[C@]4(C)[C@H]3CC[C@@H]12,"21beta-hydroxyserrat-14-en-3,16-dione",10.67,uM,=,1.02816441942447,1,O=C1CCC2[C@@H](CCC3CC4=CC(=O)[C@H]5CCCCC5[C@H]4CC[C@@H]32)C1
5581,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CN(C(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C)c1ccccc1,"Methyl-phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.285,uM,=,-0.5451551399914898,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5582,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(Oc3ccc([N+](=O)[O-])cc3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-[2,4-dinitro-5-(4-nitro-phenoxy)-phenyl]-amine",0.27,uM,=,-0.5686362358410126,0,c1ccc(Oc2cccc(NCCSCc3ccco3)c2)cc1
5583,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,C[C@@]12CCN(Cc3ccccc3)[C@@H]1N(Cc1ccccc1)c1ccc(OC(=O)Nc3ccccc3)cc12,"(3aS,8aR)-1,8-dibenzyl-3a-methyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate",41.13,uM,=,1.6141587095091752,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN(Cc3ccccc3)[C@@H]1N2Cc1ccccc1
5584,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,O=C(O)/C=C/c1ccc2occ(C(=O)Nc3ccccc3)c(=O)c2c1,(E)-3-(4-Oxo-3-(phenylcarbamoyl)-4H-chromen-6-yl)acrylic acid,9.25,uM,=,0.9661417327390326,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5585,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,COc1c(C(=O)CCC2CCN(CC3CCCCC3)CC2)ccc2[nH]ccc12,3-[1-(Cyclohexylmethyl)-4-piperidyl]-1-(4-methoxy-1Hindol-5-yl)propan-1-one,0.04,uM,=,-1.3979400086720375,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2[nH]ccc2c1
5586,936734,10.1016/j.bmc.2012.10.045,,,,Inhibition of acetylcholinesterase (unknown origin),COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.002,uM,=,-2.6989700043360187,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5587,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CCCN1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,N-(Naphth-1-ylmethyl)-2-(4-propylpiperazin-1-yl)-pyrimidin-4-amine,19.0,uM,=,1.2787536009528289,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
5588,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,5-Bis(isoquinolinium)-pent-1,5-diyl dibromide",13.0,uM,=,1.1139433523068367,1,c1ccc2c[n+](CCCCC[n+]3ccc4ccccc4c3)ccc2c1
5589,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC(C)N1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,N-Benzhydryl-2-(4-isopropylpiperazin-1-yl)pyrimidin-4-amine,20.3,uM,=,1.307496037913213,1,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1
5590,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,c1ccc(C(Nc2ccnc(N3CCN(C4CCCCC4)CC3)n2)c2ccccc2)cc1,N-benzhydryl-2-(4-cyclohexylpiperazin-1-yl)pyrimidin-4-amine,10.0,uM,=,1.0,1,c1ccc(C(Nc2ccnc(N3CCN(C4CCCCC4)CC3)n2)c2ccccc2)cc1
5591,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Clc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)cc1,N-(1-benzylpiperidin-4-yl)-1-(4-chlorophenyl)methanimine,1.5,uM,=,0.1760912590556812,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5592,2231701,10.1016/j.bmcl.2022.128574,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate incubated for 15 mins by DTNB reagent based Ellman's method,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3o2)cc1,"2-(4-((Ethyl(methyl)carbamoyl)oxy)phenyl)-4-oxo-4H-chromene-5,7-diyl bis(ethyl(methyl)carbamate)",12.3,uM,=,1.089905111439398,1,O=c1cc(-c2ccccc2)oc2ccccc12
5593,28304,10.1021/jm00086a011,,,,In vitro inhibitory activity against human Acetylcholinesterase,CCN1CC[C@@]2(C)c3cc(OC(=O)NC)ccc3CC12,"(+/-)-Methyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.038,uM,=,-1.42021640338319,0,c1ccc2c(c1)CC1NCCC21
5594,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCC(=O)NCc4cc[nH]c(=O)c4)c3C(C1)C2,"9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]-N-[(2-oxo-1,2-dihydro-4-pyridyl)methyl]nonanamide",0.00063,uM,=,-3.2006594505464183,0,O=C(CCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1cc[nH]c(=O)c1
5595,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1.[Cl-].[Cl-],4-(aminocarbonyl)-1-({[1-chloro-2-[(E)-(hydroxyimino)methyl]pyridinium-1(2H)-yl]methoxy}methyl)pyridinium chloride,460.0,uM,=,2.6627578316815743,1,c1cc[n+](COC[n+]2ccccc2)cc1
5596,1432884,10.1021/np500558b,,,,Inhibition of AChE (unknown origin) assessed as inhibition of acetylcholine hydrolysis preincubated for 15 mins by Ellman method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one hydrochloride",0.02,uM,=,-1.6989700043360187,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5597,1454323,10.1016/j.bmc.2014.04.019,,,,Inhibition of acetylcholine esterase (unknown origin),O=C(C[n+]1ccccc1)N/N=C/c1ccc(/C=N/NC(=O)C[n+]2ccccc2)cc1.[Cl-].[Cl-],"1,1'-(2,2'-2,2'-(1,4-phenylenebis(methan-1-yl-1-ylidene))bis(hydrazin-1-yl-2-ylidene)bis(2-oxoethane-2,1-diyl))dipyridinium chloride",0.0023,uM,=,-2.638272163982407,0,O=C(C[n+]1ccccc1)N/N=C/c1ccc(/C=N/NC(=O)C[n+]2ccccc2)cc1
5598,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3ccc(Cl)cc3)cc(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(2-((4-chlorophenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,0.86,uM,=,-0.0655015487564322,0,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5599,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 2",1.09667,uM,=,0.0400759632723236,1,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5600,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CCC)C1C2,"(+/-)-Heptyl-carbamic acid 1-propyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.629,uM,=,-0.201349354554731,0,c1ccc2c(c1)CC1NCC[C@@H]21
5601,1454323,10.1016/j.bmc.2014.04.019,,,,Inhibition of acetylcholine esterase (unknown origin),C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-],"N,N,N',N'-Tetramethyl-decane-1,10-diammonium; dibromide",1.0,uM,=,0.0,0,
5602,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,COCCN1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,N-Benzhydryl-2-[4-(2-methoxyethyl)piperazin-1-yl]pyrimidin-4-amine,39.2,uM,=,1.5932860670204574,1,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1
5603,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,CCN(CC)CCCOc1ccc2nc3n(c(=O)c2c1)Cc1ccccc1-3,"8-(3-(Diethylamino)propoxy)isoindolo[1,2-b]quinazolin-10(12H)-one",0.2,uM,=,-0.6989700043360187,0,O=c1c2ccccc2nc2n1Cc1ccccc1-2
5604,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 11",0.00461,uM,=,-2.336299074610352,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5605,1729471,10.1021/acs.jnatprod.7b00847,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate pretreated for 20 mins followed by substrate addition measured after 30 mins by Ellman's method,CC1(c2nccc3cc4c(cc23)OCO4)OC(O)c2c1ccc1c2OCO1,Mucroniferanine F,11.3,uM,=,1.0530784434834195,1,c1cc2cc3c(cc2c(C2OCc4c2ccc2c4OCO2)n1)OCO3
5606,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCCN(CCCC)CCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(5-(Dibutylamino)pentyloxy)phenyl)-3-phenylprop-2-en-1-one,76.87,uM,=,1.8857568810692675,1,O=C(/C=C/c1ccccc1)c1ccccc1
5607,2233511,10.1016/j.bmcl.2022.128722,,,,Inhibition of AChE (unknown origin) using acetylcholine iodide as substrate incubated for 10 mins by Ellman's method,CCC(c1ccc(O)c(OC)c1)c1ccc(OC)cc1O,4-(1-(2-hydroxy-4-methoxyphenyl)propyl)-2-methoxyphenol,4.76,uM,=,0.6776069527204931,1,c1ccc(Cc2ccccc2)cc1
5608,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)CC3CCC(O)C[N+](C)(Cc4ccccc4)CC3)sc2cc1OC,"1-Benzyl-6-[2-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-2-oxo-ethyl]-3-hydroxy-1-methyl-azocanium",0.38,uM,=,-0.4202164033831898,0,O=C(CC1CCCC[NH+](Cc2ccccc2)CC1)c1cc2ccccc2s1
5609,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COC(=O)C[N+]1(C)CCC(CCC(=O)C2Cc3cc(OC)c(OC)cc3S2)CC1,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methoxycarbonylmethyl-1-methyl-piperidinium",0.054,uM,=,-1.2676062401770316,0,O=C(CCC1CC[NH2+]CC1)C1Cc2ccccc2S1
5610,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,O=C(CCC1CCN(CC2CCCC2)CC1)c1ccc2[nH]ccc2c1,3-[1-(Cyclopentylmethyl)-4-piperidyl]-1-(1H-indol-5-yl)propan-1-one,0.094,uM,=,-1.0268721464003014,0,O=C(CCC1CCN(CC2CCCC2)CC1)c1ccc2[nH]ccc2c1
5611,28612,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 7.3-50.4,C#CCN(C)CCc1cccc(OC(=O)N(C)CC)c1,Ethyl-methyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-ethyl]-phenyl ester,16.6,uM,=,1.2201080880400552,1,c1ccccc1
5612,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@H](C1)C2.Cl,"(-)-N-{9-[((7S,11S)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]nonyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.00239,uM,=,-2.6216020990518625,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)C[C@H]1C=CC[C@@H]2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5613,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,O=c1c2cc(OCCCn3ccnc3)ccc2nc2n1CCCc1ccccc1-2,"11-(3-(1H-Imidazol-1-yl)propoxy)-6,7-dihydrobenzo[3,4]azepino[2,1-b]quinazolin-9(5H)-one",56.5,uM,=,1.7520484478194385,1,O=c1c2cc(OCCCn3ccnc3)ccc2nc2n1CCCc1ccccc1-2
5614,28607,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 5.96-26.7,C#CCNC1CCc2ccc(OC(=O)N(C)CCCC)cc21.Cl,Butyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,11.3,uM,=,1.0530784434834195,1,c1ccc2c(c1)CCC2
5615,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,CC[N+](C)(C)c1cccc(O)c1.[Cl-],Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium chloride,5.17,uM,=,0.7134905430939426,1,c1ccccc1
5616,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,O=C(CCCCC1CCSS1)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [7-(1,2,3,4-tetrahydro-acridin-9-ylamino)-heptyl]-amide",0.0327,uM,=,-1.485452247339714,0,O=C(CCCCC1CCSS1)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2
5617,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CCCCCn1nc(OCc2ccc3ccccc3c2)c2cc([N+](=O)[O-])ccc21,3-(2-Naphthylmethoxy)-5-nitro-1-pentylindazole,8.2,uM,=,0.9138138523837168,1,c1ccc2cc(COc3n[nH]c4ccccc34)ccc2c1
5618,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CCc1cc[n+](C)cc1)C2,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-methyl-pyridinium",0.9,uM,=,-0.0457574905606751,0,O=C(CCc1cc[nH+]cc1)C1Cc2ccccc2S1
5619,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,Cc1ccc(CN2CCC(CC(=O)NCCc3c[nH]c4ccccc34)CC2)cc1,N-(2-(1H-Indol-3-yl)ethyl)-2-(1-(4-methylbenzyl)piperidin-4-yl)acetamide,4.94,uM,=,0.693726948923647,1,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12
5620,2027088,10.1021/acs.jmedchem.6b01178,,,,Inhibition of AChE in human erythrocyte hemo-lyzates pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's method,COc1ccc2nc3c(c(NCCCCCCCN(CC(=O)NCCc4c[nH]c5ccc(OC)cc45)C(=O)/C=C/c4ccc(O)c(OC)c4)c2c1)CCCC3,"(E)-3-(4-Hydroxy-3-methoxyphenyl)-N-(7-((7-methoxy-1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)-N-(2-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-2-oxoethyl)acrylamide",1.29,uM,=,0.1105897102992489,1,O=C(CN(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)C(=O)/C=C/c1ccccc1)NCCc1c[nH]c2ccccc12
5621,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0356,uM,=,-1.448550002027125,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5622,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4ccc(C)cc4)CC3)c2c1,N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-2-(1-(4-methylbenzyl)piperidin-4-yl)acetamide,9.26,uM,=,0.9666109866819343,1,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12
5623,2215159,10.1016/j.ejmech.2022.114255,,,,Inhibition of AChE (unknown origin) preincubated for 5 mins followed by BuCh addition measured after 5 mins by Ellman's method,COc1ccccc1/C=C/C=C(\Br)S(=O)(=O)F,"1-bromo-4-(2-methoxyphenyl)buta-1,3-diene-1-sulfonyl fluoride",0.079,uM,=,-1.1023729087095586,0,c1ccccc1
5624,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1N2Cc1ccccc1,"o-Tolyl-carbamic acid (S)-8-benzyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.1,uM,=,-1.0,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2Cc1ccccc1
5625,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,c1ccc2c(c1)CN1CCCC1=N2,"1,2,3,9-Tetrahydro-pyrrolo[2,1-b]quinazoline",3.72,uM,=,0.5705429398818975,1,c1ccc2c(c1)CN1CCCC1=N2
5626,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4cc(Cl)ccc4c(Cl)c3C(C1)C2,"(+/-)-3,12-Dichloro-6,7,10,11-tetrahydro-9-ethyl-7,11-ethano-cyclooctan[b]quinoline",19.200000000000003,uM,=,1.2833012287035497,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5627,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,c1ccc2c(c1)CN1CCCCCC1=N2,"6,7,8,9,10,12-Hexahydro-azepino[2,1-b]quinazoline",3.76,uM,=,0.5751878449276611,1,c1ccc2c(c1)CN1CCCCCC1=N2
5628,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CCCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(-)-Octyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.016,uM,=,-1.7958800173440752,0,c1ccc2c(c1)N[C@H]1NCCC21
5629,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CCN(CC)CCCOc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(3-diethylaminopropoxy)phenyl]methanone,0.025,uM,=,-1.6020599913279625,0,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
5630,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C(NCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)=CC(=O)c2c(O)cccc21,"2-(3-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)propylamino)-5-hydroxynaphthalene-1,4-dione",0.00924,uM,=,-2.034328028779893,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5631,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccc([N+](=O)[O-])cc1,1-Methyl-4-nitro-benzene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5632,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(OCCCN3CCOCC3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(3-morpholin-4-ylpropoxy)phenyl]methanone,0.107,uM,=,-0.9706162223147904,0,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc(OCCCN2CCOCC2)cc1
5633,28610,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 6.4-45.9,C#CCNC1CCc2ccc(OC(=O)N(C)CCC)cc21.Cl,Methyl-propyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,14.6,uM,=,1.1643528557844371,1,c1ccc2c(c1)CCC2
5634,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CC(C)c1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(2-Isopropyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.015,uM,=,-1.8239087409443189,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5635,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1ccc2c(c1)C(=O)C(C)C2,6-Methoxy-2-methyl-indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5636,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(7-Morpholin-4-yl-heptyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.38,uM,=,-0.4202164033831898,0,O=C(NCCCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5637,28162,10.1021/jm00122a035,,,,Concentration of compound that reversibly inhibits acetylcholinesterase (AChE) by 50 %,C#CCCCC[n+]1ccccc1/C=N/O.[Cl-],1-Hex-5-ynyl-2-(hydroxyimino-methyl)-pyridinium chloride,61.5,uM,=,1.7888751157754168,1,c1cc[nH+]cc1
5638,1654014,10.1016/j.ejmech.2016.12.009,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate measured after 15 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)c(O)c1)O2,"(Z)-2-(4-((benzyl(methyl)amino)methyl)-3-hydroxybenzylidene)-5,6-dimethoxybenzofuran-3(2H)-one",26.3,uM,=,1.4199557484897578,1,O=C1/C(=C/c2ccc(CNCc3ccccc3)cc2)Oc2ccccc21
5639,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CCC[N+](C)(Cc4ccc([N+](=O)[O-])o4)CC3)sc2cc1OC.[I-],"4-(5,6-Dimethoxy-benzo[b]thiophene-2-carbonyl)-1-methyl-1-(5-nitro-furan-2-ylmethyl)-azepanium",0.032,uM,=,-1.494850021680094,0,O=C(c1cc2ccccc2s1)C1CCC[NH+](Cc2ccco2)CC1
5640,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)c(C)cn2Nc1ccncc1F,Methyl-carbamic acid 1-(3-fluoro-pyridin-4-ylamino)-3-methyl-1H-indol-5-yl ester,0.1,uM,=,-1.0,0,c1ccc2c(c1)ccn2Nc1ccncc1
5641,1982755,10.1021/acsmedchemlett.9b00656,,,,Inhibition of human AChE using acetylthiocholineiodide as substrate measured for every 30 sec for 5 mins by Ellman's method,COc1cc2cc(NC(=O)C3CCN(Cc4ccccc4)CC3)c(=O)oc2cc1OC,"1-benzyl-N-(6,7-dimethoxy-2H-2-oxochromen-3-yl)piperidine-4-carboxamide",0.223,uM,=,-0.6516951369518393,0,O=C(Nc1cc2ccccc2oc1=O)C1CCN(Cc2ccccc2)CC1
5642,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OCCN(C)C)C(c2ccccc2)c2c(nc3c(c2N)CC(F)(F)CC3)N1,"US9284330, S28",0.136,uM,=,-0.8664610916297825,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5643,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C(Cl)=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,"2-Chloro-3-[2-(1,2,3,4-tetrahydroacridin-9-yl-amino)ethyl]-amino-1,4-naphthoquinone",0.0960999999999999,uM,=,-1.0172766123314547,0,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5644,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0567,uM,=,-1.2464169411070931,0,c1ccc2c(c1)N[C@H]1NCCC21
5645,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2[nH]ccc2c1,3-[1-(Cyclohexylmethyl)-4-piperidyl]-1-(1H-indol-5-yl)propan-1-one,0.051,uM,=,-1.2924298239020635,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2[nH]ccc2c1
5646,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,C[n+]1c2ccccc2c(-c2cccs2)c2ccccc21.F[B-](F)(F)F,10-methyl-9-(thiophen-2-yl)acridinium tetrafluoroborate,40.9,uM,=,1.611723308007342,1,c1csc(-c2c3ccccc3[nH+]c3ccccc23)c1
5647,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",COC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CCCC3Cl,"US9284330, S20",0.732,uM,=,-0.1354889189416081,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5648,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1cc2c(cc1O)CC(C)C2=O,5-Hydroxy-6-methoxy-2-methyl-indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5649,1826274,10.1039/C8MD00384J,,,,Inhibition of AChE (unknown origin),O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1c2ccccc2nc2ccccc12,"N-(5-(1,2,3,4-tetrahydroacridin-9-ylamino)pentyl)acridine-9-carboxamide",7.599999999999999e-06,uM,=,-5.119186407719209,0,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1c2ccccc2nc2ccccc12
5650,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12,"(-)-Phenyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.021,uM,=,-1.6777807052660807,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5651,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)Cc1cc2ccc(Cl)cc2s1,(S)-hexyl 5-(2-(1-benzylpiperidin-4-yl)ethylamino)-2-(2-(6-chlorobenzo[b]thiophen-2-yl)acetamido)-5-oxopentanoate,0.1,uM,=,-1.0,0,O=C(CCCNC(=O)Cc1cc2ccccc2s1)NCCC1CCN(Cc2ccccc2)CC1
5652,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1cc2c(c(OC)c1)C(=O)C(C)C2,"5,7-Dimethoxy-2-methyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5653,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CNC(=O)Oc1ccccc1OC(C)C,propoxur,2.3,uM,=,0.3617278360175928,1,c1ccccc1
5654,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CCN3CCOCC3)CC2)cc1,4-(2-{4-[bis(4-fluoro-phenyl)-methyl]piperazine-1-yl}-ethyl)-morpholine,0.2842,uM,=,-0.546375926408549,0,c1ccc(C(c2ccccc2)N2CCN(CCN3CCOCC3)CC2)cc1
5655,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COCC[N+]1(C)CCCC(C(=O)c2cc3cc(OC)c(OC)cc3s2)CC1,"4-(5,6-Dimethoxy-benzo[b]thiophene-2-carbonyl)-1-(2-methoxy-ethyl)-1-methyl-azepanium",0.053,uM,=,-1.275724130399211,0,O=C(c1cc2ccccc2s1)C1CCC[NH2+]CC1
5656,28295,10.1021/jm00108a019,,,,In vitro concentration of compound required for reversibly inhibiting 50% of human anticholinesterase activity,C[n+]1ccn(CCN2CCCC2)c1/C=N/O.[Cl-],2-[(E)-(hydroxyimino)methyl]-3-methyl-1-[2-(1lambda~5~-pyrrolidin-1-yl)ethyl]-1H-imidazol-3-ium chloride,17.9,uM,=,1.252853030979893,1,c1cn(CCN2CCCC2)c[nH+]1
5657,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2.Cl,(+/-)-huprine Y-HCl,0.00107,uM,=,-2.9706162223147903,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5658,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,N=c1c2ccc(Cl)cc2nc2n1CCCCC2,"3-Chloro-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-(12Z)-ylideneamine",1.26,uM,=,0.1003705451175629,1,N=c1c2ccccc2nc2n1CCCCC2
5659,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CCC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC,"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophene-2-carbonyl)-1-methyl-azepanium",0.008,uM,=,-2.096910013008056,0,O=C(c1cc2ccccc2s1)C1CCC[NH+](Cc2ccccc2)CC1
5660,28162,10.1021/jm00122a035,,,,Concentration of compound that reversibly inhibits acetylcholinesterase (AChE) by 50 %,C#CCCCC[n+]1cn(C)c(/C=N/O)n1.[Cl-],"1-Hex-5-ynyl-3-(hydroxyimino-methyl)-4-methyl-4H-[1,2,4]triazol-1-ium chloride",62.5,uM,=,1.7958800173440752,1,c1n[nH+]c[nH]1
5661,1551243,10.1021/acs.jnatprod.5b00600,,,,Inhibition of human acetylcholinesterase after 30 mins by microplate reader-based Ellman's method,C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,SID144205156,0.6,uM,=,-0.2218487496163563,0,C=C1C2CC=C[C@H]1Cc1[nH]c(=O)ccc12
5662,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCCN(CCCC)CCCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(6-(Dibutylamino)hexyloxy)phenyl)-3-phenylprop-2-en-1-one,162.59,uM,=,2.2110938310589634,1,O=C(/C=C/c1ccccc1)c1ccccc1
5663,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,OCCN1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,2-[4-(4-[Benzhydrylamino]pyrimidin-2-yl)piperazin-1-yl]ethanol,21.6,uM,=,1.334453751150931,1,c1ccc(C(Nc2ccnc(N3CCNCC3)n2)c2ccccc2)cc1
5664,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,C[N+](C)(CCNC(=O)C(=O)NCC[N+](C)(C)Cc1ccccc1Cl)Cc1ccccc1Cl.[Cl-].[Cl-],Ambenonium dichloride,0.0007,uM,=,-3.154901959985743,0,O=C(NCC[NH2+]Cc1ccccc1)C(=O)NCC[NH2+]Cc1ccccc1
5665,28631,10.1021/jm0340602,,,,Inhibitory potency was evaluated against recombinant human AChE,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.0231,uM,=,-1.6363880201078556,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5666,590772,10.1021/jm901123n,,,,Inhibition of human recombinant AChE by Ellman's method,CCN(CCCNC1=CC(=O)C(NCCCCCCNC(=O)CCCCC2CCSS2)=CC1=O)Cc1ccccc1OC,"5-[1,2]Dithiolan-3-yl-pentanoic acid [6-(4-{3-[ethyl-(2-methoxy-benzyl)-amino]-propylamino}-3,6-dioxo-cyclohexa-1,4-dienylamino)-hexyl]-amide",0.16,uM,=,-0.7958800173440752,0,O=C(CCCCC1CCSS1)NCCCCCCNC1=CC(=O)C(NCCCNCc2ccccc2)=CC1=O
5667,1729471,10.1021/acs.jnatprod.7b00847,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate pretreated for 20 mins followed by substrate addition measured after 30 mins by Ellman's method,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.9,uM,=,0.2787536009528289,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5668,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.12,uM,=,-0.9208187539523752,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5669,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CC(F)(F)CC3,"US9284330, S18",0.504,uM,=,-0.2975694635544747,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5670,936728,10.1016/j.bmc.2012.10.045,,,,Inhibition of human acetylcholinesterase,COc1cc2cc(NC(=O)[C@H]3CCC[C@@H](NCc4ccccc4)C3)c(=O)oc2cc1OC,"cis-3-(Benzylamino)cyclohexanecarboxylic acid(6,7-dimethoxy-2-oxo-2H-chromen-3-yl)-amide",0.043,uM,=,-1.3665315444204136,0,O=C(Nc1cc2ccccc2oc1=O)[C@H]1CCC[C@@H](NCc2ccccc2)C1
5671,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC1CCN(c2nccc(NC(c3ccccc3)c3ccccc3)n2)CC1,N-Benzhydryl-2-(methylpiperidin-1-yl)pyrimidin-4-amine,32.2,uM,=,1.507855871695831,1,c1ccc(C(Nc2ccnc(N3CCCCC3)n2)c2ccccc2)cc1
5672,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCCN(CCCC)CCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(3-(Dibutylamino)propoxy)phenyl)-3-phenylprop-2-en-1-one,151.83,uM,=,2.18135759202845,1,O=C(/C=C/c1ccccc1)c1ccccc1
5673,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4cnccc4c(N)c3C(C1)C2,"(+/-)-11-Amino-8-ethyl-5,6,9,10-tetrahydro-6,10-methanocyclooctabenzo[b][1,7]naphthyridine",0.6639999999999999,uM,=,-0.1778319206319825,0,C1=CC2Cc3nc4cnccc4cc3C(C1)C2
5674,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]benzamide hydrochloride",0.295,uM,=,-0.530177984021837,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5675,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(7-oxo-7-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)heptyl)-benzamide",0.00565,uM,=,-2.2479515521805613,0,O=C(CCCCCCNC(=O)c1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5676,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1cc(=O)c2cc(O)ccc2o1,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-decyl}-6-hydroxy-4-oxo-4H-chromene-2-carboxamide hydrochloride",0.001,uM,=,-3.0,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5677,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",22.0,uM,=,1.3424226808222062,1,c1ccc2c(c1)N[C@H]1NCCC21
5678,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,COc1cc(O)c2c(=O)cc(C(=O)NCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc2c1.Cl,"5-Hydroxy-7-methoxy-4-oxo-N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4H-chromene-2-carboxamide hydrochloride",0.001,uM,=,-3.0,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5679,1432884,10.1021/np500558b,,,,Inhibition of AChE (unknown origin) assessed as inhibition of acetylcholine hydrolysis preincubated for 15 mins by Ellman method,CNc1ccccc1-c1nc(C(N)=O)cs1,Anithiactin B,53.0,uM,=,1.7242758696007892,1,c1ccc(-c2nccs2)cc1
5680,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@@]2(CC=C(C)C)C(=O)[C@]1(C(=O)C(C)C)C(=O)C1=C2O[C@H](C(C)(C)O)[C@H]1O,Hyperforatin J,18.55,uM,=,1.2683439139510646,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5681,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(4-Morpholin-4-yl-butyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",21.0,uM,=,1.3222192947339193,1,O=C(NCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5682,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](CCCC[n+]3ccc4ccccc4c3)ccc2c1,"1,4-Bis(isoquinolinium)-but-1,4-diyl dibromide",36.0,uM,=,1.5563025007672873,1,c1ccc2c[n+](CCCC[n+]3ccc4ccccc4c3)ccc2c1
5683,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Oc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)c(O)c1,"4-(((1-Benzylpiperidin-4-yl)imino)methyl)benzene-1,3-diol",2.6,uM,=,0.414973347970818,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5684,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCCC(C)n1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-(pentan-2-yl)-1H-pyrazol-4-yl)ethan-1-one",0.149,uM,=,-0.826813731587726,0,c1cn[nH]c1
5685,28616,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 7.99-27.5,C#CC(C)NCCc1cccc(OC(=O)N(C)CC)c1,Ethyl-methyl-carbamic acid 3-[2-(1-methyl-prop-2-ynylamino)-ethyl]-phenyl ester,13.9,uM,=,1.1430148002540952,1,c1ccccc1
5686,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Hexyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.233,uM,=,-0.632644078973981,0,c1ccc2c(c1)CC1NCCC21
5687,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1,"p-Tolyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.14,uM,=,-0.8538719643217619,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5688,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Oc1ccccc1CNC1CCN(Cc2ccccc2)CC1,2-(((1-Benzylpiperidin-4-yl)amino)methyl)phenol,2.4,uM,=,0.380211241711606,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5689,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,CN(C)C(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(-)-Dimethyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.21,uM,=,-0.6777807052660807,0,c1ccc2c(c1)N[C@H]1NCCC21
5690,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Cc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)cc1,N-(1-benzylpiperidin-4-yl)-1-(p-tolyl)methanimine,4.4,uM,=,0.6434526764861874,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5691,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cc1cc(=NCCC2CCN(Cc3ccccc3)CC2)[nH]nc1-c1ccccc1.Cl.Cl.O,[2-(1-Benzyl-piperidin-4-yl)-ethyl]-(5-methyl-6-phenyl-pyridazin-3-yl)-amine dihydrochloride hydrate,0.039,uM,=,-1.408935392973501,0,c1ccc(CN2CCC(CCN=c3ccc(-c4ccccc4)n[nH]3)CC2)cc1
5692,2201087,10.1016/j.ejmech.2020.113073,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins by DTNB reagent based Ellman's method,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc(F)cc3)cc1)OC2.[Br-],"4-((6,7-dimethoxy-4-oxoisochroman-3-ylidene)methyl)-1-(4-fluorobenzyl)pyridin-1-ium bromide",0.00015,uM,=,-3.823908740944319,0,O=C1/C(=C/c2cc[n+](Cc3ccccc3)cc2)OCc2ccccc21
5693,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CCN(CC)CCc1ccc(Oc2ccc(C(=O)c3ccc(CN(C)Cc4ccccc4)cc3)cc2)cc1,{4-[(Benzylmethylaminomethyl]phenyl}-{4-[4-(2-diethylaminoethyl)phenoxy]phenyl}methanone,0.13,uM,=,-0.8860566476931633,0,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc(Oc2ccccc2)cc1
5694,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,Cc1cc(C(=O)CCC2CC[N+](C)(Cc3ccccc3)CC2)nn1-c1ccccc1,"1-Benzyl-4-[3-(2,5-dimethyl-1-phenyl-1H-pyrazol-3-yl)-3-oxo-propyl]-1-methyl-piperidinium",0.022,uM,=,-1.6575773191777938,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccn(-c2ccccc2)n1
5695,1812363,10.1016/j.bmc.2018.12.023,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 secs for 1 hr by Ellman's assay,COc1ccc(-c2cc(=O)c3cc(OC)c(O)c([C@H]4CCC(=O)N4)c3o2)cc1,R-(-)-leucoflavonine,18.3,uM,=,1.2624510897304295,1,O=C1CC[C@H](c2cccc3c(=O)cc(-c4ccccc4)oc23)N1
5696,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,COc1ccc(OC)c2c1CC(C)C2=O,"4,7-Dimethoxy-2-methyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5697,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,COc1ccc(OCC(=O)NCC2CCN(Cc3ccccc3)CC2)cc1,N-((1-Benzylpiperidin-4-yl)methyl)-2-(4-methoxyphenoxy)acetamide,0.88,uM,=,-0.0555173278498313,0,O=C(COc1ccccc1)NCC1CCN(Cc2ccccc2)CC1
5698,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.5,uM,=,-0.3010299956639812,0,c1ccc2c(c1)N[C@H]1NCCC21
5699,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,COc1c(C(=O)CCC2CCN(CC3CCCCC3)CC2)cc(Cl)c2c1ccn2S(=O)(=O)c1ccccc1.O=C(O)/C=C/C(=O)O,1-[1-(Benzenesulfonyl)-7-chloro-4-methoxy-indol-5-yl]-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one,0.559,uM,=,-0.2525881921135766,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2c(ccn2S(=O)(=O)c2ccccc2)c1
5700,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCCN(CCCC)CCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(4-(Dibutylamino)butoxy)phenyl)-3-phenylprop-2-en-1-one,21.94,uM,=,1.3412366232386923,1,O=C(/C=C/c1ccccc1)c1ccccc1
5701,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [3-(6-chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-amide",0.000253,uM,=,-3.596879478824182,0,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2
5702,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[9-(1,2,3,4-tetrahydroacridin-9-ylamino)nonyl]benzamide hydrochloride",0.125,uM,=,-0.9030899869919436,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5703,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(CCC(=O)NCCCCCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3-(3,4,5-trimethoxyphenyl)-N-(6-oxo-6-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-hexyl)propanamide",0.00839,uM,=,-2.0762380391713,0,O=C(CCc1ccccc1)NCCCCCC(=O)NNc1c2c(nc3ccccc13)CCCC2
5704,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,COc1cc(CNC(=O)CCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccn1,"9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]-N-[(2-methoxy-4-pyridyl)methyl]nonanamide",0.00125,uM,=,-2.903089986991944,0,O=C(CCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)NCc1ccncc1
5705,28620,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 9.8-157,C#CCN(C)C(C)Cc1cccc(OC(=O)N(C)CCC)c1,Methyl-propyl-carbamic acid 3-[2-(methyl-prop-2-ynyl-amino)-propyl]-phenyl ester,33.1,uM,=,1.5198279937757189,1,c1ccccc1
5706,2134649,10.1016/j.ejmech.2021.113779,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCC(=O)N4CCNC(=O)C4)c3C(C1)C2,"4-(9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]nonanoyl)piperazin-2-one",0.00041,uM,=,-3.3872161432802645,0,O=C1CN(C(=O)CCCCCCCCNc2c3c(nc4ccccc24)CC2C=CCC3C2)CCN1
5707,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1cc2ccccc2s1,(S)-hexyl 2-(benzo[b]thiophene-2-carboxamido)-5-(2-(1-benzylpiperidin-4-yl)ethylamino)-5-oxopentanoate,0.27,uM,=,-0.5686362358410126,0,O=C(CCCNC(=O)c1cc2ccccc2s1)NCCC1CCN(Cc2ccccc2)CC1
5708,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CCN(CC)c1ccc(-c2c3ccccc3[n+](C)c3ccccc23)cc1.F[B-](F)(F)F,9-(4-(diethylamino)phenyl)-10-methylacridinium tetrafluoroborate,25.2,uM,=,1.4014005407815442,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5709,1431108,10.1016/j.bmcl.2014.10.025,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCNc4c5c(nc6cc(Cl)ccc46)C[C@@H]4C=C(C)C[C@H]5C4)c3[C@@H](C1)C2,"(+)-N,N'-bis[(7R,11R)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl]-1,6-hexanediamine",0.192,uM,=,-0.7166987712964504,0,C1=C[C@H]2Cc3nc4ccccc4c(NCCCCCCNc4c5c(nc6ccccc46)C[C@@H]4C=CC[C@H]5C4)c3[C@@H](C1)C2
5710,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1ccc(C)cc1,p-Xylene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5711,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(NC(=O)CN3CCOCC3)cc2)cc1,N-(4-{4-[(Benzylmethylamino)methyl]benzoyl}phenyl)-2-morpholin-4-yl-acetamide,0.72,uM,=,-0.1426675035687315,0,O=C(CN1CCOCC1)Nc1ccc(C(=O)c2ccc(CNCc3ccccc3)cc2)cc1
5712,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CC[N+](C)([O-])[C@@H]1N2C,"(3aS,8aS)-5-(2-ethylphenylcarbamoyloxy)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole 1-oxide",0.125,uM,=,-0.9030899869919436,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CC[NH2+][C@@H]1N2
5713,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2,"5-[1,2]Dithiolan-3-yl-pentanoic acid [3-(1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-amide",0.00696,uM,=,-2.157390760389438,0,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3ccccc13)CCCC2
5714,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,O=C(c1cnn(C2CCCC2)c1)C(F)F,"1-(1-cyclopentyl-1H-pyrazol-4-yl)-2,2-difluoroethan-1-one",0.208,uM,=,-0.6819366650372385,0,c1cnn(C2CCCC2)c1
5715,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,COc1ccc2nc3c(c(NCCCNC4=C(Cl)C(=O)c5ccccc5C4=O)c2c1)CCCC3,"2-Chloro-3-[3-(7-methoxy1,2,3,4-tetrahydroacridin-9-yl-amino)-propyl]amino-1,4-naphthoquinone",0.809,uM,=,-0.0920514783877276,0,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5716,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,Cc1cccc([N+](=O)[O-])c1,1-Methyl-3-nitro-benzene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5717,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cc12,"US8841453, 5",0.02005,uM,=,-1.6978856230437989,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5718,1431108,10.1016/j.bmcl.2014.10.025,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman method,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,"7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2(11),3,5,7,9,14-hexaen-3-amine",0.00061,uM,=,-3.214670164989233,0,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5719,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)C3CCN(Cc4ccccc4C)CC3)c2c1,N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-1-(2-methylbenzyl)piperidine-4-carboxamide,7.42,uM,=,0.8704039052790271,1,O=C(NCCc1c[nH]c2ccccc12)C1CCN(Cc2ccccc2)CC1
5720,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,Cl.Cl.O.c1ccc(CN2CCC(CCNc3cc4c(nn3)-c3ccccc3CCC4)CC2)cc1,"[2-(1-Benzyl-piperidin-4-yl)-ethyl]-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-amine dihydrochloride hydrate",0.12,uM,=,-0.9208187539523752,0,c1ccc(CN2CCC(CCNc3cc4c(nn3)-c3ccccc3CCC4)CC2)cc1
5721,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(-c2ccccc2)cc1)NCCN1CCN(Cc2ccccc2)CC1,"2-([1,1'-Biphenyl]-4-yloxy)-N-(2-(4-benzylpiperazin-1-yl)ethyl)acetamide",0.735,uM,=,-0.1337126609158051,0,O=C(COc1ccc(-c2ccccc2)cc1)NCCN1CCN(Cc2ccccc2)CC1
5722,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OCC2CC2)C(c2ccccc2Cl)c2c(nc3c(c2N)CC(C)(C)CC3)N1,"US9284330, S10",0.971,uM,=,-0.0127807700919951,0,O=C(OCC1CC1)C1=CNc2nc3c(cc2C1c1ccccc1)CCCC3
5723,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN[C@@H]1N2,"(3aS,8aR)-3a-methyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl o-tolylcarbamate",0.83,uM,=,-0.0809219076239261,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5724,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4c(nc5ccc(Cl)cc35)CCCC4)cc12,"US8841453, 12",0.03988,uM,=,-1.3992448503603818,0,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5725,1521690,10.1039/C4MD00225C,,,,Inhibition of AChE from human erythrocytes,CC[N+](CC)(CCCCCn1c(C)cc(=O)n(CCCCC[N+](CC)(CC)Cc2ccccc2[N+](=O)[O-])c1=O)Cc1ccccc1[N+](=O)[O-].[Br-].[Br-],"5,5'-(6-methyl-2,4-dioxopyrimidine-1,3(2H,4H)-diyl)bis(N,N-diethyl-N-(2-nitrobenzyl)pentan-1-aminium) bromide",0.00014,uM,=,-3.853871964321762,0,O=c1ccn(CCCCC[NH2+]Cc2ccccc2)c(=O)n1CCCCC[NH2+]Cc1ccccc1
5726,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1cc(Br)cs1,(S)-hexyl 5-(2-(1-benzylpiperidin-4-yl)ethylamino)-2-(4-bromothiophene-2-carboxamido)-5-oxopentanoate,0.18,uM,=,-0.744727494896694,0,O=C(CCCNC(=O)c1cccs1)NCCC1CCN(Cc2ccccc2)CC1
5727,28295,10.1021/jm00108a019,,,,In vitro concentration of compound required for reversibly inhibiting 50% of human anticholinesterase activity,C[n+]1ccn(COCC(C)(C)[N+](=O)[O-])c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-1-methyl-3-(2-methyl-2-nitro-propoxymethyl)-3H-imidazol-1-ium chloride,10.6,uM,=,1.0253058652647702,1,c1c[nH+]c[nH]1
5728,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 14",0.0011799999999999,uM,=,-2.9281179926938745,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5729,1641132,,,,,"Inhibition Assay: AChE inhibitory activity of compounds (Ia)-(Ie) and (-)-(Ib) and (+)-(Ib) was evaluated spectrophotometrically at 25 C. by the method of Ellman et al., using recombinant human AChE (hAChE) and Electrophorus electricus (ee) AChE and acetylthiocholine iodide as substrate (cf. G. L. Ellman et al., New and Rapid Colorimetric Determination of Acetylcholinesterase Activity Biochem. Pharmacol. 1961, vol. 7, pp. 88-95). For eeAChE inhibitory activity determination, the reaction took place in a final volume of 300 uL of 0.1 M phosphate-buffered solution pH 8.0, containing 0.03 unit/mL of ee AChE and 333 uM 5,5'-dithiobis(2-nitrobenzoic) acid (DTNB) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicates using at least 10 increasing concentrations of inhibitor and preincubating at 37 C. for 20 min. One duplicate sample without inhibitor was always present to yield 100% of AChE activity. Then, substrate acetylthiocholine (450 uM) was added and the reaction was developed at 37 C. for 5 min. The color production was measured at 414 nm.",CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@H](C1)C2,"US9238626, (-)-(Ib) HCl",0.0024,uM,=,-2.619788758288394,0,O=C(NCCCCCCCCCNc1c2c(nc3ccccc13)C[C@H]1C=CC[C@@H]2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5730,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CN(C)C1CCC(CCN(CCCc2c[nH]c3ccccc23)CCC2CCCCCC2)CC1,"4-(2-((3-(1H-Indol-3-yl)propyl)(2-cycloheptylethyl)amino)ethyl)-N,N-dimethylcyclohexan-1-amine",12.57,uM,=,1.0993352776859575,1,c1ccc2c(CCCN(CCC3CCCCCC3)CCC3CCCCC3)c[nH]c2c1
5731,2271742,10.1016/j.ejmech.2020.112792,,,,Inhibition of AChE (unknown origin),COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",1.0,uM,=,0.0,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5732,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(CCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"N'-1,2,3,4-tetrahydroacridin-9-yl-3-(3,4,5-trimethoxyphenyl)propanohydrazide",0.365,uM,=,-0.4377071355435253,0,O=C(CCc1ccccc1)NNc1c2c(nc3ccccc13)CCCC2
5733,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CN(C)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3ccccc3)cc(=O)c2c1,2-(Dimethylamino)ethyl (E)-3-(4-oxo-2-(phenylcarbamoyl)-4H-chromen-6-yl)acrylate,0.74,uM,=,-0.1307682802690238,0,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5734,973813,10.1021/np4003355,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 8 mins by Ellman's spectrophotometric method,C=C[C@@H]1[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,Huperzine C,0.489,uM,=,-0.3106911408763798,0,O=c1ccc2c([nH]1)C[C@@H]1C=CCC2C1
5735,2247716,10.1016/j.ejmech.2022.114248,,,,Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 1 to 30 mins followed by substrate addition by Ellman's method,CCCCN(CCc1c[nH]c2c(OC(=O)C(C)C)cccc12)CCC1CCCCCC1,3-(2-(Butyl(2-cycloheptylethyl)amino)ethyl)-1H-indol-7-yl dimethylcarbamate,1.368,uM,=,0.1360860973840974,1,c1ccc2c(CCNCCC3CCCCCC3)c[nH]c2c1
5736,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3c(c2)OCO3)CC1,"4-(3-Benzo[1,3]dioxol-5-yl-3-oxo-propyl)-1-benzyl-1-methyl-piperidinium",0.0415,uM,=,-1.3819519032879073,0,O=C(CCC1CC[NH+](Cc2ccccc2)CC1)c1ccc2c(c1)OCO2
5737,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,CC1=C(CCN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C(=O)C2CCCCC2=N1,"3-(2-{4-[bis(4-fluoro-phenyl)-methyl]-piperazine-1-yl}-ethyl)-2-methyl-5,6,7,8-tetrahydro-4aH-quinolin-4-one",1.0728,uM,=,0.0305187648435424,1,O=C1C(CCN2CCN(C(c3ccccc3)c3ccccc3)CC2)=CN=C2CCCCC12
5738,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,Cc1cc(C)cc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)c1,"(3,5-Dimethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.078,uM,=,-1.1079053973095196,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5739,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2onc(CCC3CCN(Cc4ccccc4)CC3)c2cc1C,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-6-methoxy-5-methyl-benzo[d]isoxazole,0.0058,uM,=,-2.2365720064370627,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
5740,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,Cl.O/N=C/C1=NCCN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1,"1-(3,5-bis(trifluoromethyl)benzyl)-4,5-dihydro-1H-imidazole-2-carbaldehyde oxime hydrochloride",85.0,uM,=,1.9294189257142929,1,C1=NCCN1Cc1ccccc1
5741,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,O=C1C(Cl)=C(NCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,"2-Chloro-3-[2-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl-amino)-ethyl]amino-1,4-naphthoquinone",0.00321,uM,=,-2.493494967595128,0,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5742,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,c1ccc2c(c1)CN1CCCCCCC1=N2,"6,8,9,10,11,12-Hexahydro-7H-5,11a-diaza-cycloocta[b]naphthalene",9.2,uM,=,0.9637878273455552,1,c1ccc2c(c1)CN1CCCCCCC1=N2
5743,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[6-(1,2,3,4-tetrahydroacridin-9-ylamino)hexyl]benzamide hydrochloride",0.064,uM,=,-1.193820026016113,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5744,28316,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.18-0.44,CN(C)C(=O)Oc1cccc(CCN)c1,Dimethyl-carbamic acid 3-(2-amino-ethyl)-phenyl ester,0.23,uM,=,-0.6382721639824072,0,c1ccccc1
5745,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](Cc3ccc(C[n+]4ccc5ccccc5c4)cc3)ccc2c1,"1,10-Bis(isoquinolinium)-1,4-phenyldimethylenyl dibromide",12.0,uM,=,1.0791812460476249,1,c1ccc2c[n+](Cc3ccc(C[n+]4ccc5ccccc5c4)cc3)ccc2c1
5746,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3cccc(Cl)c3)cc2oc1=O,"7-(3-Chloro-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5747,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(NCCCN3CCOCC3)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-N'-(3-morpholin-4-yl-propyl)-4,6-dinitro-benzene-1,3-diamine",0.37,uM,=,-0.431798275933005,0,c1cc(NCCCN2CCOCC2)cc(NCCSCc2ccco2)c1
5748,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C(=O)C3CCC[N+](C)(CC(=O)OC(C)(C)C)CC3)sc2cc1OC,"1-tert-Butoxycarbonylmethyl-4-(5,6-dimethoxy-benzo[b]thiophene-2-carbonyl)-1-methyl-azepanium",0.079,uM,=,-1.1023729087095586,0,O=C(c1cc2ccccc2s1)C1CCC[NH2+]CC1
5749,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,C=CC[n+]1ccc(CCC(=O)C2Cc3cc(OC)c(OC)cc3S2)cc1,"1-Allyl-4-[3-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-pyridinium",0.0062699999999999,uM,=,-2.202732459169284,0,O=C(CCc1cc[nH+]cc1)C1Cc2ccccc2S1
5750,849809,10.1016/j.bmc.2012.07.045,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate preincubated for 15 mins by Ellman's method,CN(C)c1ccccc1CNCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,"N1-(2-(Dimethylamino)benzyl)-N8-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine",0.00404,uM,=,-2.393618634889395,0,c1ccc(CNCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1
5751,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,CC(C)(C)C(=O)NCCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(2',2'-dimethylpropionyl)-gamma-aminobutylamino]-1,2,3,4-tetrahydroacridine",0.0216,uM,=,-1.665546248849069,0,c1ccc2nc3c(cc2c1)CCCC3
5752,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,Cc1ccc(-c2c3ccccc3[n+](C)c3ccccc23)cc1.F[B-](F)(F)F,10-methyl-9-p-tolylacridinium tetrafluoroborate,41.5,uM,=,1.6180480967120927,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5753,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,Cc1cc2c(cc1CN1CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC1)OCO2,"1-[Bis(4-fluoro-phenyl)-methyl]-4-(6-methyl-benzo[1,3]dioxol-5-ylmethyl)-piperazine",1.3417,uM,=,0.127655419775207,1,c1ccc(C(c2ccccc2)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
5754,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CC)C1C2,"(+/-)-Butyl-carbamic acid 1-ethyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",1.076,uM,=,0.0318122713303703,1,c1ccc2c(c1)CC1NCC[C@@H]21
5755,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3ccc(C)c(C)c3)cc(=O)c2c1,"2-(Diethylamino)ethyl (E)-3-(2-((3,4-dimethylphenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate",2.47,uM,=,0.3926969532596658,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5756,1549348,10.1016/j.bmc.2016.01.010,,,,Inhibition of human AChE using ATC as substrate preincubated for 5 mins followed by substrate addition measured after 2 mins by Ellman's assay,CCNCc1cccc2[nH]c3cc(Cl)ccc3c12,N-((7-chloro-9H-carbazol-4-yl)methyl)ethanamine,5.1,uM,=,0.7075701760979364,1,c1ccc2c(c1)[nH]c1ccccc12
5757,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C3=C(O[C@H](C(C)(C)O)[C@H]3O)[C@@]1(C(=O)C(C)C)C2=O,Hyperforatin B,8.83,uM,=,0.9459607035775686,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5758,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Fc1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)c(F)c1,"N-(1-benzylpiperidin-4-yl)-1-(2,4-difluorophenyl)methanimine",1.3,uM,=,0.1139433523068367,1,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5759,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCN1CC[C@@]2(C)c3cc(OC(=O)N[C@@H](C)c4ccccc4)ccc3CC12,"(+/-)-(1-Phenyl-ethyl)-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",1.33,uM,=,0.1238516409670858,1,O=C(NCc1ccccc1)Oc1ccc2c(c1)C1CCNC1C2
5760,28463,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 14.8-44.9,CCNC1CCc2ccc(OC(=O)N(C)C)cc21.Cl,Dimethyl-carbamic acid 3-ethylamino-indan-5-yl ester hydrochloride,24.5,uM,=,1.3891660843645326,1,c1ccc2c(c1)CCC2
5761,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,Cc1cccc2c1CC(C)C2=O,"2,4-Dimethyl-indan-1-one",0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5762,1289182,10.1016/j.ejmech.2013.11.026,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=[N+]([O-])c1ccc2c(c1)c(OCc1cccc3ccccc13)nn2Cc1cccc2ccccc12,3-(1-Naphthylmethoxy)-1-(1-naphthylmethyl)-5-nitroindazole,6.7,uM,=,0.8260748027008264,1,c1ccc2c(COc3nn(Cc4cccc5ccccc45)c4ccccc34)cccc2c1
5763,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CC1=C(C(=O)OC(C)C)C(c2cncnc2)c2c(nc3c(c2N)CC(C)(C)CC3)N1,"US9284330, S25",0.842,uM,=,-0.0746879085003505,0,C1=CC(c2cncnc2)c2cc3c(nc2N1)CCCC3
5764,1521690,10.1039/C4MD00225C,,,,Inhibition of AChE from human erythrocytes,CC[N+]1(Cc2ccccc2[N+](=O)[O-])CCCCCn2c(C)cc(=O)n(c2=O)CCCCC[N+](CC)(Cc2ccccc2[N+](=O)[O-])Cc2ccc(cc2)C1.[Br-].[Br-],,0.007,uM,=,-2.154901959985743,0,O=c1ccn2c(=O)n1CCCCC[NH+](Cc1ccccc1)Cc1ccc(cc1)C[NH+](Cc1ccccc1)CCCCC2
5765,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C3=CC[N+](C)(Cc4ccccc4)CC3)sc2cc1OC,"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-1-methyl-1,2,3,6-tetrahydro-pyridinium",2.67,uM,=,0.4265112613645752,1,C1=C(c2cc3ccccc3s2)CC[NH+](Cc2ccccc2)C1
5766,804208,10.1021/jm201364d,,,,Inhibition of human recombinant AChE using acetylthiocholine as substrate after 1 hr by Ellman method,Cl.O/N=C/C1=NCCN1Cc1ccc(Cl)cc1Cl,"1-(2,4-Dichlorobenzyl)-4,5-dihydro-1H-imidazole-2-carbaldehyde Oxime Hydrochloride",24.0,uM,=,1.380211241711606,1,C1=NCCN1Cc1ccccc1
5767,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,COc1ccc2nc3c(c(N)c2c1)CCCC3,7-methoxytacrine,10.5,uM,=,1.021189299069938,1,c1ccc2nc3c(cc2c1)CCCC3
5768,28603,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 5.4-38.2,C#CCNC(C)Cc1cccc(OC(=O)N(C)CCCC)c1,Butyl-methyl-carbamic acid 3-(2-prop-2-ynylamino-propyl)-phenyl ester,12.2,uM,=,1.0863598306747482,1,c1ccccc1
5769,771459,10.1016/j.bmcl.2011.07.091,,,,Inhibition of human AChE by Ellman's assay,CC(C)(C)OC(=O)N1CCN(c2nccc(NCc3cccc4ccccc34)n2)CC1,Tert-butyl 4-[4-([Naphth-1-ylmethyl]amino)pyrimidin-2-yl]piperazine-1-carboxylate,50.8,uM,=,1.7058637122839193,1,c1ccc2c(CNc3ccnc(N4CCNCC4)n3)cccc2c1
5770,2268546,10.1021/acs.jmedchem.1c00683,,,,Inhibition of AChE (unknown origin),CCN(C)C(=O)Oc1ccc(C(CCOc2ccc([N+](=O)[O-])cc2)NC)cc1,4-(1-(methylamino)-3-(4-nitrophenoxy)propyl)phenyl ethyl(methyl)carbamate,0.101,uM,=,-0.9956786262173574,0,c1ccc(CCCOc2ccccc2)cc1
5771,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,C(=C\C[n+]1ccc2ccccc2c1)\C[n+]1ccc2ccccc2c1.[Cl-].[Cl-],"1,4-Bis(isoquinolinium)-but-(2Z)-ene-1,4-diyl dichloride",17.0,uM,=,1.230448921378274,1,C(=C\C[n+]1ccc2ccccc2c1)\C[n+]1ccc2ccccc2c1
5772,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C(O[C@H]1CN2Cc3cc4c(cc3[C@]13C=C[C@@H](O)C[C@H]23)OCO4)c1ccccc1Cl,11-O-(2-Chlorobenzoyl)haemanthamine,13.0,uM,=,1.1139433523068367,1,O=C(O[C@H]1CN2Cc3cc4c(cc3[C@]13C=CCC[C@H]23)OCO4)c1ccccc1
5773,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2occ(C(=O)Nc3cccc(Cl)c3)c(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(3-((3-chlorophenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,8.54,uM,=,0.931457870689005,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5774,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,C[n+]1c2ccccc2c(-c2ccc(F)cc2)c2ccccc21.F[B-](F)(F)F,9-(4-fluorophenyl)-10-methylacridinium tetrafluoroborate,32.3,uM,=,1.509202522331103,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5775,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,CCN(CC)CCS/C(=N\O)C(=O)c1ccc(Cl)cc1.Cl,2-(4-Chloro-phenyl)-N-hydroxy-2-oxo-thioacetimidic acid 2-diethylamino-ethyl ester hydrochloride,520.0,uM,=,2.716003343634799,1,c1ccccc1
5776,1549348,10.1016/j.bmc.2016.01.010,,,,Inhibition of human AChE using ATC as substrate preincubated for 5 mins followed by substrate addition measured after 2 mins by Ellman's assay,COc1cc(/C=C/C(=O)N(Cc2cccc3[nH]c4ccccc4c23)C(C)C)ccc1O,N-Isopropyl-3-(4-hydroxy-3-methoxyphenyl)-N-((9H-carbazol-4-yl)methyl)acrylamide,22.0,uM,=,1.3424226808222062,1,O=C(/C=C/c1ccccc1)NCc1cccc2[nH]c3ccccc3c12
5777,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc2c[n+](C[n+]3ccc4ccccc4c3)ccc2c1,"1,1-Bis(isoquinolinium)-meth-1,1-diyl dibromide",654.0,uM,=,2.815577748324267,1,c1ccc2c[n+](C[n+]3ccc4ccccc4c3)ccc2c1
5778,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)C2(C)COC(O3)O2)cc1,"(4-Isopropyl-phenyl)-carbamic acid 1-methyl-8,10,12-trioxa-tricyclo[7.2.1.0*2,7*]dodeca-2,4,6-trien-4-yl ester",4.3,uM,=,0.6334684555795865,1,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1COC(O2)O1
5779,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,COc1ccc(NC(=O)c2cc(=O)c3cc(/C=C/C(=O)O)ccc3o2)cc1,(E)-3-(2-((4-Methoxyphenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylic acid,7.43,uM,=,0.8709888137605752,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5780,29410,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1.3-380 nM.,CC1Cc2ccccc2C1=O,2-Methyl-indan-1-one,0.38,uM,=,-0.4202164033831898,0,O=C1CCc2ccccc21
5781,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",Cc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCNC1N2C,"o-Tolyl-carbamic acid (S)-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.017,uM,=,-1.769551078621726,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
5782,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(CC1CC[N+](C)(Cc3ccccc3)CC1)C2,"1-Benzyl-4-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-ylmethyl)-1-methyl-piperidinium",30.0,uM,=,1.4771212547196624,1,c1ccc(C[NH+]2CCC(CC3Cc4ccccc4S3)CC2)cc1
5783,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"Methyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.0290736365056258,uM,=,-1.5365006436491475,0,c1ccc2c(c1)N[C@H]1NCCC21
5784,28302,10.1016/0960-894X(95)00371-Y,,,,Inhibition of Acetylcholinesterase (AChE) from human RBC,CN1CC[C@@]2(C)c3cc(OC(=O)NCCCCCCCCCCCN4CCOCC4)ccc3N(C)[C@@H]12,"(11-Morpholin-4-yl-undecyl)-carbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.04,uM,=,-1.3979400086720375,0,O=C(NCCCCCCCCCCCN1CCOCC1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5785,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,CCN(CC)CCOC(=O)/C=C/c1ccc2oc(C(=O)Nc3ccccc3)cc(=O)c2c1,2-(Diethylamino)ethyl (E)-3-(4-oxo-2-(phenylcarbamoyl)-4H-chromen-6-yl)acrylate,3.47,uM,=,0.5403294747908738,1,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5786,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(CCC(=O)NCC(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"3-(3,4,5-trimethoxyphenyl)-N-(2-oxo-2-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)-ethyl)propanamide",0.0407,uM,=,-1.39040559077478,0,O=C(CCc1ccccc1)NCC(=O)NNc1c2c(nc3ccccc13)CCCC2
5787,28162,10.1021/jm00122a035,,,,Concentration of compound that reversibly inhibits acetylcholinesterase (AChE) by 50 %,C#CCCOC[n+]1ccc(/C=N/O)cc1.[Cl-],1-But-3-ynyloxymethyl-4-(hydroxyimino-methyl)-pyridinium chloride,96.5,uM,=,1.9845273133437928,1,c1cc[nH+]cc1
5788,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1cc(=O)c2cc(O)c(O)cc2o1,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-decyl}-6,7-dihydroxy-4-oxo-4H-chromene-2-carboxamide hydrochloride",8.999999999999999e-05,uM,=,-4.045757490560675,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5789,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCCSc1nc2nc3c(c(N)c2s1)C1CC(CC)=CC(C3)C1,"(+/-)-11-Amino-2-thiopropyl-5,6,9,10-tetrahydro-thiazolo[4,5-b]-8-ethyl-6,10-methano cycloocta[e]pyridine",7.269999999999999,uM,=,0.8615344108590378,1,C1=CC2Cc3nc4ncsc4cc3C(C1)C2
5790,2275467,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) incubated for 40 mins by Ellman's method,Cn1c2ccccc2c2cc[n+](-c3ccc(Br)cc3Br)cc21,"2-(2,4-dibromophenyl)-9-methyl-pyrido[3,4-b]indol-2-ium",0.11,uM,=,-0.958607314841775,0,c1ccc(-[n+]2ccc3c(c2)[nH]c2ccccc23)cc1
5791,1823692,10.1021/acs.jmedchem.9b01012,,,,Inhibition of human erythrocyte AChE at 10 uM using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 2.5 mins by DTNB reagent based UV-spectrophotometric method,CCCCCCCNC(=O)Oc1ccc2c(c1)CN1CCc3ccccc3C1N2C,"6,8,13,13a-Tetrahydro-13-methyl-5H-isoquinolino[1,2-b]quinazolin-10-yl heptylcarbamate",3.8,uM,=,0.5797835966168101,1,c1ccc2c(c1)CN1CCc3ccccc3C1N2
5792,2231701,10.1016/j.bmcl.2022.128574,,,,Inhibition of human erythrocyte AChE using acetylthiocholine as substrate incubated for 15 mins by DTNB reagent based Ellman's method,CCN(C)C(=O)Oc1ccc(C2CC(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3O2)cc1,"2-(4-((ethyl(methyl)carbamoyl)oxy)phenyl)-4-oxochromane-5,7-diyl bis(ethyl(methyl)carbamate)",10.6,uM,=,1.0253058652647702,1,O=C1CC(c2ccccc2)Oc2ccccc21
5793,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CCC1=CC2Cc3nc4cc(Cl)ccc4c(NCCn4cc(CCCCCCN5CCc6cc(OC)c(OC)cc6C5c5cccc([N+](=O)[O-])c5)nn4)c3C(C1)C2,"(+/-)-3-chloro-6,7,10,11-tetrahydro-N-(2-(4-(6-(3,4-dihydro-6,7-dimethoxy-1-(4-nitrophenyl)isoquinolin-2(1H)-yl)hexyl)-1H-1,2,3-triazol-1-yl)-9-ethyl)-12-amino-6,10-methanocycloocta[b]quinoline",0.00596,uM,=,-2.2247537402597635,0,C1=CC2Cc3nc4ccccc4c(NCCn4cc(CCCCCCN5CCc6ccccc6C5c5ccccc5)nn4)c3C(C1)C2
5794,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1cc(=O)c2cc(Oc3ccccc3)ccc2o1,2-methyl-6-phenoxy-4H-chromen-4-one,3.0,uM,=,0.4771212547196624,1,O=c1ccoc2ccc(Oc3ccccc3)cc12
5795,28461,10.1021/jm020120c,,,,In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 13.6-198,C#CCNC1CCc2ccc(OC(=O)N(C)C3CCCCC3)cc21.Cl,Cyclohexyl-methyl-carbamic acid 3-prop-2-ynylamino-indan-5-yl ester hydrochloride,41.2,uM,=,1.6148972160331347,1,O=C(NC1CCCCC1)Oc1ccc2c(c1)CCC2
5796,305294,10.1021/jm049112h,,,,Inhibitory concentration against human recombinant acetylcholinesterase,NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,"N*1*-(6-Chloro-1,2,3,4-tetrahydro-acridin-9-yl)-propane-1,3-diamine",0.0215,uM,=,-1.6675615400843946,0,c1ccc2nc3c(cc2c1)CCCC3
5797,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,COc1ccc(NC(=O)c2coc3ccc(/C=C/C(=O)OCCN(C)C)cc3c2=O)cc1,2-(Dimethylamino)ethyl (E)-3-(3-((4-methoxyphenyl)carbamoyl)-4-oxo-4H-chromen-6-yl)acrylate,3.54,uM,=,0.5490032620257879,1,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5798,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,C#CCN(CCC1CCN(Cc2ccccc2)CC1)Cc1ccc2cccc(O)c2n1,2-(((2-(1-Benzylpiperidin-4-yl)ethyl)(prop-2-yn-1-yl)amino)methyl)quinolin-8-ol,4.1,uM,=,0.6127838567197355,1,c1ccc(CN2CCC(CCNCc3ccc4ccccc4n3)CC2)cc1
5799,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.0715,uM,=,-1.1456939581989194,0,c1ccc2nc3c(cc2c1)CCCC3
5800,1431108,10.1016/j.bmcl.2014.10.025,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman method,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCNc4c5c(nc6cc(Cl)ccc46)C[C@@H]4C=C(C)C[C@H]5C4)c3[C@@H](C1)C2,"(+)-N,N'-bis[(7R,11R)-3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocyclo-octa[b]quinolin-12-yl]-1,10-decanediamine",0.0175,uM,=,-1.7569619513137056,0,C1=C[C@H]2Cc3nc4ccccc4c(NCCCCCCCCCCNc4c5c(nc6ccccc46)C[C@@H]4C=CC[C@H]5C4)c3[C@@H](C1)C2
5801,28632,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in cortex,C=CCN1CC[C@@]2(C)c3cc(OC(=O)NC)ccc3N(C)[C@@H]12,"Methyl-carbamic acid 1-allyl-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.032,uM,=,-1.494850021680094,0,c1ccc2c(c1)N[C@H]1NCCC21
5802,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]ccc2c1,3-(1-Benzyl-4-piperidyl)-1-(1H-indol-5-yl)propan-1-one,0.0133,uM,=,-1.8761483590329144,0,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2[nH]ccc2c1
5803,1511335,10.1016/j.bmc.2015.07.029,,,,Inhibition of acetylcholinesterase in human erythrocytes using acetylthiocholine iodide substrate by spectrophotometric Ellman's method,CN(C)c1ccc(C(=O)NCCNc2c3c(nc4ccccc24)CCCC3)cc1.Cl,"4-Dimethylamino-N-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]benzamide hydrochloride",0.142,uM,=,-0.8477116556169436,0,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5804,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,C[n+]1c2ccccc2c(-c2ccc(NC(=O)C(F)(F)F)cc2)c2ccccc21.F[B-](F)(F)F,"10-methyl-9-(4-(2,2,2-trifluoroacetamido)phenyl)acridinium tetrafluoroborate",36.5,uM,=,1.5622928644564746,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5805,751132,10.1016/j.ejmech.2011.02.071,,,,Inhibition of human plasma BChE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",7.3,uM,=,0.8633228601204559,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5806,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,O=C(c1cnn(C2CCCC2)c1)C(F)(F)F,"1-(1-cyclopentyl-1H-pyrazol-4-yl)-2,2,2-trifluoroethanone",0.0052,uM,=,-2.283996656365201,0,c1cnn(C2CCCC2)c1
5807,1814688,10.1016/j.ejmech.2019.111737,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,O=C(/C=C/c1ccccc1)c1ccc(OCCCCCCN2CCCC2)cc1O,(E)-1-(2-hydroxy-4-((6-(pyrrolidin-1-yl)hexyl)oxy)phenyl)-3-phenylprop-2-en-1-one,3.2,uM,=,0.505149978319906,1,O=C(/C=C/c1ccccc1)c1ccc(OCCCCCCN2CCCC2)cc1
5808,814864,10.1016/j.ejmech.2012.03.022,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by Ellman's method,C#CCN1CCc2nc3nc(N4CCCC4)c(C#N)cc3c(N)c2C1,"5-Amino-7-(2-propyn-1-yl)-2-(1-pyrrolidinyl)-6,7,8,9-tetrahydropyrido[2,3-b]-1,6-naphthyridine-3-carbonitrile",0.65,uM,=,-0.1870866433571444,0,c1cc2cc3c(nc2nc1N1CCCC1)CCNC3
5809,590772,10.1021/jm901123n,,,,Inhibition of human recombinant AChE by Ellman's method,CCN(CCCCCCNC1=CC(=O)C(NCCCNC(=O)CCCCC2CCSS2)=CC1=O)Cc1ccccc1OC,"5-[1,2]Dithiolan-3-yl-pentanoic acid [3-(4-{6-[ethyl-(2-methoxy-benzyl)-amino]-hexylamino}-3,6-dioxo-cyclohexa-1,4-dienylamino)-propyl]-amide",0.15,uM,=,-0.8239087409443188,0,O=C(CCCCC1CCSS1)NCCCNC1=CC(=O)C(NCCCCCCNCc2ccccc2)=CC1=O
5810,2153545,10.1021/acs.jnatprod.1c00980,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,COc1cc2c(c(CO)c1OC)C[C@H]1c3c(cc4c(c3OC)OCO4)CC[N+]1=C2.O=C([O-])C(F)(F)F,"7,8-didehydromecambridine trifluoroacetate",66.6,uM,=,1.823474229170301,1,C1=[N+]2CCc3cc4c(cc3[C@@H]2Cc2ccccc21)OCO4
5811,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4cccc(C)c4)CC3)c2c1,N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-2-(1-(3-methylbenzyl)piperidin-4-yl)acetamide,13.5,uM,=,1.130333768495006,1,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12
5812,1826274,10.1039/C8MD00384J,,,,Inhibition of AChE (unknown origin),Cc1cc(C)c(S(=O)(=O)Nc2ccc(C3C4=C(CC(C)(C)CC4=O)N(c4ccc(Br)cc4)C4=C3C(=O)CC(C)(C)C4)cc2)c(C)c1,"N-(4-(10-(4-bromophenyl)-3,3,6,6-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8,9,10-decahydroacridin-9-yl)phenyl)-2,4,6-trimethylbenzenesulfonamide",0.14,uM,=,-0.8538719643217619,0,O=C1CCCC2=C1C(c1ccc(NS(=O)(=O)c3ccccc3)cc1)C1=C(CCCC1=O)N2c1ccccc1
5813,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(OCCCCCCCN3CCCCC3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(7-piperidin-1-ylheptyloxy)phenyl]methanone,0.11,uM,=,-0.958607314841775,0,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc(OCCCCCCCN2CCCCC2)cc1
5814,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,CC(C)(CO[N+](=O)[O-])C(=O)NCCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(2',2'-dimethyl-3'-(nitrooxy)propionyl)-gamma-aminobutylamino]-1,2,3,4-tetrahydroacridine",0.226,uM,=,-0.645891560852599,0,c1ccc2nc3c(cc2c1)CCCC3
5815,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2cc(C3CC[N+](C)(Cc4ccccc4)CC3O)sc2cc1OC,"1-Benzyl-4-(5,6-dimethoxy-benzo[b]thiophen-2-yl)-3-hydroxy-1-methyl-piperidinium",19.58,uM,=,1.291812687467119,1,c1ccc(C[NH+]2CCC(c3cc4ccccc4s3)CC2)cc1
5816,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3cccc(N)c3)cc2oc1=O,"7-(3-Amino-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5817,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1cccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)c1,"m-Tolyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.028,uM,=,-1.5528419686577808,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5818,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1cc2ccnc3c2c(c1OC)C(Br)OC3=O,"7-Bromo-5,6-dimethoxy-7H-8-oxa-1-aza-phenalen-9-one",46.442601974158165,uM,=,1.6669165433525666,1,O=C1OCc2cccc3ccnc1c23
5819,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,O=C(O[C@@H]1C=C[C@]23CCN(Cc4cc5c(cc42)OCO5)[C@H]3C1)c1ccccc1[N+](=O)[O-],3-O-(2-Nitrobenzoyl)vittatine,60.0,uM,=,1.7781512503836436,1,O=C(O[C@@H]1C=C[C@]23CCN(Cc4cc5c(cc42)OCO5)[C@H]3C1)c1ccccc1
5820,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,48.0,uM,=,1.6812412373755872,1,c1ccccc1
5821,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1cc(C[n+]2ccc3ccccc3c2)cc(C[n+]2ccc3ccccc3c2)c1,"1,10-Bis(isoquinolinium)-1,3-phenyldimethylenyl dibromide",8.0,uM,=,0.9030899869919436,1,c1cc(C[n+]2ccc3ccccc3c2)cc(C[n+]2ccc3ccccc3c2)c1
5822,1439857,10.1021/jm5010804,,,,Inhibition of human recombinant AChE after 5 mins by Ellman method,COc1ccc2nc3c(c(NCCNC4=CC(=O)c5ccccc5C4=O)c2c1)CCCC3,"2-[2-(7-Methoxy-1,2,3,4-tetrahydroacridin-9-yl-amino)ethyl]-amino-1,4-naphthoquinone",2.53,uM,=,0.4031205211758178,1,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21
5823,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COCC[n+]1ccc(CCC(=O)C2Cc3cc(OC)c(OC)cc3S2)cc1,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-(2-methoxy-ethyl)-pyridinium",0.03,uM,=,-1.5228787452803376,0,O=C(CCc1cc[nH+]cc1)C1Cc2ccccc2S1
5824,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,C#CCN(Cc1ccc2cccc(O)c2n1)C(C#N)C1CCN(Cc2ccccc2)CC1,2-(1-Benzylpiperidin-4-yl)-2-(((8-hydroxyquinolin-2-yl)methyl)(prop-2-yn-1-yl)amino)acetonitrile,64.2,uM,=,1.8075350280688527,1,c1ccc(CN2CCC(CNCc3ccc4ccccc4n3)CC2)cc1
5825,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1,3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-benzo[d]isoxazole,0.21,uM,=,-0.6777807052660807,0,c1ccc(CN2CCC(CCc3noc4ccccc34)CC2)cc1
5826,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,c1ccc2c(c1)CN1CCCCC1=N2,"6,8,9,11-Tetrahydro-7H-pyrido[2,1-b]quinazoline",3.66,uM,=,0.5634810853944107,1,c1ccc2c(c1)CN1CCCCC1=N2
5827,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(Heptylphysostigmine(-))Heptyl-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.11,uM,=,-0.958607314841775,0,c1ccc2c(c1)N[C@H]1NCCC21
5828,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1cc2ccnc3c2c(c1OC)COC3=O,"5,6-Dimethoxy-7H-8-oxa-1-aza-phenalen-9-one",19.586335945660228,uM,=,1.2919531992712203,1,O=C1OCc2cccc3ccnc1c23
5829,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CC)C1C2,"(+/-)-Heptyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.058,uM,=,-1.2365720064370629,0,c1ccc2c(c1)CC1NCCC21
5830,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 9",0.37754,uM,=,-0.4230370285143108,0,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5831,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)c1ccccc1,(S)-hexyl 2-benzamido-5-(2-(1-benzylpiperidin-4-yl)ethylamino)-5-oxopentanoate,0.53,uM,=,-0.2757241303992109,0,O=C(CCCNC(=O)c1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
5832,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,FC(F)(F)c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,1-Benzyl-N-(4-(trifluoromethyl)benzyl)piperidin-4-amine,0.11,uM,=,-0.958607314841775,0,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5833,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,CC(C)(CO[N+](=O)[O-])C(=O)NCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(2',2'-dimethyl-3'-(nitrooxy)propionyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine",0.0695,uM,=,-1.158015195409886,0,c1ccc2nc3c(cc2c1)CCCC3
5834,1627472,10.1016/j.bmc.2016.11.002,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,3.12,uM,=,0.4941545940184428,1,c1ccccc1
5835,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc12,"US8841453, 3",0.1783799999999999,uM,=,-0.7486538404114187,0,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5836,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCC(CC)n1cc(C(=O)C(F)(F)F)cn1,"2,2,2-trifluoro-1-(1-(pentan-3-yl)-1H-pyrazol-4-yl)ethanone",0.00377,uM,=,-2.423658649794207,0,c1cn[nH]c1
5837,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,Cc1cccc(CNC2CCN(Cc3ccccc3)CC2)c1,1-Benzyl-N-(3-methylbenzyl)piperidin-4-amine,4.1,uM,=,0.6127838567197355,1,c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1
5838,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4ncccc4c(N)c3C(C1)C2,"(+/-)-11-Amino-8-methyl-5,6,9,10-tetrahydro-6,10-methanocyclooctabenzo[b][1,8]naphthyridine",0.8099999999999999,uM,=,-0.0915149811213502,0,C1=CC2Cc3nc4ncccc4cc3C(C1)C2
5839,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(CCc2ccccc2)cc1)NCCN1CCN(Cc2ccccc2)CC1,N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2-(4-phenethylphenoxy)acetamide,0.9,uM,=,-0.0457574905606751,0,O=C(COc1ccc(CCc2ccccc2)cc1)NCCN1CCN(Cc2ccccc2)CC1
5840,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3cccc(F)c3)cc2oc1=O,"7-(3-Fluoro-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5841,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,C(=C/C[n+]1ccc2ccccc2c1)\C[n+]1ccc2ccccc2c1.[Br-].[Br-],"1,4-Bis(isoquinolinium)-but-(2E)-ene-1,4-diyl dibromide",7.0,uM,=,0.8450980400142568,1,C(=C/C[n+]1ccc2ccccc2c1)\C[n+]1ccc2ccccc2c1
5842,28304,10.1021/jm00086a011,,,,In vitro inhibitory activity against human Acetylcholinesterase,CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CCC)C1C2,"(+/-)-Heptyl-carbamic acid 3a-methyl-1-propyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.093,uM,=,-1.031517051446065,0,c1ccc2c(c1)CC1NCCC21
5843,1528844,,,,,"Inhibition Assay: The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G. L.; Courtney, K. D.; Anders, B.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95).This method of evaluation of the cholinesterase inhibitors activity is based on the fact that acetyl/butyrylcholinesterase interacts with the inhibitor, which prevents the acetyl/butyrylcholine hydrolysis. The inhibitor causes the enzyme activity drop which is dependent on the inhibitor concentration. The enzyme unbound with the inhibitor is able to hydrolyze acetyl/butyrylthiocholine (ASCh/BSCh). The amount of the hydrolyzed ASCh/BSCh is measured indirectly, by quantification of the product of its reaction with DTNB (5,5-dithio-bis-2-nitrobenzoic acid). Ellman's method relies therefore on the spectrophotometric quantification of product of the reaction between acylthiocholine and DTNB.",CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cc12,"US8841453, 18",0.0081,uM,=,-2.0915149811213505,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)Oc1ccc2[nH]ccc2c1
5844,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,"N'-1,2,3,4-tetrahydroacridin-9-yl-3,4,5-trimethoxybenzohydrazide",0.386,uM,=,-0.413412695328245,0,O=C(NNc1c2c(nc3ccccc13)CCCC2)c1ccccc1
5845,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,CN(Cc1ccccc1)Cc1ccc(C(=O)c2ccc(OCCCN3CCCCC3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-[4-(3-piperidin-1-ylpropoxy)phenyl]methanone,0.024,uM,=,-1.619788758288394,0,O=C(c1ccc(CNCc2ccccc2)cc1)c1ccc(OCCCN2CCCCC2)cc1
5846,745440,10.1016/j.ejmech.2011.02.019,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,COc1ccc(C(=O)c2ccc(CN(C)Cc3ccccc3)cc2)cc1,{4-[(Benzylmethylamino)methyl]phenyl}-(4-methoxyphenyl)methanone,1.82,uM,=,0.2600713879850748,1,O=C(c1ccccc1)c1ccc(CNCc2ccccc2)cc1
5847,1587903,10.1016/j.bmc.2016.07.025,,,,Inhibition of human erythrocyte ACHE preincubated for 6 mins followed by addition of acetylcholine iodide as substrate by Ellman's method,O=C(CCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1,N-(2-(1-Benzylpiperidin-4-yl)ethyl)-3-(1H-indol-3-yl)propanamide,0.273,uM,=,-0.563837352959244,0,O=C(CCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1
5848,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1,"(4-Isopropyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.11,uM,=,-0.958607314841775,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5849,1823693,10.1021/acs.jmedchem.9b01012,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured after 2.5 mins by DTNB reagent based spectrometric method,CN1c2ccc(OC(=O)NCCCCCCN3CCCC3)cc2CN2CCc3ccccc3C21,"13-Methyl-5,8,13,13a-tetrahydro-6H-isoquinolino[1,2-b]-quinazolin-10-yl-[6-(pyrrolidin-1-yl)hexyl]carbamate",0.88,uM,=,-0.0555173278498313,0,O=C(NCCCCCCN1CCCC1)Oc1ccc2c(c1)CN1CCc3ccccc3C1N2
5850,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CN1CC[C@@]2(C)c3cc(OC(=O)N4CCc5ccccc5C4)ccc3N(C)[C@@H]12,quilostigmine,0.148,uM,=,-0.8297382846050426,0,O=C(Oc1ccc2c(c1)C1CCN[C@@H]1N2)N1CCc2ccccc2C1
5851,28143,10.1021/jm980459s,,,,"Ability to inhibit acetylcholinesterase (AChE), freshly prepared from human erythrocytes",CC(C)c1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCNC2N3)cc1,"(4-Isopropyl-phenyl)-carbamic acid (S)-3a-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.11,uM,=,-0.958607314841775,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1N2
5852,813113,10.1021/jm201460y,,,,Inhibition of human erythrocytes AChE by Ellman's method,Cl.O=C(NCCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1cc(=O)c2c(O)cc(O)cc2o1,"N-{10-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-5,7-dihydroxy-4-oxo-4H-chromene-2-carboxamide hydrochloride",6.500000000000001e-05,uM,=,-4.187086643357144,0,O=C(NCCCCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc(=O)c2ccccc2o1
5853,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CC(C)=NNc1cc(NCCSCc2ccc(CN(C)C)o2)c([N+](=O)[O-])cc1[N+](=O)[O-],"[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-[5-(N'-isopropylidene-hydrazino)-2,4-dinitro-phenyl]-amine",0.44,uM,=,-0.3565473235138126,0,c1ccc(NCCSCc2ccco2)cc1
5854,29409,10.1021/jm00081a022,,,,IC50 against acetylcholinesterase; value ranges from 1-4900 nM.,COc1ccc(C)cc1,1-Methoxy-4-methyl-benzene,4.9,uM,=,0.6901960800285137,1,c1ccccc1
5855,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4cc(Cl)ccc4c(NC(=O)CCl)c3C(C1)C2,"(+/-)-2-Chloro-N-(3-chloro-6,7,10,11-tetrahydro-12-ylamido-9-methyl-7,11-methanocyclo octan[b]quinoline)acetamide",2.51,uM,=,0.3996737214810381,1,C1=CC2Cc3nc4ccccc4cc3C(C1)C2
5856,463759,10.1021/jm701491k,,,,Inhibition of AChE by Ellman's assay,O=[N+]([O-])OCCCNCCCNc1c2c(nc3ccccc13)CCCC2,"9-[N-gamma-(3'-(nitrooxy)propyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine",0.0064,uM,=,-2.193820026016113,0,c1ccc2nc3c(cc2c1)CCCC3
5857,1655757,10.1016/j.ejmech.2016.12.048,,,,Inhibition of acetylcholinesterase isolated from human red blood cells using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1cc(CCc2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)cc(OC)c1,"6-Chloro-N-(4-(3,5-dimethoxyphenethyl)phenyl)-1,2,3,4-tetrahydroacridin-9-amine",0.8,uM,=,-0.0969100130080563,0,c1ccc(CCc2ccc(Nc3c4c(nc5ccccc35)CCCC4)cc2)cc1
5858,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCN(CCC)CCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(4-(Dipropylamino)butoxy)phenyl)-3-phenylprop-2-en-1-one,5.91,uM,=,0.7715874808812554,1,O=C(/C=C/c1ccccc1)c1ccccc1
5859,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,N#Cc1ccccc1-c1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,1-[bis(4-fluoro-phenyl)-methyl]-4-1(benzyl)-4-(2-cyanophenyl)-piperazine,0.0736,uM,=,-1.1331221856625011,0,c1ccc(-c2ccc(CN3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)cc1
5860,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CC(C)(C)c1cccc(C(=O)C(F)F)c1,"1-(3-(tert-butyl)phenyl)-2,2-difluoroethan-1-one",0.00605,uM,=,-2.218244625347531,0,c1ccccc1
5861,1281563,10.1021/ml4002908,,,,Inhibition of human acetylcholine esterase-induced amyloid beta (1 to 40) aggregation by ThT-based fluorescence assay,CN(CCCCNc1c2c(nc3c(NC(=O)CNC(=O)CC[C@H](NC(=O)CNC(=O)OCc4ccccc4)C(=O)N[C@@H](Cc4ccccc4)C(=O)OCc4ccccc4)cccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2,"(8S,11S)-benzyl 11-benzyl-8-(3-(2-(9-(4-(methyl(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)amino)butylamino)-5,6,7,8-tetrahydroacridin-4-ylamino)-2-oxoethylamino)-3-oxopropyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oate",113.0,uM,=,2.05307844348342,1,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCNCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3
5862,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1cc2ccnc3c2c(c1OC)COC3(CCCO)OC,"3-(5,6,9-Trimethoxy-7H,9H-8-oxa-1-aza-phenalen-9-yl)-propan-1-ol",137.24299445654992,uM,=,2.137490185205824,1,c1cc2c3c(nccc3c1)COC2
5863,429662,10.1021/jm049655r,,,,Inhibition of AChE by microplate assay,COc1cc2ccc(=O)oc2cc1O,7-Hydroxy-6-methoxy-chromen-2-one,168.6,uM,=,2.226857570288724,1,O=c1ccc2ccccc2o1
5864,811264,10.1021/jm200840c,,,,Inhibition of human recombinant AChE-induced Abeta1-40 aggregation by thioflavin T fluorescence method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2.Cl,"N-[8-({7-chloro-15-methyl-10-azatetracyclo[11.3.1.0^{2,11}.0^{4,9}]heptadeca-2(11),3,5,7,9,14-hexaen-3-yl}amino)octyl]-1,2,3,4-tetrahydroacridin-9-amine hydrochloride",61.3,uM,=,1.787460474518415,1,C1=CC2Cc3nc4ccccc4c(NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)c3C(C1)C2
5865,1821781,10.1016/j.bmcl.2019.03.024,,,,Binding affinity to AChE (unknown origin) assessed as reduction in intrinsic protein fluorescence at 25 degC by fluorescence spectrophotometry,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(O)cc3)c2O)O1,"1-(5-Hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3-(4-hydroxy-phenyl)-propenone",29.56,uM,=,1.470704429722788,1,O=C(/C=C/c1ccccc1)c1ccc2c(c1)C=CCO2
5866,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCCc3ccccc3)cc2oc1=O,"3,4-Dimethyl-7-phenethyloxy-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCCc3ccccc3)cc2o1
5867,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)C1C2,"(+/-)-Hexyl-carbamic acid 1,3a-dimethyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.077,uM,=,-1.1135092748275182,0,c1ccc2c(c1)CC1NCCC21
5868,659615,10.1021/jm100573q,,,,Inhibition of human AChE by Ellmans test,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C=O,"(3aS,8aR)-8-formyl-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate",2.5,uM,=,0.3979400086720376,1,c1ccc2c(c1)N[C@H]1NCCC21
5869,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4[nH]ncc4c(N)c3C(C1)C2,"(+/-)-9-Amino-1H-pyrazolo[3,4-b]-3,4,7,8-tetrahydro-6-methyl-4,8-methanocycloocta[e]pyridine",50.0,uM,=,1.6989700043360187,1,C1=CC2Cc3nc4[nH]ncc4cc3C(C1)C2
5870,422568,10.1021/jm060742o,,,,Inhibition of human AChE,COc1cc(C(=O)NCCCCCCCCC(=O)NNc2c3c(cc4ccccc24)CCCC3)cc(OC)c1OC,"3,4,5-trimethoxy-N-(9-oxo-9-(2-(1,2,3,4-tetrahydroacridin-9-yl)hydrazino)nonyl)-benzamide",0.00508,uM,=,-2.2941362877160807,0,O=C(CCCCCCCCNC(=O)c1ccccc1)NNc1c2c(cc3ccccc13)CCCC2
5871,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,C#CCN(CCCC1CCN(Cc2ccccc2)CC1)Cc1ccc2cccc(O)c2n1,2-(((3-(1-Benzylpiperidin-4-yl)propyl)(prop-2-yn-1-yl)amino)methyl)quinolin-8-ol,1.5,uM,=,0.1760912590556812,1,c1ccc(CN2CCC(CCCNCc3ccc4ccccc4n3)CC2)cc1
5872,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3CC12,"(+/-)-Phenyl-carbamic acid 1-ethyl-3a-methyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.176,uM,=,-0.7544873321858502,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCNC1C2
5873,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,CC(=O)Nc1ccc(-c2c3ccccc3[n+](C)c3ccccc23)cc1.F[B-](F)(F)F,9-(4-acetamidophenyl)-10-methylacridinium tetrafluoroborate,54.3,uM,=,1.734799829588847,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5874,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,C[n+]1c2ccccc2c(N)c2ccccc21.F[B-](F)(F)F,9-amino-10-methylacridinium tetrafluoroborate,39.5,uM,=,1.5965970956264603,1,c1ccc2[nH+]c3ccccc3cc2c1
5875,377860,10.1016/j.bmcl.2006.05.030,,,,Inhibition of human serum AchE,COc1cc(Br)c(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1OC,"1-[bis(4-fluoro-phenyl)-methyl]-4-(2-bromo-4,5-dimethoxy-benzyl)-piperazine",1.0129,uM,=,0.0055665711332942,1,c1ccc(CN2CCN(C(c3ccccc3)c3ccccc3)CC2)cc1
5876,28300,10.1021/jm001088u,,,,In vitro inhibition of acetylcholinesterase from human erythrocytes,CCc1cc(=NCCC2CCN(Cc3ccccc3)CC2)[nH]nc1-c1ccccc1.Cl.Cl.O,[2-(1-Benzyl-piperidin-4-yl)-ethyl]-(5-ethyl-6-phenyl-pyridazin-3-yl)-amine dihydrochloride hydrate,0.066,uM,=,-1.1804560644581312,0,c1ccc(CN2CCC(CCN=c3ccc(-c4ccccc4)n[nH]3)CC2)cc1
5877,28147,10.1021/jm00159a021,,,,Reversible inhibition of Human AchE,CN(C)CCS/C(=N\O)C(=O)c1ccc(Br)cc1.Cl,2-(4-Bromo-phenyl)-N-hydroxy-2-oxo-thioacetimidic acid 2-dimethylamino-ethyl ester hydrochloride,710.0,uM,=,2.8512583487190755,1,c1ccccc1
5878,1655757,10.1016/j.ejmech.2016.12.048,,,,Inhibition of acetylcholinesterase isolated from human red blood cells using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition measured every 2 mins by Ellman's method,COc1cc(CCc2ccc(Nc3c4c(nc5ccccc35)CCCC4)cc2)cc(OC)c1,"N-(4-(3,5-dimethoxyphenethyl)phenyl)-1,2,3,4-tetrahydroacridin-9-amine",14.2,uM,=,1.1522883443830565,1,c1ccc(CCc2ccc(Nc3c4c(nc5ccccc35)CCCC4)cc2)cc1
5879,2275468,10.1021/acs.jmedchem.0c01887,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method,CN1c2ccc(OCc3ccccc3)cc2C(=O)N2CCc3c([nH]c4ccccc34)C21,"3-(benzyloxy)-14-methyl-7,8,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(13H)-one",3.0,uM,=,0.4771212547196624,1,O=C1c2cc(OCc3ccccc3)ccc2NC2c3[nH]c4ccccc4c3CCN12
5880,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1cc2cc[n+](C)c3c2c(c1OC)C(Br)OC3=O,"7-Bromo-5,6-dimethoxy-1-methyl-9-oxo-7H,9H-8-oxa-1-azonia-phenalene",120.4134008917124,uM,=,2.080674822548542,1,O=C1OCc2cccc3cc[nH+]c1c23
5881,1829442,10.1016/j.ejmech.2018.10.064,,,,Inhibition of human erythrocytes AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured at 1 min time interval for 10 mins by Ellman's method,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2c(ccn2Cc2ccccc2)c1,1-(1-Benzylindol-5-yl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one,0.133,uM,=,-0.8761483590329142,0,O=C(CCC1CCN(CC2CCCCC2)CC1)c1ccc2c(ccn2Cc2ccccc2)c1
5882,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,C#CCN(Cc1ccc2cccc(O)c2n1)C(C#N)CCC1CCN(Cc2ccccc2)CC1,4-(1-Benzylpiperidin-4-yl)-2-(((8-hydroxyquinolin-2-yl)methyl)(prop-2-yn-1-yl)amino)butanenitrile,0.029,uM,=,-1.537602002101044,0,c1ccc(CN2CCC(CCCNCc3ccc4ccccc4n3)CC2)cc1
5883,28162,10.1021/jm00122a035,,,,Concentration of compound that reversibly inhibits acetylcholinesterase (AChE) by 50 %,C#CCCCC[n+]1ccc(/C=N/O)cc1.[Cl-],1-Hex-5-ynyl-4-(hydroxyimino-methyl)-pyridinium chloride,305.0,uM,=,2.484299839346786,1,c1cc[nH+]cc1
5884,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,COc1ccc(NC(=O)c2cc(=O)c3cc(/C=C/C(=O)OCCN(C)C)ccc3o2)cc1,2-(Dimethylamino)ethyl (E)-3-(2-((4-methoxyphenyl)carbamoyl)-4-oxo-4H chromen-6-yl)acrylate,0.91,uM,=,-0.0409586076789063,0,O=C(Nc1ccccc1)c1cc(=O)c2ccccc2o1
5885,590772,10.1021/jm901123n,,,,Inhibition of human recombinant AChE by Ellman's method,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,"2,5-bis(6-((2-methoxybenzyl)(ethyl)amino)hexylamino)cyclohexa-2,5-diene-1,4-dione",0.0015,uM,=,-2.8239087409443187,0,O=C1C=C(NCCCCCCNCc2ccccc2)C(=O)C=C1NCCCCCCNCc1ccccc1
5886,424371,10.1016/j.bmcl.2006.08.067,,,,Inhibition of AChE,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.6,uM,=,-0.2218487496163563,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5887,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",CCOC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CC(Cl)(Cl)CC3,"US9284330, S19",0.333,uM,=,-0.4775557664936801,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5888,28155,10.1016/0960-894X(96)00102-3,,,,Inhibitory activity against acetylcholinesterase in human RBC,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,"9-methoxy-4-methyl-(1S,12S,14R)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol",0.1,uM,=,-1.0,0,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5889,1440666,10.1016/j.bmc.2014.08.033,,,,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,CCCN(CCC)CCCCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1,(E)-1-(4-(6-(Dipropylamino)hexyloxy)phenyl)-3-phenylprop-2-en-1-one,44.05,uM,=,1.643945912748067,1,O=C(/C=C/c1ccccc1)c1ccccc1
5890,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(Cc2ccccc2)cc1)NCC1CCN(Cc2ccccc2)CC1,2-(4-Benzylphenoxy)-N-((1-benzylpiperidin-4-yl)methyl)acetamide,1.27,uM,=,0.1038037209559568,1,O=C(COc1ccc(Cc2ccccc2)cc1)NCC1CCN(Cc2ccccc2)CC1
5891,2284160,10.1016/j.ejmech.2018.01.003,,,,Inhibition of AChE (unknown origin) using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,Cc1c(C)c2ccc(OCc3ccc(F)cc3)cc2oc1=O,"7-(4-Fluoro-benzyloxy)-3,4-dimethyl-chromen-2-one",3.0,uM,=,0.4771212547196624,1,O=c1ccc2ccc(OCc3ccccc3)cc2o1
5892,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,CC[n+]1ccc(CCC(=O)C2Cc3cc(OC)c(OC)cc3S2)cc1,"4-[3-(5,6-Dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-3-oxo-propyl]-1-ethyl-pyridinium",0.28,uM,=,-0.5528419686577808,0,O=C(CCc1cc[nH+]cc1)C1Cc2ccccc2S1
5893,2145516,10.1016/j.bmcl.2021.128374,,,,Inhibition of human AChE using acetylthiocholine as substrate by Ellman's method,CO[C@H]1C[C@H]2C(=C[C@@H]1OC(=O)c1ccc(Cl)c([N+](=O)[O-])c1)[C@H]1CN2Cc2cc3c(cc21)OCO3,,1.61,uM,=,0.2068258760318497,1,O=C(O[C@H]1C=C2[C@H]3CN(Cc4cc5c(cc43)OCO5)[C@H]2CC1)c1ccccc1
5894,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1cccc(C)c1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,"(2,6-Dimethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.785,uM,=,-0.1051303432547474,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5895,1460145,10.1016/j.bmc.2014.06.045,,,,Inhibition of human AChE,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCCCC2,"2-(3-(Piperidin-1-yl)propoxy)-7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",0.82,uM,=,-0.0861861476162833,0,O=c1c2cc(OCCCN3CCCCC3)ccc2nc2n1CCCCC2
5896,1796387,10.1016/j.ejmech.2018.07.056,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured after 5 mins by Ellman's method,Cc1ccc(NC(=O)c2coc3ccc(/C=C/C(=O)OCCN(C)C)cc3c2=O)cc1,2-(Dimethylamino)ethyl (E)-3-(4-oxo-3-((4-methylphenyl)carbamoyl)-4H-chromen-6-yl)acrylate,0.97,uM,=,-0.0132282657337551,0,O=C(Nc1ccccc1)c1coc2ccccc2c1=O
5897,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,FC(F)(F)c1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)cc1,N-(1-benzylpiperidin-4-yl)-1-(4-(trifluoromethyl)phenyl)methanimine,0.44,uM,=,-0.3565473235138126,0,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5898,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CCC(C)n1cc(C(=O)C(F)(F)F)cn1,"1-(1-(sec-butyl)-1H-pyrazol-4-yl)-2,2,2-trifluoroethanone",0.00647,uM,=,-2.1890957193312994,0,c1cn[nH]c1
5899,1620019,10.1016/j.ejmech.2015.10.001,,,,Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,"2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one",0.009,uM,=,-2.0457574905606752,0,O=C1c2ccccc2CC1CC1CCN(Cc2ccccc2)CC1
5900,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",COC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CCC(C)C3,"US9284330, S21",1.107,uM,=,0.0441476208787228,1,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5901,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CN(C)Cc1ccc(CSCCNc2cc(F)c([N+](=O)[O-])cc2[N+](=O)[O-])o1,"[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-(5-fluoro-2,4-dinitro-phenyl)-amine",0.12,uM,=,-0.9208187539523752,0,c1ccc(NCCSCc2ccco2)cc1
5902,28630,10.1021/jm010080x,,,,In vitro inhibition of human erythrocyte acetylcholinesterase.,Cc1ccc(NC(=O)Oc2ccc3c(c2)[C@]2(C)CCN(C)[C@@H]2N3C)cc1C,"(3,4-Dimethyl-phenyl)-carbamic acid 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.031,uM,=,-1.5086383061657274,0,O=C(Nc1ccccc1)Oc1ccc2c(c1)C1CCN[C@@H]1N2
5903,28305,10.1021/jm00086a011,,,,In vitro inhibitory activity against human AchE (Acetylcholinesterase),CCCCCCNC(=O)Oc1ccc2c(c1)[C@@H]1CCN(CCC)C1C2,"(-)Hexyl-carbamic acid 1-propyl-1,2,3,3a,8,8a-hexahydro-1-aza-cyclopenta[a]inden-5-yl ester",0.518,uM,=,-0.2856702402547669,0,c1ccc2c(c1)CC1NCC[C@@H]21
5904,304873,10.1016/j.bmcl.2005.04.005,,,,Inhibitory concentration against acetylcholinesterase,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCNC2,Stephaoxocanidine derivative,1.0617402175662611,uM,=,0.026018268272028,1,C1=C[C@@]23CCNCc4cccc(c42)O[C@H]3CC1
5905,28295,10.1021/jm00108a019,,,,In vitro concentration of compound required for reversibly inhibiting 50% of human anticholinesterase activity,C[n+]1ccn(COCCS(C)(=O)=O)c1/C=N/O.[Cl-],2-(Hydroxyimino-methyl)-3-(2-methanesulfonyl-ethoxymethyl)-1-methyl-3H-imidazol-1-ium chloride,26.5,uM,=,1.423245873936808,1,c1c[nH+]c[nH]1
5906,2027088,10.1021/acs.jmedchem.6b01178,,,,Inhibition of AChE in human erythrocyte hemo-lyzates pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's method,COc1ccc2[nH]cc(CCNC(=O)CN(CCCCCCCCNc3c4c(nc5ccccc35)CCCC4)C(=O)CCCC[C@@H]3CCSS3)c2c1,"(R)-5-(1,2-Dithiolan-3-yl)-N-(2-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-N-(8-((1,2,3,4-tetrahydroacridin-9-yl)amino)octyl)pentanamide",0.18,uM,=,-0.744727494896694,0,O=C(CN(CCCCCCCCNc1c2c(nc3ccccc13)CCCC2)C(=O)CCCC[C@@H]1CCSS1)NCCc1c[nH]c2ccccc12
5907,28294,10.1021/jm00095a008,,,,In vitro inhibition of human acetylcholinesterase.,CNc1cc(NCCSCc2ccc(CN(C)C)o2)c([N+](=O)[O-])cc1[N+](=O)[O-],"N-[2-(5-Dimethylaminomethyl-furan-2-ylmethylsulfanyl)-ethyl]-N'-methyl-4,6-dinitro-benzene-1,3-diamine",0.16,uM,=,-0.7958800173440752,0,c1ccc(NCCSCc2ccco2)cc1
5908,1709232,10.1021/acs.jnatprod.6b01178,,,,Inhibition of human erythrocyte AChE using S-acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured every 30 secs for 1 hr by Ellman's method,CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C3=C(O[C@@H](C(C)(C)O)[C@@H]3O)[C@@]1(C(=O)C(C)C)C2=O,Hyperforatin C,12.55,uM,=,1.098643725817057,1,O=C1C2=C(OCC2)C2CCCC1C2=O
5909,436796,10.1021/np0700568,,,,Inhibition of AChE by Ellman method,CC1=C[C@H]2[C@H](O)C(=O)[C@H]3CCCN4CCC[C@H]2[C@]34C1,"(1R,2R,10S,12S,13R)-12-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0^{1,6}.0^{2,13}]hexadec-14-en-11-one",16.7,uM,=,1.2227164711475833,1,O=C1C[C@@H]2C=CC[C@@]34[C@@H]1CCCN3CCC[C@H]24
5910,744971,10.1016/j.bmcl.2010.12.041,,,,Inhibition of AChE-induced amyloid beta aggregation,Nc1c2c(nc3ccccc13)CCCC2,"1,2,3,4-Tetrahydro-acridin-9-ylamine",0.2,uM,=,-0.6989700043360187,0,c1ccc2nc3c(cc2c1)CCCC3
5911,1641438,,,,,"Inhibition Assay: Procedure: 48 Ml 1xReaction Buffer was initially added to each compound test well in the 96-well black plate arranged, followed by addition of 2 Ml 100xcompound solution; the test for each concentration was performed in duplicate. To the positive control well, 2 Ml DMSO+48 Ml 1xReaction Buffer were added; while 100 Ml 20 Mm H2O2 working solution was directly added to the positive validation well. To the negative control well, 2 Ml DMSO+98 Ml 1xReaction Buffer were added, and each test was performed in duplicate. 50 Ml 4xAchE application solution was added to each of the compound test wells and the positive control wells. 100 Ml 2xworking solution was added to each of all the wells and mixed until homogenous. The enzymatic reaction was started with the volume of the overall reaction system reaching 200 Ml, which resulted in the final concentrations of the compound solution of 10 umol/L, 2 umol/L, 0.4 umol/L, 0.08 umol/L, 0.016 umol/L, 0.0032 umol/L and 0.064 umol/L.",COC(=O)C1=C(C)Nc2nc3c(c(N)c2C1c1cccc([N+](=O)[O-])c1)CC(C)(C)CC3,"US9284330, S29",0.045,uM,=,-1.3467874862246565,0,C1=CC(c2ccccc2)c2cc3c(nc2N1)CCCC3
5912,1335842,10.1021/jm401824w,,,,Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins by Ellman's method,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,"(+/-)-N-{8-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]octyl}-9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxamide hydrochloride",0.00436,uM,=,-2.360513510731414,0,O=C(NCCCCCCCCNc1c2c(nc3ccccc13)CC1C=CCC2C1)c1ccc2c(c1)C(=O)c1ccccc1C2=O
5913,588496,10.1016/j.bmc.2009.05.005,,,,Inhibition of human recombinant AChE in erythrocytes by Ellman's assay,CC1=CC2Cc3nc4oc(C5CC5)nc4c(N)c3C(C1)C2,"(+/-)-9-Amino-1-cyclopropyl-oxazolo[4,5-b]-6-methyl-3,4,7,8-tetrahydro-6,10-methano cycloocta[e]pyridine",50.0,uM,=,1.6989700043360187,1,C1=CC2Cc3nc4oc(C5CC5)nc4cc3C(C1)C2
5914,305174,10.1021/jm049695v,,,,Inhibitory activity against Acetylcholinesterase enzyme using human AChE assay,COc1cc2c(cc1OC)SC(C(=O)CC1(O)CC[N+](C)(Cc3ccccc3)CC1)C2,"1-Benzyl-4-[2-(5,6-dimethoxy-2,3-dihydro-benzo[b]thiophen-2-yl)-2-oxo-ethyl]-4-hydroxy-1-methyl-piperidinium",0.09,uM,=,-1.0457574905606752,0,O=C(CC1CC[NH+](Cc2ccccc2)CC1)C1Cc2ccccc2S1
5915,1697026,10.1016/j.bmc.2017.09.028,,,,Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method,C[n+]1c2ccccc2c(-c2ccccc2)c2ccccc21.F[B-](F)(F)F,10-methyl-9-phenylacridinium tetrafluoroborate,61.3,uM,=,1.787460474518415,1,c1ccc(-c2c3ccccc3[nH+]c3ccccc23)cc1
5916,2153545,10.1021/acs.jnatprod.1c00980,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,COc1cc2c(c3c1OCOC3)C[C@H]1c3c(cc4c(c3OC)OCO4)CCN1C2,Orientalidine,19.9,uM,=,1.2988530764097066,1,c1cc2c(c3c1CN1CCc4cc5c(cc4[C@@H]1C3)OCO5)COCO2
5917,718128,10.1016/j.ejmech.2010.12.011,,,,Inhibition of human recombinant AChE by Lineweaver-Burk plot analysis,[Br-].[Br-].c1ccc(C[n+]2ccc3ccccc3c2)c(C[n+]2ccc3ccccc3c2)c1,"1,10-Bis(isoquinolinium)-1,2-phenyldimethylenyl dibromide",250.0,uM,=,2.397940008672037,1,c1ccc(C[n+]2ccc3ccccc3c2)c(C[n+]2ccc3ccccc3c2)c1
5918,1930150,10.1016/j.ejmech.2019.02.030,,,,Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine iodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by Ellman's method,O=[N+]([O-])c1ccc(/C=N/C2CCN(Cc3ccccc3)CC2)cc1,N-(1-benzylpiperidin-4-yl)-1-(4-nitrophenyl)methanimine,0.9,uM,=,-0.0457574905606751,0,C(=N/C1CCN(Cc2ccccc2)CC1)\c1ccccc1
5919,744971,10.1016/j.bmcl.2010.12.041,,,,Inhibition of AChE-induced amyloid beta aggregation,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester,0.054,uM,=,-1.2676062401770316,0,c1ccccc1
5920,2209988,10.1016/j.ejmech.2022.114358,,,,Inhibition of human AChE by Ellman's spectrophotometric method,O=C(COc1ccc(Cl)cc1)NCCN1CCN(Cc2ccccc2)CC1,N-(2-(4-Benzylpiperazin-1-yl)ethyl)-2-(4-chlorophenoxy)acetamide,0.1889999999999999,uM,=,-0.7235381958267559,0,O=C(COc1ccccc1)NCCN1CCN(Cc2ccccc2)CC1
5921,1521646,10.1016/j.bmcl.2015.09.019,,,,Inhibition of recombinant human AChE after 10 mins by Ellman assay,CC(C)Cn1cc(C(=O)C(F)F)cn1,"2,2-difluoro-1-(1-isobutyl-1H-pyrazol-4-yl)ethan-1-one",9.78,uM,=,0.9903388547876014,1,c1cn[nH]c1
5922,28633,10.1021/jm00171a001,,,,Inhibitory activity against Acetylcholinesterase in erythrocyte,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(CCc3ccccc3)[C@@H]1N2C,"Methyl-carbamic acid 3a,8-dimethyl-1-phenethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester",0.22,uM,=,-0.6575773191777937,0,c1ccc(CCN2CCC3c4ccccc4N[C@H]32)cc1
5923,620260,10.1021/jm900628z,,,,Inhibition of human AChE in erythrocyte,CCCCCCOC(=O)[C@H](CCC(=O)NCCC1CCN(Cc2ccccc2)CC1)NC(=O)OCc1ccccc1,(S)-hexyl 2-(benzyloxycarbonylamino)-5-(2-(1-benzylpiperidin-4-yl)ethylamino)-5-oxopentanoate,0.25,uM,=,-0.6020599913279624,0,O=C(CCCNC(=O)OCc1ccccc1)NCCC1CCN(Cc2ccccc2)CC1
5924,2153545,10.1021/acs.jnatprod.1c00980,,,,Inhibition of human recombinant AChE using acetylthiocholine chloride as substrate incubated for 5 mins by DTNB reagent based Ellman's method,COc1cc2c(c3c1OCOC3)C[C@H]1c3c(cc4c(c3OC)OCO4)CC[N+]1=C2.O=C([O-])C(F)(F)F,"7,8-didehydroorientalidine trifluoroacetate",18.9,uM,=,1.276461804173244,1,C1=[N+]2CCc3cc4c(cc3[C@@H]2Cc2c1ccc1c2COCO1)OCO4
5925,2264475,10.1039/d1md00394a,,,,Inhibition of recombinant human AchE using acetylthiocholine iodide as substrate and measured upto 2 mins by Ellman's method,COc1ccc2c(=O)cc(C(=O)NCCN3CCCCC3)oc2c1,Diaportheone A1,0.09,uM,=,-1.0457574905606752,0,O=C(NCCN1CCCCC1)c1cc(=O)c2ccccc2o1
